"infect total joint replac small number infect total joint replac blood born distant sourc infect deriv oper strenuous attempt reduc risk clean air wound environ coupl prophylact antibiot reduc infect rate order magnitud decad time potenti exchang arthroplasti establish infect shown result encourag rigor infect control key difficult expens problem"
"analysi immun respons lipopolysaccharid exist interspeci crossreact idiotyp antilipid antibodi lps major surfac glycolipid gramneg bacteria work idiotyp character antibodi respons lps speci produc mab lps bind antibodi lps inhibit lps lipid indic monoclon specif lipid toxic moieti lps molecul antilipid antibodi ic prove protect gramneg bacteremia endotox shock murin protect model generat antiidiotyp antibodi ic bind antiid ic specif inhibit lipid antiid character antilp respons result reveal ic id conserv speci import interspeci crossreact id respons endotoxin relev vaccin develop septic shock discuss"
"platelet activ factor paf tumor necrosi factoralpha tnf alpha interact endotoxem shock studi bn paf antagonist bn paf receptor antagonist test vitro vivo capac block paf endotoxin recombin human tumor necrosi factoralpha rtnfmediat effect vitro bn block pafinduc platelet aggreg conscious rat pretreat min bn dosedepend attenu pafinduc hypotens mm hg shorten recoveri time arteri pressur sec bn mgkg prevent endotoxin mgkg inducedhemoconcentr reduc hr mortal  partial protect convey bn hypotens respons endotoxin mm hg bn attenu lipopolysaccharideinduc elev plasma thromboxan pg microlit tumor necrosi factoralpha ml leukopenia thrombocytopenia remain unchang"
"direct cost univers precaut teach hospit analysi increas expenditur barrier isol materi institut univers precaut bed univers hospit generat nation estim cost implement center diseas control guidelin institut univers precaut rubber glove hospit increas million pair million pair annual year review hospit purchas suppli record inpati outpati area total annual cost isol materi increas repres increas admiss adjust inflat cost isol materi increas outpati visit adjust increas increas due rubber glove addit due dispos isol gown univers precaut estim cost million unit state fiscal year adjust inflat expenditur isol materi medic center repres previous estim signific underestim cost nationwid"
"epidemiolog clinic laboratori find human ehrlichiosi unit state center diseas control oklahoma state depart health identifi patient fourfold greater chang antibodi titer respons ehrlichia cani median age patient year male ill juli report recent exposur tick patient resid expos tick state includ ehrlichiosi report thirti patient hospit complic includ acut respiratori failur patient encephalopathi patient acut renal failur patient pulmonari infiltr demonstr patient cerebrospin fluid pleocytosi patient elev level serum creatinin demonstr patient patient preexist medic problem die nonhospit patient receiv tetracyclin therapi earlier ill hospit patient signific differ interv initi antibiot therapi day defervesc patient treat tetracyclin treat chloramphenicol"
"ecolog life cycl infecti propagul cryptococcus neoforman cryptococcus neoforman biotroph smut fungus epidemiolog cryptococcosi explain exposur infect aerosolis inoculum neoforman var gattii postul princip infecti propagul basidiospor exposur eucalyptus camaldulensi host tree requir initi infect man anim neoforman var gattii export australia infect seed camaldulensi dormant dikaryot mycelium fungus neoforman var neoforman basidiospor desicc encapsul yeast cell postul act infecti propagul basidiospor show season distribut associ unidentifi host plant encapsul yeast cell dispers accumul dri bird pigeon drop act yearround vector"
"borrelia burgdorferi infect brain character organ respons antibiot immun sera mous model learn neurolog involv lyme diseas inocul inbr mice causat agent lyme diseas borrelia burgdorferi cultur brain organ measur anti burgdorferi antibodi titer studi brain isol plasmid dna content respons vitro immun sera antibiot strain burgdorferi consist infect mice result chronic infect bladder spleen sjl mice develop fewer cultureposit organ lower antibodi titer balb cbl mice organ cultur brain earli infect isol nbr studi vitro plasmid content nbr infect strain impli high select process infect dna rearrang organ vivo nbr sensit antibiot prolong incub immun sera mice human infect burgdorferi unabl complet kill organ complementmedi cytotox data demonstr burgdorferi infect brain experiment anim resist immun sera vitro sensit prolong treatment antibiot"
"cefazolin hysterectomi prophylaxi efficaci data singledos cefazolin prophylaxi hysterectomi meager evalu impact rout administr efficaci reason women undergo elect abdomin vagin hysterectomi benign diseas cefazolin intramuscular intraven random clinic trial preoper diagnos clinic surgic outcom variabl similar rout administr surgic approach risk factor infect abdomin hysterectomi includ younger age lower postop hemoglobin concentr pelvic hematoma women develop infect vagin hysterectomi heavier remain uninfect pelvic hematoma incid major oper site infect requir parenter antimicrobi therapi evalu women women undergo abdomin hysterectomi women undergo vagin hysterectomi postop infect unrel rout cefazolin administr"
"safeti immunogen haemophilus influenza type oligosaccharidecrm conjug vaccin infant age month total infant age month receiv dose vaccin compos haemophilus influenza type oligosaccharid coval link nontox diphtheria toxin variant crm hboc hibtit side effect vaccin infrequ transient mild month singl vaccin anti influenza type capsular polysaccharid antibodi concentr rose geometr prevaccin level microgramml microgramsml infant postvaccin level greater equal microgramml level longterm protect immun respons longliv children monitor month vaccin concentr greater equal microgramml anti influenza type capsular polysaccharid antibodi generat predomin igg isotyp igg subclass immun sera bactericid activ vitro confer passiv protect infant rat mening model"
"poor complianc univers precaut univers phenomenon anonym survey conduct order examin complianc univers precaut depart pediatr loyola univers medic center maywood illinoi complet questionnair return faculti member resid medic student glove worn consist venipunctur intraven catheter attend physician resid student physician wear glove occasion cite presenc highrisk factor select criterion interfer perform procedur common noncompli view poor complianc univers precaut effort order decreas incid prevent exposur bloodborn infect"
"studi assess efficaci chemoprophylaxi prevent endoscopyrel bacteraemia patient age hundr fifteen patient age age men women underw routin endoscop procedur gastroscopi bronchoscopi cystoscopi altern patient antibiot procedur recommend blood cultur patient minut complet procedur patient underw bronchoscopi cultur control posit underw gastroscopi cultur negat receiv antibiot posit control cent cystoscopi perform cultur posit antibiot cent compar control cent bacteraemia rate low bronchoscopi cent higher gastroscopi cent cystoscopi cent chemoprophylaxi effect reduc rate patient group"
"health issu mexican border rapid grow popul increas manufactur activ increas interdepend health issu mexican border demand greater attent border world separ nation varieti health status entitl util binat initi area environment health sanit cooper unit state mexico provis health servic warrant requir enhanc feder fund subsidi success"
"breast milk neonat necrotis enterocol prospect multicentr studi preterm infant formal assign earli diet necrotis enterocol develop mortal stringent confirm case exclus formulaf babi confirm diseas time common fed breast milk time common receiv formula breast milk pasteuris donor milk protect raw matern milk babi born week gestat confirm necrotis enterocol rare diet includ breast milk time common fed formula risk factor includ low gestat age respiratori diseas umbil arteri catheteris polycythaemia formulaf breastmilkf infant delay enter feed lower frequenc necrotis enterocol fall breast milk british neonat unit exclus formula feed account estim extra case necrotis enterocol year infant die"
"lipid infus increas oxygen consumpt similar septic nonsept patient investig compar metabol effect lipid infus septic nonsept patient oxygen consumpt determin indirect calorimetri rest intralipid infus ml kjmin kcalmin septic patient rest metabol rate higher nonsept control subject signific rise oxygen uptak measur group subject infus lipid preinfus respiratori quotient rq higher septic patient infus period rq decreas similar approxim group plasma catecholamin elev septic patient preinfus concentr remain unalt infus norepinephrin rose signific nonsept group lipid infus result show sepsi influenc characterist rise metabol rate occur intraven lipid"
"methicillinresist staphylococc colon infect longterm care facil object determin natur histori colon methicillinresist staphylococcus aureus mrsa patient longterm care facil specif sought determin mrsa colon predict subsequ infect design cohort studi set longterm veteran affair medic center patient total patient resid unit regular surveil cultur anterior nare main outcom measur develop staphylococc infect result thirti patient persist carrier mrsa persist carrier methicillinsuscept strain mssa twenti percent mrsa carrier episod staphylococc infect compar mssa carrier carrier relat risk ci rate develop infect mrsa carrier day carriag logist regress analysi persist mrsa carriag signific predictor infect odd ratio seventi percent mrsa infect occur mrsa carrier isol mrsa patient type colon infect strain phage type patient pattern plasmid ecori restrict endonucleas fragment patient conclus colon anterior nare mrsa predict develop staphylococc infect longterm care patient infect aris endogen carri strain colon mrsa signific greater risk infect colon mssa result offer theoret rational reduct mrsa infect intervent aim elimin carrier state"
"primari dapsoneresist hansen diseas california experi mycobacterium lepra isol found year previous untreat patient hansen diseas found harbor dapsoneresist mycobacterium lepra singl strain partial resist resist dapson mous diet higher concentr year lepra previous untreat patient present clinic san francisco calif los angel calif grew mice strain found dapson resist lepra isol obtain skin biopsi specimen patient leprosi found resist dapson conclud primari dapson resist signific problem california owe fact singl resist case report intern sourc general partial resist potenti import partial dapson resist discuss"
"hepat abscess etiolog diagnosi manag recent review pyogen hepat abscess emphas percutan versus open surgic manag devot time studi etiolog clinic condit patient studi detail review perform computer analysi multipl clinic paramet patient treat pyogen hepat abscess year period age patient year male mortal rate compar solitari multipl abscess likelihood death higher antibiot treatment percutan treatment surgic treatment primari determin outcom diseas malign immunocompromis patient solitari versus multipl abscess addit incid hepat abscess center doubl half half review reflect popul sever ill patient appar current clinic practic method manag effect choic therapi determin individu select principl time diagnosi prompt institut treatment specif patient remain standard care potenti grave diseas"
"staphylococcus aureus infect human endotheli cell potenti fc receptor express vascul recogn complic staphylococcalendovascular infect result part express fcr staphylococcus aureusinfect endotheli cell fcr measur cr label srbc preincub rabbit antisrbc igg fcr detect uninfect endotheli cell demonstr aureus infect cell igg igm label srbc fcr express depend initi bacteri densiti greater equal cfuml phagocytosi staphylococci protein synthesi igg label srbc bind block aggreg igg igm srbc coat ab portion igg bind confirm fcr specif involv interact fcr express aureus invas human endotheli cell contribut vascul accompani aureusendovascular infect"
"immun mice antibiotictr escherichia coli result enhanc protect challeng homolog heterolog bacteria murin immun respons escherichia coli expos subminim inhibitori concentr antibiot investig group mice inject week formalinkil bacteria subsequ challeng ld viabl coli mice receiv salin control die mortal mice immun ciprofloxacintr coli signific lower mice immun coli untreat treat antibiot sera mice immun ciprofloxacintr bacteria show bacteriostat capac enhanc product antibodi bound homolog heterolog lipopolysaccharid isol smooth rough gramneg strain protect observ mice immun ciprofloxacintr coli due enhanc product antibodi epitop lipopolysaccharid expos access treatment ciprofloxacin"
"instil vancomycin cerebrospin fluid reservoir clear infect pharmacokinet vancomycin instil ommaya reservoir treat reservoir infect vancomycin concentr cerebrospin fluid csf measur deriv pharmacokinet paramet tailor dose order kinet observ calcul halflif report appar volum distribut ml anticip elimin constant empir dose base schedul suggest literatur led high peak low concentr intrareservoir vancomycin patient reservoir infect varieti pathophysiolog condit result alter normal csf dynam pharmacokinet analysi individu dose optim therapi intrareservoir vancomycin"
"contamin blood cultur resourc util true consequ falseposit result determin contamin blood cultur increas resourc util studi charg length stay data episod blood cultur obtain hospit adult compar negat episod falseposit episod increas subsequ length stay median day subsequ total charg median pharmaci charg median laboratori charg median multivari analys contamin independ correl increas total subsequ laboratori charg intraven antibiot charg true cost contamin great exceed test identifi patient low risk bacteremia attent steril techniqu reduc cost decreas frequenc contamin"
"fluconazol triazol antifung agent fluconazol fluorinesubstitut bistriazol antifung agent mechan action azol involv interrupt convers lanosterol ergosterol bind fungal cytochrom subsequ disrupt fungal membran activ aspergillus spp blastomyc dermatitidi candida spp coccidioid immiti cryptococcus neoforman histoplasma capsulatum paracoccidioid brasiliensi demonstr anim model fluconazol administ oral intraven peak serum concentr achiev human volunt mg oral mumol protein bind low percent cerebrospin fluid serum ratio serum halflif long hour elimin renal clearanc unchang drug clinic trial report support fluconazol treatment candidiasi oropharyng esophag infect immunocompromis host fluconazol approv initi suppress therapi cryptococc mening role manag system fungal infect defin result compar trial fluconazol toler effect steroidogenesi mark ketoconazol antipyrin clearanc alter low dose mg fluconazol drug interact larger dose anticip agent cyclosporin phenytoin oral hypoglycem warfarin rifampin decreas metabol clearanc fluconazol fluconazol oral parenter formul daili dose mg recommend dosag reduct advis patient impair renal function"
"transmiss toxic strep syndrom infect child firefight cpr case toxic shocklik syndrom report unit state past year associ streptococcus pyogen infect report case firefight expos attempt cpr secret pyogenesinfect child firefight develop infect hand subsequ febril ill hypotens erythemat rash renal failur hypocalcemia bacteri isol blood cerebrospin fluid deceas child ident type exotoxin product isol grown hand wound firefight report case document transmiss pyogen caus toxic shocklik syndrom emerg medic technician"
"audit major colorect biliari surgeri reduc rate wound infect object reduc rate wound infect major colorect biliari surgeri designprospect audit antibiot prophylaxi copi type note oper annot discharg follow visit annual review prophylact regimen year rate wound infect modif set work consult surgeon work district general hospit patient patient major colorect resect cholecystectomi main outcom measureswound infect defin discharg wound detect observ inpati stay specif question follow visit week resultsseri prophylaxi colorect surgeri result progress reduct rate wound infect prophylaxi singl intraven dose metronidazol cefuroxim intraop lavag periton caviti wound tetracyclin prophylaxi rate infect biliari surgeri introduct lavag tetracyclin rate reduc implic actionsimpl prospect audit identifi antibiot prophylaxi success round audit result improv rate wound infect lavag tetracyclin major factor achiev"
"behavior pulmonari circul rest exercis miliari tuberculosi studi hemodynam behavior pulmonari circul rest exercis patient mtb group contrast advanc fibrocas tuberculosi patient exhibit normal pulmonari hemodynam rest exercis minor abnorm pulmonari vascular resist exercis increas padpwp gradient note patient increas rp exercis relat acut hypox vasoconstruct function complianc recruit pulmonari microvasculatur genesi function chronic alveolar hypoxia inflammatoryfibrot process interact"
"rabbit skelet muscl po hypodynam sepsi measur skelet muscl tissu po pto anesthet rabbit infus intraven bolus coli endotoxin array surfac po microelectrod hindlimb bicep femori muscl suffici read obtain construct pto histogram histogram standard deviat character microcirculatori maldistribut system consumpt vo measur expir gas method cardiac output system transport calcul sampl arteri atrial ra hindlimb venous blood cathet infraren portion vena cava simultan obtain measur blood gase satur administr endotoxin decreas approxim percent vo initi decreas percent return baselin level minut endotoxin administr system extract ratio ero voto increas hindlimb ero increas arithmet pto histogram decreas endotoxin infus mm hg plo remain baselin level mm hg ns standard deviat pto histogram remain constant experi find support notion skelet muscl microcirculatori heterogen increas endotoxin induc hypodynam sepsi"
"enhanc antibiot concentr gastric mucosa hreceptor antagonist implic treatment helicobact pylori infect measur effect cimetidin antibiot concentr lumin portion gastric mucosa guinea pig premed cimetidin mgkg intramuscular clindamycin antibiot previous character physiolog ph condit administ intramuscular level measur serum tissu highpressur liquid chromatographi hplc techniqu lumin mucosa concentr clindamycin hr ph fivefold greater compar concentr physiolog ph condit microgram microgram fold greater hr microgram microgram differ peak serum level group find antibiot characterist base affect nonconserv acid inhibitor cimetidin support presenc acid storag pool propos investig hreceptor antagonist therapeut adjunct pylori infect virtu increas gastric concentr antibiot behav weak base"
"computergener physician patient remind tool improv popul adher select prevent servic emerg consensus prevent servic minor patient receiv studi undertaken assess impact computergener remind adult patient physician patient physician adher recommend prevent servic cholesterol measur fecal occult blood test mammographi papanicolaou smear tetanus immun academ year adult patient physician univers famili medicin clinic practic random practic group studi group control physician remind patient remind physician patient remind adher defin communityori term percentag patient group receiv prevent servic recommend interv studi period adher prevent servic increas signific largest increas physician patient remind group cholesterol measur increas fecal occult blood test mammographi tetanus immun increas mcnemar chisquar test general increas greater black patient form insur coverag computerbas physician patient remind system great promis improv adher prevent servic primari care set"
"personperson transmiss brucella melitensi human brucellosi primarili occup hazard usa middl east africa ingest contamin dairi product import rout infect human infect personperson spread uncertain investig commonsourc laboratori outbreak due brucella melitensi biotyp wife microbiologist serolog proven brucellosi infect blood isol indistinguish epidem strain absenc risk factor suggest sexual intercours transmiss"
"util collect blood cultur newli insert intraven cathet prospect examin util obtain blood cultur newli insert intraven cathet children requir blood cultur placement intraven cathet blood cultur collect patient fresh insert intraven cathet butterfli needl separ venipunctur site standard techniqu skin prepar povidoneiodin rate contamin confid interv method ten patient blood cultur yield true pathogen bacterem children set blood cultur posit conclud blood cultur collect fresh intraven cathet increas risk contamin result rais possibl obtain blood cultur singl cultur improv detect bacteremia children"
"syphili visit enemi syphili number stage includ latent overlook misdiagnos possibl mind adequ treatment primari stage result high cure rate latent stage year time woman give birth infect child symptomat neurosyphili occur men women penicillin prefer treat stage diseas antibiot patient sensit penicillin"
"metabol patient sever affect tetanus metabol sever affect tetanus patient suffer characterist labil hypertens maximum systol blood pressur greater mmhg maximum diurnal chang systol pressur greater mmhg investig daili urinari excret urea nitrogen increas gradual onset opisthotonus reach peak day decreas subsequ averag cumul excret day reach urin catecholamin excret elev patient remain elev period plasma cortisol glucagon concentr increas mark case complic system bacteri infect increas protein catabol patient explain metabol effect stress hormon neurolog factor consid"
"technetiummhuman polyclon igg radiolabel hydrazino nicotinamid deriv imag focal site infect rat biolog behavior human polyclon immunoglobulin igg radiolabel technetiumm mtc method nicotinyl hydrazin deriv evalu rat technetiumm indiumigg administ normal rat biodistribut determin hr inflamm imag properti reagent compar rat deepthigh infect due escherichia coli blood clearanc antibodi prepar biexponenti function mtcigg hr inigg hr biodistribut solid organ similar small statist signific differ detect mtcigg greater inigg lung liver spleen mtcigg inigg kidney skelet muscl imag time targetbackground ratio percent residu activ compound remark similar studi establish human polyclon igg label mtc nicotinyl hydrazin modifi intermedi equival inigg imag focal site infect experiment anim"
"modern chemotherapi brucellosi human effect toxic chemotherapi human brucellosi undecid vitro antibiot activ brucella includ tetracyclin aminoglycosid aminopenicillin cephalosporin trimethoprimsulfamethoxazol erythromycin rifampin fluorin quinolon brucella speci facult intracellular parasit penetr drug phagocyt phagosom problemat studi experiment anim tissu cultur human effect regimen chemotherapi compar acut bacterem infect assess control symptom bacteremia complic relaps standard therapi therapi judg combin tetracyclin streptomycin univers effect fail prevent relaps case combin oral doxycyclin rifampin conveni popular high effect averag relaps rate trimethoprimsulfamethoxazol effect control bacteremia manifest collect seri case respond relaps drugresist brucella strain rare therapi failur local brucellosi pose special problem requir surgeri addit prolong combin chemotherapi"
"absenc bacteremia nasal septoplasti episod staphylococc bacteremia result metastat infect occur associ nasal septoplasti suggest antimicrobi prophylaxi studi design measur actual frequenc transient staphylococc bacteremia occur nasal septoplasti healthi patient blood cultur drawn immedi prior procedur patient studi nasal mucosa colon staphylococcus aureus blood cultur obtain patient show bacteri growth author conclud staphylococc bacteremia nasal septoplasti rare occurr antimicrobi prophylaxi unnecessari"
"correl gross microscop skin button total artifici heart anim pneumat artifici heart power compress air deliv percutan tube stress relief devic term skin button surround tube exit recipi tissu skin button design protect tissu damag provid secur materialtissu interfac prevent superfici invas infect primari goal skin button calv studi prospect identifi gross microscop infect skin button anim surviv sixti day gross microscop evid infect anim surviv day gross evid infect subcutan microscop abscess format anim die secondari skin button infect skin button prevent infect patholog process superfici tissu evid system effect"
"effect serotyp ureaplasma urealyticum spermatozo motil penetr vitro publish erratum fertil steril jun effect incub spermatozoa serotyp ureaplasma urealyticum spermatozo motil penetr vitro investig computerassist video microscopi paramet motil determin individu path length individu vectori distanc percentag motil polyacrylamid gel medium assess spermatozo penetr ureaplasmainfect spermatozoa signific greater path length individu distanc uninfect control ureaplasma infect signific effect percentag motil signific differ penetr distanc ureaplasmainfect spermatozoa uninfect control conclus ureaplasma advers affect motil penetr spermatozoa incub ureaplasma minut ureaplasmasperm ratio high"
"tumor necrosi factorindepend il product murin listeriosi report tnf il ifnalphabeta produc mice subleth lethal listeria monocytogen infect quantiti cytokin infect spleen increas decreas concord bacteri number organ cytokin present listeriainfect spleen il ifnalphabeta found peripher circul tnf report respons product il vivo inocul lethal dose gramneg bacterium escherichia coli fong al  exp med experi undertaken determin il product elicit gramposit bacterium monocytogen tnfdepend found passiv immun mice neutral antibodi specif tnf short inject lethal subleth listeria inoculum result complet neutral endogen produc tnf progress multipl bacteria infect organ found antitnf igg treatment result progress increas amount listeriainduc il present spleen blood death host find listeriainduc il product mice occur primarili tnfindepend pathway correl direct sever infect"
"lymphoprolif respons borrelia burgdorferi lyme diseas object compar lymphocyt prolif respons borrelia burgdorferi healthi control patient lyme diseas patient twelv patient fulfil casedefinit criteria lyme diseas twelv healthi volunt newborn serv control measur antibodi burgdorferi measur enzymelink immunosorb assay elisa prolifer peripher blood lymphocyt cultur day burgdorferi recal antigen pokewe mitogen measur radioact thymidin uptak result lymphocyt patient lyme diseas healthi seroneg control newborn show elev respons stimul burgdorferi patient control studi day patient lymphocyt respons burgdorferi exceed control case lymphocyt patient control respond burgdorferi isol sourc conclus heighten lymphocyt respons burgdorferi found patient lyme diseas elev respons frequent occur healthi control present interpret posit lymphocyt respons burgdorferi difficult ambigu clinic situat"
"effect steroid cerebrospin fluid penetr antitubercul drug tubercul mening sixteen patient oral isoniazid pyrazinamid rifampin intramuscular streptomycin tubercul mening studi concentr isoniazid pyrazinamid rifampin streptomycin cerebrospin fluid csf obtain hour administr microgramsml csf concentr isoniazid pyrazinamid minimum inhibitori concentr mycobacterium tuberculosi concentr rifampin streptomycin minim inhibitori concentr initi declin minim inhibitori concentr time csf penetr isoniazid pyrazinamid rifampin streptomycin patient receiv antitubercul drug combin steroid csf serum concentr csfserum ratio interv treatment statist greater patient receiv steroid"
"endothelin immunoreact mice gramneg bacteraemia relationship tumour necrosi factoralpha  investig role endothelin gramneg bacteraemia involv tumour necrosi factoralpha pathophysiolog measur plasma tissu lung kidney spleen immunoreact endothelin level gramneg bacteraem mice passiv immun antitumour necrosi factoralpha antibodi  plasma immunoreact endothelin level great increas escherichia coli inject pretreat antitumour necrosi factoralpha antibodi suppress elev plasma immunoreact endothelin level greater  lung tissu immunoreact endothelin level mice increas coli inject affect prior passiv immun antitumour necrosi factoralpha antibodi immunoreact endothelin spleen kidney undetect fmol wet weight  inject rmu tumour necrosi factoralpha mice increas plasma immunoreact endothelin level  antibodi endothelin min lethal dose challeng coli affect mortal  conclud rise plasma tissu endothelin occur gramneg bacteraemia independ tumour necrosi factoralpha"
"invas assess cardiovascular eicosanoid thromboxan prostacyclin random sampl male special refer influenc inherit environment factor  studi random sampl nonsmok men born men born inherit environment factor influenc platelet activ vessel wall prostacyclin format reflect invas urinari excret dinormetabolit thromboxan dinorthromboxan tx prostacyclin dinorketoprostaglandin alpha pgi  father young men high platelet activ excret tx father young men low platelet activ men born display higher tx versus pgmg creatinin pgi versus pgmg creatinin excret born excret tx pgi correl urinari output noradrenalin adrenalin  train subject differ excret tx pgi exercis regular recent acut infect unrel excret tx pgi pgi excret signific correl tx excret  studi invas evid advanc age sympathoadren tone posit correl platelet activ random sampl men patern inherit physic fit recent infect lack correl platelet activ"
"malassezia furfur fungemia central venous cathet lipid emuls infus malassezia furfur fungemia infant prolong intraven lipid emuls aliment case furfur fungemia report literatur involv neonat requir cathet remov cure  furfur underreport problem neonat adult central venous cathet receiv lipid emuls organ requir select enrich media growth sabouraud dextros agar steril oliv oil overlay case report furfur fungemia neonat uniqu neonat recov discontinu lipid emuls remov central venous cathet"
"comparison function activ igg igm classswitch human monoclon antibodi reactiv group streptococci escherichia coli influenc valenc heavi chain antibodi activ investig transfectomaderiv classswitch igg igm human monoclon antibodi mab reactiv bacteri pathogen escherichia coli group streptococcus speci iggigm pair compar vitro antigen bind opson activ vivo protect efficaci neonat rat anti coli pair igm mab fold potent assay format import protect dose pd igm mab ngrat microgram igg mab minim protect group streptococc mab igm fold potent bind opson assay microgram igm protect neonat rat microgram igg mab part protect experi demonstr util recombin dna technolog creat panel antibodi aid select potenti immunotherapeut candid"
"macrophag oxidantmedi inhibit abil live blastomyc dermatitidi conidia transform pathogen yeast phase implic pathogenesi dimorph fungal infect conidia produc myceli phase dimorph fungi thought repres infecti form organ complet transit tissueinvas yeast phase infect ensu prevent transit effect elimin pathogen blastomyc dermatitidi target murin bronchoalveolar macrophag preferenti block phase transit incub conidia spare abil conidia produc hypha ho high concentr demonstr activ effect ho irrevers hotreat conidia germin degre unabl produc yeast day incub degre catalas revers macrophageinduc inhibit phase transit suggest nonoxid defens mechan oper vivo conidia form mycelia temperatur found mammalian host effect repres host defens mechan dimorph fungal pathogen"
"serovar chlamydia trachomati da ia la chlamydia trachomati serovar identifi monoclon antibodi microimmunofluoresc test propos call da ia la distinguish relat serovar date isol respect serovar identifi distribut worldwid find meet previous establish criteria establish serovar"
"molecular epidemiolog techniqu analysi epidem endem shigella dysenteria type strain number shigella dysenteria type infect report unit state increas fivefold determin recent isol mexico relat caus epidem dysenteri worldwid southern hybrid analysi shiga toxin ribosom rna gene probe western hemispher eastern hemispher strain differ size singl ecori fragment carri shiga toxin gene ribosom dna rdna pattern observ correl strain continent origin isol test shiga toxin rdna probe result recent mexican isol chromosom similar earlier central american isol distinct asian african strain suggest signific exchang organ contin recent decad outbreak mexico caus strain present central america"
"combin releas protein lipopolysaccharid enzymelink immunosorb assay serolog screen yersinia infect elisa screen serum antibodi yersinia speci develop plasmidencod releas protein yersinia enterocolitica lipopolysaccharid enterocolitica combin antigen sera patient infect yersinia serotyp posit assay test serotypespecif elisa yersinia bacteria antigen posit screen elisa detect antibodi virul yersinia assay offer possibl diagnosi infect caus yersinia serotyp occasion includ serotypespecif elisa elisa offer substanti advantag save time money routin laboratori work"
"indiumlabel leukocyt scan detect synthet vascular graft infect effect antibiot treatment determin sensit specif indiumin label leukocyt scan prosthet vascular graft infect patient treat antibiot therapi retrospect studi perform consecut inlabel leukocyt scan perform evalu vascular graft infect scan perform patient treat antibiot averag durat antibiot therapi day twelv posit negat scan graft infect found surgic autopsi correl posit case clinic correl negat case trueposit trueneg falseposit falseneg scan graft infect sensit specif"
"treatment gramneg bacteremia septic shock haa human monoclon antibodi endotoxin random doubleblind placebocontrol trial haa sepsi studi group background haa human monoclon igm antibodi bind specif lipid domain endotoxin prevent death laboratori anim gramneg bacteremia endotoxemia method evalu efficaci safeti haa conduct random doubleblind trial patient sepsi presum diagnosi gramneg infect patient receiv singl mg intraven dose haa albumin placebo albumin intervent includ administr antibiot fluid affect studi protocol result patient sepsi treat percent gramneg bacteremia prove blood cultur patient gramneg bacteremia death day death recipi placebo percent death recipi haa percent patient gramneg bacteremia shock entri death recipi placebo percent death recipi haa percent analys stratifi sever ill entri show improv surviv haa treatment sever ill sever ill patient patient gramneg bacteremia hospit discharg death placebo percent discharg aliv compar treat haa percent benefit treatment haa demonstr patient sepsi prove gramneg bacteremia patient sepsi treat mortal rate percent recipi placebo percent haa patient toler haa antihaa antibodi detect conclus haa safe effect treatment patient sepsi gramneg bacteremia"
"evalu rapid group streptococc antigen test labor deliveri patient rapid group streptococc antigen test compar nonselect blood agar cultur unselect patient admit labor deliveri vagin specimen patient admiss perform rapid test cultur rapid test streptex latex agglutin assay equat strep test solidphas immunoassay patient posit cultur sensit rapid test streptex equat specif sensit minim increas set ruptur membran test likewis separ swab streak cultur plate perform rapid test increas sensit signific test control experi limit sensit rapid test colonyform unit conclud present test sensit routin type clinic set"
"pediatr risk mortal score predict nosocomi infect pediatr intens care unit object defin infect rate patient pediatr risk mortal prism score greater admiss pediatr icu picu design descript set bed picu admit patient age nonsurg neonat bed tertiari care pediatr hospit patient patient admit picu juli februari inclus admit greater equal hr method baselin state patient admiss determin design intensivist prism score variabl includ age length stay hospit day onset infect infect identifi design intensivist undertook prospect daili bedsid observ chart radiograph laboratori review measur main result equal portion patient prism score greater signific infect occur high prism popul  associ held age servic length stay sensit specif posit negat predict valu prism score greater bacteremia account infect skineyedrain site respiratori wound urin preval organ coagulaseneg staphylococci pseudomona aeruginosa candida sp  aureus conclus prism score greater picu admiss character popul picu increas risk infect patient develop infect negat predict yield addit inform"
"system muscl oxygen uptakedeliveri dopexamin infus endotox dog background method studi design test dopexamin dopaminerg beta adrenerg agonist increas system oxygen deliveri endotox dog interfer abil rest skelet muscl extract oxygen treatment group group control endotoxin mgkg iv endotoxin dopexamin microgramskgmin data analyz group splitplot analysi varianc signific identifi differ test post hoc duncan multipl rang test donor rbc dextran endotoxin maintain adequ perfus pressur hct blood flow left hindlimb muscl decreas control step min stabil result group cardiac output qt arteri pressur map system oxygen uptak vo decreas blood volum expans group similar volum expans dopexamin maintain qt system vo control level map system vascular resist reduc comparison control subject endotoxin increas critic isol limb muscl mlkgmin decreas critic oxygen extract pressureflow relationship limb flatten indic loss vascular reactiv group chang pressureflow curv critic oxygen extract level conclus dopexamin provid hemodynam support endotox dog increas total vo alter oxygen extract muscl"
"gramneg infect increas noninsulinmedi glucos dispos peripher glucos uptak occur insulin noninsulinmedi mechan pathway regul independ euglycem hyperinsulinem clamp techniqu previous demonstr sepsi induc bodi insulin resist purpos present studi determin infect alter noninsulinmedi glucos uptak nimgu tissu affect studi perform chronic catheter conscious rat basal mm glucos microuml insulin insulinopen condit determin nimgu hypermetabol sepsi induc sc inject live escherichia coli tracer amount cdeoxyglucos inject determin vivo glucos metabol rate rg select tissu result nimgu predomin rout glucos dispos septic nonsept rat account total rate glucos dispos rate bodi glucos dispos increas sepsi absolut rate nimgu higher septic rat nonsept anim increas result elev rg liver spleen ileum lung sepsi increas bodi insulinmedi glucos uptak basal condit due enhanc glucos uptak muscl skin insulinopen anim plasma glucos concentr elev mm bodi glucos dispos increas nonsept anim septic rat hyperglycemicinduc increment organ rg smaller tissu examin septic anim absolut rate bodi tissu glucos util group result gramneg infect increas bodi nimgu result enhanc rate glucos util tissu rich mononuclear phagocyt includ liver spleen ileum lung muscl"
"terconazol treatment vulvovagin candidiasi doubleblind random trial conduct evalu efficaci safeti terconazol vulvovagin candidiasi treatment consist daili intravagin applic regimen mg terconazol suppositori day miconazol nitrat suppositori day placebo suppositori day terconazol miconazol nitrat group signific higher therapeut cure rate placebo group evalu vagin secret microscop examin show evid leukocyt prolifer prolin aminopeptidas activ present patient bacteri vaginosi detect vagin secret patient yeast vulvovagin"
"challeng prophylaxi cesarean section physician evalu role antibiot prevent periop infect drug discov determin antibiot prevent staphylococc wound infect anim model surgeon prophylaxi improv techniqu isol identifi anaerob microorgan unaccept high incid infectionrel complic convinc obstetrician studi ultim accept periop antibiot administr prevent infect recent progress includ refin guidelin patient select drug regimen singl dose antibiot patient undergo primari cesarean section demonstr effect prophylaxi administ clamp umbil cord practic wide accept discoveri cephamycin role broadspectrum antibiot obstetr gynecolog surgeri investig studi compar efficaci cefmetazol cefotetan prevent postcesarean section infect eighteen patient group receiv dose drug umbil cord clamp predetermin elev temperatur evalu presenc ensu infect subject group develop type morbid postop complic includ wound infect endometr bladder infect cellul cefmetazol cefotetan equal effect prevent postcesarean section infect"
"cefmetazol cefonicid compar efficaci safeti prevent postop infect vagin abdomin hysterectomi singl dose cefmetazol compar singl dose cefonicid prophylaxi vagin abdomin hysterectomi determin efficaci safeti antibiot administ intramuscular minut incis made cefmetazol cefonicid similar activ aerob organ recov cefmetazol signific activ anaerob gramneg microorgan pattern regrowth vagin flora similar treatment group patient demograph characterist surgic procedur similar group differ primari prophylact failur cuff cellul studi drug cefmetazol cefonicid reach statist signific result similar rout hysterectomi cefmetazol dose intramuscular preoper safe effect agent prophylaxi hysterectomi"
"differenti white blood cell count screen group streptococc sepsi compar previous defin score system white blood cell indic part retrospect evalu infant earli onset group streptococc gbs sepsi nineteen newborn diagnos gbs sepsi januari april case control select patient admit neonat intens care unit suspect sepsi complet blood count obtain admiss hour age review signific chang ratio immatur total neutrophil gbs group time score system neonat sepsi manro al rodwel al spector al poor sensit specif posit predict negat predict initi white blood cell count criteria score system manro rodwel sensit negat predict appli repeat white blood cell count conclud singl earli complet blood count adequ screen tool earli onset gbs sepsi rule infect optim screen gbs sepsi requir repeat complet blood count hour age"
"cytokin glucocorticoid regul hepatoskelet muscl axi sepsi sepsi result muscl catabol peripher releas amino acid concomit uptak amino acid liver acutephas protein synthesi addit cytokineinduc process block muscl amino acid uptak sepsi divert amino acid peripheri liver articl evid cytokin glucocorticoid play import role regul hepat muscl protein metabol sepsi present"
"outbreak tuberculosi shelter homeless men descript evolut control outbreak tuberculosi shelter homeless men studi detail understand epidemiolog tuberculosi set shelter accommod men age yr older capac approxim client client pool approxim menyr wk period decemb januari case tuberculosi diagnos shelter client case report client preced month case year previous major outbreak case pulmonari tuberculosi sputum smear posit drug resist rare phage type mycobacterium tuberculosi isol reveal predomin type type goal control plan step achiev render infecti case noninfecti direct observ therapi find undiagnos infecti case repetit mass screen protect expos client repetit tuberculin skin test isoniazid prevent therapi make shelter environ safe exclud infecti noncompli client improv shelter ventil system implement plan rapid termin outbreak mass screen januari asymptomat case detect addit case occur shelter client yr period follow investig suggest outbreak evolv result presenc shelter increas number men undiagnos infecti pulmonari tuberculosi"
"role prophylact antibiot uncontamin neck dissect periop prophylact antibiot uncontamin head neck surgeri remain controversi perform retrospect analysi patient undergo uncontamin neck dissect wound infect develop patient receiv antibiot patient receiv antibiot develop infect differ statist signific correl flap length surgeri prior radiat treatment postop complic rate wound infect differ statist signific variabl beta error greater data demonstr efficaci prophylact antibiot uncontamin neck dissect statist signific trend exist suggest"
"helicobact pylori infect rate relat age social class popul welsh men seropreval igg antibodi helicobact pylori determin standard enzym link immunosorb assay popul random select men age year caerphilli south wale preval pylori increas sharpli middl age age age older age standardis seropreval rate lowest combin social class categori ii intermedi categori iiin highest categori iv age year preval rate combin social class categori iv doubl rate social class categori iiim time preval rate social class categori ii differ infect pattern pylori social class consist pattern peptic ulcer diseas gastric cancer"
"urinari nitrat excret relat murin macrophag activ influenc dietari arginin oral ngmonomethylarginin murin macrophag oxid arginin guanidino nitrogen nitritenitr yield intermedi effector possibl nitric oxid antimicrobi activ total bodi nitrogen oxid metabol nom measur vivo determin urinari nitrat excret mice ingest chemic defin nitritenitratefre diet report previous mycobacteri infect bacillus calmetteguerin led larg increas urinari nitrat excret increas tempor relat macrophag activ vivo substrat macrophag nitrogen oxid metabol vitro arginin delet diet amelior urinari nitrat excret respons induc bcg suggest arginin synthes endogen natur substrat nom competit inhibitor nom arginin analog ngmonomethylarginin fed mice drink water ngmonomethylarginin ingest block basal bacillus calmetteguerininduc urinari nitrat excret week time span experiment condit prove investig role macrophag nom host defens intracellular microorgan"
"nosocomi pseudomona pickettii bacteremia trace narcot tamper case select drug screen health care personnel patient univers hospit develop nosocomi infusionrel pseudomona pickettii bacteremia investig identifi addit patient receiv intraven fluid contamin pickettii ill patient surgeri patient oper control patient receiv intraven fentanyl citrat oper room dose case patient greater control patient fentanyl predrawn ml syring shown contamin pickettii contamin caus theft fentanyl predrawn synring replac distil water contamin pickettii narcot theft health care personnel patient suffer pain needless result dire unanticip consequ nosocomi bacteremia drug test workplac high controversi test health care personnel drug abus theft suspect"
"recombin fusion protein identifi lepromat sera mimic nativ mycobacterium lepra cell respons leprosi spectrum pool polyval sera lepromat leprosi patient screen lambda gt recombin dna express librari mycobacterium lepra order identifi relev antigen recogn human immun respons phage screen clone identifi code fusion protein molecular mass fusion protein clone lsr test immunoreact assay peripher blood cell sera laboratori personnel patient leprosi spectrum lsr protein predomin cell antigen evok similar lymphoprolif respons nativ bacillus individu level leprosi spectrum patient sera anti lepra antibodi react fusion protein pattern reactiv antibodi respons similar clinic type code region clone lsr lsr ident show homolog sequenc store data bank encod protein amino acid calcul molecular mass approxim kda"
"clinic spectrum fungal infect orthotop liver transplant month period identifi episod fungal infect liver transplant recipi candida speci account case clinic pattern fungal infect includ dissemin infect periton pneumon multipl site colon fungemia site diagnosi fungal infect made month case time day transplant risk factor fungal infect includ retransplant risk score intraop transfus requir urgent status roux limb biliari reconstruct adult steroid dose bacteri infect antibiot therapi vascular complic fungal infect success treat amphotericin case diminish patient surviv fungal infect frequent sourc earli morbid relat defin risk factor suggest effect prophylaxi"
"effect dietari fish oil plasma thromboxan ketoprostaglandin alpha level septic rat increas mortal sepsi high level thromboxan txb ketoprostaglandin alpha pgf alpha linol acid essenti fatti acid usual precursor txb pgf alpha fish oil rich essenti fatti acid precursor activ moieti rat fed chow essenti fatti aciddefici diet essenti fatti aciddefici diet supplement linol acid fish oil week anim underw sham oper cecal ligat punctur induc sepsi hour blood obtain analysi chow linol acid diet produc signific twofold fivefold increas level txb pgf alpha sepsi essenti fatti aciddefici diet fish oil diet protect increas level txb pgf alpha sepsi dietari restrict linol acid fish oil supplement play import role alter inflammatori mediat respons sepsi"
"hepat extract indocyanin green depress earli sepsi increas hepat blood flow cardiac output activ hepatocellular function depress sepsi occur earli stage sepsi due depress cardiac output hepat blood flow studi rat subject sepsi cecal ligat punctur hepatocellular function determin interv assess abil liver clear dose indocyanin green indocyanin green concentr continu measur vivo fiberopt cathet vivo hemoreflectomet maxim veloc kinet constant clearanc indocyanin green hepat blood flow cardiac output determin experiment shamoper rat result demonstr hepat blood flow cardiac output increas hour cecal ligat punctur hepatocellular function maximum veloc kinet constant decreas hour cecal ligat punctur linear correl hepatocellular function hepat blood flow cardiac output found condit extrem earli depress activ hepatocellular function increas hepat blood flow cardiac output form basi cellular dysfunct lead multipl organ failur sepsi"
"effect highdos igg surviv surgic patient sepsi score greater sixti consecut septic surgic patient receiv standard multimod intens care unit treatment develop sepsi score greater day random receiv kg intraven igg patient human albumin control patient repeat day prospect doubleblind multicent studi group similar age initi sepsi score acut physiolog chronic health evalu ii score signific lower mortal record iggtreat group control septic shock death iggtreat patient control result studi highdos igg improv surviv decreas death septic shock surgic patient sepsi score greater"
"clostridium difficil diseas depart surgeri signific prophylact antibiot cluster clostridium difficil diseas depart surgeri prompt program infect control evalu contribut factor fifti patient diarrhea posit assay difficil cytotoxin studi period twenti case develop patient admit surgic servic occur adjac general surgeri ward share attend surgeon hous staff periop prophylact antibiot predat difficil diseas patient short cours hour symptom typic nonspecif earli diagnosi difficult incid remain high infect control measur coincident closur surgic ward clostridium difficil diseas nosocomi infect short cours prophylact antibiot recommend periop prophylaxi recogn difficil diseas signific potenti complic"
"clinic immunolog respons haemophilus influenza type tetanus toxoid conjug vaccin infant inject month age safeti immunogen haemophilus influenza type tetanus toxoid conjug vaccin hibtt evalu healthi infant receiv inject month age local system reaction note inject geometr hib antibodi level rose microgramsml subsequ inject elicit statist signific rise geometr percentag vaccine hib antibodi level greater microgramsml serum hibtt inject percentag fell month age rose fourth inject control infant inject diphtheriatetanus toxoidpertussi vaccin nondetect level inject hibtt elicit increas hib antibodi isotyp igg greater igm greater iga igg subclass highest increas igg vaccin subject greater ml tt antibodi estim protect level studi conclud hibtt inject month safe induc protect level antibodi age highest incid mening caus hib"
"splenectomi influenc outcom pneumococc septicemia porcin model exist overwhelm postsplenectomi infect syndrom adult traumat splenectomi controversi due similar porcin immun system man chose pig studi subset peripher mononuclear cell splenectomi resist experiment pneumococc infect splenic surgeri specif immun femal miniatur pig assign oper group sham oper splenectomi splenic resect heterotop splenic autotransplant hematolog flow cytometr analysi mononuclear cell subset reveal mark leukocytosi splenectomi autotransplant signific shift monocyt cell number respons leukocyt septicemia bacteri elimin peripher blood mortal affect splenectomi spleenpreserv oper mortal splenectom anim compar shamoper control differ signific immun protect anim develop leukopenia led enhanc bacteri elimin signific decreas mortal compar nonimmun anim data show signific effect splenectomi subset porcin mononuclear cell resist experiment pneumococc septicemia"
"epidur tuberculoma spine case report epidur tuberculoma spine report rare past decad case surgic treat epidur tuberculoma thorac spine year women present"
"factor affect outcom meningococc infect prognost score evalu meningococc infect patient consist featur poor prognosi onset petechia hour present shock normal low peripher leukocyt count normal low erythrocyt sediment rate absenc mening base experi publish data suspect score longer reliabl review chart children meningococc infect decemb decemb appli prognost score mention previous find low score general good outcom higher score predict poor outcom previous suggest rash petechia purpura presenc shock normal low peripher leukocyt count continu predictor poor outcom erythrocyt sediment rate evalu owe limit amount data absenc mening correl wors outcom patient patient die evid mening involv time present alter mental status present obtund coma omin sign conclud absenc mening good predictor outcom previous thought alter mental status time present prove stronger indic poor outcom"
"antibodi respons haemophilus influenza type conjug vaccin serum antibodi respons haemophilus influenza type capsular polysaccharideprotein conjug vaccin prp hboc cp prp studi compar infant adult year children antibodi influenza type polysaccharid vaccin determin farrtyp radioimmunoassay infant receiv dose vaccin age month dose vaccin geometr antibodi concentr measur age month mg margin higher measur immun infant receiv prp hboc cp increas mg receiv prp month dose geometr antibodi concentr increas vaccin group signific differ note recipi hboc cp prp geometr antibodi concentr mg prp recipi signific lower geometr antibodi concentr mg contrast prp hboc cp prp high immunogen adult differ note year children respond dose vaccin high antibodi concentr"
"efficaci short cours oral novobiocinrifampin erad carrier state methicillinresist staphylococcus aureus vitro kill studi clinic isol methicillinresist staphylococcus aureus mrsa import nosocomi infect problem colon common invas diseas erad colon carrier state limit spread mrsa reduc potenti mortal morbid patient detect patient mrsa infect rehabilit ward led studi combin novobiocinrifampin vivo vitro found mg rifampin mg novobiocin oral daili day cours treatment patient result clear mrsa evalu cours evalu site clear mrsa patient treatment failur side effect note pretherapi isol suscept drug vitro posttherapi isol rifampin resist timedkil studi demonstr rate kill drug drug pretherapi isol treatment success failur kill rate drug combin rifampinresist isol kill ceas result studi suggest previous untreat patient isol suscept combin drug combin common effect erad mrsa carriag regimen oral administ conveni conjunct measur promis reduc spread mrsa hospit"
"ampicillinresist enterococc speci acutecar hospit prospect review enterococc isol month show resist ampicillin mic greater equal microgramsml zone diamet mm determin vitek system disk diffus microdilut mic test macrodilut mic test betalactamas negat total resist isol urin intravascular site ampicillinresist enterococci grow clinic problem"
"endogen colon gentamicinresist gramneg bacilli elabor aminoglycosid acetyltransferas member famili enterobacteriacea elabor aminoglycosid acetyltransferas aac caus nosocomi outbreak vanderbilt univers medic center persist gene aac present communiti stool cultur newli admit patient ambulatori person examin specif gene probe aacposit strain present intestin flora examin"
"increas resist staphylococcus aureus ciprofloxacin demonstr mark emerg resist ciprofloxacin staphylococcus arueus strain isol ann arbor veteran administr medic center  aureus isol test suscept methicillinresist methicillinsuscept strain highlevel resist ciprofloxacin"
"preval chlamydia trachomati infect women cervic smear test object determin preval sexual transmit diseas patient normal abnorm cervic smear design prospect studi asymptomat women normal cervic smear attend general practition newli refer patient abnorm smear attend colposcopi clinic set hospit base colposcopi clinic urban general practic list size north west glasgow subject asymptomat women attend general practition cervic smear test random select patient attend colposcopi clinic investig abnorm smear main outcom measurespres sexual transmit infect determin cultur serolog test result women cytolog abnorm current chlamydi infect prove cultur gonococc infect women normal smear chlamydi infect gonorrhoea serolog studi chlamydia trachomati specif antibodi larg proport patient expos agent group signific differ group preval sexual transmit diseas studi conclus high preval chlamydi infect present women north west glasgow irrespect cervic cytolog state"
"revers decreas oxygen consumpt hyperoxia hemodynam metabol effect minut normobar hyperoxia studi critic ill patient septic nonsept requir mechan ventil inspir fraction fio thirti minut increas fio arteri po increas mm hg bodi oxygen uptak vo decreas percent due percent decreas extract ratio subsequ minut hyperoxia signific chang vo cardiac index chang hyperoxia increas percent recoveri system vascular resist decreas vo return baselin minut recoveri origin fio due increas extract increas cardiac output decreas vo decreas deliveri reflect maldistribut blood flow function shunt protect tissu unphysiolog high po oxygen advis period hypoventil present data suggest hyperox ventil patient adequ deliveri counterproduct"
"serolog diagnosi human ehrlichiosi ehrlichia cani isol ehrlichia cani close relat rickettsi organ implic serolog morpholog causat agent human ehrlichiosi unit state  cani serial propag primari canin monocyt limit quantiti antigen obtain method continu canin macrophag cell line dh support growth isol cani establish blood carrier dog oklahoma serolog comparison oklahoma isol continu canin cell line florida isol commerci antigen slide reveal specif sensit"
"clinic diseas drug suscept biochem pattern unnam biovari complex mycobacterium fortuitum previous studi mycobacterium fortuitum identifi isol fit recogn biovari eighti clinic isol group biovari complex evalu repres isol fortuitum submit texa laboratori isol queensland australia infect involv skin soft tissu bone occur metal punctur wound open fractur isol differ biovar fortuitum resist pipemid acid mannitol inositol carbon sourc subgroup present exampl deposit american type cultur collect isol resist doxycyclin resist cefoxitin suscept amikacin ciprofloxacin sulfamethoxazol imipenem surgic debrid combin drug therapi base vitro suscept result cure cutan diseas osteomyel dna homolog studi determin taxonom status organ"
"urinari phenol glycolipid diagnosi manag leprosi simplifi assay measur phenol glycolipid pgl mycobacterium lepra urin appli diagnosi leprosi monitor antileprosi chemotherapi hundr seventi previous untreat patient normal control test specif assay falseposit result sensit assay vari type leprosi lepromat leprosi borderlin lepromat borderlin tuberculoid patient onset chemotherapi lepromat leprosi patient transient increas urinari pgl steadi declin month multipl drug therapi urinari pgl level reduc undetect assay potenti monitor chemotherapi detect treatment failur relaps patient hansen diseas"
"virola promis genus ethnopharmacolog investig data antifung virola countri tribe indian countri employ virola exud similar purpos method ethnobotan investig propos schult swain employ ethnobotan research present author success employ antifung treatment deep fungal infect skin consid incur medic laboratori analysi virola resin undertaken"
"issu cerebrospin fluid manag csf vener diseas research laboratori test polici decreas unnecessari cerebrospin fluid csf manag vener diseas research laboratori vdrl test compar polici attempt educ physician serolog test diagnos neurosyphili csf vdrl perform screen test retrospect test polici requir csf vdrl perform retrospect test regard patient serolog status polici requir patient seroposit rapid plasma reagin rpr fluoresc treponem antibodi absorb ftaab csf vdrl perform polici institut vdrl test perform csf sampl option requir retrospect polici decreas csf vdrl rate percentag seroposit patient procedur perform polici decreas csf vdrl test rate seroposit improv assur serolog test obtain evalu neurosyphili requir seroposit implement retrospect csf vdrl test"
"issu cerebrospin fluid manag acidfast bacillus smear cultur mening tuberculosi uncommon diseas unit state annual incid fewer case studi evalu approach improv cerebrospin csf acidfast bacillus afb smear cultur procedur educ option screen physician select afb analysi stop initi csf find unremark mandatori screen perform csf afb analys educ csf afb cultur rate decreas csf acquisit effect relat decreas type afb test option screen impact afb test rate mandatori screen signific decreas csf afb rate unrel type afb test laboratori employ mandatori screen report screen result immedi mechan physician bypass screen provid csf afb analysi unremark fluid highrisk patient"
"close suction drainag knee arthroplasti effect risk prospect investig perform determin remov suction drain total knee arthroplasti tka forti tkas random alloc close suction drainag hour drain remov tip cut process method give quantit cultur hour group total volum drain hour hour period volum ml drain organ isol cultur drain tip sampl hour hour drain tip yield light growth coagulaseneg staphylococci drain tip staphylococcus aureus drain tip clinic evalu wound heal compar group gain continu drainag hour drainag maintain longer period increas risk contamin bacteria"
"offic laboratori area medicin experienc tremend growth officebas laboratori recent advanc technolog reimburs practic great expand potenti segment patient care physician opportun introduc test procedur offic laboratori year ago requir area qualiti assur qualiti control constant chang regul vari state state laboratori requir respect certifi agenc today market physician choos referr laboratori resourc offic option care cost patient"
"antibiot infecti diseas select antibiot clinic practic increas complex patient predisposit infect greater varieti microorgan vari antibiot resist pattern infect antibiot treat pathogen practic approach antibiot decisionmak involv compar advantag disadvantag group antibiot rememb patient popul treat common pathogen encount practic studi penicillin deriv approxim chronolog order develop cephalosporin term generat put individu agent perspect familiar common encount advers antibiot reaction dosag guidelin special situat pregnanc pediatr patient avoid problem antibiot final refer hand aid resolv question antibiot"
"infecti skin diseas descript individu diseas includ impetigo scarlet fever toxic shock syndrom present context specif organ pictur show diseas test treatment inform diseas includ"
"antibiot common infect elder declin host defens mechan concurr diseas combin make elder patient suscept common infect bacteri antimicrobi sensit pattern elder select dose antibiot elder patient common infect pneumonia bronchiti urinari tract infect skin softtissu infect optim patient respons minim advers consequ"
"antistaphylococc activ teicoplanin vancomycin vitro experiment infect efficaci vancomycin teicoplanin experiment staphylococcus aureus infect granulocytopen mice relat activ vitro pharmacokinet profil vitro teicoplanin higher intrins activ vancomycin favor pharmacokinet profil result higher peak concentr plasma longer elimin halflif larger area concentrationtim curv vancomycin predict antibacteri efficaci drug vivo basi activ vitro pharmacokinet mathemat model appli model vitro effect express differ growth rate control cultur presenc antibiot er vivo effect express differ number cfu control antibiotictr anim en integr er time ert calcul concentr found vivo signific linear relationship found en ert dosag time drug administr dose consecut time lowest dose teicoplanin observ effect predict effect"
"pharmacokinet tissu penetr singl dose ornidazol milligram intraven antibiot prophylaxi colorect surgeri level serum tissu penetr ornidazol studi singl intraven inject mg patient prophylaxi surgic infect schedul elect colorect surgeri adequ level blood greater equal mic bacteroid fragili strain test found patient procedur hour maxim min determin ornidazol level serum mgliter betaphas elimin halflif clearanc appar volum distribut mlmin literskg patient adequ level tissu found abdomin wall epiplo fat time incis colon wall time anastomosi time closur patient adequ level tissu abdomin wall epiplo fat anaerob aerob infect occur studi patient"
"compar studi effect cephalosporin escherichia coli vitro vivo thigh muscl infect induc escherichia coli irradi mice model compar vivo pharmacodynam antibacteri effect cephalosporin cefepim ceftriaxon ceftazidim cefoperazon vitro antibacteri pharmacodynam drug vitro pharmacodynam paramet determin maximum effect measur efficaci effect concentr paramet potenc slope concentrationeffect relationship analysi vivo antibacteri pharmacodynam paramet appli dose concentr detect relationship concentr antibacteri effect vivo determin pharmacokinet cephalosporin plasma mice result show general direct relationship vivo vitro pharmacodynam cephalosporin maximum effect cefepim ceftazidim cefoperazon approxim similar vivo vitro sequenc potenc drug descend order cefepim ceftazidim cefoperazon ceftriaxon differ cephalosporin display unexpect vivo pharmacodynam ceftriaxon efficaci vitro maximum effect vivo lower low maximum effect ceftriaxon vivo explain pharmacokinet characterist drug present result conclud vitro efficaci cephalosporin necessarili predict vivo efficaci"
"thoracoscop debrid pleural irrig manag empyema thoraci sequel paper report good result obtain patient empyema thoraci treat thoracoscop debrid irrig depart subsequ experi patient report drainag pus irrig result resolut pyrexia improv general condit patient complet resolut obtain techniqu patient complet resolut obtain secondari surgic measur result resolut empyema patient die elder sever debilit advanc malign death relat techniqu toler case thoracoscop debrid irrig routin line measur empyema thoraci safe atraumat procedur exclud subsequ surgic measur valuabl time improv condit debilit patient toler aggress surgic procedur"
"success treatment dissemin cutan cytomegal inclus diseas hodgkin diseas case dissemin cutan cytomegal inclus diseas hodgkin diseas patient diffus erupt prurit eros erythemat nodul histolog inclus bodi observ perivascular area skin lesion immunohistolog inclus bodi posit stain anticytomegalovirus antibodi antifactor viiirel antibodi electron microscopi virus particl dens bodi found area inclus bodi observ treatment highdos intraven acyclovir larg amount immunoglobulin result prompt heal skin lesion subsequ patient hodgkin diseas control chemotherapi patient steadili improv relaps skin lesion year antivir therapi administ"
"cortisol respons corticotropin surviv septic shock corticotropin stimul test assess adrenocort function patient septic shock patient poor cortisol respons rise nmol corticotropin die death patient adequ respons result suggest patient septic shock relat adrenocort insuffici"
"case neonat tetanus morbid mortal neonat tetanus prevent larg diseas develop countri singl case neonat tetanus southern florida serv indic health care profession evalu degre util matern health servic impact immun program women risk case women migrat develop countri"
"bacteri transloc gut impair system immun goal studi determin influenc bacteri transloc system immun bacteria product play major role develop mainten host immun system test hypothesi measur blastogen respons mononuclear cell harvest blood spleen peyer patch mesenter lymph node control escherichia coli monoassoci mice batteri mitogen  coli monoassoci model bacteri transloc model experiment manipul affect system immun system mitogen respons lymphocyt isol coli monoassoci mice signific depress compar control group biolog signific depress vitro mitogen respons difficult determin assess abil mice control bacteri challeng vivo staphylococcus aureus abscess model observ mitogen respons biolog signific abil coli monoassoci mice control inject aureus impair result suggest associ exist bacteri transloc decreas system immun respons"
"cephalosporin rational clinic cephalosporin wide class antibiot resist penicillin inactiv betalactamas base spectrum activ gramneg bacteria cephalosporin classifi generat generat classif correl activ gramposit bacteria anaerob generat cephalosporin narrow gramneg spectrum activ gramposit bacteria staphylococcus aureus generat compound excel activ gramneg bacteria cephamycin generat subgroup includ cefoxitin cefotetan cefmetazol activ anaerob"
"empir antibiot select physician evalu reason strategi object studi evalu appropri empir antibiot select housestaff treat medic patient bacteremia design prospect observ studi universityaffili hospit seventi patient bacteremia evalu clinic grade accept accept assign antibiot prescript consensus panel consensus panel found antibiot prescript unaccept clinic grade flaw chain reason found case evalu assess clinic set correct case portal entri identifi adequ knowledg bacteri flora suspect site infect found diagnost workup correct antibiot suscept pattern correct chain reason result accept clinic grade flaw reason antibiot select made physician flaw reason inappropri antibiot select occur case fautless reason case unexpect organ blood cultur prescript broad spectrum antibiot learn respons educ effort emphas narrow broad spectrum prescrib inadequ chang physician prescrib habit"
"assess platelet antibodi flow cytometr elisa techniqu comparison studi method evalu platelet antibodi studi normal subject patient consist primarili intraven drug user ivdus posit human immunodefici virus hiv total platelet immunoglobulin igg immunoglobulin igm measur enzymelin immunosorb assay platelet lysat platelet surfac igg igm measur semiquantit flow cytometri igg igm valu show signific correl measur method platelet surfac igg total igg time greater ivdus control platelet igm signific higher ivdus control measur techniqu platelet immunoglobulin level higher ivdus thrombocytopenia ivdus normal platelet count differ achiev signific data show platelet igg igm level increas ivdu hiv infect suggest increas confin patient manifest thrombocytopenia platelet surfac antibodi total platelet antibodi measur equal studi patient popul specif detail generat platelet immunofluoresc unit discuss"
"report hivseroposit patient major depress respond fluoxetin pilot studi examin effect fluoxetin depress human immunodefici virus hivseroposit asymptomat patient patient particip azt trial met criteria major depress syndrom dsmiii treat fluoxetin mgday week initi hamilton depress score rang improv rang subject maintain remiss month follow fluoxetin treatment effect treat major depress hivseroposit asymptomat patient"
"antibodi persist gambian children highdos edmonstonzagreb measl vaccin measl antibodi concentr gambian children immunis month age highdos edmonstonzagreb ez measl vaccin month convent schwarz vaccin measur month vaccin month age schwarz vaccine produc averag fold higher concentr measl haemagglutinin inhibit hai antibodi ez vaccine month age ez vaccine schwarz vaccine measl plaqueneutralis antibodi concentr assum protect level miuml greater hai antibodi concentr month vaccin invers relat presenc matern antibodi vaccin protect level month age relat antibodi concentr vaccin decay hai antibodi month age similar ez schwarz vaccine"
"oral pharyng herp simplex virus infect allogen bone marrow transplant analysi factor infect studi analyz factor acut oropharyng herp simplex virus hsv infect patient undergon allogen bone marrow transplant leukemia lymphoma aplast anemia hsv infect develop patient seroposit hsv transplant sixti percent seroposit patient episod hsv reactiv day transplant factor patient increas risk hsv infect pretranspl diagnosi leukemia remiss time transplant condit transplant chemoradiotherapi recognit factor predispos patient hsv infect determin transplant recipi benefit antivir prophylaxi approach prevent hsv reactiv"
"evid suscept intrathym cell precursor progeni carri cell antigen receptor phenotyp tcr alpha beta tcr gamma delta human immunodefici virus infect mechan cd lymphocyt deplet individu infect human immunodefici virus type hiv demonstr progress deplet qualit dysfunct helper cd cell popul mechan propos attrit cd cell includ direct cytopath matur cell infect infect earli lymphocyt progenitor mechan lead failur regener matur function cd cell present studi determin suscept thymocyt stage matur infect hiv normal thymocyt popul inocul hiv includ unfraction uf cd cd cd tripl negat tn cd cd doubl posit dp thymocyt thymocyt popul obtain limit dilut clone cultur studi presenc hiv dna polymeras chain reaction addit examin revers transcriptas activ determin transform cell thymocyt cell line complet lack cd suscept infect hiv line uf thymocyt cdhi dp thymocyt cdhi tn thymocyt cdhi tcr alpha beta tcr gamma delta cd cd natur killer thymocyt clone express variabl level cd repres progeni tn thymocyt tcr alpha beta tcr gamma delta refer chain cell antigen receptor tcr cdhi refer strong rightward shift greater linear channel cd curv flow cytometr analysi compar control monoclon antibodi mab cd ta epitop cd capabl block infect matur immatur cdhi thymocyt anticdta mab inhibit infect cdhi tn thymocyt indic cell precursor appar tripl negat cd cdhi cdexpress suffici cd molecul infect cell sorter analysi panel cd mab demonstr shift fluoresc channel mfc cd mab tn thymocyt mfc unit intrathym cell precursor progeni repres stage cell ontogeni suscept infect hiv includ earli tn thymocyt express low level cd infect multipl stage multipl subset cell lineag man mediat cd molecul explain inabl cell pool regener set progress hiv infect"
"subacut scleros panenceph black children review case fact measl sever present young black children natal south africa case subacut scleros panenceph report region prior retrospect studi made year period patient present king edward viii teach hospit durban clinic laboratori featur subacut scleros panenceph major patient cent year age age onset year youngest patient year month oldest year male femal ratio previous histori primari measl infect obtain cent case cent occur birthday commonest mode present person intellectu behaviour disord cent myoclon seizur cent choreiform movement cent measl antibodi present csf case eeg abnorm record case pathognomon period complex found cent confirm diagnosi provid brain biopsi case necropsi case find studi suggest subacut scleros panenceph uncommon black children hitherto thought"
"preliminari report protect cynomolgus macaqu simian immunodefici virus fix infectedcel vaccin cynomolgus macaqu vaccin inactiv simian immunodefici virusinfect cell quil adjuv week week week anim similar unvaccin group challeng mid monkey infecti dose pool sivmac previous titrat vivo virus repeat isol unvaccin anim separ occas provir dna detect circul lymphocyt polymeras chain reaction amplif contrast virus provir dna found vaccin anim vaccin regimen live virus challeng elimin virus previous infect macaqu"
"safeti immunogen human immunodefici virus type hiv recombin gp candid vaccin human niaid aid vaccin clinic trial network object evalu safeti immunogen human immunodefici virus type hiv recombin envelop glycoprotein rgp candid vaccin human subject healthi adult seroneg hiv random assign group intervent subject random assign receiv microgram rgp microgram hepat vaccin placebo dose day elect nonblind administr fourth dose day measur main result clinic laboratori toxic encount follow period exceed month effect immun note lymphocyt count mitogen respons delayedtyp hypersensit serum antibodi respons hiv envelop protein detect western blot subject ci receiv microgram dose rgp common weak reactiv intens respons note western blot dose mark increas frequenc dose declin month administr fourth dose result homolog neutral activ sera subject ci complementmedi antibodydepend enhanc sera subject ci antibodi respons detect enzymelink immunosorb assay elisa frequent western blot respons persist shorter time conclus administr rgp toler safe result high rate antibodi respons western blot administr fourth dose generat serum neutral activ complementmedi antibodydepend enhanc subject fourth dose"
"abnorm function cd helperinduc lymphocyt patient widespread human papillomavirus type relat infect human papillomavirusinduc infect cellular immunodefici dysfunct interact lymphocyt lymphocyt antigenpres cell year heterosexu man year histori persist multipl refractori flat wart lesion human papillomavirus type relat dna sequenc studi patient sever deplet cd lymphocyt compensatori increas number cd lymphocyt impair lymphocyt respons stimuli found deplet increas number cd lymphocyt suppress immunoglobulin product vitro restor impair lymphocyt respons immobil anticd bead stimul lymphocyt antigen complex absenc antigenpres cell lymphocyt defect decreas antigenpres cell function pronounc cellular immunodefici due abnorm function cd helperinduc lymphocyt"
"antibodydepend cellular cytotox hivcoat target cell peripher blood monocyt hiv seroposit asymptomat patient cytotox effector cell cytotox cell nk cell monocytesmacrophag neutrophil lyse direct hivinfect hivcoat cell absenc presenc antihiv antibodi cytotox mechan invok control hiv infect earli stage diseas general immunosuppress observ stage diseas relationship antihiv effector mechan diseas remain elus present studi investig hiv seroposit asymptomat patient peripher blood monocyt pbmmediat antibodi depend cellular cytotox adcc hivcoat target cell presenc heterolog autolog antihiv serum test specif adcc hiv ag cemtr line resist tnf macrophagemedi cytotox select vitro adcc perform crreleas assay cemtr cell coat inactiv hiv unlik pbm normal control signific adcc observ pbm hiv seroposit patient presenc pool hiv antiserum adcc activ specif hiv depend ratio antiserum dilut activ pbm rifngamma normal hiv pbmmediat adcc hivcoat cemtr adcc activ pbm hiv seroposit patient presenc autolog serum examin signific adcc activ observ depend ratio serum dilut find demonstr antihiv adcc activ pbm hiv seroposit individu autolog sera support notion monocytemedi adcc oper vivo"
"longterm combin rifnalphaa zidovudin therapi hiv kaposi sarcoma clinic consequ side effect interferon alpha ifnalpha shown effect treat hiv ks patient zidovudin prove benefici aid patient drug demonstr inhibitori effect hiv replic base combin ifnalpha zidovudin treatment hiv ks order evalu toler clinic efficaci twenti homosexu men histolog prove hiv ks treat open trial rifnalphaa iu day zidovudin mg treatment discontinu month patient develop subject intoler contract sever opportunist infect hivcachexia fifteen evalu patient receiv combin treatment period month averag month dosag reduc requir base druginduc cytotox complet remiss observ patient partial remiss stabl diseas progress result respons rate negat express prior treatment posit predictor extracutan involv negat influenc tumor remiss patient initi helper cell count mm respond posit conclus combin therapi rifnalphaa azt effect control hivrel kaposi sarcoma patient contrast monotherapi ifnalpha patient sever reduc immun system benefit combin treatment"
"biolog effect interferon review articl ifn publish appar virtual tenet held valid today ifn long consid specif antivir substanc effect normal cellular metabol accept today affect normal cell divis special cellular function respect uniqu ifn prototyp famili similar substanc call cytokin function regulatori molecul held product ifn constitut specif respons viral infect today ifn integr part cytokin network cytokin produc constitut low level substanc exert multipl effect virtual cell play import role host defens viral parasit infect resist experiment tumor ifn shown exert effect immun system lymphocyt circul multipl biolog effect contribut pathogenesi diseas larg amount ifn administ induc newborn mice liver kidney pulmonari diseas field ifn cytokin research continu expand increas number therapeut applic twenti year scientist clinician surpris understood ifn act inadequ treat diseas"
"mucos immun induc enhancepot inactiv oral polio vaccin oral polio vaccin opv recommend routin immun unit state part abil induc intestin pharyng immun reinfect mucos immun produc opv enhancedpot inactiv polio vaccin ipv compar challeng vaccin type opv fewer opv ipv vaccine excret opv virus stool challeng stool virus titer higher durat shed longer ipv excret ipv opv vaccine shed virus pharynx challeng prechalleng serum neutral antibodi level statist ipv vaccine shed virus level higher opv vaccine poliovirusspecif iga level stool correl viral excret ipv effect opv prevent limit intestin infect induc higher postvaccin serum antibodi level"
"measl amish compar studi measl sever primari secondari case household outbreak measl predomin unvaccin suscept amish popul lebanon counti pennsylvania offer opportun test hypothesi secondari case household sever primari case intens exposur receiv greater virus inoculum measl case report april june constitut studi diseas sever sever assess determin frequenc durat symptom length hospit number day bed univari analysi fewer secondari case conjunct relat risk rr confid interv ci headach rr ci earach rr ci compar primari case secondari case shorter durat coryza day student test logist regress model match famili control age sex signific differ measl sever primari secondari case household"
"brain biopsi diagnost evalu patient suspect herp simplex enceph statist model clinic implic niaid collabor antivir studi group decis analysi techniqu multivari regress method statist model establish defin util brain biopsi diagnost evalu patient suspect herp simplex enceph hse strategi compar strategi brain biopsi acyclovir acv treatment day biopsyposit patient strategi ii acv therapi brain biopsi strategi result greater month surviv rate likelihood patient hse base current estim preval hse patient suspect hse strategi show slight advantag increas month surviv rate individu patient chanc posit brain biopsi predict mathemat equat base import clinic assess equat conjunct decis analysi guid clinic manag patient regard brain biopsi"
"role secretori immun hepat virus infect role intestin immun remain uncertain hepat sampl fece saliva infect primat human test virus neutral activ owl monkey infect intragastr rout develop neutral antibodi detect extract fece collect day viral challeng serum neutral antibodi present monkey day similar neutral antibodi detect fecal extract experiment infect human volunt natur infect human singl posit human specimen occult blood saliva sampl natur infect human signific viral neutral activ contrast neutral antibodi type poliovirus present human fecal saliva specimen test data suggest intestin immun play signific role protect hepat"
"unexplain rabi immigr unit state virolog investig background extens investig patient die rabi unit state fail reveal sourc exposur diseas patient immigr unit state area lao philippin mexico rabi endem method studi rabi virus isol patient patient sourc exposur anim unit state thailand proxi lao philippin mexico virus character indirect immunofluoresc neutral test reaction panel monoclon antibodi transcrib complementari dna isol amplifi polymeras chain reaction dna product analyz differenti digest restrict enzym result viral isol patient rabi variant distinct antigen genet characterist isol ident variant found specimen rabid anim obtain countri patient live immigr unit state variant found isol collect rabid anim unit state conclus rabi infect patient origin unit state result exposur lao philippin mexico patient live unit state year year month find suggest onset clinic manifest rabi occur long incub period"
"antibodi hiv nefp preval signific relationship seroconvers sensit specif enzymelink immunoassay antibodi human immunodefici virus type hiv nef gene product develop recombin escherichia colideriv protein lavbru sequenc hiv infect hemophiliac produc antinef antibodi assay earli antinef prior full seroconvers rare event popul occur subject approxim antinef antibodi detect sera repeat hiv seroneg subject expos sexual transmit mode hiv infect subject blood product subject signific associ titer antinef antibodi protect diseas hiv infect nef protein immunogen natur infect studi confirm previous report high preval antinef antibodi prior seroconvers find antinef antibodi hiv seroneg expos subject"
"rapid diagnosi herp simplex enceph nest polymeras chain reaction assay cerebrospin fluid aim improv earli diagnosi herp simplex enceph polymeras chain reaction pcr assay nest primer pair develop amplif herp simplex virus dna cerebrospin fluid csf southern blot confirm specif amplif assay appli csf sampl consecut patient herp simplex enceph verifi find herp simplex virusvir antigen brain biopsi sampl necropsi intrathec product igg antibodi virus control csf sampl patient acut febril focal encephalopathi initi suspect herp simplex enceph exclud absenc intrathec antibodi synthesi test pcr detect herp simplex virus dna patient proven herp simplex enceph posit csf sampl pcrnegat patient treat acyclovir onset symptom control subject pcr negat intern contamin control pcr result remain posit sampl drawn day onset neurolog symptom method rapid invas diagnos herp simplex enceph high sensit specif"
"antivir drug therapi major advanc molecular virolog led develop antivir compound drug includ ribavirin treatment sever respiratori syncyti virus infect children amantadin prophylaxi treatment influenza infect acyclovir varieti herpesvirus infect includ primari gingivostomat genit herp herp zoster ganciclovir treatment retin due cytomegalovirus zidovudin prophylaxi treatment human immunodefici virus infect"
"detect salivari hivspecif igg antibodi highrisk popul zair saliva blood sampl test human immunodefici virus hiv antibodi highrisk popul kinshasa zair seropreval studi sexual transmit diseas std clinic attende seroposit individu enzymelink immunosorb assay elisaposit saliva sampl sensit saliva sampl seroneg patient elisaneg specif elisaposit saliva specimen western blotposit sensit subsequ seroincid studi initi seroneg femal prostitut womanyear observ women seroconvert seroincid elisaposit saliva sampl time seroconvers detect saliva specimen confirm western blot salivari test hiv antibodi convent assay sensit detect recent seroconvers screen salivari sampl hiv antibodi conveni altern method conduct seropreval survey popul venipunctur conveni"
"clinic manifest primari herp simplex virus type infect close communiti clinic featur molecular epidemiolog primari herp simplex virus type hsv infect children younger year age investig daycar nurseri serial sera assay antihsv glycoprotein antibodi enzymelink immunosorb assay serolog examin reveal case primari hsv infect observ period fifti typic herpet gingivostomat show high rate clinic overt infect outbreak herpet gingivostomat observ observ period forti children infect hsv outbreak rate infect suscept children outbreak restrict endonucleas analysi dna isol hsv reveal strain hsv transmit children long period"
"vaccin diseas recombin virus vaccin express limit number epitop develop prevent diseas chang relat balanc viral spread immun respons circumst found infect noncytopath virus vaccin caus diseas sensit paramet includ genet background host time dose infect constitu vaccin immunopatholog damag cell unwant consequ vaccin type peptid recombin vaccin investig human immunodefici virus pathogen"
"effect antineoplast drug murin acquir immunodefici syndrom murin acquir immunodefici syndrom maid prolifer target cell infect defect retrovirus control growth primari neoplasia virusinocul mice treat antineoplast drug paradox cyclophosphamid immunosuppress effect prevent progress diseas restor normal cell function deplet number infect target cell result suggest prolifer infect target cell respons immunodefici"
"epidemiolog pattern wildtyp hepat virus determin genet variat hepat virus hav isol part world singl serotyp genet analysi vp genom region publish hav sequenc suggest distinct genotyp hav defin base geograph sourc origin isol circumv process cell cultur adapt anim passag bp segment vp genom region wildtyp hav amplifi revers transcript polymeras chain reaction amplif presenc negat positivesens primer sequenc obtain epidemiolog distinct hav isol genet group hav delin group differ group differ isol approxim investig hav isol part world differenti genet facilit studi epidemiolog transmiss"
"genom analysi adenovirus type strain immunocompromis immunocompet patient adenovirus type ad isol immunocompromis patient seroconvers record ad infect substanti clinic relev lower respiratori tract infect hepat die ad isol immunocompet immunodefici host compar restrict endonucleas analysi genom type identifi ad isol pairwis comparison comigr restrict fragment genom type divid genom cluster ad genom type isol immunocompromis patient high virul genom type found genom type identifi child sever combin immunodefici origin infect genom type observ suggest evolutionari implic"
"comparison heterotyp protect influenza taiwan hn attenu inactiv vaccin chile virus children age year famili complet doubleblind placebocontrol studi compar efficaci bival attenu cr vaccin trival inactiv ti vaccin vaccin chile hn antigen vaccin geometr titer taiwan hn cr group ti group placebo group influenza taiwan hn epidem cr recipi ti recipi placebo recipi infect influenza taiwan ti vaccin provid heterotyp protect cr vaccin children age year infect rate contrast younger children year cr vaccin tend protect ti"
"antiidiotyp respons immun antileu human immunodefici virusseroposit individu antiidiotyp antibodi anticd monoclon antibodi mab report bind human immunodefici virus hiv envelop glycoprotein gp establish hivinfect patient mount antiidiotyp respons murin mab individu symptom aidsrel complex arc immun week intramuscular inject antileu mg immunocompromis state patient made anticonst region antiidiotyp antibodi amplitud respons vari individu signific toxic allerg reaction clinic status month immun increas serum hivneutr titer purifi antiidiotyp antibodi bind gp"
"encephalitogen rat myelin basic protein aid wateroil emuls induct experiment allerg encephalomyel eae purifi myelin basic protein mbp heretofor requir incorpor wateroil emuls adsorpt particul adjuv present work absorpt salin solut mbp periton caviti mediastin lymph node increas give repeat inocul pretreat rat periton irrit condit adjuv product eae aqueous pertussi vaccin inject separ hour day mbp pertussi vaccin product eae intraderm inject aqueous mbp inject aqueous mbp direct preenlarg poplit lymph node produc eae pertussi vaccin eae induc rat mbp addit freund adjuv pertussi vaccin"
"depress distress lymphocyt subset human immunodefici virus symptom occas hivposit homosexu men evalu extent depress disord psychiatr distress psychosoci stressor relat measur human immunodefici virus hiv ill crosssect month period communiti sampl hivposit homosexu men depend variabl immun status measur cd cd cell subset number sign symptom common hiv infect cumul index hiv ill stage chose focus cd cell count immun marker close link clinic consequ hiv infect found relationship independ variabl immun status ill stage hivposit men depress distress report life stressor greater immunosuppress advanc ill stage concurr occas find suggest pattern associ depress disord distress stressor number hivrel symptom warrant studi"
"multidisciplinari baselin assess homosexu men human immunodefici virus infect overview studi design virus believ expert acquir immunodefici syndrom pathogen action major area ignor remain reason vari time infect human immunodefici virus develop acquir immunodefici syndrom relationship neurolog medic aspect diseas time neuropsycholog find preval psychiatr morbid assess homosexu men posit human immunodefici virus negat virus articl describ studi design method recruit medic demograph characterist cohort year"
"effect psychoeduc intervent reduc emot distress human immunodefici virus antibodi test examin effect psychoeduc intervent reduc emot distress voluntari serolog test human immunodefici virus physic asymptomat adult random assign standard counsel counsel session interact video program counsel individu session stress prevent train subject evalu standard distress measur entri month human immunodefici virusseroneg subject distress measur decreas signific intervent differenti treatment effect human immunodefici virusseroposit subject distress measur decreas signific stress prevent train signific increas intervent conclud stress prevent train notif human immunodefici virus seroposit"
"famili physician test human papillomavirus infect oppos view recent advanc field molecular biolog expand knowledg hpv manifest attempt separ circumst hpv test patient manag routin screen hpv shown weigh inform patient potenti oncogen virus abil repeat papanicolaou smear detect lesion hand hpv detect set abnorm papanicolaou smear acetowhit lesion biopsi lack histolog featur cil predict high risk cil hpv type affect clinic manag recommend hpv detect situ hybrid adjunct histolog analysi genit tract lesion clinic suggest hpv lesion histolog analysi equivoc abil distinguish true hpv lesion mimic crucial patient implic sexual transmit diseas"
"voluntari human immunodefici virus test accept level identif seroposit individu client clinic sexual transmit diseas elig voluntari confidenti serolog test human immunodefici virus consent test seroposit person declin voluntari test test blind studi seroposit seroposit person declin voluntari test conceal associ risk group seroposit individu accept voluntari test admit inclus risk group test voluntari test insuffici seroposit individu identifi seroposit signific defici identif risk pretest counsel person agre voluntari test"
"bronchial hyperrespons normal subject attenu influenza virus infect fourteen healthi male subject hemagglutinationinhibit antibodi titer homolog influenza virus studi subject receiv live attenu influenza virus nasal drop aerosol infect occur subject develop fold greater increas hemagglutinationinhibit antibodi titer remain asymptomat subject receiv placebo rout develop symptom show increas antibodi titer prior administr virus placebo histamin diphosph aerosol increas airway resist slight differ virus placebo group day inocul bronchomotor respons placebo group unchang greater virusinfect group bronchomotor respons signific greater preinfect state isoproterenol hydrochlorid revers prevent increas airway resist histamin suggest bronchoconstrict caus smooth muscl contract find transient asymptomat respiratori virus infect augment airway smooth muscl respons"
"induct cd human lymphotrop virus typespecif cytotox lymphocyt patient hamtsp recognit immunogen region gp envelop glycoprotein human lymphotrop virus type humor respons human lymphotrop virus type htlv character patient htlv neurolog diseas hamtsp function htlvspecif human cell respons ctl patient defin phenotyp respond ctl fine specif respons long term cell line generat hamtsp patient countri patient peripher blood lymphocyt repeat stimul vitro htlv express autolog cell line result long term cell cultur shown cd cytotox target express htlv ag panel synthet peptid span hydrophil region htlv gp envelop glycoprotein ctl line generat patient shown recogn region htlv envelop amino acid defin synthet peptid spa interest sequenc overlap region htlv envelop shown elicit strong cell respons hamtsp patient amino acid ctl line recogn htlv epitop context hla dq ctl line restrict hla drw generat independ ctl line hamtsp patient geograph area recogn region htlv envelop glycoprotein highlight immunogen natur envelop region"
"htlv myelopathi blood transfus unit state epidemiolog molecular evid link donor recipi month receiv unit blood compon year white man york citi risk factor human lymphotrop virus type htlv infect develop htlv myelopathytrop spastic paraparesi hamtsp investig blood donor identifi year white hispan woman florida platelet patient seroposit virus serum specimen obtain year donat born cuba sexual relationship men born resid caribbean polymeras chain reaction pcr studi peripher blood mononuclear cell donor recipi infect htlv molecular studi nucleotid sequenc envelop region htlv virus donor recipi ident posit publish htlv sequenc demonstr molecular heterogen donor recipi virus ident addit posit differ publish sequenc transfus hamtsp occur unit state addit case prevent screen blood donat htlv molecular studi htlv prove defin genet heterogen htlv isol unit state studi transmiss virus"
"peptideinduc antivir protect cytotox cell specif antivir cytotox immun respons vivo induc subcutan inject cell epitop lymphocyt choriomening virus lcmv nucleoprotein unmodifi free synthet peptid argproglnalaserglyvaltyrmetglyasnleuthralagln emulsifi incomplet freund adjuv immun render mice lcmvspecif protect state shown inhibit lcmv replic spleen mice protect level mice correl abil respond peptid challeng cd virusspecif cytotox cell direct demonstr peptid vaccin antivir protect vivo encourag search mixtur stabl peptid cell vaccin"
"influenc inhal cadmium immun respons influenza virus cadmium exacerb pulmonari infect previous studi cadmium enhanc mous resist influenza pneumonia report influenc cadmium intox mice factor antiinfluenza immun antibodi respons local product interferon pulmonari cellular respons interact pulmonari alveolar macrophag influenza virus cadmium inhal affect product antibodi interferon protect effect relat enhanc suppli phagocyt cell lung"
"earli specif diagnosi seroposit hiv enzymelink immunosorb assay envderiv synthet peptid describ evalu sensit specif enzymelink immunosorb assay elisa aminoacid peptid carboxytermin end hiv gp aminoacid long cyclic peptid includ vicin cystein present hiv gp hiv gp test evalu data obtain western blot wb peptidebas elisa panel compos sera patient attend special outpati clinic highrisk popul perfect agreement sampl fals found posit viral lysatebas elisa detect peptidebas elisa panel compos sera difficult resolv wb viral lysatebas elisa peptidebas elisa found posit negat fals posit final sera individu examin time seroconvers gave high absorb read weak reactiv wb weak gp band test high sensit specif capabl detect earli seroconvers instrument defin sampl found indetermin wb avoid unnecessari follow requir falseposit result obtain viral lysatebas elisa"
"epitop react human cytotox cd cell central region hiv nef protein order identifi target epitop recogn specif ctl nef protein hiv peptid deriv hivbru sequenc test nefspecif ctl generat hivseroposit donor epitop identifi point remark locat region central part nef protein residu ctl issu singl donor recogn peptid nef protein peptid recogn associ hla class molecul overlap epitop present short sequenc amino acid result suggest multipl epitop hla restrict coexist small region nef protein implic result vaccin strategi synthet peptid bear ctl epitop discuss"
"measl outbreak colleg prematricul immun requir background earli outbreak measl case occur colleg colorado percent student document adequ measl immun physician diagnos measl receipt live measl vaccin birthday serolog evid immun due immun requir effect method examin potenti risk factor measl vaccin failur conduct retrospect cohort studi student live campus dormitori student health servic vaccin record result percent case vaccin greater equal month age student live campus dormitori increas risk measl compar student live campus rr ci student vaccin month age increas risk compar vaccin greater equal month rr ci time vaccin risk factor vaccin failur measl vaccin effect calcul ci vaccin greater equal month conclus secondari school measl outbreak occur high vaccin colleg popul implement recent recommend requir dose measl vaccin colleg entrant reduc measl outbreak colleg popul"
"safeti prophylact efficaci lowdos rimantadin adult influenza epidem placebocontrol doubleblind studi evalu safeti prophylact efficaci low dose mg rimantadin hydrochlorid natur occur influenza adult conduct site onset influenza season volunt age year assign random receiv rimantadin placebo daili subject monitor advers effect evid influenza virus infect week week rimantadin recipi placebo control recipi report mild moder advers symptom relat gastrointestin central nervous system compar placebo lowdos rimantadin high effect prevent influenza virus infect versus particip influenza ill versus particip influenza leningrad hn virus recov nasopharynx placebo recipi find lowdos rimantadin toler high effect prevent influenza ill healthi adult"
"alpha interferon combin zidovudin treatment presymptomat felin leukemia virusinduc immunodefici syndrom therapeut efficaci human recombin alpha interferon ifnalpha ifnalpha zidovudin azt azt evalu presymptomat cat establish felin leukemia virus felvacquir immunodefici syndrom faid infect high level persist antigenemia subcutan inject human recombin ifnalpha kg deliv peak concentr plasma ml postadministr halflif elimin dosag ifnalpha deliv cat week signific clinic toxic oral administr azt mgkg time daili result peak concentr plasma microgramsml halflif elimin approxim treatment felvfaidsinfect cat ifnalpha combin oral administ azt result signific decreas circul core antigen begin week initi therapi azt effect circul virus antigen depend high kg low kgdosag ifnalpha cat refractori therapi week begin treatment time ifnalphatr anim develop antibodi ifnalpha neutral specif human recombin ifnalpha dose depend magnitud result studi human recombin ifnalpha effect reduc circul virus antigen load cat persist infect felvfaid"
"prepar character intraven solut igg human immunodefici virusseroposit donor intraven solut pure globulin hyperimmun igg hivig obtain pool plasma select human immunodefici virus hivseroposit asymptomat donor greater cdmicrolit cell microlit high titer antibodi hiv protein hivig high titer antibodi glycoprotein gp gp groupspecif neutral activ bind gp hypervari loop region inhibit syncytia format low concentr enhanc viral product hiv infect peripher blood monocyt inhibitori higher concentr hivig direct groupspecif antibodydepend cellular cytotox hivinfect target period month plasma donor stabl antibodi titer decreas cd cell month gram kilogram hivig inject juvenil chimpanze toler transmit hiv measur negat cell cultur igm immun respons hiv protein polymeras chain reaction halflif hiv antibodi day preliminari data suggest hivig safe product suitabl clinic trial hivinfect individu"
"cytomegalovirus infect sexual activ adolesc determin cytomegalovirus cmv infect teenag girl relat sexual activ girl year attend contracept counsel clinic studi particip screen chlamydia trachomati neisseria gonorrhoea trichomona vaginali serum antibodi cmv determin demograph sexual histori data collect interview number lifetim sex partner seroposit race greater year sexual activ greater lifetim sex partner signific risk factor cmv infect odd ratio logist regress analysi composit sexual activ variabl import risk factor cmv infect race sexual transmit diseas composit variabl sexual activ import risk factor cmv infect adolesc girl"
"pattern respiratori syncyti virus epidem finland year cycl altern preval group timeresolv fluoroimmunoassay monoclon antibodi distinguish respiratori syncyti virus rsv group strain analyz preval finland patient laboratori diagnosi rsv hospit group type antigen rsvposit nasopharyng aspir show regular altern group preval cyclic occurr virus group predomin specimen group predomin specimen epidemiolog occurr verifi reinfect hospit children group type result children greater month age infect resist sever reinfect homolog heterolog group virus studi show group antigen variat rsv signific effect epidemiolog virus"
"hiv preval midwestern emerg depart studi object determin preval human immunodefici virus hiv seroposit patient year age older emerg depart design hiv status determin anonym seropreval rate calcul confid interv calcul twenti demograph predictor categor variabl crosstabul hiv status determin associ gender male homosexu prefer signific fisher exact test type particip excess serum sampl random select patient year age older requir venipunctur ed evalu includ studi measur main result serum specimen posit hiv confid interv posit patient men statist signific risk factor hiv seroposit male sex male homosexu prefer conclus hiv seroposit occur ed popul age year factor correl hiv seroposit male homosexu prefer male sex"
"appar respons subacut scleros panenceph intrathec interferon alpha year boy subacut scleros panenceph sspe treat iu human interferon alpha ifn intrathec rout week fortnight pronounc improv clinic electroencephalograph find observ dosedepend manner patient rais hope ifn induc sustain remiss patient sspe"
"counsel patient seroposit human immunodefici virus approach medic practic person risk infect human immunodefici virus encourag learn serostatus knowledg patient seek medic care distress describ approach base crisi counsel physician work patient infect hiv physician assist patient emot reaction diagnosi direct patient manag practic issu concern method discuss safer sex inject practic present"
"acanthamoeba kerat speci acanthamoeba describ case acanthamoeba kerat relat soft contact len wear patient present week histori sever uniocular pain radial stromal infiltr subepitheli infiltr epitheli defect acanthamoeba cultur corneal biopsi specimen contact len len case corneal biopsi cultur grew castellani polyphaga escherichia coli patient treat topic dibromopropamidin isethion brolen drop neomycin polymyxin drop fortifi gentamicin drop gradual clinic improv ensu"
"prenat diagnosi congenit toxoplasmosi prenat diagnosi congenit toxoplasmosi attempt pregnant women risk give birth affect child fifteen patient seroconvert pregnanc high initi antibodi level serum sampl prenat diagnosi consist combin ultrasound screen amniocentesi funipunctur week gestat diagnosi congenit toxoplasmosi base posit toxoplasma cultur amniot fluid fetal blood presenc specif immunoglobulin antibodi fetal blood addit alter fetal hematolog cellular immunolog fetal liver test indic infect fetal infect detect fetus die utero consequ infect born week gestat antibiot treatment pyrimethamin sulfadiazin child intern hydrocephalus chorioretin unilater chorioretin children diseas subclin children born negat prenat diagnosi reach age year toxoplasma antibodi disappear investig remain children show decreas toxoplasma antibodi suggest affect prenat diagnosi fetal loss prematur deliveri occur case conclud prenat diagnosi congenit toxoplasmosi safe reliabl"
"filarialspecif igg respons correl activ wuchereria bancrofti infect filarialspecif humor immun respons adult resid area papua guinea differ transmiss wuchereria bancrofti infect compar major resid villag bonahoi area transmiss filariasi interrupt year insecticid spray program control malaria show parasitolog sign activ bancrofti infect negat circul phosphorylcholin ag peripher blood microfilaria contrast adult resid villag nanaha area expos infect phosphorylcholineag microfilariaeposit antibodi respons group adult worm excretorysecretori es ag somat antigen extract examin determin compon filarialspecif immun respons depend activ infect identif immun respons point immunolog method evalu control program lymphat filariasi adult bonahoi found signific immun respons methioninelabel es ag immunoprecipit adult somat antigen extract elisa immunoblot result consist fact individu previous expos infect bancrofti similar resid endem villag detect immun respons ag irrespect microfilarem strike immunolog differ observ group resid bonahoi dramat reduc filarialspecif igg antibodi respons adult somat ag adult es ag data suggest longitudin measur filarialspecif igg level seroepidemiolog indic bancrofti infect status"
"serum resist metacycl stage leishmania major promastigot due releas cb mechan serum resist infect promastigot leishmania major investig prior result suggest mechan resist mediat step deposit equival amount cb deposit serumsuscept noninfect promastigot harvest log stage cultur log resist infect metacycl promastigot mp purifi stationari stage cultur bind log stabl incub serum bind mp minim unstabl molecul bound initi mp releas continu incub failur bind result inabl activ kinet consumpt similar log mp deposit cb mp stabl indic initi step termin complex format intact major cb form mp spontan releas serum scb residu cb mp releas nacl data show development modif promastigot membran transit noninfect infect stage block insert lytic cb promastigot membran"
"analysi permiss associ malaria cell epitop dr molecul studi examin associ promiscu malaria cell epitop cst hladr allel larg seri singl substitut truncat variant cst prepar test abil recognis associ bind distinct hladr allel dr drw drww natur variant hladrw found associ dr molecul map ident close overlap region peptid distinct substitut drastic influenc capac peptid interact dr molecul test base analysi distribut residu recogn cell clone restrict dr allel suggest peptid cst bound dr examin alphahelix addit test subtyp drw apc cst analogu observ peptid bound conform natur variant drw molecul"
"effect toler longterm malaria prophylaxi mefloquin dose regimen measur effect toler longterm malaria prophylaxi mefloquin incid plasmodium falciparum malaria advers reaction compar peac corp volunt west africa mefloquin week volunt chloroquin phosphat week mefloquin effect chloroquin month incid falciparum infect case volunt mefloquin case volunt chloroquin daili proguanil chloroguanid hydrochlorid addit chloroquin provid addit protect mefloquin prophylaxi failur occur week week dose regimen volunt mefloquin month blood concentr mefloquin lower week alternateweek regimen week suggest blood level low week suppress parasitemia advers reaction observ result dose regimen mg mefloquin week consid travel area chloroquineresist falciparum malaria"
"import plasmodium falciparum malaria american travel africa implic prevent strategi data nation malaria surveil system analyz assess characterist travel acquir plasmodium falciparum infect africa evalu impact chloroquin resist incid import malaria number case acquir east africa stabil number import falciparum infect acquir west africa increas threefold proport travel report failur chloroquin prophylaxi increas fifti percent patient acquir malaria west africa chemoprophylaxi curb rise incid falciparum infect american travel center diseas control revis malaria prophylaxi recommend includ mefloquin area chloroquin resist malaria protect measur travel west africa improv"
"leishmania donovani chagasi clinic variant cutan leishmaniasi hondura surveil endem viscer leishmaniasi island pacif coast hondura unusu form cutan leishmaniasi encount clinic laboratori criteria case identifi month children age year primarili affect lesion general number small papular ulcer present year patient skin lesion healthi nourish montenegro skin test leishmania mexicana major antigen posit patient test lesion patient posit cultur summer case atyp cutan leishmaniasi continu occur island mainland southern hondura total parasit isol skin lesion bone marrow patient kalaazar sandfli identifi donovani chagasi indistinguish isoenzym analysi"
"rapid diagnosi malaria fluoresc microscopi light microscop interfer filter fluorochrom stain detect malaria parasit bloodfilm sensit easier timeconsum giemsa stain standard epiillumin mercuri vapour fluoresc microscop expens tropic countri malaria endem fluoresc microscopi standard light microscop interfer filter special design fluorochrom stain acridin orang detect malaria parasit thick thin bloodfilm system fluoresc colour green nuclei red cytoplasm emit stain parasit thick thin bloodfilm patient malaria examin system bloodfilm fix store year rapid scan thick thin bloodfilm magnif standard lens indic econom system rapid diagnosi malaria"
"exchang transfus adjunct treatment sever falciparum malaria case report review malaria complic fatal outcom caus plasmodium falciparum mortal due diseas parallel degre parasitemia success exchang blood transfus therapeut adjunct infect report efficaci procedur establish random control trial rational form therapi base rapid reduct parasit load direct remov decreas risk sever intravascular hemolysi consequ dissemin intravascular coagul renal dysfunct improv rheolog transfus blood reduc microcirculatori sludg improv oxygencarri capac transfus erythrocyt describ case sever falciparum malaria review literatur describ exchang transfus treatment infect"
"leishmania mexicana complex human infect republ panama parasit genus leishmania respons human cutan leishmaniasi world form major taxonom divis leishmania braziliensi mexicana complex report isol character mexicana complex human republ panama character base parasit morpholog pathogenesi infect golden hamster cellulos acet isoenzym electrophoret mobil membranespecif monoclon antibodi radioimmun bind assay techniqu"
"infect subspeci leishmania braziliensi complex vivo vitro infect leishmania braziliensi ssp relat growth kinet senekji medium determin human macrophag cell line inbr hamster system infect shown distinct subspeci   panamensi promastigot day cultur earli stationari phase infect parasit cultur day  guyanensi  braziliensi reach maximum infect day day late stationari phase growth maximum infect occur stationari growth strict growth phase depend observ popul parasit cultur day compos small high motil promastigot flagella time length cell bodi promastigot resembl infect form transmit sand fli vector distinct patholog pictur character diseas caus refer strain subspeci hamster  guyanensi develop sever lesion moder inconspicu lesion observ  panamensi  braziliensi constitut inocula"
"improv serodiagnost procedur viscer leishmaniasi enzymelink immunosorb assay elisa sensit specif serodiagnost method leishmaniasi report describ versatil assay improv protein protein conjug specif detect leishmania antibodi sera patient viscer leishmaniasi direct comparison antiimmunoglobulin conjug enzymelink protein gave signific higher absorb valu posit sera increas absorb valu sera normal individu patient diseas crossreact leishmaniasi effect increas distanc posit negat valu aid interpret result permit visual distinct posit sera negat weak reactiv sera assay effect blood serum sourc primari antibodi advantag protein antiig conjug abil detect specif antibodi dog human sera final demonstr protein elisa recombin leishmania antigen gp"
"effect multipl month dose ivermectin adult onchocerca volvulus paper assess effect adult onchocerca volvulus month dose ivermectin microgramskg month patient guatemala nodul remov month dose adult volvulus extract collagenas digest studi histolog techniqu compar worm untreat patient twelv month dose kill proport adult worm male femal leav remaind unaffect femal slowli resum embryogenesi dose number femal worm resum embryogenesi genit tract femal total degener ovari ivermectin led mark drop number male worm nodul advers reaction occur treatment accept"
"scabi nurs home erad program permethrin cream permethrin cream treat scabi larg nurs home compassionateplea protocol chronic therapyresist infest resid staff frequent visitor treat symptomat famili member group treat symptomat direct expos scabi hundr nineti person treat diagnos scabi approxim nurs home resid diagnos scabi patient multipl treatment scabicid unsuccess complet studi patient examin efficaci treatment clear lesion medic applic treatment treatment cure rate advers experi occur case mild pruritus rash"
"monoclon polyclon antibodi protect plasmodium yoelii sporozoit primari strategi malaria vaccin develop design subunit vaccin induc protect level antibodi circumsporozoit cs protein malaria sporozoit plasmodium yoelii mous model system vaccin uniform unsuccess protect sporozoiteinduc malaria demonstr antibodi yoelii cs protein provid protect establish passiv transfer model passiv transfer navi yoelii sporozoit nys igg mab yoelii cs protein protect mice challeng yoelii sporozoit bind nys sporozoit inhibit incub qgpgap synthet peptid deriv repeat region yoelii cs protein indic epitop sporozoit recogn mab includ peptid level antibodi qgpgap elisa sporozoit indirect fluoresc antibodi test cs precipit reaction similar sera mice receiv nys passiv transfer protect challeng sporozoit mice immun subunit vaccin qgpgap protect challeng sporozoit determin antibodi avid absolut concentr explain strike differ protect establish thiocyan elut assay result suggest nys protect mab lower avid qgpgap sporozoit vaccineinduc antibodi result convent antibodi assay correl protect sera protect anim inhibit sporozoit develop mous hepatocyt cultur signific sera unprotect subunit vaccineimmun anim correl protect data demonstr antibodi cs protein protect intens sporozoit infect improv understand differ protect mab nonprotect polyclon antibodi import develop malaria vaccin"
"comparison month dose ivermectin treatment onchocerciasi studi design examin optim dose interv administr ivermectin accept drug choic onchocerciasi hundr liberian onchocerca volvulus infect receiv microgramskg ivermectin placebo month reaction dose ivermectin signific initi dose signific microgramskg group skin microfilaria count group treat month microgramskg signific group treat year month initi therapi preval microfilaria anterior chamber punctat corneal opac decreas progress group year slight advantag term antiparasit effect year therapi month compar year"
"communitybas treatment onchocerciasi ivermectin safeti efficaci accept year treatment safeti accept efficaci ivermectin communitybas mass treatment onchocerciasi assess ivermectin distribut time year popul rubber plantat peopl liberia greater adult onchocerca volvulus infect sampl adult microfilari densiti reduc year treatment accept high year advers reaction occur peopl treatment receiv annual dose ivermectin sever advers reaction data show communitybas treatment ivermectin safe accept effect reduc microfilari load suggest ivermectin practic drug suitabl mass treatment campaign control human onchocerciasi"
"effect alkyl modif antimalari activ hydroxypyridin oral iron chelat antimalaria effect iron chelat attribut interact labil iron pool parasitis erythrocyt postul increas affin iron increas lipophil improv antimalari activ present studi examin antimalari effect hydroxypyridin famili bident oral effect iron chelat lipophil modifi alter length substitu ring nitrogen signific doserel suppress plasmodium falciparum cultur observ drug test vitro concentr mumol higher contrast clear segreg vivo effect berghei rat mgkg subcutan categori compound cp fail suppress malaria cp strong antimalari effect similar deferoxamin close linear correl suppress peak parasit count reduct hepat nonhem iron induc drug test lipophil compound effect suppress malaria deplet hepat iron store data hydroxypyrydin suppress malaria vivo vitro lipid solubl import determin antimalari action studi inform select oral effect ironchel compound suitabl clinic applic antimalari agent"
"electrocardiograph pattern stage chaga heart diseas rat  rest electrocardiogram obtain trypanosoma cruziinfect rat day infect phase rest electrocardiogram abnorm group normal group ii anim nineteen similar infect anim serv control rest electrocardiogram ajmalin test perform day infect phase ii iii  regard rest electrocardiogram group anim left axi deviat found phase phase ii phase iii intraventricular conduct delay found rat phase rat phase ii greater rat phase iii greater ajmalin test abnorm rat group normal rest electrocardiogram phase ii anim phase iii greater  intraventricular conduct delay found rest electrocardiogram rat group ii phase iii ajmalin test abnorm rat phase ii rat phase iii  control rat show patholog"
"inabl malaria vaccin induc antibodi protect epitop sequenc saimiri monkey immun recombin protein copi amino acid repeat plasmodium vivax circumsporozoit cs protein develop high concentr antibodi repeat sequenc sporozoit protect challeng intraven inject immunoglobulin monoclon antibodi nvs irradi vivax sporozoit monkey protect sporozoiteinduc malaria remain anim signific longer parasitem epitop map demonstr nvs recogn agdr amino acid repeat region vivax cs protein monkey immun draadgqpag produc antibodi protect epitop agdr determin fine specif protect immun respons critic construct success subunit vaccin"
"rapid microscop detect malaria parasit perman fluorochrom stain blood smear aluminum morin intra extracellular plasmodium parasit fix blood smear easili identifi fluoresc microscopi mordant aluminum ammonium sulfat stain morin pentahydroxyflavanol intens fluoresc prepar stain parasit strong resist photodegrad remain essenti unimpair year"
"detect plasmodium falciparum infect fluoresc dye benzothiocarboxypurin fluoresc dye benzothiocarboxypurin bcp intens stain nucleic acid dye penetr viabl white blood cell stain cell fixat found dye stain nucleic acid viabl plasmodium falciparum subsequ evalu stain falciparum benzothiocarboxypurin red blood cell found red blood cell membran freeli permeabl dye falciparum stain red blood cell find prompt depth analysi dye laboratori field studi altern giemsastain blood smear enhanc microscop diagnosi malari infect field studi bcp dye detect malaria fresh blood level equival giemsa method parasitemia rang bcp stain procedur fix specimen differenti stain characterist lost specimen prepar blind sampl obtain field negat giemsastain thin smear negat thick smear negat bcp analysi found bcp dye offer advantag compar microscop diagnosi falciparum infect standard giemsa stain advantag evid condit low parasitemia speed stain evalu low level train requir provid consist result"
"acridin orang fluoresc microscopi detect malaria popul lowdens parasitemia detect lowdens malaria parasit giemsastain thick smear ts requir time experi impract high sampl load acridin orang fluoresc microscopi aofm capillari centrifug blood offer altern techniqu compar aofm read ts specimen asymptomat peopl thai villag endem malaria aofm specimen prepar modifi capillari tube coat acridin orang quantit buffi coat qbc tube examin fluoresc microscop twenti specimen found posit ts parasitesmicrolit blood parasit microscop field aofm sensit rang plasmodium falciparum stage sensit vari aofm perform falciparum plasmodium vivax asexu sexual stage parasit speci stagespecif result interpret caution small sampl size low parasit densiti involv test specif rang level accuraci advantag aofm suggest test supplement ts improv speci stage differenti screen lowdens parasitemia"
"plasmodium vivax sporozoit antibodi individu expos singl malaria outbreak endem area studi seroreact plasmodium vivax antigen individu live small communiti mantena mina gerai brazil area endem malaria zone brazil month earlier transmiss vivax period day total control chemotherapi insecticid antisporozoit respons measur elisa recombin protein express yeast detect individu month infect persist month eighteen individu treat prophylact malaria live hous overt infect occur individu elisa posit antibodi blood stage parasit individu endem area posit smear ill receiv prophylaxi anticircumsporozoit posit fold serum dilut develop asexu blood stage antibodi remain parasitefre month"
"comparison high dose ivermectin diethylcarbamazin activ bancroftian filariasi haiti phase studi design compar high dose ivermectin standard diethylcarbamazin dec regimen patient toler potenti kill adult filaria durat microfilari suppress haitian subject wuchereria bancrofti microfilaremia mg oral dose ivermectin phase reduc microfilaria densiti particip random group group receiv dec mgkg day day group receiv mcgkg ivermectin group receiv mcgkg ivermectin mcgkg day day drug regimen toler advers reaction reaction occur phase consist primarili headach fever myalgia end phase patient microfilaria negat phase men receiv dec develop scrotal reaction suggest kill adult worm reaction note men receiv ivermectin year follow phase treatment group return pretreat microfilaria level percent baselin microfilaria count group rang group rang group rang individu group microfilarianeg individu microfilarianeg group result suggest dec damag adult worm greater reduct microfilaria densiti ivermectin high dose ivermectin suppress microfilaremia lymphat filariasi period longer previous report"
"immun owl monkey ringinfect erythrocyt surfac antigen plasmodium falciparum aotus nancymai immun mer mer mer repeat peptid ringinfect erythrocyt surfac antigen molecul plasmodium falciparum conjug diphtheria toxoid muramyl dipeptid mdp adjuv immun fail induc protect immun uganda palo alto strain falciparum judg maximum level parasitemia immun monkey relat control fuse polypeptid fpag combin mdp fail induc protect immun maximum level parasitemia serolog respons mer peptid invers correl safeti mdp evid"
"spleen resolv infect plasmodium yoelii role spleen resist infect nonleth plasmodium yoelii depend genotyp host dba mice infect yoelii advers affect remov spleen splenectom cbl balb mice fail resolv infect eventu die level parasitemia lower splenectom mice compar intact control splenectom mice anem spleenintact control splenectomi result larg aggreg mononuclear cell liver infect mice alter liverbodi weight ratio result mice spleenindepend mechan clear parasit lack balb mice"
"onchocercacid effect amocarzin cgp latin america open clinic trial amocarzin carri onchocerciasi patient ecuador guatemala administr food effect fast effect toler regimen mgkg daili food day patient kill femal worm nodulectomi month treatment microfilari skin count great reduc week day day remain low month day follow higher dose day regimen fast show microfilaridermia day year treatment"
"cerebellopontin angl lipoma teenag lipoma cerebellopontin angl rare lesion date patient report adult child cerebellopontin angl lipoma"
"role cellular matur neutrophil heterogen previous studi shown neutrophil pmn characterist heterogen origin pmn heterogen unknown unclear pmn function heterogen secondari matur differ due distinct subpopul cell possess function capac pmn antigen probe evalu pmn subpopul major pmns approxim exhibit high intens fluoresc monoclon antibodi moab label enrich bright pmns determin flow cytometr analysi cell function cell low intens fluoresc diminish dull pmns immunolog clonogen function techniqu studi express antigen hl cell myeloid cell order evalu antigen function heterogen morpholog matur result studi percentag antigen posit antigen enrich diminish bone marrow cell increas myeloblast cell promyelocyt myelocyt band pmns antigen enrich cell myelocyt stage increas band marrow pmns peripher blood pmns data heterogen express antigen pmns due part matur differ pmn popul rais possibl heterogen express pmn characterist matur deriv suggest antigen express precis indic myeloid function matur matur identifi cellular morpholog"
"papillari cystic neoplasm pancrea radiolog patholog characterist case clinic chart radiolog featur macroscop microscop find clinic follow data retrospect review patient papillari cystic neoplasm pancrea pcnp patient women men age year age year greatest diamet pcnps rang cm cm size cm tumour locat tail pancrea bodi head patient complain abdomin pain mass ultrasonograph comput tomographi find show solid mix solid cystic cystic type tumour angiograph pcnp hypovascular mild hypervascular mass displac surround vessel vascular encas macroscop tumour consist defin solid mass degen chang width includ haemorrhag necrosi dystroph calcif repres radiolog type pcnp patient pcnp surviv month curat resect sign local recurr remot metastasi pcnp affect distal portion pancrea young women huge size pcnp explor aggress surgic intent inher good prognosi"
"ca tumour marker gastric cancer date tumour marker gastric cancer prove unreli studi serum marker ca compar serum activ carcinoembryon antigen cea ca consecut seri patient gastric cancer result show ca assay signific separ stage ii diseas normal control cea ca ca gave differenti patient posit negat node serosa posit negat cea differenti patient posit negat node ca ca cea discrimin patient serosa posit negat studi specif cent sensit cea ca ca preliminari find ca reliabl tumour marker diseas stage activ gastric cancer longitudin studi requir full evalu clinic util"
"treatment adenocarcinoma cardia synchron chemotherapi radiotherapi twenti evalu patient adenocarcinoma cardia treat synchron administ chemotherapi cycl fluouracil cisplatin gy radiat determin tumour respons treatment complet regress tumour observ endoscop patient partial regress fourteen patient tumour resect microscop tumour found specimen patient receiv addit radiotherapi total dose gy surgeri tumour respons rapid revers dysphagia patient requir subsequ intervent relief dysphagia due fibrous strictur enhanc surviv complet endoscop respons initi chemotherapi radiotherapi tumour cm length median surviv respond patient month synchron chemotherapi radiotherapi major palliat benefit seri merit evalu"
"manometr evalu jejun limb total gastrectomi rouxorr anastomosi gastric cancer total gastrectomi rouxorr anastomosi frequent perform gastric cancer intestin motil roux limb evalu oper pressur activ investig roux limb ten patient age year undergon total gastrectomi rouxorr reconstruct investig carri fast kcal mix meal fast patient activ front abnorm ten patient display propag burst contract discret cluster contract high amplitud jejun contract fed state character sever reduc motor activ pattern abnorm total gastrectomi rouxorr anastomos provok sever disturb intestin activ"
"intraop ultrasonographi detect liver metastas patient colorect cancer total patient carcinoma colon rectum examin detect liver metastas studi compar preoper ultrasonographi inspect palpat liver surgeri intraop ultrasonographi preoper ultrasonographi inspect palpat identifi metastas patient intraop ultrasonographi detect previous unrecogn metastat tumour surgic procedur high resolut intraop ultrasonographi safe accur preoper imag surgic exploratori method examin simpl perform success relat care attent detail"
"effect gastrin receptor antagonist proglumid surviv gastric carcinoma gastric cancer remain diseas poor prognosi safe effect form therapi advanc diseas evid abund show gastrin stimul growth gastric colorect cancer cell vitro vivo blockad gastrin receptor prolong surviv xenograft nude mice perform random control studi gastrincholecystokinin receptor antagonist proglumid therapi patient gastric carcinoma proglumid effect surviv mantelcox statist confid interv proglumid treat group day compar day control group signific differ proglumid low affin gastrin receptor partial agonist activ drug specif potent gastrin receptor antagonist greater effect surviv clinic trial compound determin efficaci hormon control gastrointestin malign"
"autopsydocu cure multipl myeloma year chemotherapi multipl myeloma diagnos year woman receiv drug chemotherapi protein abnorm subsequ return normal serial bone marrow studi document complet bone marrow remiss destruct bone lesion persist radiograph progress local sigmoid adenocarcinoma resect patient present multipl brain metastas primari pulmonari adenocarcinoma prove rapid fatal autopsi evid multipl myeloma found report describ tissuedocu cure multipl myeloma year diagnosi initi chemotherapi associ multipl myeloma malign discuss"
"prospect evalu radiolog direct fineneedl aspir biopsi nonpalp breast lesion applic fineneedl aspir biopsi fnab diagnosi nonpalp breast lesion evalu method standard needl local mammograph guidanc assur accur sampl fnab method prospect appli mammograph detect breast lesion women age year patient underw surgic excis nonpalp lesion cytolog aspir suffici aspir materi obtain cytolog diagnosi patient histolog cytolog interpret compar twenti malign ultim diagnos histolog invas ductal carcinoma ductal carcinoma situ lobular carcinoma situ cytolog diagnos falseposit diagnos malign fnab falseneg read includ case lobular carcinoma situ case ductal carcinoma situ techniqu demonstr sensit specif diagnost accuraci nonsurg detect malign nonpalp breast lesion result suggest establish safeti reliabl costeffect fnab maintain clinic set procedur obviat open surgic biopsi patient unequivoc diagnosi malign standard techniqu equip communiti hospit"
"acut cell leukemialymphoma mimick hodgkin diseas secondari htlv seroconvers author observ pleiomorph lymphoma mimick hodgkin lymphoma french guyana black woman lack antibodi human cell lymphomaleukemia virus type htlv cours chemotherapi mechlorethamin vincristin procarbazin prednison mopp doxorubicin bleomycin vincaleukoblastin dacarbazin abvd typic acut cell leukemialymphoma develop htlv seroconvers specif htlv dna sequenc detect polymeras chain reaction pcr lymph node biopsi obtain chemotherapi mechan seroconvers discuss"
"immunohistochem studi main entrancerout ca peripher venous blood gastric cancer patient correl ca level peripher portal blood correl ca level portal peripher venous blood immunohistochem variabl cancer lesion examin gastric cancer patient patient benign diseas immunohistochem ca found primari lesion antigen found cancer cell invas lymphat node metastas ca local cancer cancer cell vein show ca antigen cancer cell vein lymphat metastas ca nonloc primari lesion patient ca nonloc cancer benign diseas show elev antigen level peripher portal blood ca level portal blood ml posit rate peripher blood ml posit rate addit antigen level blood patient lymphat invas node metastas signific higher patient invas metastas patient invas show elev antigen result suggest product antigen cancer cell premis ca elev peripher blood ca drain thorac duct lymphat system node metastas invas lymphat hematogen portal system"
"establish erythroid cell line jk spontan differenti red cell author establish hemopoiet cell line jk patient chronic myelogen leukemia erythroid crisi jk line predomin consist immatur cell small number matur erythroblast red cell consist specif differenti induc jk cell grow suspens cultur supplement human plasma carri doubl philadelphia chromosom hemoglobin stain benzidin posit cell type hemoglobin part hbf surfacemark analysi reveal jk cell posit glycophorin ep hae proport matur cell elev addit deltaaminolevulin acid erythropoietin epo enhanc growth jk cell suspens methylcellulos semisolid cultur total number epo receptor cell site affin higher site report establish human erythroid cell line spontan undergo termin differenti"
"mammograph screen women increas risk breast cancer hundr women dalla counti texa particip american cancer societi texa breast screen project select report famili histori breast cancer case match random select women counti famili histori control statist signific trend age increas proport women report undergon mammographi signific differ compar mammograph histori case control control age versus signific case perceiv risk breast cancer moder greater compar control mammograph histori control perceiv risk case control cite lack physician referr cost reason undergon mammographi women increas risk breast cancer famili histori undergo regular mammograph screen awar increas risk"
"murin monoclon antiidiotyp antibodi potenti network antigen human carcinoembryon antigen carcinoma gastrointestin tract curabl standard therapi therapeut approach diseas studi propos antiid mab ag substitut induc antitumor immun gastrointestin cancer patient recent generat character monoclon antiid antibodi design ab mimic biolog antigen distinct specif epitop carcinoembryon antigen cea primarili express high densiti human pancreat colon tumor cell epitop uniqu cea present cearel lower member ag famili found normal tissu antigen determin defin mab ab ab rais absent normal adult tissu immunoperoxidas stain haematopoiet cell includ granulocyt flow cytometri analysi antiid ab induc ceaspecif antibodi mice rabbit immun sera mice rabbit compet ab bind colon carcinoma cell line lst inhibit bind radioiodin ab ab antiantiid ab mice rabbit share idiotop ab monoclon ab bind cea generat mice immun ab polyclon monoclon immunoprecipit cea ab western blot analysi show ident immunostain pattern ab colon adenocarcinoma tissu section patient collect data suggest ab potenti clinic network ag immunotherapi patient cea posit tumor"
"regul hla class ii molecul express ifngamma signal transduct mechan glioblastoma cell line examin signal transduct mechan respons ifngammainduc hla class ii molecul express glioblastoma cell line tg seri experi demonstr activ protein kinas pkc involv dr dp molecul express tg cell addit activ pkc calcium influx involv dr dp molecul express tg northern blot analys actinomycin cycloheximid reveal messeng induc transcript dra dpa gene de novo protein synthesi examin region dpb gene respons ifngammainduc gene transcript gene transfer seri delet mutant upstream region dpb link report gene chloramphenicol acetyltransferas delet mutant region bp critic ifngammarespons element result suggest ifngamma activ pkc stimul calcium influx result induct transcript dra dpa gene de novo protein synthesi dpb gene specul preexit protein phosphoryl pkc presenc ca direct bind indirect interact region bp upstream sequenc lead induct transcript possibl concert nuclear protein bound promot sequenc"
"low dose il inject perilymphat tumorbear mice inhibit growth poor appar nonimmunogen tumor induc tumorspecif immun memori abil ril trigger host reactiv chemic induc fibrosarcoma ce spontan adenocarcinoma ts balb mice studi daili local administr tumor drain lymph node inject progress amount pgday ril induc appreci inhibit growth tumor doserespons surviv curv peak pgday ril direct antitumor activ shown vitro test host immun reactiv play fundament role lymphokin activ tumor inhibit lati lati fact abolish recipi mice subleth irradi treat cyclosporin reactiv cd lymphocyt suppress affect antiasialo gm antibodi morpholog data show ril lati rest recruit cell reaction mechan nonspecif predomin ril lati lead state long specif immun memori growth contralater tumor challeng signific impair lati immun memori place lati poor immunogen ce fibrosarcoma ts adenocarcinoma previous class nonimmunogen basi immunizationprotect test case adopt transfer experi show thi lymphocyt cd celldeplet lymphocyt subpopul respons immun memori final abil ril trigger lati greater effect dose ril ril beta ifngamma associ ril beta induc effect immun memori"
"abnorm process proigfii patient hepatoma hepat virus antibodyposit asymptomat individu hepatoma common malign countri high preval hepat virus infect tumor present sever persist hypoglycemia studi relationship product insulin growth factor ii igfii tumor develop hypoglycemia igfii concentr signific higher patient hypoglycemia patient euglycemia se microgram microgram serum igf suppress patient hypoglycemia microgram patient euglycemia microgram increas percentag igfii serum patient hypoglycemia tumor present partial process proigfii big igfii pass sera patient hypoglycemia patient euglycemia hepatoma acid biogel column found igfii sera patient hypoglycemia present big igfii compar patient euglycemia hepatoma signific normal control appar healthi control subject hepat virus posit increas percentag big igfii suggest abnorm process proigfii result subtl liver function infect remain determin subject increas big igfii increas risk develop hepatoma conclus confirm mark suppress igf sera patient hepatoma hypoglycemia"
"surgic treatment hysterectomi versus coniz cervic carcinoma situ women state mexico diagnos carcinoma situ cervix women underw hysterectomi conserv therapi primarili coniz year period steadi increas percentag women receiv conserv therapi younger women unmarri women american indian women receiv conserv therapi mark shift therapeut approach occur time appar controversi optim treatment cervic carcinoma situ illustr rapid chang surgic practic absenc control trial compar major treatment modal"
"respons oral leukoplakia betacaroten leukoplakia increas risk oral cancer consid premalign lesion retinoid cis retino acid frequent revers leukoplakia drug toxic suitabl largescal prevent oral cancer betacaroten natur occur nontox carotenoid biolog properti suggest efficaci oral leukoplakia began random studi cis retino acid mgkg versus betacaroten mg leukoplakia owe mark differ toxic compound outlin consent form initi elig patient refus particip guarante betacaroten studi design chang phase ii trial betacaroten compound daili month respond patient continu month treatment lesion examin histolog entri respons monitor bidimension measur photographi entri month treatment studi complet twenti evalu patient treat major respons complet partial respons rate confid limit signific toxic requir drug discontinu dose reduct result betacaroten substanti activ oral premalign lack toxic excel candid prevent agent oral cancer"
"pharmacodynam cancer therapi understand anticanc pharmacodynam relationship pharmacolog measur clinic effect grown mark recent year due advanc analyt comput technolog methotrex plasma level empir guid leucovorin dose highdos methotrex therapi standard therapeut drug monitor oncolog recent investig attempt titrat precis dose antineoplast agent base previous deriv model realtim analysi plasma drug tissu concentr studi complet progress hexamethylen bisacetamid etoposid teniposid fluorouracil fura cytarabin ara futur studi focus optim sampl strategi analysi intermedi biochem end point combin chemotherapi modul colonystimul factor sophist pharmacodynam model"
"characterist biolog role steroid hormon receptor neuroepitheli tumor tissu sampl patient neuroepitheli tumor glioblastoma anaplast astrocytoma astrocytoma analyz order evalu presenc estrogen progesteron glucocorticoid androgen receptor glucocorticoid androgenspecif bind protein present case tumor show estrogen progesteron receptor correl found grade anaplasia patient sex age presenc glucocorticoid androgen receptor biolog role receptor investig primari cell cultur deriv neuroepitheli tumor purpos dexamethason testosteron ad cultur medium concentr microgramsml signific stimul cell growth observ glucocorticoid receptorposit cultur dexamethason dose rang microgramml ad cultur modul growth observ glucocorticoid receptorneg cultur dose higher dexamethason dose induc signific decreas growth index independ glucocorticoid receptor status cultur test testosteron activ negat androgen receptor hormon induc inhibit growth index dose rang microgramsml data suggest neuroepitheli tumor specif glucocorticoid androgen bind protein glucocorticoid receptor modul growth cultur neuroepitheli tumor presenc concentr dexamethason"
"lymphocel spectrum scintigraph find lymphocel renal transplant lymphocel recogn complic renal transplant surgeri perform retrospect review renal transplant patient scintigraph exam describ pattern activ technetiummdtpa blood flow dynam imag iodineoih studi diagnost criteria lymphocel ultrason evid periren fluid collect analysi fluid demonstr bun creatinin electrolyt similar patient plasma scintigraph find attribut lymphocel abnorm area ultrasound fluid collect scintigraph find attribut lymphocel resolv patient surgic drainag periton window placement document lymphocel demonstr cold defect initi dynam imag fill equal background activ exceed background case show rim increas activ surround lymphocel rim sign"
"scintigraph evalu aggress fibromatosi benign microscop aggress fibromatosi potenti recur infiltr neighbor tissu determin exact extent therapi present studi case aggress fibromatosi examin scintigraph mtcdimercaptosuccin acid case gacitr case technetiummdimercaptosuccin acid demonstr lesion gacitr detect case"
"ffluoroacetylglucosamin potenti agent cancer diagnosi positron label substrat sugar amino acid nucleosid investig vivo evalu biochem process cancer tissu hexosamin obligatori structur compon biolog import macromolecul includ membran glycoprotein mucopolysaccharid evalu synthes pharmaceut ffluoroacetylglucosamin ffag structur analog acetylglucosamin chhemsnr mice bear spontan hepatoma tissu distribut studi min inject high uptak found tumor dose liver kidney tumor uptak ffag show highest tissu pet studi vx carcinoma rabbit visual preliminari result suggest ffag potenti agent tumor imag"
"desmoplast variant ameloblastoma report case review literatur case desmoplast variant ameloblastoma report lesion year japanes woman success treat partial maxillectomi reconstruct carri block hydroxyapatit year month case includ case report present summar review"
"character effect methyl piperidin deriv hemicholinium cholin transport tertiari methyl quaternari methylpiperidin analog hemicholinium hc previous work laboratori shown inhibitor sodiumdepend high affin cholin uptak system sdhacu effect cholin transport character neuroblastoma cell cell rapid cholin separ mechan sdhacu system sodiumindepend low affin uptak system silacu hc decreas microm cholin transport dosedepend fashion compound unabl decreas cholin transport microm cholin suggest inact respect silacu compound signific increas km vmax sdhacu system suggest competit mechan inhibit ki valu rang microm microm microm hc doserespons curv inhibit cholin transport hc chang hr preexposur cell inhibitor hr preexposur signific doserespons curv obtain compar doserespons curv untreat cell hr preexposur hr recoveri period suffici remov effect compound data suggest hc inhibit sdhacu competit revers"
"increas annual incid primari malign brain tumor elder total ageadjust cancer incid unit state race men women rose averag annual percentag chang analysi report agespecif incid primari malign brain tumor year demonstr incid rate increas dramat incid rate person age year age rate similar increas found men women analyz separ combin averag annual percentag primari brain tumor incid age rang report incid younger person vari period time common histolog type primari brain tumor elder glial origin predomin glioblastoma multiform astrocytoma tumor high malign invari fatal explain increas incid elder introduct extens ray comput tomographi true increas incid occur independ diagnost advanc"
"effect prostaglandin multipl experiment model effect tumorhost interact prostaglandin pge long incrimin immunosuppress cancer patient increas rate tumor growth due impair immunolog respons tumor investig effect pge tumorhost interact util parenter administ longact pge deriv dimethylprostaglandin dpge administr dpge found decreas rate tumor growth cost decreas tumorfre bodi mass dpge alter rest metabol rate alter part brain dopamin metabol signific decreas serum level multipl amino acid conclus elev pge level signific alter metabol tumor patient"
"malign melanoma occur pregnanc report northern israel oncolog center medic record patient treat year period malign melanoma pregnanc review signific detriment prognost effect attribut pregnanc current literatur melanoma pregnanc discuss base pregnanc contraind melanoma patient"
"renal vein leiomyosarcoma case primari leiomyosarcoma renal vein report uniqu featur case includ concomit resect isol hepat metastasi intraop radiat therapi electron microscopi immunohistochem stain confirm diagnosi review previous report case show tendenc slow tumor growth infrequ recurr metastas common primarili lung liver aggress surgic resect adjuv radiat therapi includ intraop radiat therapi recommend adjuv chemotherapi consid benefit present unclear"
"adren carcinosarcoma clinic patholog featur case adren carcinosarcoma report synchron malign adren gland case adren tumor combin carcinomat sarcomat element previous document neoplasm extrem aggress distant metastasi aris sarcomat compon rapid progress multimod therapi"
"util surgic margin radiotherapeut manag soft tissu sarcoma seventi adult patient local soft tissu sarcoma treat radiat therapi surgeri fifti treat excis tumor local recurr twenti receiv radiat excis recurr diseas local failur metastat diseas occur primari tumor multipl previous excis patient treat primari sarcoma local failur patholog wide margin singl margin microscop posit local failur occur tumor enucl grossli posit surgic margin signific local failur common truncal locat compar extrem locat addit factor analyz advers affect prognosi includ tumor grade stage inadequ radiat dose"
"acral melanoma review patient identif prognost variabl hundr patient acral melanoma treat review includ subungu lesion plantar lesion palmar lesion eighti percent present stage diseas age year male outnumb femal seventeen percent black actuari year surviv stage patient stage ii patient univari cox regress analys identifi prognost variabl affect surviv stage diagnosi race ulcer clark level thick primari lesion factor unrel surviv includ sex patient site volar subungu histolog treatment amput multivari analysi patient stage lesion identifi race ulcer signific variabl thick approach signific addit seri patient melanoma aris extrem site junction glabrous glabrous skin surviv signific poorer aris glabrous skin reflect higher incid metastat diseas diagnosi specif activ immunotherapi princip adjuv patient surviv compar report region perfus therapi acral melanoma strong racial predilect carri grave prognosi aris glabrous skin clinic entiti distinct extrem melanoma surgic manag wide excis amput primari lesion"
"longterm experi total implant cathet system cancer patient longterm experi total implant cathet system tic limit retrospect evalu perform longterm complic tic intraven infus cancer patient system implant patient median durat implant week system implant year complic relat surgic factor includ malposit reservoir skin perfor wound dehisc pneumothorax complic relat surgic factor includ drug extravas mechan malfunct vein thrombosi clot reservoir cathet skin infect sepsi total complic rate complic resolv spontan medic treatment patient requir implant system conclud longterm usag tic complic rate remain low make safe viabl altern patient requir longterm intraven therapi"
"cutan malign melanoma rochest minnesota trend incid survivorship rochest minnesota incid case cutan malign melanoma male femal patient diagnos year crude incid rate male femal evalu trend year period show rate increas male femal agespecif rate suggest highest incid occur agegroup year year older male year year older femal lesion common head neck area male lower extrem femal frequent histolog type superfici spread melanoma year surviv diminish patient cutan malign melanoma comparison expect general popul statist signific risk factor surviv depth invas lesion clark level thick lesion histolog type age patient"
"diagnosi corticotropinproduc bronchial carcinoid tumor caus cush syndrom cush syndrom due ectop product adrenocorticotrop hormon corticotropin recogn year tradit clinician thought case due lung carcinoma clinic manifest differ pituitarydepend cush syndrom report case corticotropinproduc bronchial carcinoid tumor clinic biochem indistinguish pituitarydepend cush syndrom review literatur reveal bronchial carcinoid tumor common cush syndrom due ectop secret corticotropin biochem anatom studi frequent indistinguish pituitarydepend cush syndrom difficult diagnos inferior petros sinus sampl corticotropin computer imag chest aid make diagnosi"
"adult cell leukaemialymphoma brazil relat htlv seri fourteen patient adult cell lymphomaleukaemia atll brazil main featur lymphadenopathi hepatosplenomegali hypercalcaemia high leucocyt count abnorm lymphoid cell irregular nuclei seri includ youngest patient atll month analysi monoclon antibodi show matur cell phenotyp cd cd antibodi htlv integr htlv provir dna found eleven patient htlv dna demonstr polymeras chain reaction htlvnegat atll report atll brazil corrobor serolog report htlv endem part countri follow studi requir identifi precis main rout transmiss htlv south america risk factor develop atll carrier"
"local control auricular periauricular extern canal cutan malign moh surgeri hundr nineti patient cutan malign auricl periauricular region cartilagin extern ear canal review tumor common locat preauricular postauricular region helix concha antihelix ear canal lesion excis moh microscop control margin lesion requir tempor bone resect adapt freshtissu microscop control analyz deep anterior margin suspect harbor residu tumor year minimum follow patient periauricular auricular tumor tumor patient cartilagin ear canal tumor tumor reveal recurr rate recurr common case larg tumor greater cm basal cell carcinoma morphea element multipli recurr lesion conclud moh surgeri compar effect uniform curat adapt supplement excis larg tumor region"
"clinic classif stage primari malign maxillari antrum studi patient primari malign maxillari sinus neoplasm conduct patient neck node metastas year follow tumor stage american joint committe cancer stage system maxillari sinus cancer earli stage advanc tumor system cox regress analys surviv curv show increas wors prognos advanc tumor stage system analys show signific differ surviv system signific differ surviv treatment modal histolog type malign conclud system prognost success stage demonstr signific improv detect versus differ compar system system appli equal epidermoid cancer malign antrum"
"somatostatinreceptor imag local endocrin tumor background method number tumor receptor somatostatin evalu efficaci scan ilabel tyroctreotid somatostatin analogu tumor local patient carcinoid tumor pancreat endocrin tumor paraganglioma evalu respons octreotid therapi patient result primari tumor metastas previous unrecogn visual patient carcinoid tumor patient pancreat endocrin tumor endocrin symptom patient respond therapi octreotid patient paraganglioma tumor tempor tympan jugular carotid vagal tumor visual small tympan tumor small carotid tumor scan conclus ilabel tyroctreotid scan techniqu rapid safe procedur visual tumor somatostatin receptor posit scan predict abil octreotid therapi control symptom hormon hypersecret"
"intraop radioimmunodetect ovarian cancer monoclon antibodi portabl gammadetect probe assess radioimmunoguid surgeri intraop detect ovarian cancer monoclon antibodi radiolabel handheld gammadetect probe women ovarian cancer undergo exploratori laparotomi recogn tumor glycoprotein tag inject day preoper intraperiton case intraven rout intraop abdomen survey probe probe count correl biopsi excis specimen studi routin histolog stain probe count posit evalu patient histolog confirm diseas patient probe detect cancer specimen interpret normal frozen histolog section probe identifi microscop cancer patient gross diseas specif probe preoper comput tomographi normal patient includ tumor larg cm pilot studi show abil radioimmunoguid surgeri detect occult ovarian cancer"
"prognost factor outcom surviv laparotomi patient advanc ovarian carcinoma ovarian cancer stage iibiv pretreat variabl variabl obtain intraop laparotomi investig prognost influenc outcom patient surviv laparotomi patient subject random trial sequenti versus altern combin chemotherapi median surviv laparotomi month logist regress analysi identifi stage hysterectomi bilater salpingooophorectomi omentectomi signific prognost covari laparotomi outcom base cox multivari stepwis analysi independ prognost factor surviv laparotomi secondari residu tumor size pretreat histolog differenti grade perform status high differenti grade good perform status start therapi prolong effect surviv laparotomi prognost power pretreat variabl increas substanti addit secondari residu tumor size variabl year surviv rate laparotomi high lowrisk patient laparotomi prognost inform patient advanc ovarian carcinoma benefit term surviv unclear"
"ovarian metastas rare stage adenocarcinoma cervix year period univers california los angel medic center case adenocarcinoma adenosquam carcinoma uterin cervix review determin incid ovarian metastas stage diseas patient underw exploratori laparotomi radic hysterectomi microscop ovarian metastasi literatur review identifi addit patient ovarian metastas stage adenocarcinoma cervix includ seri report rate ovarian metastas ten patient addit characterist postmenopaus adnex patholog posit pelvic lymph node ovarian preserv warrant premenopaus patient ovarian patholog evid metastat diseas surgeri bilater oophorectomi perform frozensect examin enlarg suspici node document metastas ovari left pelvi complet surgic procedur microscop spread pelvic tissu document pelvic irradi administ"
"fallaci screen interv cervic smear hundr seventi women invas cervic carcinoma interview cervic smear histori assess accuraci report relat smear histori patient tumor characterist patient report signific frequent recent normal smear document medic record interv onset cancer symptom previous smear correl direct advanc stage sixteen women normal smear month signific advanc cancer women recent abnorm smear women recent normal abnorm smear similar sociodemograph behavior characterist inaccuraci patient report smear histori cancer develop women recent normal smear conclud specif screen interv reli"
"coldknif laser coniz cervic intraepitheli neoplasia year studi women coniz perform cervic intraepitheli neoplasia cin ii iii coniz perform case posit endocerv curettag colposcopi inconclus case local destruct oper choic earli year studi coniz coldknif method laser part studi success complic rate method abnorm cytolog coniz found total case histolog confirm residu recurr cin made women correspond success rate coldknif laser coniz cin grade residu recurr cin similar cin diagnosi cone success rate compar seri strict referr criteria polici adequ"
"primari invas carcinoma vagina retrospect review conduct women invas carcinoma vagina document exposur diethylstilbestrol univers california irvin medic center long beach memori medic center saddleback memori medic center forti squamous cell carcinoma adenocarcinoma thirti treat pelvi irradi brachytherapi surgeri combin treatment crude correct year surviv rate entir group previous pelvic surgeri develop treatmentrel complic statist signific correl previous hysterectomi diagnosi primari invas carcinoma vagina onset symptom women diagnos routin examin symptom onset tend surviv advantag women includ hysterectomi counsel continu gynecolog cancer surveil age"
"carbon dioxid laser vapor diaphragmat metastas cytoreduct ovarian epitheli cancer patient intern feder gynecolog obstetr state iiic ovarian adenocarcinoma underw laser vapor largevolum cm miliari hemidiaphragmat metastas conclus standard debulk surgeri effect optim cytoreduct destruct diaphragmat metastas accomplish rapid ad morbid blood loss handheld laser modal remov isol larg smallvolum diaphragmat diseas peritoneum involv avoid morbid accompani entri pleural space"
"detect preval prognosi asymptomat carcinoma cervix patient treat infiltr carcinoma cervix asymptomat time diagnosi sixteen patient stage ia stage ib stage iia diseas asymptomat patient repres stage ia stage ib stage iia netherland popul screen cervic carcinoma conduct women age year examin preval asymptomat cervic carcinoma detect age group studi patient refer depart patient younger year cervic carcinoma asymptomat diseas detect incident screen group year older detect incident screen age categori year asymptomat patient age year undergon popul screen incident screen patient year older asymptomat diseas signific preval younger patient asymptomat patient stage ib higher suffer tumor recurr symptomat patient stage ib stage iia tumor recurr favor prognosi patient asymptomat carcinoma asymptomat present shown signific prognost factor tumor diamet lymph node status"
"find treatment colon cancer patient colon cancer involv region lymph node stage diseas year surviv rate major die recurr diseas recent trial shown increas surviv rate postop fluorouracil levamisol author discuss find implic treatment recommend stage colon cancer"
"clone cdna human lipoxygenas fulllength cdna clone encod lipoxygenas arachidonateoxygen oxidoreductas ec isol human platelet cdna librari cdna human reticulocyt lipoxygenas probe initi screen cdna open read frame encod amino acid residu calcul molecular weight independ clone reveal minor heterogen dna sequenc posit deduc amino acid sequenc choic amino acid deduc sequenc clone plt show ident human reticulocyt lipoxygenas ident human leukocyt lipoxygenas lipoxygenas cdna recogn kilobas mrna speci platelet human erythroleukemia cell hel cell phorbol tetradecanoyl acet induc megakaryocyt differenti hel cell lipoxygenas activ increas mrna lipoxygenas ident clone lipoxygenas assur express mammalian cell line cos cell human platelet lipoxygenas difficult purifi homogen clone cdna increas possibl elucid structur function enzym"
"mutat colorect cancer immunohistolog stain primari colorect carcinoma antibodi specif demonstr gross overexpress protein approxim malign tumor examin benign adenoma negat overexpress determin molecular basi overexpress examin protein express colorect cancer cell line cell line express high level elisa cellstain immunoprecipit studi direct sequenc chemicalmismatchcleavag analysi cdna polymeras chain reaction cell line show cell line express high level synthes mrnas encod mutant protein cell line express lower point mutat detect conclud overexpress synonym mutat mutat detect simpl immunohistochem analysi mutat gene commonest genet develop human colorect cancer"
"chemic carcinogenesi rodent carcinogen administr chemic maximum toler dose mtd standard anim cancer test postul increas cell divis mitogenesi turn increas rate mutagenesi carcinogenesi anim data consist mechan high proport half chemic test natur synthet rodent carcinogen conclud low dose human exposur cell kill occur hazard human rodent carcinogen lower common assum"
"gdhpdoa clinic mr imag brain part phase ii clinic trial patient presum intracrani neoplast diseas underw magnet reson mr imag intraven inject gadolinium triscarboxymethylhydroxypropyltetraazacycl ododecan hpdoa neutral nonion gadolinium chelat lower osmol formul equimolar concentr superior vitro stabil compar gadopentet dimeglumin safeti profil gdhpdoa permit administr dose mmolkg time dose gadopentet dimeglumin approv food drug administr limit clinic trial gdhpdoa prove safe efficaci agent mr imag head chang document patient monitor slight skin red inject site immedi administr patient statist signific due administr agent note laboratori evalu result differ obtain gadopentet induc transient rise serum iron bilirubin level patient administr higher dose gdhpdoa mmolkg provid improv enhanc decreas efficaci high dose note"
"primari ewe sarcoma follow ga scintigraphi avid accumul gallium citrat technetiumm methylen diphosphon mdp occur initi case primari ewe sarcoma uptak therapi defin thirti patient ewe sarcoma underw ga bone scintigraphi diagnosi complet therapi relaps evalu patient show primari site ga activ therapi twenti patient underw bone scintigraphi show uptak residu activ intens ga avid reaccumul ga occur patient primari site relaps patient underw bone scintigraphi show chang conclud greater decreas ga tcm mdp uptak occur patient success treat primari ewe sarcoma inform obtain ga scintigraphi result bone scintigraphi remain abnorm occult relaps suspect"
"endorect ultrasonograph stage rectal carcinoma endorect ultrasonographi valuabl imag method examin rectum perirect tissu assess patient rectal carcinoma prospect mhz endorect transduc determin depth invas rectal wall tumor presenc lymphadenopathi tumor stage astlercol modif duke stage system result compar histolog stage surgic specimen ultrasonographi accuraci sensit specif detect invas perirect fat ultrasonographi sensit detect perirect lymphadenopathi specif distinguish benign malign node"
"invas lobular carcinoma mammograph find year experi januari decemb case breast carcinoma diagnos treat malmo general hospit malmo sweden case involv invas lobular carcinoma ilc mammographi case demonstr find spicul opac architectur distort poor defin opac normal benign find parenchym asymmetri radiograph definit ilc lesion vari great project craniocaud view demonstr signific find frequent obliqu view secondari radiograph find present microcalcif rare physic find present diffus growth pattern tendenc form lesion opac equal parenchyma ilc extrem difficult detect mammograph radiologist alert subtl mammograph sign malign high suspici abnorm physic find mammograph"
"mammograph follow lowsuspicion lesion complianc rate diagnost yield recommend mammograph follow lowsuspicion lesion mammographi month period review establish complianc rate eventu outcom hundr forti mammogram show minim abnorm warrant shortterm period mammograph follow rate complianc month year progress mammograph chang found patient carcinoma conclud mammograph follow lowsuspicion lesion reason altern surgic biopsi patient complianc remain signific problem"
"insulinoma local select intraarteri inject calcium facilit noninvas preoper local islet cell tumor mm diamet author examin calcium insulin secretagogu arteri stimul venous sampl asv techniqu patient episod hypoglycemia calcium glucon meq cakg inject direct branch celiac plexus gastroduoden splenic hepat arteri superior mesenter arteri patient serum level insulin rose abrupt blood sampl hepat vein infus calcium arteri suppli tumor inject arteri suppli tumor result similar rise accur local insulinoma verifi surgeri patient fourth patient undergo surgeri arteriograph result posit insulinoma predict site basi result author noninvas asv replac invas portal venous sampl effect method local occult insulinoma"
"select catheter inferior petros sinus cathet design cathet select catheter left inferior petros sinus develop replac complex tipdeflector catheterguidewir system cathet easili form common straight cathet steam success test patient complic minor groin hematoma"
"petros sinus sampl techniqu rational bilater simultan sampl inferior petros sinus extrem sensit specif accur test diagnos cush diseas distinguish entiti ectop acth syndrom valuabl small hormoneproduc adenoma pituitari gland inferior petros sinus connect cavern sinus ipsilater intern jugular vein anatomi anastomos inferior petros sinus intern jugular vein venous plexus base skull vari catheter inferior petros sinus addit variat size anatomi present inferior petros sinus patient advanc prepar requir petros sinus sampl teamwork critic element member staff procedur sampl proper label process store specif needl guid wire cathet recommend procedur procedur perform specif attent area potenti technic difficulti catheter common femor vein cross valv base left intern jugular vein select catheter inferior petros sinus specif method deal area sine qua correct cathet posit inferior petros sinus demonstr reflux contrast materi ipsilater cavern sinus imag obtain document correct cathet posit special attent paid point prevent potenti complic patient adequ dose heparin inject contrast materi inferior petros sinus surround vein gentl care procedur perform outlin inferior petros sinus catheter patient complic rate low theoret risk major morbid death occur knowledg common complic groin hematoma"
"spindl epithelioid cell nevus spitz nevus natur histori biopsi clinic follow studi case spindl epithelioid cell nevus present address question potenti local recurr lesion initi excis en toto remaind case posit margin spindl epithelioid cell nevi reexcis evid residu nevus found case recurr patient averag follow period year rang year rariti recurr spindl epithelioid cell nevus justifi conserv approach manag clinic follow recommend subtot excis patholog diagnosi unequivoc"
"occup sunlight exposur melanoma navi melanoma common cancer testicular cancer male navi wide rang occup vari exposur sunlight etiolog agent present navi personyear risk case malign melanoma ascertain computer servic histori inpati hospit file maintain naval health research center total confirm case melanoma identifi activeduti white male enlist navi personnel risk melanoma determin individu occup occup group review job descript categori sunlight exposur indoor outdoor indoor outdoor compar civilian popul personnel indoor occup higher ageadjust incid rate melanoma person work occup requir spend time indoor outdoor lowest rate incid rate melanoma higher trunk common sunlightexpos head arm singl occup found elev rate melanoma aircrew surviv equipmentman sir engineman sir case melanoma excess risk occup similar job descript find anatom site melanoma studi suggest protect role regular exposur sunlight fit recent laboratori studi shown vitamin suppress growth malign melanoma cell tissu cultur mechan propos vitamin inhibit previous initi melanoma clinic appar"
"control interleukin beta express protein kinas cyclic adenosin monophosph myeloid leukemia cell examin signal transduct pathway lead express interleukin beta il beta gene human myeloid leukemia cell line cell line repres stage differenti hl promyelocyt thp matur monocyt accord previous studi observ protein kinas pkc activ phorbol myrist acet pma suffici stimulus induct il beta messeng rna mrna express il beta protein product cell line structur analog cyclic adenosin monophosph dbcamp agent elev endogen camp level prostaglandin forskolin induc il beta express strong enhanc pmainduc il beta product il beta mrna accumul nuclear run analysi show elev il beta mrna level due increas rate transcript dbcamp ad hour pma cultur enhanc il beta product impli enhanc effect signal present simultan pkc inhibitor block effect pma dbcamp induc il beta product protein kinas pka inhibitor ha effect suggest pka activ involv mechan action camp case collect present find show campdepend signal posit regulatori effect pkcdepend activ il beta gene cell deriv stage myeloid differenti"
"potenti erythropoietin respons dimethyl sulfoxid prime erythroleukemia cell evid interact signal pathway erythropoietin epo dimethyl sulfoxid dmso believ induc differenti transform erythroid cell signal transduct pathway obtain evid interact pathway rauscher murin erythroleukemia cell line low hemoglobin respons epo pretreat cell day dmso remov addit epo result mark enhanc epo specif hemoglobin design effect dmso prime prime effect dmso epo respons timedepend dmso concentrationdepend dmso prime potenti epo respons dmso prime increas total number epo respons cell dmso prime reduc time requir reach optim epoinduc respons day day epo doserespons curv leftshift approxim fold dmso prime mark increas epo receptor densiti character appar receptor popul posit cooper receptor result suggest dmso prime effect due potenti epo signal pathway result rapid dramat epoinduc hemoglobin respons"
"vitro drug sensit cell children leukemia mtt assay improv cultur condit knowledg drug resist childhood leukemia acut lymphoblast leukemia general limit lack suitabl vitro drug sensit assay part due low vitro cell surviv recent adapt high effici dimethylthiazolyldiphenyl tetrazolium bromid mtt assay test cell patient show result compar disc assay valid labori assay studi vitro drug sensit assess cell children leukemia mtt assay dose respons curv obtain mercaptopurin thioguanin tg prednisolon pred daunorubicin dnr vincristin vcr cytosin arabinosid ara asparaginas asp mafosfamid mustin cytotox effect methotrex detect case larg interindividu differ drug sensit detect compar leukemia cell newli diagnos patient leukemia cell relaps patient signific vitro resist tg pred ara mafosfamid mustin dnr vcr asp improv cultur medium method increas mtt reduct studi compon test addit insulin bovin serum albumin serum medium improv cell surviv addit succin increas amount mtt reduct conclud vitro mtt assay high facilit largescal studi drug resist patient lead ration improv exist treatment protocol"
"analysi interferoninduc gene cell chronic myeloid leukemia patient respons resist interferonalpha treatment recombin human interferonalpha ifnalpha induc hematolog remiss patient chronic myeloid leukemia patient resist develop late resist ifnalpha treatment understand molecular mechan resist analyz express ifninduc gene cell resist patient respons patient healthi control northern blot hybrid show gene induc vitro ifnalpha treat peripher blood cell patient healthi control gene induc peripher blood bone marrow cell resist patient administ inject ifnalpha conclud resist ifnalpha treatment chronic myeloid leukemia patient studi due absenc induct ifninduc gene studi includ lowmolecularweight oligoadenyl synthetas presenc antagonist ifnalpha peripher blood bone marrow cell presenc neutral antiifnalpha antibodi"
"serum erythropoietin level patient receiv intens chemotherapi radiotherapi investig potenti role recombin human erythropoietin rhepo patient receiv intens cytotox therapi measur endogen level epo patient undergo bone marrow transplant bmt seventeen patient underw allogen bmt underw autolog bmt averag unit red blood cell rbcs transfus patient rbc transfus requir autolog bmt patient signific greater allogen recipi group maintain compar hematocrit epo level measur radioimmunoassay ria patient baselin serum epo level determin time admiss hospit subsequ sampl collect hour complet chemotherapi radiotherapi day bmt hematocrit hcts measur daili patient initi serum creatinin equal mgdl differ absolut epo level individu characterist pattern observ admiss hospit initi cytotox therapi averag hct decreas averag epo level initi increas serum epo level peak day postbmt muml fell steadili averag hcts day day postbmt signific averag serum epo level decreas fourfold period day postbmt epo level inappropri low compar refer popul bone marrow failur normal control receiv cytotox therapi conclud endogen epo respons blunt week immedi postbmt clinic trial assess efficaci administr rhepo treatment anemia cytotox therapi warrant"
"efficaci interferon bowenoid papulosi precancer lesion preliminari result open random trial recombin interferon gamma patient suffer bowenoid papulosi recombin interferon gamma subcutan patient daili dose inject patient assign treatment group consist continu therapi group subcutan inject week week intermitt block therapi group week cycl consist inject day cycl intermitt singledos therapi group week cycl consist subcutan inject day cycl twentysixth week onset therapi complet respons patient treatment group treatment group patient respond partial result suggest contrast condylomata acuminata bowenoid papulosi lesion respond continu intermitt interferon gamma inject"
"aid kaposi sarcoma classic endem african type treatment low dose recombin interferonalpha treatment classic endem african form kaposi sarcoma ks radiat therapi chemotherapi wide vari degre success morbid report preliminari experi low dose recombin interferon alfab rifn alphab treatment type ks link acquir immunodefici syndrom aid ten consecut patient patient classic endem ks median age year treat longterm unit rifn alphab introna subcutan time week month patient present cutan diseas addit viscer involv month treatment patient major respons cutan lesion patient show stabl skin diseas patient addit viscer diseas patient show complet regress intramyocardi tumor involv atrium ventricl patient stabil viscer lesion mark symptomat improv occur longterm result median durat month rang satisfactori ifnalpha continu control ks patient treatment general toler side effect observ preliminari data suggest lowdos rifn alphab regimen effect classic endem african ks studi establish exact role ifnalpha altern radiat chemotherapi"
"clinic evalu interferon malign melanoma evalu interferon treatment malign melanoma treatment advanc diseas interferon sole agent combin agent studi interferon adjuv therapi highrisk primari melanoma patient result publish date human interferon alpha produc low respons rate sole agent combin cimetidin respons rate achiev recombin alpha interferon give respons advanc melanoma combin cimetidin enhanc respons rate recombin alpha interferon combin interferon cimetidin monoclon antibodi cytotox small improv respons rate dtic recombin interferon alphaa shown produc object respons rate low toxic mainten qualiti life random trial dtic sole agent compar combin treatment conduct determin signific find"
"longterm adjuv therapi highrisk malign melanoma interferon alpha fifti highrisk melanoma patient stage patient stage ii treat standard surgic intervent adjuv therapi recombin interferon alphab rifn alpha therapi total period month concomit patient stage stage ii ident stage prognost factor adjuv therapi evalu efficaci rifn alpha therapi differ year relaps incid surviv rate detect patient stage stage ii benefit longterm adjuv rifn alpha therapi treatment period month incid relaps lower comparison control stop treatment incid relaps equal treat control group result studi suggest continu lowdos rifn alpha therapi adjuv treatment malign melanoma"
"interferon alpha etretin combin treatment cutan cell lymphoma eleven patient suffer cutan cell lymphoma mycosi fungoid treat recombin interferon alphaa combin patient patient combin treatment clinic complet remiss experienc partial remiss patient progress therapi nonevalu stop treatment earli due side effect dosag interferon million unit daili month time week etretin mgkg oral studi show recombin interferon alphaa combin etretin induc remiss cutan cell lymphoma"
"cytostat cytotox effect recombin tumor necrosi factoralpha sensit human melanoma cell vitro result select cell enhanc marker malign monolay cultur human melanoma cell line stml stml stml twenti subcultur skmel deriv specimen repres stage tumor progress treat ml rtnfalpha appli effect rtnfalpha cell prolifer dna synthesi cell viabil clone effici cell divis cell morpholog immunophenotyp studi triplic experi cell line stml reveal signific dosedepend reduct growth due cytostat cytotox activ rtnfalpha decreas ce increas number cell prophas observ addit tnfalpha addit disloc chromosom metaphas format micronuclei dosedepend increas cell exhibit micronuclei dna amount cell detect end treatment hand slight sensit antiprolif effect rtnfalpha observ stml skmel stml stml signific resist cell line serial subcultiv present common phenotyp pattern malign characterist cell line stml treatment rtnfalpha enhanc malign immunophenotyp cell line test increas express late melanoma progress marker ki decreas express earli progress marker express hla hladr icam enhanc rtnfalpha treatment contrast cytokin rtnfalpha induc de novo express hladr hladrneg melanoma cell line find rtnfalpha induc cytostasi decreas cell viabil rtnfalphasensit melanoma cell effect result select rtnfalphasensit human melanoma cell popul higher prolifer rate aggress immunophenotyp vitro"
"high incid antibodi htlv tax blood relat adult cell leukemia patient adult cell leukemia atl caus human cell leukemia virus type htlv mechan leukemogen process unknown tax gene role process cluster occur htlv atl member atl famili examin antibodi tax protein compar match htlvposit blood donor investig antibodi respons protein plasmid pbhx construct express recombin tax protein tax atl patient htlv antibodyposit blood relat rate seroreact tax protein compar htlv antibodyposit control blood donor differ direct offspr atl patient match htlv blood donor greater  tax antibodi posit direct offspr atl patient reflect differ time rout htlv infect altern reflect genet differ host suscept virus strain"
"fastigi pressor respons case report distinct vasomotor cardioregulatori respons identifi experiment elicit intraop year girl local mechan stimul vicin fastigi nucleus cerebellum find discuss light current experiment knowledg anatomi physiolog fastigi pressor respons"
"correl surviv daumasduport grade system astrocytoma order examin correl prognosi histolog featur nuclear atypia mitosi endotheli prolifer necrosi supratentori adult astrocytoma author review case treat massachusett general hospit point presenc featur total number featur translat grade featur grade patient featur grade patient featur grade patient featur grade patient period surviv signific grade presenc absenc histolog featur patient age type oper radiat therapi extent tumor log rank variabl grade age radiat therapi adjust variabl cox proportionalhazard model differ surviv time patient grade statist signific compar group patient examin term age receipt radiat therapi median surviv time differ mark patient year age median surviv time month grade tumor month grade tumor month grade tumor patient year age median surviv time month grade tumor month grade tumor patient receiv radiat therapi median surviv time month grade tumor month grade tumor month grade tumor patient receiv radiat therapi median surviv time month grade tumor month grade tumor half patient die month surgeri grade system origin propos daumasduport al simpl object reproduc correl surviv time author recommend astrocytoma grade scale grade reserv rare adult supratentori astrocytoma histolog featur"
"intratumor oxygen pressur malign brain tumor oxygen pressur po brain tumor po brain cortex surround tumor pao measur simultan total resect patient previous untreat brain tumor order detect hypox region tumor inhal ono ratio enfluran anesthesia pao mm hg high compar obtain air inhal atmospher pressur simultan measur intratumor po po brain cortex surround tumor mm hg intratumor po signific lower po brain cortex surround tumor mm hg wilcoxon sign rank test influenc oxygen effect radiat result confirm hypox region human brain tumor comparison intratumor po angiograph contrastenhanc computer tomographi scan tumor vasculatur disclos correl"
"photodynam therapi spontan cancer felin canin snake chloroaluminum sulfon phthalocyanin report photodynam treatment generat sensit chloroaluminum sulfon phthalocyanin caspc spontan aris tumor photodynam therapi pdt snake neoplasm cat dog snake present varieti tumor type squamous cell carcinoma mast cell malign tumor mix carcinomasarcoma intraven inject mg caspc kilogram bodi weight hour prior irradi nm light larger tumor greater cm deep surgic debulk prior pdt signific system toxic skin photosensit observ anim tumor respons compar convent cryotherapi hyperthermia surgeri pdt caspc case led complet respons partial respons respons reduct tumor size case evalu tumor respons caspc good problem skin photosensit nonexist expect caspcpdt erad human tumor yield compar result studi longterm follow optim caspcpdt veterinari human medicin"
"increas express laminin receptor human colon cancer propos cellsurfac protein capabl interact laminin kd highaffin laminin receptor play crucial role tumor invas metastasi studi express lamininreceptorprecursor messeng rna mrna kd protein analyz human colon adenocarcinoma patient colon cancer found fold increas level lamininreceptorprecursor mrna cancer tissu compar match normal adjac colon mucosa case studi level kd laminin receptor detect affinitypurifi antilamininreceptor synthet peptid antibodi immunoblot match tumor normal tissu extract higher colon carcinoma tissu immunodetect laminin receptor tissu section antilamininreceptorpeptid antibodi confirm increas express laminin receptor specif cancer cell seri paraffin section colon lesion observ correl express laminin receptor duke classif observ increas express lamininreceptorprecursor mrna enhanc level kd laminin receptor invas phenotyp colon carcinoma detect metastasi gene product valuabl adjunct evalu human colon cancer"
"effect prior cancer chemotherapi human tumorspecif cytotox vitro respons immunopotenti biolog respons modifi tumorspecif cytotox measur fresh human biopsi specimen modif differenti stain cytotox assay imuvert cytokin induc deriv serratia marcescen produc broadspectrum activ macrophag lymphocyt dramat effect test tumor obtain patient previous treat chemotherapyrespons adenocarcinoma breast ovari test tumor obtain previous untreat patient previous treat patient chemotherapyrefractori adenocarcinoma colon lung pancrea stomach kidney gallbladd uterus prostat similar find relat prior chemotherapi treatment status obtain tumor necrosi factor interferon gamma interleukin interferon alpha basi find evid literatur specul respons chemotherapi produc massiv releas process tumor antigen specul respons lead state human immun system prime situ vaccin respond exogen macrophageactiv signal potent specif antitumor effect"
"comparison diet biochem characterist stool urin chines popul low high colorect cancer rate investig role diet stool biochemistri human colorect carcinogenesi hour food urin stool sampl collect random select particip popul fourfold differ colorect cancer risk chines sha giao peopl republ china low risk chineseamerican similar age san francisco counti calif unit state high risk find support hypothes colorect cancer risk increas consumpt highfat highprotein lowcarbohydr diet high level cholesterol stool increas daili output methylhistidin malonaldehyd urin risk increas low stool bulk low total stool fiber"
"phase trial piritrexim capsul prolong lowdos oral administr treatment advanc malign phase trial piritrexim conduct prolong lowdos oral schedul number regimen test includ daili dose day day drug therapi continu dose daili dose day consecut week week rest dose escal accomplish increas dose frequenc day day time day increas number day administr fifti patient advanc cancer enter studi hundr twenti cours consid assess myelosuppress prove doselimit toxic effect toxic effect includ stomat nausea vomit anorexia diarrhea skin rash fatigu elev liver transaminas level antitumor activ observ patient melanoma bladder cancer diseas stabil occur sarcoma pheochromocytoma recommend dose schedul phase ii clinic trial mg time day day consecut week week drug therapi"
"hematoporphyrin photodynam therapi futur head neck oncolog reflect year experi photodynam therapi consist select destruct tumor combin photosensit administ system dihematoporphyrin ether argon dyepump laser provok profound interest oncologist titil head neck oncologist potenti multiinstitut trial head neck tumor introduc literatur replet anecdot report individu research manag advanc cancer palliat superfici earli cancer field cancer mucosa condemn mucosa person year experi head neck cancer review current literatur attempt made place perspect true role futur direct technolog"
"extend retrolabyrinthin transtentori approach petrocliv lesion communic extens retrolabyrinthin approach permit safe effect access petrous tip clivus present basic techniqu involv complet mastoidectomi preserv middl ear structur remov sigmoid middl fossa plate middl posterior fossa craniotomi ligat superior petros sinus divis tentorium case exemplifi versatil approach constitut basi paper cholesteatoma basilar arteri aneurysm chordoma meningioma indic complic method discuss"
"metalloproteinas gene specif express stromal cell breast carcinoma gene identifi express specif stromal cell surround invas breast carcinoma basi sequenc product gene stromelysin member famili metalloproteinas enzym degrad extracellular matrix suggest stromelysin stromaderiv factor long postul play import part progress epitheli malign"
"germlin transmiss mutat gene cancerpron famili lifraumeni syndrom tumour suppressor gene usual function control normal cell prolifer implic inherit sporad form malign evid support concept tumour format lossfunct mutat suppressor gene predict hit model knudson demar suppressor gene affect manner numer mutat occur varieti human tumour mutat repres loss allel substitut singl base analys gene famili affect lifraumeni syndrom rare autosom domin syndrom character occurr divers mesenchym epitheli neoplasm multipl site instanc neoplasm relat exposur carcinogen includ ioniz radiat lifraumeni famili studi noncancer skin fibroblast nsf unusu radiationresist phenotyp dna deriv nsf cell famili member span generat point mutat codon ggcgac gene mutat lead substitut aspart acid glycin region identifi frequent target point mutat nsf cell line mutat retain normal allel inherit mutat predispos member famili increas suscept cancer"
"intracerebr solitari plasmacytoma report rare occurr intraparenchym plasmacytoma review literatur clonal natur neoplasm demonstr immunohistochem molecular techniqu import techniqu rule patholog entiti stress"
"moh micrograph surgeri moh micrograph surgeri versatil techniqu treatment nonmelanoma skin cancer recurr invas infiltr basal cell carcinoma unsurpass cure rate surgic margin control achiev maxim preserv normal tissu conclus tumor extirp defect readi reconstruct understand moh micrograph surgeri techniqu effect part coordin multidisciplinari approach treatment patient difficult cutan paracutan neoplasm"
"transhepat portal vein catheter local insulinoma tenyear experi import factor manag insulinoma abil local tumor accur surgeri prospect carri transhepat portal venous sampl thpvs tumor local patient organ hyperinsulin year period patient underw thpvs singl tumor subsequ identifi surgic maxim insulin gradient locat vicin tumor case specif region tumor basi site maxim insulin gradient region tail bodyneck region headuncin region gave sensit specif contrast specif cutoff level insulin gradient guid presenc tumor region increas accuraci lead signific loss sensit compar increas specif major complic procedur patient initi comput tomographicultrasound scan select angiographi local tumor subsequ thpvs led accur preoper local tumor submit surgeri surgeon identifi tumor correct oper fail tumor uncin head patient prove establish organ hyperinsulin thpvs continu region tumor pancreat head uncin process preclud noncur oper bodi tail pancrea"
"myogen regulatori protein myod express childhood solid tumor diagnost util rhabdomyosarcoma transcript muscl regulatori gene myod express normal skelet muscl myogenesi rhabdomyosarcoma tissu softtissu sarcoma report distribut myod protein determin reactiv antimyod polyclon sera normal tissu rhabdomyosarcoma cell line varieti pediatr solid tumor distribut myod protein high restrict normal tissu detect fetal skelet muscl faint adult skelet muscl human rhabdomyosarcoma cell line analyz express myod mrna transcript immunoreact protein immunohistochem express myod protein examin surgic specimen varieti pediatr solid tumor rhabdomyosarcoma specimen posit myod includ express intermedi filament protein desmin specimen origin design sarcoma type indetermin sti specimen origin design extraoss ewe sarcoma eoe posit myod suggest commit myogen differenti wilm tumor express desmin evid myogen element posit myod tumor fail express myod protein includ neuroblastoma primit neuroectoderm tumor hodgkin lymphoma embryon sarcoma liver malign fibrous histiocytoma malign rhabdoid tumor ewe sarcoma bone result express myod protein high restrict normal human tissu express gene product malign tissu diagnost rhabdomyosarcoma myod stain valuabl adjunct classif pediatr softtissu sarcoma"
"vimentin express poor prognosi nodeneg ductal nos breast carcinoma vimentin express tumor nodeneg nodeposit patient infiltr ductal nos breast carcinoma compar year surviv nodeneg nodeposit patient signific invers relat vimentin express surviv year surviv nodeneg patient vimentinposit tumor signific wors compar vimentinneg tumor nodeneg group patient vimentinposit tumor patient vimentinneg tumor surviv year tumor nodeneg patient ductal nos cancer die month express vimentin multivari analysi nodeneg group show strong correl vimentin express surviv weak signific correl histolog grade size surviv year vimentin express strong indic poor prognosi nodeneg ductal nos breast carcinoma"
"studi neuprotein express mammari paget diseas breast carcinoma extramammari paget diseas correl neuerbb gene amplif overexpress neu gene product report tumor glandular origin ductal breast carcinoma formalinfix dewax section case mammari mpd case extramammari epd paget diseas immunohistochem stain monoclon antibodi direct intracellular domain neu gene protein mpds exhibit distinct membran stain tumor cell independ presenc ductal breast carcinoma found case breast carcinoma posit neu stain contrast mpd epd negat normal epidermi negat northern blot analysi sustain immunohistolog find presenc neu mrna demonstr case mpd negat case due dilut effect nontumor cell result suggest paget cell mammari extramammari local similar phenotyp deriv genet accid neu posit mpds ductal carcinoma suggest common genet alter tumor find neu proteinposit mpds ductal breast carcinoma suggest transform process"
"detect htlv provir sequenc cdposit larg cell cutan cell lymphoma investig possibl cutan cell lymphoma larg cell type human cell leukemialymphoma virus type infect nonendem region tissu sampl case larg cell cutan cell lymphoma case small cell cutan cell lymphoma screen presenc integr provir human cell leukemialymphoma virus type dna combin southern blot hybrid enzymat dna amplif reveal human cell leukemialymphoma virus type specif sequenc case larg cell cutan cell lymphoma case small cell cutan cell lymphoma result suggest nonendem area signific proport larg cell cutan cell lymphoma case human cell leukemialymphoma virus type"
"immunodetect metastasi laminin receptor human breast cancer cell obtain fineneedl aspir biopsi fineneedl aspir biopsi breast techniqu evalu suspect lesion surgic remov increas express kd laminin receptor metastat phenotyp cancer cell colon breast cancer studi express laminin receptor evalu immunoperoxidas techniqu breast aspir benign neoplast lesion cell obtain benign sampl exhibit low level laminin receptor antigen detect affinitypurifi antibodi rais cdnaderiv laminin receptor peptid contrast smear obtain malign breast lesion cell strong stain antibodi heterogen express laminin receptor note breast aspir fix tissu specimen data suggest immunodetect laminin receptor cell obtain fineneedl aspir breast lesion valuabl adjunct prognost evalu breast lesion"
"prolifer marker ki softtissu lesion correl dna flow cytometr characterist frozen tissu immunoreact ki monoclon antibodi recogn nuclear antigen nonrest prolifer cell compar dna flow cytometri result fresh tissu divers group softtissu lesion dna index ki score independ report grade prognosi sarcoma direct comparison variabl made attempt measur prolif activ fix paraffinembed tissu immunohistochem subset lesion antibodi nuclear prolifer antigen lesion grade lesion categori reactiv benign lowgrad malign highgrad malign ki reactiv correl grade system benign lesion exhibit low ki score malign lesion exhibit high score malign fibrous histiocytoma rare posit cell dispar ki score grade histolog type independ featur fact import correl prognosi perform ki correl flow data percentag phase percentag gm phase dna index due fact ki mark cell phase exclud flow data analys antip highlight nuclei case test includ fibromatosi correl ki score histolog grade dna flow cytometr data result favor affect titrat experi reason conclud ki score variabl relat independ histolog grade histolog type dna flow valu prognost import human sarcoma suggest await clinicopatholog studi"
"altern splice endotheli cell fibronectin mrna iiic region function signific transform growth factorbeta tgfbeta thought play role modul vascular cell function vivo vitro decreas endotheli cell prolifer migrat postul biolog activ mediat tgfbeta modul specif gene express differenti screen human umbil vein endotheli cell cdna librari cdnas prepar untreat tgfbeta treat bovin aortic endotheli cell techniqu isol tgfbeta induc cdna clone sequenc analysi cdnas show correspond altern splice fibronectin mrnas fibronectin clone extradomain ed form type iii connect segment iiic fibronectin cdnas express bacteria recombin protein studi effect iiic altern splice cell attach spread migrat bovin aortic endotheli smooth muscl cell bf melanoma cell result experi show attach spread bovin aortic endotheli smooth muscl cell depend primarili presenc argglyasps rgds sequenc recombin fibronectin protein attach spread bovin aortic endotheli cell modul altern splice iiic region specif splice iiic region decreas spread increas migrat rate endotheli cell contrari cell line bf melanoma cell requir rgds sequenc adhes confirm previous find bf melanoma cell requir presenc rgds sequenc attach spread bf cell attach spread recombin protein rgds sequenc attach spread bf dramat inhibit base pair dna fragment remov end iiic region result suggest region fibronectin molecul interact cell popul promot cell attach spread altern splice modul process"
"dimension system longterm cultur human colorect adenoma studi adenomacarcinoma sequenc colon rectum limit pauciti experiment model adenoma growth progress progress recent report develop monolay cultur system princip object studi develop primari cultur system colorect adenoma simul dimension vivo growth calcium algin encapsul techniqu previous establish tumor cell line briefli fresh resect specimen wash minc small multicellular particl call microadenoma encapsul calcium algin pellet pellet maintain minimum essenti medium fetal bovin serum degre humidifi atmospher air ten eleven adenoma includ tubular tubulovil villous success cultur day cell viabil confirm histolog light electron microscopi cell character epitheli morpholog featur ultrastructur studi show high degre cellular differenti includ villous brush border desmosom tubular villuslik structur observ vitro correl case histolog parent adenoma measur prolif activ hthymidin autoradiographi immunohistochem stain monoclon antibodi ki demonstr growth fraction simpl high effici primari cultur system develop longterm mainten adenoma promot dimension growth pattern growth rate analog vivo model opportun develop experiment system longitudin studi patholog molecular paramet adenoma progress carcinoma"
"chromatin structur analysi end contigu flank region myeloperoxidas gene myeloperoxidas mpo synthesi promyelocyt stage myeloid differenti downregul mpo gene transcript myeloid cell matur examin deoxyribonucleas hypersensit site end mpo gene flank region dimethyl sulfoxid dmsoinduc differenti hl cell determin chromatin structur accompani process locat hypersensit site surround end gene prolifer uninduc cell determin observ flank region gene progress site accompani downregul mpo transcript treatment dmso evid hypersensit observ chromatin region examin day dmso exposur result provid occur chromatin structur gene inactiv differenti"
"year audit laboratori workload rate referr colposcopi cervic screen programm district object determin laboratori workload rate referr colposcopi district cervic screen programm assess feasibl accommod call women risk recal year interv year interv investig women degre abnorm designanalysi computeris screen histori date back women screen avon cervic screen programm set district health author cover popul bristol westonsupermar compris peopl femal resid age subject women age screen cervic screen programm resultslaboratori workload devot follow women abnorm increas sharpli increas number smear follow sever dyskaryosi invas cancer mild moder dyskaryosi borderlin chang increas part explain introduct april protocol follow investig base guidanc intercollegi work parti report proport women mild moder dyskaryosi recommend referr colposcopi increas steadili borderlin chang proport women test referr colposcopi recommend conclus increas laboratori follow work identifi continu result half exist laboratori capac avon devot follow work prospect maintain call recal qualiti control investig women minor cytolog abnorm justifi sustain undermin benefit screen increas rate fals posit result financi cost"
"district health author organis cervic screen publish erratum bmj nov object examin district health author organis cervic screen respect depart health guidelin determin assess problem encount designpost questionnair district health author england particip district health author england main outcom measurespopul coverag screen qualiti smear test follow abdomin test result comparison nation guidelin district cervic screen servic problem encount district resultsrepli receiv district person respons cervic screen contribut district implement comput manag scheme target date march conform guidelin time survey half call women target age group expect meet target date march complet call variat evid scheme regard dealt issu relat popul coverag qualiti test follow abnorm result problem common identifi district laboratori workload comput softwar avail resourc attend rate opportunist screen investig treatment conclusionscurr practic run cervic screen scheme examin determin extent contribut goal reduc mortal cervic cancer"
"etoposid current futur status etoposid vp antineoplast agent demonstr efficaci broad spectrum human malign includ testicular germ cell lung cancer etoposid synergist agent part combin chemotherapi etoposid call standard therapi testicular cancer small cell lung cancer activ tumor lymphoma leukemia solid tumor identifi etoposid high import chemotherapeut agent cellular anim model shown cell kill tumor respons depend dose time exposur recent clinic studi show dose schedul etoposid import effect clinic respons drug research continu etoposid part initi therapi cancer higher dose prolong schedul optim agent potenti"
"chemotherapi ovarian cancer system intraperiton podophyllotoxin epipodophyllotoxin deriv etoposid teniposid evalu intermitt treatment ovarian cancer conflict studi suggest variabl dose prior treatment major influenc outcom respons rate rang seri teniposid respons rate greater complet respons rate studi etoposid studi document activ oral etoposid patient receiv prior chemotherapi firm conclus activ etoposid drawn result expect synergi etoposid cisplatin led studi combin etoposid platin compound system intraperiton ip rout studi intraven drug combin agent previous treat untreat patient studi carboplatin cisplatin report failur previous untreat patient convers promin toxic report studi discourag respons exceed expect cisplatin studi analog combin administ ip ongo favor experi initi report univers california san diego group confirm investig prompt incorpor etoposid line strategi pharmacolog advantag etoposid ip rout relat high protein bind provid dose intens ip diseas spare system toxic final system dose intens autolog bone marrow support promis etoposid combin highdos alkyl drug"
"current strategi manag locoregion metastat gastric carcinoma gastric carcinoma remain signific death worldwid patient prognosi depend degre gastric wall penetr presenc lymph node metastas locat primari site metastat gastric carcinoma incur chemotherapi continu evolv rapid pace activ agent includ fluorouracil fu doxorubicin cisplatin methotrex mitomycin etoposid combin etoposid doxorubicin cisplatin eap report result encourag high respons rate includ complet respons rate patient metastat gastric carcinoma trial confirm result similar etoposidebas combin etoposid leucovorin fu elf result equal good respons rate toxic eap fu doxorubicin methotrex famtx regimen previous report excel respons rate investig patient locoregion carcinoma curat resect rate unsatisfactorili low curat resect consist improv surviv month patient potenti resect carcinoma signific problem recogn low rate curat resect develop widespread carcinoma curat resect attempt postop strategi adjuv chemotherapi ineffect strategi investig aggress combin etoposid fu cisplatin efp administ preoper postop patient resect gastric carcinoma result encourag curat resect rate greater manag toxic base promis result report eap patient unresect locoregion carcinoma stomach trial preoper postop eap potenti resect carcinoma stomach"
"etoposid manag metastat breast cancer etoposid extens malign play minor role treatment patient breast cancer singleag trial etoposid administ heavili pretreat patient metastat breast cancer demonstr low respons rate patient convinc evid schedul depend relationship dose intens respons sole singleag trial previous untreat patient suggest drug approxim respons rate untreat patient combin therapi trial etoposid combin cyclophosphamid doxorubicin cisplatin convinc demonstr superior drug singl agent cisplatin etoposid superior agent vitro studi suggest pretreat hormonesensit breast cancer cell estradiol increas sensit etoposideinduc dna cleavag repres futur direct etoposid breast cancer etoposid breast cancer consid investig"
"etoposid leukemia etoposid vp nsc induc complet respons cr previous treat patient acut nonlymphocyt leukemia anll singl agent etoposid success combin cytarabin daunorubicin amsacrin salvag consolid therapi previous untreat anll patient year age random assign cytarabin mgm day daunorubicin mgm day drug etoposid mgm day patient achiev cr receiv consolid cours attenu elig patient cr rate therapi cr rate therapi remiss durat signific improv median month month surviv subset analysi patient younger year age reveal prolong remiss median month month surviv median month month regimen hematolog toxic similar regimen induct signific sever consolid therapi etoposid activ anll prolong remiss induct therapi"
"highdos etoposid marrow transplant etoposid underw convent phase test doselimit toxic studi mild myelosuppress toxic infrequ greater degre myelosuppress accept higher standard dose approach advantag steep doserespons relationship chemotherapeut agent includ etoposid shown earli vitro clinic studi etoposid consid ideal agent doseescal studi wide rang clinic antitumor activ standard dose steep doserespons curv mild bone marrow suppress nonmyeloid side effect highdos etoposid studi improv intens hematolog support care includ trial autolog marrow transplant etoposid singl agent highdos trial mucos lesser degre hepat dysfunct doselimit maximum toler dose mtd set multiag phase trial etoposid cyclophosphamid total bodi irradi carmustin carboplatin result doselimit mucos toxic liver lung problem highdos etoposid toxic mtd influenc mark schedul administr etoposid continu intraven infus dose mgkg cyclophosphamid similar toxic marrow support antitumor result lymphoma set stage treatment solid tumor treatment patient sensit relaps outcom lymphoma patient respons rate longterm greater year diseasefre surviv approxim germ cell tumor respons pattern sensit relaps improv respond patient patient greater year breast cancer small cell lung cancer sclc highdos etoposid regimen intensifi standard therapi result set good breast cancer diseasefre surviv year sclc year"
"pharmacolog intraven oral etoposid epipodophyllotoxin deriv etoposid vp widespread combin chemotherapi past decad phasespecif cytotox act phase cell cycl mode action act caus break dna interact dnatopoisomeras ii format free radic studi show biexponenti decay intraven iv administr etoposid approxim administ etoposid excret approxim present urin etoposid oral iv prepar high scheduledepend daili dose day day give result superior intermitt administr bioavail oral etoposid approxim absorpt linear increas dose greater mg bioavail decreas factor influenc bioavail oral etoposid includ patient status concurr medic hepat renal function nausea vomit numer clinic trial etoposid demonstr excel activ rang tumor includ small cell lung cancer sclc malign lymphoma gestat trophoblast tumor ewe soft tissu sarcoma germ cell tumor modest activ tumor sclc compar studi carri data suggest oral etoposid administ daili day similar iv prepar rang activ studi elder patient sclc treat etoposid mg time respons rate median surviv month result similar achiev intens iv regimen studi chronic oral etoposid mgm time report recent respons observ sclc germ cell tumor patient relaps standard etoposid regimen data suggest etoposid drug schedul high respons rate oral etoposid suggest oral administr substitut iv administr substitut greater flexibl chemotherapeut administr hospit accept toxic"
"chronic oral etoposid etoposid import drug recent incorpor agent curat treatment patient advanc neoplasm includ germ cell tumor hodgkin lymphoma nhl small cell lung cancer sclc etoposid demonstr remark schedul depend random comparison shown impress surviv differ patient extens sclc receiv day versus receiv day previous clinic laboratori data etoposid intraven oral day day schedul general accept approxim oral administ drug absorb author initi etoposid studi extend administr schedul believ prolong schedul superior standard day day schedul initi test phase studi result show etoposid mgm day feasibl moder toxic phase ii studi complet complet includ studi patient sclc nhl germ cell tumor soft tissu sarcoma renal carcinoma ovarian carcinoma respons group patient sclc lymphoma germ cell tumor group respons patient resist etoposid cisplatin standard schedul patient resist highdos etoposid bone marrow transplant investig indiana univers medic center studi oral etoposid similar fashion patient advanc germ cell tumor sclc achiev result similar report author initi number combin chemotherapi program chronic oral form etoposid includ patient sclc small cell lung cancer elder patient highgrad intermedi form nhl addit chronic intraven oral etoposid salvag approach patient acut myelocyt leukemia recurr resist intermediategrad highgrad nhl preliminari pharmacokinet data suggest mgm oral dose high bioavail prolong oral mgm patient maintain minimum plasma concentr microgramml studi multipl dose continu infus etoposid maintain potenti critic plasma level progress etoposid administ repres drug featur activ spectrum broader"
"futur direct etoposid therapi etoposid import chemotherapeut agent treatment select patient germ cell tumor lymphoma small cell lung cancer sclc optim continu evolv clear schedul depend critic import recent preliminari studi suggest prolong schedul etoposid administr day effect standard day schedul result phase ii studi show chronic oral etoposid administr induc occasion respons resist tumor higherexpect respons rate patient germ cell tumor sclc preliminari data show etoposid absorpt lowdos schedul mgm day observ etoposid drug chronic schedul explor schedul depend etoposid etoposid recent proven select patient gastric ovarian poor differenti carcinoma unknown primari site drug synergist addit explor combin chemotherapi possibl ad topoisomeras inhibitor modul etoposid activ inhibit drug resist realm human test"
"clinic pharmacolog etoposid etoposid semisynthet deriv podophyllotoxin increas treat cancer etoposid phasespecif cytotox drug act late earli phase cell cycl break dna interact dnatopoisomeras ii format free radic studi show biexponenti decay intraven iv administr etoposid peak plasma concentr drug area concentr versus time curv auc linear relat iv dose interpati variabl pharmacokinet variabl exist iv etoposid metabolit etoposid identifi detect quantit disput approxim etoposid dose excret bioavail oral etoposid approxim absorpt linear increas dose rang clinic interpati intrapati variabl exist pharmacokinet oral etoposid evid etoposid accumul multipl consecut dose iv oral rout exact role liver kidney metabol excret etoposid uncertain etoposid shown high scheduledepend drug clinic studi phasespecif action etoposid increas widespread treat cancer make clinic pharmacolog drug great clinic import"
"limbsalvag surgeri treatment osteosarcoma skelet immatur individu sacrific major growth plate resect fixedlength reconstruct limb skelet immatur child osteosarcoma result signific limblength inequ growth progress limblength discrep humerus minor cosmet problem general result signific function deficit lower extrem tumor knee includ distal femur proxim tibia present dilemma limb salvag arthrodesi osteoarticular allograft endoprosthet replac result signific limblength inequ amput extrem prefer procedur techniqu rotationplasti expand endoprosthesi success treat skelet immatur patient osteosarcoma distal femur regard surviv function result obtain innov method favor compar high knee amput"
"cellular biolog bone tumor knowledg cell molecular biolog begun expand understand biolog osteosarcoma ewe sarcoma studi osteosarcoma reveal abnorm growthinhibit retinoblastoma gene releas cell normal growth control abnorm growth factor product respons tend inappropri activ cell growth tumor cell dna content cytogenet affect diagnosi prognost group osteosarcoma ewe sarcoma characterist transloc chromosom identifi transloc found malign neuroepithelioma varieti studi point neuroectoderm mesenchym origin ewe sarcoma applic biolog knowledg technolog clinic problem lead signific diagnosi treatment tumor year collabor communiti referr center physician scientist critic continu progress"
"osteoid osteoma scapula case report review literatur scapula rare locat osteoid osteoma case involv flat bone en bloc excis uncommon locat problemat surgic exposur difficult shoulder joint function affect lesion subchondr year man osteoid osteoma locat subchondr area glenoid guid needl biopsi nidus result complet heal mode treatment proper follow examin accept benign lesion situat problemat locat"
"cryosurgeri acryl cement surgic adjunct treatment aggress benign bone tumor analysi patient age articl review clinic experi cryosurgeri liquid nitrogen acryl cement polymethylmethacryl pmma treatment aggress benign bone sarcoma biolog basi techniqu result patient age treat cryosurgeri averag follow period month report approach surgic reconstruct group patient cryosurgeri reconstruct group patient bone graft reconstruct group patient composit osteosynthesi intern fixat bone graft pmma control rate recurr tumor type giantcel tumor chondroblastoma aneurysm bone cyst malign giantcel tumor nineteen lesion involv lower extrem lesion locat upper extrem secondari fractur local flap necrosi synovi fistula infect epiphyseodes perform function result excel good fair techniqu composit osteosynthesi recommend larg tumor lower extrem cryosurg result compar favor obtain en bloc resect demonstr abil cryosurgeri erad tumor avoid extens resect reconstruct procedur"
"limb reconstruct vascular fibular graft bone tumor resect limbsalvag oper increas frequenc patient malign bone tumor children biolog reconstruct desir choic convent vascular fibular graft experiment studi perform dog compar type fibular graft bridg segment defect radius ulna twenti adult dog divid group studi interv month transplant convent graft heal creep substitut partial resorb bone laid contrast vascular fibula maintain normal structur hypertrophi subperiost bone format convent fibula eventu hypertrophi vascular graft vascular graft stronger month month graft remodel resembl size shape forearm bone replac experiment result influenc treatment patient vascular fibular graft ideal diaphys defect greater cm long young children poor vascular bed bone heal delay chemotherapeut agent maxim hypertrophi extern fixat immobil graft plate act stress shield"
"modifi van nes rotationplasti treatment malign neoplasm lower extrem children techniqu modifi van nes rotationplasti limb salvag surgeri children adolesc malign sarcoma lower extrem origin procedur lesion distal femur modifi adopt select lesion proxim femur tibia sixteen skelet immatur children form base report tumor locat distal femur ten children proxim tibia proxim femur intraop complic postop complic includ infect requir debrid minor heal delay local recurr neurovascular compromis late derot psycholog decompens patient die metastat diseas die malign leukemia remain patient good function knee prosthesi user particip number sport athlet activ procedur safe low complic rate function demand activ grow child accommod futur growth extrem"
"ewe sarcoma prognost factor diseas control reemerg role surgic treatment advanc treatment ewe sarcoma dramat present treatment protocol control local diseas radiotherapi surgeri system spread limit aggress multiag chemotherapi patient local osseous ewe sarcoma year surviv rate rang estim late relaps uncommon control primari lesion critic longterm surviv studi show improv local control possibl improv surviv patient surgic treatment primari osseous ewe sarcoma"
"effect chemotherapi growth skelet immatur individu hundr twenti children nonmetastat osteogen ewe sarcoma studi assess effect multiag adjuv chemotherapi skelet growth final statur deviat height distribut normal popul note diagnosi mark retard linear growth year intens chemotherapi patient grew expect rate year distribut nutrit status score signific end year baselin distribut ultim height score signific baselin distribut final distribut signific normal popul expect absolut differ height small subgroup observ full adult statur show height cm girl cm boy"
"growth inhibit human breast cancer cell synthet progestin involv induct transform growth factor beta recent experiment work identifi intracellular bind site synthet progestin gestoden uniqu express human breast cancer cell gestoden shown inhibit growth human breast cancer cell dosedepend fashion effect endocrinerespons human endometri cancer cell gestoden induc fold increas secret transform growth factorbeta tgfbeta td human breast cancer cell synthet progestin effect indic induct mediat gestoden bind site convent progesteron receptor breast cancer cell line extent induct tgfbeta correl intracellular level gestoden bind site induct tgfbeta observ endometri cancer line hecl lack gestoden bind site express high level progesteron receptor inhibit growth td cell gestoden part revers polyclon antiserum tgfbeta data growthinhibitori action gestoden mediat part autocrin induct tgfbeta"
"coexpress fibronectin receptor vla vla immatur human erythroblast precursor cell human erythroblast precursor cell adher fibronectin fn exact natur receptor mediat interact character studi report data show immatur human erythroblast express integrin vla vla molecul act fibronectin receptor cell recent demonstr adhes fn purifi human cfu progeni preproerythroblast inhibit antibodi direct human fibronectin receptor vla extend result character immunoprecipit specif antibodi integrin express surfacelabel normal human immatur erythroblast polyclon antibodi recogn common vla beta subunit yield polypeptid kd data demonstr polypeptid kd alpha subunit alpha alpha erythroblast lysat prepar chap immunoprecipit antibodi specif recogn alpha subunit show heterodim peptid beta kd alpha addit peptid kd coprecipit alpha chain hand specif antialpha antibodi immunoprecipit alpha beta complex peptid kd reduc condit migrat singl band kd similar experi perform erythroleukem cell line ku show cell coexpress vla vla member integrin famili monoclon antibodi recogn vla alpha chain block adhes immatur erythroblast fncoat surfac demonstr vla vla function fn receptor cell"
"measur techniqu melanoma statist comparison inter intraobserv variat measur depth invas malign melanoma assess techniqu eyepiec graticul stage vernier project imag analysi signific variat found method pronounc stage vernier recommend prefer techniqu routin"
"cartilag remov prior skin graft triangular fossa antihelix concha ear skin graft larg area expos ear cartilag irregular contour pose increas risk inadequ establish circul remov cartilag structur support graft moh surgeri triangular fossa antihelix concha ear decreas risk recurr carcinoma increas chanc surviv graft"
"fineneedl aspir diagnosi intranod squamouscel carcinoma metastat skin fineneedl aspir determin presenc squamouscel carcinoma enlarg lymph node patient high risk metastas advantag includ high degre accuraci outpati inpati avail neglig potenti seed malign cell cutan oncologist techniqu patient lymphadenopathi previous histori cutan squamous cell carcinoma"
"hic month intens chemotherapi regimen children stage iii iv burkitt lymphoma cell acut lymphoblast leukemia design protocol includ month intens cytoxan cyclophosphamid bristolmy evansvill highdos methotrex mtx highdos cytarabin ara vincristin hic improv eventfre surviv ef patient advancedstag burkitt lymphoma cell acut lymphoblast leukemia test feasibl rapid cycl cytoxan highdos ara base sign earli marrow recoveri twenti patient includ stage iii burkitt lymphoma stage iv burkitt lymphoma cell enter pilot studi rate complet remiss patient relaps year actuari ef median follow month initi patient develop transvers myeliti secondari concomit administr intrathec highdos system ara conclud short intens regimen high effect patient advanc burkitt lymphoma cell ef improv previous intens regimen compar regimen longer durat"
"highdos chemoradiotherapi support marrow infus advanc neuroblastoma pediatr oncolog group studi publish erratum clin oncol jun conduct pilot protocol pediatr oncolog group pog institut examin feasibl toxic efficaci common regimen highdos chemoradiotherapi hd ctrt support autolog allogen marrow infus children metastat neuroblastoma nbl remiss month period accru patient report result complet treatment year ago hd ctrt regimen consist melphalan mgm dose total bodi irradi tbi gy gy daili dose twenti patient receiv irradi consist gy daili dose persist diseas site seventi autolog allogen marrow autolog marrow purg immunomagnet fifti children complet cr partial pr remiss cr pr octob follow month forti children relaps die complic unknown continu remiss includ treat remiss complet treatment year ago year actuari eventfre surviv ef probabl cr cr se pr pr se cr cr se pr pr se probabl ef correl remiss number interv diagnosi hd ctrt greater month month tbi dose gy gy encourag result part reflect select treatment patient nbl slower diseas pace"
"relationship tumorcel ploidi histolog subtyp treatment outcom children adolesc unresect rhabdomyosarcoma publish erratum clin oncol clinic histopatholog featur inadequ accur predict relaps surviv individu patient rhabdomyosarcoma rms studi cellular dna content ploidi rms cell relat histolog respons therapi patient unresect tumor flow cytometr techniqu found patient diploid tumor stem line histolog subtyp group abnorm ploidi hyperdiploid classif time dna content normal diploid cell exclus embryon histolog contrast tetraploidi time dna content normal cell strong alveolar histolog histolog subtyp rms abnorm ploidi aris mechan tumorcel ploidi signific impact surviv appar patient unresect nonmetastat group iii tumor subgroup hyperdiploidi confer prognosi diploidi worst patient diploid tumor surviv month tumorcel ploidi predictor treatment outcom patient embryon relat risk alveolar relat risk rms contribut signific adjust diseas stage anatom site patient unresect diploid rms unaccept high risk treatment failur justifi therapeut approach distinct subgroup"
"fludarabin phosphat synthet purin antimetabolit signific activ lymphoid malign fludarabin phosphat fluoro monophosph deriv vidarabin ara advantag resist deamin adenosin deaminas ada improv solubl mechan cytotox action compound involv metabol convers activ triphosph fludarabin phosphat substanti activ lymphoid malign chronic lymphocyt leukemia cll lowgrad hodgkin lymphoma nhl singleag activ cll compar convent combin regimen activ hodgkin diseas mycosi fungoid macroglobulinemia suggest defin clinic trial warrant hairi cell leukemia prolymphocyt leukemia previous untreat myeloma compound activ common solid tumor earli clinic trial signific myelosuppress potenti sever neurotox toxic lowdos schedul includ transient revers myelosuppress nausea vomit diarrhea somnolencefatigu elev liver enzym serum creatinin pulmonari toxic suggest patient lowdos fludarabin phosphat repeat administr toler safe neglig risk sever neurotox base singleag activ toler food drug administr recent grant group design drug treatment patient refractori cll clinic trial set fludarabin phosphat combin regimen impact natur histori lymphoid malign determin fludarabin phosphat occupi pivot role manag cll lowgrad nhl"
"american oncologist treat breast cancer assess influenc clinic trial present studi design assess prefer method treatment breast cancer american oncologist impact clinic trial practic mail questionnair surgic radiat medic oncologist questionnair hypothet patient breast cancer respond select prefer treatment patient primari breast cancer physician offer choic local excis radiat therapi modifi radic mastectomi physician prescrib adjuv chemotherapi premenopaus woman estrogen receptorneg axillari node negat breast cancer postmenopaus woman estrogen receptorneg nodeposit diseas polici favor male femal physician specialti respond treat young woman inflammatori breast cancer initi chemotherapi radiat surgeri recommend chemotherapi postmenopaus patient estrogen receptorneg diseas minim symptomat bone metastas clinic trial compar treatment strategi appli patient questionnair prefer treatment primari breast cancer inflammatori breast cancer support result clinic trial recommend adjuv chemotherapi nodeneg breast cancer base consist demonstr improv surviv random trial short follow shown delay recurr recommend adjuv chemotherapi postmenopaus woman nodeposit breast cancer contrari result larg random control trial metaanalysi shown polici lead improv surviv report suggest larg random clinic trial minim impact practic result run counter belief treatment"
"hydroperoxycyclophosphamid purg breast cancer mononuclear cell fraction bone marrow patient receiv highdos chemotherapi autolog marrow support phase trial design vivo bone marrow treatment breast cancer patient receiv highdos chemotherapi autolog bone marrow support abm hydroperoxycyclophosphamid hc activ deriv cyclophosphamid activ breast cancer phase bone marrow purg trial ficollsepar mononuclear cell mnc devoid granulocyt rbcs oppos buffi coat twenti patient metastat breast cancer studi patient receiv cycl adriamycin doxorubicin adria laboratori columbus fluorouracil methotrex duke afm regimen marrow harvest mnc fraction marrow prepar treat hc concentr microgramsml patient microgramsml patient microgramsml patient microgramsml patient cryopreserv patient receiv highdos system cyclophosphamid cisplatin carmustin infus purg marrow studi end point marrow engraft defin wbc count greater cell microlit dose level microgramsml hc signific delay time engraft day compar unpurg histor control day microgramsml engraft signific delay compar lower concentr escal hc attempt signific correl observ time leukocyt engraft hc concentr methylcellulosebas tissu cultur assay demonstr statist signific correl colonyform unitgranulocytemacrophag cfugm content purg marrow day engraft nineti percent patient respond clinic entir program complet longer follow requir assess ultim benefit intens therapi longterm surviv"
"phase clinic trial floxuridin highdos continu infus leucovorin calcium sixti patient metastat diseas treat continu infus folin acid leucovorin calcium lv deoxyfluorouridin floxuridin fudr lv constant intraven iv infus mgm day fudr iv push day pm daili dose rang mgm program toler doselimit toxic diarrhea stomat hematolog toxic minim eighti percent assess patient fail chemotherapi regimen complet remiss month partial remiss rang month observ heavili pretreat patient popul respons rate data suggest combin therapi lv fudr clinic differ patient sensit drug combin recommend dose fudr initi therapi cycl mgm day subsequ escal mgm patient extrem sensit phase ii studi progress dose"
"extraor applic osseointegr implant osseointegr implant provid support craniofaci prosthes provid clinician approach treatment complex craniofaci reconstruct problem surgic techniqu review mayo clinic experi present"
"antisecretori antilesion effect histamin hreceptor antagonist rat effect histamin hreceptor antagonist aminopiperidinomethylpyridyloxyci butenylamino cyclobutenedion hydrochlorid investig secretagogueinduc acid secret vivo vitro experiment gastric duoden lesion rat microgramskg inhibit histaminestimul acid secret dosedepend gastric lumenperfus rat inhibitori effect observ hr famotidin fmd microgramskg antisecretori effect acid secret recov control level hr administr cold stress indomethacininduc lesion signific inhibit fmd min cold stress indomethacin treatment hr cold stress indomethacin treatment inhibit lesion format signific antilesion effect observ fmd rat isol gastric mucos sheet inhibit histaminestimul acid secret dosedepend noncompetit action produc uniqu mechan inhibitori effect remain wash mucosa potent timedepend inhibitori effect fmd cimetidin observ wash mucosa data suggest potent long antisecretori effect vivo vitro properti respons long antilesion action"
"potent select inhibit methyl ucn protein kinas ucn staurosporinerel compound isol cultur broth streptomyc sp show potent select inhibitori activ protein kinas cellular inhibitori activ ucn protein kinas cytotox ucn compar staurosporin mechan inhibitori activ investig vitro ucn staurosporin inhibit activ catalyt domain protein kinas spite direct inhibit catalyt domain protein kinas cytotox ucn lower staurosporin addit ucn show select inhibitori activ protein kinas staurosporin sole structur differ seri alkyl deriv ucn synthes investig interest compound betamethoxi deriv show fold greater potenc fold select inhibitori activ protein kinas ucn"
"stimulatori effect maitotoxin insulin releas insulinoma hit cell role calcium uptak phosphoinositid breakdown hamster insulinoma hit cell maitotoxin mtx induc timedepend concentrationdepend releas insulin requir presenc extracellular calcium respons complet block cinnarizin cadmium inhibit type calcium channel blocker nifedipin manganes mtx induc ca uptak cell dosedepend mode uptak block cinnarizin nifedipin cadmium partial inhibit manganes mtx induc phosphoinositid breakdown hit cell respons partial block cadmium affect nifedipin cinnarizin manganes high concentr potassium ion induc insulin releas calcium uptak hit cell effect potassium block partial nifedipin cadmium cinnarizin high concentr potassium induc phosphoinositid breakdown hit cell result suggest mtxelicit releas insulin attain mechan nifedipinesensit action result mtxinduc activ type calcium channel mimick high potassium concentr nifedipineinsensit action initi activ phosphoinositid breakdown mtx activ phospholipas result format inositol trisphosph releas intracellular calcium releas insulin extracellular space cinnarizin propos block mtxelicit mechan blockad calcium channel block inositol trisphosphateinduc releas intern calcium mechan capabl elicit releas insulin"
"molecular surgeri basement membran argon laser argon laser success weld number tissu chemic cellular mechan process precis defin biochem model develop vitro defin extracellular matrix murin engelbrethholmswarm eh sarcoma control experiment sampl eh basement membran irradi trimedyn argon laser joulescm degre sampl dilut cold phosphatebuff salin gel degre time gelat reaction spectrophotomet nm irradi reduc absorb compar control independ dilut fold rang gelat measur determin amount protein bradford assay collect centrifug minut argonirradi sampl protein precipit control addit mm betamercaptoethanol eh extract block effect laser gelat reaction addit gelat carri absenc calcium magnesium differ lasertr sampl control basement membran protein separ electrophoresi polyacrylamid gel denatur reduc denatur reduc condit differ polypeptid composit note irradi control sampl coomassi silverstain techniqu"
"cancer mortal worker expos tetrachlorodibenzodioxin background anim epidemiolog studi exposur dioxin tetrachlorodibenzodioxin tcdd increas risk cancer method conduct retrospect cohort studi mortal worker plant unit state produc chemic contamin tcdd occup exposur document review job descript measur tcdd serum sampl worker death death certif result mortal cancer previous tcdd stomach liver nasal cancer hodgkin diseas hodgkin lymphoma signific elev cohort mortal softtissu sarcoma increas signific death standard mortal ratio smr percent confid interv subcohort worker greater equal year exposur greater equal year latenc mortal signific increas softtissu sarcoma death smr percent confid interv cancer respiratori system smr percent confid interv mortal cancer combin slight signific elev cohort smr percent confid interv higher subcohort greater equal year exposur greater equal year latenc smr percent confid interv conclus studi mortal worker occup exposur tcdd confirm high relat risk report cancer previous studi conclus increas risk softtissu sarcoma limit small number misclassif death certif excess mortal cancer combin cancer respiratori tract softtissu sarcoma result exposur tcdd exclud contribut factor smoke occup exposur chemic"
"comparison myelographi ct follow versus gadolinium mri subarachnoid metastat diseas children evalu children primari intracrani neoplasm subarachnoid metastat diseas samd myelographi comput tomograph follow myelo ct cerebrospin fluid csf histopatholog examin magnet reson imag gadolinium dtpa mri gd decemb decemb boy median age year rang year tumor histolog includ primit neuroectoderm tumor pnet ependymoma lowgrad astrocytoma anaplast astrocytoma glioblastoma multiform atyp rhabdoid tumor malign fibrous histiocytoma thirteen tumor origin posterior fossa supratentori spinal cord median interv diagnost test day mri gd posit myelo ct csf case mri gd superior delin spinal cord nodul sugar coat myelo ct readili reveal nerv root sleev fill defect case myelo ct posit mri gd reveal samd mri gd safe noninvas test initi imag modal presenc samd"
"salivari flow rate patient head neck cancer year radiotherapi clinic studi univers texa  anderson cancer center unstimul stimul salivari flow rate obtain patient head neck cancer receiv mantl unilater facial bilater facial field radiotherapi year earlier magnitud salivari flow rate reduct compar healthi control group primarili relat radiat dosag amount salivari gland tissu includ irradi field flow rate lower women group differ statist signific"
"intramuscular hemangioma oral region report case occurr intramuscular hemangioma intraor perior local rare knowledg tumor adequ diagnosi treatment case present discuss histopatholog differenti diagnosi discuss adequ primari excis avoid recurr"
"analysi interleukin effector cell popul adopt immunotherapi rat gliosarcoma allogen cytotox lymphocyt prevent tumor recombin interleukin ril effector cell popul adopt immunotherapi fischer strain rat gliosarcoma model vivo cytotox nonspecif activ lymphocyt specif activ cytotox lymphocyt ctls assess modifi vivo neutral winn assay effector cell tumor cell combin unit ril stereotact implant frontal centrum semioval fischer rat day addit effector cell ril unit administ burr hole nonspecif activ splenocyt lymphokineactiv killer lak cell plasticadher nonadher specif activ ctls syngen genet ident allogen genet dissimilar syngen ctls lymphocyt fischer rat prime vivo cell restimul vitro allogen ctls generat expos da rat lymphocyt irradi fischer lymph node cell fisher tumor cell vitro control group includ rat bear tumor untreat receiv peripher administr ril receiv syngen unstimul lymphocyt ril set anim inoculum tumor signific improv surviv shown group treat nonadher adher lak cell equal syngen ctls allogen ctls untreat control anim mantelhaenzel nonparametr logrank equat treatment allogen ctls prevent tumor"
"activ earli event mitogen respons py purinoceptor coval bound benzoylbenzoyladenosin triphosph benzoylbenzoylatp bzatp photoaffin analog atp ligand py purinoceptor adenin nucleotid receptor present intact swiss cell epidermoid carcinoma cell photolysi serumstarv cell presenc microm bzatp extens wash remov unincorpor bzatp induc releas arachidon acid trace photoincorpor bzatp effect microm bzatp atp incub medium assay photoincorpor bzatp stimul product prostaglandin accumul cyclic amp previous studi demonstr event obligatori earli step pathway lead dna synthesi cell line evid purinoceptor activ extracellular atp bzatp link pertussi toxinsensit gtpbind protein consist observ find pertussi toxin inhibit effect photoincorpor bzatp arachidon acid releas result bzatp effect agonist py purinoceptor concern stimul dna synthesi cell photolysi irrevers intact cell promot activ earli event requir dna synthesi"
"boron neutron captur therapi intracerebr rat gliosarcoma efficaci boron neutron captur therapi bnct treatment intracerebr implant rat gliosarcoma test preferenti accumul tumor achiev continu infus sulfhydryl boran dimer nabh rate microgram bodi weight day day day tumor initi day infus schedul result averag blood concentr microgramsml group gliosarcomabear rat microgramsml group similar gliosarcomabear rat treat bnct estim tumor level group microgram day borontr borontr rat expos mwmin radiat brookhaven medic research reactor yield thermal neutron fluenc approxim approxim cm tumor untreat rat median postiniti surviv time day reactor radiat increas median postiniti surviv time mwmin mwmin day rat receiv mwmin bnct median postiniti surviv time day anim surviv greater month mwmin group median surviv time calcul anim remain aliv greater month bnct estim radiat dose tumor bnct group gy equival similar gliosarcomabear rat treat gy kilovolt peak ray median surviv time day tumor initi"
"identif transform growth factor beta famili member present boneinduct protein purifi bovin bone character polypeptid present boneinduct protein extract bovin bone led clone regulatori molecul distant relat transform growth factor beta human bone morphogenet protein bmps describ bmp bmp bmp show extens sequenc similar bmp molecul suffici induc de novo bone format vivo addit synergist contribut bmprelat molecul osteogen activ deminer bone strong implic presenc growth factor activ fraction high purifi bone extract"
"adenovirus ea gene repress differenti teratocarcinoma cell teratocarcinoma cell line differenti vitro treatment retino acid camp wide model system studi molecular event respons cellular commit differenti earli develop previous experi suggest intrigu parallel control gene express cell differenti regul gene express adenovirus ea transfect eaexpress plasmid termin differenti nonprolifer cell generat high frequenc coloni divid cell express ea cell line establish coloni prolifer presenc retino acid lost fulli differenti phenotyp character absenc express seri differentiationspecif gene conclud express viral ea gene product interfer retino acidinduc cell differenti result suggest differenti process defin marker termin differenti perman event revers ea express"
"frequent mutat gene human esophag cancer sequenc alter gene detect human tumor brain breast lung colon propos mutat span major portion code region inactiv tumor suppressor function gene knowledg transform mutat oncogen mutat tumor suppressor gene report human esophag tumor examin human esophag carcinoma cell line human esophag squamous cell carcinoma polymeras chain reaction amplif direct sequenc presenc mutat exon cell line tumor specimen mutat allel frameshift missens mutat missens mutat detect occur base pair codon adjac mutat previous report cancer identif aberr gene allel tumor test suggest mutat locus common genet event pathogenesi squamous cell carcinoma esophagus"
"activ erythropoietin receptor friend viral gp erythropoietin modul murin fvr resist gene leukemogen membran glycoprotein gp encod friend spleen focusform virus bind erythropoietin receptor epor sto stimul erythroblastosi li andrea lodish baltimor natur london direct compar effect gp erythropoietin epo produc retrovirion encod gp epo epor infect epor virus interleukin depend da cell bound ilabel epo grew interleukin presenc epo cell parent da cell factorindepend superinfect epo virus friend spleen focusform virus addit epo virus caus diseas mice mimick friend erythroleukemia fvr homozygot suscept retrovir diseas resist epo viral friend viral erythroleukemia result gp epo stimul epor fv gene encod protein control respons ligand fv protein epor gene map opposit end mous chromosom result import implic understand signal transduct epor role host genet variat control suscept oncogen protein"
"adenocarcinoma colon rectum patient year age patient adenocarcinoma colon rectum treat nation naval medic center year symptom present younger patient present durat time onset symptom diagnosi group month risk factor carcinoma colon rectum identifi patient year signific greater proport patient year stage diseas compar older group patient versus cent stage diseas common patient year age versus cent proport patient stage diseas similar age group cumul surviv rate group ten year cent year surviv rate patient year stage diseas cent stage diseas cent young patient stage diseas dead month synchron metachron carcinoma colon rectum uncommon patient year patient year age carcinoma colon rectum symptomat advanc diseas time present surviv time patient stage diseas similar popul patient carcinoma colon rectum"
"oncolog risk skin preserv mastectomi combin reconstruct breast oncolog surgeon agre remov nippl areola recent scar site biopsi mastectomi treatment carcinoma breast agreement remain uninvolv mammari skin preserv facilit perform reconstruct breast lead improv aesthet result oncologist fear practic lead increas incid local tumor recurr determin fear justifi patient undergon unilater bilater mastectomi reconstruct treatment earli carcinoma breast studi preserv uninvolv skin instanc patient document follow studi month averag follow time month peripher local recurr observ cent rate earli local recurr lower report seri modifi radic mastectomi skin preserv reconstruct suggest skin preserv confer addit risk local recurr carcinoma breast proper select patient"
"gastric lymphoma patient treat stage stage iie primari gastric lymphoma hodgkin pain weight loss predomin symptom physic find absent cent patient anem result gastrointestin contrast studi suggest malign condit cent find specif lymphoma endoscop find suggest malign process cent yield biopsi cent patient undergo oper explor cent resect patient receiv postresect adjuv therapi chemotherapi radiotherapi patient combin primari nonsurg treatment consist chemotherapi radiotherapi combin therapi instanc recurr success treat year surviv rate cent signific differ surgic nonsurg regimen tumor smaller centimet year surviv rate cent versus cent larger neoplasm patient year age favor surgic therapi compar nonsurg treatment conclud endoscopi limit diagnost studi treatment program superior choic therapi individu"
"nutrit approach cancer prevent emphasi vitamin antioxid carotenoid main human cancer complex lifestyl relat causat enhanc inhibit factor tobacco smoke chew expos human genotox carcinogen promot substanc likewis western dietari tradit involv carcinogen promot orient tradit implic carcinogen promot import virtual situat regular intak fruit veget appreci lower risk cancer paper review main human cancer analyz mechan protect effect fruit veget prevent human cancer requir definit optim level recommend daili micronutri"
"veget fruit carotenoid risk cancer low intak veget fruit carotenoid consist increas risk lung cancer prospect retrospect studi addit low level betacaroten serum plasma consist subsequ develop lung cancer simplest explan betacaroten protect retinol preform vitamin relat similar manner lung cancer risk betacaroten function mechan requir convers vitamin import carotenoid constitu veget fruit adequ explor prospect retrospect studi suggest veget fruit intak reduc risk cancer mouth pharynx larynx esophagus stomach colon rectum bladder cervix fewer studi consist studi epidemiolog evid present persuas lung cancer"
"prediagnost serum level carotenoid vitamin relat subsequ cancer washington counti maryland serum specimen collect volunt washington counti maryland serum frozen degre time assay prediagnost sampl cancer case match control subject assay site studi colon rectum pancrea lung melanoma basal cell skin breast prostat bladder serum betacaroten level show strong protect associ lung cancer suggest protect associ melanoma bladder cancer suggest nonprotect associ rectal cancer serum vitamin level protect associ lung cancer site show impress associ low level serum lycopen strong pancreat cancer strong cancer bladder rectum"
"vitamin cancer prevent epidemiolog evid epidemiolog evid protect effect vitamin hormonedepend cancer strong studi dietari vitamin index calcul found statist signific protect high intak confer approxim twofold protect effect compar low intak addit studi assess fruit intak found signific protect cancer esophagus larynx oral caviti pancrea evid protect effect vitamin compon fruit strong consist cancer stomach rectum breast cervix strong evid recent lung cancer studi found signific protect effect vitamin food sourc vitamin betacaroten ascorb acid carotenoid factor fruit veget act joint increas consumpt fruit veget general encourag"
"vitamin cancer prevent anim experi human studi suggest vitamin protect cancer serum alphatocopherol concentr studi predict cancer cohort adult finland follow cancer diagnos person level serum alphatocopherol determin store serum sampl degre cancer patient match control subject individu low level alphatocopherol fold risk cancer compar higher level strength associ serum alphatocopherol level cancer risk vari cancer site strongest gastrointestin cancer combin group cancer unrel smoke associ strongest nonsmok men women low level serum selenium find agre hypothesi dietari vitamin circumst protect cancer"
"gastric juic ascorb acid effect diseas implic gastric carcinogenesi nitroso compound noc strong implic causat cancer stomach suggest ascorb acid reduc risk gastric cancer prevent format gastric juic recent measur gastric juic ascorb acid concentr measur gastric juic ascorb total vitamin ascorb acid dehydroascorb acid find suggest ascorb acid secret gastric lumen gastric juic concentr greater plasma gastric patholog affect secret lead valu gastric juic lower plasma level stimul gastric secret rais vitamin concentr individu valu initi low role ascorb acid prevent format noc protect gastric cancer discuss light find"
"interact chloramphenicol metabolit coloni stimul factor role chloramphenicolinduc bone marrow injuri recent demonstr chloramphenicol cap metabolit produc intestin bacteria dehydrocap dhcap nitrophenylaminopropan npap cytotox bone marrow vitro cap coloni stimul factor csfs play essenti role hematopoiet cell growth toxic cap metabolit involv interact csf csfproduc cell present studi found increas concentr rhgmcsf rhgcsf complet revers inhibitori effect cap human cfugm growth growth kg cell gmcsf revers inhibitori effect cap hl cell inhibit dhcap nitrosocap cap npap affect csf addit inhibitori effect cell growth dhcap cap inhibit csf product buffi coat cell affect cell viabil cap npap inhibit csf product suggest dual toxicinhibitori effect intestin metabolit cap dhcap hematopoiet cell growth hand csf product render potent potenti mediat cap induc aplast anemia"
"kaposi sarcoma involv bone marrow kaposi sarcoma ks predomin cutan malign clinic variant extracutan site involv uncommon diseas variant epidem ks human immunodefici virus relat african lymphadenopath variant extracutan ks involv lymph node gastrointestin tract respiratori tract author report descript patient classic ks bone marrow involv addit patient ks variant bone marrow involv bone marrow tumor invas consid patient ks hematolog abnorm"
"ethanol acceler arrest differenti hl cell effect clinic relev ethanol concentr myeloid differenti hl cell promyelocyt leukemia line studi exposur noninduc stem cell mm ethanol result increas cell increas superoxid product express mo antigen hl cell induc differenti myeloid line dimethylsulfoxid dmso retino acid ra shift smaller cell size increas cell acquisit abil produc superoxid report previous author ethanol present differenti increas cell increas percentag cell produc superoxid express mo decreas cell size total growth incub period regrowth experi period differenti increas arrest presenc ethanol repres termin commit induc present absenc induc increas percentag readili revers examin rna content flow cytometri reveal decreas peak rna content dmso ra induc differenti decreas accentu presenc ethanol result higher gagb ratio nonexpos cell find ethanol enhanc growth arrest hl cell expos myeloid induc partial differenti occur process result termin arrest cell undergon fewer postinduct cell divis normal fulli compet"
"magnet reson imag comput tomographi pediatr head neck mass fifti magnet reson imag mri comput tomographi ct studi head neck mass pediatr patient review retrospect lesion patholog proof metastat recurr lesion prior patholog confirm primari site includ malign tumor benign tumor inflammatori mass congenit lesion mri perform rang predomin good excel detect lesion extent involv contrast surround tissu ct comparison mri prove equal detect factor preoper diagnosi result suggest mri method choic initi evalu pediatr head neck region patient requir multipl examin ct mri conjunct complic case possibl involv lesion calcif boni involv"
"hemangioma temporali muscl rare case intramuscular hemangioma temporali muscl report clinic examin carotid arteriogram comput tomograph scan aspir cytolog suggest vascular natur tumor exact diagnosi made histopatholog examin temporari occlus ipsilater extern carotid arteri subperiost dissect permit complet wide excis bleed"
"synthesi type collagen heal wound human quantifi wound heal surgic patient sampl wound fluid collect silicon rubber tube postop day concentr carboxytermin propeptid type procollagen picp aminotermin propeptid type iii procollagen piiinp measur specif radioimmunoassay concentr picp fluid day sd microgram day microgram sign rank test day concentr reach time higher day microgram peak picp antigen intact propeptid set free synthesi type procollagen detect sephacryl gel filtrat analysi wound fluid sampl concentr piiinp microgram day microgram day microgram day compar day final day fold concentr microgram compar day reach method present paper separ repetit quantif synthesi type type iii procollagen human wound heal"
"rectus abdomini muscl flap microvascular anastomos repair recurr sarcoma radic resect recurr leiomyosarcoma thorac wall stabil goretex graft skin soft tissu defect repair larg rectus abdomini flap circul secur endend microvascular anastomosi inferior epigastr arteri intern mammari arteri cut tumor remov"
"impact physician complianc screen mammographi older women screen mammographi underutil women older year general consensus regular annual screen evalu reason underutil studi random sampl women los angel calif older year women found underscreen women older year approxim women year women age year older mammogram analys reveal import factor predict women mammogram physician talk mammographi women time depend age group mammogram time physician discuss discuss lengthi complex result physician discuss screen mammographi patient major impact breast cancer screen behavior"
"relationship papanicolaou test contact medic care system stage diagnosi cervic cancer relationship papanicolaou pap test physician visit stage diagnosi cervic cancer assess interview women invas cervic cancer women situ cervic cancer signific smaller percent studi subject invas diseas situ diseas pap test year prior diagnosi age raceadjust odd ratio group differ visit physician reason period pap test decreas increas age group physician visit percent subject invas diseas age year pap test diagnosi physician preced year women region distant invas diseas pap test group age year physician strategi earli detect reflect miss opportun bring receiv care system"
"decreas mortal user estrogen replac therapi prospect studi postmenopaus femal resid retir communiti southern california evalu detail relationship estrogen mortal year follow death women histori estrogen lower ageadjust mortal lifetim nonus confid interv mortal decreas increas durat lower current user women estrogen distant past current user year estrogen reduct mortal oral estrogen user relat risk death distinguish specif dosag oral estrogen longest time women estrogen replac therapi reduc mortal categori acut chronic arteriosclerot diseas cerebrovascular diseas group women reduc mortal cancer reduct statist signific mortal remain combin estrogen user lifetim nonus"
"combin hepat vena caval resect autogen caval graft replac side caudat hepat lobectomi resect retrohepat vena cava perform year woman recurr adren carcinoma vena cava replac graft construct autogen superfici femor vein includ review literatur detail previous report case combin hepat caval resect knowledg prior report autogen vein graft set surgic anesthet techniqu includ total vascular exclus liver venoven bypass method develop larg part experi liver transplant type surgeri perform high rate success"
"photodynam therapi treat tumor extrahepat biliari duct case report poor surviv rate patient extrahepat bile duct tumor document year treat white woman diabet diagnos histolog proven adenocarcinoma common bile duct inject dihematoporphyrin ether photodynam therapi treatment biliari duct juli patient aliv jaundic karnofski perform status occur blood chemistri time inject time photodynam therapi transient elev blood chemistri valu white blood cell count occur hour photodynam therapi alanin aminotransferas aspart aminotransferas amylas signific"
"pigment spindl cell naevus report case pigment spindl cell naevus pscn usual naevi heavili pigment papul found leg young patient histolog pscn character symmetr prolifer spindleshap pigment melanocyt group larg junction nest pagetoid spread singl cell epidermi frequent found opinion pscn distinct benign acquir melanocyt naevus past frequent misdiagnos atyp spitz naevi malign melanoma"
"factor xiiia nodular malign melanoma spitz naevi distribut factor xiiiaposit dermal dendrit cell studi seri nodular malign melanoma compar spitz naevi pattern distribut recogniz diffus spread tumour locat peripheri tumour correl diagnosi melanoma spitz naevus distribut function growth pattern tumour diffus pattern common diagnosi distribut factor xiiiaposit cell malign melanoma spitz naevi"
"granulocytemacrophag colonystimul factor synerg interleukin support prolifer human myeloma cell role granulocytemacrophag colonystimul factor gmcsf growth multipl myeloma mm investig patient mm patient prolifer myeloma cell vivo recombin gmcsf signific increas endogenousilmedi spontan myeloma cell prolifer occur day cultur tumor cell vitro gmcsf detect day cultur supernat myeloma bone marrow cell endogen gmcsf produc myeloma bone marrow microenviron myeloma cell contribut spontan myelomacel prolifer observ day cultur fact prolifer partial block antigmcsf monoclon antibodi stimulatori effect rgmcsf mediat il abrog antiil monoclon antibodi rgmcsf reproduc increas endogen il product shortterm cultur bone marrow cell mm patient ildepend myeloma cell line xg cell line rgmcsf shown act direct myeloma cell stimul twofold il respons rgmcsf induc il product xg cell sustain growth detect gmcsf level found peripher bone marrow blood mm patient gmcsf produc local tumor environ enhanc il respons myeloma cell vivo similar report vitro"
"retrovir transform cerebr microvascular endotheli cell macrophag microvascular endotheli cell properti report cellcondit medium lcm transform porcin cerebr microvascular pcmv endotheli cell cell macrophag properti lcm cytokin cell virus murin retrovirus found cell lcm evid suggest lcm cytokin cell virus involv pcmv endotheli cell transform criteria transform includ focus format decreas serum requir growth morpholog includ nonadher propag suspens cultur decreas growth respons stimul endotheli cell mitogen macrophag characterist transform cell design rvte includ pinocytosi lowdens lipoprotein fc receptormedi phagocytosi phagocytosi bacteria zymosan express macrophag enzym marker constitut product colonystimul factor transform cell retain properti nontransform cell includ express fviiirag vitro organ capillari structur clone rvte cell show macrophag cerebr microvascular endotheli cell properti present cell organ nontransform cell express morpholog function characterist classic macrophag find suggest brain capillari pathophysiolog involv macrophag cerebr microvascular endotheli cell reticuloendotheli phenotyp repertoir express transform cerebr microvascular endotheli cell show cerebr capillari endotheli cell vivo deriv hematopoiet phagocyt precursor"
"consist involv bcr gene breakpoint pediatr acut leukemia investig relationship bcrabl fusion mrnas childhood acut lymphoblast leukemia examin pediatr philadelphia chromosom phposit acut leukemia revers polymeras chain reaction pcr procedur cell leukemia singl bcrabl pcr product detect correspond breakpoint minor breakpoint cluster region mbcr intron bcr gene product fusion protein cell remain leukemia breakpoint major breakpoint cluster region mbcr shown pcr southern blot analys leukemia low level mbcr pcr product result altern splice bcrabl precursor rna screen addit leukemia patient fail therapi day induct failur earli relaps found case unsuccess cytogenet express mbcrabl rna children mbcr breakpoint white blood cell level excess present compar mbcr breakpoint hematolog clinic featur suggest chronic myelogen leukemia cml lymphoid blast crisi result phposit pediatr leukemia breakpoint occur breakpoint cluster region bcr gene chromosom revers pcr reliabl detect patient cytogenet capabl detect addit phposit leukemia miss standard cytogenet mbcrtype breakpoint product childhood leukemia present clinic appar lymphoid blast crisi cml suggest breakpoint locat exclus determin biolog clinic featur pediatr phposit"
"synergist inhibit verapamil quinin glycoproteinmedi multidrug resist human myeloma cell line model effort develop clinic approach overcom glycoproteinmedi multidrug resist mdr evalu combin chemosensit verapamil quinin multidrugresist mdr human myeloma cell line model clonogen assay verapamil concentr microgramsml bracket plasma level achiev oral administr highdos intraven iv infus dose quinin held constant microgramsml plasma concentr readili achiev oral administr dose level verapamil test combin quinin prove effect drug individu revers resist doxorubicin vinblastin synergist chemosensit interact observ verapamil microgramml combin quinin capabl restor sensit doxorubicin fulli reduc resist vinblastin effect verapamil microgramsml combin mumol verapamil mumol quinin increas accumul retent anthracyclin resist cell greater extent drug individu inhibit drug efflux effect verapamil mumol find suggest combin chemosensit verapamil quinin prove overcom mdr patient drugrefractori cell neoplasm multipl myeloma hodgkin lymphoma"
"anticd monoclon antibodi etoposidecytosin arabinosid combin vivo purif bone marrow acut nonlymphocyt leukemia pharmacolog immunolog method vivo bone marrow bm purg acut nonlymphocyt leukemia anll combin augment effect method etoposid vp microgramsml cytosin arabinosid ara mgml tandem anticd monoclon antibodi moab chosen cd found stem cell pool major patient anll agent test singl sequenti hour incub drug preced complementmedi lysi vp combin ara kill log human anll cell line hl drug concentr kill log normal commit granulocytemacrophag stem cell cfugm ad singl exposur complement drugtreat cell greater log hl kill similar pharmacolog agent differenti kill clonagen leukem cell colonyform unitleukemia cfu patient anll drug treat blast versus normal cfugranulocytemacrophag cfugm log cfu kill drug concentr spare log cfugm similar log anll cfu elimin sequenti vpara treatment synergi demonstr log cfu elimin cd found normal cfugm pool stage longterm bm cultur perform determin pluripot stem cell elimin drugmoab purg combin differ cfugm bfu product week cultur vpara vparacmi treat cell compar untreat control indic spare earli progenitor cell sequenti vivo treatment human anll cfu vpara complementmedi lysi synergist kill cfu spare earli normal hematopoiet progenitor cell effect purg bm"
"flow cytometri clinic estim circul hematopoiet progenitor autolog transplant cancer patient optimum method harvest circul hematopoiet progenitor autolog transplant support myeloabl cancer therapi uncertain lack assay marrowrepopul stem cell cfugm assay common indirect indic qualiti graft poor standard result evalu retrospect base knowledg hematopoiet progenitor express cd cd differenti antigen develop dualcolor direct immunofluoresc flow cytometri assay aim replac cfugm assay advantag purpos appli assay blood sampl obtain daili recoveri pancytopenia induc highdos cyclophosphamid etoposid cancer therapi recombin human gm colonystimul factor rhgmcsf cd cell circul hematopoiet progenitor increas cfugmml level clinic adequ largescal harvest leukapheresi total cd cell correl cfugm data fit linear regress line equat cfugmml cd cell microlit seri patient treat myeloabl chemoradiotherapi earli hematopoiet recoveri marrow function predict accur number transplant cdcd cell total nucleat cell cfugm cdcd cell cdcd cell data present articl favor clinic cdcd flow cytometri assay guid harvest circul hematopoiet progenitor autolog transplant contribut understand role play circul hematopoiet progenitor cell subset marrow recoveri myeloabl cancer therapi"
"variabl dna measur multipl tumor sampl human colon carcinoma dna ploidi cellcycl distribut separ fresh tissu sampl colorect adenocarcinoma analyz flow cytometri dna ploidi concord sampl case remain case dna histogram multipl sampl similar ploidi sampl discord relationship observ duke stage histolog grade concord discord sampl colon carcinoma singl sampl show diploid diploidcycl dna histogram detect aneuploid dna pattern comparison scrape fineneedl aspir tumor altern sampl method tumor dna ploidi analysi strong associ tumor ploidi ploidi multipl sampl concord case tumor scrape fineneedl aspir correl abnorm ploidi observ tissu sampl data suggest singl doubl tissu sampl show aneuploid dna pattern substanti proport colorect cancer"
"serum glycoconjug precancer cancer diseas oral caviti sera healthi control normal individu habit tobacco chew patient oral precancer pc condit patient oral cancer oc studi level total sialic acid tsa lipidbound sialic acid lsa mucoid protein proteinbound hexos pbh galactos mannos glycoconjug level insignific control normal tobacco chewer paramet signific elev oral pc patient compar control level pbh lsa show signific increas oral pc patient compar normal tobacco chewer signific increas observ level tsa lsa mucoid protein pbh oc patient compar control normal tobacco chewer patient oral pc increas level biomark found progress malign diseas elev level tsa lsa statist signific stage iv patient compar stage iii patient patient metastas higher level biomark patient primari oc elev lsa level statist signific result suggest evalu serum glycoconjug level diagnosi patient oral pc oc addit earli detect stage diseas"
"prospect random comparison protract infusion fluorouracil week bolus cisplatin metastat colorect carcinoma midatlant oncolog program studi hundr eighti patient advanc measur colorect cancer previous treat chemotherapi enter prospect random clinic trial midatlant oncolog program maop assess week cisplatin mgm ad protract schedul fluorouracil fu infus pif mgm week week liver primari indic lesion approxim studi group tumor measur requir radiograph confirm respons rate pif arm confid interv ci compar ci arm week cisplatin ad pif median surviv time month group week cisplatin add effect pif colorect carcinoma"
"prognost histopatholog ewe sarcoma longterm follow distal extrem primari tumor patholog materi patient diagnos initi ewe sarcoma distal extrem treat nation cancer institut protocol review correl clinic outcom histolog tumor categor base recent patholog criteria diagnost group typic ewe sarcoma atyp ewe sarcoma predomin peripher neuroepithelioma pn thirti patient typic ewe atyp diagnost categori pn primit rhabdomyosarcoma primit sarcoma bone synovi cell sarcoma case metastat neuroblastoma osteosarcoma lymphoma found forti patient local diseas diagnosi metastas patient typic ewe sarcoma metastat diseas time diagnosi patient typic ewe sarcoma metastas compar patient group pattern relaps group compar typic ewe patient patient develop lymph node metastas patient develop brain metastas presenc metastat diseas diagnosi strong negat prognost factor histolog group independ prognost clinic outcom patient local diseas patient typic osseous ewe sarcoma improv surviv patient tumor typic atyp ewe sarcoma poorer diseasefre surviv general accept histopatholog prognost criteria exist ewe sarcoma potenti propos classif evalu larger retrospect prospect studi"
"prognost factor yolk sac tumor ovari clinicopatholog analysi case twenti ovarian cancer patient yolk sac tumor germ cell tumor yolk sac tissu compon diseas endoderm sinus tumor mix germ cell tumor embryon carcinoma polyembryoma treat cytoreduct surgeri combin chemotherapi prognost factor investig group patient stage diseas favor prognosi stage ii iv diseas differ prognosi signific case residu tumor absent case ascit absent ml volum endoderm sinus tumor intestin microcyst pattern common survivor die age preoper serum alphafetoprotein level maximum tumor size tumor weight signific correl prognosi advanc case chemotherapi regimen includ cisplatin gave result vincristin dactinomycin cyclophosphamid optim treatment yolk sac tumor tumor yolk sac tissu compon ovari discuss light result"
"bone sarcoma malign neoplasm childhood cancer studi explor relationship histolog variant bone sarcoma previous therapi patient unrel malign neoplasm diagnos childhood sarcoma bone common malign neoplasm smn report late effect studi group institut consortium consist pediatr oncolog center western europ canada unit state author attempt relat histolog subtyp bone tumor clinic factor previous therapi genet predisposit morpholog variant shown biolog signific tumor etiolog import literatur subtyp bone tumor clinic experiment review author investig effect factor time interv diagnosi smn bone sarcoma anthracyclin signific shorten interv year primari diagnosi signific affect interv leukemialymphoma shortest interv retinoblastoma longest author demonstr signific relationship morpholog characterist osteosarcoma predispos condit lesion diagnos chondrosarcoma malign fibrous histiocytoma occur exclus patient receiv radiat therapi site smn develop"
"southwest oncolog group studi human tumor clone assay predict respons patient ovarian cancer total patient epitheli ovarian cancer tumor refractori prior chemotherapi prior chemotherapi southwest oncolog group institut tumor sampl specimen ship central laboratori drugsensit test human tumor clone assay patient prior histori chemotherapi failur median prior chemotherapeut agent treat effect agent found clone assay patient patient tumor form coloni vitro manifest sensit agent treat clinician choic agent patient remain patient treat chemotherapi deterior perform status earli death complet partial respons rate patient treat assay result versus patient treat clinician choic statist signific differ surviv option versus month patient histori prior chemotherapi treat standard combin chemotherapi clinic respons compar vitro sensit agent trueposit rate trueneg rate evalu patient data author conclud human tumor clone assay increas respons rate surviv select patient advanc chemotherapyrefractori ovarian cancer studi weaken step patient select necessit inadequ tumor coloni format vitro inabl treat patient earli death rapid declin perform status assay worthi addit studi predict respons combin chemotherapi patient prior histori chemotherapi final central chemosensit test laboratori feasibl test vitro predict assay cooper group set"
"achiev life goal adult survivor modern treatment childhood cancer assess impact diagnosi modern treatment childhood cancer achiev adult goal author evalu employ health life insur coverag marriag divorc reproduct pediatr cancer patient area evalu relat common set diseas demograph factor includ age follow age diagnosi gender marit status histori diseas recurr diagnosi patient younger year age diagnosi diagnos made januari decemb median age diagnosi year median age follow year percentag unemploy male respond differ popul norm percentag unemploy femal respond slight higher unit state popul approxim survivor report form employmentrel discrimin level signific lower prior report companyoff health insur provid fulltim parttim employ respond life insur purchas fulltim employ men women percentag lower report unit state popul twenti percent life insur difficulti obtain fifti percent subject marri live marri percentag marri men women signific lower unit state norm twenti percent marri live marri divorc separ longer live marri women age year marri women age year signific higher frequenc divorc similar age unit state women general histori childhood cancer influenc decis marri live marri occasion import decis dissolv marit relationship patient diagnosi treatment childhood cancer influenc decis children current studi suggest pediatr cancer patient achiev adult life goal addit research defin popul greatest risk failur achiev goal"
"prolong respons carboplatin infant brain stem glioma adult children brain stem glioma surviv time month radiat therapi xrt infant tumor present addit complex treatment neurotox radiat develop brain report month child biopsyproven brain stem glioma clinic radiograph evid diseas progress treat month cours carboplatin radiat therapi month respons clinic respons start month radiograph evid document month magnet reson imag toxic minim longitudin neuropsycholog assess demonstr continu improv month post diagnosi motor function expect age level cervicomedullari astrocytoma young patient clinic set futur trial chemotherapi xrt"
"postop follow patient earli breast cancer pattern care clinic oncologist review literatur eighti clinic oncologist southeastern unit state survey determin strategi follow care primari treatment earlystag breast cancer frequenc histori physic examin complet blood count liver function test carcinoembryon antigen level chest ray skelet survey bone scan liver scan mammogram observ hypothet low highrisk patient assess year mammogram recommend respond histori physic examin modal period bone liver scan minor patient review literatur support strategi respond survey underscor costeffect histori physic examin detect recurr follow base survey support literatur recommend reason costconsci follow present"
"imag parapharyng hemangiopericytoma radioimmunoscintigraphi spect indiumlabel anticea antibodi comparison digit subtract angiographi comput tomographi immunohistochemistri year male patient parapharyng hemangiopericytoma investig radiolog orthopantomographi comput tomographi digit subtract angiographi oper malign suspect patient imag gamma camera radiolabel monoclon anticarcinoembryon antigen antibodi includ singl photon emiss comput tomographi radioantibodi accumul strong neoplasm tumor background ratio sampl excis tumor stain immunohistochem desmin vimentin muscl actin cytokeratin cea carcinoembryon antigen factor viii show antibodi uptak unspecif natur due cea express tumor"
"result treat ductal carcinoma situ breast conserv surgeri radiat therapi determin frequenc pattern time tumor recurr breast outcom women ductal carcinoma situ dcis treat conserv surgeri radiat therapi studi surgeri typic consist local excis evalu microscop margin resect median radiat dose tumor site cgi median follow time month patient experienc recurr breast time recurr protract case failur occur month year year actuari rate tumor recurr breast patient recurr primari tumor site invas carcinoma invas recurr site breast clinic patholog factor signific increas risk recurr number patient studi popul small author reach conclus patient dcis treat conserv surgeri radiat therapi care mammograph patholog evalu recurr breast patient recurr typic occur primari site recurr occur long treatment care mammograph patholog assess reduc local recurr rate consid essenti patient consid conserv surgeri radiat therapi"
"interferon system carcinoma cervix effect radiat chemotherapi thirteen patient advanc carcinoma cervix studi paramet interferon system compar agematch sexmatch control patient measur serum interferon level control patient antibodytyp interferoninhibitori activ control interferonsynthes potenti higher control patient success radiat chemotherapi paramet normal patient chang patient respond therapi"
"immunohistolog detect epiderm growth factor receptor human esophag squamous cell carcinoma epiderm growth factor receptor egf express studi immunohistolog patient esophag squamous cell carcinoma egf faint express basal parabas layer normal esophag epithelia cancer nest patient strong express area dysplast epithelia cancer nest patient patient strong express egf lymph node metastas frequent prognosi poorer faint express egf egf express show mosaic pattern patient diffus pattern patient patient mosaic pattern lymph node metastas frequent wors prognosi diffus pattern express egf metastat lymph node similar strong express area primari cancer mosaic pattern egf express import indic malign esophag squamous cell carcinoma primari cancer cell strong express egf metastas lymph node frequent"
"immunohistochemistri collagen iv express colorect carcinoma duke classif establish prognost colorect cancer patient duke class surviv individu patient vari recent studi show prognost signific genet alter colorect carcinoma import tumor stromal compon note surround tissu overlook method longitudin studi patient colorect cancer oper author determin influenc prognosi lymphocyt infiltr express collagen type iv tumor stroma age sex duke classif grade tumor differenti vasoinvas number posit lymph node analyz follow year lymphocyt infiltr collagen iv express score mild moder sever surviv analyz cox proportionalhazard model densiti lymphocyt invas show signific influenc surviv collagen iv express analyz singl variabl signific relat prognosi colorect cancer patient multivari analysi collagen iv express show trend prognosi statist signific duke classif presenc vasoinvas lymph node status signific influenc surviv conclus immunohistochemistri collagen iv import addit stain techniqu prognost addit collagen iv immunostain facilit recognit vascular invas highlight basement membran vessel"
"phase ii trial carboplatin vinblastin treatment advanc squamous cell carcinoma esophagus cisplatin regimen activ treatment esophag cancer respons rate advanc diseas carboplatin toxic cisplatin singl agent respons esophag tumor defin role carboplatin esophag cancer author treat chemotherapyna patient advanc squamous cell carcinoma esophagus carboplatin vinblastin carboplatin mgm intraven iv day week vinblastin mgm iv day week major respons signific renal toxic mild gastrointestin toxic emesi diarrhea observ hematolog toxic sever patient prior radiat therapi rt patient prior rt exhibit grade hematolog toxic general toxic cisplatin regimen carboplatin vinblastin activ treatment squamous cell carcinoma esophagus hematolog toxic regimen sever patient receiv prior rt"
"phase ii multiinstitut trial lowdos phosphonacetylaspart highdos fluorouracil shortterm infus treatment adenocarcinoma pancrea southwest oncolog group studi adenocarcinoma pancrea high lethal malign chemotherapi impact natur histori diseas pala potenti fluorouracil fu shown synergi vivo vitro twenti patient treat intraven push dose pala mgm hour hour infus fu mgm regimen repeat week partial respons elig patient estim respons rate toxic sever toxic death patient experienc grade toxic fluorouracil pala schedul effect adenocarcinoma pancrea"
"doseintens regimen fluorouracil treatment metastat colorect carcinoma fluorouracil fu deliv doseintens schedul patient metastat unresect colorect carcinoma schedul consist bolus singledos fu therapi mg day infus fu mgmday day day infus mgmday partial remiss elig patient signific toxic includ mucos diarrhea handfoot syndrom necessit dose reduct patient author conclud fu moder intens schedul moder level respons easili achiev convent schedul fuleucovorin combin tumor respons dose intens fu regimen limit"
"neoadjuv chemotherapi radic surgeri local advanc cervic cancer prognost factor respons surviv januari septemb patient local advanc cervic carcinoma intern feder gynecolog obstetr figo stage ibiii receiv cours neoadjuv chemotherapi nac includ cisplatin bleomycin methotrex pbm fifteen percent patient achiev complet respons cr partial respons pr pretreat characterist analyz respons nac signific lower respons rate found patient tumor size cm diamet bilater parametri involv pelvic side wall biolog paramet studi relat chemorespons patient achiev cr pr signific improv year surviv rate compar respond nac radic surgeri respond patient median number lymph node remov lower expect incid lymph node metastas detect clinic patholog featur consid signific correl lymph node status twelv oper patient diseas recurr patholog parametri involv cervic infiltr equal deeper mm found signific prognost factor recurr year diseasefre surviv stage ibiia iib iii found oper patient rate increas stage ibiia iib iii prospect random trial compar nac surgeri radiotherapi progress"
"prognost factor treatment hepatocellular carcinoma transcathet arteri embol arteri infus januari decemb prospect trial transcathet arteri treatment carri hepatocellular carcinoma hcc hundr seventi patient includ okuda stage system employ patient stage ii hcc treat transcathet arteri embol tae gelatin spong anticanc agent protocol gelatin spong iodiz oil mix anticanc agent protocol iodiz oil mix anticanc agent protocol patient stage iii hcc treat iodiz oil anticanc agent protocol patient unsuccess superselect catheter proper hepat arteri selding techniqu obstruct main trunk portal vein treat percutan transcathet arteri infus common hepat arteri stage protocol tumor type extens area tumor involv portal vein involv method treatment presenc ascit icterus found signific factor initi respons therapi treatment method import factor respect surviv rate year protocol protocol protocol protocol factor prove signific influenc prognosi tumor type import prognost signific afp ascit treatment protocol area tumor involv"
"cancer radiat therapi cancer uterin cervix radiationinduc cancer radiat therapi cancer uterin cervix investig patient includ patient treat radiat therapi postop radiat therapi surgeri observedexpect ratio primari cancer patient radiat therapi patient postop radiat therapi signific increas observ risk primari cancer site combin assess site site basi signific excess note rectum cancer leukemia bladder cancer radiat therapi group surgeri group signific excess lung cancer observ radiat therapi surgeri group attribut causat factor radiationinduc cancer suggest develop appar organ involv irradi field"
"evalu simpl line width test involv magnet reson spectroscopi plasma carcinoma ovari magnet reson spectroscop mrs measur human plasma report general applic marker malign patient malign mrs line width signific patient benign diseas healthi control author investig test women ovarian carcinoma benign pelvic mass benign nongynecolog diseas healthi control mrs measur perform plasma sampl degre degre line width paramet obtain averag width half height methyl methylen peak reson spectra degre hz threshold abnorm result signific correl result test presenc absenc malign studi demonstr specif posit predict low test manag patient carcinoma ovari degre correl result test clinic status women carcinoma ovari observ patient test predict preoper benign malign natur pelvic mass"
"ki immunostain human breast tumor relationship prognosi ki label quantifi nonmalign breast tissu breast carcinoma count ten random highpow field section plane rc evalu area highest label densiti hdc procedur prove high correl rs kiposit fraction nonmalign tissu rc hdc signific lower compar carcinoma rc hdc carcinoma ki label signific pt stage axillari lymph node status tumor grade invers relat progesteron receptor status median count method rc hdc cutoff point signific curv diseasefre surviv median follow month obtain cox multivari analysi fail demonstr independ effect ki label contrast ki reactiv independ prognost higher cutoff level select"
"high preval antibodi hepat virus patient hepatocellular carcinoma japan japan hepatocellular carcinoma hcc preval cancer report fatal rate show consist signific increas decad hcc case posit hepat surfac antigen hbsag investig potenti role hepat virus hcv develop hcc sera hbsagneg hcc patient collect district japan assay antibodi hcv antigen hcvab larg number patient found posit hcvab comparison report preval sera blood donor histori blood transfus found case posit hcvab signific lower rate observ hcc patient posit hbsag negat hcvab"
"hodgkin lymphoma brain hodgkin diseas immunohistochem studi hodgkin lymphoma nhl central nervous system cns rare report complic hodgkin diseas hd patient nhl brain hd studi histolog immunohistochem method patient decad treat radiat chemotherapi experienc relaps hd develop nhl evid hd time diagnosi nhl die year diagnosi brain neoplasm larg cell immunoblast lymphoma cell lineag patient hd increas risk nhl cns poor prognosi"
"dna rna flow cytometr studi multipl myeloma clinic correl flow cytometr studi cellular dna rna content acridineorang techniqu conduct patient multipl myeloma mm patient treat protocol clinic respons evalu criteria chronic leukemiamyeloma task forc aneuploid dna stemlin found untreat patient median dna index dna marrow aspir biopsi specimen median percentag cell abnorm dna content aspir biopsi specimen posit correl percentag bone marrow plasma cell observ signific higher prolifer phase found marrow biopsi specimen compar marrow aspir signific higher rna content rna index rna observ aneuploid versus diploid patient biopsi materi differ respons memori hospit protocol diploid aneuploid patient patient dna greater remiss durat shorter compar dna equal differ cellular rna content note respond nonrespond studi demonstr correl cellular rna content respons previous patient treat vincristin adriamycin dexamethason vad dna aneuploidi advers prognost factor mm patient treat protocol demonstr prognost model mm univers depend chemotherapeut regimen"
"immunohistochem evalu progesteron receptor frozen section paraffin section cytolog imprint breast carcinoma monoclon antibodi progesteron receptor pr jzb kd immunocytochem visual pr kind breast cancer specimen includ cryostat section tumor frozen degre paraffin section tumor fix formalin bouin fixat vari period time room temperatur degre imprint cryostat section prepar tissu frozen section diagnosi store degre fixat zamboni solut section convent frozen specimen imprint cryostat section store vari period time stain peroxidaseantiperoxidas techniqu avidinbiotin techniqu paraffin section type specimen pr immunostain local nuclei carcinoma cell display heterogen intens distribut posit cell close correspond found immunohistochem techniqu immunostain steroidbind assay pr stain frequent posit differenti moder poor differenti carcinoma meaning correl found pr stain extent diseas similar result obtain immunostain estrogen receptor materi monoclon antibodi dp gamma choos techniqu suit type specimen obtain valid inform receptor status breast carcinoma size clinic present"
"compar studi histopatholog hormon receptor peanut lectin bind ki immunostain nucleolar organ region protein human breast cancer current studi perform case human femal breast cancer compar result morpholog method develop detect estrogen receptor er progesteron receptor pgr lectin peanut agglutinin pna bind site monoclon antibodi ki immunoreact number argyrophil nucleolar organ region ag paramet evalu serial cryostat section repres close relat ident neoplast popul signific posit correl found occurr estrogen progesteron peanut receptor ki immunoreact number mitot index er pgr pna receptor show signific invers correl ki immunoreact mitot index number ag result provid data support hypothesi progesteron pna receptor estrogeninduc metabol respons target cell function estrogen receptor number reflect cell kinet tumor metabol differenti neoplast cell invers correl prolifer index"
"nucleolar organ region precancer cancer lesion bronchus silver stain techniqu nucleolar organ region protein ag studi paraffin section specimen normal bronchial epithelium atyp squamous metaplasia carcinoma situ microinvas squamous cell carcinoma number ag nucleus normal epithelium sd atyp squamous metaplasia borderlin lesion carcinoma situ microinvas squamous cell carcinoma high signific differ ag number atyp squamous metaplasia carcinoma situ ag stain techniqu differenti diagnosi difficult borderlin lesion bronchial epithelium"
"insulin secret action patient pancreat cancer author investig insulin secretori capac insulin action preoper patient pancreat carcinoma agematch weightmatch healthi subject patient classifi diabet impair glucos toler igt nondiabet postabsorpt serum insulin level se uuml igt compar administr oral glucos peak insulin achiev lower igt peak insulin level igt signific higher compar insulin respons nonglucos stimuli document subject slow arginin infus test serum insulin igt patient control insulin action assess euglycem hyperinsulinem clamp techniqu glucos turnov rate estim hglucos infus steadyst plasma glucos concentr maintain mgdl insulin infus rate mukgmin compar high physiolog insulin level observ uuml uuml postabsorpt rate endogen glucos ra higher mgkgmin mgkgmin high physiolog insulin concentr negat ra valu document subject complet suppress ra assum total bodi glucos consist lower mgkgmin mgkgmin consist state insulin resist patient pancreat cancer manifest insulin resist virtu decreas total bodi glucos decreas insulin respons glucos due inher beta cell dysfunct decreas islet cell mass identifi histolog morpholog"
"pancreat mucin cystadenocarcinoma pseudosarcomat mural nodul report case immunohistochem studi case pancreat mucin cystadenocarcinoma pmc pseudosarcomat mural nodul pmn nodul previous type tumor ovarian mucin tumor omt similar nodul report natur discuss detail similar tumor ovarian tumor stress immunohistochem studi carri disclos nodul strong posit stain vimentin moder posit keratin epitheli membran antigen find histolog detail favor epitheli natur nodul conclud nodul foci anaplast carcinoma high prolif cell rate explain coexpress vimentin keratin"
"prognost implic tumor diamet carcinoma head pancrea hundr twenti patient carcinoma head pancrea divid tumor diamet group group cm group cm group cm tumor diamet group fold eliminatori curabl analysi perform patient liver metastas group patient die month group patient aliv month start complaint patient extrahepat metastas surviv month group month group month group actuari surviv rate inoper patient reach group month group month group month start complaint group curabl curat oper patient respect actuari surviv rate reach month month month actuari surviv rate patient irresect vessel invas reach group month group month group month actuari surviv rate patient irresect tumor reach month month month start complaint group actuari surviv rate curat oper patient reach group month group month group patient aliv month start complaint small tumor greatest chanc curat oper averag longest surviv small tumor liver metastas carri wors prognosi larg tumor liver metastas tumor found resect time oper size tumor affect surviv"
"respons rate relaps wilm tumor effect agent hundr eighti children wilm tumor treat unit kingdom children cancer studi group wt studi seventi patient relaps treatment surgeri chemotherapi radiat therapi depend stage histolog characterist forti patient evalu diseas respons line chemotherapi evalu respons chemotherapi imposs remain patient surgeri radiat therapi time relaps line combin chemotherapi includ ifosfamid etoposidevm cisplatincarboplatin bleomycin melphalan thiotepa lederl laboratori pearl river ny complet respons partial respons patient favor histolog find stage ten stage ii stage iii stage iv stage diseas surviv survivor treat chemotherapi receiv combin treatment chemotherapi radiat therapi surgeri unfavor histolog find stage surviv author conclud patient local diseas favor histolog find salvag rate stage histolog find likelihood cure relaps remot addit effect chemotherapeut agent patient"
"primari treatment larg massiv adult sarcoma iododeoxyuridin aggress hyperfraction irradi decad author experi treatment unresect adult soft tissu boni sarcoma year combin hyperfraction radiat therapi intraven iododeoxyuridin radiosensit regimen design minim toxic permit deliveri aggress radiat therapi patient solitari lesion metastasi treat hope potenti cure durabl palliat formid cancer larg massiv requir field extens treatment plan author report result patient larg unresect sarcoma tumor rang cm averag cm treat hyperfraction radiat therapi minimum follow year follow year follow death local control control lesion cm cm cm greater cm morbid modest experi compar favor author earlier trial misonidazol toxic reduc"
"ultrasound ultrasoundguid fine needl aspir biopsi supraclavicular lymph node patient esophag carcinoma ultrasound combin ultrasoundguid fineneedl aspir biopsi ugfab supraclavicular lymph node pretreat stage patient squamous cell carcinoma esophagus patient underw comput tomographi ct scan chest abdomen ultrasound abdomen supraclavicular region supraclavicular lymph node metastas stage iv diseas tumor node metastasi tnm classif cytolog diagnos patient patient metastas found patient ugfab replac invas diagnost procedur due superfici locat ultrasound ugfab supraclavicular lymph node simpl perform contribut improv stage squamous cell carcinoma esophagus"
"alter protein tyrosin kinas level human colon carcinoma understand molecular mechan biolog indic colon tumorigenesi author examin tyrosin kinas activ cytosol particul fraction homogen specimen human colon carcinoma compar adjac normal mucos tissu total protein tyrosin kinas activ precis detect miniphosphocellulos column purif synthet peptid gluasparagin aspalanin alaglutyrosin tyralaalaarginin argargargglycin gli artifici substrat tyrosin kinas activ colon carcinoma normal mucosa reduc cytosol fraction activ particul fraction elev respect protein concentr averag specif activ ratio normal cytosoliccarcinoma cytosol normal particulatecarcinoma particul tyrosin kinas activ cellular distribut cytosol tyrosin kinas activ normal mucosa carcinoma vari case percentag cytosol tyrosin kinas activ carcinoma tissu lower normal tissu differ due histolog type presenc adenomat compon signific decreas cytosol tyrosin kinas correl duke stage advanc duke stage averag specif activ ratio normal cytosolcarcinoma cytosol decreas studi colon carcinogenesi alter cellular level tyrosin kinas activ averag specif activ ratio normal cytosolcarcinoma cytosol correl colon tumor growth"
"watch wait care surgic treatment stage differenti earli ovarian cancer patient differenti epitheli ovarian cancer stage ia ib ic iia figo observ surgic treatment adjuv therapi care surgic stage requir extent stage procedur assess individu patient patient enter studi dutch oncolog center fulfil inlet criteria studi exclud central patholog review perform remain case reveal borderlin tumor patient moder poor differenti tumor patient tumor nonepitheli histolog cell type patient case materi histolog review exclus case patient analyz patient lost follow period rang month month tumor recurr found patient month follow die short diagnosi recurr satisfactori respons secondari treatment patient underw extens stage procedur diseasefre year surviv patient inaccur stage diseasefre year surviv conclud differenti earli stage iaiia ovarian cancer carri excel prognosi surgic treatment complet surgic stage patient stage ic diseas malign periton wash consid applic object consist assess tumor grade encourag surgic stage regard golden standard defin subset lowrisk patient includ defin futur trial earli ovarian cancer"
"loss express blood group antigen cellular invas spread oral squamous cell carcinoma membranebound carbohydr influenc metastat behavior cancer cell forti squamous cell carcinoma scc buccal maxillari alveolar mucosa studi retrospect monoclon antibodi react blood group type chain structur antigen stain entir tumor correl stage tumor spread tumor loss stain invas site tumor correl signific stage tumor develop histolog grade malign find support view featur relat cell deeper part carcinoma import clinic behavior tumor loss antigen express relat stage tumor invas carcinoma cell"
"ras gene mutat intraduct papillari neoplasm pancrea analysi case intraduct papillari neoplasm pancrea analyz presenc ras gene mutat neoplasm show point mutat ras codon incid mutat low compar found ordinari pancreat adenocarcinoma presenc mutat correl sever cellular atypia appar relat size tumor neoplasm mutat smaller mutat analysi suggest ras gene mutat genet alter tumor progress occur develop neoplasm pancrea"
"osteosarcoma young children clinicopatholog featur osteosarcoma children younger year age treat children hospit danafarb cancer institut boston year time period present children treat longterm survivor children treat diseasefre averag follow year year mark onset effect chemotherapi osteosarcoma highdos methotrex leucovorin rescu patholog featur behavior osteosarcoma young children similar osteosarcoma older children adolesc combin complet wide surgic resect amput aggress chemotherapi offer chanc longterm surviv"
"fineneedl aspir hepatocellular carcinoma combin cytolog histolog approach cytolog featur fineneedl aspir fna hepatocellular carcinoma hcc document previous report morpholog featur tumor cell sinusoid stroma cytohistolog correl tissu aspir rare report describ cytolog pattern case hcc term histolog pattern observ cell block prepar aspir specimen classifi world health organ classif tumor classifi predomin pattern thirti case gave trabecular pattern smear subdivid centralsinusoid pattern case peripheralsinusoid pattern case case gave pseudoglandular pattern seventeen case gave compact pattern inconspicu sinusoid case sinusoid easili recogn cell block section cytolog featur intranuclear cytoplasm inclus eosinophil globul bile secret smear cell block mallori hyalin ground glass inclus recogn cell block attent paid sinusoid stroma diagnosi hcc fna cell block wide util effect cytolog pattern classifi histolog classif"
"clinic present treatment outcom trilater retinoblastoma report case trilater retinoblastoma present clinic present treatment outcom patient compar case previous report literatur posit famili histori obtain patient age diagnosi bilater retinoblastoma month age diagnosi trilater diseas month result latent interv month time diagnosi trilater retinoblastoma death month patient die spinal metastas patient receiv therapi surviv averag month diagnosi trilater diseas patient receiv form definit therapi surviv month patient complet dramat respons therapi comput tomographi scan local intracrani tumor present autopsi aggress local therapi warrant"
"factor relat consequ weight loss patient stomach cancer norwegian multicent experi norwegian stomach cancer trial patient stomach cancer includ nation prospect multicent studi surgic unit particip inform weight loss diagnosi patient median weight loss kg patient experienc weight loss logist regress analysi author found weight loss increas age advanc stage diseas tnm stage iv decreas karnofski index lauren diffus versus intestin tumor type tumor locat cardiaesophagus increas weight loss reduc resect rate signific associ weight loss postop complic rate found odd ratio postop mortal weight loss group kg versus kg conclus weight loss reflect favor tumor status weight loss increas postop morbid lead weight higher death rate surgeri"
"zinc copper breast cancer joint studi northern itali southern franc relationship breast cancer trace element zinc zn copper cu investig hospit base casecontrol studi milan itali montpelli franc variabl dietari intak zn cu milan blood level milan montpelli measur dietari intak evalu questionnair dietari histori type blood level zn cu measur case control cu blood level show contradictori tendenc sampl higher control milan higher case montpelli tend lessen adjust relat variabl odd ratio quantil trend reach statist signific sharp differ evidenc opposit regard zn blood valu case control sampl zn valu signific higher case control differ remain signific sampl adjust relat variabl pool comput sampl adjust risk factor relat variabl reach fourth quartil ci dietari intak miner measur milan sampl show differ case control stronger relationship dietari blood zn evidenc case respect control author suggest higher zn level case relat higher incorpor zn cancer case miner play role tumor growth promot"
"type ii oestrogen bind site human colorect carcinoma case colorect adenocarcinoma investig presenc oestrogen receptor progesteron receptor tumour specif bound oestradiol bind exclus result presenc high number type ii oestrogen bind site oestrogen receptor absent present low concentr immunohistochem investig nuclear oestrogen receptor gave negat result antioestrogen receptor antibodi recognis oestrogen receptor type ii oestrogen bind site presenc specif type ii oestrogen bind site progesteron bind offer evid potenti role steroid receptor colorect carcinoma"
"improv silver stain nucleolar organis region paraffin wax section invert incub techniqu publish erratum clin pathol jun simpl modif silver stain nucleolar organis region agnor devis perform incub slide invert result minim undesir background stain persist problem invert incub facilit commerci plastic coverpl techniqu addit advantag publish stain protocol method straightforward fast maintain high degre contrast background agnor"
"neuromesenchym hamartoma small bowel present case long small bowel strictur patholog featur similar neuromuscular vascular hamartoma show addit extens fatti submucos infiltr fibrous intramur nodul controversi natur disord separ entiti account mesenchym tissu origin particip propos altern term neuromesenchym hamartoma small bowel"
"pharyng adenocarcinoma intestin featur high grade adenocarcinoma aris primarili pharynx year man present ctscan reveal tumour mass grow pharynx larg affect parapharyng soft tissu lymph node metastas found clinic present morpholog immunohistochem studi display similar featur intestin origin knowledg previous exampl neoplasm report site histogenet origin discuss"
"cystic hygroma massiv recurr adult life cystic hygroma consid diseas childhood time adult life recurr stage rare present difficulti diagnosi due previous treatment author present case earli pharmacolog intervent prevent potenti life threaten situat world literatur review"
"papillari adenocarcinoma middl ear case papillari adenocarcinoma middl ear present patient unusu short histori otalgia aural discharg facial palsi present tumour larg surgic resect feasibl option manag rare tumour discuss relev literatur review"
"trend femal breast cancer connecticut unit state trend femal breast cancer examin age period cohort year mortal connecticut mortal connecticut incid birth cohort pattern evid set data result confirm continu increas invas breast cancer provid evid strong birth cohort pattern time seri year birth cohort trend real part cohort pattern minim underdetect data obtain autopsi blind biopsi cohort model appli breast cancer mortal indic modest declin recent breast cancer mortal face appar longterm increas suggest control breast cancer mortal develop recent decad earlier detect improv treatment final contrast prior report evid clinic import differ time trend pre postmenopaus breast cancer"
"recent life chang larg bowel cancer data melbourn colorect cancer studi larg popul base epidemiolog studi colorect cancer melbourn colorect cancer studi etiolog factor investig person recent life degre upset experienc result includ interview histolog confirm case colorect cancer occur month period melbourn australia age sex match communiti control conduct method assess effect recal bias hospit control investig major ill death famili member major famili problem major work problem found signific common case year preced diagnosi compar control case report signific upset recent life control signific differ result found male femal colon cancer rectal cancer patient possibl recal bias complet control studi import factor explain casecontrol differ recent life percept signific develop larg bowel cancer"
"indiumantimyosin scintigraphi doxorubicin therapi patient advanc breast cancer indiumantimyosin inantimyosin scan perform women advanc breast cancer cycl chemotherapi consist cyclophosphamid fluorouracil doxorubicin total cumul dose doxorubicin mgm antimyosin uptak myocardium quantifi heartlung ratio hlr antimyosin uptak myocardium observ patient hlr chemotherapi left ventricular eject fraction ef determin chemotherapi patient decreas ef present intens antimyosin uptak hlr versus hlr valu correl ef valu chemotherapi posit antimyosin studi chemotherapi includ doxorubicin presenc myocardi damag patient antimyosin studi sensit method detect myocyt damag patient doxorubicin therapi"
"indiumlabel anticolorect carcinoma monoclon antibodi accumul tumor tissu patient colorect carcinoma indium label murin monoclon antibodi zce carcinoembryon antigen cyt mab tumor glycoprotein imag patient colorect cancer encourag result object studi assess frequenc mab local tumorfre benign tissu scan patient undergon exploratori surgeri radioimmunoscintigraphi inzc incyt review conjunct oper histopatholog report local tumor tissu patient receiv zce cyt common site involv degen joint diseas abdomin aneurysm postop bowel adhes local inflammatori secondari surgeri extern irradi review patient medic histori result concurr diagnost modal lessen falseposit rate inlabel mab scan interpret"
"ffluorofucos tracer assess glycoconjug synthesi tumor positron emiss tomographi potenti ffluorofucos fffuc assess glycoconjug synthesi tumor positron emiss tomographi pet investig tissu sampl method tumor model timeradioact profil found constant level lewi lung carcinoma ll clearanc pattern rapid clearanc normal tissu result prefer uptak ratio tumor imag brain pancrea metabol studi fucos load effect tissu uptak prove tracer biochem activ fucos analog imag intracrani rat glioma ll lung hepatoma mice autoradiographi arg intramuscular vx carcinoma rabbit pet demonstr doubleradionuclid arg similar distribut imag fffuc cfucos tumorliv uptak ratio found metastasi model show higher uptak tracer compar primari tumor model"
"spect imag pediatr brain tumor hexaki methoxyisobutylisonitril technetium technetiummhexamibi hexaki methoxyisobutylisonitril technetium develop myocardi perfus agent biolog properti similar thallium ti ti recent observ diagnosi brain tumor conjunct singlephoton emiss comput tomographi spect imag technolog possibl biolog similar radiopharmaceut extend affin tumor test yr femal patient brain stem astrocytoma show mark focal uptak mtchexamibi site tumor recurr defin biopsi prior tispect studi tumornorm cortex radioact ratio mtchexamibispect studi spatial resolut mtchexamibi imag high observ suggest mtchexamibi merit studi potenti agent spect imag human brain tumor"
"beta camera static dynam imag chargedparticl emit radionuclid biolog sampl detect system base microchannel plate construct imag charg particl emit radionuclid biomed sampl techniqu signific advantag convent film autoradiographi investig distribut radiolabel compound shorter acquisit time due high sensit easier sampl handl direct quantif abil perform dynam studi detector perform show spatial resolut mm carbon mev good linear homogen nois level cmsec success imag system perform betaemitt sulfur iodin yttrium positron emitt gallium ga fluorin dynam studi axon transport smethionin nerv static imag ylabel monoclon antibodi slice tumor present system show promis rapid quantit imag chargedparticl emit radionuclid small biolog sampl"
"modifi anterior compart resect major patient soft tissu sarcoma anterior compart thigh preserv small portion quadricep intact nerv suppli compromis radic procedur local control rate distal vastus mediali spare long slender branch provid innerv dissect femor nerv inguin ligament branch uninvolv area quadricept farthest locat tumor essenti modifi anterior compart resect improv dramat function extrem"
"granular cell neoplasm extrahepat biliari tree morpholog ultrastructur immunohistochem studi review literatur recent case biliari granular cell tumor cystic duct prompt literatur review extens patholog examin tumor question total case black femal case present biliari symptom simpl surgic resect complet control benign condit granular cell tumor deriv neural crest cell"
"bilater malign phyllod tumour report rare bilater primari malign phyllod tumour diagnosi support identif benign epitheli element lesion case illustr typic dimorph featur malign phyllod tumour contralater tumour regard metastat histolog confirm"
"migrat stimul activ serum breast cancer patient assay measur abil stimul migrat fibroblast collagen gel carri serum treat untreat breast cancer patient healthi control migrat stimul activ found serum untreat breast cancer patient immedi surgic resect primari tumour day resect patient year tumour resect receiv adjuv treatment healthi women match age migrat stimul activ cancer patient serum indistinguish migrat stimul factor produc vitro fetal cancer patient skin fibroblast behaviour biochem fraction procedur presenc activ serum treat breast cancer patient distinguish oncofet protein produc tumour"
"axilla zone surgeon uk give inadequ primari treatment patient oper breast cancer spurious reason regard axillari clearanc unnecessarili extens surgeri reli total mastectomi tumour excis node sampl postop radiotherapi clear relapsefre surviv improv adjuv therapi inadequ explor axilla doubli unjustifi obvious risk failur remov node metastas patient depriv cure primari treatment extent tumour spread inadequ assess patient risk receiv adjuv treatment"
"prothymosin alpha antisens oligom inhibit myeloma cell divis function prothymosin alpha investig antisens oligodeoxyribonucleotid direct select region mrna case synchron human myeloma cell releas stationari phase incub fresh medium antisens oligom cell divis prevent inhibit sens oligom random antisens oligom effect detail analysi synchron cell popul sensetr untreat cell divid approxim hr growth initi cell incub antisens oligom mer target base downstream initi codon enter mitosi approxim cell divis late failur divid correl direct deficit prothymosin alpha continu presenc intact intracellular antisens oligom period hr antisens oligom effect time induct prothymosin alpha mrna growth stimul mrna level cell cycl conclud antisens dna caus specif hybrid arrest translat data suggest prothymosin alpha requir cell divis evid prothymosin alpha direct regul mitosi"
"sequenc function express xenopus oocyt human insulinoma islet potassium channel regul insulin secret involv coordin control ion channel betacel membran isol character cdna genom clone encod voltagedepend channel isoform express human islet human insulinoma channel isoform design hpcn deduc amino acid sequenc residu mr relat shaker famili drosophila channel hpcn homolog human channel isoform isol hpcn hpcn amino acid sequenc ident electrophysiolog characterist hpcn determin microinject synthet rna xenopus oocyt microelectrod voltageclamp record oocyt inject hpcn rna reveal voltagedepend outward current inactiv slowli time outward current inhibit aminopyridin ki mm insensit tetraethylammonium ion ba delay rectifi channel hpcn restor rest membran potenti beta cell depolar contribut regul insulin secret"
"dimer mammalian progesteron receptor occur absenc dna relat releas kda heat shock protein studi demonstr dimer mammalian progesteron receptor pr occur absenc dna specif immun coisol assay perform extract human breast cancer cell monoclon antibodi specif fulllength form progesteron receptor pr result coisol signific amount truncat form receptor pr indic presenc stabl prpr dimer solut posit correl observ abil receptor form oligomer solut abil bind specif dna sequenc abil form stabl prpr oligom absenc dna found correl releas kda heat shock protein hsp unactiv pr complex result support hypothesi dimer absenc dna import mechan control receptor dnabind function hsp releas key step regul dimer suggest hsp function repress dnabind activ indirect block receptor dimer"
"pancreat tumor pathogenesi reflect causat genet lesion transgen mice myc express target pancreat acinar cell develop mix acinarduct pancreat adenocarcinoma month age contrast effect pancrea simian virus tumor antigen activ ras adult mice lesion compos exclus acinar cell earli stage mycinduc patholog transform acinarderiv cell islet suggest islet hormon influenc progress exocrin pancreat tumor find demonstr initi oncogen alter influenc pattern subsequ tumor pathogenesi human exocrin pancreat tumor predomin ductal adenocarcinoma support suggest transform acinar cell contribut genesi diseas man"
"william vulvovaginoplasti supralev total pelvic exenter patient delay william vulvovaginoplasti supralev total pelvic exenter patient die carcinoma cervix month vulvovaginoplasti die chanc attempt intercours report intercours occas reconstruct patient experi pleasant unpleas state husband satisfi patient experi satisfactori husband remain patient aliv evid recurr diseas month oper patient report satisfactori sexual relat approxim preexenter frequenc remain sexual relat surgeri give main reason lack opportun william vulvovaginoplasti reason altern vagin reconstruct patient exenter improv result method vagin reconstruct continu evalu"
"roentgenograph evalu augment breast perform retrospect studi determin sensit mammographi detect breast cancer aris women augment breast women breast implant breast cancer develop mammogram biopsi cancer identifi mammograph sensit retrospect case mammograph find suggest benign malign process women palpabl mass earli diseas clinic diseasefre present sensit mammographi detect palpabl cancer control group women implant tumor cm sensit result suggest sensit mammographi detect breast cancer decreas implant present investig determin effect prosthes mammograph evalu"
"score system preoper evalu metastat spine tumor prognosi assess system prognosi metastat spine tumor evalu case undergon surgeri paramet employ assess system general condit number extraspin bone metastas number metastas vertebr bodi metastas major intern organ lung liver kidney brain primari site cancer sever spinal cord palsi paramet rang point total score obtain patient correl prognosi valuabl predict prognosi predict singl paramet conclus excision oper perform case score point palliat oper score point"
"total sacrectomi reconstruct huge sacral tumor author carri success total sacrectomi case giant cell tumor chordoma anterior posterior approach feasibl resect huge sacral tumor en bloc import reconstruct continu pelvic ring spinal column spinal instrument sacral rod ao plate total sacrectomi largescal timeconsum collabor oper team relay pelvic spinal surgic techniqu requir postop patient stand month plan rehabilit ambul spite structur neurolog damag caus total sacrectomi reward procedur term improv morbid mortal"
"infiltr lower respiratori tract helperinduc lymphocyt htlv adult cell leukemialymphoma human cell lymphotrop virus type htlv causat agent adult cell leukemialymphoma atll disord peripher blood multipl organ infiltr malign transform lymphocyt investig natur pulmonari diseas patient serolog evid htlv infect case endobronchi biopsi specimen show infiltr bronchial mucosa pleomorph cell exhibit high degre nuclear irregular cell morpholog ident malign cell found peripher blood infiltr dermi express oktleu phenotyp receptor interleukin analog gene rearrang studi leukem blood cell monoclon origin situ hybrid endobronchi biopsi specimen fulllength htlv probe fail detect retrovir rna provir dna studi lymphocyt involv lower respiratori tract htlv atll character express malign phenotyp inabl document actual cellular infect retrovirus molecular hybrid techniqu"
"diagnosi ovarian cancer pathologist diagnos contribut pathologist agre panel gynecolog pathologist cancer steroid hormon studi multicent populationbas casecontrol studi ovarian breast endometri cancer women year age permit diagnos contribut pathologist compar panel gynecolog pathologist diagnosi ovarian cancer made contribut pathologist subject agreement group pathologist primari epitheli ovarian cancer primari nonepitheli ovarian malign agreement diagnosi major cellular subtyp ovarian malign rang endometrioid cancer clear cell carcinoma conclud diagnosi patholog featur primari ovarian cancer high predict nonetheless diagnosi histolog type vari suffici review process consid clinic investig decis involv specif histolog diagnos ovarian cancer"
"dissect cardin ligament radic hysterectomi cervic cancer emphasi ligament surgic experi carcinoma uterus rectum provid insight surgic anatomi lamina separ paraves space pararect space prove lamina consist cardin ligament pelvic splanchnic nerv descend order cardin ligament connect stalk insert wall uterus rectum extend aspect pelvic wall clarif structur relationship led develop procedur dissect cardin ligament radic hysterectomi preserv ligament facilit systemat dissect cardin uterosacr ligament posterior manipul lead reduct blood loss prevent brisk bleed venous plexus"
"elus colon malign definit preoper local colonoscopi biopsi standard practic diagnosi colon malign inabl endoscopi obtain precis distanc measur anal verg make local lesion oper difficult reason preoper barium enema intraop colonoscopi advoc pinpoint site lesion thought easili locat oper patient present malign lesion colon diagnos verifi histolog undetect oper subsequ colonoscop examin patient underw laparotomi receiv colon resect patient tumor identifi intraop colonoscopi resect bowel patholog examin follow colonoscopi patient present spontan pass polyp invas adenocarcinoma multipl colonoscop examin fail identifi site lesion date tumor recur period follow rang month year patient demonstr poor document understood aspect behavior colon malign abil spontan regress slough bowel wall base instanc local potenti malign colon lesion recommend submucos dye inject initi endoscopi colonoscopi oper room immedi prior oper"
"patholog nonpalp breast cancer princip goal mammograph screen earli detect breast cancer review record women refer nonpalp suspici abnorm mammogram subsequ prove cancer requir mammograph local biopsi subsequ surgeri therapi found invas tumor show evid microinvas noninvas total patient lymphadenectomi part definit surgeri patient infiltr tumor malign node histolog section patient noninvas microinvas tumor found involv node mammograph abnorm led biopsi seri calcif patient mass lesion mass lesion calcif asymmetri patient nodal metastas mass calcif indic biopsi increas tumor size found correl invas tumor histopatholog examin incid lymph node metastas thirti patient infiltr tumor tumor size greater cm lymph node posit patient tumor cm size note patient microscop tumor involv node year actuari surviv patient infiltr tumor cent patient noninvas microinvas tumor cent median follow month"
"intraven administr recombin human granulocytemacrophag colonystimul factor cutan erupt intraven administr recombin human granulocytemacrophag colonystimul factor patient leukemia receiv marrow aplasiainduc chemotherapi result develop widespread erythemat macul papul erupt parallel time infus granulocytemacrophag colonystimul factor skin biopsi specimen erupt display characterist consist variabl mixtur granulocyt lymphocyt increas number size dermal macrophag mild moder epiderm exocytosi intercellular edema rare dyskeratot keratinocyt immunophenotyp analysi specimen notabl keratinocyt intercellular adhes molecul express administr recombin human cytokin pharmacolog dose postul induc immunolog status skin result express cutan erupt"
"intraepitheli anchor fibril compon cultur human keratinocyt cultur human cervic carcinoma cell intracellular pool antigen react anchor fibril antibodi af af keratinocyt antigen form basement membran structur apic portion cell flow cytometr techniqu pretreat cell aceton reveal larg intracellular pool antigen intracellular epitop calcium sensit form recess dystroph epidermolysi bullosa retent intracellular portion anchor fibril suggest relat intracellular anchor fibril antigen diseas"
"famili multipl desmoplast trichoepithelioma kindr famili multipl desmoplast trichoepithelioma desmoplast trichoepithelioma ad group lesion inherit pattern occur multipl primari tumor implic nosolog status treatment desmoplast trichoepithelioma consid"
"vivo ultraviolet irradi human skin result profound perturb immun system relev ultravioletinduc skin cancer publish erratum arch dermatol sep ultraviolet exposur human skin delet function antigenpres langerhan cell resid epidermi langerhan cell capabl activ lymphocyt present antigen nickel tumor antigen lymphocyt activ lymphocyt involv develop contact dermat immun surveil immunogen skin cancer delet function langerhan cell result abrog epiderm antigen present ultraviolet irradi simultan induc epiderm antigenpres cell popul distinct langerhan cell popul induc suppress immun respons suppress immun respons ultraviolet irradi murin model critic growth immunogen ultravioletinduc skin neoplasm ultraviolet irradi human skin facilit growth human neoplasm spread skin infect due induct suppressor cell"
"drug respons head neck tumor nativest histocultur describ chemosensit test head neck tumor nativest histocultur dimension cultur system maintain import vivo properti includ tissu architectur fifteen specimen head neck tumor evalu sensit drug cisplatin ddp concentr microgramsml fluorouracil concentr microgramsml combin cisplatin fluorouracil dose growth measur drug respons success complet specimen contamin prior institut rigor antibiot wash result cisplatin sensit patient fluorouracil sensit patient fluorouracilcisplatin sensit patient preliminari result nativest histocultur techniqu feasibl test chemosensit head neck tumor"
"progress challeng psychosoci behavior research cancer twentieth centuri research psychosoci behavior aspect cancer shown steadi growth develop parallel histori medic techniqu treat cancer tabl outlin parallel evolut role american cancer societi nation cancer institut nci spearhead nurtur research area document interest psychooncolog question trace back centuri search etiolog factor psycholog variabl explain individu vulner cancer psycholog studi cancer patient report massachusett general hospit memori sloankett cancer center interest psychosoci behavior research issu address time care termin ill humanist approach includ pain control ethic concern relat patient status subject experiment protocol measur qualiti life cancer patient protocol multidisciplinari collabor group make absenc formal train area design valid accur measur scale specif symptomolog patient cancer tabl outlin gave increas recognit support psychosoci dimens cancer period produc seri key confer examin broad research educ perspect produc recommend remain benchmark regard instrument conceptu model pitfal psychosoci research train educ organ research effort precis ad field past year studi measur concurr psycholog endocrin immun function statist model incorpor qualiti life data correct factor surviv data twist qali broaden definit medic outcom includ function status advanc psychiatr measur answer question cancer challeng identifi summari tabl noteworthi observ comprehens research today carri disciplin approach call area social scienc inact cancer research anthropolog contribut tool expertis requir address problem"
"social environ social support research relev social support cancer plenti american cancer societi workshop methodolog issu behavior psychosoci scienc nonetheless critic shortcom continu character attempt empir establish thing extent social support predict adjust cancer diagnosi treatment promin failur adequ address larg element social structur social class urban investig shape person risk cancer caregiv recommend psychosoci research link social support cancer conduct popul beset poverti adequ access health care fund train mainten multidisciplinari multicultur team research work communitybas organ hospit serv underserv"
"social support cancer patient implic futur research clinic care review assess past progress current practic futur research clinic practic involv social support cancer patient review conceptu social supportstress paradigm state art measur social support current work field social support cancer consid argument made social support measur relev experi cancer patient potenti adapt exist instrument dukeunc function social support scale demonstr taxonomi stage cancer requir addit type social support measur intervent outlin intervent discuss term tradit support group intervent oncologist primari care physician argument made inclus qualiti life function measur outcom clinic trial care cancer patient final address existenti philosoph religi issu surround cancer treatment discuss"
"recommend behavior research prevent earli detect cancer lifestyl pattern affect cancer risk research healthrisk behavior behavior chang critic cancer prevent report recommend prioriti decad psychosoci research cancer prevent detect lead prioriti futur research fill gap basic knowledg left rush intervent outcom studi research theoret driven aim develop broad principl applic divers health behavior studi includ relev process data stage behavior chang consid desir simpl outcom studi epidemiolog investig expand includ measur relev behavior impact clinic outcom establish research lay percept health risk individu healthsystem barrier effect cancer prevent detect studi address minor underprivileg popul crucial fund agenc narrow categor mandat imped interdisciplinari research multipl risk factor interact boundari relax promot approach fund agenc basic research longterm invest develop effect intervent"
"epidemiolog perspect lifestyl modif health promot cancer research clinic patientori focus medicin psycholog contrast epidemiolog public health approach assess role lifestyl factor health promot cancer research unifi hostagentenviron epidemiolog paradigm appli contemporari cancer prevent issu princip smoke cessat dietari modif demonstr differ infer prevent strategi research opportun integr populationbas approach dynam patient behavior risk cancer salient role psychosoci stress person social resourc social epidemiolog perspect studi psychosoci determin physic health status offer approach resolv outlin differ perspect relev understand etiolog lifestyl behavior alter"
"psychoneuroimmunolog implic oncolog accumul evid central nervous system cns regul activ immun system signific immun system cancer remain controversi psychosoci influenc immun function potenti provid mechan account report associ psychosoci factor cancer prognosi"
"scientif inquiri childhood cancer psychosoci research theoret conceptu methodolog issu investig behavior treatment procedurerel distress paper discuss current status scientif inquiri childhood cancer psychosoci research investig behavior treatment procedurerel distress serv model illustr outlin theoret conceptu methodolog issu problem exist area childhood cancer psychosoci research specif issu relat process scientif inquiri theoreticalconceptu model measur assess behavior treatment strategi discuss exampl issu address investig procedurerel distress present recommend facilit growth develop field childhood cancer psychosoci research offer"
"qualiti life research oncolog past achiev futur prioriti status qualiti life research oncolog assess prioriti futur research regard conceptu theoret develop focus content research research design practic strategi research implement transfer inform clinic practic medic polici decisionmak identifi general agreement qualiti life subject multidimension construct comprehens theoret model develop appli fulli recommend futur research base conceptu model explic interrelationship qualiti life domain stage cancer care model longitudin research attend specif crossclass crosscultur issu avoid overgener theori research base larg view major cultur encourag inclus theorybas qualiti life assess standard compon clinic trial success endeavor requir addit standard qualiti life measur rang cancer patient popul includ develop agespecif norm instrument design assess entir famili system"
"methodolog issu assess qualiti life cancer patient qualiti life assess employ success descript evalu studi oncolog cancer clinic trial date limit rang issu imped conduct clinic trialbas qualiti life investig includ absenc theoret model guid develop qualiti life measur relianc ad hoc approach qualiti life assess insuffici attent practic constraint oper clinic research set primari import develop multidimension qualiti life instrument psychometr robust suggest futur work instrument develop focus refin generic cancerspecif measur develop diagnosticspecif questionnair modul psychometr work guid theoret model relationship healthrel qualiti life domain wide accept patient repres sourc qualiti life data suggest effort direct improv valid reliabl physiciangener assess patient perform status treatment toxic determin feasibl employ famili member proxi rater psycholog social health status patient unwil unabl provid inform addit attent paid logist problem aris clinic trialbas qualiti life investig research design data collect procedur select minim patient medic staff institut burden"
"qualitylifeadjust surviv compar cancer treatment commentari twist twist chronic diseas situat treatment comparison favor therapi definit outcom requir follow period addit intermedi endpoint relev clinic signific compar treatment endpoint time symptom toxic twist twist attempt address qualiti life patient receiv compet regimen paper commentari techniqu emphasi problem inher implement twist measur attempt incorpor patient prefer twist argu twist intuit appeal clinic set formid design psychometr hurdl overcom fulli operation concept"
"progress psychosoci behavior cancer research enabl strategi major compon workshop methodolog behavior psychosoci cancer research discuss enabl strategi strategi futur goal area psychosoci behavior oncolog accomplish report describ comment discuss place special plenari session repres fund agenc american cancer societi nation cancer institut nation institut mental health nation scienc foundat present view agenc program promot research psychosoci behavior oncolog conclud progress made field strategi place ensur continu progress suggest made strategi acceler broaden progress"
"behavior psychosoci cancer research build past prepar futur report identifi general conclus emerg workshop methodolog behavior psychosoci cancer research conclus address divers topic includ focus area methodolog emphasi transfer technolog knowledg appli set recognit role basic behavior research answer clinic question recogn strengthen tie field behavior psychosoci oncolog basic behavior social scienc field emerg import addit research minor special popul suggest meet challeng pose area critic continu progress field"
"fertilityspar treatment patient ovarian cancer varieti malign neoplasm produc ovari legion consid individu young woman earli diseas preserv childbear capabl risk conserv surgeri low patient advis care monitor group patient essenti approach"
"chromogranin posttransl modif secretori granul primari structur chromogranin multipl domain subject posttransl modif explor chromogranin proteolyt cleavag glycosyl intermolecular disulfid link biochem cell biolog approach antichromogranin regionspecif immunoblot chromaffin granul suggest bidirect endoproteolyt cleavag chromogranin control experi rule artifactu cleavag granul isol lysi isol chromogranin deriv peptid gel filtrat chromatographi sodium dodecyl sulfatepolyacrylamid gel electrophoresi sdspage termin amino acid sequenc establish cleavag site includ dibas site secret chromogranin bovin chromaffin cell initi cleavag prolong exposur secret chromogranin secretori cell chromogranin cleavag pattern qualit similar neuroendocrin tissu cleavag complet adren medullari anterior pituitari hormon storag vesicl termin fragment kilodalton promin hypothalamus similar cleavag pattern human pheochromocytoma granul judg chromogranin regionspecif immunoblot fragment isol sdspage microsequenc presenc fulllength chromogranin core protein chromaffin granul solubl proteoglycan suggest bovin human chromaffin granul glycoprotein stain chondroitinas abc digest chemic deglycosyl regionspecif immunoblot human bovin chromogranin display intermolecular disulfid crosslink sdspage gel immunoblot result document divers structur path chromogranin molecul endocrin secretori cell translat"
"comparison frtl cell growth vitro xenotranspl cell thyroid recipi mous present work design compar vitro cell growth kinet vivo growth condit similar label hthymidin purpos frtl cell cultur monolay dimension spheroid embed collagen gel transplant simultan nude mice treat perchlor low iodin diet growth transplant compar thyroid host mice intact thyroid fraction hthymidinelabel follicular cell flc label increas sluggish maximum week goitrogen exposur subsequ autoregulatori decreas week fold higher flc found adenoma indic focal failur growthrestrain mechan nonconflu monolay cultur flc high larg individu cluster cell tight mutual contact solid high cellular graft grow transplant monodispers cell show averag flc time higher flc ident stimul mous thyroid collagenembed cell form dimension spheroid flc decreas week vitro vivo week vitro vivo suggest effect autoregul excess growth condit flc higher flc simultan assess host thyroid differ remain day period studi conclud frtl cell grow monolay dimension spheroid vitro xenotransplant vivo invari show higher prolifer rate compar environment condit normal follicular epithelium thyroid host mice confluent monolay growth dens pack dimension transplant grow intens growthretard cell cell interact oper grow frtl cell effect dampen replic rate thyrocyt monolay hull normal follicl local failur mechan growth rate compar graft frtl cell result adenoma format normal thyroid observ call caution transfer vitro growth studi frtl cell vivo condit prevail normal thyroid"
"regul pancreastatin releas human pancreat carcinoid cell line vitro object experi investig influenc activ messeng system protein kinas adenyl cyclasecamp calcium mobil secret pancreastatin pst chromogranin cga human pancreat carcinoid cell line bon tissu cultur stimul protein kinas phorbol ester microm caus signific doserel releas pst control treatment bon cell grade dose bromocamp mm isobutylmethylxanthin ibmx mm stimul doserel releas pst control incub bon cell ionomycin microm increas releas pst control doserel manner combin ibmx ionomycin result addit effect treatment phorbol ester ibmx result synergist effect pst releas pretreat bon cell monensin agent prevent process precursor smaller peptid signific decreas pst cga secret respons phorbol ester ionomycin find protein kinas camp ca mobil particip cga pst secret observ secret pst cga respons theophyllin quantit absenc quantit relationship releas pattern pst cga respons phorbol ester ionomycin support simpl precursorproduct relationship cga pst monensin experi consist notion pst deriv cga bon cell"
"regul truncat lutein hormon receptor plasma membran rat mous leydig cell regul truncat lh receptor investig type mous tumor leydig cell ma mltc rat testi leydig cell rtl rat tumor leydig cell rc receptor number measur bind ihcg cell cultur monolay addit nm lh detect effect bind site rtl rc cell ma mltc cell caus loss bind site effect ma mltc cell mimick inhibit receptor intern mm nan prevent addit proteas inhibitor incub rtl rc cell proteas inhibitor caus fold increas bind site fold increas lh nmstimul camp product rtl ma cell incub presenc ihcg radioact protein complex approxim mol wt releas incub medium conclud lh receptor regul proteolysi plasma membran mous rat leydig cell truncat lh receptor mous leydig cell involv regul rat continu process"
"breast cancer screen older women practic barrier report primari care physician annual mammographi combin clinic breast examin reduc mortal breast cancer survey patient physician suggest mammographi underutil studi examin physician report breast cancer screen practic barrier mammographi vari patient age data primari care physician intern medicin familygener practic obstetricsgynecolog particip mail statewid survey analyz physician report screen elder women signific younger women famili histori breast cancer medic specialti physician demograph practic characterist report screen practic physician knowledg belief breast cancer older women report screen practic analyz barrier order mammographi cost patient view barrier women age pain view greater barrier younger women physician consist believ elder patient face barrier compar younger women investig requir examin primari care physician report agerel differ breast screen barrier mammographi"
"role tumorderiv cytokin immun system mice bear mammari adenocarcinoma induct regulatori macrophag normal mice vivo administr rgmcsf dimethylbenzanthraceneinduc immunogen nonmetastat murin mammari adenocarcinoma balb mice previous work shown splenocyt tumor bearer reduc respons mitogen ag includ tumor ag nk cytotox cell activ reduc splenocyt tumor bearer mac macrophag induc mammari tumor bearer capabl regul lymphocyt respons mitogen tumor ag cell cell contact interact increas pge product found tumor constitut releas granulocytemacrophag gmcsf factor vivo vitro respons system increas cell macrophag lineag tumorbear mice tumor cell line establish vivo tumor express releas gmcsf shown northern western blot analys daili inject wk rgmcsf normal mice induc hemopoiet immunolog alter similar observ tumor bearer mac mac macrophag detect spleen bone marrow mice treat rgmcsf addit splenocyt rgmcsftreat mice reduc respons mitogen periton exud cell vitro regul prolif respons lymphocyt normal mice suppress partial revers addit indomethacin cultur suggest pge contribut effect rgmcsf enhanc vitro releas pge spleen bone marrow periton cell normal mice data high level gmcsf constitut produc tumor respons hemopoiet immunolog alter observ tumorbear mice"
"insulin growth factor mitogen human keratinocyt squamous cell carcinoma normal adult human keratinocyt monolay cultur scl skinderiv squamouscel carcinoma cell line investig express receptor insulin growth factor igf insulin demonstr affin crosslink radiolabel igf igf insulin bound specif cell type cell express type igf receptor affin igf greater igf greater insulin insulin receptor highest affin insulin present cell keratinocyt scl cell differ iigf bind iigfbound type type ii igf receptor normal keratinocyt bound predomin membran igf bind protein scl igf slight potent igf stimul growth keratinocyt scl cell keratinocyt concentr igf rang ngml igf ngml result signific increas cell number maximum dose ngml igf igf caus time increas cell number scl cell igf potent igf insulin lower concentr igf igf maxim concentr ngml stimul time increas thymidin incorpor stimulatori effect insulin scl time potent igf effect igf scl complet inhibit type igf receptor antibodi alpha ir suggest igf mitogen type igf receptor insulin action partial block alpha ir suggest insulin act insulin type igf receptor igf igf mitogen normal transform human keratinocyt action primarili mediat type igf receptor insulin mitogen igf receptor insulin receptor"
"inositol phosphat format human squamous cell carcinoma line scc studi bradykinin calcium ionophor sodium fluorid phospholipas plcmediat hydrolysi membran phosphoinositid import signal transduct pathway coupl cellsurfac receptor hormon growth factor addit plc activ modul intracellular calcium activ gtp bind protein report differenti activ plc human keratinocyt cell line sccf studi judg specif pattern inositol phosphat format hormon growth factor previous shown stimul plc varieti cell type screen activ sccf cell bradykinin activ stimul plcdepend generat inositol triphosph insp insp rapid metabol inositolbiphosph insp inositoltetrakisphosph insp subsequ degrad inositol monophosph respons elicit bradykinin concentr depend ec nm suggest involv specif bradykinin receptor treatment cell calcium ionophor result direct format insp insp precursor treatment cell aif putat activ gtp bind protein result generat inositol monophosph major metabolit absenc detect insp format observ suggest plc complex present sccf cell differenti activ yield insp insp insp observ effect due direct plcdepend hydrolysi membran phosphoinositid"
"thyroid cancer import recent advanc understand biolog natur thyroid cancer earli diagnosi diseas advanc controversi manag thyroid cancer includ extent surgeri indic iodin effect thyroidstimul hormon suppress predict outcom review current status diagnosi manag type thyroid cancer care review extens document"
"hepat dynam sequenti ct section enhanc profil bolus ionic nonion contrast agent enhanc characterist portion liver dynam sequenti bolus comput tomographi ct iodin contrast materi dsbct prospect evalu patient iothalam meglumin iopamidol iohexol patient receiv agent baselin noncontrast ct perform dsbct perform ml intraven bolus administ mlsec scan start bolus initi scan time rapid cephalocaud tabl increment yield contigu mmthick section rate section minut postcontrast imag peak enhanc iopamidol iohexol superior iothalam meglumin peak enhanc decreas contrast agent declin precipit iothalam meglumin enhanc caudal section iopamidol iohexol superior iothalam meglumin data suggest enhanc characterist nonion agent optim detect focal hepat lesion ionic agent"
"linkag earlyonset famili breast cancer chromosom human breast cancer caus genet alter somat cell breast occasion suscept diseas inherit map gene respons inherit breast cancer identif earli lesion critic develop breast cancer general popul chromosom local gene inherit suscept breast cancer famili earlyonset diseas genet analysi yield lod score logarithm likelihood ratio linkag linkag breast cancer suscept ds earlyonset famili negat lod score famili lateonset diseas likelihood ratio favor linkag heterogen famili rang greater basi multipoint analysi loci region"
"detect ki prolifer rate breast cancer correl clinic patholog featur situ determin prolif activ perform breast cancer ki monoclon antibodi immunohistochem method tumor prolifer rate analyz correl tumor size nodal status relationship ki prolif activ nuclear estrogen receptor content investig adjac tissu section ki valu rang median premenopaus patient greater ki valu median postmenopaus median author observ correl lymph nodal involv statist signific relationship tumor size found invers correl spearman coeffici ki valu nuclear estrogen receptor content result similar report kinet measur suggest situ detect ki prolifer rate method obtain cell cycl inform follow studi assess eventu prognost relev"
"fluoresc cytochem detect estrogen progesteron receptor breast fineneedl aspir estrogen progesteron receptor studi fineneedl aspir biopsi specimen patient primari recurr metastat breast carcinoma ligand estradiolcarboxymethyloxinebovin serum albumin fluorescein isothiocyan fitcbsa estradiol hydroxyprogesteron hemisuccin bovin serum albumin tetramethyl rhodamin isothiocyan tmritcbsa progesteron fluoresc cytochem method find obtain aspir cell fluoresc cytochem techniqu compar result obtain cell popul tumor remov fluoresc cytochem techniqu biochem dextranco charcoal dcc assay needl aspir concord estrogen receptor concord progesteron receptor biochem cytochem result high degre correl demonstr fineneedl aspir imprint prepar cytochem techniqu studi suggest fluoresc cytochem techniqu effect tool assess estrogen progesteron receptor content fineneedl aspir primari metastat breast cancer fluoresc cytochem techniqu perform easili communiti hospit suit specimen insuffici size biochem assay"
"evalu vitro bromodeoxyuridin label breast carcinoma commerci kit prognost signific phase fraction analys breast carcinoma report investig cell prolifer kit amersham corpor arlington height il vitro bromodeoxyuridin brdu label evalu cell cycl kinet flow cytomet radioisotop simplifi assay clinicalbas laboratori provid standard reagent recommend method studi perform determin data deriv compar publish phase data thymidin label brdu method breast carcinoma primari infiltr ductal carcinoma primari lobular carcinoma show median brdu label rang benign lesion brdu uptak estrogen receptor er progesteron receptor pr status correl brdu label highest phase fraction er prnegat tumor correl brdu uptak histolog tumor type size observ signific correl brdu uptak lymph node status patient age histolog tumor grade observ phase studi breast carcinoma techniqu shown similar data cell prolifer kit practic method vitro phase analysi concomit histolog examin tumor tissu sampl"
"express blood group antigen le sialylatedl human colorect carcinoma immunohistochem studi doublelabel techniqu studi doublelabel immunohistochemistri gain insight coexpress interrelationship blood group antigen bga differenti antigen normal colon bga sequenti moieti synthet pathway pairedwis sialylatedlel le studi sialylatedl le synthes type type backbon normal colon le sialylatedl express cell base surfac crypt repres undifferenti differenti enterocyt consid oncofet natur consid precursor synthesi le individu cancer sialylatedlea le detect cancer cell malign gland separ gland subcellular compart cell le coexpress individu cell cancer express bga cancer le express separ malign gland individu tumor find colorect cancer differenti antigen sialyl le le express individu cell malign gland recapitul normal colon crypt antigen backbon occasion express cell subcellular compart precursor accumul common cancer antigen synthet pathway coexpress cell express le gland lack coexpress explain possibl aberr synthesi le altern pathway"
"tumorsecret vascular permeabl factor increas cytosol ca von willebrand factor releas human endotheli cell vascular permeabl factor vpf tumorsecret heparinbind protein mr approxim respons increas vessel permeabl fluid accumul tumor growth vascular permeabl factor promot growth human umbil vein endotheli cell ec bovin pulmonari ec vitro shown time guinea pig vpf halfmaxim maxim dose approxim pmol picomolar human vpf potent stimuli human ec result ca increas maxim fourfold inositol triphosph ip format unlik maxim respons thrombin histamin ca respons maxim vpf dose preced characterist delay guinea pig vpf select increas ca cultur aortic pulmonari arteri ec aortic smooth muscl cell human fibroblast neutrophil affinitypurifi rabbit antibodi rais synthet peptid repres vpf termin amino acid adsorb vessel permeabilityincreas activ ec growthpromot activ specif activ respons increas ec ca similar mediat increas ca cultur ec vpf induc increas von willebrand factor releas data vpf act direct ec rapid cellular event vivo vitro action involv phospholipas activ ca increas von willebrand factor releas"
"immunoreact receptor express insulinlik growth factor insulin human adren tumor immunohistochem studi case immunoperoxidas method human adren tumor examin evid immunoreact receptor express insulinlik growth factor igf insulin frequenc igf adrenocort carcinoma signific higher adenoma adren gland adrenocort carcinoma show strong intens stain igf igf receptor insulin receptor signific correl immunoreact receptor express igf insulin found adrenocort carcinoma adrenocort adenoma cush syndrom pheochromocytoma adrenocort adenoma conn syndrom stain strong insulin receptor igf insulin play role growth adrenocort carcinoma tissu possibl autocrin mechan express insulin receptor adrenocort adenoma presenc cush syndrom pheochromocytoma function"
"critic analysi largest report mass fecal occult blood screen program unit state fecal occult blood test detect colon cancer remain controversi perform mass screen program januari februari intens media promot includ minut televis air time total primari practition notifi mail hemoccultii test distribut individu return nineti percent respond inform program televis total person test posit fecal occult blood inform center physician initi work inform physician workup return patient diagnost test number test patient test repeat hemoccult barium enema colonoscopi perform thirti colorect cancer polyp identifi predict number cancer number patient test posit increas direct decad thirti patient cancer underw barium enema colonoscopi versus patient negat work cancer found carcinoma situ patient duke duke duke distant metastas found particip thirti percent tumor locat transvers colon conclud screen identifi earli cancer potenti curabl limit bowel wall massiv hemoccult distribut short interv patient physician complianc disturb low total colon evalu mandatori tumor reach flexibl sigmoidoscop workup unnecessari repeat hemoccult inadequ indic physician educ"
"factor influenc surviv pancreaticoduodenectomi pancreat cancer eighti patient carcinoma head pancrea underw pancreaticoduodenectomi actuari year surviv patient median surviv month hospit survivor analyz effort determin factor influenc longterm surviv negat lymph node absenc blood vessel invas favor longterm surviv strongest predict factor negat lymph node status median surviv month compar month lymph node involv tumor blood transfus predict patient receiv fewer unit median surviv month compar month receiv unit import determin longterm surviv pancreaticoduodenectomi pancreat cancer biolog tumor lymph node status blood vessel invas perform resect unit blood transfus import factor influenc surviv"
"implic periton cytolog stage earli pancreat cancer cytolog examin periton wash perform patient pancreat ductal adenocarcinoma head bodi tumor select potenti resect comput tomograph ct find salin ml instil aspir laparoscopi patient laparotomi malign cell found periton wash patient cancer pancreat head versus bodi laparoscopi versus laparotomi patient ascit versus ascit cytolog posit patient prior percutan needl biopsi versus liver metastas found patient negat cytolog pancreat head cancer posit cytolog resect versus negat cytolog surviv signific longer patient negat cytolog conclud pancreat cancer shed malign cell peritoneum earli common laparoscop lavag effect cytolog studi ascit precondit cytolog studi presenc necessarili impli carcinomatosi intraperiton spread cancer cell promot tumor biopsi cytolog find provid addit index resect cytolog find correl durat surviv studi show local pancreat cancer suggest caution biopsi potenti curabl lesion"
"express abh blood group antigen ulex europaeus agglutinin type iv collagen sinusoid hepatocellular carcinoma express blood group antigen lewi lewi ulex europaeus agglutinin uea factor viiirel antigen type iv collagen sinusoid examin immunohistochem case hepatocellular carcinoma hcc case cirrhosi case chronic activ hepat control sampl normal liver sinusoid endotheli cell hcc characterist show diffus strong immunoreact abh blood group antigen specimen compar abo blood group sinusoid endotheli cell diffus strong posit uea receptor contrast cirrhosi chronic activ hepat sinusoid endotheli cell posit abh blood group antigen uea receptor normal liver sinusoid endotheli cell posit abh blood group antigen uea receptor test factor viiirel antigen lewi blood group antigen negat sinusoid endotheli cell type iv collagen distribut diffus space diss group express strongest hcc blood vessel portal tract fibrous septa posit abh blood group antigen uea receptor factor viiirel antigen type iv collagen negat lewi blood group antigen find suggest sinusoid endotheli cell undergo capillar cirrhosi chronic activ hepat major sinusoid endotheli cell hcc phenotyp characterist capillari"
"pleomorph anaplast neuroblastoma nude mice pleomorph anaplast neuroblastoma children age year transplant nude mice noteworthi observ made case transplant tumor gave rise softtissu sarcoma case hepat metastas strike modif murin hepatocyt result hyperchromat dysplast nuclei find evid hepat area surround metastas pleomorph anaplast neuroblastoma cell"
"glomus tumor coccyx curabl coccygodynia year woman present recurr sever coccygodynia underw explor pilonid sinus found precoccyg glomus tumor involv boni trabecula coccyx knowledg glomus tumor involv coccyg bone previous document view relief patient pain surgic excis coccyx tumor causal role suggest"
"malign mix tumor malign ameloblastoma fibrosarcoma maxilla present rare case carcinosarcoma malign ameloblastoma fibrosarcoma left maxilla develop year japanes man tumor recur repeat multipl surgic remov radiotherapi chemotherapi led progress cachexia patient die year hospit histopatholog examin reveal recurr tumor carcinosarcoma progress malign ameloblastoma fibroma autopsi confirm diagnosi malign mix tumor lung metastasi malign ameloblastoma fibrosarcoma"
"respons women age invit screen breast cancer mammographi pilot studi publish erratum bmj jul object determin suffici benefit gain offer screen breast cancer mammographi women age invit screen designpilot studi women elig screen person invit result studi compar result routin screen younger women age general practic set group general practic south manchest patient women age practic list total exclud general practition invit letter return post offic main outcom measuresrespons rate invit screen assess indic crude popul coverag ratio crude invit popul coverag ratio correct invit popul coverag ratio result patient age invit exclud trace screen compar women age respons indic higher younger women older crude popul coverag ratio crude invit popul coverag ratio correct invit popul coverag ratio women age compar women age biopsi older women gave posit result give cancer detect rate compar younger women conclus result show potenti high attend routin screen older women invit younger women result found cost benefit screen older women reassess"
"recreat sun exposur puerto rico trend cancer risk awar person sunbath engag activ beach expos larg amount uv radiat hundr adult visit beach puerto rico survey determin knowledg risk sun exposur evalu sunscreen group consist yearround puerto rican resid tourist nineti percent believ sun skin cancer half subset live year puerto rico believ person receiv exposur risk major group understood sun protect factor number nonscreen oil half puerto rican resid rare sunscreen protect sunbath sunscreen import factor sought sun protect factor perceiv abil aid tan"
"cutan angiolipoleiomyoma describ case cutan angiolipoleiomyoma rare tumor previous report term cutan angiomyolipoma clinic tumor acquir solitari asymptomat nodul acral locat patient age rang year median year malefemal ratio sign tuber sclerosi renal angiomyolipoma absent case histolog tumor subcutan circumscrib compos smooth muscl vascular space connect tissu matur fat tumor fat predomin compon smooth muscl predomin elast tissu stain reveal blood vessel develop elast lamina blood vessel lack addit histolog featur occasion observ includ vascular thrombi glomus bodi focal mucin deposit"
"risk develop subsequ nonmelanoma skin cancer data southeast arizona skin cancer registri collect june studi patient nonmelanoma skin cancer basal cell squamous cell carcinoma remov observ subsequ nonmelanoma skin cancer develop june twelv categori nonmelanoma skin cancer develop basi type nonmelanoma skin cancer type fourth nonmelanoma skin cancer analys show highest risk subsequ nonmelanoma skin cancer develop year rate develop nonmelanoma skin cancer depend type squamous cell carcinoma basal cell carcinoma total risk decreas day studi"
"histolog pattern analysi basal cell carcinoma studi seri consecut neoplasm studi attempt defin histolog pattern consecut case basal cell carcinoma correl pattern adequaci margin surgic excis major histolog pattern identifi nodular case superfici case micronodular case infiltr case morpheic case mix pattern major histolog pattern present case studi nodular superfici basal cell carcinoma complet remov simpl surgic excis high percentag case micronodular infiltr morpheic basal cell carcinoma higher incid posit tumor margin excis mix pattern consist combin nodular micronodular infiltr type exhibit behavior similar pattern result greater chanc incomplet surgic remov"
"treatment portwin stain childhood flashlamppump puls dye laser seventi patient age month year averag age year month portwin stain treat flashlamppump puls dye laser lighten achiev averag treatment patient lighten averag treatment lighten treatment lighten treatment averag lighten treatment percentag lighten increas number treatment increas patient clearanc portwin stain patient age month year patient respons treatment lighten patient age year patient lighten complic includ cutan depress patient hyperpigment patient hypopigment patient complic transient disappear complet"
"induct dna fragment chronic lymphocyt leukemia cell chronic lymphocyt leukemia cell type cll neoplast disord character accumul small rest lymphocyt peripheri phenotyp cell suggest frozen earli stage matur glucocorticoid hormon common treat patient cll result reduct peripher lymphocyt count undefin mechan report glucocorticoid stimul dna fragment characterist suicid process apoptosi program cell death pcd suspens cell patient cll effect mimick ca ionophor involv sustain increas cytosol ca concentr specif antibodi bind membran igm leukem cell induc pcd similar mechan phorbol ester block dna fragment cell kill respons agent suggest activ protein kinas desensit cell pcd target cll cell antibodi induc unbalanc sustain ca increas repres ration strategi destruct leukem cell"
"transform growth factorbetainduc inhibit cell function suscept differ cell phenotyp function relev immunosuppress tumorbear state present studi investig natur humor compon generat tumorbear host induc immun dysfunct cell cellfre ascit fluid cultur supernat sn obtain ascit cultur mh hepatoma cell grow ascit sn sampl test abil influenc generat ctl respons tnp alloantigen generat antitnp ctl respons requir restrict cd cell mark suppress addit ascit sn condit sampl inhibit antiallo ctl respons capabl altern pathway allorestrict cd cd activ cd ctl precursor ctl activ resist ascit sn ascit sninduc suppress effect cd suscept found mediat transform growth factorbeta tgfbeta activ tgfbeta activ detect mh ascit cultur sn suppress cd function requir antitnp ctl respons complet prevent addit antitgfbeta antibodi cultur rtgfbeta induc similar pattern immunosuppress observ ascit sn result tgfbeta produc tumor cell induc deleteri effect cell cd subset provid explan molecular mechan previous observ cd select suppress tumorbear state"
"express vhiii crossreact idiotyp human lymphocyt associ staphylococc protein bind staphylococcus aureus cowan stimul demonstr staphylococc protein spa altern bind site specif human ig chain region vhiii subgroup major mitogen compon staphylococcus aureus cowan sac spa sac stimul subpopul cell express ig vhiii chain subgroup present studi investig relationship spa bind express vhi vhiii crossreact idiotyp cri surfac tonsillar lymphocyt enrich express nonexpress cri examin ig secret cell line establish popul cell ebv transform vhiii cri denrich popul yield cell line secret spareact ig contrast vhi criexpress line secret spareact ig crineg cell popul yield cell line secret spareact ig anticip major vhiii ig cell cri sac stimul cri cri popul show preferenti stimul popul data support propos sac stimul human cell mediat bind spa altern bind site igv region vhiii subgroup"
"intraperiton cisplatin cytarabin treatment refractori recurr ovarian carcinoma preclin evalu suggest impress concentrationdepend cytotox synergi cisplatin cytarabin ovarian carcinoma evalu clinic relev observ patient refractori recurr ovarian carcinoma enter phase ii trial intraperiton ip cisplatin mgm cytarabin mg treatment administ day maximum month cours surgic reevalu patient clinic evid diseas day regimen discontinu secondari develop sever thrombocytopenia cours platelet decreas mm addit toxic includ abdomin pain moder sever time therapi patient fever evid infect bacteri periton patient declin surgic reassess fourteen confid interv ci assess patient demonstr surgic defin respons includ ci patient tumor nodul cm diamet ci patient lesion greater cm ci surgic defin complet respons crs patient cm diseas patient larger tumor nodul ip cisplatincytarabin result high surgic defin respons rate patient minim residu ovarian carcinoma activ low patient bulki intraabdomin diseas"
"intrapleur cisplatin cytarabin manag malign pleural effus lung cancer studi group trial malign pleural effus common signific problem patient advanc malign pleurodesi tetracyclin scleros agent usual treatment malign pleural effus contrast approach intrapleur chemotherapi potenti advantag treat malign addit control effus intracavitari cisplatinbas chemotherapi cytotox scleros proven safe effect intraperiton rout ovarian cancer malign mesothelioma previous experi intrapleur cisplatinbas chemotherapi part plan seri trial malign mesothelioma lung cancer studi group evalu intrapleur cisplatin cytarabin patient malign pleural effus varieti solid tumor april novemb patient cytolog proven symptomat previous untreat malign pleural effus enter studi singl dose cisplatin mgm cytarabin mg instil pleural space chest tube immedi remov patient evalu toxic respons hour week month recurr effus consid complet respons cr partial respons pr defin greater decreas amount effus serial chest radiograph patient experienc revers grade renal toxic patient grade hematolog toxic patient grade cardiopulmonari toxic respons rate cr pr week patient median length respons month cr month pr outcom trial suffici encourag regimen incorpor subsequ trial malign pleural mesothelioma"
"prognost factor guid perplex tradit number variabl predict outcom patient earlystag breast cancer test simpl perform inexpens recent number factor tumor prolif index nuclear dna content amplif overexpress growthpromot gene oncogen identifi potenti predictor outcom patient breast cancer increas pressur introduc test routin clinic practic clinic practition identifi test group test predict advers outcom clinic inform provid tradit factor aim prognost test breast cancer predict patient destin develop recurr cancer prognost test express term relat risk rr ratio risk breast cancer recurr patient test posit risk test negat methodolog guidelin satisfi studi evalu predict abil test includ incept cohort assembl referr pattern laboratori clinic outcom assess blind fashion complet follow achiev adjust extran prognost factor carri statist method approach suggest clinician choos test combin test discrimin high lowrisk patient practic decis threshold risk defin prognost test seri test warrant adjuv therapi individu patient complex base clear present risk benefit patient"
"methionin uptak human cerebr cortex matur infanc age age amino acid transport blood normal frontal cortex studi positron emiss tomographi pet seventeen patient yr inject intraven tracer dose methionin baselin pet scan obtain assess competit inhibit cmethionin uptak patient receiv oral phenylalanin infus amino acid hr pet studi uptak cmethionin frontal cortex decreas fold yr bloodbrain transfer cmethionin yr exceed adult valu fold competit inhibit reduc methionin uptak patient older yr development parallel find anim neutral amino acid transport system modul human brain amino acid level meet chang development metabol"
"clinic relev immunohistochem detect multidrug resist glycoprotein breast carcinoma women breast carcinoma local advanc cancer confirm metastas express glycoprotein evalu start chemotherapi regimen includ multidrug resistancerel drug monoclon antibodi avidinbiotinimmunoperoxidas techniqu glycoprotein detect tumor sampl result express semiquantit manner account number posit tumor cell index specif stain intens index patient nonmetastat cancer cycl chemotherapi cancer recurr subsequ cycl chemotherapi patient render clinic diseasefre surgeri radiat end point defin localregion recurr metastasi strong glycoproteinposit stain major tumor cell phenotyp signific correl initi respons chemotherapi shorter progressionfre surviv pretreat evalu glycoprotein express prognost patient local advanc breast cancer"
"phase clinic pharmacokinet trial flavon acet acid flavon acet acid synthet benzopyron deriv unknown mechan action thirti patient men women treat week week week dose flavon acet acid rang dose equal drug administ intraven hour dose greater equal infus period lengthen hour treatment patient includ hydrat treatment alkal maintain urin ph greater equal doselimit toxic effect hypotens pharmacokinet studi reveal linear behavior patient studi begin peak plasma level rang microgramsml termin halflif hour immunolog monitor perform patient transient increas cd leuposit cell note patient patient increas correl fold increas cell kill object tumor respons trial recommend phase ii dose schedul studi elucid drug mechan action defin immunolog properti recommend"
"tumor suppressor gene prospect cancer research cancer thought aris accumul genet mutat singl cell recent tumorigen mutat studi detail activ oncogen discoveri tumor suppressor gene inactiv mutat elicit tumorigenesi ad dimens understand neoplasia retinoblastoma suscept gene rb prototyp tumor suppressor gene shown suppress transform phenotyp cancer addit studi reveal tumor suppressor gene oper varieti tissu varieti mechan mechan regul choic cellular prolifer differenti involv process initi dna replic regul express gene intercellular communic adhes transduct extern signal intracellular effector elucid mechan enhanc understand oncogenesi fundament oper cell"
"stress respons protein srp determin primari human breast carcinoma clinic histolog prognost correl express estrogenregul protein heatshock stressrespons protein srp evalu human breast carcinoma establish breast cancer cell line result obtain northern western blot analys immunohistochem method concord immunohistochem assess srp express breast carcinoma median patient follow year perform twenti percent lymph nodeneg lymph nodeposit tumor overexpressor univari analysi demonstr signific correl srp overexpress estrogen receptor er content ps protein express nodal metastas advanc stage lymphaticvascular invas shorter diseasefre surviv period shorter surviv studi popul regress tree analysi show srp express independ prognost indic diseasefre surviv patient posit lymph node cox proport hazard model confirm independ prognost signific nodal involv stage er content fail recogn srp overexpress signific independ paramet predict patient outcom patient popul observ associ srp overexpress aggress tumor suggest biolog role srp human breast carcinoma"
"therapeut advantag hypox cell tumor theoret studi presenc hypox cell solid tumor long consid problem cancer treatment radiat therapi treatment anticanc drug general strategi activ explor overcom problem oxygen tumor sensit hypox cell radiat chemotherapi kill hypox cell hypox cell cytotoxin present studi examin impact strategi standard radiat therapi regimen dose gy major assumpt full reoxygen reoxygen tumor cell demonstr hypox cell cytotoxin produc level tumor cell kill higher order magnitud produc full oxygen tumor optimum hypox cell radiosensit provid cytotoxin kill approxim hypox cell time assumpt make differ reoxygen occur worst case reoxygen hypox cell cytotoxin perform optimum radiosensit analysi show hypox cell tumor major therapeut advantag recommend research effort concentr develop superior hypox cell cytotoxin improv hypox cell radiosensit parallel emphasi develop agent increas hypoxia"
"diffus bind monoclon antibodi tnt multicellular tumor spheroid tumor spheroid ht human colon adenocarcinoma melanoma establish investig uptak clearanc kinet tnt monoclon antibodi target necrot cell tumor data reveal rapid uptak tnt ab fragment spheroid model antibodi irrelev specif lym ab fragment bound poor spheroid unlik previous report monoclon antibodi tumor cellsurfac antigen tnt show linear uptak increas time satur tumor spheroid unexpect uptak subpopul cell viabl outer rim spheroid preclin studi provid import inform therapeut potenti tnt monoclon antibodi treatment cancer micrometastas"
"longitudin studi women negat cervic smear endocerv status longitudin studi women receiv negat cervic smear report show incid definit equivoc cervic intraepitheli neoplasia cin signific smear lack endocerv compon smear includ endocerv compon incid definit cytolog evid cin signific lower women smear includ endocerv compon conclud women smear report negat lack endocerv compon rescreen earlier women negat smear includ endocerv compon"
"chromogranin storag secret sensit specif diagnosi pheochromocytoma chromogranin store releas catecholamin adren medullari sympathet neuron vesicl elev plasma patient pheochromocytoma hormon differenti diagnosi hypertens examin elev level chromogranin compar diagnost sensit greater diagnost specif level plasma catecholamin subject pheochromocytoma evalu comparison refer group includ normotens control subject essenti hypertens subject renovascular hypertens subject primari aldosteron subject sign symptom suggest pheochromocytoma diagnosi ultim rule normal plasma level chromogranin modest rise chromogranin essenti hypertens correl chromogranin diastol blood pressur normotens patient patient essenti hypertens impair diagnost chromogranin pheochromocytoma renal failur elev plasma chromogranin independ blood pressur plasma chromogranin correl tumor mass tumor chromogranin content tumor norepinephrin content urinari vanillylmandel acid excret correl plasma urinari catecholamin blood pressur patient pheochromocytoma plasma chromogranin level differ subject pheochromocytoma stratifi age sex tumor locat tumor patholog drug diagnosi treatment pheochromocytoma clonidin metoprolol phentolamin tyramin effect plasma chromogranin concentr pheochromocytoma chromogranin local catecholamin solubl core chromaffin granul account vesicl solubl protein conclud chromogranin emerg catecholamin pheochromocytoma chromaffin granul plasma chromogranin sensit specif diagnost tool evalu actual suspect pheochromocytoma plasma chromogranin predict pheochromocytoma tumor size catecholamin product drug common employ diagnosi treatment pheochromocytoma effect plasma chromogranin level preserv chromogranin evalu pheochromocytoma measur chromogranin adjunct diagnosi pheochromocytoma"
"simplifi diagnost approach pheochromocytoma review literatur report institut experi pheochromocytoma unusu potenti devast tumor high index suspicion likelihood pheochromocytoma lower absenc typic symptom find nonetheless screen broaden includ patient lower risk diseas resist labil hypertens minim symptomat extens diagnost evalu reserv clinic laboratori find suggest symptom group patient pheochromocytoma consid exclud overlap symptom patient pheochromocytoma symptom flush suggest pheochromocytoma ill visual symptom flank pain pallor suggest pheochromocytoma combin symptom symptom triad headach palpit diaphoresi present major pheochromocytoma patient smaller number pheochromocytoma patient presenc entir triad specif sensit hypertens hypertens unexplain orthostat hypotens suggest pheochromocytoma twentyhour urin studi consist abnorm patient pheochromocytoma elev signific proport pheochromocytoma patient valu greater fold upper limit normal suggest pheochromocytoma present warrant intens subsequ evalu imag studi reliabl diagnosi pheochromocytoma confirm exclud diseas patient higher clinic likelihood elev urinari test lower clinic likelihood persist signific elev urinari test imag studi perform combin clinic screen hour urinari test imag studi reliabl approach patient suspect harbor pheochromocytoma"
"myeloma manifest larg jugular tumor case report author report case cranial plasmacytoma multipl myeloma palsi lower cranial nerv osteolyt lesion adjac jugular foramen demonstr angiogram exceed hypervascular arterioven shunt resembl paraganglioma forti case cranial intracrani plasmacytoma literatur review find cranial plasmacytoma common hypervascular tumor dural tumor intraparenchym tumor poor vascular"
"prognost factor stage ib squamous cervic cancer patient low risk recurr half cervic cancer patient tumor recur radic surgeri negat lymph node clear resect margin evalu patient squamous cell tumor underw radic hysterectomi pelvic lymphadenectomi januari decemb thought low risk recurr clinic histopatholog factor predict tumor recurr detail retrospect record review complet patholog review accomplish case year actuari surviv rate patient develop recurr diseas die clinic featur evalu prognost factor patient age patient race cervic diamet extent gross cervic involv presenc contact bleed histopatholog featur examin depth invas number mitos charact tumorstrom border histolog differenti lymphvascular space invas width tumor depth invas correl increas tumor width node marginposit patient exclud differenti featur identifi patient risk recurr half patient poor differenti tumor sole featur criterion adjuv therapi result overtreat lowrisk patient"
"famili ovarian cancer isra jewish women women ovarian cancer epitheli origin ovarian cancerpron famili identifi account case degre relat underw prophylact oophorectomi earli ovarian carcinoma diagnos famili aggreg ovarian cancer occur isra jewish popul"
"cone cerclag pregnanc report techniqu cone cerclag result outcom patient requir diagnost cone biopsi pregnanc age patient year rang gestat age week rang time procedur major complic hemorrhag signific problem trimest abort patient requir betasympathomimet suppress uterin activ longer hour procedur patient invas carcinoma cervic intraepitheli neoplasia cin iii cin ii case endocerv ectocerv margin negat patient cin multifoc microinvas posit margin cone cerclag safe easi method perform diagnost cervic coniz pregnanc"
"queuin trna anticodon wobbl base maintain prolif pluripot potenti hl cell presenc differenti agent thioguanin thioguanin tginduc differenti hypoxanthin phosphoribosyltransferas imp pyrophosph phosphoribosyltransferas ec defici hl cell character day growth morpholog differenti proceed addit trna wobbl base queuin presenc tg maintain prolif capabl cell abil tg induc differenti correl myc mrna regul queuin effect paramet treatment tg day commit hl cell granulocyt differenti commit cell respond monocyt induc phorbol myrist acet nonetheless cell treat queuin tg maintain promyelocyt morpholog capabl induc monocyt pathway phorbol myrist acet stabil fms mrna cell adher absenc queuin phorbol myrist acet incap induc monocyt marker tgtreat cell data present tginduc differenti hl cell trnafacilit event trna wobbl base queuin capabl maintain prolif pluripot potenti cell"
"metastat melanoma facial nerv isol metastat malign melanoma facial nerv report present illustr primari melanoma helix ear treat excision biopsi wedg resect primari melanoma clark level iv mm thick facial paresi slowli develop gross evid recurr melanoma ear neck ct scan show mass region stylo mastoid foramen reoper primari site reveal metastat melanoma facial nerv expand approxim time normal size composit resect melanoma paralyz face immedi rehabilit masset muscl transfer patient receiv rad area postop remain free diseas date return profess dentist detail studi specimen repres primari metastasi facial nerv"
"evalu distinct ectop pituitari acth depend cush syndrom clinic featur biochem test radiolog find effici laboratori radiolog investig differenti ectop pituitari depend cush syndrom studi base find patient verifi cush diseas patient ectop acth syndrom clinic featur strong favour ectop type male sex histori month basal biochem featur strong indic ectop syndrom includ plasma mmol hco greater mmol serum cortisol midnight greater nmol urin free cortisol greater nmol hour plasma acth greater ng highdos dexamethason suppress test suppress cent serum cortisol urin free cortisol oxogen steroid indic ectop sourc acth suppress greater nmol midnight cortisol combin occur ectop syndrom patient cush diseas urin free cortisol suppress nmol hour found patient cush diseas ectop group metyrapon test increas equal fold deoxycortisol hour patient ectop acth increas greater fold patient cush diseas failur respond dexamethason metyrapon found patient cush diseas patient ectop group patient patient fail respond test conclud patient present clinic obvious cush syndrom measur plasma acth reliabl divid convent test driven pituitari driven ectop acth"
"genet mechan tumor suppress human gene mutat gene encod kilodalton cellular protein found frequent human tumor cell suggest crucial role gene human oncogenesi model stepwis mutat loss allel tumorigenesi human osteosarcoma cell line sao complet lack endogen singl copi exogen gene introduc infect cell recombin retrovirus pointmut wildtyp version cdna sequenc express wildtyp suppress neoplast phenotyp sao cell express mutat confer limit growth advantag cell absenc wildtyp wildtyp phenotyp domin mutat allel configur result suggest retinoblastoma gene mutat allel gene essenti role oncogenesi"
"reoper colorect carcinoma manag patient intraabdomin recurr colorect carcinoma surgeri remain primari mode therapi cure signific palliat anticip appreci import close follow primari resect coupl improv diagnost modal surgeon detect earlier recurr select patient benefit resect recurr diseas improv surgic techniqu result decreas rate morbid mortal safe hepat resect metastat diseas select patient procedur produc year surviv rate approach clear consensus reach studi agre posit prognost indic includ absenc extrahepat diseas small number intrahepat lesion low cea level duke stage primari likewis patient recurr diseas local surgeri cure play signific role palliat aggress resect generous surgic margin patient diseas yield year surviv rate approach patient unresect diseas carcinomatosi palliat obtain surgic therapi judgment treat patient preoper intraop surgic intervent obstruct perfor anatom physiolog compromis improv qualiti life patient intraabdomin recurr"
"merkel cell neoplasm eyelid periocular region merkel cell clear oval cell epidermi outer root sheath hair follicl epitheli origin share ultrastructur featur neuroendocrin cell found associ touch receptor eyelid occur singl epidermi extern root sheath hair eyelash special touch spot altern eyelash typic electron microscop antigen featur includ densecor granul intranuclear rodlet spinous process posit reaction specif cytokeratin epitheli membran antigen neuronspecif enolas chromogranin synaptophysin merkel cell carcinoma develop precursor cell give rise keratinocyt merkel cell ten merkel cell carcinoma occur eyelid periocular region tend bulg lesion lid margin elder patient reddish color erythemat telangiectat vessel diagnosi base frequent presenc neurofila paranuclear aggreg intermedi filament addit featur typic normal merkel cell tumor mimic lymphoma undifferenti carcinoma frequent invad lymphat vessel merkel cell carcinoma recur give rise region node metastas half metastas wide result death initi treatment prompt aggress wide resect routin postop irradi metastat lesion respond radiat therapi cytostat drug treatment palliat"
"surgic strategi earli gastric cancer diagnost therapeut option earli gastric cancer review japan rate detect earli gastric cancer increas minut gastric cancer identifi result advanc diagnost method result histopatholog stage larg number resect specimen led surgic option base size depth primari lesion classic resect radic resect limit lymphadenectomi endoscop surgeri"
"adjuv chemotherapi fluorouracil vincristin ccnu patient duke colorect cancer swedish gastrointestin tumour adjuv therapi group prospect control random trial test adjuv postop combin chemotherapi fluorouracil lomustin ccnu vincristin versus adjuv therapi patient oper duke colorect cancer report total patient age year recruit patient colon rectal cancer protocol violat case exclud twenti patient limit resect cancer year follow signific differ tumourfre surviv rate surviv rate treat control group twenti patient start chemotherapi discontinu treatment sideeffect gastrointestin tract patient treatment discontinu recurr diseas conclus system administr combin chemotherapi colorect cancer oper worthwhil routin clinic practic"
"retest subject posit hemoccult screen colorect cancer prospect random screen studi earli detect colorect cancer rehydr hemoccult ii test possibl increas specif test retest patient initi posit hemoccult ii test investig offer test cent return posit case cent repeat test perform patient posit cent posit initi test rectosigmoidoscopi cm doubl contrast enema carcinoma found patient posit retest patient negat retest specif test increas cent cent sensit unchang rescreen offer date increas number patient return test cent posit test repeat patient cent posit colorect neoplasm found posit repeat test compar negat repeat test conclus screen earli detect colorect cancer rehydr hemoccult ii test investig patient posit retest procedur reduc workload cent reduc sensit"
"epiderm growth factor receptor express colorect cancer epiderm growth factor egf receptor express estim invas human colorect cancer immunohistochemistri degre express quantifi integr optic densiti measur stain section tumour stain posit duke tumour exhibit signific higher level receptor duke tumour addit histolog high grade cancer express receptor strong low grade conclud high egf receptor concentr poor prognost factor colorect malign"
"levamisol fluorouracil therapi resect colon cancer indic object evalu benefit risk postop treatment levamisol fluorouracil fu patient colon cancer design computer search medlin cancerlit perform refer list retriev articl check random trial therapi levamisol combin fu colon cancer distant metastas includ studi evalu criteria result review random trial satisfi criteria studi demonstr signific improv surviv rate levamisol fu patient colon cancer patholog confirm metastas adjac lymph node duke stage subgroup analysi studi demonstr similar benefit toxic effect drug general mild studi show differ surviv rate treatment group sampl small detect clinic statist import differ conclus patient colon cancer suffer relaps recommend offer opportun particip clinic trial adjuv therapi stage diseas enter clinic trial levamisol fu adjuv therapi"
"retinoid modul insulin growth factorbind protein inhibit breast carcinoma prolifer retinoid induc cellular differenti inhibit cellular prolifer prolifer human breast carcinoma cell vitro mark inhibit compound hand insulin growth factor igf receptor involv growth breast carcinoma cell autocrin paracrin effect effect igf igfii modul specif bind protein igfbp examin possibl mechan retino acid inhibit cancer growth alter bps block igf growth effect retino acid ra microm complet block effect igf ngml enhanc prolifer mcf cell cultur effect ra signific chang specif igfbind site cell ra induc fold increas igfbind activ condit medium measur polyethylen glycolimmunoglobulin precipit assay charcoal absorpt assay increas kda igfbp ligand blot effect ra igfbp time concentr depend contrast experi kda bps decreas find support hypothesi ra inhibit growth breast carcinoma cell increas secret igfbp direct modul growth effect igf"
"evalu serum level immunosuppress substanc oral cancer patient serum level immunosuppress substanc studi patient primari oral cancer patient cancer evalu paramet monitor therapi recurr tumor valu serum patient cancer patient microgramsml microgramsml normal healthi control microgramsml cutoff set microgramsml sd patient cancer sever infecti diseas show conspicu high serum level valu close correl reactiv protein valu posit rate increas patient oral cancer level serum cancer patient signific higher control level found elev stage diseas advanc stage iii stage iv histolog analysi tumor cell patient squamous cell carcinoma scc show serum level poor differenti scc higher microgramsml patient differenti scc microgramsml patient recurr metastat cancer die cancer exhibit mark elev serum level patient remain free cancer follow period show signific lower serum level rise fall serum level close correl diseas progress remiss data strong suggest serum paramet monitor diseas stage effect therapi patient oral cancer"
"literaci laryngectomi treat head neck cancer patient read write entir popul otolaryngologist radiat oncologist activ practic state north carolina survey assess level awar illiteraci adult unit state determin physician illiteraci treatment decis process patient head neck cancer exclud respond treat patient head neck cancer physician practic state north carolina respons rate respond estim correct preval illiteraci adult popul forti percent respond state patient abil read write make treatment recommend head neck cancer survey accompani literatur review suggest physician perceiv illiteraci problem signific impact patient head neck cancer lack data enabl quantifi effect illiteraci treatment outcom studi report step examin illiteraci negat affect patient outcom"
"paratesticular myxoma unusu benign intrascrot neoplasm present case paratesticular myxoma clinic histori find light microscopi immunohistochemistri pathogenesi primari paratesticular myxoma rare lesion consid differenti diagnosi intrascrot mesenchym tumor"
"astroblastoma electron microscopi immunohistochem find case report clinic histolog immunohistochem electron microscop featur cerebr astroblastoma report patient young woman superfici pariet tumor macroscop find includ delin superfici nodul hard central core histolog studi disclos predomin papillari tumor hyalin vessel tumor cell scarc posit immunohistochem stain glial fibrillari acid protein extens diffus posit vimentin neuronspecif enolas intens posit epitheli membran antigen papillari area ultrastructur studi show abund intermedi filament form bundl tumor cytoplasm membran junction extern lamina cell contact collagen fiber base immunohistochem ultrastructur characterist filament tumor cell vimentin filament peculiar immunohistochem pattern glioma aid histolog diagnosi rare tumor type"
"intramedullari spinal cord germinoma case report case intramedullari spinal cord germinoma conus medullari lumbago pain lower extrem present intramedullari spinal cord germinoma determin biopsi specimen local irradi gy tumor mark decreas size clinic symptom disappear"
"ganglioneuroma spinal cord report describ year boy harbor intramedullari ganglioneuroma involv entir length spinal cord terminolog patholog neurobiolog behavior tumor discuss"
"mammographi earli breast cancer detect screen mammographi shown reduc breast cancer mortal filmscreen mammographi xeromammographi high sensit specif mammographi accredit program assur physician patient facil mammographi highest qualiti lowest radiat dose mammograph sign earli cancer includ small mass calcif architectur distort neodens dens tissu result falseneg examin cancer palpabl advers effect biopsi delay"
"carcinoma ductus choledochus retrospect review patient treat carcinoma common bile duct demonstr improv diagnost capabl lead earlier manag resect therapi abil resect tumor direct translat improv longterm surviv effort obtain proof malign prior resect frustrat inabl obtain adequ repres tissu frozen section choledochoscop biopsi incision biopsi highest yield posit diagnos experienc hand program fewer preoper test emphasi earli oper diagnosi definit treatment costeffect manag patient common bile duct cancer"
"effect midazolam cerebr blood flow oxygen consumpt interact nitrous oxid patient undergo craniotomi supratentori cerebr tumour cerebr blood flow cerebr metabol rate oxygen measur patient craniotomi supratentori cerebr tumour modif ketyschmidt techniqu xenon intraven anaesthesia induc midazolam mgkg fentanyl pancuronium maintain midazolam continu infus fentanyl pancuronium nitrous oxid oxygen oxygen air concentr midazolam blood patient nglitr measur patient lung ventil oxygen concentr midazolam blood patient doubl nglitr flow measur patient lung ventil noo concentr midazolam blood group patient doubl nglitr flow measur patient lung ventil oxygen air relationship found dose midazolam cerebr blood flow oxygen consumpt nitrous oxid combin midazolam effect variabl"
"capillari hemangioma treatment flash lamppump puls dye laser strawberri capillari hemangioma common vascular neoplasm incid approxim neonat develop week life month year incid rise lesion grow larg year life ulcer obstruct vital organ function great major spontan regress year life parent alarm sight hemangioma reassur great major regress spontan treatment cryosurgeri irradi radium instil corticosteroid therapi surgic excis ineffect signific morbid describ children capillari hemangioma treat flash lamppump puls dye laser patient rang age week year begin laser therapi patient underw sd laser treatment regress lesion patient demonstr diminut size color hemangioma treatment ill effect ulcer hemorrhag infect scar evid hyperpigment hypopigment puls dye laser therapi consid option treatment capillari hemangioma prefer prior full evolut therapeut approach hemangioma slow regress older children"
"effect radiotherapi radic neck dissect cancer head neck retrospect analysi radic neck dissect perform year period cancer oral caviti pharynx larynx carri hundr thirteen patient underw radiotherapi primari cancer site neck underw periop adjuv radiotherapi underw definit radiat cure salvag surgeri patient receiv radiotherapi nonrecurr diseas twenti addit patient underw radiat surgic failur radic neck dissect goal studi determin radiotherapi alter end result diseas stage onset diseas similar radiotherapi nonradiotherapi group preoper radiotherapi effect stage diseas primari site lesser extent lymph node limit impact surviv failur control diseas neck occur patient receiv radiotherapi primari diseas recurr rate lower combin therapi group surgic group patient stage diseas year diseasefre surviv surviv rate patient receiv radiotherapi surviv combin therapi group patient stage diseas worst result patient irradi surgic failur surviv patient requir salvag radic neck dissect failur definit radiotherapi cure surviv"
"juvenil embryon alveolar rhabdomyosarcoma head neck adult clinic patholog immunohistochem studi case site head neck region orbit nasopharynx nasal caviti frequent locat juvenil embryon alveolar rhabdomyosarcoma patient younger year compar neoplasm adult uncommon clinicopatholog immunohistochem studi juvenil rhabdomyosarcoma patient age year present femalemal ratio orbit contigu paranas sinus involv nasal caviti sphenoid sinus middl ear soft tissu neck preauricular region primari site tumor involv paramening site case alveolar rhabdomyosarcoma contribut advers outcom patient longterm diseasefre survivor patient die tumor aliv persist diseas immunohistochem studi case demonstr reactiv vimentin musclespecif actin hhf desmin ten case juvenil rhabdomyosarcoma rare present head neck adult consid differenti diagnosi small cell neoplasm patient fourth decad life"
"compar analysi techniqu detect breast cancer cell bone marrow method morpholog immunocytochem fluoresc activ cell sorter fc analysi compar respect effici detect breast cancer cell bone marrow seri experi techniqu compar bone marrow cell artifici mix amount breast cancer cell seri bone marrow breast cancer patient bone metastas result obtain mixtur seri analyz fc analysi detect breast cancer cell bone marrow border line morpholog method detect immunocytochem method superior detect breast cancer cell mixtur note morpholog immunocytochem method percentag breast cancer cell detect time higher percentag ad cell enrich invers proport percentag ad cell result result separ cell centrifug due densiti breast cancer cell superior immunocytochem method confirm seri experi"
"microinvas carcinoma uterin cervix intern feder gynecolog obstetr stage ia intern feder gynecolog obstetr figo subdivid stage ia cervic cancer metric criteria demarc stage ia stage ib earli stromal invas stage ia denot invas protrus carcinoma situ stroma microcarcinoma stage ia small cancer number order magnitud larger stage ia lesion maximum depth invas mm maximum horizont spread mm larger lesion classifi stage ib studi review patient previous classifi stage ia diseas yield stage ia stage ia lesion cancer reclassifi stage ib hundr patient greater equal year patient stage ia diseas present stage iib diseas year coniz patient stage ia lesion develop invas recurr die patient reclassifi stage ib lesion includ treat conserv develop recurr figo classif guidelin treatment stage ia lesion treat conserv treatment stage ia individu risk factor vascular space involv confluenc high sensit low specif"
"leiomyosarcoma bone clinicopatholog immunohistochem ultrastructur studi case author identifi leiomyosarcoma lms review nonmatrixproduc spindl cell sarcoma bone initi recogn lms diagnos malign fibrous histiocytoma fibrosarcoma patient women rang age year site includ proxim humerus distal femur rib tumor present clinic radiograph featur consist diagnosi primari bone neoplasm repres solitari metastasi primari uterin lms radiograph show lytic bone destruct motheaten case soft tissu extens histolog tumor show broad interlac fascicl spindl cell pleomorph nuclei frequent mitos necrosi case focal storiform pattern bizarr multinucl cell case focal promin osteoclast giant cell extens immunoreact muscl actin case desmin case electron microscopi show definit smooth muscl differenti includ cytoplasm filament densiti write patient free diseas includ patient presum metastasi aliv local recurr diseas dead diseas experi suggest lms bone distinct clinicopatholog entiti common previous recogn applic immunohistochemistri electron microscopi nonmatrixproduc bone sarcoma facilit diagnosi addit case"
"clinic characterist treatment outcom children acut lymphocyt leukemia syndrom pediatr oncolog group studi children acut lymphocyt leukemia treat consecut studi pediatr oncolog group syndrom ds comparison clinic laboratori characterist show signific differ leukocyt count racial distribut sex ratio platelet count incid mediastin mass lymphadenopathi hepatosplenomegali percentag blood bone marrow blast children syndrom ds nds children ds slight older time present higher hemoglobin valu relat frequenc major immunophenotyp earli pre pre compar patient ds report treatment regimen categor convent consolid therapi intens cox regress analysi reveal presenc ds higher leukocyt count black race age older year independ poorer eventfre surviv ef children treat convent chemotherapi cohort children receiv intens chemotherapi ds longer independ risk factor fact eventfre surviv ef mark improv level compar observ children diagnos nds hand toxic requir interrupt treatment signific frequent intens treat children ds compar similar treat patient nds death result toxic occur infrequ"
"psychosoci adjust women breast cancer plethora studi investig psychosoci adjust women breast cancer correl clinic prognosi studi conduct vari degre methodolog rigor assess made qualiti exist evid identifi evid factor predict adjust status women breast cancer studi review methodolog standard critic apprais studi prognosi develop sackett colleagu depart clinic epidemiolog biostatist mcmaster univers hamilton ontario canada studi investig psychosoci adjust women breast cancer meet criteria review studi clinic prognosi review focus direct methodolog rigor requir futur investig studi employ prospect design deliber measur control extran prognost variabl affect adjust futur investig incorpor adequ precis measur measur psychosoci variabl object reliabl valid"
"prognosi pregnanc breast cancer surviv patient pregnanc pa breast cancer difficult predict reason combin rare natur histori breast cancer pregnanc intric vari individu valid data collect analysi problemat studi gather patient year chart women stage ii iii breast cancer pregnant year postpartum time breast cancer diagnosi analyz patient pa breast cancer compar nonpregn women compar age treat hospit physician period patient lost year follow patient year follow patient distant metastas time lost follow consid die time stage patient pa breast cancer surviv signific patient pregnanc pa breast cancer"
"combin hormon therapi tamoxifen fluoxymesteron versus tamoxifen postmenopaus women metastat breast cancer updat analysi random trial perform determin therapi tamoxifen tam fluoxymesteron flu efficaci tam postmenopaus women metastat breast cancer patient fail tam subsequ receiv flu dose drug mg oral daili object respons tam patient tam flu patient side time diseas progress tam flu median versus month cox model durat respons surviv similar treatment arm patient estrogen receptor er greater year age older high signific advantag treatment tam flu respons rate time progress note patient group tam flu show surviv advantag cox model data requir confirm prospect random trial suggest substant therapeut advantag tam flu tam elder women er fmol greater"
"sphincter preserv rectal cancer local excis postop radiat therapi author report preliminari result patient local mobil resect rectal cancer treat local excis postop radiat therapi rt negat surgic resect margin receiv fluorouracil fu median follow month month year actuari surviv incid local failur site failur compon failur incid local failur increas stage tumor size greater cm versus equal cm patient develop local failur month underw salvag abdominoperin resect local control month salvag surgeri patient underw abdominoperin resect clinic presum local failur tumor found specimen patient initi local control underw salvag nonsalvag surgeri evid diseas pelvi time follow local excis postop rt altern standard surgeri select case addit follow experi order determin approach ultim local control surviv rate similar low anterior resect abdominoperin resect"
"flow cytometr dna analysi hepatocellular carcinoma prognost nuclear dna content studi retrospect flow cytometri case resect hepatocellular carcinoma occurr dna aneuploidi detect patient correl signific tumor size presenc vascular invas intrahepat metastasi patient dna aneuploid tumor signific wors prognosi dna diploid tumor subdivid group tumor size dna aneuploid patient surviv time signific shorter patient low dna index high dna index greater equal cox multivari analysi nuclear dna content provid signific prognost vascular invas intrahepat metastasi result nuclear dna content import prognost hepatocellular carcinoma"
"predictor physician nonadher chemotherapi regimen physician nonadher cancer treatment regimen diminish treatment efficaci compromis clinic research influenc clinic demograph psychosoci patient characterist physician adher breast cancer chemotherapi investig role clinician attitud chemotherapi hundr women recent diagnos breast cancer week treatment fifti patient experienc unjustifi modif chemotherapeut agent stepwis multipl regress reveal independ contribut increas patient age treatment set clinic versus academ communiti privat practic stage diseas physician nonadher regimen complex delay seek treatment presenc psychiatr disord contribut general unjustifi regimen modif patient psycholog psychiatr factor influenc prescrib behavior vincristin physician awar factor contribut unnecessari treatment modif reduc frequenc behavior"
"complet remiss refractori anaplast adult wilm tumor treat cisplatin etoposid year woman underw left radic nephrectomi stage ii anaplast wilm tumor receiv adjuv therapi year computer tomographi ct abdomen reveal mass left renal fossa retroperiton adenopathi ctguid needl biopsi nondiagnost patient progress diseas treatment dactinomycin doxorubicin vincristin achiev complet respons treatment cisplatin etoposid therapi wilm tumor adult discuss"
"express class ii human leukocyt antigen thyrocyt lymphocyt infiltr human thyroid tumor immunofluoresc studi surgic thyroid section papillari carcinoma pc medullari carcinoma mc anaplast carcinoma ac follicular carcinoma fc adenoma ad examin indirect immunofluoresc techniqu employ monoclon antibodi evalu express human leukocyt antigen hla class dr dp dq class ii thyrocyt phenotyp distribut inflammatori cell ten pc fc investig presenc intercellular adhes molecul icam situ deposit immunocomplex circul thyroid autoantibodi evalu increas express class antigen found pc fc mc ac ad anomal express class ii antigen observ pc fc ac ad mc express dp dq reveal portion drposit gland reduct microsom autoantigen express found icamposit thyrocyt detect moder lymphocyt infiltr notic pc correl dr dp dq coexpress cell natur killer cell virtual absent author specul weak class ii antigen express partial complet loss microsom autoantigen absenc icam thyrocyt account limit engag immunocompet cell observ thyroid tumor"
"advanc medic imag cancer diagnosi treatment decad signific eye develop improv diagnosi treatment plan monitor human cancer comput tomographi ct magnet reson imag mri spectroscopi mrs singl photon emiss comput tomographi spect positron emiss tomographi pet innov advanc morpholog function imag led dramat improv abil diagnos monitor human cancer frequent anatom detail demonstr exceed view surgeri function biochem imag show metabol activ receptor status normal patholog state vivo function biochem studi differenti normal neoplast nonviabl tissu make measur progress regress diseas physiolog preced morpholog find diseas process vivo biochem probe demonstr diseas anatom abnorm evid gross anatomi longer adequ endpoint therapi protocol today physiolog imag evalu respons treatment hour administr therapi adjuv metabol tumor imag studi provid complimentari inform morpholog evalu human cancer ultim lead patient care"
"natur histori colorect cancer opportun intervent understand natur histori colorect cancer provid basi intervent influenc outcom intervent includ earlier detect colorect cancer remov premalign adenoma demonstr mucos field defect preced neoplasia evalu baselin risk chang dietari modif identif inherit dietari risk factor control trial evalu earli detect colorect cancer fecal occult blood test enrol patient earli stage cancer improv surviv observ data mortal reduct report studi patient adenoma demonstr high synchron metachron rate basi complet colon evalu initi surveil follow program hyperprolifer lack normal differenti observ field defect colon preced neoplasia inherit factor recent shown import larger proport individu destin develop colorect adenoma cancer observ natur histori colorect cancer provid opportun applic radiolog endoscop techniqu diagnosi surveil examin merit research answer critic question rais impact intervent"
"imag techniqu diagnosi carcinoma colon variabl publish result colonoscopi barium enema examin confus optimum result depend meticul prepar technic excel oper profici mistak place colonoscopi barium enema competit posit method ideal complement evalu high risk individu includ posit hemoccult test exclus signific patholog doublecontrast enema reli cost patient detect abnorm barium enema colonoscop verif biopsi sequenc procedur provid costeffect approach earli detect control cancer estim observ ac guidelin reduc mortal rate"
"imag bone tumor progress bone tumor manag occur result cooper surgeon oncologist pathologist radiologist radiologist contribut care patient bone tumor major tumor detect preliminari diagnosi accomplish radiographi tumor local extent assess magnet reson imag mri lesser degre comput tomographi ct distant spread malign document radionuclid scintigraphi skeleton ct lung combin estim local extent distant spread assur adequ stage definit manag decis preoper close percutan biopsi histolog diagnosi accomplish outpati basi fluoroscop ct guidanc arteriographi employ deliveri local chemotherapi combin arteriographi mri mr spectroscopi evalu tumor respons limbsalvag surgeri mri sequenti assess tumor bed bone scintigraphi ct detect skelet pulmonari metastas radiologist role undergo continu redefinit"
"primari neoplasm hollow organ gastrointestin tract stage follow number imag modal stage follow patient primari neoplasm gastrointestin gi tract continu increas magnet reson imag mri comput tomographi ct ultrasonographi techniqu stage follow stage ct frequent detect liver metastas increas substitut chest radiograph detect lung metastas ct imag test choic preoper stage esophag carcinoma ct stage patient gastric carcinoma colorect carcinoma current mri stage gi tract malign limit lack adequ oral intralumin contrast agent degrad imag due motion sonographi techniqu endoscop ultrasound promis detect local invas gi tract malign ct follow patient tumor gi tract detect liver adren nodal metastas local recurr abil ct detect extralumin mass ct pelvi recommend routin follow procedur patient undergon abdominalperon resect ct mri detect local recurr suffer inabl differenti scar recurr tumor initi hope mri capabl differenti postop scar tissu recurr tumor realiz posit ct mri find occasion percutan biopsi requir confirm local recurr"
"liver tumor imag liver tumor imag paradigm dilemma diagnost decisionmak current era abund high technolog part reflect multipl imag techniqu wide worldwid includ ultrasound radionuclid scintigraphi rns comput tomographi ct magnet reson imag mri techniqu design stage extent liver cancer comput tomographi arteri portographi ctap intraop ultrasound ious author conced ct scan singl test close fit design gold standard liver tumor imag mri matur techniqu prefer local factor profound influenc select sequenc imag studi includ equip radiolog skill institut interest specif clinic circumst patient diagnost algorithm decis tree sequenti imag workup liver tumor suspect tend institut specif"
"stage follow breast cancer patient stage system breast cancer unlik neoplasm distant recess site earli develop clinic stage evalu establish clinic assess breast lesion wrong compar patholog examin benign malign clinic measur tumor centimet larger histolog size clinic assess axillari node clear metastat incorrect case clinic patholog stage provid effect discrimin prognosi treat patient prognosi accur determin patholog stage singl import prognost indic axillari nodal status posit number posit node american joint committe cancer union intern contra cancer agre tnm stage breast carcinoma prefer stage system follow treat patient detect local recurr chest wall mastectomi irradi breast lumpectomi earli detect contralater breast cancer physic examin period mammographi tendenc overinvestig asymptomat patient bone scan blood test correct critic recent year"
"primari neoplasm central nervous system children modern diagnost imag techniqu detect primari neoplasm central nervous system cns children safe accur specif cell type degre malign neoplasm peculiar cell type size mediat hydrocephalus clinic present demand care extens imag techniqu evalu geographi charact ad basic observ determin neoplasm surround edema detect spread evalu residu recurr neoplasm prime respons pediatr neuroradiologist child neurosurgeon oncologist"
"magnet reson imag evalu spinal tumor magnet reson imag mri recent begun replac myelographi postmyelographi comput tomographi ct extent bone scan procedur choic evalu spinal tumor applic mri role review extradur space mri sensit techniqu detect tumor vertebr bodi time superb delin suspect thecal sac imping intradur extramedullari space mri general accur myelographi postmyelographi ct noninvas final intramedullari space mri unquestion procedur choic evalu suspect cord tumor general mri initi procedur evalu suspect tumor spine space lie frequent requir examin"
"radioimmunolog imag therapi target radioact tumor antitumor antibodi evolv laboratori curios practic diagnost therapeut techniqu promis widespread benefit common human cancer develop hybridoma techniqu kohler milstein produc monoclon antibodi singl import contribut develop field larg array monoclon antibodi human tumor creat label varieti radioisotop clinic trial identifi literatur interv present studi begin form basi conclus benefit combin antitumor antibodi isotop specif instanc clinic manag patient malign neoplasm melanoma lymphoma neuroblastoma colorect malign radiolabel antibodi demonstr occult tumor disclos convent methodolog radioimmunotherapi malign lymphoma achiev durabl remiss patient fail convent form therapi part advanc achiev intellig applic principl immunochemistri imag physic tumor immunolog progress slow steadi instanc term magic bullet warrant describ target radiolabel antibodi human tumor igg gd antigen neuroblastoma introduc cheung cd antigen cell develop royston stand consist high concentr radioact target human tumor clinic trial technic innov fulfil initi promis futur bright radioimmunolog method diagnosi therapi genet engin permit develop human antibodi biolog properti favor tumor local chemic approach broaden rang isotop diagnost therapeut radiolabel applic modern imag methodolog positron emiss tomographi pet detect lesion smaller size permit quantit imag dosimetri greater speed eas computer work station lead broader applic fusion imag radioantibodi imag view simultan tct mri anatom correl abnorm site antigenreact tumor deposit"
"singl photon emiss comput tomographi positron emiss tomographi cancer imag singl photon emiss comput tomographi spect positron emiss tomographi pet improv inform radioisotop imag patient cancer nuclear medicin techniqu offer potenti studi region function biochemistri radiolabel substrat chemic malign preced anatom pet spect detect anatom occur superior spect compar planar imag demonstr cardiac brain imag radiopharmaceut technetium mtc suit spect imag larg amount radioact administ collimatorcamera system optim kev photon mtc current interest imag cancer spect relat gallium citrat monoclon antibodi label iodin indium spect imag radioisotop advantag compar planar imag defin abil quantit distribut singl photon emitt mtc demonstr spect system head ring detector offer promis improv quantit imag pet capabl imag tracer biolog import element positron label radioisotop short halfliv requir cyclotron close pet facil promin radiopharmaceut pet fluorodeoxyglucos fdg pet studi fdg patient primari brain tumor demonstr abil determin degre malign differenti necrosi recurr tumor radiat therapi chemotherapi predict prognosi metabol function cancer studi includ amino acid accumul thymidin uptak oxygen util intermediari metabol receptor status pet potenti make major impact character malign effect therapi"
"direct medic imag cancer magnet reson method singl photon emiss comput tomographi magnet reson method singl photon emiss comput tomographi spect develop technolog provid function anatom inform role diagnosi monitor cancer subject current clinic research magnet reson imag mri delin organ tissu heterogen differ relax paramet water fat proton proton nuclei imag studi magnet reson spectroscopi mrs provid inform state natur occur infus molecul spect quantifi distribut radiolabel agent tissu organ label monoclon antibodi provid high specif imag tumor spatial resolut limit technolog factor proton mri highest current resolut mm vivo deep tissu resolut mrs spect limit cubic centimet recent advanc technolog signific increas specif abil detect small deep lesion"
"imag adult central nervous system primari malign glioma stage follow classif stage system primari adult glioma propos system high signal intens found proton densiti tweight magnet reson mr scan site tumor surround edema includ infiltr tumor"
"prolifer dna ploidi malign breast tumor relat earli oral contracept earli abort premenopaus breast cancer patient histori oral contracept oc year age signific higher tumor cell prolif activ higher phase fraction spf higher fraction dna aneuploid tumor compar user higher spf earli oc user appar patient aneuploid tumor patient euploid tumor abort spontan induc fullterm pregnanc higher spf compar young patient breast cancer adjust pariti abort oc earli oc higher spf earli abort higher spf younger patient higher spf higher frequenc aneuploid tumor found user oc lower median age diagnosi user signific age relationship spf frequenc aneuploidi dna analys select patient breast cancer larger tumor conclus drawn articl generaliz patient smaller primari tumor case diagnos breast cancer screen higher tumor prolif activ frequenc aneuploidi earli oc user line previous report find wors prognost indic wors surviv earli user oc compar young women breast cancer"
"treatment patient advanc colorect cancer cisplatin fluorouracil leucovorin base vitro studi demonstr synergi fluorouracil fu leucovorin lv cisplatin cddp human colon cancer cell line clinic trial initi determin effect combin patient advanc unresect colorect carcinoma fifti patient enrol studi receiv prior convent fu chemotherapi treatment consist week cours highdos lv mgm administ intraven iv bolus fu mgm cddp mgm administ hour infus consecut day median treatment cycl object tumor respons patient includ complet remiss respons rate previous untreat patient confid limit stabl diseas occur patient tumor progress patient median surviv time month patient aliv year regimen toler primari side effect mild revers gastrointestin symptom myelosuppress episod lifethreaten toxic eastern cooper oncolog group ecog grade iii advers reaction requir dose reduct occur patient result trial suggest fu lv cddp activ safe toler combin regimen patient advanc colorect cancer"
"serum tumor marker patient alloc goodrisk poorrisk clinic trial patient germ cell tumor alloc patient advanc germ cell tumor gct treatment program base clinic characterist standard design clinic trial today studi shown substanti differ exist entri criteria differ influenc outcom clinic trial factor contribut differ clear due patient select bias hundr unselect consecut patient alloc treat goodrisk poorrisk treatment program memori sloankett cancer center mskcc reassign risk status indiana univers iu classif result compar southeastern cancer studi group secsg result criteria substanti agreement total end result identif goodrisk patient result poorrisk patient differ substanti patient classifi poorrisk mskcc criteria indiana criteria major discrep occur iu stage patient achiev complet respons major factor contribut differ risk assign serum tumor marker serum tumor marker incorpor risk assign criteria gct clinic trial minim number goodrisk gct patient poorrisk trial"
"salvag chemotherapi patient germ cell tumor memori sloankett cancer center experi twenti advanc germ cell tumor gct patient treat success platinbas induct regimen fail achiev durabl complet respons cr remain aliv median follow month analysi prognost factor respons surviv conduct patient receiv salvag chemotherapi surviv respons salvag therapi signific enhanc patient prior cr induct chemotherapi treatment cisplatinbas salvag regimen testi primari site normal serum human chorion gonadotropin level normal serum lactat dehydrogenas level site metastasi indiana class patient prior incomplet respons ir poor prognosi patient aliv median follow month compar patient prior respons cr median follow month poor surviv patient fail achiev durabl cr induct chemotherapi warrant continu investig salvag therapi identif prognost featur direct salvag therapi aid interpret clinic trial salvag regimen"
"prognost imag analysi ovarian cancer histolog grade import treatment decis ovarian cancer grade system signific subject compon reduc includ object measur diagnost decis imag analysi determin nuclear area ploidi distribut patient epitheli ovarian cancer result relat tumor grade clinic outcom nuclear area optic densiti number hyperploid cell standard deviat measur signific higher grade tumor compar grade tumor rapid progress tumor compar aggress malign recurr tumor compar primari lesion number nuclei high dna content found prognost import imag analysi addit prognost inform epitheli ovarian cancer"
"resect primari liver cancer hepat hilus primari liver cancer plc hepat hilus design tumor situat main branch portal vein pedicl hepat vein contact intrahepat vena cava main tumor locat segment iv viii concentr central part liver call central type plc differ tumor locat segment ii iii vi vii call peripher type plc surgic treatment plc signific improv past decad resect central type plc difficult hazard institut admit plc januari april case central type case resect success resect patient die sepsi month oper mortal mode oper segment suggest improv present surviv rate compar similar number patient peripher type tumor period treat surgeon result show notic differ year year year surviv rate resect central type plc peripher type plc discuss improv surgic techniqu mental awar suggest"
"structur function integr ovarian tumor tissu obtain ultrason aspir patient ovarian epitheli cancer surviv increas residu diseas approach surgic remov tumor previous studi cavitron ultrason surgic aspir cusa cavitron laserson corp stamford ct show success remov ovarian tumor area consid unresect diaphragm spleen stomach small bowel cusa approv food drug administr gynecolog surgeri experiment basi studi design test ultrason irradi produc cusa caus alter cell structur physiolog gynecolog tissu adjac area pair tumor sampl unirradi irradi obtain ten patient portion patholog structur evalu physiolog tissu cultur evalu histolog section stain hematoxylin eosin show cusa irradi produc minor tissu distort observ light microscop correct diagnosi made case tissu fragment obtain cusa specimen trap stain ten patient initi tumor cell viabil similar specimen type flow cytometr dna analysi confirm surgic method produc match sampl cell surviv highfrequ ultrasound function intact patient cell cusa specimen trap surviv divid greater extent knifedissect tumor cell surgic rout attain similar number passag cultur reason extrapol vitro observ pelvic tumor tissu normal surround tissu left situ pelvic tissu believ uninjur cusa ultrason irradi"
"express progesteron receptor coincid arrest dna synthesi human breast cancer main model account heterogen express estrogen receptor er progesteron receptor pr human breast cancer propos clonal model stem cell model author previous provid evid support stem cell model found prolifer cell erposit er human breast cancer lack er erneg er er subpopul interrel author analyz eighteen erpr primari breast tumor simultan express er pr immunohistochemistri dna synthesi autoradiographi minut hthymidin incorpor author demonstr averag number er pr cell similar thymidinelabel index er er pr pr subpopul dnasynthes cell er pr author conclud cellular subpopul express er pr ident express pr lower rate cellular prolifer er express"
"amplif oncogen mammari carcinoma shown fineneedl biopsi procedur measur amplif oncogen human cancer cell cell obtain fineneedl biopsi repeat sampl individu metastas drawback low number cell obtain overcom slotblot hybrid techniqu measur gene amplif patient mammari cancer primari tumor metastas analyz level amplif oncogen erbb detail techniqu suitabl analyz alter occur cancer progress identifi subgroup mammari cancer characterist"
"predict recurr time esophag carcinoma assess histolog factor dna ploidi cytophotometr analysi nuclear dna content patient squamous cell carcinoma esophagus relationship histopatholog featur dna distribut pattern surviv time investig standpoint recurr patient die recurr year surgeri year year rate death recurr year higher patient survivor year frequent possess type ii dna pattern type iii iv rate death recurr year type ii lower rate type iii rate type iv survivor year higher type iii type iv recurr year found type ii inclin appar curat resect patient type ii care follow year late recurr type iv recurr year regard heal recurr occur year find suggest growth rate esophag carcinoma reflect dna aneuploidi dna analysi esophag carcinoma valuabl paramet postop follow plan"
"serial immunocytolog analysi blood tumor cell patient neuroblastoma tumor surveil test determin malign cell respons resist therapeut regimen patient neuroblastoma convent method surveil sensit tumor cell shed circul immunocytolog analysi blood function sensit monitor system studi blood sampl obtain patient dissemin neuroblastoma diagnosi therapi sampl analyz monoclon antibodi immunoperoxidas stain determin circul neuroblast present patient presenc absenc circul neuroblast yield inform sensit convent test author conclud immunocytolog analysi blood includ convent monitor method surveil patient dissemin neuroblastoma"
"recurr pelvic desmoid tumor success treat tamoxifen case recurr retroperiton desmoid tumor success treat tamoxifen nolvadex tablet ici pharma divis ici america wilmington de report patient present late pregnanc larg retroperiton pelvic desmoid tumor treat surgic excis megestrol acet tumor recur month treat surgeri time radiat therapi desmoid tumor quick recur patient treat tamoxifen result complet tumor regress remain stabl month tamoxifen consid line therapi recurr desmoid tumor"
"ruralurban differ stage diagnosi relationship cancer screen stage diagnosi examin malign identifi screen determin ruralurban differ exist georgia data obtain populationbas cancer registri regist incid cancer resid metropolitan atlanta ten neighbor rural counti black white patient primari invas malign newli diagnos includ studi resid rural area unstag cancer urban resid patient stage diagnosi rural patient tend advanc diseas urban patient relat excess nonloc malign rural georgia white black rural excess nonloc prostat cancer black pronounc differ access util earli detect method contribut ruralurban differenti extent diseas diagnosi"
"detect ct arteri portographi colorect cancer metastas liver prospect evalu accuraci realtim ultrasonographi comput tomographi ct infus hepat angiographi iha comput tomographi arteri portographi ctap perform resect liver metastas colorect cancer total detect rate percent percent ct percent iha percent ctap sensit lesion diamet smaller cm percent ctap ct found iha local smallest lesion detect ctap small cm diamet ctap prove detect liver metastas techniqu recommend preoper plan hepatectomi patient liver metastas"
"intraepitheli bodi colorect adenoma leuchtenberg bodi revisit presenc intraepitheli inclus bodi leuchtenberg bodi record rectal colon specimen patient larg moder number intraepitheli bodi record percent colorect adenoma patient famili adenomat polyposi fap convers fap adenoma specimen ulcer coliti dysplasia similar amount intraepitheli granul feulgen studi demonstr granul dna nuclear fragment destroy lymphocyt pathogenesi phenomenon remain obscur presenc larg moder number intraepitheli bodi colorect adenoma strong rais suspicion fap"
"subsit distribut incid colorect cancer zealand purpos studi examin subsit distribut incid colorect cancer age group registr colorect cancer nation cancer registri zealand approach percent present studi base individu age year regist colorect cancer subsit distribut colon left colon rectum age group year signific skew excess colon cancer individu age year year colon excess accompani relat reduct left colon cancer age adjust incid rate period compar stratifi age group subsit incid rate increas subsit individu age year evid side cancer elder sex mark reduct incid left colon cancer rectal cancer individu year contrast incid colon cancer remain stabl young individu time trend studi skew subsit distribut larg bowel cancer age group increas time due vari etiolog factor act cohort"
"colorect cancer differ communiti geograph distant patient urban medic center studi clinic oncolog reli hospitalderiv patient hospit vari proport patient local catchment area distant place larger proport referr studi differ type patient analyz colorect cancer patient larg urban medic center year period hundr nineti patient local communiti percent extend communiti percent distant communiti percent patient local communiti tend older minor ethnic group addit local communiti patient advanc diseas time present grade tumor site distribut larg bowel similar group adjust age sex race stage diseas surviv distant communiti patient compar local extend communiti patient popul distant patient tend favor socioeconom factor advanc diseas differ account larg part prognosi patient larg cooper trial studi account respect proport local communiti geograph distant patient analyz general treatment outcom"
"intraabdomin desmoid tumor famili polyposi coli case report tumor regress prednisolon therapi case intraabdomin desmoid tumor famili polyposi coli fpc regress disappear prednisolon treatment report year japanes man abdomin lump admit hospit proctocolectomi year fpc rectal cancer laparotomi tumor present abdomin wall mesenteri retroperitoneum small part tumor resect diagnos microscop desmoid tumor prednisolon administr mgday subject symptom amelior desmoid tumor slowli regress bilater hydronephrosi continu result retroperiton fibrosi knowledg case document case retroperiton fibrosi patient fpc characterist desmoid tumor famili polyposi coli gardner syndrom method manag discuss"
"polycyst ovari syndrom bulimia hundr fifti patient classifi suffer polycyst ovarian syndrom pcos patient suffer clear organ disord endocrinopathi receiv bulimia investig test edinburgh bite questionnair abnorm eat behavior patient pcos show signific increas bite score approxim abnorm eat pattern score suggest clinic bulimia compar women group organ endocrinopathi work suggest women pcos screen abnorm eat behavior rais possibl treatment psycholog consid abnorm eat behavior present"
"endoscop biopsi limit accuraci diagnosi ampullari tumor endoscop biopsi specimen surgic resect specimen collect seri japanes patient ampullari tumor retrospect review investig clinic implic endoscop biopsi endoscop biopsi specimen classifi group base degre epitheli atypia group atypia group mild atypia group moder atypia adenoma group sever atypia carcinoma situ group invas carcinoma final diagnosi resect ampullari tumor adenoma case carcinoma case adenoma carcinoma case biopsi accuraci carcinoma group carcinoma case biopsi accuraci intramur protrud type expos protrud type ulcer type diagnost accuraci adenoma group case ampullari adenoma carcinoma case biopsi diagnosi adenoma group carcinoma found deeper layer surgic resect specimen biopsi diagnosi adenoma rule possibl deeper carcinoma ampullari tumor"
"evalu endosonographi tn stage oesophag cancer strategi treatment cancer oesophagus depend tumour stage time diagnosi resect curat treatment confin earli tumour stage tumour local infiltr unresect requir palliat treatment comput tomographi wide preoper stage fail defin correct endoscop ultrasound direct visualis pariet wall stage gastrointestin tumour compar prospect studi patient tumour oesophagus investig preoper endoscop ultrasound comput tomographi determin stage tumour infiltr local lymph node involv thirti patient underw oper resect dissect enter studi intraop find histopatholog assess refer tn stage oesophag tumour correct preoper stage accomplish endoscop ultrasound stage stage compar comput tomographi high signific fisher exact test studi show endoscop ultrasound preoper tn stage tumour oesophagus"
"chondrosarcoma soft tissu group chondrosarcoma aris soft tissu rare varieti myxoid mesenchym collect case tumour myxoid mesenchym review case chondrosarcoma report princip clinic radiograph histolog differ varieti discuss surgic treatment prognosi"
"determin plasma calcitonin generel peptid concentr immunochemiluminometr assay normal person patient medullari thyroid carcinoma neuroendocrin tumor doubt concentr circul calcitonin generel peptid cgrp plasma cgrp measur detect follow medullari thyroid carcinoma mtc develop immunochemiluminometr sandwich assay cgrp antibodi purifi polyclon antiserum human cgrp assay sensit limit detect pmol multipli deriv nanogram high specif crossreact human calcitonin ct normal plasma cgrp valu rang pmol median detect level valu sampl patient mtc elev unoper patient pmol median oper patient gross persist recurr tumor pmol median contrast cgrp valu normal postop patient elev ct detect tumor rang pmol median cgrp level increas pentagastrin inject mtc patient ct valu cultur mtc cell vitro secret larg amount cgrp rat nerv root ganglia human osteoblast microvessel endotheli cell secret lesser amount conclud cgrp circul normal plasma low level plasma cgrp concentr frequent high patient mtc primarili gross tumor metastas plasma ct assay prefer test mtc cgrp assay deserv prospect studi role predict gross metastasi"
"iiodobenzylguanidin treatment malign pheochromocytoma efficaci safeti iiodobenzylguanidin imibg assess patient malign pheochromocytoma nonrandom singl arm trial patient treat imibg sa megabequerelmg month patient bone soft tissu metastas soft metastas bone metastas follow period rang month number dose rang mci gigabequerel gbq mciadministr cumul activ gbq mci absorb cumul dose tumor rang gy benefici effect treatment observ patient complet remiss diseas observ patient die studi respond treatment hormon respons complet partial durat rang month patient relaps die month patient partial tumor respons locat soft tissu durat rang month patient hormon respons object improv clinic status blood pressur clearcut relationship cumul dose respons main sideeffect observ patient widespread bone metastas dose gbq pancytopenia resolv treatment discontinu studi suggest repeat imibg treatment effect patient advanc malign pheochromocytoma"
"quantit phase cell primari carcinoma antibodi subunit ribonucleotid reductas show phase restrict point block human cancer appar low growth fraction bulk cell presum cycl quiescent state due inabl past distinguish cell alloster subunit ribonucleotid reductas mrr constitut express cycl cell acquir transit lost exit distinguish cell estim proport cell primari human breast colorect adenocarcinoma analyt dna flow cytometri adfc immunoperoxidas stain section monoclon antibodi mrr mab mrr adfc fresh tumor reveal low percentag cell phase immunoperoxidas stain mrr reveal unexpect high proport posit cell phase indic high content primari human tumor human cancer block transit predomin quiescent differenti state block interpret human cancer respond putat regulatori event restrict point phase relat growth factor defici densiti inhibit antiprolif cytokin gene product flow cytometri dna mrr content found human colon cancer cell line arrest phase serum depriv densiti inhibit similar human breast cancer cell line arrest phase medroxyprogesteron acet mpa tamoxifen exposur find match situ observ support concept restrict point block primari human tumor"
"insulin growth factor iimedi prolifer human neuroblastoma neuroblastoma embryon tumor typic aris cell develop adren medulla igfii mrna express high level adren cortex birth detect birth adren medulla neuroblastoma cell line earli adren medullari precursor express igfii cell line test growth stimul igfii cell line matur adren medullari cell express igfii sk grow igfii autocrin mechan clin invest elbadri romanus helman cooper rechler israel  examin human neuroblastoma tumor tissu igfii gene express situ hybrid histochemistri reveal igfii express tumor cell neuroblastoma detect cell nonmalign tissu includ adren cortic cell stromal fibroblast eosinophil tumor find igfii function autocrin growth factor neuroblastoma paracrin growth factor suggest growth regulatori pathway util neuroblastoma mimic precursor cell type individu tumor aris"
"pattern epiderm growth factor receptor basal squamous cell carcinoma presenc immunoreact epiderm growth factor receptor human skin tumor investig indirect immunoperoxidas techniqu sixteen basal cell carcinoma squamous cell carcinoma evalu specimen studi receptor posit specimen promin stain cell membran nodular basal cell carcinoma specimen increas stain peripheri tumor cell mass"
"basal cell carcinoma recur radiotherapi uniqu difficult treatment subclass recurr basal cell carcinoma twenti basal cell carcinoma bccs recur radiat therapi addit treatment modal treat moh micrograph surgeri mms tumor size cm tumor aros midfac region undergon multipl previous treatment modal present recurr rate follow month basal cell carcinoma recur radiotherapi deserv special subclassif recurr bcc difficult erad high recurr rate standard surgic excis radiotherapi tumor larg aggress invas aris cosmet crucial midfac region extens subcutan tissu plane common moh surgeri inher abil examin margin map tumor extens conserv tissu uniqu suit treatment difficult tumor"
"medic necess evalu treatment portwin stain laser improv laser deliveri system safe effect treatment portwin stain patient age satisfactori result obtain laser treatment increas number patient seek consult birthmark imper physician recogn medic syndrom problem portwin stain review patient facial portwin stain reveal hypertrophi nodular patient decad life increas signific morbid lesion believ laser treatment minim medic psycholog complic result natur evolut portwin stain"
"retrovir transduct protein kinas gamma cytotox lymphocyt clone lead immort retent specif function molecular pathway respons deliv prolif signal cell surfac nucleus lymphocyt unresolv recent data implic protein kinas pkc involv tcr signal pathway address role pkc cell activ effect high level express pkcgamma isoenzym murin ctl clone examin unlik parent cell requir period ag stimul cell activ growth cell express retrovir transduc pkcgamma gene propag cultur independ ag stimul maintain ident function specif parent ctl constitut pkcgamma express mimic physiolog pkc activ abrog requir tcrag interact cell activ"
"dexamethason inhibit induct monocyt chemotacticactiv factor product il tumor necrosi factor recent purifi molecular clone monocyt chemotact activ factor mcaf play major role recruit activ monocyt inflammatori process examin effect potent antiinflammatori agent dexamethason dxs product factor wide rang concentr dxs inhibit product mcaf mrna protein level human fibrosarcoma cell line stimul il tnfalpha examin turn synthes mcaf mrna show dxs decreas stabil mcaf mrna addit actinomycin cycloheximid abolish effect dxs indic de novo mrna protein synthesi requir process addit nuclear run analysi reveal dxs inhibit transcript il tnfactiv mcaf gene destabil mcaf mrna inhibit transcript gene contribut decreas mcaf mrna steadi state level dxs"
"dna sequenc ig chain cluster rearrang mous cell line mous myeloma cell line mpc iggb kappa variant deriv studi dna rearrang occur ig chain locus variant acquir vh gene epsilon gene rearrang genom southern blot analysi initi direct map epsilon gene rearrang observ vh region rearrang link invers event sequenc origin ch cluster alpha gene subsequ studi shown dna rearrang region alpha gene detect mous myeloma hybridoma cell line express specif isotyp"
"examin htlv integr skin lesion type adult cell leukemia atl independ cutaneoustyp atl confirm southern blot analysi clinic featur adult cell leukemialymphoma atl frequent accompani skin erupt recent cutan type atl propos clinic studi analyz viral integr human cell leukemia virus htlv monoclon rearrang cell receptor tcr gene blood lymphocyt cutan infiltr cell atl patient clinic featur skin erupt classifi result southern blot analysi propos cutaneoustyp atl detect monoclon integr htlv cell monoclon skin peripher lymphocyt demonstr time studi patient clinician awar htlv posit cutan cell lymphoma cutaneoustyp atl examin viral integr cell monoclon skin lesion requir make exact diagnosi cutan atl"
"immunoloc tnfalphacachectin human melanoma cell studi cultiv malign melanoma investig abil metastat cell produc macrophag cytokin tnfalphacachectin cell macrophag properti infiltr migrat tnfalphacachectin tumor cell line deriv human malign melanoma cultiv malign melanoma deriv vitro cell line angioma fibroblast immunohistochemistri antitnfalphacachectin monoclon antibodi show tnfalphacachectin produc parent melanoma cell line tumor cell cultiv malign melanoma vitro tumor nodul produc tnfalphacachectin deriv melanoma cell line origin result show tnfalphacachectin produc hematopoiet tumor cell cultiv tumor model prepar type human tumor cell line promis provid tool explor relationship tnfalphacachectin oncogenesi"
"immunohistochem alter basement membran compon squamous cell carcinoma investig alter basement membran bm squamous cell carcinoma scc investig tumor cytolog characterist bowen diseas sccbd sccnb tumor studi immunohistochem doubl immunofluoresc stain mous monoclon antibodi core protein heparan sulfat proteoglycan hspg chondroitin sulfat glycosaminoglycan chs rabbit antiserum laminin ln type iv collagen differenti high keratin sccnb ln hspg detect tumor nest bm show loss continu larg lost poor differenti poor keratin sccnb suggest poor differenti sccnb greater enzymat degrad bm compon differenti sccnb chs detect part bm sccbd absent sccnb examin sccnb lost abil synthes chs sccbd degrad chs continu produc scc bm qualit normal epidermi sccbd distinguish sccnb chs content bm"
"identif melanoma progress antigen integrin vla express integrin receptor vla studi normal cultur melanocyt melanoma cell line normal melanocyt synthes vla reveal detect level vla melanoma cell line express vla vla synthes melanoma line parallel analyz express previous character melanoma cell surfac antigen antigen tumor progress human melanoma reveal strike similar vla sequenti immunoprecipit experi show ident integrin vla cell surfac receptor collagen laminin fibronectin"
"reproduc imag interpret immunoscintigraphi perform indium iodinelabel oc ab antibodi inject patient import criterion clinic imag techniqu correct reproduc interpret forti pair immunoscintigraph examin perform patient suspect ovarian carcinoma recurr ab fragment oc antibodi label indium iodin planar scintigraphi ps emiss comput tomographi ect imag interpret blind separ observ reproduc evalu kappa concord index intra interobserv reproduc general satisfactori kappa valu binomi analysi kappa valu ect show superior indium intraobserv interobserv studi ps signific differ reproduc radionuclid"
"relationship uptak technetiummsnpyridoxylmethyltryptophan hepatocellular carcinoma prognosi relationship technetiummsnpyridoxylmethyltryptophan mtcpmt uptak hepat tumor surviv studi case hepatocellular carcinoma hcc median surviv patient hepat tumor show increas uptak delay mtcpmt imag day signific longer surviv time day patient hepat tumor show increas uptak radioact relationship abil hepat tumor mtcpmt surviv analyz patient hcc show fill defect mtccolloid liver imag relat therapi serum valu bilirubin alphafetoprotein result degre mtcpmt uptak hepat tumor close correl prognosi patient hcc"
"comparison mbq mbq iodin postop ablat residu thyroid tissu patient differenti thyroid cancer random prospect studi compar efficaci low dose mbq high dose mbq iodin administr postop ablat residu function thyroid tissu patient differenti thyroid cancer unabl demonstr differ low highdos radioact iodin scintigraph ablat remnant tissu patient mbq ablat dose dose dose radioiodin mbq ablat patient    dose forti percent patient ablat low dose ablat high dose elev thyroglobulin level time complet scintigraph ablat conclus find differ mbq mbq iodin regard number dose complet scintigraph ablat residu function thyroid tissu"
"extracrani metastat glioblastoma thalliumchloridetechnetiummhmpao spect imag sequenti thalliumchlorid technetiummhexamethylpropyleneamin oxim singlephoton emiss comput tomographi spect imag obtain patient extracrani metastat glioblastoma multiform thallium uptak high time scalp background patholog confirm extracrani metastas moder time scalp background intracrani biopsi specimen show gliosi scatter atyp astrocyt technetiummhmpao uptak decreas intracrani frontal pariet lobe irradi decreas encapsul scalp lesion high scalp mass defin border mechan tumor uptak agent review"
"technetiummmethylen diphosphon mdp uptak sympathet effus index malign review literatur report patient sympathet pleural effus secondari cell lymphoma accumul bone imag agent technetiummmethylen diphosphon mtcmdp case signific malign cell present cytolog examin pleural fluid multipl pleural biopsi present review publish literatur pleural effus accumul bone tracer conclud pleural effus accumul mtcmdp consid malign secondari malign work essenti cytolog exam pleural fluid unremark"
"htlv leukemialymphoma south florida report case adult cell leukemialymphoma atl south florida februari juli seroposit human lymphotrop virus type htlv seroneg human immunodefici virus type hiv dna extract tumor biopsiesperipher blood lymphocyt patient shown polymeras chain reaction pcr htlv provir dna blot hybrid dna extract patient htlv cdna probe reveal monoclon pattern provir integr consist diagnosi atl patient women patient haiti jamaica bahama patient aggress hodgkin lymphoma patient present sinus retroorbit involv gastric lymphoma perfor patient develop hypercalcemia patient die year diagnosi lost follow studi case hodgkin lymphoma diagnos hospit ten case atl preval htlvrelat lymphoma sampl tissu patient htlv screen case atl undetect conclud initi survey retrovir etiolog consid patient popul risk htlv infect present hodgkin lymphoma"
"comparison characterist esophag squamous cell carcinoma head neck cancer gastric cancer ongo review patient surgic treat primari squamous cell carcinoma concurr gastric cancer head neck cancer incid intraesophag multipl occurr esophag cancer head neck cancer gastric cancer higher concurr cancer differ clinicopatholog characterist concurr head neck gastric cancer higher incid metachron occurr find suggest case esophag cancer concurr head neck cancer gastric cancer intraesophag multipl esophag carcinoma frequent preoper serial evalu import design treatment estim prognosi"
"activ vitro expans tumorreact lymphocyt lymph node drain human primari breast cancer feasibl vitro activ lymphocyt drain lymph node dln breast cancer patient examin lymphocyt isol dln patient examin prolif respons ril autolog tumor cell ril tumor cell general pattern cellular respons observ cell dln unrespons stimuli lymphocyt dln respond moder ril combin ril tumor antigen synergist effect prolifer cell dln assay phorbol dibutyr ionomycin ril stimul expans dln lymphocyt fold day expand cell popul stimul antigen ril predomin cd cd cell vari proport cd cd subset popul cytotox autolog tumor mcf target cell"
"neuroendocrin carcinoid tumour breast variant carcinoma neuroendocrin differenti carcinoid tumour frequent develop gastrointestin tract organ bodi case report mamma descript argyrophil carcinoid neuroendocrin mammari tumour investig perform immunohistochem ultrastructur examin exist true carcinoid mamma controversi issu mammari neoplasm monomorph cytonuclear featur small cell carcinoid varieti compos larger cell examin immunohistochem ultrastructur examin kind tumour ductal lobular carcinoma focal extens neuroendocrin featur result dual differenti neoplast precursor stem cell epitheli endocrin line treatment case ordinari type mammari carcinoma"
"character histopatholog correl cytosol protein benign malign breast tumor signific differ cytosol protein level exist normalbenign cancer breast tissu posit correl cytosol protein level histolog grade carcinoma differenti carcinoma lower cytosol protein poor differenti carcinoma slab gel electrophoregram total number band ident normal benign malign condit addit kd protein band consist present malign case absent normal benign case extens biophys examin band provid insight protein alter cancer cell molecular level"
"lactat conserv surgeri radiotherapi breast cancer year woman earli stage invas breast cancer treat wide excis tumor axillari lymph node dissect breast irradi year gave birth normal babi attempt breast feed full lactat untreat breast irradi breast underw minor pregnanc postpartum produc small amount colostrum milk week postpartum report lactat breast irradi case review factor affect breast function radiotherapi discuss scant inform safeti infant nurs irradi breast recommend"
"subren capsul assay chemosensit test primari esophag squamous cell carcinoma effici subren capsul assay srca studi fresh tissu esophag squamous cell carcinoma dayday carcinoma case evalu day cancer cell continu prolifer day implant decreas host reaction recogn histolog day day immun reaction signific influenc evalu srca day immunohistochem stain antibromodeoxyuridin monoclon antibodi reveal exist cancer cell dna synthes stage stage graft day chemosensit test srca patient studi evalu fu administr produc respons case vds cddp combin cddp vds effect case cddp blm case"
"squamous carcinoma distal esophagus surviv studi surviv studi squamous carcinoma distal esophagus treat southern california permanent medic group interv undertaken found radiat therapi surgeri equal efficaci term cure patient distant diseas perform status suffici toler treatment find surviv benefit patient treat palliat surgeri plan invas endoscop chemotherapi radiat palliat reserv surgeri special circumst"
"lymphoscintigraphi ilabel epiderm growth factor ilabel epiderm growth factor egf scan studi patient advanc cervic cancer abnorm lymph node imag inject reveal abnorm uptak pelvic lymph node patient abnorm computeris tomograph ultrasound scan convent radiolog confirm presenc diseas"
"imag modal recurr head neck tumor patient recurr neoplasm head neck present perplex manag problem accur preoper assess diseas crucial thirti patient suspect recurr neoplasm compris studi comput tomographi scan magnet reson imag patient underw comput tomographi magnet reson imag assess anatom extent patholog malign benign tumor contrast enhanc essenti detect diseas comput tomographi scan differenti recurr tumor difficult patient undergon radiat magnet reson imag demonstr superior visibl recurr parotid paranas sinus neoplasm laryng pharyng recurr comput tomographi demonstr mass infiltr normal fat tissu plane lymphadenopathi correl high recurr diseas imag techniqu fine point determin recurr neoplasm present"
"bromodeoxyuridin cytokinet studi prognost indic cancer head neck tradit measur head neck tumor fail predict patient outcom clinic nonadvanc diseas problem unpredict tumor behavior focus cell prolifer studi studi limit difficult methodolog newer method quantifi tumor cell prolifer bromodeoxyuridin applic head neck squamous cell carcinoma shown present studi relat eas cell prolifer evalu techniqu larg number head neck tumor studi enabl correl tumor behavior made"
"introduct limbsalvag surgeri sarcoma articl histori limbsalvag surgeri definit term describ aspect procedur stage discuss"
"limb salvag pediatr surgeri expand prosthesi limb spare grow children prove effect oncolog perspect good longterm accept patient adult perform experienc surgeon limb spare compromis surviv rate signific increas local recurr rate compar crossbon amput discuss includ patient evalu surgic option materi method result"
"resect reconstruct bone tumor proxim tibia proxim tibia common site benign malign tumor articl review pertin anatomi clinic present stage method tumor area discuss method resect reconstruct guidelin procedur select allograft reconstruct discuss depth"
"endoprosthet reconstruct bone tumor resect proxim tibia advent success adjuv chemotherapi radiat therapi protocol primari malign tumor develop customdesign metal endoprosthes made success limb salvag procedur malign proxim tibia transpos medial gastrocnemius flap propos dr jean duboussett pari critic softtissu reconstruct routin permit excel activ passiv rang motion patient articl describ oper techniqu technic success proxim tibial endoprosthesi reconstruct"
"resect reconstruct softtissu sarcoma extrem softtissu sarcoma uncommon malign tumor diagnosi made earli patient chanc surviv treat softtissu sarcoma goal surgeon prolong patient surviv total erad local diseas minim function deficit addit treatment articl discuss evalu histolog stage"
"allograft reconstruct shoulder bone tumor resect larg skelet defect result tumor resect shoulder creat reconstruct challeng orthoped surgeon bone allograft offer advantag compar reconstruct techniqu function outcom general satisfactori osteoarticular graft intercal segment creat arthrodesi combin standard proxim humerus metal implant patient expect specif oncolog factor consid select optim method reconstruct"
"resect reconstruct tumor distal radius primari object surgic manag patient distal radius tumor control diseas accur stage diagnost method appli preoper predict amount resect obtain adequ tumor margin amount remain bone soft tissu assist reconstruct inform method reconstruct chosen patient optim longterm function stabil predict result fewest potenti complic"
"tumor shoulder girdl techniqu resect descript surgic classif limbspar surgeri safe reliabl bone softtissu tumor shoulder girdl eighti nineti percent patient highgrad sarcoma shoulder safe treat surgic techniqu attent paid patient select preoper stage plan addit care skelet muscular reconstruct surgic defect success outcom univers classif schemata type vi shoulder girdl resect develop classif system base bone resect status abductor mechan relationship glenohumer joint system permit easi descript comparison limbspar procedur perform"
"cdna clone sequenc human fibrillarin conserv nucleolar protein recogn autoimmun antisera isol kilobas cdna clone encod human fibrillarin screen hepatoma librari parallel dna probe deriv fibrillarin gene saccharomyc cerevisia nop xenopus laevi rna blot analysi mrna approxim nucleotid length human fibrillarin express vitro migrat sds gel kda protein specif immunoprecipit antisera human scleroderma autoimmun diseas human fibrillarin aminotermin repetit domain approxim amino acid length rich glycin arginin residu similar aminotermin domain yeast xenopus fibrillarin occurr putat rnabind domain rnp consensus sequenc protein consist associ fibrillarin small nucleolar rnas protein sequenc align show amino acid human fibrillarin ident yeast fibrillarin ident xenopus fibrillarin ident suggest evolutionari conserv import function earli pathway ribosom biosynthesi"
"free radicalderiv quinon methid mediat skin tumor promot butyl hydroxytoluen hydroperoxid expand role electrophil multistag carcinogenesi free radic deriv peroxid hydroperoxid anthron thought mediat tumor promot compound promot activ phorbol ester attribut part abil stimul cellular generat oxygen radic hydroperoxid metabolit butyl hydroxytoluen ditertbutylhydroperoxylmethylcyclohexadienon bhtooh previous shown tumor promot mous skin bhtooh extens metabol murin keratinocyt radic speci primari radic generat bhtooh phenoxyl radic disproportion form butyl hydroxytoluen quinon methid reactiv electrophil electrophil speci previous postul mediat tumor promot present studi undertaken examin role electrophil promot activ bhtooh biolog activ chemic analog bhtooh trideuteromethylbhtooh tertbutylbhtooh compar parent compound trideuteromethylbhtooh tertbutylbhtooh reduc abil inabl form quinon methid parent compound generat phenoxyl radic incub keratinocyt cytosol potenc bhtooh trideuteromethylbhtooh tertbutylbhtooh induc ornithin decarboxylas marker tumor promot commensur capac generat butyl hydroxytoluen quinon methid initi result confirm stage tumor promot protocol femal sencar mice data quinon methid mediat tumor promot bhtooh provid direct evid electrophil intermedi elicit stage carcinogenesi"
"surviv groin dissect malign melanoma groin dissect perform patient malign melanoma superfici dissect patient radic dissect patient patient palpabl node patient histolog involv patient nonpalp node patient histolog posit node year surviv rate patient histolog negat node year surviv rate patient histolog posit node respect year diseasefre surviv rate patient palpabl posit inguin node patient involv deep node patient nonpalp histolog involv inguin node patient develop involv deep node patient uncertain clinic status node preoper posit deep node prophylact node dissect frozen section inguin group node provid reliabl method sampl error determin microscop involv node decid superfici radic groin dissect patient posit node year surviv rate inguin group involv inguin deep node involv respect year diseasefre surviv rate surviv therapeut groin dissect part depend procedur patient posit deep node undergo incontinu dissect inguin iliac obtur node appreci year surviv rate"
"role resect manag melanoma metastat adren gland melanoma metastat adren gland diagnos death exceed rare develop comput tomograph ct scan record patient melanoma metastat adren gland review eighteen patient men women twenti patient unilater diseas patient diagnos autopsi leav analysi treatment surviv twenti patient receiv specif activ immunotherapi receiv chemotherapi dacarbazin lomustin bleomycin vincristin receiv diagnosi adren diseas adren metastas diagnos ct scan patient symptom pain ten patient diagnos ct entri chemotherapi protocol patient underw resect diseas underw unilater adrenalectomi underw unilater adrenalectomi bowel resect underw bilater adrenalectomi patient underw partial resect larg unilater tumor fourteen patient adren metastas diseas initi continu chemotherapi treat symptomat surviv group underw resect cure month month surviv group unresect tumor month month patient underw resect cure live year detect adren metastasi patient unresect tumor true patient metastat melanoma local adren gland benefit earli detect surgic intervent"
"evalu preoper comput tomographi gastric malign nineti patient gastric malign underw comput tomographi ct surgeri ct find neoplast invas adjac organ metastasi enlarg lymph node compar find laparotomi case autopsi case permit evalu diagnost accuraci ct predict resect present neoplast invas adjac organ overestim underestim ct case invas adjac organ ct fals posit case fals negat case liver metastasi enlarg region distant lymph node present ct overestim underestim extent case diagnosi fals posit case fals negat case posit negat predict valu ct resect tumor routin preoper ct gastric malign conclud limit surgic explor feasibl remain method choic"
"hepatoblastoma origin caudat lobe radic resect inferior vena cava complet resect rare hepatoblastoma caudat lobe involv inferior vena cava ivc report system chemotherapi year child underw exploratori laparotomi hospit resect attempt tumor caudat lobe extens invad retrohepat ivc lack distant metastas establish extrahepat collater confirm imag thought radic resect tumor success perform extend left hepat lobectomi includ total excis caudat lobe involv portion ivc reconstruct ivc clinic manifest aris caval congest serum alphafetoprotein declin normal limit experi case introduc radic resect hepat malign caudat lobe extend ivc"
"partial total penectomi cancer squamous carcinoma peni remain uncommon tumor unit state proper select patient partial total penectomi perform understand salient surgic anatomi result adequ local control cancer excel function cosmet result"
"primari hepat carcinoid tumor electron microscop immunohistochem studi case primari carcinoid tumor liver strike morpholog electron microscop featur report convent histolog examin show promin paranuclear clear zone numer tumor cell electron microscop examin clear zone correspond paranuclear mass intermedi filament admix neurosecretori granul cytoplasm organell"
"secretin provoc test diagnosi zollingerellison syndrom secretin stimul test prefer provoc test suspect case zollingerellison syndrom pure secretin prepar gastrinspecif radioimmunoassay sampl sequenc import proper interpret test gastric acid analysi assess hypergastrinemia confirm acid hypersecret exclud achlorhydria proper perform interpret secretin provoc test offer safe expediti reliabl evalu patient hypergastrinemia"
"dna flow cytometri colorect carcinoma correl dna stemlin prognost indic dna flow cytometri fcm perform paraffinembed tissu block surgic resect colorect carcinoma crc forti percent tumor exhibit aneuploidi diploid seventi percent patient aneuploid diploid group aliv follow month yr surviv site tumor locat duke stage serum cea level predict dna stemlin irrespect ploidi pattern serum cea level greater higher mortal poor yr surviv similar advanc duke stage higher mortal forti percent patient lesion duke advanc stage receiv adjuv therapi eighti percent subgroup patient die patient aneuploid tumor role fcm assess prognosi crc deserv clinic evalu random control trial"
"magnet reson imag small hepatocellular carcinoma thirti patient small hepatocellular carcinoma hccs size mm initi detect ultrasound histolog confirm examin magnet reson mr imag comput tomograph ct scan angiographi mr imag demonstr hcc nodul patient tumor mm diamet patient tumor mm diamet total hcc nodul detect patient mr imag hand hcc lesion found ct scan patient patient angiographi mr imag hcc nodul demonstr patient weight imag patient shown low intens area iso intens area weight imag patient shown high intens area patient shown high intens area weight imag resect case patient high intens area weight imag signific fatti chang note hcc nodul histolog studi resect specimen suggest mr imag diagnost imag modal small hcc mm"
"intrahepat lymphat opacifi hepat arteriographi patient hepatocellular carcinoma extrahepat lymph node metastas uncommon advanc case hepatocellular carcinoma hcc account hcc case intrahepat lymphat run hepat hilus opacifi hepat arteriographi patient treat hepat arteri embol select embol portal branch lymph node metastas hepat hilus found follow clinic case suggest communic tumor lymphat respons lymph node metastasi"
"inflammatori pseudotumor liver acut myelomonocyt leukemia patient inflammatori pseudotumor liver acut myelomonocyt leukemia report spike fever epigastralgia elev level serum reactiv protein crp alkalin phosphatas alp ultrasonographi show hypoecho mass liver ultrason guid fine needl aspir biopsi mass reveal compos fibrous connect tissu infiltr plasma cell eosinophil neutrophil diagnosi inflammatori pseudotumor liver made mark reduct size lesion decreas level crp alp occur specif treatment emphas import ultrason guid aspir biopsi diagnosi inflammatori pseudotumor liver surgeri"
"endoderm sinus tumor ovari pregnanc case report serum alphafetoprotein screen led detect endoderm sinus tumor ovari year femal week pregnanc surgeri chemotherapi postpon week level serum alphafetoprotein increas deliveri delay week gestat deliveri patient receiv chemotherapi cours cisplatin etoposid bleomycin mother month chemotherapi child"
"laparoscop pelvic lymphadenectomi stage earli carcinoma cervix laparoscop pelvic lymphadenectomi perform patient incis peritoneum round infundibulopelv ligament side gave access retroperiton space subsequ laparoscop surgeri precis dissect extern intern iliac vessel umbil arteri obtur nerv peritoneum left open lymph drain periton caviti lymphocel observ node remov signific morbid sensit specif preliminari experi remov line region lymph node cervix patholog examin skip metastas rare earli cervic carcinoma risk miss posit node low brachytherapi vagin surgeri microinvas carcinoma coniz appli safe stage laparotomi case negat node"
"squamous cell carcinoma antigen patient local advanc cervic cancer undergo neoadjuv chemotherapi serum level squamous cell carcinoma antigen measur sampl patient cervic cancer nineti patient primari tumor recurr diseas serum sampl obtain cycl chemotherapi surgeri week surgeri month interv follow patient local advanc cervic cancer receiv neoadjuv chemotherapi squamous cell carcinoma antigen serum level elev greater ngml patient primari tumor patient recurr carcinoma percentag posit increas signific stage higher squamous cell tumor adenocarcinoma pretreat squamous cell carcinoma antigen level predict neoadjuv chemotherapi respons serial measur chemotherapi show good correl clinic respons patient surgeri squamous cell carcinoma antigen posit correl patholog find lymph node status cervic parametri infiltr diseasefre surviv signific longer patient squamous cell carcinoma antigen pretreat valu lower ngml compar patient marker higher ngml abnorm squamous cell carcinoma antigen serum level preced clinic detect recurr patient median lead time month"
"epiderm growth factor receptor express normal ovarian epithelium ovarian cancer correl receptor express prognost factor patient ovarian cancer previous studi breast bladder cancer suggest epiderm growth factor receptor express proport cancer poor clinic outcom monoclon antibodi specif reactiv extracellular domain epiderm growth factor receptor local receptor immunohistochem frozen section normal ovari epitheli ovarian cancer normal ovarian epithelium found express epiderm growth factor receptor case ovarian cancer express immunohistochem detect receptor epiderm growth factor receptor express relat histolog grade stage poor surviv median length surviv patient tumor express epiderm growth factor receptor month compar month patient tumor express epiderm growth factor receptor breast bladder cancer express epiderm growth factor receptor ovarian cancer poor prognost factor"
"detect loss heterozygos formalinfix paraffinembed tumor specimen polymeras chain reaction polymeras chain reactionbas procedur detect dna length polymorph generat natur occur genet delet insert sequenc method consist simpl step assay requir restrict enzym analysi southern blot hybrid identif ethidium bromidestain gel procedur detect loss heterozygos loci includ hbb betaglobin gene cluster chemic induc mous skin tumor varieti tissu prepar includ microdissect formalinfix paraffinembed specimen shortterm cultur fluorescenceactiv cell sort epitheli popul approach detect tumorspecif reduct homozygos polymorph chromosom loci map putat tumorsuppressor loci involv carcinogenesi"
"character preneoplast neoplast lesion rat pancrea nodul acinar cell increas prolif potenti develop pancrea carcinogentr rat untreat age rat larg nodul class adenoma phenotyp genotyp characterist nodul cell compar normal pancrea transplant acinar cell carcinoma method nuclei acinar cell normal pancrea adenoma carcinoma situ normal diploid dna content determin flow cytometri primari carcinoma hypodiploid dna content transplant carcinoma aneuploid dna content tetraploid rang explant nodul adenoma fail grow soft agar carcinoma posit assay primari carcinoma serial transplant transplant nodul adenoma fail transfect dna carcinoma situ yield higher frequenc nih transform dna adenoma dnas transform ras sequenc studi cell nodul adenoma low growth potenti lack critic phenotyp genotyp characterist transform malign cell present primari transplant carcinoma"
"induct morpholog featur malign melanoma pigment lesion transform murin melanocyt bfgfcdna ras myc neu ea oncogen malign melanoma show remark degre heterogen morpholog featur biolog behavior prognosi communic author attempt correl morpholog heterogen melanoma transform activ oncogen studi histolog featur melanocyt lesion induc murin melanocyt transform basic fibroblast growth factor fgfcdna ras neu myc ea oncogen lesion compar observ human patholog tumor form graft syngen mice subcutan inject nude mice studi syngen mice benign melanocyt lesion reminisc intraderm nevus observ melanocyt transform fgfcdna myc ea oncogen benign lesion form neutransform melanocyt graft concomit keratinocyt malign tumor form cell graft fibroblast contrast ras melanocyt form malign tumor nude mice fgftransform melanocyt induc benign lesion transform melanocyt oncogen form malign tumor distinct homogen morpholog featur depend transform oncogen melanoma epithelioid cell spindl cell small round cell anaplast cell growth pattern distinguish transform ras neu ea myc oncogen histolog type analog observ human melanoma tumor studi suggest molecular mechan tumor heterogen distinct oncogen oncogenelik activ activ tumor discret part tumor"
"treatment angioma scleros inject hydroxypolyethoxydodecan author discuss indic hydroxypolyethoxydodecan scleros treatment angioma refer cavern venous evolut angioma immatur angioma fail involut ten month scleros agent employ connect embol subsequ surgeri arterioven angioma relev cutaneoussubcutan develop author success interstiti scleros techniqu andrew method techniqu involv interstiti inject obtain sclerosi thin thread fibrous tissu stroma blood vessel scleros therapi complet regress low flow angioma partial reduct simplifi ensu surgic excis case partial regress angioma obtain scleros therapi surgeri remain angioma lesser degre bleed area lend surgic explor oral caviti increas reliabl radic intervent due reduc size lesion result aestheticfunct point view"
"intraop pancreat fine needl aspir biopsi result patient intraop fine needl aspir biopsi nab undiagnos pancreat mass studi patient year period cytolog diagnos correl histolog specimen autopsi result clinic follow benign diseas document patient aliv malign year laparotomi aspir interpret benign suspici malign unsatisfactori malign diseas final diagnosi patient cytolog concord interpret suspici patient benign cytolog prove malign diseas falseneg rate cent total patient benign diseas benign cytolog remain patient unsatisfactori cytolog report cent sensit cent specif cent complic rate report falseposit cytolog report complic rare repres case report addit sampl minim risk intraop pancreat nab safe easi accur biopsi techniqu histor wedg core needl biopsi biopsi method choic pancreat mass found laparotomi"
"surgic voic restor blomsing prosthesi laryngopharyngoesophagectomi pharyngogastr anastomosi surgic voic restor blomsing techniqu establish procedur patient undergon simpl laryngectomi oper hypopharyng carcinoma extens requir reconstruct region skin myocutan flap reanastomosi colon jejunum stomach report blomsing prosthesi patient undergon pharyngogastr repair laryngopharyngoesophagectomi fail achiev satisfactori voic patient initi develop good speech prosthesi patient subsequ prosthes remov recurr malign diseas procedur signific alter qualiti voic remain patient continu devic year insert good voic product"
"selenium forag crop cancer mortal counti potenti protect effect selenium status risk develop cancer examin anim epidemiolog studi ecolog studi investig associ counti forag selenium status site sexspecif counti cancer mortal rate weight squar regress consist signific invers associ observ cancer lung rectum bladder esophagus cervix model limit rural counti cancer lung breast rectum bladder esophagus corpus uteri model counti consist signific posit associ observ rural counti model remark degre consist invers associ strengthen likelihood causal relationship low selenium status increas risk cancer mortal"
"rapid analysi carcinoembryon antigen level gallbladd bile identif patient high risk colorect liver metastasi recent found immunoanalysi carcinoembryon antigen cea level gallbladd bile sensit method detect colorect liver metastas human method past detect cea bodi fluid cumbersom time consum requir acid extract extens dialysi column purif singlestep solidphas radioimmunoassay design specif serum cea analysi develop commerci replac method paramet methodolog adapt kit paramet methodolog adapt kit gallbladd bile present combin pretreat procedur bile radioimmunoassay permit rapid reproduc accur measur cea level gallbladd bile"
"liver transplant hepatoblastoma american experi current role liver transplant treat malign tumor liver uncertain select histolog type pool data result liver transplant children hepatoblastoma present half children aliv month transplant evid recurr patient die tumor recurr die unifoc intrahepat tumor prognosi compar multifoc tumor tumor extrahepat spread microscop vascular invas predomin embryon anaplast epithelium poor prognosi compar tumor vascular invas predomin fetal epithelium conclud continu effort treat unresect hepatoblastoma liver transplant justifi role adjuv chemotherapi improv result defin"
"populationbas studi function status social support network elder patient newli diagnos cancer assess function status social support network men women age year older newli diagnos cancer live mexico counti function limit includ depend transport mental incompet poor recent memori percentag patient function limit increas sharpli increas age substanti number patient evid poor social support network subject live children live vicin multipl logist regress analysi predictor poor social support network includ hispan white ethnic advanc age low incom recent migrant area subject function limit poor social support network subject limit deleteri combin impair function status limit social support network explain elder cancer patient increas risk receiv therapi potenti complex involv evalu treatment cancer care adequ assess function status support mechan older patient provid adequ support ensur complianc treatment"
"recurr pigment melanocyt nevus benign lesion mistaken malign melanoma melanocyt nevi recur incomplet remov pigment lesion clinic patholog simul malign melanoma situ exampl recurr pigment melanocyt nevus emphasi light microscop immunohistochem find report promin hmb stain nevi confus differenti malign melanoma differenti diagnosi recurr pigment melanocyt nevi discuss emphasi distinguish lesion malign melanoma immunohistochem observ recurr develop result prolifer melanocyt remain epidermi adnexa incomplet remov approach manag recurr nevi discuss"
"secretori carcinoma breast studi secretori carcinoma breast singl case report separ analys problem children adult studi femal patient age year patient present palpabl mass areola tumor estrogen receptor negat analyz progesteron receptor posit histolog pattern present vari proport classic secretori carcinoma microacini abund secret papillari featur promin solid papillari apocrin featur tumor strong reactiv alphalactalbumin carcinoembryon antigen polyclon negat gross cystic diseas fluid protein anticarcinoembryon antigen monoclon patient mastectomi local excis axillari nodal metastas initi follow month month median month patient treat local excis local recurr patient axillari nodal metastas patient aliv comparison patient year age reveal import differ younger patient longer interv detect biopsi month treatment recommend initi wide excis quadrantectomi low axillari dissect case premenarch patient strong effort preserv breast bud jeopard local control"
"intralumin crystalloid struma ovarii immunohistochem dna flow cytometr ultrastructur studi recent encount uniqu case follicular variant papillari carcinoma aris struma ovarii numer intrafollicular crystalloid evid capsular vascular invas metastas dna content papillari carcinoma aneuploid contrast diploid dna manifest histolog benign thyroid tissu natur crystalloid signific aneuploid dna content discuss"
"tall cell variant papillari carcinoma thyroid gland comparison common form papillari carcinoma dna morphometr analysi tall cell variant papillari carcinoma thyroid manifest aggress behavior usual form papillari carcinoma thyroid morphometr analysi nuclear featur dna analysi yield inform predict aggress behavior dna content morphometr featur neoplast cell tall cell variant measur compar measur obtain neoplast cell usual form papillari carcinoma tall cell neoplasm aneuploid usual papillari neoplasm benign cell separ malign cell case differ tall usual papillari carcinoma cell observ dna content chromatin textur nuclear size shape differ clinic behavior neoplasm explain basi characterist"
"squamous cell carcinoma situ aris ovarian matur cystic teratoma report case histopatholog cytogenet flow cytometr dna content analysi squamous cell carcinoma situ aros ovarian matur teratoma dermoid cyst year woman flow cytometr dna content analysi paraffinembed situ carcinoma show normal dna content moder high prolif activ phase fraction estim cytogenet analysi situ cancer benign cystic portion tumor reveal xx karyotyp addit benign cystic portion tumor reveal homozyg chromosom heteromorph compar heterozyg marker found peripher blood lymphocyt result show squamous cell carcinoma situ euploid suggest matur cystic teratoma deriv singl germ cell meiosi"
"extramammari paget diseas bronchial epithelium report case knowledg extramammari paget diseas bronchial epithelium tumor display paget cell scatter bronchial epithelium lesion infiltr bronchial submucosa pulmonari parenchyma microglandular papillari pattern area addit histolog find coexist adenocarcinomat compon situ involv bronchial gland duct paget cell observ suggest extramammari paget diseas bronchial epithelium variant pulmonari adenocarcinoma bronchial gland"
"adult common acut lymphoblast leukaemia present skin infiltr year man present multipl rais erythemat skin lesion pyrexia epistaxi diagnosi common acut lymphoblast leukaemia made morpholog cytochem immunolog cytogenet examin peripher blood bone marrow biopsi skin reveal leukaem infiltr similar cell"
"monoclon antibodypurg autolog bone marrow transplant therapi multipl myeloma eleven patient plasma cell dyscrasia underw highdos chemoradiotherapi anticel monoclon antibodi moabtreat autolog bone marrow transplant abmt major patient advanc duriesalmon stage myeloma diagnosi pretreat chemotherapi receiv prior radiotherapi time abmt patient demonstr good perform status karnofski score greater marrow tumor cell patient residu monoclon marrow plasma cell patient paraprotein highdos melphalan total bodi irradi tbi complet respons partial respons toxic death granulocyt greater mm note median rang day posttranspl pt untransfus platelet greater mm note median day pt patient natur killer cell cytotoxicsuppressor cell predomin earli pt return cell month pt normal tt ratio year pt polyclon marrow plasma cell note patient transplant complet respond return paraprotein myeloma subsequ respond alpha interferon therapi patient aliv month pt remain diseasefre month pt preliminari studi confirm highdos melphalan tbi achiev high respons rate unexpect toxic patient sensit diseas moabbas purg techniqu inhibit engraft follow short longterm outcom determin relaps postabmt heavili pretreat patient suggest abmt altern treatment strategi evalu earlier diseas"
"beta globin enhanc element confer regul express human gamma globin gene human embryonicfet erythroleukemia cell line construct fusion gene compris gamma beta globin element globin sequenc link neomycin resist neor gene defin cis act sequenc respons development stagespecif express induct fetal globin gene embryonicfet erythroleukemia cell result gamma promot requir proper initi transcript accumul gamma globin transcript respons hemin induct requir addit presenc gamma interven sequenc enhanc element beta globin gene gamma promot provid element development stagespecif gene express fetal life contrast beta enhanc erythroidspecif development stage genespecif"
"detect residu leukemia bone marrow transplant chronic myeloid leukemia role polymeras chain reaction predict relaps polymeras chain reaction pcr detect residu leukemiaspecif mrna blood marrow patient complet hematolog cytogenet remiss allogen bone marrow transplant bmt chronic myeloid leukemia cml step pcr method involv nest primer step detect cell dilut normal cell elabor measur exclud falseposit falseneg result patient blood marrow studi simultan result concord posit negat twenti patient transplant chronic phase cp unmanipul donor marrow studi blood cell patient studi month postbmt pcr posit negat subsequ studi blood cell patient studi month year postbmt pcr negat patient transplant cp celldeplet marrow cell studi blood posit month postbmt blood negat year postbmt patient longer cp studi bmt unmanipul donor marrow blood posit month postbmt base clinic result transplant cohort conclud pcr posit month bmt patient expect longlast remiss pcr posit bmt probabl cure reduc techniqu prove earli assess transplant protocol inadvert increas risk relaps"
"reliabl palpat assess tumour joint uiccajc classif cervic lymph node base size node recogn error palpat detect presenc tumour size studi anim tumour model system compar abil independ observ vari experi detect stage superfici transplant growth preclin medic student good consult ent surgeon predict presenc tumour abil stage tumour accur relat experi whilst experienc observ accur estim size tumour cm accur larger greater cm tumour constant understag phenomenon import clinic implic relat current nodal stage criteria"
"epidemiolog primari osteogen sarcoma san francisco bay area california epidemiolog studi repres analysi regist case osteogen sarcoma og year period januari decemb san francisco bay counti inclus studi limit patient diagnos decad life resid bay area time diagnosi determin epidemiolog characterist og record patient bay area resourc cancer control histolog proven og review incid og influenc age gender race effect statist signific geograph variat incid og discov statist signific result present support continu search environment variabl someday reveal etiolog factor og"
"solitari fibromatosi bone rare variant congenit general fibromatosi congenit general fibromatosi part spectrum fibromatos infanc childhood lesion multipl fibrous natur virtual organ central nervous system congenit general fibromatosi limit skeleton rare manifest solitari bone lesion solitari osseous lesion behav differ multipl osseous lesion solitari lesion regress treatment high incid recurr margin excis multipl osseous lesion regress treatment"
"assess squamous cell carcinoma antigen scc marker epidermoid carcinoma anal canal measur squamous cell carcinoma antigen scc epidermoid carcinoma anal canal patient sampl diagnosi treatment follow sampl analyz posit threshold ngml diagnosi sensit marker percent specif percent seri pretherapeut level scc correl papillon clinic stage system correl nodal invas prognost time diagnosi follow relaps level scc ngml increas signific sensit marker percent patient relaps develop ill correl level scc prognost conclus level scc clinic follow patient epidermoid carcinoma anal canal"
"antitumor antilymphocyt heteroconjug augment colon tumor cell lysi vitro prevent tumor growth vivo crosslink antitumor antibodi specif tumor cell surfac antigen antilymphocyt antibodi specif lymphocyt receptor complex tcrcd produc heteroconjug direct cell lyse tumor cell test abil antitumor antilymphocyt cd heteroconjug redirect human peripher blood lymphocyt pbls lyse human colon cancer cell cytotox assay murin colon tumor model demonstr vitro cultur human pbls produc low level tumor lysi pbls treat antitumor anticd heteroconjug produc signific greater tumor cell lysi similar nude mice inject lst human colon cancer cell treat cultur human pbls antitumor anticd heteroconjug surviv signific longer salin control mice mice treat pbls heteroconjug ab heteroconjug equal effect prolong anim surviv irrelev heteroconjug monoclon antitumor antibodi show therapeut benefit antitumor anticd heteroconjug repres effect approach tumorspecif cellular immunotherapi"
"polyamin level healthi tumor tissu patient colon adenocarcinoma tissu polyamin level determin patient colon adenocarcinoma identifi biochem indic character growth metabol human solid tumor polyamin content determin tumor healthi mucosa sampl distanc resect edg patient polyamin content tumor compar mucosa result demonstr spermidin concentr higher tumor healthi mucosa differ statist signific spermin tumor increas lesser degre statist signific differ observ mucosa local spermin concentr mucosa tumor show valu close neoplasia"
"isol character normal neoplast colon epitheli cell popul aim present studi character rat mucos colon cell harvest crypt continuum differenti dimethylhydrazineinduc neoplasia collect colonocyt perform modifi nonenzymat isol procedur base ca chelat gentl mechan dissoci light electron microscopi histomorpholog examin hthymidin incorpor studi activ gradient alkalin phosphatas thymidin kinas cytoskeleton protein tyrosin kinas distinct cell popul harvest crypt region tempor sequenc mirror zonal function distribut situ dimethylhydrazin administr mark protein tyrosin kinas activ note colon cell harvest upper crypt zone misplac sustain kinas activ preced actual polyp tumor format observ consist expans colon prolif compart boundari preneoplast period companion studi human colon epitheli specimen corrobor find observ normal transform murin colonocyt believ character manipul colonocyt vitro model provid import clue molecular event differenti program carcinogen process colon cell"
"human cd cell clone secret idiotypespecif high affin igm monoclon antibodi previous demonstr occurr natur arisen human antiidiotyp cell clone transform ebv ebv show evid ebv express cd surfac ag kb mrna transcript encod protein addit show presenc kb mrna precursor ig produc cd cell polyreact natur igm antibodi encod unmut copi germlin vh gene studi present data demonstr monoreact high affin charact antiidiotyp antibodi mab produc ebv data agreement previous observ show vh chain mab encod extens somat mutat vhv gene consist agdriven immun respons role remark antiidiotyp antibodi mainten cell memori discuss"
"mhcrestrict recognit autolog melanoma tumorspecif cytotox cell evid restrict domin hla allel autolog melanomaspecif ctl recogn common tumor ag taa context hla class antigen demonstr hlaa restrict ag cell line homozyg hlaa ctl generat stimul hlaa allogen melanoma current studi investig cell line patient heterozyg hla region locus determin relat import region allel mhcrestrict recognit tumor shown hlaa restrict ag allogen melanoma express hlaa substitut autolog tumor generat hlaarestrict ctl cell line express hlaa hlaa hlaa allel govern restrict melanoma taa autologousstimul hlaa ctl line demonstr restrict hlaa allel examin cytotox assay coldcompetit assay prolifer assay evid restrict hlaallel hlaa autologousstimul ctl singl region allel tumor recognit autolog hlaa tumor lyse hlaarestrict hlaarestrict ctl domin restrict allel demonstr hlamatch allogen melanoma stimul tumor generat tumorspecif ctl stimul heterozyg hlaa lymphocyt hlaamatch allogen melanoma result ctl specif autolog tumor restrict hlaa ag stimul hlaamatch allogen melanoma fail induc tumorspecif ctl restrict hlaa ag data suggest domin hla region ag level cell restrict recognit autolog melanoma level tumor taa express context hla region allel generat specif ctl lymph node cell pbl hla region match allogen melanoma patient heterozyg hla region locus understand domin restrict allel obtain appropri match allogen melanoma select"
"cytotox cell clone isol ovarian tumorinfiltr lymphocyt recogn multipl antigen epitop autolog tumor cell ctl clone develop tumor infiltr lymphocyt til ascit patient ovarian carcinoma cocultur til autolog tumor cell subsequ clone presenc autolog tumor cell ctl clone express preferenti cytolyt activ autolog tumor cell allogen ovarian tumor cell nksensit cell line cytolyt activ ctl autolog tumor inhibit antitcr wt mab antihla class anticd mab nk function antibodi leu clone autolog tumor cell vitro reveal ctl clone ovarian til express differenti abil lyse autolog tumor cell clone specif analysi autolog tumor specif ctl suggest recogn antigen determin present ovarian tumor cell result presenc antigen epitop tumor cell design ovaa ovab ovac ovac unstabl determin present simultan separ type ovarian clone distinguish basi express result ctl til detect intratumor antigen heterogen heterogen identifi ovarian tumor cell report signific understand cellular immun ovarian cancer develop adopt specif immunotherapeut approach ovarian cancer"
"evid function bind vivo tumor reject antigen antigenpres cell tumorbear host spleen cell balb mice bear syngen csam fibrosarcoma treat antithi antibodi yield celldeplet apc fraction apc fraction test capac present exogen modifi tumor meth ag vitro puls result show compar agpres capac obtain apc fraction normal spleen cell indic apc function affect tumorbear mice examin apc csambear mice bind endogen generat csam tumor ag surfac stimul tumorspecif cell round inocul apc fraction csambear mice vitro puls result induct potent anticsam immun resist involv anticsam cell induct anticsam immun exclud fact vivo immun exclud fact vivo immun deliv thi celldeplet thi cellenrich fraction spleen cell csambear mice failur sephadex gpass spleen cell deliv anticsam resist demonstr absolut requir apc induc vivo immun final vivo resist found tumor specif apc fraction csambear meth bear balb mice induc immun resist select tumor cell challeng result apc tumorbear host exert unaffect apc function exogen ag function present tumor ag generat endogen tumorbear state produc tumorspecif immun vivo"
"multipl spinal epidur metastas unexpect frequent find prospect studi patient malign diseas suspect spinal epidur metastasi myelographi confin clinic suspect site includ lumbar thorac spinal canal fifti myelogram reveal epidur metastasi twelv myelogram show separ lesion myelogram show separ lesion case multipl lesion lesion asymptomat time diagnosi conclud multipl spinal epidur metastas common occurr occur case find import clinic implic examin spinal canal epidur metastas confin clinic suspect site includ extens area spinal canal techniqu"
"gemistocyt astrocytoma reapprais gemistocyt astrocytoma consid slowgrow astrocytoma behav aggress clarifi biolog clinic behavior rare tumor author retrospect identifi patient gemistocyt astrocytoma tumor diagnos treat june juli patient lost follow review exclud origin slide obtain tumor diagnos recurr autopsi patholog materi remain patient review set histolog criteria thirteen patient group pure gemistocyt astrocytoma defin glial tumor gemistocyteshighpow field background fibrillari astrocyt fifteen patient group mix gemistocyt astrocytoma defin glial tumor gemistocyteshighpow field background anaplast astrocyt twenti tumor meet criteria exclud analysi median age patient year group year group group median karnofski perform scale score greater patient underw surgic procedur total partial resect biopsi postop radiat therapi major interstiti brachytherapi chemotherapi ten patient reoper tumor recurr reoper treatment recurr includ brachytherapi chemotherapi repeat irradi patient origin underw gross total resect aliv biopsi die signific differ median surviv time group week group rang week week group rang week analysi patient show prognosi patient year age week surviv time patient preoper symptom month week surviv time patient seizur symptom week surviv time surviv time correl presenc perivascular lymphocyt infiltr author conclud presenc gemistocyt glial neoplasm poor prognost sign irrespect patholog background propos gemistocyt astrocytoma classifi anaplast astrocytoma treat"
"improv surviv adjuv chemotherapi treatment medulloblastoma children newli diagnos medulloblastomaprimit neuroectoderm tumor mbpnet posterior fossa treat author institut patient manag uniform treatment includ aggress surgic resect postop stage evalu extent diseas craniospin radiat therapi local boost begin children mbpnet prospect assign risk group standardrisk mbpnet treat radiat therapi poorrisk group receiv similar radiat therapi adjuv chemotherapi chloroethylcyclohexylnitrosourea ccnu vincristin cisplatin year actuari diseasefre surviv rate patient treat patient die week oper exclud surviv rate statist patient treat compar treat differ diseasefre surviv rate time children standardrisk factor signific differ year surviv rate poorrisk patient treat prior compar treat group younger age diagnosi correl poorer surviv rate relationship age outcom signific children treat result demonstr encourag surviv rate children mbpnet treat aggress surgic resect radiat therapi chemotherapi result strong suggest chemotherapi role possibl children mbpnet"
"interstiti chemotherapi drug polym implant treatment recurr glioma malign glioma difficult treat chemotherapi effect agent bcnu carmustin system toxic short halflif serum obviat problem method develop local sustain releas chemotherapeut agent incorpor biodegrad polym implant drugimpregn polym tumor site prolong local exposur minim system exposur phase ii studi patient recurr malign glioma treat bcnu releas interstiti polyanhydrid biodegrad polym implant polym wafer resect caviti intraop complet tumor debulk polym releas therapeut drug approxim week increas concentr bcnu studi treatment toler level advers reaction bcnu wafer treatment averag surviv period reoper week dose group week dose group week highest dose group surviv time week reoper week origin oper median surviv time week postimpl week initi surgeri eighteen patient live year time initi diagnosi patient live year intracrani implant polym frequent hematolog blood chemistri urinalysi test reveal system effect interstiti chemotherapi therapi toler safe placebocontrol clinic trial start trial measur effect treatment dose surviv patient recurr malign glioma"
"character astrocytoma meningioma pituitari adenoma phosphorus magnet reson spectroscopi phosphorus magnet reson mr spectroscopi noninvas measur phosphat compound ph brain cell author obtain local phosphorus mr spectra normal brain lowgrad astrocytoma glioblastoma meningioma pituitari adenoma found differ spectra tumor type compar normal brain spectra lowgrad astrocytoma show signific reduct phosphodiest pde peak glioblastoma character signific reduct pde peak elev phosphomonoest pme peak alkalin intracellular ph spectra meningioma pituitari adenoma mark glial tumor meningioma show signific reduct phosphocreatin pde inorgan phosphat alkalin ph pituitari adenoma resembl meningioma higher pme peak number tumor studi small characterist spectrum tumor type present find preoper identif tumor understand growth metabol vivo"
"hemangiopericytoma sciatic nerv case report author report case hemangiopericytoma aris sciatic nerv found invas epineurium spare surround tissu adequ resect requir sacrific nerv hemangiopericytoma ad short list mesoderm peripheralnerv tumor"
"dose depend time onset radiationinduc growth hormon defici growth hormon gh secret insulininduc hypoglycemia assess occas survivor childhood malign diseas receiv cranial irradi dose rang hypothalamicpituitari axi gy estim schedul fraction week test occas year treatment result gh test defin normal gh peak respons greater mu year comparison year stepwis multipl linear regress analysi show dose time irradi age therapi signific influenc peak gh respons late incid gh defici similar dose rang gh test result normal gy normal greater equal gy year speed onset year depend dose conclud requir gh replac therapi time introduct influenc dose irradi receiv hypothalamicpituitari axi"
"deep femor lymphadenectomi preserv fascia lata preliminari report invas vulvar carcinoma forti patient primari invas vulvar carcinoma treat radic vulvectomi deep femor lymphadenectomi preserv fascia lata cribriform fascia rational techniqu base anatom knowledg topograph distribut groin lymph node confirm studi cadav preliminari data show number superfici deep femor lymph node remov patient number node rang similar number report anatomi book addit year actuari surviv rate compar literatur preliminari result suggest surgic techniqu studi radic oncolog procedur classic groin lymphadenectomi consist remov fascia lata cribriform fascia"
"breast examin relat occurr advanc breast cancer hundr femal enrolle group health cooper puget sound develop advancedstag breast cancer period interview practic breast examin bse breast cancer screen modal medic reproduct histori subject descript perform examin score mention recommend bse techniqu random sampl women advancedstag breast cancer popul interview comparison relat women practic bse risk advancedstag breast cancer bse user confid interv frequenc bse differ women advancedstag breast cancer control subject subject subgroup defin age mammographi frequenc clinic breast examin profici bse general low case control subject small percentag women report examin frequenc decreas occurr advancedstag breast cancer compar women perform bse result suggest care perform bse avoid develop advancedstag breast cancer bse practic seattlearea women benefit"
"express antimetastat gene nm human breast cancer associ good prognosi nm gene identifi murin melanoma cell express cell metastat potenti express nm detect human breast tumor hybrid immunocytochemistri measur nm mrna patient primari breast cancer found variabl level nm express nm gene express higher level differenti tumor signific invers relationship nm express nodal status express nm posit longer diseasefre surviv surviv relationship signific studi show nm express human breast cancer good prognosi lack lymph node metastasi suggest nm gene product play import role suppress metastat phenotyp"
"longterm follow patient recurr malign glioma treat adjuv adopt immunotherapi august octob denver brain tumor research group conduct clinic trial autolog human recombin interleukin rilactiv lymphocyt treat patient recurr highgrad glioma trial involv surgic resect decompress intracavitari implant lymphokineactiv killer lak cell autolog stimul lymphocyt asl ril plasma clot month stimul lymphocyt ril infus rickham reservoir attach cathet direct tumor bed lak cell rilactiv peripher blood lymphocyt cultur day asl lectin rilactiv peripher blood lymphocyt cultur day patient treat evalu group age year rang year karnofski rate rang decadron dose entri mg rang averag number lymphocyt implant rang ril date patient die recurr tumor growth median surviv time week rang median surviv time immunotherapi week rang signific differ surviv immunotherapi found patient receiv previous chemotherapi steroid prior chemotherapi influenc vitro generat asl lak cell"
"disposit cerebr metastas malign melanoma implic radiosurgeri radiosurgeri general indic continu defin cerebr metastas malign melanoma treat brain irradi limit benefit innov treatment radiosurgeri make deliveri dose radiat higher usual determin patient candid radiosurgeri retrospect analysi comput tomograph brain scan perform patient cerebr metastas malign melanoma undertaken patient found cerebr metastas amen radiosurg approach illustr radiat dosevolum histogram patient tumor characterist suggest seri repres cerebr metastas malign melanoma implic radiosurgeri normal tissu radiat toler effect melanoma discuss"
"earli diagnosi breast cancer univers screen essenti breast cancer strike women unit state earli diagnosi breast cancer improv chanc surviv univers screen expert evalu earli clinic sign symptom breast cancer mortal rate reduc physician achiev goal activ role patient educ promot avail afford screen mammographi"
"primari ct diagnosi abdomin mass pac environ display mediumfilm versus cathod ray tube crtaffect observ perform interpret comput tomograph ct imag import research issu time implement growth pictur archiv communic system radiolog author perform multiobserv receiv oper characterist roc studi determin perform radiologist read abdomin ct studi display film highresolut workstat video monitor made display mode total examin evalu radiologist record ordin confid rate demonstr presenc absenc abdomin mass roc analysi show small differ confid rate assign individu reader detect interpret task result group show signific reduct improv observ perform rate workstat display mode analyz result studi demonstr current crt display technolog adequ enabl primari detect abdomin mass ct examin"
"zollingerellison syndrom prospect assess abdomin local gastrinoma abil abdomin ultrasound local gastrinoma prospect studi patient zollingerellison syndrom result assess laparotomi autopsi percutan liver biopsi hepat gastrinoma sensit specif posit predict negat predict slight sensit detect gastrinoma liver comput tomographi ct select angiographi detect extrahepat gastrinoma sensit specif posit predict negat predict enabl detect tumor case detect ct detect angiographi specif extrahepat gastrinoma similar modal ct equal effect detect extrahepat gastrinoma angiographi signific effect ct author conclud low sensit remain initi imag modal patient zollingerellison syndrom"
"epitheli tumor ovari ct find correl hundr thirti patient epitheli ovarian tumor prospect studi comput tomographi ct surgeri ultrasound perform patient tumor patholog examin tumor benign borderlin malign ct result compar surgic patholog find patient ct enabl detect tumor enabl detect tumor benign serous cystadenoma correct character sensit ct benign mucin cystadenoma correct character sensit ct malign suggest patient borderlin tumor ct accuraci character benign versus malign tumor includ borderlin tumor ct patient studi ct sensit ct signific superior signific differ specif"
"intraop seed implant extens recurr head neck carcinoma patient extens recurr carcinoma head neck treat surgic resect intraop iodin seed implant surgeri perform resect tumor expos tumor bed implant seed implant intraop space cm adjac seed soft tissu tumor bed small patch gelatin spong cover bone nerv blood vessel involv diseas reconstruct flap patient averag dose deliv implant seed cgi determin year actuari surviv rate entir group year local diseas control rate major complic transient wound infect flap necrosi fistula format carotid blowout result surgic resect seed implant potenti curat treatment patient extens recurr head neck carcinoma consid tradit unresect treat palliat therapi"
"symptom direct evalu surveil recurr carcinoma breast specif postop test diagnos recurr carcinoma breast evalu abil impact diseas sixti patient recurr contralater primari diseas divid group base method diagnosi patient complaint interv schedul follow visit test document recurr categor interv follow prearrang regular follow period receiv test recommend attend physician surgeon document recurr classifi routin follow thirteen patient present contralater primari diseas metastat diseas bone lung local liver multipl median time discoveri recurr primari treatment month interv routin group nineti cent failur occur month surviv time recurr signific greater patient diagnos routin surviv time primari therapi death signific improv routin group contralater primari diseas includ method diagnosi contralater primari carcinoma physic examin mammogram strong recommend follow test limit mammogram physic examin"
"axillari lymphadenectomi intraduct carcinoma breast ten year period axillari lymph node dissect part treatment intraduct carcinoma breast patient treat modifi radic mastectomi treat mammari preserv consist excis lesion axillari dissect radiat therapi axillari node dissect yield posit node axillari dissect intraduct carcinoma breast yield involv node instanc reserv lesion demonstr microinvas"
"express beta integrin normal human keratinocyt major cell adhes event extracellular matrix mediat cell surfac receptor beta integrin keratinocyt express polypeptid beta integrin class beta alpha alpha alpha alpha alpha beta polypeptid epitheli cell alpha beta collagen receptor alpha beta fibronectin receptor alpha beta major basement membran receptor express alpha beta complex low process beta integrin fast keratinocyt halfmaxim matur hour addit function cellmatrix interact beta integrin alpha beta alpha beta role maintain keratinocyt cellcel interact rest basal keratinocyt beta integrin cellcel adhes receptor activ wound heal receptor reloc mediat event involv cellmatrix interact"
"state cancer registri increas screen behavior sister daughter breast cancer patient pennsylvania cancer registri contact breast cancer patient adult sister daughter sister daughter counsel higher averag risk breast cancer mammographi breast examin result show percent increas mammographi percent increas breast examin rate counsel control group cost counsel sister daughter indic increas cost effect implement practic"
"subscapular elastofibroma young pitcher case report subscapular elastofibroma scapulothorac bursiti symptomat mass basebal pitcher process repres reactiv soft tissu respons repetit stress inferior border scapula assum mass subscapular area repres scapulothorac bursiti elastofibroma mass treat conserv scapulothorac bursiti elastofibroma studi evalu incid subscapular mass colleg profession pitcher unit state follow report anticip studi complet author request inform confirm case elastofibroma basebal pitcher"
"glucos transport bloodbrain barrier human brain tumor glucos transport human brain local endotheli cell express bloodbrain barrier mechan induct express exclus link restrict vascular permeabl investig glucos transport express vessel human astrocyt tumor pulmonari metastas brain immunohistochem techniqu vessel lowgrad astrocytoma anaplast astrocytoma posit glucos transport glioblastoma vessel transporterposit specimen vessel metastat tumor negat glucos transport decreas transport express observ highergrad tumor occur independ increas vascular permeabl lowgrad astrocytoma glioblastoma transport express contrast enhanc invers relat vessel anaplast astrocytoma transporterposit contrast enhanc find suggest separ mechan induc glucos transport permeabl restrict human bloodbrain barrier potenti implic therapi prognosi astrogli neoplasm"
"effect treatment longterm survivor malign astrocytoma review record consecut patient glioblastoma anaplast astrocytoma evalu longterm consequ radiat therapi chemotherapi defin longterm survivor patient glioblastoma anaplast astrocytoma live longer median surviv histor control year patient glioblastoma year patient anaplast astrocytoma longterm survivor dement die evid tumor recurr surviv year die tumor recurr remain survivor signific impair shortterm memori function neurolog deficit gait apraxia function independ prove radiotherapi chemotherapi causal factor dismal therapeut outcom studi suggest restraint radiotherapi patient brain tumor favor prognos glioblastoma anaplast astrocytoma lowgrad astrocytoma oligodendroglioma"
"chemotherapi medulloblastomaprimit neuroectoderm tumor posterior fossa chemotherapi margin efficaci adult malign brain tumor contrast drug therapi effect medulloblastomaprimit neuroectoderm tumor mbpnet posterior fossa common childhood primari central nervous system tumor time diseas recurr varieti singl agent drug combin result tumor shrinkag increas surviv addit chemotherapi standard radiotherapi improv rate length diseasefre surviv children mbpnet extens tumor diagnosi remain determin drug drug combin effect mbpnet patient benefit chemotherapi chemotherapi reduc select case obviat radiotherapi reduc treatmentrel sequela"
"compar vitro activ newer quinolon pseudomona speci xanthomona maltophilia isol patient cancer vitro suscept pseudomona speci pseudomona aeruginosa pseudomona putida pseudomona fluorescen xanthomona maltophilia quinolon antimicrobi agent determin newer agent pd pd pd sparfloxacin temafloxacin activ pseudomona speci  maltophilia isol general suscept pseudomona isol inhibit newer quinolon"
"therapeut outcom patient suffer malign melanoma conjunctiva eighti case conjunctiv melanoma treat studi determin factor affect outcom patient lesion therapeut procedur perform local excis local excis brachytherapi sr local excis cryotherapi liquid nitrogen brachytherapi sr local excis extern beam irradi local excis brachytherapi cryotherapi median follow period year longest shortest year sixti patient show complet regress melanoma develop recurr die metastas melanoma develop equal frequenc preexist naevus primari acquir melanosi de novo small tumour higher chanc regress larger cumul surviv rate year year death year year death caus metastas death metastas occur year cumul surviv rate patient small tumour quadrant bulbar conjunctiva mm thick signific higher patient larger tumour quadrant bulbar conjunctiva mm thick year local excis beta ray irradi sr cryotherapi recommend treatment choic behaviour conjunctiv melanoma remain unpredict individu case"
"increas lysi patient cdposit leukem cell cell coat anticd fab antibodi crosslink anticd fab antibodi anticd fab anticd fab bispecif hybrid ab antibodi ab generat bispecif ab molecular mass kd capac react cd cell cd acut lymphoblast leukemia cell studi cytotox lymphocyt ctls lyse patient cd cell addit bispecif ab effector ctls interleukin ilstimul peripher blood mononuclear cell pbmcs ctl clone ilstimul pbmcs assay cytotox crlabel cd cell activ shown mark enhanc addit bispecif ab ctl clone establish lack cytotox cd cell addit bispecif ab induc signific level cytotox ctls deriv patient show signific cytotox autolog cd cell addit bispecif ab ab affect cytotox ctls cd leukem cell target find suggest bispecif ab immunotherapi patient cd"
"preliminari studi immunotherapeut approach treatment human myeloma chimer anticd antibodi multipl myeloma diseas convent chemotherapi limit ideal treatment passiv antibodi suitabl cell surfac antigen neoplast plasma cell cd antigen present major neoplast plasma cell confirm detail examin bone marrow aspir patient strong express cd confin cell criteria lightscatt profil possess cytoplasm ig plasma cell vast major neoplast plasma cell involv cell line model found cd antigen act target chimer antibodi prepar antibodi okt chimer antibodi consist fab portion mous monoclon antibodi link stabl thioether bond fc molecul deriv human igg form mous fabhuman fc contrast parent antibodi chimer molecul mediat antibodydepend cellular cytotox adcc effici human blood mononuclear effector cell effect low concentr cd antigen present natur killer cell deleteri action antibodi effector cell function antibodi fail affect growth progenitor cell granulocytemacrophag erythroid lineag present normal bone marrow suspicion cell express antigen advantag cd molecul found serum patient myeloma modul vitro fourteen patient florid myeloma chemotherapeut regim undiminish capac mediat adcc chimer antibodi compar normal individu mainten adcc activ coupl suppress antibodi respons patient auger treatment chimer antibodi"
"select hypersensit granulocytemacrophag colonystimul factor juvenil chronic myeloid leukemia hematopoiet progenitor juvenil chronic myelogen leukemia jcml good model studi myeloprolifer jcml hematopoiet progenitor cell grow vitro low cell densiti addit exogen stimulus previous studi demonstr prolifer depend granulocytemacrophag colonystimul factor gmcsf remov monocyt cell popul cultur elimin spontan myeloprolifer suggest paracrin role monocyt stimul subsequ studi shown increas gmcsf product jcml monocyt consist find plausibl sole mechan examin hematopoiet growth factor doserespons curv jcml gm erythroid nonadher progenitor cell popul display mark select hypersensit gmcsf respons interleukin csf ident control doserespons curv demonstr myeloid leukemia hypersensit specif growth factor involv pathogenesi diseas"
"express laminin receptor lbp human rat hepatoma cell dramat cellular occur hepatocarcinogenesi major alter extracellular matrix format relationship cell microenviron studi express laminin major noncollagen glycoprotein basement membran laminin receptor kd lamininbind protein rat faza htc human hepg hbgc hepatoma cell line express varieti liverspecif function laminin found rough endoplasm reticulum cell indirect immunoperoxidas method electron microscop examin radiolabel laminin immunoprecipit media cell extract resolv electrophoresi sodium dodecyl sulfat gel major polypeptid comigr subunit engelbrethholmswarm tumor laminin immunoblot analysi show mr polypeptid correspond subunit laminin northern blot analys demonstr larg amount mrnas chain mrna conclud tumor cell produc laminin chain contrast normal adult hepatocyt man rat lack laminin mrnas day primari cultur chain mrnas detect steadyst level kd lamininbind protein mrna fold threefold higher rat hepatoma cell fresh isol day cultur normal rat hepatocyt human hepatocyt steadyst level kd lamininbind protein mrnas vari depend donor reach level human hepatoma cell"
"cyclosporin enhanc growth carcinogeninduc enzymealt foci rat liver cyclosporin power immunosuppress success organ transplant efficaci liver transplant patient primari hepat tumor remain controversi high rate recurr origin tumor transplant liver studi experiment test cyclosporin exert effect growth carcinogeniniti liver cell shortterm assay rat liver carcinogenesi dietari cyclosporin maintain suffici level blood cyclosporin suppress host immun function enhanc develop glutathion transferas placent formposit hepatocyt foci liver male rat treat singl week dose diethylnitrosamin mgkg wk dietari cyclosporin acceler growth preform glutathion transferas placent formposit foci induc singl dose diethylnitrosamin mgkg promot regimen cholinedefici diet enhanc size hepatocyt foci cyclosporin due stimul growth inhibit regress mechan cyclosporin modifi growth preneoplast lesion liver fulli understood involv immunolog relev cell liver kupffer cell pit cell process suggest"
"hepat virus integr hepat virusrel hepatocellular carcinoma childhood taiwan hepatocellular carcinoma major malign children yr age studi status hepat virus dna hepatocellular carcinoma nontumor liver tissu children posit serum hbsag matern hbsag hepatocellular carcinoma tissu children show integr hepat virus dna host cellular dna sequenc pattern singlesit integr children multiplesit integr pattern child demonstr remain children hepat virus dna demonstr tumor tissu subgenom fragment hepat virus genom probe found gene fragment surfac antigen gene fragment conserv sequenc singlesit integr hepat virus dna childhood hepatocellular carcinoma hit critic region result insert mutagenesi earli develop hepatocellular carcinoma short incub period exposur environment carcinogen earli life childhood hepatocellular carcinoma provid good model studi carcinogen potenti hepat virus"
"liposarcoma aris cheek report case review literatur point made liposarcoma oral caviti rare slow grow mistaken benign lesion direct correl microscop biolog behavior prognosi treatment primarili surgic radiat select case differenti tumor respond favor radiat"
"cohort studi fat intak risk breast cancer newli incid histolog confirm case breast cancer identifi cohort women enrol canadian nation breast screen studi women complet dietari questionnair occurr breast cancer estim intak dietari fat nutrient evid posit associ breast cancer total fat intak relat risk confid interv day evid doserespons relationship"
"hypothesi nonsteroid antiinflammatori drug reduc incid largebowel cancer nonsteroid antiinflammatori drug nsaid inhibit prostaglandin synthesi tumor growth rodent colon assess nsaid relat risk human largebowel cancer hospitalbas casecontrol studi patient colorect cancer control patient regular nsaid continu year interview multivari relat risk estim confid interv estim decreas durat increas trend statist signific similar result obtain cancer cancer control invers associ appar colon cancer rectal cancer men women subject younger older year regular nsaid discontinu year previous regular risk regular nsaid aspirin drug present data suggest sustain nsaid reduc incid human largebowel cancer"
"rise incid adenocarcinoma esophagus gastric cardia analys cancer incid data area unit state reveal steadili rise rate adenocarcinoma esophagus gastric cardia increas men period rang year exceed type cancer contrast stabl trend squamous cell carcinoma esophagus slight declin adenocarcinoma distal portion stomach adenocarcinoma esophagus gastric cardia disproportion affect white men rare occur women mid white men adenocarcinoma account esophag cancer cardia cancer account half stomach cancer subsit rise incid rate similar demograph pattern point investig poor understood cancer"
"influenc chromosom integr glucocorticoidregul transcript growthstimul papillomavirus gene cervic carcinoma cell cervic carcinoma cell gene specif human papillomavirus transcrib viral sequenc integr host cell chromosom glucocorticoid activ promot element human papillomavirus transientexpress assay analyz effect dexamethason transcript rate human papillomavirus gene integr chromosom site cervic cancer cell line dexamethason led increas transcript rate integr ee sequenc cell led decreas sw cell affect transcript rate hela cell viral promot element deriv hela sw cell dexamethason activ transcript integr ee sequenc test transientexpress assay cell line dexamethason consist activ viral promot domin regulatori mechan depend chromosom integr site overrid respons viral promot steroid hormon growth rate dexamethasonetr cell line correl consist express papillomavirus gene support role mainten prolif phenotyp cervic carcinoma cell human papillomavirus integr host cell genom variabl random select chromosom loci regulatori mechan influenc viral gene express cell growth differ cancer independ clonal origin"
"human catecholmethyltransferas clone express membran form cdna clone human catecholmethyltransferas hcomt adenosylmethioninecatechol methyltransferas ec isol human hepatoma cell line hep cdna librari hybrid screen porcin cdna probe cdna clone sequenc found insert nucleotid deduc primari structur hcomt compos amino acid residu predict molecular mass kda terminus hydrophob segment amino acid residu respons insert hcomt endoplasm reticulum membran primari structur hcomt exhibit high homolog porcin partial cdna sequenc deduc amino acid sequenc tryptic peptid sequenc found porcin liver catecholmethyltransferas comt code region hcomt cdna control cytomegalovirus promot transfect human kidney cell endogen comt activ approxim unit mg protein untransfect cell increas unit mg protein transfect plasmid comt cdna comt activ recombin protein inhibit competit ic nm select comt inhibitor ro anticomt monoclon antibodi recogn immunoblot major polypeptid appar molecular mass kda reason agreement predict molecular mass recombin hcomt shown immunoblot analysi membran fraction rna blot analysi reveal comt mrna transcript kilobas hep poli rna"
"stimul camp phosphomonoest product melanotropin melanoma cell nmr studi major part present understand molecular basi signal transduct gain vitro studi classic biochem method studi nmr spectroscopi investig respons live mr mous melanoma cell stimul melanocytestimul hormon msh melanotropin presenc isobutylmethylxanthin synergist dose forskolin microm msh induc transient approxim min rise cellular concentr cyclic adenosin monophosph camp coincid time equival decreas approxim atp detect chang phosphocreatin concentr observ concomit msh induc strike unexpect increas concentr phosphomonoest pme metabolit approxim fold increas total pme signal area signal assign phosphoethanolamin level pmes remain high hr declin slowli approxim hr basal level perfus fresh cultur medium increas pme observ stimul msh contrast stimul high dose forskolin microm isobutylmethylxanthin mm effect stimul product camp induc pme respons evalu cell energet enhanc product phosphoethanolamin due ethanolamin phosphoryl result hydrolysi phosphatidylethanolamin specif phospholipas respons pmes regul campindepend process suggest exist altern transduct pathway control msh"
"mononuclear phagocyt major popul effector cell respons reject allograft tumor cell mice understand situ mechan immunolog respons recipi anim allograft tumor cell type cell infiltr reject site examin meth cell allogen cbl strain mous tumor cell ceas grow day accompani infiltr leukocyt tumor cell total elimin periton caviti day highest cytotox activ meth cell obtain periton exud cell harvest day day exud cell consist popul examin flow cytometri isol sort homogen morpholog identifi lymphocyt granulocyt mediums mononuclear granular cell cytotox activ confin exclus popul effector cell cytotox meth cell concanavalin stimul allogen spleen cell ch cba balb dba strain mous effector cell total inert concanavalin activ syngen spleen cell cbl cbl strain mous effector cell phenotyp thi cd lyt lyt lt immunoglobulin asialo gm morpholog function distinct cytotox cell natur killer cell lymphokineactiv killer cell adher mononuclear phagocyt"
"intracrani chordoma preadolesc case report chordoma rare tumor deriv notochord remnant occur primarili sacrum clivus cervic region tumor occur children sacrum case clivus chordoma preteenag report clival chordoma unusu radiolog featur year boy literatur entiti review"
"immunochem studi differenti bind properti monoclon antibodi react tn red cell monoclon antibodi moab bric igm bric igg produc immun mice ovarian cyst blood group glycoprotein tn red cell rbcs specif determin inhibit tn sialoglycoprotein sgps mucin armadillo asg ovin osg submaxillari glycoprotein monosaccharid bric agglutin tn group rbcs react immunohistochem vascular endothelium tumor cell group adenocarcinoma bric inhibit acetylgalactosamin galnac tn sgps mucin hemagglutin inhibit test radioimmunoassay bric agglutin tn rbcs specif stain tumor cell group patient breast carcinoma group patient adenocarcinoma hemagglutin inhibit test bric readili inhibit tn sgps partial inhibit galnac inhibit mucin sensit radioimmunoassay bric inhibit galnac tn sgp fold effect inhibitor mucin asg desial osg high content termin alphagalnacserin threonin residu postul bric specif termin alphagalnac unit carbohydr chain exclus reaction bric tn sgp combin site larger galnac alpha includ amino acid residu juxtaposit galnac tn sgp view specif agglutin tn rbcs bric reagent examin polyagglutin rbcs"
"medullari thyroid cancer immunohistochem humor studi separ antigen author investig humor tissu express antigen medullari thyroid cancer mtc calcitonin ct calcitonin generel peptid cgrp carcinoembryon antigen cea neuronspecif enolas nse somatostatin srif thyroglobulin tg antigen studi neoplast cell immunohistochemistri specif antisera plasma specif radioimmunoassay eighteen patient male femal patient age year studi follow month rang month patient die diseas follow month rang month immunostain primari tumor express ct cea case nse posit cgrp srif tg metastat tissu posit case ct stain cea nse cgrp srif tg stain posit case percentag posit cell degre stain variabl antigen express antigen neoplast cell hypersecret antigen circul case ct cea level antigen elev patient metastas accur predict metastas effect treatment previous metastas surgeri case nse cgrp srif patient increas plasma concentr antigen occur advanc phase diseas detect level serum tg observ outcom diseas compar express ct cea nse cgrp tg correl found contrari srif express primari tumor differenti group patient surviv rate srifposit patient surviv rate year srifneg patient surviv rate year year"
"small cell carcinoma larg intestin author studi clinic patholog featur small cell carcinoma larg intestin locat colon adenoma present squamous differenti tumor endocrin differenti present tumor method neuronspecif enolas densecor granul synaptophysin present case seventi percent tumor metastas liver patient dead month follow twenti poor differenti adenocarcinoma undifferenti carcinoma larg intestin access period show endocrin squamous differenti fewer liver metastas small cell carcinoma tumor studi small cell histolog characterist correl liver involv endocrin marker histolog featur small cell carcinoma larg intestin aggress tumor propens earli liver involv spectrum squamous endocrin glandular featur larg bowel tumor low degre differenti identif small cell compon clinic relev"
"autom immunohistochem estrogen receptor fix embed breast carcinoma author immunohistochem assess presenc estrogen receptor er formalinfix paraffinembed tissu section breast carcinoma autom method pronas calbiochem la jolla ca predigest alkalin phosphatas detect method result compar obtain autom peroxidaseantiperoxidas method dnase pretreat fix embed section method er immunostain frozen section method biochem result dextranco charcoal cytosol dcc assay compar dcc assay method gave sensit sensit method increas case dcc result show greater fmolmg protein find er immunohistochem studi formalinfix paraffinembed tissu assay method provid clinic inform result posit negat result surround normal element posit receptor receptor level fmolmg protein improp tissu preserv absenc fresh tissu er assay dcc assay frozen section immunostain understand limit method"
"ovarian myxoma studi case longterm follow case call ovarian myxoma report year girl year follow evid recurr case year woman recur intraperiton year surgeri tumor myxoid round stellat cell immunohistochem electron microscop em dna flow cytometr fcm studi perform formalinfix paraffinembed tissu patient primari tumor recurr tumor cell express vimentin focal posit desmin myoglobin em find suggest fibroblast differenti aneuploid cell popul present recurr tumor dnafcm studi case call ovarian myxoma report date follow exceed month author conclud presenc aneuploidi late recurr case suggest ovarian myxoma behav lowgrad sarcoma histogenesi tumor remain unsettl similar found myxoma locat"
"local reaction radioiodin treatment thyroid cancer purpos compar rate local complic result radioiodin ablat thyroid cancer patient residu intact thyroid lobe patient extens surgic treatment prior radioiodin administr patient method retrospect studi patient receiv patient divid group depend extent previous surgic thyroid excis group compris patient lobectomi hemithyroidectomi ablat radioiodin dose group compris patient extens thyroid excis total subtot thyroidectomi radioiodin treatment result sixti percent patient group experienc degre neck pain tender radioiodin ablat residu thyroid case local reaction sever accompani develop transient hyperthyroid local complic rate patient undergon extens thyroid excis ablat therapi sever reaction conclus patient unilater surgic excis radioiodin therapi higher rate local complic patient treat extens surgeri prior radioiodin ablat radioiodin employ patient inform complic evid support dose effect pathogenesi complic recommend dose mci initi ablat patient repeat dose complet thyroid ablat"
"sudden symptomat brain tumor altitud highaltitud cerebr edema present wide varieti neurolog manifest symptom resolv descent persist neurolog symptom descent suggest intracrani lesion brain tumor sudden symptomat altitud report previous report case previous unsuspect brain tumor sudden symptomat high altitud"
"surgic stage cervic cancer noninvas radiolog method detect paraaort lymph node metastas reliabl combin fna enlarg lymph node sensit low undetect microscop metastas lead treatment failur patient paraaort lymph node metastasi treat extendedfield radiat die year ct scan diagnost method evalu cervic cancer assess primari tumor urinari tract gastrointestin tract liver parenchyma retroperitoneum permit guidanc fna arrang radiat port surgic stage direct assess periton caviti retroperiton space metastat tumor includ enlarg lymph node resect dubious benefit oper morbid accept fewer intestin complic extraperiton approach longterm morbid minim paraaort radiat dose employ cgi surgic stage provid data frequenc paraaort lymph node metastasi stage cervic cancer treatment strategi develop extendedfield radiat result year surviv rate patient microscop paraaort lymph node metastasi patient surviv treatment surgic stage produc modest boost surviv rate high rate pelvic system failur extendedfield radiat prophylact patient probabl lymph node metastasi radiograph studi surviv rate similar patient irradi surgic stage find paraaort lymph node diseas abil predict detect nonsurg posit paraaort node diseas improv extend radiat adjuv therapi frequent oper patient high risk metastat diseas studi haie al prophylact paraaort radiat patient high risk paraaort metastasi patient high probabl local diseas control paraaort radiat signific reduc incid paraaort distant metastas patient paraaort lymph node metastas frequent occult system metastas patient pelvic failur common effect system therapi emerg mark improv surviv patient paraaort lymph node metastasisabstract truncat word"
"manag malign bone tumor children adolesc seri pediatr patient affect osteosarcoma ewe sarcoma fibrosarcoma malign fibrous histiocytoma bone treat nineti percent patient receiv chemotherapi surgic resect sixti percent patient aliv month consid diseas free function result surgeri evalu musculoskelet tumor societi score diaphys resect resect upper extrem pelvi result excel good case resect proxim femur distal femur proxim tibia reconstruct nonexpans prosthes result excel good hand arthrodes lower extrem case good result correl result lack articul limb shorten progress skelet growth"
"dexamethasonenonsuppress cortisol case aldosteroneproduc adenoma forti patient aldosteroneproduc adenoma apa subject dexamethason suppress test dst surgeri serum cortisol urinari excret hydroxycorticosteroid suppress dexamethason patient dst patient case suppress dst clinic manifest dst patient similar dst patient hypertens hypokalemia high serum aldosteron level suppress pra found patient cut surfac adenoma patient includ case golden yellow typic apa atrophi adjac normal tissu evid exclus dst patient remov affect adren serum cortisol level suppress dexamethason dst patient case find suggest autonom cortisol product apa evalu cortisol produc adenoma tissu presenc steroidogen enzym studi immunohistochemistri mrna analysi adenoma adjac nonneoplast adren dst dst patient immunohistochem analysi demonstr steroidogen enzym express apa tumor tissu dst dst patient group mrnas code steroidogen enzym present nonneoplast tumor tissu quantit analysi mrna level reveal adren dst patient mrnas abund nonneoplast tissu tumor tissu dst case mrnas abund tumor tissu nonneoplast tissu result tumor cell dst patient autonom synthes aldosteron cortisol diamet tumor dst patient exceed cm dst patient smaller patient larg apa adren insuffici anticip remov tumor"
"endotheli marker malign vascular tumour liver superior qbend von willebrand factor ulex europaeus agglutinin monoclon antibodi qbend rais cd antigen human endotheli cell membran haemopoiet progenitor cell studi marker neoplast vascular cell angiosarcoma malign haemangioendothelioma liver qbend sensit specif von willebrand factor vwf ulex europaeus agglutinin uea label endotheli cell cross react epithelia uea stain uniform strong clear histolog variant tumour qbend prove differenti diagnosi malign vascular tumour liver"
"generat soft ray free electron laser propos diagnos treat breast cancer diagnosi treatment breast lesion mark enhanc uniqu sourc monochromat ray concentr beam monochromat ray photon generat collis free electron laser fel electron beam optic beam interact zone deliv ray shirtsleev environ absenc compton scatter photoelectr interact tissu improv conspicu lesion time increas attenu ray malign normal tissu make tumor obvious edg subtract chemic analysi tumor vivo radiat dose tenth fiftieth deliv lowestdos mammograph ray techniqu increas sensit specif permit predict histolog negat necess biopsi select bondbreak depth tissu rayactiv photodynam therapi explor"
"effect surgic adjuv therapi highrisk rectal carcinoma background radiat therapi adjunct surgeri rectal cancer shown reduc local recurr improv surviv previous studi combin radiat chemotherapi improv surviv signific compar surgeri compar adjuv radiat regard standard therapi design combin regimen optim contribut chemotherapi decreas recurr improv surviv compar adjuv radiat method hundr patient rectal carcinoma deepli invas metastat region lymph node random assign postop radiat cgi radiat fluorouracil preced cycl system therapi fluorouracil semustin methylccnu result median follow year combin therapi reduc recurr rectal cancer percent percent confid interv percent initi local recurr reduc percent percent confid interv percent distant metastasi percent percent confid interv percent addit combin therapi reduc rate cancerrel death percent percent confid interv percent death rate percent percent confid interv percent acut toxic effect includ nausea vomit diarrhea leukopenia thrombocytopenia effect seldom sever sever delay treatmentrel reaction smallbowel obstruct requir surgeri occur percent patient receiv radiat frequenc complic compar treatment group conclus combin postop local therapi radiat fluorouracil system therapi fluorouracilbas regimen signific substant improv result therapi rectal carcinoma poor prognosi compar postop radiat"
"clinic import myeloidantigen express acut lymphoblast leukemia childhood background leukem cell percent patient acut lymphoblast leukemia express myeloid antigen lymphoid antigen reflect cell cell lineag relat myeloidantigen express featur prognosi controversi method analyz clinic laboratori featur present diagnosi consecut case children immunophenotyp includ singl dualfluoresc analys classifi leukem cell lymphoblast identifi myeloidantigen express simultan express lymphoid antigen myeloid antigen cd cd cd cell classifi frenchamericanbritish system result forti patient lineag myeloidantigen express patient lineag patient lineag determin myeloidantigen express morpholog correl prognost featur recogn previous multivari analysi show myeloidantigen express import predictor relaps childhood signific prognost factor statist whitecel count greater equal liter diagnosi import high signific prognost featur month estim diseasefre surviv patient percent myeloidantigen express low whitecel count percent myeloidantigen express high whitecel count percent myeloidantigen express low whitecel count percent myeloidantigen express high whitecel count conclus myeloidantigen express import independ predictor poor respons chemotherapi childhood"
"interstiti irradi hyperthermia treatment recurr malign brain tumor june june recurr malign glioma recurr solitari brain metastas patient treat phase studi interstiti irradi hyperthermia patient age rang year karnofski perform status score rang glioblastoma anaplast astrocytoma melanoma adenocarcinoma cathet implant stereotact comput tomographybas preplan hyperthermia administ brachytherapi mhz helic coil microwav antenna multisensor fiberopt thermometri probe goal heat tumor degre minut minut hyperthermia treatment implant cathet afterload highact iodin seed deliv tumor dose gy patient sensat heat complic includ seizur patient revers neurolog patient scalp burn infect evalu month follow scan show definit improv radiolog tumor slight improv stabl show tumor progress ten patient underw reoper persist tumor necrosi eleven patient aliv week treatment thirteen patient die brain tumor die extracrani melanoma metastas die brain melanoma metastas die pulmonari embolus median surviv week median surviv reach anaplast astrocytoma subgroup conclud interstiti brain hyperthermia helic coil microwav antenna technic feasibl level toxic accept comput tomograph respons rate encourag"
"express plateletderiv growth factor transform growth factor ros gene varieti primari human brain tumor ribonucl acid isol wide spectrum central nervous system tumor examin express plateletderiv growth factor pdgf tumor growth factor tgfbeta ros messeng ribonucl acid glioblastoma cell line examin cell cultur tumor explant explant includ glioblastoma anaplast astrocytoma astrocytoma ependym tumor meningioma medulloblastoma ganglioglioma comparison nontumor glial cell cultur includ pdgf chain express glioblastoma cell line glioblastoma anaplast astrocytoma explant pdgf express astrocytoma ependymoma vari malign remaind tumor nontumor glial cell pdgf chain express tumor malign ependymoma nontumor glial cell cultur tgfbeta express tumor nontumor glial cell express tgfbeta express benign malign tumor nontumor glial cell cultur ros messeng ribonucl acid express glioblastoma cell line glioblastoma cell explant tumor nontumor glial cell"
"spinal glioblastoma report case review literatur intramedullari glioblastoma uncommon tumor occur chiefli cervicothorac segment slight tendenc occur earli decad life short clinic histori diagnosi report case discuss salient featur tumor patholog featur treatment light relev literatur"
"oral cancer survey case univers connecticut oral patholog biopsi servic survey univers connecticut oral patholog biopsi servic undertaken analyz case oral cancer access year period inclus total specimen access malign oral neoplasm diagnos report sixti origin state invas intraor squamous cell carcinoma predomin tumor total lip cancer constitut malign minor salivari gland adenocarcinoma account total malign verruc carcinoma carcinoma situ miscellan form oral cancer account remaind case invas squamous cell carcinoma analyz year sex distribut locat subsit age diagnosi histolog grade histolog grade found character case squamous cell carcinoma biopsi servic tend parallel result separ relat statewid analysi oral cancer intraor squamous cell carcinoma connecticut longer time span conclud pictur oral cancer character case univers connecticut oral patholog biopsi servic general reflect diseas statewid level"
"ectat blood vessel portwin stain lack innerv role pathogenesi innerv pattern portwin stain investig indirect immunohistochemistri antibodi protein gene product pgp neuronspecif enolas nse calcitonin generel peptid cgrp neurofila nf patholog dilat vessel middl deep dermi found defect innerv singl nerv fiber vicin structur skin show normal densiti fiber nse pgp immunoreact li nerv fiber observ innerv vessel normal morpholog structur skin sweat gland hair follicl free nerv end nerv bundl nerv bundl pass ectat vessel give branch cgrpli nerv fiber detect run epidermi fiber found ectat vessel nfli fiber innerv normal vessel dermi relat dilat vessel occasion fiber observ lack innerv import develop diseas result decreas tonus vessel loss neuron trophic factor"
"communiti studi delay present sign melanoma medic practition absenc effect treatment advanc tumor earli diagnosi treatment local tumor effect reduc burden ill melanoma studi examin factor preval sign melanoma mole chang size shape color itch tingl bleed weep rais individu random select sampl household length delay seek medic advic factor medic practition delay action medic practition present sign result larg proport sampl observ sign melanoma previous month sampl report sign previous year sought medic advic sign recommend period sampl seek advic delay report thought sign clear sampl underr import earli detect treatment lesion result deficit knowledg general public sign melanoma sever diseas risk delay"
"potenti role postop hepat arteri chemotherapi patient highrisk hepatoma relationship oper find hepatoma postop prognosi studi clarifi indic adjuv hepat arteri chemotherapi hepatectomi result adjuv hepat arteri chemotherapi mgkg doxorubicin mgkg mitomycin infus fluorouracil report hundr sixti patient undergon hepatectomi hepatoma studi oper find hepatoma surgic margin mm intrahepat metastasi tumor embolus proxim branch portal vein lack capsul format relat prognosi risk factor recurr patient risk factor surviv rate patient adjuv arteri chemotherapi signific higher patient adjuv hepat arteri chemotherapi effect therapi studi prospect patient undergo hepatectomi highrisk hepatoma"
"surgic manag carcinoma extrahepat bile duct gallbladd periampullari tumor exclud result french surgic associ survey hundr fifti case primari carcinoma extrahepat bile duct gallbladd periampullari tumor exclud collect surgic center review retrospect hundr patient upper lesion proxim carcinoma middl lower bile duct carcinoma remain patient diffus lesion resect rate upper local compar middl lower local oper mortal rate proxim carcinoma signific lower resect compar palliat surgeri year surviv oper death exclud tumor resect compar palliat surgeri longterm result surgic resect correl local region extens diseas result studi show resect extrahepat bile duct carcinoma upper local worthwhil longterm surviv"
"bronchoalveolar carcinoma factor affect surviv hundr thirti consecut patient men women underw pulmonari resect bronchoalveolar carcinoma age year lobectomi patient pneumonectomi segmentectomi wedg excis patient lymph node metastas neoplasm solitari patient stage stage ii stage iiia stage iiib oper death thirti complic occur patient median follow year recurr bronchoalveolar carcinoma develop patient year surviv patient stage surviv patient neoplasm ident expect surviv year compar patient diseas patient multipl bilater diseas patient bilater diseas signific factor advers affect surviv includ presenc sign symptom diffus malign invas mucinproduc tumor histolog absenc scar conclud bronchoalveolar carcinoma uniqu natur histori influenc local neoplast process lymph node metastas earli aggress pulmonari resect safe offer potenti cure presenc bilater cancer omin"
"primari cyst tumor mediastinum retrospect analysi perform patient primari cyst tumor mediastinum institut januari april divid patient group group group januari april signific increas preval malign group versus due increas number lymphoma versus malign neurogen tumor versus signific increas number malign tumor anterior versus paravertebr versus compart group patient tumor symptomat group versus increas ancillari diagnost studi perform evalu tumor versus logist regress analysi identifi date present symptom size anterior mediastin compart preoper predictor malign surgic approach tumor includ median sternotomi versus anterior mediastinotomi cervic mediastinoscopi group versus longterm result support surgic resect benign lesion aggress multimod approach malign lesion"
"surgic manag carcinoid heart diseas metastat carcinoid tumor flush diarrhea cardiac symptom carcinoid syndrom cardiac failur major morbid mortal carcinoid diseas report case success cardiac valvar surgic intervent result prolong allevi cardiac symptom surviv"
"inflammatori breast cancer histor prognosi inflammatori breast cancer poor conduct retrospect review evalu recent memori sloankett cancer center experi evalu role combin chemotherapi compar effect surgeri radiat localregion failur fifti patient localregion inflammatori breast cancer diagnos identifi treat combin chemotherapi year surviv year diseasefre surviv rate twenti patient treat induct chemotherapi mastectomi adjuv chemotherapi surviv diseasefre surviv rate similar achiev patient treat mastectomi chemotherapi residu cancer found patient treat induct chemotherapi extens diseas present includ complet respond localregion failur rate"
"prognost signific carcinoembryon antigen colorect carcinoma serum level resect recurr carcinoembryon antigen evalu patient follow month preoper postop carcinoembryon antigen level predict recurr surviv independ tumor stage multivari regress analysi age locat tumor stage preoper postop carcinoembryon antigen level factor signific prognost variabl respect adjust surviv recurr diseas found patient exclud patient stage iv diseas carcinoembryon antigen level recurr greater ngml patient intraabdomin recurr carcinoembryon antigen level recurr predict postrecurr surviv subgroup locoregion diseas life span patient liver lung metastas influenc carcinoembryon antigen level recurr preoper postop carcinoembryon antigen level poorer prognost group patient colorect cancer benefit adjuv treatment carcinoembryon antigen recurr effect diagnos intraabdomin recurr project surviv develop localregion diseas"
"prognost factor primari retroperiton softtissu sarcoma analyz independ treatment variabl age sex sign symptom site size histopatholog find grade clinic present treatmentdepend variabl resect type oper surgic margin surgic boundari microscop margin adjuv radiotherapi adjuv chemotherapi patient primari retroperiton softtissu sarcoma admit univari multivari analysi surviv diseasefre surviv perform major factor surviv outcom abil complet resect lesion patient underw complet resect examin independ prognost factor surviv diseasefre surviv grade conclud complet resect grade lesion primari determin surviv tumor macroscop remov advantag demonstr extens surgic resect current adjuv therapi"
"radioimmunoguid surgeri iodin patient colorect cancer preliminari data murin monoclon antibodi label iodin suggest clinic appar occult site colorect cancer identifi intraop handheld gamma detect probe report preliminari data multicent trial approach patient primari recurr colorect cancer hundr patient primari suspect recurr colorect cancer receiv intraven infus mg monoclon antibodi radiolabel bq iodin twenti patient primari colorect cancer patient recurr colorect cancer examin gamma detect probe patient local antibodi tumor includ primari tumor site recurr tumor site tumor site identifi repres occult site detect gamma detect probe sensit predict posit detect total occult site patient identifi patient recurr cancer antibodi studi provid uniqu data preclud resect patient patient extend potenti curat procedur"
"radic resect carcinoma ampulla vater hundr consecut patient underw radic resect ampullari cancer retrospect review frequent clinic find includ jaundic signific greater weight loss anemia eighti patient underw subtot pancreatectomi patient underw total pancreatectomi postop mortal patient reoper postop complic requir patient year surviv rate patient die tumor recurr year resect patient surviv signific impair microscop lymphat invas region nodal metastasi tumor grade epithelium origin multivari analysi microscop lymphat invas signific reduc patient surviv radic resect ampullari cancer perform low morbid mortal remain procedur choic ampullari carcinoma"
"year result cisplatin fluorouracil infus head neck cancer part development process head neck intergroup trial adjuv chemotherapi advanc resect head neck carcinoma radiat therapi oncolog group philadelphia pa conduct nonrandom pilot studi chemotherapi consist cours cisplatin fluorouracil infus chemotherapi administ prior surgeri patient induct surgeri addit patient sequenti popul rough compar respect tumor site stage twelv patient induct group sequenti group aliv evid diseas report follow median surviv month sequenti group month induct group patient complet clinic respons induct chemotherapi aliv twenti patient receiv induct chemotherapi undergo surgeri initi plan lack surgeri year surviv group signific induct group sequenti group"
"effect destruct cervic intraepitheli neoplasia cin degre semm cold coagul year experi total women cin treat semm cold coagul primarili cytolog standard suitabl criteria ablat adher patient treat visit colposcopist expect diagnosi wors cin women treat visit women histolog glandular wors expect show persist cervic diseas subsequ follow achiev year actuari term primari success rate year year similar age group repeat coldcoagul persistentrecurr cin success advis outcom pregnanc establish treatment rate miscarriag preterm oper deliveri increas coldcoagul cin degre perform effect treatment call question expens practic"
"vagin epitheli abnorm patient cin clinic patholog featur manag women cin treat laser region gynaecolog oncolog centr queen elizabeth hospit gateshead exist vagin epitheli abnorm cin histolog diagnosi vagin lesion upper vagina involv lesion cervix confluent vagina lesion confluent biopsi form cervic vagin compon show grade intraepitheli neoplasia biopsi show lesion laser treatment effect vagin lesion recommend select patient care follow suffic"
"carcinoma breast measur manag treatment data seri paper explor insight biolog accompani treatment human tumour obtain estim volum relat treatment adopt work hypothesi regress slope reflect composit individu tumour indirect intrins growth rate effect treatment breast prove suitabl site measur interpret result led develop style manag carcinoma breast measur base sequenti therapi mbst paper method measur detail statist evalu qualiti data patient tumour present exponenti regress line fit describ volum relat treatment radiat chemotherapi hormon simpl classif steep slope introduc"
"detect colorect liver metastas intraop ultrasonographi intraop ultrasonographi liver carri patient undergo surgeri colorect cancer palpat liver preoper abdomin ultrasonographi comput tomographi scan perform patient metastas identifi patient cent intraop ultrasonographi diagnos metastas palpat abdomin ultrasonographi ct scan identifi metastas patient includ patient metastas detect techniqu identif local impalp liver metastas intraop ultrasonographi"
"primari papillari carcinoma thyrogloss duct cyst report case literatur review thyrogloss duct cyst common anomali thyroid develop frequent branchial cleft abnorm children enlarg cervic lymph node neck mass general duct cyst benign cent case malign world literatur case malign thyrogloss cyst review addit case discuss instanc duct cyst type neoplasia includ thyroid papillari carcinoma cent mix papillaryfollicular carcinoma cent squamous cell carcinoma cent follicular adenocarcinoma cent malign struma epidermoid carcinoma anaplast carcinoma cent case survey thyroid gland examin microscop cent malign foci primari malign thyrogloss duct cyst metastas discuss"
"radioimmunoguid surgeri laparotomi colorect cancer radioimmunoguid surgeri rig anticea ab monoclon antibodi assess patient primari excis procedur undergo surgeri colorect carcinoma antibodi local percent primari tumour percent princip tumor procedur addit inform extent primari tumor obtain patient percent undergo excis primari carcinoma patient percent seri incorrect inform obtain extent primari tumour patient percent incorrect inform obtain procedur rig correct predict subsequ duke stage percent case sensit percent specif percent accur identif individu node imposs techniqu influenc surgic procedur perform case percent primari surgeri patient undergo laparotomi percent rig primari colorect carcinoma provid addit inform extent local advanc tumor principl subsequ surgeri influenc establish techniqu greater role procedur determin extent recurr tumour larger follow seri requir defin addit inform provid techniqu exploit"
"nuclear shape prognost discrimin colorect carcinoma search reliabl prognost discrimin retrospect analysi case colorect carcinoma undergon curat resect year assess nuclear morphometri case stage duke classif grade histolog patient seri perimet area nuclear shape factor interphas nuclei determin carcinoma inform obtain imag analysi system trace nuclear profil magnif digit video screen nuclear shape factor defin degre circular nucleus perfect circl record nuclear shape factor greater poor outcom multipl regress model show singl nuclear paramet shape factor high signific predictor surviv variabl remain high signific correct sex age histolog grade duke classif find nuclear shape factor greater equal determin nuclear morphometri independ morphometr nuclear variabl great import prognosi larg bowel carcinoma"
"primari de novo adenocarcinoma colon measur mm diamet lymph node metastas report case colon adenocarcinoma measur mm rare report carcinoma measur mm diamet subseros extens locus minori resistentia metastas lymph node associ previous report residu adenomat tissu found suggest de novo carcinoma"
"develop character high specif antibodi human chorion gonadotropinbeta fragment addit high concentr hcg pregnanc urin higher concentr fragment hcg betasubunit biolog inact materi complic immunolog measur hcg crossreact polyclon monoclon antibodi hcg betasubunit employ assay hcg urin develop antibodi fragment specif measur fragment presenc free hcg beta remain difficult due intrins crossreact antibodi intact hcg beta attempt increas specif assay optim develop high specif monoclon antibodi design crossreact free hcg betasubunit liquid solid phase immunoassay format monoclon antibodi immunoradiometr assay measur specif hcg beta fragment urin pregnanc sera individu cancer produc hcg betasubunit discov hcg beta fragment bind monoclon antibodi simultan indic epitop antibodi determin expos hcg beta fragment intact hcg free hcg betasubunit hcg beta fragment retain hcg betarel epitop intact bind monoclon antibodi"
"calcium transport plasma membran glucoserespons rat insulinoma insid plasma membran vesicl glucoserespons rat insulinoma show atp mgdepend uptak ca km concentr give halfmaxim activ ca nm presenc microm free ca km atp microm km mg microm glucos mm decreas ca uptak insulin secretagogu effect glyceraldehyd stimul ca uptak calmodulin increas uptak ca trifluoperazin vanad inhibit uptak ca mgdepend atpas tumor fold higher requir ca suggest enzym respons ca transport ca transport activ repres small fraction total caatpas activ physiolog import ca transport insulin secret evid inhibit ca uptak glucos lead decreas ca efflux cell inhibit lead increas intracellular free ca insulin releas"
"transcript regul ferritin messeng ribonucl acid level insulin cultur rat glioma cell recent data shown ferritin ubiquit protein role regul cellular differenti present studi investig express ferritin mrnas cultur cell rat glioma cell line respons insulin import role cellular growth differenti insulin stimul steadi state level ferritin heavi chain ferritin light chain mrnas increas level ferritin heavi light chain mrna detect incub insulin plateau reach heavi chain mrna light chain mrna respons dosedepend maxim nm mrnas treatment cell actinomycin show insulin effect posttranscript stabil mrnas actinomycin inhibit insulininduc accumul mrnas suggest transcript stimul ferritin gene insulin nuclear run assay show insulininduc increas ferritin heavi chain mrna due increas rate gene transcript demonstr insulin growth factor igf increas ferritin heavi light chain mrna level dosedepend fashion maximum effect obtain concentr nm mrna level igf fold potent absolut level maximum stimul fold greater insulin combin insulin nm igf nm show addit effect result suggest ferritin heavi light chain gene transcript regul insulin influenc igf"
"regul insulin epiderm growth factor transform growth factoralpha level growth factordegrad enzym mechan growth factor degrad role process play regul cell growth understood insulin degrad believ mediat specif metalloproteas insulindegrad enzym ide previous shown ide degrad transform growth factoralpha tgf alpha epiderm growth factor egf vitro select surpris tgf alpha egf structur similar bind receptor compar affin spectrum proteas inhibitor analyz degrad tgf alpha egf insulin human hepatoma hepg cell result suggest bacitracinsensit metalloproteas involv degrad tgf alpha egf insulin degrad tgf alpha egf mediat part ide inhibit activ metalloproteas decreas growth factor deplet suggest enzym play import role control extracellular growth factor level exist separ degrad pathway egf tgf alpha explain factor exert differenti effect system degrad tgf alpha ide provid mechan interact insulin tgf alphaegf signal system"
"effect hepat virus alcohol drink cigarett smoke famili tendenc hepatocellular carcinoma independ interact effect relat develop hepatocellular carcinoma assess communitybas casecontrol studi hepat virus habitu alcohol drink cigarett smoke peanut consumpt histori hepatocellular carcinoma famili male newli diagnos hepatocellular carcinoma patient recruit consecut period studi case group teach medic center northern southern taiwan healthi communiti resid match case age sex ethnic group residenti area select control group carrier status hbsag hbeag determin blind radioimmunoassay risk factor obtain standard interview structur questionnair condit logist regress analysi show signific associ hepatocellular carcinoma carrier status hbsag hbeag odd ratio carrier hbsag carrier hbsag hbeag doserespons relationship cigarett smoke hepatocellular carcinoma odd ratio smoke cigarett day signific associ hepatocellular carcinoma observ habitu alcohol consum odd ratio famili histori hepatocellular carcinoma diseas develop odd ratio frequenc peanut consumpt signific hepatocellular carcinoma"
"puls doppler ultrasound detect angiograph evid recurr hepatocellular carcinoma arteri embol treatment hepatocellular carcinoma treat transcathet arteri embol regain size routin follow puls doppler ultrasound detect type recurr compar ultrasonographi comput tomographi hepatocellular carcinoma hepatocellular carcinoma diagnos angiographi show recurr detect ultrasonographi detect comput tomographi doppler signal obtain peripher portion tumor vessel stain angiogram hepatocellular carcinoma undetect hepatocellular carcinoma recurr signal disappear transcathet arteri embol falseneg hepatocellular carcinoma puls doppler ultrasound show faint tumor stain angiogram negat ultrasonographi comput tomographi puls doppler ultrasound superior ultrasonographi comput tomographi routin procedur detect recurr hepatocellular carcinoma treat transcathet arteri embol"
"acquir cisplatin resist human ovarian cancer cell enhanc repair cisplatindna lesion reduc drug accumul studi undertaken investig acquir resist cisplatin human ovarian cancer cell cell line acp studi assess respect characterist drug accumul efflux cytosol inactiv drug dna repair experi perform drug exposur acp cell line fold resist cisplatin cell studi respect ic dose drug accumul rate similar cell line resist cell line twofold effici efflux drug reduc total drug accumul equival micromolar drug exposur equival level total cellular drug accumul cell line form level cisplatindna damag suggest cytosol inactiv drug contribut differenti resist cell line resist cell twofold effici repair cisplatindna lesion cellular dna transfect plasmid dna conclud pair cell line alter drug uptakeefflux dna repair major contribut factor acquir resist cisplatin"
"biolog basal cell carcinoma part basal cell carcinoma common malign human rare metastat capabl signific local destruct disfigur part articl review current understand basal cell carcinoma biolog part examin signific clinic histolog ultrastructur featur relat invas potenti genet characterist includ tumor growth rate chromosom abnorm oncogen presenc discuss express import cell matrix protein includ keratin fibronectin hla antigen review topic explor part ii includ host immunolog respons theori pathogenesi valuabl line therapeut regimen treatment multipl cancer"
"late metastas cutan melanoma case report literatur review develop delay metastas rare document patient invas cutan melanoma case includ document literatur describ year woman acral lentigin melanoma hand thick mm thirteen year excis postop irradi subcutan metastasi develop arm year patient die dissemin bone metastas case delay metastas typic featur femal sex locat site back arm neck scalp primari tumor thick mm"
"multipl granular cell tumor giant speckl lentigin nevus nevus flammeus child describ year girl multipl cutan granular cell tumor giant speckl lentigin nevus extens nevus flammeus associ granular cell tumor pigment skin lesion report previous support neural origin tumor abnorm neural crest develop propos explain coexist uncommon unusu extens cutan disord patient case repres variant phakomatosi pigmentovasculari"
"abnorm epiderm argon laser treatment year woman congenit portwin stain forehead treat time month interv argon laser month treatment moder blanch mild scale confin treat area observ biopsi specimen treat area reveal signific decreas ectat vessel epiderm similar actin keratosi disorgan cell layer mark cytolog abnorm analysi peripher blood lymphocyt defect dna repair negat multipl argon laserinduc phototherm effect respons observ case lead premalign epiderm transform"
"systemat computeraid search optim stage system colorect cancer hundr nineti patient curat resect colorect cancer classifi categori depth tumour penetr tt lymph node status nn comput categori group stage combin total logic classif generat optim model select group classif equal stage number give greatest prognost inform year surviv akaik criterion result show total classif includ stage classif duke system predict patient outcom level stagedetermin import level major prognosi occur advanc stage classic turn point conclud order find optim stage cancer systemat computeraid search classif databas"
"epidur evok cortic potenti monitor cervicomedullari glioma surgeri report describ patient intramedullari ependymoma region cervicomedullari junction abolit somatosensori evok potenti median nerv stimul intraop monitor cortic potenti elicit epidur cervic cord stimul tumor remov posterior epidur stimul depolar ascend fiber stimul singl peripher nerv recommend case oper vital area epidur evok cortic potenti monitor intraop"
"influenc drug interv effect methotrex fluorouracil treatment advanc colorect cancer import interv methotrex mtx fluorouracil fu studi patient previous untreat measur advanc colorect cancer random receiv mtx mgm fu mgm hour arm hour arm mtx patient receiv leucovorin lv hour mtx mgm oral hour dose regimen repeat week fu escal toler arm signific arm respect respons rate time progress ttp median month month surviv median month month signific differ arm found respons rate median ttp median surviv subgroup patient rectal primari compris patient arm signific factor prognost surviv perform status number metastas treatment age influenc surviv toxic similar arm primarili gastrointestin mucos arm toxic death secondari neutropenia infect arm arm death arm arm possibl drugrel combin mtx lv rescu fu activ regimen advanc colorect cancer efficaci increas colon rectal cancer interv mtx fu long hour short hour"
"clonogen growth vitro independ biolog prognost factor ovarian carcinoma retrospect analysi perform investig prognost growth human tumor clonogen assay system ovarian cancer patient signific differ surviv probabl determin method kaplanmei found univari analysi patient ovarian carcinoma tumor manifest clonogen growth defin growth greater equal coloni plate patient tumor grow clonogen growth vitro wors prognosi logrank test number general accept prognost factor intern feder gynecolog obstetr figo stage residu tumor mass grade prognost import patient popul multivari analysi base cox regress model identifi clonogen growth signific independ prognost paramet ovarian carcinoma addit convent risk factor estim surviv individu patient accomplish combin factor residu tumor mass age clonogen growth sequenc decreas potenti risk"
"line platinum therapi patient ovarian cancer previous treat cisplatin effort critic defin incid clinic characterist secondari respons cisplatinbas therapi patient ovarian cancer previous treat cisplatinbas program retrospect review undertaken patient memori sloankett cancer center receiv greater equal cisplatincarboplatinbas program eighti patient identifi met entri criteria cisplatinfre interv cfi month complet regimen institut cisplatincarboplatin program assess patient measur diseas laparotomi perform assess respons respond includ surgic defin complet respons crs respons rate cr rate base durat cfi month month month twenti patient receiv noncisplatincarboplatin treatment cisplatin program patient treatment month complet initi therapi experienc respons rate cr rate conclus secondari respons cisplatincarboplatinbas treatment common patient ovarian cancer previous respond agent increas frequenc greater distanc initi therapi"
"treatment relaps hodgkin lymphoma dexamethason highdos cytarabin cisplatin marrow transplant combin chemotherapi capabl cure patient newli diagnos intermedi highgrad hodgkin lymphoma nhl treatment relaps nhl remain problemat bone marrow transplant bmt offer chanc diseasefre surviv interim chemotherapi await bmt patient bulki diseas report patient median age year fail primari therapi doxorubicinbas regimen subsequ treat cycl dexamethason mg intraven iv day day cisplatin mgm continu infus day cytarabin iv hour dose day dhap plan bmt histolog includ diffus largecel diffus mix diffus smallcleav lymphoblast twenti patient stage iv diseas symptom elev lactat dehydrogenas ldh patient treat median previous chemotherapi regimen sixti percent patient high tumor burden md anderson criteria object respons dhap patient includ complet respons crs partial respons prs respons median month myelosuppress major toxic treatmentrel death date patient undergon subsequ bmt project year diseasefre surviv conclud dhap regimen effect shortterm salvag therapi relaps nhl patient longterm prognosi multipli relaps patient remain poor"
"primari cancer hodgkin diseas updat result italian multicentr studi risk primari cancer spc evalu patient treat hodgkin diseas hd period januari decemb median follow seri year rang treatment categori includ radiotherapi rt patient chemotherapi cht patient combin rt cht patient salvag treatment resist relaps hd patient fifti spcs observ occur year initi treatment secondari acut nonlymphoid leukemia anll frequent spc case secondari hodgkin lymphoma nhl occur patient secondari solid tumor st observ patient calcul actuari risk se develop spc year treatment modal anll risk case observ radiotherapi group cht rt salvag group show highest actuari risk fact year group statist signific differ observ cht rt group compar cht rt group relationship chemotherapeut regimen anll case occur mechlorethamin vincristin procarbazin prednison mopp rt group case group receiv doxorubicin bleomycin vinblastin dacarbazin abvd rt statist signific differ anll actuari risk found compar patient receiv mopp rt treatment group respect st actuari risk year signific differ found group treat modal data confirm multivari analysi treatment modal age independ variabl anll st develop base prolong follow analysi actuari spc risk year report reflect real spc incid seri"
"pattern intrathorac hodgkin diseas assess comput tomographi comput tomographi ct defin site intrathorac abnorm hodgkin diseas determin pattern progress diseas thorax establish place pattern spread differenti diagnosi thorac abnorm hundr patient newli diagnos hodgkin diseas studi chest ct seventi patient intrathorac abnorm pattern contigu spread anterior mediastinalparatrach area mediastin lymph node group aortopulmonari subcarin posterior mediastin intern mammari hila lung extens discret nodul involv pleura pericardium chest wall occur anterior mediastinalparatrach mass enlarg greater thorac diamet probabl pattern contigu lymph node spread occur chanc small hodgkin diseas spread anterior mediastinalparatrach area contigu manner unusu occur diagnos hodgkin diseas"
"multipl myeloma vmcpvbap altern combin chemotherapi superior melphalan prednison highrisk patient efficaci altern vincristin melphalan cyclophosphamid prednisonevincristin carmustin doxorubicin prednison vmcpvbap polychemotherapi compar prednison mp regimen induct treatment multipl myeloma mm hundr mm patient enter studi march juli analysi perform decemb treatment group show signific differ respect major prognost factor median surviv month vmcpvbap mp arm induct chemotherapi cycl patient achiev compon reduct greater signific differ observ treatment arm term remiss durat month surviv month patient younger year show advantag altern polychemotherapi diagnosi plasma cell label index li serum beta microglobulin beta evalu patient signific reduc surviv observ patient li greater equal month beta greater equal mg month poorrisk subgroup vmcpvbap superior mp"
"phase clinic plasma cellular pharmacolog studi gemcitabin deoxycytidin analog gemcitabin difluorodeoxycytidin dfdc studi phase clinic pharmacolog trial dose rang mgm administ minut week time week week maximumtoler dose mtd mgm doselimit toxic myelosuppress thrombocytopenia anemia quantit import granulocytopenia nonhematolog toxic minim respons patient adenocarcinoma colon lung document maximum dfdc plasma concentr reach minut infus proport total dose administ elimin due deamin rapid termin halflif minut dose independ deamin product difluorodeoxyuridin dfdu elimin biphas kinet character long termin phase hour sole metabolit detect urin concentr dfdc triphosph circul mononuclear cell increas proport dfdc dose infus mgm increment dfdc triphosph dfdctp observ higher dose result plasma dfdc concentr greater mumol mgm suggest satur dfdc phosphat accumul recommend dose phase ii clinic trial solid tumor mgmwk"
"interleukin prospect lymphocytemedi destruct pediatr malign immunolog therapi cancer specul turn centuri anim vitro recent patient irrefut evid obtain lymphocyt respons reproduc benefici antitumor effect result biolog respons modif fourth modal cancer treatment integr standard approach radiat chemotherapi surgeri extent immun approach enabl erad microscop amount residu diseas children recurr malign remain critic issu test decad enthusiasm approach abund critic evalu clinic trial essenti focus mechan effect therapi"
"altern hepat intraarteri floxuridin fluorouracil toxic regimen treatment liver metastas colorect cancer hepat intraarteri hia infus floxuridin fudr implant pump shown promis treatment colorect cancer metastas liver potenti benefit therapi offset high incid treatmentlimit biliari toxic week hia bolus fluorouracil fu effect metastat colorect cancer liver biliari toxic limit system side effect decemb began phase ii trial altern hia fudr fu implant pump attempt extend durat treatment obviat limit biliari fudr system fu drug toxic effect patient receiv continu hia fudr mgkg bodi weight day day hia bolus fu mgkg pump sideport day cycl repeat day sixti patient enrol trial fulli evalu patient previous receiv chemotherapi major respons complet respons partial respons observ patient median surviv pump implant patient month contrast experi singleag hia fudr regimen patient treatment termin drug toxic altern hia fudr fu efficaci similar hia fudr close monitor adjust appropri toxic effect requir treatment termin"
"preferenti local human adher lymphokineactiv killer cell tumor microcircul efficaci adopt immunotherapi solid tumor lymphokineactiv effector cell depend abil cell local adequ tumor tissu present quantit studi vivo movement fluoresc label adher lymphokineactiv killer lak cell cell inject intraarteri lowdos interleukin normal matur granul tissu implant vx carcinoma grown rabbit ear chamber small proport lak cell accumul preferenti tumor microcircul vivo increas frequenc longterm adhes interact tumor vasculatur stasi blood flow tumor vasculatur observ day inject subsequ necrosi tumor observ diffus infiltr lymphocyt monocyt granulocyt interstiti space tumor develop necrosi low ratio effector cell target cell suggest addit direct cytotox respons adopt immunotherapi mediat tumor vasculatur mechan adopt immunotherapi account develop improv strategi cancer treatment"
"cancer popul live nuclear facil survey mortal nationwid incid state report unit kingdom increas leukemia lymphoma young person live nuclear instal concern rais report mortal survey conduct popul live nuclear facil unit state facil began servic cancer death occur counti nuclear instal studi counti match comparison control counti region million cancer death control counti year studi death due leukemia cancer frequent studi counti control counti childhood leukemia mortal relat risk compar studi counti control plant start start leukemia mortal age relat risk start counti state cancer incid data facil standard registr ratio childhood leukemia increas signific start increas anted oper facil studi limit correl approach larg size geograph area counti prove absenc effect excess cancer risk present counti nuclear facil small detect method employ"
"esophag ultrasound preoper stage carcinoma esophagus esophag ultrasound esophag wall view discret layer lymph node easili identifi size shape margin intern structur assess altern method preoper clinic evalu primari tumor region lymph node patient carcinoma esophagus esophag ultrasound attempt clinic stage patient carcinoma esophagus patient assess inabl pass esophag ultrasound probe malign strictur stage system carcinoma esophagus develop intern union cancer american joint committe cancer twenti patient true determin patholog review resect esophagus esophag ultrasound correct identifi patient accuraci patient diseas overstag esophag ultrasound patient earli tumor confin submucosa patient diseas understag esophag ultrasound patient advanc tumor invad esophag wall incorrect esophag ultrasound determin call suggest border musculari propria requir care attent evalu esophag ultrasound twenti patient true determin patholog review resect specimen esophag ultrasound correct identifi patient accuraci patient fals identifi diseas fals identifi diseas sensit specif posit predict negat predict assess esophag ultrasound esophag ultrasound altern method visual esophag wall region lymph node earli experi show promis esophag ultrasound clinic stage carcinoma esophagus"
"lack effect pregnanc outcom melanoma world health organis melanoma programm determin effect pregnanc prognosi melanoma investig women treat stage primari cutan diseas childbear year women treat pregnanc pregnanc complet pregnanc pregnanc women receiv treatment pregnant primari tumour signific greater thick group confound factor site age pariti differ group tumour thick control surviv rate women melanoma diagnos treat pregnant differ group cox regress analysi show differ group women pregnant diagnosi women melanoma advis pregnanc basi thick site tumour evid vascular spread hormon status"
"activ epsteinbarr virus latent gene protect human cell death apoptosi epsteinbarr virus ebv human herpesvirus establish persist asymptomat infect circul lymphocyt pool mechan virus persist understood limit lifespan cell vivo ebvinfect cell gain access longliv memori cell pool show vitro system ebv express full set viruscod latent protein protect human cell program cell death apoptosi delet mechan restrict entri memori found ebvposit burkitt lymphoma bl cell clone retain origin tumour cell phenotyp express virus latent protein nuclear antigen ebna extrem sensit apoptosi respect resembl tumour normal cell origin found germin centr lymphoid tissu contrast isogen bl cell clone activ express ebv latent protein resist induct apoptosi ebv latent protein activ cell prolifer import mediat enhanc cell surviv"
"nurs role limb salvag surgeri limb salvag surgeri proven valuabl option sarcoma patient reconstruct option vast includ metal implant allograft combin nurs implic patient unlimit patient educ assess close complic infect nonunion allograft limit mobil nurs care complic reward work patient great"
"patient delay seek care cancer symptom patient delay seek care cancer symptom common document research studi fear denial lack inform cancer financi contribut delay patient educ import factor decreas length delay improv treatment outcom make good opportun patient educ primari care physician posit influenc prognosi type cancer breast cancer malign melanoma skin"
"characterist erythroleukemia cell select vincristin resist acceler inducermedi differenti induct murin erythroleukemia cell melc dssc termin differenti hexamethylenebisacetamid hmba character latent period hr onset commit terminalcel divis increas transcript globin gene melc variant deriv parent cell line select resist vincristin vc induc differenti latent period studi show acceler hmbainduc commit characterist melc low level fold vc resist independ deriv cell line resist vc acceler differenti stabl phenotyp passag approxim month absenc vc lowlevel vcresist melc display increas level glycoprotein mdr mdr mdr mrnas exhibit crossresist colchicin doxorubicin cell show increas level protein kinas activ ii reduc accumul hvc iii restor vc sensit presenc verapamil melc select higher level vc resist approxim fold express high level glycoprotein mdr gene hmbainduc differenti dssc decreas hvc accumul glycoprotein content chang vctransport protein critic process induc differenti constitut present vcresist melc account enhanc sensit induc protein accumul exposur vcsensit cell hmba contribut differenti decreas level vc accumul"
"effect sitedirect mutagenesi residu cystein cystein lecithincholesterol acyltransferas activ nativ lecithincholesterol acyltransferas lcat phosphatidylcholinesterol acyltransferas phosphatidylcholinesterol acyltransferas ec protein lcat enzym free cystein replac glycin residu sitedirect mutagenesi express cultur chines hamster ovari cell stabli transfect human lcat gene mass lcat secret determin immunoassay differ nativ mutant speci lcat specif activ unchang mutant speci cysteinefre doubl mutant cys cys replac fulli activ synthesi cholesteryl ester result consist catalyt role lcat free cystein residu classic inhibitor lcat activ dithiobisnitrobenzo acid dtnb strong inhibit nativ enzym partial inhibitori activ mutant enzym speci singl sh residu doubl mutant signific inhibit dtnb data interpret suggest cys cys vicin interfaci bind site residu dtnb exert effect steric inhibit"
"transfect glioma cell connexin cdna analysi express intercellular coupl cell prolifer glioma cell express low level gap junction protein connexin mrna display weak dye coupl implant rat cerebrum cell quick give rise larg glioma investig role gap junction tumor characterist cell lipofectinmedi transfect introduc fulllength cdna encod connexin transfect clone obtain exhibit amount connexin mrna transcrib insert cdna immunocytochem analysi reveal increas amount connexin immunoreact transfect cell local area intercellular contact cytoplasm level dye coupl assess found correl amount connexin mrna cell prolifer day cell express transfect cdna grew slowli transfect cell transfect cell examin role gap junction tumorigenesi"
"differenti hl leukemia type regulatori subunit antisens oligodeoxynucleotid campdepend protein kinas mark decreas type campdepend protein kinas regulatori subunit ri alpha increas type ii protein kinas regulatori subunit rii beta correl growth inhibit differenti induc varieti type human cancer cell vitro vivo siteselect camp analog direct determin ri alpha growthinduc protein essenti neoplast cell growth human hl promyelocyt leukemia cell expos mer ri alpha antisens oligodeoxynucleotid effect cell replic differenti examin ri alpha antisens oligom brought growth inhibit monocyt differenti bypass effect exogen camp analog effect ri alpha antisens oligodeoxynucleotid correl decreas ri alpha receptor increas rii beta receptor level growth inhibit differenti abolish cell expos simultan ri alpha rii beta antisens oligodeoxynucleotid rii beta antisens oligodeoxynucleotid previous shown specif block differenti induc camp analog result provid direct evid ri alpha camp receptor play critic role neoplast cell growth camp receptor isoform display specif role camp regul cell growth differenti"
"titrat intraven barbitur control symptom patient termin cancer patient termin cancer seri sever dehuman physic psycholog symptom improv symptom control final day hour life administ intraven barbitur continu provid heavi sedat continu somnol titrat dosag reduc minimum desir steadyst achiev improv symptom control provid patient digniti maintain death"
"manag soft tissu sarcoma extrem manag soft tissu sarcoma undergon continu undergo import purpos report review present diagnosi natur histori soft tissu sarcoma import care rigor method evalu emphas result multidisciplinari treatment goal limb salvag review time intervent select patient pulmonari metastas experi longterm surviv review import earli continu multidisciplinari treatment evalu emphas"
"giant cell tumor bone giant cell tumor common benign tumor bone plain radiograph demonstr distinct featur mislead diagnosi aid imag modal bone scan comput tomographi angiographi recurr rate high newer treatment outcom"
"lack effect chronic administr oral betacaroten serum cholesterol triglycerid concentr previous studi suggest chronic oral administr retinol retinoid elev plasma triglycerid concentr effect chronic oral administr betacaroten carotenoid partial metabol retinol plasma lipid concentr studi studi subject mo enrol skincancerprevent studi patient random assign receiv placebo mg betacaroten oral studi entri fast blood sampl obtain measur triglycerid total cholesterol hdl cholesterol retinol betacaroten retinol concentr chang minim group betacaroten concentr increas averag nmol placebo group nmol activetreat group group experienc similar small increas triglycerid total cholesterol concentr small decreas hdl cholesterol daili oral administr mg betacaroten affect plasma lipid concentr"
"betacaroten effect serum lipoprotein immunolog indic human dose betacaroten cancerprevent trial chosen base epidemiolog data mechan putat antineoplast effect betacaroten unknown involv modul immun system measur plasma carotenoid concentr select immunolog indic baselin wk healthi human group ingest mg betacaroten mo random placebocontrol openlabel parallel studi plasma betacaroten concentr mark increas wk correl dose betacaroten concentr plateau wk mg group develop doseconcentr curv optim betacarotenedos select achiev target plasma concentr unabl identifi effect betacaroten ingest immunolog indic studi modest increas highdensitylipoprotein cholesterol observ betacarotenetr group"
"develop intrapancreat transplant model pancreat duct adenocarcinoma syrian golden hamster intrapancreat subcutan sc inocul cultur pancreat cancer cell deriv induc primari pancreat cancer syrian hamster result tumor recipi hamster intrapancreat allograft grew rapid invas metastas lymph node liver case comparison sc tumor grew slower form larg encapsul mass invas metastas histolog tumor site show fair differenti adenocarcinoma ductalductular type resembl induc primari cancer similar primari induc pancreat cancer tumor cell allograft express bloodgrouprel antigen includ le le le tumor antigen tag tumor cell express le ca dupan express antigen retain metastas present pattern reactiv allograft intrapancreat transplant rapid model product pancreat cancer morpholog similar human pancreat cancer"
"epitheli cell immort human papillomavirus premalign characterist organotyp cultur hpv hpvimmort human foreskin keratinocyt cell line analyz organotyp epiderm raft cultur passag level cultur system normal cultur keratinocyt stratifi differenti manner similar normal epidermi hpvimmort cell line display epiderm morpholog organotyp cultur abnorm resembl premalign lesion vivo featur premalign lesion share hpvimmort cell line includ disorgan tissu architectur mitot cell present live layer epiderm sheet abnorm mitos enlarg nuclei variabl cell size shape hpvimmort cell line stabl term epiderm morpholog longterm passag cultur hpvimmort cell line lost morpholog appar termin squamous differenti potenti longterm passag monolay cultur result strong support idea immort squamous epitheli cell cultur hpvtransform gene generat morpholog premalign cell"
"express vlaalpha vlaalpha vlabeta chain normal mucosa adenoma colon colon carcinoma liver metastas late antigen vla protein member integrin superfamili cellsurfac receptor function involv cellcel matrix interact heterodim common beta chain alpha chain count vla vla vla complex alpha beta found act collagen receptor platelet vla complex alpha beta laminin receptor monoclon antibodi indirect immunoperoxidas method investig express vlaalpha vlaalpha vlabeta chain normal colon mucosa sampl colon adenoma carcinoma accompani liver metastas protein express colon epithelium vlaalpha present cryptic gland absent mucos surfac case general adenoma strong posit vla protein case show focal vlaalpha negat area carcinoma reveal heterogen vlaalpha express tumor complet posit tumor reveal focal loss antigen case negat reduc antigen express statist duke stage vlaalpha express tumor vlabeta found extens express carcinoma partial express carcinoma absent carcinoma compar primari tumor liver metastas show rough pattern antigen express regulationloss vla protein subset epitheli colon tumor disturb cellcellcellmatrix interact augment invas properti cell"
"basal cellspecif hyperproliferationrel keratin human breast cancer normal breast tissu noninvas breast carcinoma keratin antibodi reactiv predomin basalmyoepitheli cell layer termin larger duct lumin cell stain similar reaction pattern found antibodi direct keratin antibodi found negat keratin preexist myoepitheli cell intraduct carcinoma antibodi reactiv hyperproliferationrel keratin ll complet negat normal breast tissu noninvas breast carcinoma invas carcinoma diffus focal posit antibodi case invas breast carcinoma studi basal cell phenotyp detect high concord found carcinoma immunostain basal cell hyperproliferationrel keratin marker prolifer marker ki support conclus basal cell breast cancer show extens prolifer absenc ki stain tumor cell prolifer"
"musculoskelet infect microbi adhes antibiot resist osteomyel intraarticular infect septic diseas present pathogen featur characterist molecular mechan involv adhes substrata review mechan microbi adhes bone cartilag substrata present relat host tissu respons antibiot treatment"
"diagnost imag osteomyel imag procedur diagnos osteomyel uniqu strength weak plain radiograph inexpens accur provid delay diagnosi comput tomographi magnet reson imag excel differenti soft tissu infect osteomyel comput tomographi magnet reson imag bone scan accur diagnost tool bone violat surgeri trauma structur alter present indium leukocyt indium polyclon antibodi studi accur diagnosi"
"antibiot therapi osteomyel antibiot therapi osteomyel dramat chang past twenti year diagnost criteria osteomyel remain confus practic physician bone biopsi cultur standard determin specif antimicrobi therapi newest potent antimicrobi treat increas broad bacteri spectrum etiolog osteomyel tremend econom incent outpati oral therapi generat cephalosporin fluoroquinolon replac older toxic regimen aminoglycosid treat gramneg osteomyel due suscept organ"
"surgic approach osteomyel laser doppler flowmetri determin nonviabl bone surgic manag osteomyel includ radic debrid nonviabl bone laser doppler flowmetri method direct assess function microcircul bone earli result techniqu surgic adjunct manag osteomyel promis"
"infecti arthriti patient present acut monarticular arthriti asymmetr effus joint diseas suspect bacteri process synovi fluid find leukocyt count glucos predict infect bacteriolog analysi smear cultur evalu synovi effus chronic monarticular process high infecti mycobacteri fungal etiolog frequent requir cultur synovi tissu addit process fluid acut polyarticular syndrom manifest dissemin gonococc infect dgi viral infect adult diagnost clue includ histor physic find exposur histori type rash major pathogen adult remain staphylococcus aureus initi therapi direct organ urinari tract infect present proper recommend therapi dgi ceftriaxon penicillinresist strain present urban center earli recognit treatment bacteri arthriti prevent poor outcom elder patient joint diseas chronic mycobacteri fungal infect surgeri combin medic manag"
"vertebr osteomyel vertebr osteomyel caus varieti microorgan hematogen pyogen form characterist diseas peopl age predomin male popul frequent caus aureus ivda younger patient heavier predomin male aeruginosa common pathogen diseas general monomicrobi secondari contigu process pressur sore polymicrobi infect particip anaerob general rule lumbar greater thorac greater cervic involv rule general popul cervic spine involv frequent thorac involv ivda diabet patient repres patient vertebr osteomyel tendenc higher morbid mortal simultan involv adjac vertebr end plate interven disk general rule vertebra general involv posterior element spine involv infrequ posterior element involv common actinomycosi coccidioidomycosi neoplasm newer diagnost modal ct mri radionuclid scan detect diseas earlier convent radiograph immunobil bed rest antimicrobi therapi general suffici therapi pyogen tubercul vertebr osteomyel select circumst presenc mark instabl spine presenc neurolog deficit progress previous neurolog deficit surgic intervent prompt diagnosi proper manag prognosi general good"
"zygomat approach skullbas lesion modif preauricular skullbas approach section downward displac zygomat arch coronoid process mandibl dissect section base tempor muscl coronoid insert retract upward approach direct unobstruct access tempor infratempor fossa adequ vascular tempor muscl maintain exposur encompass intern carotid arteri neck vascular control extens reconstruct elimin techniqu patient lesion skull base oper mortal morbid consist temporari restrict mandibular open patient"
"simpl techniqu posterior wire traumat instabl mid lower cervic spine technic note wire bone fusion treatment traumat cervic instabl uncommon procedur author describ semirigid wire techniqu stabil acut injur movement segment mid lower cervic spine result briefli discuss"
"manag delay union nonunion maxillari osteotomi delay union nonunion maxillari osteotomi unusu varieti surgic move manag problem divid earli late therapi case present illustr method treatment"
"composit temporali pedicl flap interposit graft temporomandibular joint arthroplasti preliminari report fifteen temporomandibular joint patient evalu preoper postop evalu effect composit fascia muscl periosteum temporali pedicl flap interposit disc replac modifi craniomandibular index cmi symptom sever index ssi assess clinic subject symptom eighteen month postop signific reduct cm ss indic signific clinic improv mandibular rang motion signific reduct translat evid indic increas mandibular open owe compensatori rotat movement studi composit temporali pedicl flap good autogen tissu reconstruct temporomandibular joint"
"tissu respons composit ceram hydroxyapatitedeminer bone implant studi evalu tissu reaction materi ceram hydroxyapatit cha composit materi deminer bone powder dbp cha ratio collagen vehicl materi test subcutan pocket mandibular onlay calvari onlay model specimen evalu histolog day postimplant ceram hydroxyapatit implant subcutan elicit fibrous respons minim inflamm induc bone format specimen subcutan implant composit materi induc bone evid associ dbp cha onlay specimen small amount reactiv bone extend host bone implant composit onlay bone fill entir bodi implant result studi cha particl osteoinduct heterotop site osteoconduct ingrowth minim onlay bone induc dbp mix cha particl implant subcutan intraoss site conclud composit implant provid combin osteoinduct properti dbp bulk structur support osteoconduct cha particl"
"bone respons hydroxyapatit particl shape rabbit tibia hole drill rabbit tibia fill commerci hydroxyapatit product particl caus mild inflammatori reaction disappear month line origin bone visibl month differ heal pattern discov product bone caviti fill hydroxyapatit particl shape particl affect heal process"
"protocol manag temporomandibular joint ankylosi manag protocol temporomandibular joint tmj ankylosi consist aggress resect ipsilater coronoidectomi contralater coronoidectomi line tmj temporali fascia cartilag reconstruct ramus costochondr graft rigid fixat earli mobil aggress physiotherapi present protocol retrospect evalu patient involv tmjs treat postop year facial asymmetri present unilater case remain correct maximum postop interincis open year mm increas excurs present joint joint preoper pain present joint preoper result studi protocol effect treatment tmj ankylosi"
"magnet reson imag muscl childhood dermatomyos document muscl involv child thought dermatomyos requir perform invas procedur electromyographi muscl biopsi describ patient dermatomyos magnet reson imag mri demonstr muscl involv involv muscl increas signal intens tweight imag se normal tweight imag se involv muscl uniform good correl distribut muscl involv mri function test follow mri scan patient favor outcom demonstr affect muscl return normal signal intens mri find specif proper clinic context establish diagnosi dermatomyos mri establish muscl biopsi site addit mri monitor progress diseas"
"modif health assess questionnair spondyloarthropathi publish erratum rheumatol feb function status measur develop ad item health assess questionnair haq compar anthropometr measur spinal mobil forti patient spondyl evalu haq measur spine flexibl fingerfloor smyth test neck rotat chest expans modif haq rais difficulti score sd sd indic increas abil captur function limit neck rotat correl strong haq score suggest import role measur clinic manag followup spondyl"
"vitamin bone recent studi effect vitamin bone includ character receptor bone bone deriv cell receptor show similar affin tissu receptor concentr affect stage cell cycl glucocorticoid treatment affect number receptor site extens studi effect macromolecular synthesi bone collagen anabol antianabol effect found differ respons reflect state differenti cell signific effect osteocalcin synthesi role protein vitamin action bone unclear influenc activ alkalin phosphatas hydroxylas bone receptor growth factor product cytokin influenc treatment find consist direct anabol effect vitamin metabolit bone process integr complet pictur vitamin action physiolog pharmacolog level vivo recent studi consist earlier result hypercalcem effect mediat direct effect bone studi analog suggest stimul bone resorpt dissoci effect differenti cell monocyt lineag"
"spinal bone loss ovulatori disturb background osteoporosi develop women estrogen defici amenorrhea lose bone acceler rate extent bone loss differ ovulatori women regular menstrual cycl train intens sedentari method measur densiti cancel spinal bone thorac vertebra lumbar vertebra quantit comput tomographi occas year premenopaus women year age women consecut ovulatori cycl immedi enter studi twenti women train marathon ran regular intens normal level activ length women menstrual cycl luteal phase diet exercis level hormon level determin defin ovulatori disturb anovulatori cycl cycl short luteal phase result sd spinal bone densiti women decreas mg cubic centimet year percent year amenorrhea develop woman year observ percent cycl greater day long ovulatori disturb occur percent cycl bone loss strong disturb percent varianc women anovulatori cycl lost bone miner rate mg cubic centimet year percent year women train marathon menstrual cycl similar women group conclus decreas spinal bone densiti women differ exercis habit correl asymptomat disturb ovul amenorrhea physic activ"
"effect estron sulfat postmenopaus bone loss estrogen replac therapi confer benefici effect postmenopaus women slow rate bone loss decreas risk coronari arteri diseas multicent placebocontrol studi evalu lowest effect daili dose estron sulfat mg combin mg element calcium supplement prevent bone loss supplement prevent bone loss postmenopaus period spinal bone miner densiti measur quantit comput tomographi compar baselin bone miner densiti increas signific month mg daili mg daili differ mg mg dose statist signific estron sulfat administr mg produc signific lipid measur month observ point preval rate advers event compar estron sulfat group placebo group estron sulfat mg daili combin mg element calcium supplement minimum effect dosag prevent loss spinal bone miner densiti postmenopaus women month period"
"bone trabecular pattern analysi syndrom comput panoram radiographi part ii visual pattern analysi frequenc gradat enhanc visual pattern analysi mandibular bone trabecul patient syndrom normal person perform rotat panoram radiographi laser scan system find patient syndrom consist geromorph somat characterist syndrom"
"silicon rubber fossa implant remov partial arthrotomi arthroscop examin intern surfac fibrous capsul thirteen temporomandibular joint examin arthroscop evalu fibrous encapsul silicon elastom disk replac implant partial arthrotomi perform remov silicon rubber implant arthroscop examin intern surfac fibrous capsul pseudodisk verifi continu fibrous barrier condyl fossa"
"tripl bone label canin mandibl fluoresc microscopi evalu bone format canin mandibl augment hydroxylapatit ha granul fluorochrom inject time interv therapeut radiat treatment oxytetracyclin dcaf alizarincomplexon intraven mark bone level time oxytetracyclin defin baselin bone implant ha detect anim irradi anim nonirradi control group marker dcaf design level bone start radiat demonstr irradi anim anim control group uptak alizarincomplexon determin level bone found end irradi marker demonstr dog irradi control dog boni trabecula found surfac ha granul generat bone direct ha granul surround haversian system part normal bone turnov demonstr place month implant ha"
"peripher giant cell granuloma evid osteoclast differenti case peripher giant cell granuloma oral caviti immunohistochem analyz assess natur giant cell giant cell unreact test antibodi recogn myelomonocyt macrophag marker lysozym mac ham show strong immunoreact mb antibodi reactiv osteoclast conclud giant cell character giant cell granuloma exhibit phenotyp distinct giant cell found site chronic inflamm true osteoclast"
"le fort iii advanc osteotomi child year age longitudin studi patient craniofaci synostosi syndrom crouzon apert pfeiffer underw le fort iii advanc age year averag age year rang year averag follow year includ clinic dental cephalometr examin prescrib protocol studi demonstr procedur safe perform younger child accept level morbid remark degre postop stabil maxillari segment vertic inferior growth movement midfaci segment demonstr minim anterior horizont growth occlus disharmoni develop period follow attribut anticip mandibular develop correct orthognath surgeri role surgic overcorrect anteriorpul headgear therapi releas intermaxillari fixat discuss le fort iii osteotomi justifi earli childhood psycholog physiolog reason"
"polyurethan foamcov implant capsular contractur laboratori investig experi conduct rabbit compar polyurethan foamcov implant ident smooth silicon gel implant object method measur capsular contractur signific differ identifi foamcov implant consist develop capsular contractur case mild degre clinic signific foamcov implant hard contractur evid hematoma separ foam"
"dynam lumbric simul splint claw hand deform claw hand deform result low ulnar combin low ulnar median nerv palsi incapacit situat splint revers claw substitut lumbric interossei start earli prevent perman stiff finger claw posit effect restor function hamper day day work surfac splint"
"natur recombin human il receptor antagonist block effect il bone resorpt prostaglandin product inhibitori factor il identifi urin supernat human monocyt cultur shown act receptor antagonist investig natur inhibitor purifi human urin uilra recombin molecul express gene il antagonist isol monocyt rilra alter respons human ril alpha organ cultur fetal rat long bone neonat mous calvaria prepar similar ident molecul antibodi rilra react uilra western blot analysi uilra rilra specif block stimul bone resorpt ril cultur system increas pge product cultur calvaria resorpt effect parathyroid hormon tnfalpha block uilra prepar intrins resorb activ gel chromatographi fraction elut earlier uilra concentr ratio rilra ril low block resorpt respons fetal rat long bone concentr ratio requir block il action neonat mous calvaria inhibitori effect competit increas concentr il overcam block bone resorpt system inhibit pge product calvaria"
"oper manag basilar impress osteogenesi imperfecta patient osteogenesi imperfecta neurolog signific basilar impress treat past year experi result therapeut strategi difficult problem case discuss respect diseas process neurolog involv radiolog find mode surgic therapi error manag success result learn experi recommend extens remov anterior boni compress transor approach posterior rigid fixat transfer weight head thorac spine effort prevent basilar invagin"
"microcomput reconstruct analysi spinal deform lung volum hypokyphot scoliosi current techniqu imag chest deform limit dimension represent clinic test lung volum measur base pulmonari function studi effortdepend author evalu spine deform lung volum dimension microcomput imag techniqu result preoper postop chest comput tomogram underw boundari detect expert human observ data process polygon surfac tile creat dimension color imag spine lung display comput techniqu visual anatom relationship angl assess spinal deform relat lung volum measur individu lung volum dimension microcomput imag techniqu object measur lung volum assess postop"
"cobb angl versus spinous process angl adolesc idiopath scoliosi relationship anterior posterior deform standard clinic measur adolesc idiopath scoliosi cobb angl measur endplat end vertebr bodi stand radiograph measur anterior column structur describ anterior spinal deform posterior spinal deform spinous process angl measur curv join tip spinous process comput model radiograph studi cobb angl spinous process angl vertebr rotat show adolesc idiopath scoliosi result larger angul anterior element posterior element explain inher limit posterior instrument includ cotreldubousset instrument noninvas posterior surfac measur system"
"digit radiographi reduc scoliosi ray exposur digit radiolog computer system acquir ray digit electron format possess great expand dose respons curv broad rang ray dose produc diagnost imag potenti advantag includ signific reduc radiat exposur loss imag qualiti acquisit imag constant densiti irrespect exposur reduc repeat rate unsatisfactori film author prospect studi adolesc scoliosi convent full dose digit full half dose ray found digit made ap imag anatom area depict full half dose digit full dose equal convent half dose cobb angl easili measur dose ap dose digit digit depict risser sign half dose repeat rate nil studi indic digit compens exposur error studi digit radiat dose reduc half scoliosi patient improv imag qualiti good contrast wide rang ray exposur"
"result treatment idiopath scoliosi charleston bend orthosi author present preliminari retrospect review treatment patient idiopath scoliosi charleston bend thoracolumbosacr orthosi tlso lowprofil spinal orthosi onset treatment patient age year risser stage femal achiev menarch month start orthot treatment singl structur curv treat patient time patient fail treatment curv progress degre degre addit patient success complet treatment reach skelet matur degre curv progress curv chang degre decreas patient remain treatment charleston bend tlso worn nighttim sleep hour toler excel patient complianc low psycholog stress success curv control orthos experi patient longer follow"
"surfac electr stimul versus brace treatment idiopath scoliosi surfac electr stimul scolitron devic appli adolesc patient treatment idiopath scoliosi adequ follow patient failur rate due curv progress scolitron patient fusion chang brace remain patient consid success curv progress successfulfailur slight curv progress requir chang treatment paramet analyz found indic success treatment scolitron devic electr stimul found ineffect prevent curv progress idiopath scoliosi"
"fusion level hook pattern thorac scoliosi cotreldubousset instrument studi report result treatment adolesc king type idiopath curv cotreldubousset instrument imbal type curv distract direct hook pattern cross thoracolumbar junction employ imbal modifi hook pattern employ compress forc thoracolumbar junction employ imbal observ type curv basic thorac curv hook pattern type curv modifi hook pattern requir obtain improv correct balanc mechan product imbal explain dimension analysi deform forc generat cotreldubousset system"
"sagitt plane analysi idiopath scoliosi patient treat cotreldubousset instrument hundr sixti patient idiopath scoliosi underw preoper postop sagitt plane analysi thorac spine thoracolumbar junction lumbar spine data suggest mild moder improv thorac hypokyphosi cross thoracolumbar junction revers rod bend revers hook derot rod provid physiolog sagitt contour cotreldubousset instrument mid distal lumbar spine preserv time enhanc lumbar lordosi"
"complic cotreldubousset instrument sacropelvi clinic biomechan studi author review earli complic patient fuse sacropelvi cotreldubousset instrument texa scottish rite hospit sixteen patient studi averag follow month method sacropelvi fixat evalu iliosacr screw sacral screw techniqu caudl end cotreldubousset rod fashion insert posterior iliac crest galveston techniqu set sacral screw fail surgeri set iliosacr screw fail postop failur occur set cotreldubousset rod galveston techniqu medic complic observ occur sacral screw group calf spine biomechan evalu system undertaken determin strength fixat system fail flexion time sacral screw weakest pull direct sacrum cotreldubousset rod insert galveston techniqu strongest experienc rod deform flexion failur iliosacr screw intermedi strength fail rotat axi screw pull direct ilium author conclud cotreldubousset rod insert galveston techniqu strongest safest method sacropelvi fixat test"
"surgic treatment scoliosi spinal muscular atrophi popul seventi patient diagnos spinal muscular atrophi scoliosi develop patient incid thirti patient retrospect review chart review interview averag follow year onset scoliosi averag year twenti patient treat nonsurg surgic patient improv sit balanc endur surgeri complic surgeri includ loss correct patient pseudarthrosi patient requir prolong ventilatori support prolong surviv patient spinal muscular atrophi justifi aggress orthopaed manag scoliosi prevent progress deform improv sit comfort"
"factor affect fusion rate adult spondylolisthesi author examin factor affect fusion rate surgic treatment consecut adult patient spondylolisthesi factor signific improv fusion rate combin anterior posterior fusion rigid postop immobil cast patient isthmic spondylolisthesi fusion rate rais posterior fusion combin anterior posterior fusion patient degen spondylolisthesi frequent combin anterior posterior fusion contribut high fusion rate patient isthmic spondylolisthesi postop cast immobil result higher fusion rate compar fusion rate obtain brace immobil"
"normal dystrophin mcleod myopathi dystrophin gene studi patient mcleod syndrom link recess myopathi local xp duchenn muscular dystrophi gene locus code dystrophin histopatholog studi patient muscl show mild subclin myopathi immunolog studi dystrophin separ biopsi specimen analysi dystrophin gene dna blood sampl detect abnorm suggest duchenn muscular dystrophi gene albeit close mcleod locus involv mcleod myopathi"
"magnet reson imag sacroiliac joint inflamm consecut seri patient symptom compat sacroili underw magnet reson imag mri sacroiliac joint diagnost sensit mri similar comput tomographi convent radiographi mri potenti provid uniqu inform diseas process sacroili demonstr abnorm subchondr bone periarticular bone marrow result studi suggest earli inflammatori sacroili occur subchondr structur sacroiliac joint"
"chondron articular cartilag iii morpholog cellular microenviron chondron isol osteoarthrit cartilag chondron isol human canin osteoarthrit cartilag lowspe homogen techniqu chondron morpholog evalu differenti interferencecontrast microscopi phasecontrast microscopi histochem ultrastructur method chondrocyt viabil assess fluorescein diacet stain chondron metabol investig autoradiographi result suggest initi collagen proteoglycan distribut chondron chondrocyt prolifer form cluster techniqu offer potenti studi cell matrix interact degen osteoarthr"
"progress osteoarthr hand metacarp bone loss twentyyear followup incid case examin prospect relationship metacarp bone mass osteoarthr oa hand incid data histor cohort tecumseh communiti health studi tecumseh mi women examin radiograph evid oa bone mass year subject age rang measur oa evalu highest score assign wristhand joint sum score wristhand joint adjust age women classifi oa measur oa cortic area baselin greater bone mass women develop oa year period experi signific greater widen medullari caviti time indic increas bone resorpt women increas level oa involv increas likelihood greater cortic area loss conclud women develop oa higher baselin bone mass women develop oa women greater likelihood bone loss time"
"suppress type ii collageninduc arthriti monoclon antibodi mous monoclon antibodi rais chicken type ii collagen suppress delay onset chicken type ii collageninduc arthriti dba mice correl suppress antimous type ii collagen antibodi respons immun chicken type ii collagen epitop recogn suppress antibodi found present cyanogen bromid cbdigest collagen peptid cb cb confirm find administr cb cb peptid suppress induct arthriti"
"osteolyt monostot paget diseas lumbar vertebra case report osteolyt monostot paget diseas osteiti deforman lumbar vertebra occur year woman isol lytic process involv entir vertebr bodi posterior element open biopsi show extens remodel cement line myelofibrosi osteoclast resorpt typic paget diseas"
"scapular allograft report case malign tumor scapula adequ treat limbspar partial total scapulectomi resect glenoid portion scapula total scapulectomi result unsight shoulder attempt minim function impair restor stabil cosmesi scapular glenoid allograft offer good biolog replac report describ case year woman year man massiv osteoarticular allograft patient good stabil cosmesi function restor resect glenoid portion patient shoulder stabil cosmesi limit function restor total scapulectomi report scapular allograft previous publish literatur"
"bilater femor retrovers acetabular dysplasia case report retrovers proxim femur number acquir condit unusu congenit form unusu acetabular dysplasia year woman bilater hip pain roentgenograph evid acetabular dysplasia valgus neckshaft angl physic find consist femor retrovers comput tomographi demonstr degre retrovers side symptomat relief obtain bilater varus intern rotat osteotomi proxim femur date case retrovert femora acetabular dysplasia report literatur"
"simpl bone cyst effect methylprednisolon synovi cell cultur ten year ago protocol depomedrol inject develop treatment unicamer bone cyst concept design tumor surgeon base theori cautious approach reproduc result gradual increas clinic accept understand heal process restrict lack experiment model attempt elucid mechan heal cell cultur model investig effect methylprednisolon synovi cell initi dose drug test maxim note concentr mgml quantifi morpholog dna assay cell protein analysi electron microscopi result suggest methylprednisolon direct effect cellular compon unicamer bone cyst"
"apolipoprotein apo inhibit capac monosodium urat crystal stimul neutrophil character intraarticular apo demonstr apo bind urat crystal vivo factor modul abil monosodium urat crystal stimul leukocyt regul gouti inflamm lipoprotein bear apo apo bind urat crystal suppress crystalneutrophil interact studi observ urat crystal coat apo monocyt origin diminish abil stimul neutrophil apo detect surfac urat crystal recov gout patient analyz apo noninflammatori synovi fluid found particl heterogen size predomin alpha prebeta electrophoret mobil local articular synthesi portion synovi fluid apo suggest synovi fluidplasma concentr ratio apo signific higher apo apo wide synthes extrahepat tissu cultur rheumatoid synovi cell passag secret apo portion synovi fluid apo heavili sialyl conclud synovi fluid apo part local origin apo bind urat crystal modul gouti inflamm"
"cartilag express type ii collagen mutat inherit form osteoarthr mild chondrodysplasia famili express sever domin inherit osteoarthr mutat trace genom sequenc singl base chang predict amino acid substitut cystein arginin residu triplehel domain type ii collagen molecul alakokko  baldwin  moskowitz  prockop  proc natl acad sci usa  present studi examin predict protein phenotyp evid articular cartilag obtain affect famili member underw hip surgeri cartilag collagen solubil cnbr digest cystein residu label reduct alkyl ciodoacet collagen cnbrpeptid fraction ion exchang revers phase column chromatographi peptid alpha ii chain alpha ii cb found radiolabel tryptic peptid prepar identifi microsequ analysi result show approxim quarter alpha ii chain present polymer extracellular collagen patient cartilag argci substitut protein exhibit abnorm properti includ disulfidebond alpha iidim sign posttransl overmodif prematur cartilag failur osteoarthr result abnorm type ii collagen express cartilag matrix"
"report fluorosi unit state secondari drink water year femal resid wellston okla found osteosclerosi routin chest roentgenogram subsequ investig disclos osteosclerosi fluorosi secondari ingest water mumol fluorid recommend level mumol water sampl obtain properti adjac index case similar depth index case fluorid concentr water greater mumol urin sampl member household obtain drink water elev urinari fluorid level fluorosi develop area unit state result natur occurr fluorid groundwat endem area reason measur fluorid concentr water time drill"
"vivo muscl magnet reson spectroscopi clinic investig mitochondri diseas investig sensit specif rapid phosphorus magnet reson spectroscopi mrs protocol detect metabol abnorm vivo skelet muscl patient mitochondri diseas examin patient mitochondri myopathi sixteen mild minim myopath sign symptom phosphorus magnet reson spectra rest gastrocnemius muscl show abnorm intracellular energi state mark increas intracellular inorgan phosphat concentr decreas phosphocreatin concentr studi patient diseas muscl inflammatori myopathi metabol myopathi muscular dystrophi myasthenia gravi present similar clinic featur spectra show increas intracellular inorgan phosphat concentr muscl diseas evid muscl fiber necrosi abnorm muscl energi state case due secondari mitochondri dysfunct case polymyos dermatomyos myopathi readili distinguish mitochondri myopathi basi clinic examin blood test conclud phosphorus mrs rest muscl practic clinic set sensit specif mitochondri myopathi conjunct standard noninvas test"
"centronuclear myopathi heterogen distinct clinic type myosin isoform pattern studi muscl patient centronuclear myopathi cnm immunocytochemistri myosin heavi chain mhcspecif monoclon antibodi determin subtyp cnm express prenat mhc assess arrest develop muscl muscl woman childhoodonset cnm express prenat mhc prenat mhc strong express muscl fiber brother link cnm find repres st immunocytochem evid express prenat myosin isoform nonregener postnat human muscl suggest link form cnm differ type true arrest matur muscl"
"clinic evalu iti type hollow cylind implant hollow cylind implant introduc number articl publish iti implant system articl shortterm result iti type implant patient report result show stage implant compar implant system"
"massiv osteolysi maxillofaci bone report case case massiv osteolysi encount affect mandibl maxilla mandibl case report exist literatur massiv osteolysi mandibl rare diseas case surgic treat clinic histopatholog assess"
"african burkitt lymphoma case report light electron microscop find african burkitt lymphoma occur year american boy jaw tumor proptosi abdomin mass histolog tumor consist monoton overgrowth undifferenti lymphocyt starri sky differenti diagnosi african versus american form burkitt lymphoma versus burkitt lymphoma discuss"
"inherit diseas bone densiti children articl radiograph manifest genet diseas predomin affect bone miner consid osteogenesi imperfecta diseas diffus osteopenia hereditari ricket rachiticlik condit osteopetrosi diseas increas bone densiti emphas recognit radiograph manifest accur diagnosi therapeut intervent determin recurr risk genet counsel"
"metabol bone diseas morphometri histori develop radiolog morphometr techniqu trace emphas pathophysiolog background relev therapi techniqu longitudin compar studi assess technic limit method present"
"patholog metabol bone diseas skelet manifest divers group metabol bone diseas mediat alter function osteoblast osteoclast abnorm rate miner understand patholog condit requir familiar normal anatomi physiolog skeleton accur identif metabol bone diseas frequent demand histolog confirm sophist analysi undecalcifi bone specimen label tetracyclin histomorphometr techniqu procedur assess morpholog featur character specif diseas state common type metabol bone diseas acquir disord nonetheless rare form frequent genet base intrins alter bonecel popul"
"radiograph osteopenia radiograph bone result physiolog process resorpt bone remodel bone respons stress appli relat rate process determin structur radiograph affect bone"
"osteoporosi current techniqu recent develop quantit bone densitometri knowledg proper interpret bone densitometri studi understand medic intervent univers physician instrument technic perform bone densiti studi uniform high qualiti defici medic technic expertis princip deterr widespread implement recommend clinic applic time nonetheless current impetus dissemin inform osteoporosi make newer instrument readili limit cost techniqu anticip recommend standard medic practic"
"osteoporosi osteoporosi condit decreas bone tissu increas likelihood fractur place signific burden societi term health cost morbid common type osteoporosi involut subtyp recogn type type type postmenopaus osteoporosi common perimenopaus postmenopaus women age estrogen defici domin factor pathogenesi disord type age relat osteoporosi elder women men age bone loss group relat age estrogen defici negat calcium balanc varieti environment genet factor approach manag osteoporosi develop lifelong strategi maxim peak bone mass minim agingrel postmenopaus bone loss estrogen medic approv prevent bone loss general strategi prevent bone loss maxim peak bone mass includ adequ calcium intak adequ exercis avoid excess alcohol tobacco caffein"
"function stabil canin cervic spine injuri month vivo studi clinic instabl vivo problem spinal instabl criteria subject base vitro experi author perform vivo experi canin model studi natur histori spinal instabl function heal time week injuri produc surgic sham laminectomi bilater facetectomi cc mm steel ball implant vertebra time surgeri standard function flexionextens stereoradiograph cervic spine obtain injuri immedi injuri week postinjuri immedi kill anim general author found decreas rang motion rom cc level compar preinjuri valu injuri signific facetectomi maximum decreas occur week postinjuri week recoveri rom sever injuri rom spinal level explain simultan presenc destabil factor caus injuri sham facetectomi destabil injuri stabil mechan muscl spasm begin heal adapt respons late phase injuri signific differ canin model human cervic spine present find extrapol human situat caution"
"analysi chondroitin sulfat proteoglycan core protein cspgcp gene achondroplasia pseudoachondroplasia achondroplasia pseudoachondroplasia autosom domin skelet dysplasia result shortlimb dwarfism histolog ultrastructur studi cartilag pseudoachondroplasia homozyg achondroplasia suggest structur abnorm chondroitin sulfat proteoglycan cspg major structur protein extracellular matrix gene encod cspg core protein cspgcp logic candid gene analysi condit cdna probe encod cspgcp identifi restrict fragment length polymorph rflps dna panel control individu gross alter cspgcp locus note dna individu achondroplasia individu pseudoachondroplasia addit allel frequenc rflps signific control patient condit generat famili achondroplasia close linkag cspgcp locus skelet dysplasia exclud bgl ii polymorph similar generat famili pseudoachondroplasia cspgcp gene tight link diseas phenotyp result mutat chondroitin sulfat proteoglycan core protein locus achondroplasia pseudoachondroplasia famili"
"muscl condit late poliomyel studi adapt postpolio muscl subject age year particip highintens resist exercis program seventi percent met criteria postpolio syndrom isometr isokinet strength muscl endur measur polioaffect muscl identifi muscl biopsi biopsi measur enzymat activ histochem histopatholog analys pretrain strength valu half healthi control fiber area healthi control oxid enzym activ low train signific increas isometr isokinet strength observ maintain time demonstr remain adapt muscl compens longstand polio"
"corticosteroid inject adhes capsul investig site forti patient frozen shoulder month assign random receiv shoulder inject subacromi bursa glenohumer joint week interv treatment group intraarticular methylprednisolon lidocain intraburs methylprednisolon lidocain intraarticular lidocain intraburs lidocain physic therapi program carri patient assess pain rang motion perform physic therapist uninform natur inject therapi signific differ outcom intraburs inject intraarticular inject inject steroid lidocain advantag lidocain restor shoulder motion partial transient pain relief occur steroidtr patient"
"brace patellar instabl knee pain secondari problem patellar track common initi treatment problem conserv patellar orthot extens treat varieti extensor mechan problem million health care dollar spent annual brace patellar orthot market today design devic unclear lack solid biomechan foundat practic mechan function brace reduc displac abnorm patellofemor track orthot design test practic biomechan principl appli medial direct forc patella role treat patient knee pain secondari patellar malalign instabl defin control clinic studi patellar brace lack"
"magnet reson imag shoulder sensit specif predict sensit specif predict magnet reson imag diagnosi lesion rotat cuff glenohumer capsul glenoid labrum evalu nineti patient fifteen asymptomat volunt magnet reson imag demonstr cent sensit cent specif diagnosi complet tear consist predict size tear rotat cuff definit correl atrophi supraspinatus muscl size complet chronic tear rotat cuff sensit specif magnet reson imag differenti tendin degener cuff cent differenti normal tendon affect tendin sign imping sensit specif cent format spur acromion acromiocalvicular joint correl high increas age patient chronic diseas rotat cuff sensit specif magnet reson imag diagnosi labral tear glenohumer instabl cent studi show highresolut magneticreson imag excel invas tool diagnosi lesion rotat cuff glenohumer instabl"
"test posterolater instabl knee normal subject result examin anesthesia appar normal knee examin subject general epidur anesthesia unrel oper lachman anterior drawer posterior drawer pivotshift test negat knee knee stabl varus valgus stress degre flexion externalrot recurvatum test negat knee posit revers pivotshift sign present cent knee suggest signifi abnorm negat test contralater knee result posterolater drawer test variabl difficult quantifi firm endpoint amount maximum extern rotat tibia measur refer line medial border foot extrem variabl degre flexion knee extern rotat determin refer slight greater averag degre degre flexion normal rang maximum extern rotat foot degre degre flexion knee degre degre flexion presenc larg angl extern rotat posit revers pivotshift sign correl strong increas ligament laxiti mild varus align knee"
"effect singl infus aminohydroxypropyliden calcium bone metabol healthi volunt monitor month recent bisphosphon prevent postmenopaus bone loss effect bisphosphon normal bone metabol unknown aminohydroxypropylidenediphosphon apd studi healthi subject effect singl mg apd infus biochem paramet calcium bone metabol investig month healthi male volunt singl moder dose apd reduc biochem paramet bone resorpt time follow month urinari hydroxyprolin excret basal level decreas serum calcium level return basal valu biochem paramet bone format serum alkalin phosphatas osteocalcin show slight increas month stimul parathyroid increas serum dihydroxyvitamin format paramet decreas repres coupl bone resorpt bone format"
"estrogen progestin therapi prevent osteoporosi attitud practic general internist gynecologist studi object assess combin hormon therapi cht prescrib pattern impedi cht prescrib endometri biopsi monitor therapi design mail questionnair survey subject gynecologist general internist boston teach hospit measur main result base respons rate internist gynecologist report prescrib cht internist compar gynecologist report half femal patient older year age logist regress analysi internist data femal gender physician odd ratio belief cht decreas myocardi infarct risk odd ratio knowledg cht benefit risk odd ratio prescrib endometri biopsi perform major physician unexpect vagin bleed occur case unclear menopaus transit physician concern litig time perform baselin endometri biopsi conclus author sampl nation internist provid care menopaus women internist gender knowledg strong cht prescrib find import educ implic internist routin provid inform counsel women osteoporosi cht"
"schwartzjampel syndrom domin inherit schwartzjampel syndrom sjs rare congenit multisystem disord unknown pathogenesi character distinct face skelet deform joint contractur short statur muscl hypertrophi clinic myotonia continu muscl fiber activ inherit pattern sjs assum autosom recess report occurr classic sjs syndrom father son consanguin famili suggest sjs potenti domin pattern inherit"
"identif alphamotor nerv fiber potenti lumbar epidur space clinic signific alphaeffer compon spinal root potenti srps record lumbar epidur space stimul tibial peron nerv clinic diagnosi clinic treatment normal volunt clinic case lumbar disc herniat ldh examin srp tibial nerv stimul normal control group consist kind potenti latenc simultan electromyogram emg record stimul muscl shortest latenc potenti potenti ascend volley includ orthodrom affer antidrom alphaeffer volley long latenc potenti potenti descend volley reflex evok alphaeffer group ia affer compon alphaeffer fiber potenti record method chang intens stimul identifi alphaeffer compon potenti record potenti conduct blockag spinal root clinic case demonstr abnorm posit prolong durat potenti method introduc estim paramet quantit present studi show sign patient test examin determin level lumbar motor radiculopathi extent patholog neuropathi"
"magnet reson imag lumbar disc herniat comparison myelographi fifti patient surgic confirm lumbar disc herniat level studi retrospect compar diagnost accuraci highfield strength surfac coil magnet reson imag mri myelographi disc herniat classifi group mri find unilater singledisc herniat central singledisc herniat multilevel disc herniat magnet reson imag diagnosi unilater singledisc herniat extrem reliabl myelographi consid unnecessari convers mri find central singledisc herniat multilevel disc herniat definit myelographi locat disc caus symptom"
"ultrason level diagnosi lumbar disc herniat diagnost ultrasound measur spinal canal propos ultrasound lumbar disc herniat fulli assess purpos investig evalu effect ultrasound level diagnosi herniat nucleus pulposus prospect ultrasound examin perform consecut patient clinic suspect lumbar disc herniat disc patient surgic confirm lumbar disc herniat disc trueposit ultrasound diagnos disc trueposit myelograph diagnos patient trueposit neurolog diagnos convers ultrasound diagnos show posit echogram nonop patient result suggest ultrasound aid diagnos level lumbar disc herniat"
"system procedur percutan intradisc laser nucleotomi percutan intradisc laser nucleotomi piln studi author laser laboratori purpos report develop piln altern chemonucleolysi percutan discectomi appli establish safe easi accur shorttim therapi method lumbar disc herniat laser irradi intradisc pressur idp decreas nucleus pulposus gradual replac cartilagin fibrous tissu evalu heat distribut thermocoupl thermographi determin safe optimum irradi condit develop doublelumen needl bare quartz fiber neodymiumyttriumaluminumgarnet yag laser devic improv easi safe tip type pressur transduc made improv therapeut result method"
"unstabl lumbar spine hypermobl postlaminectomi case mechan symptom effect spinal fusion spinal instrument morbid condit unstabl lumbar spine hypermobl postlaminectomi case studi dura nerv root adhes affect minim movement spine mechan symptom instabl hypermobl effect spinal instrument instabl studi spinal instrument instantan rigid fixat maintain fusion obtain prevent adhes bone format stenosi spinal instrument effect treatment instabl"
"lumbar trapezoid plate lumbar spondylolisthesi clinic studi preoper postop instabl author studi effect lumbar trapezoid plate spinal plate pedicl screw perform lumbar spondylolisthesi observ effect remain adjac disc regard preoper postop instabl author examin preoper postop lumbar rom rang motion displac motor unit level occurr instabl remain disc horizont rotat displac patient postop month patient spondylolyt spondylolisthesi patient degen spondylolisthesi author studi effect fuse vertebr angl reduct spondylolisthesi remain upper lower adjac disc preoper postop fuse disc height intervertebr fusion affect remain adjac disc compensatori function remain motor unit level influenc fuse intervertebr angl reposit spondylolisthesi fusion physiolog lordot posit purpos consid import prevent graft bone posterior lumbar interbodi fusion plif collaps maintain achiev align lumbar spine"
"natur histori degen spondylolisthesi pathogenesi natur slippag clarifi natur degen spondylolisthesi mechan progress disk slippag studi clinic radiograph patient progress slippag observ patient progress slippag note patient show narrow intervertebr disk spur format subcartilagin sclerosi ossif ligament suggest mechan spinal restabil prevent progress diseas general joint laxiti observ patient believ involv pathogen mechan diseas correl clinic symptom progress slippag find suggest care natur mechan spinal restabil natur diseas import"
"longterm result anterior interbodi fusion treatment degen spondylolisthesi thirti patient women men underw anterior decompress interbodi fusion degen spondylolisthesi februari august averag age surgeri year rang year averag follow period year month rang month year clinic evalu score rate system japanes orthopaed associ joa score patient joa score point rate satisfactori survivorship analyz method kaplan meier determin cumul percentag patient satisfactori result result obtain seventi percent patient satisfactori result year anterior interbodi fusion year year irrespect age surgeri patient general maintain satisfactori result year age"
"clinic studi stabil combin distract compress rod instrument posterolater fusion unstabl degen spondylolisthesi author examin stabil combin distract compress rod instrument posterolater fusion consecut patient unstabl degen spondylolisthesi oper perform float fusion decompress procedur mobil fuse level check week oper disc space angl function radiograph film brace averag period postop follow month patient mobil found time patient mobil disappear week patient year pseudoarthrosi found patient solid fusion rate valu percent slippag slip angl slight improv lumbar lordosi normal rang follow"
"relationship complementmedi microvasculopathi histolog featur clinic durat diseas dermatomyos accumul evid complementmedi microvasculopathi play pathogen role dermatomyos previous studi demonstr neoantigen cb complement membran attack complex muscl microvasculatur childhood adult case dermatomyos character relationship vascular complement deposit histolog quantit histopatholog analys perform dermatomyos biopsi specimen adult children signific correl percentag fascicl fiber focal myofibrillar loss chang earli evolut ischem muscl fiber damag percentag fascicl capillari deposit membran attack complex convers biopsi specimen higher percentag fascicl perifascicular atrophi membran attack complex deposit signific common fasciclefascicl analysi support observ patient biopsi specimen negat microvascular membran attack complex clinic weak signific longer time patient vascular complement deposit data support hypothesi complementmedi vasculopathi primari immunopathogen event evolut muscl lesion dermatomyos"
"magnet reson imag primari skelet muscl diseas pattern distribut sever involv magnet reson imag lower extrem perform low field system patient repres categori biopsyproven primari skelet muscl diseas muscular dystrophi congenit myopathi polymyos intermuscular distribut abnorm signal intens grade involv individu muscl assess larg differ degre patholog signal intens individu muscl found categori muscular dystrophi polymyos patient involv signific sever patient congenit myopathi definit pattern select involv statist evid select muscl spare found gracili muscl signific affect muscl diseas group muscl signific spare includ rectus femori sartorius muscl thigh tibiali posterior muscl leg common anatom function characterist muscl relat distribut muscular diseas"
"identif osteoclast precursor multilineag hemopoiet coloni osteoclast deriv hemopoiet stem cell lineag mechan differenti regul larg unknown evid osteoclast differenti induc contactdepend interact bone marrow stromal cell hemopoiet precursor analyz osteoclast lineag coloni generat semisolid medium mous spleen cell presenc erythropoietin wehi bcondit medium interleukin il day individu coloni pick half coloni phenotyp morpholog cell cytospin prepar half incub day bone marrowderiv cell line ts induc osteoclast differenti hemopoiet cell bone slice presenc dihydroxyvitamin incub bone resorpt assess scan electron microscopi resorpt induc cell deriv singlelineag coloni resorpt cell differenti granulocytemacrophag gm coloni multilineag coloni minor gm coloni osteoclast precursor suggest gm coloni osteoclast typic gm coloni form multilineag coloni analag multilineag coloni granulocyt macrophag cell type resorpt cell form ilderiv coloni incub bone slice ts cell result suggest osteoclast deriv multilineag precursor il act generat cell capabl osteoclast differenti form resorpt cell incub bone marrow stromal cell presenc dihydroxyvitamin"
"high concentr betaestradiol stimul trabecular bone format adult femal rat effect low concentr betaestradiol bone format resorpt effect bone concentr circul pregnanc investig effect administr high dose month femal wistar rat biochem histomorphometr indic bone format resorpt anim receiv exogen mgkgday day show serum concentr nm compar nm receiv vehicl bone format rate measur proxim tibial metaphysi administr doubl fluorochrom label great increas group micronsmicronsday compar control serum alkalin phosphatas iu control increas rate bone format signific increas trabecular bone volum treatment affect urinari hydroxyprolin excret histomorphometr indic bone resorpt find suggest high concentr strong stimul format trabecular bone repres import mechan calcium store accumul pregnanc rat anticip miner requir lactat"
"differenti diagnosi osteiti condensan ilii sacroili publish erratum rheumatol sacroili seroneg spondyloarthropathi show pelvi plain film find indistinguish osteiti condensan ilii comput tomographi ct differenti earlier plain radiographi condit make differenti clinic aim studi verifi criteria recent propos european spondylarthropathi studi group eesg classif spondyloarthropathi ct scan synovi part sacroiliac joint consecut patient meet essg criteria show typic find osteiti condensan ilii plain film mix consecut patient osteiti condensan ilii meet essg criteria scan examin joint space surfac abnorm blind independ observ patient spondyloarthropathi group osteiiti condensan ilii group show clear eros joint space narrow mm joint differ statist signific result suggest criteria valid group seroneg spondyloarthropathi differenti clinic seroneg spondyloarthropathi sacroili mimick osteiti condensan ilii true osteiti condensan ilii"
"trigger finger secondari anomal lumbric insert case report review literatur trigger finger common clinic entiti frequent caus stenos tenosynov condit relat tenosynov trigger review present rare anomali fourth lumbric muscl insert trigger finger complet reliev excis anomal muscl rare anatom variant ad list potenti trigger finger"
"intern derang temporomandibular joint histochem studi purpos studi correl histolog find temporomandibular joint tmj condyl disc macroscop surgeri patient intern derang joint includ women men age year rang year tissu lesion vari degre mild softtissu fray bone remodel extens resorpt cartilag bone format high phosphatas enzym activ loss articular soft tissu breakdown cortic bone reaction aris hard tissu occur articular surfac layer"
"drug lower uric acid level avoid misus gouti arthriti point drug lower uric acid level deserv emphasi agent manag acut gout form drug initi low dose gradual increment achiev serum uric acid level mgdl data support wide presum notion drop uric acid level low rang mgdl hasten resorpt tophi improv joint function uricosur agent probenecid benemid sulfinpyrazon anturan interact number drug patient physician awar final import care frequent monitor month therapi drug"
"chronic fatigu syndrom real epsteinbarr virus longer consid import chronic fatigu syndrom diseas relat psychiatr disord subtl immunolog dysfunct interact factor care histori physic examin simpl laboratori test suffici establish diagnosi therapi antidepress nonsteroid antiinflammatori drug effect select patient follow conduct empathi optim import case"
"laboratori test rheumat diseas care histori physic examin remain crucial aspect diagnos rheumat disord rheumatolog condit mind laboratori test support confirmatori test nonspecif lack sensit limit recogn test invalu tool clinician confront task differenti array rheumatolog disord"
"histopatholog metastat tempor bone tumor tempor bone metastasi report increas frequenc understand process tempor bone metastasi complet histolog evalu tempor bone essenti studi tempor bone patient evalu pattern tempor bone involv note depend mode spread tempor bone involv tempor bone occur late diseas process asymptomat"
"famili chondrocalcinosi due calcium pyrophosph dihydr crystal deposit english famili famili predisposit chondrocalcinosi cc due calcium pyrophosph dihydr cppd crystal deposit english kindr famili character prematureonset polyarticular cc structur arthropathi famili recurr childhood fit strong subsequ develop cc affect member famili resembl sporad diseas show predomin lateonset oligoarticular cc mild arthriti destruct chang case knee synovi fluid level inorgan pyrophosph ppi nucleosid triphosph pyrophosph ntpp differ sporad case cc due cppd ppi ntpp level group higher normal knee synovi fluid urinari ppi level normal control screen metabol abnorm negat case report famili cc uk associ condit childhood fit absenc overt primari abnorm ppi metabol suggest factor relat crystal nucleationgrowth relev predisposit case"
"treatment freiberg diseas oper techniqu method treat freiberg diseas metatars head shorten metatars bone oper perform patient feet excel relief pain obtain patient persist stiff metatarsophalang joint"
"correct coxa vara childhood pauwel shape osteotomi longterm result correct coxa vara pauwel shape intertrochanter osteotomi evalu children ten children unilater hip diseas normal bilater hip diseas due generalis skelet dysplasia case growth plate vertic femor head displac inferior abnorm metaphysi femor neck result osteotomi correct deform long inclin growth plate correct degre adequ support provid metaphys defect displac femor head"
"joint propriocept normal osteoarthrit replac knee measur joint posit sens knee method test propriocept contribut joint capsul ligament leg support splint held posit flexion subject percept posit record visual analogu model compar actual angl flexion eighti normal osteoarthrit knee examin knee semiconstrain hing joint replac assess elast bandag knee steadi declin joint posit sens age subject normal knee osteoarthrit knee impair joint posit sens age knee replac improv joint posit sens slight semiconstrain replac greater effect hing replac effect elast bandag subject poor posit sens dramat improv accuraci propos reduc propriocept elder osteoarthrit subject respons initi advanc degener knee"
"natur histori nontraumat avascular necrosi femor head studi natur histori nontraumat avascular necrosi femor head anfh hip patient steroidinduc relat misus alcohol idiopath averag length follow year collaps occur focus bone necrosi occupi weightbear surfac femor head flat head due subchondr fractur earli manifest collaps classif type base radiograph find provid accur prognosi individu case anfh plan treatment assess outcom"
"effect menopaus hormon replac therapi urinari excret pyridinium crosslink pyridinolin pyr deoxypyridinolin pyr crosslink collagen molecul present extracellular matrix releas degrad contrast wide distribut collagen pyr present bone cartilag signific amount connect tissu pyr specif bone tissu urinari excret pyr pyr sensit marker bone matrix degrad specif high pressur liquid chromatographi assay measur pyr pyr crosslink fast urin sampl earli postmenopaus women premenopaus women match age menopaus induc increas fu pyr pmolmumol creatinin increas fu pyr pmolmumol creatinin postmenopaus women hormon replac therapi urinari pyr pyr return premenopaus level month contrast unchang level placebo treatment excret pyr pyr signific lower fast excret similar decreas hormon replac therapi pyr pyr excret measur urinari sampl high correl fast sampl correl fast valu weak pyr pyr correl urinari crosslink marker bone turnov fu hydroxyprolinecreatinin plasma osteocalcin signific low pyr osteocalcin pyr hydroxyprolin pyr osteocalcin pyr hydroxyprolin suggest marker reflect event bone metabol final singl measur fast excret excret crosslink signific correl pyr pyr subsequ spontan rate bone loss assess repeat measur radial bone miner content postmenopaus womenabstract truncat word"
"correl serum osteocalcin dihydroxyvitamin level paget diseas bone studi correl serum dihydroxyvitamin osteocalcin level sbgp paget diseas bone measur serum calcium phosphat pth hydroxyvitamin alkalin phosphatas sap urinari hydroxyprolinecreatinin ratio uoh prolcreat patient paget diseas bone age sexmatch control expect sap uoh prolcreat sbgp level signific elev tendenc decreas serum level paget patient respect control group signific differ patient control serum calcium phosphat pth hydroxyvitamin paget patient subdivid subgroup subgroup normal sbgp level ngml subgroup increas sbgp level greater ngml serum level subgroup signific lower control subgroup show level similar control group found posit linear correl sap sbgp sap uoh prolcreat negat linear correl sbgp uoh prolcreat paget patient result point role diseas activ"
"hyposomatomedinemia men postpoliomyel syndrom age onset postpoliomyel syndrom pps coincid tendenc declin activ growth hormonesomatomedin ghsmc axi normal plasma smc rang men age unitsml age men plasma smc level unitsml signifi detect spontan gh secretori puls ghsmc axi stimul dna rna protein synthesi muscl cell increas size number defici ghsmc axi theoret contribut secondari factor occurr sever pps author measur plasma smc level men pps age healthi men similar age pps men valu equal unitsml equal unitsml proport healthi men analysi varianc includ age factor show smc signific lower pps men healthi men addit comparison total immobil nurs home men lower smc valu fact smc valu slight higher healthi men similar age data reveal biochem featur pps hyposomatomedinemia play contributori role pathogenesi syndrom"
"stimul dorsal root ganglia degrad rabbit annulus fibrosus author sought determin narrow intervertebr neural foramen associ vibrat stimul mechanosensit dorsal root ganglia result degrad proteoglycan collagen annulus fibrosus propos work model dorsal root ganglianeuropeptidemedi degener spinal motion segment degrad proteoglycan collagen rabbit annulus observ narrow neural foremen degrad process acceler vibrat vibrat absenc structur abnorm spinal motion segment induc matrix degrad pronounc stimul dorsal root ganglia biolog event similar postul foment combin structur abnorm environment factor involv human disc degener"
"coexist cervic lumbar disc diseas retrospect analysi patient requir cervic disc surgeri perform determin frequenc coexist lumbar disc spine abnorm durat follow rang year averag year sixti percent women men age rang year anteced motor vehicl injuri occur case work injuri spine sixti percent histori prior back injuri found undergon lumbar disc surgeri high number patient demonstr abnorm lumbar radiograph myelogram includ bulg disc major root defect minor root defect spinal stenosi spondylolisthesi myelogram normal case site lumbar abnorm includ ls multilevel higher incid lumbar disc abnorm multilevel cervic spondylosi relationship residu symptom myelograph abnorm studi author institut suggest autoimmun basi frequent coexist cervic lumbar disc diseas demonstr antigen properti nucleus pulposus high serum immunoglobulin"
"nighttim brace adolesc idiopath scoliosi charleston bend brace preliminari report author report preliminari experi charleston bend brace treatment adolesc idiopath scoliosi brace hold patient posit maximum side bend correct worn night patient prospect multicent studi met criteria skelet immatur risser curvatur greater degre brace prior treatment greater year follow initi treatment structur curv patient hundr fifteen patient show improv degre chang curvatur twenti patient demonstr increas curvatur greater degre base preliminari result continu bend brace treatment nighttim justifi adolesc idiopath scoliosi patient doubl curv observ close increas compensatori curv"
"analysi sagitt plane instabl lumbar spine vivo segment instabl secondari degen disc diseas result chronic lowback pain sagitt plane segment instabl character lumbar motion full extens full flexion author studi movement translat method kinemat analysi implement concept instabl factor translat angular compon motion evalu comput increment motion paramet stage spinal bend total amount translat angul obtain combin ratio term instabl factor factor increas linear instabl decreas rotat instabl author review control subject patient chronic lowback pain diagnos patient categor group idiopath lowback pain lumbar disc prolaps degen disc diseas radiograph subject spine level obtain low dose radiographi perform serial subject move full extens full flexion found group patient degen disc diseas averag agecorrect instabl factor mmradian signific larger normal subject mmradian signific differ instabl factor patient idiopath lowback pain lumbar disc prolaps"
"lumbar isthmic spondylolisthesi children adolesc radiolog evalu result oper treatment clinic radiolog follow studi group children adolesc compris boy girl underw spondylodesi spondylolisthesi year report sagitt rotat lumbosacr joint angl lumbar lordosi wedg olisthet vertebra round upper sacrum show statist correl amount slip note estim risk progress spondylolisthesi spondylolisthesi accompani scoliosi note close correl patient profit oper solid fusion achiev case posterolater spondylolysi perform graft iliac crest interbodi fusion techniqu combin turn reliabl surgic method combin techniqu requir case high degre slip"
"knodt rod distract instrument lumbosacr arthrodesi review patient undergo lumbosacr fusion year period determin effici safeti knodt rod distract instrument age rang year age year follow year twenti patient underw decompress fusion spinal stenosi underw spinal arthrodesi instabl underw spondylolisthesi underw fusion diagnos posterior midlin approach lamin hook site prepar care prevent dural compress tent balanc distract restor soft tissu tension stabil attempt made reduc deform posterior mass fusion augment allograft bone perform patient autogen bone major patient custommold lumbosacr orthosi month oper neurolog complic dural tear pseudomeningocel sacral lamina instrument patient patient underw rod remov reason remov pain due loosen patient failur fusion rod remov patient abnorm found insert sacral lamina lead neurolog complic major problem loosen necessit rod remov patient knodt rod distract instrument safe effect method intern fixat lumbosacr fusion"
"microscop assist posterior lumbar interbodi fusion microscop assist posterior lumbar interbodi fusion perform patient spondylolisthesi chronic lower back pain previous lower back surgeri improv satisfactori result occur patient roentgenograph stabl interbodi fusion occur patient poorest result highest rate pseudarthrosi occur patient doublelevel fusion pseudarthrosi occur patient doublelevel fusion unsatisfactori clinic result occur patient doublelevel fusion advantag microscop techniqu examin surgic site blood loss surgic dissect surgic salvag techniqu procedur reserv singlelevel patholog lumbosacr spine"
"role supraspinatus infraspinatus muscl glenohumer kinemat anterior instabl investig socket mechan respons control kinemat static posit glenohumer joint suprascapular nerv block perform select patient recurr anterior instabl defect labrum kinemat document roentgenogram posit horizont motion plane combin paralysi supraspinatus infraspinatus muscl result abnorm anterior translat roentgenogram normal ballsocket kinemat retain remain roentgenogram consist arthroscop find undamag glenoid articular surfac detach absent labrum injuri labrum reduc depth socket half half socket provid contour glenoid remain intact balanc muscl envelop requir maintain normal kinemat select activ posit unstabl shoulder retain glenoid depth suffici produc observ ballsocket kinemat vivo studi shoulder kinemat clarifi interact role socket muscl envelop maintain glenohumer stabil demand stress activ shoulder motion"
"histolog immunohistochem studi calcium pyrophosph dihydr crystal deposit diseas articular cartilag synovi membran meniscus ten patient calcium pyrophosph dihydr cppd crystal deposit diseas show strong immunoreact dermatan sulfat proteoglycan type collagen protein hypertroph chondrocyt crystal pericellular matrix deposit crystal electron microscopi reveal small crystal form hypertroph chondrocyt degener matrix electrondens granular materi cellular debri chondrocyt kind observ articular tissu ten patient osteoarthrosi hypertroph chondrocyt uniqu immunohistochem characterist initi format cppd crystal"
"famili cervic dysplasia twelv famili member generat affect inherit form cervic vertebr dysplasia affect peopl abnorm cervic vertebra defect axi caudad mode transmiss disord autosom domin appar complet penetr variabl express patient symptom passiv correct tilt head audibl clunk hypoplasia left superior facet cervic vertebra patient local symptom neurolog involv muscl spasm patient suboccipit pain develop radiograph reveal anterior atlantooccipit disloc symptom resolv reduct arthrodesi appar complet penetr disord physician care patient type congenit malform cervic spine examin close relat member famili clinic find tilt head torticolli limit cervic motion suggest addit evalu examin includ radiograph cervic spine flexion extens dimension computedtomographi reformat demonstr complex cervic anatomi patient patient recogn abnorm examin local neurolog symptom develop magnet reson imag spine flexion extens valuabl identif potenti disastr situat impend damag cord patient instabl evolv symptom"
"tibial collater ligament bursa mr imag bursa tibial collater ligament tcl visual magnet reson mr imag distend fluid author experi find signifi patholog condit medial capsuloligament complex bursa find tcl bursiti tcl bursiti suspect set isol pain medial joint line absenc mechan symptom prolong relief symptom inject steroid bursa support diagnosi case present fluidfil tcl bursa identifi mr imag case tcl bursiti suspect differenti diagnosi mr find discuss"
"deposit calcium pyrophosph dihydr crystal ligamentum flavum evalu mr imag ct patient spinal canal stenosi deposit calcium pyrophosph dihydr ligamentum flavum radiolog evalu perform magnet reson imag comput tomographi surgeri perform patient patholog examin surgic specimen demonstr deposit calcium pyrophosph crystal ligamentum flavum focal enlarg ligamentum flavum present cervic spine diffus bilater enlarg identifi lumbar spine enlarg ligament caus compon spinal stenosi caus neurolog sign symptom patient evid calcium pyrophosph deposit deposit calcium pyrophosph dihydr ligamentum flavum caus focal diffus enlarg signific spinal stenosi"
"anterior tibial translat maximum quadricep contract clinic signific quadricep exercis spare earli rehabilit acl reconstruct concern prematur stretch acl graft aim studi determin maximum isometr quadricep contract signific translat tibia anterior degre degre degre degre degre flexion role acl knee stabil analyz compar amount tibial translat normal acl defici reconstruct knee locat motion arc quadricep contract produc anterior tibial translat determin anterior tibial translat measur arthromet kt manual maximum translat appli knee rest manual maximum translat test determin magnitud anterior tibial translat produc high anterior forc appli direct proxim calf translat compar tibial translat intrins induc quadricep contract test perform normal acl defici reconstruct knee anterior tibial translat produc maximum quadricep contract measur degre degre degre degre degre flexion extens exercis result anterior tibial displac drawer half translat produc manual maximum translat instrument laxiti test produc greater anterior translat tibia maximum isometr quadricep contract anterior tibial translat maximum isometr knee extens test knee"
"contribut glenohumer ligament anterior stabil shoulder joint purpos studi investig ligament stabil mechan prevent anterior instabl glenohumer joint fresh thaw unembalm cadaver shoulder dissect preserv joint capsul glenohumer ligament coracohumer ligament subscapulari tendon halleffect strain transduc superior middl inferior glenohumer ligament humerus scapula fix specif design mount apparatus glenohumer joint degre degre degre abduct mount apparatus model ttc instron univers test instrument appli extern rotat torqu humerus strain produc glenohumer ligament record channel chart record degre abduct superior middl glenohumer ligament develop strain degre abduct inferior middl glenohumer ligament develop strain strain develop superior glenohumer ligament degre abduct inferior glenohumer ligament develop strain strain middl glenohumer ligament"
"miner balanc infantil cortic hyperostosi effect corticosteroid effect miner metabol therapeut dose corticosteroid investig infantil cortic hyperostosi untreat case calcium phosphorus magnesium balanc strong posit sever case treatment prednisolon alter negat calcium magnesium balanc faecal loss calcium high effect persist month steroid discontinu period pronounc retard linear growth month treatment stop miner balanc posit rapid catch growth infanc negat effect corticosteroid calcium phosphorus magnesium metabol contribut inhibit bone growth steroid stunt"
"bone resorpt stabil softtissu larg chin advanc larg advanc genioplasti perform patient advanc mm horizont osteotomi inferior border mandibl preserv musculoperiost pedicl advanc genial segment preoper postop longterm follow cephalometr radiograph retrospect analyz evalu osseous softtissu chin follow period month initi advanc preserv repres osseous resorpt envelop soft tissu chin boni movement ratio horizont osteotomi inferior border mandibl stabl procedur larg chin advanc broadcast musculoperiost pedicl remain attach advanc genial segment minim osseous resorpt achiev predict softtissu"
"applic techniqu cotreldubousset instrument scoliosi deform case posterior cotreldubousset spinal instrument devic devic choic techniqu effect correct kind spinal deform requir lengthi preoper plan technic demand surgic procedur versatil adapt spinal deform cotrel dubousset techniqu rigid system immobil requir postop immobil patient resum normal live activ quick"
"minor anatom abnorm hip joint persist childhood relationship idiopath osteoarthrosi retrospect review made roentgenogram patient idiopath osteoarthrosi hip roentgenogram onset earli diseas measur made anteroposterior crosstabl roentgenogram compar hip normal patient twenti patient abnorm measur singl individu compar normal patient abnorm control group avail view addit dimens ad previous studi literatur studi lend support biomechan theori etiolog idiopath osteoarthrosi hip"
"radiocolloid manag hemophil arthropathi children adolesc radiocolloid treatment hemophil arthropathi fifti joint patient inject mci yttrium silic local anesthesia preinject arthrogram perform ensur correct placement needl plaster pari cast immobil joint day follow period year rang year joint pain free joint experienc hemorrhag episod hemorrhag frequenc decreas month year radiat risk outweigh benefit procedur forti joint rate improv patient roentgenograph joint chang complic occur needletrack necros extravas radiocolloid sever pain joint immedi inject massiv hemorrhag episod form treatment suggest hemophiliac fail respond intens physic hematolog therapi patient inhibitor"
"congenit anomali cervic spine congenit anomali cervic spine uncommon major afflict individu asymptomat mild restrict neck motion symptom develop due cervic instabl degen osteoarthrosi recent inform patient upper cervic anomali atlantooccipit fusion anomali odontoid transvers atlant ligament great propens develop earli instabl neurolog problem secondari minor traumat event symptom occur lower cervic spine adult life due degen arthriti hypermobil articul adjac area synostosi good prognosi cervic lesion overshadow hidden unrecogn anomali high incid signific scoliosi sprengel deform renal anomali deaf neurolog malform earli recognit treatment problem substanti benefit spare patient deform ill"
"osteoarthrosi retard develop osteoporosi observ coexist osteoarthrosi osteoporosi clinic roentgenograph biochem featur dorsal lumbar spine review postmenopaus women nineteen women osteoporosi vertebr collaps osteoarthrosi patient compar patient osteoarthrosi spine vertebr collaps patient spinal osteoporosi osteoarthrosi older advanc menopaus physic smaller statur bodi weight group higher serum parathyroid hormon level nonthiazid diuret frequent nullipar group patient osteoarthrosi hip lesser degre patient affect osteoarthrosi fewer fractur forearm site patient osteoporosi incid femor neck fractur group compar result suggest osteoarthrosi relat factor protect effect progress osteoporosi result confirm earlier observ postmenopaus osteoporosi osteoarthrosi distinct diseas result normal age"
"analysi case vertebr osteomyel sixti case bacteri vertebr osteomyel juli juli analyz age men women rang year portal entri hematogen case gunshot wound case adjac retroperiton abscess case biopsi perform patient complic relat diseas gramneg rod predomin bacteria isol blood cultur posit patient test eleven organ isol blood cultur correl organ recov biopsi specimen eleven patient disk level involv patient spontan fusion lost follow studi fail fuse surgic fusion patient die recommend diagnosi includ collect blood cultur radionuclid bone scan manag recommend includ system antibiot week immobil bed rest spinal orthos surgeri abscess present neurolog complic occur instabl factor medic treatment fail"
"fraction lengthen flexor tendon clubfoot surgeri massiv scar lengthen flexor digitorum flexor halluci longus constant find clubfoot surgeri method fraction lengthen tendon method proven effect prevent complic"
"histochem local calcium potassium pyroantimon articular tissu calcium pyrophosph dihydr crystal deposit diseas ultrastructur local calcium articular cartilag meniscus synovium patient calcium pyrophosph dihydr cppd crystal deposit diseas examin potassium pyroantimon focal area deposit cppd crystal tissu show electrondens precipit antimonycalcium complex cytoplasm hypertroph chondrocyt cppd crystal margin intracellular lipid droplet electrondens amorph materi margin lipid droplet electrondens amorph materi degener matrix surround hypertroph chondrocyt slender rodlik structur consist electrondens precipit antimonycalcium complex suggest precursor rodlik cppd crystal observ degener matrix find suggest hypertroph chondrocyt contribut format cppd crystal intracellular accumul calcium subsequ releas high concentr calcium surround matrix"
"method assess clubfoot deform literatur clubfeet inadequ common method languag assess deform lack sever clubfoot deform give result standard procedur sever deform correct limit releas sever deform requir radic procedur paper present languag assess number year import develop languag assess identifi type clubfoot deform import treatment condit develop field pediatr orthoped"
"perspect recent trend scoliosi correct basic principl scoliosi surgeri learn harrington era valid today experi confirm care select vertebra instrument anterior releas rigid curv impart convert deform import care fusion techniqu decad develop occur increas knowledg biomechan intern instrument spine dimension appreci scoliot curv biomechan advanc center understand loadshar properti afford multipl spinal purchas site segment spinal instrument rod system link coupler advanc provid increas stiff instrument spine reduct correct loss improv fatigu properti implant fewer pseudarthros import advanc decad improv awar dimension approach scoliot deform preserv improv sagitt contour import loss normal thorac kyphosi lumbar lordosi emphas conceptu gain led develop instrument system correct deform advantag problem risk understood make intellig choic treatment"
"recoveri osteopenia adolesc girl anorexia nervosa osteopenia frequent complic anorexia nervosa determin deficit bone miner ill studi adolesc patient prospect month dual photon absorptiometri spine bodi follow weight height bodi mass index bmi increas signific girl weight loss minim gain kg spontan mens occur girl estrogen replac bone miner densiti lumbar spine chang signific sd cm bodi bone miner densiti increas  gain bone miner patient osteopenia spine bodi weight height bmi signific predictor chang bone miner densiti increas bone mass occur weight gain return mens convers weight loss decreas bone densiti patient fail gain weight estrogen therapi result increas spinal bodi bone miner studi group women recov adolesc normal bodi bone miner age osteopenia lumbar spine conclud osteopenia adolesc reflect bone loss combin decreas bone accret weight rehabilit result increas bone miner return mens estrogen independ effect bone mass persist osteopenia recoveri deficit bone miner acquir adolesc complet revers"
"prospect doubl blind dummi placebo control studi compar triamcinolon hexacetonid inject oral diclofenac mg tds patient rotat cuff tendin prospect doubl blind placebo control studi carri compar effect subacromi inject triamcinolon oral diclofenac patient rotat cuff tendin week period form treatment superior placebo reduc pain improv activ abduct reduc function limit triamcinolon show greatest effect respect signific superior diclofenac patient show improv variabl respond consid"
"growth promot peptid osteoarthr insulin insulin growth factor growth hormon alter cartilag bone radiograph fundament featur osteoarthr oa endogen compound regul bone cartilag metabol quantifi radioimmunoassay patient oa suitabl normotens control match age sex race height weight level growth promot compound abnorm oa demonstr low level insulin growth factor igf elev level insulin growth hormon gh compar control find support role peptid pathophysiolog oa"
"asymptomat versus symptomat herniat thorac disc frequenc characterist detect comput tomographi myelographi retrospect review myelogram patient identifi symptom sign refer thorac cord root nerv postmyelographi comput tomograph scan criteria frequenc asymptomat thorac herniat disc athd calcul postmyelographi comput tomograph scan athd analyz imag characterist compar seri symptomat thorac herniat disc symptomat thorac herniat disc literatur unabl identifi imag featur reliabl classifi disc athd symptomat thorac herniat disc result call question proprieti prophylact surgeri athd lesion radiograph impress"
"spinal charcot arthropathi charcot joint spine document clinic entiti common tabe dorsali spinal neuropath joint produc diseas process includ syringomyelia review author discuss treatment spinal charcot arthropathi emphasi surgic therapi result"
"radiograph manifest congenit anomali skull congenit anomali pediatr skull caus divers group disord purpos discuss entiti classifi radiograph skull similar varieti diseas enlarg pariet foramina sinus pericranii aplasia cuti congenita anterior fontanell dermoid cephalocel craniolacunia exampl locel craniolacunia exampl calvari defect numer wormian bone tabl oi cleidocrani dysplasia congenit hypothyroid hypophosphatasia disord common defect ossif wormian bone osteopetrosi import rare boni dysplasia sclerosi hyperostosi skull partial list disord caus similar radiograph find found tabl craniosynostosi result abnorm skull shape sutur involv predict deform calvari configur knowledg growth develop skull understand vari congenit skull anomali enabl radiologist provid diagnosi inform differenti diagnosi confront specif radiograph find"
"mild spondyloepiphys dysplasia namaqualand type genet linkag type ii collagen gene cola namaqualand spondyloepiphys dysplasia nsed mild autosom domin form spondyloepiphys dysplasia maxim femor capit epiphys vertebr bodi condit present larg multigener south african famili clinic import virtu sever progress degen osteoarthropathi hip joint frequent necessit prosthet joint replac adulthood linkag studi molecular marker shown loci nsed type ii collagen gene link lod score recombin fraction"
"quantit gait analysi unilater bilater total hip replac qualit quantit analysi gait evalu outcom patient total hip arthroplasti degen arthriti patient unilater bilater degen hip diseas evalu effort character preoper postop gait characterist patient evalu subject hiprat scale gaitevalu mat data compar obtain control group patient patient show mark improv subject rate measur quantit gait paramet patient unilater hip diseas improv greater extent bilater diseas arthroplasti conclud total hip arthroplasti great improv gait characterist patient degen arthriti improv quantifi document system gait evalu"
"indomethacin inhibit middl ear bone resorpt local osteoclast bone resorpt respons patholog middl ear result hear loss vertigo chronic otiti media otosclerosi local control osteoclast bone resorpt incomplet understood small local activ molecul cytokin shown affect resorpt process addit prostaglandin inhibitor shown modul resorpt process number vitro studi studi indomethacin cyclooxygenas inhibitor test model local bone resorpt pressur gerbil bulla experiment period indomethacin found inhibit number osteoclast resorpt area surfac bulla endogen cyclooxygenas metabolit intermedi sequenc cellular event result local bone resorpt system model"
"muscl perform voluntari activ twitch properti perceiv effort normal subject patient chronic fatigu syndrom decreas maxim forcegener capac degre central activ muscl subject percept effort measur prolong submaxim isometr exercis male patient suffer chronic fatigu syndrom naiv healthi male subject maxim voluntari isometr torqu generat elbow flexor measur min interv endur sequenc min repetit isometr contract durat rest interv produc initi maxim voluntari torqu electr stimuli deliv elbow flexor measur contractil forc interv voluntari contract degre central motor activ maxim voluntari contract assess sensit method twitch interpol addit perceiv effort requir achiev target submaxim contract record standard report scale high degre central activ achiev maxim contract endur sequenc patient maxim forc sd control subject sd relat torqu produc voluntari electr stimul contract signific patient control subject test signific differ perceiv exert patient control subject find support concept poor motiv muscl contractil failur import pathogenesi fatigu patient chronic fatigu syndrom"
"differenti regul insulin growth factor igf igfii releas cultur neonat mous calvaria parathyroid hormon transform growth factorbeta dihydroxyvitamin previous studi found pth stimul bone resorpt releas insulin growth factor igf igfii cultur neonat mous calvaria igf igfii stimul osteoblast prolifer collagen synthesi result suggest increas releas igf resorpt mediat part coupl bone format bone resorpt present studi osteolyt agent transform growth factorbeta tgf beta dihydroxyvitamin examin effect igf releas neonat mous calvaria pth tgf beta stimul resorpt increas releas igf igfii stimul resorpt igfii releas compar pth inhibit releas igf nm inhibit basal releas igf nm inhibit releas igf induc pth tgf beta effect specif vitamin metabolit occur hydroxyvitamin concentr calcitonin muml decreas stimul resorpt affect stimul igfii releas inhibit igf releas evid effect releas igf independ bone resorpt support conclus modul product secret igf igfii calvari cell result previous studi suggest pth tgf beta differenti regul mous calvari cell igf igfii product"
"cyclosporin vitro decreas bone resorpt osteoclast format fusion cell monocytemacrophag lineag studi vitro effect cyclosporin cya bone resorpt fetal rat long boneresorb assay cya inhibit pthstimul unstimul bone resorpt inhibitori effect cya basal resorpt dose depend pronounc period equal microgramml cultur day period day cytotox effect rule absenc decreas hthymidin incorpor bone concentr microgramsml cya histomorphometri perform day cultur show cya microgramml decreas number osteoclast bone section day cultur osteoclastsbon section day  data suggest effect cya osteoclast differenti function matur osteoclast assess mechan inhibitori effect cya osteoclast differenti order determin level action prolifer fusion osteoclast precursor action direct indirect autoradiograph studi perform bone section incub bone hthymidin cultur cya decreas slight signific percentag label nuclei osteoclast number osteoclast label nucleus  number nuclei osteoclast decreas day cyatreat bone  result demonstr cya slight decreas prolifer osteoclast precursor mark decreas fusion similar effect observ cultur rat marrow macrophag cya microgramml inhibit fusion macrophag multinucl cell elicit nm dihydroxyvitamin slight effect prolifer cell assess autoradiographi cya inhibit format multinucl cell fusion index long term cultur human cord blood monocyt cellular model osteoclast differenti contrast cya effect format myotub fusion cultur mononucl rat myoblastsabstract truncat word"
"recurr nonsens mutat growth hormon receptor patient laron dwarfism addit classic effect growth growth hormon gh shown number action initi interact specif high affin receptor present varieti tissu purif rabbit liver protein abil bind gh isol cdna encod putat human growth hormon receptor belong class transmembran receptor previous shown putat growth hormon receptor gene genet link laron dwarfism rare autosom recess syndrom caus target resist gh inabl express fulllength code sequenc lack test growthpromot function hamper direct confirm role growth identifi nonsens mutat growth hormon receptor gene lie posit amino termin extrem caus truncat molecul delet larg portion gh bind domain full transmembran intracellular domain independ patient laron dwarfism born consanguin parent homozyg defect defect ident consist cg tg transit result confirm growthpromot activ receptor suggest cpg doublet repres hot spot mutat growth hormon receptor gene respons hereditari dwarfism"
"characterist respond nonrespond prospect studi osteoporosi cohort elder japanes american live hawaii recruit epidemiolog studi osteoporosi male subject simultan examin epidemiolog studi heart diseas baselin data collect men women previous heart diseas examin compar respond nonrespond target popul osteoporosi studi consist men women men women particip initi osteoporosi examin sex nonrespond older higher systol blood pressur level respond male nonrespond higher stroke preval frequent recent vasodil medicin femal nonrespond frequent histori femal hormon respond respond nonrespond similar respect comparison variabl suggest nonrespons bias major influenc exposurediseas associ osteoporosi cohort publish report deal nonrespons characterist cohort studi osteoporosi"
"nurs manag adolesc idiopath scoliosi manag adolesc idiopath scoliosi patient intric patient brace surgeri recommend lot teach assess compass deal adolesc biggest concern peer import independ decis make brace surgic intervent long understand consequ newer surgic instrument anesthesia nurs care postop mobil chang manag oper scoliosi patient signific nurs assess neurolog respiratori function emot development adolesc patient chang nurs understand rational assess treatment restrict teach patient famili"
"spinal stenosi arthriti arthriti spinal stenosi result disc degener narrow accompani facet joint culmin nerv root entrap symptom back leg pain gradual period year slowli worsen patient older patient treat initi nonop measur concentr pain relief mainten activ symptom worsen surgic intervent reliev pain decompress affect nerv root patient instabl requir fusion patient satisfi result surgeri reliev preoper leg pain pain relief dramat patient return normal activ elder patient toler procedur surpris age contraind surgeri elder deni benefit surgic decompress nurs intervent patient learn spinal stenosi assist pursu treatment result improv qualiti live"
"rectal examin general practic object investig factor influenc general practition decis rectal examin patient anorect urinari symptom designpost questionnair survey settinggener practic london devon subject general practition return questionnair main outcom measuresnumb rectal examin month indic score deriv answer question respond rectal examin symptom confid score respond confid diagnosi made rectal examin result general practition fewer rectal examin month month factor signific fewer rectal examin small partnership femal general practition expect examin repeat lack time surgeri wait time week urgent outpati appoint import general practition deter rectal examin reluct patient expect examin repeat lack time chaperon confid diagnosi signific rectal examin percept taught rectal examin medic school male general practition conclusionsfactor clinic judgment influenc frequenc rectal examin general practic rectal examin common trend larger group practic diagnost confid increas greater emphasi put rectal examin undergradu postgradu teach"
"gracili muscl transposit faecal incontin transposit gracili muscl faecal incontin perform patient gain satisfactori contin improv benefit oper patient die intercurr diseas closur preexist colostomi anal manometri compar control group show alter rest pressur median mmhg rang mmhg maximum squeez pressur increas median mmhg rang mmhg mmhg rang mmhg signific lower mmhg rang mmhg control group patient benefit oper increas maximum squeez pressur abil retain viscous fluid rectum measur patient gain satisfactori contin improv contin retain median volum ml rang ml leakag compar ml rang ml control group patient retain maximum amount viscous fluid min control subject min conclud gracili transposit result normal contin accept contin achiev select patient provid care attent paid technic detail procedur provid systemat postop exercis perform"
"anatomi anal sphincter relat structur contin women studi magnet reson imag anal contin nullipara reproduct age studi magnet reson imag intern extern anal sphincter easili delin interven longitudin musculatur puborectali muscl anococcyg raph anorect lumen vagina uterus bladder urethra coccyx pubi shape sphincter cylindr anterior compon averag mm thick mm long fifti percent anterior thick attribut intern sphincter anorect angl vari degre rang angl portion rectal lumen support anococcyg raph levat plate plane puborectali muscl consist degre find anterior anal sphincter substanti thick length contrast mark view pictur literatur femal anal sphincter narrow anterior half posterior length form small bundl muscl broad band knowledg relationship import primari repair obstetr sphincter lacer surgic correct anal incontin"
"final outcom ursodeoxychol acid treatment patient radioluc gallston hundr twenti patient radioluc gallston function gallbladd treat mg ursodeoxychol acid udca kgday treatment conclus complet partial gallston dissolut achiev cent achiev complet gallston dissolut judg normal oral cholecystogram ultrasonogram perform patient normal udca stop patient cystic duct obstruct sever biliari pain respons partial stone dissolut arrest progress lifet analysi show complet gallston dissolut rate year cent normal oral cholecystogram cent normal oral cholecystogram ultrasonogram patient complet gallston dissolut shown partial stone dissolut month partial stone dissolut month cent complet gallston dissolut year efficaci correl invers stone size age sex obes treatment satur indic acquir surfac gallston calcif develop patient lifet analysi cent year patient achiev complet gallston dissolut achiev partial stone dissolut high partial gallston dissolut rate ultim efficaci udca achiev complet gallston dissolut low"
"reactiv hepat virus replic patient receiv cytotox therapi report prospect studi hundr chines patient receiv induct cytotox therapi malign lymphoma prospect studi determin incid morbid mortal predispos factor reactiv hepat virus replic cytotox therapi hepat surfac antigenposit hepat surfac antigenneg patient hepat develop cytotox therapi hepat attribut exacerb reactiv chronic hepat hepat surfac antigenposit patient hepat surfac antigenneg patient sudden increas reactiv hepat virus replic gave rise icter hepat nonfat hepat failur death patient posit hepat surfac antigen posit hepat antibodi seroneg hepat surfac antigenposit patient male sex factor increas risk reactiv hepat virus replic recommend hepat surfac antigenposit patient malign receiv cytotox therapi close monitor"
"safeti day sequenti extracorpor shock wave lithotripsi dissolut gallston methyl tertbutyl ether dog passag stone fragment extracorpor shock wave lithotripsi eswl gallston result biliari colic duct obstruct pancreat patient rapid dissolut fragment methyl tertbutyl ether mtbe prevent side effect achiev complet clearanc gallston hour month year longer studi examin safeti day eswl fragment mtbe dissolut surgic implant human gallston dog anim random assign treatment group assess mtbe absorpt gallbladd observ hematolog chemistri profil shock wave lithotriptor mtbe dissolut therapi sacrif immedi treatment dog week dog result demonstr eswl moder trauma gallbladd result increas mtbe absorpt histolog evid mucos disrupt blood profil demonstr increas level aspart aminotransferas dog sacrif week combin treatment residu evid gallbladd injuri remain stone materi anim sever injuri occur shock wave pass lung airfil colon studi suggest day sequenti fragment gallston eswl dissolut stone fragment mtbe mild moder revers gallbladd trauma rapid achiev clearanc gallston"
"famili occurr inflammatori bowel diseas background method assess famili occurr inflammatori bowel diseas copenhagen counti longterm interest epidemiolog disord interview patient inflammatori bowel diseas diagnos degre relat disord nineti percent patient ulcer coliti crohn diseas provid adequ inform result compar general popul degre relat patient ulcer coliti crohn diseas fold increas risk diseas patient standard age sex risk diseas increas increas risk crohn diseas signific relat patient ulcer coliti risk ulcer coliti degre relat patient ulcer coliti virtual independ generat degre relat belong sex patient relat risk ulcer coliti degre relat tend higher diseas diagnos patient age risk independ current age relat preval diseas patient ulcer coliti crohn diseas degre relat increas preval diseas increas conclus fold increas famili risk ulcer coliti crohn diseas strong suggest disord genet"
"retain intrahepat stone treatment piezoelectr lithotripsi combin stone extract extracorpor shock wave lithotripsi eswl perform patient orient cholangiohepat intrahepat stone segment strictur intrahepat duct patient previous undergon biliari surgeri basket extract tube tract time lithotripsi indic eswl failur anticip difficulti basket extract stone tube tract piezoelectr lithotriptor procedur averag total number shock wave administ rang averag number treatment session rang number shock wave singl session rang frequenc shot power patient stone success fragment complet remov stone fragment remov success rate includ complet incomplet success difficulti target stone sever strictur deform intrahepat duct factor respons failur signific complic observ"
"oral cholecystographi contemporari gallston imag review introduct nonop altern elect cholecystectomi manag gallston resurrect oral cholecystographi ocg articl review basic principl involv proper perform ocg interpret result imag role ocg current manag gallston discuss"
"rest total energi expenditur patient inflammatori bowel diseas patient inflammatori bowel diseas present weight loss elev energi expenditur frequent suggest document studi rest metabol rate rmr total daili energi expenditur tdee measur outpati inflammatori bowel diseas healthi control subject measur rmr percentag predict fatfre mass signific control subject sd patient tdee express multipl rmr control subject patient patient subgroup greater equal desir bodi weight increas rmr predict fatfre mass underweight patient normalweight patient tdeermr valu patient subgroup conclud stabl outpati inflammatori bowel diseas minim increas energi"
"factor affect enterohepat circul oral contracept steroid oral contracept steroid undergo enterohepat circul relev estrogen compound direct conjug liver anim studi show convinc evid import enterohepat circul studi human convinc import rout rate metabol ethinyl estradiol review antibiot report anecdot reduc efficaci oral contracept steroid control studi confirm observ gut flora alter oral antibiot blood level ethinyl estradiol reduc antibiot cotrimoxazol enhanc activ ethinyl estradiol"
"efficaci octreotid acet treatment sever postgastrectomi dump syndrom present studi evalu acut chronic longact somatostatin analog octreotid acet treatment patient sever postgastrectomi dump syndrom acut phase patient sever dump studi consecut day hour ingest dump breakfast random doubleblind fashion day octreotid microgram subcutan minut test meal day equal volum vehicl inject addit group postgastrectomi patient dump studi similar fashion act control placebo treatment test meal result increas puls rate plasma level glucos glucagon pancreat polypeptid neurotensin insulin similar control group respect placebo glucagon neurotensin show magnitud increas placebo treatment octreotid acet prevent develop vasomotor gastrointestin symptom complet ablat respons plasma peptid complet ablat diarrhea pretreat octreotid acet complet suppress rise plasma insulin respons meal ablat late hypoglycemia dump treatment octreotid acet result delay gastric empti transit time minut versus minut placebo minut control chronic daili treatment octreotid acet result minim side effect patient demonstr stabl fast plasma glucos normal liver function test averag weight gain month period addit patient resum employ longact somatostatin analog octreotid acet high effect prevent develop symptom sever dump syndrom vasomotor gastrointestin"
"autolog implant periton mesothelium rabbit man purpos studi periton physiolog origin biopsi method devis human rabbit periton mesotheli cell cultur character decid verifi cell implant autolog periton dialysi case acut loss mesotheli surfac staphylococc periton induc rabbit day antibiot autoimpl cultur mesotheli cell previous mark case thymidin htdr implant rabbit sacrif day show mesotheli cell direct morpholog observ autoradiographi urem capd patient recov sever periton implant million periton mesotheli cell previous cultur frozen morpholog sign evid laparoscopi periton biopsi perform day implant fact implant interest applic medicin surgeri"
"attenu alcoholinduc hepat fibrosi polyunsatur lecithin characterist featur alcohol liver injuri includ fibrosi strike membran alter phospholipid offset abnorm yr studi conduct baboon anim femal male fed liquid diet supplement polyunsatur lecithin mgkcal yr ethanol total energi isocalor carbohydr compar group baboon fed equival amount diet ethanol devoid lecithin group compar increas lipid develop ethanolf anim strike differ degre fibrosi septal fibrosi cirrhosi transform lipocyt transit cell develop baboon fed regular diet ethanol septal fibrosi develop anim fed lecithin progress stage perivenular fibrosi pericellular perisinusoid fibrosi signific lesser activ lipocyt transit cell anim lecithin continu amount ethanol diet rapid mo progress cirrhosi accompani increas transform lipocyt transit cell result compon lecithin exert protect action fibrogen effect ethanol previous found cholin amount present lecithin compar action polyunsatur phospholipid respons protect effect"
"hepat virus nucleocapsidpr fusion protein express attenu salmonella oral vaccin hybrid hbv nucleocapsidpr fusion protein stabli express aromaticdepend attenu salmonella typhimurium salmonella dublin strain live recombin bacteria administ balb mice induc high titer antihepat virus core ag hbc detect antipr serum antibodi oral feed recombin salmonella mice rate seroconvers antihbc depend salmonella strain carrier strain high titer antihbc antibodi lower titer antipr serum igg antibodi observ week singl oral immun ig class igg subclass distribut antihbc antibodi oral immun consist induct function cell"
"isol character cdna encod human nuclear antigen predomin recogn autoantibodi patient primari biliari cirrhosi autoantibodi nuclear ag sp recent recogn nuclear protein appar molecular mass kda dot distribut cell nuclei immunoscreen lambda gt cdna express librari deriv hela cell antisp autoimmun serum kb cdna sp code fragment sp isol express cdna recombin protein elisa reveal fragment carri major sp autoepitop antisp autoantibodi predomin occur patient suffer primari biliari cirrhosi sp cdna hybrid probe isol longer cdna human liver placentaderiv lambda gt cdna librari overlap fragment assembl generat full length cdna code protein molecular mass kda isoelectr point sp autoantigen express vitro cdna authent captur immunoblot assay comigr sdspage authent hela autoantigen kda show aberr electrophoret mobil comput base protein sequenc analysi sp autoantigen reveal region strike sequenc similar alpha alpha domain human human mhc class ag transact transcript regulatori protein"
"evid target oxodehydrogenas enzym cell respons primari biliari cirrhosi primari biliari cirrhosi pbc chronic autoimmun liver diseas includ presenc lymphoid infiltr portal tract high titer autoantibodi pyruv dehydrogenase pdhe branch chain ketoacid dehydrogenase bckde biliari tract destruct mechan autoimmun respons induc specif damag biliari epithelium role cell pbc unknown address issu advantag mous mab coin studi reactiv panel liver tissu normal subject panel liver specimen patient pbc progress scleros cholang chronic activ hepat cah human autoantibodi pdhe react exclus immunoblot pdhe bind lipoyl domain protein inhibit pdhe activ vitro addit attempt develop clone cell line react pdhe bckde liver biopsi patient pbc compar cah monoclon produc typic mitochondri fluoresc section normal liver pancrea lung heart thyroid kidney produc distinct intens reactiv stain bile duct patient pbc pbc liver biopsi studi bile duct light microscopi react intens cultur supernat dilut monoclon contrast bile duct liver specimen normal cah progress scleros cholang react reactiv exclus mitochondri readili detect dilut import generat cd cd alpha beta tcr clone cell line patient pbc cah produc il specif respons pdhe bckde"
"pharmacist health consultantten year pharmacist remain readili access trust sourc inform health order assess qualiti counsel health matter progress profess activ decad studi similar report conduct visit communiti pharmaci request advic pharmacist proper treatment infant diarrhea interview volunt addit inform question pharmacist answer predetermin hypothet case involv month infant diarrhea vomit find includ approxim pharmacist recommend product caution percent inquir fever nausea vomit diet infant condit pharmacist approach health counsel increas awar harm potenti provid inappropri medic inform"
"warnerlambertparkedavi award lectur pathobiolog intestin epitheli barrier major rout passiv permeat intestin epithelia paracellular intercellular tight junction lie serv ratelimit barrier paracellular pathway view static clear structur permeabl tight junction high dynam inflammatori event cytokin neutrophil transmigr revers effect tight junction key barrier regul physiolog event activ absorpt cell nanutri cotransport physiolog regul junction major import absorpt nutrient parcellular solvent drag"
"clinic featur misdiagnos append children studi object compar clinic featur children misdiagnos append children append initi diagnos correct design retrospect review hospit emerg depart clinic record set univers medic center annual ed census patient particip children year admit april discharg diagnosi append measur record review histor physic examin laboratori patholog featur patient initi present physician final present correct diagnosi made chi analysi student test clinic featur misdiagnos patient patient diagnos correct compar result hundr eighti case identifi initi misdiagnos initi present misdiagnos patient younger vomit pain onset constip diarrhea dysuria sign symptom upper respiratori infect misdiagnos case lower quadrant tender document bowel sound periton sign rectal examin final present misdiagnos patient pain durat day temperatur letharg irrit measur conclus clinic featur children misdiagnos append differ children append initi diagnos correct"
"effect tetrahydroaminoacridin cognit function behaviour alzheim diseas object determin efficaci tetrahydroaminoacridin tha alzheim diseas design random doubleblind multipl crossov trial treatment period consist week activ drug therapi week placebo administr set referralbas geriatr practic communiti hospit patient thirti patient moder sever alzheim diseas subject includ stage diseas determin reisberg scale psychotrop drug month inform consent obtain patient kin intervent fifti mg tha daili match placebo result initi patient experienc liver toxic gastrointestin side effect studi complet studi toler minimum dose patient clinic statist signific effect tha cognit function status behaviour result individu patient show subgroup tharespons patient conclus tha clinic import benefit alzheim diseas appreci toxic effect"
"primari cytomegalovirus infect gastric ulcer normal host year woman present epigastr pain vomit upper gastrointestin endoscopi reveal gastric ulcer histolog examin biopsi ulcer show cytomegalovirus inclus bodi igm antibodi cytomegalovirus recent primari infect store serum pregnanc month previous cytomegalovirus antibodi evalu immun system reveal abnorm awar case seroconvers document normal host cytomegalovirus infect gastrointestin tract normal host unusu common morbid immunocompromis host cytomegalovirus role pathogenesi gastrointestin lesion nonimmunocompromis patient"
"noninvas measur portal venous blood flow patient cirrhosi effect physiolog pharmacolog stimuli present studi aim evalu combin puls dopplerrealtim ultrasonographi noninvas method measur portal blood flow man measur techniqu perform healthi subject patient portal hypertens ten patient group evalu prior ingest standard meal ensur placebo remain patient group effect isosorbid dinitr mgsl administr placebo studi group food intak caus signific increas portal blood flow mlmin effect due signific rise blood veloc cmsec group isosorbid dinitr signific reduc portal blood flow mlmin signific declin blood veloc cmsec observ placebo administr signific hemodynam effect group result suggest doppler measur gave accur noninvas estim portal blood flow techniqu monitor physiolog pharmolog stimuli patient portal hypertens"
"ulcer proctiti central sweden populationbas epidemiolog studi ulcer proctiti tradit regard subgroup ulcer coliti populationbas epidemiolog studi ulcer proctiti virtual nonexist epidemiolog studi inflammatori bowel diseas uppsala health care region case ulcer proctiti diagnos male predomin male femal ratio annual incid rate higher urban rural area annual incid rate increas threefold period affect age group year age urban rural area sex differ tempor trend epidemiolog characterist ulcer proctiti extens ulcer coliti suggest ulcer proctiti specif diseas etiolog differ extens ulcer coliti"
"epidemiolog inflammatori bowel diseas larg populationbas studi sweden previous populationbas incid studi inflammatori bowel diseas limit small number short durat inadequ casefind address problem identifi person confirm ulcer coliti crohn diseas uppsala health care region agespecif incid rate sex slight greater male ulcer coliti femal crohn diseas incid rate ulcer coliti crohn diseas higher urban rural area annual incid rate ulcer coliti increas studi period rate crohn diseas remain increas incid ulcer coliti result mark increas number patient ulcer proctiti analys year birth cohort suggest born higher risk ulcer coliti crohn diseas effect account born half year season cohort effect combin urban preponder diseas suggest environment involv ulcer coliti crohn diseas"
"induct ps hsp gene marker mucos ulcer digest tract recent discov ps protein express estrogen control subset estrogen receptorposit breast cancer estrogenindepend manner normal stomach mucosa ps gene belong famili gene encod peptid conserv cystein domain domain function ps protein unknown suggest cell growth stimulatori activ report express ps gene digest tract restrict stomach strong induc mucos ulcer tract notabl crohn diseas ps gene express restrict mucos layer adjac ulcer region epiderm growth factorsecret cell lineag shown induc mucos ulcer human hsp gene tandem duplic ps gene domain coexpress ps gene normal stomach mucosa breast cancer express crohn diseas suggest ps gene express provid marker mucos ulcer digest tract"
"diarrhea ciguatera fish poison preliminari evalu pathophysiolog mechan ciguatera fish poison clinic syndrom consist combin gastrointestin neurolog symptom occur eat toxin tropic reef fish major morbid hawaii south pacif australia caribbean effort defin pathophysiolog mechan respons diarrheal compon ill examin effect crude fraction toxin prepar isol rabbit ileal tissu uss chamber model crude toxin prepar prepar toxic ctenochaetus strigosus methanolchloroform toxin fraction prepar pool toxic fish sampl gave strike increas transepitheli electr potenti differ shortcircuit current enterotox activ mediat calcium examin light microscopi intestin mucosa damag toxin prepar data demonstr toxin involv ciguatera fish poison direct stimul intestin fluid secret accompani tissu damag suggest calcium messeng mediat process"
"local calcitonin generel peptid human esophag langerhan cell previous undescrib calcitonin generel peptideimmunoreact intraepitheli cell specimen esophag mucosa obtain biopsi surgic resect individu calcitonin generel peptideimmunoreact cell spars normal mucosa increas mark esophag inaccess routin histolog stain osmic show dendrit form resembl langerhan cell skin cytolog ident determin immunocytochem test human antigen marker ia hladr okt langerhan cell leum leum intraepitheli macrophag cd tcr lymphocyt leu lymphocyt merkel cell chromogranin amin precursor uptak decarboxyl cell doubl local show calcitonin generel peptid immunoreact coloc ia hladr okt marker studi show intraepitheli langerhan cell esophag mucosa calcitonin generel peptid serv immunomodul"
"cirrhosi portal hypertens patient adult niemannpick diseas woman niemannpick diseas type present age upper gastrointestin bleed ascit peripher edema evalu show massiv hepatosplenomegali infiltr liver niemannpick cell cirrhosi evid portal hypertens chronic gastrointestin bleed thrombocyctopenia platelet dysfunct treat success splenectomi cirrhosi portal hypertens report previous adult niemannpick diseas absenc"
"mechan gallston format women effect exogen estrogen premarin dietari cholesterol hepat lipid metabol aim defin mechan conjug estrogen premarin exogen estrogen ayerst laboratori york increas risk develop cholesterol gallston determin role dietari cholesterol studi gallbladd motor function biliari lipid composit secret cholesterol absorpt cholesterol synthesi esterif peripher blood mononuclear cell clearanc chylomicron remnant bile acid kinet anovulatori women studi low mumol high mumol cholesterol diet premarin increas lithogen index bile increas biliari cholesterol secret lower chenodeoxychol cdca pool synthesi alter biliari bile acid composit ca dcacdca increas stimul cholesterol esterif enhanc clearanc chylomicron remnant increas dietari cholesterol stimul biliari secret cholesterol bile acid phospholipid result alter lithogen index reduct cdca pool synthesi premarin revers increas dietari cholesterol premarin increas cholesterol enter bodi diet recov biliari cholesterol newli synthes bile acid premarin increas cholesterol recov biliari lipid conclud premarin increas biliari cholesterol enhanc hepat lipoprotein uptak inhibit bile acid synthesi action premarin divert dietari cholesterol bile"
"specif reaction enzym link immunosorb assay serum antibodi entamoeba histolytica giardia lamblia endem area serum sampl indian children diarrhoea compar children resid unit kingdom diagnos ulcer coliti crohn diseas indetermin coliti enzym link immunosorb assay specif entamoeba histolytica giardia lamblia unit kingdom patient high igg respons elisa histolytica lamblia confirmatori elisa show british sera react specif bovin serum protein protozo antigen prior incub sera bovin serum prohibit reaction bovin serum integr part crude solubl antigen elisa histolytica lamblia replac purifi antigen prepar british sera react common block agent bovin serum albumin casein normal sheep serum reaction attribut uptak dietari antigen enhanc immunolog respons antigen patient inflammatori bowel diseas"
"biphas modul acetaminophen bioactiv hepatotox pretreat interferon induc polyinosinicpolycytidyl acid interferon interferon induct inhibit cytochrom reduc bioactiv hepatotox acetaminophen inhibit induct enhanc acetaminophen hepatotox possibl biphas modul acetaminophen hepatotox interferon investig outbr male cd mice age young inbr male cbl mice interferon induc polyinosinicpolycytidyl acid poli mgkg intraperiton day singl dose acetaminophen mgkg intraperiton hepatotox assess peak plasma concentr alanin aminotransferas alt occur hr acetaminophen treatment poli inhibit hepatotox acetaminophen day maxim inhibit day convers maxim fold enhanc alt concentr observ cd mice mgkg acetaminophen day poli cbl strain poli inhibit hepatotox acetaminophen day maxim fold enhanc alt concentr observ mgkg acetaminophen day poli mechan toxicolog enhanc examin male cbl mice treatment regimen biochem assess hepatotox confirm detail histolog evalu plasma concentr acetaminophen metabolit determin highperform liquid chromatographi acetaminophen bioactiv quantifi product glutathionederiv cystein mercaptur acid conjug acetaminophen poli pretreat produc fold increas acetaminopheninduc alt releas correl histolog evid centrilobular necrosi poli pretreat produc respect fold fold increas product cystein mercaptur acid conjug correl peak alt concentr cystein mercaptur acid hepatotox acetaminophen inhibit day interferon induct convers enhanc week toxicolog enhanc due increas catalyz bioactiv acetaminophen"
"glutathion disulfid format oxid stress acetaminopheninduc hepatotox mice vivo protect effect allopurinol acetaminophen mgkg induc hepatotox fast icr mice vivo acetaminophen caus longlast reduct hepat atp content irrevers loss hepat xanthin dehydrogenas activ transient increas xanthin oxidas activ effect occur parenchym cell damag releas cellular enzym hepat content gsh gssg initi deplet acetaminophen affect gssggsh ratio recoveri phase hepat gsh level gssg content increas faster gsh result gssggsh ratio acetaminophen administr mitochondri gssg content increas control greater acetaminophentr mice extrem elev tissu gssg level accompani fold increas plasma gssg concentr enhanc biliari efflux hepat gssg format biliari excret affect acetaminophen allopurinol protect dosedepend acetaminopheninduc cell injuri loss atp increas gssg content total liver mitochondri compart inhibit reactiv metabolit format high protect low nonprotect dose allopurinol complet inhibit hepat xanthin oxidas dehydrogenas activ high dose prevent increas mitochondri gssg content data longlast primarili intracellular oxid stress progress phase acetaminopheninduc cell necrosi protect effect allopurinol involv inhibit reactiv oxygen format xanthin oxidas result antioxid properti"
"experiment reduct portal hypertens mechan increas liver portal flow studi isol perfus rat liver demonstr increas portal pressur increas portal blood flow normal cirrhot liver pig portal hypertens mesenter portal pressur lower mechan increas liver portal blood flow balloon pump portal vein"
"cholecystokinin enhanc hepatobiliari scan eject fraction calcul indic diseas gallbladd chronic acalcul cholecyst repres cent elect treat diseas gallbladd cent success rate reliev patient chronic pain report surgic treatment recommend base symptom cholecystokinin eject fraction quantit measur empti gallbladd cent accur predict patient reliev symptom surgic treatment studi report consecut experi month period patient"
"computer identif patholog duodenogastr reflux hour gastric ph monitor duodenogastr reflux natur occur sporad event incid occurr detriment effect difficult assess reliabl hour gastric ph monitor detect duodenogastr reflux studi central ph monitor purpos confid abil measur display ph data reflect gastric ph environ suffici sensit test gastric ph dog measur fast state feed pentagastrin stimul antrum alkalin fast state display data frequenc distribut graph sensit reflect induc ph test consist gastric ph posit simultan hour gastric monitor perform normal subject probe cm lower esophag sphincter cm posit probe read ph unit time base principl gastric ph monitor perform cm lower esophag sphincter normal subject patient fulfil ritchi clinic criteria patholog duodenogastr reflux data obtain arrang variabl subject discrimin analysi sixteen variabl identifi coeffici multipli deriv score score high probabl patholog duodenogastr reflux test appli valid popul consist addit normal subject patient meet ritchi criteria normal subject normal score patient abnorm score compar diisopropyl iminodiacet acid disida scintigraphi group normal subject patient hour gastric ph monitor superior detect patholog duodenogastr reflux studi show applic comput technolog diagnos patholog duodenogastr reflux patient complex foregut complaint"
"tongu forc measur system assess oralphas swallow disord computeraid measur system high sensit beam transduc develop provid quantit reliabl measur tongu strength tool applic diagnosi treatment dysphag patient oralstag dysfunct devic custom comfort adapt individu audiovisu feedback enhanc subject interest motiv devic proven reliabl measur upward side tongu thrust bodi subject measur separ session dysphag patient"
"intussuscept diagnost test stool occult blood retrospect review perform determin diagnost test occult blood stool children suspect intussuscept nineti children barium enema studi suspect intussuscept children barium enema confirm intussuscept histori physic find gross blood rectum stool test occult blood patient posit comparison children intussuscept stool posit occult blood stool occult blood signific intussuscept clinic factor signific intussuscept abdomin mass vomit episod irrit poor feed abdomin pain lethargi signific group conclus author suggest stool test occult blood evalu children present nonspecif sign symptom support intussuscept"
"plasma thrombinantithrombin iii complex diagnosi primari hepatocellular carcinoma complic liver cirrhosi detect hypercoagul state diagnosi primari hepatocellular carcinoma hcc complic liver cirrhosi lc plasma level thrombinantithrombin iii complex tat determin patient lc hcc level ngml hcc patient hcc patient level ngml occur hcc patient serum alphafetoprotein level ngml patient hcc cm diamet level hcc patient signific decreas day treatment transcathet arteri embol infus antitumor agent affect plasma antithrombin iii level result suggest plasma tat level diagnosi hcc complic lc"
"apprais gut lavag studi intestin humor immun direct investig intestin humor immun requir collect intestin secret mucos biopsi specimen invas techniqu gut lavag polyethyleneglycol electrolyt lavag solut collect intestin secret immunoglobulin antibodi studi evalu fifti patient studi immunolog normal patient volunt patient untreat coeliac diseas patient activ crohn diseas proteas inhibitor ad prompt sampl prevent proteolysi immunoglobulin content treat lavag sampl assay enzym link immunosorb assay immunoglobulin antibodi content studi serial lavag specimen show earli faecal contamin specimen neglig quantiti immunoglobulin specimen clear steadi state reach variat immunoglobulin content serial specimen uniform dilut ingest polyethyleneglycol gut lavag fluid iga predomin secretori compris total iga gut lavag fluid content control coeliac crohn group high valu total igm iga igm antigliadin antibodi detect coeliac group high valu igg crohn diseas group method gut lavag effect bowel cleanser noninvas obtain intestin secret studi humor immun gastrointestin diseas"
"jejun immunoglobulin antigliadin antibodi secret adult coeliac diseas compar local intestin immunoglobulin ig secret adult patient coeliac diseas control subject perfus small bowel segment occlud balloon analysi perfus fluid content ig secretori compon result compar number ig plasma cell test segment fold fivefold increas jejun secret rate iga monomer polymer igm patient coeliac diseas compar control subject high iga igm secret rate parallel increas ig plasma cell lamina propria contrast igg plasma cell densiti increas bare signific patient coeliac diseas result high igg secret rate jejun secret rate secretori compon signific increas patient coeliac diseas free dimer iga present jejun fluid antigliadiniga detect serum jejun fluid patient coeliac diseas antigliadiniga polymer iga link secretori compon jejun fluid dimer iga link secretori compon serum result combin rais secretori compon secret rate evid secretori compon satur suggest serum intestin antigliadin iga origin coeliac diseas"
"inflammatori bowel diseas tobacco smoke casecontrol studi casecontrol studi carri stockholm sweden evalu associ cigarett smoke exposur environment tobacco smoke childhood subsequ develop inflammatori bowel diseas inform smoke obtain postal questionnair relat risk crohn diseas current smoker compar smoke confid limit men women result ulcer coliti relat risk ulcer coliti recent exsmok compar smoke increas risk crohn diseas found expos environment tobacco smoke childhood relat risk relat risk ulcer coliti"
"mortal death crohn diseas review year experi leiden univers hospit hundr seventi patient women crohn diseas leiden univers hospit identifi follow complet sixti patient die death relat crohn diseas patient relat diseas unrel incident death identifi patient signific decreas death relat diseas death amyloidosi malnutrit disappear postop death decreas standardis mortal ratio show excess mortal patient higher women men comparison recent year period show signific decreas standardis mortal ratio men women patient diseas start age year excess mortal compar older patient studi support view prognosi crohn diseas improv general high qualiti medic surgic manag import younger patient"
"efficaci biofeedback train improv faecal incontin anorect physiolog function efficaci biofeedback treatment faecal incontin anorect function evalu patient faecal incontin treat biofeedback train medic therapi outcom anorect function compar faecal incontin patient receiv medic therapi month follow show patient biofeedback convent treatment group treat convent improv year follow show biofeedback group free soil addit improv result similar convent treat group free soil addit improv anal pressur rest squeez rectal distens volum induc sustain inhibit extern intern anal sphincter contin rectal infus salin signific reduc group patient compar control biofeedback treatment effect abnorm anorect function patient improv improv faecal incontin due medic intervent regress symptom time result biofeedback train"
"comparison gall bladder bile endoscop obtain duoden bile patient gall stone diseas women men sd age year bile obtain endoscop aspir stimul gall bladder ceruletid fine needl punctur gall bladder local anaesthet total lipid concentr punctur bile sampl sd dl signific higher endoscop bile sampl dl total bile acid phospholipid biliari cholesterol express mol cholesterol satur index show signific differ type sampl glycochol acid concentr endoscop obtain bile mol mol signific higher punctur bile sampl punctur bile exhibit signific shorter nucleat time day day determin nucleat time endoscop bile aspir gall bladder stimul ceruletid led adequ concentr sampl studi subject cholesterol monohydr crystal format nativ bile observ sampl punctur bile sampl endoscop obtain bile presenc cholesterol crystal determin nucleat time punctur bile discrimin cholesterol pigment gall stone correl comput tomogram analysi"
"isol lipas colipas defici brother brother arab origin age year isol congenit lipas colipas defici develop histori pass greasi stool earli infanc remark steatorrhoea low serum caroten vitamin concentr exocrin pancreat stimul lipas colipas activ duoden fluid complet absent amylas trypsin bile salt ph valu normal aetiolog exocrin pancreat insuffici found report congenit combin lipas colipas defici brother"
"stimul glucagon secret gastric inhibitori polypeptid patient hepat cirrhosi hyperglucagonemia porcin gastric inhibitori polypeptid gip infus iv microgram min patient biopsyproven hepat cirrhosi surgic portacav anastomos hyperglucagonemia postabsorpt state infus result elev blood level immunoreact gip upper rang observ ingest larg mix meal accompani signific increment immunoreact glucagon irg plasma similar infus cirrhot patient surgic portacav anastomos normal plasma irg level postabsorpt state effect plasma irg level ingest triglycerid hyperglucagonem cirrhot patient portacav anastomos result elev plasma immunoreact gip signific elev plasma irg level chromatographi studi show increment plasma irg administr gip triglycerid larg account increas pancreatictyp glucagon signific effect administr gip triglycerid blood level glucos immunoreact insulin conclud porcin gip glucagonotrop patient cirrhosi liver show elev level irg plasma postabsorpt state effect due divers portal blood system circul attribut hypersensit alphacel stimul gip"
"treatment duoden cimetidin clinic endoscop histolog studi studi effect cimetidin treatment endoscop diagnos duoden sixti patient solitari endoscop find duoden patient underw fiberopt endoscopi upper gastrointestin tract unit year studi retrospect good clinic respons appar patient treat cimetidin fair respons control random prospect studi evalu effect cimetidin duoden statist signific improv clinic endoscop score found patient treat cimetidin improv histolog score reach statist signific improv demonstr placebotr patient duoden peptic syndrom good respons cimetidin treatment behav duoden ulcer diseas"
"colon volvulus complic celiac sprue colon volvulus rare report complic celiac sprue describ patient longstand celiac sprue recurr sigmoid volvulus develop cecal volvulus surgeri asymptomat glutenfre diet associ celiac sprue colon volvulus report isol case document surpris major predispos condit colon volvulus patient celiac sprue colon bacteri ferment malabsorb carbohydr celiac sprue lead excess gas product flaccid bowel loop sigmoid redund long mesenteri cecal hypermobl uncommon motil disord celiac sprue propos factor suggest likelihood develop colon volvulus celiac sprue great possibl celiac sprue consid patient colon volvulus background histori recurr abdomin distent malabsorpt symptom"
"physician inflammatori bowel diseas essay stori physician inflammatori bowel diseas ibd emphas import denial control physician patient guilt suppos psychosomat origin ibd suggest physician blame patient sick"
"erythrocyt sediment measur crohn diseas activ opposit trend ileiti versus coliti test hypothesi erythrocyt sediment rate esr correl clinic activ inflammatori diseas colon small bowel stratifi crohn diseas patient anatom involv measur correl esr clinic activ anatom subgroup patient crohn diseas involv primarili colon trend direct correl clinic score esr patient crohn diseas limit colon direct correl pronounc statist signific contrast opposit trend observ patient small bowel diseas patient diseas involv predomin small bowel diseas limit small bowel statist signific invers correl clinic score esr differ direct correl crohn coliti versus ileiti statist signific studi evid import analyz putat indic diseas activ separ protean form crohn diseas occur"
"biliari sludg critic updat biliari sludg year poor defin entiti low amplitud nonshadow echo depend part gallbladd shift influenc postur sonograph point view detect sludg impli coexist smallsiz solid compon gel embed materi chemic natur biliari sludg recent recogn predomin compos coaggreg cholesterol monohydr crystal liquid crystallin droplet case obstruct jaundic symptomat liver diseas bilirubin granul embed gel matrix mucous glycoprotein pathogen point view biliari sludg biliari stasi condit character impair gallbladd contract prolong total parenter nutrit fast pregnanc includ mucus hypersecret favor cholesterol nucleat crystal growth bile infect sludg intermedi step format type stone epidemiolog point view sludg rare asymptomat freeliv popul common select seri symptomat patient clinic point view sludg fluctuat includ frequent disappear reappear suggest earli stage gallston format revers"
"thorac succuss splash symptom sign achalasia patient thorac succuss splash due achalasia note splash slosh sensat chest relat jog bend examin splash sound heard mid sternum posterior chest patient rock vigor back"
"gallbladd perfor correl cholescintigraph sonograph find niemeier classif retrospect analyz cholescintigram sonogram consecut patient gallbladd perfor determin sensit preoper detect gallbladd perfor correl find modifi niemeier classif cholescintigraph criteria perfor free spill pericholecyst hepat activ scintigraph gallston ileus sign detect case sonograph criteria perfor pericholecyst fluid pneumobilia gallston present patient cholescintigraph pattern perfor niemeier classif type acut free perfor scan demonstr free spill type ii subacut pericholecyst abscess scan show pericholecyst activ type iii chronic cholecystoenter fistula scan show scintigraph gallston ileus cholescintigraphi superior sonographi modal insensit detect gallbladd perfor"
"support evid valid epidemiolog necropsi gallston object epidemiolog necropsi measur occurr unsuspect diseas examin necropsi record patient die reason estim unsuspect diseas deriv epidemiolog necropsi approxim occur live popul designset test hypothesi necropsi record adult patient univers kansa medic center examin presenc gallston patient previous cholecystectomi gallston diagnos life exclud data stratifi age race compar screen survey canada surgic seri york screen survey itali denmark crude necropsi detect rate rate screen survey standard feder census kansa citi resultsconclus standard occurr rate similar suggest epidemiolog necropsi accur assess occurr asymptomat gallston live popul strengthen valid research tool"
"congenit hepat fibrosi autosomaldomin polycyst kidney diseas congenit hepat fibrosi found famili autosomaldomin polycyst kidney diseas congenit hepat fibrosi common characterist autosomalrecess polycyst kidney diseas report famili show complic autosomaldomin polycyst kidney diseas famili close linkag mutat caus diseas dna marker chromosom demonstr clinic congenit hepat fibrosi differ famili children congenit hepat fibrosi die birth famili approxim year follow show detect progress liver diseas"
"sequenti esophag motil studi endoscop inject sclerotherapi prospect investig assess prospect effect endoscop intravaric sclerosi ei esophag function perform esophag manometri cirrhot patient ei session wk fourth session ei impact lower esophag sphincter pressur signific decreas amplitud peristalt wave observ immedi postei lower esophagus modif durat veloc progress peristalt wave fold increas simultan contract observ earli ei revers assess late esophag test ei correl demonstr esophag motor paramet dose scleros conclud scleros inject esophag wall acut impair esophag motil motor function partial restor wk complet ei suggest dysmotil revers"
"reduct hepat venous pressur gradient consequ volum contract due chronic administr spironolacton patient cirrhosi ascit effect plasma volum contract induc wk administr spironolacton furosemid hepat venous pressur gradient evalu consecut alloc patient cirrhosi ascit spironolacton group hepat venous pressur gradient decreas signific signific contract circul plasma volum statist signific correl chang hepat venous pressur gradient circul plasma volum simultan determin system hemodynam signific negat correl hepat venous pressur gradient chang posttreat plasma aldosteron level found furosemid group hepat venous pressur gradient circul plasma volum signific decreas data demonstr signific reduct hepat venous pressur gradient chronic administr spironolacton due volum contract patient cirrhosi ascit"
"combin prednison colchicin patient primari scleros cholang primari scleros cholang cholestat liver diseas character inflamm fibrosi biliari tract diseas unknown effect medic treatment exist studi patient receiv combin lowdos prednison mgday colchicin mg bid compar group concurr histor control month signific improv liver test result baselin valu patient receiv prednison colchicin untreat control month signific differ biochem test appreci treat untreat patient analysi serial liver biopsi show differ histolog chang group yr follow death control group treat group untreat patient develop ascit gastrointestin bleed develop untreat patient develop ascit contrast treat group ascit bleed develop patient conclud combin colchicin prednison retard histolog progress progress standard liver test yr therapi trend clinic deterior improv surviv yr treatment basi find advoc empir drug patient primari scleros cholang suggest psc evalu control clinic trial treatment incur diseas"
"modifi krask approach diseas midrectum modif dr paul krask approach remov midrect lesion patient senior author patient rang age yr averag yr male femal patient indic surgeri villous adenoma carcinoid recurr dysplasia previous endoscop polypectomi site posit distal margin neoplasm low anterior sigmoid resect adenocarcinoma elder poorrisk patient lesion middl rectum cm anal verg averag cm postop stay rang day day averag follow patient yr month yr patient local recurr lesion morbid mortal conclud modif krask approach offer good altern excis midrect lesion term technic eas efficaci safeti patient toler modifi krask approach situat part surgeon armamentarium"
"chemic periton secondari intraperiton vancomycin previous report literatur exist chemic periton due vancomycin patient periton dialysi remain controversi report similar episod steril periton patient receiv intraperiton ip vancomycin prior report implic chang brand vancomycin prepar vancocin vancol contribut factor note occurr episod switch vancocin generic prepar abbott laboratori highperform liquid chromatograph hplc profil prepar show vancocin lower level impur presenc contamin brand contribut clinic differ observ conclud chemic periton due ip vancomycin administr occur increas awar entiti case identifi"
"transmiss rift valley fever virus adult mosquito ingest virus larva publish erratum trop med hyg jun studi abil culex pipien aed circumluteolus ae mcintoshi expos larva liver tissu rift valley fever rvf virusinfect hamster infect transstadi transmit virus adult adult transmit virus bite hamster exposur larva adult cx pipien adult ae neomelaniconion speci infect infect cx pipien half infect ae circumluteolus ae mcintoshi test transmit rvf virus bite hamster transmiss rate mosquito oral infect larva higher mosquito oral infect adult anim infect rvf virus abort die vicin mosquito larva breed habitat infect tissu anim contamin water"
"import intraop cholangiographi laparoscop cholecystectomi laparoscop cholecystectomi lc electrocoagul success perform select patient cholangiographi perform patient patient common duct stone unsuspect preoper gallbladd remov patient underw open common duct explor case anatom anomali discov cholangiographi perform cystic duct structur divid prevent complicationcommon duct injuri cholangiographi attempt patient undergo lc"
"inguin hernia complic flexibl sigmoidoscopi flexibl sigmoidoscopi part routin preoper workup patient age fifti present inguin hernia recent experi patient left inguin hernia sigmoid colon herniat scrotum bring awar possibl increas risk perfor sigmoid colon flexibl sigmoidoscopi iatrogen incarcer hernia case present clinic entiti recogn complic prevent"
"plasma glucagon concentr cirrhosi relat liver function portalsystem shunt system vascular resist urinari sodium excret test hypothesi increas plasma glucagon concentr result portalsystem shunt liver dysfunct arteri vasodil stimul sodium retent cirrhosi twenti studi perform patient alcohol liver diseas ascit liver function quantit elimin rate antipyrin caffein stabl isotop cholic acid administ oral intraven portalsystem shunt fraction calcul ratio intraven oral clearanc isotop cholic acid cardiac output measur doppler echocardiographi plasma glucagon concentr increas patient ascit compar patient ascit pgml pgml unrel urinari sodium excret heart rate arteri pressur cardiac output system vascular resist plasma glucagon concentr correl halfliv model compound caffein antipyrin oral intraven cholic acid shunt fraction increas plasma glucagon concentr cirrhosi result diminish hepat clearanc increas plasma concentr glucagon hyperdynam circulatori state sodium retent"
"elev plasma aluminum level normal infant receiv antacid aluminum aluminum toxic document encephalopathi anemia osteomalacia excret primarili renal patient renal insuffici risk aluminum accumul toxic demonstr urem children treat aluminum antacid purpos studi determin plasma aluminum level elev infant normal renal function prolong aluminum antacid ten studi infant age month receiv antacid week compar control infant age month receiv antacid studi patient consum mgkg day sem element aluminum averag week plasma aluminum level microgram signific greater control group microgram conclud plasma aluminum level elev infant normal renal function consum high dose aluminum antacid safeti antacid aluminum assum judici infant care monitor aluminum dose plasma level"
"gastric empti infant children limit util hour measur gastric empti measur perform infant children hour liquid feed hour measur predict variabl hour measur indic hour measur good predictor hour measur gastric empti measur children continu hour feed rapid empti observ st hour studi"
"gallston lithotripsi relev physic principl technic issu basic understand shock wave generat essenti radiologist perform gallston lithotripsi shock wave differ ordinari acoust wave rapid rise time posit pressur compon rise compress forc approach atm lowamplitud sustain negat pressur rarefact compon shock wave creat type shock wave generat sparkgap electromagnet piezoelectr author describ compar type shock wave generat regard equip select shock wave generat share common interact tissu interact review propos mechan stone fragment"
"air fissur ligamentum tere sign intraperiton air plain radiograph patient acut spontan pneumoperitoneum develop vertic direct area hyperluc upper quadrant radiograph abdomen obtain patient supin find absenc characterist sign free air plain radiograph author knowledg previous recogn repres intraperiton gas confin fissur ligamentum tere flt locat hyperluc area confirm comput tomographi laparotomi patient distinct configur air flt subtl reliabl indic pneumoperitoneum"
"liver cirrhosi doppler waveform hepat vein publish erratum radiolog aug author compar doppler ultrasonograph pattern hepat vein hvs group patient affect liver cirrhosi healthi subject compar sex age detect differ hv waveform group investig relationship differ sever diseas childpugh classif modif system hemodynam waveform hvs arbitrarili classifi pattern hv normal waveform hv lower oscil revers phase hv complet flat waveform resist index superior mesenter arteri reflect peripher splanchnic imped hyperdynam circul measur subgroup cirrhot patient waveform hvs healthi subject correspond hv pattern cirrhot patient hv found hv hv sever function impair greatest hv group hv group signific correl decreas resist index superior mesenter arteri subgroup patient normal hv waveform consid adjunct tool noninvas evalu liver diseas pathophysiolog hv blood flow unclear signific correl sever diseas decreas splanchnic resist hv waveform occur presenc mark rearrang liver tissu hyperdynam system circul"
"sclerotherapi esophag varic endoscop inject sclerotherapi ei frequent patient esophag varic control acut hemorrhag prophylaxi techniqu interest ei increas method improv patient outcom clinic trial ei acut hemorrhag demonstr efficaci improv outcom research disagre find recent data prophylaxi ei fail support ei indic ethanolamin oleat compar favor scleros agent approv ei intravaric method frequent paravaric method efficaci perform rapid percentag patient develop signific complic ei high percent common complic includ retrostern pain pyrexia sepsi ei import clinic tool manag esophag varic"
"glucos intoler hyperinsulinemia cirrhosi result spontan surgic portosystem shunt assess spontan portosystem shunt collater contribut hyperinsulinemia cirrhosi patient alcohol cirrhosi underw hour oral glucos toler test day day elect sidesid portacav shunt glucos insulin peptid respons oral glucos postshunt exagger compar preoper valu compar preoper valu fast molar ratio peptid insulin postop increas versus indic improv hepat function result suggest extrahepat portosystem shunt secondari spontan splanchnic collater play role hyperinsulinemia cirrhosi decreas hepat degrad insulin patient secondari hepatocellular dysfunct result shunt portal blood liver"
"somatostatin gallston longterm administr somatostatin analogu octreotid complic gallston format somatostatin inhibit hepat bile secret gallbladd empti effect octreotid gallbladd bile composit remain unknown test hypothesi octretid alter hepat bile composit gallbladd stasi increas gallbladd bile solut concentr fourteen control prairi dog receiv daili salin inject anim receiv microgram octreotid subcutan time day day cholecystectomi common bile duct cannul perform octreotid increas hepat bile concentr bilirubin monoglucuronid total bilirubin total protein rsa index gallbladd stasi decreas octreotid group gallbladd bile total calcium bilirubin monoglucuronid total bilirubin total protein total lipid increas octreotid group anim receiv octreotid decreas hepat gallbladd bile ph differ cholesterol satur index observ data suggest prairi dog octreotid alter hepat bile composit gallbladd stasi increas gallbladd bile calcium bilirubin protein lipid hydrogen ion concentr conclud octreotid alter gallbladd bile composit increas likelihood cholesterol calcium bilirubin precipit"
"munich gallbladd lithotripsi studi result year patient object evalu longterm result type shock wave treatment patient radioluc gallbladd stone design cohort studi set singlecent trial patient patient gallston elig patient treat intervent patient receiv extracorpor shock wave lithotripsi adjuv therapi bile acid result lithotripsi watertank lithotriptor group watercushion lithotriptor low energi level group watercushion lithotriptor high energi level group rate complet fragment clearanc month lithotripsi differ signific group patient singl stone mm diamet rate fragment clearanc group group group patient singl stone mm rate fragment clearanc group group group patient stone rate fragment clearanc group group group patient fragment mm hour lithotripsi show higher probabl fragment disappear larger fragment clearanc rate higher patient compliant noncompli bile acid therapi advers effect includ liver hematoma patient biliari pain attack patient mild biliari pancreat patient cholestasi patient elect cholecystectomi patient endoscop sphincterotomi patient conclus rate complet disappear stone shock wave therapi depend size number initi stone diamet largest fragment mode shock wave treatment adjuv therapi bile acid import complet fragment clearanc"
"nonsteroid antiinflammatori drug peptic ulcer diseas evid accumul nonsteroid antiinflammatori drug nsaid clinic import gastroduoden ulcer pathogenesi involv impair mucos resist injuri acidpept environ multifactori controversi ulcer caus nsaid occur mucosa inflam infect helicobact pylori histolog normal mucosa drug link unexpect high incid ulcer complic histori peptic ulcer diseas common case nonsteroid antiinflammatori drug exacerb peptic diathesi de novo ulcer associ drug ulcer complic support ulcer preval data crosssect studi data casecontrol cohort studi random experiment trial druginduc gastric ulcer prevent misoprostol blocker therapi therapi report promot ulcer heal continu nsaid adequ control trial small gastric duoden ulcer readili heal larger gastric ulcer requir vigor prolong therapi relat efficaci therapi prevent ulcer heal ulcer prevent complic remain establish"
"stationari map manometri evalu dysphagia method assess esophag motil map techniqu cathet withdraw cm step entir esophagus evalu simpler method common involv cathet stationari entir evalu compar techniqu patient refer evalu dysphagia emphasi distal cm esophagus primari locat esophag motil disord excel correl techniqu distal amplitud distal durat percentag peristalt contract manometri diagnosi similar method patient patient manometri diagnos result techniqu chang diagnosi clinic import patient map techniqu identifi segment motil disord miss stationari techniqu stationari manometri sensit specif rate identifi motil disord compar map manometri conclud stationari manometri simpl accur method evalu esophag pressur distal disord patient normal result stationari studi benefit map identifi rare segment motil disord"
"radiograph techniqu efficaci evalu esophag dysphagia radiograph examin esophagus determin structur function dysphagia perform multipl techniqu includ fullcolumn studi produc distend film solid bolus mucos relief film identifi mucos defect esophag presenc varic doublecontrast film motion record fluoroscopi efficaci techniqu depend qualiti studi specif disord detect esophag lesion produc dysphagia classifi extrins structur lesion intrins structur lesion esophag motil disord radiograph studi prefer screen techniqu patient dysphagia sensit evalu mucos lesion radiograph studi superior endoscopi detect abnorm motil esophag ring strictur"
"symptom achalasia young women mistaken indic primari anorexia nervosa case young women dysphagia regurgit weight loss diagnos anorexia nervosa reevalu show achalasia caus symptom present relat observ misinterpret esophag symptom occur consequ inadequ histori bias patient emaci age gender lead view aspect patient histori behavior suggest patholog attitud eat bodi weight consequ misinterpret symptom indic eat disord patient case disord attitud eat bodi weight develop coexist achalasia clinic evalu patient symptom suggest anorexia nervosa bulimia nervosa includ histori swallow vomit order recogn esophag motor disord"
"modul mediat releas human intestin mast cell sulfasalazin aminosalicyl acid intestin mast cell thought contribut mucos inflamm ulcer coliti crohn diseas releas inflammatori mediat sulfasalazin metabolit aminosalicyl acid effect therapeut agent inflammatori bowel diseas shown inhibit generat inflammatori product cell examin effect agent vitro human intestin mast cell mediat releas sulfasalazin found signific enhanc goat antihuman igeinduc histamin releas intestin mast cell respons human blood basophil metabolit aminosalicyl acid effect inhibitor stimul histamin releas mast cell basophil aminosalicyl acid inhibit product prostaglandin stimul intestin mast cell sulfasalazin immunolog stimul induc histamin releas mast cell basophil enhanc ongo mast cell activ sulfasalazin explain case advers reaction drug inhibit mast cell histamin releas prostaglandin generat aminosalicyl acid demonstr potenti therapeut modal agent"
"rectal irrig shortchain fatti acid distal ulcer coliti preliminari report colon cell patient ulcer coliti util shortchain fatti acid ineffici expos decreas concentr compound test irrig inflam mucosa shortchain fatti acid conduct week preliminari trial patient distal coliti patient daili rectal irrig ml solut acet mm propion mm butyr mm patient stop week improv complet resolut symptom complet trial judg improv show chang diseas activ index score se se equal mucos histolog score se se equal ulcer coliti patient benefit increas contact higher usual level critic energi substrat"
"gallston dissolut methyl tertbutyl ether patientsefficaci safeti patient cholesterol gallbladd stone elig percutan transhepat litholysi methyl tertbutyl ether mtbe punctur gallbladd success stone dissolv solitari stone treatment averag hr multipl stone hr hospit day patient bile leakag develop report mild complaint end treatment residu gallbladd patient develop recurr stone mtbe exhal distribut fatti tissu excret renal metabolit tertbutanol methanol found trace gallbladd histolog patient show chronic cholecyst find independ treatment time interv treatment end oper consist stonerel caus mtbe"
"medic dissolut gallston clinic experi limonen simpl safe effect solvent retain gallston bile duct account case postcholecystectomi syndrom solvent limonen prepar inject direct biliari system patient dissolv disintegr retain gallston outcom retain stone complet disappear case partial dissolut chelat agent partial dissolut ineffect make method effect guidelin observ includ vitro trial dissolut test cautious observ side effect frequent hepat pancreat function test treatment prepar perform"
"evalu portalsystem shunt rat mesenter splenic bed rat partial portal vein ligat splenic blood flow shunt portal system circul intrasplen inject microspher determin degre shunt magnitud portalsystem shunt biochem endocrin consequ portalsystem shunt occur level expect degre shunt found effort resolv discord find shunt splenic mesenter bed studi anesthet portal hypertens rat degre durat portal vein stenosi shunt mesenter bed averag rang influenc degre durat portal vein stenosi contrast shunt splenic bed averag rang demonstr variat group determin degre portal vein stenosi shunt splenic bed consist greater found mesenter bed mesenter splenic shunt correl serum bile acid level mesenter shunt relat invers weightadjust liver mass serum testosteron level base data obtain portal hypertens rat conclud splenic inject microspher overestim portalsystem shunt contrast mesenter inject microspher yield valu shunt correl independ determin biochem endocrin consequ shunt observ support valid mesenter shunt measur obtain"
"distribut cholesterol vesicl micell human gallbladd bile influenc treatment chenodeoxychol acid ursodeoxychol acid present studi aim determin relat distribut cholesterol vesicular micellar phase gallbladd bile gallston patient gallstonefre subject gallston patient treat chenodeoxychol acid treat ursodeoxychol acid mgkgday wk cholecystectomi vesicular micellar fraction bile separ sucros densiti gradient ultracentrifug clear separ phase obtain vesicl identifi quasielast light scatter spectroscopi uniform size hydrodynam radius proport cholesterol vesicular fraction signific higher untreat gallston group compar gallstonefre ursodeoxychol acid chenodeoxychol acid group low cholesterol satur bile group part biliari cholesterol carri vesicular fraction cholesterolphospholipid ratio vesicular fraction averag gallston gallstonefre chenodeoxychol acid group ursodeoxychol acid group signific lower ratio nucleat time bile gallston group short day compar gallstonefre chenodeoxychol acid ursodeoxychol acid group day"
"prophylact sclerotherapi esophag varic longterm result singlecent trial surviv prophylact sclerotherapi assess singlecent studi involv cirrhot alcohol patient enrol yr wedg hepat vein pressur gradient measur pressur greater equal mm hg random receiv sclerotherapi treatment rest random patient group bled treat emerg endoscopi sclerotherapi stratif presenc ascit undertaken median follow mo rang mo surviv unrandom patient signific longer random patient signific differ treat sclerotherapi control alcohol cirrhot patient undergo sclerotherapi yr surviv control benefit sustain yr surviv nonalcohol patient group ident death caus varic bleed forti percent patient larg varic bled compar patient small varic wedg hepat vein pressur mm hg accur identifi alcohol patient low risk varic bleed nonalcohol patient episod varic bleed attribut elect sclerotherapi conclud popul prophylact sclerotherapi improv surviv discrep surviv alcohol nonalcohol cirrhot patient suggest factor varic hemorrhag respons differ"
"dual associ hla dr dr primari scleros cholang human leukocyt antigen type perform patient primari scleros cholang investig report associ human leukocyt antigen type diseas result show signific increas frequenc antigen dr compar control   caus signific rise frequenc human leukocyt antigen dr haplotyp patient patient contrast signific reduct frequenc antigen dr  pc complet absenc dr haplotyp patient group fisher exact test drposit individu includ drdr heterozygot elimin signific secondari associ dr note remain patient drposit compar dr negat control pc patient drposit drposit kaplanmei analysi demonstr surviv influenc presenc haplotyp individu antigen patient drposit signific younger age drposit age yr yr student test"
"signific natur polymer albumin receptor hepat infect hepatocyt lack inform presenc nativ albumin polym serum structur similar produc glutaraldehyd treatment cast doubt postul hepat virus attach hepatocyt mediat polymer albumin sandwich enzymelink immunosorb assay murin monoclon antibodi rais glutaraldehydepolymer albumin detect nativ albumin polym human serum crossreact albumin polym presenc polymer albumin receptor hepg cell studi radioreceptor assay purifi hepat virus synthet peptid analog part pres sequenc studi polymer albumindepend attach virus hepg cell antibodi rais pres peptid inhibit pres hepat virus attach hepg cell glutaraldehydetr polymer albumin found immunolog crossreact nativ albumin polym level found signific rais sera patient liver diseas polymer albumin specif satur receptor hepg cell class bind site equilibrium dissoci constant kd pmol kd pmol albumin monom unabl compet polymer albumin receptor site hepg cell antipr antibodi inhibit hepat virus pres bind hepatocyt ad extran polymer albumin antibodi interfer virus attach hepg cell"
"assay hepat virus dna polymeras chain reaction relationship pre encod viral surfac antigen polymeras chain reaction evalu diagnost tool chronic hepat virus carrier hepat virus dna detect serum hbsagposit virus carrier aliquot small al detect limit clone hepat virus dna ag primer pair region hbv genom result sensit detect amplifi hepat virus dna southern blot subsequ scintil count densitometri semiquantit assay primer pair parallel optim detect hbeagposit hbsag carrier hbe antibodyposit symptomat hbsag carrier asymptomat hbe antibodyposit hbsag carrier found hepat virus dna serum antivir therapi hepat virus dna disappear polymeras chain reaction assay patient hbeag negat polymeras chain reaction detect relaps earlier convent dot blot pre antigen assay serum liver sampl chronic carrier enzymelink immunosorb assay immunoblot virem carrier strong posit pres pres antigen hepat virus dnaposit hbsag carrier detect pre antigen vice versa data show assay hepat virus dna serum polymeras chain reaction profici dot blot replac serolog assay hbeag pre antigen"
"detect hepat virus dna polymeras chain reaction plasma volunt blood donor negat hepat surfac antigen plasma sampl volunt blood donor test hepat virus hbv dna dot blot hybrid polymeras chain reaction pcr donor negat hepat surfac antigen hbsag normal serum alanin aminotransferas level plasma sampl posit hbv dna dot blot hybrid assay sampl posit hbv dna pcr primer pair specif surfac core region person receiv hbvdnaposit plasma develop posttransfus hepat remain month approxim blood donor taiwan low titer hbv dna sensit method screen donor futur current serolog test remain practic present"
"comparison shunt fraction estim transcolon iodineiodoamphetamin technetiummpertechnet group dog experimentallyinduc chronic biliari cirrhosi portosystem shunt fraction estim transcolon iodineiodoamphetamin imp previous valid relat portal vein macroaggreg albumin inject experiment model cirrhosi transcolon technetiummpertechnet tco propos altern tracer imp studi portal circul cirrhot patient compar shunt fraction estim pair transcolon imp tco studi perform group dog common bile duct ligat surgeri pertechnet estim shunt fraction postop studi relat imp good correl method demonstr slope regress line substanti tco valu reach imp shunt valu approxim appar inabl accur assess high shunt flow limit quantit aspect tco studi patient sever portosystem shunt"
"quantif hepatobiliari function integr part imag technetiummmebrofenin health diseas studi undertaken check feasibl measur hepat extract fraction hef excret valu integr part hepatobiliari imag technetiummmebrofenin health diseas control subject hef excret min time common bile duct cbd gallbladd gb small intestin min rise serum bilirubin patient decreas hef increas excret result delay cbd gb small intestin control subject patient bilirubin mg excret valu min similar valu calcul entir min data suggest hepat phase studi time reduc min normal refer valu establish min patient bilirubin greater mg data collect durat continu min"
"intestin obstruct distens foley jejunostomi cathet jejunostomi effect permit postop nutrit support patient complic gastrointestin diseas case present distens foley balloon cathet jejunostomi tube led intestin obstruct initi detect radiograph identif problem remov air foley balloon patient complet convalesc surgeri possibl obstruct foley jejunostomi cathet recogn potenti problem postop period"
"norwalk virus genom clone character major epidem outbreak acut gastroenter result infect norwalk norwalk virus virus purifi stool specimen volunt experiment infect norwalk virus construct recombin complementari dna cdna deriv clone repres viral genom specif clone shown hybrid post pre infect stool sampl volunt infect norwalk virus purifi norwalk virus correl observ hybrid signal stool sampl clinic symptom acut gastroenter volunt hybrid assay overlap clone restrict enzym analys partial nucleotid sequenc inform clone norwalk virus singlestrand rna genom posit sens polyadenyl tail end size kilobas consensus amino acid sequenc motif typic viral rnadepend rna polymeras identifi norwalk virus clone avail norwalkspecif cdna sequenc inform viral genom permit develop sensit diagnost assay studi molecular biolog virus"
"surgic option postgastrectomi syndrom oper perform treatment peptic ulcer diseas lead varieti iatrogen disord collect refer postgastrectomi syndrom etiolog disord remain unclear loss vagal innerv bypass ablat destruct pylorus involv pathogenesi disord poor understood psycholog element involv pathogenesi ulcer oper proxim gastric vagotomi result fewest physiolog abnorm mildest postop symptom continu popular oper effect mark reduct incid disabl postgastrectomi syndrom fortun symptom sever necessit remedi oper uncommon conserv medic manag suffic disabl symptom refractori evalu patient accur classif syndrom essenti guarante satisfactori result surgic intervent numer surgic procedur develop deal syndrom vari result rouxen procedur emerg oper choic postgastrectomi syndrom rouxen procedur univers success oper lead recent recogn postgastrectomi state rouxen stasi syndrom prevent remain form therapi remedi oper undertaken adequ time elaps origin oper form conserv treatment fail"
"reoper versus altern retain biliari calculi retain common bile duct stone treat oper dissolut extract fragment papillotomi reoper approach requir expertis likelihood success depend composit size stone good result obtain nonop multidisciplinari team reoper rare"
"mechan sutur perfor thorac esophagus safe procedur patient late treat perfor thorac esophagus exclud ruptur carcinoma intraop wound mechan sutur exclus delay perfor treatment rang hour hour length perfor centimet sutur cover flap ten instanc antireflux procedur instanc digest ostomi perform death patient comatos arriv result small seri suggest myotomi expos mucosa flap essenti element techniqu perfor centimet late treat primari surgic closur"
"stercor perfor colon stercor perfor colon rare report case review defin syndrom stercor perfor facilit accur diagnosi treatment featur local general periton univers cent correct diagnos oper recognit diseas involv segment colon focal point perfor essenti adequ surgic treatment postul reason higher postop mortal closur perfor proxim colostomi cent exterior cent compar resect diseas segment exterior cent resect exterior treatment choic situat"
"adrenerg control intern anal sphincter abnorm patient idiopath faecal incontin histolog function evid intern anal sphincter abnorm patient idiopath faecal incontin vitro respons intern anal sphincter noradrenalin import sympathet neurotransmitt electr field stimul stimul intrins innerv studi muscl strip patient incontin undergo postan repair control undergo resect low rectal carcinoma studi contractionrespons curv noradrenalin signific ec concentr requir produc cent maximum contract higher incontin patient electr field stimul produc initi contract control group block phentolamin contract present incontin patient result abnorm adrenerg innerv intern anal sphincter patient idiopath faecal incontin"
"achalasia cardia longterm result oesophagomyotomi posterior partial fundopl forti patient achalasia cardia treat heller myotomi posterior fundopl approxim degre sutur gastric fundus edg myotomi postop follow period year clinic result good excel case cent fair case cent residu dysphagia gastrooesophag reflux barium studi show decreas oesophag diamet disappear distal narrow normal oesophag empti occur postop manometr studi patient reveal signific decreas lower oesophag sphincter pressur signific increas length infradiaphragmat segment oesophag bodi recoveri peristalt wave proxim ten patient cent twentyhour ph monitor show patholog reflux patient studi asymptomat techniqu effect improv oesophag symptom control longterm reflux"
"gallston pancreat choos time treatment patient gallston pancreat initi primari care physician prompt diagnosi time intervent crucial reduc morbid mortal initi manag includ support medic care surgic consult time surgeri dictat serum enzym level liver function test result patient condit role endoscop intervent evolv surgeri endoscop sphincterotomi prefer primari therapi gallston pancreat remain unresolv sphincterotomi stone extract viabl option select case patient sever gallston pancreat"
"endoscopi versus ray studi gastrointestin tract futur health care implic esophagogastroduodenoscopi patient colonoscopi patient gastrointestin ray studi endoscop procedur day ray studi patient symptomat barium swallow find confirm ray find confirm unconfirm ray find falseposit falseneg suboptim nondiagnost barium enema find confirm ray find falseposit falseneg suboptim conclud clinic privat practic reli ray studi high margin diagnost error factor consid initi cost advantag ray studi lost futur recommend continu dilemma ray studi versus endoscopi factor initi lower price ray studi"
"neuroendocrin design gut enter nervous system en thought compon autonom nervous system vast network neuron wide dispers gut en domin regul gut function action peptid peptid neurotransmitt intens studi role en regul secretori process gastric acid secret motil clear en play broader role regul gut function includ mucos defens gut immun respons sphincter function alter regul gut function en suspect number condit includ achalasia hirschsprung diseas inflammatori bowel diseas chaga diseas chronic intestin pseudoobstruct biliari dyskinesia tachygastria irrit bowel syndrom improv knowledg pathophysiolog troublesom condit make effect therapi futur"
"roux oper postgastrectomi syndrom aim paper describ techniqu indic result roux oper treatment postgastrectomi syndrom roux gastrojejunostomi cm roux limb procedur choic alkalin reflux gastriti virtual elimin reflux bile pancreat juic stomach slow transit roux limb good advantag slow gastric empti patient dump patient delay gastric empti respond combin total gastric resect remov aton gastric remnant speed empti roux gastrojejunostomi prevent reflux esophag reservoir ingesta upper gut roux oper roux limb slow empti pain full nausea food vomit result call roux stasi syndrom prevent roux stasi syndrom uncut roux limb treatment syndrom electr pace suppress ectop pacemak emerg limb offer solut vex problem"
"function comparison doubl tripl ileal loop pouch ileal pouch function patient oper surgeon compar seventeen patient doubl loop ileal pouchan anastomosi ipaa tripl loop pouch patient examin month month ileostomi closur ten pouch patient evalu month greater month ileostomi closur differ maximum rest pressur maximum squeez pressur group incid daytim nocturn leakag lower pouch group percent group percent maximum toler volum mtv pouch group greater group differ statist signific differ complianc pouch group greater month group statist signific patient evacu spontan differ hour frequenc defec greater month group signific group median frequenc nocturn defec greater month pouch group signific group tripl loop pouch compliant pouch function result shown lower incid nocturn leakag lower frequenc defec day night"
"rectopexi ineffect treatment obstruct defec symptom obstruct defec attribut rectal intussuscept rectopexi advoc surgic manag studi patient obstruct defec underw manometri proctographi rectopexi seventeen patient femal male age year studi eleven underw anterior posterior fixat rectum posterior fixat preoper patient demonstr rectoan intussuscept fifteen signific pelvic descent signific chang maximum rest pressur maximum voluntari contract pelvic descent anorect angl postop initi follow patient signific amelior symptom longer follow month longterm improv remaind poor clinic result spite complet resolut rectal intussuscept report worsen symptom reflect increas tenesmus stool frequenc case satisfactori result empti rectum complet demonstr rectoan intussuscept preoper evacu proctographi poor result complet empti rectoan intussuscept conclus rectopexi ineffect treatment obstruct defec patient"
"anal sphincter function intersphincter resect stapl ileal pouchan anastomosi studi determin effect direct ileal pouchan anastomosi pressur sensori compon anal canal ileal pouch find relat postop contin thirti patient ileal pouchan anastomosi contin episod minor incontin studi month ileostomi takedown maximum rest pressur anal canal signific lower patient imperfect result mm hg contin patient mm hg postop maximum squeez anal pressur slight greater contin incontin patient mm hg mm hg greater postop rectoileoan inhibitori reflex present percent linear correl strength rectal ileal distens depth resp durat intern sphincter relax preoper observ disappear postop group patient simultan measur pouch anal pressur patient imperfect result reveal reduc posit pouch anal pressur gradient compar contin group low pouchan pressur gradient thought respons increas incid soil patient"
"studi autoimmun initi betacel destruct vii evid antigen betacel lead autoimmun destruct betacel bb rat diabet syndrom biobreed bb rat believ result destruct betacel autoimmun respons initi event autoimmun destruct betacel remain larg unknown investig initi antigen betacel neonat adult bb rat lead autoimmun destruct betacel pancreat graft neonat bb rat remain larg intact insul transplant renal subcapsular space acut diabet bb rat similar transplant islet graft neonat bb rat subject autoimmun destruct contrast islet graft obtain adult bb rat treat silica prevent insul rapid destroy diabet recipi result betacel neonat bb rat betacel adult bb rat recognit immunolog effector observ previous inform initi role macrophagesdendrit cell develop insul bb rat suggest betacellspecif antigen preced insul result autoimmun destruct betacel bb rat"
"minor papilla cannul dorsal ductographi pancrea divisum recent pancrea divisum repres major technic barrier complet evalu pancreat ductal anatomi technic refin made achiev minor papilla cannul dorsal ductographi attempt consecut dorsal ductogram structur patholog demonstr subject chronic pancreat pancreat stone pseudocyst ductal cut pancreat cancer partial agenesi patient find patient alcohol abus exclud ductal patholog present abnorm ventral ductogram present case demonstr dorsal ductographi appreci addit diagnost yield clinic situat pancreatographi minor papilla cannul perform major papilla cannul fail reveal ventral pancreatogram pancrea divisum"
"longterm follow patient undergon balloon dilat gastric outlet obstruct balloon dilat gastric outlet obstruct supplant vagotomi drainag resect therapi institut longterm data demonstr percentag patient ultim requir surgic intervent evalu patient treat hydrostat balloon dilat institut asymptomat follow year patient requir surgeri acut perfor symptom continu obstruct addit attempt dilat patient previous gastric resect satisfactori longterm result endoscop therapi initi cost tenth surgic intervent figur factor loss product hand potenti chronic blockad instruct contrari activ patient continu acidsuppress therapi conclud balloon dilat remain viabl altern select patient gastric outlet obstruct"
"twelv hour overnight oesophag ph monitor patient reflux symptom result continu hour overnight ph monitor durat ph review patient heartburn regurgit normal subject patient reflux normal subject medic control patient acid reflux patient subsequ underw reflux surgeri overlap group surgeri reduct acid reflux similar normal subject patient surgeri deem fail reflux oper success differ found preoper reflux valu subgroup monitor ph select candid surgeri result good predictor outcom object evalu surgic result"
"effect increas helicobact pylori ammonia product urea infus plasma gastrin concentr propos hypergastrinaemia subject helicobact pylori infect caus action ammonia produc organ ureas activ antral cell investig hypothesi examin effect plasma gastrin increas bacterium ammonia product infus urea intragastr pylori posit duoden ulcer patient minut control intragastr infus dextros solut mlminut similar infus urea mmol continu hour urea infus median gastric juic urea concentr rose mmol rang mmol rang result increas ammonium concentr mmol rang mmol rang appreci rise ammonia product result chang plasma gastrin concentr experi repeat month erad pylori time median basal gastrin ng rang signific erad ng rang occas gastric juic ammonium concentr reduc mmol rang urea infus rais ammonium concentr chang plasma gastrin concentr conclus augment pylori ammonia product earli chang plasma gastrin"
"dissoci system mucos humor immun respons coeliac diseas examin humor immun coeliac diseas express serum system immun saliva jejun aspir gut lavag fluid mucos immun aim defin featur secretori immun respons iga igm concentr antibodi valu gliadin food protein measur enzym link immunosorb assay elisa activ diseas remiss establish secret obtain invas techniqu saliva gut lavag fluid indirect measur event jejunum serum saliva jejun aspir adult untreat coeliac diseas treat patient immunolog normal control subject studi intestin secret obtain gut lavag untreat treat patient coeliac diseas control subject jejun aspir iga igm gut lavag fluid igm concentr signific rais patient untreat coeliac diseas lavag fluid igm concentr remain higher patient treat coeliac diseas control serum salivari immunoglobulin concentr similar group patient untreat coeliac diseas higher valu antibodi gliadin compar treat patient control subject bodi fluid test predomin iga igg class serum iga igm class jejun aspir gut lavag fluid valu salivari iga antibodi gliadin signific higher untreat coeliac antibodi valu general low larg overlap coeliac diseas patient control subject"
"impair sulphat phenol colon mucosa quiescent activ ulcer coliti substanti amount phenol produc human colon bacteri ferment protein colon mucosa anim phenol inactiv predomin conjug sulphat purpos studi confirm sulphat phenol isol colonocyt man evalu mucos sulphat inflammatori bowel diseas phenol paracetamol rectal dialysi bag incub paracetamol colonocyt isol resect colon specimen yield se mumol dri weight paracetamol sulphat minut virtual undetect valu paracetamol glucuronid paracetamol sulphat detect rectal dialys control subject se nmolhour sulphat signific impair patient activ ulcer coliti nmolhour patient ulcer coliti remiss nmolhour sulphat patient crohn coliti nmolhour similar control subject impair capac mucosa sulphat phenol quiescent activ ulcer coliti pose metabol burden colon epitheli cell continu expos endogen phenol colon lumen"
"aminosalicyl acid potent inhibitor interleukin beta product organ cultur colon biopsi specimen patient inflammatori bowel diseas interleukin beta biopsi specimen inflam colon mucosa patient activ inflammatori bowel diseas studi compar normal colon mucos biopsi specimen signific greater amount interleukin beta present rectal mucosa median rang pgmg produc organ cultur pgmg valu interleukin beta cultur correl concentr thromboxan organ cultur inflam biopsi specimen presenc aminosalicyl acid dexamethason reduc amount interleukin beta detect dose studi aminosalicyl acid reduc amount leukotrien detect cultur"
"candidacid activ crohn diseas neutrophil abil normal crohn diseas neutrophil kill candida albican studi neutrophil isol peripher blood suspend phosphat buffer salin cell ml albican grown stationari phase broth cultur suspend phosphat buffer salin organismsml neutrophil candida incub degre shake water bath presenc fresh serum minut sampl withdrawn neutrophil lyse candida surviv assess coloni count result compar control suspens candida incub serum minut presenc autolog serum normal neutrophil kill signific candida crohn diseas neutrophil sd minut minut result alter signific normal neutrophil incub candida presenc crohn diseas serum normal serum crohn diseas neutrophil incub candida presenc normal serum autolog serum improv candidacid abil minut minut phagocytosi measur radiometr assay normal neutrophil patient crohn diseas impair abil kill granuloma provok organ due serum inhibitor defect phagocytosi"
"bad symptom bowel dysfunct patient irrit bowel syndrom prospect control studi emphasi stool form symptom bowel function patient irrit bowel syndrom abnorm diari frequent telephon interview day period assess symptom defec stool type unselect femal hospit patient irrit bowel syndrom women admit recurr colon pain consult doctor complain healthi control subject unexpect abdomin pain bloat occur control subject pain time frequent patient consid sever bloat occur time defec frequent errat time stool form produc stool extrem form indic rapid fluctuat intestin transit time urgenc time preval patient control subject strain finish defec time preval accompani feel incomplet evacu combin lead misdiagnosi constip normal relat stool form symptom distort possibl due rectal irrit complain intermedi patient control subject paramet closer control subject patient patient irrit bowel syndrom real complaint bowel function abnorm"
"provis gastrointestin endoscopi relat servic district general hospit work parti clinic servic committe british societi gastroenterolog number endoscop examin perform rise epidemiolog data workload develop unit show annual requir head popul approach upper gastrointestin flexibl sigmoidoscopi colonoscopi ercp open access endoscopi general practition desir increas sought district general hospit serv popul workload entail procedur annual perform half day routin session emerg work high standard train experi staff work purpos built accommod design promot effici safe practic endoscopi unit adjac day care facil ray depart easi access ward endoscopi unit endoscopi room fulli ventil cleaningdisinfect area room patient recept prepar recoveri accommod administr storag staff amen servic consult base clinic session requir made consult session clinic assist hospit practition staff specialist session consult expect commit session week endoscopi extra consult session provid effici servic special train nurs sister grade endoscopi nurs care patient work supplement care assist post endoscopi depart assist analog oper depart assist propos maintain prepar instrument give technic assist procedur full time secretari employ record appoint audit comput base ercp collabor intervent radiologist work high qualiti ray equip special prepar radiolog screen room facil serv hospit gastrointestin measur laboratori conveni combin endoscopi unit hospit gastrointestin measur technician staff laboratori endoscopi unit servic depart analog radiolog depart annual budget"
"preval gallston diseas institution person present result studi undertaken larg geriatr nurs home assess preval gallston diseas institution person hundr seventeen resid underw ultrasound examin gallbladd women half men gallston diseas stratifi age women men age year posit diseas summari preval gallston diseas nurs home popul found unexpect high"
"manag dietari complianc coeliac diseas elisa home test detect gluten improv complianc glutenfre diet coeliac diseas simpl prototyp test kit develop detect gluten food home test base monoclon antibodi heatstabl gluten protein crossreact appropri barley rye protein suitabl wide rang raw cook food food extract dilut hydrochlor acid drop extract transfer antibodyco tube enzymelabel gluten detect antibodi ad min tube wash colour develop ad reaction stop min stabilis blue colour home kit compar quantit laboratori kit qualit agreement good kit distinguish food trace gluten content accept glutenfre diet slight higher unaccept gluten content trial prototyp kit coeliac diseas patient divers age educ background test correct identifi food accept unaccept"
"evid role prostacyclin system hormon portal hypertens possibl prostacyclin system hormon mediat splanchnic hyperemia chronic portal hypertens evalu rabbit normotens state rabbit chronic partial ligat portal vein rabbit portal hypertens pht ketoprostaglandin alpha pgf alpha prostacyclin degrad product elev twofold vascular bed system arteri system venous portal venous compar level control anim pht rabbit exogen prostacyclin infus cyclooxygenas blockad system arteri system venous portal venous rout result equal elev ketopgf alpha reciproc vascular bed restor origin precyclooxygenas blockad hemodynam hemodynam equal magnitud irrespect site infus pht control signific chang ketopgf alpha hemodynam intraport infus conclud prostacyclin achiev system level escap hepat degrad result portosystem shunt anim chronic portal hypertens"
"nonpropuls esophag contract gastroesophag reflux nonpropuls esophag contract radiolog tertiari contract corkscrew esophagus suggest presenc motil disord lead impair acid clearanc goal studi determin preval role gastroesophag reflux ger patient tertiari contract thirti consecut patient spontan repetit nonpropuls esophag contract note esophagographi studi endoscopi infus esophag manometri ambulatori ph monitor patient esophag symptom dysphagia heartburn chest pain found esophag endoscopi biopsi nineteen patient repetit nonlumenobliter nonperistalt tertiari contract corkscrew esophagus forc lumenobliter simultan contract rosari bead esophagus twenti patient ger ph criteria valu time ph upright ph supin ph number episod greater min ph esophag motil reveal nutcrack esophagus low lesp nonspecif esophag motil disord symptom sever nonperistalt contract correl ger radiolog demonstr free reflux presenc heartburn predict ger conclud ger occur patient nonpropuls tertiari esophag contract esophagographi play role induct abnorm peristalt activ esophag bodi ger endoscop evid esophag characterist symptom recogn ph monitor specul detect treatment ger improv symptomat manag patient nonpropuls esophag contract"
"symptom sensit index valuabl addit paramet hour esophag ph record twentyhour esophag ph monitor quantit measur gastroesophag reflux demonstr tempor relationship symptom reflux symptom index numer score develop quantifi associ symptom reflux symptom index primarili assess specif patient reflux symptom propos refer score symptom specif index limit score develop evalu score symptom sensit index quantifi subject sensit reflux fifti consecut patient refer laboratori ambulatori ph record studi convent reflux variabl index calcul statist signific correl index found discord specif sensit index patient base find studi advoc symptom sensit index addit symptom specif index incorpor futur ph studi optim interpret result"
"radiograph evalu suspect small bowel obstruct plain abdomin radiograph enteroclysi studi review blind consecut patient undergo enteroclysi suspect small bowel obstruct plain radiograph unreli predict presenc obstruct determin enteroclysi surgeri patient normal abnorm nonspecif plain radiograph vari degre small bowel obstruct demonstr enteroclysi convers patient obstruct plain radiograph normal enteroclysi studi minor adhes enteroclysi correct predict presenc obstruct absenc obstruct level proxim distal obstruct etiolog obstruct oper patient enteroclysi advoc definit studi patient clinic uncertainti diagnosi small bowel obstruct"
"extracorpor piezoelectr lithotripsi complic bile duct stone today common bile duct stone extract endoscop endoscop sphincterotomi stone remov dormia basket mechan lithotript problem encount larger stone duct stenosi conserv therapi serv altern surgic intervent patient endoscop measur fail stone fragment achiev extracorpor shock wave lithotripsi remain fragment remov endoscop author report success disintegr common bile duct stone dornier lithotript stone local achiev ray shock wave generat underwat spark discharg report experi result extracorpor piezoelectr shock wave lithotripsi epl patient complic bile duct stone lithotript stone visual ultrasound shock wave produc piezoelectr acoust generat fragment achiev complet stone remov result show piezoelectr lithotripsi method treatment complic bile duct stone prove electrohydraul electromagneticgener shock wave system renunci general anesthesia analgesia sedat treatment render lithotript system attract elder frail patient"
"annular pancrea extrahepat biliari obstruct annular pancrea rare congenit abnorm increas diagnos endoscop retrograd cholangiopancreatographi ercp adult popul present duoden gastric ulcer duoden obstruct pancreat rare congenit abnorm suggest biliari obstruct result pancreat case report primari extrahepat biliari obstruct constrict annulus report report case describ resolut symptom return normal biochem test patient literatur embryolog annular pancrea review suggest entiti ad differenti diagnosi extrahepat biliari obstruct"
"endoscop manag retain cystic duct stone find residu common bile duct stone cholecystectomi frequent encount problem effect nonop therapi exist retain stone cystic duct remnant rare present case multipl retain stone long variant cystic duct remnant cholecystectomi common duct explor success manag endoscop sphincterotomi balloon extract"
"estrogen receptor extern anal sphincter anal compet women reduc age year depend effect estrogen studi sampl extern anal sphincter analyz presenc estrogen receptor found present median concentr fmol milligram protein rang women fmol milligram protein rang men find interest regard treatment idiopath anal incontin"
"alanin aminotransferas clinic practic review alanin aminotransferas enzym produc liver serum activ measur marker hepat diseas review explor biochemistri laboratori analysi alanin aminotransferas term signific human health diseas cut level defin abnorm arbitrari decreas specif test appar healthi patient small import group patient alanin aminotransferas abnorm liver diseas treatabl diagnos base histori physic examin biochemicalserolog profil liver biopsi complement diagnost process select circumst literatur pertain critic review"
"vagus nerv gastric secret relationship peptic ulcer diseas peptic ulcer diseas ancient process diseas produc remain mysteri advanc made medicin scienc advanc made understand digest gastrointestin diseas treatment peptic ulcer diseas improv understand digest process grew current surgic treatment peptic ulcer diseas princip articul lester dragstedt md phd base observ research laboratori present histor perspect role vagus nerv control gastric secret relationship peptic ulcer diseas place emphasi dragstedt contribut"
"water electrolyt balanc ileoan anastomosi water electrolyt balanc studi patient ileoan anastomosi pouch patient convent ileostomi nonoper patient quiescent ulcer coliti serum electrolyt concentr daili urinari volum daili loss sodium potassium chlorid measur patient daili fecal weight daili loss sodium potassium analyz patient ileoan anastomosi convent ileostomi serum chlorid patient ileoan anastomosi signific lower convent ileostomi nonoper patient daili urinari loss sodium nonoper patient signific higher patient ileoan anastomosi convent ileostomi daili urinari loss chlorid patient ileoan anastomosi signific lower nonoper patient daili fecal loss potassium patient ileoan anastomosi signific higher convent ileostomi daili urinari volum fecal weight differ signific patient ileoan anastomosi convent ileostomi present studi water sodium balanc ileoan anastomosi similar convent ileostomi chlorid balanc alter ileoan anastomosi"
"miniperfor colon postpolypectomi perfor requir laparotomi year experi consecut colonoscop polypectomi oper intervent perfor patient special defin limit perfor treat nonop specif complic term miniperfor general detect hour polypectomi character local pain tender sign diffus spread periton irrit free intraabdomin retroperiton air ray document actual perfor complet resolut symptom hour confirm diagnosi miniperfor success depend good bowel prepar colonoscopi earli recognit perfor institut bowel rest intraven antibiot miniperfor spontan close oment adher frequent serial clinic examin mandatori frank perfor advanc periton prompt recogn treat surgic understand level cauteri injuri colon wallseros burn miniperfor frank perfor essenti manag complic colonoscop polypectomi"
"incarcer colonoscop inguin hernia pulley techniqu remov relat safeti colonoscopi accept diagnost therapeut procedur evalu patient colorect disord unusu complic colonoscopi anecdot report hernial incarcer publish present case side hernial incarcer colonoscop permit reduct hernia remov instrument convent mechan incarcer dictat size hernia risk incarcer explain pulley techniqu remov instrument surgic intervent"
"gender differ man criteria irrit bowel syndrom object studi determin gender differ exist man criteria diagnosi irrit bowel syndrom outpati set women men entri complaint abdomin pain alter bowel habit underw full evalu boardcertifiedelig gastroenterologist systemat rate presenc absenc man criteria irrit bowel syndrom defin absenc organ diseas explan entri complaint determin made boardcertifi gastroenterologist patient studi month rater independ studi rate transcript patient clinic visit clinic data clinic laboratori data obtain month studi period result month telephon follow patient physician sixti percent studi popul organ diseas explan entri symptom repres irrit bowel syndrom studi similar proport type organ diseas irrit bowel syndrom experienc men women total sampl subject correl man criteria irrit bowel syndrom women correl man criteria irrit bowel syndrom signific men correl opposit direct signific conclud signific gender differ exist man criteria diagnosi irrit bowel syndrom man criteria diagnost men"
"impair esophag empti hiatal hernia concurr videofluoroscopi manometri analyz esophag empti barium swallow patient axial hiatal hernia volunt subject divid group volunt maxim phrenic ampullari length cm control patient volunt maxim ampullaryhiat hernia length greater equal cm reduc swallow reducinghernia group patient hernia reduc swallow complet esophag empti retrograd flow achiev test swallow control reducinghernia group nonreducinghernia group impair empti reducinghernia group attribut late retrograd flow barium squirt retrograd hernia empti impair empti nonreducinghernia group attribut earli retrograd flow occur immedi les relax nonreducinghernia group longer acid clearanc time control conclud gastroesophag junction compet sever impair patient nonreduc hiatal hernia suggest mechan subgroup hiatal hernia involv pathogenesi reflux diseas"
"small intestin transit portal hypertens rat purpos studi determin effect portal hypertens gastrointestin transit portal hypertens induc group rat stage portal vein ligat techniqu control group rat underw sham oper ten day crlabel kreb buffer solut instil duodenum distribut radioact length small intestin determin minut portal hypertens consist establish studi group splenic pulp pressur mm hg sd portal hypertens control  measur intestin transit reveal delay transit portal hypertens group retent radioact proxim quartil intestin greater percentag retain portal hypertens control   minut geometr transit locat proxim studi interv portal hypertens group conclud portal hypertens delay intestin transit abnorm predispos bacteri overgrowth contribut alter digest absorpt"
"increas uptak bromodeoxyuridin hepatocyt earli stage primari biliari cirrhosi relationship dna synthesi activ hepatocyt biopsi specimen liver volum studi stage primari biliari cirrhosi vitro bromodeoxyuridin thymidin analogueantibromodeoxyuridin reaction comput tomographi bromodeoxyuridin se label index patient earli histolog stage stage stage ii primari biliari cirrhosi time control subject signific higher femal patient chronic aggress hepat compens cirrhot patient viral origin femal patient stage iii primari biliari cirrhosi se liver volum earli stage primari biliari cirrhosi cm time control subject cm result suggest liver volum larg earli stage primari biliari cirrhosi mark increas dna synthesi hepatocyt"
"glucos fat metabol shortterm starvat cirrhosi evalu metabol consequ shortterm hour starvat glucos fat metabol studi healthi subject patient stabl cirrhosi hour hour starvat hglucos cpalmit turnov indirect calorimetri patient control show signific increas free fatti acid concentr turnov shortterm starvat valu hour starvat higher cirrhosi fat oxid enhanc patient increas fast contrast control increas net glucos oxid decreas postabsorpt cirrhot postabsorpt glucos turnov control starvat induc greater decreas glucos turnov patient  reflect plasma glucos concentr conclus effect starvat glucos fat metabol enhanc cirrhosi fast hypoglycemia prevent decreas glucos remain establish explain defect liver function se"
"ascit increas rest energi expenditur liver cirrhosi purpos studi investig effect ascit energi metabol patient liver cirrhosi rest energi expenditur determin patient liver cirrhosi ascit moder larg volum rest energi expenditur measur perform indirect calorimetri rest energi expenditur predict calcul harrisbenedict equat remov ascit fluid paracentesi metabol stress factor absent case interv day measur weight loss kg observ paracentesi rest energi expenditur measur indirect calorimetri show statist signific decreas kcalday remov ascit repeat indirect calorimetri method analysi result patient ascit remov produc consist decreas rest energi expenditur statist signific differ measur obtain indirect calorimetri provid harrisbenedict equat moder reliabl predict real rest energi expenditur patient result suggest inert volum ascit patient increas rest energi expenditur acceler protein energi malnutrit complic"
"incid gallston danish popul year incid gallston diseas assess ultrasonographi age sexstratifi random popul danish origin age year respons rate nonrespond differ respond variabl gallston diseas year incid gallston diseas men age year figur women incid gallston signific higher subject age year compar age year sex differ gallston incid decreas increas age signific higher incid gallston diseas found subject polyp gallbladd spontan disappear gallston"
"prostaglandin einduc diarrhea mice import colon secret present studi investig basi induct diarrhea prostaglandin pge mice pge induc dose timedepend diarrhea shortest posttreat time diarrhea onset approxim min pge dose microgramskg dose pge produc accumul fluid small intestin colon enteropool enteropool reach maximum min decreas approxim min min time diarrhea onset pge treatment alter gastric empti gastrointestin propuls strong enhanc expuls glass bead colon decreas time bead expuls shortest time expuls glass bead observ microgramskg induct diarrhea pge unaffect cecectomi shamcecectomi doserespons curv time onset diarrhea pge displac anim ligat ileocecocolon icc junction intralumin fluid accumul colon evalu mice icc ligat increas pge administr min remain greater vehicletr anim onset diarrhea stimul colon bead expuls produc pge control mice observ anim acut icc ligat dose microgramskg"
"enteroclysi small bowel seri comparison radiat dose examin time respect radiat dose total examin fluoroscopi time compar patient underw enteroclysi underw small bowel seri examin upper gastrointestin gi tract enteroclysi skin entri radiat dose rad mgi fluoroscopi time minut time greater small bowel seri examin upper gi tract rad mgi minut time greater small bowel seri upper gi examin rad mgi minut total examin complet time enteroclysi minut half small bowel seri upper gi examin minut time shorter small bowel seri upper gi examin minut higher radiat dose enteroclysi consid short examin time age clinic condit patient report higher accuraci decid radiograph examin small bowel"
"peptic ulcer diseas ct evalu author retrospect describ comput tomograph ct find patient peptic ulcer diseas patient gastriti duoden bowelwal thicken ten remain patient ct evid ulcer perfor penetr case unsuspect clinic patient acut free perfor pneumoperitoneum show free extravas oral administ contrast materi precis site perfor establish case ct patient ulcer penetr ct evid bowelwal thicken inflammatori adjac soft tissu organ includ pancrea liver lesser omentum ulcer crater ct find penetr mimic diseas process ct detect uncompl peptic ulcer diseas"
"diagnost fineneedl punctur gallbladd guidanc februari januari fineneedl diagnost punctur gallbladd dpg perform continu ultrasound guidanc symptomat patient gallston attempt gallbladd punctur aspir success patient gaug needl continu visual needl tip aspir volum vari ml averag standard deviat ml biliari analysi reveal elev cholesterol satur index patient cholesterol gallston attenu comput tomograph examin hu relat patient pigment stone attenu hu nucleat time prolong patient pigment stone day day patient cholesterol stone patient remain hospit hour dpg reexamin outpati basi month complic detect shortterm observ longterm follow author conclud dpg safe valuabl techniqu diagnost work gallston patient establish suitabl nonop treatment"
"asialoglycoprotein receptor function benign liver diseas evalu mr imag arabinogalactanco ultrasmal superparamagnet iron oxid aguspio prepar specif asialoglycoprotein asg receptor hepatocyt magnet reson mr imag contrast agent evalu spectrum benign liver diseas anim model activ hepatocyt asg receptor direct reflect liver function direct assess measur liver relax time vitro mr signal intens vivo measur dimension assess liver function liver relax time nativ mr signal intens liver respons liver aguspio probe percentag decreas liver signal intens intraven administr mumolkg aguspio normal liver fatti liver acut hepat chronic hepat cirrhosi redistribut hepatocytespecif aguspio spleen present hepat cirrhosi normal liver fatti liver result studi cellular hepat abnorm detect quantit mr receptor imag"
"percutan rotat contact biliari lithotripsi initi clinic result kensey nash lithotrit percutan rotari lithotrit introduc concept fragment percutan remov gallston fluid vortex generat pull calculi highspe blade fragment stone predomin micron result treat patient instrument reveal larg stone burden small stone mm composit remov gallbladd suffici size accommod prong basket rotat time minut requir procedur complet access lost case major complic occur repeat oral cholecystographi gallbladd visual week patient ursodeoxychol acid administ month patient residu stone aggreg hospit stay rang hour patient patient underw surgeri resum light activ day strenuous activ full diet week"
"sulphasalazin prednison compar sulphasalazin treat activ crohn diseas doubleblind random multicent trial object determin sulphasalazin prednison effect sulphasalazin treat activ crohn diseas design random doubleblind placebocontrol trial set multicent trial univers hospit general hospit patient patient activ crohn diseas van hee activ index patient random assign complet treatment analyz intervent week patient receiv sulphasalazin advers effect occur prednison mg initi prednison therapi taper increment mg wk mg week thirti patient receiv sulphasalazin placebo measur main result week treatment van hee activ index decreas median interquartil rang initi patient treat sulphasalazin prednison median interquartil rang patient treat sulphasalazin week treatment figur interquartil rang interquartil rang crohn diseas activ index decreas week median interquartil rang patient receiv sulphasalazin prednison median interquartil rang patient receiv sulphasalazin week treatment figur interquartil rang interquartil rang conclus prednison addit sulphasalazin patient activ crohn diseas result signific faster initi improv signific result week treatment diseas activ measur van hee activ index"
"manag extens tracheoesophag fistula cervic esophag exclus giant tracheoesophag fistula occur ventilatordepend patient result signific ventilatori embarrass cervic exclus fistula safe control fistula quick restor adequ ventil critic ill patient"
"medic treatment esophag achalasia doubleblind crossov studi oral nifedipin verapamil placebo calcium channel blocker previous shown decreas lower esophag sphincter les pressur improv symptom achalasia perform placebocontrol doubleblind crossov studi assess effect oral nifedipin verapamil les pressur amplitud esophag bodi contract clinic symptomatolog patient symptomat achalasia diagnos endoscopi barium swallow manometri patient random receiv mg nifedipin mg verapamil placebo underw esophag manometri baselin week drug diari card record grade symptom drug plasma level determin correl manometr clinic find nifedipin verapamil caus statist signific decreas les pressur nifedipin caus signific decreas amplitud contract smooth muscl portion esophagus statist signific differ clinic symptomatolog note drug individu improv dysphagia chest pain note conclud reduct les pressur contract amplitud distal esophag bodi oral nifedipin verapamil signific alter clinic symptomatolog patient achalasia"
"manag dysphagia suspect esophag motor disord fifti patient suffer dysphagia suspect esophag motor disord treat pneumat dilat ridermoel techniqu fifteen achalasia demonstr manometr studi forti remark clinic improv procedur period follow averag year rang patient dilat delay year result dilat excel good case earli complic consist esophag perfor surgic treat mortal observ late complic procedur conclud pneumat dilat initi procedur treatment dysphagia suspect esophag motor disord"
"reevalu manometr criteria vigor achalasia distinct clinic disord clinic manometr data consecut patient idiopath achalasia analyz distinct subset vigor achalasia identifi statist analys fail detect uniqu group subject base distribut contract wave amplitud patient fall percentil wave amplitud greater mm hg compar amplitud convent threshold diagnosi vigor achalasia amplitud mm hg remaind amplitud mm hg subject amplitud mm hg amplitud mm hg close resembl measur clinic featur subject amplitud greater mm hg male older year year longer durat symptom compar remaind month chest pain esophag symptom basal residu lower sphincter pressur respons treatment differ group data highfidel manometri techniqu identifi rare subset achalasia patient contract amplitud exceed mm hg older possibl greater durat symptom present similar idiopath achalasia outcom convent treatment similar vigor nonvigor patient make distinct question"
"ulcer coliti diseas activ subject assess patientcomplet questionnair orthotop liver transplant scleros cholang assess liver transplant subsequ immunosuppress cyclosporin prednison affect ulcer coliti symptomatolog survey questionnair surviv patient pretranspl colonoscopydocu ulcer coliti transplant primari scleros cholang june septemb follow week sem patient asymptomat colonoscopydocu ulcer coliti report continu ulcer coliti quiescenc patient symptomat colonoscopydocu ulcer coliti time liver transplant report improv ulcer coliti sever signific improv frequenc bowel movement report crampi abdomin pain bowel urgenc occurr pus mucus stool incid ulcer coliti flare number day unabl function due ulcer coliti symptom data demonstr ulcer coliti symptom sever signific improv liver transplant immunosuppress cyclosporin prednison"
"carbon tetrachlorideinduc alter hepat calmodulin free calcium level rat pretreat chlordecon calmodulin low molecular weight ca bind protein regul larg number cell activ includ cell divis previous studi laboratori excess accumul ca hepatocyt succeed rapid glycogen breakdown suppress cell divis rat receiv ccl previous dietari exposur ppm chlordecon calmodulin play major role caregul event report local mitot apparatus cell divis assess subcellular distribut calmodulin estim cytosol phosphorylas cytosol free ca level liver rat fed ppm ppm chlordecon diet day ccl microliterskg administr understand role cacalmodulin chlordecon ccl toxic hepatotox assess determin serum ast alt succeed histopatholog observ liver section serum aminotransferas signific elev hr ccl administr normal rat return control level hr serum ast alt elev severalfold higher progress increas observ start hr ccl administr chlordecon rat histopatholog observ liver section necrot swollen lipidladen cell provid find commensur serum enzym data data normal rat recov ccl hepatotox ccl hepatotox progress chlordecon rat recoveri normal rat ccl administr result slight increas phosphorylas start hr"
"collagen coliti chronic diarrhea usual workup chronic diarrhea fail provid diagnosi endoscop find normal altern etiolog consid case collagen coliti repres altern diagnosi patient year woman complain abdomin cramp wateri diarrhea month span key element diagnosi subepitheli collagen deposit mucosa colon symptom resolv support care diet diphenoxyl essenti featur treatment collagen coliti review"
"simpl score identif patient high risk organ diseas colon famili doctor consult room local ib studi group order develop score system select patient high risk organ diseas colon colonoscopi barium enema conduct studi gps local health care district modena year consecut patient consult gp chronic abdomin pain answer guid questionnair checklist simpl paramet suggest presenc organ diseas colon regist gp final diagnosi patient underw colonoscopi barium enema data collect analys stepwis logist regress analysi obtain weight score diagnosi irrit bowel syndrom score organ diseas score greater paramet explor signific common patient organ diseas weight posit score esr greater mm hour histori blood stool leukocytosi greater cm age greater year slight fever presenc neoplast colon diseas degre relat contrari paramet frequent patient irrit bowel syndrom weight negat score visibl distens abdomen feel distens presenc irrit bowel syndrom degre relat flatul irregular bowel movement score system correct classifi case sensit diagnosi organ diseas"
"breakdown gastric mucus presenc helicobact pylori potenti helicobact pylori degrad gastric mucus examin coloni pylori cultur antral mucos biopsi specimen patient autoimmun gastriti wash steril salin pass sterilis filter filtrat examin ureas proteas mucolyt activ filtrat fail hydrolys bovin serum albumin degrad stabl mucus glycoprotein structur high particl weight separ human gastric mucus sepharos high particl weight mucus glycoprotein extens degrad incub pylori filtrat possess ureas activ presenc urea releas fragment mr approxim high particl weight mucus glycoprotein broken compar extent incub jack bean ureas presenc urea ammonium carbon mm carbonatebicarbon buffer ph treat urea jack bean ureas result loss high particl weight mucus glycoprotein gastric mucus patient gastriti gastric ulcer due mucolyt action extracellular proteas produc pylori result destabilis effect carbonatebicarbon buffer generat mucos surfac pylori ureas hydrolys transud plasma urea"
"valproat metabol hepatotox drug plasma concentr valproat metabolit pattern excret urin adult develop hepatotox treatment epilepsi sodium valproat patient develop degre revers renal insuffici whilst infecti mononucleosi case show evid impair mitochondri betaoxid valproat impair stage catalys fatti acylcoa dehydrogenas stage catalys hydroxyacylcoa dehydrogenas stage catalys enoylcoa hydratas possibl stage catalys hydroxyacylcoa dehydrogenas impair betaoxid meant valproat metabol divert altern pathway plasma concentr suspect hepatotox metabolit envalpro normal valproatetr popul case analog spontan acquir human disord branch chain amino acid metabol suggest valproat hepatotox repres consequ valproat overload limit mitochondri betaoxid capac caus accumul toxic product endogen branch chain amino acid metabol"
"colon interposit esophag diseas histolog find colon mucosa follow month year thirti patient subject colon interposit benign esophag diseas carcinoma esophagus gastric cardia studi endoscopi sign mucos diseas interpos colon month yr month oper endoscop find interpos colon macroscop normal patient sign inflamm includ hyperemia hyperemia friabil observ patient histolog specimen obtain endoscopi examin microscop find compar preoper graft patient chronic inflammatori observ graft mucosa consist mononuclear cell infiltr lamina propria accompani crypt dilat deform patient inflamm proxim graft endoscopi remain patient graft mucosa microscop compar normal alter unexpect mild mark chang locat function colon segment"
"gluten challeng patient celiac diseas evalu alpha antitrypsin clearanc aim studi monitor intestin structur alpha antitrypsin clearanc alpha atcl order offer altern gluten challeng biopsi addit evalu possibl reduc time gluten challeng twelv patient presumpt diagnosi celiac diseas base clinic histolog ground studi jejun histolog normal glutenfre diet alpha atcl normal gluten introduc return normal diet challeng wk measur alpha atcl end st wk jejun biopsi obtain end wk wk alpha atcl abnorm patient normal wk alpha atcl abnorm patient normal postchalleng biopsi show atrophi normal patient normal alpha atcl wk patient abnorm alpha atcl stop challeng week patient normal clearanc wk normal biopsi wk abnorm result month data support hypothesi alpha atcl evid gluten toxic gluten challeng test abnorm earli wk gluten reintroduc"
"gastric adapt relax symptom vagotomi gastric adapt relax report impair vagotomi abnorm implic pathogenesi postvagotomi symptom associ previous demonstr gastric adapt relax measur healthi volunt patient year high select vagotomi truncal vagotomi drainag seventeen patient asymptomat remaind symptomat includ patient persist diarrhoea fast subject intub ryle tube pressur microtransduc flaccid ml plastic bag gastric corpusfundus pressur record distens bag air ml pressur indic deriv area pressur curv median rang pressur indic healthi volunt cmho high select vagotomi cmho truncal vagotomi drainag cmho patient diarrhoea abnorm high pressur indic pressur indic patient group normal rang conclud gastric adapt relax remain abnorm patient postvagotomi diarrhoea asymptomat symptom"
"advantag narrowrang medium molecular weight hydroxyethyl starch volum mainten porcin model fecal periton object compar effect hydroxyethyl starch solut molecular weight rang volum mainten porcin model fecal periton design random prospect trial set laboratori investig subject adolesc femal pig weigh approxim kg intervent compar diafilt pentastarch high molecular weight hetastarch volum mainten porcin model fecal periton number averag molecular weight pentastarch higher hetastarch weight averag molecular weight lower narrow rang medium weight molecul infus rate agent adjust maintain baselin arteri hct equal hr instrument induct fecal periton main outcom measur volum fluid requir maintain arteri hct compar comparison hemodynam histolog respons agent result signific pentastarch requir prevent hemoconcentr hetastarch mlkg hemodynam colloid osmot pressur oxygen transport respons similar capillari patenc greater alveolar capillari barrier thick micron pentastarch hetastarch judg electron microscopi conclus data suggest pentastarch retain circul capillari leak syndrom compar hetastarch"
"incontin rectal prolaps prospect manometr studi prospect manometr studi perform femal patient rectal prolaps vari degre incontin incontin patient regain contin surgeri patient improv improv intern extern sphincter function correct rectal prolaps preoper rest anal pressur signific higher contin patient incontin patient maximum voluntari contract pressur postop signific increas rest anal pressur maximum voluntari contract pressur group preoper rest anorect angl signific acut contin patient incontin patient signific chang rest anorect angl prolaps repair patient remain incontin signific lower preoper rest anal pressur patient improv regain contin similar maximum voluntari contract pressur lower preoper patient preoper rest anal pressur mm hg maximum voluntari contract pressur mm hg persist incontin surgeri"
"vascular respons obstruct gut multiorgan system failur due hypotens sepsi import death patient bowel obstruct investig pathophysiolog entiti anim model day bowel obstruct blood flow superior mesenter arteri measur pitressin norepinephrin separ experi control pitressin moder dosag caus substanti fall gut blood flow obstruct anim blood flow reduct percent percent sham obstruct anim similar norepinephrin infus effect gut blood flow obstruct anim blood flow reduct percent percent sham obstruct anim agent doserel effect gut blood flow maintain higher level drug infus period bowel obstruct anim demonstr splanchnic flow respons vasoact drug infus experiment condit splanchnic vasoconstrict import featur normal hemodynam homeostasi suggest result explain aspect pathophysiolog multiorgan failur caus worsen system hypotens bowel obstruct"
"develop applic vitro model screen antihepat virus therapeut develop effect antihepat virus agent hamper lack reliabl vitro system screen therapeut effort circumv problem develop vitro system screen antihepat virus drug hepat virus dnatransfect hep cell cell line design produc replic viral dna intermedi matur dane particl high level viral antigen subconflu cell treat varieti common antihepat virus therapeut efficaci determin analyz replic cellular extracellular hepat virus dna content southern blot slotblot hybrid slotblot method sensit reproduc rapid correl southern blot analysi media hepat virus dna indic intracellular replic hepat virus dna permit sampl media cell provid valuabl method identifi monitor effect antihepat virus therapeut system test agent confirm deoxyguanosin strong inhibit viral replic test effect correl vivo system"
"hepat aminonitrogen clearanc ureanitrogen control subject patient cirrhosi simplifi method function hepat nitrogen clearanc amino acid infus measur liver cell mass clinic feasibl test limit methodolog problem simplifi procedur measur ureanitrogen synthesi rate function hepat nitrogen clearanc subject normal liver function patient cirrhosi method base consecut hr urin collect blood sampl total bodi water calcul nomogram base age anthropometr data gut urea hydrolysi assign fix fraction synthesi control subject patient cirrhosi final solut singl amino acid alanin infus substrat urea synthesi ureanitrogen synthesi rate increas linear increas alphaaminonitrogen concentr slope regress function hepat nitrogen clearanc reduc cirrhosi hr hr hepat nitrogen clearanc linear relat clinic status childpugh score routin liver function test galactos elimin capac establish quantit liver function measur simplifi method make measur hepat nitrogen clearanc suitabl routin clinic test prove studi alter nitrogen metabol cirrhosi special refer hepat encephalopathi"
"autoantibodi primari biliari cirrhosi analysi reactiv eukaryot prokaryot oxo acid dehydrogenas complex compon mammalian oxo acid dehydrogenas complex previous identifi autoantigen primari biliari cirrhosi report present data show polypeptidespecif crossreact antibodi present patient sera antibodi react pyruv dehydrogenas complex crossreact protein mammalian antigen main immunogen region protein local singl lipoyl domain polypeptidespecif antibodi bind alpha beta pyruv dehydrogenas complex antibodi react polypeptid oxoglutar dehydrogenas complex branchedchain oxo acid dehydrogenas complex show crossreact recogn antigen pyruv dehydrogenas complex antibodi compon mammalian pyruv dehydrogenas complex crossreact effect protein yeast escherichia coli antibodi titer mammalian antigen signific higher bacteri antigen argu bacteri origin primari biliari cirrhosi"
"quantit intrins drugmetabol capac human liver biopsi specimen support intacthepatocyt theori hepat drug metabol decreas patient sever liver diseas unclear extent due alter hepat blood flow reduc intrins metabol capac studi quantit needlebiopsi specimen intrins capac liver tissu patient mild liver diseas chronic activ hepat cirrhosi metabol model compound vitro hydroxyl lowextract drug bufuralol result format nmol bufuralolgm wet wthr mild diseas liver tissu signific reduc liver tissu exhibit chronic activ hepat nmolgm wet wthr cirrhosi nmolgm wet wthr format rate monoethylglycinexylidid main metabolit highextract drug lidocain vari wide signific group relat drugmetabol capac hepatocyt content liver tissu morphometr studi perform biopsi piec origin submit metabol activ biopsi piec relat fraction volum hepatocyt calcul mild diseas liver tissu nmol bufuralolml hepatocyt hr mumol monoethylglycinexylidideml hepatocyt hr cirrhot liver tissu nmol bufuralolml hepatocyt hr mumol monoethylglycinexylidideml hepatocyt hr form differ signific"
"micronodular cirrhosi hepatocyt retain normal hydroxyl capac vitamin studi rat carbon tetrachlorideinduc cirrhot model test compet cirrhot liver metabol vitamin hepatocyt isol control cclinduc cirrhot rat liver partial hepatectom rat transform hydroxyvitamin studi presenc hepatocyt concentr nmol mumol histolog micronodular cirrhosi present ccltreat rat control normal liver portal venous pressur intrahepat collagen content signific increas ccltreat rat differ found group total ioniz serum calcium metabolit alt ast alkalin phosphatas cytochrom nmol hepatocyt control cirrhot rat signific increas group phenobarbit methylcholanthren administr hydroxyvitamin format power law equat vari control pmolhr hepatocyt cirrhot rat statist signific differ found slope hydroxyvitamin format axi intercept found lower cirrhot rat basal rest condit induc mix function oxidas signific increas hydroxyvitamin format control cirrhot rat group found respond similar addit modul enzym calcium ionophor parathyroid hormon partial hepatectomi effect activ cell sequestr found unperturb hepatocyt obtain cirrhot partial hepatectom liver data compens micronodular cirrhosi hydroxyl general intrins normal cellular level remain fulli respons vivo vitro modul activ"
"rapid induct hepat fibrosi gerbil parenter administr irondextran complex parenter administr irondextran complex gerbil caus hepat hemosiderosi fibrosi wk type iii collagen synthesi liver develop perisinusoid stellat cell refer myofibroblast immunohistolog cell shown larg intracellular deposit ferritin hepat fibrosi aggreg cell aggreg kupffer cell occur hemosiderosi liver appreci necrosi hepatocyt trigger fibrot respons found fibrosi relat accumul ferritin perisinusoid stellat cell contrast rat mice accumul ferritin perisinusoid cell develop hepat fibrosi respons parenter administ iron accumul similar greater amount total iron liver rapid induct hepat fibrosi gerbil respons parenter administ iron provid model investig mechan induct collagen deposit respons iron overload quick evalu therapeut treatment iron overloadinduc fibrosi vivo ironchel drug"
"regul collagen product fresh isol cell popul normal cirrhot rat liver effect lactat previous work shown lactic acid lesser extent pyruv acid increas collagen synthesi signific liver slice ccltreat rat normal rat purpos report document cell cirrhot liver respons lactatestimul increas collagen synthesi found incorpor hprolin proteinbound hhydroxyprolin increas threefold fourfold hepatocyt ccltreat rat compar normal rat hepatocyt hepatocyt normal ccltreat rat modifi collagen synthes capac mmol lactic acid ad incub medium nonparenchym cell obtain liver ccltreat rat synthes collagen hepatocyt synthesi stimul twofold lactic acid nonparenchym cell fatstor ito cell increas collagen synthesi lactic acid present incub medium result suggest increas lactic acid level observ patient alcohol hepat cirrhosi play import role develop fibrosi stimul collagen product fatstor ito cell"
"apic secret lysosom enzym rabbit pancrea occur secretagogu regul pathway increas pancreat duct obstruct lysosom hydrolas cathepsin apic secret rabbit pancreat acinar cell regul oppos constitut pathway intraven infus cholecystokinin analogu caerulein result high correl apic secret digest lysosom enzym suggest discharg presecretori compart zymogen granul lysosom enzym enter compart result missort duct obstruct reliev caeruleinstimul apic secret cathepsin amylas increas ratio cathepsin amylas secret caerulein stimul anim obstruct find duct obstruct increas amount lysosom digest enzym accumul secretagogu releas compart duct obstruct increas degre lysosom enzym missort compart pancreat duct obstruct lysosom hydrolas coloc digest enzym organell size distribut resembl zymogen granul subject secret respons secretagogu stimul organell import develop pancreat"
"laparoscop cholecystectomi laparoscop cholecystectomi endoscop techniqu diffus surgic communiti great rapid datta panelist consid procedur respect safeti effect recognit made compar trial techniqu open cholecystectomi virtual literatur complic rate societi american gastrointestin endoscop surgeon develop minim credenti criteria determin compet laparoscop surgeri includ complet approv resid train general surgeri train laparoscop techniqu surgeon experienc procedur complet approv techniqu requir hand laboratori practic observ proctor actual surgic procedur datta panelist reiter import requir procedur perform anim subsequ laparoscop procedur patient supervis expert laparoscop cholecystectomi"
"abnorm liver enzym level evalu asymptomat patient chronic elev serum aminotransferas level absenc symptom reflect chronic hepat signific liver diseas patient persist abnorm alkalin phosphatas level extrahepat biliari tract diseas chronic cholestat disord physician discov unsuspect liver diseas undu risk expens inconveni patient care histori physic examin time follow blood test time referr percutan liver biopsi endoscop retrograd cholangiopancreatographi"
"pancreat pseudocyst drain wait acut pain upper abdomen patient recov pancreat abdomin trauma herald pancreat pseudocyst small cyst resolv spontan larger cm requir treatment prevent complic ruptur adjac structur infect author describ oper nonop treatment method success report"
"peptic ulcer diseas treat option treatment peptic ulcer diseas divers agent effect offer real advantag tradit therapi omeprazol prilosec benefit owe potent inhibit acid secret approv purpos treatment helicobact pylori infect prove benefici answer forthcom final diseas process allevi risk factor import counsel nonsteroid antiinflammatori drug cigarett smoke necess"
"laparoscop cholecystectomi cholecystectomi perform year great interest develop laparoscop cholecystectomi procedur offer patient reduc hospit stay faster return work pain improv cosmet result septemb develop techniqu perform laparoscop cholecystectomi perform case good result techniqu surgeon fulli evalu common duct oper cholangiographi laparoscop approach patient candid cholecystectomi techniqu offer minim invas altern open cholecystectomi"
"los angel experi laparoscop cholecystectomi surgeon compet diagnost laparoscopi perform laparoscop cholecystectomi lc structur endors cours experienc faculti import month lcs perform hospit number open cholecystectomi decreas cholecystectomi perform cholangiographi attempt routin duct success cannul inquiri made hospit mile radius total lcs perform gray area address patient slight increas liver function test jaundic unsuspect stone discov cholangiographi project progress explor common bile duct cystic duct direct common bile duct insert tube author recommend proper train caution sound judgment commenc lc"
"train credential grant clinic privileg laparoscop general surgeri lack scientif data compar tradit open oper laparoscop surgeri gain rapid accept implement general surgeon individu hospit respons develop privileg criteria search guidanc amount type addit train requir grant clinic privileg laparoscop general surgeri laparoscop surgeri involv techniqu learn general surgeri resid train techniqu regular includ general surgeri resid program addit train grant separ privileg laparoscop surgeri adequ train surgeon experienc abdomin biliari tract surgeri acquir preceptorship diagnost laparoscopi attend laparoscop surgeri includ didact instruct live anim experi assist procedur human proctor certifi compet experienc general surgeon"
"atracurium decay format laudanosin human group investig report plasma concentr laudanosin metabolit atracurium high immedi administr atracurium declin time profil metabolit plasma unusu author describ model atracurium decay laudanosin disposit satisfactorili explain data model reveal atracurium molecul degrad laudanosin generat laudanosin occur process rapid involv approxim atracurium dose proceed halflif min slower involv residu proceed halflif min atracurium degrad hofmann elimin proceed central noncentr compart laudanosin form atracurium gain access central compart disappear plasma biexponenti pattern cirrhot patient atracurium dose degrad rapid laudanosin dispos slowli author propos rapid degrad atracurium plasma proceed nucleophil substitut reaction plasma nucleophil substitut laudanosin moieti atracurium laudanosin moieti atracurium requir establish sustain plasma concentr laudanosin excret atracurium degrad pathway generat laudanosin small"
"compar studi temporomandibular symptom mandibular advanc bilater sagitt split osteotomi rigid versus nonrigid fixat rigid fixat attach proxim distal segment boni heal osteotomi site increas popular effect rigid fixat temporomandibular joint question purpos studi evalu effect rigid fixat bilater sagitt split osteotomi temporomandibular dysfunct symptom forti patient mandibular advanc surgeri evalu temporomandibular joint dysfunct twenti receiv rigid fixat twenti receiv nonrigid fixat determin statist signific differ temporomandibular sign symptom patient treat rigid intern fixat bilater sagitt split osteotomi mandibular advanc patient treat nonrigid wire fixat"
"retrospect evalu tmj proplastteflon implant retrospect review meniscectomi proplastteflon implant perform factor interincis open occlus joint sound joint degener patient satisfact examin surgic success rate averag follow period month patient demonstr signific condylar degener year follow chang necessarili result symptomatolog joint dysfunct implant result remov surgic postop procedur contrast clinician experienc lower success rate"
"microleakag retrofil apic amalgam investig effect increas thick amalgam retrofil seal abil studi compar seal abil condens guttapercha sealer apic canal upper central incisor fill condens guttapercha seal amalgam amalgam retrofil seal apic root teeth fill canal effect techniqu determin abil inhibit penetr methylen blue dye period hour week month hour materi show compar seal abil seal abil condens guttapercha signific amalgam week period end studi depth margin penetr materi increas time amount dye penetr increas acut amalgam increas guttapercha uniform end studi specimen retrofil amalgam exhibit total dye penetr exceed full thick amalgam mm spread root canal space hand margin penetr dye condens guttapercha mm end studi present investig prove doubt thick retrograd amalgam seal apex fill canal invit failur"
"preval shovelshap incisor saudi arabian dental patient preval maxillari incisor shovel studi radiograph saudi patient radiomorpholog characterist classif develop shovel teeth categor find studi show shovelshap incisor central incisor incisor frequenc den invaginatus occurr shovelshap incisor investig percent shovelshap incisor show presenc den invaginatus preval found central shovelshap incisor shovelshap incisor"
"stage closur entir primari palat time closur anterior palat alveolus subject debat late repair defect complic high fistula format subject patient problem palat fistula extend period time util singl procedur perform child month age complet close anterior hard palat alveolus cleft lip seri consist consecut patient unilater cleft primari secondari palat mucos turnov flap vomer nasal mucos flap provid nasal line buccal sulcus flap veau flap complet oral repair nineti percent patient complet stabl closur anterior palat alveolus year incid fistula format seri lower report util protocol excel exposur anterior palat alveolar defect lip repair earli restor anatom relationship establish good nostril floor sill low fistula format benefit procedur increas oper time consid minim light aforement advantag"
"congenit cleft palat anomali case atyp cleft palat abnorm identifi year girl present cleft local obliqu posit soft palat patient cleft palat repair final accept soft palat movement speech"
"surgic treatment noma noma gangren stomat affect children develop countri leav dread mutil mouth amput lip cheek nose lid maxilla palat mandibula reconstruct account size defect presenc trismus constrict mandibl age child child general condit year patient treat unit plastic reconstruct surgeri hopit canton universitair case tracheostomi avoid intranas intub fibroscopi children age year underw general anesthesia complex reconstruct procedur includ latissimus dorsi musculocutan peduncul free flap cranial flap galea cranial bone skin graft retroauricular tempor skin flap patient return africa dramat function cosmet improv satisfactori mouth open mandibular function obtain"
"mainten condyleproxim segment posit orthognath surgeri twenti patient underw bilater sagitt ramus osteotomi correct mandibular retrognathia condylar posit devic cpd intraop patient maintain preoper condyleproxim segment posit cpd patient postop condyleproxim segment posit group compar evalu vertic horizont rotat signific improv observ vertic horizont condylar posit group cpd signific differ proxim segment rotat"
"potenti periodont pocket format untreat accessori root canal teeth extract periodonticendodont involv patient treat hemisect root amput root process histolog case show presenc accessori root canal remnant pulpal tissu bacteria necrot debri demonstr case studi residu necrot tissu untreat root canal result periradicular pathosi specul inflammatori process persist drainag result sulcus time plaqu concret develop"
"retrospect clinic studi endodont treat mandibular incisor select chines popul clinic studi incid number canal human teeth correl percentag obtain laboratori sampl studi incid canal mandibular incisor compar figur obtain vitro extract teeth clinic studi low percentag obtain examin clinic record due racial differ sampl examin"
"crosssect tomographi diagnost techniqu determin buccolingu relationship impact mandibular molar inferior alveolar neurovascular bundl twenti patient impact mandibular molar examin precis crosssect tomograph techniqu assess radiograph size shape branch pattern locat degre cortic mandibular canal inclin impact mandibular molar buccolingu plane mandibular canal includ bifid canal accur identifi case crosssect canal uncort partial cortic radioluc oval measur averag sd mm diamet locat frequent buccal aspect impact mandibular molar mandibular canal notch cortic plate mandibl molar root surfac cystic expans quantif cortic bone destruct readili assess techniqu conclud diagnost inform obtain crosssect tomogram signific aid oral maxillofaci surgeon preoper diagnost workup radiat risk compar accept local techniqu"
"assess salivari function healthi premenopaus postmenopaus femal elder repres rapid grow segment popul major group femal averag woman anticip live life menopaus women undergo hormon replac attempt reliev menopaus symptom understood relationship menopaus hormon replac therapi oral structur oral discomfort xerostomia salivari hypofunct postmenopaus women effect menopaus status estrogen therapi subject report oral dryness discomfort object measur major salivari gland output assess healthi premenopaus postmenopaus femal complaint xerostomia burn mouth alter quantiti saliva occur popul studi suggest healthi women salivari gland function signific influenc menopaus hormon replac therapi"
"random doubleblind trial mazindol duchenn dystrophi evid growth hormon relat progress weak duchenn dystrophi conduct month control trial mazindol putat growth hormon secret inhibitor boy duchenn dystrophi muscl strength contractur function abil pulmonari function test baselin month treatment mazindol mg placebo studi design power greater detect slow expect rate progress weak mazindol benefit strength point studi side effect attribut mazindol includ decreas appetit dri mouth behavior chang gastrointestin symptom mazindol dosag reduc patient effect mazindol gh secret estim indirect compar postabsorpt igf level obtain month mazindol treat placebo group mazindoltr patient gain weight height placebotr patient signific effect igf level observ mazindol dose slow progress weak duchenn dystrophi"
"sensit restor class abrasioneros lesion effect restor treatment reduc sensit class erosionabras lesion evalu efficaci toothcolor restor materi reduc sensit compar lesion restor glass ionom restor materi composit resin dentin bond agent composit resin dentin bond agent glass ionom liner composit resin glassionom liner restor signific reduc sensit air hot cold water glass ionom restor restor composit resin dentin bond agent signific reduc sensit increas sensit air cold lesion restor evalu month"
"microleakag gingiv dentin margin class composit restor line lightcur glass ionom cement studi compar microleakag lightcur autoset glass ionom liner class composit lamin glass ionom restor determin amount microleakag gingiv cementumdentin margin standard nonundercut shape class caviti gingiv margin cementoenamel junction prepar mesial distal surfac molar establish total caviti random divid group line glass ionom group ketacbond espepremi serv control group xrionom kerr group xrionom polyacryl acid paa pretreat kerr group vitrabond specimen thermocycl cycl aqueous solut basic fuchsin minut dwell time individu embed epoxi resin statist analysi differ group lightcur glass ionom group show signific leakag control group remov smear layer polyacryl acid solut influenc microleakag restor lightcur glass ionom liner"
"effect endodont access prepar resist crownroot fractur investig involv creation coronalradicular fractur vitro compar fractur resist intact human mandibular molar molar vari tooth prepar forti fresh extract carious nonrestor human mandibular molar random divid treatment group molar subject constant increas occlus load coronalradicular fractur occur tooth prepar signific diminish resist coronalradicular fractur"
"extraor parotid sialolithotomi extraor approach duct surgeri remov parotid stone simpl procedur stone accur locat relat skin surfac combin sialographi sonographi provid inform case report demonstr stepstep approach diagnosi local surgeri manag extraglandular sialolith"
"indic simultan orthognath septorhinoplast surgeri orthognath rhinoplast surgeri combin success guidelin understood relat indic contraind establish general yield predict result tip posit rotat project difficult aspect predict avoid simultan surgeri major deform dorsum easili correct conjunct maxillari surgeri case demonstr guidelin present discuss"
"relationship indic surgic remov impact molar incid alveolar osteiti hundr forti impact molar surgic remov patient surgeri patient assess clinic radiograph reason remov tooth specif record hundr eighti impact teeth remov prophylact reason therapeut reason standard oper procedur environ preoper postop regimen observ surgeri case determin absenc presenc sign symptom alveolar osteiti found factor contribut develop alveolar osteiti signific relat find reason extract extract undertaken therapeut prophylact reason"
"locat abnorm panoram radiograph edentul patient seri panoram radiograph edentul patient examin presenc pathos determin predict basi found occurr abnorm sex age locat radioluc radiopac retain root teeth record size anterior posterior locat edentul jaw radiopac frequent found abnorm subject retain root radioluc retain teeth signific correl found chisquar test type locat abnorm sex patient signific relationship locat type abnorm radiopaqu radioluc lesion frequent found mandibl unerupt teeth retain root frequent posterior maxilla select radiograph detect retain root unerupt teeth posterior maxilla product term prosthodont treatment outcom studi find basi select intraor site specif intraor radiograph asymptomat edentul patient"
"pancreat autoantibodi pancreat function sjogren syndrom pancreat autoantibodi determin patient sjogren syndrom relat function paramet pancreat duct autoantibodi pda detect sera patient show abnorm exocrin pancreat function islet cell antibodi ica detect sera patient includ individu diabet mellitus conclus pda occur patient sjogren syndrom exocrin pancreat dysfunct"
"medic dental implic cocain abus increas suppli cocain crack potent smokeabl form cocain danger cocain abus high morbid mortal recogn oral maxillofaci surgeon frequent unknow treat patient cocain educ cocainerel problem prepar deal complic articl discuss natur cocain pharmacolog system affect oral manifest cocain abus recommend clinic manag patient"
"prevent dri socket overview dentist exodontist oral surgeon oral maxillofaci surgeon plagu postextract complic common dri socket incept profess design attach maladi year includ alveolar osteiti postextract osteiti osteomyelit syndrom alveolar sicca dolorosa fibrinolyt alveol myriad attempt elimin pain condit made avail nonetheless signific progress made endeavor reduc incid time inventori proven method assist practition reduc incid complic practic articl present review past investig merit regard summari recommend conclus articl"
"effect remov inferior alveolar neurovascular structur mandibular growth erupt perman dentit puppi investig perform effect remov inferior alveolar neurovascular structur perman dentit mandibular growth puppi erupt decidu teeth inferior alveolar neurovascular structur remov unilater test anim week examin reveal decidu teeth side oper exfoli perman teeth replac hand perman teeth side oper replac exfoli decidu teeth period week germ perman teeth side oper buri mandibular bone perman teeth side oper erupt mandibular measur demonstr translat transform growth development process normal side oper side oper"
"orofaci odontogen infect review microbiolog current treatment orofaci odontogen infect common current evid anaerob play major role infect common microbi isol bacteroid fusobacteria peptococci peptostreptococci viridan streptococci drainag establish penicillin drug choic therapi metronidazol good altern clinician awar current view articl stateart review practic clinician microbiolog antimicrobi therapi orofaci odontogen infect"
"comparison sign temporomandibular joint dysfunct occlus discrep symptomfre popul men women date conclus explan predomin femal patient temporomandibular joint tmj dysfunct purpos studi survey normal popul symptom presenc putat sign tmj dysfunct associ sign occlus discrep determin presenc gender variat subject men women examin presenc putat sign tmj dysfunct limit mandibular open mm deviat open joint sound subject examin presenc sign occlus discrep anterior slide centric relat cr centric occlus slide cr nonwork occlus contact work disclus contact distal canin cr mandibular posit condyl superior posit posterior aspect articular tubercl mandibular posit mandibular maxillari teeth maximum intercusp signific differ preval putat sign tmj dysfunct occlus discrep men women conclud factor presenc sign tmj dysfunct occlus discrep respons high predomin femal patient tmj dysfunct"
"intracoron radioluc unerupt teeth case report review literatur panoram radiograph obtain orthodont treatment reveal intracoron radioluc unerupt perman molar unusu entiti success treat surgic endodont intervent restor orthodont treatment treatment enabl tooth maintain pulpal vital erupt complet root format function report review propos etiolog condit discuss surgic intervent present detail case"
"comparison temporari restor lightcur resin versus polymer temporari restor temporari restor materi import compon endodont therapi adequ seal access prepar visit protect obtur canal microleakag perman restor efficaci cavit lightcur composit product compar carbon black coron microleakag protocol teeth examin previous receiv coron restor teeth access restor cavit expos dye clear dimension assess reveal cavit consist provid effect seal addit great deal microleakag observ perman restorationtooth interfac leak perman restor remov entireti initi endodont treatment"
"primari parotid malign clinic patholog review hundr nineti patient primari malign tumor parotid gland underw surgeri mayo clinic review surviv pattern analyz kaplanmei productlimit method separ histolog result signific group surviv rate highest patient acin cell adenoid cystic lowgrad mucoepidermoid carcinoma intermedi patient highgrad mucoepidermoid carcinoma lowest remain histolog type encount cox multipl linear regress identifi patient tumor characterist greatest prognost signific order decreas strength region metastat involv pain male gender grade stage advanc age demonstr independ prognost signific fifti percent patient requir facial nerv sacrific asymptomat present high posit correl observ advanc grade stage"
"dri mouth diagnos treat multipl dri mouth elder common occurr multipl etiolog normal phenomenon age attempt elucid made sjogren syndrom occur diagnos labial biopsi medic frequent dri mouth dosag adjust drug discontinu symptom sever strategi manag dri mouth explor"
"inhibit fluorouracilinduc stomat oral cryotherapi mucos signific doselimit toxic fluorouracil fu combin leucovorin hypothes oral cryotherapi local vasoconstrict temporarili decreas blood flow oral mucous membran cryotherapi time peak serum fu level oral mucous membran exposur fu develop mucos test hypothesi patient schedul receiv cycl fu leucovorin random oral cryotherapi time chemotherapi administr serv control group subsequ mucos signific reduc group assign receiv cryotherapi judg attend physician patient routin recommend cryotherapi procedur patient receiv daili bolus fu leucovorin"
"fineneedl aspir biopsi salivari gland januari decemb author associ perform fineneedl aspir biopsi patient clinic signific mass salivari gland patient present medic colleg virginia hospit clinic virginia commonwealth univers period rang year fineneedl aspir diagnos correl histolog diagnos longterm patient outcom sensit neoplasm specif absenc neoplasm diagnost effici predict posit aspir neoplasm fineneedl aspir surgic excis salivari gland mass unnecessari patient primari metastat neoplasm involv salivari gland fineneedl aspir aid surgeon map extent surgic procedur preoper prepar patient procedur costeffect"
"aerob anaerob microbiolog peritonsillar abscess thirti aspir pus peritonsillar abscess studi aerob anaerob bacteria show bacteri growth total bacteri isol anaerob aerob facult recov account isol specimen anaerob aerob facult anaerob bacteria present patient aerob facult mix aerob anaerob flora singl bacteri isol recov infect streptococcus pyogen anaerob bacteria predomin bacteri isol staphylococcus aureus isol bacteroid sp isol includ bacteroid melaninogenicus group peptostreptococcus sp pyogen betalactamaseproduc organ recov specimen test retrospect studi highlight polymicrobi natur import anaerob bacteria peritonsillar abscess"
"protein antibodi label normal salivari gland myoepithelium histogenet implic salivari gland tumor neoplast modifi myoepitheli cell key role develop histolog characterist salivari gland tumor protein express tumor suggest support role princip compon human salivari gland report proteinposit myoepithelium confirm import aspect requir immunoperoxidas stain parotid salivari gland show pattern obtain antibodi protein neuronspecif enolas neurofila compar musclespecif actin cytokeratin cell process acini duct evid antibodi doubl immunofluoresc stain antibodi protein neuronspecif enolas combin musclespecif actin reveal coloc antigen myoepitheli cell local nerv fiber adjac separ acini myoepitheli cell appar protein stain rich network unmyelin nerv interstiti tissu evid ultrastructur misinterpret myoepithelium result import implic histogenet classif salivari gland tumor"
"vitro natur killer lymphokineactiv killer activ patient bronchogen carcinoma author examin peripher blood mononuclear cell patient bronchogen carcinoma determin natur killer nk lymphokineactiv killer lak activ vitro incub media media interferon gamma ifn ml interleukin il ml result show lymphocyt patient bronchogen carcinoma acquir lak activ level activ acquir signific lower compar lymphocyt control subject il cultur supplement autolog human serum ah specif releas versus specif releas lak activ defin cytotox nkresist cell line patient lymphocyt augment cell cultur il ifn compar il pair test control subject unchang signific differ group patient histolog type tumor stage diseas nk activ defin kill nksensit target cell patient lymphocyt signific control lymphocyt specif releas versus specif releas studi feasibl il ifn therapi patient bronchogen carcinoma"
"spirometr find mortal smoker relat ventilatori function mortal studi male femal smoker period particip copenhagen citi heart studi prospect communiti studi men women random select general popul citi copenhagen end subject smoker die mortal analyz proport hazard model cox addit measur ventilatori function mortal analysi includ age sex bodymass index alcohol consumpt school educ diabet mellitus heart diseas bronchial asthma confound factor forc expiratori volum fev percentag predict forc vital capac fvc percentag predict ratio fev fvc signific risk factor mortal sex relat risk death decreas fev fvc percentag predict studi confirm lower ventilatori function strong risk factor mortal smoker sex"
"effect sulindac abnorm cough reflex dri cough order determin role prostaglandin abnorm cough reflex patient dri cough effect cyclooxygenas inhibitor cough symptom examin measur cough symptom score cough reflex sensit inhal capsaicin doubl blind random cross studi compar effect placebo sulindac mg daili week studi hypertens patient angiotensin convert enzym inhibitor cough patient idiopath dri unproduct cough increas sensit cough reflex chang blood pressur control hypertens patient sulindac therapi patient angiotensin convert enzym cough signific reduct cough symptom score signific increas dose capsaicin caus cough threshold sensit caus cough maximum respons sulindac therapi compar placebo patient idiopath dri unproduct cough sulindac alter symptom cough cough reflex respons capsaicin result suggest prostaglandin involv cough angiotensin convert enzym inhibitor therapi import pathogenesi common dri cough unknown"
"immun reactiv bronchogen carcinoma relat year surviv rate perform prospect studi correl paramet immun respons year surviv rate patient bronchogen carcinoma paramet initi examin start treatment delay hypersensit skin test lymphoblastogenesi natur killer nk cell activ interleukin il product employ assess immun compet reaction classifi grade accord intens year surviv rate patient show grade immun respons calcul correl respons treatment surviv rate note lymphoblastogenesi skin test nk cell activ show poorer correl exact correl note il product immun respons"
"laryng mask airway tracheal tube insert unskil personnel short train programm naval medic traine insert laryng mask airway lma tracheal tube ett random order total anaesthetis patient attempt success defin detect expir carbon dioxid guedel airway remov subsequ rose endtid kpa satisfactori lung expans ventil airway intervent anaesthetist lma insert success compar ett attempt lma insert success satisfactori ett placement progress insert quicker lma ett studi assess lma emerg"
"method needleelectrod placement posterior cricoarytenoid muscl electromyographi author develop method needleelectrod placement posterior cricoarytenoid muscl pca electromyographi pca muscl easili reach insert needl electrod cricothyroid membran midlin penetr lamina cricoid cartilag subglott caviti access pca muscl electrod insert afford percartilagin approach report detail techniqu laboratori knowledg report needleelectrod placement pca muscl percartilagin approach electrod insert techniqu appli dog research purpos patient laryng motor disord clinic diagnosi simpl techniqu requir usual skill reliabl electromyograph record obtain method untoward effect hematoma infect repeat placement observ approxim examin perform date reason assum percartilagin rout electrod insert pca muscl feasibl man techniqu electrod placement intrins laryng muscl review compar"
"serial munchausen syndrom proxi case munchausen syndrom proxi msbp present child famili victim high incid matern psychiatr histori marit difficulti munchhausen syndrom mother seventi percent children famili victim msbp children die multiplechild msbp reflect signific matern psychopatholog found case msbp deterior consequ mother children famili syndrom identifi child effect intervent made"
"acut respiratori infect month life clinic radiolog physiolog predictor etiolog clinic radiolog physiolog characterist identifi pathogen assess infant age week present outpati clinic acut respiratori infect eighti case cultur rapid diagnost test rsv posit eighti infant cultur rapid diagnost test chlamydia posit addit respiratori pathogen identifi includ parainfluenza case rhinovirus case pertussi case cmv case multipl pathogen identifi case chlamydia rsv case chlamydia parainfluenza case chlamydia cmv case clinic characterist hospit predictor specif pathogen ray obtain rsv infect chlamydia infect parainfluenza infect pertussi infect case identif pathogen ray find distinguish patient pathogen pathogen sever find present case pathogen identifi compar case pathogen identifi ns moder find present case pathogen identifi compar case pathogen identifi slightneg find present case pathogen identifi compar case pathogen identifi puls oximetri case pathogen identifi rsv chlamydia pertussi"
"doubleblind random studi prolong higherdos oral amoxycillin purul bronchiectasi thirti patient bronchiectasi daili expector purul sputum convent antibiot cours random alloc receiv sachet amoxycillin match placebo daili week doubleblind studi patient amoxycillin placebo withdrawn studi treatment respons patient amoxycillin withdrawn week assess pretreat characterist group similar independ assess respons base patient diari card show higher proport improv amoxycillin group placebo group patient amoxycillin group spent signific time confin bed work treatment frequenc exacerb studi treatment phase similar group sever studi treatment amoxycillin group greater reduct purul sputum volum exacerb studi treatment amoxycillin group cent pretreat volum placebo group cent pretreat volum concentr haemophilus spp sputum exacerb similar group advers effect experienc minor patient amoxycillin withdrawn develop rash patient amoxycillin placebo diarrhoea week necessit withdraw patient amoxycillin placebo studi treatment sputum stool cultur collect regular studi show import bacteri flora group prolong higherdos antibiot therapi patient sever purul bronchiectasi signific reduc host patient inflammatori respons colon microorgan reduc morbid"
"hemoptysi ctbronchoscop correl case comput tomograph ct chest radiograph find retrospect correl found fiberopt bronchoscopi fob patient present hemoptysi abnorm involv airway depict ct total case total group focal abnorm involv central airway identifi subsequ prove malign total ct show bronchiectasi focal airway abnorm shown fob case depict ct malign diagnos patient includ result fob normal malign cell identifi transbronchi biopsi ct abnorm identifi case malign case small cell lung cancer ct definit stage document direct mediastin invas metastat diseas fob definit stage case ct studi provid falseneg result conclud care perform ct effect modal evalu patient present hemoptysi"
"coal worker pneumoconiosi ct assess expos worker correl radiograph find studi sign coal worker pneumoconiosi cwp comput tomographi ct author obtain thorac ct scan coaldustexpos worker concomit evalu convent posteroanterior radiographi profus extent diseas assess ct group miner group miner worker compens radiograph evid cwp group miner appli compens radiograph evid cwp ct sign cwp consist micronodul nodul progress massiv fibrosi compar analysi demonstr superior optim ct techniqu chest radiographi evalu simpl silicosi improv sensit detect small parenchym opac ct addit inform stage diseas clarifi ambigu ilo classif small opac ct equival radiographi complic silicosi identif necrosi ct evalu complementari plain radiographi assess cwp addit highresolut ct achiev accur evalu small parenchym opac"
"crosssect physiolog lung graviti influenc physiolog lung affect intrapulmonari local diseas process anatom physiolog differ axial crosssect plane affect distribut diseas physiolog gradient ventil perfus lymph flow stress lung present axial plane anatom differ branch pattern interstiti design develop secondari pulmonari lobul found region dispar anatomi physiolog appli concept corticomedullari organ lung diseas exhibit propens central peripher portion lung analysi appli anatomi physiolog secondari pulmonari lobul"
"airway evalu children ultrafast ct pitfal recommend ultrafast comput tomograph ct evalu airway perform msec lowresolut imag cine ct msec highresolut imag highresolut ct determin imag strategi ultrafast ct pediatr airway author prospect compar ultrafast ct endoscopi children studi perform patient cine ct perform highresolut ct patient normal anatomi patient focal tracheal stenos tracheomalacia laryngomalacia laryngoesophag cleft irregular narrow subglott area laryng papilloma focal stenosi stoma granuloma cine ct result agre endoscopi case case focal stenosi misinterpret cine ct tracheomalacia highresolut ct result agre endoscopi case result techniqu combin highresolut ct entir airway cine ct select area agre endoscopi case tracheoesophag cleft miss combin techniqu greatest diagnost accuraci ultrafast ct evalu pediatr airway cine highresolut mode"
"simpl method correct singl breath total lung capac underestim singl breath method underestim total lung capac comparison multipl breath method tlcmb inhomogen ventil distribut studi propos simpl correct singl breath tlc tlcsb inert gas phase iii slope account effect uneven ventil distribut model uniform lung ventil design compos serial dead space alveolar compart arrang parallel relat ventil determin phase iii plateau correct tlcsb tlcmb subject diffus interstiti diseas chronic obstruct pulmonari diseas healthi subject limit accept correct tlccorr determin confid interv tlcsbtlcmb healthi subject correct result signific increas tlcsb tlccorr remain limit accept patient emphysema show larg improv tlc estim presenc poor ventil zone singl breath patient explain partial correct"
"lung fibrosi induc thorotrast year woman develop progress short breath pulmonari hypertens respiratori failur die pulmonari fibrosi year thorac fistulographi thorotrast bout acut respiratori failur occur featur noncardiogen pulmonari oedema lung tissu obtain biopsi necropsi show abund radioact particl thorium dioxid lung particl congreg wall blood vessel perivascular fibrous zone consist causal role thorotrast develop lung fibrosi suggest fibrosi due combin effect alpha radiat interstiti perivascular zone recurr pulmonari oedema due endotheli damag"
"effect sulfur thermal water lymphocyt prolif respons studi effect sulfur water thermal therapi phenotyp prolif respons peripher lymphoid cell ten subject affect chronic upper respiratori diseas suffer articular periarticular disord sulfur water ho therapi modifi phenotyp function peripher blood mononuclear cell pbmc modifi system immunolog reactiv result obtain analyz respons mitogen peripher blood mononuclear cell cell cultur graduat amount ho vitro studi shown import dosedepend inhibitori effect ho mitogen induc lymphocyt prolifer il product hs present ho primari compon respons inhibit result consist local immunosuppress role ho explain part observ therapeut effect inhal therapi upper respiratori allerg disord"
"human serolog respons envelop protein adenyl cyclas toxin bordetella pertussi human serolog respons envelop protein adenyl cyclas toxin bordetella pertussi examin immunoblot techniqu antigen recogn sera individu cultureconfirm pertussi sera infant immun dose convent cell pertussi vaccin includ da protein shown antigen relat mycobacteri heatshock protein da protein react sera convalesc individu da protein react sera vaccin individu antibodi adenyl cyclas toxin common sera individu diagnos pertussi  pertussi lipooligosaccharid recogn antibodi sera data suggest antigen play role immun pertussi"
"surfact treatment fullterm newborn respiratori failur surfact inactiv shown signific factor anim model lung injuri import form respiratori failur fullterm newborn fourteen fullterm newborn respiratori failur pneumonia patient meconium aspir syndrom patient treat mgkg calf lung surfact extract intratrach hour maximum dose group fraction inspir oxygen fi treatment sem airway pressur map cm ho patient show signific improv oxygen initi surfact treatment arterialalveolar oxygen ratio ratio rise surfact treatment minut remain improv hour oxygen index incorpor map oxygen variabl improv signific minut improv sustain hour chest radiograph blind score normal sever opacif improv margin signific initi surfact treatment"
"intraven streptomycin streptomycin effect drug treatment tuberculosi recommend intramuscular rout method drug deliveri accompani pain unaccept patient advent improv intraven therapi occur past year reevalu intraven drug warrant describ shortterm intraven streptomycin patient pulmonari tuberculosi"
"central pulmonari embol normal ventilationperfus scandiagnosi nuclear pulmonari arteri flow studi pulmonari embol uncommon children occur pediatr patient undiagnos untreat pulmonari embol high mortal rate high index clinic suspicion reliabl diagnost modal ensur prompt accur diagnosi report case patient sever central pulmonari embol normal ventilationperfus scan embolus identifi nuclear pulmonari flow studi dynam imag obviat contrast pulmonari angiographi tradit ventilationperfus scan normal sever central pulmonari embol situat earli dynam imag detect sever obstruct central pulmonari arteri approach obviat contrast pulmonari angiographi hemodynam stabl patient"
"oral corticosteroid therapi patient stabl chronic obstruct pulmonari diseas metaanalysi purpos evalu effect oral corticosteroid therapi patient stabl chronic obstruct pulmonari diseas data identif englishlanguag literatur search medlin bibliograph review retriev articl identifi origin studi oral corticosteroid chronic obstruct pulmonari diseas publish studi select submit photocopi studi method section nonstudi physicianinvestig explicit criteria independ assess studi qualiti ten studi met criteria studi met criteria data extract compar outcom qualifi studi defin respons therapi greater increas baselin forc expiratori volum fev defin treatment effect size studi proport patient respond corticosteroid therapi minus proport patient respond placebo potenti confound variabl relat elig criteria treatment protocol assess studi result data synthesi ten studi met criteria found signific differ elig criteria treatment protocol studi design associ found treatment effect size public date studi size patient age fev studi report effect size rang calcul weight effect size ci studi meet criteria includ calcul weight effect size ci conclus patient stabl chronic obstruct pulmonari diseas receiv oral corticosteroid therapi greater improv baselin fev approxim similar patient receiv placebo"
"mechan bronchodil effect chronic airflow limit object examin mechan bronchodil theophyllin salbutamol influenc dyspnea daili activ method twenti patient chronic airflow limit particip multipl crossov random placebocontrol trial effect theophyllin salbutamol combin pulmonari function dyspnea daili activ examin correl forc expiratori volum fev maximum expiratori pressur mip independ variabl dyspnea score daili activ depend variabl examin result drug prove benefici effect general addit synergist drug improv fev theophyllin signific improv mip correl fev dyspnea score adjust mip correl mip dyspnea score adjust fev conclus airway calibr respiratori muscl strength play independ import role dyspnea daili activ patient chronic airflow limit airway calibr greater import"
"current status etoposid manag small cell lung cancer etoposid scheduledepend drug excel activ small cell lung cancer sclc singleag etoposid achiev respons rate rang depend schedul drug administr characterist treat popul rout etoposid administr intraven versus oral impact respons rate provid dose adjust made oral therapi combin activ agent etoposid proven effect manag sclc etoposid substitut doxorubicin vincristin cyclophosphamid doxorubicin vincristin cav regimen loss efficaci etoposid cisplatin ep combin thought synergist proven effect salvag regimen cav failur regimen altern cav ep found investig modest effect sclc cav ep altern regimen studi date demonstr ep induct effect standard induct regimen ep potenti advantag easili integr thorac radiat therapi rt import limiteddiseas patient recent pilot studi employ ep induct hyperfraction thorac rt yield year surviv rate greater promis result evalu ongo phase iii trial unit state data etoposid activ agent sclc includ compon induct therapi patient schedul etoposid administr warrant studi"
"random trial compar intraven oral etoposid combin cisplatin treatment small cell lung cancer random multicent studi patient small cell lung cancer random assign treatment cisplatin mgm intraven iv day etoposid mgm iv day cisplatin mgm iv day etoposid mgm iv day mgm oral day regimen repeat week prior random patient stratifi extent diseas perform status gender total patient random assign parenter treatment regimen patient receiv cisplatin ivor etoposid therapi treatment arm compar patient characterist limit diseas ld patient constitut patient popul oral iv etoposid regimen complet respons cr partial respons pr rate confid interv ci oral etoposid regimen ci iv etoposid regimen regimen ld patient achiev cr pr time progress surviv compar treatment arm hematolog toxic compar treatment arm patient experienc grade neutropenia thrombocytopenia moder sever anemia weight loss predomin iv oral regimen"
"targetflow inspiratori muscl train pulmonari rehabilit patient copd effect addit targetflow inspiratori muscl train tfimt perform inspiratori muscl general exercis capac psycholog paramet pulmonari rehabilit program pr studi patient copd select ventilatori limit exercis age patient year fev approxim percent predict patient particip tenweek pr program random receiv addit tfimt pr imt pr tfimt perform targetflow resist devic generat mouth pressur durat inspir respiratori cycl impos train period maxim inspiratori mouth pressur emgfatig diaphragm signific pr imt group pr group maxim work load psycholog symptom increas extent group minut walk distanc increas group increas signific pr imt group pr group addit tfimt pr select group patient copd ventilatori limit extra benefici effect perform inspiratori muscl exercis perform"
"combin thermodilut dimension echocardiograph evalu ventricular function respiratori support peep ten patient requir respiratori support episod acut respiratori failur arf therapeut level peep determin measur lung chest wall complianc ct peep challeng cm ho challeng hemodynam monitor combin thermodilut measur ventricular rv eject fraction ef dimension echocardiograph measur rv size permit assess effect increas level peep rv function rv preload reflect rv enddiastol volum edv dimension rv enddiastol area eda remain unchang rv diastol complianc progress decreas hand rv systol function assess rvef dimension rv fraction area contract fac progress depress substanti deleteri effect peep note high level peep includ reduc ct augment pulmonari vascular resist inadequ increas rv preload compens increas rv afterload result depress rv systol function contribut reduct cardiac output final dimension echocardiographi prove sensit fastrespons thermodilut evalu chang rv function"
"natur killer cell activ rat model amiodaroneinduc interstiti lung diseas role lymphocyt pathogenesi amiodaroneinduc lung diseas controversi increas percentag lymphocyt bronchoalveolar fluid patient anim amiodaron pulmonari toxic report assess lymphocyt function activ measur natur killer cell activ lung blood rat amiodaroneinduc pulmonari toxic amiodaron treat rat exhibit patholog evid amiodaroneinduc lung diseas week treatment injuri sustain extens remaind studi period control rat histolog normal lung blood nk activ equal present amiodaronetr control group signific studi percent percent greater nk cell activ lung rat treat amiodaron suggest local immun respons lung data support concept lymphocyt play import role pathogenesi amiodaroneinduc lung diseas"
"fiberopt bronchoscopi refractori cough fiberopt bronchoscopi fb low yield diagnosi chronic cough greater week unselect patient assess yield fb cough year period patient nonloc chest roentgenogram refractori diagnost effort empir bronchodil antituss therapi percent patient undergo fb cough greater bronchoscopi diagnost find broncholithiasi tracheobronchopathia osteochondroplastica tubercul bronchostenosi laryng dyskinesia arytenoid polyp tracheobronchi neoplasm detect age greater year femal sex independ predict posit result fisher exact test durat cough month airflow smoke status patient prior pulmonari extrathorac neoplasm exclud percent studi diagnost diagnos potenti made thorac comput tomograph scan patient indirect laryngoscopi fiberopt bronchoscopi respect yield diagnosi refractori chronic cough reason procedur care select patient"
"comparison incent spirometri intermitt posit pressur breath coronari arteri bypass graft fifti patient random receiv incent spirometri intermitt posit pressur breath ippb addit convent chest physic therapi coronari arteri bypass graft slow vital capac peak expiratori flow read decreas rapid equal extent group surgeri part recov sixth postop day pop arteri po valu similar group pop pop number chest film show atelectas number individu patient atelectas reveal statist signific differ group base variabl studi devic equal effici coronari surgeri"
"manag lung diseas late life approach advanc pulmonari diseas apd progress incur condit ultim lead death signific distress symptom paper review hospic approach care emphasi treat symptom caus patient distress physician outpati set improv patient qualiti life import aspect care includ manag hypoxia malnutrit osteoporosi advers drug reaction symptomat relief dyspnea relief emot symptom depress anxieti panic discuss"
"compens respiratori alkalosi induc acclim simul altitud conscious intact rat previous acclim wk barometr pressur torr whx made alkalot decreas inspir fraction ambient barometr pressur torr control normox litterm nx inspir fraction lower approxim arteri pco decreas progress similar group control min initi arteri ph increas whx  hypocapnia continu deltahcodelta ph mmolph negat nx min indic nonrespiratori compens alkalosi whx deltahcodelta ph chang alkalosi cumul renal excret base mueq alkalosi increas nx whx differ due larger increas hco excret nx data suggest smaller compens hypocapn alkalosi whx part due smaller increas renal base excret base avail limit renal base excret smaller renal respons whx secondari low plasma hco concentr accompani altitud acclim"
"effect ligat embol kf multipl tracer measur dog lung isol bloodperfus dog lung capillari filtrat coeffici kf permeabilitysurfac area product urea ps measur determin respons method alter filtrat area lobe ligat ll glass bead embol gbe constant perfus rate mlmin lobe ligat kf decreas mincmho ps chang ml kf gram perfus bloodfre dri lung weight unchang ll mincmho indic surfac area gram measur kf remain ps gram dri lung doubl ml ll suggest recruit occur remain lobe lobe embol micron glass bead beadskg bodi wt ps decreas ml kf alter mincmho constanc kf gbe impli vascular pressur increas kf measur transmit block flow vessel measur filtrat area gbe ps decreas signific gbe loss perfus surfac area bead block flow small arteri vessel"
"time lung permeabl edema rat expos oxygen rat expos oxygen determin earli lung permeabl lead develop pulmonari edema time develop increas solut flux assess clearanc mtclabel diethylenetriamin pentaacet mtcdtpa lung accumul ilabel albumin ialbumin lung end point relat develop pulmonari edema measur wetdri weight ratio lung weight fluid pleural caviti signific occur hyperoxia sharp increas index lung permeabl wetdri weight ratio occur exposur pleural effus develop volum effus signific correl mtcdtpa clearanc ialbumin flux"
"stimul rat endotheli cell transform growth factorbeta product bleomycin studi examin hypothesi mediat lung endotheli cell promot lung collagen synthesi pulmonari fibrosi bleomycin induc pulmonari fibrosi human anim effect drug endotheli cell examin endotheli cell condit media prepar presenc dose bleomycin test abil stimul lung fibroblast collagen synthesi result show dosedepend stimul endotheli cell secret collagen synthesi stimulatori activ bleomycin peak dose greater equal ngml stimul select collagen protein synthesi gel filtrat analysi show activ resid fraction estim molecular mass rang kd activ inhibit antitransform growth factorbeta tgfbetaantibodi nonimmun control igg presenc tgfbeta confirm mink lung epitheli cell assay northern blot reveal signific increas tgfbeta mrna bleomycinstimul endotheli cell vitro stimul endotheli cell bleomycin upregul tgfbeta product increas transcript view chemotact matrix synthesi stimulatori properti cytokin increas tgfbeta product play import role bleomycininduc pulmonari fibrosi"
"purif character major human pneumocysti carinii surfac antigen previous studi pneumocysti carinii identifi major surfac antigen rat human isol protein mol wt antigen ident studi rat human carinii protein purifi solubil zymolyas molecular siev ion exchang chromatographi nativ protein appar mol wt greater base molecular siev studi crosslink studi protein glycoprotein treatment endoglycosidas result decreas mol wt carbohydr composit rat carinii glycoprotein distinct human isol glucos mannos galactos glucosamin occur approxim equimolar ratio human carinii protein glucos mannos predomin sugar rat carinii protein evalu humor immun respons human carinii protein enzymelink immunosorb assay purifi protein develop patient subsequ develop carinii pneumonia demonstr serum antibodi respons surfac antigen subject histori carinii pneumonia detect antibodi purifi carinii protein great facilit investig host carinii interact"
"doubleblind comparison intranas budesonid placebo nasal polyposi intranas budesonid microgram time day evalu patient refer treatment nasal polyposi age rang year polypectomi time previous week treatmentfre baselin period patient treat doubleblind fashion budesonid placebo week treatment period placebotr patient start receiv budesonid open trial addit week patient rate nasal symptom daili nasal examin nasal inspiratori flow rate ifr measur clinic visit week treatment respons budesonid signific greater respons placebo greater reduct nasal blockag caus polyp observ physic examin mirror increas nasal ifr patient rate sever frequenc nasal blockag reduc budesonid placebo equal switch placebotr patient budesonid treatment result reduct nasal blockag increas nasal ifr result demonstr topic nasal budesonid microgram time day effect treatment nasal polyp"
"express neurophysinrel precursor cell membran smallcel lung carcinoma monoclon antibodi mab smallcel lung carcinoma surfac antigen recogn common epitop vasopressinneurophysin oxytocinneurophysin hypothalam nuclei report identif neurophysin precursor human lung carcinoma lx cell membran mab immunoaffin chromatographi solubil membran result singl band approxim kda western blot analysi demonstr immunoreact band mab antivasopressin antibodi vasopressin precursor propressophysin termin sequenc band demonstr amino acid homolog terminus human propressophysin substitut cys residu tumor antigen arg absenc immunoreact antibodi cytosol extract cultur medium suggest nonsecret process intact propressophysin peptid northern analysi lx mrna mer terminus rat propressophysin result band approxim base pair base pair larger hypothalam messag situ hybrid lx tumorbear nude rat brain probe demonstr specif hybrid rat hypothalamus xenograft tumor find suggest express propressophysin protein tumor cell line preferenti target cell membran"
"laryng exercis exerciseinduc asthma exerciseinduc asthma defin bronchospasm distal airway initi exercis larynx respond produc exacerb allevi symptom attack evalu thirti subject test includ normal exerciseinduc asthma laryng respons exercis determin measur area glottic apertur exercis glotti visual flexibl laryngoscop video imag record monitor respir asthma induc subject exercis ergomet minut breath dri air degre measur subsequ made record imag relat glottic area compar group data quantifi normal physiolog respons larynx exercis demonstr substanti laryng contribut asthma induc exercis"
"alter cellular immun function atelectat lung pulmonari atelectasi common predispos lung infect previous shown atelectasi impair alveolar macrophag antibacteri function studi examin effect atelectasi cytotox function lymphocyt harvest bronchoalveolar space atelectat lung segment bronchoalveolar lavag specif studi natur killer lectindepend cellmedi cytotox peripher blood bronchoalveolar lavag lymphocyt atelectat lower lobe contralater normal lobe group dog observ declin natur killer lectindepend cellmedi cytotox preatelectasi control valu affect lung lobe simultan measur cytotox activ bronchoalveolar lavag lymphocyt harvest unaffect contralater normal lung compar control valu hand natur killer lectindepend cellmedi cytotox activ peripher blood lymphocyt signific increas anim lower lobe atelectasi pretreat normal control atelectasi influx polymorphonuclear leukocyt bronchoalveolar compart find confirm presenc natur killer cell cytotox lymphocyt bronchoalveolar compart demonstr atelectasisinduc impair local bronchoalveolar lymphocyt function dysfunct local lung cellular host defens render atelectat lung suscept infect"
"hemoptysi indic bronchoscopi indic bronchoscopi patient hemoptysi normal nonloc chest roentgenogram continu controversi review record bronchoscopi perform hemoptysi patient normal nonloc chest roentgenogram bronchogen carcinoma identifi bronchoscopi addit neoplasm found presenc nonloc abnorm increas rate bronchogen carcinoma diagnost yield specif anatom diagnosi bleed site identifi bronchoscopi compar patient normal chest roentgenogram factor male sex age year packyear smoke histori identifi patient yield bronchoscopi high"
"ultrasound assess posit tongu induct anaesthesia tongu posit assess femal patient induct anaesthesia thiopenton propofol video record midlin sagitt section tongu made ultrasound transduc chin repres figur analys observ awar patient state satisfactori record tongu movement inconsist direct mm anterior tongu mm posterior tongu movement detect suggest tongu import airway obstruct induct anaesthesia"
"factor analysi difficult tracheal intub laryngoscopyinduc airway obstruct studi patient histori difficult tracheal intub ray laryngoscopi local anaesthesia curv macintosh blade standard intub posit view obtain record previous general anaesthesia patient ray show posit blade tip beneath epiglotti improv vision suggest reproduc assess consist eas intub complementari angl assess patient peardrop effect laryngoscopi epiglotti press posterior pharyng wall result tongu compress absenc muscl paralysi remov blade caus correct anaesthesia neuromuscular block suggest occur readili correct blade remov iatrogen airway obstruct moder difficult tracheal intub common anticip"
"diagnost sensit techniqu diagnosi lung tumor flexibl fiberopt bronchoscop comparison brush biopsi imprint cytolog forcep biopsi histolog forcep biopsi brush forcep biopsi consecut case pulmonari neoplasia flexibl fiberopt bronchoscop guid ray televis fluoroscopi imprint histolog section prepar forcep biopsi specimen techniqu compar diagnost sensit result imprint brush biopsi specimen histolog section posit malign sensit brush biopsi specimen independ locat morpholog tumor sensit forcep biopsi specimen lower neoplasm unidentifi bronchoscopi sensit diagnost accuraci method joint specif agreement final morpholog tumor type found case posit brush biopsi specimen case posit imprint cytolog case posit histolog forcep biopsi specimen routin bronchoscopi method combin obtain highest diagnost yield"
"prolong venous infus cisplatin concurr radiat therapi lung carcinoma feasibl studi fifti patient resect inoper bronchogen carcinoma enter feasibl studi cisplatin cddp continu infus concurr radiat therapi radiat therapi regimen consist gy day week week week split gy total dose cddp daili dose mgm administ cover day radiat treatment central venous cathet portabl pump predict durat infus lost due complic relat venous access pump toxic moder probabl locoregion major respons complet partial month treatment complet twenti patient underw resect year actuari probabl surviv high respons surviv rate warrant studi concurr cddp continu infus radiat therapi inoper lung carcinoma"
"lifethreaten airway obstruct present hodgkin diseas mediastin involv hodgkin diseas common signific symptom result diseas site common rare sever airway obstruct occur author report case hodgkin diseas lifethreaten airway obstruct major featur clinic present earli clinic literatur describ complic review general anesthesia endobronchi intub avoid patient airway obstruct altern method diagnosi manag discuss"
"vocal fold sulcus vocal fold sulcus dysphonia recogn recent awar exist combin laryngostroboscopi enhanc manag group patient case treat initi voic therapi subsequ combin microlaryng teflon inject vocal cord repres photomicrograph end result treatment present good voic subject object obtain patient satisfactori improv"
"tracheostomi closur restrict respiratori insuffici retrospect studi present patient requir ventilatori support tracheostomi period month year whilst tertiari referr centr care patient restrict respiratori insuffici patient underw closur longstand tracheostomi postop follow period year document indic complic tracheostomi closur patient sever chronic restrict respiratori insuffici requir longterm respiratori support discuss conclud benefit oper tracheostomi closur outweigh disadvantag unusu type patient"
"differenti diagnosi lung tumor positron emiss tomographi prospect studi predict natur calcifi lung tumor perform prospect studi case methyl cmethionin met case ffluorodeoxyglucos fdg case positron emiss tomographi pet tumormuscl radioact ratio malign benign met fdg ratio malign tumor higher metabol demand benign lesion tumor cm diamet difficult accur evalu due pet resolut compar diagnosi patholog met studi show sensit specif accuraci fdg studi show signific differ observ tracer studi suggest pet studi met fdg differenti diagnosi lung tumor"
"effect antihistaminedecongest combin young children common cold random control clinic trial test hypothesi antihistaminedecongest combin clinic signific relief symptom upper respiratori tract infect young children random assign children treatment group antihistaminedecongest placebo treatment differ studi group proport children consid parent hour initi assess drug placebo treatment differ group individu composit symptom score parent children elig drug trial believ child medicin cold symptom proport parent believ child medicin differ consent particip refus parent medicin initi visit report improv follow child receiv drug placebo treatment conclud clinic signific improv symptom upper respiratori tract infect includ signific placebo effect young children antihistaminedecongest prescrib"
"prognosi idiopath pulmonari fibrosi patient mucous hypersecret order determin prognosi patient chronic idiopath pulmonari fibrosi ipf evalu clinic laboratori bronchoalveolar lavag bal data onset ipf patient surviv yr women men yr age se patient divid group mucous hypersecret patient hypersecret group poorer surviv rate yr patient hypersecret group yr signific negat correl sputum volum durat surviv patient glucocorticoid treatment found signific larger number neutrophil eosinophil differenti cell count bronchoalveolar lavag fluid balf group group neutrophil eosinophil chest radiograph find laboratori data includ pulmonari function test correl surviv rate find suggest mucous hypersecret neutrophil eosinophil balf determin prognosi patient chronic ipf"
"serum lavag lactat dehydrogenas isoenzym pulmonari alveolar proteinosi pulmonari alveolar proteinosi pap rare diseas character accumul lipoproteinac materi alveolar space serum lactat dehydrogenas ldh note elev patient pap previous studi sought extend observ seri patient pap total serum ldh concentr ldh isoenzym fraction measur lung lavag total ldh ldh isoenzym determin lavag effluent total serum ldh elev lavag patient prelavag serum ldh prelavag alveolararteri gradient show signific correl decreas serum ldh found lavag patient postlavag data pair test magnitud decreas vari isoenzym pattern lavag isomorph pattern unchang lung lavag mark contrast ldh isoenzym pattern observ lavag effluent show lower percent ldh ldh higher percent ldh ldh ldh compar prelavag isoenzym percentag serum unpair test correl total serum ldh concentr total lavag ldh concentr data confirm elev serum ldh common find pap ldh elev found consist alveolar fluid point sourc serum ldh"
"breath circuit respiratori work infant recov respiratori failur object compar cardiopulmonari function spontan breath continuousflow breath circuit major differ circuit degre flow resist offer exhal valv design random crossov trial patient twelv infant month age recov respiratori failur variabl etiolog patient weigh kg studi intervent patient connect respiratori circuit random sequenc min equilibr assess cardiopulmonari function airway pressur paw fio maintain unchang measur main result ventil gas exchang circulatori function alter signific chang breath circuit paw esophag pressur fluctuat alter largest breath circuit exhal valv highflow resist paw fluctuat record patient breath flowresistor circuit increas weight exceed cm ho patient weigh greater kg paw fluctuat decreas greater cm ho ten patient thresholdresistor circuit conclus result evalu characterist respiratori circuit spontan breath infant children avoid unnecessari equipmentrel increas respiratori work"
"reliabl magnitud estim dyspnea measur reliabl magnitud estim open scale evalu physiolog stabl popul adult chronic respiratori diseas experienc chronic dyspnea magnitud estim measur dimens dyspnea perceptu sensit relationship extern inspiratori resist load stimuli number reflect perceiv intens breath effort respons express power function measur visit day correl expon power function visit high stabl"
"lung abscess ctguid drainag lung abscess drain cathet guid comput tomographi ct patient sepsi standard medic therapi patient receiv antibiot day patient undergon bronchoscopi abscess cure clinic radiograph criteria patient surgeri avoid patient patient underw surgeri remov organ tissu decort lung abscess evacu complic includ hemothorax requir chest tube patient minor complic clog cathet patient transient elev intracerebr pressur patient hemothorax occur patient cathet travers normal lung percutan drainag cathet travers juxtapos abnorm pleura rout abscess patient ctguid drainag lung abscess effect method treat lung abscess refractori convent therapi procedur obviat major oper patient cathet rout abscesspleur syndesi prefer ct plan rout"
"respiratori rate greater minut clinic indic pneumonia filipino children cough diagnosi epidemiolog acut respiratori tract infect ari children year investig manila part studi children treat outpati clinic cough week durat studi test valid respiratori rate rr greater minut identifi ari sever necessit treatment antibiot popul children radiolog confirm pneumonia sensit rr greater minut specif falseposit rate falseneg rate popul children pneumonia sensit posit predict valu low valid rr greater minut vari popul preval ari"
"aspir pneumon risk factor manag critic ill patient pulmonari aspir gastric content signific sourc patient morbid mortal increas healthcar cost prevent identifi patient risk aspir initi prophylaxi effect method reduc complic aspir pneumon hreceptor antagonist prophylact agent efficaci reduc gastric acid conveni administr"
"diagnosi pneumocysti carinii pneumonia invas sampl respiratori secret infant infect hiv present fever tachypnoea hypoxia radiolog evid bilater pneumon fluoresc antibodi techniqu identifi pneumocysti carinii hour secret obtain nasopharyng aspir rapid invas method line investig suspect carinii pneumonia immunocompromis patient"
"air pollut fatal lung diseas utah counti uniqu situat found utah counti made estim fraction respiratori cancer nonmalign respiratori diseas nmrd death attribut communiti air pollut cap counti counti similar includ low smoke rate steel mill construct ww ii caus substanti cap subsequ differ mortal rate respiratori cancer nmrd strike counti similar counti utah includ analysi comparison counti respiratori cancer nmrd death attribut cap counti nmrd death respiratori cancer death slight frequent salt lake counti smoke rate high"
"health effect volcan ash repeat studi mount sakurajima volcano kyushu japan proxim larg residenti area emit enorm amount volcan ash frequent erupt previous studi investig time respiratori effect chronic exposur volcan ash studi demonstr low preval respiratori symptom area highest exposur slight excess preval symptom exposur volcan ash confirm find previous studi preval studi chronic respiratori symptom resid repeat kanoya tashiro locat km crater mt sakurajima concentr suspend particul matter kanoya frequent exceed nation environment qualiti standard summer winter time higher found tashiro women age resid kanoya tashiro complet modifi atsdld questionnair preval nonspecif respiratori diseas low kanoya tashiro similar preval found women smoke restrict analysi individu histori occup exposur dust exposur passiv smoke slight higher preval nonspecif respiratori diseas kanoya tashiro differ signific eye symptom equal preval area"
"interact chemic high vascular pressur injuri isol canin lung publish erratum appl physiol mar chemic mechan insult lung occur concomit trauma hypothes pressur threshold vascular pressureinduc mechan injuri decreas chemic insult lung normal isol canin lung lobe injur airway acid instil aai intravascular oleic acid oa expos short min period elev venous pressur hipv rang cmho hipv stress capillari filtrat coeffici kf mlmincmho isogravimetr capillari pressur pc cmho aai oa lung pattern respons hipv similar group kf prehipv peak venous pressur pv remain cmho increas revers peak pv exceed cmho reflect coeffici sigma total protein measur pressur exposur averag aai oa lobe contrast result expect pore stretch occur high pressur group sigma measur hipv stress pv exceed cmho signific larger measur recoveri period"
"coughenhanc mucus clearanc normal lung studi effect cough clear mucus nonsmok subject normal lung function separ studi day subject breath micron mass median aerodynam diamet mtclabel iron oxid particl control breath condit seat front gamma camera retent lung activ measur initi particl inhal control day subject sat quiet front camera cough day subject perform control cough st retent measur pair analysi retent cough measur signific control control cough control cough retent signific cough control measur cough control cough increas rate radiolabel particl clear bronchial airway individu follow experi subject perform rapid inhal cough show similar enhanc particl clearanc cough result suggest observ enhanc mucus clearanc cough rapid inhal normal lung due stimul mucociliari apparatus phase gasliquid flow mechan"
"intens week chemotherapi goodprognosi patient smallcel lung cancer week intens chemotherapi regimen treat patient smallcel lung cancer sclc forti patient limit diseas ld extens diseas ed good prognost featur regimen consist cisplatin mgm intraven iv day etoposid mgm iv day altern week ifosfamid iv day doxorubicin mgm iv day total week dose modif made defin hematolog criteria respond patient limit diseas subsequ receiv mediastin radiotherapi respons chemotherapi complet respons cr rate forti patient limit diseas ld achiev respons rate cr rate patient extens diseas ed achiev respons rate cr rate median surviv group week ld week ed week hematolog toxic predict wide fluctuat wbc count convent week regimen quarter treatment cours delay frequent leukopenia dose reduct requir case averag deliv dose intens calcul shown project nonhematolog toxic mild nausea vomit common week schedul chemotherapi prove activ toler compar convent week chemotherapi random studi"
"water edg obstetr anesthesia meet conflict exist satisfi parturi desir oral intak tradit restrict standard obstetr anesthesia depart survey institut provid obstetr servic reveal great vari oral intak polici evid benefit withhold fluid evid risk prolong fast potenti liabil matern mortal rare anesthesiarel common etiolog aspir signific factor modern era higher risk anesthesia morbid general anesthesia difficult intub implic oral intak risk factor pulmonari aspir literatur consist emphas critic role proper train dedic obstetr anesthesia personnel parturi candid region anesthesia nonparticul diet liber region anesthesia antacid prophylaxi recommend"
"lung scan pulmonari embol clinic pulmonari angiograph correl group patient suspect pulmonari embol studi ventil perfus lung scan pulmonari angiographi symptom clinic sign analys bayesian techniqu produc pretest odd pulmonari embol individu patient group embol discrimin basi major overlap exist group invalid approach individu patient strict diagnost criteria interpret lung scan accur pulmonari angiographi gold standard expens signific number patient cent indetermin diagnost group patient test yield diagnost result sensit cent specif cent seri likelihood lung scan correct diagnos pulmonari embol cent correct exclud embol cent strict criteria interpret lung scan reliabl inform obtain presenc absenc pulmonari embol larg proport patient suspect condit inform discrimin clinic sign symptom"
"natur histori transplant lung rate pulmonari function chang longterm survivor heartlung transplant longterm pulmonari function hlt preserv evid function declin result transplant age provid allograft remain free complic longterm survivor ob maintain adequ oxygen mark alter pulmonari function abil preserv gas exchang reason level oxygen factor permit extend surviv ob period month greater preliminari studi suggest declin feffvc time pulmonari function normal index impend airway diseas physiolog longterm point view hlt remain viabl option select patient endstag cardiopulmonari diseas"
"singlelung transplant pulmonari vascular diseas patient endstag pulmonari vascular diseas receiv slts patient general difficult earli postop cours surviv month achiev good recoveri ventricular function good function result slt viabl option select patient sever pulmonari hypertens ventricular function sever impair"
"bodi composit bioelectricalimped analysi compar deuterium dilut skinfold anthropometri patient chronic obstruct pulmonari diseas bodi composit import measur nutrit status patient chronic obstruct pulmonari diseas copd generat regress model bioelectr imped bi deuterium dilut ho refer method copd patient age sd stabl pulmonari cardiac condit height squar divid resist htres correl total bodi water tbw measur ho fit regress equat predict tbw compris htres bodi weight bipredict tbw estim bifatfre mass ffm compar skinfoldthicknessbas ffm predict anthrffm relat biffm signific overestim kg found anthrffm result suggest bi measur bodi composit patient sever copd"
"pulmonari embolectomi year experi center consecut patient acut massiv pulmonari embol underw pulmonari embolectomi cardiopulmonari bypass oper mortal rate analyz clinic hemodynam variabl univari multivari analys assess predict factor postop outcom multivari analysi disclos cardiac arrest cardiopulmonari diseas independ predictor oper death longterm follow rang month month inform discharg patient die complain persist mild sever exert dyspnea york heart associ class ii result assess preoper risk patient undergo pulmonari embolectomi show patient benefit optim medic therapi pulmonari embolectomi remain accept procedur view longterm result"
"improv outcom tertiari center pediatr intens care statewid comparison tertiari nontertiari care facil object compar outcom pediatr intens care hospit level resourc design prospect blind comparison outcom care set tertiari nontertiari hospit oregon southwestern washington patient critic ill children admit respiratori failur head trauma month measur main result sever ill adjust mortal rate determin admiss day physiolog profil pediatr risk mortal score care modal assess daili crude mortal rate tertiari patient time higher nontertiari patient  tertiari patient number outcom accur predict physiolog profil observ death survivor predict death survivor greater nontertiari patient number death signific predict observ death survivor predict death survivor odd ratio die nontertiari tertiari facil mortal risk group greater patient tertiari facil receiv invas arteri cathet complex mechan ventil care patient nontertiari facil receiv laborintens care hour vital sign conclus care ill children tertiari pediatr icus improv chanc surviv"
"inhibit methylprednisolon leukocyteinduc pulmonari damag background method purpos studi twofold develop chronic model leukocytemedi pulmonari injuri evalu protect effect methylprednisolon rabbit inocul ip zymosan blood gase circul leukocyt evalu survivor kill day microscop studi evalu lung lipid peroxid product malondialdehyd result intraperiton zymosan result mark decreas pao circul leukocyt increas cellular alveolar septa interstiti edema increas lung malondialdehyd pulmonari damag partial prevent methylprednisolon administ zymosan inocul methylprednisolon hr conclus author conclud local nonsept inflammatori stimulus provok remot lung methylprednisolon counteract process administ earli onset inflamm"
"biotinyl dna probe specif human chromosom evalu allograft lung clone kilobas dna probe deriv heterochromatin chromosom investig regener reepitheli allograft lung recipi receiv sex mismatch donor organ patient monitor vari period time year transbronchi biopsi situ hybrid paraffinembed biopsi util probe reveal bronchial alveolar epithelium arteri venous endothelium peripher lung retain donor phenotyp irrespect episod acut chronic reject oblit bronchiol injur cellular subset contrast migratori cell lymphocyt macrophag gradual vari rate infiltr allograft lung replac preexist donor element case activ ob manifest infiltr bronchiol sexmismatch lymphocyt instanc quiescent recipi lymphocyt colon allograft unassoci histolog reject macrophag similar sex cluster air space dna probe chromosom situ hybrid techniqu monitor cellular alter time recipi sex mismatch allograft"
"lymphokineactiv killer cell activ lung cancer studi evalu local pulmonari immun effector cell lytic activ purifi lymphocyt popul isol balf obtain patient bronchogen carcinoma patient lung disord cancer ten normal control volunt match age smoke histori cell evalu nk lak cell lytic activ nkresist laksensit tumor target pulmonari tumor daudi tumor cell nksensit tumor lak activ detect balf patient cancer remain patient cancer subject pulmonari diseas cancer normal volunt detect lytic activ peripher blood lymphocyt subject nk lytic activ kill pulmonari tumor target tumoricid interleukin requir lak cell activ detect balf recov patient pulmonari lak lytic activ result demonstr activ lak cell capabl kill pulmonari tumor cell present balf patient bronchogen carcinoma lytic lak cell popul repres local pulmonari respons lung cancer absenc system tumoricid activ function status pulmonari immun effector cell type quantiti cytokin lung determin local respons bronchogen carcinoma control diseas"
"magnet reson imag diagnosi pulmonari infarct report time knowledg mri featur differenti noninvas pulmonari infarct pneumonia subject angiograph proven pulmonari infarct show high weight mri signal locat embol territori patient pneumonia patient emboli infarct weight imag"
"amiodaroneinduc pulmonari toxic immunoallergolog test bronchoalveolar lavag phospholipid content amiodaron wide antiarrhythm drug pulmonari toxic advers effect estim mortal percent order determin element diagnosi examin patient amiodaroneinduc pulmonari toxic patient treat evid pulmonari toxic main pulmonari diseas healthi volunt daili cumul dose durat treatment similar group pulmonari function test spirometri diffus capac arteri blood gase roentgenograph examin pulmonari biopsi immunoallergolog test skin reaction lymphoblast transform test human basophil degranul test provid discriminatori element apt observ increas cellular bronchoalveolar lavag differenti cell count presenc foami macrophag distinguish apt apt phospholipid composit bal fluid show decreas total phospholipid phospholipidprotein ratio patient compar normal subject reflect sever pulmonari diseas specif causat agent observ uniqu pl decreas apt remain normal apt phosphatidylserin phosphatidylinositol ps pi confirm evalu stage diseas determin eventu specif element conclud data establish diagnosi apt analysi bal pl content"
"effect fast slow intralipid infus gas exchang pulmonari hemodynam prostaglandin metabol intralipid percent ml infus fast slow random patient lung injuri relat plasma prostaglandin pg concentr gas exchang pulmonari hemodynam data collect baselin midpoint infus infus vasodil vasoconstrictor pg metabolit ketopgf alpha thromboxan measur radial arteri blood sampl slow intralipid infus increas shunt fraction qsqt chang pulmonari arteri pressur mpap fast intralipid infus increas mpap chang qsqt prostaglandin level chang signific infus group pg substrat remov hemodynam metabolit valu decreas parallel conclus unabl demonstr effect relationship plasma level ketopgf alpha thromboxan observ pulmonari hemodynam respons slow fast intralipid infus"
"treatment atelectasi select bronchial suction curvedtip cathet guid mark appli techniqu select bronchial suction sbs treatment atelectasi middl lower lobe patient refractori success treat consid sbs curvetip cathet guid mark ctcgm techniqu choic treatment refractori convent respiratori therapi effect bronchoscopist"
"giant cell interstiti pneumonia giant cell interstiti pneumonia distinct uncommon form interstiti pneumonia distinguish promin larg activ phagocyt alveolar giant cell histiocyt origin presenc chronic interstiti pneumonia multinucl type granular pneumocyt identifi multinucl cell lack viral intranuclear inclus type measl pneumonia giant cell interstiti pneumonia idiopath occur occup exposur hard metal cobalt report case give recognit uncommon interstiti pneumonia"
"return tuberculosi screen prevent therapi approxim percent individu expos mycobacterium tuberculosi infect percent develop clinic activ tuberculosi time live tuberculin skin test screen patient greatest risk contract diseas young weaken immun system poor nutrit alcohol drug abus chronic ill human immunodefici virus infect depend characterist local popul individu medic risk factor reaction indur mm general repres infect isoniazid therapi person posit skin test decreas risk diseas percent famili physician play critic role effort elimin tuberculosi unit state year"
"adult respiratori distress syndrom basic scientist clinician written numer articl divers adult respiratori distress syndrom ard specif diagnost test ard condit character interstiti lung edema reduct lung complianc alveolar small airway closur decreas function residu capac persist hypoxia increas amount pulmonari blood flow cours nonventil poor ventil alveoli recent studi emphas role macrophag polymorphonuclear neutrophil lung defens injuri advanc understand pathophysiolog ard produc signific chang clinic manag syndrom specif treatment ard cornerston therapi earli recognit elimin initi factor sepsi ard singl diseas process repres final common pathway manifest varieti lung injuri goal therapi elimin predispos condit support patient mode ventilatori pharmacolog therapi present"
"quantit abnorm ga uptak pulmonari interstiti vascular diseas test detect diffus lung diseas gallium modal diagnos follow clinic diseas tumor infect inflammatori disord interstiti lung diseas appreci mild moder scan activ disord time optim spect singlephoton emiss comput tomographi scan techniqu design obviat problem spect scan util comput acquisit provid dimension scan addit benefit color aid discern differ uptak spect scan perform patient interstiti lung diseas etiolog addit patient follow spect scan determin respons treatment patient present exampl"
"immunoglobulin antineutrophil cytoplasm antibodi produc respiratori tract patient wegen granulomatosi wegen granulomatosi wg smallvessel vascul unknown etiolog involv upper lower respiratori tract kidney recent associ made presenc serum antineutrophil cytoplasm antibodi anca wg wg frequent involv lung sought evalu bronchoalveolar lavag bal fluid obtain patient wg presenc anca immunoglobulin ig anca found bal stain pattern observ serum patient activ diseas highest serum bal igg anca titer iga igm anca detect serum bal patient protein analysi bal fluid reveal patient activ untreat wg approxim fourfold elev total protein versus mgdl disproportion greater increas ratio igg albumin bal igg index normal increas igg index patient activ wg suggest local product igg anca occur lung"
"size distribut human lung elastinderiv peptid antigen generat vitro vivo proteaseantiproteas hypothesi emphysema develop suggest degrad elastin lung interstitium give rise abnorm quantiti circul elastinderiv peptid edp period inflamm recent studi shown relationship emphysema high level edp human plasma report character elastin digest basi antigen size method prepar size distribut edp found plasma nonsmok smoker emphysema patient gel filtrat elastin digest prepar hydrolysi human lung elastin low ratio neutrophil elastas elastin generat broad protein peak approxim dalton contrast high ratio neutrophil elastas human lung elastin gave broad protein peak size distribut dalton rang digest show distinct immunochem properti polyclon antibodi direct lowratio digest show minimum detect ngml homolog antigen requir ngml highratio digest detect inhibit indirect elisa assay gel filtrat plasma normal nonsmok major normal smoker reveal singl immunoreact edp fraction approxim dalton plasma select normal smoker emphysema patient high level circul edp greater ngml fraction complex pattern peptid dalton compon repres immunoreact materi lower molecular weight peptid repres remain circul elastin antigen"
"tenyear follow studi cotton textil worker follow studi respiratori function cotton textil worker perform yr origin crosssect studi nonsmok femal smoke male textil worker restudi origin group major lost follow left industri preval byssinosi femal worker time follow compar time initi studi men byssinosi preval follow compar time initi studi similar preval respiratori symptom signific higher follow time initi studi signific shift decrement fev fvc document survey annual declin ventilatori capac greater expect femal fvc yr fev yr male worker fvc yr fev yr se total airborn dust concentr measur time follow studi mgm averag respir dust concentr mgm conclud continu exposur high dust concentr cotton textil industri increas preval respiratori symptom progress impair lung function increas respiratori impair smoker nonsmok"
"relationship respiratori symptom pulmonari function tar nicotin carbon monoxid yield cigarett data consecut survey tucson epidemiolog studi evalu relationship cigarett smoker respiratori symptom pulmonari function tar nicotin carbon monoxid yield cigarett subject report smoke regular survey age adjust intens durat smoke depth inhal risk chronic phlegm cough dyspnea relat tar nicotin yield subject pulmonari function test survey spirometr indic signific relat daili dose tar nicotin product cigarett yield daili number cigarett smoke effect pronounc past current dose differenti pulmonari function due yield cigarett small comparison differ pulmonari function smoker nonsmok"
"protect effect theophyllin bronchial hyperrespons patient allerg rhiniti disord upper respiratori tract allerg rhiniti common bronchial hyperrespons respons chronic cough common symptom patient allerg rhiniti previous shown sole present manifest bronchial hyperrespons theophyllin wide patient asthma bronchodil effect action bronchial reactiv controversi aim studi determin effect theophyllin administr bronchial hyperrespons patient allerg rhiniti complain chronic cough fourteen patient studi judg atop basi posit skin test common allergen control spirometri flowvolum curv specif airway conduct sgaw measur bronchial challeng perform increas concentr carbachol doserespons curv construct concentr carbachol decreas sgaw baselin pd determin interpol doserespons curv control measur patient receiv random doubleblind crossov fashion theophyllin mgkgday oral placebo day measur redon washout period day measur repeat patient receiv theophyllin placebo period day measur perform end studi period control patient normal baselin lung function data show mark bronchial hyperrespons pd amount microgram carbachol normal greater microgram signific pd note placebo washout compar control valu"
"lymphokineinduc airway hyperrespons rat evalu potenti role lymphocyt chronic airway inflamm respons repeat administr rat interleukin il princip lymphokin respons lymphocyt prolifer lewi rat weight receiv unit il vehicl subcutan day day anim anesthet urethan intub measur pulmonari resist rl airway respons aerosol methacholin mch lung lavag perform anim exsanguin lung fix formalin histolog edema extent infiltr bronchi pulmonari vein arteri cell score blind il increas airway respons mch concentr mch caus doubl rl versus mgml geometr il vehicl group il signific increas total cellular return percentag lymphocyt neutrophil eosinophil lavag il caus edema mix cellular infiltr bronchovascular tree lymphocyt predomin airway vein correl present airway respons airway inflamm edema vascular infiltr releas il lymphocyt airway import mediat airway hyperrespons"
"acut effect interleukin lung mechan airway respons rat studi acut effect interleukin il princip lymphokin respons lymphocyt prolifer lung mechan airway respons methacholin mch rat lewi fisher rat anesthet intub intraven intraarteri line insert il kg infus intraven min lewi fisher rat vehicl administ lewi fisher rat blood pressur heart rate respiratori frequenc tidal volum vt minut ventil ve lung resist rl measur min min infus il lung complianc measur min il bronchial provoc test mch perform min infus il subsequ anim exsanguin lung remov histolog examin infus il alter heart rate blood pressur vt ve rl increas signific min return baselin min lung complianc decreas signific rat strain il increas airway respons lewi rat concentr mch caus doubl rl ecrl mgml mgml iltreat control rat airway respons chang signific fisher rat ecrl mgml iltreat control rat"
"morphometr analysi lung bronchopulmonari dysplasia studi lung develop children bronchopulmonari dysplasia bpd light microscop morphometri thick lung section stain elast fiber lung obtain autopsi patient bpd age month children age day month die lung diseas patient bpd demonstr sever somat growth retard reduc lung volum abnorm lobar volum proport central bronchi volum proport gland smooth muscl increas bpd bronchiolar densiti increas tend normal advanc age bronchiolar diamet slight smaller bpd bronchiolar smooth muscl hypertrophi constant histolog featur strike chang note alveolar structur develop total alveolar number sever decreas patient bpd compar control subject evid compensatori alveolar develop increas age lung intern surfac area correspond reduc linear intercept increas section stain elast tissu demonstr patient bpd simplifi acinar structur thicken tortuous irregular distribut alveolar elast fiber conclud sever fatal bpd mark impair lung develop alveolar hypoplasia reduc intern surfac area addit bronchial bronchiolar smooth muscl hypertrophi bronchial gland hyperplasia import contribut factor airflow limit"
"characterist children epiglott develop complic pulmonari edema review perform consecut case epiglotti occur year period delin rate clinic characterist complic pulmonari edema result prior util dual manag protocol children receiv endotrach intub children manag placement artifici airway children vari age develop complic experienc sever airway obstruct progress respiratori arrest evid pulmonari edema develop short endotrach intub children die due complic result upper airway obstructioninduc cardiorespiratori arrest contrast child milder degre airway obstruct manag artifici airway exhibit clinic evid pulmonari edema mechan develop complic pulmonari edema epiglott uncommon complic occur endotrach intub patient mark respiratori insuffici artifici airway institut case pediatr epiglott potenti complic pulmonari edema anticip placement artifici airway patient sever degre upper airway obstruct"
"screen lung cancer critiqu mayo lung project nation cancer institut unit state recent sponsor largescal random control trial screen earli lung cancer trial conduct john hopkin medic institut memori sloankett cancer center mayo clinic particip middleag older men chronic heavi cigarett smoker high risk develop lung cancer screen procedur chest radiographi sputum cytolog screen test establish detect earli stage asymptomat lung cancer hopkin memori trial studi popul offer year chest radiographi sputum cytolog month control popul offer year chest radiographi trial addit sputum cytolog confer lung cancer mortal rate advantag mayo clinic trial compar offer chest radiographi sputum cytolog month offer advic test obtain year trial demonstr signific increas lung cancer detect resect survivorship group offer screen month compar control group signific differ lung cancer mortal rate group statist power trial limit result justifi recommend largescal radiolog cytolog screen earli lung cancer time"
"applic imag lung cancer applic imag lung cancer patient focus recent screen high risk patient recommend intuit clinic judgment prevail practic justifi chest radiograph patient categori crosssect imag procedur tailor stage process individu larg central primari confirm abnorm note chest radiograph patient high risk thoracotomi general subject radiolog stage radiolog stage process review critiqu emphas role identifi diseas site suggest nonrespect"
"differenti intens breathless distress evok normal subject exercis  studi design examin normal subject differenti intens breathless amount distress evok specif word instruct  preliminari studi show signific differ distress score exercis measur separ occas  ten subject perform ident increment cycleergomet exercis test separ occas quantifi intens distress modifi borg scale  subject signific correl intens minut ventil subject signific correl distress minut ventil subject display signific correl regist distress  intens greater distress slope intensityminut ventil greater slope distressminut ventil  individu signific correl intens distress wide scatter slope relationship subject maximum intens distress correl  element breathless sensat identifi select measur depend word instruct subject  wide intersubject variat magnitud breathless intens distress estim differ subject compon sensat follow common pattern"
"pneumonia updat diagnosi treatment pneumonia common infecti diseas necessit hospit elder patient number misconcept exist clinic radiolog featur pneumonia elder patient earli recognit therapi reduc morbid enhanc surviv articl explor manifest pneumonia elder diagnost approach contemporari therapi"
"role salvag oper limit smallcel lung cancer combin modal treatment chemotherapi radiat produc tumor regress patient smallcel lung cancer impact surviv small patient limit diseas surviv year surviv time extrem short failur respond relaps treatment local control remain problem patient recurr primari site attempt prolong surviv achiev cure undertook surgic resect patient limit smallcel lung cancer complet remiss standard treatment local recurr treatment patient male femal median age year rang patient treat chemotherapi receiv preoper radiotherapi primari site mediastinum patient underw oper relaps complet remiss patient respons treatment slight respons progress chemotherapi achiev partial respons greater cm residu mass twelv patient requir pneumonectomi lobectomi patient unresect diseas bulki residu mass oper microscop residu diseas patholog examin show smallcel lung cancer patient mix smallcel smallcel smallcel lung cancer patient stage diseas stage ii stage iii median surviv date diagnosi entir group week date oper week project year surviv rate patient residu mass die local progress distant metastat diseas develop patient die year recurr diseas patient aliv year diagnosi patient requir lobectomi stage diseas stage ii stage iii diseas pure smallcel lung cancer mix smallcel smallcel tumor patient patholog stage diseas remain aliv compar stage ii diseas stage iii summari relaps failur respond chemotherapi due smallcel lung cancer mix tumorabstract truncat word"
"radon health radon daughter decay product thought lung cancer uk assess made nation radiolog protect board nrpb nation survey radon level home hous anticip found high level reapprais upward effect radon daughter product caus lung cancer review scientif evid reveal direct evid incrimin radon decay product level found home lung cell carcinogenesi issu involv scientif disciplin high complex debat scientist requir epidemiolog studi lung cancer low radon exposur indirect evid link low level radon exposur lung cancer insuffici warrant remedi action propos nrpb accept uk govern"
"modifi muscl spare posterolater thoracotomi modifi posterolater thoracotomi combin advantag complet muscl spare thoracolumbar fascial slide excel exposur techniqu easi perform procedur postop pain cough effect earli ambul achiev experi approach patient suggest offer attract altern standard muscl cut posterolater thoracotomi approach elect procedur"
"inhal micronis gentamicin powder deliveri system forti patient undergo routin bronchoscopi randomis receiv inhal micronis gentamicin powder mg nebulis gentamicin solut mg hour procedur similar level gentamicin detect bronchoalveolar lavag fluid group micronis powder sd mg nebulis solut mg micronis gentamicin powder prepar caus cough half patient stop receiv full dose dri powder gentamicin conveni formul long term inhal treatment problem cough overcom"
"select differ macrophag popul monokin product resolv pulmonari granuloma fibrosi alveolar macrophag product interleukin activ il macrophagederiv growth factor fibroblast mdgf examin chronic inflammatori reaction lead granuloma format fibrosi group rat receiv singl transtrach inject xonotlit attapulgit short chrysotil uicc chrysotil asbesto salin month treatment induc chang xonotlit granuloma format attapulgit short chrysotil fibrosi uicc chrysotil month granulomat reaction resolv great diminish fibrosi persist irrevers parallel examin cell popul obtain bronchoalveolar lavag reveal multinucl giant macrophag mgc present lavag fluid anim resolv granulomat reaction absent obtain anim lung fibrosi evalu monokin product inflammatori macrophag reveal signific differ enhanc product il activ type lung injuri earli stage month decreas month contrast augment mdgf product observ anim lung fibrosi persist month data product select cytokin differenti pathway modul outcom chronic inflammatori respons"
"treatment intract aspir laryng stent obtur twenti patient treat laryng stent potenti revers chronic aspir lifethreaten magnitud intract aspir divers includ chronic neurolog diseas extens head neck surgeri sever gastroesophag reflux advantag techniqu note comparison invas procedur disadvantag laryng stent complic encount cover longterm result show patient signific improv chronic aspir stent place patient achiev adequ oral deglutit aspir stent remov"
"surgic applic ultrathin flexibl bronchoscop infant ultrathin flexibl bronchoscop control distal angul convent diagnost examin lower airway smallest infant instrument pass small endotrach tracheostomi tube ventil maintain direct visual control manipul surgic instrument studi airway dynam anatomi intraop extub patient"
"radiolog abnorm sheetmet worker construct industri unit state canada relationship asbesto exposur investig advers health effect sheetmet worker past exposur asbesto crosssect medic examin worker conduct citi unit state canada total worker employ industri durat onset asbesto exposur sd chest ray abnorm found half group pleural fibrosi frequent found abnorm present case abnorm found case parenchym interstiti fibrosi found case abnorm found case radiolog abnorm increas durat exposur increas posit smoke histori higher preval radiolog detect parenchym abnorm find confirm dyspnea exert grade medic research council questionnair examine assess detail point scale questionnair person mark short breath approxim slight dyspnea individu radiolog abnorm experienc short breath radiolog abnorm cigarett smoke result higher preval dyspnea result past construct sheetmet worker signific expos asbesto job effort made minim anticip health consequ asbesto exposur continu trade avoid"
"lymphocyt nonlymphoid cell human nasal polyp immunohistochem stain perform polyp specimen patient mucos biopsi specimen middl inferior turbin patient signific cd suppressorcytotox cd helperinduc cell found polyp number cd cd cd lymphocyt nasal polyp similar number macroscop unaffect mucosa middl turbin score inferior turbin lower healthi subject differ smaller cd cell detect vari number polyp organ cluster signific hladr cell found polyp middl turbin inferior turbin eosinophil found moder larg number polyp patient mast cell plasma cell detect moder number neutrophil found patient middl inferior turbin vari small number eosinophil mast cell plasma cell neutrophil found find role chronic inflamm celldepend disturb discuss regard pathogenesi nasal polyp"
"bronchopulmonari dysplasia improv lung function year age evalu natur histori bronchopulmonari dysplasia studi patient age year group normal height weight percentil child grew establish somat growth curv children abnorm valu group maintain normal total lung capac function residu capac residu volum residu volumetot lung capac ratio elev age age year patient forc expiratori volum fev catch improv year age predict children normal fev year age continu normal fev age year rest singlebreath carbon monoxid uptak lung normal measur age year major patient posit methacholin challeng test result age low incid clinic diagnos asthma studi demonstr patient bronchopulmonari dysplasia normal lung function age normal lung growth evid mild moder lung diseas continu lung growth repair school year"
"pulmonari atelectasi signal pattern mr imag assess signal characterist type pulmonari atelectasi magnet reson mr imag author studi obstruct atelectasi oa patient nonobstruct atelectasi noa patient patient underw electrocardiograph gate mr imag studi thorax standard spinecho sequenc signal differ observ type atelectasi tweight imag convers oa noa signific spindensityweight imag tweight studi tweight imag case oa hyperintens case noa demonstr low signal intens differ pathophysiolog oa noa account observ oa alveolar air total resorb secret accumul obstruct lung result increas free fluid prolong relax time lead high signal intens tweight imag noa short relax time lung tissu absenc secret potenti magnet suscept effect due residu air respons low signal pattern"
"apic opac pulmonari tuberculosi highresolut ct find elucid natur apic opac common patient tuberculosi refer apic cap apic pleural thicken patient upper lobe tuberculosi studi highresolut comput tomographi hrct homogen apic opac cm thick chest radiograph fifteen histori pulmonari tuberculosi year durat show evid ipsilater pleurisi hrct scan apex thorax patient scan level show extrapleur fat interspers vessel account plain radiograph opac scan obtain level slight visibl aerat lung show extrapleur fat mm thick peripher atelectat lung central caudal level aerat lung thicken pleura visibl plain radiograph hrct show extrapleur fat mm thick thicken pleura mm thick atelectat lung peripher area emphysemat bulla bronchiectasi atelectat lung central"
"interstiti lung diseas impact postprocess digit storag phosphor imag abil resolv fine linear structur interstiti lung diseas measur limit perform characterist imag system convent screenfilm radiographi compar algorithm isodos storag phosphor digit radiographi mm bit pixel matrix detect interstiti lung abnorm document comput tomographi patient abnorm healthi control subject perform evalu analysi varianc fisher pair comparison test averag receiv oper characterist area observ reader moder mark highfrequ edgeenhanc algorithm storag phosphor digit radiograph equival perform screenfilm radiographi default mode low mediumfrequ edgeenhanc algorithm gray scale revers mode storag phosphor digit radiographi inferior screenfilm radiographi author conclud highfrequ edgeenhanc algorithm perform screenfilm radiographi detect interstiti diseas"
"outpati assess infant bronchiol hundr thirteen infant younger month bronchiol prospect identifi histor physic laboratori clue initi emerg depart evalu predict diseas sever base total ill patient classifi mild patient sever patient diseas initi emerg depart evalu find group compar independ clinic laboratori find identifi strong sever ill ill toxic general oxygen satur determin puls oximetri gestat age younger week respiratori rate min greater atelectasi chest roentgenogram age younger month infant oxygen satur determin puls oximetri singl object predictor sever diseas"
"role passiv immun bovin respiratori syncyti virusinfect calv role passiv immun bovin respiratori syncyti virus brsv infect neonat calv evalu calv divid group colostrumdepriv shaminocul colostrumdepriv brsvinocul colostrumf brsvinocul calv inocul lowpassag field isol brsv consecut day combin respiratori tract rout euthan day receiv inocul arteri oxygen tension pao decreas signific time colostrumdepriv brsvinocul calv signific treatment group signific decreas arteri oxygen satur observ group time percentag pneumon lung volum determin comput data digit signific greater infect colostrumdepriv calv compar group brsv antigen detect calv avidinbiotin immunoperoxidas stain passiv immun deriv colostrum feed decreas sever brsv infect calv"
"immun respons bordetella pertussi infect vaccin assess antibodi cellular immun respons healthi children immun approxim month age acellular diphtheriatetanuspertussi vaccin antibodi respons filament hemagglutinin fha pertussi toxin pt similar pattern antibodi titer reach valu equal patient convalescentstag pertussi fhainduc dna synthesi peripher blood mononuclear cell maximum week primari seri level equal patient pertussi high amount ptinduc dna synthesi observ immun nonimmun children pt act nonspecif mitogen respons mitogen activ subset lymphocyt observ young infant compar older children young infant bordetella pertussi infect respond fha stimul older children"
"detect characterist fungal protein elong factor ef pneumocysti carinii taxonom status pneumocysti carinii uncertain carinii categor fungus protozoan recent comparison rna sequenc homolog carinii genera fungi protozoa suggest carinii closer affin ascomycet protozoa translatori system fungi requir solubl protein factor peptid chain elong eukaryot system date addit protein elong factor ef uniqu fungi western blot analysi cellfre extract carinii deriv rat polyclon antibodi rais rabbit saccharomyc cerevisia ef antief crossreact materi detect lysat candida albican cerevisia includ fungal control cross reaction detect lysat carinii cariniiinfect rat lung protozoan control trichomona vaginali"
"metaanalysi epidemiolog special refer studi associ exposur environment tobacco smoke lung cancer critiqu metaanalysi set statist tool combin integr result independ studi scientif issu stringent condit integr valid met report point difficulti obtain sound metaanalys control clinic trial epidemiolog studi demonstr hastili improp design metaanalys lead result scientif valid note care typic metaanalysi appli result clinic trial food drug administr requir strict adher principl discuss paper drug sponsor metaanalysi separ clinic studi support drug applic care carri epidemiolog studi demonstr report nation research council purport associ exposur environment tobacco smoke risk lung cancer basi metaanalysi studi retrospect remain prospect natur council conclud smoker expos environment tobacco smoke greater risk acquir lung cancer smoker expos opinion conclus unwarr poor qualiti studi base"
"monoclon immunofluoresc compar silver stain investig pneumocysti carinii pneumonia hundr eighti specimen patient posit hiv respiratori tract symptom febril ill examin presenc pneumocysti carinii specimen induc sputum sampl bronchoalveolar lavag fluid establish optim method laboratori diagnosi comparison made detect organ monoclon antibodi immunofluoresc convent silver stain method commerci reagent immunofluoresc compar immunofluoresc signific sensit silver stain result immunofluoresc obtain northumbria biolog reagent"
"pneumothorax patient wegen granulomatosi treatment immunosuppress agent present case year woman wegen granulomatosi develop pneumothorax receiv treatment cyclophosphamid glucocorticoid lung expand tube drainag patient recov complet immunosuppress treatment continu combin sulphamethoxazoletrimethoprim role antimicrobi drug treatment wegen granulomatosi briefli discuss"
"upper respiratori tract infect upper respiratori tract infect common acut infect human review discuss clinic import aspect epidemiolog etiolog clinic present diagnosi manag complic prevent common cold pharyng otiti media sinus episod common cold pharyng viral origin curat therapi streptococc pharyng acut otiti media sinus secondari bacteri infect antibiot therapi import"
"pharmacokinet cefepim patient respiratori tract infect steadyst pharmacokinet cefepim evalu middleag elder patient acut lower respiratori tract infect receiv intraven preinfus postinfus serum sampl total urin output collect dose interv day therapi cefepim concentr serum time exhibit multicompartment profil peak trough concentr serum determin valid highperform liquid chromatographi method standard deviat mgliter steadyst volum distribut literkg elimin halfliv rang total bodi clearanc rang mlmin mlmin disposit cefepim steadi state patient compar previous observ healthi elder volunt predict perform regress equat deriv singledos studi volunt relat creatinin clearanc total bodi renal clearanc cefepim exhibit slight bias predict error mlmin similar precis predict observ total bodi clearanc versus mlmin renal clearanc versus mlmin signific pharmacokinet cefepim infect patient unalt ill steadyst disposit cefepim predict data deriv singledos studi volunt"
"comput tomographyguid minithoracotomi resect small peripher pulmonari nodul small peripher pulmonari nodul rang size mm mm excis patient comput tomographi mark skin nodul minim surgic exposur oper identif nodul cm maximum diamet patient twenti patient singl nodul patient multipl nodul preoper diagnosi inaccur patient patient malign suspect tumor demonstr convers patient malign nodul excis preoper diagnosi correct thirti patient requir treatment biopsi requir addit intervent small peripher pulmonari nodul requir biopsi diagnosi percutan needl aspir biopsi unsuccess technic difficult comput tomographyguid thoracotomi effect minim invas surgic altern"
"bilater iliac vein filtrat effect altern caval filtrat patient megacava greenfield filter bilater iliac vein patient undergo percutan filter placement patient megacava inferior vena cava diamet greater mm patient filter effect prevent pulmonari embol follow month patient reveal chronic venous insuffici venous stasi iliac filtrat consid patient caval filter larg caval size technic difficult due iliac vein tortuos"
"exercis test assess pulmonari diseas chapter type exercis test indic request type test discuss normal physiolog respons exercis review exampl abnorm respons varieti diseas state discuss small number respons limit specif exercis test establish diagnosi narrow differenti diagnosi exercis test valuabl case patient symptom limit exercis investig rest fail resolv diagnost question exercis test circumst serv uniqu function diagnosi manag pulmonari diseas"
"bronchoalveolar lavag techniqu bal perform fiberopt bronchoscop decad provid clinician research abil safe sampl inflammatoryimmun cell milieu human lung standard bal process lavag constitu assist determin optim care patient varieti lung diseas render diagnosi select case indispens diagnosi pulmonari infiltr immunocompromis patient play import role improv clinic manag final continu yield increas amount data research studi mechan pathogenesi lung diseas bal valuabl tool increas relev practic chest medicin"
"stabl reproduc porcin model acut lung injuri induc oleic acid background method previous studi acut lung injuri induc oleic acid attempt limit influenc secondari pulmonari circul cardiopulmonari variabl data collect process intermitt studi design continu monitor variabl swine system pulmonari pressur mix venous oxygen satur svo arteri oxygen satur sao minut oxygen consumpt product hr infus oleic acid person comput program produc sec updat deadspac ratio vdvt venous admixtur qspqt pulmonari pvr system vascular resist svr cardiac output qt data result oleic acid infus increas pvr svr heart rate hr pulmonari arteri pressur mpap qspqt vdvt decreas qt sao svo thirti minut oleic acid infus increas hr qspqt vdvt mpap pvr svr gradual decreas preoleic acid infus level decreas sao svo qt observ time min period chang cardiopulmonari variabl conclus method continu monitor demonstr swine dynam stabil oleic acid infus"
"target feedback devic ventilatori muscl train previous studi success target feedback devic extern resistor train ventilatori muscl patient chronic obstruct pulmonari diseas articl describ detail design function target feedback devic conjunct extern resist target feedback devic time pressur target feedback inform target achiev target feedback devic consist readili electron compon simpl construct adjust extern pressur knob permit set pressur target adjust intern compon control breath frequenc inspiratori time breath waveform"
"treatment limit smallcel lung cancer concurr etoposidecisplatin radiotherapi intensif highdos cyclophosphamid southwest oncolog group studi march southwest oncolog group enrol previous untreat patient limit smallcel lung cancer treatment program administ highdos cyclophosphamid mgkg late intensif treatment consist induct chemoradiotherapi week consolid chemotherapi week intensif week median age year eighti percent patient southwest oncolog group swog perform status twenti patient complet prescrib treatment treatmentrel death result intensif fifti patient respons analysi thirti patient achiev complet remiss cr fifteen achiev partial remiss pr median surviv patient month patient receiv intensif remain aliv cr median surviv month sequenc treatment surviv advantag group possibl toxic induct consolid treatment delay administr highdos cyclophosphamid"
"doseintens metaanalysi chemotherapi regimen smallcel carcinoma lung determin chemotherapi dose intens di influenc treatment outcom publish studi limit extensivestag smallcel carcinoma lung sccl retrospect analyz relationship intend di respons complet respons cr partial respons pr median surviv ms agent regimen includ cyclophosphamid doxorubicin vincristin etoposid cisplatin relat di rdi studi regimen calcul refer regimen weight regress analysi addit analysi individu drug rdi combin perform cav increas rdi regimen show correl outcom individu drug rdi correl posit rdi correl negat attain cr limit diseas unduli influenti observ elimin extensivestag diseas rdi correl posit cr pr random trial correl lost statist signific unduli influenti observ elimin cae cave rdi regimen correl posit ms extensivestag diseas rdi limit diseas rdi correl negat ms ep signific correl conclud dioutcom correl consist chemotherapi regimen sccl metaanalysi retrospect data generat hypothes test prospect clinic trial studi sampl method analysi appreci affect conclus"
"surgic treatment limit smallcel lung cancer univers toronto lung oncolog group experi patient limit smallcel lung cancer undergon combin modal therapi includ surgeri institut seventi patient male femal median age year surgeri adjuv chemotherapi forti male femal median age year chemotherapi complet partial respons oper pretreat stage reveal stage stage ii stage iii tumor twenti patient requir pneumonectomi lobectomi resect patient gross microscop residu diseas postop patholog examin show smallcel lung cancer smallcel lung cancer mix residu tumor postop stage reveal stage stage ii stage iiia tumor median surviv entir group week project year surviv rate surviv differ patient treat chemotherapi oper undergo initi oper chemotherapi median surviv patient patholog stage diseas reach project year surviv rate signific patient stage ii median week stage iii median week diseas project year surviv rate patient adjuv chemotherapi remain aliv month sixti patient die evid diseas patient relaps primari site primari distant site distant site summari resect improv control primari site signific proport patient stage diseas achiev longterm surviv cure combin modal therapi includ surgeri stage ii iiia patient surviv predict similar stage iiia smallcel lung carcinoma treat surgic"
"surfact apoprotein concentr sputum diagnosi pulmonari alveolar proteinosi pulmonari alveolar proteinosi pap diseas characteris accumul surfact alveoli diagnos basi invas biopsi procedur measur apoprotein sp concentr sputum diagnosi pap sputum sampl patient pap twenti patient pulmonari diseas assay monoclon antibodi sp sp concentr time higher patient pap control suggest measur diagnosi pap lung biopsi contraind"
"origin nasal polyp nasoethmoid complex patient nasal polyp systemat examin locat place origin polyp record photograph polyp place origin remov serial section examin patient polyp origin nasal mucosa polyp extend mucosa anterior part middl meatus polyp origin mucosa ethmoid cell ostium direct mucosa line edg ostium ostia block polyp indic polyp format ethmoid cell"
"periop effect methylprednisolon lung surgeri plasma concentr ca ca methylprednisolon salin placebo solut infus intraven patient undergo elect lobectomi lung cancer state complement system surgeri effect methylprednisolon biolog activ product complement studi measur plasma ca ca anaphylatoxin leukocyt count peripher blood periop placebo group plasma concentr ca signific increas postop day ca risen signific hour surgeri day methylprednisolon infus surgeri elimin postop elev ca ca postop leukocyt count peripher blood higher methylprednisolon group control observ methylprednisolon reduc influx leukocyt peripher blood airway attenu product biolog activ complement"
"intratrach administr endotoxin cytokin iii interleukin il receptor antagonist inhibit endotoxin ilinduc acut inflamm endotoxin lipopolysaccharid lps compon gramneg bacteria induc alveolar macrophag express interleukin il lipopolysaccharid il sever acut neutrophil inflamm lung intratrach inject suggest lpsinduc il express contribut pathogenesi lpsinduc acut inflamm present studi role il lpsinduc acut pneumonia investig quantit acut inflamm occur hour intratrach inject lps compar timepoint intratrach coinject lps il receptor antagonist ilra ilra found inhibit lpsinduc acut inflamm greater measur number neutrophil recov bronchoalveolar lavag lpsinduc emigr neutrophil inhibit recombin il betainduc neutrophil emigr lung inhibit ilra coinject intratrach il beta coinject recombin il beta lps increas neutrophil exodus compar intratrach inject agent intratrach inject lps induc progress increas ilra mrna express lung rna prepar suggest endogen ilra play import role negat feedback mechan downregul lps initi ilmedi acut inflamm conclus ilra inhibit lps ilinduc neutrophil inflamm prove clinic antiinflammatori agent therapi septic asept ilmedi acut inflamm"
"contrast role tumor necrosi factor pathogenes iga igg immun complex lung injuri recent studi suggest develop acut gamma immunoglobulin igg immun complex lung injuri partial depend tumor necrosi factor tnfdepend mechan neutrophil pmn recruit author sought defin role intrapulmonari tnf igg alveol examin role iga immun complex alveol neutrophilindepend model acut lung injuri igg immun complex lung injuri result mark rise intrapulmonari tnf activ accompani progress pulmonari pmn accumul intratrach instil neutral concentr antitnf mark reduc pmn influx measur hour effect pmn recruit quantit hour iga immun complex deposit result acut lung injuri accompani increas number intrapulmonari mononuclear phagocyt neutrophil lung lavag fluid obtain iga immun complexinjur rat neutrophil monocyt chemotact activ albeit twofold fourfold lower concentr observ iggmedi alveol contrast igg complexmedi alveol lung lavag fluid igainjur rat tnf activ intratrach administr antitnf antibodi effect develop iga lung injuri assess morpholog measur vascular permeabl vitro exposur isol alveolar macrophag perform igg immun complex result dosedepend tnf secret exposur iga complex result low level tnf secret data suggest tnfmediat pulmonari neutrophil recruit igg lung injuri manifest chiefli late phase approxim hour develop alveol virtual absenc intrapulmonari tnf activ evolv iga immun complex alveol part account limit pmn recruit observ model"
"role bacteri adher otiti media effus adher nontyp haemophilus influenza streptococcus pneumonia nasopharyng epitheli cell investig vitro strain higher affin epitheli cell children adult children adher signific greater patient otiti media effus normal subject secretori iga nasopharyng secret found antibodi activ bacteria adher bacteria signific smaller group secretori iga antibodi activ group activ result suggest bacteri adher nasopharynx play import role pathogenesi otiti media effus children secretori iga nasopharyng secret relat decreas adher"
"lidocain middl ear anesthesia ear canal produc inject lidocain hydrochlorid skin extern ear canal ear canal tympan membran middl ear surgeri perform inject fluid found middl ear tympanotomi collect analyz percentag lidocain fluid calcul enzym immunoassay techniqu fifteen surgic case undertaken perilymphat fluid middl ear suspect tympanotomi otosclerosi lidocain found middl ear suffici fluid collect author question valid presenc clear fluid middl ear reaccumul sole criterion identifi perilymph cerebrospin fluid"
"stapedotomi techniqu result ten year experi compar studi stapedectomi fifti patient underw stapedotomi otosclerosi random chosen follow year patient follow year stapedotomi patient underw stapedectomi followup longer year patient stapedectomi local anesthesia perform remov footplat stape endaur incis cover oval window gelfoam patient stapedotomi perform general anesthesia endopreauricular incis make small hole footplat cover hole blood surgic area group show improv hear oper airbon gap stapedotomi group signific stapedectomi group endopreauricular incis general anesthesia prefer endaur incis local anesthesia oper field wider conveni surgeon conduc patient safeti signific complic group"
"improv stent method choanal atresia repair short intranas stent secur sublabi number advantag provid secur fixat extern ligatur columella short length stent sit oper area atret plate remov lessen chanc intranas syechia format elimin possibl eros anterior septal nasal alar region pressur exert stent stent protrud nose grasp infant young children visibl extern schoolag children undergon repair unilater choanal atresia attend school suffer embarrass teas tube protrud nose compar stent method posterior stent secur dislodg"
"fat myringoplasti guinea pig fat myringoplasti simpl offic techniqu repair tympan membran perfor involv wedg piec fat ear lobul perfor search literatur fail reveal control studi efficaci method patient avoid invas procedur control perfor guinea pig tympan membran treat fat myringoplasti paper patch intervent week procedur ear examin photograph microscop studi histolog fat myringoplasti heal rate exceed rate control paperpatch group result stratifi respect locat size perfor result histolog studi suggest control studi human warrant"
"monotherm differenti calor test patient menier diseas monotherm differenti calor test determin vestibular recruit decruit variabl discrimin peripher central vestibular lesion previous report strong associ vestibular recruit menier diseas studi examin patient unilater menier diseas nystagmus beat frequenc nbf slowcompon veloc scv respons record electronystagmographi eng electronystagmograph find show unilater dysfunct present patient slowcompon veloc nystagmus beat frequenc unilater hypofunct frequent eng find absolut vestibular recruit occur patient relat recruit found patient slowcompon veloc higher sensit nystagmus beat frequenc excel clinic concord monotherm calor test studi detect peripher vestibular diseas menier patient slowcompon veloc determin unilater hypofunct relat vestibular recruit"
"paranas sinus boni anatom variat mucos abnorm ct analysi endoscop sinus surgeri coron plane computer tomograph ct scan dramat improv imag paranas sinus anatomi compar sinus radiograph increas subtl boni anatom variat mucos abnorm region detect data background preval find determin clinic relev detail analysi coron plane ct scan paranas sinus obtain consecut imag patient conduct special attent direct identifi boni anatom variat mucos abnorm anatom variat studi includ pneumat middl turbin paradox curvatur middl turbin haller cell pneumat uncin process boni anatom variat detect patient found similar frequenc patient scan sinus complaint scan nonsinus reason mucos abnorm detect patient patient scan evalu sinus complaint mucos abnorm note case predomin detect anterior ethmoid region patient scan nonsinus evalu mucos abnorm detect case predilect anterior ethmoid region discuss preval clinic signific paranas sinus boni anatom variat mucos abnorm includ guid assist otolaryngologist radiologist evalu coron sinus ct scan"
"blood filter sudden deaf sixteen patient sudden deaf sd diagnos basi batteri audiometr test medic surgic patholog requir drug treatment underw monitor hemorheolog profil disturb microcircul link sd plasma viscos filter lowshear posit pressur system micronsdiamet pore nuclepor filter blood red unfraction white cell monitor sd patient control match age sex socioeconom status blood filter filter red blood cell signific impair sd patient suggest alter microcircul link sudden deaf"
"conserv manag epistaxi retrospect studi assess clinic surgic manag epistaxi perform patient requir hospitalis ent depart la paz hospit madrid previous histori type manag hospitalis time volum transfus consid nasal pack employ cent patient patient cent hospitalis day cent patient requir transfus death studi support clinic conserv manag treatment patient epistaxi"
"improv techniqu insert tube patient subglott stenosi improv method insert silicon tube tracheostomi stoma patient subglott stenosi present silicon tube pull trachea cathet insert tracheostomi stoma advanc stenot subglott space pull mouth coneshap dilat proxim end vertic limb tube facilit passag end stenot subglott space method patient good result suggest techniqu attempt insert tube usual method fail perform local anesthesia special instrument technic easi"
"acoust reflectometri assess hear loss children middl ear effus sought associ acoust reflectometri hear loss ear middl ear effus zealand children age year reflectometri signific conduct hear loss associ present entir sampl correl coeffici vari hz frequenc pure tone averag associ persist sampl ear deem fill effus correl coeffici vari hz hz reflect greater detect frequenc pure tone averag loss db sensit specif techniqu acoust reflectometri explor extend permit ration decis manag middl ear effus"
"quantit dna ploidi squamous intraepitheli neoplasia laryng glotti dna content laryng glottic biopsi specimen spectrum squamous intraepitheli neoplast sin evalu imag analysi combin dna histogram featur defin abnorm dna cell popul interpret repres intraepitheli neoplast transform eighteen biopsi specimen classifi dysplasiakeratosi grade sin aneuploid eighteen biopsi specimen grade sin ii aneuploid biopsi specimen grade sin iii abnorm quantiti nuclear dna twelv biopsi specimen sin ii grade sin iii grade consid repres keratin form dysplasia found increas aneuploid quantiti dna conclud propos singrad scheme laryng epitheli abnorm exhibit strong correl nuclear dna content addit aneuploidi observ sin ii sin iiigrad biopsi specimen promin keratin"
"modif fluoresc allergosorb test inhibit assay determin crossreact aeroallergen fluoresc allergosorb test adapt inhibit assay determin crossreact aeroallergen method similar antigen determin found short ragwe giant ragwe cocklebur lambquart rough pigwe marsh elder goldenrod cocklebur giant ragwe high potent abil competit bind short ragwe ige pollen demonstr lower potenc crossreact antigen fluoresc allergosorb testinhibit assay method determin crossreact aeroallergen"
"point period preval otiti media effus evalu daili tympanometri previous studi daili tympanometr screen automat imped tympanoscop high incid type tympanogram day durat contrari concept pathogenesi patholog otiti media effus repeat studi healthi children ear attend kindergarten tympanometri perform daili month convent imped apparatus az automat imped tympanoscop zs imped apparatus day type tympanogram shortlast episod occur begin end studi period ear type tympanogram day examin point preval cent period preval cent accord find previous epidemiolog studi secretori otiti imped tympanoscop case curv day higher point period preval make imped tympanoscop unsuit scientif clinic purpos"
"cochlear otosclerosi statist analysi relationship spiral ligament hyalin hear loss paper present analysi relationship amount hyalin spiral ligament secondari cochlear otosclerosi spongiosi amount hear loss relationship previous studi parahi linthicum found larger amount hyalin greater hear loss hyalin measur amount toxic enzym excret ear fluid enzym suspect affect metabol function hair cell"
"isol congenit round window absenc adult unilater round window atresia present care ct scan demonstr round window occlus cochlear fenestr result modest hear improv previous report case review"
"burkitt lymphoma tonsil case burkitt lymphoma involv tonsil year bedouin boy present biolog behaviour clinic present unusu neoplasm discuss english languag literatur review diagnosi made histolog examin electron microscopi confirm immunohistochemistri patient show excel symptomat respons surgeri chemotherapi"
"glasgow benefit plot method report benefit middl ear surgeri convent result middl ear surgeri report term postop closur airbon gap improv airconduct threshold relev assess technic success procedur lessen monaur disabl necessarili assess patient benefit determin factor hear nonoper ear paper suggest preoper postop plot airconduct threshold ear addit method present result proport patient fall main preoper impair group identifi import potenti benefit surgeri group percentag patient achiev postop hear categori calcul surgeon audit result make comparison seri"
"ototox reaction erythromycin report case bilater hear loss patient treat intraven erythromycin lactobion ototox reaction occur patient normal renal hepat function fact serum erythromycin level predict normal rang addit hear loss mark labyrinth hyporreflexia observ hear loss improv treatment discontinu labyrinth abnorm persist suggest erythromycin caus perman vestibular damag"
"microdril versus perfor stapedotomi purpos studi compar hear result perform stapedotomi microdril perfor group patient similar year stapedotomi creat mm fenestra patient signific differ group hear result result show continu improv postop month hear stabil hand microdril prove traumat perfor ear"
"pilot studi pemirolast patient season allerg rhiniti pemirolast potent longact oral effect antiallerg agent evalu clinic activ prevent symptom season allerg rhiniti evalu random doubleblind placebocontrol parallel group season trial test safeti toler prophylact activ thirti patient histori fall season allerg rhiniti treat week pemirolast mg bid placebo begin approxim week onset ragwe season atlanta daili evalu symptom score disclos statist signific sneez rhinorrhea stuffi nose treatment pemirolast differ evalu symptom rescu medicin side effect short studi preliminari studi pemirolast warrant evalu treatment allerg rhiniti"
"loracarbef concentr middl ear fluid loracarbef concentr plasma middl ear fluid mef measur specimen obtain approxim dose mgkg standard deviat concentr mef mgliter concentr plasma smaller dose mgliter concentr plasma larger dose larger dose concentr mef greater mic strain usual pathogen acut otiti media test specimen"
"noncongenit hereditari hear loss children prospect document younger sibl children sensorineur hear loss hereditari underw interv audiolog examin sibl unrel famili found progress sensorineur hear loss earli audiogram document normal hear level age continu test children earli identif intervent advoc regular otolaryngolog audiolog follow normal audiolog assess made younger sibl children document sensorineur hear loss definit nongenet origin hear loss older child recess sensorineur hear loss onset infanc childhood present anteced famili histori normal behavior audiogram earli life"
"immunotherapi patient sever summer hay fever uncontrol antiallerg drug object evalu efficaci safeti immunotherapi hyposensitis patient sever summer hay fever design randomis doubl blind placebo control studi biolog standardis depot grass pollen extract settingallergi clinic royal brompton nation heart hospit london patient adult age year histori sever grass pollen allergi uncontrol standard antiallerg drug patient perenni asthma specif exclud interventionpati randomis receiv activ prepar alutard sq grass pollen phleum pratens extract placebo rate subcutan inject week increas dose mainten dose reach mainten dose month main outcom measuresclin efficaci evalu symptom drug diari card visual analogu score grass pollen season postseason assess patient doctor conjunctiv skin sensit local allergen provoc measur month treatment result high signific decreas median alutard sq median placebo confid interv differ median total symptom score alutard sq treat group signific differ found total drug visual analogu symptom score reduc activ group postseason assess doctor patient show larg improv favour alutard sq provoc test show greater fold reduct activ group conjunctiv allergen sensit decreas earli phase respons decreas late phase cutan respons intraderm allergen total activ inject system reaction minut inject rapid revers intramuscular adrenalin mild delay urticari reaction hour conclusionimmunotherapi effect patient sever summer hay fever anaphylact reaction limit specialis centr patient select extrem import chronic perenni asthma specif exclud reaction occur minut hour wait patient inject unnecessari"
"manag posterior epistaxi fibreopt nasolaryngoscop posterior epistaxi treat repeat nasal pack fail situat ligat feed arteri morbid mortal logic approach locat bleed site arrest haemorrhag local treatment exact locat bleed area identifi activ bleed nose fibreopt nasolaryngoscop bleed arrest chemic thermal cauteri fail situat small nasal pack confin bleed site approach manag posterior epistaxi effect reduc durat hospit stay signific reduc discomfort patient current practic indiscrimin blind nasal pack hope arrest nasal haemorrhag incident pressur bleed site evalu"
"argon laser stapedotomi laser otolog year report excel hear result laser energi surgeri otosclerosi argon laser consecut primari stapedotomi procedur postop airbon gap db patient db ear postop hear secondari granulomat reaction complic uncommon mild patient treat outpati basi result compar favor report laser surgeri otosclerosi conclud excel hear result obtain argon laser stapedotomi procedur"
"respons human ril ril rtnf middl ear guinea pig human recombin interleukin ril interleukin ril tumor necrosi factor rtnf inject transtympan middl ear normal guinea pig effus volum cellular content determin sacrific rapid dissect ear hour ril produc cellular effus polymorphonuclear neutrophil leukocyt clear hour rtnf yield cellular effus lymphocyt hour clear hour ril produc signific effus compar control ril rtnf inflammatori effus middl ear extent generat middl ear otiti media cytokin potenti contribut pathogenesi otiti media effus"
"agerel balanc hearingimpair children studi compar balanc skill hearingimpair children hear children order determin deficit balanc exist hearingimpair children ascertain deficit agerel twenti hearingimpair subject chosen sampl conveni pennsylvania school deaf age group ten subject year age group year age group year age group select criteria includ bilater sensorineur hear loss greater equal db normal intellig iq greater equal balanc measur balanc subtest bruininksoseretski test motor profici age group test compar subject score balanc subtest standard score result show age group score hearingimpair children lower standard score older group signific higher score youngest group score older group signific differ subject balanc score balanc subtest standard score found age group suggest balanc deficit agerel gender differ found balanc score"
"botulinum toxin treatment spasmod torticolli botulinum toxin administ patient doubleblind placebo control trial toxin effect placebo improv head posit pain measur object rate scale videofilm assess control trial treatment botulinum toxin continu open fashion total patient torticolli receiv toxin total treatment period follow period month patient pain benefit treatment period improv neck postur occur treatment period durat week side effect frequent dysphagia common treatment period botulinum toxin effect treatment toticolli treatment initi dose lower end rang studi mous unit"
"bimanu simultan motor perform impair abil shift attent parkinson diseas abil share time shift attent bimanu simultan motor task studi patient parkinson diseas pd age intelligencematch control task consist draw triangl domin hand squeez rubber bulb nondomin hand motor perform measur variabl amplitud squeez frequenc squeez veloc draw triangl elimin varianc due baselin differ singlehand perform bimanu simultan perform pd control turn similar frequenc squeez veloc draw triangl amplitud squeez differ group signific reduc pd arguabl disturb bimanu perform pd patient due disord time share decreas abil shift attent visual cu task visual cu task result agre current evid pd patient impair reli intern control regul shift attent extern cue"
"mispercept comprehens difficulti stroke patient doctor nurs relat doctor nurs relat involv recent aphas stroke patient predict patient perform comprehens test result show doctor nurs relat underestim recept disabl patient illustr lack agreement health profession implic manag consid"
"practic effect preprogram discret movement parkinson diseas effect practic simpl choic reaction time rts parkinson diseas pd control subject discret aim task analys control practic led select decreas choic rts report previous opposit effect pd group chang choic rts substanti reduct simpl rts result suggest pd subject advanc inform initi discret movement rapid abil preprogramm movement requir practic reconcili result studi report inabl preprogramm pd made discuss task characterist preclud preprogram"
"surgic manag exophyt chiasmatichypothalam tumor childhood sixteen children underw oper radic resect chiasmatichypothalam tumor clinic present correl age infant year age present macrocephali failur thrive sever visual failur children age year predomin precoci puberti mild visual deficit older children greater year slowli progress loss vision infant biolog aggress tumor spite lowgrad histolog die progress tumor growth eleven children age year aliv clinic radiograph evid diseas progress month year surgeri patient follow period month year month adjuv therapi radic surgic resect author conclud radic surgic resect chiasmatichypothalam tumor perform minim morbid radic resect delay time diseas progress older children postpon irradi resect postirradi recurr tumor provid neurolog improv longlast clinic remiss chiasmatichypothalam tumor infanc aggress neoplasm requir multimod therapi"
"longterm follow review children sever close head trauma thirti children age year year suffer sever close head trauma caus coma week median durat coma week patient remain persist veget state death year recov conscious discharg suffer diminut abil major perman disabl common motor disabl pure spastic hemiparesi case basal ganglia syndrom case ataxia case combin hemiparesi ataxia case patient regain independ ambul epilept dysarthr degre cognit abil profit normal educ system attempt postsecondari educ social problem common worst outcom intracrani bleed brain contus computer tomographi ct scan acut stage normal ct scan degre residu disabl children adult trauma similar sever"
"neurobehavior outcom year sever head injuri experi traumat coma data bank outcom year sustain sever head injuri investig patient admit neurosurgeri servic center particip traumat coma data bank tcdb elig survivor qualiti recoveri year injuri assess glasgow outcom scale gos patient complet neuropsycholog assess perform elig survivor capac patient undergo neuropsycholog test year injuri criterion recoveri reflect signific relationship neurolog indic acut injuri gos score time hospit discharg neurobehavior data year injuri general compar sampl patient character impair memori slow inform process contrast languag visuospati abil recov normal rang lowest postresuscit glasgow coma scale gcs score pupillari reactiv predict year gos score neuropsycholog perform lowest gcs score predict neuropsycholog perform year postinjuri patient nonreact pupil resuscit notwithstand limit relat scope tcdb attrit follow materi result characterist pattern neurobehavior recoveri sever head injuri encourag neurobehavior outcom measur clinic trial evalu intervent headinjur patient"
"intracarotid hydroxyethyl methacryl solut caus stroke dog hydroxyethyl methacryl hema advoc polymer solut prevent deflat detach balloon intervent neuroradiolog pertin unpolymer hema untoward effect accident releas carotid arteri balloon ruptur deflat mongrel dog underw transfemor catheter common carotid arteri subsequ inject hema solut volum cc dog cc cc angiographi perform time inject reveal evid intravascular thrombosi spasm surviv anim sacrif hour brain fix examin histopatholog brain normal autolyz examin anim histopatholog document cerebr infarct vari size foreign substanc blood vessel suggest intravascular polymer anim inject cc hema solut surviv hour literatur review reveal document toxicolog intravascular hema increas popular compound polymer detach balloon introduc brain investig warrant understand physic properti compound potenti risk"
"hemiparkinson complic ommaya reservoir case report author describ case year woman develop symptom hand rest tremor transient focal rigid paresthesia deficit occur treatment intrathec methotrex ommaya reservoir deepli result trauma contralater mesencephalon"
"stereotact investig limbic epilepsi multimod imag analysi system technic note methodolog develop stereotact investig limbic epilepsi imageanalysi system simultan display structur function imag brain valid accuraci system establish phantom studi surgic plan electrod implant guid stereotact magnet reson imag digit subtract angiographi posit emiss tomographi methodolog spatiotempor relationship cerebr structur function identifi seizur onset propag human limbic system epilepsi"
"evalu sensori pain relief trigemin neuralgia intracrani microvascular decompress trigemin glycerol rhizotomi nineteen patient trigemin neuralgia treat trigemin ganglion glycerolysi glycerolysi intracrani microvascular decompress good degre pain relief receiv glycerol group subject report mild reduct fine tactil sensat similar respons report treat glycerol decompress group degre sensori loss mild thermal test useless discriminatori tool degre sensori loss greater surgic procedur perform invas trigemin ganglion glycerolysi"
"transcrani doppler ultrasonographi clinic applic cerebrovascular diseas transcrani doppler ultrasonographi introduc noninvas procedur assess intracrani cerebr circul lightweight portabl equip transcrani doppler examin facilit bedsid assess critic ill hospit patient outpati clinic applic includ diagnosi vasospasm patient subarachnoid hemorrhag assess intracrani collater flow patient extracrani arteri occlus diseas detect intracrani arteri stenosi identif feed arteri arterioven malform monitor hemodynam effect treatment confirm clinic diagnosi brain death intensivecar unit monitor braininjur patient intraop postop monitor neurosurg patient transcrani doppler technolog provid insight pathophysiolog mechan varieti cerebrovascular condit clinician find transcrani doppler technolog specif question status intracrani circul investig expand clinic research util technolog"
"arteri respons migrain headach superfici tempor arteri thought main focus pain migrain attack diamet measur direct highresolut ultrasound machin measur arteri size migrain patient unilater head pain show lumen wider pain pain side migrain attack diamet radial arteri tempor arteri pain side smaller attack generalis vasoconstrict share tempor arteri affect side suggest local vasodilatori respons find suggest cephal arteri play role migrain pathogenesi"
"evok potenti assess follow patient wilson diseas treatment patient wilson diseas prospect studi evok potenti magnet reson imag mri oral penicillamin therapi led decreas auditori brainstem abp somatosensori sep conduct time neurolog symptomat patient abp sep normal symptomfre patient mri show cerebr lesion patient quantifi indic brain atrophi unaffect treatment abp sep reveal revers compon diseas detect mri sensit measur treatment efficaci"
"effect uvulopalatopharyngoplasti sleep architectur pattern obstruct breath retrospect studi obstruct sleep apnea patient polysomnogram uvulopalatopharyngoplasti evalu postop signific improv sleep architectur respiratori indic addit group patient posit record polysomnogram time spent supin sleep posit chang postop signific decreas apnea hypopnea index posit studi signific improv sleep architectur respiratori indic major patient uvulopalatopharyngoplasti sleep posit"
"molecular biolog occlus stroke childhood factor involv occlus diseas adult oper child major differ factor damag endothelium age group initi catastroph atherosclerosi versus endotheli task decad ration explor effect endotheliummedi kinin endotheli secretori product angiospasm platelet aggregr prostaglandin lipoprotein pediatr stroke"
"infantil spasm infantil spasm seizur disord young infant divers etiolog suggest aris disturb central nervous system function suscept period develop prognosi normal intellectu neurolog develop parallel etiolog earli treatment acth lead seizur control major patient treat physician anticip side effect modal"
"rett syndrom autist disord rett syndrom disord note date femal character pervas development disabl appar normal earli infanc addit gait difficulti stereotyp hand movement loss communic purpos hand skill autist behavior earli sign result misdiagnosi signific clinic abnorm neuropatholog featur modest consist laboratori abnorm diagnost marker identifi current status research rs consid context autism disord autist featur occur fragil syndrom concept autism neurobiolog base behavior develop autism regard umbrella categori expand list specif disord"
"tourett syndrom recent advanc clinic genet studi limit tourett syndrom broaden strong evid chronic motor tic tourett syndrom manifest autosom domin gene high penetr genet link obsessivecompuls disord establish case tourett syndrom nongenet phenocopi associ tourett syndrom attent deficit hyperact disord complic therapi psychostimul drug precipit exacerb tic individu high proport patient tourett syndrom neuropsycholog deficit learn disabl pathophysiolog incomplet understood support hypothesi dopamin receptor supersensit strong suggest abnorm serotonin metabol possibl abnorm neuropeptid system explor treatment tic reli primarili neurolept dopamin receptor block activ clonidin patient behavior problem obsessivecompuls symptom treat pharmacolog agent treatment attent deficit disord patient tic begin behavior strategi clonidin line drug psychostimul great caution rare instanc combin psychostimul neurolept"
"floppi infant recent advanc understand disord affect neuromuscular junction clinician evalu floppi infant numer condit hypotonia infanc briefli outlin articl condit affect brain spinal cord motor unit disord neuromuscular transmiss includ distinct recent congenit myasthen syndrom infant botul discuss"
"rehabilit pediatr patient neuromuscular diseas rehabilit program patient neuromuscular diseas develop accur diagnosi establish diagnosi ramif suggest natur diseas hope improv ration realist program program develop interdisciplinari team includ pediatr neurologist greatest understand patient problem ultim respons implement monitor program child cerebr palsi common requir servic physic occup therapist knowledg orthopedist program child potenti limit child traumat brain injuri requir addit psycholog intervent intens educ program child famili mental health profession child motor unit diseas duchenn muscular dystrophi requir addit servic philosophi care child ambul independ cost child reach potenti includ item orthos adapt equip respir care issu address form care establish program children program individu meet patient famili point overemphas"
"ultrasound evalu neurolog diseas childhood realtim cranial sonographi intracrani doppler neuromuscular sonographi sonograph techniqu applic neurolog evalu infant children limit age specif oper skill experi advantag realtim cranial intracrani doppler sonographi make techniqu evalu young infant serial assess ventricular size studi critic ill infant neuromuscular sonographi assess floppi infant guidanc biopsi make increas valuabl tool"
"dwarf locus mutant lack pituitari cell type result mutat poudomain gene pit mutat mous dwarf locus dw interrupt normal develop anterior pituitari gland result loss express growth hormon prolactin thyroidstimul hormon hypoplasia respect cell type disrupt gene encod poudomain transcript factor pit occur character allel dwarf locus data pit specif phenotyp cell type anterior pituitari direct link transcript factor commit progress event mammalian organogenesi"
"tonic contravers ocular tilt reaction due unilater mesodiencephal lesion studi patient tonic contravers ocular tilt reaction due unilater paramedian mesodiencephal lesion contrast previous report patient ocular tilt reaction due unilater mesodiencephal lesion paroxysm ipsivers ocular tilt reaction find consid context previous clinic experiment data type ocular tilt reaction follow stimul destruct peripher central vestibular system otolith input interstiti nucleus cajal contralater vestibular nucleus motor output interstiti nucleus cajal cervic ocular motoneuron involv ocular tilt reaction propos patient unilater mesodiencephal lesion tonic contravers ocular tilt reaction due persist decreas rest activ ipsilater interstiti nucleus neuron paroxysm ipsivers ocular tilt reaction due transient increas activ interstiti nucleus neuron case ocular tilt reaction due unilater mesodiencephal lesion point exist cross gravicept pathway vestibular nucleus contralater interstiti nucleus cajal"
"estim incid dementia idiopath parkinson diseas proport patient idiopath parkinson diseas pd consid dement rang dementia affect surviv pd incid rate dementia proport accur measur diseas frequenc previous estim proport patient pd dementia record cohort idiopath form pd major medic center review clinic record cohort year month estim incid rate dementia identifi case dementia patientrecord number personyear follow case denomin estim incid rate personyear observ age cohort year cumul incid dementia increas age year age surviv member cohort dement agespecif incid rate dementia cohort pd signific greater similar age cohort healthi elder peopl agespecif standard morbid ratio compar peopl similar age patient pd highest increas risk dementia age"
"antemortem diagnosi diffus lewi bodi diseas presenc widespread cortic lewi bodi lb patholog criteria diffus lewi bodi diseas dlbd describ serial neurolog mental status examin patient dlbd patient alzheim diseas ad patient parkinson diseas pd patient dlbd includ neocort neurofibrillari tangl nft consist coincid ad patient dlbd gait impair concurr mild moder dementia abnorm tone rest tremor promin earli symptom subject dlbd ad patient dlbd frequent abnorm eeg background posterior slow frontal domin burst pattern time mild moder dementia agit hallucin delus frequent earli symptom dlbd patient patient dlbd concomit ad numer alz negat cortic plaqu patient dlbd distinct clinic syndrom differenti ad patholog featur includ absenc alz immunoreact differenti dlbd ad"
"abnorm pulsatil secret lutein hormon men epilepsi relationship natur paroxysm discharg compar pulsatil secret lutein hormon lh men clinic electrograph document tempor lobe seizur agematch control serum lh measur drawn minut hour eeg telemetri group group differ signific averag baselin lh secret total lh secret averag puls amplitud group seizur show signific greater variabl baselin lh secret puls frequenc men unilater paroxysm eeg find puls frequenc signific greater epileptiform discharg left slow left epileptiform discharg slow relationship puls frequenc natur paroxysm discharg make endocrin abnorm attribut medic strengthen notion tempor lobe epileptiform discharg disrupt hypothalam regul pituitari secret"
"neuroexcitatori plasma amino acid elev migrain investig role glutam glu aspart acid asp migrain measur plasma amino acid migrain patient aura attack compar profil plasma amino acid profil tension headach patient healthi control attack migraineur notabl aura substanti higher plasma glu asp level control tension headach patient addit patient migrain aura show low plasma histidin level migrain attack glu lesser extent asp level increas result suggest defect cellular reuptak mechan glu asp migraineur hypothes similar defect neuronalgli cell level predispos brain migraineur develop spread depress"
"borderzon hemodynam cerebrovascular diseas investig exist chronic select hemodynam impair arteri borderzon region brain positron emiss tomographi pet measur region vascular transit time rt equal ratio region cerebr blood volum cerebr blood flow region oxygen extract fraction roef patient sever intern carotid arteri stenosi occlus normal control twenti patient tia amaurosi fugax day pet normal brain ct stereotact local method locat anterior posterior borderzon region middl cerebr arteri mca territori calcul ratio borderzon ipsilater mca territori rt roef signific differ control ratio patient subgroup includ greater equal stenosi occlus contralater greater equal stenosi abnorm hemodynam mca territori found evid select borderzon hemodynam impair group patient sever carotid arteri diseas"
"comparison algorithm test autom evalu sensat estim vibratori detect threshold detect character follow sensori abnorm neurolog diseas approach epidemiolog control clinic trial studi algorithm test find threshold automat system compar algorithm stimulus condit index finger healthi subject great toe patient mild neuropathi threshold obtain linear ramp increas rate micronssec provid accur repeat threshold compar threshold obtain forcedchoic test rate accept sensit site studi slow automat test insensit part threshold obtain fast linear rate micronssec overestim threshold sensit part disappear threshold stimulus increas exponenti rate notic differ jnd unit interspers null stimuli bekesi null stimuli provid accur repeat fast estim threshold sensit part good perform bekesi test prefer forc choic evalu sensat patient neuropathi"
"left disorient dementia alzheim type demonstr left orient confront subject impair patient dementia alzheim type patient multiinfarct dementia compar degre dementia impair independ aphasia spatial disorient"
"dopamin betahydroxylas activ cerebrospin fluid idiopath torsion dystonia postmortem biochem studi genet linkag studi idiopath torsion dystonia suggest involv dopamin betahydroxylas dbh determin csf dbh activ jewish jewish patient childhoodonset idiopath torsion dystonia found differ control popul"
"inconsist respons divalproex sodium hemichoreahemibal report patient hemichoreahemibal vascular origin treat divalproex sodium depakot respond initi mark improv patient hemibal recur continu therapi divalproex sodium uniform effect treatment hemichoreahemibal"
"oxid reaction parkinson diseas free radic generat oxid reaction contribut pathogenesi parkinson diseas pd free radic capabl react instantan membran lipid caus lipid peroxid membran injuri cell death dopamin metabol oxid reaction capabl generat free radic recent evid substantia nigra patient pd increas iron enhanc oxid decreas glutathion protect format free radic end product lipid peroxid increas substantia nigra patient pd support notion free radic generat contribut dopamin neuron death hypothesi suggest antioxid therapi slow rate progress pd rais concern metabolit levodopa therapi acceler rate neuron degener"
"level mrna putat kainat receptor affect seizur situ hybrid rna blothybrid techniqu examin region distribut mrna putat kainat receptor adult rat brain ii test possibl seizur affect express receptor gene highest densiti hybrid distribut hippocamp pyramid granul cell medial habenula purkinj cell molecular layer cerebellum olfactori bulb recurr limbic seizur caus massiv delay revers reduct level kainat receptor mrna dentat gyrus lesser decreas found pyramid cell field hippocampus superfici cortex find provid evid unusu pattern physiolog activ alter genom express subclass glutam receptor brain"
"immunodomin region helpercel sensit human nicotin receptor alpha subunit myasthenia gravi myasthenia gravi autoimmun respons nicotin acetylcholin receptor achr occur alpha subunit achr epitop domin antibodi respons main immunogen region epitop involv helper cell sensit studi overlap synthet peptid complet achr alphasubunit sequenc propag polyclon achrspecif helper cell line myasthen patient hla type respons helper line individu peptid studi immunodomin sequenc segment identifi residu region includ residu form main immunogen region cholinerg bind site frequent sequenc motif propos relat epitop format"
"condit spinal stretch reflex implic rehabilit purpos articl describ techniqu potenti appli patient hyperact spinal stretch reflex ssrs progress clinic research condit individu muscl muscl group electromyograph biofeedback condit ssrs explain research data subhuman primat addit human experi review potenti applic ssr condit discuss issu requir delin research specif train effect ascertain"
"wilson diseas year experi thirti chines patient fulfil criteria wilson diseas year period review male femal equal affect twenti patient symptomat asymptomat present decad thirti cent relat screen show evid diseas parent rare affect cent half adult symptomat femal present primari amenorrhoea liver laboratori test abnorm cent patient gammaglutamyltranspeptidas sensit index renal diseas infrequ serum caeruloplasmin level singl biochem paramet prognost signific seventi cent symptomat patient show improv treatment penicillamin"
"bicarbonatebuff lidocaineepinephrinehyaluronidas eyelid anesthesia doublemask random clinic trial conduct determin subcutan eyelid inject bicarbonatebuff lidocaineepinephrinehyaluronidas mixtur pain unbuff inject twenti patient receiv buffer ph unbuff ph inject inject patient record pain scale pain sever pain pain score buffer inject versus unbuff inject seventeen patient rank buffer inject pain bicarbonatebuff lidocaineepinephrinehyaluronidas mixtur effect make ophthalm anesthesia pain"
"optic nerv sheath meningocel clinic radiograph featur case review literatur thirteen patient dilat intraorbit optic nerv sheath expand patul cerebrospin fluid csf space studi highresolut comput tomographi ct magnet reson imag mri eleven patient bilater find headach visual complaint present patient sign optic nerv dysfunct present patient patient visual acuiti wors cerebrospin fluid pressur mild elev patient patient underw surgic procedur visual acuiti improv author propos term meningocel condit suggest mri fatsuppress techniqu axi sagitt view radiograph procedur choic"
"strategi control disord movement purpos articl fourfold theori motor control dualstrategi hypothesi outlin methodolog theoret framework develop theori examin motor dysfunct discuss context theori syndrom parkinson diseas cardiovascular accid spastic discuss final potenti applic theori physic therapi consid"
"challengerobot rehabilit neurolog motor impair rehabilit robot research area origin engin emerg decad broad aim robot technolog assist peopl movement dysfunct neurolog impair popul gain provis robot assist therapi aid interfac machin match physic intellectu abil user multidisciplinari approach encompass behavior engin perspect essenti achiev aim date publish report larg restrict engin journal confer report therapi literatur articl seek introduc physic therapist robot describ applic rehabilit neurolog impair patient suggest issu deserv investig"
"brain potenti movement traumat brain injuri brain potenti assess function abnorm underli impair movement purpos articl illustr examin potenti addit overview topic articl includ report studi demonstr differ brain potenti patient traumat brain injuri healthi control subject patient postacut phase hemiplegia slow cortic potenti simpl goaldirect forearm finger movement record frontal pariet electrod movementrel electroencephalograph activ movementrel potenti record patient show reduc brain potenti movement paret limb lesser extent reduc brain potenti movement nonparet limb waveform obtain patient unusu uncharacterist crosscort movementrel potenti correl specif electrod configur specif movement condit brain potenti foreperiod interv simpl reaction time paradigm record patient traumat brain injuri control subject determin function signific relat posit appar movementrel potenti data preliminari studi electroencephalograph potenti obtain prepar execut movement provid inform basi motor dysfunct"
"movement disorderslimb movement basal ganglia primari concern articl review experiment method lead understand function role basal ganglia control movement model basal ganglia impair consid parkinson diseas huntington diseas review focus primarili akinesia bradykinesia key abnorm basal ganglia dysfunct general electromyographi kinemat analysi movement character specif movement disord specif damag sustain central nervous system trace structur provid insight extent involv function role structur control movement data review suggest basal ganglia play specif role initi regul forc control"
"return work person traumat brain injuri support employ approach support employ place person competit employ month individu experienc sever head injuri injuri due motor vehicl accid year pass injuri refer client unconsci day refer client achiev competit postinjuri employ compar group competit employ injuri job retent rate report job warehous cleric servicerel occup hour job coach requir place maintain client support employ"
"function evalu quadripleg patient hand neuroprosthesi object retrospect studi compar abil quadripleg patient complet activ daili live portabl hand neuroprosthesi neuroprosthesi provid synthet hand grasp function neuromuscular stimul paralyz forearm hand muscl data obtain telephon interview patient record videotap twenti quadripleg patient includ studi function spinal cord injuri level level median success rate percentag patient complet activ ten activ hand neuroprosthesi hand neuroprosthesi patient perform task neuroprosthesi relat improv patient larger patient"
"impair awar behavior limit traumat brain injuri sixti traumat brain injur patient divid group patient group overestim behavior compet patient group ii show behavior rate similar relat report behavior compet patient group iii underestim behavior compet group patient greater evid bilater multiplesit lesion group ii iii patient speed lefthand finger tap wors group group ii iii standard neuropsycholog test find fail separ group specif brain lesion site relat group membership impair awar behavior limit traumat brain injuri relat neuropsycholog measur standard test bilater impair heteromod cortex import phenomenon exist month year postinjuri"
"maxim exercis test mental retard adolesc adult reliabl studi data maxim exercis test mental retard individu data reliabl maxim exercis test mental retard individu purpos studi determin reliabl grade exercis test mental retard adolesc adult test conduct geograph center center mental retard adolesc boy girl syndrom educ trainabl recruit nonresidenti school subject complet balkewar treadmil protocol exhaust treadmil time heart rate hr record time test approxim week center mental retard adult women men iq recruit local workshop group home subject complet treadmil walk protocol metabol measur exhaust time test vari month center subject achiev treadmil time min test min test hr bpm reliabl coeffici test center subject achiev vmax mlkgmin test mlkgmin test reliabl coeffici data show maxim exercis test reliabl popul mental retard individu exhibit similar valu nonretard peer"
"famili trigemin anesthesia famili congenit trigemin anesthesia isol abnorm unusu disord knowledg famili previous report report famili affect member demonstr facial anesthesia bilater corneal nasal septal damag secondari traumat magnet reson imag demonstr hypoplasia gasserian ganglia trigemin nerv affect father affect son pathogenesi disord congenit hypoplasia trigemin nerv gasserian ganglia inherit domin fashion"
"enhanc vitro uptak retent htetraphenylphosphonium nervous system tumor cell photodynam therapi promis treatment human brain tumor select retent compound tumor cell lipophil cation compound tetraphenylphosphonium tpp select varieti carcinoma preferenti retent tpp demonstr breast carcinoma cell line mcf compound test previous cell deriv nervous system tumor present studi tritiatedtpp htpp uptak retent cell cultur histolog type nervous system tumor measur data compar posit control mcf negat control normal african green monkey kidney epithelium cv normal human fibroblast wi cell line uptak retent characterist group specif patholog tumor type individu tumor variabl notabl malign astrocytoma grade iiiiii glioblastoma malign neurofibrosarcoma cell show preferenti uptak retent htpp relat meningioma cell normal control clonogen assay util cytotox lipophil cation compound dequalinium show strong retain htpp suscept effect dequalinium weak retain data demonstr human experiment anim nervous system tumor cell line retain lipophil compound possess deloc posit charg lipophil cation compound intraop delin tumor margin photodynam therapi nervous system tumor"
"tension pneumocephalus treatment control decompress close waters drainag system case report success treatment patient tension pneumocephalus control decompress extern drainag advantag techniqu includ releas high pressur capabl maintain constant low pressur enabl facilit seal dural tear method patient lead resolut tension pneumocephalus recurr complic"
"cerebrospin fluid rhinorrhea acoust neurinoma surgeri technic note author describ method prevent cerebrospin fluid csf rhinorrhea surgeri acoust neurinoma mastoid air cell expos craniectomi skeleton pack bone dust cover surgicel soak tisseel fibrin glue techniqu reduc number acoust neurinoma case requir secondari mastoidectomi csf leakag"
"effect glucos administr carbohydr metabol head injuri role intraven infus glucos limit ketogenesi effect glucos cerebr metabol sever head injuri studi comatos patient patient random assign aliment glucos system protein wast arteri concentr energi substrat cerebr metabol energi substrat monitor day postinjuri group negat nitrogen balanc wast system protein substanti protein intak blood cerebrospin fluid csf glucos concentr highest day remain higher normal fast level day studi patient receiv exogen glucos differ blood csf glucos concentr group patient glucos group higher plasma insulin level standard deviat microuml compar microuml salin group blood concentr betahydroxybutyr acetoacet pyruv glycerol free fatti acid higher salin group glucos group cerebr oxygen consumpt similar group cerebr metabol glucos keton bodi depend glucos administ glucos group glucos energi substrat util brain salin group keton bodi betahydroxybutyr acetoacet replac glucos extent brain total energi product cerebr lactat product csf lactat concentr lower salin group studi suggest administr glucos earli recoveri period sever head injuri major suppress ketogenesi increas product lactic acid traumat brain limit avail nonglycolyt energi substrat"
"manag meralgia paresthetica meralgia paresthetica syndrom pain dysesthesia anterolater thigh caus entrap neurinoma format femor cutan nerv conserv treatment success reliev symptom patient syndrom patient requir surgic treatment intract symptom neurolysi transposit common procedur section femor cutan nerv perform case success patient earli symptomat relief subsequ develop neurolog sign symptom undetect pelvic neoplasm anatom variat nerv neurinoma occur frequent easili handl section lead recurr neurolysi transposit"
"posttraumat intracerebr pneumatocel case report pneumocephalus occur head trauma occur neurolog surgeri result erod infect neoplasm pathophysiolog involv presenc craniodur fistula ingress air ballvalv mechan air enter exit cranium csf leak permit air entranc fluid leav intracrani space success splash consid diagnost pneumocephalus patient nonspecif sign symptom headach high index suspicion patient recent head trauma diagnosi made radiograph ct scan general perform rule intracrani hematoma cerebr contus head trauma reveal small quantiti air unsuspect physician therapi noninvas craniodur defect heal spontan select situat requir oper repair fistula"
"headach public health problem headach appar frequent pain syndrom report american western european societi high percentag popul headach specif sever headach report preval varieti societi worldwid preval rate vari low peopl republ china preval vari socioeconom group remain uncertain sever headach specif migrain reason unknown common women studi report decreas preval older age group posit famili histori common precis role genet unknown major problem epidemiolog studi remain difficulti uniform definit headach syndrom"
"classif diagnosi headach disord headach disord recent reclassifi oper diagnost criteria assist make correct diagnosi diagnost criteria accept worldwid"
"basic mechan vascular headach understand treat pain condit identifi discov sourc develop knowledg peripher central pain transmiss headach develop anim model import review anatomi neurochemistri electrophysiolog pharmacolog trigeminovascular system experiment anim emphas relev final common pathway migrain cluster headach syndrom human base recent anatom dissect pericarotid cavern sinus plexus suggest import focus investig cluster headach pathophysiolog plexus anatom point converg nerv give rise sign sympathet parasympathet activ sensori symptom develop cluster patient nocicept system trigeminovascular axon assum import role concern transmiss nocicept inform electrophysiolog evid support trigemin nucleus caudali import site converg viscer vessel somat forehead input mediat referr vascular pain superfici tissu import role concern initi local increas blood flow enhanc protein permeabl steril inflamm axon releas vasoact neuropeptid plasma extravas develop dura mater trigemin stimul extravas block administr ergot alkaloid sumatriptan serotonin agonist prejunct neuron mechan action drug blockad releas suggest base experiment evid vasoconstrict relat therapeut efficaci remain determin organ system real threaten tissu injuri import stimulus depolar sensori fiber stimulus extern condit reduc blood flow hypoglycemia brain possess intrins neuron mechan nociceptor synthes glutamateinduc neurotox seizur molecul relev includ bradykinin prostaglandin leukotrien potassium experiment evid present demonstr trigemin nerv mediat hyperemia cortic gray matter axonreflex mechan import role nerv establish hyperem period recircul ischemia sever hypertens limit autoregulationabstract truncat word"
"concept migrain state central neuron hyperexcit articl explor hypothesi migrain aura state central neuron hyperexcit author propos central neuron hyperexcit involv overact excitatori amino acid glutam possibl aspart stimuli activ migrain attack evok neuron depolar slow depolar shift spread suppress spontan neuron activ glutam depend mechan low brain mg consequ reduc gate glutamaterg receptor provid link physiolog threshold migrain attack mechan attack promot glutam hyperact neuron hyperexcit suscept glutamatedepend spread depress"
"develop hydroxytryptamin receptor pharmacolog migrain satisfactori anim model migrain exist attempt determin common mechan action effect antimigrain agent benefit elucid pathogenesi neurolog syndrom present review demonstr clinic data develop past year elucid role specif ht receptor subtyp pathophysiolog migrain larg number acut prophylact antimigrain agent share abil interact ht receptor subtyp human brain summar tabl acut antimigrain drug ergot sumatriptan share high affin htid receptor lower affin hta receptor receptor present intracrani blood vessel htd receptor locat nerv termin act inhibit releas ht neurotransmitt theoret htid receptor agonist acut inhibit releas vasoact paininduc substanc perivascular space conceiv drug act receptor stop progress perivascular process addit number prophylact antimigrain drug display high affin ht htc receptor human brain receptor found blood vessel present nervous system receptor mediat neuron depolar cellular level ht receptor play key role develop inflamm smooth muscl system theoret abil ht antagonist protect perivascular inflamm account efficaci prophylact treatment migrain data offer approach analysi antimigrain agent drug select clinic migrain studi base select specif ht receptor subtyp agent display high affin select htd receptor clinic evalu effect lack thereof import specif ht receptor site pathogenesi migrain futur attempt determin common mechan action effect antimigrain agent facilit elucid pathogenesi neurolog syndrom"
"manifest migrain migrain disord multipl manifest affect circul gastrointestin tract central nervous system involv autonom nervous system respons clinic featur attack migrain vari fragment clinic spectrum phase potenti perman sequela"
"modern pharmacotherapi migrain rectal ergotamin naproxen major candid ad hoc treatment migrain attack dramat episod intraven dhe prochlorperazin author prefer longterm stabil simpler measur fail valproat major addit migrain therapi"
"advanc cluster headach physician combin art scienc medicin manag fascin human ailment choic drug length treatment prescrib great influenc individu physician experi convict reason needless chronic narcot avoid author regimen combin ergotamin prophylaxi verapamil prednison episod cluster headach lithium chronic cluster headach manag treatmentresist patient remain problemat care perform trigemin radiofrequ thermocoagul procedur worthwhil"
"druginduc headach headach induc medic nonheadach condit import headach perpetu symptomat medic primari headach disord discuss detail articl clinic featur mechan druginduc headach review ergotamin analges rebound phenomena manag strategi druginduc headach outlin"
"oromandibular disord headach critic apprais oromandibular disord function disord pain anatom region temporomandibular joint diagnosi treatment controversi lack conform disord health care provid articl clear classif disord critic review evalu treatment"
"psycholog behavior aspect chronic headach import physician awar expect psycholog patient understand psycholog person variabl impact care realiz import patient educ cogniz environment factor influenc headach pain behavior empir data nonpharmacolog treatment biofeedback relax stress cope train serv adjunct altern procedur combin medic nonpharmacolog treatment yield greatest clinic outcom headach type show minim respons nondrug therapi cluster menstrual posttraumat headach age person variabl bear nondrug treatment outcom"
"surgic decompress transposit ulnar neuropathi factor determin outcom fifti surgic decompress nerv transposit ulnar neuropathi perform patient patient men averag age year time surgeri follow rang month averag month diseas involv nondomin arm patient bilater case predispos condit identifi patient abus alcohol patient diabet mellitus fifti percent patient surgeri symptom year patient symptom year symptomat improv relat magnitud slow ulnar nerv conduct veloc elbow signific correl success decompress reliev symptom ulnar nerv conduct veloc elbow respond surgeri respond df total patient show symptomat improv decompress simpl decompress ulnar nerv perform local anesthesia transposit nerv case compress nerv occur predomin epicondylar groov narrow nerv groov present case scar tissu found adher nerv case pseudoneuroma found forti oper result symptomat improv typic note patient month postop"
"blood flow direct lumbar nerv root effect clip lumbar nerv root blood flow rate region nerv root canal studi experiment hog blood flow rate measur hydrogen washout techniqu entranc zone clip microvascular clip blood flow rate nerv root decreas comparison initi control rate clip exit zone reduc blood flow rate blood flow direct lumbar nerv root nerv root canal found predomin proxim current data imping nerv root occur ischem induc"
"prevent stroke modif risk factor epidemiolog research reveal major risk factor cerebrovascular diseas review concentr import risk factor elev blood pressur common import respons stroke rais cholesterol smoke factor import increas risk stroke amen modif drug diet intervent strategi avoid stroke produc substanti reduct drug level risk factor individu popul high level highrisk approach produc modest reduct level risk factor individu popul drug lifestyl modif mass approach prevent stroke achiev continu medic effort deal highrisk individu polit strategi encourag healthier lifestyl popul"
"cytosol free calcium focal cerebr ischemia effect nimodipin calcium histolog damag role calcium mediat neuron death ischemia strong evid support link includ studi cell cultur measur calcium accumul mitochondria ischemia direct measur shift extracellular calcium microelectrod danger high concentr intracellular free calcium hypothes lead neuron damag direct vivo measur paramet ischemia import techniqu measur intracellular free calcium data studi dramat demonstr time intracellular free calcium induc focal ischemia addit data present cellular damag attenu agent block calcium channel nimodipin block voltagesensit calcium channel mk block receptoroper channel support concept agent owe benefici effect abil reduc accumul intracellular calcium"
"effect nimodipin acut ischem stroke pool result random trial review pool data doubleblind placebocontrol studi nimodipin acut ischem stroke compar effect mg nimodipin oral placebo studi patient adher entri inclus criteria end point mortal outcom end treatment period day outcom assess mathew scale physician clinic judgement treatment control group match respect demograph data risk factor baselin mathew score treatment group patient die treatment period control group die mortal reduct signific neurolog impair end treatment period document nimodipin treatment impair improv patient moderatesever stroke baselin mathew score administr nimodipin occur hour stroke onset patient year incid advers reaction modest minor sever remot relat studi medic"
"sleep disturb survivor nazi holocaust object method sleep disturb common report victim extraordinari stress persist decad studi design test hypothesi survivor nazi holocaust signific sleep problem depress healthi comparison subject sever survivor problem correl length time spent concentr camp forti survivor depress patient healthi subject age live communiti sleep pattern preced month pittsburgh sleep qualiti index rate instrument inquir qualiti latenc durat effici disturb sleep sleep medic daytim dysfunct result survivor signific greater sleep impair healthi comparison subject measur subscal index impair depress patient sleep disturb daytim dysfunct subscal specif item subscal survivor signific frequent awaken due bad dream loss enthusiasm depress subject sleep disturb frequenc nightmar signific posit correl durat survivor intern concentr camp conclus find suggest holocaust survivor impair sleep frequent nightmar problem year liber"
"largescal neurocognit network distribut process attent languag memori cognit comport subserv interconnect neural network highlevel comput architectur includ parallel distribut process cognit problem resolv sequenti hierarch progress predetermin goal simultan interact multipl possibl constraint satisfactori fit achiev result textur mental activ character infinit rich flexibl model complex behavior map level multifoc neural system specif anatom site give rise brainbehavior relationship local distribut network anatom address channel transfer inform content chemic address pathway modul behavior tone approach blueprint reexplor neurolog foundat attent languag memori frontal lobe function"
"impair sequenc memoryguid saccad supplementari motor area lesion paradigm saccad record electrooculograph patient infarct affect left supplementari motor area saccad made visual target visuallyguid saccad antisaccad normal patient memoryguid saccad made rememb posit flash occur preserv patient slight impair sequenc memoryguid saccad sever impair patient previous report supplementari motor area play import role program sequenti limb movement data suggest area play similar role control sequenti eye movement"
"brain ph head injuri imageguid magnet reson spectroscopi studi suggest brain acidosi follow head trauma therapi aim correct acidosi propos direct measur intracellular ph clinic situat studi intracellular brain ph patient head injuri glasgow coma score patient investig combin approach phosphorus magnet reson spectroscopi magnet reson imag examin time min time day injuri hour day spectra obtain patient assist ventil patient spontan ventil spectra analyz yield ph region studi patient ph valu normal alkalot rang compar agematch normal control differ found patient assist ventil patient spontan ventil analyz group brain ph focal lesion increas day reach peak alkalot rang week return normal week acut injuri result suggest evid posttraumat intracellular brain acidosi recent human head injuri therapi aim alkalin brain cell reconsid"
"magnet motorevok potenti epilepsi effect diseas anticonvuls medic magnet motorevok potenti record patient medic intract tempor lobe epilepsi compar potenti healthi volunt motorevok potenti reevalu patient substanti reduct antiepilept drug dose object assess effect epilepsi anticonvuls medic central motor system subject receiv antiepilept treatment cortic threshold intens mark elev peripher latenc prolong cortic threshold intens peripher latenc decreas approach control valu anticonvuls medic reduc increas patient treat anticonvuls agent addit high level interict epileptiform activ high frequenc seizur signific decreas central motor conduct time part threshold intens central motor conduct time diminish reduct anticonvuls treatment increas drug administ durat epilepsi locat epilept focus type epilept seizur affect motorevok potenti conclus central motor pathway endogen facilit epileptiform activ clinic sign involv absent anticonvuls medic exert major revers effect magnet motorevok potenti"
"follow studi intract seizur childhood hundr forti children seizur refractori medic therapi year year onset major children uncontrol seizur mental retard onset seizur younger year age age onset signific yr sem group children borderlin normal intellig follow data show remiss seizur signific proport children borderlin normal intellig linear decreas percentag persist seizur rate year remiss seizur frequent yr group mental retard seizur type effect outcom children focal atroph brain lesion wors defin patholog brainimag studi"
"relationship clinic featur psycholog status primari fibromyalgia clinic featur psycholog status determin minnesota multiphas person inventori mmpi patient primari fibromyalgia syndrom pfs analyz univari multivari techniqu determin clinic featur relat psycholog status intrins pfs se central featur pfs number pain site number tender point fatigu poor sleep independ psycholog status discrimin analysi identifi variablespatientreport depress anxieti stress pain sever predict mmpi subgroup accuraci musculoskelet featurepain sever provid accuraci greater data suggest concept central featur fibromyalgia independ psycholog status relat pfs pain sever influenc psycholog factor"
"brain death organ donat neurosurg unit audit recent practic object assess potenti increas yield donor compar current pattern brain death organ donat neurosurg unit report recent nation audit designretrospect review death prospect data set region neurosurg unit serv million popul result death patient die ventil discontinu ventil medic contraind donat found patient test brain death patient die ventil test patient longer ventil consent donat sought medic suitabl brain dead patient grant half permiss multiorgan donat kidney remov conclus organ lost owe transplant team logist failur seek consent relat brain dead patient estim size pool potenti donor depend type patient consid ensur die ventil test brain death potenti donat withdraw ventil yield donor ventil patient hopeless brain damag secur donor rais ethic econom issu"
"treatment fulmin hepat failur insulin glucagon random control trial insulin glucagon therapeut modal investig treatment fulmin hepat failur fhf complet random control trial insulin glucagon patient fhf viral toxin exposur control treatment group consist patient differ signific etiolog admiss laboratori valu mortal signific control treatment group time random death discharg signific group peak level alphafetoprotein statist higher survivor nonsurvivor conclud type error exist combin insulin glucagon treatment fhf"
"analges studi treatment patient migrain prior attend citi london migrain clinic eighti unselect patient attend citi london migrain clinic time drug intak altern treatment thirti question regular daili dose medic fifteen combin drug bought counter otc drug prescrib gp eleven otc drug prescript drug notic drug prescrib gp obtain counter group drug singl type thirti altern treatment attack"
"vasospasm contribut monosodium glutamateinduc headach consumpt monosodium glutam long consid precipit headach suscept patient studi direct effect glutam metabolit glutamin arteri contractil examin ring rabbit aorta high concentr glutam caus signific concentrationdepend contract ec maximum tension mg wt tensionmg tissu agonist antagonist alphaadrenerg histaminerg serotonerg cholinerg gabanerg receptor inhibit prostaglandin synthesi fail influenc glutam contract high concentr calcium channel blocker verapamil inhibit glutam respons glutam glutamin exhibit concentr depend relax norepinephrin ne phenylephrin pe histamin serotonin ht prostaglandin alpha pgf alphainduc contract kainic acid agonist subpopul central glutam receptor potenti glutamateinduc vasoconstrict higher concentr produc irrevers inhibit glutam contractil central glutam receptor antagonist ketamin induc revers concentr depend inhibit glutamateinduc contract glutam contractil depend extracellular calcium intact endothelium neuron function result demonstr direct effect glutam peripher arteri tone dietari consumpt larg quantiti msg repres health hazard individu preexist vascular diseas"
"blink reflex cluster headach investig involv trigemin system cluster headach twelv subject electricallyelicit blink reflex symptomat period examin eleven case amplitud contralater respons symptomat side signific lower stimulus intens asymptomat side blink reflex evalu biolog druginduc phenomena cluster headach"
"assess treatment children headach development perspect childhood headach common pediatr problem clinic research evalu behavior treatment biofeedback relax train viabl intervent ad development perspect evalu treatment childhood headach increas effect strategi paper present development issu relat assess treatment childhood headach major area develop examin impact area treatment assess headach discuss major area cognit develop regul psychosoci develop provid practic suggest applic child develop principl assess intervent practic development"
"health status patient tension headach treat acupunctur physiotherapi sixti femal patient chronic tension headach random divid treatment groupsacupunctur physiotherapi function sick impact profil mental mood adject check list intens frequenc headach assess treatment treatment patient show signific dysfunct posit mental general popul sampl treatment group improv function physiotherapi group mental increas physiotherapi group intens frequenc headach signific reduc physiotherapi group acupunctur group intens headach signific improv physiotherapi group improv headach intens persist unchang month treatment"
"nocturn sleep record cassett eeg chronic headach headach patient complain poor sleep sleep disturb shown play role chronic pain record nocturn sleep channel cassett eeg monitor devic common migrain patient individu muscl contract tension headach chronic tensionvascular headach suffer migrain patient essenti normal sleep rapid eye movement rem sleep rem latenc increas patient tension headach reduc sleep time sleep effici decreas sleep latenc frequent awaken increas nocturn movement mark reduct slow wave sleep chang rem sleep latenc mixedel headach tension vascular featur reduc sleep increas awaken diminish slow wave sleep rem sleep decreas amount reduc latenc find suggest patient intermitt migrain minim sleep disturb chronic headach worsen chronic poor sleep muscl contract headach frequent awaken decreas slow wave sleep similar sleep fibros chronic tensionvascular headach depress substrat channel sleep record miss contributori sleep apnea nonetheless cassett eeg facilit outpati evalu refractori headach"
"conting negat variat migrain conting negat variat cnv eventrel slow potenti record healthi volunt patient suffer migrain aura cnv cnv foreperiod forewarn reaction time task cnv record vertex cnv record multipl electrod site assess topograph differ twelv migrain patient aura increas cnv amplitud cnv amplitud increas electrod posit fz cnv analysi earli late cnv compon improv discrimin migrain aura cnv migrain aura cnv paramet control level confirm previous result data obtain discuss term arous activ stress biobehavior model migrain welch"
"centrifug intens durat countermeasur soleus muscl atrophi mechan acceler countermeasur employ prevent atrophi slowtwitch muscl weight bear present studi daili centrifug rat durat gravit intens test mechan acceler amelior atrophi soleus muscl induc weight bear tailtract model soleus muscl atrophi day weight bear countermeasur centrifug treatment complet prevent atrophi relat precontrol wet weight soleus muscl weightbear group receiv daili treatment atrophi observ weightbear group compar precontrol group evid obtain centrifug effect exposur countermeasur weightbearinginduc atrophi soleus muscl"
"effect carotid denerv decerebr ventilatori respons clarifi mechan involv ventilatori respons inhal low concentr air role arteri chemoreceptor forebrain structur investig unanesthet adult cat ventilatori respons observ conscious anim intact carotid denerv cd midcollicular decerebr result show initi small ventilatori depress unaffect cd subsequ characterist tachypnea blunt cd prolong exposur tachypnea observ decerebr residu hyperventil note higher concentr conclud carotid chemoreceptor mediat tachypnea origin suprapontin structur shown comparison intact decerebr anim blunt tachypnea cd caus relat hypercapnia observ cd anim residu hyperventil observ decerebr anim caus central acidosi peripher potenti chemoreceptor activ result decreas arteri blood pressur accompani inhal decerebr anim"
"florid refractori schizophrenia turn treatabl variant hla narcolepsi narcolepsi hallucinatori compon unusu promin lead develop ill indistinguish schizophren syndrom psychot symptom domin symptomatolog primari ill obscur patient convent antipsychot drug ineffectu treatment stimul produc substanti improv diagnosi narcolepsi confirm human leukocyt antigen type sleep laboratori test result support rem intrus hypothesi causat schizophrenia seri schizophren patient implic diagnosi treatment discuss"
"neurotox action veratridin rat brain neuron cultur mechan neuroprotect ca antagonist nonselect slow ca channel effect ca antagonist local anesthet neuron cell degener induc veratridin studi primari rat brain neuron cultur cell death quantifi measur lactat dehydrogenas ldh releas cultur medium neuron cell degener cadepend absenc extracellular ca hr exposur microm veratridin fail produc releas ldh ca antagonist nonselect slow ca channel flunarizin cinnarizin lidoflazin prenylamin bepridil inhibit veratridineinduc releas ldh ic valu microm ca antagonist select slow ca channel potent inhibit veratridineinduc releas ldh concentr order potenc nicardipin greater gallopamil verapamil greater niludipin greater nitrendipin greater nifedipin greater nimodipin greater diltiazem test local anesthet incomplet inhibitor veratridineinduc releas ldh good correl found potenc drug inhibit releas ldh induc microm veratridin neuron cultur bind affin batrachotoxin bind site na channel rat cortex synaptosom prepar conclud protect veratridineinduc neurotox mediat block veratridinesensit na channel properti nonselect ca antagonist appar direct relationship ca antagonist activ effect unrel local anesthet activ"
"central adenosinerg system involv ethanolinduc motor incoordin mice clarifi behavior interact ethanol adenosin report previous occur central due peripher hemodynam chang effect adenosin agonist nphenylisopropyladenosin pia nphenylisopropyladenosin cyclopropylcarboxamidoadenosin antagonist theophyllin sulfophenyltheophyllin enprofyllin ethanolinduc motor incoordin evalu rotorod adenosin agonist antagonist dose depend accentu attenu ethanolinduc motor incoordin suggest central mechan adenosin modul effect ethanol confirm previous report adenosin agonist antagonist enprofyllin weak adenosin antagonist potent inhibitor cyclic amp phosphodiesteras alter ethanol motor incoordin support involv brain adenosin receptor mechan ethanoladenosin interact result pia nphenylisopropyladenosin experi show fold greater potenc diastereoisom suggest predomin adenosin subtyp cyclopropylcarboxamidoadenosin data complex mechan point addit involv unknown subtyp adenosin effect ethanol blood brain level hpia note suffici amount enter brain suggest adenosin receptor activ adequ produc behavior interact ethanol escap administ hpia brain peripher circul rule peripher support central mechan ethanoladenosin interact"
"interact methylaspart cgs administ intramuscular intracerebroventricular pigeon behavior effect methylaspart nmda competit nmda antagonist cisphosphonomethylpiperidinecarboxyl acid cgs studi pigeon nmda decreas respond fixedratio schedul food present time potent administ intracerebroventricular compar intramuscular cgs time potent produc catalepsi administ durat catalepsi similar rout administr administ cgs decreas respons rate dose produc catalepsi administ dose cgs decreas respond produc behavior effect ratedecreas effect nmda attenu cgs cgs administ antagon nmda ratedecreas effect nmda attenu  cgs dose produc catalepsi elimin respond larg differ potenc  administr nmda cgs slower onset catalepsi cgs administ suggest compound readili cross bloodbrain barrier administ parenter inabl cgs attenu ratedecreas effect nmda cgs nmda administ suggest nmda decreas respond mechan administ  pigeon result antagon nmda studi studi nmda cgs administ parenter result peripher mediat interact agonistantagonist interact simpl competit antagon"
"mechan restraint resid skill nurs facil preval pattern predictor pattern risk factor mechan restraint determin skill nurs facil restraint resid begin studi remain resid restrain follow year facil characterist restraint resid characterist independ initi restraint older age disorient depend dress greater particip social activ nonus antidepress unsteadi disrupt behavior agit wander frequent cite reason initi restraint"
"respons treatment antihistamin famili myotonia congenita famili myotonia congenita found generat greatgrandpar index case affect subsequ generat mild sever affect case segreg parallel line famili grandmoth index case note improv antihistamin index case prescrib trimeprazin show strike reduct sever symptom antihistamin deserv evalu safe effect treatment myotonia congenita"
"transcrani doppler acut hemispher brain infarct studi cerebrovascular anatomi intraarteri digit angiographi blood flow veloc middl cerebr arteri mca transcrani doppler tcd ultrasonographi patient acut hemispher ischem brain infarct compar angiographi tcd clinic find hour onset symptom locat extent chronic ischem brain damag assess ct perform month ictus abnorm tcd manifest unobtain mca flow signal signific depress mca flow veloc high proxim mca occlus demonstr angiographi abnorm tcd predict larger chronic ct lesion extens ischem chang mca territori data demonstr earli tcd convey inform cerebr tissu prognosi hemispher ischemia"
"pseudospast guillainbarr syndrom report woman guillainbarr syndrom develop flexion postur arm hand resembl upper motor neuron dysfunct emg demonstr involuntari peripher generat continu motor unit discharg caus postur"
"suppress carbamazepineinduc rash prednison report experi patient develop rash short introduct carbamazepin treat prednison antihistamin sixteen patient success continu carbamazepin discontinu drug"
"handcuff neuropathi compress neuropathi due tight applic handcuff occur patient superfici radial nerv affect hand median nerv neurolog deficit persist long year handcuf nerv conduct studi exclud maling diagnos patient intox handcuf arrest forc handcuff mechan accident overtighten applic unrecogn factor neuropathi"
"mesencephal cholinerg nuclei progress supranuclear palsi antibodi cholin acetyltransferas chat mesencephal cholinerg cell nuclei studi autopsi materi case progress supranuclear palsi psp control chatimmunoreact neuron quantifi section span rostrocaud extent nucleus psp signific decreas number neuron detect immunoreact chat adjac central gray substanc nuclei nucleus edingerwestph rostral interstiti nucleus medial longitudin fasciculus interstiti nucleus cajal cell loss evid group neuron found deep layer superior colliculus contrast estim number chatimmunoreact cell bodi cranial nerv iii iv mesencephal reticular format parabigemin nucleus control result compat notion psp region select destruct cholinerg neuron"
"central nervous system involv von hippellindau diseas fifti individu von hippellindau diseas vhl studi gadoliniumenhanc magnet reson imag mri determin frequenc distribut cns lesion clinic featur review thirti cns tumor frequent affect site cns exclud retina cerebellum spinal cord brainstem region predilect craniocerv junction conus medullari demonstr studi forti percent vhl patient cns tumor neurolog asymptomat cerebellar tumor spinal cord tumor brainstem tumor clinic sign symptom multipl lesion common age vhl patient year similar age cns vhl patient year suggest lack age associ cns lesion common occur decad life patient risk vhl evalu gadoliniumenhanc mri year age ophthalm examin initi st year life enhanc mri detect cns tumor patient vhl gene"
"prognost studi cervic myelopathi evok spinal cord potenti hundr twenti case cervic spondylot ossif posterior longitudin ligament opll myelopathi case long tract sign subject surgic treatment studi identifi import factor influenc postop outcom evok spinal cord potenti escp disappear posit wave potenti level respons lesion slow conduct veloc unsatisfactori outcom localizedles case diagnos escp excel result signific extensiveles case oper method case found local lesion show extens lesion differ csm opll opll csm demonstr extens lesion"
"cerebr blood flow oxygen metabol patient vascular dementia binswang type perform clinic neuroradiolog studi includ positron emiss tomographi patient vascular dementia binswang type clinic featur case consist slowli progress dementia vascular risk factor hypertens histori minor stroke characterist white matter lesion brain comput tomogram magnet reson imag digit subtract angiographi cervic intracrani arteri demonstr occlus lesion patient cerebr blood flow cerebr metabol rate oxygen mark reduc white matter control valu decreas pariet control frontal tempor cortic abnorm detect brain comput tomographi magnet reson imag conclud vascular dementia binswang type caus disconnect cerebr cortex subcort structur due ischem damag white matter"
"open trial highdosag antioxid earli parkinson diseas high dosag tocopherol ascorb administ patient earli parkinson diseas preliminari openlabel trial eventu control doubleblind studi evalu antioxid test endogen toxin hypothesi etiolog parkinson diseas primari endpoint trial treat patient levodopa time levodopa treat patient compar group patient antioxid time levodopa extend group antioxid result pilot studi suggest progress parkinson diseas slow administr antioxid larg multicent control clinic trial underway north america evalu tocopherol deprenyl potenti confirm result"
"chromosom breakpoint probe mark cm region encompass fragil locus fraxa report valid cell hybrid panel rapid physic local dna probe vicin fragil locus fraxa region defin panel lie dxs dxs closest genet marker flank fraxa interest region distal dxs defin probe dxs polymorph probe st dxs dxs kb detect taqi rflps combin inform probe clone irradiationreduc hybrid line polymorph probe dxs heterozygos probe map dxs region proxim chromosom breakpoint correspond hunter syndrom locus id physic order cendxsdxsdxsdxsdx dxsidsdxstel perform linkag analysi marker centr etud du polymorphism humain famili larg set fragil famili establish dxs distal fraxa relat posit dxs dxs respect fraxa remain uncertain result place genet halfway dxs dxs dxsdxs cluster defin present closest proxim closest distal polymorph marker respect fraxa polymorph probe combin heterozygos repres major improv genet analysi fragil famili diagnost applic"
"identif high polymorph microsatellit vntr argininosuccin synthetas locus exclus dystonia gene doparespons dystonia larg kindr doparespons dystonia clinic variant idiopath torsion dystonia distinguish form dystonia frequent occurr parkinson diurnal fluctuat symptom dramat therapeut respons dopa linkag gene caus classic dystonia larg jewish kindr dyt group ashkenazi jewish famili gelsolin gsn argininosuccin synthetas ass loci chromosom recent determin report discoveri high inform gt repeat vntr polymorph ass locus analysi larg kindr doparespons dystonia polymorph convent rflps region exclud loci region form dystonia proof genet heterogen classic idiopath torsion dystonia doparespons dystonia"
"sudden cervic pain spontan cervic epidur hematoma case cervic epidur hematoma report acut neck pain mild effort close radicular pain neurolog deficit lesion typic present extrem rare difficult diagnosi prognosi depend preoper neurolog state author emphas import prompt identif lesion diagnosi confirm comput tomographi emerg neurosurg laminectomi mandatori"
"unconsci midazolam erythromycin yr boy suffer asymptomat ventricular septal defect erythromycin antibiot prophylaxi adenoidectomi sixti minut premed oral midazolam mg kg oral atropin mg kg infus erythromycin mg start mg erythromycin infus patient lost conscious vital function remain normal min awaken spontan time plasma concentr midazolam ng ml order investig interact midazolam erythromycin studi pharmacokinet midazolam children age undergo minor otolaryngolog surgeri plasma concentr midazolam patient lost conscious signific greater children concomit administr erythromycin alter pharmacokinet midazolam result reduc hepat clearanc midazolam caus enzym inhibit drug erythromycin"
"radiosurgeri acoust neurinoma eighti patient acoust neurinoma underw stereotact radiosurgeri gamma unit univers pittsburgh pittsburgh pa month oper neuroimag studi perform patient year follow show tumor smaller unchang larger year actuari rate preserv hear hear previous undetect neuropathi trigemin facial nerv occur week year radiosurgeri median month improv median interv month onset hear loss signific increas averag tumor diamet deterior cranial nerv function develop patient averag tumor diamet mm radiosurgeri import treatment altern select acoust neurinoma patient"
"effect discontinu phenytoin carbamazepin valproat concomit antiepilept medic report prospect control studi effect reduct discontinu phenytoin pht patient carbamazepin cbz patient valproat vpa patient concomit antiepilept drug princip serum concentr concomit phenobarbit pb concentr decreas discontinu pht total cbz concentr increas free cbz concentr increas discontinu pht chang cbz epoxid cbz concentr vpa concentr increas discontinu pht vpa concentr increas discontinu cbz ethosuximid esm concentr increas discontinu cbz pht concentr decreas discontinu cbz pht free fraction decreas discontinu vpa concentr total free cbz increas vpa discontinu concomit decreas total cbz decreas free cbz decreas pb concentr pht discontinu signific occur week end discontinu implic clinic practic serum concentr time reflect steadi state free concentr add clinic inform gain analysi total serum concentr"
"cognit function timeday variat serum carbamazepin concentr epilept patient treat monotherapi paramet antiepilept drug treatment shown affect cognit function drug dose durat treatment studi present studi assess cognit function relat timeday variat serum carbamazepin cbz concentr epilept patient treat monotherapi studi male femal age year durat cbztherapi year patient seizurefre month daili cbz dose test batteri includ test motor speed reaction time attent memori experiment design subject test time close expect daili maximum minimum serum cbz concentr studi balanc block block test noon block test noon blood sampl collect hr  subject show signific differ serum cbz concentr test time suggest maximum concentr noon test batteri show consist differ perform time high versus low serum concentr supplementari analysi correl perform level cognit test variabl relat cbz treatment show consist trend"
"immunolog aspect carbamazepin treatment epilept patient immun abnorm found epilept patient receiv antiepilept drug phenytoin pht produc decreas serum iga igm level decreas blastic transform circul lymphocyt stimul phytohemoagglutinin pha effect carbamazepin cbz immun respons conflict elucid effect cbz immunolog paramet serum concentr iga igg igm phagocytosi kill properti polymorphonuclear leukocyt pmns cytotox activ natur killer cell respons lymphocyt mitogen agent studi forti healthi individu epilept patient treat carbamazepin cbz monotherapi age rang year enter studi student test evalu data cbz effect serum immunoglobulin concentr lymphocyt reactiv phytohemoagglutinin pha mitogen cbz produc signific enhanc phagocytosi kill properti pmns increas natur killer nk cell activ negat effect cbz therapi immun system observ studi"
"effect felbam plasma level carbamazepin metabolit felbam fbm antiepilept drug undergo clinic evalu unit state control clinic trial conduct nation institut health clinic center fbm ad constant carbamazepin cbz monotherapi cbz total concentr reduc activ fbm treatment reduct rang effect evid week treatment reach plateau week clarifi interact mechan free total concentr cbz plasma metabolit determin highperform liquid chromatographi hplc ultrafiltr patient patient fbm treatment reduc cbz concentr increas cbzepoxid cbz concentr free fraction compound unmodifi fbm capabl induc cbz metabol cbzfbm interact clinic relev"
"doubleblind placebocontrol cross trial progabid add therapi epilept patient doubleblind cross trial progabid pgb placebo compar add therapi patient moder sever epilepsi patient complet studi advers drug reaction elev liver transaminas gastriti acut psychosi administr reason remain patient seizur frequenc reduc greater patient pgb treatment patient placebo number day seizur signific reduc pgb treatment patient physician prefer end trial favor pgb mild clinic side effect present patient treat pgb placebo increas liver transaminas observ patient doubleblind studi follow period data show pgb previous report patient respond complet antiepilept drug compound toler liver function monitor"
"develop revers conting inefficaci toler anticonvuls effect carbamazepin relationship time drug administr anticonvuls efficaci amygdala kindl seizur studi kindl develop rat receiv carbamazepin cbz mgkg cbz amygdala stimul cbz kindl full seizur anim cbz stimul cbz group show good anticonvuls respons rat receiv cbz develop kindl seizur remain unrespons cbz treatment conting inefficaci drugnaiv cbz anim repeat receiv cbz electr stimul develop toler anticonvuls effect conting toler toler revers period treatment cbz kindl anim drugfre cbz administr time drug seizur find suggest inefficaci toler cbz affect tempor conting drug administr respons reinstat alter conting"
"kindl suscept genet seizur predisposit inbr mice olfactori bulb kindl rate studi inbr strain genet seizurepron mice dba el epilept inbr strain cbl ddi ch ch dba mice stimul seizur kindl mice studi week age develop spontan movementinduc seizur activ el strain audiogen seizuresuscept dba mice requir fewest number stimul reach stage seizur se nonepilept ch mice requir stimul reach stage seizur kindl rate el ddi strain intermedi kindl rate strain signific strain find show seizuresuscept el mous kindl rapid genet similar nonepilept ddi control suggest inherit seizur suscept acceler kindl rate nonepilept mice kindl rapid el mice suggest genet factor influenc seizur suscept primari import determin kindl rate"
"hippocamp glucos util subsequ amygdaloidkindl general seizur local cerebr glucos util postict phase amygdaloidkindl general seizur studi quantit autoradiograph cdeoxyglucos method conscious rat measur initi termin behavior seizur gs seizur termin gsii determin dynam metabol postict phase glucos util neocortex remark depress gs gsii hippocampus signific increas gs decreas gsii compar control hippocamp glucos util observ sector pyramid cell layer ca molecular layer metabol develop amygdaloidkindl seizur begin limbic structur includ hippocampus transient increas hippocamp glucos util observ earli postict phase hippocampus key structur initi maintain termin kindl seizur"
"panic disord seizur patient diagnost pitfal panic disord psychiatr diagnosi main featur paroxysm attack anxieti strike sudden appar provoc physician explain attack ictal phenomenon patient seizur similar complex partial seizur report patient seizur panic disord recognit diagnost entiti result benefici chang treatment find increas incid panic disord seizur clinic popul compar general popul"
"effect epilepsi sleep depriv rate benign epileptiform transient sleep seventi individu eeg record benign epileptiform transient sleep bet identifi record review laboratori year period record abnorm patient genuin epileptiform discharg found record patient histori epilepsi thirti patient proven histori epilepsi antiepilept drug therapi record patient number bet unit time signific higher record rest laboratori popul bet convent surfac montag ipsilater ear referenti montag ierm show signific higher number bet unit time surfac montag studi thirti record perform sleep depriv sd ierm consid sd record show signific higher number bet unit time sd record find support general consensus individu bet normal variant high occurr bet record rais suspicion epilepsi"
"dream epilepsi relationship dream epilepsi illustr patient awak epilept seizur recurr dream night sleep similar content case eeg show anterior tempor spike discharg suggest role tempor lobe associ dream seizur"
"epilepsi continu spikewav slow sleep treatment children epilepsi continu spikewav slow sleep csws report main clinic featur csws includ onset year age occurr type seizur partial motor general motor atyp absenc presenc languag disturb abnorm behavior base emot impair eeg find character sleep trace show continu greater diffus slow spike wave activ treatment valproat vpa ethosuximid esm clonazepam czp spike wave complex status disappear symptom sign csws decreas suggest combin treatment treatment csws"
"sexual behavior sampl femal epilepsi sampl femal epilept outpati examin incid psychosexu disord epilept femal psychosexu disord compar epilept femal sexual disord normal femal control select clinic eeg paramet epilept femal sexual disord show lower marriag rate longer durat ill sexual color prodromata predomin partial complex seizur higher incid menstrual abnorm hyposexu exhibition psychosexu disord frequent note tempor lobe eeg abnorm signific higher"
"attitud major employ employ peopl epilepsi year studi begin major san francisco bay area employ sampl year interv year period assess attitud employ epilept worker time document trend sustain posit chang valid effort organ focus rais public awar disord"
"antiepilept drug monitor epilepsi clinic prospect evalu assess site therapeut drug monitor epilepsi clinic manag decis record immedi antiepilept drug concentr year prospect studi carbamazepin cbz phenytoin pht valproat vpa phenobarbit pb assay perform clinic attend activ manag epilept patient result drug analysi led alter manag patient visit monitor dosag increas respons circul concentr consult decreas unsuspect poor complianc uncov patient ad discontinu basi assay result time appoint rearrang attend result therapeut rang major dosag adjust low result therapeut level chang dose concentr therapeut rang persuad doctor alter dosag regimen increas dose recommend site monitor impact clinic decisionmak greater consult form subtl simpl quest therapeut result"
"effect lactulos lactitol protein digest metabol convent germ free anim model relev result treatment portosystem encephalopathi protein digest metabol studi laboratori rat miniatur pig investig mechan action lactulos lactitol treatment patient portosystem encephalopathi lactulos betagalactopyranosylbetafructofuranos lactitol betagalactopyranosylglucitol increas excret nitrogen materi faec decreas nitrogen excret urin similar degre report human patient studi germ free rat lactulos effect observ suggest lactulos effect mediat gut flora measur alpha epsilondiaminopimel acid content faec confirm enhanc faecal nitrogen due increas contribut bacteria similar result lactulos lactitol suggest perspect protein metabol lactitol act similar lactulos treatment portosystem encephalopathi"
"relat pain depress institution age nurs home congreg resid classifi basi dsmiiir symptom checklist suffer major minor depress complet geriatr depress scale gds profil mood state pom major depress report intens pain greater number local pain complaint minor depress nondepress individu report intens pain fewest local complaint effect remain strong function disabl health status control statist pain intens number local complaint correl gds pom factor score strength direct associ vari level depress itemitem examin local complaint depress individu report pain physician identifi physic problem account pain result compar previous research pain younger individu implic treatment depress elder discuss"
"oestrogen progesteron receptor acoust neuroma tissu sampl fourteen consecut male femal acoust neuroma assay hormon receptor monoclon antibodi ma dextran coat charcoal dcc isoelectr focus ief techniqu seri unequivoc posit result find varianc previous publish result"
"effect nicardipin somatosensori evok potenti patient acut cerebr infarct evalu effect nicardipin calcium channel blocker somatosensori evok potenti sep patient acut cerebr infarct post treatment latenc prolong affect hemispher shorten chang latenc signific prolong hour post treatment affect hemispher nicardipin ni effect sep compon intact hemispher seventi cent patient hypertens decreas blood pressur bp nicardipin undesir side effect worsen neurolog sign studi demonstr nicardipin prolong latenc shortlat compon sep affect hemispher acut ischaem stroke decreas bp observ suggest nicardipin therapi impair neuron function ischaem zone"
"platelet monoamin oxidas activ parkinsonian patient monoamin oxidas mao play pivot role methylphenyltetrahydropyridin mptp induc parkinson increas mao activ platelet patient idiopath parkinson diseas pd report studi possibl high mao activ repres trait vulner pd enhanc neurotox effect environment compound discuss"
"specif affect autonom symptom depress parkinson diseas previous investig suggest numer symptom diagnos depress sleep appetit disturb specif medic ill patient altern diagnost criteria develop studi hypothesi test parkinson diseas pd compar patient pd report depress mood patient pd depress mood depress patient show signific higher frequenc autonom affect symptom depress depress patient pd report signific higher frequenc worri brood loss interest hopeless suicid tendenc social withdraw depreci idea refer anxieti symptom loss appetit initi middl insomnia loss libido compar depress patient signific group differ observ frequenc anergia motor retard earli morn awaken"
"neurophysiolog observ corticospin project upper limb subject rett syndrom aim present studi investig excit corticospin neuron integr project alpha motor neuron corticospin tract subject age rett syndrom electromagnet stimul motor cortex cervic motor root evok motor action potenti bicep brachii hypothenar muscl phasic stretch reflex bicep brachii record studi excit spinal alpha motor neuron motor cortex stimul evok motor action potenti low threshold abnorm short latenc prolong durat contrast cervic motor root stimul result respons normal latenc durat phasic stretch reflex low threshold short latenc prolong durat conclud rett syndrom corticospin pathway intact result suggest disord synapt control betz cell motor cortex spinal alpha motor neuron involv consequ dysfunct supraspin descend motor pathway"
"stroke rehabilit australian patient profil function outcom prospect multiinstitut popul base studi identifi surgic stroke admiss hospit major australian citi demograph diagnost profil natur function recoveri stroke survivor refer inpati rehabilit present median durat rehabilit stay day function independ score measur modifi barthel index admiss compar discharg improv stair climb lowest admiss bowel control lowest residu deficit discharg stroke studi group repres unimpair age popul respect ethnic differ attribut age variabl identifi signific side sever paralysi age sex marit status ethnic stroke rehabilit outcom influenc etiolog site lesion arteri distribut occup educ"
"status cochlear implant children american academi otolaryngologyhead neck surgeri subcommitte cochlear implant cochlear implant medic devic part surgic electr stimul provid hear decad investig studi ongo defin safeti efficaci profound deaf children period children age year implant singleelectrod multielectrod devic extens auditori speech educ psycholog test perform implant result show cochlear implant auditori detect speech signal compar preimplant period signific improv auditori discrimin speech product skill limit openset word sentenc recognit children complic devic minim cochlear implant provid sound deaf children unabl benefit hear aid complex assess rehabilit parent counsel perform center multidisciplinari staff provid effect care patient special auditori prosthesi"
"phenotyp variabl glutar aciduria type report fourteen case canadian indian kindr describ patient glutar aciduria type canadian indian kindr live manitoba northwest ontario patient mark clinic variabl diseas famili typic clinic normal earli growth develop onset neurolog abnorm precipit infect week month age patient earli development delay thought normal year age patient die sever mental physic handicap mild mental retard incoordin patient macrocephali neonat period comput tomographi patient find abnorm glutar acid hydroxyglutar acid detect increas amount urin patient concentr lower report patient glutaryl coenzym dehydrogenas activ skin fibroblast interleukindepend lymphocyt rang control valu correl clinic sever urin glutar acid concentr level residu enzym activ recommend organ acid analysi urin patient unexplain cerebr palsi disord comput tomograph scan abnorm suspicion glutar aciduria glutarylcoenzym dehydrogenas measur fibroblast lymphocyt glutar acid increas urin"
"manag midfac fractur intracrani injuri recent advanc radic chang manag facial fractur ct scan extens exposur rigid plate fixat set trauma center permit earli oper improv result subset patient facial fractur intracrani injuri ici sought identifi paramet increas risk ici sought examin safeti limit earli craniofaci repair patient intracrani injuri midfac fractur treat year period concomit ici major motor vehicl accid mva frontal sinus orbitoethmoid fractur highest risk ici orbitozygomat fractur caus mvas surpris high incid ici result show earli craniofaci repair perform safe general surgic neurosurg support"
"feasibl revers benzodiazepin toler flumazenil examin benzodiazepin antagonist flumazenil revers toler benzodiazepin precipit withdraw seizur antiepilept effect flumazenil abil revers toler dose leav suffici receptor free bind benzodiazepin investig electroencephalograph studi patient partial generalis seizur show flumazenil short min dosedepend suppress effect epilept discharg partial seizur receptor occup studi patient show mg flumazenil intraven occupi receptor mg occupi receptor patient partial seizur toler clonazepam mg flumazenil seizurefre day inject intermitt therapi benzodiazepin antagonist prevent revers toler benzodiazepin agonist investig"
"carpal tunnel syndrom correl pressur measur intraop electrophysiolog nerv studi carpal tunnel syndrom cts patient control subject cathet introduc carpal tunnel slowli retract mm step pressur measur continu infus techniqu group patient control median nerv antidrom sensori action potenti asap detect intraop stimul proxim center distal carpal tunnel record finger sensori conduct veloc scv asap amplitud consid ss ss segment intracarp tunnel pressur signific higher cts patient control highest valu locat mm distal proxim border flexor retinaculum scv asap amplitud decreas distal part ss carpal tunnel"
"vector shortlat somatosensoryevok potenti median nerv stimul method develop record shortlat somatosensoryevok potenti median nerv stimul negat electr forc record orthodiagon bipolar electrod neck direct opposit impuls conduct proxim peripher cervic somatosensori pathway sequenti trace vector opposit electr forc made dimension display reproduc actual time sequenc electr event structur fix generat subcort nuclei analyz techniqu multipl generat potenti na nb visual techniqu function evalu somatosensori pathway cervic cord"
"pain shoulder part extrins disord shoulder disord common manifest pain limit function care histori examin physician local problem shoulder joint surround tissu adjac site refer pain shoulder common extrins shoulder pain includ postur problem cervic spine disord"
"tabl estim individu risk fetal neural tube ventral wall defect incorpor prior probabl matern serum alphafetoprotein level ultrasonograph examin result tabl provid estim risk open spina bifida patient elev matern serum alphafetoprotein level normal result detail anatomi ultrasonograph scan risk provid prior popul risk level elev matern serum alphafetoprotein assumpt sensit ultrasonograph examin formula base sequenti multipl odd bay theorem arbitrari reduct power degre ultrasonograph inform modifi odd made nonindepend ultrasonographi matern serum alphafetoprotein test wide rang result risk show decis offer amniocentesi negat scan individu"
"relationship laparoscop find report pelvic pain assess batteri includ standard measur behavior psychosoci factor chronic pain condit administ women schedul laparoscop surgeri surgeon blind patient report pain data complet american fertil societi classif endometriosi adhes basi observ physic diseas american fertil societi classif score signific relat assign pain pain group extent physic diseas evalu procedur signific correl rate pain level number index impair group patient laparoscop diagnos patholog condit report higher pain level greater interfer group report pain negat laparoscop result women observ patholog condit report pain symptom"
"acut toler morphin analgesia continu infus singl inject rat studi aim determin declin analges effect morphin continu infus singl inject correl brain concentr morphin analges effect morphin brain serum concentr determin continu infus constant rate singl subcutan inject agent analges effect determin measur threshold motor respons noxious stimul brain serum concentr morphin detect radioimmunoassay ilabel morphin constantr mgkg intraven morphin infus peak analgesia maintain increas pain threshold decreas analgesia time brain morphin concentr tend increas ng ng singl morphin inject mgkg subcutan recoveri analgesia occur faster rate decreas morphin brain concentr decreas pain threshold min inject decreas brain concentr ns absenc correl analgesia morphin brain concentr constantr morphin infus singl inject suggest develop acut toler pharmacodynam natur"
"effect system medetomidin alpha adrenoceptor agonist experiment pain human effect system intraven medetomidin alpha adrenoceptor agonist pain threshold studi healthi human subject medetomidin produc dosedepend cumul dose microgram sedat effect evalu visual analog scale dosedepend decreas blood pressur heart rate administr medetomidin pain threshold electr stimul tooth pulp cutan heat pain threshold uninfluenc medetomidin index cutan thermal sensit innocu stimuli width thermoneutr zone uninfluenc medetomidin medetomidin produc signific attenu affectivemotiv compon unpleas tourniquetinduc ischem pain sensorydiscrimin compon pain magnitud estim ischem pain attenu result suggest system medetomidin subanesthet sedat hypotens dose signific influenc intens threshold experiment pain affectivemotiv compon pain attenu"
"pupilspar oculomotor nerv palsi due midbrain infarct vasculopath oculomotor nerv palsi pupillari spare thought due ischem damag nerv subarachnoid space cavern sinus present case patient isol pupilspar oculomotor nerv palsi due midbrain infarct focal ischem midbrain lesion consid case pupilspar oculomotor nerv palsi"
"initi therapi patient wilson diseas tetrathiomolybd patient wilson diseas present acut neurolog symptom clinic wors initi treat penicillamin anticopp drug therapi offer solut treatment problem develop evalu drug ammonium tetrathiomolybd purpos theoret tetrathiomolybd optim properti includ blockad copper absorpt properti form complex copper blood render copper nontox articl present result patient treat tetrathiomolybd week initi therapi patient present acut neurolog symptom worsen present method assay preliminari stabil studi method evalu therapeut end point respect copper metabol"
"cognit behaviour impair elder peopl institut provid level care object compar preval degre cognit behaviour impair elder patient institut provid level care design preval studi set nurs home home age psychogeriatr ward provinci psychiatr hospit patient subject year age older elig inclus random sampl select compris resid nurs home home age particip agre nurs home home age psychogeriatr ward agre particip main outcom measur miniment state examin mmse kingston dementia rate scale kdrs result mmse score cognit impair resid nurs home home age patient psychiatr hospit number kdrs score cognit impair patient receiv highest level care home age special care behaviour problem psychiatr hospit conclus cognit behaviour impair widespread institut level care plan servic alloc resourc govern fund agenc degre preval impair elder peopl institut"
"evolut energi expenditur nitrogen excret sever headinjur patient object aim studi estim influenc therapeut level energi expenditur ee excret homogen group patient consid hypermetabol design ee excret headinjur patient measur simultan phase patient treat day injuri set acut care hospit patient sever headinjur patient weight sd kg age sd yr intervent phase patient sedat fentanyl microgramskghr flunitrazepam microgramskghr mechan ventil patient receiv continu total parenter nutrit nonprotein calor intak averag kcalday includ glucos fat intralipid total intak averag day consist crystallin amino acid phase patient receiv sedat breath spontan tracheostomi patient receiv parenter enter nutrit nonprotein calor intak averag kcalday consist carbohydr fat total intak averag day measur main result ee signific higher phase phase kcal interindividu variabl low phase excret high period studi correl level ee rq period indic predomin fat oxid conclus demonstr parallel evolut ee protein catabol headinjur patient therapeut mechan ventil sedat nutrit major effect ee excret"
"noninvas cerebr optic spectroscopi monitor cerebr oxygen deliveri hemodynam object present algorithm noninvas measur cerebr oxygen satur cerebr oximetri cerebr hemodynam infrar spectroscopi design vitro correl oximetri measur refer measur illustr case hemodynam oximetr record set tertiari care neurosci icu patient braininjur patient prolong decreas level conscious chosen illustr exampl intervent channel multipl wavelength diffus infrar transmiss spectroscopi interfac scalp adhes transmiss data collect gross superficialdeep spatial resolut satur calcul base deep signal observ longitudin patient technolog arteri input cerebr respons function generat iv tracer bolus deconvolut measur cerebr transit time measur main result posit linear regress fit diffus transmiss oximetri measur blood oxygen satur rang note conclus approach overcom previous identifi difficulti cerebr oximetri demonstr excel vitro correl techniqu perform clinic difficulti simultan measur cortic transit time"
"individu differ children respons pain role tempera parent characterist sixti famili enlist studi explor factor distress behavior year children receiv diphtheriatetanuspertussi immun home visit month immun measur obtain behavior style questionnair measur tempera parent report medic relat attribut good patient parent attitud pain children respons child pain parent predict distress upcom immun child distress behavior immun evalu modif procedur rate scalerevis procedur child assess pain elicit oucher children procedur rate scalerevis score thirti low equal high distress score greater equal sd factor posit correl distress behavior includ difficult child cluster characterist individu temperament dimens adapt parent attitud attribut parent predict distress strongest correl find document variat children demonstr respons pain offer insight innat environment factor result impli treatment strategi deriv parent knowledg tailor individu characterist child effect allevi painrel distress medic set"
"methsuximid intract childhood seizur methsuximid ad therapeut regimen children intract epilepsi patient drug toler result greater reduct seizur frequenc irrevers advers effect methsuximid frequent overlook effect adjunct antiepilept children intract seizur"
"sucros analges newborn infant effect sucros analges agent newborn infant assess standard pain hospit procedur blood collect heel lanc circumcis infant drank ml sucros solut prior blood collect cri blood collect procedur control infant receiv ml steril water cri infant ingest sucros return baselin level blood collect control infant requir minut return baselin find obtain infant receiv sucros pacifi prior circumcis specif control infant underw standard circumcis procedur intervent cri time watermoisten pacifi reduc cri cri reduc provid infant sucroseflavor pacifi suck find parallel result obtain studi pain infant rat provid potent simpl benign intervent allevi stress pain routin experienc human infant"
"cerebr venographi mr author describ dimension timeflight magnet reson mr angiographi techniqu creat project venogram head techniqu appli healthi volunt patient superior sagitt straight sinus intern cerebr vein galen vein visual volunt vein high percentag subject systemat comparison digit subtract angiographi dsa intraarteri contrast medium inject mr venographi patient show good correl techniqu mr venographi prove identifi thrombosi patenc cerebr vein sinus show collater venous drainag venous drainag arterioven malform good correl convent contrast angiographi mr venographi conclus mr venographi consid reliabl show cerebr venous system inform addit convent spinecho imag"
"mark cerebrospin fluid void indic success shunt patient suspect normalpressur hydrocephalus author blind review chart patient normalpressur hydrocephalus diseas unknown character radiolog chronic communic hydrocephalus clinic gait apraxia dementia incontin undergon creation ventriculoperiton shunt initi clinic respons surgeri grade excel good fair poor year follow case magnet reson mr imag obtain patient blind review magnitud cerebrospin fluid csf flow void grade basi extent degre signal loss cerebr aqueduct signific correl exist good excel respons surgeri increas csf flow void presenc deep white matter infarct mr imag correl poor respons surgeri basi find suggest patient fulfil clinic criteria nph increas csf flow void undergo creation shunt"
"function outcom measur stroke rehabilit examin statist analysi function outcom stroke discuss mathemat relat improv function discharg function score demonstr mathemat predictor variabl improv discharg function score regress coeffici improv discharg function score equal admiss function score mathemat defin relat exist argu relat admiss function score discharg function score posit strong relat admiss function score improv negat stroke popul ignor statist concept confound differ raw correl partial correl predictor led confus function outcom research"
"platelet volum aggreg adenosin triphosph releas cerebr thrombosi compar blood platelet aggreg adenosin triphosph releas platelet count platelet crit percentag volum platelet platelet volum acut subacut chronic period cerebr thrombosi patient control acut subacut period platelet aggreg platelet count platelet crit platelet volum signific patient control adenosin triphosph releas rate volum platelet signific greater acut period infarct size show signific posit correl platelet aggreg adenosin triphosph releas rate negat correl platelet count result suggest platelet aggreg reduc acut period due consumpt platelet thrombogenesi remain individu platelet hyperact platelet consumpt acut period increas infarct size chronic period platelet crit platelet volum signific patient control adenosin triphosph releas rate signific greater suggest sustain platelet consumpt chronic enhanc secret individu platelet"
"treatment ischem intracrani hypertens cat accept efficaci treatment ischem cerebr edema show cat model focal cerebr ischemia infarct volum reduc ventriculocistern perfus oxygen fluorochem emuls bisperfluorobutylethylen accompani effect ventriculocistern perfus reduct intracrani pressur hour start perfus signific differ intracrani pressur nonperfus control rang torr cat perfus oxygen nutrient solut fluorochem rang torr anim perfus oxygen fluorochem emuls rang torr perfus oxygen fluorochem emuls warrant studi treatment elev intracrani pressur"
"persist remiss depress symptom late life object relat poor health onset depress symptom late life recogn attent characterist predict persist remiss depress symptom previous analys author found increas disabl declin health preced emerg depress symptom older communiti resid account varianc explain discrimin analys aim present analysi examin relev health disabl persist depress symptom method repres sampl adult age older assess center epidemiolog studi depress scale baselin twenti month individu assess depress symptom characterist communiti resid depress symptom persist month compar symptom remit result health differ age sleep disturb ad formal support servic account varianc persist depress remiss group advanc age worsen health persist symptom improv health remiss conclus previous studi untoward health disabl play major role onset depress symptom find show substanti contribut chronic"
"cerebr palsi plan surviv surviv children south east thame region born diagnos form cerebr palsi investig children studi aliv cerebr palsi regard condit peopl live condit die surviv vari diagnost group suffer spasic quadriplegia dyskinet mix cerebr palsi sever affect evid suggest immobl sever mental subnorm strongest predictor mortal children cerebr palsi major sever affect patient surviv adulthood plan surviv fund evalu programm maximis health independ qualiti life"
"glossopharyng neuralgia cardiac syncop long term treatment perman pace carbamazepin glossopharyng neuralgia cardiac syncop develop year man symptom control temporari perman transven pace carbamazepin"
"mtc hmpao spect pediatr migrain mtc hmpao spect brain imag perform headachefre period young migraineur affect common migrain cm case classic migrain clm case hemipleg migrain hm case spect find negat patient cm case clm case hm posit find remain patient case clm hm show decreas tracer distribut temporooccipit region case pariet region case decreas temporooccipit perfus report prodrom symptom exclus contralater area hypoperfus impair region cerebr vascular autoregul exist headachefre interv patient suffer classic hemipleg migrain"
"cerebr vein thrombosi shown mri year man short histori left facial pain numb subsequ headach normal physic examin normal ct scan head lumbar punctur yield normal csf increas pressur mri show thrombosi superior sagitt sinus subsequ confirm angiographi mri sensit test detect intracrani venous thrombosi investig choic disord suspect"
"cluster diathesi present evid sympathet defect vasomotor control anterior cerebr arteri aca side headach cluster period cluster headach patient util transcrani doppler measur reactiv major intracrani vessel cluster reactiv signific lower cluster period aca side headach nineteen patient sequenti full cycl cluster period show patient activ cluster period describ lesion gallium singlephoton emiss computer tomographi spect region cavern sinus fade patient move cluster felt lesion repres cavern sinus plexus lesion postul central lesion cluster sympathet outflow point explain aca reactiv cluster"
"relax train school class reduc headach complaint effect teacherpres progress relax train prt headach fear failur school problem studi school student ten physic educ lesson student receiv prt placebo train effect train investig student presenc headach pretrain diari signific differ found train group headach frequenc durat intens psycholog variabl basi previous find recommend present prt fair small group select subject complet class"
"pharmacokinet tiaprofen acid oral administr fast patient migrain attack studi examin pharmacokinet mg tiaprofen acid nsaid belong arylpropion class singl oral dose migrain patient migrain attack plasma concentr tiaprofen acid determin hplc analysi drug absorpt migrain attack absorpt half life attack hr attack hr maximum plasma concentr attack ugml attack ugml pharmacokinet paramet evalu affect headach attack conclud tiaprofen acid absorpt metabol affect migrain attack data suggest tiaprofen acid treatment migrain"
"paratop frameworkrel crossreact idiotop antiacetylcholin receptor antibodi crossreact idiotop target therapeut intervent autoimmun diseas investig role pathogenesi experiment autoimmun myasthenia gravi eamg analyz id rat antiachr mab control myeloma protein ir antiid bound direct bind assay affin rat antiachr mab test antiid ir recogn antiachr mab specif crossreact confirm inhibit studi antiachr mab control rat myeloma protein ir ir addit id express mab mous antihuman achr mab recogn antiid antiid antiid ir bound affin purifi igg sera rat eamg preimmun lewi igg result suggest extens share idiotop antiachr mab present eamg serum antiachr mab main immunogen region rat strain share paratoperel crossreact idiotop view fact antimain immunogen region antibodi form predomin fraction polyclon respons achr conceiv antiid recogn antibodi therapeut applic select immun absorb immunotoxin therapi"
"skin epidur record spinal somatosensori evok potenti median nerv stimul correl absenc spinal impair pain sens clinic lesion studi intraop epidur record made test origin clinic signific spinal somatosensori evok potenti sep follow median nerv stimul intraop respect peak latenc spinal coincid compon dorsal cord potenti phase revers posit ventral dorsal side cervic epidur space maxim amplitud vertebr level nerv input dermatom main contributor modal sensori impair hand dermatom examin select patient cervic lesion show normal convent sep compon erb field cortic loss spinal statist loss spinal decreas pain sensat dermatom interpret due damag central grey matter cord includ dorsal horn result suggest spinal origin sourc spinal cord segment good indic detect centromedullari cervic cord damag"
"develop infratentori atrophi patient idiopath cerebellar ataxia late onset ct studi develop infratentori atrophi patient suffer idiopath cerebellar ataxia late onset studi retrospect evalu consecut comput tomographi ct scan patient evid olivopontocerebellar atrophi opca clinic test magnet reson imag mri patient atrophi cerebellum brain stem visibl time progress rough parallel manner remain brain stem left intact patient opca definit brainstem atrophi visibl earlier cerebellar clinic symptom present data suggest ct investig regular interv prognost cerebellar ataxia"
"impair vertic motion detect downgaz palsi due rostral midbrain infarct present case acut onset vertic gaze palsi consist impair downgaz apraxia downward head movement neuropsycholog deficit hypersomnia impair attent disord memori affect control ct mri reveal bilater postischaem lesion dorsomedi thalamus mesodiencephal junction dorsomedi red nucleus restrict territori posterior thalamosubthalam paramedian arteri includ region rostral interstiti nucleus medial longitudin fascicl main premotor nucleus generat vertic saccad patient oculograph examin electrooculographi magnet search coil record show sever impair downward upward saccad minor deficit vertic pursuit vestibuloocular reflex visual function normal psychophys test motion percept reveal signific deficit detect vertic movement due central adapt mechan order minim oscillopsia elev threshold vertic motion percept case vertic gaze palsi altern explan lesion midbrain tegmentum damag subcort visual pathway involv motion percept"
"cerebr palsi rhizotomi year follow evalu gait analysi recent increas popular select rhizotomi reduct spastic cerebr palsi led demand object studi outcom longterm follow result author present result gait analysi children spastic cerebr palsi underw select posterior rhizotomi sagitt plane gait pattern studi surgeri year surgeri digit camera system paramet measur includ rang motion knee thigh stride length speed walk cadenc rang motion knee signific increas year surgeri improv normal rang year surgeri contrast postop measur thigh rang exceed normal valu year decreas normal rang year improv rang motion continu year children develop extend thigh knee posit upright walk postur stride length speed walk improv cadenc remain essenti unchang year follow studi examin rhizotomi object approach provid encourag result earli function outcom"
"spontan decompress syringomyelia magnet reson imag find case report case year woman chiari malform cervicothorac syrinx present patient clinic year period spontan complet resolut syrinx document serial magnet reson studi accompani minim chang object symptomatolog"
"carbon monoxideinduc delay amnesia delay neuron death chang acetylcholin concentr mice investig interrelationship delay amnesia delay neuron death acetylcholin concentr induc carbon monoxid exposur mice test retent passiv avoid task amnesia observ day exposur mice expos day train case mice expos day train amnesia observ retent test day train number pyramid cell hippocamp ca subfield lower control day exposur neurodegener pariet cortex area observ day exposur find amnesia neuron death produc delay mice expos addit delay amnesia close relat delay neuron death hippocamp ca subfield hglutam hglycin bind site chang exposur day exposur concentr acetylcholin bind hquinuclidinyl benzil frontal cortex striatum found signific chang hippocampus show signific chang suggest delay amnesia induc exposur result delay neuron death hippocamp ca subfield dysfunct acetylcholinerg neuron frontal cortex striatum hippocampus"
"administ hand symptom diagram diagnosi epidemiolog studi carpal tunnel syndrom noninvas test carpal tunnel syndrom cts limit diagnost administ hand symptom diagram develop diagnosi epidemiolog studi cts diagram rate classic cts probabl diagram rate compar nerv conduct diagnos patient upper extrem complaint hand diagram rate classic probabl cts sensit specif posit predict negat predict diagram conclud diagram diagnost tool valuabl occup popul screen"
"motor neuron diseas amyotroph sclerosi amyotroph sclerosi insidi develop adultonset progress anterior horn cell degener degener descend motor pathway recogn import clinic syndrom middl centuri increas clinic research interest condit remain obscur broadest term epidemiolog characterist diseas interpret evid genet environment major chang view diseas wide develop percept diseas elder person middleag adult previous taught etiolog hypothes encompass broad rang postul pathophysiolog mechan review detail clinic limit diseas defin modern diagnost techniqu interest support symptomat therapi grow intervent shown modifi biolog determin motor system degener"
"tourett syndrom tic disord diagnosi pathophysiolog treatment report discuss definit characterist pathophysiolog treatment tic disord major emphasi tourett syndrom diagnosi tic disord depend presenc motor phonic tic patient problem varieti morbid featur includ obsessivecompuls symptom attentiondeficit hyperact disord behavior difficulti learn disabl conserv estim tourett syndrom suggest preval rate syndrom inherit sexinfluenc autosom domin pattern chronic multipl tic disord obsessivecompuls disord altern phenotyp putat gene current evid continu support pathophysiolog mechan involv synapt neurotransmiss dopaminerg system primari candid therapeut essenti clarifi patient problem relat tic behavior difficulti pharmacotherapi motor phonic tic strict symptomat reserv function disabl symptom comprehens individu treatment program requir care individu tic disord"
"effect hydrocephalus prostaglandin thromboxan ventricular cerebrospin fluid concentr prostaglandin alpha prostaglandin ketoprostaglandin alpha prostacyclin metabolit thromboxan assay ventricular cerebrospin fluid obtain patient hydrocephalus obstruct communic patient receiv dexamethason hydrocortison day sampl patient receiv nonsteroid antiinflammatori compound hour sampl median valu differ signific type hydrocephalus concentr lumbar cerebrospin fluid obtain patient intracrani patholog lumbar myelographi lumbar disc diseas evid eicosanoid accumul ventricl hydrocephalus signific role symptomatolog"
"reflex sympathet dystrophi syndrom consensus report ad hoc committe american associ hand surgeri definit reflex sympathet dystrophi syndrom report propos reflex sympathet dystrophi defin pain syndrom pain accompani loss function evid autonom dysfunct clinic set diagnosi anatom psycholog diagnos varieti system ill medicoleg factor compon assess treatment plan establish prioriti emerg care acut injuri system ill psychiatr problem chronic anatom problem order earli accur diagnosi improv prognosi"
"congenit demyelin motor sensori neuropathi focal fold myelin sheath patient index case sib congenit motor sensori neuropathi clinic genet electrophysiolog featur resembl dejerinesotta diseas hereditari motor sensori neuropathi hmsn type iii sural nerv biopsi patient reveal segment demyelin remyelin hypertroph onion bulb ubiquit classic hmsn type iii strike discrimin featur hmsn type iii abund focal myelin thicken tomacula present teas fibr pathogen implic discuss case corrobor heterogen congenit motor sensori neuropathi"
"experienti phenomena tempor lobe epilepsi fact hypothes experienti phenomena occur tempor lobe seizur reproduc electr stimul tempor lobe structur typic encompass perceptu mnemon affect featur combin isol common relat patient individu past experi phenomena rais interest question brain mechan involv human psychophysiolog anatom substrat evoc phenomena wide distribut tempor lobe includ tempor isocortex limbic structur amygdala hippocampus parahippocamp gyrus argument present experienti phenomena posit express tempor lobe limbic function result ictal paralysi recent concept parallel distribut process rumelhart mcclelland import parallel distribut cortic network higher cognit function goldmanrak provid theoret framework hypothesi explain experienti phenomena base conform concept hypothesi assum tempor lobe epilept discharg electr stimul tempor lobe structur induc elabor pattern excit inhibit wide distribut neuron network capabl form specif matrix repres substrat experi neuron network engag parallel distribut process capac recreat total experi fragment network activ toler great deal degrad random inactiv compon interfer random nois loss inform content featur compat assumpt local epilept neuron discharg electr stimul involv tempor lobe structur creat matrix repres featur individu experi kind activ tempor lobe seizur experi limit resist degrad influenc mount nois inevit attend seizur discharg"
"role diencephal patholog human memori disord evid penetr paranas brain injuri patient report develop sever memori impair penetr brain injuri caus snooker cue enter left nostril basal region brain initi memori disord clinic featur dens amnes syndrom anterograd retrograd amnesia subsequ show signific recoveri memori function formal memori test carri month injuri demonstr mark verbal memori impair sever patient amnes syndrom nonverb memori test impair mild patchi retrograd amnesia regress affect month period injuri cognit task perform averag averag level neuropsycholog evid frontal lobe dysfunct neuroradiolog investig stage injuri fail demonstr lesion thalam nuclei magnet reson imag show lesion hypothalamus region mamillari bodi studi demonstr mark focal memori disord diencephal injuri occur direct patholog bodi thalamus structur adjac hypothalamus mamillari bodi play import role human memori function hitherto consid"
"singl unit analysi human ventral thalam nuclear group activ correl movement neurosurg oper relief movement disord singl thalam neuron identifi activ relat verbal cu activ movement movementrel cell activ neuron examin contralater movement order determin movement consist pronounc chang fire rate optim respons optim respons determin analysi histogram neuron activ construct onset emg activ synchron success repetit activ movement movementrel cell exhibit optim respons movement make fist extens flexion wrist flex extend elbow point entir upper extrem extend tongu lift leg movementrel cell record singl parasagitt plane individu patient optim respons relat movement involv part bodi movementrel cell classifi activ respons somatosensori stimul combin cell voluntari cell combin cell activ advanc emg activ activ movement distinguish cell respond sensori stimul sensori cell movementrel cell combin voluntari cell type locat anterior sensori cell tend show mediolater somatotop organ parallel sensori cell cutan recept field combin cell respond somatosensori stimul part bodi involv activ movement relat optim respons cell combin cell respond passiv movement joint optim respons activ movement joint activ combin cell parkinsonian tremor clarifi role sensori feedback tremor"
"spongiform encephalopathi transmit experiment creutzfeldtjakob famili gerstmannstrausslerscheink diseas comparison made effect experiment intracerebr inocul marmoset brain homogen case creutzfeldtjakob diseas cjd member wo famili cerebr amyloid spongiform encephalopathi gerstmannstrausslerscheink gss syndrom inocul marmoset develop spongiform encephalopathi se incub time month cjd group month gss group subsequ passag affect anim group result se develop month incub anim inocul cjd gss materi passag experi sever affect region brain thalamus case total occupi vacuol grey matter mass sever consist affect vacuol observ cerebellar granul cell layer molecular layer brain stem fine vacuol case minor inconsist differ diseas transmit cjd compar gss differ origin transmiss se caus passag inocula sever astrocyt gliosi accompani spongiform amyloid identifi marmoset experiment transmit diseas pathogenesi spongiform chang thalamus studi seri marmoset light electron microscopi month intracerebr inocul cjd gss homogen compar control dilat irregularlyshap cisterna larg complex vacuol typic se present abund month incub consid deriv cisterna neuron smooth endoplasm reticulum"
"hemodynam effect nasal cpap examin doppler echocardiographi effect increment applic nasal continu posit airway pressur cm ho heart rate pulmonari arteri pressur cardiac index studi noninvas doppler echocardiographi analysi varianc group normal volunt sleep apnea patient signific effect heart rate pulmonari arteri pressur ventricular size cardiac index found increas posit intrathorac pressur consequ lung hyperinfl subject normal cardiac function nasal cpap safe hemodynam viewpoint simpl repeat noninvas techniqu assess clinic safeti efficaci prescrib nasal cpap cardiac hemodynam individu patient"
"respiratori muscl strength control ventil patient neuromuscular diseas assess relationship respiratori mechan muscl strength control ventil patient neuromuscular diseas nmd compar pimax pemax rv frc tlc total respiratori elast er vt ti tt ve vtti titt vtti effect imped patient nmd healthi control subject seat posit breath room air er nmd patient percent higher subject ti tt vt nmd approxim half valu percent greater subject nmd pimax pemax rang percent valu signific respiratori muscl weak patient demonstr paco greater mm hg ventilatori output nmd modul respiratori mechan increas spite muscl weak central drive patient nmd decreas fact increas ve accur measur central drive abnorm intrins respiratori mechan effect conscious respons reflex"
"effect cardiac output reduct rate desatur obstruct apnea nadir sao obstruct apnea depend apnea durat rate fall satur dsaodt postul low patient congest heart failur sleep apnea reduct human obstruct sleep apnea steepen dsaodt mechan postul lower svo increas pulmonari capillari blood oxygen uptak faster deplet alveolar oxygen studi examin dsaodt onset apnea spontan breath adult baboon nonrepetit obstruct apnea creat clamp indwel cuf endotrach tube end expir baselin measur anim bolus rapidact betaadrenerg blocker continu infus reduc cardiac output limit cardiovascular respons obstruct asphyxia fiberopt cathet continu monitor sao svo cardiac output esophag pressur relat thorac gas volum respitrac monitor insur equival lung volum onset apnea betaadrenerg blockad reduc rest percent block unblock dsaodt percent percent percent apnea dsaodt durat apnea unaffect betaadrenerg blockad conclud dsaodt influenc limit preced induc obstruct asphyxia"
"hyperprolactinemia increas hypoprolactinemia decreas tyrosin hydroxylas messeng ribonucl acid level arcuat nuclei substantia nigra zona incerta effect experiment produc hypoprolactinemia hyperprolactinemia tyrosin hydroxylas mrna signal level examin dopaminerg neuron ovariectom rat mrna signal level relat quantiti arcuat nuclei zona incerta substantia nigra evalu situ hybrid immunocytochemistri catalyt activ stalkmedian emin sme determin vitro rate dihydroxyphenylalanin dopa accumul inhibit dopa decarboxylas brocresin chronic administr bromocriptin bromo dopamin da agonist day reduc circul rat prl rprl level compar vehicletr control bromo treatment decreas mrna signal level arcuat nuclei intens immunostain arcuatemedian emin area rate dopa accumul sme concomit administr ovin prl oprl revers effect bromo result mark increas mrna signal level intens immunostain rate dopa accumul treatment oprl day increas mrna signal level arcuat nuclei activ sme compar vehicl chronic treatment haloperidol da antagonist increas circul level endogen rprl increas activ sme valu similar oprl treatment contrast oprl mrna level arcuat nuclei haloperidoltr rat similar level vehicletr anim evalu effect prl speci specif oprl rprl continu infus jugular vein osmot minipump mrna level arcuat nuclei elev control level oprl rprl administr mrna level da perikarya locat zona incerta substantia nigra alter treatment da agonist da antagonist prl result hypoprolactinemia hyperprolactinemia select reduc augment mrna level tuberoinfundibular dopaminerg neuron alter mrna content contribut decreas increas activ hypoprolactinemia hyperprolactinemia"
"humor aggress age humor respons aggress cartoon investig rate pain funni cartoon young elder men women signific age differ found sex differ found young elder femal invert relationship pain funni rate young elder male relationship pain funni preliminari step explor age differ humor relev work elder person"
"approach diagnosi mening cerebrospin fluid evalu csf evalu singl import aspect laboratori diagnosi mening analysi csf abnorm produc bacteri mycobacteri fungal infect great facilit diagnosi direct initi therapi basic studi csf perform patient mening includ measur pressur cell count white cell differenti determin glucos protein level gram stain cultur bacteri mening limulus lysat assay test identifi bacteri antigen rapid diagnosi strong suspicion tubercul fungal mening csf submit acidfast stain india ink prepar cryptococc antigen contraind increas intracrani pressur larg volum ml obtain cultur histori resid southwest elicit complementfix antibodi coccidioid immiti order newer test base immunolog method gene amplif techniqu hold great promis diagnosi infect caus organ difficult cultur present small number great lumbar punctur diagnosi mening injudici procedur result death brain herniat lumbar punctur avoid focal neurolog find suggest concomit mass lesion brain abscess lumbar punctur approach great caution mening accompani evid signific intracrani hypertens institut antibiot therapi suspect mening delay neuroradiolog studi obtain exclud abscess measur institut reduc intracrani pressur"
"fluctuat interict brain imag repeat iimp spect scan epilept patient singl photon emiss comput tomographi spect brain scan isopropyliodin iodoamphetamin iimp perform time interict period year man intract frontal lobe epilepsi normal ray ct find scan show decreas iimp uptak frontal lobe abnorm imag regard primari focus epilepsi basi region agreement focal epilept discharg eeg scan show normal imag scan show abnorm imag frontal lobe frequenc clinic seizur unchang interv scan eeg record scan show basic activ frequenc epilept discharg fluctuat spect brain imag suggest sever function inactiv focal hypoperfus imag epilept focus fluctuat interict state relat clinic featur epilepsi"
"aberr regener case syringobulbia select activ abducen facial nerv saccad patient suffer syringobulbia syringomyelia exhibit phasic contract ipsilater facial muscl levat labii left facial muscl twitch occur exclus saccad select activ abducen facial nerv interpret result bilater misrout regener neuron parapontin reticular format facial nerv tegmentum ponti"
"famili eat epilepsi eatingrel seizur affect individu sibl belong famili present type epilepsi partial affect individu seizur complex simpl secondarili general major onset epilepsi case decad life remark degre intrafamili consist observ regard age onset symptomatolog seizur time eat seizur studi demonstr sibl cluster partial epilepsi implic time genet suscept aetiolog eat epilepsi"
"transient ischaem attack smallvessel diseas dutch tia studi group histori comput tomogram patient transient cerebr ischaemia studi symptom sign complet resolv hour episod suggest posterior fossa ischaemia exclud comput tomographi clinic featur resolv show relev infarct small deep lacunar infarct confid interv ci larger cortic infarct histori type infarct patient compar lacunar infarct preced histori unilater motor sensori symptom featur attribut cerebr cortex posit predict lacunar symptom negat predict patient cortic infarct histori lacunar tia occur left hemispher speech affect patient transient ischaem attack relev infarct visibl comput tomographi histori suggest lacunar ischaemia studi patient ischaem stroke evid lacunar infarct lacunar tia prognosi cortic tia preced cortic infarct altern cortic infarct occur warn"
"role condit verbal expect placebo respons condit expect model offer recent year explan placebo respons earlier work condit placebo respons human subject current studi examin relat contribut made condit verbal expect group receiv combin expect condit manipul group receiv expect group condit group control group subject respons compar placebo cream iontophoret pain stimul result suggest condit power verbal expect creat placebo respons"
"profil opioid analgesia human intraven bolus administr alfentanil fentanyl morphin compar experiment pain report examin relationship plasma drug concentr analges effect bolus dose alfentanil fentanyl morphin assess individu differ analges respons volunt predict opioid yield dispar analges profil physicochem pharmacokinet characterist differ ten healthi volunt receiv intraven bolus dose alfentanil fentanyl morphin normal salin day stimul teeth electr measur brain evok potenti ep pain report pr repeat assess analges effect concurr drew blood sampl assess opioid plasma concentr test period relationship opioid plasma concentr analges effect defin alfentanil ambigu morphin fentanyl exhibit mark hysteresi observ noteworthi individu differ analges respons drug differ greatest morphin alfentanil inter intrasubject variabl analges respons drug relat physicochem properti drug test"
"heart rate autonom compon pain respons autonom variabl recommend measur affectivemotiv compon pain respons object algesimetri present studi compon heart rate respons pain heat stimuli relat stimulus sensat variabl analyz twelv healthi subject serv sixti phasic stimuli vari temperatur pain threshold deliv marstock thermod session heart rate respir subject stimulus rate record simultan phasic heat stimul pain threshold induc tonic increas heart rate sec high intens stimul generat steeper rise greater increas low intens stimul general heart rate respons close relat subject sensat stimulus intens differenti tempor analysi demonstr sec stimul autonom respons determin sole stimulus temperatur approxim sec relat subject judgement heart rate respons reflect nocifens reflex induc sensori compon subsequ longerlast respons relat affect cognit evalu separ stage painprocess autonom indic clinic algesimetri"
"effect calcium antagonist nilvadipin focal cerebr ischemia spontan hypertens rat studi efficaci preischem postischem system treatment calcium antagonist nilvadipin perman focal cerebr ischemia model spontan hypertens rat rat underw microsurg middl cerebr arteri occlus blind assign singl intraperiton inject nilvadipin mgkg amount polyethylen glycol minut immedi hour hour occlus left middl cerebr arteri neurolog condit rat close examin rat kill hour remov brain slice coron stain triphenyltetrazolium chlorid size infarct determin neurolog improv observ treat rat area infarct signific reduc group treat immedi hour occlus middl cerebr arteri treatment start hour occlus ineffect"
"singl case huntington diseas simultan occur obstruct hydrocephalus case simultan occur huntington diseas obstruct hydrocephalus present huntington neurodegen diseas normalpressur hydrocephalus descript obstruct hydrocephalus report obstruct hydrocephalus display famili tendenc present"
"autism fragil syndrom conceptu methodolog issu investig associ autism fragil syndrom yield conflict result studi indic strong correl indic relat disord paper review relev research controversi discuss conceptu methodolog problem involv inquiri conclud autism fragil relat prove fruit understand role chromosom varieti behavior disord unravel theoret account etiolog autism"
"progress search genet linkag tourett syndrom exclus map cover autosom genom gill de la tourett syndrom neuropsychiatr disord autosom domin mode inherit reduc penetr singl genet locus research group genet linkag studi underway detect chromosom locat gene predispos disord strong clear evid linkag produc tourett syndrom paper present overview method progress group center yale univers erasmus univers exclud linkag larg portion genom lab screen genet marker loci linkag gene disord seri affect famili unit state canada netherland norway autosom genom exclud assumpt genet heterogen import factor tourett syndrom pedigre pool summari"
"molecular genet basi mapl syrup urin diseas famili defect allel branch chain acyltransferas local gene human chromosom mapl syrup urin diseas human result inherit defect branch chain alphaketoacid dehydrogenas mitochondri multienzym complex varieti genet produc phenotyp affect function complexspecif subunit vari clinic express observ patient partial explain defect involv subunit report local gene branch chain acyltransferas compon complex human chromosom describ proband compound heterozygot locus allel inherit father produc transcript nucleotid delet code region delet found branch chain acyltransferas gene impli delet transcript aris error transcript process cell patient mother normal amount mrna subunit proband inherit nonexpress allel result proband produc acyltransferas protein great impair complex activ phenotyp normal sibl shown genet similar mother inherit mother nonexpress allel father normal allel"
"taysach diseas moroccan jew delet phenylalanin alphasubunit betahexosaminidas taysach diseas inherit lysosom storag disord caus defect betahexosaminidas alphasubunit gene carrier frequenc taysach diseas signific elev ashkenazi jewish moroccan jewish popul jewish group found mutat taysach diseas ashkenazi moroccan jew analysi moroccan jewish taysach patient reveal frame delet delta adjac phenylalanin codon present posit alphasubunit sequenc mutat impair subunit assembl betahexosaminidas result absenc enzym activ moroccan patient found carri alphasubunit allel unidentifi mutat deficit mrna analysi oblig carrier unrel moroccan jewish famili show harbor delta mutat rais possibl defect preval mutat ethnic group"
"propofol infus control status epilepticus patient status epilepticus resist convent treatment respond propofol infus report electroencephalogram confirm seizur success treatment"
"gaug spinal cathet gaug needl small diamet intrathec cathet potenti combin certainti intrathec inject advantag repeat risk high incid headach dural punctur report problem place cathet"
"paraesthesia lumbar epidur cathet comparison air salin lossresist techniqu epidur space locat obstetr patient loss resist air salin incid paraesthesia air group salin group signific differ group term complic qualiti analgesia provid"
"telephon elicit voic speech brain injur subject initi speech delay earli stage recoveri brain injuri found high percentag patient speech swallow problem make bedsid assess swallow safeti difficult listen sound aspir materi vocal cord patient high risk silent aspir unabl cooper videofluoroscop studi telephon time aphasia treatment elicit speech assess swallow safeti earli brain injuri studi recruit subject brain injuri refer earli swallow evalu coma follow command initi voic speak subject question condit face face ring telephon room result record videotap analyz investig quantifi differ subject respond telephon stimulus techniqu elicit voic speech earli brain injuri patient bedsid assess swallow safeti serv stimul brain injur subject coma"
"disabl driver unmet challeng survey undertaken determin drive impair secondari disabl injuri address state licens law train program state driver submit voluntarili reevalu disabl injuri provis made report individu state author physician report impair driver requir report base survey licens bureaus capit major citi state clerk sourc inform injur person general awar report requir supervisor slight inform rehabilit center survey provid site train disabl driver voluntari submiss reevalu head injuri occur head injur patient year postonset sought reevalu resum regular drive involv subsequ traffic accid common guidelin establish state ensur reevalu individu disabl condit deliveri accur inform licens avail train program"
"cost oper support work program traumat braininjur individu paper present preliminari analysi cost returnwork program emphas support employ approach person sustain sever traumat brain injuri analysi span year result hour staff intervent time requir achiev job stabil cost ongo follow support servic averag hour week cost total staff time cost expend jobsit train advocaci effort applic find statelevel agencylevel polici weigh individu characterist client program design outcom client achiev result servic"
"revers nerv conduct block patient polyneuropathi ultrasound thermotherapi therapeut dosag studi investig effect ultrasound nerv conduct patient polyneuropathi bodi control group patient clinic physiolog evid polyneuropathi test patient group np ach pain symptom patient group sever ach pain burn sensat unpleas tingl hyperesthesia lower extrem minut therapeut ultrasound dose wcm appli anterior surfac leg pathway deep peron nerv peron nerv conduct studi perform ultrasound treatment compound muscl action potenti cmap record extensor digitorum brevi muscl nerv conduct studi patient group reveal signific decreas reduc dose wcm wcm amplitud cmap baselin negat peak increas increas dose wcm wcm proxim latenc minut ultrasound applic dose wcm dose wcm greater return pretreat valu minut cessat ultrasound therapi group np signific amplitud cmap proxim latenc ultrasound therapi dose wcm conclud ultrason therapi therapeut dosag revers conduct block patient pain polyneuropathi"
"goal attain scale outcom measur postacut brain injuri rehabilit relationship month final goal attain scale gas score preadmiss final portland adapt inventori pai score work outcom graduat comprehens postacut brain injuri rehabilit program examin final gas score higher program graduat obtain desir work outcom preadmiss final pai score lower success program graduat final gas score signific correl outcom measur preadmiss pai score predict work outcom month gas score predict final gas score initi pai score distinguish program success failur program success dropout case illustr modifi applic gas postacut brain injuri rehabilit result studi case analys support gas quantifi individu measur monitor patient progress structur team confer ongo rehabilit plan decisionmak concis relev communic famili referr sourc fund sourc program evalu context object outcom measur result support clinic util gas studi recommend assess psychometr characterist gas applic"
"factor predict satisfactori home care stroke studi prospect investig factor predict optim poststrok home care hundr thirti occurr stroke patient primari support person evalu initi hospit stroke year poststrok discrimin function analysi identifi group baselin data home care situat rate optim group membership predict valid accuraci patient risk optim home care caregiv depress marri patient averag knowledg stroke care report famili dysfunct find suggest caregiverrel problem collect effect rehabilit outcom treatment reduc caregiv depress minim famili dysfunct increas famili knowledg stroke care"
"visual illus patient medullari syndrom disturb visual percept nystagmus rare phenomenon case year woman develop progress hemisensori deficit left facial sensori deficit vertigo stagger left left ptosi vertic diplopia ataxia left upper extrem rotatori nystagmus primari posit increas amplitud left gaze sign symptom consist medullari syndrom rehabilit patient complain visual disturb typic oscillopsia disturb illus compensatori mechan nystagmus result retin error purpos case present studi pathophysiolog oscillopsia patient nystagmus stimul awar visual disturb stroke patient"
"higher incid carpal tunnel syndrom oophorectom women determin hormon menopaus relat onset carpal tunnel syndrom cts healthi women younger year subject bilater oophorectomi year studi evalu seventi healthi menstruat women match age control complain symptom present sign suggest cts sensori motor nerv conduct studi oophorectom group clinic cts control group relat risk oophorectom group confid interv nerv conduct studi abnorm oophorectom women control group symptom tend milder control symptom develop year oophorectomi women cts suggest women develop cts oophorectomi frequent control"
"advanc treatment complex cerebrovascular disord intervent neurovascular techniqu treatment complex cerebrovascular disord includ intracrani aneurysm carotid cavern sinus fistula vertebr fistula arterioven malform atherosclerosi brachiocephal vessel arteri vasospasm perform select case intervent neurovascular techniqu recent advanc microballoon technolog perman solidifi polym newer embol agent highresolut digit subtract angiographi roadmap techniqu steerabl microguid wire cathet great improv access distal intracrani circul mark reduc morbid procedur intervent neuroradiolog emerg import adjunct neurosurgeri select cerebrovascular disord"
"antiepilept drug cognit function behavior children evid recent studi effect antiepilept drug cognit function behavior children review basi publish studi individu shown differ deleteri effect phenytoin general contrast minim effect valproat carbamazepin differ result attribut psycholog test age differ dissoci affect higher cognit function phenytoin affect motor function carbamazepin increas speed perform prescrib care children epilepsi account differ effect cognit function behavior"
"computer neuropsycholog assess cognit function children epilepsi rang computeraid test neuropsycholog assess investig children epilepsi age year compar control age group children age year cope complex test wide rang function reaction time measur motor speed inform process memori speed perform tend increas age group differ inform process appar age year precis control stimulus respons requir defin minor differ epilepsi control group fulfil computer test undergo refin includ voic languag recognit artifici intellig"
"electroencephalograph paramet assess cognit function children epilepsi biolog psycholog possibl consid attempt explain cognit dysfunct individu child epilepsi electroencephalograph eeg inform relev children studi relat direct effect seizur discharg learn behavior discharg divid transient prolong prolong seizur discharg includ nonconvuls status epilepticus wake status epilepticus slowwav sleep addit influenc seizur discharg preliminari find suggest children epilepsi subtl disord arous mechan sleep possibl impair daytim perform"
"discontinu antiepilept drug children outgrown epilepsi effect cognit function cognit function frequent impair children epilepsi compar agematch control hard evalu signific contributori factor effect antiepilept drug studi children outgrown epilepsi treat multicent studi assess aspect cognit function children form epilepsi treatment antiepilept drug definit result interim analysi find suggest shortterm memori decreas subgroup children treat epilepsi compar control"
"mri ct spect pet diagnos dementia differenti diagnosi dementia syndrom pose difficult clinic problem common dementia alzheim diseas ad mark normal laboratori test neuroimag play import role evalu dement patient grow comput tomographi ct exclud revers treatabl dementia subdur hematoma tumor recent magnet reson imag mri improv abil diagnos vascular diseas show presenc cerebr infarct white matter diseas visibl ct singl photon emiss comput tomographi spect positron emiss tomographi pet techniqu visual cerebr function glucos metabol blood flow provid posit evid support diagnosi ad"
"intraven administr phosphoryl acid alphaglucosidas lead uptak enzym heart skelet muscl mice lysosom storag disord glycogenosi type ii caus acid alphaglucosidas defici studi investig applic mannos phosphat receptormedi enzym replac therapi correct enzym defici affect tissu bovin test acid alphaglucosidas phosphoryl mannos residu intraven administ mice found heart increas activ skelet muscl increas major target organ uptak nonphosphoryl human placenta acid alphaglucosidas heart skelet muscl signific effici uptak dephosphoryl bovin test enzym detect phosphoryl bovin test acid alphaglucosidas remain present mous skelet muscl administr halflif measur skelet muscl heart uptak phosphoryl bovin test nonphosphoryl human placenta acid alphaglucosidas measur organ brain increas acid alphaglucosidas activ highest liver spleen conclud applic mannos phosphat receptormedi enzym replac therapi offer perspect treatment glycogenesi type ii"
"time test basic function mobil frail elder person studi evalu modifi time version test mathia al patient refer geriatr day hospit age year patient observ time rise arm chair walk meter turn walk back sit result time score reliabl interrat intrarat correl logtransform score berg balanc scale gait speed barthel index adl predict patient abil safe data suggest time test reliabl valid test quantifi function mobil clinic chang time test quick requir special equip train easili includ part routin medic examin"
"miniment state exam score vari educ black white previous studi suggest educ race affect perform standard mental status test order defin relationship prospect longitudin studi devis answer question race level educ affect score miniment state mms exam dement peopl numer cutpoint maxim sensit specif util mms diagnos dementia black vari educ attain total white black individu recruit citi hospit primari care geriatr clinic evalu subsequ longitudin year period order assess accur presenc absenc dementia dement total mms score perform item mms analyz reveal peopl grade educ consist signific wors result educ grade borough attent item recal tabl dog copi sentenc write phrase repeat total score total lower educ group mms score rang tradit thought suggest dementia consist signific differ black white equal educ educ group score defin dementia maxim sensit specif mms diagnosi lower educ group defin dementia maxim sensit specif"
"physician practic diagnosi dement disord treatabl untreat dementia physician abil conduct refer patient differenti diagnosi profound effect health outcom patient health care cost studi undertaken assess physician practic regard diagnosi dement disord data physician respons rate specialti obtain administ mail questionnair result major physician provid histori physic examin neurolog examin physician refer patient psychiatr neuropsycholog examin provid servic result point defici key area formal publish diagnost criteria mental status cognit function test physician survey dsmiii nincdsadrda diagnost criteria physician provid mental status test continu educ close knowledg gap emphas"
"local technetiummglucar zone acut cerebr injuri potenti structur similar technetiummlabel glucar acid mtcglucar fructos suggest agent enter cell sugar transport system studi llcpk cell demonstr inhibit mtcglucar uptak fructos confirm potenti relationship anaerob metabol glucos fructos hypothes mtcglucar concentr area acut ischem injuri test hypothesi adult rat middl cerebr arteri mca occlus reperfus inject mtcglucar vivo vivo imag acquir anim studi fdg high resolut pet imag radionuclid imag compar result triphenyl tetrazolium chlorid ttc stain convent histopatholog thirti rat signific accumul mtcglucar ttc stain indic infarct involv hemispher remain rat ttc stain suggest viabil involv hemispher mtcglucar accumul rat studi mtcglucar fdg mtcglucar accumul center occlud mca territori fdg activ decreas region result suggest mtcglucar sensit marker acut sever cerebr injuri mechan local fdg"
"meralgia paresthetica coronari bypass surgeri meralgia paresthetica neurolog disord character local paresthesia numb anterolater aspect thigh involv femor cutan nerv involv motor deficit meralgia paresthetica result varieti observ rare complic heart oper oper uncertain prolong relax posit oper tabl recoveri room stretcher meralgia paresthetica heart oper frogleg posit leg vein harvest patient condit advis untreat benign limit natur"
"neurofibromatosi type report famili review current evalu treatment signific advanc past decad great improv understand neurofibromatosi type genet diseas result bilater acoust neuroma emerg gadoliniumenhanc magnet reson imag earli detect minut intracanalicular eighthnerv tumor cm diamet recombin dna studi clarifi genet underli neurofibromatosi type separ varieti relat condit von recklinghausen neurofibromatosi earli diagnosi surgic remov tumor offer hope preserv hear facial nerv function report evalu treatment famili multipl affect individu exemplifi conclus"
"revers myeloneuropathi nitrous oxid abus serial electrophysiolog studi detail electrophysiolog studi perform patient myeloneuropathi induc abus nitrous oxid year present paresthesia weak lhermitt phenomena exhibit sign sensorimotor polyneuropathi ataxia arreflexia subnorm serum vitamin level baselin electrophysiolog test reveal reduc motor unit potenti prolong wave latenc absent reflex denerv potenti delay motor sensori conduct peripher nuchal delay median nerv stimul reevalu month abstin treatment vitamin show substanti clinic improv parallel improv electrophysiolog find occur residu minor conduct delay loss reflex electromyograph evid denerv abnorm posterior tibial sep note find confirm revers myeloneuropathi nitrous oxid abus describ profil electrophysiolog recoveri subject abstain neurotox exposur"
"nervemuscl involv larg famili mitochondri cytopathi electrophysiolog studi thirteen patient mitochondri cytopathi investig repres generat age stage sever diseas assum metabol defect diseas multisystem disord metabol defect locat complex respiratori chain clinic disord symptom hear loss retin pigment degener ataxia cardiomyopathi muscular fatigu neuropathi patient investig nerv conduct studi concentr needl emg sfemg macro emg examin neurophysiolog studi reveal sign myopathi younger member slight muscular symptom advanc stage neuropath axon type macro emg interpret indic muscl fiber membran abnorm earli stage singl fiber emg studi metabol defect disturb neuromuscular transmiss"
"diagnost prognost electrophysiolog test meralgia paresthetica electrophysiolog diagnosi unilater meralgia paresthetica assess sidesid comparison snap amplitud sncvs sep latenc stimul femor cutan nerv determin relev diagnosi test sidesid comparison result compar patient unilater meralgia paresthetica normal subject longterm outcom consid order determin electrophysiolog find contribut prognosi studi snap amplitud comparison found diagnosi sncv sep latenc comparison snap amplitud affect side result test found predict outcom result test depend method nerv rout"
"effect short spaceflight mechan characterist rat muscl aim studi investig contractil protein characterist day cosmos day cosmos spaceflight experi perform skin fiber soleus gastrocnemius laterali plantari muscl isol wistar rat reduct fiber diamet explain decreas maxim tension soleus tension unalt gastrocnemius plantari calcium sensit myofila modifi soleus gastrocnemius tensionpca relationship shift higher calcium concentr indic decreas appar calcium bind constant troponin tensionpca relationship unalt plantari spaceflight final studi time reach steadi tension increas rate forc develop soleus contrari slow plantari chang gastrocnemius found result analyz refer muscl function disus atrophi"
"patient percept tic movement disord determin subject percept patient abnorm movement patient hyperkinesia interview question direct voluntari intent versus involuntari aspect symptom hundr patient tic disord thought abnorm movement involuntari forti tic disord patient state motor phonic tic intent produc fifteen voluntari involuntari compon predomin voluntari respons predict correct diagnost categori tic versus tic patient referr categori incorrect result suggest larg proport motor phonic symptom experienc tic patient irresist purpos execut akin compuls involuntari hyperkinesia common discuss"
"symptom diseas associ idiopath intracrani hypertens pseudotumor cerebri casecontrol studi identifi symptom coexist medic condit idiopath intracrani hypertens iih administ item questionnair time diagnosi iih patient agedmatch control nineti percent iih patient women age obes recent weight gain common patient control symptom common report iih patient headach transient visual obscur tvo intracrani nois icn daili occurr symptom common patient control control report iih symptom lower frequenc condit previous iih common patient control includ iron defici anemia thyroid diseas pregnanc antibiot intak oral contracept conclud previous studi iih uncontrol retrospect underestim frequenc symptom iih patient report chanc spurious associ common medic condit medic profil young obes woman headach tvo icn alert clinician diagnosi iih symptom occur daili"
"infarct anterior rostral cerebellum territori branch superior cerebellar arteri report patient isol infarct anterior part rostral cerebellum territori branch superior cerebellar arteri clinicoanatom correl base ct mri patient patholog data ninth main clinic featur ipsilater dysmetria axial lateropuls dysarthria unsteadi patient clinic present mimick lacunar stroke dysarthria clumsi hand syndrom edemat cerebellar infarct sign brainstem compress patient spontan improv signific sequella angiographi patient patholog examin arteri patient disclos occlus vertebrobasilar system patient cardiac sourc emboli conclus infarct anterior part rostral cerebellum regard benign condit frequent cardiac sourc emboli"
"comparison function structur brain disturb wilson diseas assess function structur brain disturb wilson diseas wd evok potenti ep magnet reson imag mri neurolog symptomat asymptomat patient assess ep imag abnorm prolong ep conduct time imagingoutlin presenc cerebr lesion brain atrophi find ep mri sensit techniqu evalu brain involv wd"
"interict spike wake sleep local foci tempor lobe epilepsi examin variat interict spike sleep wake assess differ reliabl local epilept foci forti patient studi prospect spike assess rate field foci final local determin surgeri electrocorticographi seizur onset comparison interict eeg foci final local made patient slowwav sleep activ spike compar wake patient show maxim spike sleep stage restrict field rapid eye movement rem sleep wake extens field slowwav sleep occur foci rapid eye movement sleep patient similar ident spike rate foci field distribut wake rem sleep rem foci unilater find suggest local primari epileptogen area reliabl rem sleep wake wake slowwav sleep"
"phenytoin toxic due interact clobazam benzodiazepin antiepilept drug clobazam ad exist treatment clinic toxic report patient addit clobazam led week clinic obvious phenytoin pht intox patient maximum toler pht dose symptom high pht level resolv lower pht dose clobazam norclobazam level elev interact relat interfer hepat degrad pht clinician awar pht intox patient start clobazam"
"predict free phenytoin level base total phenytoinalbumin ratio potenti error hypoalbuminemia therapeut monitor pharmacolog activ free drug fraction proteinbound medic phenytoin repres major diagnost challeng clinic laboratori medicin free drug level benefici clinic situat current method predict free phenytoin concentr unreli recommend general author demonstr linear relationship serum level total bound phenytoin patient seizur disord signific correl observ total phenytoin albumin level compar independ measur concentr free phenytoin percent free phenytoin good correl exist free phenytoin level total phenytoinalbumin ratio patient normal elev albumin level signific weaker correl found patient hypoalbuminemia total phenytoinalbumin ratio clinic predict free phenytoin level uncompl patient hypoalbuminemia"
"critic apprais mitogeninduc lymphocyt prolifer depress patient object author goal evalu util mitogeninduc lymphocyt prolifer assay clinic research psychoimmunolog method examin depress patient match comparison subject assay signific differ group combin result studi result previous studi depress patient comparison subject examin determin lymphocyt prolifer depress result depress patient lower prolif respons match comparison subject lower depress subscal anergia subscal total score psychiatr rate scale patient higher prolif respons match comparison subject find unexpect unexplain depress patient lower prolif respons match comparison subject fewer obsess compuls psychomotor agit schedul affect disord schizophrenia interview patient higher prolif respons match comparison subject stepwis discrimin analysi cluster analysi contribut understand determin vitro lymphocyt prolifer cell depress patient conclus longitudin studi multipl serial determin mitogeninduc lymphocyt prolifer minim design make assay evalu immun system depress"
"depress symptom stroke object primari purpos studi assess relat lesion locat mood veget disturb stroke method fifti inpati outpati singl unilater stroke includ patient past cns psychiatr disord exclud modifi visual analogu dysphoria scale inclus impair aphas patient sleep eat disturb measur report nurs assess locat lesion determin ct scan classifi dimens left dorsalventr frontalnonfront result measur dysphor mood sleep disturb result signific interact lesion dimens differ found regard eat disturb greater dysphoria sleep disturb found subject left parietaloccipit left inferior frontal superior frontal tempor lesion subject lesion locat depress symptom function impair measur activ daili live motor strength sever aphasia conclus result support hypothesi lesion locat valid signific factor mixtur influenc result dysphor mood state stroke relat site lesion subsequ depress symptom complex report previous"
"natur olfactori deficit alzheim diseas object aim studi determin specif natur olfactori deficit alzheim diseas previous studi note impair odor identif unanim presenc odor detect deficit method odor identif test patient alzheim diseas elder control subject univers pennsylvania smell identif test odor detect assess subject alzheim diseas control subject forcedchoic threshold test geraniol odor result signific deficit olfactori identif present subject earliest stage cognit impair deficit increas alzheim diseas progress overlap individu smell identif test score cognit impair patient normal elder subject hand odor detect deficit alzheim diseas advanc smell identif test score correl miniment state score geraniol detect conclus odor identif impair earli alzheim diseas influenc cognit status acuiti odor detect alter disord pattern hyposmia alzheim diseas suggest disord begin nose theoriz previous refin olfactori test diagnost evalu earli dementia"
"nonfear panic disord neurolog patient valid lactat challeng object nonfear panic disord meet dsmiii criteria panic disord subject fear anxieti author determin preval group neurolog patient assess diagnost valid panic disord subtyp evalu respons patient nonfear panic disord sodium lactat antipan pharmacotherapi method subject neurolog patient refer year univers hospit psychiatr consult servic negat medic workup symptom patient met dsmiii criteria panic disord report subject anxieti fear panic episod diagnos nonfear panic disord afterward patient receiv sodium lactat infus hour sodium chlorid infus treat antipan medic month result neurolog patient refer psychiatr evalu met criteria panic disord met criteria nonfear panic disord respond posit lactat placebo experienc reduct symptom month follow period detail case report patient present conclus find support construct predict diagnost valid nonfear panic disord subtyp panic disord suggest lack attent group lead underestim preval panic disord withhold potenti success treatment group"
"organ procur patient fatal head injuri fate potenti donor month retrospect review victim fatal head injuri level trauma center undertaken estim donor organ avail determin procur failur analyz function result organ transplant group donor procur failur patient die princip head injuri includ failur initi resuscit inelig failur physiolog support denial consent elig donor donat vascular organ heart liver kidney instanc elig donor appropri identifi failur physiolog support prevent earli death denial consent found major potenti remedi procur failur seri base data estim patientsmillion populationyear surviv initi meet elig requir organ donat data kidney transplant donor group demonstr graft surviv rate follow period averag month prolong donor hypotens highdos vasopressor advers affect allograft surviv current limit organ procur victim fatal head injuri stem limit abil maintain cardiopulmonari function long procur process complet high rate denial consent organ harvest kin"
"brain activ seizur patient preced tempor lobectomi eventrel potenti record occipit pariet scalp patient suffer intract partial complex seizur prior undergo tempor lobectomi subject present languag nonlanguag visual stimuli dividedfield oddbal paradigm behavior perform buttonpress accuraci reaction time run count compar group accuraci wors left tempor group patient show tremend variabl amplitud latenc respons notabl observ slow wave activ present patient control subject schedul left tempor resect evinc amplitud reduct schedul tempor resect addit number patient show respons result discuss context util noninvas eventrel potenti measur examin memori impair integr neural structur mediat memori function patient popul"
"age onset alzheim diseas relat languag dysfunct age onset alzheim diseas ad found relat diminish languag perform patient probabl ad hierarch linear model construct assess effect age onset diseas durat perform patient ad languag task read auditori comprehens write dictat control diseas sever result univari analysi depend variabl averag languag task perform reveal signific effect age onset ad diseas durat assess possibl relationship age onset ad languag perform reflect effect normal age languag task normal subject similar age score perfect dementia sever measur convinc relationship found test score age"
"distribut cerebr muscarin acetylcholin receptor vivo patient dementia control studi iqnb singl photon emiss comput tomographi highaffin muscarin receptor antagonist iqnb quinuclidinyliodobenzil label iodin singl photon emiss comput tomographi imag muscarin acetylcholin receptor patient dementia healthi control highresolut singl photon emiss comput tomograph scan perform hour intraven administr approxim mci iqnb normal subject imag retain ligand show consist region pattern correl postmortem studi relat distribut muscarin receptor normal human brain high radioact count basal ganglia occipit cortex insular cortex low count thalamus virtual count cerebellum patient clinic diagnosi alzheim diseas obvious focal cortic defect frontal posterior tempor cortex patient clinic diagnosi pick diseas obvious frontal anterior tempor defect region interest statist analysi relat region activ reveal signific reduct bilater posterior tempor cortex patient alzheim diseas compar control studi demonstr practic acetylcholin receptor imag iqnb singl photon emiss comput tomographi data suggest focal abnorm muscarin bind vivo character patient alzheim diseas pick diseas studi address question partial volum artifact receptor quantif"
"widespread function effect discret thalam infarct order investig function effect thalam structur metabol remot morpholog intact cerebr region positron emiss tomographi ffluorodeoxyglucos studi region cerebr metabol rate glucos rcmrglu patient chronic unilater bilater infarct strict confin thalamus patient group comput tomograph scan show anterior medial posterior lesion compar match group healthi subject hemispher cmrglu mumol minut glucos metabol signific lower hemispher ipsilater infarct mumol minut patient bilater infarct lower hemispher cmrglu mumol minut unilater lesion mumol minut depend infarct locat thalamus differenti depress rcmrglu largest effect frontal occipit area medial infarct ipsilater thalam deactiv metabol pattern anterior thalam infarct close normal posterior infarct depress rcmrglu visual inferior limbic cortex cerebellar metabol rate normal limit case pattern region cerebr deactiv relat categori thalam projectionsintrathalam limbic system basal ganglia diffus cortic area specif defin neocort area small brain lesion widespread function sequela potenti demonstr positron emiss tomographi"
"effect sleep dyskinet movement parkinson diseas gill de la tourett syndrom huntington diseas torsion dystonia effect sleep involuntari movement dyskinesia parkinson diseas huntington diseas primari secondari torsion dystonia gill de la tourett syndrom studi total patient normal subject video electroencephalograph telemetri movement typic wake pattern occasion unequivoc sleep complet studi condit reappear similar circumst movement occur awaken lighten sleep stage sleep movement rare deeper phase sleep movement occur sleep awaken preced arous phenomena rare sleep spindl slow wave control group show normal semipurpos movement condit sleep rare dyskinesia normal movement similar circumst sleep result common effect generat system excit final common motor pathway"
"posttraumat torticolli report case torticolli precipit neck trauma dystonia began day trauma differ clinic idiopath torticolli mark limit rang motion lack improv sleep honeymoon period absenc gest antagonistiqu worsen action present improv support idiopath torticolli onset pain immedi trauma mark spasm paracerv muscl predomin featur anticholinerg therapi benefit improv occur botulinum toxin inject conclud torticolli caus peripher trauma uniqu clinic characterist"
"earli descript slowli progress aphasia slowli progress aphasia general dementia import issu presentday neuropsycholog research histor credit descript pick germanspeak author publish vivid descript pertin case pick contemporari max rosenfeld author observ patient slowli progress spatial disorient visual recognit deficit discuss patient remark modern context partial atrophi brain"
"frontal impair hypoperfus neuroacanthocytosi cerebr blood flow tomographi xenon inhal hmpao mtc hexamethylpropylen amin oxim technetium tc inject reveal sever hypoperfus frontal lobe year woman confirm neuroacanthocytosi find occur conjunct neuropsycholog deficit consist select frontal lobe dysfunct observ document type dementia neuroacanthocytosi"
"comparison motor respons apomorphin levodopa parkinson diseas magnitud pattern motor respons singl dose subcutan apomorphin oral levodopa compar patient parkinson diseas apomorphin produc shorter motor respons levodopa qualiti respons drug virtual indistinguish clinic observ support notion integr striatal postsynapt dopamin receptor key determin respons dopaminerg treatment parkinson diseas"
"evalu vigabatrin add drug manag sever epilepsi effect addit vigabatrin antiepilept drug therapi patient sever medic refractori epilepsi report forti patient experienc side effect predomin neurotrop drug withdrawn side effect commonest side effect drowsi behaviour chang remain patient week rang forti patient show mark improv seizur frequenc reduct compar pretrial period render seizur free appar toler effect drug note patient exacerb seizur occur drug withdrawn quick vigabatrin promis antiepilept drug"
"diurnal differ respons oral levodopa diurnal differ durat qualiti motor respons levodopa frequent patient qualiti durat motor respons object assess morn afternoon oral levodopa dose patient parkinsonian motor fluctuat complain diurnal variat respons normal levodopa medic result suggest control condit elimin effect diet overlap levodopa effect respons levodopa remain unchang day durat respons predict plasma levodopa level"
"accuraci predict progress patient stroke unit aim studi check accuraci predict factor affect progress physic abil activ daili live patient admit stroke unit seri patient admit consecut stroke unit assess test motor function cognit abil admiss basi assess predict made abil patient discharg patient assess level motor abil activ daili live discharg accuraci predict check predict found signific correl outcom relationship close clinic manag individu patient"
"shydrag syndrom effect fludrocortison threodihydroxyphenylserin blood pressur region cerebr blood flow case shydrag syndrom blood pressur cerebr blood flow sit supin posit studi influenc fludrocortison synthet mineralocorticoid threodihydroxyphenylserin dop precursor norepinephrin examin sit region cerebr blood flow rcbf measur xe inhal show tendenc decreas fludrocortison reduc fall blood pressur signific dop reduc fall diastol blood pressur rcbf signific"
"function outcom select posterior rhizotomi children cerebr palsi recent increas popular select posterior rhizotomi demand object document surgic outcom reason author analyz status children spastic cerebr palsi rhizotomi determin effect therapi muscl tone rang movement motor function postop test show reduct muscl tone compar preoper assess rang motion lower extrem signific increas improv function gross motor skill note increas rang motion knee thigh gait detect ambulatori patient studi computer dimension motion analysi preliminari find select posterior rhizotomi reduc spastic increas rang motion contribut improv activ function mobil"
"spontan neuron hyperact medial intralaminar thalam nuclei patient deafferent pain electr activ record singl cell thalamus patient chronic pain deafferent local anesthesia patient underw electrod implant thalamotomi treatment pain patient singl unit identifi discharg spontan highfrequ rhythmic burst discharg type short burst compris spike burst frequenc long train spike similar frequenc reconstruct electrod trajectori record made region aspect mediodors thalam nucleus central nucleus small part central median nucleus parafascicular nucleus patient spontan neuron burst activ exhibit imposs studi activ evok natur cutan stimul due continu spontan neuron discharg anim human studi suggest pain relat deafferent accompani spontan hyperact dorsal horn spinal cord ventral posterior thalam nuclei author present evid spontan neuron hyperact intralaminar thalam nuclei patient pain relat deafferent find suggest spontan neuron discharg patient pain relat deafferent widespread central nervous system previous appreci result import implic surgic treatment chronic pain"
"relationship bodi brain temperatur traumat braininjur rodent recent work shown mild moder level hypothermia profound reduc histolog biochem sequela cerebr ischem injuri present studi author examin effect fluidpercuss injuri brain temperatur anesthet rat effect anesthesia brain temperatur uninjur rat relationship brain rectal temporali muscl temperatur normothermia hypothermia hyperthermia studi moder magnitud fluidpercuss brain injuri atmospher rat result show brain temperatur anesthet injur rat anesthet uninjur rat unanesthet uninjur rat standard error degre degre degre degre degre degre signific differ temperatur general anesthesia injur uninjur rat greater absenc brain injuri brain temperatur signific lower anesthet rat unanesthet rat anesthet braininjur rat temporali muscl temperatur correl brain temperatur degre degre rang brain temperatur rapid chang induct hypothermia hyperthermia contrast rectal temperatur vari inconsist brain temperatur observ brain injuri influenc brain temperatur model anesthesia decreas brain temperatur level produc cerebr protect model extern monitor temporali muscl temperatur provid reliabl indirect measur brain temperatur experiment brain injuri author essenti monitor control brain temperatur studi experiment brain injuri"
"anticonvuls behavior effect competit methylaspart acid receptor antagonist cgp cgp kindl model epilepsi comparison mk carbamazepin oral activ competit methylaspart nmda receptor antagonist cgp dlaminomethylphosphonopenteno acid ethyl ester cgp evalu amygdalakindl rat model complex partial secondarili general seizur anticonvuls behavior effect compound compar noncompetit nmda receptor antagonist mk methyldihydroxyhdibenzocycloheptenimin antiepilept drug carbamazepin major drug treatment partial general seizur human compar evalu compound inject dose mgkg cgp cgp mgkg mk mgkg carbamazepin contrast carbamazepin cgp cgp mk exert weak anticonvuls effect fulli kindl rat increas focal seizur threshold weak anticonvuls effect nmda receptor antagonist kindl rat profound untoward behavior effect behavior syndrom induc nmda receptor antagonist kindl rat character mark ataxia hyperact case cgp mk stereotypi head weav low absent effect nmda receptor antagonist kindl seizur suggest compound clinic antiepilept partial secondarili general seizur view recent clinic find psychotomimet effect mk epilept patient similar excitatori effect produc cgp cgp mk kindl rat competit nmda receptor antagonist produc psychotomimet effect human"
"rediscov tactil agnosia eighti patient damag level nervous system rang peripher nerv cerebr cortex underw somesthet assess order determin degre basic complex perceptu motor disord affect tactil object recognit tor determin tor impair absenc basic sensorimotor impercept result suggest basic intermedi disord somesthet function impair tor commensur sever degre tor impair patient peripher lesion patient cortic lesion hemiparesi hemianopia preclud normal tor hemineglect contribut substanti tor impair impair tor occur absenc basic somesthet dysfunct constitut tactil agnosia tactil agnosia subtl nondis disord distinguish nonagnos sever disabl disord astereognosi tactil agnosia result unilater damag parietotempor cortic possibl includ somatosensori cortex hemispher"
"monitor cortic blood flow temporari arteri occlus aneurysm surgeri thermal diffus method aneurysm surgeri region cortic blood flow cobf continu monitor patient thermal diffus flow probe attempt assess effect temporari major arteri occlus blood flow outcom cobf ml min safe period temporari clip appli distal perfor minut occlus time shorten cobf ml min patient suffer basal infarct detect cobf monitor attent paid blood flow deep structur temporari clip appli site proxim perfor branch direct measur cobf estim time temporari occlus major vessel toler"
"chronic headach function shunt pressur monitor chronic headach shuntdepend patient small ventricl long treat regard intracrani pressur studi pressur monitor patient demonstr fell distinct categori headach caus intracrani hypertens headach hypotens show relat symptom pressur therapeut procedur treat categori oppos clear intracrani pressur monitor essenti success manag complaint"
"intracrani aneurysm intervent neurovascular treatment detach balloonsresult case patient complex surgic difficult intracrani aneurysm treat intervent neurovascular techniqu neurolept anesthesia transfemor femor approach silicon microballoon flow direct intracrani circul guid direct aneurysm detach aneurysm elimin circul parent arteri preserv broadbas ectat aneurysm test occlus perman occlus aneurysm parent vessel perform patient aneurysm includ case involv anterior case involv posterior circul treat techniqu case parent vessel occlud case primari occlus aneurysm achiev preserv parent arteri therapyrel complic includ death stroke follow examin perform month treatment follow rang month year patient standard surgic therapi fail aneurysm surgic inaccess anatom locat intervent techniqu make detach balloon therapeut altern"
"map distribut amobarbit sodium intracarotid wada test tcm hmpao spect intracarotid amobarbit sodium wada test local speech memori function prior surgic treatment tempor lobe seizur author mix technetiumm hexamethylpropyleneamin oxim hmpao amobarbit sodium inject mixtur patient epilepsi singl photon emiss comput tomographi spect brain perform determin intracerebr distribut amobarbit sodium result spect compar convent digit subtract angiographi dsa distribut tcm hmpao amobarbit sodium vari patient patient spect reveal statist distribut predict convent angiographi distribut differ dsa differ signific spect reveal infrequ deliveri mesial tempor lobe structur emphas caution intracarotid amobarbit sodium test predict outcom remov area"
"development dyslexia women neuropatholog find patient brain male case dyslexia show symmetri planum temporal predomin leftsid cerebrocort microdysgenesi report women dyslexia brain planum temporal symmetr brain multipl foci cerebrocort glial scar present women scar myelin suggest origin late intrauterin earli postnat life scar left perisylvian involv portion vascular border zone tempor cortex scar numer occur border zone anterior middl posterior cerebr arteri symmetr case show variabl extent brain wart molecular layer ectopia focal architecton dysplasia ident male case women primari brain neoplasm oligodendroglioma lowgrad astrocytoma women show small angioma reexamin previous report male case disclos myelin glial scar control brain asymmetr plana temporal show myelin glial scar signific anatom find discuss etiolog factor consid effect autoimmun diseas nervous system"
"time topographi cerebr blood flow aura headach migrain attack ten year studi result fragment knowledg region cerebr blood flow migrain aura classic migrain present studi number repeat studi patient larg determin statist signific sequenc event statist signific spatial relat observ event decreas region cerebr blood flow posterior cerebr hemispher develop patholog process accompani aura symptom headach occur region cerebr blood flow remain decreas headach phase region cerebr blood flow gradual chang abnorm low abnorm high appar chang headach patient headach disappear region cerebr blood flow remain increas region cerebr blood flow reduct aura symptom great major patient unilater bilater headach unilater headach local side region cerebr blood flow reduc aura symptom origin aura symptom perceiv occur contralater origin hypoperfus hemispher result suggest simpl model migrain attack patholog disturb cerebr hemispher aura symptom time delay headach stimul local vascular nociceptor bilater headach caus unilater cerebr disturb explain recent neuroanatom neurophysiolog find"
"ataxia peripher neuropathi benign variant peroxisom dysgenesi year boy panperoxisom dysfunct clinic featur includ hypotonia areflexia ataxia cognit vision hear hepat function normal panel peroxisom marker includ longchain fatti acid phytan acid pipecol acid catalas compartment abnorm uniqu benign syndrom disord peroxisom biogenesi"
"okt encephalopathi okt therapi induct immunosuppress patient underw renal transplant produc obtund quadriparesi comput tomograph scan evid brain edema find resolv day support therapi okt withdraw"
"orocaec transit time duchenn muscular dystrophi smooth muscl degener occur duchenn muscular dystrophi measur fast orocaec transit time patient advanc duchenn muscular dystrophi muscular dystrophi healthi control signific differ found contrast report gastric hypomotil duchenn muscular dystrophi found evid impair small intestin motil"
"effect ph buffer reduc pain subcutan infiltr bupivicain publish erratum emerg med jul author propos ph buffer bupivicain sodium bicarbon reduc pain local subcutan infiltr doubleblind prospect studi healthi adult volunt receiv ml subcutan infiltr buffer bupivicain dorsum random chosen hand ph adjust ad ml sodium bicarbon meq correct ml vial commerci bupivicain dilut control hand inject amount unbuff agent pain score infiltr nonseg visual analogu scale student test pair measur analyz intergroup pain score differ forti subject report pain buffer bupivicain note modest increas subject report differ pain score buffer agent mm compar mm control differ controlexperiment mm df author conclud addit sodium bicarbon bupivicain reduc pain local infiltr"
"research physic medicin rehabilit xii measur tool applic brain injuri basic principl techniqu measur relev biomed disciplin purpos articl explain import medic rehabilit illustr choos assess instrument describ natur measur medic rehabilit exampl brain injuri rehabilit reliabl basic scientif measur valid ultim criterion close purpos measur content valid criterion valid construct valid explain sensit rehabilit intervent signific patient real live ecolog valid emphas measur function outcom disabl show improv rehabilit impair measur extens select list measur coma global status disabl communic cognit impair handicap present main illustr exampl illustr choos measur studi comprehens programlevel outcom studi learningbas intervent develop general purpos databas measur activ daili live mobil publish evid reliabl valid found scale ecolog valid sensit outcom measur studi clinic util measur scarc gap span clinic research limit resourc physic medicin rehabilit benefit formal studi reliabl valid measur instrument increas sophist choic measur"
"recoveri time independ function poststrok stroke patient undergo physic rehabilit monitor daili determin length time recov independ function patient admit attain sit posit independ walk independ negoti stair independ discharg patient attain sit supin independ patient achiev abil walk independ patient learn negoti stair independ time admiss achiev independ function time onset stroke achiev independ function model relat explanatori variabl age sex side lesion comorbid presenc depress extent impair percept cognit auditori comprehens verbal express variabl found influenc recoveri time age influenc rate recoveri walk stair climb perceptu impair influenc rate achiev independ sit stair climb depress comprehens influenc walk"
"ventilatori function predictor fatal stroke object investig relat ventilatori function subsequ mortal due cerebrovascular diseas designprospect longitudin studi subject total male civil servant age year entri examin whitehal studi main outcom measuremort cerebrovascular diseas icd year follow result men sinus rhythm entri die due stroke year follow compar men forc expiratori volum greater equal litr litr die cerebrovascular diseas rate ratio adjust age systol blood pressur confid interv increas risk occur tertil systol blood pressur nest casecontrol analys control precis confound effect age height smoke match employ grade physiolog risk factor model effect forc expiratori volum independ age height smoke habit employ grade blood pressur weight cholesterol concentr glucos toler electrocardiograph abnorm histori chest pain histori intermitt claudic conclusionsmeasur ventilatori function assist clinic decis treat mild hypertens impair ventilatori function stroke share common"
"avail transplant organ brain stem dead donor intens care unit object audit januari june quantifi separ heart kidney liver lung cornea increas transplant organ brain stem dead potenti donor intens care unit compar increas achiev octobernovemb intens nation public transplant designprospect audit death intens care unit england januari june subsequ case studi impact public offer donat octobernovemb set region special health author england patient patient die intens care unit confirm brain stem dead general medic contraind organ donat main outcom measuresorgan specif suitabl transplant report intens care unit consent donat specif suitabl organ procur specif organ report suitabl transplant offer result brain stem dead potenti donor estim organ specif suitabl heart kidney liver lung cornea refus relat account major loss suitabl organ type kidney loss equival brain stem dead actual kidney donor discuss organ donat import reason miss kidney donor loss equival brain stem dead actual donor procur difficulti alloc organ notabl miss suitabl liver lung donor offer total liver donor offer suitabl lung donor month procur suitabl offer organ rare kidney modest order heart cornea corneal donat brain stem dead potenti donor improv increas brain stem dead actual corneal donor specif measur promot corneal donat organ offer reduc refus rate restrict offer procur discuss donat account equal number lost donat heart equival donat heart octobernovemb intens posit public transplant rate refus discuss fell compar januaryjun offer suitabl donor increas signific compar month notabl heart donor expect kidney donor expect kidney notic increas actual donor actual audit donor expect donor conclus strategi increas suppli transplant organ brain stem dead potenti donor intens care unit identifi reduc refus relat avoid procur suitabl organ logist initi deterior initi suitabl organ donor care initi convert restrict offer unrestrict offer ensur discuss famili earli referr transplant team coordin time discuss donor care agreement medic suitabl donat specif organ solv logist problem procur prerequisit increas offer translat increas donat impact public measur offer suitabl donor actual donat"
"dacronwoven pacemak pouch influenc longterm pacemak mobil pacemak migrat interfer correct pace system function patient comfort dacron pouch develop prevent problem assess efficaci pouch measur factor pacemak mobil patient longterm follow patient divid group basi dictat oper report group pouch anchor stitch group pouch group anchor stitch pacemak header pouch averag age studi popul year total follow time month group month group month group month signific differ pacemak measur movement inferosuperior lateromedi direct differ distanc incis scar pacemak header group signific differ group group degre tilt pacemak chest wall compar degre degre group degre degre degre degre group data suggest dacron pouch restrict pacemak mobil parallel chest wall longterm follow reduc angl pacemak tilt relat chest wall"
"sleepwalk precipit treatment sleep apnea nasal cpap year man long histori snore observ apneic episod excess daytim sleepi underw night polysomnographi demonstr sever obstruct sleep apnea nasal cpap trial episod sleepwalk observ period delta sleep rebound"
"alzheim diseas relat disord state mental hospit data nationwid survey notwithstand decad transfer elder nurs home geriatr patient continu resid state mental hospit patient thought suffer alzheim diseas relat disord adrd studi report data nationwid survey state hospit exploratori adrd patient serv state hospit admiss trend reason admiss sourc referr civil commit nurs home patient dement ill place state hospit continuum care adrd patient discuss"
"differ membran interact scrapi amyloid precursor protein normal scrapi creutzfeldtjakob diseaseinfect brain membran interact hydrophob normal prpc infecti isoform prpsccjd scrapi creutzfeldtjakob diseas amyloid precursor protein studi normal isoform hamster human scrapi amyloid precursor protein found microsomalsynaptosom membran anchor sole termin glycolipid glycolipid cleavag result dissoci membran chang behavior high hydrophob hydrophil protein suscept proteas contrast prpsccjd isoform resist releas glycolipidcleav enzym part prpsccjd releas membran prolong trypsin treatment yield proteaseresist product kda result demonstr proteolyt resist membranebound prpsccjd isoform presenc appar diseaseinduc mechan membran interact scrapi cjdinfect microsom synaptosom membran"
"creutzfeldtjakob diseas allogen dura review risk safeti surgeon lay public recent express concern safeti allogen dura relat transmiss creutzfeldtjakob diseas case result tissu procur commerci agenc adher criteria accept american associ tissu bank southeast organ procur foundat review discuss risk safeti allogen dura find reassur surgeon safeti allogen dura proper process catalogu bona fide reput tissu bank date document case report center diseas control creutzfeldtjakob diseas transmit allogen dura obtain regist tissu bank"
"clinic diagnost cocain abus review research literatur psychophysiolog effect cocain studi group cocain addict patient exhibit fleet unform organ delus hallucin case report case present qualiti advers subject effect cocain emphas differenti diagnosi cocain delusion disord paranoid schizophrenia discuss guidelin accur differenti diagnosi provid"
"neurobehavior effect phenytoin prophylaxi posttraumat seizur order determin potenti negat neurobehavior effect phenytoin prevent develop posttraumat seizur subject random phenytoin placebo receiv neurobehavior assess month postinjuri receiv assign drug month receiv drug sever injur phenytoin signific impair perform month signific differ found function phenytoin moder injur patient month sever group year patient stop receiv phenytoin protocol year improv placebo case measur conclud phenytoin negat cognit effect combin lack evid effect prevent posttraumat seizur week rais question longterm prophylaxi find negat phenytoin proven efficaci control establish seizur cognit effect wors anticonvuls drug"
"physic pharmacolog restraint nurs home patient dementia impact special unit casecontrol studi special dementia unit tradit unit state investig physic pharmacolog restraint patient diagnosi dementia physic restraint observ dementia unit patient comparison unit patient bed day adjust odd ratio confid interv pharmacolog restraint routin dementia unit patient comparison unit patient adjust odd ratio confid interv multivari logist regress identifi resid nonspeci nurs home unit nonambulatori status transfer depend mental status impair hip fractur histori high nurs staffpati ratio found independ predictor physic restraint physic abus behavior sever mental status impair frequent famili visit found signific predictor pharmacolog restraint advanc patient age larg nurs home size patient nonambulatori status protect result support conclus physic pharmacolog restraint constitut separ treatment modal risk factor special dementia unit success reduc physic pharmacolog restraint"
"retrovirusinduc spongiform myeloencephalopathi mice region distribut infect target cell neuron loss occur absenc viral express neuron casbr murin leukemia virus mulv induc spongiform myeloencephalopathi result progress hindlimb paralysi situ hybrid casbr mulvspecif probe studi viral express central nervous system infect cell concentr region spongiform lesion gliosi detect lumbosacr spinal cord brainstem deep cerebellar region suggest causat link level virus express degre patholog diseas viral express suffici diseas signific viral express observ region exhibit patholog cerebellar cortex hippocampus corpus callosum peripher nervous system diseas nondiseas region endotheli glial cell identifi main target cell neuron diseas region show viral express region distribut spongiform laid earli infect express detect day postinfect region diseas result nonneuron cell distinct properti region central nervous system suggest indirect mechan neuron loss consequ viral express nonneuron cell"
"respons suxamethonium myasthen patient remiss cumul dose infus determin dose respons suxamethonium patient diagnos myasthenia gravi true remiss asymptomat receiv therapi ed ed valu suxamethonium mgkg mgkg infus rate mgkghour requir maintain depress singl twitch respons monitor integr electromyographi valu rang normal patient conclud myasthen patient true remiss demonstr resist suxamethonium"
"modif pain inject propofol comparison lignocain procain pain inject propofol assess control randomis studi patient receiv lignocain mg procain mg isoton salin ml inject propofol vein back hand incid pain inject control group compar studi lignocain procain signific reduc pain statist differ group"
"lidocain potenti cocain toxic studi hypothesi toxic effect cocain enhanc presenc lidocain studi popul male spraguedawley rat weigh method anim receiv intraperiton inject cocain mgkg lidocain mgkg combin dose cocain simultan mgkg lidocain incid time seizur death record group compar chi analysi varianc analys result dose mgkg lidocain induc seizur death effect simultan inject cocain lidocain dramat increas incid seizur death cocain incid seizur anim receiv mgkg cocain increas addit mgkg lidocain equal equal death occur anim receiv mgkg cocain addit mgkg lidocain result death anim equal group similar rat receiv mgkg cocain incid death increas mgkg lidocain equal conclus rat toxic cocain signific increas simultan exposur lidocain"
"genet juvenil form taysach diseas lebanes child abnorm betahexosaminidas alpha gene clinic phenotyp lebanes patient juvenil form taysach diseas studi clinic featur progress spastic ataxia cognit declin protein code sequenc betahexosaminidas alphachain complementari dnas isol polymeras chain reaction complet normal transit nucleotid posit exon result substitut normal arginin cgc histidin cac patient cousin marriag heterozyg mutat abnorm allel carri father identifi mutat respons infantil jewish taysach diseas biosynthet immunoprecipit studi cultur fibroblast show synthesi alphachain precursor matur form alphasubunit detect"
"neuroanatomi fragil syndrom posterior fossa occurr specif posterior fossa abnorm measur magnet reson imag brain investig group male fragil syndrom comparison group consist male development disabl male normal iq size posterior cerebellar vermi signific decreas fourth ventricl signific increas group male fragil syndrom compar male comparison group neuroanatom abnorm secondari hypoplasia atrophi"
"visual dysfunct alzheim diseas relat normal age publish erratum ann neurol mar patient alzheim diseas ad compar agematch young healthi control subject visual deficit function observ color stereoacu contrast sensit backward mask homogen pattern critic flicker fusion threshold normal relat agematch healthi subject color major error tritanomal blue axi color stereoacu deficit unrel sever dementia accord model vision describ function modular diffus cortic local contrast sensit depress frequenc rang ad patient impair low high spatial frequenc contrast observ normal age pattern highfrequ loss healthi elder subject show depress critic flicker fusion threshold reduc contrast sensit high frequenc relat young group differ group found vision test subset ad group receiv detail neuroophthalmolog examin abnorm found find normal threshold critic flicker fusion suggest widespread visual dysfunct report relat patholog primari visual associ cortex ad retina optic nerv"
"nerv growth factor prevent toxic neuropathi mice taxol promis antitumor drug therapeut limit toxic sensori neuropathi taxol cytotox dorsal root ganglion neuron vitro effect prevent cotreat trophic protein nerv growth factor sought develop anim model determin nerv growth factor prevent taxol neuropathi vivo administr taxol mice result profound sensori neuropathi character decreas dorsal root ganglion content peptid neurotransmitt substanc elev threshold thermal induc pain diminish amplitud compound action potenti caudal nerv coadministr nerv growth factor prevent sign neurotox find suggest administr nerv growth factor prevent toxic sensori neuropathi"
"local hdihydroergotaminebind site cat central nervous system relev migrain dihydroergotamin dhe treatment choic abort acut attack migrain efficaci year mechan action disput data site action dihydroergotamin provid insight mechan action identifi locus potenti abnorm pathophysiolog migrain vitro vivo autoradiograph techniqu local specif bind site hdihydroergotamin cat brain examin bind dorsal horn cervic spinal cord medulla nucleus tractus solitarius area postrema descend spinal trigemin nucleus mesencephalon cerebr cortex highest densiti bind site found dorsal medial raph nuclei midbrain brain region label intraven administr hdihydroergotamin import brain area specif label key nuclei involv cranial pain transmiss suggest dihydroergotamin act central site migrain"
"neurolog status spina bifida patient orthoped surgeon purpos paper review recent develop neurolog assess spina bifida patient determin neurosegment level lesion recognit spastic progress paralysi potenti deform function expect status neurolog deficit remain import factor determin myelomeningocel patient ultim function abil accur neurolog assess assist meet aim orthoped manag includ prevent joint contractur correct deform prevent skin sore obtain locomotor function"
"gait analysi treatment ambulatori child cerebr palsi surgic treatment children cerebr palsi chang stage singl joint procedur comprehens simultan boni softtissu correct regimen treat multipl joint level plane abnorm subject error base sole clinic examin scientif evalu provid clinic gait analysi preoper postop analys provid clinician inform neurolog pattern determin surgic protocol judg"
"impact day care dementia patientscost relat view forti patient psychogeriatr day centr analys resourc cost level base interview staff relat relat econom outcom cost util analysi month period prior day care compar month care resourc home increas institut care reduc fifti percent patient improv particip day care cost util analysi appli cost year pound"
"serum creatinin independ predictor surviv stroke prospect studi relationship serum creatinin surviv elder subject admit stroke monitor period month poststrok multivari proport hazard model serum creatinin remain independ predictor mortal account import predictor level conscious miniment state score age leucocyt count presenc heart diseas diabet heart failur atrial fibril cardiovascular medic associ elev serum creatinin mortal found patient subgroup ctproven infarct intracerebr haematoma conclud serum creatinin independ predictor surviv stroke studi requir confirm relationship elucid mechan"
"intracrani hypertens relat memori function year sever head injuri relationship intracrani hypertens residu memori deficit close head injuri evalu month year neurobehavior outcom data obtain traumat coma data bank intracrani pressur analyz percentag time exceed mm hg maximum record hour injuri memori measur includ recal word list prose recal visual memori design obtain month year injuri intracrani hypertens occur half traumat coma data bank cohort met criteria neurobehavior follow studi linear regress analysi disclos effect elev intracrani pressur measur memori month result negat year follow examin conclud elev intracrani pressur exert effect memori function effect diminish year survivor sever head injuri"
"influenc calcium antagonist nimodipin induc hypertens behavior cerebr pial arteri bloodbrain barrier cerebr edema cerebr infarct cat hour occlus middl cerebr arteri thirti anesthet cat random assign group cat nimodipin treatment nimodipin treatment combin induc hypertens control group behavior cerebr pial arteri measur microscop observ cranial window middl cerebr arteri cat clip hour transorbit approach hour circul reestablish middl cerebr arteri evan blue dye inject intraven minut anim kill administr nimodipin salin treat control group start minut middl cerebr arteri clip maintain end experi induc hypertens produc administr dopamin occlus damag bloodbrain barrier bbb judg extravas evan blue dye cerebr edema infarct evalu histolog find promin control group extent hemispher affect standard error extravas edema infarct hand extravas evan blue dye cerebr edema signific extens group treat nimodipin induc hypertens extravas hemispher edema group treat nimodipin extravas hemispher edema infarct size similar group hemispher"
"kenneth mckenzi harvey cush earli neurosurg treatment spasmod torticolli dr kenneth mckenzi train peter bent brigham hospit dr harvey cush time patient spasmod torticolli cush treat innov oper disord good result case spark interest dr mckenzi publish case year review surgic histori peter bent brigham hospit found origin record document case record includ postop draw intraop field dr cush sketch dr mckenzi illustr postop sensori examin pre postop photograph patient"
"spinal man declar brain death complex spinal automat patient declar brain dead movement tend cerebrospin shock abat postul manifest reflect physiolog potenti isol spinal cord spinal movement includ revis guidelin determin cerebr death"
"comparison midazolam nalbuphin intraven sedat introduct nalbuphin intraven sedat midazolam ad qualiti sedat short oper procedur greater tendenc patient receiv nalbuphin midazolam sleep afternoon treatment compar receiv midazolam signific patient nausea vomit midazolamnalbuphin group patient midazolam group"
"genet map dna probe xq defin strategi dna studi fragil syndrom fragil syndrom common famili mental retard character fragil site end long arm chromosom unusu genet cytogenet link condit make genet counsel difficult dna studi limit genet counsel nearest polymorph dna loci recombin fraction fragil mutat fraxa polymorph loci recent region chromosom posit loci relat fraxa defin genet linkag studi affect famili locidx dxs dxs id dxs recombin fraction fraxa closest locus dxs distal fraxa recombin fraction polymorph loci detect dna enzymat digest limit number restrict endonucleas strategi dna studi base restrict endonucleas probe detect polymorph women strategi great increas util dna studi provid genet advic famili fragil syndrom"
"intermedi hyperhomocysteinemia result compound heterozygos methylenetetrahydrofol reductas mutat subject thermolabil methylenetetrahydrofol reductas mthfr discov oblig heterozygot sever mthfr defici famili member subject normal mthfr specif activ lymphocyt extract normal serum folat cyanocobalamin intermedi hyperhomocysteinemia high serum folat cyanocobalamin excess accumul serum homocystein biochem featur subject distinguish subject homozyg thermolabil mthfr specif activ approxim normal heterozygot sever mthfr defici enzym thermost specif activ normal propos subject genet compound allel sever mutat allel thermolabil mutat mthfr gene postul subject genet compound suscept develop intermedi hyperhomocysteinemia normal folat level nonetheless hyperhomocysteinemia due compound heterozygos correct oral folic acid therapi"
"distribut alphachain betahexosaminidas mutat taysach carrier dna carrier taysach gene test presenc mutat common found ashkenazi jew call insert splice junction adult mutat ashkenazi jew test insert mutat splice junction mutat adult mutat jewish carrier test oblig carrier insert mutat adult mutat remain"
"muscl rehabilit impair elder nurs home resid base observ muscl function age exacerb frailti program muscl strengthen develop correct specif defect muscl pilot studi undertaken function impair nurs home resid age rang year mark deterior muscl function secondari age disus multipl chronic ill fourteen subject complet week program advers effect patient improv muscl function endur strength speed increas program subject increas spontan activ decreas depend improv evid month rehabilit result suggest care supervis shortterm program muscl rehabilit nurs home resid achiev enhanc level physic function"
"wrist flexion adjunct diagnosi carpal tunnel syndrom effect minut wrist flexion median motor sensori evok potenti latenc individu studi nineteen subject carpal tunnel syndrom cts diagnos increas median nerv latenc wrist valu normal rang assign control group slight prolong sec evok potenti latenc observ group flexion differ group signific establish ad wrist flexion convent screen method"
"detect lower motor neuron dysfunct pharynx larynx electromyographi studi assess util clinic electromyographi emg detect lower motor neuron lmn upper motor neuron umn dysfunct affect intrins muscl larynx pharynx twenti subject examin clinic diagnos includ periop nerv injuri cerebr infarct medullari infarct rest activ motor unit action potenti muap morpholog muap recruit evalu case medic record exclud emg data analyz clinic evid lmn umn dysfunct intrins muscl larynx pharynx diagnosi lmn dysfunct rest clinic data consist cranial nerv injuri poliomyel wallenberg syndrom unilater bulbar palsi criteria umn dysfunct includ previous cerebr brainstem infarct mass lesion presenc hemiparesi electromyograph abnorm signific lmn dysfunct signific umn dysfunct paramet test muap recruit sensit specif"
"neurobehavior effect phenytoin carbamazepin valproic acid implic traumat brain injuri due risk posttraumat epilepsi phenytoin carbamazepin valproic acid prescrib patient traumat brain injuri tbi review literatur examin evid neurobehavior impair due carbamazepin phenytoin valproic acid compar studi perform tbi popul make difficult determin medic prefer direct infer studi epilepsi patient tbi patient hazard due differ popul report find epilepsi patient subtl consist studi drug exert effect cognit motor function epilept patient impair worsen increas serum level vari length experi drug make difficult assign relat weight evid compar assess cognit behavior effect anticonvuls tbi popul"
"neuroacanthocytosi clinic haematolog patholog studi case nineteen case includ case famili nonfamili case multisystem neurolog diseas acanthocytosi peripher blood normal plasma lipoprotein mild acanthocytosi easili overlook scan electron microscopi neurolog asymptomat relat signific acanthocytosi identifi famili screen includ clinic affect age onset rang yrs clinic progress mark phenotyp variat cognit impair psychiatr featur organ person chang occur half case seizur orofaciolingu involuntari movement pseudobulbar disturb common caus dysphagia dysarthria sever bite lip tongu rare chorea symptomat case dystonia tic involuntari vocal akineticrigid featur occur case movement disord computer tomographi demonstr cerebr atrophi caudat atrophi common nonspecif focal symmetr signal abnorm caudat lentiform nuclei magnet reson imag case depress absenc tendon reflex note case neurophysiolog abnorm axon neuropathi sural nerv biopsi case show evid chronic axon neuropathi promin regen activ predomin affect larg diamet myelin fibr serum creatin kinas activ increas case clinic evid myopathi postmortem neuropatholog examin case reveal extens neuron loss gliosi affect corpus striatum pallidum substantia nigra par reticulata cerebr cortex spare spinal cord show evid anterior horn cell loss exampl mcleod phenotyp link abnorm express kell blood group antigen identifi singl famili includ femal genet neuroacanthocytosi unclear heterogen pedigre data associ mcleod phenotyp suggest locus disord short arm chromosom"
"idiopath intracrani hypertens prospect studi patient manag patient idiopath intracrani hypertens iih base presenc progress visual loss character clinic iih complet monitor clinic status visual function consecut newlydiagnos patient period month averag follow month age onset symptom rang yrs women obes weight kg common symptom headach transient visual obscur intracrani nois patient initi complaint sustain visual loss visual loss determin goldmann perimetri autom perimetri contrast sensit test abnorm snellen acuiti patient blind eye goldmann visual field grade improv patient visual function deterior deterior visual field grade signific weight gain year diagnosi visual loss patient iih common revers patient evalu perimetri strategi contrast sensit test care examin optic disc"
"dual task perform process resourc normal subject patient parkinson diseas recent year grow consensus investig presenc absenc extern cue guid behaviour attent import factor determin deficit found patient parkinson diseas pd earlier studi author suggest pattern impair intact perform explain term differenti resourc demand task combin deplet level central process resourc pd patient experi report employ dualtask paradigm assess normal subject relat process demand cu uncu version stroop task result support propos noncu task made greater demand subject limit process resourc perform resourc demand secondari task concurr stroop test produc normal subject pattern impair perform report previous pd patient experi dualtask paradigm employ group pd patient normal agedmatch control patient show increas reaction time stroop task perform resourc demand secondari task patient show interf effect concurr foot tap articulatori suppress task result support hypothesi pd patient deplet central process resourc present data altern explan result consid possibl repres deficit switch process resourc task combin demand outweigh resourc"
"shortterm memori sentenc comprehens investig patient cross aphasia relationship shortterm memori impair sentenc comprehens explor hand patient focal temporopariet lesion hemispher general clinic profil characterist patient memori word list suggest occurr mirror imag cross aphasia detail analysi patient abil repeat comprehend sentenc import differ case previous report patient shortterm memori impair suggest differ relat unusu pattern neuroanatom organ cognit function involv symptom dissoci implic model normal languagememori interact"
"taskdepend variat parkinsonian motor impair studi visuallyguid arm movement patient parkinson diseas pd suggest relationship slow movement reduct ratio movement amplitud peak veloc recent studi pd impair learn natur movement perform visual guidanc movement sequenti motor behaviour speech address issu pd subject agesexmatch control compar perform task requir lower jaw singl rapid visuallyguid movement equival movement singl speech syllabl inher visual guidanc learn speech movement produc natur sequenc pd subject manifest similar deficit visuallyguid jaw lower previous report arm movement reduc velocityamplitud ratio increas movement durat contrast analog jaw movement sequenti speech task unimpair measur result suggest pd motor impair influenc varieti factor includ degre task familiar natur avail visual inform"
"effect anticonvuls treatment low level folat thiamin amin metabolit cerebrospin fluid total epilept patient studi respect biogen amin precursor metabolit csf level folat thiamin blood csf length treatment phenytoin pht pht intox cns atrophi alter csf amin metabolit level relat primarili pht intox low csf folat thiamin level length treatment cns atrophi pht intox increas csf hydroxyindoleacet acid hiaa low folat level decreas csf hiaa homovanil acid low thiamin level decreas csf hiaa methyoxyhydroxyphenylethylen glycol remain extent alter biogen amin metabol mediat low cns vitamin level lead deficit cerebr function"
"human olfactori discrimin unilater frontal tempor lobectomi olfactori discrimin detect studi patient unilater cerebr excis left tempor lobe left frontal lobe left pariet lobe frontal tempor lobe normal control subject detect threshold butyl alcohol measur separ nostril differ subject group nostril exclud primari sensori loss discrimin task involv monorhin present repair unfamiliar odor subject judg qualiti result show signific deficit discrimin confin nostril ipsilater lesion patient tempor lobe remov patient frontal lobe excis impair patient frontal lesion includ orbit cortex impair found nostril patient left pariet lesion demonstr signific deficit normal subject show consist perform left nostril result interpret reflect import orbitofront cortex olfactori discrimin tempor lobe lesion disrupt input orbitofront cortex produc poorer perform nostril differ normal subject birhin impair patient orbitofront damag suggest relat advantag orbit region olfactori process"
"sequenc parkinson diseas abnorm program control movement central program deficit parkinson diseas pd studi reaction time rt experi experi pd patient control perform sequenc hand postur vari length number postur repetit heterogen delay interv movement movement pd group plan repetit movement control heterogen sequenc rt increas sequenc length pd group impli preprogram interrespons time irt data repetit sequenc show pd group difficulti control movement irt faster sequenc longer time schedul termin sequenc movement heterogen sequenc pd group made error slower control chang hand postur suggest deficit switch respons rt decreas longer delay similar group irt continu improv pd group similar type sequenc suggest deficit specif program respons experi subject made decis number hand postur sequenc pd patient decis time improv longer delay heterogen sequenc suggest problem identifi number hand postur result implic level motor dysfunct pd emphas influenc sequenc length complex"
"pain control ambulatori elder pain control elder matter etiolog set major clinic challeng age uniqu physiolog decreas percept pain enhanc sensit opioid analges principl evalu patient pain review includ object instrument pain assess viewpoint physician patient good pain control achiev nonopioid acetaminophen nonsteroid antiinflammatori drug opioid analges case adjuv agent discuss concern patient addict cancer pain relief program"
"plastic integrin express nervederiv connect tissu cell human schwann cell perineuri cell fibroblast express mark pattern beta integrin nerv develop neoplasia vitro strike select express pattern beta alpha alpha alpha integrin subunit reveal endoneurium perineurium epineurium fetal adult human peripher nerv immunostain specif antibodi alpha subunit express schwann cell fetal adult nerv alpha epitop express exclus adult tissu primarili present perineuri cell alpha epitop express innermost cell layer perineurium fetal adult nerv tumor cell schwannoma cutan neurofibroma express alpha alpha subunit indic schwann cell potenti express alpha subunit vivo cell cultur establish human fetal nerv neurofibroma reveal express alpha alpha epitop schwann cell perineuri cell fibroblast schwann cell alpha epitop occasion concentr adjac schwann cell cellcel contact find emphas nerv connect tissu cell chang profil express extracellular matrix receptor condit regulatori control signal exert axon humor factor extracellular matrix peripher nerv plastic play import role nerv develop neoplast process affect connect tissu compart peripher nerv"
"differenti diagnosi mut cbl methylmalon aciduria dnamedi gene transfer primari fibroblast methylmalon aciduria caus mutat gene encod methylmalonyl coenzym mutas apoenzym mut gene requir provis cofactor cbl mut cbl form classic differenti somat cell complement describ method differenti diagnosi mut cbl methylmalon aciduria dnamedi gene transfer methylmalonyl coa mutas cdna clone gene transfer function methylmalonyl coa mutas cdna clone mut fibroblast reconstitut holoenzym activ measur metabol cpropion cultur ident gene transfer cbl fibroblast effect method differenti diagnosi mut cbl genotyp cell patient clinic diagnosi methylmalon aciduria shown facil sensit specif method genet diagnosi work establish principl dnamedi gene transfer identifi genotyp diseas result mutat genet loci type differenti genotyp diagnosi import establish applic somat gene therapi individu patient"
"modifi translabyrinthin approach preserv hear acoust tumour surgeri remov acoust schwannoma translabyrinthin approach previous consid incompat hear preserv modifi approach prevent loss endolymph success remov intracanalicular acoust schwannoma origin inferior vestibular nerv preserv hear oper ear report repres preliminari find techniqu manag intracanalicular acoust tumour"
"clinic featur associ case motor neuron diseas case motor neuron diseas studi retrospect case note teach centr age onset rang year year durat ill death year subgroup diseas present progress bulbar palsi present age year previous unrecognis excess femal suffici equal sex ratio incid diseas age group potenti causat clinic associ emerg relat note occup exposur leather product trauma surgic procedur diseas trend patient motor neuron diseas give histori abstent alcohol"
"progress degener tempor lobe studi positron emiss tomographi year man twelv year progress histori prosopagnosia recent difficulti intellectu skill preserv positron emiss tomographi pet reveal area tempor lobe hypometabol addit area sever hypometabol left tempor pole repres progress focal cortic degener similar primari progress dysphasia affect tempor lobe"
"cyclosporin akinet mutism extrapyramid syndrom liver transplant patient develop akinet mutism day introduct intraven cyclosporin immunosuppress liver transplant patient addit develop florid orofaci dyskinesia resolv complet akinet mutism withdraw cyclosporin patient time akinet mutism extrapyramid syndrom develop absenc identifi suggest cyclosporin precipit factor subsequ patient show sign pseudobulbar palsi abnorm pon mri scan suggest central pontin myelinolysi cpm patient experienc signific fluctuat serum sodium risk factor central pontin myelinolysi exact relationship earlier cyclosporin relat mutism clear"
"grade white matter lesion ct mri simpl scale develop test simpl point scale grade white matter lesion anterior posterior region brain twenti ct scan mri scan separ judg observ presenc sever white matter lesion observ radiologist neurologist ct scan periventricular grade extent absent part involv white matter extend subcort region mri lesion grade lesion singl multipl focal lesion multipl confluent lesion pairwis agreement combin observ scan correct chanc kappa statist maxim agreement weight kappa anterior posterior region combin ct scan mri scan point scale separ region suitabl basi crosssect longitudin studi larg seri patient"
"communiti hospitalbas stroke program north carolina oregon york stroke diagnosi factor influenc diagnost evalu patient acut stroke patient communiti hospitalbas stroke program unspecifi stroke diagnosi specif diagnosi eventu treatment deriv part diagnost test examin effect clinic condit geograph demograph factor incid diagnost test acut stroke multivari analysi race sex histori hypertens histori diabet influenc chanc test older age strong reduc chanc receiv extens evalu ct scan util ct diagnost studi includ cerebr angiographi radionuclid brain scan eeg ekg increas odd receiv ct scan increas patient marri decreas histori previous stroke histori previous tia increas chanc cerebr angiogram histori cardiac diseas decreas chanc strike region geograph differ ct radionuclid brain scan cerebr angiographi part reflect differ avail technolog urban rural hospit result evalu stroke patient remain heterogen"
"intrathec baclofen spastic cerebr palsi seventeen patient congenit spastic cerebr palsi patient form spastic inject intrathec dose placebo baclofen microgram microgram microgram random doubleblind manner muscl tone upper lower extrem assess ashworth score inject hour afterward hour function upper extrem evalu inject hour afterward muscl tone lower extrem signific decreas hour baclofen inject remain lower baselin hour afterward upper extrem tone function signific affect singl dose confus drowsi occur youngest children studi microgram dose clear hour find intrathec baclofen reduc spastic children cerebr palsi adult spastic spinal origin"
"confirm visual evok potenti diagnost test migrain attempt replic result studi diagnost test report sensit specif migrain techniqu base peakpeak measur fast background electroencephalograph activ visual evok potenti vep studi vep latenc amplitud differ signific show substanti overlap group migrain patient ten agematch healthi control recognis previous fast activ measur object peakpeak measur confirm measur fast wave activ vep background diagnosi migrain"
"abnorm pattern detect fragil patient pulsedfield gel electrophoresi fragil syndrom frequent inherit form mental retard incid male character presenc fragil site xq induc vitro folat depriv inhibitor deoxynucleotid synthesi mode inherit unusu link trait incomplet penetr male femal phenotyp normal male transmit mutat daughter rare express symptom penetr high son daughter carrier women genet physic map xqq region confirm diseas locus locat fragil site hypothes propos account abnorm inherit diseas includ sequenc rearrang meiotic recombin mutat affect reactiv inact chromosom differenti femal germ cell detect rearrang methyl reflect local inact chromosom pulsedfield gel analysi dna fragil patient probe close fragil locus probe dxs detect abnorm pattern fragil patient normal control express male transmitt"
"lexic organ noun verb brain analysi neuropsycholog disord lexic process provid import clue general organ lexic system intern structur process compon report patient select dysfunct specif semant categori abstract versus concret word live thing versus inanim object anim fruit veget proper support hypothesi neural organ semant process compon organ categori report select dysfunct grammat categori noun verb suggest dimens lexic organ grammat class word result report studi provid unambigu evid fundament question natur locus organ lexic system nounverb distinct repres semant phonolog orthograph lexicon grammaticalclass knowledg repres independ lexic form repres separ redund modalityspecif lexicon report perform braindamag subject modalityspecif deficit restrict princip virtual verb oral written product contrast perform suggest grammaticalclass distinct redund repres phonolog orthograph output lexic compon"
"natur opioid respons implic neuropath pain hypothes deriv studi opioid infus recent year observ respons patient opioid drug influenc properti inher pain pain syndrom pathophysiolog evolv belief type pain neuropath pain unrespons drug concept import implic clinic practic basic understand opioid mechan critic evalu opioid respons relat neuropath pain propos clinic relev definit paradigm investig paradigm illustr analges respons opioid infus patient neuropath pain detail present pharmacokinet pharmacodynam relationship patient central pain respond prompt infus hydromorphon analysi hypothes opioid respons man defin degre analgesia achiev dose escal intoler side effect occurr complet adequ analgesia opioid respons continuum quantal phenomenon opioid respons determin divers group patient characterist painrel factor drugselect effect neuropath mechan reduc opioid respons result inher resist drug complex factor contribut opioid respons observ outcom reliabl predict opioid withheld assumpt pain mechan factor preclud favor respons clinic opioid paradigm investig opioid respons includ dose escal maxim toler level repeat monitor analgesia effect"
"pain memori phantom limb review clinic observ paper review report phantom limb sensat resembl somatosensori event experienc limb amput present descript phenomenon ampute part seri clinic studi somatosensori memori predomin replica distress preamput lesion pain experienc time amput qualiti sensat preamput pain patient experi pain emphas suffer real pain describ vivid detail insist experi cognit recollect earlier pain report somatosensori memori common discontinu painfre interv experi pain amput somatosensori memori report cutan lesion deep tissu injuri bone joint pain pain preamput postur experi somatosensori memori relat durat preamput pain time amput age gender prosthet level amput number limb amput amput accid ill result suggest somatosensori input suffici intens durat produc central neural structur combin cognitiveevalu memori preamput pain give rise unifi experi past pain refer phantom limb implic pre postop pain control discuss"
"diphtheriatetanuspertussi vaccin neurolog ill updat review epidemiolog evid widespread impress dtp vaccin brain damag base histor precedentsmallpox rabi vaccin recogn caus devast neurolog ill analog pertussi diseas encephalopathi recent anecdot evid case seri noncaus relationshipcoincid explain tempor relat dtp vaccin neurolog ill dtp vaccin age emerg idiopath neurolog diseas relationship dtp vaccin neurolog ill lack specif case seri impact physician lay public impress safeti pertussi vaccin great proport scientif import case seri generat hypothes provid evid pertussi vaccin causal relat acut neurolog ill brain damag observ studi cohort ecolog design find associ dtp vaccin neurolog ill power detect associ rare observ nces investig casecontrol design offer chanc provid causal evid dtp vaccin neurolog ill nces publish casecontrol studi issu studi found rare associ dtp vaccin type acut neurolog ill bias chanc account associ demonstr nces associ replic casecontrol studi nces demonstr dtp vaccin perman brain damag"
"clinic judgment detect children speechlanguag problem pediatrician reli clinic judgment deriv observ parent concern identifi children development problem popular recommend altern repeat administ standard screen test test time consum unlik clinic judgment detect rate preliminari research clinic judgment show cluster parent concern relat children perform screen test present studi previous research refin assess parent concern children speechlanguag develop studi famili seek pediatr care children speechlanguag screen yield posit result parent concern speechlanguag develop children negat screen result parent concern speechlanguag develop standard screen test occasion development surveil process find show problem children development problem detect clinic judgment base parent concern"
"pain manag orthoped patient pain familiar phenomenon orthoped nurs dunwoodi thing patient fundament qualiti life reliev pain orthoped nurs posit contribut posit manag pain comprehens approach pain manag involv particip patient patient pain approach patient achiev pain relief"
"hurt elder safe drug reliev pain pharmacolog manag pain elder patient common difficult clinic problem alter drug metabol pharmacodynam elder drug choic younger patient side effect occur judici monitor toxic oral medic part multimod approach achiev adequ analgesia elder patient"
"movement analysi aid earli diagnosi cerebr palsi purpos articl review research relat clinic analysi movement aid earli diagnosi cerebr palsi histor perspect clinic techniqu physician physic therapist earli diagnosi cerebr palsi present includ recent research find clinic sign predict movement disord predict neuromotor behavior common recent studi highlight futur trend movement analysi includ digit kinemat analysi term preterm infant fetal ultrasound techniqu discuss"
"implic dynam system approach understand infant kick behavior implic dynam system approach understand movement dysfunct infant discuss tradit theori motor develop attribut movement hierarch matur central nervous system dynam system approach emphas movement organ result interact particip subsystem development real time articl discuss theoret perspect dynam system approach organ leg movement low highrisk preterm fullterm infant development movement lowrisk preterm infant week gestat age week postgest age differ movement lowrisk preterm infant week postgest age fullterm infant preliminari data highrisk preterm infant present base data necess review reinterpret tradit concept motor develop explor suggest offer question pose dynam system perspect influenc practic physic therapi evalu treatment infant risk movement dysfunct"
"cognit strategi coincid time task research find suggest experi cognit strategi contribut success perform perceptualmotor task articl critic review select literatur effect informationprocess skill prefer movement time experi task difficulti perform coincid time task theoret inform research find discuss applic clinic practic consid clinic recommend includ assess coincid time skill function activ provid opportun explor dynam interact environ"
"measur treatment cerebr palsi argument approach articl describ shift therapeut strategi patient cerebr palsi function abil stress therapi coincid emphasi develop function assess document intervent outcom research function arm movement kinemat analysi patient group"
"dorsal rhizotomi children cerebr palsi support concept motor control result select dorsal rhizotomi research suggest therapist question common clinic assumpt movement dysfunct rational perform select dorsal rhizotomi base clinic assumpt spastic disord movement reduc elimin spastic improv movement articl review literatur relat movement dysfunct effect select dorsal rhizotomi evid disord motor control children spastic cerebr palsi select dorsal rhizotomi reduc spastic increas joint rang motion abnorm movement pattern persist spastic reduc coordin movement pattern acquir slowli relat intens period physic therapi argu result provid evid presenc spastic insuffici explan abnorm movement pattern propos physic therapist redirect effort develop method reduc spastic develop adequ assess treatment measur techniqu assess motor control children cerebr palsi maxim function potenti children cerebr palsi identifi problem relat motor control appli sound principl motor learn treatment"
"cerebellar degener meig syndrom report case meig syndrom middleag man eventu cerebellar degener syndrom extrapyramid symptom preced cerebellar sign symptom year patient idiopath meig syndrom show improv highdos anticholinerg therapi patient lack respons agent subsequ cerebellar symptom reminisc situat parkinsonian patient respond medic indic widespread degen diseas associ extrapyramid symptom spinocerebellar disord patholog report autopsi case place group spinocerebellar disord high differenti list"
"experi surgic treatment takayasu diseas review patient takayasu diseas determin incid stroke relationship involv thorac aortic arch branch describ surgic experi patient requir vascular surgic procedur critic thorac aortic arch arteri stenos upper lower extrem ischemia renal arteri stenos patient initi stroke caus occlus thorac aortic arch arteri patient underw bypass procedur critic thorac arch stenos remain free stroke year patient anastomot stenos graft occlus late follow develop stenos relat diseas activ time oper procedur bypass graft origin subclavian axillari arteri develop anastomot stenos anastomot stenos occur bypass graft origin ascend aorta contrast report anastomot fals aneurysm occur occlus major aortic arch arteri takayasu diseas stroke bypass critic stenos aortic arch arteri protect stroke perform graft origin ascend aorta anastomot stenos anastomot aneurysm common studi suggest aggress surgic treatment perform good result"
"murin retrovir neurovirul correl enhanc abil ofvirus infect select replic activ resid microgli cell publish erratum pathol determin biolog basi ts momulv neurovirul vivo newborn cfw mice inocul neurovirul ts momulv nonneurovirul wt momulv tempor respons virus infect central nervous system cns spleen thymus studi compar experiment procedur includ singl doubl label situ immunohistochemistri select morphometr analys steadi state immunoblot viral protein cellular target virus infect ident ts wt momulv consist sequenti splenic megakaryocyt splenic thymic lymphocyt cns capillari endotheli cell cns pericyt microglia resid microgli cell serv major reservor amplifi virus infect cns ts momulvinfect mice similar signific role play microglia wt momulvinfect mice genesi progress sever spongiform lesion ts momulvinfect mice tempor spatial correl amplifi virus infect microglia hyperplasia hypertrophi virusinfect nonvirusinfect microgli cell direct virus infect neuron observ develop clinic neurolog diseas spongiform lesion ts momulvinfect mice correl accumul viral gag env gene product cns select accumul env precursor polyprotein prenv compar wt momulvinfect mice neurovirul ts momulvinfect mice occur enhanc abil replic cns infect activ microglia fundament chang cellular tropism topographi virus infect"
"secondari deposit beta amyloid extracellular neurofibrillari tangl alzheimertyp dementia hippocamp area autopsi specimen brain age dement nondement subject examin doubl stain bodian beta protein case year extracellular neurofibrillari tangl nfts immunoreact beta protein case year minor nfts immunoreact betaprotein antiserum betaimmunoreact nfts frequent area senil plaqu observ area lack betaimmunoreact senil plaqu ultrastructur betaimmunoreact nfts reveal consist extracellular amyloid fibril extracellular locat bundl pair helic filament astrogli process degener neurit find suggest beta immunoreact nfts secondari deposit amyloid fibril"
"induct dose propofol infant month age children year age propofol dose satisfactori induct anesthesia determin infant month age children yr age singl bolus propofol thirti inject lid reflex test anesthesia mask appli patient consid asleep gross movement patient breath dose requir satisfactori induct patient ed se mgkg infant mgkg older children pain inject occur infant children"
"chang indic penetr keratoplasti vancouv indic penetr keratoplasti pk assess clinicopatholog review corneal button submit ophthalm patholog servic vancouv lead indic pk bullous keratopathi keratoconus scar chronic inflamm graft failur scar activ kerat secondari virus fuch dystrophi princip factor respons graft failur judg clinicopatholog correl author compar find seri"
"manag chalazion survey ontario ophthalmologist owe variabl lack standard chalazion manag survey ontario ophthalmologist undertaken result highlight ophthalmologist problem chalazion manag suggest chalazion oper treat respect oper"
"thromboxan amimet potent microvascular permeabl factor conjunctiva studi demonstr thromboxan tx mimet carbocyclictxa elicit microvascular permeabl respons conjunctiva potent microvascular permeabl factor date conjunctiva potenc exceed report leukotrien conjunctiv microvascular permeabl respons inhibit txaantagonist daltroban bm sq prostaglandin pg increas conjunctiv microvascular permeabl potent suscept pretreat daltroban sq pge pgf alpha prostacyclin analog carbocyclin increas conjunctiv microvascular permeabl conjunctiva exhibit uniqu microvascular permeabl respons txamimet view experiment support absenc cutan microvascular permeabl respons carbocyclictxa"
"retin degener mous caus defect beta subunit rod cgmpphosphodiesteras mice homozyg mutat display hereditari retin degener classic line serv model human retin pigmentosa affect anim retin rod photoreceptor cell begin degener postnat day week photoreceptor left degener preced accumul cyclic gmp retina correl defici activ rod photoreceptor cgmpphosphodiesteras recent isol candid complementari dna gene mous retin librari complet character cdnas encod subunit bovin photoreceptor phosphodiesteras candid cdna show strong homolog cdna encod bovin phosphodiesteras beta subunit present evid candid cdna murin homologu bovin phosphodiesteras beta cdna conclud mous locus encod rod photoreceptor cgmpphosphodiesteras beta subunit"
"phacofragment hard len nucleus posterior segment foreign bodi forcep stabil hard len nucleus phacofragment posterior segment techniqu remov hard len nucleus minim manipul larger incis"
"glaucoma laser trial glt result argon laser trabeculoplasti versus topic medicin glaucoma laser trial research group glaucoma laser trial multicent random clinic trial involv patient design assess efficaci safeti argon laser trabeculoplasti alt altern treatment topic medic control intraocular pressur iop patient newli diagnos previous untreat primari openangl glaucoma poag patient eye random assign alt laser lf eye eye assign timolol maleat medic mf eye medic initi chang eye step regimen iop control year follow lf eye lower iop mf eye mmhg fewer lf eye mf eye requir simultan prescript medic control iop year follow lf eye control alt control alt alt timolol control step medic regimen year mf eye remain control timolol control step regimen major differ treatment approach respect visual acuiti visual field year follow"
"nystagmus syndrom incid characterist nystagmus syndrom unclear consecut patient nystagmus clinic recogniz ocular patholog account nystagmus twenti fine rapid horizont nystagmus dissoci nystagmus pendular form latent manifest latent nystagmus total patient nystagmus esotropia find suggest fine rapid horizont nystagmus dissoci occur frequent patient syndrom"
"intraocular len implant penetr keratoplasti improv unaid visual acuiti astigmat safeti patient combin corneal diseas cataract twenti eye combin corneal diseas cataract prospect nonsimultan intraocular len iol placement penetr keratoplasti major penetr keratoplasti plan extracapsular cataract extract ecc placement iol follow iol placement month rang month graft failur occur secondari surgeri graft sutur remov eye iol surgeri nineti percent eye achiev refract error diopter desir result corneal astigmat decreas secondari surgeri wound revis unaid visual acuiti eye advantag excel unaid visual acuiti reduc astigmat lack anisometropia graft failur outweigh disadvantag delay final visual rehabilit month increas secondari capsulotomi rate seri separ surgeri compar previous report tripl procedur result"
"result blepharoptosi surgeri earli postop adjust author review case eye blepharoptosi correct extern levat resect twenti patient eyelid unsatisfactori result author adjust eyelid week surgeri eleven eyelid reoper week surgeri delay initi final surgeri earli group week late group week reoper differ number procedur requir achiev satisfactori outcom patient eyelid unsatisfactori result offer declin late repair earli late reoper effect correct unsatisfactori result extern levat resect benefit earli surgeri reduct time final result eas perform potenti cost save opportun correct unsatisfactori result"
"visual prognosi correl presenc internallimit membran histopatholog specimen obtain epiretin membran surgeri forti patient unilater macular epiretin membran erm underw par plana vitrectomi membran peel improv visual acuiti author retrospect review histopatholog vitrectomi specimen instanc determin presenc internallimit membran ilm advers effect visual acuiti eleven specimen long segment ilm determin light microscopi minimum month follow eye achiev visual acuiti eye ilm present achiev visual acuiti eye entir seri achiev visual acuiti differ group ilm versus ilm statist signific presenc long segment ilm histopatholog specimen vitreous surgeri remov macular erm favor visual outcom"
"semiconductor diod laser photocoagul retin vascular diseas author success perform clinic transpupillari retin photocoagul eye patient retin vascular diseas galliumaluminiumarsenid gaala diod laser emit nm retin photocoagul perform treatment power mw exposur durat micron diamet treatment spot patient treat diod argon green laser requir time greater laser energi diod compar argon creat ophthalmoscop similar lesion parallel experiment retin photocoagul chinchilla rabbit requir time power creat ophthalmoscop similar lesion diod laser argon laser intraop subretin hemorrhag occur rare patient incid treatment spot patient complain moderatemark pain treatment initi topic anesthesia transpupillari diod laser clinic perform therapeut retin photocoagul"
"repair rhegmatogen retin detach american academi ophthalmolog current techniqu rhegmatogen retin detach repair retin detach repair success success repair depend care preoper examin choic surgic procedur surgic procedur tailor individu eye base detail preoper examin retina vitreous postop complic infrequ compar ophthalm surgic procedur cataract extract strabismus repair surgeon observ eye care postop period monitor treat complic aris improv surgic techniqu coupl understand pathophysiolog rhegmatogen retin detach continu improv anatom function success retin detach repair"
"retin pigment epitheli tear fovea preserv good visual acuiti describ patient spontan retin pigment epitheli tear fovea maintain visual acuiti year year rip patient longstand serous detach retin pigment epithelium agerel macular degener prior develop tear tear disc area size center fovea foveal fixat document presum absenc pigment epithelium observ suggest remain redund pigment epithelium pigment epithelium direct beneath central macula requir mainten visual acuiti"
"inflammatori mediat postop aphak pseudophak baboon eye measur prostaglandin leukotrien aqueous humor baboon eye day phacoemulsif posterior chamber len implant evalu effect steroid eye drop cyclooxygenas inhibitor eye drop synthesi mediat inflamm eye undergon phacoemulsif show signific elev prostaglandin postop period compar normal phakic control eye level prostaglandin signific higher eye posterior chamber len implant signific higher eighth postop day amount leukotrien detect limit eye complic develop cyclooxygenas inhibitor eye drop signific reduc amount prostaglandin postop day steroid eye drop effect"
"potenti mental status system absorpt anticholinerg ophthalm medic concern elder case report anticholinerg toxic administr common parasympatholyt cyclopleg mydriat case report children adult elder risk develop mental status secondari anticholinerg ophthalm medic concern elder druginduc mental status behavior mistaken exacerb disord onset diseas alzheim diseas dementia clinician awar potenti complic monitor mental status action"
"pathophysiolog effect interleukinb rabbit retina interleukin potent immunomodul shown initi aspect inflammatori respons determin effect ilb central nervous system cns rabbit retina adjac factor inject minim trauma patholog physiolog effect monitor intravitr inject unit ilb induc alter visual evok potenti vep mark intravascular red blood cell accumul hemorrhag cellular inflamm epiretin vessel analysi event show slow occasion hyperexcit compound action potenti optic tract cortic vep correl maximum inflammatori respons histolog studi show appar respons occur hour intraocular challeng hour inject extens intravascular red blood cell accumul progress hemorrhag accompani increas number mononuclear mn cell polymorphonuclear pmn cell polymorphonuclear cell continu increas time give singl wave inflamm peak hour inject number mn cell steadili increas event permeabl bloodbrain barrier correl electrophysiolog dysfunct forti hour inject mn inflamm reactiv gliosi residu pmn inflamm evid neutral specif antibodi inhibit respons hour inject conclud rabbit retina valuabl model vivo analysi cns inflamm"
"eyelid movement botulinum therapi patient lid spasm quantit analysi lid motil present individu hemifaci spasm meig syndrom data obtain magnet search coil techniqu prior week inject botulinum toxin orbiculari oculi muscl treatment peak veloc blinkrel lid lower lid rais slower normal lid saccad normal botulinum treatment signific decreas occur amplitud blink lid saccad peak veloc blink phase botulinum treatment signific alter blink lidlow kinemat saccad lidlow kinemat normal provid evid orbiculari oculi muscl play primari role downward lid saccad"
"scientif basi medic therapi cataract antioxid cataract major agedepend visual impair blind geograph distribut cataract intens durat sunlight ultraviolet frequenc place exposur anim human oxygen result cataract format studi communic ocular len physiolog damag expos environ activ speci oxygen common refer oxyrad photochem nonphotochem model result suggest intraocular generat activ oxygen constitut signific risk factor pathogenesi senil cataract cataractogen effect oxyrad thwart nutrit metabol antioxid ascorb vitamin pyruv agent prophylaxi therapi cataract"
"role vitamin cataract prevent biochem evid suggest oxid stress caus accumul free radic involv pathogenesi senil cataract amount antioxid vitamin expect prevent retard process activ observ vitro vivo studi experimentallyinduc cataract recent epidemiolog studi found cataract patient tend lower serum level vitamin carotenoid control subject present investig compar report consumpt supplementari vitamin cataract patient individu match cataractfre subject reveal group signific supplementari vitamin result suggest reduct risk cataract random control trial vitamin supplement cataract prevent warrant"
"epidemiolog evid role antioxid vitamin carotenoid cataract prevent relationship antioxid nutrient status senil cataract examin subject cataract control subject clear lens subject low percentil moder thth percentil plasma nutrient nutrient intak level vitamin vitamin carotenoid compar subject high level percentil odd ratio cortic cx cataract subject low plasma carotenoid level posterior subcapsular psc cataract person low plasma vitamin low vitamin intak increas risk cx psc cataract subject consum fewer serv fruit veget day increas risk cx psc cataract"
"preval lattic degener relat axial length sever myopia studi eye patient myopia diopter eye patient lattic degener retina patient lattic lesion uniocular binocular male lattic degener femal lattic degener contrari previous publish data found invers relationship axial length preval lattic degener sever myopic eye greatest preval lattic degener eye found eye axial length mm diopter preval lattic degener eye found eye axial length mm diopter greater explain observ retin detach cataract surgeri note common patient moder sever myopia"
"photic retin injuri endoillumin vitrectomi treat patient develop paramacular area lightinduc retin damag endoscop epimacular membran remov postop color photograph show complet absenc membran fluorescein angiographi demonstr previous absent superior paramacular lesion consist photic injuri oper microscop illumin elimin corneal shield implic endoillumin sourc injuri recommend procedur avoid complic care plan vitreous surgeri epimacular membran remov filter minim length surgeri light output low maintain maxim light pipe distanc retina eccentr orient light pipe intermitt variabl site illumin techniqu"
"light damag detach retina inject homolog fibroblast retin vascular wing rabbit induc traction retin detach eleven day focal area detach expos minut visibl light intraocular fiberopt probe histolog damag detach retina expos light demonstr outer retina affect sever"
"correl intraocular pressur control progress glaucomat damag primari openangl glaucoma fifti patient primari openangl glaucoma earli glaucomat damag medic therapi laser trabeculoplasti year progress glaucomat damag document factor stabil progress glaucoma evalu eye intraocular pressur higher mm hg follow period uniform progress glaucomat convers eye intraocular pressur mm hg remain stabl approxim half eye intraocular pressur mm hg progress glaucomat patient remain stabl slight younger progress glaucomat initi optic nerv head initi visual field find number medicin medic histori patient gender race statist stabil progress glaucoma find reinforc import intraocular pressur control primari openangl glaucoma identifi marker determin proper level intraocular pressur individu patient"
"method document len opac test anterior segment camera digit analyz eye patient determin measur len opac correl measur obtain standard clinic grade system lens grade clinic nuclear opac nuclear color cortic opac posterior subcapsular opac lens photograph analyz devic result compar camera system show good reproduc result correl clinic grade nuclear capac cortic opac posterior subcapsular opac eye posterior subcapsular opac camera system document follow len opac accuraci reproduc previous"
"failur initi vitreoretin surgeri sever prolif vitreoretinopathi perform initi vitreoretin surgeri eye rhegmatogen retin detach complic sever prolif vitreoretinopathi eye undergon previous scleral buckl perform vitreous base dissect eye anterior prolif vitreoretinopathi vitreoretin oper eye remain total reattach main initi anatom failur reoper recurr prolifer vitreous base addit vitreoretin surgeri follow period month retina total reattach final anatom failur anterior prolif vitreoretinopathi prolifer relax retinotomi success reattach eye postop visual acuiti"
"aphak visual field autom perimetri accur test visual field aphak patient demand due optic distort induc high correct lens test procedur improv aspher contact len fullapertur loos trial len found contact len enhanc abil patterndevi printout statpac analysi identifi glaucomat visual field abnorm program humphrey visual field analyz"
"predict infant visualevok respons test futur visual acuiti review record infant abnorm eye examin visualevok respons ver test age month subsequ underw longterm follow ophthalmolog examin durat month infant initi diagnos ocular disord includ cortic blind optic nerv hypoplasia congenit cataract retinopathi prematur standard optotyp visualacu determin follow record children eye fixat behavior obtain remain children eye result reveal patternrevers ver latenc predict visual acuiti equal wors patient good fixat behavior fix follow ff poor fixat ff flash ver latenc predict visual acuiti good fixat statist signific pattern ver amplitud flash ver amplitud predict visual function predict power pattern ver latenc visual function relat reflect macular function low variabl analysi variabl ver factor normal infant pattern ver latenc variabl sensit ver factor detect quantifi patholog result retrospect studi suggest pattern ver latenc import predict power visual function infant initi abnorm ophthalmolog examin"
"clear ultraviolet block lens puva patient recogn patient receiv photochemotherapi puva wear uvblock sunglass day ingest methoxypsoralen patient wear tint sunglass difficulti interfer colour percept reduc definit condit low background light consid cosmet unaccept studi uvblock properti number lens tint assess lens len coat found suitabl puva patient orcolit uv orma uvx rodenstock lambda sola uv gard polaroid polar lens"
"grave diseas current concept grave diseas organspecif autoimmun disord univers agreement mechan grave diseas activ thyroid due antibodi capabl attach activ tsh receptor follicular cell extrathyroid featur caus antibodi hyperthyroid clinic diagnosi general straightforward confirm vitro measur thyroid hormon tsh measur radioiodin uptak valuabl treatment specif immunolog defect purpos lower thyroid hormon level normal achiev antithyroid medic radioiodin iodin thyroidectomi clinic situat strong argument made iodin therapi safe definit posttreat hypothyroid lifelong thyroxin expect"
"ophthalmopathi grave diseas fortun patient thyroidrel eye diseas mild ocular involv spontan involut patient hyperthyroid develop suffici sever ocular abnorm requir surgic intervent patient thyroid eye find symptomat manag requir topic drop oral steroid allevi eye problem approxim half patient present acut sever thyroid orbit find nonsurg therapi suffici control eye diseas half eventu multipl surgic procedur requir discuss previous time sequenc procedur crucial achiev optim result"
"cyclocryotherapi select case congenit glaucoma investig efficaci cyclocryotherapi procedur destroy ciliari epithelium decreas product aqueous humor retrospect studi eye advanc primari congenit glaucoma undergon procedur eye divid group group compris eye undergon convent surgic procedur congenit glaucoma prior cyclocryotherapi group ii eye undergon previous procedur eye month cyclocryotherapi success defin iop greater equal mmhg greater equal mmhg medic success rate eye signific differ success rate group ii greater chronic hypotoni iop mmhg found eye eye develop cataract treatment cyclocryotherapi cyclocryotherapi reason addit treatment eye advanc uncontrol primari congenit glaucoma"
"factor delay diagnosi childhood amblyopia prevent perman visual impair amblyopia import goal pediatr vision screen case amblyopia diagnos child benefit maxim treatment review patient record practic privat pediatr ophthalmologist confirm late detect frequent occurr children amblyopia good access health care casecontrol studi identifi factor delay diagnosi children advers outcom diagnos year age compar optim outcom diagnos year age chart review identifi children amblyopia particip studi late diagnos case patient serv control patient children earli diagnos characterist posit famili histori strabismus greater degre strabismus strabismus present higher matern educ level greater parent suspicion eye problem exist increas chanc parent request eye examin led diagnosi parent children late diagnos express concern amblyopia report children suffer advers consequ amblyopia diagnos earli amblyopia detect child primari health care provid physician children earli diagnos report complianc american academi pediatr guidelin vision screen infanc referr vision problem"
"differenti detach retina vitreous membran color flow doppler sonograph criteria diagnosi retin detach vitreous membran establish case diagnosi made difficult case differenti difficult studi highresolut color flow doppler evalu differenti retin detach vitreous membran sonograph evalu includ color flow doppler perform symptomat eye eye area retin detach detect blood flow portion detach retina fifteen eye vitreous hemorrhag membran flow detect diabet patient vitreous membran retin detach flow detect neovascular membran patient complet choroid detach surgeri demonstr good flow area detach conclud difficult case highresolut color flow doppler enabl differenti area retin detach vitreous membran patient diabet"
"acepromazin effect intraocular pressur investig effect topic applic acepromazin maleat intraocular pressur iop adult rhesus monkey monkey divid group group monkey eye normal group monkey experiment chronic glaucoma eye normal fellow eye drop acepromazin maleat solut instil eye monkey group glaucomat eye monkey group eye serv control iop measur drug administr hour detail slitlamp examin anterior segment acepromazin produc chang iop eye group produc fall pressur eye high iop group evid hour instil maxim hour remain hour pupil show chang size transient ptosi observ treat eye monkey"
"conjunctiv retract sutur fornix adjust strabismus surgeri fornix approach strabismus surgeri advantag incis made eyelid conjunctiv sutur comfort patient minim postop scar major disadvantag fornix approach adjust sutur techniqu poor exposur musclesutur apparatus poor postop knot exposur describ subconjunctiv retract sutur adjust sutur surgeri fornix approach sutur retract conjunctiva expos adjust musclesutur apparatus simultan fixat globe tie noos pole sutur prevent noos slippag present techniqu excel exposur fixat globe complet coverag knot conjunctiva adjust"
"multipledos doserespons relationship topic carbon anhydras inhibitor mk multipledos doserespons curv mk studi center doublemask random placebocontrol parallel studi mk patient bilater primari open angl glaucoma ocular hypertens intraocular pressur greater mm hg washout ocular hypotens medic patient receiv dose pm day parallel hour intraocular pressur curv perform prestudi day hour curv day signific doserespons relationship mk daili minimaleffect dose mk activ hour postdos peak percent decreas pressur hour postdos"
"multipledos efficaci comparison topic carbon anhydras inhibitor sezolamid mk multipledos daili efficaci topic carbon anhydras inhibitor mk racem compound compar pharmacolog activ enantiom center doublemask random placebocontrol parallel studi sezolamid hydrochlorid mk mk placebo daili patient bilater primari open angl glaucoma ocular hypertens morn intraocular pressur greater mm hg eye washout ocular hypotens medic parallel hour modifi diurnal curv perform studi day hour curv day compound demonstr signific lower intraocular pressur hour dose hour dose sezolamid mk morn trough activ measur percent chang intraocular pressur prestudi sezolamid mk peak effect occur hour dose administr sezolamid mk hour dose administr sezolamid consist demonstr slight greater decreas intraocular pressur mk differ statist signific"
"relationship visual acuiti refract error pupil size radial keratotomi defin relationship residu refract error uncorrect visual acuiti pupil diamet compar eye incis radial keratotomi prospect evalu radial keratotomi studi protocol match control eye paramet measur correct visual acuiti uncorrect visual acuiti chang cyclopleg refract enlarg pupil diamet correct visual acuiti radial keratotomi control group variabl sd higher radial keratotomi group averag uncorrect visual acuiti radial keratotomi group variabl time higher chang refract dilat occur control radial keratotomi patient indic signific differ chang refract dilat eye radial keratotomi equal split hyperop chang myopic chang control eye chang hyperop direct myopic direct radial keratotomi patient myopic chang uncorrect visual acuiti indic posit spheric aberr yield aspher surfac uncorrect visual acuiti"
"clinic detect nerv fiber atrophi preced onset glaucomat field loss standard perimetri nerv fiber layer color fundus photographi perform annual eye elev intraocular pressur eye glaucomat field defect develop met rigid criteria manual kinet suprathreshold static perimetri individu nerv fiber layer photograph read mask observ sensit identifi nerv fiber layer defect readabl photograph time field loss occur eye nerv fiber layer defect year field loss contrast nerv fiber layer consid abnorm normal eye hypertens eye locat nerv fiber layer field defect close correspond nerv fiber layer loss general widespread examin experi sever optic nerv damag influenc result mild focal defect readili recogn sever diffus atrophi nerv fiber layer defect expand time develop coalesc adjac area damag"
"radiat safeti postiodin hyperthyroid therapi purpos studi develop guidelin base patient measur iodin treat hyperthyroid patient resum close person contact extern exposur rate measur patient ioniz survey meter upright posit initi measur record min postdos administr meter exposur rate measur day postdos administr meter patient thyroid administ dose rang mci patient measur equal mrhr meter day patient equal mrhr meter day guidelin prepar base administ dose ration conform exist radiolog health standard"
"treatment exophthalmo current procedur grave exophthalmo fail achiev complet correct standard orbit decompress modifi maxim degre volumetr increas axi globe orbit preoper exophthalmo averag mm postop exophthalmo mm postop ct studi demonstr remain posterior orbit wall combin persist increas intraocular muscl volum block retrodisplac globe adequ total volumetr increas increas muscl volum vari cc residu exophthalmo modifi wall expans excel aesthet result visual improv resolut chemosi exposur kerat"
"system drug interact topic glaucoma medic topic administ ophthalm medic capabl attain clinic import serum concentr evidenc varieti system side effect produc drug capabl interact drug administ oral intraven import medic administ elder popul receiv multipl medic physician desk refer unit state pharmacopeia drug inform directori numer warn potenti interact topic glaucoma medic system administ drug literatur support interact limit quantiti qualiti anecdot case report summar inform nonocular interact topic ophthalm glaucoma medic system administ medic clinic evid interact lack case"
"fifti year ophthalmolog renown glaucoma expert began resid gonioscopi exist short tonographi memoir dr shaffer share anecdot insight gain half centuri ophthalmolog practic"
"safe stop patch prior report half amblyopia patient success treat occlus subsequ requir mainten patch retrospect studi design discov clinic characterist stabl outcom primari occlus includ patient amblyopia relat strabismus anisometropia media opac year success primari occlus patient compli treatment achiev equal vision exclud age rang month month eighti patient requir occlus design clinic stabl group csg remain subsequ patch unequ acuiti constitut mainten patch group mpg csg patient older begin month end month primari occlus mpg patient month primari occlus discontinu equal recognit acuiti csg patient equal fixat behaviour preferenti mpg patient distribut diagnos sever amblyopia present length follow similar group visual outcom follow slight csg conclud general patch safe discontinu birthday follow primari occlus import ensur stabl result patient preverb children requir mainten patch"
"peripher contrast sensit glaucoma ocular hypertens contrast sensit measur patient glaucoma ocular hypertens grade high medium low risk clinic group measur made central peripher degre degre degre degre axi meridian degre degre degre degre sine wave grate cyclesdegre revers hz display hz refresh rate monitor normal valu establish compar eye patient primari open angl glaucoma poag minim field loss detect humphrey perimet rais iop disc field loss poag normal central contrast sensit degre degre eccentr valu greater standard deviat normal case high risk low risk patient high risk patient abnorm peripher contrast sensit field defect threshold elev point db normal normal peripher contrast sensit suspect point result assess term screen glaucoma suspect"
"precapsular film age human len precursor pseudoexfoli older patient observ layer subtl opacif anterior len capsul ground glass film biomicroscop precapsular film pcf uniform radial grey line mid zone hole paracentr region occasion roll string len capsular materi obtain cataract extract studi patient film scan electron microscopi pcf friabl incomplet fibrillar layer roll edg suggest loos attach ultrastructur compon fibril nm diamet similar finer fibril pseudoexfoli psx materi life psx materi layer stain posit elast microfibril protein fibrillin len radial striation similar suggest condit relationship pcf precursor psx find patch fibrillar network control patient impli pcf common patient cataract age seldom detect clinic"
"diod laser trabeculoplasti dlt primari openangl glaucoma ocular hypertens pilot studi carri examin efficaci diod laser trabeculoplasti treatment primari openangl glaucoma ocular hypertens devic portabl attach standard slitlamp microscop power spot size micron puls laser trabeculoplasti carri eye glaucoma result ocular hypotens effect mmhg week treatment mmhg month conclud diod laser trabeculoplasti effect mode treatment eye openangl glaucoma ocular hypertens"
"centuri cerebr achromatopsia review enquiri earli clinic evid colour centr cerebr cortex man success dismiss part centuri imperfect evid reason evid reject earlier accept today preval concept vision function role cerebr cortex domin fact prevent accept evid show special colour visual cortex concept overthrown demonstr function special visual cortex primat evid colour centr human brain accept today knowledg colour area pathway primat brain give complet account pathophysiolog cerebr achromatopsia man"
"ocular muscl propriocept visual local target man passiv deviat eye degre degre degre achiev forc appli suck contact len caus direct visual target eye misjudg direct passiv movement amount rough sixth angl passiv deviat result perceiv direct hand instant move target straight ahead signal result interpret muscular effer ident normal eyedevi subject main differ target local condit result proprioceptor output deviat eye data demonstr assess direct target eye free move depend part inform receiv brain proprioceptor orbit case contralater orbit surpris ipsilater orbit contribut constitut clear evid pure outflow theori visual direct judgement helmholz addit provid situat complet versus incomplet oculomotor paralysi model previous propos describ function visual local mechan assum inform deriv code posit eye orbit copi muscular activ eye muscl propriocept propos altern model affer effer signal activ contract stretch muscl provid inform cns data gather normal subject made strabism suction len fair proport strabism patient support model describ mechan local singl punctat target dark"
"audit ophthalmolog wait list hospit case note patient adult ophthalm surgic wait list mid mid review inform referr sourc previous eye surgeri outpati visit treatment end record vital status patient end ascertain wait list patient women men elder year list cataract surgeri end month wait list entri patient cataract patient receiv surgeri care health author remaind die receiv surgeri wait list longer unfit surgeri left district end month wait list entri origin wait list popul die"
"mast cell number stain characterist normal allerg human conjunctiva studi report number metachromat dyestain characterist mast cell mcs conjunctiva normal subject patient season allerg conjunct caus pollenosi addit monoclon antibodi mcspecif enzym tryptas enumer tryptaseposit cell immunohistochem tarsal conjunctiv mcs found present increas number allerg compar nonallerg subject mcs exhibit stain formaldehyd resist compat identif connect tissu mcs basophil high posit stain tryptas confirm metachromat cell stain toluidin blue mcs basophil normal allerg subject"
"photoreceptor peripherin normal product gene respons retin degener rds mous retin degener slow rds retin disord inbr strain mice outer segment photoreceptor cell fail develop candid gene recent rds defect travi brennan danielson kozak sutcliff  natur london ident normal gene product intracellular local determin report amino acid sequenc bovin photoreceptorcel protein peripherin previous local rim region photoreceptor disk membran ident sequenc mous protein encod normal rds gene differ sequenc attribut speci variat monoclon antibodi western blot analysi local wildtyp mous peripherinrd protein isol mous rod outer segment show bovin peripherin exist subunit link disulfid bond relat amount peripherinrd protein rhodopsin retin extract normal rds mutant mice compar identif peripherin protein encod normal rds gene local membran rod outer segment serv basi studi direct defin role protein morphogenesi mainten outer segment understand mechan rds mutat retin degener"
"comparison penetr keratoplasti epikeratoplasti surgic manag keratoconus patient intoler contact lens eye keratoconus surgic correct epikeratoplasti penetr keratoplasti percentag eye group visual acuiti contact lens year equal eye penetr keratoplasti group eye epikeratoplasti group penetr keratoplasti procedur result higher percentag eye visual acuiti epikeratoplasti group eye compar eye procedur result signific corneal flatten penetr keratoplasti group produc averag diopter keratometr reduct epikeratoplasti group year postop irrevers graft failur occur eye penetr keratoplasti group graft reaction complic note eye epikeratoplasti group procedur effect surgic manag keratoconus"
"quantit analysi len vitrectomi fluorophotometri measur amount autofluoresc len evalu quantit len vitrectomi thirteen phakic patient rang age year studi unilater vitrectomi follow period year rang month autofluoresc len measur center ocular axi fluorophotometri len autofluoresc eye underw vitrectomi signific higher contralater eye oper increas autofluoresc correl signific age time vitrectomi correl increas autofluoresc length postop follow air vitrectomi base result oxid len protein intraop develop nuclear cataract vitrectomi"
"reproduc topograph measur normal glaucomat optic nerv head laser tomograph scanner acquir independ topograph imag optic nerv head normal eye eye primari openangl glaucoma laser tomograph scanner imag field view degre resolut pixel pixel size approxim micron pixel topograph imag repres height posit height standard deviat topograph imag calcul pixel posit standard deviat singl height measur normal eye micron rang micron area peripapillari retina micron rang micron measur optic nerv head area glaucomat eye standard deviat micron rang micron peripapillari retina micron rang micron optic nerv head signific differ standard deviat singl height measur normal glaucomat eye optic nerv head area peripapillari retina correl found standard deviat measur pupil size age subject"
"fall elder patient glaucoma analyz determin fall ambulatori elder age year older receiv comprehens examin glaucoma consult servic previous year fall requir medic attent restrict activ report confid interv ci particip logist regress adjust potenti confound variabl greatest singl risk factor fall nonmiot topic eye medic odd ratio cl addit risk factor fall femal sex cl cardiac medic cl characterist risk fall miotic eye medic cl visual field impair greater cl sedat cl find suggest ocular system medic major predictor fall elder popul seek ophthalmolog care glaucoma medic pose greater risk fall major visual impair"
"locul fluid previous undescrib fluorescein angiograph find choroid neovascular macular degener macular photocoagul studi read center foveal photocoagul studi compon macular photocoagul studi design evalu laser treatment reduc risk sever visual loss eye defin choroid neovascular membran macular degener extend foveal center baselin angiogram studi patient enrol eye grade studi januari read center staff note unusu pattern hyperfluoresc latetransit frame previous pattern call locul fluid consist demarc area hyperfluoresc repres pool fluorescein compartment space anterior choroid neovascular leakag locul fluid conform pattern typic cystoid macular edema pool area deep sensori retina shape bear resembl cystoid macular edema pattern import recogn confus angiograph pattern extent choroid neovascular differenti serous detach tear retin pigment epithelium"
"lowdos aspirin risk cataract random trial physician observ studi rais question benefit aspirin develop cataract physician health studi random doublemask placebocontrol trial male physician age year provid opportun collect inform lowdos aspirin therapi mg altern day affect develop extract cataract agerel cataract physician assign aspirin therapi placebo relat risk confid interv cataract extract frequent aspirin placebo group differ statist signific relat risk confid interv younger men age year relat risk confid interv cataract develop confid interv cataract extract random trial data tend exclud larg benefit aspirin find cataract develop null data extract agerel cataract statist signific exclud small moder benefit alternateday aspirin therapi extract agerel cataract"
"exposur phenothiazin drug risk cataract clinic report increas risk ocular opac user phenothiazin drug recent epidemiolog studi found associ cataract histori tranquil examin effect major tranquil phenothiazin haloperidol risk cataract extract control suspect risk factor diabet steroid match cohort studi perform inform larg health mainten organ seattl wash antipsychot phenothiazin drug increas risk cataract extract rough time individu current user expos time year prior extract risk increas individu prior antidiabet agent system steroid benzodiazepin contrari prior report elev risk antihypertens protect effect aspirin acetaminophen ibuprofen"
"effect antiflammin endotoxininduc uveiti rat antiflammin phospholipas ainhibitori antiinflammatori synthet oligopeptid deriv region highest aminoacid sequenc similar uteroglobin lipocortin endotoxininduc uveiti model anterior uveiti eye suggest induc phospholipas activ preliminari report demonstr topic administr antiflammin inhibit endotoxininduc uveiti rat studi antiinflammatori effect antiflammin compar corticosteroid endotoxininduc uveiti measur phospholipas enzym activ inflammatori cell count aqueous humor histopatholog featur antiflammin effect corticosteroid abil suppress endotoxininduc uveiti"
"autogen fascial graft expos retin buckl patient expos scleral buckl element receiv autogen fascial graft altern buckl remov patient success coverag scleral buckl redetach infect patient postop ptosi requir repair autogen fascial graft procedur patient expos retin buckl signific risk retin redetach buckl remov"
"longitudin studi children famili histori strabismus factor determin incid strabismus longitudin studi ocular refract posit fixat perform children famili histori strabismus children examin regular interv month year age result discuss term refract age correl refract develop strabismus amblyopia children develop constant intermitt esotropia strabismus note month age case esotrop children dioptr hypermetrop month hypermetropia remain unchang year addit children dioptr hypermetrop month develop squint contrast squint children hypermetropia children chang emmetropia emmetropis pronounc year age implic result earli diagnosi strabismus amblyopia discuss"
"associ fuch corneal endotheli dystrophi axial hypermetropia shallow anterior chamber angl closur glaucoma seri patient fuch dystrophi present detail clinic measur show associ axial hypermetropia shallow anterior chamber patient cornea develop oedema requir penetr keratoplasti comparison eye fellow eye corneal oedema reveal anomali measur due process decompens patient compar remain patient corneal oedema eye similar profil anomal measur observ group patient compar separ control group case signific trend hypermetropia short axial length shallow anterior chamber note spheric equival refract error patient fuch dystrophi compar control axial length mm compar mm anterior chamber depth mm compar mm differ statist signific signific differ keratometri measur patient control patient problem relat shallow anterior chamber manifest angl closur glaucoma requir surgic peripher iridectomi aetiolog fuch dystrophi ametropia discuss mode associ outlin previous unrecognis associ ration basi wide accept practic combin penetr keratoplasti len extract practic implic import differenti diagnosi treatment fuch dystrophi angl closur glaucoma"
"effect betablock alter bodi posit induc ocular hypertens intraocular pressur iop measur eye healthi volunt bodi posit eye pretreat levobunolol placebo appli mask randomis fashion serv control iop respons levobunolol posit signific pressur rise relat posit signific eye treat drug placebo levobunolol alter relat iop bodi posit lower effect offer protect patient glaucoma"
"function vagotomi induc unilater forc nostril breath decreas intraocular pressur open close angl glaucoma evid central regul intraocular pressur suggest vagal tone increas glaucoma simplex nasal cycl simultan congestiondecongest respons nasal caviti reflect dynam lateralis autonom nervous system lateralis present sympathet activ induc left brain hemispher stimul parasympathet activ induc hemispher stimul subsequ demonstr forc unilater nostril breath induc select contralater hemispher stimul measur relat increas electroencephalograph amplitud contralater hemispher altern lateralis plasma catecholamin function vagotomi report left hemispher stimul minut forc unilater nostril breath led signific bilater decreas mmhg intraocular pressur patient open close angl glaucoma signific increas iop patient neovascular juvenil onset close angl glaucoma"
"injector high viscous silicon oil syring devic inject evacu high viscous silicon oil develop problem remov air interf manoeuvr solv provid special outlet plunger handl convent glass syring slight modifi commerci motor perfusor chosen power devic prove good failsaf case"
"anisometrop strabism amblyopia age group year prospect studi result treatment forti children age year strabism anisometrop amblyopia prospect amblyopia treatment efficaci optimis treatment term number cure children time achiev cure rate initi improv visual acuiti evalu relat age start treatment type initi degre amblyopia adher treatment regimen complianc treatment critic factor predict success outcom compliant children cure visual acuiti differ amblyop amblyop eye line month age treatment regimen type initi degre amblyopia compar group low complianc compliant children cure month shorter treatment time averag younger children initi improv visual acuiti faster year year age anisometrop moder amblyopia start treatment repres group low complianc conclud earli diagnosi strabismus combin general popul screen age detect amblyopia caus anisometropia microstrabismus efficaci cure case major factor treatment failur found inadequ adher treatment regimen"
"postur studi pulsatil ocular blood flow ocular hypertens normotens measur pulsatil ocular blood flow pobf record group healthi ocular normotens volunt ocular hypertens patient recruit outpati pneumotonometr probe link langham ocular blood flow system enabl read intraocular pressur variat heart rate ocular puls erect supin posit pulsatil ocular blood flow calcul valu pressurevolum relationship previous live human eye assumpt supin postur accompani signific rise intraocular pressur normal eye sem mmhg greater extent ocular hypertens eye mmhg pobf differ signific normotens ocular hypertens group erect supin postur group assumpt supin postur accompani signific fall pobf normal microlitersmin ocular hypertens microlitersmin reduct pobf repres decrement pulsatil ocular blood flow reduc supin postur result tissu hypoxia subject risk develop glaucoma companion paper describ measur pobf group patient chronic open angl glaucoma treat topic timolol"
"prognost signific pattern visual evok potenti ocular hypertens paper report prospect studi ocular hypertens patient evalu prognost signific transient abnorm pattern visual evok potenti vep develop glaucoma patient vep abnorm diagnosi ocular hypertens develop glaucomat field defect follow period compar patient normal vep diagnosi conclud appropri design pattern vep test valuabl complement care prefer computeris static perimetri addit find support content glaucomat diseas optic nerv rudimentari pattern process mechan type unit magnocellular pathway affect earlier lumin process mechan"
"cocaineinduc iriti case year man present emerg depart iriti intranas cocain episod iriti patient casual cocain differenti diagnosi iriti propos pathophysiolog mechan discuss"
"eye infect articl overview diagnosi treatment eye infect eye infect rang benign limit lethal primari care physician determin infect base determin treat refer patient"
"hereditari hemorrhag macular dystrophi treat brother hemorrhag macular lesion eye similar problem affect fellow eye patient month general fine granular retin pigment epithelium peripher iri transillumin defect observ sibl studi famili suggest disord domin inherit sorsbi pseudoinflammatori macular dystrophi macular lesion brother treat argon green laser photocoagul brother krypton red laser photocoagul brother treat krypton red laser photocoagul attain final visual function addit differ treatment method contribut final outcom"
"simpl transposit procedur complic strabismus combin recess resect recti muscl vertic horizont transposit correct complic paralyt ocular deviat patient transpos muscl reattach globe parallel spiral tillaux adjac paralyz muscl postop patient demonstr fusion primari posit requir slight head turn fuse surgic complic patient develop symptomat cyclotropia diplopia anterior segment ischemia"
"comparison total partial tenonectomi trabeculectomi compar result method tenonectomi time trabeculectomi eye random assign partial tenonectomi total tenonectomi statist signific differ success rate surgic group upper limit intraocular pressur mm hg criterion success differ postop medic surgic intervent group advantag exist techniqu find suggest equival result anticip total partial tenonectomi"
"therapeut ultrasound treatment glaucoma publish erratum ophthalmol jul multicent clinic trial therapeut ultrasound treatment glaucoma includ center unit state treatment perform eye studi limit patient refractori glaucoma benefit convent medic surgic techniqu approxim treatment show initi decreas intraocular pressur pretreat mm hg mm hg kaplanmei surviv analysi singl treatment success rate intraocular pressur mm hg month posttreat retreat subsequ failur year multitreat success rate common complic posttreat intraocular pressur increas hour mild iriti complic includ scleral thin treatment phthisi bulbi treatment"
"flexibl cystoscopi adjunct extracorpor shockwav lithotripsi ancillari procedur extracorpor shockwav lithotripsi eswl includ placement subsequ remov doubl pigtail ureter stent simpl techniqu develop insert stent flexibl cystoscop procedur perform patient basi local anaesthesia placement stent success patient remov success patient"
"doubl pigtail stent stone retriev unsuccess ureteroscopi insert doubl pigtail stent ureter dilat analys effect indwel doubl pigtail stent success rate calculus extract ureteroscopi initi ureteroscopi fail month period ureteroscopi fail patient treat ureteroscopi combin ureter stent treat ureter stent group indwel stent success ureteroscopi spontan pass calculus case compar unstent case ureterolithotomi patient stent stent conclud fail ureteroscop manipul calculi insert doubl pigtail stent higher subsequ success rate remov stone ureteroscopi consequ lower rate ureterolithotomi"
"immunofluoresc histochem stain confirm identif diseas call interstiti cystiti interstiti cystiti compris complex diseas typifi symptom pelvic pain function complaint aid clinician determin loss anatom capac histochem stain pascolloid ironvan geison counterstain offer improv diagnost abil pathologist correl immunofluoresc find distinct diseas identifi immunofluoresc stain indic result respons urothelium endothelium injuri loss bladder capac diseas expect age immunofluoresc stain igm capillari interstitium sensit predictor"
"women idiopath sensori urgenc earli interstiti cystiti interstiti cystiti rare consid urinari symptom referr gynaecolog clinic recent concept diagnosi condit emerg common entiti earli late form diseas mast cell densiti detrusor muscl report diseas marker substanti diagnosi interstiti cystiti classic diagnost featur exist assess mast cell count bladder biopsi women idiopath sensori urgenc control patient undergo colposuspens procedur pure genuin stress incontin studi group clear increas detrusor muscl mast cell popul detrusor mastocytosi control patient show increas earli interstiti cystiti consid lower urinari tract symptom patient appar idiopath sensori urgenc"
"symptom versus flow rate versus urodynam select patient prostatectomi prostatectomi perform basi symptom patient refer famili doctor patient wait list prostatectomi hospit undergon urodynam investig found unobstruct urodynam criteria screen peak urinari flow rate ml urodynam evid obstruct case patient symptom outflow obstruct flow rate greater ml found obstruct year postop patient select surgeri combin symptomat urodynam criteria pleas symptomat result failur detrusor instabl resolv prostatectomi symptomat failur treatment residu obstruct demonstr patient undergon prostatectomi asymptomat time studi illustr object measur assess patient prior prostatectomi order select patient obstruct import screen flow rate emphasis patient underw surgeri cystometr evid obstruct symptomat result surgeri result patient assess urodynam select criteria fail identifi routin cystometri preoper assess patient cystometri role assess patient preoper flow rate greater ml remain symptomat prostatectomi"
"patholog delin papillonodular type cystic partial differenti nephroblastoma review case eleven case previous unrecogn papillonodular variant cystic partial differenti nephroblastoma cpdn type cpdn featur convent type cpdn addit grossli demonstr papillonodular project extend septa cyst lumina septa show expansil tumor mass case convent type type cpdn diagnos infant nephrectomi total partial case addit chemotherapi radiat therapi case recurr note period extend month year case follow data nephrectomi regular follow visit recurr manag choic pathologist awar variant cpdn overtreat avoid revis criteria cpdn summar discret cystic tumor lumin papillonodul case septa papillonodul present solid portion tumor blastem cell admix normal aberr deriv tumor papillonodul classifi convent papillonodular type cpdn"
"acut effect captopril ibuprofen proteinuria patient nephrosi captopril decreas protein excret patient nephrosi evalu captopril acut antiproteinur effect evalu role renal hemodynam glomerular permselect effect renal clearanc studi perform patient diabet nephrosi protein excret renal hemodynam measur baselin administr captopril measur contribut renal prostaglandin patient restudi separ day combin administr captopril prostaglandin synthetas inhibitor ibuprofen treatment signific reduc protein excret chang greater combin therapi captopril glomerular filtrat rate gfr decreas signific filtrat fraction ff decreas captopril combin therapi signific correl found proteinuria gfr ff treatment captopril contrast decreas proteinuria correl chang gfr combin drug administr ratio immunoglobulin albumin clearanc index glomerular permselect unaffect captopril decreas signific combin drug administr result suggest acut antiproteinur effect captopril due ff gfr glomerular perselect addit ibuprofen enhanc antiproteinur effect captopril decreas gfr enhanc permselect glomerular capillari membran"
"combin versus sequenti chemoendocrin therapi advanc prostat cancer final result random southwest oncolog group studi cytotox chemotherapi provid surviv benefit metastat prostat cancer frequent patient advanc refractori diseas evalu effect chemotherapi earlier diseas southwest oncolog group swog perform random trial septemb octob compar endocrin therapi diethylstilbestrol des orchiectomi cyclophosphamideadriamycin doxorubicin adria laboratori columbus chemotherapi progress versus initi combin chemoendocrin therapi hundr forti patient regist declar inelig patient combin chemoendocrin therapi arm slight higher respons rate compar endocrin therapi loglinear model tumor respons treatment arm adjust stratif factor favor combin arm patient endocrin therapi arm object partial respons cross chemotherapi stabl diseas differ initi respons rate time treatment failur surviv ident treatment arm seventi percent patient initi endocrin therapi arm die median surviv month compar chemoendocrin therapi arm median surviv month signific effect treatment surviv observ adjust stratif variabl cox regress model exploratori surviv analys patient arm combin show margin signific time treatment failur surviv advantag patient treat des orchiectomi initi endocrin therapi eighti percent patient treat orchiectomi die compar treat des data support addit cytotox chemotherapi initi endocrin therapi patient metastat prostat cancer"
"cardiovascular effect microinject angiotensin ii brainstem renal hypertens rat cardiovascular effect microinject angiotensin ii aii area postrema ap nucleus solitari tract nts rostroventrolater medulla studi urethan anesthet shamnormotens nt kidney clip renal hypertens rat microinject aii ng ap renal hypertens rat elicit dosedepend decreas blood pressur heart rate renal sympathet nerv activ similar effect observ nts nt rat low dose aii ng ap nts depressor high dose aii ng observ modest pressor effect nt anim decreas heart rate renal sympathet activ observ pressor effect aiiantagonist sarvalalaaii nts ap increas blood pressur heart rate inhibit cardiovascular effect low dose aii group rat contrast sarvalalaaii affect pressor action high dose aii nt group microinject aii rostroventrolater medulla produc signific cardiovascular effect renal hypertens group result modest pressor effect nt rat result acut activ aii receptor ap nts contribut pressor effect aii renal hypertens rat"
"problem clinic diagnosi stress incontin signific number women suffer urinari incontin requir surgic intervent prior proceed surgeri essenti women undergo preoper assess detect nonsurg urinari leakag paper review reliabl initi histori basic clinic test evalu women lower urinari tract abnorm"
"nonsurg treatment detrusor overact postmenopaus women detrusor overact subsequ urg incontin increas preval women age women treat detrusor instabl hyperreflexia postmenopaus good candid treatment younger counterpart nonsurg treatment detrusor overact postmenopaus women"
"histolog connect vagina levat ani muscl implic urinari tract function proxim urethra mobil structur voluntari control posit integr part initi urin contin paper describ histolog vagina attach medial portion levat ani muscl intim attach vagina urethra respons part control urethr posit histolog examin serial microscop slide women dissect bodi studi pelvi crosssect cadav perform smooth muscl collagen elastin fiber vagin wall paraurethr tissu direct interdigit muscl fiber medial portion levat ani region proxim urethra strong connect lie level entri urethra bladder extend downward level perin membran urogenit diaphragm area mobil portion urethra insepar natur vagina urethra region make connect levat ani vagina control proxim urethr posit observ suggest specif role medial levat ani muscl control vesic neck posit open question specif part play arrang void contin relat factor influenc lower urinari tract function"
"urethr mobil relationship stress incontin women multipl physiolog factor urethr support make femal contin mechan abnorm urethr support lead defici transmiss abdomin pressur urethra result genuin stress incontin women techniqu measur urethr mobil determin urethr mobil diagnosi urinari incontin inform surgic procedur correct genuin stress incontin"
"rise prostat cancer incid increas transurethr resect examin associ prostat cancer incid rate rate transurethr prostatectomi explor reason nation report dramat increas incid rate prostat cancer strong correl incid stage prostat cancer combin local diseas increas transurethr resect common surgic procedur perform reliev urinari obstruct due benign enlarg prostat analys suggest increas detect exist tumor transurethr resect primari reason observ increas incid rate prostat cancer analys mortal trend nonwhit laboratori studi histolog natur clinic asymptomat tumor suggest part increas reflect real risk prostat cancer"
"unexplain excess risk bladder cancer men popul studi risk bladder cancer time great men women estim genderspecif incid rate absenc exposur carcinogen factor data obtain interview white individu bladder cancer white control nation bladder cancer studi incid data nation cancer institut surveil epidemiolog end result program total ageadjust incid bladder cancer case personyear men women yield ratio absenc exposur cigarett occup hazard urinari tract infect genderrel risk persist incid bladder cancer men women yield ratio explan excess risk men includ environment dietari exposur identifi innat sexual characterist anatom differ urin habit hormon factor"
"contracept efficaci testosteroneinduc azoospermia normal men world health organ task forc method regul male fertil multicentr studi ten centr countri assess contracept efficaci hormonallyinduc azoospermia healthi fertil men subject receiv mg testosteron enanth week intramuscular inject men cumul rate month azoosperm consecut semen sampl men enter month efficaci phase continu testosteron inject form contracept pregnanc month efficaci phase concept confid interv personyear discontinu studi azoospermia achiev month dislik inject schedul time azoosperm day sd reappear spermatozoa detect men case led discontinu studi pregnanc testosteron inject stop estim median time azoospermia recoveri sperm concentr millionml month subject baselin sperm concentr month hormon regimen induc azoospermia provid high effect sustain revers male contracept minimum sideeffect"
"epidemiolog clinic aspect hemolyt urem syndrom minnesota background frequenc hemolyt urem syndrom character microangiopath hemolyt anemia thrombocytopenia renal failur increas escherichia coli serotyp implic causat agent inform basic epidemiolog clinic aspect syndrom method conduct retrospect populationbas studi hemolyt urem syndrom minnesota resid year age assess trend diseas occurr describ clinic ill identifi predictor diseas sever outcom conduct casecontrol studi patient onset ill examin risk factor result hundr seventeen patient identifi annual incid increas case childyear children case case case  coli isol patient percent stool specimen submit test present typic hemolyt urem syndrom elev polymorphonuclearleukocyt count hospit admiss shorter durat prodrom presenc bloodi diarrhea predict sever diseas casecontrol studi patient attend larg daycar center children control odd ratio suggest daycar attend risk factor basi populationattribut risk factor account percent case conclus studi evid increas incid hemolyt urem syndrom relat increas incid coli infect hemolyt urem syndrom import pediatr public health problem"
"success renal transplant acceler develop young urem children examin impact renal transplant subsequ develop children chronic renal failur children undergo primari renal transplant month age allograft function year prospect studi psychometr test perform averag month transplant reevalu averag month surgeri comparison individu pretransplant posttransplant mental develop score patient assess bayley mental develop index stanfordbinet intellig quotient reveal averag increas transplant signific improv mental perform patient rang mild delay mental develop index stanfordbinet iq score rang normal mental develop greater equal bayley psychomotor develop index score frequent lower mental develop index score increas averag transplant patient pair data signific individu improv occipitalfront circumfer standard deviat score note children transplant conclud success renal transplant young children chronic renal failur signific improv cognit psychomotor function improv cephal growth"
"prostat cancer comparison digit rectal examin transrect ultrasound screen prostat cancer screen studi asymptomat men compar digit rectal examin transrect ultrasound identifi cancer detect rate cancer diagnos digit rectal examin contrari experi higher rate achiev transrect ultrasound case systemat multipl needl biopsi lobe ultrasound guidanc routin perform result techniqu cancer fortuit diagnos addit unilater diseas suspect patient bilater diseas biopsi digit rectal examin transrect ultrasound identifi number patient small cm cancer contrari report found transrect ultrasound superior digit rectal examin consid effect screen examin equival transrect ultrasound prefer lower cost algorithm screen outlin digit rectal examin prostat specif antigen determin"
"trace element urinari stone format aspect patholog mechan urinari stone format urinari stone serum hour urin concentr trace element determin urinari stone patient induct coupl plasma atomicemiss spectroscopi data obtain activ stone patient stone episod occur month previous compar healthi individu urinari nickel manganes lithium excret serum nickel manganes cadmium concentr statist signific lower activ stone patient compar previous stone episod healthi individu differ concentr trace element found patient previous stone episod healthi individu nickel manganes lithium cadmium signific patholog mechan stone format mineralog crystallograph viewpoint smooth flow enzymat reaction biolog system"
"nonpalp cancer prostat assess transrect palpabl cancer prostat wide believ clinic signific author compar clinic signific palpabl prostat cancer nonpalp prostat cancer discov transrect ultrasound strong associ lesion volum measur preoper transrect volumetr measur radic prostatectomi specimen permit tumor size measur transrect reason estim gross tumor volum subsequ clinic seri biopsyprov cancer group size measur find digit rectal examin dre gleason score patient prostat cancer statist signific differ gleason score palpabl nonpalp cancer demonstr size tumor locat prostat held constant assum gleason score reliabl indic malign potenti clinic signific author conclud nonpalp prostat cancer detect transrect clinic signific prostat cancer discov dre"
"knowledg hemodialysi capd patient prescrib medicin questionnair design determin compar extent knowledg continu ambulatori periton dialysi capd hemodialysi hd patient medicin administ oral outpati attend clinic investig unknown patient data collect pertain target drug calcium supplement phosphat binder vitamin folic acid hd capd group close match age sex sixti percent capd hd patient medic dose folic acid accur recal capd hd patient indic calcium supplement phosphat binder capd patient compar hd patient hd patient knew indic target drug capd hd patient knew expect durat therapi trend decreas knowledg medic work increas age capd patient drug inform suppli physician capd patient obtain inform lay sourc opportun question medicin capd hd patient knowledg capd hd patient studi grossli defici term indic effect durat action dose miss"
"posttraumat priapism treat metaraminol bitartr case report year male posttraumat priapism day treat success metaraminol bitartr inject corpus cavernosum result suggest alphaadrenag agent inject corpus cavernosum consid posttraumat priapism"
"angiotensin ii mainten gfr renal blood flow renal arteri narrow time renal blood flow gfr respons narrow renal arteri conscious dog review initi respons threat renal perfus renal vasodilat minut secondari vasoconstrict mediat angiotensin ii begin develop angiotensin iimedi contract mesangi cell demonstr appar reduc filtrat surfac area glomerular capillari intraren effect angiotensin ii restor gfr back normal week time circul plasma angiotensin ii level longer elev contrast effect gfr angiotensin ii minim effect renal blood flow stenosi blood flow determin hydraul resist stenosi ii renal vasoconstrict effect flow due hemodynam properti stenos iii major site action angiotensin ii glomerulus angiotensin ii homeostat role mainten gfr renal arteri narrow compon role involv mesangi contract"
"angiotensin convert enzym inhibitor progress chronic renal failur renal failur establish loss critic amount function renal mass progress larg bodi experiment evid support hypothesi glomerular capillari hypertens import pathogenesi progress chronic renal failur divers type includ subtot renal ablat diabet nephropathi convert enzym inhibitor effect slow arrest progress glomerular injuri experiment model associ normal system intraren pressur clinic studi diabet nephropathi chronic renal failur etiolog support concept renal hemodynam factor import human renal diseas treatment convert enzym inhibitor prove therapeut intervent convert enzym inhibitor specif advantag antihypertens agent due benefici renal hemodynam effect suggest experiment studi question await investig pathogenesi hypertens glomerular injuri complex involv particip divers biolog system predict wide varieti therapeut maneuv dispar mechan action effect arrest prevent glomerular injuri"
"molecular biolog renal reninangiotensin system paper describ interrel seri studi design examin molecular cellular aspect renin express releas kidney immunocytochem techniqu northern blot analysi situ hybrid measur renin activ revers hemolyt plaqu assay demonstr intraren distribut renin renin gene express cell number renin secretori cell vari divers physiolog patholog condit studi demonstr renal preglomerular vasculatur plastic capac elicit recruit renin renin gene express cell"
"distribut endogen albumin glomerular wall proteinur patient glomerular proteinuria relat part loss impair normal barrier function glomerular capillari wall investig function properti barrier endogen albumin reveal glomerular wall proteinur patient compar nonproteinur control immunoelectron microscopi protein gold method control biopsi peak albumin accumul note subendotheli area portion lamina densa gradual taper distribut epitheli side basement membran urinari space epitheli cell weak label tissu proteinur patient albumin distribut entir width glomerular basement membran pattern accumul vari patient urinari space show signific label floccul materi mesangi area heavili label tissu control proteinur patient lysozom glomerular tubular epitheli cell accumul albumin evid reabsorpt result reveal exist normal condit barrier locat subendotheli area glomerular basement membran loss idiopath nephrot syndrom lead diffus distribut albumin glomerular capillari wall"
"guanidino compound increas cerebrospin fluid brain urem patient inhibit gaba glycin respons mous neuron cell cultur guanidino compound found mark increas cerebrospin fluid brain tissu urem patient guanidin methylguanidin creatinin guanidinosuccin acid appli mous spinal cord neuron primari dissoci cell cultur evalu effect postsynapt respons gammaaminobutyr acid gaba glycin intracellular microelectrod record techniqu guanidin methylguanidin creatin guanidinosuccin acid revers dosedepend manner inhibit gaba glycin respons guanidinosuccin acid potent inhibitor amino acid respons decreas potenc methylguanidin guanidin creatinin guanidinosuccin acid inhibit respons gaba glycin concentr similar found cerebrospin fluid brain tissu patient termin renal insuffici guanidino compound test exert effect concentr higher found urem biolog fluid tissu inhibitori effect guanidin methylguanidin respons gaba addit effect guanidino compound gaba respons antagon coapplic benzodiazepinereceptor antagonist cgs result suggest guanidin methylguanidin creatinin guanidinosuccin acid inhibit respons inhibitori neurotransmitt gaba glycin block chlorid channel observ action studi guanidino compound contribut pathogenesi complex neurolog symptomatolog encount uremia"
"alter renal medullari hemodynam pressurenatriuret respons genet hypertens concept kidney play major role longterm control arteri pressur base pressurenatriuret respons hypothesi hypertens develop relationship sodium excret arteri pressur alter transplant studi form renal dysfunct develop genet form hypertens spontan hypertens rat shr dahl saltsensit rat nonetheless factor respons reset kidney hypertens remain unknown report pressurenatriuret relationship shr dahl rat brookhaven rapp strain shift higher pressur prior develop diseas papillari blood flow reduc young prehypertens shr recent studi mechan pressurediuresi mediat inhibit sodium reabsorpt proxim tubul thin descend limb henl deep nephron renal interstiti pressur pressur flow vasa recta circul observ suggest elev renal medullari vascular resist respons shift pressurenatriuresi relationship higher pressur hypertens"
"incid advanc chronic renal failur end stage renal replac treatment object determin age relat incid advanc chronic renal failur area england designprospect studi patient newli identifi advanc chronic renal failur year period subsequ monitor patient clinic month settingdevon blackburn subject patient popul develop advanc chronic renal failur serum creatinin concentr greater mumol time year period main outcom measur result patient million popul year develop advanc chronic renal failur age relat incid rose million year age million year age patient refer nephrologist patient dialysi die month present receiv dialysi die dialysi year unsuit treatment exclud patient million popul year age start long term renal replac treatment conclus patient suitabl renal replac treatment refer nephrolog opinion deni treatment treatment rate unit kingdom rose rate million year million year number patient receiv treatment rise million doubl present number predict resourc implic nhs"
"preval advanc renal failur northern ireland object determin preval advanc chronic renal failur northern ireland part assess renal associ level servic provis treatment patient designprospect notif patient reach defin level advanc chronic renal failur serum creatinin concentr greater equal mumol blood urea concentr greater equal mmol year follow year notif settingnorthern ireland patient patient serum creatinin blood urea concentr higher defin level newli detect march februari main outcom measuresurviv notif result patient agesmillion populationyear advanc chronic renal failur compar millionyear age found earlier studi popul patient older year seventeen patient requir dialysi die month notif surviv month year longer patient attend renal clinic surviv period month renal replac treatment conclus increas number patient disclos survey compar earlier survey owe increas number older patient patient disabl renal failur capabl treatment develop complic requir frequent hospit admiss suitabl transplant resourc implic nhs"
"etoposid therapi testicular cancer past decad dramat stride made treatment metastat testicular cancer earli cisplatin vinblastin bleomycin pvb produc durabl complet remiss cr approxim treat patient earli etoposid emerg drug singleag activ cisplatinrefractori patient base preclin data demonstr synergi cisplatin etoposid drug combin prove salvag therapi cure approxim patient evalu etoposid part initi therapi southeastern cancer studi group secsg compar pvb bleomycin etoposid cisplatin bep previous untreat patient metastat germ cell tumor bep signific toxic prove superior pbv patient advanc diseas vari dose schedul etoposid provid patient potenti avenu treatment highdos etoposid carboplatin drugrefractori patient produc durabl cr cohort treat patient evalu part initi salvag therapi schedul depend etoposid small cell lung cancer led evalu daili oral administr etoposid patient refractori previous etoposid therapi object respons rate approxim observ summari etoposid remain integr part treatment regimen testi cancer incorpor innov dose schedul combin etoposid improv therapeut index diseas"
"mechan impair insulin secret chronic renal failur suggest sustain rise rest level cytosol calcium ca pancreat islet respons impair insulin secret chronic renal failur crf evid event lack mechan affect insulin secret studi conduct normal crf normocalcem parathyroidectom ptx crf rat answer question rest level ca islet crf rat higher control crfptx rat hdeoxyglucos uptak camp product islet group insulin content glucoseinduc insulin secret islet crf rat lower control crfptx rat contrast glyceraldehydeinduc insulin releas crf islet normal basal atp content glucosestimul atp content atpadp ratio net lactic acid output vmax phosphofructokinas ca atpas islet crf rat lower normal crfptx anim data show glucos glyceraldehydeinduc insulin secret impair crf impair glucoseinduc insulin releas crf due defect metabol glucos defect due reduc atp content induc part high ca islet high ca islet crf rat due augment pthinduc calcium entri cell decreas calcium extrus islet secondari reduc activ ca atpas"
"evalu efficaci safeti doxazosin hypertens renal dysfunct japanes doxazosin studi group doxazosin administ daili patient renal hypertens hypertens renal dysfunct doxazosin produc signific reduct blood pressur stabl treatment period signific chang observ heart rate blood pressur mark decreas decreas patient receiv doxazosin monotherapi patient receiv combin therapi patient cumul efficaci ratio final daili dose mgday mgday side effect observ patient sever side effect disappear continu administr doxazosin abnorm laboratori valu item observ patient serum creatinin blood urea nitrogen valu regard renal function paramet show signific negat influenc observ respect doxazosin therapi clinic consid patient receiv doxazosin monotherapi patient receiv combin therapi patient conclus daili administr doxazosin consid antihypertens therapi renal hypertens hypertens renal dysfunct"
"glomerular structur lipid progress renal diseas year remark advanc made understand lipoprotein metabol pathogenesi renal diseas anim model vitro cell cultur central work problem progress renal diseas human review recapitul theori lancet ii progress diseas depend part damag inflict glomerulus lipoprotein glomerular environ high low pressur basement membran damag destruct damag mesangi epitheli cell permit filtrat protein consequ hyperlipidemia therapeut measur employ proteinuria persist hyperlipidemia follow suggest lipoprotein toxic contribut final common path renal damag progress renal diseas lipoprotein toxic arteri call atherosclerosi term ignor complex glomerulus tubular damag caus filter lipoprotein clear insuffici knowledg metabol damag kidney confid attribut patholog progress diseas singl process"
"similar glomerular sclerosi atherosclerosi human renal biopsi specimen role lipoprotein glomerulopathi recent work focus progress natur renal injuri hemodynam alter implic pathogenesi predomin lesion focal glomerulosclerosi document atherogen toxic lipid cardiovascular morbid lipid renal injuri lipid toxic endothelium glomerulus vascular bundl author particip symposium present evid associ hyperlipidemia glomerulosclerosi anim model associ signific expand therapeut armamentarium treat hyperlipidemia fact glomerular injuri moder pharmacolog treatment hyperlipidemia rat renal ablat model evid exist similar associ human renal diseas clinic practic made observ renal biopsi specimen time link atherogenesi lipid deposit human glomerular injuri"
"serum lipid patient chronic renal failur longterm proteinrestrict diet disord lipid metabol believ play import role acceler progress chronic renal diseas uremia examin hypothet role lipid larg popul patient longterm dietari protein restrict experi conclus evid lipid acceler progress function deterior patient reduc renal function hyperlipidemia factor affect prognosi primari renal diseas dietari protein restrict effect maintain normal slight elev serum lipid level patient earli renal failur patient renal failur maintain diet elev ratio polyunsatur satur fatti acid favor lipid composit erythrocyt membran low percentag satur fatti acid high percentag polyunsatur fatti acid compar patient unrestrict diet"
"desmopressininduc improv bleed time chronic renal failur patient correl platelet serotonin uptak atp releas hemostat defect result lifethreaten hemorrhag episod common occurr chronic renal failur patient hemorrhag tendenc correl laboratori test bleed time identif specif hemostat defect role bleed dyscrasia elucid studi demonstr factor viii coagul activ factor viii relat antigen vwfag normal great elev urem renal failur patient great prolong bleed time multimer state von willebrand factor normal patient bleed time normal patient minut postinfus desmopressin ddavp signific factor viiivwf properti blood cell count coagul factor observ postddavp treatment signific increas platelet serotonin uptak atp releas detect ddavp treatment result ddavp act platelet membran substanti abil ddavp block vasopressininduc platelet aggreg dose timedepend fashion perturb movement storag serotonin releas adenosin triphosph atp platelet urem individu propos play critic role regul bleed time"
"rate progress chronic renal failur alter cost renal replac therapi endstag renal diseas unit state exceed billion dollar year nonimmunolog mechan contribut progress renal injuri renal failur divers etiolog base potenti advers renal effect process number dietari pharmacolog intervent propos potenti benefici slow rate progress chronic renal failur endstag renal diseas articl review current evid anim model human support efficaci propos intervent"
"excret urinari protein induc extracorpor piezoelectr lithotripsi investig carri renal injuri caus extracorpor piezoelectr lithotripsi epl edap lithotriptor urinari protein molecular weight rang immunoglobulin igg acetylbetaglucosaminidas nag albumin lysozym monitor patient day day unilater epl treatment patient obstruct renal stone previous untreat patient stablis hypertens persist urinari infect due infect stone patient healthi confirm clinic haematolog biochem investig albumin level increas signific day treatment statist nonsignific increas decreas record level nag lysozom igg limit detect mg patient albumin level return normal day treatment eplinduc increas albumin record patient compar increas level nag lysozym infect stone find transient glomerular injuri epl treatment"
"stone lower urinari fibrinolyt activ control comparison urinari fibrinolyt activ stone control fail demonstr signific differ fail confirm earlier independ observ due methodolog design differ studi suggest reserv signific lower urinari fibrinolyt activ risk factor renal stone diseas dietari inform part studi suggest reduct meat intak stone increas urinari fibrinolyt activ account discrep studi case observ signific"
"small cell carcinoma urinari tract small cell carcinoma urinari tract rare lethal report case primari small cell carcinoma kidney urinari bladder prostat light microscop immunohistochem electron microscop find patient small cell carcinoma prostat die dissemin diseas year diagnosi patient small cell carcinoma urinari bladder free tumour month partial remiss induc patient distant metastas small cell carcinoma kidney chemotherapi protocol similar drug regimen small cell carcinoma lung patient surviv month immunohistochem studi reveal absenc argyrophil immunostain tumour cell case posit stain keratin stain neuronspecif enolas patient reactiv prostatespecif antigen negat densecor membranebound granul identifi cytoplasm patient paraneoplast syndrom found indic occurr ectop hormon specif cytoplasm granul origin implic recognit distinct entiti requir full morpholog immunohistolog ultrastructur biolog featur order defin origin tumour evalu effect chemotherapi larger seri patient"
"effect verapamil antitumour action mitozantron doxorubicin renal carcinoma cell vitro ten renal carcinoma establish cultur sensit mitozantron verapamil measur se selenomethionin incorpor studi tumour spread kidney sensit mitozantron enhanc verapamil tumour carcinoma similar experi perform doxorubicin drug activ antitumour action relat concentr verapamil effect potenti doxorubicin action increas proport concentr verapamil ad"
"caffein affect bladder patient symptom frequenc urgenc complain symptom exacerb tea coffe seri women confirm detrusor instabl asymptomat women mg caffein citrat urodynam studi perform group detrusor instabl statist signific increas detrusor pressur bladder fill administr caffein differ volum contract height contract bladder capac normal women abnorm cystometri"
"experi simplifi techniqu treatment femal stress urinari incontin year period simpl procedur correct stress urinari incontin perform consecut patient fail previous antiincontin procedur success achiev case failur success treat repeat procedur oper time rang min median averag hospit stay day simplic reliabl techniqu recommend surgic correct femal stress urinari incontin"
"treatment benign prostat hyperplasia phytosterol randomis doubleblind studi prepar curbicin obtain pumpkin seed dwarf palm plant cucurbita pepo sabal serrulata compar placebo treatment symptom caus prostat hyperplasia patient part studi carri month period urinari flow micturit time residu urin frequenc micturit subject assess effect treatment signific improv treatment group untoward side effect note"
"semen analysi patient oper impalp test semen analysi perform men undergon orchiopexi unilater impalp test bilater impalp test patient unilater impalp test vari sperm analysi patient unilater impalp canalicular test normal sperm analysi patient bilater impalp test azoosperm subsequ qualiti semen depend origin anatom posit undescend test"
"comparison urethr reaction full silicon hydrogenco siliconis latex cathet indwel urinari cathet induc inflammatori reaction strictur urethra cathet encrust urinari infect disadvantag longterm catheteris present studi male patient catheteris random part normal treatment type cathet siliconis latex hydrogelco latex full silicon cathet durat catheteris day urethr inflammatori reaction assess cytolog urethr swab specimen cathet encrust studi scan electron microscop sem analysi full silicon cathet induc mildest degre inflamm urethra percentag inflammatori cell smear latex cathet group age patient durat catheteris effect inflammatori reaction mark patient haemodynam abnorm hydrogel coat effect prevent encrust siliconis latex cathet resist encrust inflammatori reaction variabl patient urethr cathet restrict suprapub tube patient shock circulatori develop biocompat physic properti urinari cathet compat devic manufactur"
"black tobacco mate bladder cancer casecontrol studi uruguay casecontrol studi bladder cancer involv interview incid case control carri montevideo uruguay analysi conduct separ sex point estim relat risk smoke variabl ingest infus herb ilex paraguariensi mate select dietari item obtain stratifi logist regress analysi men smoker black tobacco show relat risk rr higher blond tobacco smoker mate exposur show signific doserespons adjust age resid social class hospit type tobacco smoke intens smoke durat veget consumpt fold increas risk heavi consum joint exposur type tobacco mate consumpt show multipl effect women show similar increas risk mate consumpt result suggest high mortal rate bladder cancer observ uruguay explain combin effect black tobacco smoke mate ingest"
"extraren product calcitriol normal urem human previous report low serum level dihydroxyvitamin increas product administr hydryoxyvitamin ohd anephr human normal alveolar macrophag synthes stimul gammainterferon lipopolysaccharid determin macrophag deriv peripher blood monocyt extraren sourc result demonstr macrophag normal individu synthes appar km ohd nm maximum veloc fmol dmicrogram dna activ enzym reduc physiolog concentr pmol incub medium normal macrophag hydroxyl polar metabolit catabol activ signific enhanc physiolog concentr chronic renal failur peripher macrophag exhibit enhanc alphahydroxylas activ fmol dmicrogram dna control decreas capac degrad exogen physiolog concentr reduc synthesi degre compar observ normal cell product macrophag correl sever hyperparathyroid human pth supraphysiolog concentr ng stimul alphahydroxylas activ macrophag normal urem subject result demonstr normal peripher macrophag metabol ohd macrophag uremia display higher rate synthesi lower rate catabol normal macrophag defici hyperparathyroid play role stimul product macrophag chronic renal failur"
"progress renal insuffici analges nephropathi impact continu drug abus twenti patient analges nephropathi appar cessat drug abus test blood acetaminophen salicyl occas routin renal control examin patient creatinin level mgdl deterior renal function note year observ period group patient signific progress renal insuffici observ creatinin level rose mgdl observ period group blood test acetaminophen salicyl posit patient group patient group chi data emphas import continu analges abus hidden medic staff regard progress renal insuffici analges nephropathi"
"function status qualiti life predictor earli mortal patient enter treatment end stage renal diseas investig associ function status qualiti life newlyent dialysi patient subsequ risk mortal enrol patient dialysi facil southeastern state function status assess karnofski perform scale kps qualiti life spitzer qualiti life index sqli se follow day patient cohort die kps score se survivor survivor sqli score se survivor survivor strong gradient risk mortal found measur control covari includ age race sex primari renal failur presenc comorbid kps sqli score independ correl risk mortal conclud function status qualiti life strong independ risk factor subsequ mortal dialysi patient easili measur indic serv predict subsequ risk mortal adjust casemix estim comparison dialysi popul"
"effect probucol renal function rat bilater ureter obstruct ascertain potenti role reactiv oxygen metabolit pathophysiolog obstruct uropathi examin effect probucol antioxid agent renal function normal rat rat unilater releas bilater ureter obstruct buo hour durat rat fed standard diet standard diet percent probucol week prior studi probucol lower serum cholesterol normal buo rat probucol signific affect renal function normal rat buo rat probucol greater inulin pah clearanc hour day releas buo rat buo probucol kidney obstruct rat higher level malondialdehyd index lipid peroxid greater number leukocyt cortex decreas level reduc glutathion increas level oxid glutathion renal cortex obstruct rat treat probucol signific higher level reduc glutathion kidney obstruct rat probucol decreas cholesterol lipidlow agent lovastatin modifi renal function rat buo data interpret role reactiv oxygen speci pathophysiolog obstruct nephropathi improv renal function probucoltr rat buo due effect agent affect accumul reactiv oxygen metabolit decreas number leukocyt infiltr renal cortex"
"dimension morphometr analysi segment glomerulosclerosi rat idiopath nephrot syndrom experiment model nephrosi viscer epitheli cell involv entir glomerular popul segment sclerot report affect number glomeruli convent determin percentag glomeruli affect sclerot lesion base examin random select section glomeruli normal section affect sclerosi region capillari tuft ct assess real incid spatial extens sclerot level singl glomerulus serialsect morpholog analysi measur volum glomerulus sclerosi lesion glomeruli control rat glomeruli adriamycin adr treat rat surfac area bowman capsul bc ct sclerot region measur stereolog techniqu consecut section individu glomerulus volum calcul volum bc ct signific control adr rat micron distribut glomerular volum paramet adr rat spread control anim indic glomeruli smaller larger sclerot found control rat adr rat glomeruli affect sclerot lesion"
"fosinopril prevent hyperfiltr decreas proteinuria posttranspl hypertens hypertens renal mass reduct induc glomerular hypertens gh hyperfiltr hf renal injuri gh contribut allograft loss posttranspl hypertens patient pt ht hf gh evalu renal respons acut protein intak api ace inhibit prevent gh effect fosinopril fos evalu pt ht azathioprin prednison patient receiv mgday fos month baselin map mm hg signific reduc mm hg rise mm hg fos administ gfr mlmin decreas month rise fos gfr respons api month fos clear respons appar month disappear fos discontinu proteinuria mg decreas mg month rise mgday therapi gfr respons api control uninephrectom donor lack respons api pt ht suggest hf gh reduct gfr restor respons api reduct proteinuria ace inhibit fosinopril amelior hf gh effect benefici prevent hemodynamicmedi allograft injuri"
"lactat higheffici hemodialysi hemodynam blood gas potassiumphosphorus symptom hemodynam measur higheffici hemodialysi hehd dialysi solut lactat mm bicarbon mm mm acet acet mm cardiac output determin thorac electr bioimped subtl differ hemodynam respons lactat versus bicarbon blood pressur cardiac output total peripher resist affect solut acet lactat bicarbon hehd chang cardiac output acet hehd mark increas cardiac output concurr moder fall blood pressur tpr acet lactat hehd hypoxemia bicarbon hehd po chang lactat hehd correct ph plasma hco concentr delay valu signific obtain bicarbon hehd hour dialysi potassium remov compar dialysi solut phosphorus remov lactat tend slight bicarbon acet result suggest lactat mm dialysi solut suitabl altern acet hehd hemodynam profil similar bicarbon acet result suggest hypoxemia acet dialysi solut intrins acet due low dialysi solut pco level acceler consumpt oxygen substrat metabol"
"multicent trial carnitin mainten hemodialysi patient carnitin concentr lipid effect previous studi report conflict result carnitin supplement plasma lipid patient chronic renal failur perform center doubleblind placebo control trial evalu effect posthemodialysi intraven inject carnitin esrd patient mainten hemodialysi thirti patient receiv month carnitin infus mgkg postdialysi patient receiv placebo infus group patient baselin predialysi plasma red blood cell total carnitin level normal predialysi plasmafre carnitin concentr freetot ratio subnorm plasma acyl level elev postdialysi plasma free total carnitin concentr subnorm plasma red blood cell total carnitin level rose eightfold carnitin recipi unchang baselin receiv placebo signific observ plasma triglycerid hdlcholesterol lipoprotein paramet carnitin placebo treat group conclud carnitin metabol alter uremia randomlyselect hemodialysi popul carnitin inject dose mgkg result signific increas blood tissu carnitin level major effect lipid profil"
"influenc calcium acet calcium citrat intestin aluminum absorpt risk aluminum al accumul patient chronic renal failur led al phosphat binder frequent al al phosphat binder administ calcium citrat ca citr algel mark enhanc al absorpt determin calcium acet ca acet augment al absorpt normal volunt oral day cours drug combin dose time daili aluminum hydroxid gel al ml al ml ca acet mg al ml ca citr mg day wash occur al level measur flameless atom absorpt spectrophotometri daili urin al excret measur day baselin day drug plasma al obtain baselin drug hour al excret microgram creatinineday baselin versus treatment combin versus sd versus versus al excret signific greater combin differ signific plasma al microgramslit baselin versus treatment combin versus sd versus versus"
"prostat carcinoma cell line demonstr abnorm tumor suppressor gene prostat carcinoma cell line du pc examin abnorm retinoblastoma rb putat tumor suppressor gene found abnorm rb gene product du western blot analysi polymeras chain reaction amplif direct dna sequenc demonstr base substitut mutat generat stop codon exon northern southern western blot analysi gene product normal du pc fail demonstr express transcript northern blot analysi protein western blot analysi rb gene product normal northern western blot analysi work extend correl abnorm express putat tumor suppressor gene human malign"
"effect ileal conduit patient activ radic cystectomi twenti month patient undergon radic cystectomi bladder cancer univers texa  anderson cancer center survey assess effect ileal conduit urinari divers postop activ postop percent patient activ percent moder activ percent sedentari chemotherapi patient gender found statist signific effect postop activ level chemotherapi result decreas activ patient percent percent increas sedentari patient percent percent differ activ level percent nonchemotherapi patient fifti percent men activ compar percent women percent women men moder activ percent sedentari experi ileal conduit signific negat effect activ effect chemotherapi control percent patient receiv chemotherapi experienc chang increas activ"
"cecal tubular lengthen techniqu creation catheteriz conduit creation contin catheriz stoma integr compon success contin urinari divers techniqu lengthen contin appendicovesicostomi techniqu extend applic mitrofanoff principl urinari tract reconstruct"
"biofeedback treatment psychogen void dysfunct young man psycholog problem long histori social inadequaci present void dysfunct videocystometrographi reveal normal fill phase normal initi void interrupt strain patient mark sphincter electromyograph emg activ temporari amelior achiev infiltr sphincter lignocain hydrochlorid biofeedback therapi case optim result expect longterm behavior therapi"
"treatment renal transplant stone extracorpor shockwav lithotripsi prone posit patient renal transplant lithiasi success treat extracorpor shockwav lithotripsi eswl prone posit pathogenesi treatment transplant lithiasi discuss perform eswl renal transplant patient prone posit advantag standard posit techniqu"
"studi antireflux nippl valv kock ileal urinari reservoir experiment investig dog assess construct mainten function kock ileal urinari reservoir contin antireflux nippl valv laboratori investig dog simultan clinic trial human fifteen dog underw creation hemikock ileal reservoir effer valv limb anastomos bladder enterocystoplasti affer antireflux nippl valv intussuscept cm mesenteri remov nippl stabil metal absorb polysorb stapl marlex collar uret anastomos affer limb reservoir contralater system left intact control ten dog vivaria twelv thirti month studi nippl valv remain intact viabl nonreflux revis kidney remain histolog normal dog dilat uret secondari ureteroil stenosi concurr calculi format calculi form expos metal stapl marlex absorb stapl found promot heal nidus stone format intussuscept nippl valv mesenteri remov reproduc function reliabl prevent reflux valv histolog preserv divert kidney upper urinari tract drainag normal calculi minim proper placement stapl elimin marlexanchor collar minim calculi"
"radiograph spectrum renal osteodystrophi chronic renal failur result bone collect renal osteodystrophi includ osteiti fibrosa osteosclerosi soft tissu calcif osteomalacia adult ricket children earli recognit renal osteodystrophi aggress clinic control serum calcium phosphat level intervent spare patient late complic fractur pain loss skelet function"
"effect angiotensinconvert enzym inhibit dietari protein restrict treatment proteinuria angiotensinconvert enzym inhibitor dietari protein restrict report reduc urinari protein loss patient chronic glomerular diseas evalu therapi patient ingest constant metabol diet proteinkg bodi weight day steadyst achiev week baselin period patient random assign enalapril titrat reduc arteri pressur mm hg isocalor kg protein diet patient group complet addit week observ treatment period enalapril result averag reduct urinari protein albumin loss reduc creatinin clearanc albumin synthesi unchang nitrogen balanc increas slight mmol dietari protein restrict consist effect proteinuria albuminuria albumin synthesi nitrogen balanc mmol decreas therapi result modest increas plasma potassium concentr mainten albumin synthesi presenc reduct urinari protein loss convey longterm advantag treatment proteinur patient angiotensinconvert enzym inhibitor remain determin"
"preserv renal reserv chronic renal diseas proteininduc increas glomerular filtrat rate gfr term renal reserv abrog onset renal diseas notion inconsist result anim studi suggest alter protein intak modul glomerular hemodynam experiment renal diseas normal subject patient renal diseas receiv protein meal provid kg bodi weight protein subject pretreat placebo angiotensin convert enzym inhibitor enalapril signific increas inulin paraaminohippur pah clearanc note normal subject patient renal diseas increas gfr basal valu normal subject patient moder renal failur advanc renal failur plasma renin activ unchang protein meal placebo studi increas enalapril administr enalapril pretreat alter glomerular vasodil hyperfiltr protein meal conclud protein meal induc glomerular hyperfiltr renal diseas proteininduc hyperfiltr mediat angiotensin ii glomerular hyperfiltr implic progress renal diseas data suggest patient advanc renal failur highprotein diet exert detriment effect kidney"
"surviv patient endstag renal diseas base age medic condit time treatment patient begin dialysi treatment chronic renal failur januari decemb classifi low averag high risk death surviv group shown signific month classif scheme simpl perform bedsid effort monitor qualiti assur dialysi unit account signific differ expect surviv reflect casemix observ unit"
"link hypophosphatemia skelet mass adult assess histomorphometri comput tomographi absorptiometri purpos patient method link hypophosphatemia xlh common inherit form ricket influenc skelet mass adulthood controversi incomplet character measur bone mass skelet site histomorphometr radiograph techniqu adult men xlh age rang year subject receiv medic therapi xlh puberti result subject underw transiliac bone biopsi elev cancel bone volum osteoid calcifi bone group supranorm miner bone volum normal subject ns measur trabecular bone densiti vertebr miner densiti comput tomographi elev subject group increas integr spine bone miner densiti bmd assess dual photon absorptiometri dpa elev subject normal total bodi calcium total bodi bmd dpa forearm bone miner content assess singl photon absorptiometri predomin cortic bone normal subject group paramet region bmd dpa normal upper lower limb normal spine rib relationship indic bone mass biochem clinic paramet diseas sever men tend higher score axial bone densiti premenopaus women valu turn tend higher postmenopaus women ns conclus conclud axial bone mass increas adult xlh dramat partial attribut hyperosteoidosi peripher bone mass diminish group trend adult untreat xlh normal indic bone mass assess varieti techniqu common measur site find suggest osteoporot fractur develop late complic xlh adult"
"interstiti cellular infiltr detect fineneedl aspir biopsi nephriti fineneedl aspir biopsi fnab detect renal mononuclear interstiti inflamm patient type nephriti iga nephropathi focal necrot glomerulonephr interstiti nephriti classifi chronic glomerulonephr mesangi prolif iga chronic glomerulonephr focal glomerulosclerosi normal histolog examin microscop hematuria control regular renal biopsi histolog immunofluoresc studi simultan obtain compar analysi control differenti count mononuclear infiltr subtyp cell infiltr helper suppressorcytotox cell detect immunoperoxidas stain fnab correl clinic manifest renal function test general result increas mononuclear cell infiltr monocyt lymphocyt activ lymphocyt fnab patient iga nephropathi interstiti nephriti focal necrot glomerulonephr monocyt iga nephropathi interstiti nephriti compar control lymphocyt focal necrot glomerulonephr classifi glomerulonephr number infiltr activ lymphocyt signific increas focal necrot glomerulonephr interstiti nephriti focal glomerulosclerosi fnab sensit histolog examin quantif interstiti cellular infiltr cytolog differenti count patient decreas increas cell count accentu fnab compar peripher blood strong posit correl local peripher count"
"acut renal failur critic ill patient prognosi recoveri kidney function prolong dialysi support object clarifi prognosi eventu recoveri kidney function patient experi prolong dialysi depend acut renal failur arf design retrospect chart review set inpati larg referralbas hospit patient twenti consecut survivor arf requir greater wk dialysi support result patient critic ill develop arf treatment icu clinic patient character multipl episod renal ischemia nephrotoxin exposur dialysi depend multipl renal insult prolong dialysi support durat wk patient recov suffici kidney function discontinu dialysi preexist renal impair greater risk irrevers renal failur patient discontinu dialysi renal recoveri incomplet conclus renal damag critic ill patient surviv arf requir prolong dialysi support recov lifesustain kidney function"
"studi bilater histolog meiotic analysi men undergo varicocel ligat fifti men underw testicular biopsi time varicocel ligat biopsi score portion biopsi subject meiotic analysi men follow month consist histolog meiotic abnorm evid varicocel side defect contralater side thirteen pregnanc record occur johnsen score testi greater"
"concentr transferrin beta microglobulin albumin semin plasma relat sperm count number studi shown relationship transferrin level semin plasma sperm count present studi level transferrin beta microglobulin albumin measur sampl semin plasma subject normal sperm count azoospermia oligozoospermia polyzoospermia vasectom protein relat sperm count conclud general relationship semin plasma protein sperm number product sperm control entri plasma protein semin plasma"
"rapid baroreceptor reset chronic hypertens implic normal arteri pressur purpos studi examin abil baroreceptor renal hypertens rabbit reset rapid acut arteri pressur carotid sinus cs vascular isol baroreceptor activ record slow ramp increas cs pressur hypertens kidney wrap mm hg normotens kidney wrap mm hg rabbit anesthet chloralos control measur made hold pressur minut level arteri pressur record experi baroreceptor threshold pressur pth higher hypertens mm hg compar normotens mm hg nerv activ hypertens wide rang pressur cs distens sonomicromet signific group increas hold pressur control mm hg minut extent baroreceptor reset delta pthdelta hold pressur normotens hypertens decreas hold pressur mm hg reset similar normotens hypertens hypertens rabbit acut minut exposur baroreceptor normotens mm hg decreas pth mm hg increas nerv activ level signific normotens anim alter cs distens"
"penil duplex sonographi diagnosi venogen impot studi test hypothesi measur cavern arteri diastol veloc resist index provid quantit noninvas measur penil corpor venous leakag seventi men studi duplex ultrasonographi intracavernos inject mg papaverin fourteen men normal erect serv control sixti men year histori transient fade incomplet erect subject peak systol veloc enddiastol veloc measur resist index calcul peak systol velocityenddiastol velocitypeak systol veloc men normal erect peak systol veloc greater cmsec enddiastol veloc cmsec group patient incomplet erect group ii classifi subgroup twenti patient enddiastol veloc greater cmsec normal peak systol veloc greater cmsec suspect corpor venous leakag group eighteen patient normal enddiastol veloc cmsec twelv group peak systol veloc cmsec peak systol veloc rang cmsec patient suspect arteri insuffici group fifteen patient enddiastol veloc greater cm peak systol veloc cm suspect venous leakag arteri insuffici group twenti patient abnorm diastol flow underw infus pharmacocavernosometri determin salin mainten infus rate maintain intracavernos pressur mm hg full erectil respons"
"efficaci bladder train older women urinari incontin efficaci bladder train evalu random clinic trial involv noninstitution women year older urinari incontin subject urodynam categor urethr sphincter incompet detrusor instabl concomit sphincter incompet bladder train reduc number incontin episod effect similar urodynam diagnost group quantiti fluid loss reduc greater patient detrusor instabl diurnal nocturn voluntari micturit reduc effect nocturn micturit observ subject unstabl detrusor function recommend bladder train consid initi step treatment women urinari incontin provid prior comprehens clinic evalu prescrib urodynam character"
"simpl renal cyst children diagnosi follow assess sonograph frequenc simpl renal cyst children author retrospect review result abdomin sonograph studi children perform year period januari decemb patient abnorm renal function dysplast kidney famili histori polycyst kidney diseas exclud studi author review sonogram reveal simpl cyst patient cyst distribut age sex measur cm maximum diamet sixteen cyst upper pole kidney follow sonograph studi cyst patient year show chang size cyst largest cyst drain percutan cyst manag conserv patient show deterior renal function author conclud pediatr patient demonstr normal renal function intervent simpl renal cyst identifi sonographi"
"nonpalp prostat cancer detect mr imag patholog specimen magnet reson mr imag patient clinic palpabl prostat cancer confin lobe studi evalu abil mr imag depict clinic nonpalp prostat cancer patient undergon imag imag tweight sequenc axial sagitt plane undergo radic retropub prostatectomi patholog examin palpabl tumor present patient unsuspect tumor present area distinct palpabl tumor patient mr imag success depict palpabl tumor sensit unsuspect tumor sensit sensit mr imag detect nonpalp posterior locat tumor greater locat anterior mr imag falseposit nonpalp tumor patient specif basi data mr imag greater sensit depict posterior locat cancer limit high falseposit rate depict nonpalp tumor"
"determin prostat volum transrect cancer screen part comparison prostatespecif antigen assay investig radiologist object defin highrisk group prostat cancer research measur gland volum compar result screen blood test prostatespecif antigen psa assay total men age year refer prostat cancer screen program transrect ultrasound digit rectal examin patient evid cancer statist signific increas psa valu note increas gland volum rang psa valu patient cancer exceed volumeadjust percentil standard deviat patient negat biopsi result patient psa valu volumeadjust percentil estim risk prostat cancer time general screen popul research conclud knowledg transrect gland volum prostatespecif antigen assay type import object variabl futur prostat cancer screen program volumeadjust percentil present guid costeffect manag current earli detect effort"
"primari signetr cell carcinoma urinari bladder primari signetr cell carcinoma uncommon malign aris urinari bladder author report case collect institut median age ten men women year frequent present hematuria case mucos lesion cystoscop visibl eleven tumor nonurach origin urach diagnosi tumor stage stage stage stage unknown patient dead diseas rang month median month aliv metastat diseas aliv dead unrel literatur review author accept case met criteria combin case statist analysi prognosi wors pure diffus versus mix tumor nonurach versus urach origin differ year surviv rate stage diseas statist signific"
"transform growth factorbeta product antiglomerular basement membran diseas rabbit purpos studi assay presenc collagen synthesi stimulatori activ kidney immuneinduc renal injuri result sever fibrosi glomerular interstiti compart model antiglomerular basement antigbm diseas rabbit induc day inject antigbm antibodi renal cortex tissu sampl time point condit media prepar diseas renal cortic sampl show collagen synthesi stimulatori activ test rabbit mesangi cell activ estim molecular weight rang kd neutral antibodi transform growth factorbeta tgfbeta standard assay tgfbeta mink lung epitheli cell line confirm increas tgfbeta activ condit media diseas cortex day day anim signific activ previous acidif suggest tgfbeta present renal condit media activ form increas renal cortic secret activ tgfbeta accompani increas renal cortic tgfbeta mrna content day induct subsequ return control level similar increas tgfbeta activ present nonacidifi condit media purifi glomeruli diseas day anim accompani signific increas tgfbeta mrna acidif signific differ note control diseas sampl suggest presenc substanti latent tgfbeta activ control glomerular condit media controlcondit media inhibitor activ ad exogen tgfbeta result support conclus associ increas tgfbeta secret increas renal cortic collagen synthesi model consist role cytokin direct fibrogenesi kidney"
"frequent lithium administr lower urin volum object studi design determin patient maintain regimen lithium day schedul lower urin volum patient receiv multipl dose day method crosssect studi patient lithium clinic receiv dose schedul patient admit hospit measur lithium level creatinin clearanc urin volum maximum osmol result multipl daili dose lithium higher urin volum dose schedul durat lithium treatment daili dose lithium affect maximum osmol creatinin clearanc conclus urin volum reduc give lithium daili lower total daili dose lithiuminduc polyuria relat extraren renal effect"
"dipstick analysi urinari protein comparison chemstrip multistixsg boehringermannheim chemstrip ame multistixsg urin dipstick assay detect proteinuria evalu chemstrip precis multistixsg inconsist duplic pair precis poorest group inexperienc technologist multistixsg chemstrip yield inconsist multistixsg urin supplement protein standard evalu proteinsuppl consecut acquir patient specimen multistixsg chemstrip perform statist similar fashion sensit predict negat test result supplement sampl sensit patient sampl sensit predict negat test result multistixsg compar chemstrip conclud test suffici sensit detect low level proteinuria rang function screen test renal diseas"
"effect polyc function isol perfus rat kidney  minim chang nephrot syndrom occurr heavi proteinuria explain basi reduct charg select glomerular filtrat barrier propos caus neutral anion group circul polycation factor  effect polyc protamin polylysin function isol perfus rat kidney examin  polylysin polym high molecular weight induc heavi proteinuria simultan caus mark increas renal vascular resist fall filtrat rate protamin approxim molecular weight high concentr induc modest proteinuria absenc effect vascular resist filtrat rate  polylysin polym lower molecular weight induc proteinuria protamin concentr microgramsml affect protein excret provok substanti natriuresi larg due effect tubular handl sodium filtrat rate remain steadi fraction sodium excret rose mark  natriuret effect protamin block heparin indomethacin verapamil suggest mechan natriuresi depend prostaglandin product entri calcium verapamilsensit channel"
"sex surviv tradeoff qualiti quantiti life patient local prostat cancer treat surgeri radic prostatectomi radiotherapi controversi physician surgeri offer higher surviv rate surgic treatment produc higher rate sexual impot studi assess men surviv sexual potenc trade treatmentchoic techniqu interview men age year prostat cancer hypothet rate surviv year surgeri impot surgeri radiotherapi repres publish estim respond unwil trade surviv trade greater advantag year surviv choos radiotherapi maintain sexual potenc median year surviv trade rang trade surviv sexual potenc signific relat level educ age interest sex frequenc sexual intercours abil achiev erect conclud men choos treatment lower longterm surviv increas chanc remain sexual potent men difficult identifi clinic practic physician discuss surgeri radiotherapi option patient local prostat cancer"
"posttranspl renal arteri stenosi immunolog phenomenon retrospect review consecut kidney transplant perform year reveal develop renal arteri stenosi patient comparison group control group similar patient age interv elaps transplant reveal signific differ donor recipi age degre hla compat serum creatinin level signific differ number acut reject episod seri male patient affect sizabl proport patient detect murmur graft area high blood pressur increas creatinin level absenc surgic injuri extract implant graft anatom site stenosi correl degre immunolog intoler suggest immunolog factor posttranspl renal arteri stenosi"
"acut renal function extracorpor shock wave lithotripsi patient solitari function kidney twelv consecut patient solitari function kidney treat renal stone extracorpor shock wave lithotripsi eswl modifi dornier hm lithotriptor studi day treatment urinari excret electrolyt acetylbetaglucosaminidas nag alkalin phosphatas kallikrein glycosaminoglycan albumin beta microglobulin clearanc creatinin inulin paraaminohippur acid determin serum level creatinin urea beta microglobulin aldosteron plasma renin activ urinari flow rate free water clearanc urinari excret nag kallikrein beta microglobulin signific increas hour eswl urinari excret alkalin phosphatas albumin glycosaminoglycan unchang glomerular filtrat rate signific decreas effect renal plasma flow unchang filtrat fraction stabl serum lactic dehydrogenas increas signific eswl remain high period observ serum level creatinin beta microglobulin aldosteron unalt decreas plasma renin activ immedi treatment explain water immers extracellular volum expans treatment"
"ureter calculi natur histori treatment era advanc technolog patient ureter stone manag expect treat varieti invas noninvas techniqu depend stone composit size locat expect patient experi surgeon patient document ureter calculi pass stone spontan passag rate proxim middl distal uret basket fluoroscop control distal stone success attempt approach fail ureteroscopi perform success rate ureteroscopi initi treatment distal stone remov achiev patient statist serv remind tradit therapi ureter stone lost role contemporari practic"
"manag upper tract calculi patient tubular urinari divers retrospect review patient urinari divers present stone center year period underw procedur suspect stone episod eventu outcom excel patient attempt retrograd transstom manipul success present case note technic manag principl frequent patient serv combin percutan antegrad transstom retrograd extracorpor shock wave lithotripsi"
"vacuum tumesc devic role papaverin select patient conduct prospect studi determin posit predict papaverin test select patient vacuum constrict devic success altern oper manag impot total men present impot clinic evalu seri papaverin dosag mg patient receiv physicianadminist trial vacuum constrict devic month home repeat object evalu initi respons devic poor patient achiev rigid erect month home patient achiev rigid erect posit predict good respons papaverin trial"
"intracavern inject vasoact drug treatment impot year experi case patient impot vari etiolog month institut intracavern inject therapi vasoact drug papaverin papaverin alphablock ceritin multilevel act drug patient return followup visit regular contact patient sexual activ restor dropout rate episod prolong erect patient repres record inject patient treat complic percentag patient suffer nodul perman deform case intracavern fibrosi percentag satisfi patient satisfact index greater improv spontan erect sexual intercours obtain case longer inject occasion remain depend"
"interstiti temperatur measur transurethr microwav hyperthermia microwav hyperthermia present investig treatment allevi symptom urinari outlet obstruct benign prostat hyperplasia clinic techniqu intracavitari microwav applic evalu safeti efficaci institut transrect techniqu direct microwav radiat insert rectum adjac prostat transurethr approach symmetr radiat applic locat prostat urethra transrect prostat heat techniqu requir surfac cool prevent hazard temperatur interven rectal mucosa transurethr applic radiat prostat urethra heat confin obstruct tissu immedi surround applic concern express possibl thermal injuri prostat adjac rectum transurethr hyperthermia treatment report present interstiti temperatur measur prostat rectal temperatur patient temperatur observ decreas rate ccm outward applic clinic signific temperatur increas observ cm prostat capsul rectal mucosa"
"treatment benign prostat hypertrophi longact gonadotropinreleas hormon analogu year experi benign prostat hypertrophi common ailment elder men treat surgeri androgen enhanc prostat hypertrophi withdraw logic treat condit recent gonadotropinreleas hormon analogu produc chemic castrat case benign prostat hypertrophi report experi men treat month inject gonadotropinreleas hormon prolong period men treat month prostat volum decreas averag initi volum correl clinic object improv men attain normal flow rate residu urin volum remain unalt ten patient experienc subject amelior report object subject improv maxim decreas prostat volum reach month treatment treatment addit shrinkag month discontinu treatment prostat volum return pretreat valu similar decreas flow rate note symptom remain improv longer period conclud mode treatment offer major men benign prostat hypertrophi proper patient select base serum prostat specif antigen augment posit result therapi restrict patient consid high risk surgic anesthet intervent continu indefinit"
"bioavail potassium magnesium citratur respons potassiummagnesium citrat bioavail potassium magnesium citratur respons determin compound potassiummagnesium citrat normal volunt result compar potassium citrat magnesium citrat subject particip phase studi potassiummagnesium citrat potassium citrat magnesium citrat potassium chlorid stabil metabol diet subject ingest singl load test medic time urin collect hour test load includ potassiummagnesium citrat meq potassium meq magnesium meq citrat potassium citrat meq potassium chlorid meq magnesium citrat meq urinari potassium magnesium citrat measur collect period potassiummagnesium citrat provid equival potassium bioavail potassium citrat potassium chlorid compar magnesium bioavail magnesium citrat gave highest citratur respons cumul increment urinari citrat postload mg daili potassiummagnesium citrat mg daili potassium citrat mg daili magnesium citrat potassiummagnesium citrat gave optimum citratur respons addit provid absorb potassium magnesium"
"laser treatment obstruct incrust ureter cathet incrust develop ureter cathet obstruct report case obstruct reliev laser lithotripsi insid lumen cathet complet noninvas techniqu prove select case"
"endopyelotomi secondari ureteropelv junction obstruct children percutan endopyelotomi shown success treat ureteropelv junction obstruct adult data publish procedur children describ patient week year underw percutan endopyelotomi treat ureteropelv junction obstruct fail open dismemb pyeloplasti preoper obstruct demonstr nephrostogram diuret renogram ultrasonographi percutan endopyelotomi success reliev obstruct patient requir secondari endoscop procedur patient persist obstruct day endopyelotomi ureteropelv junction subsequ requir percutan resect persist flap obstruct tissu patient ureteroves strictur note time stent remov treat endoscop incis patient year postop followup diuret renogram ultrasound excretori urographi demonstr patent ureteropelv junction patient remain asymptomat endopyelotomi safe effect treat secondari ureteropelv junction obstruct children"
"cavern nerv graft restor erectil function denerv rat potenc preserv men radic prostatectomi patient cavern nerv sacrif order excis tumor patient consid nerv reconstruct time surgeri interposit nerv graft possibl test rat model anim divid group sham control group pelvic explor conduct divis cavern nerv nerv ablat group mm segment cavern nerv excis graft group mm cavern nerv excis bilater replac interposit graft genitofemor nerv month interv postop anim group underw mate test determin potenc ratio vagin intromiss unsuccess mount ratio determin mate test anim explor attempt made stimul erect electr pelvic nerv result month show ratio rat graft nerv ablat low compar sham oper anim month graft group approach sham group ablat group remain unchang electr stimul month produc erect nerv ablat graft rat erect shamoper anim month rat graft nerv ablat anim intact anim produc erect electr stimul result suggest cavern nerv graft rat success restor potenc surgic injuri applic techniqu man"
"obstruct recan uret embryon develop major controversi exist terminolog etiolog pathogenesi congenit obstruct diseas uret provid addit inform controversi subject compar studi ureter develop rat human embryo light electron microscopi perform fetal develop observ demonstr exist obstruct phenomena level ureteroves junction chwalla membran uret end embryon period uret undergo physiolog recan process"
"color doppler ultrasound compar radionuclid scan spermat cord torsion canin model high resolut color doppler ultrasound simultan display blood flow superimpos detail gray scale anatom imag singleblind studi design adult male dog underw intravagin spermat cord torsion subsequ evalu technetium mpertechnet radionuclid color doppler ultrasound imag techniqu torsion degre creat surgic examin modal hour anim hour anim procedur testicular torsion diagnos perfus absent mark diminish color doppler imag radionuclid scan case degre greater torsion diagnos modal hour time delay observ diagnos torsion assess relat testicular perfus color doppler ultrasound radionuclid scan error correct detect relat decreas perfus instanc color doppler imag spectral analysi detect enhanc diastol compon arteri signal degre torsion spectral pattern coupl relat decreas blood flow presumpt diagnosi hour partial torsion subsequ appar absent perfus hour radionuclid repeat color doppler ultrasound color doppler ultrasound prove superior radionuclid scan detect diminish perfus experi detail inform provid spectral anatom display color doppler ultrasound recommend evalu acut scrotal patholog uncertain etiolog"
"bladder train older women urinari incontin relationship outcom urodynam observ purpos studi clarifi mechan bladder train affect urinari incontin urodynam data specif urodynam diagnos women urinari incontin compar month treatment bladder train treatment women sphincter incompet detrusor instabl treatment women longer fulfil urodynam diagnost criteria sphincter detrusor dysfunct control sever treatment number incontin episod posttreat chang urodynam diagnosi sensat void void volum complianc function urethr length flow time show signific pre posttreat evalu correl chang number incontin episod bladder train affect lower tract urodynam variabl specif urodynam diagnosi mechan action reflect adapt behavior physiolog detect techniqu criteria studi occur"
"adipos tissu fatti acid composit relat diet plasma lipid concentr hemodialysi patient adipos tissu fatti acid composit serum lipid profil dietari intak patient mainten hemodialysi studi august analys carri normotriglyceridem ntg hypertriglyceridem htg type iv hyperlipidemia patient correl found dietari intak polyunsatur fatti acid pufa ratio polyunsatur satur fatti acid ratio carbohydr content hand serum lipid concentr group adipos tissu linolen acid correl negat serum cholesterol group strong correl found dietari intak pufa adipos tissu linol acid content pufa doublebond index ratio adipos tissu linol acid content ratio doublebond index signific differ dietari intak adipos tissu fatti acid composit observ ntg htg patient evid found exogen dietari influenc serum lipid concentr adipos tissu linol acid content reflect dietari intak pufa"
"bedwet child current manag frustrat problem bedwet frustrat problem experienc signific number children role physician exclud problem time educ famili treatment option suit child parent child understand problem realiz outlook nighttim bladder control excel easier start longterm care"
"human papillomavirus prostat cancer evid found situ dna hybrid human papillomavirus benign squamous tumor intraepitheli neoplasia invas squamous cancer role human papillomavirus precursor cervic dysplasia studi inform role human papillomavirus prostat hyperplasia cancer studi formalinfix paraffinembed tissu case glandular hyperplasia case prostat cancer situ dna hybrid human papillomavirus commerci biotinyl dna probe detect avidinbiotin peroxidas techniqu found evid dna hybrid human papillomavirus prostat tissu result show associ prostat cancer hyperplasia human papillomavirus genom studi"
"fibrin format vessel wall hyperplast malign prostat tissu explor mechan coagul activ adenocarcinoma prostat occurr distribut compon coagul fibrinolysi pathway situ studi immunohistochem techniqu appli frozen section fresh malign benign hyperplast prostat tissu obtain transurethr resect fibrinogen distribut perivascular tumor connect tissu malign benign diseas present adjac area normal prostat antibodi specif fibrin dimer crosslink site stain vascular endothelium focal malign benign tissu neoplast cell benign hyperplast glandular epitheli cell stain weak patchi distribut tissu factor focal lowmolecularweight urokinasetyp plasminogen activ focal stain vascular endothelium observ tissu plasminogen activ plasminantiplasmin complex neoantigen contrast tissu stain observ factor vii factor factor xiii subunit highmolecularweight urokinasetyp plasminogen activ plasminogen activ inhibitor protein protein similar find benign hyperplast neoplast prostat tissu lack intact tumor cell coagul pathway fibrin format presenc fibrin vascular endothelium consist concept coagul activ prostat cancer due direct effect tumor cell clot mechan activ induc solubl tumor product activ procoagul activ host vascular endotheli cell find lack effect warfarin anticoagul clinic patient prostat cancer contrast find tumor type suggest coagul activ contribut progress adenocarcinoma prostat"
"antibiot potenti hazard male fertil individu agent major class antibiot shown signific advers effect spermatogenesi spermatozo function mammal human infertil signific alter semen paramet document nitrofuran patient sulfasalazin common antibiot minocyclin shown toxic sperm concentr inform clinician mind treatment antibiot advers affect fertil potenti men class antibiot agent penicillin quinolon minim effect male fertil maintain clinic efficaci patient requir longterm antibiot suppress therapi investig relat toxic antibiot mechan antibiot affect spermatogenesi spermatozo function background current state knowledg advers effect antibiot male fertil present review"
"parathyroid function normocalcem renal transplant recipi evalu calcium infus extent secondari hyperparathyroid involut remain poor defin renal transplant offer clinic situat metabol stimuli hyperparathyroid remov examin hyperparathyroid resolv transplant evalu renal transplant recipi normocalcem month transplant sensit site immunoradiometr assay intact serum pth pth concentr normal rang found abnorm parathyroid function challeng iv calcium infus patient demonstr signific elev basal pth concentr elev ioniz calcium normal total serum calcium albumin concentr pth respons infus calcium mark abnorm confirm hyperparathyroid estim renal threshold phosphat concentr low patient normal basal pth concentr elev basal pth bone miner densiti measur radius singl photon absorptiometri spine dual energi ray absorptiometri normal transplant recipi normal basal pth concentr"
"macrophag nephrot rat regul apolipoprotein biosynthesi cholesterol content independ effect nephrot syndrom rat cholesterol content biosynthesi apolipoprotein apo resid periton macrophag investig nephrot syndrom increas risk coronari atherosclerosi hypothes macrophag nephrot rat accumul cholesterol undergo transform foam cell concomit increas apo biosynthesi nephrot syndrom induc rat puromycin aminonucleosid periton macrophag expos vivo ascit fluid deriv plasma sixfold elev lipoprotein accumul unesterifi esterifi cholesterol immunoprecipit assay incub isol cell smethionin immunoblot analysi incub medium demonstr fold increas apo secret compar normal macrophag increas accompani fold increas cellular apo messeng rna determin quantit solut hybrid assay periton macrophag cultur nephrot rat period hypercholesterolemia show distinct high reproduc morpholog dissoci apo biosynthesi macrophag cholesterol content insight respons periton macrophag vivo endogen hyperlipemia"
"random comparison nephrotox iopamidol diatrizo high risk patient undergo cardiac angiographi hundr high risk patient renal impair serum creatinin greater equal mgdl random doubleblind manner iopamidol nonion low osmolar radiocontrast agent diatrizo convent radiocontrast agent cardiac angiographi subsequ follow studi renal function baselin clinic angiograph variabl similar iopamidol diatrizo group chang renal function angiographi pronounc iopamidol compar diatrizo measur sd increas serum creatinin versus mgdl maxim increas serum creatinin versus mgdl percent patient maxim increas serum creatinin greater mgdl versus differ document diabet patient insulin signific differ agent number patient develop clinic sever acut renal dysfunct conclud iopamidol nephrotox diatrizo high risk patient cardiac angiographi differ nephrotox small major clinic signific major high risk patient document insulin diabet patient iopamidol prefer agent patient advanc renal impair studi warrant"
"simpl stand increment cystometri screen method detrusor instabl hundr consecut neurolog normal women complain urinari incontin underw stand increment retrograd mediumfil water cystometrogram day sit stand continu retrograd mediumfil water urethrocystometri visit novemb februari studi assess reproduc sensit specif predict valu simpl cystomet stand increment retrograd cystometri found inexpens simpl reproduc sensit cystometrogram yield similar result patient sensit found cystometrogram cystometrogram detect detrusor instabl sensit predict absenc negat predict detrusor instabl found patient base result conclud multichannel urodynam highpreval popul stand retrograd increment water cystometri occas offer physician accur altern diagnosi detrusor instabl"
"cyproteron acet prostat cancer cyproteron acet progest antiandrogen potent antigonadotrop activ result rapid suppress serum testosteron singl agent cyproteron acet yield total androgen blockad combin lowdos diethylstilbestrol orchiectomi lhrh agonist improv theori result therapi clinic test cyproteron acet prove equival diethylstilbestrol mark toxic conjunct lhrh agonist transient block flare phenomenon continu block peripher androgen receptor necess action prove cyproteron acet afford transient object improv patient respond form hormon depriv experi role limit drug suppress hot flush orchiectomi lhrh agonist therapi cyproteron acet induc local tumor regress owe revers effect neoadjuv adjuv androgen withdraw therapi patient lowerstag diseas undergo radic surgeri radiotherapi advers effect relat hormon withdraw impot infertil lassitud gynecomastia breast tender occur cardiovascular complic approxim treat men"
"suramin treatment prostat carcinoma refractori convent hormon manipul suramin relat compound view growth factor enzym bind properti repres respect approach treatment cancer preliminari analysi suramin treatment metastat prostat cancer object respons rate impress work optim suramin administr patient elucid postul mechan action develop relat compound specif enzym growth factor antagonist properti"
"advanc prostat carcinoma earli versus late endocrin therapi landmark observ huggin hodg androgen depriv mainstay treatment advancedstag prostat cancer earli poor control studi suggest enhanc surviv hormon therapi view fell disfavor result observ vacurg studi recent prolifer experiment clinic data support earli androgen depriv includ reanalysi vacurg data suggest surviv advantag younger patient stage diseas highgrad tumor undergo androgenabl therapi time diagnosi riskbenefit analysi present review strong support earli hormon therapi final longterm surviv patient metastat prostat cancer requir develop treatment strategi effect androgenresist tumor cell concert earli androgen depriv"
"futur develop nonhormon system therapi prostat carcinoma prostat cancer common type cancer men increas public awar screen method signific proport men continu present metastat diseas men respond initi hormon intervent time major recurr hormon unrespons tumor present therapi impact research continu identifi cellular molecular aspect prostat cancer implic site therapeut intervent"
"total androgen ablat canadian experi multicent random doubleblind trial compar total androgen blockad obtain castrat pure antiandrogen nilutamid simpl castrat begun hundr patient receiv combin treatment orchiectomi placebo featur evalu efficaci bone pain respond combin treatment month number favor respons evalu npcp criteria simpl castrat combin treatment statist signific differ group time progress logrank test surviv logrank test increas median surviv month measur show differ treatment total androgen blockad patient diseas progress year dead year review result similar report studi suggest improv modest improv total androgen blockad testicular androgen ablat"
"megestrol acet lowdos estrogen manag advanc prostat carcinoma megestrol acet lowdos estrogen effect lowcost altern pharmacolog surgic castrat flutamid manag patient advanc prostat cancer potenti benefit combin androgen ablat achiev comparison convent hormon therapi limit"
"role alphareductas inhibitor treatment advanc prostat carcinoma biolog prostat support concept dht oblig androgen respons normal hyperplast growth select maintain malign transform unknown consist emerg androgeninsensit diseas highlight spectrum biolog evolut cancer capabl tumor depend dht neoplast growth uniqu characterist alphareductas inhibitor offer potenti action warrant systemat evalu"
"nonsteroid antiandrogen casodex advanc prostat carcinoma pure antiandrogen advantag steroid antiandrogen cyproteron acet type treatment patient advanc prostat cancer steroid side effect mark inhibitori effect libido addit long halflif pure antiandrogen casodex result mainten high serum antiandrogen concentr allay concern clinic signific small rise serum testosteron concentr antiandrogen choic treatment androgenrespons diseas defin choic base extens clinic evalu drug monotherapi clinic efficaci toler drug import factor determin antiandrogen choic favor pharmacokinet emphas treatment diseas high sustain concentr antagonist present prevent androgen stimul casodex pure antiandrogen long halflif produc object subject respons similar surgic pharmacolog castrat toler profil make strong candid futur antiandrogen choic treatment advanc prostat cancer"
"standard contracept diaphragm manag stress urinari incontin manag stress urinari incontin sui consist surgic intervent pharmacolog manipul twelv patient sui evalu manag fit standard contracept diaphragm complet resolut sui achiev patient patient achiev contin withdrew studi discomfort diaphragm complet resolut sui achiev patient"
"multilocular cyst kidney studi patient review literatur multilocular renal cyst distinct renal tumor gross extern absenc normal renal tissu septa loculi distinguish renal cystic lesion interlocular septa fibrous tissu embryon tissu separ adjac loculi patient multilocular renal cyst underw renalspar procedur radic nephrectomi histolog specimen show evid immatur renal tissu neoplasia patient month year month evid local recurr metastat diseas found difficult distinguish multilocular renal cyst cystic wilm tumor multicyst clear cell carcinoma basi imag studi surgic intervent effect method differenti multilocular renal cyst malign lesion kidney"
"mobil epididymi clinicopatholog entiti genesi male infertil treatment epididymopexi mobil epididymi play import role genesi male infertil constitut percent consecut seri idiopath infertil patient examin fertil infertil mobil epididymi detect infertil patient clinic pictur characterist epididymi wide separ testicl move freeli side side bodi tail ill form epididymovas angl obtus azoospermia persist patient intermitt patient testicular biopsi show tubular dilat epididymopexi perform patient fix epididymi testicl patient show improv semen qualiti result pregnanc failur due advanc testicular damag infertil mobil epididymi result obstruct effer ductul testicular ischemia interfer sperm matur transport deliveri"
"simpl urodynam evalu incontin elder femal nurs home patient descript analysi present descript analysi function mental urodynam status popul incontin elder femal nurs home patient hundr fifti intermedi care femal patient age year identifi incontin urin daili urolog evalu patient classifi categori incontin normal cystometrogram detrusor instabl di stress incontin si overflow incontin oi thirteen week patient studi simpl water cystometri follow evalu patient urodynam find differ initi evalu women di si oi found normal cystometr paramet time follow studi initi normal cystometr find evid di si strong correl urinari incontin patient normal cystometr find moder sever cognit impair present simpl urodynam evalu identifi patient si oi benefit specif therapi urodynam evalu incontin elder femal nurs home patient provid direct plan treatment strategi"
"pharmacokinet metabol nilutamid data pharmacokinet metabol nilutamid rat dog human normal volunt patient advanc prostat carcinoma studi carbonnilutamid radioimmunoassay highperform liquid chromatographi hplc review rat bioavail oral rout complet major plasma radioact unchang nilutamid hour hour clearanc mlhourkg bodi weight metabol studi identifi urinari metabolit major metabolit result reduct nitro group initi hydroxylamin primari amino group normal volunt compound rapid absorb display linear kinet dose rang mg declin slowli plasma termin phase forti forti hour studi patient advanc stage prostat carcinoma singledos kinet cnilutamid kinet repetit daili dose week measur termin phase plasma unchang nilutamid hour total radioact hour sd area curv plasma radioact percent unchang nilutamid urinari excret radioact slow incomplet collect time long regard day consist metabolit steadyst plasma level nilutamid reach week conclud human unlik speci plasma decay nilutamid slow elimin exclus metabol singledaili dose hepat impair expect prolong plasma decay renal impair effect"
"castrat nilutamid castrat placebo advanc prostat cancer review combin antiandrogen treatment surgic medic castrat improv efficaci endocrin treatment prostat cancer block effect adren androgen nonsteroid antiandrogen nilutamid shown promis result preliminari open studi shortterm day comparison nilutamid buserelin buserelin placebo nilutamid mgday signific reduc bone pain fewer patient experienc worsen pain control group initi buserelininduc increas prostat acid phosphatas prevent nilutamid similar increas testosteron gonadotropin concentr control group nilutamid prevent tumor flare start lutein hormonereleas hormon lhrh treatment endocrin respons affect multicent random doubleblind placebocontrol trial castrat nilutamid involv patient combin nilutamid castrat decreas bone pain improv perform status increas number patient object regress compar patient castrat receiv nilutamid nilutamid general toler visual disord gastrointestin disord alcohol intoler report patient receiv nilutamid result suggest nilutamid improv efficaci castrat patient prostat cancer current studi investig effect treatment surviv riskbenefit ratio"
"pharmacolog antiandrogen combin androgen suppress antiandrogen therapi antiandrogen compound block effect androgen direct target cell inhibit bind androgen receptor ar chemic class antiandrogen present market clinic trial steroid cyproteron megestrol acet nonsteroid flutamid nilutamid steroid antiandrogen interact ar progestin glucocorticoid receptor give rise progestin glucocorticoid effect contrast nonsteroid antiandrogen interact ar devoid hormon antihormon activ nilutamid transform activ metabolit unlik flutamid interact dog rat human prostat ar vitro kinet lead prolong interact ar vivo administr rat prostat cancer treatment combin antiandrogen surgic chemic estrogen lhrh agonist castrat obtain complet suppress androgen antiandrogen block specif target site trophic effect adren androgen left intact castrat secret suppress treatment adrenalectomi aminoglutethimid ketoconazol suppress corticoid synthesi shown nilutamid counteract trophic effect prostat castrat rat adren androgen administ continu minipump circul level similar record castrat men nilutamid imped flare effect testosteron increas induc lhrh agonist begin treatment shown rat treat buserelin increas prostat weight observ initi day treatment lhrh agonist inhibit combin treatment nilutamid combin treatment nilutamid castrat test experiment androgendepend cancer model shionogi tumor administr nilutamid mice castrat twenti hour inocul tumor cell delay tumor reduc number final absenc androgen effect antiandrogen activ product demonstr human tumor cell cultur cell transfect mmtv androgendepend promot coupl cat report gene"
"antisperm antibodi detect concurr cytofluorometri indirect immunofluoresc microscopi antisperm antibodi serum semin plasma detect concurr flow cytometri epifluoresc microscopi fluoresceinconjug antihuman immunoglobulin experiment condit design advantag monoclon antisperm antibodi test aspect assay clinic applic perturb membran integr alter local bind number sperm cell posit bound antibodi specimen select infertil patient femal male signific level antisperm antibodi differ incid isoimmun femal partner antibodyposit antibodyneg male differ local antigen target serum versus semin plasma antibodi men support idea case immun sperm cell result alter sperm antigen"
"effect reprocess cuprophan polysulfon dialyz beta microglobulin remov hemodialysi patient publish erratum kidney dis jul defin relationship dialyz reus remov beta microglobulin beta dialysi patient receiv hemodialysi studi thirteen patient dialyz convent cuprophan dialyz thirteen patient dialyz highflux polysulfon dialyz patient group dialyz dialyz primari phase studi reprocess dialyz reus phase dialyz time reus phase serum beta level measur predialysi postdialysi adjust fluid loss dialysi convent cuprophan dialyz primari phase studi result increas serum beta level increas serum beta level reus phase differ chang concentr beta primari reus phase statist signific dialysi highflux polysulfon dialyz primari phase decreas postdialysi concentr serum beta compar predialysi level decreas serum beta level observ dialysi highflux polysulfon reprocess dialyz reus phase data show evid advers effect clearanc beta dialysi reus dialyz time result confirm previous studi report highflux dialysi polysulfon dialyz remov substanti amount beta dialysi convent cuprophan dialyz"
"concomit iron aluminum mass transfer deferoxamin infus hemofiltr variabl tissu overload alter remov rate iron aluminum urem owe higher affin deferoxamin dfo higher plasma concentr fe impair al remov case simultan bodi burden fe al plasma kinet mass transfer studi urem patient fe al status normal ferritin level microgram ngml al mumol microgram group increas ferritin greater microgram al mumol microgram group dfo mgkg random sequenc administ week hour hemofiltr hf result show group dfo dose maximum fe al mass transfer achiev hf mgkg dose dfo signific rais al mass transfer group fe mass transfer slight affect plasma fe level higher al al mass transfer eventu exceed fe fenorm feoverload patient bias al mass transfer enhanc group hf higher dfo dose dfo week reduc fe loss mumolwk patient normal ferritin level fe al overload patient al remov al mass transfer exceed fe mass transfer depend degre tissu burden time dfo infus dfo dose"
"calcitriol metabol patient chronic renal failur studi calcitriol metabol white patient chronic renal failur age sexmatch normal subject plasma level calcitriol pgml control pgml metabol clearanc rate mcr calcitriol mlminkg control mlminkg product rate pr calcitriol ngkg control ngkg signific lower patient moder renal failur averag creatinin clearanc ml mlmin compar respect valu normal control subject mcr calcitriol determin patient renal failur receiv calcitriol microgram week mcr remain unchang mlminkg plasma level calcitriol increas pgml mechan mcr calcitriol decreas renal failur part due presenc inhibitori factor degrad enzym urem plasma ultrafiltr urem plasma obtain hemodialysi patient infus normal spraguedawley rat mcrs calcitriol mlminkg mark suppress comparison rat infus ultrafiltr normal plasma mlminkg urem plasma factor inhibit synthesi calcitriol conclud metabol degrad calcitriol decreas patient renal failur urem plasma inhibitori factor suppress synthesi degrad calcitriol"
"communityacquir acut renal failur acut renal failur occur hospit present admiss hospit defin outcom communityacquir acut renal failur undertook prospect studi patient admit hospit acut elev serum creatinin concentr month period admiss serum creatinin determin screen patient valu greater mumol mgdl valu compar baselin creatinin select patient acut elev serum creatinin occur hospit hundr patient enter studi incid hospit admiss seventi percent patient preren azotemia intrins acut renal failur obstruct classifi peak serum creatinin mumol mgdl mortal lowest group preren azotemia group volum contract due vomit decreas fluid intak diarrhea fever glucosuria diuret common group intrins acut renal failur sever renal failur highest mortal ischem acut tubular necrosi common hospitalacquir intrins acut renal failur etiolog patient druginduc nephrotox infectionrel common etiolog intrins acut renal failur obstruct renal failur mortal common due benign prostat hypertrophi"
"serial glomerular tubular dynam thyroidectom rat remnant kidney serial measur perform munichwistar rat sixth nephrectomi undergon prior select thyroidectomi tx group thyroidectomi thyroxin replac txt group determin effect tx glomerular tubular dynam relat tx attenu renal failur progress week inulin clearanc rate cin txt tx rat mlmin singlenephron filtrat rate sngfr glomerular plasma flow qa glomerular transcapillari hydraul pressur delta proxim tubular reabsorpt jv reduc tx compar txt rat protein excret uprot txt rat mg tx anim glomerular mesangi matrix expans focal tubulointerstiti frequent txt tx rat week cin sngfr qa glomerular ultrafiltr coeffici kf jv similar tx txt glomerular capillari pressur pgc remain lower tx rat mm hg txt uprot txt mg tx rat glomeruli show focal sclerosi txt rat tx group maxim glomerular planar area increas week txt group tx group measur signific txt tx glomeruli week minim focal tubulointerstiti found txt progress observ week reduc pgc week result disproportion greater increas affer ra effer arteriolar resist tx rat week ra decreas valu ident txt anim lower pgc tx rat result reduc arteri pressur conclus reduc pgc sole function correl decreas proteinuria glomerulosclerosi afford tx partial nephrectomi model suppress nephrectomyrel hypertrophi tubulointerstiti injuri tx exclud partial protect factor"
"plateletcompl interact mesangi prolif nephriti rat complement report mediat mesangiolysi glomerular hypercellular rat model glomerulonephr gn induc antithi antibodi investig mechan complementmedi hypercellular author determin effect complement deplet inhibit cell prolifer effect primarili inhibit leukocyt infiltr rat deplet complement cobra venom factor cvf signific mesangiolysi control day versus scale cell prolifer assess immunostain prolifer cell nuclear antigen pcnacyclin cellcycledepend antigen versus cellsglomerular crosssect leukocyt infiltr assess immunohistochem label versus cellsglomerular crosssect report recent platelet mediat glomerular cell prolifer model studi examin mechan complementmedi cell prolifer involv effect glomerular platelet local glomerular uptak inlabel platelet quantit normal cvftreat rat hour induct gn rat antithi gn substanti glomerular accumul platelet time studi peak hour platelet glomerulus complement deplet profound reduc glomerular platelet local antithi gn platelet glomerulus time studi studi demonstr import role complement mediat platelet local antithi gn effect account complementdepend neutrophilindepend glomerular hypercellular model"
"glomerular basement membran expans passiv heymann nephriti absenc increas synthesi type iv collagen laminin fibronectin distribut synthet rate glomerular basement membran compon examin passiv heymann nephriti model experiment membran nephropathi extens tissu injuri develop includ subepitheli electrondens deposit podocyt foot process effac expans glomerular basement membran level mrna type iv collagen laminin fibronectin isol glomeruli quantit slotblot analysi show chang experiment anim compar control week week month diseas induct immunoelectron microscopi goldlabel antilaminin igg reveal differ number particl bound glomerular basement membran experiment anim control immunofluoresc type iv collagen antisera antilaminin antibodi show differ intens pattern stain extens glomerular damag glomerular basement membran thicken evid found increas synthet rate type iv collagen laminin fibronectin accumul basement membran laminin damag glomeruli altern process diminish densiti matrix compon accumul unmeasur matrix constitu account expans glomerular basement membran experiment membran nephropathi"
"manag staghorn stone combin lithotripsi percutan nephrolithotomi solut irrig treatment staghorn partial staghorn calculi remain complex modern method stone remov describ result treatment stone method percutan nephrolithotomi extracorpor shockwav lithotripsi solut irrig combin stone complet clear solut irrig achiev complet clearanc stone complet clear small asymptomat fragment mm remain satisfactori outcom stonefre asymptomat fragment mm achiev stone"
"impact extracorpor piezoelectr lithotripsi manag ureter calculi audit present manag patient ureter calculi requir activ treatment month period review patient primari ureter calculi ureter calculi compos fragment result extracorpor piezoelectr shockwav lithotripsi epl renal calculi patient calculus steinstrass primari procedur includ situ epl pushbang retrograd ureteroscopi dormia basket extract pushpul antegrad ureteroscopi combin success primari procedur predict stone size site durat uret upper tract dilat signific success group success rate complet stone extract patient requir procedur achiev situ epl pushbang primari secondari procedur success treat patient patient requir ureterolithotomi complic rate epl success treat approxim half ureter calculi rang treatment maintain low rate open surgeri"
"extracorpor shock wave affect urinari excret glycosaminoglycan urinari excret glycosaminoglycan gag studi anaesthetis dog patient singl kidney anim studi hour administr shock wave kidney contralater organ serv control urinari excret gag measur side patient studi extracorpor shock wave lithotripsi eswl anim increas urinari excret gag observ side mark treat kidney increas reflect tissu injuri expos kidney induc extracorpor shock wave increas urinari excret gag observ patient"
"night studi primari diurnal nocturn enuresi preliminari result clam ileocystoplasti modifi convent urodynam apparatus provid overnight monitor bladder rectal pressur group patient primari diurnal nocturn enuresi underw daytim rapid fill cystometri overnight natur fill cystometri overnight studi effect detect detrusor instabl patient deem normal rapid fill cystometri undergon clam ileocystoplasti dri await procedur clam remain effect manag patient resist nocturn diurnal enuresi care select adopt overnight cystometri prove invalu adjunct investig patient primari diurnal nocturn enuresi previous felt urodynam normal"
"void urin suitabl flow cytometr dna analysi sampl bladder wash frequent provid cellular materi flow cytometr dna analysi void urin potenti sourc similar materi aim studi determin void urin yield satisfactori specimen compar qualit result flow cytometr dna analysi cell specimen void urin sampl bladder wash urin specimen gave satisfactori dna histogram compar bladder wash differ appar bladder tumour conclud bladder wash provid superior materi flow cytometr dna analysi flow cytometr dna analysi fresh void urin defici preclud routin clinic practic"
"radic radiat treatment invas local advanc bladder carcinoma elder patient total patient invas local advanc carcinoma bladder tt underw radiat treatment signific higher complet respons rate observ dose equal gy dose cumul radiat effect cre valu radiat effect unit reu multivari analysi decreas time diagnosi bladder carcinoma radiat treatment transurethr resect signific increas surviv increas categori sediment rate negat prognost factor radiat dose cre level signific effect surviv univari analysi increas cre level signific increas surviv multivari analysi import predictor surviv patient show complet local respons studi emphasis import treat patient adequ radiat dose short period time order achiev maximum radiobiolog effect increas possibl cure"
"activ complement kallikreinkinin fibrinolysi coagul system urinari cathet effect time temperatur biocompat studi urethr strictur induc latex cathet combin siliconelatex cathet openheart surgeri report strictur differ postcatheteris type affect greater length urethra recent shown complement activ cathet inflamm contrast clinic silent cathet present studi design investig associ catheterinduc inflamm activ mediat inflamm contact system investig vitro condit optimis biocompat studi data complement kallikreinkinin system activ potenti harm siliconelatex cathet involv pathophysiolog catheterinduc urethr strictur vitro biocompat test perform degre glass test tube vitro complement kallikreinkinin investig"
"haemospermia prospect studi prospect studi men haemospermia present experienc episod year simpl investig led diagnosi men patholog detect diagnosi made remain men simpl investig patient year age haemospermia potenti treatabl found routin investig includ cystoscopi younger men invas investig identifi patholog invas investig reserv patient problem prolong excess associ symptom"
"intravascular retent renal handl purifi natur intramolecular crosslink hemoglobin plasma half time unmodifi hemoglobin uhb intramolecular crosslink hemoglobin alpha alpha xl beta beta xl measur anesthet rat intraven bolus mg gm rule possibl differ plasma half time caus differ acut effect renal excretori function glomerular filtrat rate gfr effect renal plasma flow erpf measur simultan plasma half time experi determin higher dose mg gm compound delay effect hour gfr erpf massiv urinari excret uhb occur alpha alpha xl beta beta xl excret plasma half time alpha alpha xl beta beta xl averag hour time longer uhb case decreas gfr erpf occur transient increas gfr erpf urin flow system blood pressur similar increas occur albumin administr suggest expans vascular volum initi factor renal function hour mg gm uhb alpha alpha xl beta beta xl control albumin intratubular hemoglobin cast intravascular precipit evid acut hour studi hour perl stain materi found alpha alpha xl specimen hour administr perl stain materi present renal tubul cell albumintr kidney"
"factor xiii substrat fibronectin fibrinogen alpha antiplasmin plasma urin patient nephrosi plasma urin concentr factor xiii circul substrat fibronectin fibrinogen alpha antiplasmin measur group patient nephrot syndrom result compar obtain group normal volunt control group patient endstag renal diseas esrd mild signific reduct plasma level abnorm urinari excret alpha antiplasmin found nephrot group plasma concentr factor xiii fibronectin fibrinogen signific elev patient nephrosi contrast patient esrd show signific differ plasma concentr factor xiii fibronectin alpha antiplasmin modest elev fibrinogen compar normal control signific correl found serum creatinin concentr plasma level factor xiii circul substrat nephrot group measur quantiti factor xiii small quantiti fibronectin found urin patient nephrosi elev plasma factor xiii fibronectin fibrinogen concentr nephrot group consid result combin increas synthesi possibl contract intravascular distribut macromolecular protein face neglig urinari loss presenc observ abnorm nephrot group absenc nephrot esrd group exclud renal failur abnorm clinic signific abnorm uncertain potenti contribut thrombophil diathesi platelet hyperaggreg nephrot syndrom"
"fluorouracil recombin human interferon alfaa treatment metastat chemotherapyrefractori urotheli tumor thirti patient advanc metastat chemotherapyrefractori urotheli tumor receiv combin fluorouracil fu recombin human interferon alfaa thirti site metastas present studi patient median eastern cooper oncolog group perform status rang patient fail respond primari combin methotrexatecisplatinbas chemotherapi confid interv patient achiev partial respons durat respons month median month rang month patient achiev partial respons month durat control residu diseas radiat surgic excis remain diseasefre addit period month data suggest combin fu recombin human interferon alfaa synergist clinic signific treatment urotheli tumor respons rate combin drug higher anticip agent addit confirmatori trial evalu signific find"
"donat kidney famili member primari care physician prepar potenti donor relat kidney surviv famili member impuls offer donat stop physic emot financi ramif famili primari care physician guid educ potenti donor arrang screen communiti eas financi strain author discuss thing potenti kidney donor"
"compar studi cephradin amoxicillinclavulan treatment recurr urinari tract infect eighti femal patient histori recurr urinari tract infect treat random scheme cephradin patient mg amoxicillinclavulan patient day treatment equal effect cure rate cephradin amoxicillinclavulan show similar relaps rate cephradin amoxicillinclavulan advers effect similar group cephradin amoxicillinclavulan"
"administ intraurethr chlorpromazin unusu priapism priapism prolong pain penil erect unaccompani sexual desir allevi ejacul etiolog priapism numer divers priapism advers effect psychotrop medic case year man demonstr priapism hour insert crush chlorpromazin tablet urethr meatus peni report priapism induc rout drug administr previous pathophysiolog treatment priapism review"
"impact breakthrough clinic trial surviv popul base tumor registri statist model develop studi impact breakthrough clinic trial mopp hodgkin diseas pvb dissemin testicular cancer surviv connecticut tumor registri nation cancer institut surveil epidemiolog end result seer registri program segment regress model conjunct cox semiparametr proport hazard model parametr weibul exponenti cure model model determin approxim surviv began improv dramat indic improv treatment long surviv level indic full popul surviv impact realiz addit degre parametr model fit determin surviv improv occur parametr famili result model dissemin approxim year hodgkin diseas year dissemin testicular cancer diseas site surviv broke prior trend time breakthrough trial start public indic earlier moder success precursor trial combin chemotherapi initi improv popul surviv trend reason differ dissemin time cancer site examin order understand factor respons speed dissemin effect util therapi"
"routin screen cancer prostat screen prostat cancer remain unclear digit rectal examin transrect ultrasonographi determin serum prostatespecif antigen level lead earli detect malign procedur shown reduc diseasespecif mortal prostat cancer potenti error found uncontrol trial suggest benefit screen exist larg random control clinic studi demonstr decreas mortal prostat cancer prove screen benefici studi perform patient inform potenti benefit risk screen treatment"
"transient oliguria renal tubular dysfunct km run race studi renal function ultramarathon runner km race runner develop transient oliguria renal tubular dysfunct anuria immedi race featur renal failur fold increas urin beta microglobulin excret microgramsmin smaller increas urin total protein excret mgmin postrac period postrac creatinin clearanc remain prerac level studi vari mlmin contrast postrac increas remain runner mlmin osmol clearanc remain low mlmin compar prerac valu mlmin urin flow rate mlmin compar prerac valu mlmin renal dysfunct persist patient receiv intraven fluid immedi race result fluid restrict race full recoveri renal function yr subject ran comrad marathon"
"photosensit destruct human bladder carcinoma cell treat chlorin econjug microspher photosensit conjug chlorin ce coval bound microndiamet polystyren microspher investig photodynam destruct mghu human bladder carcinoma cell vitro microspher avid carcinoma cell confoc laser scan fluoresc microscopi show local cytoplasm appar lysosom visual label acridin orang contrast fluoresc unconjug ce present cellular membran cemicrospher conjug led foldhigh intracellular concentr compar unconjug ce cell incub presenc cemicrospher conjug microm equival subsequ irradi nm dye laser pump argonion laser show dosedepend phototox lead total inhibit coloni format radiant exposur jcm contrast cell incub unconjug ce microm unconjug microspher laser irradi unaffect cell pretreat cemicrospher conjug irradi presenc ho show signific increas phototox effect consist import role excitedst singlet oxygen mechan injuri solut photosensit generat singlet oxygen cemicrospher conjug time effici unconjug ce mark greater phototox cemicrospher conjug compar unconjug ce consequ high intracellular ce concentr attain phagocytosi conjug site intracellular local conjug effici system deliveri photosensit drug carcinoma cell"
"immunotactoid glomerulopathi past year immunotactoid glomerulopathi recogn increas frequenc lesion character histolog high organ ultrastructur deposit compos immunoglobulin complement negat amyloid congo red stain clinic serolog patient evid cryoglobulinemia amyloidosi system lupus erythematosus paraproteinemia disord glomerular deposit high organ tactoid fibrillar characterist immunotactoid glomerulopathi multisystem diseas process repres primari glomerulopathi patient immunotactoid glomerulopathi present proteinuria nephrot rang half patient hypertens hematuria renal insuffici progress end stage renal diseas occur patient report date experi treat disord prednison immunosuppress limit impress patient success undergon renal transplant proteinuria recur recurr immunotactoid glomerulopathi renal allograft gain insight clinic histopatholog disord past year pathogenesi area research"
"prolong surviv remnant kidney surgic ablat sixth renal mass munichwistar rat fed high protein diet lead focal sclerosi remnant kidney progress renal failur experiment data suggest injuri result intraglomerular hypertens chronic glomerular hyperfiltr data human larg limit patient unilater renal agenesi uninephrectomi unilater renal diseas kidney transplant donat isol case report document focal sclerosi progress renal failur patient remnant kidney obtain data human remnant kidney survey urologist nephrologist unit state abroad criteria inclus studi surgic resect oper result presenc remnant kidney adequ period follow defin year greater total patient identifi center twelv patient renal cancer tuberculosi patient observ year postop stabl serum creatinin level mumol mgdl patient year postoper patient observ year serum creatinin level mumol mgdl increas serum creatinin level longest surviv patient undergon success pregnanc chang serum creatinin observ demonstr human surviv year stabl serum creatinin presenc remnant kidney"
"evalu hemodialysi patient treat erythropoietin evalu hemodialysi patient treat erythropoietin epo patient hemoglobin level dl random receiv epo kg placebo time week week patient epo signific elev hematocrit level signific increas midweek predialysi blood urea nitrogen bun level versus mmol mgdl serum phosphorus versus mm mgdl protein catabol rate increas signific level serum creatinin potassium episod hyperkalemia frequent patient epo patient placebo hematocrit increas clearanc bloodwat urea decreas clearanc creatinin potassium phosphorus decreas patient epo increas appetit protein intak frequent episod hyperkalemia elev phosphorus level result combin increas intak decreas dialyz clearanc bloodwat clearanc calcul kt"
"manag acut pyelonephr emerg depart observ unit studi object determin moder sever ill patient acut pyelonephr treat success outpati basi aspect histori physic examin initi laboratori data predict failur outpati therapi hospit design retrospect chart review patient diagnosi acut pyelonephr year period set emerg depart observ unit urban teach hospit serv resid citi counti denver type particip women age symptom physic examin initi laboratori data consist diagnosi pyelonephr intervent patient receiv iv antibiot rehydr analges antiemet observ unit hour admit hospit discharg home oral antibiot measur main result sixti patient acut pyelonephr manag success outpati hospit direct observ unit consid ill home return persist symptom ed therapi hospit clinic laboratori variabl predict success failur ed observ unit therapi time initi present conclus select patient observ unit initi therapi acut pyelonephr adequ clinic respons initi treatment discharg oral antibiot therapi follow"
"treatment pyelonephr observ unit studi object determin feasibl manag patient acut pyelonephr outpati initi treatment iv antibiot emerg depart observ unit design prospect uncontrol set ed observ unit type particip nonpregn femal patient year older immunocompromis diseas evid septic shock intervent patient receiv iv dose trimethoprimsulfamethoxazol hour dose interv promethazin acetaminophen nausea fever baselin laboratori data urinalysi urin blood cultur obtain measur main result patient observ sign septic shock nausea vomit abil toler oral intak end observ period patient discharg oral trimethoprimsulfamethoxazol addit patient clinic recal admit posit blood cultur conclus patient acut pyelonephr signific fever nausea vomit treat effect outpati period observ iv antibiot"
"kinet model intracellular ph comparison nmr experiment valu dialys urem patient intraerythrocyt ph valu time bicarbon hemodialysi studi nuclear magnet reson simultan ph valu blood obtain gazometr method compart model simplest kinet model explain shift proton concentr extra intracellular media linear regress determin exchang constant valu good correl experiment calcul proton concentr model describ patient individu experiment constant determin condit singl blood ph determin dialysi permit determin initi intraerythrocyt ph monitor intraerythrocyt ph hemodialysi"
"femal pseudohermaphrodit placent aromatas defici descript present document case placent aromatas defici defici caus matern viril pregnanc pseudohermaphrodit femal fetus yr primigravida show progress viril trimest urinari excret estrogen mumolday week pregnanc nonstress test show reactiv pattern serum level human placent lactogen nmol matern serum level estrogen low androgen high trimest dehydroepiandrosteron sulfat load test induc mark increas matern serum level androgen increas observ estrogen woman deliv vagin live fullterm infant exhibit femal pseudohermaphrodit cord serum level estrogen extrem low androgen high aromatas activ placenta determin convers handrostenedion betahestradiol hestron fmolmicrogram proteinmin control fmolmicrogram proteinmin sulfatas activ placenta pmolmicrogram proteinmin compar pmolmicrogram proteinmin control rate aromat normal control placenta obtain coincub sampl normal placenta patient presenc aromatas inhibitor patient placenta exclud"
"termin sequenc major erythropoiet factor anephr patient ident insulin growth factor erythropoiet factor present anephr patient normal hematocrit isol plasma reversedphas gel permeat hplc activ fraction purifi analysi termin sequenc ident publish sequenc human insulin growth factor igf recombin human igf ident elut posit isol erythropoiet factor reversedphas hplc molecular weight gel permeat hplc hrigf stimul erythroid coloni format human bone marrow cultur previous shown isol human erythropoiet factor result suggest igf replac erythropoietin stimul erythropoiesi patient anemia renal failur"
"measur urinari lipopolysaccharid antibodi elisa screen urinari tract infect hundr twenti clinic urin specimen submit routin microbiolog examin test parallel convent microscopi cultur lipopolysaccharid antibodi enzym link immunoabsorb assay elisa assess elisa screen urinari tract infect elisa compar routin method specif sensit predict posit negat test elisa microscopi variabl elisa absorb increas increas bacteri number result vari wide urin greater equal bacteriaml posit elisa urin bacteriaml posit elisa greater equal bacteriaml cultur pseudomona sp staphylococcus aureus streptococcus faecali posit elisa proteus sp coliform coagulas negat staphylococci conclud develop requir elisa routin screen urinari tract infect"
"percutan nephrolithotomi calculi horsesho kidney patient kidney underw percutan nephrolithotomi unit calculi horsesho kidney standard stage percutan access techniqu minor modif situ disintegr ultrasound electrohydraul lithotripsi moieti nephrostomi drainag requir percutan access problem minim periop problem blood transfus requir postop patient total kidney render free stone percutan nephrolithotomi kidney left asymptomat stone fragment mm  kidney free stone extracorpor shock wave lithotripsi give stone clearanc rate conclud percutan nephrolithotomi accept treatment stone horsesho kidney treatment choic patient imag difficult imposs"
"extracorpor shock wave lithotripsi urinari calculi experi treatment patient siemen lithostar lithostar march june patient upper urinari tract calculi treat medic center lithostar lithotriptor stone locat calic case renal pelvi uret periren hematoma note patient resolv spontan day auxiliari procedur perform case includ doubl stent ureter cathet ureterorenoscopi percutan nephrostomi zeiss loop percutan nephrolithotripsi treatment perform general region anesthesia followup month show rate free stone lithostar upgrad overhead lithotripsi modul call lithostar total patient upper urinari stone underw treatment overhead modul initi experi reveal fragment stone session patient session analges sedat patient doubl stent insert"
"treatment steinstrass repeat extracorpor shock wave lithotripsi experi piezoelectr lithotriptor patient renal stone underw extracorpor shock wave lithotripsi eswl monotherapi edaplt piezoelectr lithotriptor steinstrass develop case stone fragment pass spontan treat success residu stone fragment uret repeat eswl patient requir ureteroscop manag open ureterolithotomi repeat eswl consid good initi method treat complic steinstrass"
"cystourethrometr find patient detubular colon segment bladder replac urodynam evalu perform men month cystoprostatectomi bladder replac detubular colon segment patient contin day incontin night degre necessit condom cathet patient awaken hour void remaind nocturia compar normal men age residu volum ml urethr closur pressur normal patient studi preoper postop signific chang observ shorten profil length maxim flow rate normal pattern intermitt patient cystoplasti contract record patient amplitud contract cm water simultan bladder urethr pressur record bladder fill demonstr chang urethr pressur patient creation reservoir low pressur care preserv infraprostat urethra import contin patient absenc normal sacral rout reflex cystoprostatectomi import contribut nocturn incontin"
"detect reflux nephropathi infant mtechnetium dimercaptosuccin acid studi dimercaptosuccin acid dmsa studi perform infant year risk renal scar patient present urinari tract infect asymptomat void cystourethrogram perform case excretori urographi ivp abnorm detect dmsa studi compar scar ivp studi abnorm excel correl site site basi fever system disord reliabl sign determin upper tract involv infect incid dmsa abnorm infant increas high grade vesicoureter reflux decreas low grade reflux signific differ incid abnorm kidney infect noninfect group suggest renal scar occur steril reflux"
"continu intraves drug deliveri system rat describ system continu infus drug rat urinari bladder revers model hydronephrosi prepar renal unit nephrostomi tube placement mm silast nephrostomi tube introduc hydronephrot kidney gaug angiocath nephrostomi tube connect alzet mini osmot pump implant subcutan locat abil system deliv continu dose test agent bladder evalu pump fill solut methylen blue phosphat buffer salin pump implant urinari sampl collect daili basi subsequ analyz concentr methylen blue complet experi specimen kidney uret bladder histolog examin result demonstr averag recoveri theoret deliv dose day period renal histolog demonstr chronic inflammatori site nephrostomi tube placement upper lower tract urotheli identifi model system continu deliveri drug rat urinari tract result histolog alter lower urinari tract"
"determin coeffici kinet friction urinari cathet materi coeffici kinet friction play import role biocompat urinari cathet method determin vivo coeffici kinet friction comparison catheterurethr interact materi product urinari cathet type lubric"
"radiocontrast enhanc urinari tract stone urologist treat stone diseas method eswl pcl ur encount problem poor stone visual fluoroscopi difficulti local urinari tract ut stone fragment result incomplet stone extract prolong surgeri increas risk recurr postop complic sought found increas radioopac miner ut stone simpl preoper perfus techniqu capac radioopacif demonstr vitro incub fragment human miner stone aqueous solut barium lanthanid natur actinid incub led radiocontrast enhanc heavi metal incorpor measur ray fluoresc analysi dog implant human stone fragment vivo model ut perfus retrograd pyelic cathet heavi metal salt solut ensu radioopacif implant utston estim abdomin radiographi metal incorpor measur retriev stone radioopac enhanc heavi metal incorpor observ element sr ba lanthanid gd yb patholog evalu urotheli line anim treat lanthanid salt show toxic effect"
"cytostat effect suramin prostat cancer cell cultur primari tumor suramin undergo clinic trial chemotherapeut agent prostat cancer effect suramin cultur human epitheli cell deriv normal benign hyperplast malign prostat tissu examin serumfre medium suramin inhibit clonal growth prostat cell halfmaxim dose approxim microgramsml growth inhibit suramin complet revers hour exposur conjunct suramin alter cellular phenotyp regard express keratin prostatespecif antigen suramin report antagonist growth factormedi mitogenesi tenfold excess growth factor appreci suppress cytostat activ suramin comparison activ chemotherapeut agent suramin suboptim inhibitori effect revers induc termin differenti cellular phenotyp"
"chronic effect focus electrohydraul shock wave renal function hypertens chronic effect focus electrohydraul shock wave studi minipig model fifteen anim underw unilater nephrectomi compensatori renal hypertrophi place minimum month baselin studi carri consist serum creatinin blood urea nitrogen plasma renin level intraarteri blood pressur measur hinulin clearanc ten anim underw shockwav treatment shock treatment altern upper lower pole kidney week interv total shock wave administ minipig month period control pig underw sham procedur renal function blood pressur evalu repeat signific decreas renal function note experiment anim compar control addit renin mediat hypertens observ excess number total shock wave deliv kidney"
"renal arteri duplex doppler ultrasound dog urinari obstruct recent clinic studi duplex doppler sonographi identifi alter renal arteri blood flow obstruct hydronephrot kidney report distinguish obstruct nonobstruct collect system dilat attempt verifi clinic find establish tempor relationship alter doppler spectrum onset urinari obstruct evalu surgic induc urinari obstruct dog perform laparotomi dog left uret isol ligat dog left intact dog control group duplex doppler examin left renal arteri perform time postop month identifi statist signific differ doppler resist index calcul group day week resist index discriminatori threshold greater obstruct nonobstruct produc test sensit specif conclud studi renal arteri duplex doppler sonographi detect chang renal perfus result urinari obstruct chang detect earli hour obstruct high falseposit falseneg rate limit abil modal reliabl distinguish obstruct nonobstruct collect system dilat"
"effect radiat therapi hyperthermia human prostat carcinoma cell line grown athym nude mice effect radiat hyperthermia human prostat carcinoma xenograft athym nude mice investig human prostat carcinoma sublin lnpca inocul subcutan thigh male athym nude mice tumor reach size approxim mm treat radiat hyperthermia combin combin treatment hyperthermia deliv immedi radiat exposur comparison time requir reach tumor volum observ time treatment defin therapeut impact tumor growth combin treatment result median tumor volum doubl time day compar day day hyperthermia radiat analysi tumor doubl time proport hazard regress condit experi effect radiat hyperthermia lnpca tumor addit impact treatment regimen manag prostat cancer requir investig"
"imag guid local magnet reson spectroscopi acut urinari tract obstruct magnet reson spectroscopi local spectroscopi magnet reson imag studi effect acut urinari obstruct vivo pig kidney accumul urin renal pelvi collect duct result peak local phosphorus spectra origin renal papilla reson ppm inorgan phosphat ph urin ph imag show dilat renal pelvi signific time depend fall renal atp urinari obstruct rapid overshoot atp disappear phosphat peak releas obstruct mechan phenomenon discuss conclud magnet reson spectroscopi earli evid urinari obstruct vivo clinic diagnosi"
"preliminari experi puls dye laser treatment urolithiasi report initi experi puls dye laser patient urolithiasi patient rang age year patient femal male patient stone kidney uret bladder surgic time rang minut patient treat spinal general anesthesia size ureter stone rang cm renal stone cm chemic analysi stone patient chemic analysi reveal stone calcium monohydr calcium dihydr struvit candela miniscop patient permit access ureter dilat patient ureter stent patient suffer ureter perfor success defin adequ disintegr stone passag fragment necess secondari procedur criterion patient success treat success rate"
"diagnosi heterozyg state adenin phosphoribosyltransferas defici base detect vivo somat mutant blood cell applic screen heterozygot accur diagnosi heterozygot autosom recess disord unknown mutat difficult uniqu phenomenon occur vivo design method diagnosi heterozygot adenin phosphoribosyltransferas aprt defici make qualit distinct normal heterozyg subject cultur peripher blood mononuclear cell diaminopurin aprtdepend cytotoxin search vivo mutat cell fifteen putat heterozygot examin found possess mutant cell high frequenc fals negat diagnosi analysi genom dna resist clone heterozygot clarifi lost germin intact allel thirteen member aprtdefici famili examin prove heterozygot individu separ residenti area japan heterozygot found authent heterozygos valid separ method heterozygot fals posit diagnosi rule data show calcul heterozygot frequenc confid limit compat calcul data incid dihydroxyadenin urolithiasi genet approach identifi heterozygot test search enzym defici human"
"pharmacokinet bioavail intravenousor enoxacin elder patient complic urinari tract infect pharmacokinet oral fluoroquinolon antibiot normal volunt studi extens limit patient data exist enoxacin steadyst pharmacokinet bioavail determin repeat mg intraven oral dose compartment noncompartment method elder age year men complic urinari tract infect averag peak enoxacin concentr oral dose mgliter valu major pharmacokinet paramet noncompartment similar oral administr area concentrationtim curv mgliter volum distribut volum distributionbioavail literskg total bodi clearanc total bodi clearancebioavail mlmin kg halflif paramet analysi enoxacin plasma concentr data compart pharmacokinet model reveal mark similar administr rout enoxacin high bioavail oral administr"
"distal urethr electr conduct duec preliminari assess role quick screen test incontin women measur distal urethr electr conduct duec detect movement urin distal urethra duec screen test women attend urodynam clinic incontin women void ml find correl subsequ urodynam diagnosi urethr sphincter incompet detrusor instabl"
"regul pulsatil lutein hormon secret experiment uremia previous studi shown male rat experiment uremia manifest profound suppress circul lh testosteron level paradox castrat gonadotropin level elev great nonurem castrat control rat investig phenomenon character pulsatil lh secret experiment uremia matur orchidectom male wistar rat subtot nephrectomi demonstr reduct lh puls frequenc increas puls amplitud increas lh level compar shamoper control puls paramet high correl plasma creatinin determin mechan increas puls amplitud test respons postcastr urem pituitari exogen gnrh microgramskg latin squar design plasma lh respons linear relat logarithm gnrh dose urem control rat mark increas urem rat conclud uremia decreas lh puls frequenc independ testicular feedback pituitari hypersensit gnrh magnifi lh puls amplitud major factor caus paradox lh hyperelev castrat"
"small arteri resist increas develop renal hypertens vascular pressur measur princip arteriol upstream small arteri rat cremast muscl investig vascular resist kidney clip goldblatt hypertens pressur measur made proxim distal site vessel servonul micropipett system vessel diamet measur video microscopi arteriol extern spermat arteri diamet decreas week hypertens arteri pressur elev week hypertens mm hg versus mm hg likewis vascular pressur elev site pudicepigastr arteri extern spermat arteri arteriol pressur drop extern spermat arteri increas week hypertens arteri pressur elev week hypertens mm hg versus mm hg proxim pudicepigastr arteri pressur elev time week mm hg versus mm hg hypertens develop increas pressur drop arteri compar situat week data small arteri upstream microcircul contribut signific increas vascular resist hypertens addit data increas small arteri resist develop uniform vessel branch"
"renal nerv modul renin gene express develop rat kidney ureter obstruct chronic unilater ureter obstruct uuo newborn rat activ renin gene express obstruct kidney increas renin distribut affer glomerular arteriol kidney investig role renal nerv respons spraguedawley rat subject uuo sham oper chemic sympathectomi perform inject guanethidin control group receiv salin vehicl wk renal renin distribut determin immunocytochemistri renin mrna level determin northern blot hybrid compar salinetr rat uuo renin remain local juxtaglomerular region kidney rat uuo receiv guanethidin renin mrna level eightfold lower obstruct kidney rat receiv guanethidin receiv salin addit group rat uuo subject unilater mechan renal denerv renin gene express obstruct kidney suppress ipsilater contralater renal denerv find chemic mechan denerv suppress increas renin gene express neonat kidney ipsilater uuo conclud renal sympathet nerv modul renin gene express develop kidney chronic uuo"
"express smooth muscl cell phenotyp rat mesangi cell immun complex nephriti alphasmooth muscl actin marker mesangi cell prolifer mesangi cell prolifer common glomerulonephr unclear prolifer vivo alter phenotyp investig mesangi mesangi prolif nephriti induc antibodi thi antigen present mesangi cell day glomeruli display de novo immunostain alphasmooth muscl actin mesangi pattern correl onset prolifer persist day increas desmin vimentin mesangi region note immunoelectron microscopi confirm actinposit cell mesangi cell doubl immunolabel demonstr smooth muscl actinposit cell activ prolifer northern analysi isol glomerular rna confirm increas alpha betagamma actin mrna day complement deplet platelet deplet prevent reduc prolifer maneuv prevent smooth muscl actin actin gene express studi experiment model nephriti confirm smooth muscl actin express marker mesangi cell injuri mesangi cell prolifer glomerulonephr rat distinct phenotyp chang mesangi cell assum smooth muscl cell characterist"
"percutan needl biopsi preced preoper chemotherapi manag massiv renal tumor children nation wilm tumor studi nwts group unit state put emphasi accur stage histolog therapi wilm tumor intern societi pediatr oncolog siop europ focus preoper therapi safer surgeri current approach combin benefit polici manag massiv renal tumor children consecut patient obtain percutan posterior needl biopsi obtain adequ tissu histolog proceed preoper chemotherapi vincristin dactinomycin tumor shrinkag suffici tumor remov feasibl unev time oper tumor found total total necrot includ viabl tumor histolog correspond needl biopsi find case unfavor histolog rhabdoid sarcoma miss suboptim therapi primari needl biopsi biopsyrel complic subcapsular intratumor bleed recogn patient conclud percutan posterior needl biopsi safe yield definit detail histolog massiv renal tumor children preoper chemotherapi facilit surgeri patient"
"molecular character major nephritogen domain autoantigen antitubular basement membran diseas antitubular basement membran alpha tbm diseas form primari interstiti nephriti mediat autoimmun cell alpha tbm antibodi mice human nephritogen immun respons direct glycoprotein found proxim tubul kidney isol cdnas express librari encod common framework domain antigen common domain relat evolutionarili famili intermedi filament protein northern hybrid reveal isoform rang base pair situ hybrid studi transcript found tubular epithelium candid peptid fragment deduc synthes sequenc encod common framework domain peptid residu bind monoclon mreactiv alpha tbm antibodi stimul growth mreactiv helper cell induc nephritogen effector cell capabl produc interstiti nephriti result uniqu immunodomin region antigen inform particip emerg autoimmun injuri basement membran"
"earli detect program prostat cancer result identif highrisk patient popul hundr sixti men underw transrect ultrasound prostat trus digit rectal examin dre serum prostatespecif antigen psa determin part earli detect program prostat cancer thirti cancer detect dre highest sensit specif percent percent trus psa compar sensit specif posit predict valu dre trus psa determin percent percent percent found cancer detect rate percent patient symptom bladder outlet obstruct percent patient symptom detect rate percent physicianref patient percent refer patient suggest present time util medic resourc increas prostat cancer detect educ men annual medic evalu primarycar physician encourag incorpor risk assess screen dre part routin practic man abnorm find examin increas risk refer urologist evalu"
"incontin manag scale elder inpati men elder inpati urinari incontin success treat manag object identifi suitabl method urin loss elder inpati men extern cathet util case incontin manag role sever incontin extern cathet investig elder inpati men quantit incontin measur show incontin patient extern cathet approxim sd episod day compar sd episod day noncathet incontin patient clinic manag method patient measur sever incontin"
"endoscop treatment vesicoureter reflux children neurogen bladder endoscop subureter inject teflon perform children uret neurogen bladder vesicoureter reflux grade iiiiv follow evalu ultrasonographi void cystourethrogram month interv year reveal success correct reflux percent uret"
"pediatr testicular tumor john hopkin experi testicular neoplasm constitut percent childhood malign rank eighth childhood cancer mortal testicular tumor children eighteen year major patient white patholog analysi tumor reveal percent germin percent nongermin stage undertaken patient serum marker chest ray film computer tomographi scan lymphangiographi patient underw radic orchiectomi therapi depend tumor type stage surviv cohort excel patient succumb diseas detail result treatment approach avoid excess treatment morbid review"
"postprostatectomi retent forti patient urinari retent prostatectomi underw urodynam evalu fifteen patient found persist residu obstruct patient detrusor hyporeflexia patient combin outflow obstruct detrusor hyporeflexia demonstr patient urinari retent due compromis mental status abnorm detect remain patient urodynam evalu proper evalu unsatisfactori void prostatectomi cystoscopi limit urodynam test essenti"
"strip fetal membran term procedur safe efficaci prospect random investig undertaken lowrisk group pregnant women term week gestat determin strip fetal membran safe result earlier deliveri nineti patient enter studi underw strip membran control fifti percent patient strip group deliv week compar nonstrip group pregnanc strip group advanc week gestat compar pregnanc control group singl gravida control group develop chorioamnion labor infect complic strip membran earlier deliveri complic"
"coexist intrauterin pregnanc ectop pregnanc salping fallopian tube case report current epidem pelvic inflammatori diseas recent advanc gynecolog techniqu result mark increas incid combin pregnanc case report coexist intrauterin pregnanc acut salping ectop gestat fallopian tube led earli diagnost error"
"transcerv balloon tuboplasti multicent studi transcerv balloon tuboplasti repres noninvas techniqu treat proxim tubal occlus multicent studi women confirm bilater proxim tubal occlus underw procedur patient proxim obstruct fallopian tube recan concomit distal bilater tubal occlus diagnos success proxim tubal balloon recan patient remain patient clinic pregnanc confirm median follow period month result normal deliveri result trimest miscarriag patient diagnos ectop pregnanc patient conceiv month procedur demonstr continu tubal patenc repeat hysterosalpingogram conclud transcerv balloon tuboplasti safe outpati techniqu repres altern vitro fertil microsurg reanastomosi fallopian tube"
"hypothesi inhibit endotheliumderiv relax factor haemoglobin pathogenesi preeclampsia aetiolog preeclampsia unknown haemodynam studi suggest clinic find explain generalis vasoconstrict disord abnorm endotheli cell function vasoconstrict attribut increas concentr haemoglobin found preeclampsia compar normal pregnanc free haemoglobin deriv haemolysi placent haemorrhag concentr present preeclampsia vasodilat mediat endotheliumderiv relax factor inhibit infus oxyhaemoglobin human coronari arteri inhibit acetylcholineinduc vasodilat suggest increas free haemoglobin concentr vasoconstrict preeclampsia"
"preliminari report oocyt donat extend reproduct potenti women background fertil women year age older decreas ovarian failur thought irrevoc lost donat oocyt young year women ovarian failur consid infertil chanc pregnant women gonad hormon replac result endometrium recept implant endometri respons replac decreas women age method test efficaci oocyt donat older women enrol women year ovarian failur trial hormon replac embryo transfer oocyt obtain women undergo ovarian hyperstimul sole gamet donat result stimul cycl donor synchron cycl recipi result embryo transfer viabl pregnanc establish twin sixth pregnanc end miscarriag normal infant deliv cesarean section stillborn infant deliv vagin outcom compar women age ovarian failur particip donoroocyt program infertil ovul women older undergo standard vitro fertil signific differ rate implant ongo pregnanc note older women compar younger women receiv donat embryo rate higher rate infertil ovul women similar age undergo standard vitro fertil conclus preliminari result suggest endometrium retain abil respond gonad steroid recept environ embryo implant gestat older women"
"prematur ruptur membran term nullipar women hazard hundr consecut women prematur ruptur membran prom term manag expect hour seventi spontan labor augment oxytocin twenti labor induc subject deliv studi interv artifici ruptur membran serv control statist signific differ frequenc amnion endometr cystiti neonat infect low apgar score low cord arteri blood ph instrument deliveri cesarean deliveri morbid induc labor membran ruptur long time conclud expect manag prom term increas perinat morbid"
"zinc status women prematur ruptur membran term zinc concentr measur atom absorpt spectrometri blood scalp hair pubic hair colostrum patient term prematur ruptur membran prom matern zinc index establish patient express averag rank determin sd matern zinc index patient prom signific lower patient complic versus invers relationship matern zinc index pariti statist signific result suggest subnorm tissu zinc content pregnanc play role causat factor prom term"
"realtim microcomputerbas analysi spontan augment labor attempt develop reproduc object measur adequ uterin activ labor realtim measur intrauterin pressur amplitud contract frequenc interv durat integr made patient receiv oxytocin augment determin activ pressur integr requir centimet cervic dilat express kpa activ pressur express kpa augment group signific higher activ pressur integr centimet normal labor trend reach statist signific subject requir oxytocin augment labor develop higher activ pressur normal labor correl uterin contractil index montevideo unit alexandria unit activ pressur progress labor poor conclud women dysfunct labor requir uterin activ progress labor women progress labor computerderiv area curv predictor labor progress montevideo unit"
"accuraci safeti transvagin sonograph placent local transvagin sonograph local placenta perform patient suspect placenta previa patient diagnosi confirm cesarean deliveri case placenta previa found sonographi deliveri result predict posit test predict negat test patient lowinsert placenta diagnos sonographi found placenta previa deliveri sensit specif techniqu instanc transvagin sonographi perform vagin hemorrhag aggrav bleed observ transvagin sonograph local placenta prove accur safe diagnost procedur"
"effect periton fluid endometriosi patient endometri stromal cell prolifer vitro late prolif phase endometri stromal cell grown shortterm cultur model stromal compon endometriot implant cell grown medium medium supplement concentr cellfre fraction periton fluid obtain patient endometriosi fluidsampl pair match base presenc absenc endometriosi laparoscopi similar periton fluid estradiol concentr stromal cell prolifer reflect hthymidin incorpor sequenti cell harvest hour greater cell expos endometriosi periton fluid expos endometriosi periton fluid reach statist signific exposur periton fluid concentr linear doserespons relationship hthymidin incorpor periton fluid concentr deriv stromal cell expos fluid sampl obtain endometriosi patient addit prolifer hour signific greater cell grown endometriosi periton fluid grown nutrient medium data impli factor secret periton fluid endometriosi patient play role prolifer mainten diseas implant"
"antepartum intrapartum event women expos utero diethylstilbestrol retrospect cohort design analyz effect intrauterin diethylstilbestrol des exposur antepartum intrapartum event gravida expos des higher likelihood deliv abdomin undergo manual remov placenta hemorrhag postpartum period increas risk event remain control age race pariti construct labor curv desexpos women plot cervic dilat time curv similar nullipar desexpos women nullipar control desexpos parous women experienc prolong labor find suggest addit advers effect intrauterin des exposur interact uterus placenta alter desexpos patient"
"experiment clinic studi radiofrequencyinduc thermal endometri ablat function menorrhagia method ablat endometrium introduc clinic practic radiofrequ electromagnet energi heat endometrium probe insert cervix preliminari studi suggest patient treat develop amenorrhea signific reduct flow advantag radiofrequ endometri ablat laser ablat resect avoid intravascular fluid absorpt simplic special oper hysteroscop skill requir speed oper reduc cost compar yag laser paper describ experiment studi perform develop techniqu"
"preoper angiograph uterin arteri embol manag cervic pregnanc diagnosi cervic ectop pregnanc made intraop presenc extens hemorrhag attempt evacu case hysterectomi treatment control bleed report case cervic pregnanc detect ultrasound pregnanc termin uterin arteri success embol angiograph techniqu result surgic evacu perform minim hemorrhag hysterectomi requir patient potenti fertil retain"
"success treatment cervic pregnanc oral etoposid cervic ectop pregnanc uncommon entiti signific morbid devast effect futur fertil woman cervic gestat quantit serum betahcg level higher miuml fetal cardiac activ ultrasound treat success oral etoposid fetocid agent avoid oper intervent preserv patient fertil"
"pregnanc friedreich ataxia pregnanc woman friedreich ataxia complic onset preterm labor preeclampsia administr magnesium sulfat mgsoho usual intraven dosag result dramat develop profound motor weak respiratori distress magnesium act antagon action acetylcholin motor end plate neuromuscular junction oper synergist neuromuscular disord magnesium sulfat patient friedreich ataxia similar neurodegen diseas contraind"
"fetal level tobramycin matern administr singl dose tobramycin mgkg intraven woman present week heterotop pregnanc intrauterin ovarian gestat live fetus excis adnexum tobramycin level measur matern serum fetal fluid tissu antibiot level high fetal spleen kidney"
"uclaunivers utah epidemiolog survey autism prenat perinat postnat factor recent epidemiolog survey conduct utah autist patient dsmiii criteria found medic record autist survey presenc potenti patholog prenat perinat postnat factor result compar ident survey nonautist sibl result previous publish survey normat data potenti patholog factor group factor occur signific frequent autist patient previous observ signific differ occurr factor histori singl multipl sibl autism confirm increas viraltyp ill gestat singleincid case etiolog brain patholog characterist disrupt normal develop produc syndrom autism remain obscur data epidemiolog survey suggest role genet factor explor"
"barrier contracept method preeclampsia recent investig suggest women barrier method contracept increas risk preeclampsia data prospect pregnanc studi examin relationship contracept concept preeclampsia preeclampsia rate women barrier contracept signific higher rate women nonbarri contracept rate women contracept studi odd ratio preeclampsia barrier contracept user studi confid interv cl cl compar nonbarri contracept user cl cl compar women contracept adjust risk factor found associ preeclampsia barrier contracept addit studi resolv issu recommend women advis avoid barrier contracept data link preeclampsia"
"umbil arteri doppler velocimetri labor admiss test doppler ultrasound umbil arteri flow veloc waveform studi prospect admiss test labor ward record made women stage labor uterin contract evalu relat intrapartum fetal outcom variabl associ found abnorm flow veloc waveform cord complic meconiumstain amniot fluid abnorm fetal heart rate trace associ oper deliveri fetal distress low apgar score minut small gestat age fetus signific abnorm flow veloc waveform gestat age fetus umbil arteri acidemia compar normal ph result doppler record umbil arteri flow veloc waveform admiss test labor ward good predictor fetal distress unselect popul"
"clinic patholog correl endometri caviti fluid detect ultrasound postmenopaus patient registri ultrasound procedur span year search retrospect discov case endometri caviti fluid collect postmenopaus women twenti case identifi medic record review patient lost follow seventeen patient surgic procedur primari evalu laparotomi remov uterus adnexa women cancer ovarian tubal endometri cervic women benign gynecolog condit includ uterin fibroid ovarian serous cystadenoma cervic dysplasia case appar subclin pyometra women endometri patholog consist prescrib hormon therapi breast cancer endometri hyperplasia"
"cocain abus abruptio placenta decreas birth weight shorter labor patient report ingest cocain hope decreas durat labor review computer record women abus cocain compar control women ingest cocain older higher pariti birth weight birth weight percentil gestat age deliveri signific decreas neonat incid abruptio placenta doubl women factor tend shorten labor total durat labor signific group data add accumul evid cocain abus increas obstetr morbid support belief cocain shorten labor"
"vulvar paget diseas fluoresceinaid visual margin women extramammari paget diseas vulva fluorescein intraven order visual diseas margin ultraviolet light diagnost modal techniqu found posit predict negat predict accuraci fluorescein techniqu compar gross visual histolog map techniqu total field map predict accuraci test determin chi test demonstr fluorescein visual signific predictor diseas state fluorescein visual suggest adjunct surgic manag patient primari vulvar paget diseas"
"success gamet intrafallopian transfer revers declin fertil women year age assess impact assist reproduct technolog potenti fertil older women report experi gamet intrafallopian transfer gift larg number women year age older hundr twenti gift cycl initi women month seventi tubal transfer perform result clinic pregnanc rate transfer contrast clinic pregnanc rate transfer women older patient requir counsel decreas likelihood success assist reproduct technolog"
"sensit specif screen syndrom alphafetoprotein hcg unconjug estriol matern age publish erratum obstet gynecol sensit specif matern serum screen syndrom biochem marker evalu detect rate combin matern serum alphafetoprotein msafp hcg unconjug estriol ue establish retriev analyz serum specimen women confirm syndrom pregnanc compar specimen women normal outcom risk cutoff trimest detect rate msafp hcg ue time higher msafp marker detect rate syndrom increas matern age increas repres screen popul ue omit detect rate decreas thousand women screen prospect msafp marker prospect msafp marker msafp marker posit predict syndrom high older women addit hcg ue matern serum screen increas posit predict depend matern age result confirm efficaci screen syndrom matern age serum marker"
"factor postpartum hemorrhag vagin birth casecontrol studi perform studi risk factor postpartum hemorrhag case hemorrhag defin hematocrit decreas point admiss postdeliveri redcel transfus patient antenat bleed exclud vagin deliveri postpartum hemorrhag occur case control match case multipl logist regress control covari predictor variabl factor signific associ hemorrhag prolong stage labor adjust odd ratio preeclampsia odd ratio mediolater episiotomi previous postpartum hemorrhag twin arrest descent softtissu lacer augment labor forcep vacuum deliveri asian hispan ethnic midlin episiotomi nullipar data predict postpartum hemorrhag counsel patient advis home deliveri intraven access labor autolog blood donat"
"hysterosalpingocontrast sonographi uterus fallopian tube result clinic trial contrast medium patient feasibl diagnost efficaci patient toler diagnost modal hysterosalpingocontrast sonographi hycosi evalu clinic studi patient suspect infertil echogen contrast medium ultrasound administ transcerv convent tool hysterosalpingographi balloon cathet flow multipl fraction contrast medium fallopian tube observ real time imag plane transvagin probe patent tube diagnos correct hycosi result compar find hysterosalpingographi laparoscopi mode scan sensit tube left specif tube supplementari doppler techniqu duplex color doppler provid addit inform special case suspect tubal occlus led improv diagnost accuraci contrast agent toler hycosi demonstr normal anatomi tubal patenc high reliabl permit advanc select patient invas diagnost procedur requir"
"potenti prenat predict syndrom statist analysi determin feasibl combin screen test prenat detect syndrom evalu potenti relationship propos predictor determin concentr chorion gonadotropin frozen serum sampl women matern age weight fetal bipariet diamet femur length alphafetoprotein concentr correct gestat age matern weight potenti predictor independ slight correl matern serum alphafetoprotein matern serum human chorion gonadotropin matern serum human chorion gonadotropin bipariet diameterfemur length demonstr approxim lognorm distribut similar matern serum alphafetoprotein scientif sound variabl combin identif pregnanc increas risk syndrom"
"labor endur exercis pregnanc studi design test hypothesi continu regular run aerob program half pregnanc negat effect outcom labor onset outcom labor independ monitor condit recreat athlet unev half pregnanc daili exercis perform quantit concept pregnanc comparison made women continu exercis regular preconcept level pregnanc discontinu regular exercis regimen end trimest incid preterm labor similar group labor began signific earlier exercis group day women continu exercis lower incid abdomin vagin oper deliveri activ labor shorter min deliv vagin final clinic evid acut fetal stress meconium fetal heart pattern apgar score frequent exercis group birth weight reduc gm data negat initi hypothesi condit women regular perform aerob run continu exercis regimen benefici effect outcom labor"
"growth factor activ blood women preeclampsia develop elev earli pregnanc preeclampsia pregnancyspecif disord uncertain pathophysiolog endotheli cell injuri current studi demonstr pregnanc growth factor activ elev compar postpartum valu blood women preeclampsia month onset clinic manifest toxemia cohort primigravid women pregnanc multipl serial plasma sampl women preeclampsia match normal women assay mitogen activ data ratio predeliverypostdeliveri plasma mitogen activ greater women predestin meet strict criteria diagnosi preeclampsia compar match normal primigravid women growth factor activ distinguish women preeclampsia develop normal peer pregnanc earli trimest gestat similar studi perform plasma obtain greater week post partum group patient clinic indistinguish reveal differ index mitogen activ result elev mitogen activ ratio prepartum versus postpartum plasma anted clinic recognit preeclampsia return normal resolut syndrom"
"effect nifedipin therapi fetal placent doppler waveform preeclampsia remot term twenti patient preeclampsia gestat age week treat oral nifedipin deliveri oral daili dose mgday rang mgday fetal aorta intern carotid arteri umbil arteri uteroplacent doppler flow veloc waveform record treatment serial nifedipin concentr time doppler studi ngml rang ngml nifedipin therapi signific decreas matern systol blood pressur baselin mm hg diastol blood pressur baselin mm hg signific differ resist index baselin postnifedipin doppler studi fetal uteroplacent vessel oral nifedipin control blood pressur preeclampsia affect resist indic fetal uteroplacent vessel measur doppler techniqu"
"inhibit spontan uterin contract trimest pregnant baboon oxytocin antagonist effect potent oxytocin antagonist produc laboratori spontan uterin contract pregnant baboon examin type uterin contract studi immedi oper nocturn period labor bolus intraven inject oxytocin antagonist uterin activ examin hour inject oxytocin antagonist caus precipit decreas approxim contractil forc amplitud frequenc minut inject forc diminish approxim end hour nocturn labor contract contrast uterin contract immedi oper diminish minut oxytocin antagonist result oxytocin antagonist potent inhibitor suggest oxytocin primari regul spontan nocturn labor uterin contract pregnant baboon"
"observ oligohydramnio prolong pregnanc increas evid implic reduc amnion fluid volum major determin fetal risk prolong pregnanc sought determin reduc fetal urin product oligohydramnio pregnanc reach week ultrasonograph measur fetal bladder obtain minut hour gestat verifi week oligohydramnio present prolong pregnanc similar measur perform normal pregnanc deliv elect repeat cesarean section week gestat hour fetal urin product rate calcul sequenti bladder volum measur result investig suggest diminish fetal urin product oligohydramnio prolong pregnanc mechan fetal urin product reduc prolong pregnanc remain unknown possibl reduc fetal swallow diminish amnion fluid volum result placent senesc"
"mechan lead reduc lung expans lung hypoplasia fetal sheep oligohydramnio aim determin mechan oligohydroamnio reduc fetal lung expans eventu lung hypoplasia studi fetal sheep day oligohydramnio produc drainag amniot allanto fluid gestat oligohydramnio led revers reduct lung liquid volum hour oligohydramnio tracheal pressur relat amniot pressur rose mm hg pressur tend rise fetal pleural space abdomen relat amniot pressur fall amniot sac pressur increment relat amniot pressur occur fetal trachea pleural caviti abdomen nonlabor uterin contract signific increas mm hg oligohydramnio oligohydramnio increas flexion fetal thoracolumbar spine quantifi reduct ratio spinal radius curvatur spine length control oligohydramnio set twin fetus expos oligohydramnio affect similar degre spinal flexion impos normal fetal sheep cadav increas abdomin mm hg pleural mm hg tracheal mm hg pressur caus signific reduct fetal lung expans conclud oligohydramnio fetal sheep increas spinal flexion lead compress abdomin content upward displac diaphragm lung compress favor loss fetal lung liquid accentu nonlabor uterin contract revers lead pulmonari hypoplasia prolong"
"isol character gene human genom encod betaestradiol dehydrogenas comparison jar bewo choriocarcinoma cell line betaestradiol dehydrogenas requir enzymat interconvers estradiol weaker relat sex steroid estron isol sequenc complementari deoxyribonucl acid clone betaestradiol dehydrogenas bewo choriocarcinoma cell line comparison bewo complementari deoxyribonucl acid sequenc previous deriv placent complementari deoxyribonucl acid sequenc yield greater homolog isol gene betaestradiol dehydrogenas jar human choriocarcinoma cell line elucid primari nucleic acid structur signific differ jardeduc complementari deoxyribonucl acid sequenc differenti human placent bewo form betaestradiol dehydrogenas indic exist gene betaestradiol dehydrogenas human genom evalu betaestradiol dehydrogenas gene express bewo jar cell compar express lutein granulosa cell messeng ribonucl acid human placent betaestradiol dehydrogenas identifi cell type kilobas band northern blot analysi messeng ribonucl acid speci measur kilobas abund present granulosa cell speci messeng ribonucl acid involv regul estradiol dehydrogenas gene determin"
"turner syndrom variant turner syndrom suspect femal short statur gonad dysgenesi lymphedema pathognomon featur turner syndrom disord consid girl short statur delay puberti articl discuss natur histori turner syndrom complic occur organ system review physic featur complic karyotyp turner syndrom agespecif screen therapi cover"
"almitrin mimic hypoxia fetal sheep pontin lesion almitrin bimesyl potent longlast respiratori stimul adult speci act stimul peripher chemoreceptor shown accumul specif exact mechan action uncertain fetal lamb produc profound inhibit breath denerv peripher chemoreceptor respect action similar hypoxia investig almitrin hypoxia mimet examin effect almitrin fetal lamb day gestat lesion pon chang fetal depress respons hypoxia stimul remain fetus lesion bilater encompass area pon show normal fetal depress respons hypoxia act control almitrin mg iv caus pronounc stimul breath min fetus lesion caus stimulatori respons hypoxia remain fetus respons hypoxia inhibitori almitrin caus inhibit breath min conclud action almitrin hypoxia act specif chemoreceptor prove tool studi central chemoreceptor mechan"
"elev plasma norepinephrin level infant substanceabus mother infant substanceabus mother isam signific growth neurodevelopment abnorm origin abnorm unknown postul isam increas sympathet nervous system tone alter catecholamin level measur plasma norepinephrin epinephrin dopamin level number receptor affin betaadrenoreceptor bind site lymphocyt alphaadrenoreceptor bind site thrombocyt healthi isam age month sd healthi control age month norepinephrin level venous blood fold higher isam control infant nmol nmol differ plasma epinephrin dopamin level differ number bind site receptor affin beta alphaadrenoreceptor conclud isam elev circul norepinephrin level compar control specul increas sympathet nervous system tone isam absenc adrenoreceptor regul creat catecholamin suprasensit"
"attent deficit children expos alcohol prenat twenti children fetal alcohol syndrom fetal alcohol effect fasfa compar attent deficit disord add children normal control experiment task design isol compon attent parent complet questionnair child activ level function children complet short form iq test children group rang year result children fasfa signific impair intellectu attent deficit behavior problem similar children add find impli treatment facilit learn children add benefit children fasfa"
"longterm behavior effect prenat alcohol exposur rat prenat exposur alcohol varieti behavior disturb life report anim behavior teratogen effect alcohol focus assess younger anim purpos paper review longer behavior consequ gestat alcohol exposur anim meant comprehens review focus select studi conclud prenat alcohol exposur long effect occur challeng stress circumst hypothes anim matur compensatori mechan strategi develop compens dysfunct behavior problem detect compensatori system break result stress complex test procedur age"
"neuroanatom neurochem abnorm nonhuman primat infant expos week dose ethanol gestat ethanol oral administ week gravid pigtail macaqu macaca nemestrina dose gmkg st week gestat dose gmkg week matern peak plasma ethanol concentr mppec rang mgdl kg dose mgdl kg dose thirti live born infant assess abnorm physic behavior develop ocular patholog neuropatholog neurochem assess anim month postnat age microphthalmia note anim expos ethanol retin ganglion cell loss signific intrauterin ethanol exposur microphthalmia retin ganglion cell loss observ delay fullgest expos anim structur anomali found brain gross inspect light microscopi chemic abnorm striatal nuclei identifi striatal dopamin concentr increas increas mppec exposur mgdl anim expos week ethanol gestat striatal dopamin concentr decreas increas mppec exposur mgdl anim week exposur ethanol delay week gestat pattern associ note mppec ultrastructur alter caudat nucleus extent ultrastructur alter increas increas mppec fullgest expos anim decreas increas mppec delayeddos anim"
"effect ethanol hexos uptak cultur rat brain cell effect ethanol hexos uptak glial cell investig primari cultur prepar term rat fetus specif deoxyglucos dg uptak signific reduc hr exposur ethanol concentr mm mm inhibitori effect mm ethanol increas durat exposur dg uptak inhibit hr astrocyt cultur brain term fetus rat fed ethanol pregnanc show essenti dg uptak respons vitro ethanol treatment kinet dg uptak show signific decreas vmax presenc ethanol interact found ethanol insulin stimul dg uptak protein content cultur data suggest ethanol modul hexos uptak astrocyt cultur fetal rat brain insulin action glial cell affect ethanol"
"factor analysi patient histori fail tracheal intub pregnanc patient histori fail tracheal intub pregnanc investig ray laryngoscopi deliveri partial elev epiglotti view glottic structur found patient consid present difficulti patient blade tip fail make contact hyoid explain tongu compress pear shape prevent sight larynx abnorm anatom indic patient level difficulti encount angular measur jaw protrus line join upper incisor point anterior vocal cord midpoint surfac mandibl lower angl triangl import angl incisor"
"comparison preparatori techniqu urin cytolog method prepar urin cytolog compar retrospect method cell urin fix prepar smear method cell fix smear prepar urin cytolog report correl subsequ histolog analysi specif urin cytolog method high sensit method method differ signific cell prepar techniqu signific sensit urin cytolog cellular fixat smear prepar prefer smear prepar fixat"
"gene map alport famili basement membran antigen phenotyp present studi undertaken determin differ alport kindr antigen phenotyp basement membran result defect distinct genet loci allel mutat singl locus analyz linkag alport gene polymorph loci chromosom famili alport syndrom famili epiderm basement membran affect member show alter immunohistolog reactiv discrimin antibodi fns identifi kd peptid ncl domain basement membran collagen famili epiderm basement membran affect individu react antibodi diseas gene map xqq region long arm chromosom famili alter basement membran antigen famili normal basement membran antigen conclud alport syndrom kindr aros allel mutat singl genet locus time exclud possibl tight link gene involv gene chain type iv collagen chromosom find suggest alport gene encod basement membran collagen chain"
"obstetr complic young teenag compar pregnanc outcom teenag primigravida equal year adult primigravida year similar prenat care socioeconom status racial balanc incid preterm labor deliveri low birthweight infant signific higher teenag incid preeclampsia signific higher adult cesarean deliveri frequent teenag higher incid infant small gestat age anemia abnorm present labor birthweight infant black teenag signific lower birthweight white teenag birthweight signific lower infant teenag adult prenat care socioeconom factor racial balanc compar young teenag adult teenag signific greater risk deliveri smaller infant preterm labor low birthweight infant"
"accuraci clinic find laparoscopi pelvic inflammatori diseas accuraci clinic diagnosi pelvic inflammatori diseas determin women present pelvic pain primari care physician refer gynecologist laparoscopi laparotomi endometri biopsi fimbrial minibiopsi reveal preval pelvic inflammatori posit negat predict valu gynecologist histopatholog diagnosi standard clinic accuraci gynecologist chanc suggest expect bias visual diagnosi laparoscopi sensit specif salping standard fimbrial histopatholog diagnosi result support routin laparoscopi supplement negat endometri fimbrial minibiopsi accur diagnos pelvic inflammatori diseas"
"heterotop pregnanc vitro fertil embryo transfer seventeen case heterotop pregnanc report clinic pregnanc vitro fertil high preval tubal damag ivf patient superovul multipl embryo transfer predispos patient condit patient report abdomin pain vagin bleed patient symptom acut abdomin emerg transvagin ultrasonographi superior transabdomin ultrasonographi diagnosi extrauterin pregnanc presenc intrauterin gestat sac patient symptom exclud diagnosi concomit extrauterin pregnanc pelvi care visual earli diagnos viabl ectop pregnanc ruptur abolish mortal morbid offer chanc patient select conserv treatment patient extrauterin gestat sac treat transvagin aspir inject potassium chlorid ultrasonograph guidanc outcom intrauterin pregnanc favor method treatment ectop pregnanc"
"forskolin methotrex induc intermedi trophoblast phenotyp cultur human choriocarcinoma cell human placenta membran vital mainten nutrit protect develop fetus placent develop cytotrophoblast give rise chorion membran fuse form differenti syncytium cell respons placent protein steroid hormon product mechan involv differenti trophoblast unknown intermedi stage characterist phenotyp document vivo observ chemic dissimilar xenobiot agent induc bewo choriocarcinoma cell chang usual cytotrophoblast phenotyp acquir morpholog function characterist typic intermedi trophoblast incub bewo cell cultur presenc mumol methotrex hour stimul human chorion gonadotropin secret fold aromatas activ fold morpholog find hormon includ increas nuclear size cytoplasm expans observ computerinterfac imag analyz planimetr morphometri nuclear area cell reveal fold increas incub methotrex effect forskolin direct activ adenylyl cyclas evalu model cytotrophoblast differenti addit mumol forskolin bewo cultur result dramat trophoblast cell phenotyp increas human chorion gonadotropin synthesi fold aromatas activ fold nuclear area fold induc untreat cell addit increas hthymidin incorpor fold afford treatment result suggest biochem cytolog human trophoblast differenti induc vitro activ adenylyl cyclas pathway forskolin unknown appar independ signal methotrex"
"endometri thick measur endovagin ultrasonographi identifi endometri abnorm diagnost curettag year method choic diagnos endometri cancer women postmenopaus bleed cost curettag perform today huge approxim group women diagnos endometri cancer expans techniqu obtain endometri sampl evalu invas endovagin ultrasonographi identifi endometri abnorm group women evalu studi endometri thick measur endovagin ultrasonographi indic endometri abnorm demonstr women postmenopaus bleed endometrium mm thick endometri cancer found curettag endometri thick women endometri cancer mm compar mm women atroph endometrium cutoff limit endometri abnorm mm posit predict identifi endometri abnorm limit studi curettag procedur avoid"
"fetal urin output influenc residu amniot fluid volum prematur ruptur membran fetal urin product women prematur ruptur membran differ control group correl fetal urin output residu amniot fluid volum residu amniot fluid volum prematur ruptur membran depend alter fetal renal function"
"clinic implic subchorion placent lucenc forti patient identifi perinat diagnost referr center subchorion placent lucenc lucenc vari simpl multicyst cover subchorion placent surfac clinic follow patient demonstr increas incid advers pregnanc outcom conclud pregnanc higher risk subchorion placent lucenc intraplacent fetal anomali"
"evid human chorion gonadotropinlutein hormon receptor regul involv decreas level receptor messeng ribonucl acid inject pseudopregn rat pharmacolog dose hcg lead characterist decreas lhhcg bind isol luteal cell steadi state level lhhcg receptor mrna determin rat ovari hcginduc regul receptor northern blot perform mer probe guanin cytosinerich carboxyltermin untransl region lhhcg receptor cdna hybrid probe lhhcg receptor mrna high specif probe hybrid rat luteal cell rna fraction signal detect nontarget tissu lhhcg receptor level quantit ihcg bind isol membran fraction treatment control group examin mrna level receptor hcginduc regul show steadi decreas gradual increas control level day pseudopregn ihcgbind activ regul parallel mrna profil experiment control group examin level mrna alphaactin show chang period suggest loss lhhcg receptor mrna due general loss mrna luteal cell result suggest hcginduc regul lhhcg receptor luteal cell involv regul receptor messag level"
"retino acid stimul placent hormon secret choriocarcinoma cell line vitro retino acid ra activ metabolit vitamin import mediat cellular differenti shown stimul human cg hcg secret jeg choriocarcinoma cell vitro order determin ra stimul hcg secret trophoblast cell line evalu effect ra hcg hcgalpha subunit hcgalpha progesteron secret choriocarcinoma cell line jeg jar bewo ra stimul hcg hcgalpha secret dosedepend fashion cell line time requir give statist signific increment hcg hcgalpha control cell addit ra cholera toxin microgramsml result addit synergist stimul hcg hcgalpha secret cell line cycloheximid microm abolish effect ra hcg hcgalpha secret bewo cell line progesteron secret respons ra inconsist progesteron secret jeg bewo cell line stimul high concentr ra progesteron secret jar cell stimul intracellular level camp affect ra treatment jeg jar cell dosag ra signific alter cell number cell line ra physiolog concentr stimul hcg hcgalpha secret choriocarcinoma cell line vitro ra physiolog mediat placent hormon product unknown"
"vitro fertilizationembryo transfer ivf unit state result ivf registri medic research intern societi assist reproduct technolog american fertil societi fourth annual report unit state registri vitro fertilizationembryo transfer ivf relat practic present report describ experi unit state member clinic respect treatment outcom clinic report perform ovarian stimul cycl treatment includ frozen ivf donor oocyt clinic pregnanc live deliveri nineti percent clinic deliveri total babi born live deliveri rate ivf base retriev gamet intrafallopian transfer gift base retriev ivf gift combin base retriev zygot intrafallopian transfer zift relat practic base retriev addit treatment result present frozen ivf donat oocyt"
"handl tubal infertil introduct vitro fertil consequ studi aim quantifi import social econom consequ alter handl tubal infertil establish ivf treatment number tubal oper reduc import posit implic avail oper theater elect oper avail hospit bed patient group total durat certif ill calcul cost live birth tubal surgeri compar ivf treatment life tabl analys demonstr high signific increas rate deliveri complet ivf treatment patient compar tubal surgeri"
"fertil surgeri primari ovarian pregnanc primari ovarian pregnanc occur parous fertil women accident event relat presenc iud affect implant indic alter fertil reproduct perform postop remain unmodifi"
"oocyt preembryo donat women ovarian failur extend clinic trial outcom seri preembryo transfer women ovarian failur twenti fertil women function nonanonym donor provid oocyt vitro fertil undergo control ovarian hyperstimul transvagin ultrasound direct oocyt aspir recipi year age receiv hormon replac therapi preembryo transfer oocyt obtain aspir result transfer preembryo recipi coupl twenti result pregnanc preclin clinic ongo deliv implant rate individu transfer fresh preembryo conclud oocyt donat safe high effici achiev pregnanc women ovarian failur"
"treatment tubal ectop pregnanc salpingotomi tubal sutur salpingectomi publish erratum fertil steril jun thirti women unruptur tubal ectop pregnanc ep random assign undergo salpingotomi tubal sutur salpingotomi tubal sutur reproduct perform patient compar patient underw salpingectomi ep histor control life tabl analysi cumul probabl intrauterin pregnanc iup month salpingotomi tubal sutur salpingotomi tubal sutur cumul probabl iup salpingectomi month signific lower salpingotomi tubal sutur differ cumul probabl ep salpingotomi tubal sutur signific higher salpingectomi women subsequ underw laparoscopi laparotomi signific differ found degre adhes salpingotomi tubal sutur find suggest iup conserv treatment higher salpingectomi recurr ep higher intrauterin pregnanc occur earlier salpingotomi tubal sutur salpingotomi tubal sutur rapid return tubal function heal secondari intent"
"ovarian hyperandrogen role sensit gonadotropin determin ovarian hyperandrogen repres enhanc gonadotrop stimul augment ovarian sensit gonadotropin undertaken evalu hour integr concentr serum total testosteron lutein hormon lh ovarian respons exogen gonadotrop stimul end group women hyperandrogen anovulatori earli follicular phase cycl control subject continu blood withdraw hour portabl corm pump corm middleport ny exogen stimul human chorion gonadotropin current observ support notion ovarian hyperandrogen repres combin impact increas gonadotrop support coupl augment ovarian sensit gonadotrop stimul"
"endometri antibodi versus ca detect endometriosi detect endometri antibodi indirect immunofluoresc method establish human endometri carcinoma cell line evalu compar ca detect endometriosi hundr patient sera infertil gynecolog gynecolog oncolog servic evalu sensit antibodi test specif contrast sensit specif ca preliminari find offer promis antibodi detect method adjunct diagnosi endometriosi"
"matur immatur oocyt cocultur granulosa cell increas number embryo transfer immatur human oocyt cocultur granulosa cell preovulatori follicl greater number immatur oocyt incub granulosa cell dispers cumulus corona cell compar immatur oocyt cultur media fifti percent immatur oocyt fertil cocultur granulosa cell compar fertil immatur oocyt cultur granulosa cell case embryo develop immatur oocyt transfer determin immatur oocyt contribut pregnanc"
"comparison doppler flow veloc waveform amniot fluid column nonstress test monitor postdat pregnanc hundr thirti pregnanc exceed day monitor week sonograph estim amniot fluid column daili matern record fetal movement thriceweek nonstress test addit woman receiv week studi uteroplacent umbil circul doppler ultrasound fetal death studi individu method fetal surveil absenc enddiastol frequenc umbil arteri sensit predict fetus develop fetal distress stage combin test sonograph estim amniot fluid column improv predict minim fall specif result strong suggest combin umbil arteri doppler waveform amniot fluid determin adequ method monitor postdat pregnanc"
"low incid posit amnion fluid cultur preterm labor week absenc clinic evid chorioamnion order determin util amniocentesi detect subclin chorioamnion asymptomat afebril women preterm labor intact membran enrol women week gestat prospect studi enrol women fulfil clinic laboratori criteria studi women exclud leukocyt count exceed microl asymptomat afebril women posit cultur amnion fluid bacteria fungi mycoplasma homini ureaplasma urealyticum chlamydia trachomati virus sepsi prove infant deliv patient clear relationship histolog evid chorioamnion failur tocolyt therapi fetal lung profil matur amnion fluid sampl week gestat amnion fluid sampl week amniocentesi detect chorioamnion asymptomat afebril women preterm labor intact membran week gestat reserv case inform fetal lung matur"
"comparison continu versus sequenti estrogen progestin therapi postmenopaus women pilot studi perform compar efficaci safeti continu versus sequenti schedul common prescrib medic ovarian hormon replac conjug equin estrogen medroxyprogesteron acet bleed pattern endometri histolog metabol paramet studi postmenopaus women prospect random continu schedul daili estrogen progestin sequenti schedul conjug estrogen day medroxyprogesteron acet day dose studi mg conjug estrogen mg medroxyprogesteron acet signific greater bleed observ mg dosag conjug estrogen bleed pattern similar schedul amenorrhea preval women mg dosag estrogen continu progestin schedul frequent endometri atrophi observ continu schedul support concept prolong schedul promot amenorrhea patient dose schedul modest insignific increas highdens lipoprotein cholesterol sequenti therapi prevent estrogeninduc decreas lowdens lipoprotein cholesterol continu schedul mg dosag conjug estrogen signific increas triglycerid continu sequenti schedul report continu schedul mg dosag medroxyprogesteron acet elicit action circul lipid attent direct examin longterm effect lower dosag continu"
"endotoxin vagin fluid women bacteri vaginosi concentr endotoxin vagin fluid measur women bacteri vaginosi control normal vagin flora vagin fluid women bacteri vaginosi signific greater amount endotoxin versus endotoxin unitsmg vagin fluid endotoxin vagin fluid contribut activ prostaglandin system provok prematur labor"
"persist tubal pregnanc persist tubal pregnanc manifest acut symptom persist rise betahcg titer conserv surgeri condit complic relat recent practic conserv surgic manag tubal pregnanc written identif therapi condit pathophysiolog case persist studi case fail conserv procedur instanc surgeon concentr appropri maxim dilat portion tube blood clot abort product concept implant site locat medial uterus avoid complic includ medial explor possibl mesosalping inject vasopressin understand natur histori patholog process valuabl manag case persist identifi sole continu betahcg titer"
"regul gene express choriocarcinoma methotrex hydroxyurea choriocarcinoma high malign neoplasm trophoblast origin remark mark degre sensit chemotherapeut agent treat cell line deriv choriocarcinoma patient antineoplast agent methotrex hydroxyurea hu nucleotid deplet previous shown effect choriocarcinoma found pleiotrop regul gene gene hcg alphasubunit betasubunit placent alkalin phosphatas strong induc methotrex hu express myc oncogen prolifer reduc undetect level drug treatment express beta microglobulin compon class major histocompat locus unchang addit mechan induct hu gene hcg alphasubunit gene found occur level transcript similar effect methotrex hu mechanist unrel antimetabolit induct specif gene express choriocarcinoma cell suggest effect due nucleotid pool alter specif ligand effect hcg alphasubunit promot transcript regul hurespons element"
"women mental physic health pregnanc month postpartum longitudin studi conduct investig women mental physic health time childbirth determin health relat length matern leav thirti marri employ time mother complet questionnair pregnanc week month month postpartum result show pregnanc postpartum month number day mother ill infect steadili increas addit depress symptom mother rose pregnanc week postpartum declin women return work period studi signific declin depress symptom observ prenat period postpartum month find demonstr signific mental physic health group time mother"
"endometri ablat roller ball electrod endometri ablat control menorrhagia safe effect altern hysterectomi select patient endometri ablat resectoscop equip roller ball electrod patient techniqu effect yag laser endometri ablat offer gynecologist advantag speed low cost safeti compar laser approach"
"increas risk ectop pregnanc matern cigarett smoke part casecontrol studi ectop pregnanc evalu potenti etiolog role cigarett smoke matern cigarett smoke time concept increas risk ectop pregnanc doserespons relationship adjust odd ratio hand partner smoke ectop pregnanc studi supplementari argument causal effect smoke develop ectop pregnanc"
"carcinoma femal reproduct organ crosssect imag crosssect imag techniqu comput tomographi ct magnet reson imag mri play integr role evalu patient carcinoma femal reproduct system ct mri tissuespecif benign malign diseas differenti techniqu diagnosi clinic base histori physic examin histolog diagnosi made ct mri recommend noninvas evalu tumor extent design optim therapi facilit effect treatment ultim influenc patient prognosi evalu tumor uterus includ endometri cervic carcinoma ct limit evalu extens diseas believ ct rise proportion size extent diseas major limit suboptim tissu contrast resolut make differenti small tumor surround normal tissu difficult mri render excel soft tissu contrast direct tumor visual assess tumor volum depth penetr extens adjac tissu assess paramet crucial decid choic therapi surgeri radiat chemotherapi combin initi manag ovarian cancer includ surgic stage tumor debulk ct remain primari stage techniqu resid primarili identif tumor metastas patient follow progress ct mri laparotomi ovarian cancer supersed technic advanc radiolog crosssect imag signific improv accuraci noninvas tumor stage limit techniqu addit technic improv tissu character immin"
"laparoscop cauteri treatment endometriosisrel infertil life tabl analysi paramet exponenti method appli pregnanc rate patient undergo laparoscop cauteri exclus patient male factor infertil exclud estim cure rate patient stage ii diseas signific signific differ anovul complic endometriosi greater infertil factor present signific differ observ patient stage diseas averag fecund decreas valu observ stage ii anovul infertil factor conclud laparoscop cauter effect mode therapi treatment stage ii endometriosi infertil"
"endometri epitheli cell periton fluid earli follicular phase periton fluid pf obtain earli follicular phase women laparoscopi part infertil investig cell present pf pellet cultur develop endometri epitheli cell coloni identifi women identif cell coloni facilit monoclon antibodi bw specif marker number endometri epitheli cell coloni show larg variat pf sampl signific distinct incid number cell coloni found women minim endometriosi signific correl number cell coloni found women infertil mechan male infertil factor data retrograd transport viabl endometri cell menstruat occur women patent tube implic result relat retrograd menstruat endometriosi infertil discuss"
"detect progesteroneinduc secretori protein synthes uteri endometriot implant rat induc endometriosi steroid modul secretori activ uterus effect ectop endometrium protein synthesi secret util dimension electrophoresi visual protein produc uteri endometriot implant steroidtr reproduct cyclic rat surgic induc endometriosi greater protein visual uterin cultur progesteron stimul estrogensuppress rat distinct glycoprotein induc uterin protein molecular weight mr isoelectr point pi protein detect endometriot implant cultur progesteroneinduc uterin protein play role luteal endometri physiolog valuabl assess endometri function aberr secretori behavior ectop endometrium suggest involv reproduct dysfunct endometriosi"
"intraop manag ureter injuri oper laparoscopi injuri uret oper laparoscopi rare diagnosi made radiolog postop period patient present symptom sign suggest ureter injuri report case ureter injuri result oper laparoscopi endometriosi injuri diagnos treat laparoscopi procedur increas util oper laparoscopi perform complex procedur increas potenti oper injuri uret prior visual retroperiton dissect uret case reduc complic permit prompt diagnosi event injuri"
"predict activ renin assay diagnosi ectop pregnanc increas frequenc ep earli diagnosi focus interest research biochem marker establish hormon valu plasma spontan ongo pregnanc week amenorrhea ep case earli abort examin predict valu trophoblast cl product patholog pregnanc associ low hcg low activ renin discrimin ectop abort spontan gestat"
"bone miner densiti lumbar spine endometriosi subject compar agesimilar control popul purpos studi compar lumbar bone miner densiti bmd women endometriosi agesimilar control eighti women north american center age yr laparoscop proven endometriosi studi patient enrol studi efficaci nafarelin gnrh agonist fifti women age yr palo alto area regular menstrual cycl major medic problem serv agesimilar control group predomin greater white bmd lumbar spine cm studi subject control studi patient control normal valu age bmd signific group bmd correl sever time diagnosi endometriosi bmd posit correl weight group height studi patient margin height control studi show differ bmd endometriosi patient agesimilar control group normal bmd"
"nifedipin treatment sever preeclampsia conduct random clinic trial patient sever preeclampsia week gestat receiv nifedipin mg sublingu mgday oral hydralazin mg intraven mgday oral effect control blood pressur achiev nifedipin subject hydralazin statist signific differ matern side effect minor group acut fetal distress develop nifedipin subject treat hydralazin prolong gestat day nifedipin day hydralazin differ reach statist signific infant born women treat nifedipin deliv advanc gestat age versus week statist signific weigh versus statist signific tend fewer minor complic averag number day spent neonat intens care unit signific lower nifedipin group versus day lead averag reduct total matern neonat hospitalizationrel charg nifedipinetr pregnanc conclud nifedipin effect conveni lowcost treatment patient sever preeclampsia undesir side effect"
"etiolog preterm birth indig popul prevent logic expect assess expect preterm birth prevent determin preterm birth popul indig women studi singleton birth predomin black indig popul occur novemb april identifi proport preterm birth prevent current treatment modal forti percent preterm birth occur week gestat age time practition attempt tocolysi remaind occur week matern medic obstetr complic occur week spontan prematur ruptur membran preterm birth calcul theoret prevent fourth present cm cervic dilat treat appropri tocolyt deliv potenti prevent birth occur group present cervic dilat cm conclud improv preterm birth rate signific current level difficult achiev"
"risk factor shoulder dystocia engin studi clinicianappli forc report engin risk factor clinicianappli forc vagin deliveri newborn specif present interpret data seri experi forcesens devic random select vagin birth includ shoulder dystocia deliveri birth injuri result clinicianappli peak forc typic routin deliveri difficult deliveri shoulder dystocia deliveri time requir deliv fetal shoulder doubl nonroutin deliveri addit impuls rate applic forc distinguish routin nonroutin deliveri conclud proper perceiv forc forc rate durat forc object paramet recogn manag shoulder dystocia predict threshold birth injuri"
"salpingoscopi light microscop electron microscop correl publish erratum obstet gynecol order examin abil salpingoscopi diagnos intratub patholog fallopian tube evalu salpingoscop histolog flexibl rigid salpingoscop observ document intratub photographi salpingoscop criteria establish criterion assign numer tube evalu patenc mucos fold architectur erythema adhes dilat base criteria tube grade normal abnorm mild moder sever histolog tube evalu patenc epitheli vascular dilat adhes activ inflamm tube signific histolog find histolog normal fallopian tube examin transmiss electron microscopi discord case histolog reveal epitheli stromal detect salpingoscopi fallopian tube sever diseas diagnos method transmiss electron microscopi histolog abnorm tube show flatten epithelium mark reduc ciliari distribut degener secretori epitheli cell larg intracellular vacuol swollen nuclei spars chromatin result salpingoscop observ consist histolog find endotub diseas sever moder patholog document light microscopi transmiss electron microscopi frequent diagnos salpingoscop magnif"
"serial endovagin sonographi ectop pregnanc treat methotrex methotrex therapi newli establish treatment modal ectop pregnanc perform studi determin time frame resolut sonograph identifi mass therapi determin role sonographi manag patient eighteen patient treat methotrex laparoscop proven ectop pregnanc consent longterm follow endovagin sonographi patient constitut studi group time requir sonograph resolut mass variabl poor patient complianc sonograph follow affect conclus resolut time hundr day longest period accur resolut mass patient mass persist negat hcg titer enlarg adnex mass therapi necessarili predict treatment failur ten patient requir surgeri ruptur serial sonographi alter manag patient warrant routin basi follow sonographi complic suspect patient consid methotrex therapi endovagin sonogram cardiac activ remain relat contraind treatment determin mass ectop pregnanc remain hcg negat persist mass interpret treatment failur"
"measur sexual behavior risk pelvic inflammatori diseas women sexual behavior affect risk acquir pelvic inflammatori diseas risk character studi associ pelvic inflammatori diseas sexual behavior analyz data multicent casecontrol studi involv women hospit initi episod pelvic inflammatori diseas hospit control women histori pelvic inflammatori diseas studi particip provid inform frequenc intercours number recent sexual partner previous histori gonorrhea logist regress method adjust confound factor women report sexual partner time hospit pelvic inflammatori diseas relat risk confid interv women report recent sexual partner lesser extent frequent sexual intercours histori gonorrhea increas woman risk pelvic inflammatori diseas frequent intercours strong risk factor pelvic inflammatori diseas subgroup women low risk acquir sexual transmit diseas marri women recent sexual partner intercours time week risk pelvic inflammatori diseas compar similar women intercours week frequent intercours increas risk acquir sexual transmit diseas increas woman risk pelvic inflammatori diseas"
"epidemiolog characterist preterm deliveri etiolog heterogen preterm deliveri week complet gestat result divers etiolog pathway group idiopath preterm labor preterm prematur ruptur membran medic complic data public provid suffici detail subdivid preterm deliveri case group tabul spite inconsist terminolog incomplet report pattern identifi black women mark higher risk preterm deliveri pronounc preterm prematur ruptur membran idiopath preterm labor predomin lowerrisk white popul observ encourag subcategori preterm deliveri studi etiolog prevent"
"investig placent circul color doppler ultrasonographi placent circul normal complic pregnanc studi color doppler ultrasonographi flow veloc waveform obtain pregnanc discrimin fetal matern intraplacent blood flow color doppler ultrasonographi improv understand pathophysiolog pregnanc disord alter placent circul color ultrasonographi prenat differenti diagnosi intrauterin mass"
"reproduct factor risk endometri cancer role reproduct factor endometri cancer risk analyz casecontrol studi conduct greater milan area women case histolog confirm endometri cancer women control admit acut nonmalign hormon gynecolog condit hospit cover compar catchment area compar nullipar women parous women lower risk endometri cancer evid declin risk increas number birth risk diseas decreas number spontan induc abort multivari relat risk estim compar spontan induc abort women spontan abort women induc abort trend risk statist signific parous women consid associ emerg endometri cancer age birth risk decreas increas age birth compar women birth occur age relat risk women greater equal year birth multivari trend risk statist signific reproduct factor consid risk estim tend greater younger age premenopaus women flatten subsequ strata age associ endometri cancer age birth observ women equal year older group observ age birth birth younger women decreas risk endometri cancer suggest shortterm protect effect pregnanc find consist latestag promot effect reproduct factor endometri carcinogenesi"
"pregnancyrel mortal york citi death risk factor identifi risk factor pregnancyrel mortal york citi analyz pregnancyrel death occur lead death ectop pregnanc complic embol intrapartum cardiac arrest hypertens mortal ratio determin compar characterist women death pregnancyrel women surviv deliveri live infant york citi period black hispan women mortal ratio time higher white hispan women comparison women age older die pregnancyrel older time factor increas risk pregnancyrel mortal includ year educ lack privat medic insur previous pregnanc fewer prenat visit studi suggest current maternalhealth familyplan servic requir achiev reduct prevent pregnancyrel mortal"
"human amniot fluid modul collagenas product cultur fibroblast model fetal membran ruptur particip mechan factor ruptur fetal membran normal labor prematur ruptur critic involv enzymat mechan propos studi analyz effect human amniot fluid gestat age collagenas synthesi cultur fibroblast result show term amniot fluid capabl induc synthesi collagenas proteas fibroblast reveal select increas collagenas activ immunoreact collagenas nonterm amniot fluid fail phenomenon propos model studi collagen degrad fetal membran term gestat"
"earli diagnosi vulvar neoplasia result vulvar examin vulvar examin facilit earli diagnosi treatment vulvar neoplasia patient found invas squamous cell carcinoma vulva carcinoma situ vulva melanoma patient benefit earli diagnosi definit treatment vulvar conserv"
"preval marijuana pregnanc pilot studi examin preval marijuana group pregnant women qualit rapid urin screen detect marijuana metabolit juli aug consecut patient underw anonym urin toxicolog screen time admiss labordeliveri unit patient identifi consecut number age race marit status gravid pariti obstetr servic clinic privat preval posit urin toxicolog screen marijuana studi popul posit test women screen preval greater clinic patient privat patient  distribut race marit status marijuanaposit negat group signific specif proport black singl women higher marijuanaposit group find suggest marijuana common obstetr patient associ marijuana pregnanc perinat morbid unreli natur patient drug histori support rapid inexpens screen techniqu general screen consid"
"earli recours laparoscopi manag suspect ectop pregnanc accuraci morbid nineti patient suspect ectop pregnanc ep subject laparoscopylaparotomi month period greenwich district hospit london audit case ep potenti avoid laparoscopi perform potenti avoid laparoscopi laparotomi case laparotomi unnecessari addit falseposit diagnos ep made laparoscopi result avoid loss part singl remain fallopian tube sensit pregnanc test laparoscopi laparotomi case pulmonari embolus avoid patient day hospit save"
"ascertain matern death york citi matern death york citi defin death woman pregnant month pregnanc termin pilot studi seek improv matern death ascertain found select medic examin report contribut addit percent total matern death vital statist review contribut percent linkag death tape women reproduct age live birth fetal death tape contribut percent medic examin case incorpor surveil data accur ascertain pregnanc death"
"effect matern iodin supplement pregnanc reduc matern thyroid hormon concentr pregnanc advers affect fetal neurolog develop context nation iodin supplement programm concern express theoret possibl iodin supplement pregnanc advers affect fetal develop result matern thyroid inhibit wolffchaikoff effect doubl blind control trial villag papua guinea measur motor cognit function show signific differ age year children mother receiv supplementari iodin pregnanc control children mother receiv placebo"
"suicid pregnanc postnat year object calcul age adjust mortal ratio suicid women year childbirth pregnanc identifi characterist postnat suicid childbear women designretrospect studi base popul data england wale subjectswomen age commit suicid year childbirth pregnanc main outcom measuresobserv expect mortal ratio total postnat sampl year age group unmarri mother suicid stillbirth observ expect mortal ratio suicid pregnanc year age group time suicid relat deliveri frequenc method suicid result standardis mortal ratio postnat suicid calcul actual total sixth expect low ratio found stillbirth rate time women childbirth low ratio pronounc present teenag mother unmarri mother women commit suicid childbirth month tendenc violent method standardis mortal ratio suicid pregnanc calcul pregnant women teenag substanti increas risk conclusionswomen year childbirth pregnanc low risk suicid high rate psychiatr morbid underreport matern suicid explain find affect magnitud motherhood protect suicid concern depend import focus suicid prevent clinic practic"
"duchenn becker muscular dystrophi genet prenat diagnosi futur prospect dmd bmd understood genet biochem molecular level genet level disord result mutat link gene encod dystrophin biochem level dmd result defici larg protein call dystrophin bmd result dystrophin present abnorm amount molecular structur date thousand patient analyz mutat dystrophin gene peripher blood dna alter dystrophin protein muscl tissu sever clinic phenotyp patient compar dystrophin gene mutat dystrophin protein alter reveal unexpect high degre correl inform deriv molecular analysi dna protein patient molecular diagnosi high predict clinic patient expect follow molecular diagnos independ patient age provid prognosi larg major muscular dystrophi patient clinic symptom diseas appar prognost molecular diagnos proven valuabl patient isol case famili histori disord prenat genet diagnosi dmd bmd involv southern blot pcr techniqu search delet dna risk fetus complic famili linkag studi intragen flank rflps recent assay dystrophin content fetal skelet cardiac muscl risk abortus accomplish definit discrimin affect normal fetus case delet analys famili dna studi equivoc utero fetal skelet muscl biopsi dystrophin protein assay accomplish risk pregnanc famili dna studi uninform dystrophin present skelet muscl week male fetus pregnanc continu result term birth healthi male infant futur hold excit opportun neonat screen treatment devast neuromuscular diseas"
"intrauterin devic pelvic inflammatori diseas women health studi reanalyz women health studi whs larg wide accept influenti casecontrol studi relationship intrauterin contracept devic iud pelvic inflammatori diseas pid data collect hospit citi octob august paper research publish conclud iud increas risk pid report cite estim rr relat risk pid current iud user noniud user confid interv care examin report reveal data support conclus antithet author arriv report whs publish anticip shortcom report correct undertook complet reanalysi whs data criteria result compar publish report reanalysi reveal rr current iud user compar noncontraceptor conclus whs iud increas risk pid"
"coagul screen epidur analgesia preeclampsia questionnair survey current practic small crosssect obstetr unit cover unit kingdom deliveri reveal mark lack standard practic request coagul screen preeclampt patient requir epidur procedur retrospect audit carri coagul screen request preeclampt patient epidur analgesia consid borderlin abnorm coagul found patient platelet count litr present case signific thrombocytopenia litr coagul abnorm encount sever preeclampsia diastol blood pressur greater mmhg proteinuria greater coagul abnorm reduc platelet count litr studi support anaesthet practic restrict request coagul test sever preeclampt patient patient line test limit platelet count"
"comparison food frequenc questionnair report standard portion size classifi individu nutrient intak individu intak retinol caroten vitamin folacin calcul food frequenc questionnair report portion size compar intak calcul standard portion size inform data casecontrol studi determin associ nutrient intak risk cervic dysplasia supplement standard portion size inform depart agricultur reanalyz signific differ found intak calcul report portion size data calcul standard portion size data nutrient correl nutrient intak obtain method data collect rang calcul rho statist measur consist classif particip group high medium low nutrient intak led valu rang indic misclassif studi particip determin effect misclassif studi outcom odd ratio calcul nutrient amount obtain method collect portion size data result replac report portion size data standard portion size data lead conflict outcom specif nutrient research relationship diet diseas"
"gender role social support postpartum depress symptomatolog benefit care women assum vulner depress symptomatolog childbirth extent symptomatolog predomin found men life cycl stage address studi examin gender differ postpartum depress symptomatolog link postpartum symptomatolog gender role relationship sampl obtain childbirth prepar class data show gender differ depress symptomatolog month childbirth women manifest decreas depress symptomatolog men show slight increas preparenthood point partial link women equival higher distress level protect effect vari social support contrast men depend primarili spous gender experienc decreas spous support childbirth femal lack support strong symptomatolog homemak compar employ women women matern leav context gender role data highlight benefit femal bond contrast cost care depict research"
"extern cephal version term random control trial tocolysi object assess role extern cephal version ecv term tocolysi design random control trial month period settingharar matern hospit harar zimbabw subject women breech present term recruit satisfi elig criteria women studi group control group end studi women recruit ecv interventionecv attempt intraven inject microgram hexaprenalin forward backward somersault maximum period min main outcom measuressuccess rate term present labour caesarean section variabl relat fetal outcom resultsecv reduc frequenc breech present labour caesarean section troublesom complic procedur conclus care select women breech present ecv term tocolysi safe reduc rate breech present labour caesarean section rate research determin role ecv earli labour"
"insulin stimul synthesi releas human chorion gonadotropin choriocarcinoma cell line recent studi shown insulin regul placent lactogen progesteron estrogen product human trophoblast cell studi perform examin insulin regul product hcg type cell preincub jeg jar cell cellsml human term trophoblast cell cellsml expos test hormon serumfre dulbecco modifi eagl medium secret hcg jeg cell stimul human insulin human proinsulin porcin insulin dosedepend manner lowest effect dose mg time studi show hcg secret peak insulin exposur contrast decern peak insulin serumfre media exposur jeg cell mgliter insulin stimul hcg synthesi immunoreact intracellular hcg cell grown presenc insulin smethionin label intracellular hcg immunoprecipit smethioninehcg secret medium control cultur time period human placent lactogen releas total trichloroacetic acidprecipit smethionin protein increas insulininduc stimul hcg synthesi inhibit cycloheximid addit insulin signific affect total intracellular protein incub insulin increas hcg releas jar cell human term trophoblast cell mous monoclon antibodi igf receptor inhibit stimul insulin jeg cell conclud insulin stimul synthesi secret hcg jeg cell jar cell hcg regul choriocarcinoma cell differ primari human placent trophoblast cell effect insulin jeg cell mediat part insulin growth factor receptor"
"effect betacaroten regress progress cervic dysplasia clinic experi order gain insight causal relat betacaroten cancer perform random placebocontrol trial effect betacaroten regress progress rate cervic dysplasia examin experiment group receiv supplement dose mg betacaroten daili month control group receiv placebo capsul outcom paramet definit regress progress base degre dysplasia medic period number patient show progress small conclus effect betacaroten regress percentag observ ci broad definit ci strict definit secondari analysi effect total intak betacaroten diet medic regress percentag cervic dysplasia studi show posit effect paper discuss extent issu studi design mask potenti effect result affect evid causal relat betacaroten cancer"
"select fallopian tube canal infertil increas common problem occlus fallopian tube princip recent surgeri treatment success rate surgeri low occlus proxim tube select fallopian tube canal fluoroscop guidanc success allevi proxim tubal obstruct procedur perform outpati set safe costeffect altern surgeri"
"death emerg depart retrospect review consecut emerg depart death nontrauma account death group averag age year male femal ratio trauma caus fatal group younger averag age year male femal ratio common nontrauma death sudden death uncertain coronari arteri diseas cancer heart diseas chronic obstruct lung diseas drug overdos sudden infant death syndrom common trauma death motor vehicl accid gunshot wound autopsi rate death certif error"
"efficaci potassium magnesium essenti hypertens doubleblind placebo control crossov studi object evalu antihypertens activ potassium combin magnesium patient mild hypertens design doubl blind randomis placebo control crossov trial week durat settingscardiolog outpati depart sassoon general hospit pune india patient adult mild hypertens diastol blood pressur mm hg interventionpati receiv placebo potassium mmolday combin magnesium mmolday crossov design drug treatment measurementsblood pressur heart rate assess week interv biochem paramet month interv resultspotassium combin magnesium produc signific reduct systol diastol blood pressur signific reduct serum cholesterol concentr biochem variabl chang magnesium addit effect urinari potassium excret increas signific group receiv potassium combin magnesium drug toler complianc satisfactori conclusionpotassium mmolday lower arteri blood pressur patient mild hypertens give magnesium ad advantag"
"resympathectomi upper extrem resympathectomi perform patient bilater ischaem hand phenomena extend oper techniqu resect part intercost nerv surround tissu procedur posterior extrapleur approach follow year sympathet ganglia remov previous surgeri axillari approach cent patient transient respons month year cent respons direct subject improv reoper cent patient continu wave doppler ultrasound studi show signific increas peak forward frequenc oper data conclud obtain resympathectomi effect reoper reserv special case surviv digit essenti"
"oscillometr finger blood pressur versus brachial auscult blood pressur record studi recent market proprietari finger blood pressur monitor marshal astro compar standard auscult brachial mercuri sphygmomanomet subject measur undertaken standard set american heart associ sensit finger blood pressur measur systol diastol blood pressur diagnosi high blood pressur systol greater mm hg diastol greater mm hg specif systol diastol blood pressur posit predict valu systol diastol blood pressur studi popul preval hypertens correl coeffici pearson systol valu devic diastol pressur valu obtain finger monitor found higher obtain mercuri sphygmomanomet differ standard deviat pair test systol diastol pressur devic mm hg mm hg valu accord propos nation standard systol diastol blood pressur measur mm hg mercuri sphygmomanomet measur differ due techniqu monitor employ devic devic recommend evalu blood pressur"
"leukocyt count predictor hypertens exploratori studi person observ progress normotens essenti hypertens match subject remain normotens initi leukocyt count wbc found relat develop hypertens risk increas confid interv person highest compar lowest quartil wbc relationship prove larg independ bodi mass index bodi fat distribut alcohol tobacco consumpt parent histori hypertens increas wbc reflect greater sympathet tone direct increas peripher vascular resist imped circul small blood vessel confirm studi add condit grow list wbc predict simpl cheap test consid inclus prospect epidemiolog studi diseas"
"plasma fibrinogen coronari risk factor scottish heart health studi plasma fibrinogen measur sampl men women age year particip scottish heart health studi relat cardiovascular risk factor women higher fibrinogen level men sex multivari analysi show fibrinogen posit age smoke total cholesterol bodi mass index negat alcohol consumpt women earli menopaus systol blood pressur fibrinogen level univari analys show weak posit associ fish consumpt sex male white fish consumpt enter final model women histori contracept pill usag signific lower fibrinogen level relationship fibrinogen physic activ complex larg explain smoke find support hypothesi rais fibrinogen mechan major risk factor promot coronari heart diseas risk factor explain total varianc fibrinogen level general popul"
"effect generat gender joint distribut lipid apolipoprotein phenotyp popul larg generat gender effect joint distribut total plasma cholesterol total ln triglycerid lntrig hdlcholesterol hdl ldlcholesterol ldl apolipoprotein ai apo ai aii apo aii lnapo studi male grandpar mgp femal grandpar fgp male parent mp femal parent fp male children mc femal children fc homogen varianc test reveal lipid varianc gender generat specif apolipoprotein varianc homogen strata absenc heterogen varianc signific heterogen ldllntrig lntrigapo aii covari found gender parent generat presenc heterogen varianc signific heterogen correl gender generat found hdlldl totalldl totallntrig lntrigldl totallnapo hdllnapo bivari distribut analys princip compon reveal generat gender specif cohort similar eigenvalu distinct eigenvector princip compon dimension lipid apolipoprotein distribut conclud amount variabl explain princip compon cohort interindividu variabl distribut lipid apolipoprotein trait generat gender specif studi document role varianc covari play determin risk diseas special subgroup popul larg demonstr varianc covari risk factor trait character life process age sexual dimorph studi argu futur biometr genet epidemiolog studi coronari arteri diseas account age gender effect interindividu variabl covari risk factor"
"risk ratio risk differ estim effect risk factor cardiovascular diseas elder articl review natur effect hypertens smoke cholesterol incid cardiovascular diseas emphas effect vari age method section discuss briefli concept addit multipl statist model tool summar data result section summar data associ incid stroke coronari heart diseas elder major risk factor tradit multipl model parsimoni character individu joint effect age high blood pressur term risk ratio smoke cholesterol addit model parsimoni discuss consequ observ studi prevent cardiovascular diseas elder"
"signific fill thallium reinject delay imag comparison region wall motion angiograph find identifi revers defect reinject small amount thallium tl hr delay imag perform patient coronari arteri diseas perfus abnorm postexercis tl imag thallium uptak visual score judg normal group revers defect group ii fill reinject group iiia fill reinject group iiib fill reinject observ segment segment show persist defect stress delay imag wall motion group iiia wors group ii group iiib group iiia show wave ecg group ii group iiib data reinject tl imag identifi fill area redistribut delay imag hold promis assess tissu viabil convent imag underestim"
"effect longterm coenzym captopril treatment surviv function capac rat experiment induc heart infarct effect coenzym coq captopril function capac hemodynam surviv studi rat recov experiment myocardi infarct rat random group receiv coq captopril combin drug ml tap water daili week day coronari arteri ligat coq captopril combin treatment signific improv exercis capac evalu lactat product standard treadmil exercis test signific heart rate blood pressur observ studi captopriltr group coq treatment increas maximum heart rate signific effect blood pressur observ captopril coq decreas pulmonari congest data suggest captopril prevent ventricular hypertrophi placebotr rat larg infarct observ coq treatment captopril treatment improv month probabl surviv compar placebo coq combin treatment tend improv surviv statist signific"
"ancient tempor arter realism characterist amarnian art detail harpist repres tomb paatonemheb bc dynasti clue diagnosi eye close swollen lid harpist stare space round shoulder wast face tempor ara heighten hollow broken line join extrem eyebrow corner eye detail found harpist blind result tempor arter polymyalgia rheumatica"
"propag deep venous thrombosi identifi duplex ultrasonographi investig efficaci anticoagul prevent continu thrombosi prospect evalu patient acut deep venous thrombosi duplex ultrasonographi patient hospit conclus ultrason evid deep venous thrombosi identifi level calf ii calfpoplit iii calfpoplitealfemor iv calfpoplitealfemoraliliac duplex scan obtain admiss subsequ occas therapi progress thrombosi defin advanc thrombus proxim venous level demograph data symptom risk factor deep venous thrombosi physic find anticoagul regimen hematolog variabl ascertain adequaci anticoagul defin elev baselin activ partial thromboplastin time patient progress thrombosi stabl improv duplex scan progress occur ii iii iiiii iiiiv demograph clinic variabl examin smoke correl progress thrombus averag heparin dose stabl group unitshr unitshr group progress activ partial thromboplastin time stabl group progress group patient stabl group consist adequ anticoagul progress group consist anticoagul patient stabl thrombus progress thrombus suffer nonfat pulmonari emboli clot progress determin duplex scan predict acut complic deep venous thrombosi"
"clinic spectrum symptomat extern iliac fibromuscular dysplasia extern iliac fibromuscular dysplasia rare asymptomat disord report symptomat patient year period review pathophysiolog mechan account distinct lower extrem ischem sequela emboliepisod focal digit ischemia blue toe patient resect primari anastomosi focal iliac ulcer fibromuscular dysplasia patient resect replac patient remov embol sourc reliev symptom chronic ischemiagradu onset full leg claudic patient treat oper graduat intralumin dilat patient prosthet bypass arteriographi subsequ show remodel lumen patient underw dilat dissectionacut onset leg ischemia result presum dissect extern iliac segment month conserv manag antiplatelet agent exercis symptom resolv complet arteriogram show spontan restor normal lumen dissect segment clinic present fibromuscular dysplasia mimic arteri process atherosclerosi diagnosi made arteriographi specif magnif view extern iliac arteri care surveil renal arteri treatment tailor clinic present symptom microembol diseas resect replac requir chronic ischemia intralumin dilat general suffici durabl prove simpler accept altern replac bypass acut dissect surgic intervent defer limb viabl spontan heal remodel persist symptom indic intervent ischem manifest extern iliac fibromuscular dysplasia"
"initi clinic evalu carotid arteri laser endarterectomi clinic studi carotid arteri laser endarterectomi began april report describ case perform patient men women age year indic asymptomat stenosi transient ischem attack stroke evolut emerg case elect case includ reoper case surgic exposur system heparin vascular control longitudin arteriotomi cleavag plane atheroma media develop argon ion laser radiat nm direct micron quartz fiber power laser radiat cut atheroma arteri weld end point residu atheromat debri vapor individu laser exposur arteriotomi close sutur blood flow restor endarterectomi cm long requir joul clamp time minut shunt case arteri perfor injuri result laser light complic hematoma respiratori arrest transient neurolog deficit carotid endarterectomi technic feasibl argon ion laser radiat present seri postop observ averag month rang month shown satisfactori result angiograph follow examin carri"
"influenc extracorpor circul erythrocyt flow properti blood influenc extracorpor circul red blood cell flow properti blood studi patient undergo aortacoronari bypass graft blood sampl drawn admiss general anesthesia oper extracorpor circul immedi extracorpor circul hour extracorpor circul echinocyt found short extracorpor circul disappear hour wash cell buffer restor normal discocyt shape plasma factor respons red cell membran lipid affect analysi membran protein reveal decreas ankyrin extracorpor circul prevent proteas inhibitor prepar suggest increas proteolyt activ plasma extracorpor circul red cell deform alter plasma viscos hematocrit mark reduc hemodilut prime solut low level result low blood viscos extracorpor circul lower degre oper degre conclud red cell affect extracorpor circul flow properti blood impair improv hemodilut"
"prostacyclin prostaglandin mediat reduct increas arteri pressur cardiopulmonari bypass aspir shed pulmonari venous blood increas arteri pressur aortic crossclamp period cardiopulmonari bypass treat hypotens drug notic aspir shed excess pulmonari venous blood open pleural caviti reduct arteri pressur obviat pharmaceut intervent studi investig relationship reduct arteri pressur level prostacyclin prostaglandin peripher pulmonari venous blood ten men undergo coronari bypass oper episod increas arteri pressur mm hg aortic crossclamp reduc mm hg aspir ml rang ml pulmonari venous blood pleura back circul peripher prostacyclin level measur ketoprostaglandin alpha prostaglandin level measur radioimmunoassay techniqu signific lower peak arteri pressur pgml lowest arteri pressur pgml ketoprostaglandin alpha prostaglandin prostaglandin alpha prostaglandin level aspir pulmonari venous blood pgml pgml hypotens effect shed pulmonari venous blood aspir back pleura circul mediat high level prostacyclin prostaglandin power vasodil"
"myocardi temperatur cardiac oper influenc ventricular function mainten heart integr frequent neglect coronari oper ventricular dysfunct limit success surgic procedur addit cardiopleg solut myocardi hypothermia ischem cardiac arrest import factor guarante ventricular perform studi design measur myocardi temperatur patient coronari arteri diseas signific stenosi coronari arteri comparison stenosi coronari arteri evalu influenc myocardi temperatur ventricular hemodynam cardiopulmonari bypass ventricular function assess thermodilut techniqu measur ventricular eject fraction ventricular enddiastol volum ventricular endsystol volum ventricular temperatur differ signific group lowest degre degre group stenosi coronari arteri degre degre group stenosi coronari arteri left ventricular septal temperatur group differ investig period ventricular hemodynam impair group stenosi coronari arteri decreas ventricular eject fraction immedi termin bypass increas ventricular enddiastol volum index ventricular endsystol volum index cardiac index decreas group analysi covari reveal signific correl ventricular eject fraction ventricular enddiastol volum ventricular endsystol volum myocardi temperatur conclud ventricular hypothermia difficult achiev patient diseas coronari arteri constant myocardi hypothermia import guarante ventricular function easili evalu thermodilut techniqu"
"intraop coronari arteri endarterectomi excim laser compar continuouswav laser excim laser exhibit vitro advantag nontherm ablat process linear relat number puls depth crater nm nsec puls durat repetit rate laser specif design clinic applic time cardiopulmonari bypass symptomat patient bypass graft mm diamet core specif ultraviolettip fiberopt scope introduc coronari arteriotomi upstream patient downstream patient contact stenosi laser power increas deliv clear stenosi occlus qualiti angioplasti control calibr neolumen cardiopleg solut output lasertr segment eighth day sixth month coronari arteriogram patient studi eighth day lasertr coronari arteri segment show earli parallellink patent neolumen competit bypass graft flow patient studi month recan segment patent patient venous graft occlud upstream laser angioplasti patent main limit method lie fact laser coronari recan confin fiber core diamet conclud excim laser angioplasti safe effici surgic procedur cathet flexibl remain critic problem assum tool multifib system suitabl intraop percutan rout"
"risk myocardi infarct death treatment low dose aspirin intraven heparin men unstabl coronari arteri diseas risc group men unstabl coronari arteri diseas unstabl angina wave myocardi infarct mi randomis doubleblind placebocontrol treatment oral aspirin mgday day intermitt intraven heparin risk mi death reduc aspirin day risk ratio confid interv month month aspirin reduc event rate wave mi unstabl angina independ electrocardiograph abnorm concurr drug therapi heparin signific influenc event rate group treat aspirin heparin lowest number event initi day treatment sideeffect high patient complianc"
"reninangiotensinaldosteron system autosom domin polycyst kidney diseas background high incid hypertens percent occur earli autosom domin polycyst kidney diseas cyst enlarg caus bilater renal ischemia subsequ releas renin propos form hypertens method investig hypothesi measur plasma renin activ aldosteron concentr shortterm longterm convertingenzym inhibit patient hypertens due polycyst kidney diseas patient essenti hypertens normotens patient polycyst kidney diseas normal subject group compar respect age sex bodysurfac area degre hypertens sodium excret renal function result shortterm studi se plasma renin activ signific higher hypertens patient polycyst kidney diseas patient essenti hypertens supin ng liter upright posit ng liter convertingenzym inhibit ng liter arteri pressur measur supin upright posit plasma aldosteron concentr measur upright posit signific higher normotens patient polycyst kidney diseas normal subject week convertingenzym inhibit renal plasma flow increas renal vascular resist filtrat fraction decreas signific hypertens patient polycyst kidney diseas patient essenti hypertens conclus reninangiotensinaldosteron system stimul signific hypertens patient polycyst kidney diseas compar patient essenti hypertens increas renin releas due renal ischemia caus cyst expans contribut earli develop hypertens polycyst kidney diseas"
"predict carotid endarterectomi upper gastrointestin endoscopi coronari angiographi background method nation repres popul year age older demonstr quarter coronari angiographi upper gastrointestin endoscopi carotid endarterectomi perform reason medic paper examin specif characterist patient age sex race physician age boardcertif status experi procedur hospit teach status profitmak status size predict procedur perform appropri result general found variabl appropri care percent explain basi standard easili obtain data patient physician hospit procedur perform teach hospit increas likelihood reason medic angiographi endoscopi endarterectomi addit angiographi perform reason older affluent patient treat surgeon perform high low number procedur decreas likelihood endarterectomi percent conclus appropri care close predict easili determin characterist patient physician hospit present appropri improv assess direct level patient hospit physician"
"regress coronari arteri diseas result intens lipidlow therapi men high level apolipoprotein background method effect intens lipidlow therapi coronari atherosclerosi men high risk cardiovascular event assess quantit arteriographi men year age apolipoprotein level greater equal mg decilit document coronari arteri diseas famili histori vascular diseas complet year doubleblind studi includ arteriographi base line treatment patient dietari counsel random assign treatment lovastatin mg day colestipol time day niacin time day colestipol time day convent therapi placebo colestipol lowdens lipoprotein ldl cholesterol level elev result level ldl highdens lipoprotein hdl cholesterol chang slight conventionaltherapi group percent substanti patient treat lovastatin colestipol percent niacin colestipol percent conventionaltherapi group percent patient definit lesion progress regress proxim coronari segment regress chang percent comparison progress chang frequent patient receiv lovastatin colestipol percent receiv niacin colestipol percent regress frequent lovastatin colestipol percent niacin colestipol percent multivari analysi reduct level apolipoprotein ldl cholesterol systol blood pressur increas hdl cholesterol correl independ regress coronari lesion clinic event death myocardi infarct revascular worsen symptom occur patient assign convent therapi compar assign receiv lovastatin colestipol assign receiv niacin colestipol relat risk event intens treatment percent confid interv conclus men coronari arteri diseas high risk cardiovascular event intens lipidlow therapi reduc frequenc progress coronari lesion increas frequenc regress reduc incid cardiovascular event"
"outcom predictor outcom pediatr submers victim receiv prehospit care king counti washington predictor outcom pediatr submers victim treat seattl king counti prehospit emerg servic studi victim year identifi hospit admiss paramed medic examin report proport fatal sever outcom patient compar risk factor patient die sever neurolog impair subset victim found cardiopulmonari arrest surviv rate survivor unimpair mild impair risk factor occur common victim die sever impair submers durat greater minut patient cardiopulmonari resuscit durat longer minut patient factor ascertain prehospit phase care submers durat steadili increas risk sever fatal outcom risk minut risk minut risk minut risk greater minut children receiv greater minut cardiopulmonari resuscit escap death sever neurolog impair rate save victim victim cardiopulmonari arrest higher report children prompt prehospit advanc cardiac life support effect medic intervent pediatr submers victim prehospit inform provid valuabl predictor outcom"
"histolog investig vascular malform face transarteri embol ethibloc agent twenti vascular malform locat facial area highflow arterioven malform slowflow malform underw combin treatment embol surgeri embol perform simultan superselect angiographi branch extern carotid arteri biodegrad fibros agent ethibloc case histolog examin surgic specimen confirm good target orient transarteri inject ethibloc limit techniqu discuss agent prove thrombogen fibrogen properti vascular wall degener ruptur embol instanc necrosi interstiti tissu skin embol treatment vascular malform face curat facilit subsequ surgeri examin case"
"surgic augment skin blood flow viabil pig musculocutan flap model porcin rectus abdomini musculocutan tram flap model design valid pig tram flap base deep inferior epigastr die vessel cm transvers skin paddl superior end rectus abdomini muscl model subsequ test hypothesi surgic augment flap viabil vascular territori expans specif observ ligat superior epigastr se vessel day prior rais tram flap signific increas length area viabl skin transvers skin paddl treatment flap compar contralater shammanipul control flap signific increas skin viabil accompani signific increas skin muscl capillari blood flow treatment tram flap compar control mechan vascular territori expans unclear postul hypoxia result ligat superior epigastr vessel prior flap surgeri play role trigger deep inferior epigastr arteri territori previous perfus superior epigastr arteri increas skin muscl capillari blood flow transvers paddl tram flap rais deep inferior epigastr vascular pedicl"
"critic ischemia time surviv pattern experiment pig flap previous work critic ischemia time suggest greater suscept myocutan flap skin flap ischemia reperfus injuri durat ischemia affect surviv area flap pig model anim oper critic ischemia time surviv pattern buttock skin latissimus dorsi myocutan island flap determin submit hour normotherm ischemia averag critic ischemia time cit determin hour buttock skin latissimus dorsi myocutan flap percentag total area surviv tas flap surviv advers affect increas ischem interv flap model statist signific decreas percentag total area surviv found hour ischemia buttock skin latissimus dorsi myocutan flap"
"clinic autonom therapeut observ sibl postur hypotens sympathet failur due inabl synthes noradrenalin dopamin defici dopamin beta hydroxylas brother sister longstand symptom postur hypotens wors morn exercis warm weather male erect unaffect ejacul prolong absent nocturia urinari bladder bowel sweat abnorm autonom function test confirm sympathet adrenerg failur spare sympathet cholinerg intact parasympathet function neurolog abnorm noradrenalin adrenalin undetect plasma plasma dopamin elev urinari level noradrenalin adrenalin metabolit detect limit dopamin metabolit normal elev dopamin betahydroxylas activ undetect plasma immunohistochem studi perivascular cutan tissu confirm normal peptiderg tyrosin hydroxylas immunoreact absent dopamin betahydroxylas immunoreact find consist enzymat deficit convers dopamin noradrenalin parent clinic biochem normal treatment patient synthet amino acid threodihydroxyphenylserin hydroxyl group convert noradrenalin dopadecarboxylas reduc symptom sign postur hypotens increas level plasma noradrenalin urinari metabolit male ejacul behaviour includ feel confid optim tendenc argument laevo isom rais blood pressur plasma noradrenalin level drug direct pressor effect action prevent dopadecarboxylas inhibitor carbidopa"
"clinic diagnosi tamponad malawi consecut seri malawian patient tamponad secondari tuberculosi compar patient congest cardiac failur pericardi effus retrospect studi patient tamponad impalp apex beat pulsus paradoxus soft heart sound paradox rise jugular venous pressur fewer murmur result signific chi test yate correct presenc discrimin physic sign posit predict cent negat predict cent diagnosi tamponad clinic diagnosi tamponad primari health care personnel malawi lead earlier treatment"
"effect longterm verapamil therapi serum lipid metabol paramet calcium antagonist success manag hypertens decad longterm metabol effect defin impact calcium antagonist verapamil serum lipid metabol paramet hypertens patient verapamil monotherapi year treatment period year total cholesterol triglycerid level signific baselin highdens lipoprotein cholesterol increas signific mmol initi treatment mmol year import biochem paramet includ serum glucos potassium uric acid level unaffect verapamil therapi side effect advers cardiovascular event occur verapamil therapi studi dropout agent increas longterm manag essenti hypertens"
"antiatherosclerot vasculoprotect action calcium antagonist treatment hypertens prevent complic attribut blood pressur elev pressurerel stroke atherosclerot complic hypertens coronari arteri diseas manifest coronari morbid mortal reduc signific antihypertens therapi disappoint outcom reflect advers metabol effect tradit therapi diuret beta blocker lack specif vasoprotect properti increas attent paid newer antihypertens agent typic fewer advers effect physiolog mechan antihypertens action calcium play key role genesi atherosclerosi calcium antagonist posit affect vascular diseas investig observ calcium antagonist display clear antiatherosclerot properti experiment clinic studi recent publish clinic studi coronari arteri diseas shown develop slowli slower progress individu stenos higher regress rate frequent occurr lesion patient treat chronic verapamil compar receiv convent therapi similar investig evalu antiatherogen properti calcium antagonist includ frankfurt isoptin progress studi fip multicent isradipin diuret atherosclerosi studi mida intern nifedipin trial atherosclerosi coronari therapi intact largescal montreal heart institut studi result studi precis end point myocardi infarct cerebr infarct peripher vascular diseas revolution treatment hypertens identifi therapeut approach control pressurerel atherosclerot complic diseas"
"secondari prevent verapamil myocardi infarct danish studi group verapamil myocardi infarct effect verapamil death major event death reinfarct acut myocardi infarct studi doubleblind random placebocontrol multicent trial danish verapamil infarct trial ii davit ii hundr seventi patient start treatment verapamil mgday patient placebo treatment continu month month nineti death major event occur verapamil group death major event placebo group eighteenmonth mortal rate hazard ratio confid limit major event rate verapamil placebo group combin result trial result danish studi verapamil myocardi infarct metaanalysi demonstr treatment verapamil week acut myocardi infarct result reduct pool odd ratio confid interv death major event reinfarct conclud longterm treatment verapamil acut myocardi infarct signific reduct mortal major event reinfarct rate"
"relat lipid atherosclerosi epidemiolog evid clinic implic coronari arteri diseas cad lead death develop countri elucid risk factor mechan cad high prioriti data framingham heart studi largescal epidemiolog studi identifi major risk factor cad demonstr advers effect increas total lowdens lipoprotein cholesterol level protect effect highdens lipoprotein cholesterol recent investig includ lipid research clinic trial helsinki heart studi shown lower total cholesterol rais highdens lipoprotein cholesterol signific reduc risk cad hypertens signific risk factor cad assumpt blood pressur reduct offer signific benefit term cad risk antihypertens efficaci diuret beta blocker fail signific reduc cad morbid mortal advers effect antihypertens agent lipid profil glucos metabol metabol paramet account disappoint perform reduc cad morbid mortal result newer agent angiotensinconvert enzym inhibitor calcium antagonist free advers effect garner attent potenti reduc cad risk"
"effect hydralazin prostaglandin region myocardi function ischem canin heart effect hydralazin prostaglandin region myocardi function studi dog sixteen dog random assign drug treatment group dog group treat mgkg hydralazin administ bolus group receiv prostaglandin infus total dose microgramskg region myocardi function assess measur myocardi segment shorten systol call index percent systol shorten ss ischem heart prepar creat partial occlus coronari blood flow degre induc ischemia determin reduct ss hydralazin reduc ss ischem myocardium increas cardiac index stroke volum index coronari blood flow prostaglandin increas ss cardiac index stroke volum index ischem heart prepar hydralazin induc dissoci global ventricular function region myocardi function prostaglandin present find emphas evalu vasoact drug effect region myocardi function global hemodynam"
"increas plasma cholesterol independ thyroid function longterm amiodaron therapi dosedepend relationship object determin longterm amiodaron treatment rise plasma cholesterol analyz relat thyroid function design consecut entri trial includ cardiac patient initi amiodaron medic exclud abnorm thyroid function defin peak thyroidstimul hormon tsh respons thyrotropinreleas hormon trh greater mu amiodaron treatment patient twenti patient remain euthyroid studi intervent oral administr amiodaron durat treatment month rang month measur fast plasma lipid thyroid hormon peak tsh trh valu record month amiodaron treatment result plasma cholesterol gradual increas mmol treatment mmol month amiodaron medic peak tsh respons trh chang age sexspecif refer valu appli patient cholesterol valu percentil treatment number rose year treatment rise plasma cholesterol equal increas apoprotein plasma cholesterol relat daili dose amiodaron plasma concentr amiodaron desethylamiodaron thyroxin triiodothyronin revers triiodothyronin rt linear regress analysi posit relat plasma cholesterol cumul dose amiodaron conclus longterm amiodaron treatment dosedepend increas plasma cholesterol independ thyroid function"
"cardiac rehabilit coronari arteri bypass graft effect exercis perform risk factor coronari arteri bypass graft cabg nonselect patient cardiac rehabilit program includ medic follow physic train outpati group individu basi home effect program exercis test variabl coronari risk factor medic year surgeri compar nonexercis control group studi group show increas ratepressur product indic favor effect myocardi oxygen consumpt lower frequenc angina exercis test reduct rest systol diastol blood pressur mmhg fewer smoker fewer patient longact nitrat suggest organ cardiac rehabilit program advantag cabg"
"frameshift mutat lead type antithrombin defici thrombosi type antithrombin iii atiii defici commonest form inherit atiii defect character quantit reduct immunolog function detect protein condit high incid thromboembol disord previous investig shown atiii gene major case grossli intact precis molecular defect remain unknown investig molecular basi type atiii defici italian kindr enzymat amplif atiii gene sequenc affect famili member direct sequenc amplifi genom dna mutat delet singl posit codon identifi affect individu result frameshift lead prematur termin codon effect result null allel"
"cardiac myosininduc myocard heart autoantibodi involv induct diseas recent demonstr cardiac myosin capabl induc autoimmun myocard genet predispos mice diseas parallel coxsackievirus binduc autoimmun myocard respect hightit autoantibodi specif cardiac myosin line evid suggest autoantibodi involv induct autoimmun myocard immunoperoxidas stain heart section cardiac myosinimmun sw mice reveal igg deposit damag muscl fibr infiltr area intact tissu myosin autoantibodi bind surfac viabl cardiac myocyt isol mice react myocyt permeabil deterg mice treat singl high dose cyclophosphamid reduc humor immun respons develop sever myocard fact autoantibodi titer reduc level adjuvantinject control passiv transfer hightit myosin autoantibodi fail induc myocard titer recipi compar found mice cardiac myosininduc diseas result suggest hightit myosin autoantibodi secondari primari diseas"
"circadian variat myocardi ischemia implic manag extend ambulatori electrocardiograph monitor patient customari environ clear evid circadian pattern myocardi ischem episod patient effort angina highest activ occur noon coincid peak diurnal variat frequenc acut myocardi infarct stroke sudden death number potenti common trigger mechan includ catecholamin secret sympathet nervous system activ blood pressur heart rate cortisol secret aggreg platelet exhibit similar surg result coincid morn peak myocardi oxygen demand increas oxygen suppli reduc person aris morn attent vulner period merit time choic medic prevent reduc ischemia modifi potenti diseasetrigg mechan"
"angiotensin form angiotensinogenas extraren vasculatur kidney intent studi character angiotensin form angiotensinogenas aifa rat extraren arteri wall clarifi enzym present kidney aim identifi aifa human vasculatur establish affect essenti hypertens spraguedawley rat vascular section patient undergo correct surgeri studi enzym kinet assay perform angiotensin radioimmunoassay purifi natur angiotensinogen fast protein liquid chromatographi employ biochem character seri aifa isoelectr point molecular weight ph optima detect rat extraren vascular differ distribut enzym activ renal tissu extraren arteri main form renal renin present low activ aifa demonstr human extraren vasculatur behav plasma renin essenti hypertens result exist intrins human vascular ras extraren renal arteri extraren arteri aifa general stimul essenti hypertens previous postul"
"role angiotensin renal vasoconstrict observ develop genet hypertens studi examin renal function determin role kidney pathogenesi mainten phase hypertens okamotoaoki strain spontan hypertens rat shr compar agematch wistarkyoto rat wki week shr moder hypertens reduc glomerular filtrat rate gfr renal blood flow rbf increas renal vascular resist crossbreed studi reduct rbf gfr young shr genet link hypertens primari pathogenet import combin elev vascular resist reduc rbf gfr young shr implic increas activ vasoconstrictor system decreas activ vasodil system observ laboratori support notion endogen angiotensin ii contribut renal vasoconstrict young shr development phase hypertens acut chronic inhibit angiotensin convert enzym reduc arteri pressur reduc renal vascular resist increas renal blood flow young adult shr renal vascular tone shr depend angiotensin convert enzym activ wki abil angiotensin convert enzym inhibitor produc renal vasodil respons part antihypertens effect studi renal vascular reactiv angiotensin ii exagger young shr strain differ renal reactiv angiotensin ii abolish cyclooxygenas inhibit indomethacin indic endogen prostanoid counteract constrictor action angiotensin ii pronounc buffer activ wki"
"influenc angiotensin renal function renal vascular hypertens scope magnitud role angiotensin play generat mainten elev blood pressur model renal vascular hypertens continu expand clear specif angiotensin depend mechan contribut import pathophysiolog hypertens alter renal function model kidney clip hypertens rat generat angiotensin local intraren environ kidney potenti import mechan contribut alter renal function model applic antagonist reninangiotensin system rat model renal vascular hypertens effect angiotensin attenu renal hemodynam excretori behavior nonclip kidney angiotensin attenu effici autoregul renal hemodynam nonclip kidney evid inhibit angiotensin revers improv alter hemodynam excretori function angiotensin contribut import pathophysiolog hypertens model alter impair abil nonclip normal kidney excret sodium volum"
"thromboxan biosynthesi cardiovascular diseas sudden fissur atherosclerot plaqu suggest primari trigger transient spontan ischemia coronari cerebr circul measur urinari dehydrotxb dinortxb result aspirin trial suggest episod platelet activ site acut vascular lesion mediat part enhanc thromboxan tx biosynthesi episod increas metabolit excret detect unstabl angina aspirin mgday prevent fatal nonfat thrombot event set similar dynam thrombot process occur earli phase acut myocardi infarct suggest thromboxan metabolit measur result isi trial show similar impact shortterm aspirin therapi unstabl angina percutan translumin coronari angioplasti transient enhanc txa biosynthesi aspirinsuppress periprocedur thrombot complic hand insulindepend diabet mellitus type iia hypercholesterolemia reproduc persist abnorm txadepend platelet function associ reflect system local stimulus platelet activ continu episod alter lowdos mgday aspirin larg suppress thromboxan metabolit excret diseas lowdos aspirin select prostaglandin htxareceptor antagonist import tool test hypothesi txadepend platelet activ repres import transduc enhanc thrombot risk metabol abnorm"
"effect bay thromboxan antagonist collageninduc thromboembol rabbit bay rfluorophenylsulfonamidotetrahydro carbazolepropano acid potent inhibit platelet aggreg thromboxan ainduc contract smooth muscl coronari arteri thrombosi previous demonstr inhibit arachidon acidinduc sudden death bay purpos studi investig effect bay thromboembol provok collagen collagen fibril dissolv isoton glucos solut inject margin ear vein anesthet rabbit sudden death occur minut due elev thromboxan level caus intravascular platelet aggreg myocardi ischemia vehicletr group anim die promin paramet massiv fall blood pressur anim pretreat mgkg oral bay surviv show transient hypotens effect trace electrocardiogram heart rate unchang bay elucid role thromboxan cardiovascular respiratori diseas"
"aspirin reduc growth medial neointim thicken ballooninjur rat carotid arteri analyz effect aspirin growth experiment induc vascular thicken rat carotid arteri vascular thicken induc denud endothelium left carotid arteri balloon cathet administr aspirinrich food kg bodi wtday start week continu week injuri rat control group equal size receiv normal food size tunica media neointima open vessel lumen measur cross section carotid segment aid videomorphometri system result show aspirin group neointim lesion signific smaller control group mm versus mm thicken tunica media reduc mm versus mm suggest aspirin reduc medial hypertrophi neointim outgrowth injuryinduc atherosclerosi"
"effect naproxen sulindac blood pressur respons atenolol twenti patient mild moder essenti hypertens control atenolol enter week doubleblind placebocontrol trial effect sulindac naproxen blood pressur bp control atenolol administ week naproxen sulindac administ atenolol week crossov week data analyz patient drop develop skin rash naproxen signific increas systol bp compar placebo mm hg percent confid interv signific differ systol bp sulindac administr compar placebo naproxen signific effect diastol bp observ weight increas naproxen sulindac compar placebo kg clinic signific extent week therapi naproxen greater potenti sulindac increas systol bp control hypertens patient receiv atenolol increas minor clinic signific"
"highdos epinephrin improv outcom pediatr cardiac arrest studi object anim studi suggest standard dose epinephrin sde treatment cardiac arrest human low compar outcom sde highdos epinephrin hde children refractori cardiac arrest design prospect intervent versus histor control group type particip similar group consecut patient median age year wit cardiac arrest remain arrest sdes mgkg intervent treatment addit sde versus hde mgkg measur main result rate return spontan circul longterm surviv compar fourteen hde group return spontan circul sde group children surviv discharg hde neurolog intact follow signific toxic hde observ conclus hde provid higher return spontan circul rate longterm outcom sde seri pediatr cardiac arrest hde warrant incorpor standard resuscit protocol earli point prevent irrevers brain injuri"
"system atropin administr cardiac arrest fix dilat pupil object system administr atropin cpr postpon brain death determin reput abil produc fix dilat pupil studi effect atropin administ usual dose adjunct endotrach intub cardiac arrest determin interfer neurolog assess design group children studi group consist patient receiv atropin mgkg prior endotrach intub group consist patient previous evid brainstem diseas suffer wit arrest prompt return spontan circul receiv atropin dose mgkg result group pupillari size averag mm mm mm atropin group pupillari examin conduct minut return spontan circul pupillari diamet mm pupil reactiv light group conclus atropin administr convent dose slight pupillari dilat abolish pupillari light reactiv"
"echocardiograph left ventricular mass electrolyt intak predict arteri hypertens object identifi predictor arteri hypertens patient hundr thirti normotens adult larg employ popul method echocardiographi standard blood test hour urin collect baselin interv year year result follow subject men women systol blood pressur greater mm hg diastol blood pressur greater mm hg mm hg baselin subject develop hypertens greater left ventricular mass index compar bodi surfac area higher hour urinari sodiumpotassium excret ratio compar differ race initi age systol diastol blood pressur coronari risk factor plasma renin activ likelihood develop hypertens rose lowest quartil sexadjust left ventricular mass index highest quartil parallel trend regular quartil sodiumpotassium excret ratio multivari analys follow systol pressur subject remain normotens predict initi age systol blood pressur black race sexadjust left ventricular mass index final diastol blood pressur predict initi plasma triglycerid level urinari sodiumpotassium ratio low renin activ black race plasma glucos level conclus echocardiograph left ventricular mass normotens adult direct relat risk develop subsequ hypertens left ventricular mass improv predict futur systol pressur diastol pressur relat initi metabol status black race independ determin higher subsequ blood pressur"
"noninvas detect occlus diseas carotid siphon middl cerebr arteri recent transcrani doppler sonographi introduc clinic practic noninvas investig larg intracrani arteri determin accuraci detect stenos occlud lesion consecut patient studi transcrani doppler sonographi select cerebr arteriographi statist analysi find separ arteri segment high valu sensit specif found detect obstruct carotid siphon main stem middl cerebr arteri diagnost reliabl transcrani doppler sonographi confirm calcul chancecorrect measur agreement kappa close subanalys transcrani doppler sonographi valuabl tool noninvas detect intracrani lesion middl cerebr arteri carotid siphon"
"quinapril elder patient quinapril hydrochlorid nonsulfhydryl angiotensin convert enzym ace inhibitor extens test found effect administ day hypertens patient sex degre hypertens cardiac compromis includ left ventricular hypertrophi congest heart failur observ earlier ace inhibitor led report class drug ineffect older hypertens patient ascertain role quinapril greater equal mgday older patient blood pressurelow effect hypertens patient equal year age compar patient greater year age excel respons observ patient greater year age mild moder hypertens diastol bp mm hg moder sever hypertens diastol bp mm hg reduct blood pressur achiev quinapril compar obtain younger hypertens numer statist greater mild moder group mm hg mm hg addit percentag patient experienc advers experi lower greater group equal group main advers experi report includ dizzi headach cough fatigu hypotens find quinapril safe effect older hypertens younger patient"
"quinapril chronic heart failur angiotensin convert enzym inhibitor firm establish treatment patient chronic heart failur chf benefici acut chronic hemodynam effect reflex tachycardia drug toler angiotensin convert enzym inhibitor produc symptomat improv improv exercis capac grade heart failur improv prognosi patient sever heart failur quinapril recent introduc nonsulfhydryl ace inhibitor intermedi halflif make suit treatment patient chf acut chronic hemodynam effect quinapril similar ace inhibitor larg multicent random placebocontrol studi patient mild moder chf mgday quinapril signific improv clinic status exercis capac doserel manner incid side effect differ signific placebo initi studi quinapril promis warrant clinic investig compound"
"elev insulin norepinephrin neuropeptid hypertens investig relationship insulin sympathet activ plasma norepinephrin neuropeptid serum glucos insulin concentr measur ten age weight sexmatch normotens untreat hypertens subject fast ingest oral glucos dose hypertens higher fast serum insulin microuml plasma norepinephrin pgml concentr normotens glucos load increas serum insulin plasma norepinephrin concentr group hypertens higher postglucos insulin norepinephrin level normotens fast neuropeptid higher hypertens normotens correl age group postglucos serum insulin correl posit plasma norepinephrin normotens paramet correl negat hypertens hypothes elev plasma norepinephrin neuropeptid level reflect increas level sympathet nervous activ hypertens turn respons abnorm relationship plasma ne insulin level"
"dietari calcium vascular reactiv genet hypertens lyon rat strain order examin relationship exist dietari calcium develop hypertens develop longterm studi lyon hypertens rat strain lh control strain lyon normotens ln low blood pressur rat ll enrich hca depriv lca normal nca calcium diet evolut bodi weight systol blood pressur bp plasma calcium magnesium monitor week age total cardiovascular reactiv contractil respons isol aorta norepinephrin measur week age lh rat hca diet fail develop hypertens bp mm hg lh rat lca diet exhibit higher blood pressur level control fed nca diet ln rat hca diet slight decreas bp lca effect ll rat contrari lca diet slight increas bp vivo respons ne signific higher lh compar ll ln rat fed nca diet hca lca diet induc signific decreas respons lh rat hca diet increas respons ln rat decreas ll contrast age vitro contractil respons isol aorta ne signific decreas lh compar ln ll rat receiv nca diet lh ln rat hca diet contractil respons mark increas signific differ observ lca diet"
"sodium sensit sodium retain hypertens differ sodium sensit sodium retain hypertens theoret consid water tank model bodi fluid volumeblood pressur regul outlet valv attach tank base area reciproc total peripher resist tpr water pour tank rate amount na intak equilibrium achiev water level volum output outlet repres arteri pressur map cardiac output urinari na excret height outlet tank bottom size crosssect area outlet correspond intercept slope renal function pressurenatriuresi curv nonsodium sensit hypertens due shift curv higher blood pressur level elev height outlet chang slope size outlet sodium sensit hypertens due depress slope curv reduc outlet size map water level water volum increas result sodium retain hypertens tpr reciproc base area remain unchang unchang result nonsodium retain hypertens tpr elev map sensit sodium intak determin renal function curv bodi fluid volum determin renal function curv tpr tpr develop hypertens major factor determin bodi fluid volum chang small amount larg amount sodium sensit blood pressur sodium retent consid separ"
"hemodynam endocrin effect mental stress untreat borderlin hypertens mental arithmet mirror trace compar untreat patient borderlin hypertens test random sequenc standard protocol task signific increas systol diastol blood pressur heart rate cardiac index plasma renin decreas peripher resist mental arithmet increas cholesterol triglycerid hdl plasma catecholamin chang signific lipid correl blood pressur method explor relationship hemodynam reactiv stress presenc progress atherosclerosi test effect antihypertens drug stressinduc influenc atherosclerot complic hypertens"
"role protein kinas calcium regul norepinephrin releas vascular adrenerg neuron hypertens studi design investig role protein kinas calcium vascular adrenerg transmiss hypertens perfus mesenter vasculatur spontan hypertens rat shr week agematch wistarkyoto rat wki examin effect protein kinas inhibitor endogen norepinephrin releas vascular respons nerv stimul endogen norepinephrin releas pressor respons periarteri nerv stimul signific greater shr wki protein kinas inhibitor inhibit stimulationinduc norepinephrin releas pressor respons dosedepend manner magnitud suppress respons pronounc shr wki calcium remov extracellular fluid reduc norepinephrin releas strong shr wki result demonstr regul norepinephrin releas depend protein kinas calcium blood vessel shr contribut partial pathogenesi form hypertens"
"vascular renin hypertens uptak versus synthesi convent radioimmunoassay techniqu demonstr aortic wall renin activ deriv plasma longer halflif plasma renin blood pressur elev renin inject nephrectom rat correl aortic renin plasma renin vascular extraren tissu synthes renin ribonucleas protect techniqu detect renin messeng rna demonstr wide varieti extraren tissu renin messag brain liver renin messeng rna level unaffect dietari salt system blood pressur function studi isol human resist vessel demonstr presenc renin activ contractil respons ad renin substrat suggest extraren tissu renin activ deriv uptak local synthesi system regul carri function"
"role basic fibroblast growth factor vascular lesion format present studi investig basic fibroblast growth factor bfgf play role prolif respons smooth muscl cell smcs denud injuri rat carotid smooth muscl found express mrna bfgf bfgf protein found present rat aorta immunoblot analysi system administ bfgf potent mitogen vascular smcs arteri denud balloon cathet increas replic control denud devic filament loop minim damag medial smcs show similar increas replic versus bfgf infus unmanipul vessel smcs unrespons infus bfgf infus mitotoxin bfgf conjug saporin caus greater decreas number viabl smcs arteri wall balloon injuri prolong administr bfgf microgramsday week balloon injuri caus approxim twofold increas intim thicken result show bfgf synthes arteri wall potent mitogen smcs vivo suggest releas endogen bfgf capabl stimul smc prolifer subsequ lead intim lesion format"
"myocardi capillari permeabl region ischemia reperfus vivo canin heart effect superoxid dismutas studi assess effect superoxid anion scaveng superoxid dismutas myocardi capillari permeabilitysurfac area ps product small hydrophil molecul ischemia reperfus openchest dog underw minut occlus left anterior descend coronari arteri hour reperfus myocardi plasma flow rate capillari extract chromium label edta technetium mlabel diethylenetriaminepentaacet acid measur singleinject residuedetect method ischemia minut start reperfus dog scaveng treatment nonprotect control group dog treat system unitskg superoxid dismutas hour start minut ischemia control group dog develop reperfus ventricular fibril contrast superoxid dismutas group ischemia plasma flow rate myocardi capillari extract fraction ps valu similar group minut start reperfus plasma flow rate increas signific group control group capillari extract fraction increas ns spite higher plasma flow increas capillari extract fraction plasma flow induc increas ps superoxid dismutasetr group capillari extract fraction decreas accord increas plasma flow rate result unchang ps ns sixti minut reperfus plasma flow rate capillari extract fraction ps return preocclus valu group ns increas capillari extract fraction ps valu control group suggest increas capillari permeabl ischemia reperfus superoxid anion particip direct indirect respons"
"mechan earli ischem contractil failur inexcit metabolit accumul vascular collaps basi earli ischem contractil failur investig perfus ferret heart degre isovolum left ventricular develop pressur fell onset total global ischemia reach minut monophas action potenti record reveal decreas excit period phosphorus nuclear magnet reson spectra obtain resolut show signific inorgan phosphat phosphocreatin ischemia intracellular ph phi atp chang slowli metabolit account rapid fall forc gaug contribut intravascular pressur compar ordinari aortic flow occlus tissuelevel ischemia induc massiv coronari microembol level precapillari arteriol function depress develop signific slowli microembol heart accumul inorgan phosphat proton compar ordinari ischemia microembol time function depress reflect close concomit inorgan phosphat phi result provid evid support import vascular collaps mechan earli ischem contractil failur"
"signific number stimuli initi ouabaininduc arrhythmia intact heart ouabaininduc arrhythmia model studi trigger activ result delay afterdepolar intact heart initi arrhythmia promot pace fast rate relev number stimuli unknown conscious dog formalininduc atrioventricular block investig effect variat pace mode behavior nonsustain trigger rhythm progress level ouabain intox induct sustain ventricular tachycardia vt twenti experi analyz ouabain administ bolus microgramskg continu infus minut pace protocol repeat maximum complet induct vt vt initi experi repeat week ad microgramskg ouabain bolus increas infus rate correspond repeat vt induc interstimulus interv msec number stimuli pace protocol effect protocol number induc beat stimul train postpac interv induct vt studi initi vt occur minut bolus ouabain induc vt invers relat bodi weight anim progress ouabain intox result signific increas number induc beat stimul train signific shorten postpac interv stimul faster rate stimuli result signific pronounc increas number induc beat higher level signific shorter postpac interv success level ouabain intox"
"ca transient cardiomyopath hamster heart intracellular ca transient studi isol heart healthi cardiomyopath hamster late failur perfus glucos pyruv heart healthi hamster develop similar pressur perfus glucos pyruv ca transient compar amplitud perfus substrat hand heart cardiomyopath hamster late failur develop normal pressur perfus pyruv develop depress pressur perfus glucos amplitud ca transient fell sever high diastol ca cardiomyopath hamster heart perfus switch pyruv glucos high phosphomonoest sugar evidenc nuclear magnet reson studi depress oxygen consumpt cardiomyopath hamster heart perfus glucos reflect inhibit glycolysi subsequ decreas mitochondri activ adequ deliveri substrat mitochondria cardiomyopath hamster myocardium longer capabl maintain ca homeostasi"
"effect precondit ischemia reperfus arrhythmia coronari arteri occlus reperfus rat sever arrhythmia occur predict reperfus minut coronari occlus rat data ischem precondit pc heart reduc incid arrhythmia effect pc cycl minut coronari occlus minut reperfus develop arrhythmia subsequ minut coronari arteri occlus reperfus studi rat group underw minut occlus reperfus preced pc arrhythmia monitor ischemia minut reperfus biopsi creatin phosphat adenosin triphosph ischem nonischem zone left ventricl pc reduc incid ventricular tachycardia vt occlus control versus pc subsequ reperfus ventricular fibril vf develop pc anim versus control irrevers vf pc versus control vt occur pc versus control pc reduc durat vt vf delay arrhythmia onset reperfus differ creatin phosphat level ischem zone end reperfus pc anim compar control irrevers vf versus nmolmg protein ns"
"passiv smoke heart diseas epidemiolog physiolog biochemistri evid increas risk death heart diseas similar exist surgeon general conclud caus lung cancer healthi nonsmok epidemiolog studi conduct varieti locat reflect increas risk death ischem heart diseas myocardi infarct nonsmok live smoker larger studi demonstr signific doserespons effect greater exposur greater risk death heart diseas epidemiolog studi complement varieti physiolog biochem data show advers affect platelet function damag arteri endothelium increas risk heart diseas realist exposur exert signific advers effect exercis capabl healthi peopl heart diseas reduc bodi abil deliv util oxygen anim experi depress cellular respir level mitochondria polycycl aromat hydrocarbon acceler initi develop atherosclerot plaqu note cardiovascular effect nonsmok smoker nonsmok sensit smoker affect physiolog system sensit low dose compound satur physiolog adapt smoker undergo result longterm exposur toxin cigarett smoke event find cardiovascular diseas incorrect comput cigarett equival passiv exposur extrapol effect exposur nonsmok effect direct smoke smoker result suggest heart diseas import consequ exposur combin epidemiolog studi demonstr physiolog exposur biochem evid element signific advers effect cardiovascular system lead conclus heart diseas increas risk translat time death etsinduc heart diseas lung cancer death contribut great estim death annual passiv smoke toll make passiv smoke lead prevent death unit state today activ smoke alcohol"
"multicent patenc trial intraven anistreplas compar streptokinas acut myocardi infarct team studi investig thrombolyt therapi shown improv clinic outcom administ earli onset symptom acut myocardi infarct mechan benefit believ reestablish mainten coronari arteri patenc anistreplas generat thrombolyt agent easili administ long durat action compar anistreplas unit min therapi food drug administrationapprov regimen intraven streptokinas million unit min random doubleblind multicent patenc trial undertaken patient year age electrocardiograph st segment elev treat hour symptom onset coronari patenc determin read blind fashion angiogram obtain earli minut minut hour hour begin therapi earli total patenc defin thrombolysi myocardi infarct grade perfus high anistreplas streptokinas therapi patenc pattern similar patent arteri show complet grade perfus anistreplas streptokinas similar residu coronari stenosi determin quantit valid computerassist method slight patent arteri earli anistreplas stenosi diamet streptokinas patient patent arteri earli intervent reocclus risk day defin angiograph found low anistreplas streptokinas averag coronari perfus grade greater percent residu stenosi follow initi evalu differ treatment group enzymat electrocardiograph evolut signific group rapid inject anistreplas small mm hg transient minut differenti fall blood pressur hospit mortal rate compar anistreplas streptokinas stroke occur patient stroke hemorrhag bleed event advers experi occur uncommon similar frequenc group end point studi patenc safeti anistreplas streptokinas show favor compar outcom differencesabstract truncat word"
"detect patient risk paroxysm atrial fibril sinus rhythm wavetrigg signalaverag electrocardiogram determin patient risk paroxysm atrial fibril detect sinus rhythm signalaverag electrocardiogram trigger wave record patient paroxysm atrial fibril paf group control patient root squar voltag lp lp lp msec durat ad filter hz wave spatial magnitud measur lp lp signific lower paf control group lp versus microv lp versus microv signific differ lp found group ad signific longer paf control group versus msec differ paf control group remain signific divid presenc absenc organ heart diseas criteria lp microv ad greater msec defin atrial late potenti gave sensit specif find suggest patient risk paroxysm atrial fibril detect sinus rhythm wavetrigg signalaverag electrocardiogram"
"vivo technetiumm antibodi imag platelet alphagranul rabbit endotheli neointim prolifer angioplasti examin specif technetiumm monoclon antibodi imag identifi activ platelet intervent injuri site atherosclerot rabbit arteri subgroup unheparin rabbit underw serial percutan translumin aortic angioplasti pta procedur intravascular stent placement vivo vivo gamma camera imag scan immunoelectron microscopi determin intravascular loci fab antibodi bind angiograph vessel patenc imagederiv ratio vivo bind injur versus uninjur vascular segment signific increas pta pta week interv pta stent placement compar control experi vivo imag bloodfre excis aorta confirm local pta pta stent placement site versus control antibodi uptak decreas signific week pta stent placement vivo vivo electron microscop studi confirm dens platelet fibrin red blood cell deposit region acut injuri endotheli neointim prolifer week pta immunoelectron microscop studi confirm specif vivo bind versus nonrelev igg site alphagranul gmp express activ platelet studi local site plateletderiv mitogen releas arteri pta injuri site"
"reduct myocardi reperfus injuri intraven adenosin administ earli reperfus period adenosin influenc function cell type thought involv pathogenesi myocardi reperfus injuri previous demonstr intracoronari administr adenosin enhanc myocardi salvag hour reperfus determin benefici effect obtain prolong period reperfus intraven rout administr closedchest dog subject minut proxim left anterior descend coronari arteri occlus hour reperfus anim random receiv intraven adenosin mgkgmin equal volum ringer lactat minut reperfus area risk defin vivo monastr blue infarct size measur histolog mallori trichrom stain serial global region ventricular function determin contrast ventriculographi analyz computer radial shorten method biopsi obtain central ischem zone assess endotheli ultrastructur capillari obstruct signific effect heart rate blood pressur note adenosin infus transmur collater blood flow ischemia similar group infarct size express percentag anatom area risk signific adenosinetr group control versus treat anim progress decreas transmur blood flow note control anim reperfus result signific reduct hour compar preocclus mlmin baselin versus mlmin hour contrast flow adenosin anim hour similar baselin valu mlmin baselin versus mlmin hour ns signific higher control group radial shorten ischem zone signific improv control versus treat anim hour control versus treat anim reperfus treat anim electron microscopi show reduc neutrophil erythrocyt plug capillari relat preserv endotheli cell structur adenosin groupabstract truncat word"
"identif viabl myocardium patient chronic coronari arteri diseas left ventricular dysfunct comparison thallium scintigraphi reinject pet imag ffluorodeoxyglucos patient chronic coronari arteri diseas left ventricular dysfunct distinct ventricular dysfunct aris myocardi fibrosi ischem viabl myocardium import clinic implic positron emiss tomographi pet enhanc fluorinelabel fluorodeoxyglucos fdg uptak myocardi segment impair function reduc blood flow evid myocardi viabil reinject thallium rest immedi stressredistribut imag provid evid myocardi viabil demonstr thallium uptak region appar irrevers defect compar method studi patient chronic coronari arteri diseas left ventricular dysfunct eject fraction irrevers defect standard exerciseredistribut thallium singlephoton emiss comput tomographi spect imag thallium reinject immedi redistribut studi spect imag reacquir patient underw pet imag fdg oxygenlabel water total myocardi segment analyz compar transaxi tomogram irrevers thallium defect redistribut imag reinject fdg uptak demonstr irrevers defect irrevers defect subgroup degre thallium activ relat peak activ normal region irrevers defect mild peak activ moder peak reduct thallium activ consid viabl basi fdg uptak segment contrast irrevers defect sever reduct thallium activ peak fdg uptak present segment sever defect ident number segment demonstr enhanc uptak thallium reinject sever irrevers defect data myocardi viabil concord techniqu segment identifi viabl identifi scar pet thallium reinject studi observ suggest thallium imag identifi viabl myocardium patient chronic coronari arteri diseas left ventricular dysfunct irrevers defect mild moder reduct thallium activ repres viabl myocardium confirm fdg uptakeabstract truncat word"
"analysi baroreflex control heart rate conscious dog pacinginduc heart failur autonom compon baroreflex control heart rate evalu conscious mongrel dog week ventricular pace beatsmin arteri baroreflex sensit brs determin slope linear regress puls interv versus preced systol arteri pressur respons bolus inject phenylephrin nitroglycerin brs signific depress heart failur state nitroglycerin slope sd versus msecmm hg phenylephrin slope versus msecmm hg depress brs dog time control acut pace minut beta adrenerg blockad metoprolol rest heart rate heart failur state depress normal state versus atropin signific increas rest heart rate normal state heart failur state versus dog heart failur state high rest cardiac sympathet tone low rest vagal tone nitroglycerin administr metoprolol depress brs normal state heart failur state atropin decreas brs normal state heart failur state"
"reentrant ventricular arrhythmia late myocardi infarct period mechan shortlongshort cardiac sequenc facilit induct reentri electrophysiolog mechan shortlongshort stimul cardiac sequenc facilit induct ventricular tachyarrhythmia investig dog day ligat left anterior descend coronari arteri dog reentri develop surviv electrophysiolog abnorm epicardi layer infarct zone prematur stimul result critic long arc function conduct block activ wavefront circul end arc coalesc conduct slowli distal arc reactiv site proxim arc initi figur reentrant circuit epicardi isochron activ map effect refractori period erp determin stimul protocol basic train beat cycl length msec singl prematur stimulus basic train beat cycl length msec abrupt lengthen cycl train msec basic train beat cycl length msec protocol found result differenti lengthen erp adjac site border epicardi ischem zone protocol induc compar shorten lengthen erp site differenti lengthen erp adjac site result increas dispers refractori prematur stimulus induc function conduct block site develop longer arc conduct block longer reentrant pathway slower conduct circul wavefront protocol time refractori expir proxim arc circul wavefront reexcit site initi reentri lengthen erp singl long cycl protocol rang total increas erp seri long cycl protocol epicardi site longer erp locat close center ischem zone show lengthen refractori protocol compar normal site border ischem zone strong suggest increas dispers refractori protocol caus shorter memori ischem myocardium cumul effect preced cycl length"
"ischem heart diseas platelet aggreg caerphilli collabor heart diseas studi caerphilli collabor heart diseas studi base larg cohort men age year time studi platelet aggreg induc collagen thrombin adp measur fast blood sampl relat preval angina past myocardi infarct electrocardiograph evid ischem heart diseas number subject aspirin nonsteroid antiinflammatori drug drug affect platelet aggreg day blood sampl collect exclus subject data men relat demonstr angina signific relat shown past myocardi infarct electrocardiograph evid ischemia adpinduc aggreg primari secondari electrocardiograph evid ischemia thrombininduc aggreg strongest relat twofold increas odd past myocardi infarct subject highest adpinduc primari platelet aggreg compar lowest signific relat detect collageninduc aggreg account number confound factor small impact relat platelet aggreg ischem heart diseas evid includ establish effect aspirin reduc incid ischem heart diseas relat describ simpli effect ihd platelet"
"myocardi infarct mexicanamerican hispan white san antonio heart studi mexicanamerican men experi reduc cardiovascular mortal compar hispan white men ethnic differ cardiovascular mortal women differ men result lower incid cardiovascular diseas lower case fatal rate mexicanamerican incid cardiovascular diseas mexicanamerican unknown collect data preval myocardi infarct individu examin san antonio heart studi populationbas survey cardiovascular diseas conduct mexicanamerican hispan white age year myocardi infarct assess minnesotacod electrocardiogram report histori physiciandiagnos heart attack end point ageadjust preval myocardi infarct lower mexicanamerican men hispan white men adjust age diabet status presentabs odd myocardi infarct defin criterion approxim lower mexicanamerican men hispan white men women preval myocardi infarct end point slight higher mexicanamerican hispan white differ signific ethnic differ preval studi statist signific pattern parallel pattern mortal due cardiovascular diseas result support hypothesi reduc cardiovascular mortal rate observ mexicanamerican men reflect lower incid myocardi infarct reduc case fatal rate result higher preval"
"diltiazem increas lateonset congest heart failur postinfarct patient earli reduct eject fraction advers experi committe multicent diltiazem postinfarct research group multicent diltiazem postinfarct trial mdpit report consist diltiazem effect worsen congest heart failur chf month follow acut myocardi infarct puzzl light observ patient find suggest left ventricular dysfunct lvd baselin diltiazem cardiac event cardiac mortal recurr nonfat infarct patient placebo hypothes diltiazem increas frequenc late chf cardiac event patient predispos lvd character variabl primari mdpit analysi found patient pulmonari congest anterolater wave infarct reduc eject fraction ef baselin chf follow marker lvd chf frequent patient lvd random diltiazem baselin ef late chf receiv placebo receiv diltiazem life tabl analysi patient ef confirm frequent late chf diltiazem addit diltiazem rise frequenc late chf progress greater increas sever decrement baselin ef diltiazem effect absent patient pulmonari congest baselin ef suggest uniqu associ diltiazemrel late chf systol lvd"
"transesophag doppler echocardiographi evalu coronari blood flow veloc baselin condit dipyridamoleinduc coronari vasodil transesophag echocardiographi evalu proxim coronari arteri anatomi coronari blood flow veloc cbfv assess potenti transesophag echocardiographi evalu cbfv variat induc coronaryact drug studi patient highqual puls wave doppler record cbfv patient transesophag doppler evalu cbfv perform minut cessat dipyridamol infus mgkg minut minut aminophyllin infus mg inject minut cessat dipyridamol infus cbfv paramet evalu step studi protocol maxim diastol veloc maxim systol veloc index coronari flow reserv evalu ratio maxim diastol veloc record dipyridamol administr ratio diastol veloc record dipyridamol administr patient normal left anterior descend coronari arteri group remain signific equal stenosi group group patient cbfv paramet increas signific dipyridamol infus return baselin valu aminophyllin infus group patient hand cbfv paramet increas dipyridamol infus dipyridamolebaselin maxim diastol veloc diastol veloc ratio group versus group versus group group patient"
"regurgit jet size transesophag compar transthorac doppler color flow imag combin echocardiographi doppler color flow map transthorac imag window standard method noninvas assess valvular regurgit studi compar regurgit jet area doppler color flow imag deriv newer transesophag approach measur obtain convent transthorac apic view maxim regurgit jet area determin visual estim lesion sever obtain patient underw color flow examin techniqu seventi regurgit lesion visual transesophag flow imag mitral aortic tricuspid jet transthorac studi patient reveal fewer regurgit lesion valv mitral aortic tricuspid comparison maxim jet area determin transesophag transthorac studi show good correl cm systemat overestim transesophag techniqu tee ttx subgroup mitral insuffici valv lesion visual techniqu larger transesophag approach versus cm semiquantit visual grade individu valv lesion independ observ reveal higher grade regurgit jet classifi mild versus moder versus sever versus esophag imag transthorac imag transesophag color flow map techniqu yield higher preval valvular regurgit transthorac techniqu patient jet area estim regurgit lesion sever greater transesophag color doppler imag compar standard transthorac imag"
"elev pulmonari arteri pressur independ predictor mortal analys studi base hemodynam angiograph data obtain cohort predomin black patient left heart catheter patient prospect week fatal event record cox surviv analysi variabl found independ relat surviv pulmonari arteri pressur pamp number stenos vessel left ventricular lv eject fraction multivari stepwis analysi pamp enter model largest chi prognost variabl chi pamp percent higher deced compar survivor mm hg mm hg sd mm hg increas pamp fourfold increas relat risk die find independ pulmonari vascular resist attribut primari pulmonari vascular parenchym diseas subgroup patient normal lv eject fraction greater percent patient reduc eject fraction percent pamp emerg independ predictor mortal marker cardiac diseas impair systol contractil function patient obstruct coronari arteri diseas pamp provid prognost inform multivari surviv analysi"
"renal vein thrombosi initi manifest goodpastur syndrom report patient present renal vein thrombosi nephrosi progress alveolar hemorrhag renal failur renal biopsi immunofluoresc serum antiglomerular basement membran antibodi titer studi confirm diagnosi goodpastur syndrom knowledg report renal vein thrombosi initi present goodpastur syndrom"
"safeti efficaci thrombolyt therapi superior vena cava syndrom experi cleveland clinic thrombolyt therapi superior vena cava svc syndrom retrospect review sixteen patient indwel central venous cathet treat urokinas streptokinas urokinas kg bolus kg streptokinas bolus venogram perform percent patient complet clot lysi relief symptom thrombolyt therapi effect percent patient receiv urokinas percent patient receiv streptokinas central venous cathet percent patient success lyse percent patient success lyse cathet present thrombolyt therapi perform equal day symptom onset percent patient success thrombolyt therapi perform greater day symptom onset percent patient success symptom reliev cathet preserv patient thrombolyt therapi effect factor predict success urokinas compar streptokinas presenc central venous cathet durat symptom equal day"
"risk factor gestat diabet black popul longterm longitudin studi gestat diabet mellitus black women risk factor identifi age obes famili histori diabet presenc hypertens poor predictor histori previous larged infant pariti age pregnanc preval smooth muscl nuclear autoantibodi higher gestat diabet subject gestat diabet subject requir insulin glycem control obes lower frequenc bf phenotyp higher frequenc bff phenotyp lower frequenc type allel polymorph locus adjac insulin gene restrictionfragmentlength polymorph flank insulin apolipoprotein iii gene gestat diabet mellitus hyperlipidemia subsequ atherosclerosi"
"calcium channel blocker geriatr hypertens calcium channel blocker treat angina pectori decad longact form agent year made practic antihypertens agent increas popular role treat elder hypertens patient vasodil mild diuret action logic treatment choic major hypertens patient increas peripher vascular resist offer advantag dual benefit hypertens patient angina effect carbohydr lipid metabol disadvantag includ cost side effect profil includ headach palpit ankl edema constip"
"congest heart failur current overview congest heart failur chf diseas primarili older patient due systol diastol dysfunct manag heart failur due fill abnorm compar poor ventricular systol disord pose diagnost pitfal elder current understand chf influenc diagnosi manag focus review"
"train increas muscl blood flow rat peripher arteri insuffici studi investig effect physic train muscl blood flow bf rat peripher arteri insuffici treadmil run bilater stenosi femor arteri adult rat perform reduc exercis hyperemia hindlimb limit rest muscl bf rat divid normal sedentari acut stenos stenos day experi stenos sedentari limit cage activ stenos train run treadmil progress intens program minday dayswk wk hindlimb bf determin sr celabel microspher low min high treadmil speed min depend abil maxim hindlimb bf reduc approxim normal acut stenos group total hindlimb bf mlmin chang stenos sedentari anim wk cage activ redistribut bf occur hindlimb factor contribut higher bf distal limb muscl train anim redistribut bf hindlimb occur stenos train anim distal limb bf increas approxim proxim tissu addit increas total hindlimb bf train collater bf enhanc increas oxygen deliveri ischem muscl contribut mark improv exercis toler evid train anim"
"paradox embol underestim entiti plea comprehens work forti case arteri embol review work includ echocardiographi patient arteriographi echocardiographi arteriographi abdomin aortic ultrasound sourc emboli probabl cardiac mural cardiac thrombus detect echocardiogram cardiac arrhythmia cardiac patholog detect mural thrombus probabl arterioarteri proxim arteri thrombus detect probabl paradox embol fulfil johnson criteria cardiac defect left shunt detect contrast echo patient cardiac catheter paradox embol meet johnson criteria evid sourc unknown sourc convent work negat incomplet patient year probabl paradox embol patient origin unknown conclus signific proport patient arteri embolus discharg sourc emboli unknown paradox embol consid contrast salin transesophag echocardiogram patient year"
"splenoren arteri shunt treatment renovascular hypertens approach lumbarretroperiton incis period year consecut patient oper splenoren arteri shunt lumbotomi incis retroperiton approach male femal medium age year case uncontrol sever hypertens averag medium time month patient variabl degre renal insuffici diagnosi made util standard method includ case angiographi abdomin aorta celiac axi renal arteri patient die oper due intestin infarct remain medium time month patient improv cure renal insuffici hypertens cure improv fail patient success autotranspl precis exposit surgic techniqu present comment advantag indic review literatur surgic experi techniqu splenoren arteri anastomosi"
"clinic result femoropoplit bypass extern support dacron graft comparison knee anastomosi end septemb dacron graft implant femoropoplit bypass oper distal end graft anastomos knee poplit arteri graft knee poplit arteri cumul patenc rate knee graft month knee graft month kink stenosi arteriosclerot proxim mid poplit arteri knee bent angiograph remark explain femoropoplit graft occlud time late result knee graft knee graft"
"crural arteri bypass adjunct arterioven fistula modif distal anastomosi carri crural arteri bypass adjunct arterioven fistula lower extrem patient sever ischem symptom poor distal run blood flow rate implant graft rang mlmin reconstruct crural arteri mlmin stenot lesion note postop angiogram patient stasi symptom caus downward blood flow distal vein patient remain good function graft year surgeri modifi distal corner anastomosi addit interrupt simpl sutur made anterior wall concomit arteriotomi venotomi incis make common posterior wall vessel incis vascular pocket form distal corner anastomosi prevent strictur anastomosi vein final ligat distal fistula intercept downward blood flow distal vein modif techniqu recommend prevent strictur distal anastomosi postop stasi symptom"
"preoper evalu surgic treatment tricuspid regurgit acquir valvular heart diseas kayboyd method carpentieredward ring method studi compar result annuloplast repair tricuspid regurgit tr doppler echocardiographi sixti patient underw tricuspid annuloplasti studi thirti patient receiv kayboyd annuloplasti carpentieredward ring annuloplasti classif tr base direct area regurgit flow doppler echocardiogram appli preoper kayboyd group case show massiv tr case show local tr preoper local tr control case case massiv tr show grade iii residu tr group case show massiv tr case show local tr case control postop conclud kayboyd method accept local tr method employ massiv tr analyz regurgit pattern tr doppler echocardiogram select surgic techniqu"
"quantit method evalu tricuspid regurgit quantit method evalu regurgit tr propos order select suitabl treatment function tr acquir valvular heart diseas regurgit volum beat vtr calcul dimension color doppler continuouswav doppler echocardiographi studi patient preoper vtr show signific correl tricuspid annular diamet enddiastol atrial pressur ventricular enddiastol pressur patient classifi group preoper vtr group vtr cc group ii vtr cc group iii vtr greater equal cc  classif correl intraop find tr group patient vtr decreas tricuspid valv repair group ii patient underw tricuspid annuloplasti show decreas vtr cc surgeri group iii underw tricuspid annuloplasti tricuspid valv replac tricuspid annuloplasti show signific degre postop vtr cc patient tricuspid valv replac show preoper peakpeak pressur differ tricuspid valv eject phase rvsptav equal mmhg tricuspid annular diamet enddiastol greater equal mm conclus tricuspid valv repair requir group tr group ii tr ii patient tricuspid annuloplasti adequ tr correct group ii tr iii patient substanti procedur tricuspid valv replac perform preoper rvsprav equal mmhg tricuspid annular diamet enddiastol greater equal mm"
"surgic indic aortic arch hypoplasia infant determin surgic indic aortic arch hypoplasia distal arch outer diamet distal arch index ratio distal arch diamet normal aortic ring diamet postop pressur gradient aortic arch studi patient month age underw surgeri coarctat aortic arch hypoplasia ratio pressur gradient arch radial arteri evalu postop level stenosi maximum ratio pressur gradient toler surgeri consid oper result negat correl found distal arch outer diamet postop pressur gradient ratio distal arch index postop pressur gradient ratio correl prove order obtain postop pressur gradient ratio distal arch outer diamet mm distal arch index distal arch outer diamet mm distal arch index consid aortic arch hypoplasia repair"
"annuloaort ectasia debakey type ii dissect aneurysm gaucher diseas annuloaort ectasia extrem rare complic gaucher diseas report success surgeri patient gaucher diseas complic annuloaort ectasia aortic dissect cabrol oper accomplish bleed sternal adapt problem"
"repair coarctat persist arteri arch atresia fourth aortic arch coarctat aorta persist arteri arch atresia fourth aortic arch left common carotid left subclavian arteri treat surgic month boy transposit great arteri doubleoutlet ventricl aortic arch repair sidesid anastomosi left common carotid left subclavian arteri patch repair coarctat segment origin left subclavian arteri ligat patent ductus arteriosus pulmonari arteri band balloon atrioseptostomi perform anomali"
"ptfe graft correct anomal drainag persist left superior vena cava techniqu correct persist left superior vena cava lsvc drainag left atrium year patient situs inversus left atrial isomer common atrium mitral valv regurgit surgeri occlus lsvc mark increas venous pressur preclud ligat malposit heart unusu atrial anatomi correct intraatri baffl attempt correct intracardiac anomali lsvc divid anastomos atrial appendag segment ptfe graft postop unev angiogram demonstr excel perform graft"
"rapid express heat shock protein rabbit cardiac ischemia effect myocardi ischemia express heat shock protein hsp examin vivo rabbit model myocardi ischemia northern blot function studi carri openchest anesthet rabbit larg margin branch left circumflex occlud time min piezoelectr crystal implant midwal ischem zone enddiastol length endsystol length percent segment shorten assess express hsp measur northern blot singl min coronari occlus doubl express hsp cycl min ischemia min reperfus result threefold increas hsp mrna measur piezoelectr crystal show mild myocardi dysfunct concomit increas hsp increas hsp mrna repetit ischemia transient occur earli return baselin ischemia western blot analysi monoclon antibodi hsp compar sham postischem myocardi hsp level amount hsp evid earli strike"
"payment mechan pattern medic servic hypertens studi explor relationship medic servic hypertens patient mechan payment singl primari care practic payment mechan explor public assist capit health mainten organ hmo feeservic pattern examin reimburs type variabl age sex visit reason number visit medic test order referr made recommend follow visit ill sever control studi focus diagnosismild moder hypertens concurr chronic ill enumer includ analysi medic visit physician examin year period patient random sampl payment mechan statist signific differ found patient behavior total number patient visit physician behavior number medic recommend revisit highest visit frequenc found public assist close cover hmo distant choos feeservic climat cost conscious studi explor impact reimburs mechan health care servic"
"associ postdexamethason cortisol level blood pressur depress inpati examin clinic data depress inpati complet dexamethason suppress test dst determin elev postdst serum cortisol level exhibit classic physiolog stigmata cush syndrom hypertens signific frequent dst nonsuppressor normal suppressor percent blood lymphocyt count signific lower nonsuppressor confound gender age bodi weight antihypertens account find implic morbid mortal rate patient affect disord discuss"
"free peptidebound amino acid indic ischem damag rabbit spinal cord concentr free peptidebound amino acid aspart asp glutam glu glycin gli gammaaminobutyr acid gaba studi ischemia recircul ventral dorsal gray matter rabbit spinal cord concentr amino acid ten minut min ischemia day recoveri found signific chang min min ischemia decreas free asp gaba level part gray matter greater decreas concentr free amino acid ventral horn correspond greater morpholog damag part spinal cord ischemia min ischemia recircul decreas peptidebound glu ventral horn asp glu dorsal horn found"
"select vasopressin inhibit rat heart failur decreas afterload result venodilat hemodynam effect select inhibit arginin vasopressin avp antagonist chyreavpa cla studi normal rat rat week coronari arteri ligat larg myocardi infarct elev left ventricular enddiastol pressur normal rat avp inhibit microgramskg bolus avp antagonist chang heart rate atrial left ventricular systol left ventricular enddiastol aortic pressur circulatori fill pressur unstress vascular volum blood volum venous complianc rat infarct elev left ventricular enddiastol pressur avp inhibit chang heart rate atrial pressur circulatori fill pressur blood volum aortic pressur decreas mm hg venous complianc increas mlmm hgkg unstress vascular volum decreas mlkg conclud inhibit avp specif antagonist effect venous arteri circul normal rat rat left ventricular dysfunct heart failur chronic myocardi infarct avp inhibit decreas arteri pressur caus venodilat"
"pharmacolog activ bepaf web select hetrazepino antagonist platelet activ factor hetrazepin web intern nonproprietari bepaf thienotriazolodiazepin structur relat recent platelet activ factor paf antagonist web potent select paf antagonist vitro vivo web inhibit pafinduc human platelet neutrophil aggreg vitro ic valu microm inhibitori action aggreg induc agonist potenc vitro compar recent web casalsstenzel muacev weber pharmacol exp ther  guinea pig infus paf ng kg min oral mgkg intraven mgkg treatment web abrog intrathorac accumul inlabel platelet bronchoconstrict hypotens final occur death dosedepend fashion oral mgkg intraven mgkg web share beta agonist fenoterol steroid dexamethason properti protect elder nmri mice lethal effect paf anesthet rat intraven mgkg oral mgkg web inhibit pafinduc hypotens doserel manner coadministr web inhibit pafinduc increas vascular permeabl rat skin effect halftim durat action rat estim oral administr intraven applic conclus hetrazepin web strong select paf antagonist vitro equipot web contrast vivo oral web depend speci consid paramet time potent exogen pafinduc alter recent hetrazepin web mice rat oral web superior web"
"risk angina pectori plasma concentr vitamin caroten relat risk angina pectori plasma concentr vitamin caroten examin popul casecontrol studi case angina identifi chest pain questionnair control select sampl men age plasma concentr vitamin caroten signific invers relat risk angina signific relat vitamin smoke confound factor invers relat angina low plasma caroten disappear plasma vitamin substanti reduc adjust smoke vitamin remain independ invers relat risk angina adjust age smoke habit blood pressur lipid relat weight adjust odd ratio angina lowest highest quintil vitamin concentr confid interv find suggest popul high incid coronari heart diseas benefit eat diet rich natur antioxid vitamin"
"blood pressur measur dental checkup repres hour registr effect dental checkup blood pressur investig normotens patient men women age year year hour continu noninvas blood pressur registr carri patient blood pressur measur regist hour give total amount blood pressur measur dental checkup appoint famili dentist includ blood pressur valu display diurnal variat visit dental surgeon accompani rise blood pressur signific differ blood pressur valu hour period checkup period rest period dental checkup systol diastol pressur fell degre relat hour valu visit surgeon"
"assess stabl ischem heart diseas test patient understand import risk factor pathogenesi myocardi ischemia noninvas invas test essenti manag patient suspect coronari arteri diseas cad coronari angiographi remain gold standard diagnosi cad data obtain risk factor assess medic histori noninvas test inform import cardiac catheter data defin prognosi direct manag"
"preval hemodynam signific stenosi carotid arteri asymptomat veteran popul result previous studi suggest signific stenosi carotid arteri occur cent asymptomat patient popul studi repres vascular surgeon examin cohort patient veteran administr medic center duplex scan volunt group year age treat outpati depart nonvascular problem patient similar age group signific arteri occlus diseas lower extrem major patient men age year risk factor total popul includ hypertens diabet mellitus coronari arteri diseas peripher vascular diseas smoke signific greater cent diamet stenosi carotid arteri discov patient preval group cent versus cent group preval patient cardiac diseas cent compar cent cardiac diseas smoke cent rate signific diseas compar cent rate nonsmok hypertens diabet signific risk factor signific stenosi carotid arteri found patient coronari arteri diseas peripher vascular diseas smoke present"
"syndrom bilater hemispher border zone ischemia symptom compat vertebrobasilar ischemia report patient unilater bilater carotid occlus diseas intracrani steal phenomena propos explain symptom review patient angiograph document sever bilater carotid stenosi equal mm residu lumen occlus symptom suggest vertebrobasilar insuffici patient identifi retrospect evalu prospect symptom includ combin hemodynam mediat transient bilater motor sensori visual impair dysarthria dysphagia diplopia general absent patient addit symptom compat transient hemispher retin ischemia anatom region subserv bilater vertebrobasilar symptom correl angiograph estim arteri border zone hemispher repres bilater hemispher border zone ischemia brain stem ischemia intracrani steal invok"
"correl amino acid releas neuropatholog outcom rat brain middl cerebr arteri occlus vivo brain microdialysi studi amino acid releas striatum cortex rat perman middl cerebr arteri occlus process brain histopatholog assess volum ischem damag hour occlus ischem damag vari occlus middl cerebr arteri point proxim distal lenticulostri vessel proxim occlus elev dialys content amino acid largest increas occur potenti neurotox amino acid aspart glutam taurin basal efflux observ smaller increas metabol amino acid basal efflux distal occlus affect amino acid efflux striatum releas cortex signific lower proxim occlus compar releas data acut histopatholog outcom proxim occlus result larg volum ischem damag cortex striatum hemispher volum smaller volum ischem damag note distal occlus hemispher volum volum ischem damag amount amino acid releas signific correl"
"angiograph contrast media interfer laserinduc fluoresc excit detect atherosclerot human coronari arteri laserinduc fluoresc conjunct angiographi laser angioplasti guidanc effect radiopaqu contrast media excit detect arteri fluoresc previous report fluoresc emiss spectra human coronari arteri necropsi specimen excit puls excim laser excit nm examin addit contrast media sodium meglumin diatrizo sodium meglumin ioxagl iopamidol decreas fluoresc intens observ wavelength contrast agent examin decreas intens fluoresc emiss mark wavelength nm wavelength nm similar effect observ contrast media dilut blood absorpt spectra contrast media demonstr absorpt ultraviolet center nm conclud preferenti absorpt ultraviolet rang contrast media interfer excit detect laserinduc fluoresc visibl light excit obviat interfer laserinduc fluoresc analysi plaqu"
"normal doppler indic diastol dysfunct pace sign ischem mitral regurgit twenti patient angina undergo diagnost cardiac catheter underw cardiac pace simultan hemodynam doppler echocardiograph evalu assess effect pacinginduc ischem mitral valv veloc seventeen patient signific coronari arteri diseas patient normal coronari arteri doppler hemodynam measur perform rest immedi pace discontinu maxim predict heart rate patient experienc signific increas sever mitral regurgit pace reveal doppler examin group signific increas earli late peak fill veloc immedi pace discontinu result decreas late earli ratio decreas left ventricular enddiastol pressur increas signific mm hg mm hg cardiac pace patient coronari diseas develop mitral regurgit signific increas left ventricular enddiastol pressur mm hg mm hg late earli wave amplitud late earli ratio doppler measur group conclud mitral regurgit caus pacinginduc myocardi ischemia normal doppler indic mitral inflow turn mask persist worsen left ventricular diastol dysfunct"
"puls rate coronari heart diseas death nhane epidemiolog follow studi determin associ elev rest puls rate chd incid death white men independ risk factor associ exist women black data examin nhane epidemiolog follow studi follow period year elev rr chd incid found older white men baselin puls greater beatsmin compar beatsmin control multipl risk factor rr cl risk death cardiovascular diseas noncardiovascular diseas elev white men elev puls rate independ risk factor chd incid increas white women elev puls rate risk death cardiovascular diseas noncardiovascular diseas elev white men elev puls rate independ risk factor chd incid increas white women elev puls rate risk death cardiovascular diseas elev black men women elev puls rate risk death noncardiovascular diseas elev black men elev puls rate associ cardiovascular death strike black women adjust baselin risk factor rr cl studi assess associ puls rate chd black elucid mechan group"
"util echocardiographi diagnost strategi postinfarct ventricular septal ruptur comparison dimension echocardiographi versus doppler color flow imag diagnost accuraci doppler color flow imag diagnosi postinfarct ventricular septal defect establish studi patient unexplain hypotens murmur periinfarct period evalu convent dimension echocardiographi doppler color flow imag presenc ventricular septal defect confirm oximetri ventriculographi oper repair autopsi case dimension doppler color flow imag specif exclud ventricular septal defect doppler color flow imag correct identifi confirm ventricular septal defect studi sensit combin dimension criteria correct identifi sensit doppler color flow imag superior convent dimension imag diagnosi postinfarct ventricular septal defect addit doppler color flow imag local septal defect guid therapi techniqu repair care perform doppler color flow examin exclud result rapid diagnosi ventricular septal defect elimin timeconsum confirmatori test"
"dipyridamol perfus scintigraphi experi applic hundr seventi patient suspect unstabl angina evalu safeti accuraci potenti clinic util intraven dipyridamol perfus scintigraphi thallium patient suspect unstabl angina coronari angiographi noncardiac side effect induc chest discomfort st segment similar group signific arrhythmia occur patient prolong chest pain extens revers imag abnorm creatinin kinasemb releas elect bypass surgeri twenti patient normal coronari arteri singlevessel diseas scintigraph patient sensit specif vessel sensit vessel specif group differ follow period patient imag abnorm coronari revascular death intergroup differ similar patient group angiographi scintigraph defect frequent extens revascular perform subsequ death occur dipyridamol perfus scintigraphi accur altern exercis test evalu patient unstabl angina pectori risk method safe consid guid diagnosi prognosi manag"
"myocardi metabol hemodynam effect sustain intraven infus nifedipin metoprolol patient unstabl angina test sustain intraven infus nifedipin combin nifedipin metoprolol earli manag patient unstabl angina pectori hour run period nifedipin titrat stepwis fashion dose microgramsmin nifedipin treatment coronari blood flow increas mlmin doubl product myocardi oxygen consumpt arteri coronari sinus epinephrin level unchang myocardi lactat uptak increas mumolmin free fatti acid uptak mumolmin small nonsignific improv amino acid metabol observ metoprolol ad patient led decreas doubl product myocardi oxygen consumpt mlmin lactat uptakeoxygen uptak ratio increas metoprolol ns number episod chest pain decreas hour nifedipin group hour nifedipin metoprolol group conclud acut phase unstabl angina intraven nifedipin care titrat improv coronari blood flow oxid metabol addit metoprolol reduct myocardi oxygen demand treatment result signific hemodynam stabil"
"fragment atrial activ patient transient atrial fibril predict atrial fibril af import patient wolffparkinsonwhit syndrom select pacemak therapeut modal patient transient af respons atrial activ width extrastimuli examin comparison patient af result index subsequ occurr af program electr stimul basic stimuli singl doubl extrastimuli pp ppp deliv high atrium atrial activ examin prolong atrial activ caus extrastimuli term fragment frg defin prolong basic stimuli frg zone defin zone coupl interv extrastimuli pp pp caus frg delta max frg defin differ widest frg atrial wave width basic stimuli fragment reproduc induc extrastimuli invers relationship frg durat coupl interv extrastimuli pp pp frg zone delta max frg wider longer patient transient af comparison control group singl doubl extrastimuli af induc doubl extrastimuli signific high patient af"
"manag multipl risk factor coronari heart diseas patient hypertens hypertens intervent trial involv diuret betablock demonstr disappoint benefit term reduct coronari heart diseas chd suggest elev blood pressur chd causal relat data suggest antihypertens agent optim manag hypertens review recommend therapi major risk factor chd includ increas blood pressur elev serum cholesterol level smoke high preval general popul cluster patient hypertens treatment hypertens demand multifactori approach risk factor chd diuret betablock advers affect serum lipid profil negat chd benefit afford blood pressur reduct"
"effect doxazosin serum lipid review clinic data molecular basi alter lipid metabol goal antihypertens treatment reduct high blood pressur effect manag elev cholesterol level risk factor coronari heart diseas chd control clinic trial doxazosin shown antihypertens efficaci compar class antihypertens agent lower level total cholesterol lowdens lipoprotein ldl cholesterol triglycerid increas level highdens lipoprotein cholesterol doxazosin inhibit develop chd front doxazosin bind alpha adrenoreceptor inhibit receptormedi respons epinephrin norepinephrin doxazosin direct indirect effect lipid metabol increas ldl receptor activ decreas intracellular ldl synthesi reduc synthesi secret lowdens lipoprotein cholesterol stimul lipoprotein lipas activ doxazosin inhibit platelet aggreg longterm studi determin action translat reduct morbid mortal rate chd year result treatment mild hypertens studi tomh demonstr expect reduct blood pressur antihypertens agent studi lipid vari type antihypertens treatment favor doxazosin"
"preliminari result norwegian doxazosin postmarket surveil studi twelveweek experi studi design investig safeti efficaci doxazosin control blood pressur general medic practic result present concern patient evalu week period blood pressur signific reduc treatment doxazosin mm hg heart rate signific alter addit doxazosin signific reduc total cholesterol level reduc triglycerid level increas highdens lipoprotein cholesterol level highdens lipoproteintot cholesterol ratio calcul risk coronari heart diseas reduc week period thirti percent patient report side effect number patient experienc sever advers reaction small twenti patient discontinu treatment advers event dose doxazosin reduc"
"doxazosin studi cohort patient hypertens general practic interim report object studi assess safeti efficaci doxazosin substanti cohort hypertens patient drawn general practic total patient enter studi untreat hypertens patient patient advis chang diet smoke habit lifestyl studi twenti percent cigarett smoker concurr diabet present baselin blood cholesterol exceed mgdl mmol mgdl mmol patient decreas blood pressur produc doxazosin mm hg week therapi decreas heart rate beatmin mainten dose patient mgday side effect consid relat possibl relat treatment report patient treatment discontinu patient advers event relat possibl relat treatment doxazosin doxazosin produc signific decreas total cholesterol lowdens lipoprotein cholesterol triglycerid level signific increas highdens lipoprotein cholesterol ratio highdens lipoproteintot cholesterol potenti reduct year coronari heart diseas risk framingham equat calcul"
"open noncompar studi doxazosin essenti hypertens experi general practic netherland antihypertens efficaci safeti lipid effect doxazosin select alpha inhibitor assess general practic set hundr twenti patient enter studi involv phase week baselin period week period patient receiv mg doxazosin daili week mainten period week efficacyevalu patient consid therapi success sit diastol blood pressur equal mm hg greater equal mm hg reduct baselin greater equal mm hg reduct baselin daili dose patient consid therapi success mg final visit sit systolicdiastol blood pressur patient reduc mm hg baselin mm hg investig global assess efficaci daili doxazosin therapi excel good patient patient report total side effect side effect mild moder sever patient discontinu treatment advers experi investig global assess toler excel good patient doxazosin produc signific decreas total cholesterol triglycerid level baselin final visit high signific reduct calcul risk score coronari heart diseas basi framingham heart studi risk equat"
"doxazosin atenolol monotherapi mild moder hypertens random parallel studi year follow efficaci safeti doxazosin atenolol compar year period doxazosin dose year mgday atenolol dose mgday produc sustain similar reduct blood pressur evid toler doxazosin decreas blood pressur mm hg mm hg atenolol decreas mm hg mm hg reduct blood pressur atenolol parallel signific decreas heart rate beatsmin doxazosin produc clinic meaning heart rate contrast atenolol doxazosin reduc triglycerid level atenolol increas highdens lipoprotein cholesterol level atenolol increas highdens lipoproteintot cholesterol ratio atenolol valu signific atenololtr patient doxazosin reduc calcul lowdens lipoprotein cholesterol level atenolol unchang advers effect atenolol lipid level appar negat benefici effect blood pressur reduct calcul coronari heart diseas chd risk increas signific contrast reduct calcul chd risk doxazosin group statist signific point studi safeti profil drug similar ad potenti reduct calcul risk chd hypertens patientsdoxazosin repres line drug treatment essenti hypertens"
"cardiovascular diseas risk profil articl present predict equat cardiovascular diseas endpoint base measur risk factor subject origin offspr subject framingham heart studi age year initi free cardiovascular diseas equat predict risk develop myocardi infarct coronari heart diseas chd death chd stroke cardiovascular diseas death cardiovascular diseas equat demonstr potenti import control multipl risk factor blood pressur total cholesterol highdens lipoprotein cholesterol smoke glucos intoler left ventricular hypertrophi oppos focus singl risk factor parametr model advantag exist standard regress model unlik logist regress provid predict length time probabl express straightforward cox proport hazard model"
"doubleblind comparison doxazosin enalapril patient mild moder essenti hypertens antihypertens efficaci safeti doxazosin enalapril compar general practic set agent produc compar statist signific reduct blood pressur clinic relev heart rate side effect group mild moder disappear toler continu treatment doxazosin contrast enalapril produc signific reduct total serum cholesterol concentr reduct level triglycerid favor increas highdens lipoproteintot cholesterol ratio reduct calcul coronari heart diseas risk produc doxazosin high signific greater produc enalapril"
"doubleblind compar studi doxazosin prazosin administ betablock diuret antihypertens efficaci safeti doxazosin daili prazosin daili compar patient mild moder essenti hypertens diastol blood pressur dbp mm hg adequ control diuret betablock doxazosin produc signific greater reduct stand supin dbp prazosin signific group differ systol blood pressur heart rate daili dose efficacyevalu patient mg doxazosin mg prazosin sixteen patient treat doxazosin patient treat prazosin consid therapeut success decreas stand dbp greater equal mm hg equal mm hg greater equal mm hg reduct baselin efficacyevalu patient treat doxazosin show improv sever categori hypertens improv sever report patient treat prazosin doxazosin produc favor effect serum lipid level prazosin statist signific group differ observ side effect experienc doxazosin prazosin mild moder toler disappear continu treatment evalu toler excel good doxazosin prazosintr patient clinic efficaci rate excel good patient treat doxazosin patient treat prazosin"
"addit doxazosin treatment regimen patient hypertens adequ control betablock doxazosin patient hypertens adequ control betablockad blood pressur normal patient blood pressur equal mm hg reduct blood pressur obtain doxazosin combin metoprolol oxprenolol final daili dose mg pindolol atenolol mgday exerciseinduc increas systol diastol blood pressur lower combin betablock doxazosin therapi betablock week treatment combin doxazosin betablock signific reduc total serum cholesterol triglycerid level side effect mild patient withdrawn therapi"
"doubleblind compar studi doxazosin prazosin treatment essenti hypertens hundr sixti patient part multicent compar studi doxazosin prazosin drug produc signific reduct blood pressur increas heart rate blood pressur consid mark decreas decreas patient treat doxazosin patient treat prazosin statist signific group differ antihypertens efficaci observ doxazosin prazosin toler patient group therapi withdrawn"
"clinic experi doxazosin general medic practic zealand studi investig safeti efficaci doxazosin treatment larg popul patient essenti hypertens assess effect doxazosin serum lipid profil calcul risk develop coronari heart diseas patient assign group baselin diastol blood pressur greater equal mm hg group baselin diastol blood pressur mm hg group control previous antihypertens therapi doxazosin treatment monotherapi patient signific reduc blood pressur patient group mm hg week maintain control blood pressur patient group heart rate essenti unchang group final daili dose mg achiev group treatment doxazosin improv sever categori hypertens patient group patient consid therapi success doxazosin favor effect serum lipid profil group patient major lipid achiev statist signific result signific decreas calcul risk develop coronari heart diseas doxazosin toler patient side effect relat possibl relat treatment patient dose doxazosin reduc patient withdrew doxazosin therapi side effect"
"doxazosin treatment essenti hypertens general medic practic latin america latin american studi assess general practic set efficaci toler daili doxazosin treatment mild moder essenti hypertens sit diastol blood pressur mm hg patient treat doxazosin week monotherapi combin antihypertens agent final visit doxazosin produc chang sit systolicdiastol blood pressur mm hg daili dose mg hundr sixti evalu patient consid therapeut success lipid analys identifi statist signific reduct total serum cholesterol decreas triglycerid level framingham heart studi equat doxazosin produc high signific reduct calcul probabl develop coronari heart diseas year patient evalu report side effect consid relat treatment ten patient report side effect unrel treatment report event unknown relationship side effect mild moder toler disappear continu treatment patient discontinu therapi dose reduc preval side effect headach dizzi investig assess antihypertens efficaci excel good patient toler consid excel good patient"
"multicent studi doxazosin treatment essenti hypertens franc studi design assess efficaci toler doxazosin patient mild moder sever essenti hypertens general practic set nineti adult age year part week studi consist placebo phase week doseadjust phase doxazosin week mainten phase week doxazosin final daili dose mg produc signific reduct blood pressur point measur studi chang sit blood pressur end treatment mm hg patient categor success failur consid therapeut success efficacyevalu patient demonstr improv sever categori hypertens treatment doxazosin produc reduct serum cholesterol triglycerid level attain statist signific calcul probabl develop coronari heart diseas year framingham equat signific reduc chanc baselin chanc final visit twenti patient report side effect possibl relat treatment preval vertigo headach patient dose doxazosin reduc withdrawn prematur investig assess toler reduc consid excel good patient"
"clinic experi doxazosin general medic practic netherland studi design investig efficaci toler daili doxazosin treatment essenti hypertens sit diastol blood pressur mm hg general medic practic fifti patient mild moder essenti hypertens enter studi week durat consist baselin run period week doseadjust phase doxazosin week mainten phase week doxazosin initi mgday week dose doubl blood pressur normal sit diastol blood pressur equal mm hg greater equal mm hg reduct baselin signific side effect emerg maximum daili dose administ mg doxazosin produc signific final chang sit blood pressur mm hg final daili dose mg heart rate signific alter nonsignific decreas total cholesterol concentr triglycerid observ effect doxazosin blood pressur serum cholesterol result signific reduct calcul risk coronari heart diseas investig assess patient toler doxazosin excel good patient"
"longterm studi doxazosin treatment mild moder essenti hypertens general medic practic studi assess longterm week antihypertens efficaci safeti doxazosin treatment mild moder essenti hypertens defin sit stand diastol blood pressur mm hg patient success complet initi week trial continu uninterrupt week extens studi optim antihypertens efficaci achiev week maintain patient durat year final sit blood pressur mm hg reduc baselin level mm hg occasion decreas heart rate observ consid clinic relev beatsmin final dose doxazosin patient evalu efficaci mgday patient equal mgday increas daili mainten dose observ initi phase longterm extens studi year treatment patient consid therapeut success sit diastol blood pressur greater equal mm hg reduct baselin equal mm hg greater equal mm hg reduct patient worsen sever categori hypertens total serum cholesterol concentr reduc signific end week reduct total serum cholesterol level persist extens studi final reduct"
"doxazosin treatment mild moder essenti hypertens echocardiograph studi sixteen patient mild moder essenti hypertens receiv mgday doxazosin daili dose mg blood pressur reduct supin stand high signific signific heart rate observ signific reduct left ventricular mass chang left ventricular systol function side effect mild patient withdrew studi"
"echocardiograph assess doxazosin left ventricular mass patient essenti hypertens singl daili dose doxazosin week period produc signific reduct blood pressur left ventricular mass index patient mild moder hypertens systol shorten coeffici increas trend improv eject fraction rate circumferenti fiber shorten systol contract time preejectiveeject ratio observ chang heart rate record patient side effect serum lipid profil modifi favor regard lowdens lipoprotein cholesterolhighdens lipoprotein cholesterol ratio produc reduct blood pressur left ventricular mass favor modifi serum lipid profil doxazosin produc benefici chang coronari heart diseas risk profil"
"efficaci safeti doxazosin treatment patient mild moder essenti hypertens elev level cholesterol hypertens patient elev serum cholesterol frequent sinist addit coronari risk factor select alpha adrenoreceptor inhibitor uniqu abil control risk factor forti patient age year includ men sustain hypertens elev serum cholesterol level includ trial monotherapi doxazosin administ daili rang mg influenc drug high blood pressur elev serum cholesterol evalu week period consist week singleblind placebo lead period open week doseadjust period final week mainten period efficacyevalu patient achiev adequ blood pressur control diastol blood pressur mm hg decreas diastol blood pressur greater mm hg daili dose mg doxazosin persist occur heart rate patient evalu lipid data nonsignific trend increas highdens lipoprotein cholesterol reduct total cholesterol signific reduct serum triglycerid concentr combin blood pressur blood lipid level result reduct calcul risk coronari heart diseas eleven patient report side effect withdrawn therapi result confirm antihypertens anticholesterolem efficaci daili treatment doxazosin"
"multicent studi doxazosin treatment patient mild moder essenti hypertens concomit intermitt claudic studi assess efficaci safeti daili doxazosin treatment patient mild moder essenti hypertens sit diastol blood pressur dbp mm hg concomit intermitt claudic doppler anklearm ratio walk toler treadmil week treatment doxazosin signific reduct systol blood pressur dbp observ blood pressur reduc mm hg baselin mm hg end treatment minor heart rate occur continu treatment statist signific baselin efficacyevalu patient blood pressur normal dbp equal mm hg greater equal mm hg reduct baselin daili dose mgday doxazosin improv hypertens sever categori patient blood pressur ratio thigh arm ankl arm show statist signific treatment doxazosin thigh blood flow rest reactiv hyperemia minut arteri occlus chang statist tendenc painfre distanc improv laboratori data signific chang treatment doxazosin patient studi report mild moder side effect toler disappear continu treatment patient therapi withdrawn patient requir dose reduct"
"doxazosin treatment chronic congest heart failur result random doubleblind placebocontrol studi studi evalu effect daili administr oral doxazosin patient chronic congest heart failur chf stabil period week digitali diuret patient chronic chf random receiv addit doxazosin placebo doubleblind fashion patient underw week dose adjust increas dose doxazosin mg daili placebo week evalu addit week maxim toler dose blind studi drug treatment group evalu respect symptom heart failur index qualiti life left ventricular function frequenc type arrhythmia advers event mortal rate doxazosin mg daili produc favor trend investig patient assess symptomat chang doxazosin signific higher level voluntari submaxim exercis favor trend left ventricular eject fraction increas baselin placebo ns month steadydos period patient treat doxazosin signific reduct ventricular arrhythmia signific fewer morbid mortal cardiac event includ episod worsen heart failur sever prompt discontinu studi myocardi infarct death doxazosin toler produc major side effect slight higher frequenc minor treatmentrel side effect compar placebo ns"
"effect doxazosin platelet aggreg normotens subject patient hypertens vitro studi vitro assay investig effect doxazosin platelet aggreg induc epinephrin collagen adenosin diphosph plateletrich plasma normotens subject patient hypertens compar doxazosin produc concentrationdepend inhibit platelet aggreg group signific lower concentr requir inhibit platelet aggreg plasma patient hypertens concentr doxazosin inhibit platelet aggreg vitro similar clinic control blood pressur patient hypertens"
"evid antiplatelet aggreg action doxazosin patient hypertens vivo studi eighteen patient age year includ studi patient diagnosi mild moder essenti hypertens sit diastol blood pressur mm hg studi design singl blind phase phase placebo week phase ii activ treatment week increas dose doxazosin week mgday result show doxazosin antihypertens effect dose depend systol diastol blood pressur decreas signific effect heart rate observ doxazosin signific inhibit platelet aggreg induc epinephrin adenosin diphosph collagen dosedepend manner addit treatment doxazosin lower total serum cholesterol triglycerid level chang standard biochem paramet doxazosin offer distinct therapeut advantag modul atherogen thromboembol factor coronari heart diseas"
"role oxygen free radic ischem reperfus myocardium recent year interest role oxygen radic myocardi ischemia reperfus injuri sequenti unival reduct oxygen rise reactiv intermedi product tissu concentr intermedi product oxygen limit aerob myocardium surviv exist delic balanc generat oxid mainten antioxid defens mechan sourc identifi product activ oxygen speci ischemia reperfus sourc mutual interact abil scaveng oxygen free radic includ vitamin improv mechan mitochondri sarcoplasm reticulum function anim model ischemicreperfus injuri suggest oxygen free radic part respons myocardi damag model caution interpret data"
"invers correl plasma vitamin mortal ischem heart diseas crosscultur epidemiolog essenti antioxid determin plasma middleag men repres european studi popul differ sixfold agespecif mortal ischem heart diseas ihd popul common plasma cholesterol mmol blood pressur classic risk factor lack signific correl ihd mortal absolut level vitamin alphatocopherol show strong invers correl evalu popul cholesterol diastol blood pressur moder correl inferior vitamin stepwis regress multipl regress analysi mortal predict lipidstandard vitamin vitamin cholesterol inclus lipidstandard vitamin retinol paramet blood pressur present studi crosscultur differ idh mortal primarili attribut plasma status vitamin protect function"
"inherit abdomin aortic aneurysm determin mode inherit abdomin aortic aneurysm data degre relat proband collect result segreg analysi perform data report model includ nongenet genet model compar likelihood method nongenet model reject statist signific evid favor genet model found genet model compar parsimoni genet model suscept abdomin aortic aneurysm determin recess gene autosom diallel major locus multifactori compon addit major locus increas likelihood data signific"
"chronic therapi congest heart failur benazepril hcl angiotensin convert enzym inhibitor benazepril hcl oral effect angiotensin convert enzym ace inhibitor previous shown signific acut hemodynam benefit patient congest heart failur studi patient york heart associ class iii iv congest heart failur treat mg benazepril hcl singl daili oral dose day determin clinic hemodynam chronic therapi patient underw clinic evalu day period invas hemodynam studi day trial plasma ace activ aldosteron level fell signific renin level rose therapi benazepril hcl produc signific reduct arteri pressur system vascular resist increas cardiac output decreas pulmonari arteri wedg pressur respons day therapi equival initi dose clinic effect includ reduc rest exert paroxysm nocturn dyspnea reduc peripher edema patient develop symptomat orthostat hypotens benazepril hcl daili effect toler oral agent chronic treatment advanc congest heart failur"
"cardiorespiratori effect antagon diazepam sedat flumazenil patient cardiac diseas specif benzodiazepin antagonist flumazenil intens studi clinic experi detail invas hemodynam studi cardiac patient publish present studi hemodynam respiratori variabl measur cardiac patient undergo catheter left side heart sedat intraven diazepam revers sedat flumazenil sleep dose diazepam mg sd caus slight decreas arteri pressur mm hg pulmonari capillari wedg pressur mm hg left ventricular enddiastol pressur mm hg signific respiratori gas homeostasi intraven flumazenil mg result spontan awaken return full orient caus signific alter hemodynam respiratori variabl measur revers diazepaminduc sedat flumazenil cardiac patient safe effect"
"surgic repair wolffparkinsonwhit syndrom complic myocardi bridg myocardi bridg myocardi ischemia supraventricular tachycardia present case wolffparkinsonwhit syndrom combin myocardi bridg patient complain angina pectori paroxysm supraventricular tachycardia sever constrict left anterior descend coronari arteri systol myocardi scintigram reveal myocardi ischemia anterosept wall paroxysm supraventricular tachycardia myotomi prevent myocardi bridg interrupt accessori conduct pathway success accomplish stage oper"
"altern techniqu repair sinus venosus atrial septal defect techniqu closur sinus venosus atrial septal defect singl patch held place sutur atrium underneath superior vena cava superior vena cava requir enlarg potenti damag arteri sinoatri node avoid"
"comparison supraannular subannular pledget sutur mitral valv replac ten fresh canin heart compar peak left ventricular pressur requir disrupt prosthet mitral valv sutur place horizont mattress sutur subannular supraannular pledget group consist anim mm medtron mitral valv secur mitral posit ten pledget sutur aorta cannul normal salin solut infus left ventricl valvar disrupt occur peak pressur locat mechan disrupt note peak left ventricular pressur requir valvar disrupt individu sutur broken specimen subannular myocardi ruptur occur posterior portion mitral annulus extent atrioventricular groov addit posterior wall left atrium dissect upward subsequ signific greater pressur requir group subannular sutur placement compar supraannular group versus mm hg data suggest placement horizont mattress sutur pledget subannular posit superior recommend method supraannular sutur placement mechan valv"
"cholesterol screen result negat label effect result massachusett model system blood cholesterol screen project previous studi effect label individu hypertens found increas psychosoci distress diminish feel absente studi found effect similar studi relat label high blood cholesterol level publish massachusett model system blood cholesterol screen project investig label effect occur result communitybas screen educ referr program conduct worcest lowel question percept physic psycholog questionnair screen particip question part follow questionnair individu identifi high blood cholesterol level screen comparison baselin follow result demonstr signific negat effect age sex racial incom educ group contrari respons question reveal small statist signific improv percept physic psycholog absenc negat label effect attribut posit support approach particip counsel project"
"weight gain time menopaus studi prospect weight chang effect weight chang coronari heart diseas risk factor populationbas sampl middleag women women studi premenopaus age year restudi women gain averag kg year period women gain kg lost kg signific differ weight gain women remain premenopaus natur menopaus kg kg weight gain signific increas blood pressur level total cholesterol lowdens lipoprotein cholesterol triglycerid fast insulin weight gain common occurr women time menopaus relat coronari heart diseas risk factor observ period effort lose weight prevent weight gain mitig worsen coronari heart diseas risk factor middleag women"
"lipoproteinrel coronari risk factor patient angiograph defin coronari arteri diseas relat number stenos arteri determin index estim antagon low densiti lipoprotein ldl high densiti lipoprotein hdl improv separ group coronari artherosclerosi patient undergo coronari catheter women men analys total cholesterol tc hdl cholesterol hdlc apolipoprotein apo apolipoprotein apo subject categor group number stenos arteri greater areal stenosi thirti patient show signific coronari atherosclerosi group serum apo tc concentr direct relat number stenos vessel concentr apo hdlc negat correl number stenos arteri atherogen index ath index calcul product serum concentr apo tc minus hdlc divid product apo hdlc prove satisfactori individu lipoprotein compon discrimin subject stenosi identif coronari group improv ath index"
"effect longterm treatment metoprolol hydrochlorothiazid plasma lipid lipoprotein order evalu effect year antihypertens treatment plasma lipid lipoprotein patient diastol blood pressur rang mmhg random alloc group receiv hydrochlorothiazid metoprolol drug respons insuffici control blood pressur blood pressur effect reduc group patient hydrochlorothiazid show signific increas lowdens lipoprotein cholesterol ldl month treatment signific increas triglycerid observ month decreas highdens lipoprotein cholesterol hdl month treatment patient metoprolol patient treat hydrochlorothiazid metoprolol total cholesterol increas month triglycerid increas month ldl increas month treatment patient lipid paramet affect studi period conclud longterm antihypertens treatment hydrochlorothiazid metoprolol drug induc lipid effect deserv recognit case counteract benefit reduct blood pressur prevent coronari heart diseas"
"wive coronari highrisk men higher risk tromso heart studi blood lipid blood pressur bodi mass index bmi smoke dietari exercis habit studi wive men high risk coronari heart diseas chd tromso survey men age year identifi high risk chd hdlcholesteroltot cholesterol equal total cholesterol greater equal mmol men individu wive attend screen wive compar agematch marri women general popul signific higher total cholesterol level mmol mmol lower hdlcholesteroltot cholesterol higher bmi higher coronari risk score found wive highrisk men higher proport individu daili cigarett smoker receiv fewer year educ dietari habit increas risk chd marri women general popul find support hypothesi member household person increas risk chd increas risk due share lifestyl"
"verapamil increas serum alkalin phosphatas hypertens patient rat verapamil decreas intestin absorpt calcium increas serum parathyroid hormon pth induc osteopenia prospect studi verapamil mg time daili month patient hypertens effect calcium homeostasi record dose verapamil signific reduc supin systol diastol blood pressur sd mmhg mmhg serum alkalin phosphatas alp increas signific mu kat mu kat isoenzym alp skelet origin verapamil treatment excret sodium urin increas nacreatinin ratio verapamil excret calcium phosphat potassium chang pth slight increas end verapamil treatment microgram increas ng serum ca affect verapamil verapamil mmol verapamil mmol increas serum alp demonstr verapamil affect bone cell metabol man effect secondari enhanc pth secret"
"lower extrem arteri diseas elder subject systol hypertens ratio anklearm systol blood pressur anklearm index aai invas indic flowsignific atherosclerosi measur burden diseas high risk popul preval lower extrem arteri diseas lead assess method systol hypertens elder program shep subject age older systol blood pressur greater mmhg entri studi aai consid indic flowsignific lead preval lead method preval intermitt claudic ic ic confirm lead preval lead measur aai increas age women histori current smoke lower level high densiti lipoprotein studi popul systol hypertens lead measur aai preval previous elder popul risk factor atherosclerosi"
"prospect comparison rubidium pet thallium spect myocardi perfus imag util singl dipyridamol stress diagnosi coronari arteri diseas purpos present studi prospect compar myocardi perfus imag rubidium rb positron emiss tomographi pet thallium tl imag singlephoton emiss tomographi spect record studi singl dipyridamol handgrip stress read set imag display techniqu seri patient previous coronari arteriographi sensit specif accuraci rb pet tl spect patient previous therapeut intervent exclud remain patient show sensit specif accuraci rb pet tl spect improv contrast resolut pet result mark superior imag confid identif defect"
"reduc unnecessari coronari care unit admiss comparison decis aid object determin publish decis rule ischem heart diseas practic reduc unnecessari admiss coronari care unit design prospect cohort studi set communiti hospit emerg room patient consecut patient present emerg room chief complaint chest pain measur clinic inform includ observ previous publish decis aid collect special form time emerg room visit follow inform obtain medic record patient admit telephon interview patient discharg author compar resid actual decis predict decis aid abil predict complic identifi patient admiss intens care main result conclus decis aid reduc unnecessari admiss increas rate inappropri discharg clinic relev subgroup patient decis admit discharg obvious clinic ground complic present resid chose discharg decis aid examin combin verifi admiss safe avert unnecessari admiss"
"arginin vasopressin gene express chronic cardiac failur rat arginin vasopressin avp increas patient experiment anim chronic cardiac failur ccf import increas biosynthesi avp hypothalamus heretofor investig purpos present studi ccf secondari infarct myocardi tissu induc ligat left anterior descend coronari arteri sham oper anim serv control week hypothalam avp mrna determin solut hybrid sens antisens strand rna blood pressur lower ccf sham anim mm hg total heart left ventricl weight signific higher ccf rat plasma avp higher ccf sham ccf pgml plasma atrial natriuret peptid higher ccf sham anim pgml avp mrna hypothalamus signific higher ccf sham anim pgmicrogram total rna differ betaactin mrna hypothalamus sham ccf rat indic avpmrna increas specif ccf result demonstr increas avp biosynthesi hypothalamus addit releas hormon posterior pituitari occur ccf"
"studi myocardi protect immatur heart safeti prolong aortic clamp hypocalcem glutamateaspart blood cardioplegia studi test hypothesi multidos hypocalcem aspartateglutamateenrich blood cardioplegia safe effect protect prolong aortic clamp immatur heart puppi week age kg vent cardiopulmonari bypass subject minut degre global ischemia cardiopleg protect underw minut aortic clamp degre multidos aspartateglutamateenrich blood cardioplegia ca mmol preced degre blood cardiopleg induct reperfus puppi underw blood cardiopleg perfus minut interven ischemia assess effect cardiopleg solut deliveri techniqu left ventricular perform assess minut bypass discontinu starl function curv heart studi highenergi phosphat tissu amino acid hour normotherm ischemia result profound function depress peak stroke work index control versus gm kg deplet adenosin triphosph versus control mumolgm dri weight glutam loss versus control mumolgm contrast hour aortic clamp multidos blood cardioplegia preced degre blood cardioplegia complet recoveri left ventricular function peak stroke work index gm kg mainten adenosin triphosph glutam aspart level control level adenosin triphosph mumolgm aspart versus control mumolgm glutam mumolgm puppi heart receiv blood cardiopleg perfus ischemia complet recoveri control stroke work index conclud method myocardi protect adult amino acidenrich reducedcalcium blood cardioplegia appli safe neonat heart complet function metabol recoveri prolong aortic clamp"
"type abnorm gene plasminogen famili predisposit thrombosi publish erratum proc natl acad sci apr gene code plasminogen compar abnorm gene japanes patient polymeras chain reaction dna sequenc analysi type abnorm gene code plasminogen identifi patient type mutat guanosin gct code ala activesit histidin replac adenosin result act code threonin mutat shown loss cleavag site fnuhi endonucleas restrict enzym recogn gctgc actgc type ii mutat guanosin gtc code val replac thymidin result ttc code phenylalanin chang readili shown digest ava ii endonucleas restrict enzym recogn ggtcc gttcc type mutat found ident plasminogen variant identifi japanes patient amino acid sequenc analysi detect isoelectr focus type ii mutat uniqu amino acid substitut connect region fourth kringl plasminogen dna sequenc analysi reveal abnorm gene carri silent nucleotid substitut locat primarili intron flank region"
"histopatholog studi spinal cord ischemia isohistogen rat upperhalfbodi transplant model studi histopatholog spinal cord expos longdur complet ischemia author develop upperhalfbodi transplant model inbr rat model infant lewi rat transplant inguin region adult lewi rat microsurg vascular anastomosi week donor rat expos complet ischemia minut function spinal cord compar preserv histopatholog observ degener proport complet ischemia durat note minut ischemia group week donor rat substanti differ normal spinal cord observ condit equal ischemia durat younger anim greater ischem toler"
"sever singlevessel coronari arteri stenosi durat angina determin recruit collater vessel balloon angioplasti occlus determin factor influenc presenc collater vessel coronari occlus perform standard contrast inject contralater coronari arteri consecut patient previous myocardi infarct undergo percutan translumin coronari angioplasti vessel diseas left anterior descend arteri coronari arteri left circumflex arteri presenc collater vessel coronari occlus defin partial complet epicardi opacif collater vessel vessel dilat relat clinic angiograph electrocardiograph paramet angiograph collater vessel balloon inflat show weak statist signific correl percent diamet stenosi angioplasti durat angina combin lesion sever durat angina collater vessel coronari occlus relat lesion sever greater equal durat angina greater equal month presenc collater vessel absenc stsegment shift greater equal mm minut coronari occlus"
"characterist black patient admit coronari care unit metropolitan seattl result myocardi infarct triag intervent registri miti black white patient chest pain presum cardiac origin admit coronari care unit hospit metropolitan seattl black men women younger admit central citi hospit develop evid acut myocardi infarct ami subset ami patient black younger prior coronari arteri bypass graft surgeri prior hypertens hospit white higher rate coronari angioplasti coronari arteri bypass graft surgeri thrombolyt therapi cardiac catheter equal group hospit mortal black white patient adjust key demograph clinic variabl logist regress differ appar question prematur onset coronari arteri diseas excess system hypertens differenti intervent black person rais investig differ age referr pattern coronari angioplasti bypass surgeri black white patient ami metropolitan seattl similar outcom"
"late result repeat coronari arteri bypass oper determin clinic outcom longterm result coronari arteri bypass oper studi preoper clinic status catheter data consecut patient year period follow time month maximum studi group includ men women age year greater year sixti percent patient sever angina york heart associ class iv vessel coronari arteri diseas poor left ventricular function reoper perform interv month procedur distal anastomos oper mortal rate day addit cardiac morbid myocardi infarct heart failur patient multivari analysi show increas risk women risk ratio patient poor left ventricular function risk ratio cumul year surviv rate estim rate patient poor left ventricular function differ signific probabl remain free cardiacrel event myocardi infarct angioplasti oper cardiac death year end follow surviv patient york heart associ class ii patient year reoper good function status conclud reoper effect carri increas oper risk"
"cardiovascular risk factor cluster ratio total cholesterol highdens lipoprotein cholesterol angiograph document coronari arteri diseas high level cardiac risk factor tend cluster act synergist develop suitabl practic marker cluster evalu consecut patient time coronari angiographi analys lipid rheolog clinic arteriograph profil varieti interwoven relat ratio total cholesterol highdens lipoprotein hdl cholesterol totalhdl cholesterol close relat presenc extent greater equal diamet reduct greater equal coronari arteri divid patient quartil cluster high lowlevel risk factor demonstr highest lowest quartil totalhdl cholesterol highest quartil character moder elev total cholesterol level patient quartil low hdl cholesterol level high triglycerid tendenc high hemoglobin fibrinogen level histori smoke previous myocardi infarct multivessel diseas result suggest totalhdl cholesterol serv marker obstruct coronari diseas cluster potenti modifi risk factor"
"ventricular tachycardia acceler ventricular rhythm present month life fourteen infant age month present institut year ventricular tachycardia vt acceler ventricular rhythm structur normal heart vt long qt syndrom aliv betablock therapi implant pacemak twelv infant acceler ventricular rhythm die month life unrel condit aliv median age year rang month year lost follow hemodynam compromis occur acceler ventricular rhythm ventricular rate close sinus rate sinus rate qrs durat acceler ventricular rhythm ms averag qrs durat sinus rhythm fusion beat atrioventricular dissoci captur beat ventriculoatri conduct present treatment attempt survivor acceler ventricular rhythm thought success treatment success withdrawn survivor free acceler ventricular rhythm receiv antiarrhythm medic follow excel longterm outcom lack hemodynam compromis rhythm reason withhold antiarrhythm therapi infant acceler ventricular rhythm await resolut rhythm"
"character spontan termin sustain ventricular tachycardia coronari arteri diseas character chang cycl length qrs morpholog spontan termin sustain ventricular tachycardia vt electrocardiogram record vt cycl length measur period beat termin episod patient coronari arteri diseas beat design period stabl arrhythmia serv refer occur termin forti episod vt occur set antiarrhythm drug therapi episod occur patient treat antiarrhythm drug variabl cycl length index standard deviat cycl length percentag consecut cycl vari greater equal ms greater equal ms greater variabl termin standard deviat cycl length ms greater equal ms stabl period standard deviat cycl length ms greater equal ms true irrespect antiarrhythm drug differ standard deviat cycl length beat beat greater antiarrhythm drug group ms group receiv antiarrhythm drug ms differ signific specif pattern cycl length variabl characterist vt termin found"
"comparison lisinopril versus atenolol mild moder essenti hypertens antihypertens effect safeti profil lisinopril mg atenolol mg compar random doubleblind parallel group trial patient essenti hypertens week therapi seat blood pressur bp decreas mm hg lisinopril mm hg atenolol lisinopril produc greater reduct sit systol bp atenolol stand bp decreas mm hg lisinopril mm hg atenolol import hematolog biochem profil drug eleven patient receiv lisinopril receiv atenolol withdrawn advers experi patient default treatment lisinopril group atenolol group drug toler suitabl line therapi essenti hypertens"
"hemodynam effect renin inhibit enalkiren chronic congest heart failur previous effort block reninangiotensin system patient chronic congest heart failur chf focus distal site system angiotensinconvert enzym angiotensin ii receptor recent work led develop agent direct inhibit renin proxim step cascad studi investig hemodynam effect renin inhibit patient chronic chf enalkiren primateselect dipeptid renin inhibitor previous shown suppress plasma renin activ lower blood pressur hypertens patient acut intraven administr enalkiren mgkg produc increas cardiac index literminm stroke volum index mlm decreas left ventricular fill pressur mm hg atrial pressur mm hg heart rate beatsmin system vascular resist dynescm observ renin inhibit produc hemodynam benefit patient chronic chf potenti provid approach interf reninangiotensin system patient disord"
"effect bucindolol neurohormon activ congest heart failur examin effect betaadrenerg blockad neurohormon activ patient congest heart failur men assess hemodynam supin peripher renin norepinephrin level month oral therapi bucindolol nonselect beta antagonist baselin plasma renin activ correl hemodynam paramet norepinephrin level weak correl left ventricular enddiastol pressur stroke volum index pulmonari vascular resist plasma renin decreas bucindolol therapi ngmlhour standard deviat plasma norepinephrin unchang pgml wide divers norepinephrin respons bucindolol observ reduct level patient elev plasma norepinephrin decreas heart rate tend decreas min betaadrenerg blockad suggest neurohormon antagon receptor level metaiodobenzylguanidin uptak occur bucindolol therapi suggest unchang adrenerg uptak norepinephrin betablock therapi reduct plasma renin activ presenc beta blockad respons renin norepinephrin level longterm bucindolol therapi predict patient improv hemodynam status chisquar renin norepinephrin"
"outcom direct coronari angioplasti acut myocardi infarct candid candid thrombolyt therapi coronari angioplasti prior thrombolyt therapi perform patient acut myocardi infarct ami patient divid group depend candid candid thrombolyt therapi patient consid thrombolyt candid present cardiogen shock greater equal year age coronari arteri bypass surgeri reperfus time greater hour thrombolyt nonthrombolyt candid similar rate reperfus nonfat reinfarct recurr myocardi ischemia thrombolyt candid lower mortal rate lower incid bleed improv left ventricular eject fraction follow angiographi thrombolyt nonthrombolyt candid eject fraction improv patient anterior wall ami thrombolyt candid nonthrombolyt candid patient reperfus time greater hour outcom suggest direct coronari angioplasti viabl altern method reperfus patient ami candid thrombolyt therapi nonthrombolyt candid highrisk group patient direct coronari angioplasti benefici subgroup patient cardiogen shock patient present greater hour onset chest pain evid ongo ischemia"
"effect calciumentri blocker nicardipin intraren hemodynam essenti hypertens effect calciumentri blocker nicardipin intraren hemodynam studi essenti hypertens week studi perform patient essenti hypertens regular sodium diet week sodiumrestrict diet fourth week nicardipin mg administ fourth week urinari sodium excret rate unav plot axi arteri pressur map axi administr nicardipin assum differ map intercept renal function curv repres effect filtrat pressur glomerular capillari intraren hemodynam affer arteriolar resist ra effer arteriolar resist glomerular pressur pg gross filtrat coeffici kfg calcul map regular salt diet lower mm hg nicardipin renal blood flow rate rbf mlmin glomerular filtrat rate gfr mlmin alter ra estim reduc dynecm note dynecm pg mm hg kfg mlmm hg essenti hypertens character promin increas ra result mainten normal pg caentri blocker work normal intraren hemodynam essenti hypertens dilat affer arteriol"
"twelveyear incid coronari heart diseas middleag adult era hypertens therapi framingham offspr studi publish erratum med apr purpos provid inform incid coronari heart diseas chd offspr origin cohort framingham heart studi patient method offspr origin particip framingham heart studi underw baselin examin standard cardiovascular risk factor entri studi offspr year free chd year time men women develop chd result multivari proport hazard model chd signific age lower highdens lipoprotein cholesterol hdl level number cigarett smoke fast glucos level lowdens lipoprotein cholesterol ldl high chd men borderlin women triglycerid lowdens lipoprotein cholesterol signific chd adjust hdl glucos blood pressur medic half hypertens individu systol pressur chd women conclus studi confirm import common chd risk factor cigarett smoke ldl extend prognost role hdl middleag cohort impact blood pressur hypertens medic reduc studi data suggest attenu due success treatment"
"furosemideihippuran renographi angiotensinconvert enzym inhibit diagnosi renovascular hypertens purpos previous demonstr greater sensit ihippuran renographi mtcdtpa scintigraphi diagnos renovascular hypertens rvh studi assess predict diagnost furosemideihippuran renographi angiotensinconvert enzym ace inhibit patient rvh patient method patient investig univers miamijackson memori medic center twenti patient rvh twenti patient normal minim decreas renal function serum creatinin level mgdl renal insuffici serum creatinin level mgdl renographi perform minut oral administr mg captopril minut intraven inject microgramskg enalaprilat forti milligram furosemid administ intraven minut inject ihippuran residu cortic activ rca ihippuran measur minut result rvh rca ace inhibit peak cortic activ convers rvh present ihippuran cortic activ steadili increas test reach minut azotem patient rca rvh differenti intrins renal diseas obtain baselin renogram ace inhibit compar rca studi rca ace inhibit rca increas indic worsen renal function ace inhibit rvh intrins renal diseas rca remain unchang decreas indic improv renal function ace inhibit test specif sensit popul direct correl result angioplasti surgeri high blood pressur rca intervent conclus furosemideihippuran renographi ace inhibit high predict identifi patient rvh"
"infus stabl prostacyclin analogu iloprost patient peripher vascular diseas lack antiplatelet effect risk thromboembol purpos prostacyclin potent inhibitor platelet function vasodil treat peripher vascular diseas aim studi monitor thrombot status patient treat infus stabl prostacyclin analogu iloprost patient method thirteen patient peripher vascular diseas underw iloprost infus day hour day dose rang ngkgminut variabl paramet thrombosi platelet reactiv shearinduc hemostat plug format thrombus format collagen fiber coagul spontan thrombolysi dislodg hemostat plug measur anticoagul blood sampl hemostatometri immedi hour infus day hour initi infus result analysi data patient hour infus show platelet reactiv spontan thrombolysi coagul signific enhanc patient signific platelet hyperreact observ infus patient test undergo iloprost infus show enhanc thrombot reaction mark enhanc coagul iloprost employ vitro concentr correspond therapeut peak blood level caus inhibit platelet function signific enhanc coagul threshold vitro iloprost concentr antiplatelet effect increas spontan thrombolysi observ therapeut blood level conclus find challeng view antagon platelet function import factor iloprost therapi platelet hyperreact patient mark enhanc coagul infus iloprost general repres risk thromboembol patient prethrombot condit"
"protamineheparininduc pulmonari hypertens pig effect treatment thromboxan receptor antagonist hemodynam coagul advers hemodynam reaction protamin neutral heparin infrequ import clinic problem pretreat swine thromboxan receptor antagonist report prevent pulmonari hypertens respons occasion protamin revers heparin anticoagul current studi control group pig receiv intraven heparin iukg min neutral dose protamin mgkg treatment group pig treat ident thromboxan receptor antagonist mgkg infus intraven min protamin infus hemodynam coagul profil monitor procedur pulmonari hypertens develop reach peak min protamin administr time administ treatment group statist differ control treatment group peak pulmonari arteri pressur peak pulmonari vascular resist interv return pulmonari arteri pressur peak baselin valu versus min sd control treatment group thromboxan plasma concentr increas group correl pulmonari hypertens respons platelet aggreg collagen inhibit thromboxan receptor antagonist bleed time prolong normal rang treat pig coagul test group return baselin revers heparin protamin unaffect"
"coronari left ventricular hemodynam respons revers flunitrazepaminduc sedat flumazenil patient coronari arteri diseas effect revers flunitrazepaminduc sedat flumazenil coronari hemodynam myocardi oxygen consumpt mvo left ventricular lv perform investig doubleblind trial patient stabl coronari arteri diseas undergo cardiac catheter coronari sinus blood flow measur continu thermodilut arteri coronari sinus blood analyz oxygen lactat content determin lv perform obtain cardiac output measur thermodilut left heart catheter data revers flunitrazepaminduc sedat patient random alloc receiv placebo flumazenil increment mg end procedur placebo group signific hemodynam observ flumazenil group heart rate cardiac index maximum veloc shorten relax time constant signific alter contrast aortic pressur lv enddiastol pressur baselin mmhg increas flumazenil administr repres return presed valu mvo coronari resist signific alter csbf increas slight baselin mlmin increas electrocardiograph evid myocardi ischemia observ studi data show revers benzodiazepin effect flumazenil major alter lv systol function relax coronari hemodynam patient coronari arteri diseas cautious lv enddiastol pressur increas time administr"
"morphometri subepitheli circul sheep airway effect vascular congest order quantit subepitheli microvascular volum relat airway lumen conduct morphometr analysi vascular compart wall trachea micron depth epitheli basement membran mm bronchiol sheep lung fix bronchial pulmonari arteri perfus glutaraldehyd experiment condit bronchial arteri pressur mm hg pulmonari arteri pressur mm hg control bronchial arteri pressur mm hg pulmonari arteri pressur mm hg pulmonari hypertens ph bronchial arteri pressur mm hg pulmonari arteri pressur mm hg pharmacolog vasodil sodium nitroprussid ph venous pressur atmospher control condit microvascular volum fraction compris subepitheli tissu trachea mm mm bronchiol ph increas microvascular volum fraction bronchiol effect microvasculatur trachea ph approxim doubl microvascular volum fraction trachea bronchiol ph increas wall thick ph ph decreas airway crosssect area mm bronchiol observ demonstr microvasculatur constitut volum fraction subepitheli airway tissu vascular congest narrow bronchiolar lumen"
"estim left ventricular fill pressur posit endexpiratori pressur human critic ill accur measur left ventricular lv fill pressur pulmonari arteri occlus pressur ppao import diagnost therapeut purpos patient receiv posit endexpiratori pressur peep ppao reflect lv fill pressur elev pericardi pressur ppc propos human ppc atrial pressur pra equal referenc ppao pra improv assess lv fill pressur ppc elev similar shown dog nadir ppao immedi airway disconnect peep nadir ppao accur reflect lv fill pressur lv fill pressur greater equal mm hg examin method estim lv fill pressur ppao measur condit increas ppc primari determin differ measur left atrial pressur pla relat ppc call transmur pla platm lv fill pressur compar accuraci ppao nadir ppao ppao relat pra reflect platm postop cardiac surgeri patient airfil pericardi balloon cathet left atrial cathet insert surgeri peep sequenti increas cm ho found pra exceed ppc increas peep ppc equal cm ho peep ppao nadir ppao similar platm"
"fibrin fibrinogenrel antigen patient venous diseas venous ulcer abnorm system fibrinolysi implic pathogenesi venous ulcer patient venous diseas prolong euglobulin lysi time elev plasma fibrinogen level metabol fibrinogen fibrin patient studi techniqu involv electrophoresi densitometr analysi captur fibrinrel antigen measur concentr proport individu fibrin fibrinogen degrad product patient venous diseas lower extrem group patient venous diseas mark elev level total fibrinrel antigen dimer termin degrad product crosslink fibrin level monom breakdown product fibrinogen crosslink fibrin monom measur fibrinogenolysi normal patient patient ulcer level dimer disproportion higher expect fibrin monom level individu basi signific elev dimer present patient venous diseas ulcer patient venous diseas ulcer conclud patient venous diseas uniform evid enhanc fibrin format evidenc elev level total fibrinrel antigen dimer venous diseas accompani ulcer"
"deterior delay perform femor angioplasti uncommon delay occur assess arteriographi angioplasti attempt review retrospect arteriogram patient delay occur assess progress superfici femor arteri sfa diseas interv delay day rang day occur arteriogram angioplasti attempt arteriograph deterior found patient preclud angioplasti patient initi arteriographi side sfa diseas whilst arteriographi contralater femor approach discuss aetiolog phenomenon suggest made reduc incid"
"hemodynam profil prostaglandin isoproterenol prostacyclin nifedipin experiment porcin pulmonari hypertens background method compar hemodynam effect vasodil experiment embol pulmonari hypertens random control trial pig weigh kg anesthesia induct cannul arteri central venous thermodilut output pulmonari arteri cathet anim repetit embol glass bead mu order establish pulmonari hypertens pulmonari arteri pressur pap doubl baselin prostaglandin pge isoproterenol prostacyclin pgi nifedipin compar dose produc equival reduct system bp result pge pgi decreas pap pulmonari vascular resist pvr pge decreas pap mm hg prostacyclin decreas pap mm hg produc largest increas cardiac output qt isoproterenol chang pap mark increas heart rate beatsmin result signific arrhythmia nifedipin increas pvr dyneseccm decreas qt conclus vasodil demonstr uniqu hemodynam drug profil isoproterenol infus character tachycardia arrhythmia pge pgi effect decreas pap pvr nifedipin depress qt signific glassbead embol model acut pulmonari hypertens"
"effect milrinon pulmonari vasculatur normal dog dog pulmonari hypertens object studi effect milrinon pulmonari vasculatur background suggest bipyridin deriv select pulmonari vasodil effect method preliminari studi milrinon administr normal dog low dose bolus microgramskg min continu infus microgramskgmin high dose bolus microgramskg min continu infus microgramskgmin main studi milrinon administr dog pulmonari hypertens due pulmonari embol induc massiv inject autolog muscl cube pulmonari hypertens dog divid group group receiv embol control group receiv lowdos milrinon group receiv highdos milrinon equival preliminari studi group hemodynam measur blood sampl obtain baselin min start milrinon infus result milrinon chang pulmonari arteri pressur mpap normal dog milrinon decreas mpap signific dog pulmonari hypertens pulmonari vascular resist index remain constant level normal dog decreas signific dog pulmonari hypertens arteri pressur maintain constant level group highdos milrinon administr decreas system vascular resist index svri signific lowdos milrinon administr decreas svri slight conclus milrinon select pulmonari vasodilatori effect dog pulmonari hypertens mechan produc select pulmonari vasculatur dog pulmonari hypertens unknown inhibit platelet aggreg decreas mpap result increas camp caus milrinon studi resolv pulmonari vasodilatori effect milrinon dog pulmonari hypertens"
"prospect studi sodiumlithium countertransport hypertens utah year prospect studi cohort normotens adult utah pedigre screen determin baselin level sodiumlithium countertransport increas risk futur hypertens subsequ hypertens ascertain detail follow medic questionnair respons previous segreg analys subset pedigre member respond famili relationship addit countertransport level shown statist infer major gene segreg sodiumlithium countertransport level normotens adult infer segreg analysi carri recess major gene high sodiumlithium countertransport onset hypertens occur compar low sodiumlithium countertransport genotyp group relat risk elev baselin sodiumlithium countertransport level genotyp inform segreg analysi increas risk futur hypertens complet cohort adult pedigre member relat risk adjust risk factor reduc relat risk conclud presenc major gene sodiumlithium countertransport close link gene actual level sodiumlithium countertransport increas risk hypertens onset high sodiumlithium countertransport level increas risk futur hypertens individu polygen environment effect determin sodiumlithium countertransport level"
"highnorm blood pressur progress hypertens framingham heart studi studi sought determin individu highnorm blood pressur diastol blood pressur mm hg progress hypertens frequent normal blood pressur diastol blood pressur mm hg advanc higher cardiovascular risk categori individu framingham heart studi normal highnorm blood pressur categori year develop hypertens hypertens defin diastol blood pressur mm hg greater initi antihypertens therapi men women normal blood pressur develop hypertens compar men women highnorm blood pressur relat risk develop hypertens highnorm blood pressur men confid interv ci women ci ageadjust relat risk estim proport hazard model men women risk factor examin baselin systol diastol blood pressur metropolitan relat weight chang weight time signific predictor futur hypertens men women initi blood pressur normal men highnorm blood pressur systol blood pressur chang weight identifi risk factor futur hypertens result probabl individu blood pressur highnorm rang develop hypertens twofold threefold higher normal blood pressur"
"renal manifest nacl sensit borderlin hypertens rat compar normotens wistarkyoto rat spontan hypertens rat exhibit exagger alter renal sympathet nerv activ excretori function volum expans exagger natriuresi environment stress antinatriuresi borderlin hypertens rat filial offspr spontan hypertens rat wistarkyoto rat develop hypertens increas dietari nacl intak present investig sought determin dietari nacl intakeinduc transit normotens state wistarkyoto parent hypertens state spontan hypertens parent borderlin hypertens rat accompani similar transit renal sympathet nerv activ excretori respons volum expans environment stress borderlin hypertens rat fed nacl diet remain normotens exhibit renal sympathet nerv activ excretori respons volum expans environment stress similar wistarkyoto parent borderlin hypertens rat fed nacl diet develop hypertens exhibit respons similar spontan hypertens parent dietari nacl intakeinduc transit normotens state wistarkyoto parent hypertens state spontan hypertens parent borderlin hypertens rat accompani similar transit renal sympathet nerv activ excretori respons volum expans environment stress result suggest increas dietari nacl intak induc unmask capabl respons genet convey borderlin hypertens rat spontan hypertens rat parent latent form"
"exclus na antiport candid gene human essenti hypertens primari abnorm contribut pathogenesi human essenti hypertens unknown genet contribut disord suggest genet linkag analysi test specif candid gene contribut pathogenesi essenti hypertens intermedi phenotyp phenotyp elev erythrocyt nali countertransport slc support major gene inherit pedigre analysi strike similar slc na exchang suggest mutat na antiport gene locus apnh result elev slc contribut subsequ pathogenesi hypertens test hypothes genet linkag analysi apnh candid gene determin genotyp apnh flank loci pedigre support major gene segreg elev slc exclud linkag apnh major slc locus lod score odd ratio linkag analysi hypertens sibl pair demonstr apnh explain varianc slc hypertens individu greater final direct test linkag apnh gene predispos hypertens linkag hypertens sibl pair allel share apnh greater expect random assort hypertens sibl versus greater upper confid limit mutat apnh rare contribut pathogenesi hypertens popul"
"methodolog sodium sensit assess age sex articl address methodolog sodium sensit assess report suggest high sodium intak elev blood pressur trial reduct sodium intak reduc blood pressur high implic find discuss studi sodium sensit suffer call normal probabl fallaci control condit intervent sodium restrict incorrect assign pronounc respons subgroup studi popul find review age sex determin respons blood pressur variat sodium intak limit data suggest subject older higher blood pressur level benefit reduct sodium intak addit elder subject high dietari sodium intak higher risk develop hypertens find nonexperiment experiment studi tend support view find sex differ consist systemat approach assess factor mechan respons sodium sensit subject determin benefit data basi discrimin sodiumsensit sodiumresist hypertens subject"
"racial ethnic modifi saltblood pressur respons relat sodium blood pressur centuri question substanti bodi epidemiolog experiment data accumul strong implic nacl causal role genesi arteri hypertens prospect studi perform divers popul manipul nacl exposur diet infus repeat document nacl pressor effect similar studi biraci popul demonstr greater preval salt sensit black compar white reason observ clear intrins hypertensioninduc renal abnorm limit natriuret capac reduc naatpas pump activ membran ion transport disturb differenti exposur psycholog stressor greater insulin resist dietari factor reduc ca intak suggest possibl play role salt sensit widespread phenomenon critic import determin factor account racial differ salt sensit preval salt sensit general popul unknown current definit salt sensit vari unidirect comparison bidirect criteria blood pressur increas salt load blood pressur decreas salt restrict inadequ identifi saltsensit individu manifest extrem blood pressur chang dietari sodium plasma volum manipul sensit criteria diagnos salt sensit facilit understand racial ethnic differ preval salt sensit"
"biohistori slaveri blood pressur differ black today hypothesi genet factor play import role variat blood pressur level genet factor explain higher averag blood pressur level western hemispher black compar african black consid genet makeup popul larg determin biolog ecolog forc past examin biohistori black specif slaveri era conduct overview salient find investig includ articl publish histor evid transatlant slave trade world slaveri centuri centuri reveal condit exist natur select genet virtual inevit slave popul period histori mortal extrem high fertil reproduct success low survivor plantat societi western hemispher depend constant import captiv million africa viabil plantat communiti major death saltdeplet diseas diarrhea fever vomit argu individu enhanc geneticbas abil conserv salt distinct surviv advantag bequeath genotyp subsequ generat western hemispher black predict black america greater frequenc individu enhanc geneticbas abil conserv salt african black"
"sodiumpotassium interact hypertens hypertens cardiovascular diseas epidemiolog evid suggest low potassium intak probabl occurr hypertens stroke shortterm respons increas potassium intak increas sodium excret increas potassium excret shortterm respons increas sodium intak increas potassium excret increas sodium excret experiment studi increas amount potassium block noxious influenc sodium sodium potassium concomit consid investig associ cation hypertens cardiovascular diseas chlorid ion import sodium effect import potassium effect extens explor"
"consensus approach electrolyt blood pressur commentari set hypothesi putat benefici detriment effect specif electrolyt blood pressur regul fact reflect high integr respons interact cation anion speci paradigm impact intak electrolyt arteri pressur influenc concurr consumpt electrolyt heterogen blood pressur respons human isol manipul nutrient sodium calcium potassium determin part adequaci dietari intak miner element hypothesi valid continu research area strategi improv blood pressur control human treatment nacl sensit human effect approach correct dietari defici potassium calcium restrict dietari nacl"
"dietari sodium reduct hypertens prevent treatment nutritionalnonpharmacolog approach treatment prevent hypertens great interest sodium reduct primari method recommend purpos general public interest reduct dietari sodium intak respond decreas tabl salt purchas lower sodium food product food label guid food purchas countervail trend conveni food dine increas difficulti individu lower sodium intak clinic trial sodium reduct combin lifestyl therapi demonstr feasibl reduc dietari sodium intak year varieti popul trial lifestyl weight loss intervent achiev signific reduct bodi weight alcohol consumpt increas physic activ varieti studi longterm sodium reduct feasibl accept patient negat consequ intervent observ case improv intak nutrient occur nonpharmacolog intervent result hypertens control signific proport trial popul studi demonstr forego type intervent signific contribut hypertens treatment prevent"
"perspect reduc salt intak epidemiolog clinic experiment evid link excess salt consumpt hypertens evid benefici conclud public polici advis american reduc salt intak mild hypertens increas risk problem amen treatment treatment clinic hypertens likelihood identif risk success capac time conduct success prevent field trial difficult individu modifi diet success strategi modifi food suppli chang public demand public respond dietari advic accept identifi product salt commerci prepar food consumpt increas futur major respons lower salt consumpt fall food manufactur begin respond ampl opportun reduc salt content food mark temporari object modest unrealist object discourag attempt follow"
"overview random trial sodium reduct blood pressur test effect systol diastol blood pressur provid precis estim magnitud conduct overview random clinic trial aim reduc intak sodium human subject exclud pool analys trial confound design compar intak level usual rang popul publish report review abstract inform duplic differ reconcil twenti trial outcom data aggreg subject includ data pool separ hypertens normotens subject trial combin sampl size weight blood pressur reduct net control mm hg systol diastol confid limit hypertens subject mm hg normotens subject combin blood pressur reduct mm hg reduct urinari sodium excret rang mmol hr individu trial doserespons relat trial found normotens hypertens subject result sodium reduct lower blood pressur hypertens normotens individu period month find high consist result observ epidemiolog studi implic prevent strategi blood pressur control"
"neurovascular mechan sodium balanc pathogenesi hypertens physiolog studi clarifi role brain interplay salt balanc hypertens neural mechan endocrin secret play pivot role adapt mammal intak excret sodium maneuv alter concentr sodium plasma modifi sensit baroreceptor reflex alter vascular reactiv mediat part releas vasopressin research suggest brain indirect modul abil vascular endothelium releas vasoact factor collect studi illustr multipl effect sodium ion peripher neural central endocrin mechan particip regul arteri pressur"
"genet trait relat hypertens electrolyt metabol genet cultur herit intercorrel trait relat hypertens carri utah pedigre person sibship hypertens person hypertens person trait establish marker sodiumsensit hypertens relat indirect electrolyt metabol risk hypertens signific recess monogen effect high total herit found urinari kallikrein high fat pattern index intraerythrocyt sodium nali countertransport ouabain bind site famili correl strong attribut share environ genet effect found naatpas pump activ intraerythrocyt magnesium plasma digoxin factor plasma renin activ plasma sodium concentr anthropometr variabl test show high signific genet herit low insignific share famili environment effect genet determin cellular cation test correl genet trait includ plasma lipid anthropometr measur cellular cation test hypertens individu famili dyslipidem hypertens plasma insulin level correl obes lipid abnorm cellular cation flux test hypertens"
"sympathet neural contribut saltinduc hypertens dahl rat dahl strain model examin mechan involv genet sensit resist saltinduc hypertens dahl saltsensit rat develop hypertens fed high salt diet dahl saltresist rat remain normotens base earli experi thought hypertens dahl saltsensit rat epitom overrid import renal humor mechan saltinduc hypertens studi past year demonstr alter sympathet neural mechan particip critic genet predisposit saltinduc hypertens dahl saltsensit rat articl briefli review sympathet neural mechan dahl rat includ evid role affer baroreceptor central neural peripher adrenerg mechan saltinduc hypertens dahl saltsensit rat"
"relat sodium intak renal function regul arteri pressur longterm regul arteri pressur requir mainten balanc sodium water intak sodium water excret normal salt water balanc lead stabl bodi fluid volum mainten normal renal function critic establish extracellular fluid volum homeostasi review focus role kidney longterm control salt water balanc emphasi relat sodium intak reninangiotensinaldosteron system renal sympathet nerv activ regul arteri pressur renal sodium water excret accumul evid recent year demonstr low level elev renin releas circul angiotensin ii aldosteron activ renal sympathet outflow alter renal function normal natriuret diuret respons arteri pressur signific imped circumst mainten normal sodium water excret requir signific elev arteri pressur compromis renal function lead elev arteri pressur maintain adequ sodium water balanc period increas sodium intak result chronic elev arteri pressur compromis kidney maintain normal extracellular bodi fluid volum"
"dietari salt blood pressur perspect dietari salt restrict valuabl sole adjunct therapi hypertens disord abund clear hypertens patient compris heterogen group regard salt sensit blood pressur appar methodolog obstacl defin salt sensit individu patient dietari trial defin patient respons salt restrict easili defin marker salt sensit target ponder therapi promis lead includ assess membran ion transport sodiumlithium exchang activ reninangiotensin system includ phenomenon modul hypertens volum regulatori hormon atrial natriuret factor intens studi hypertens patient blood pressur respons normal subject salt restrict mark great variabl possibl deleteri consequ populationwid salt restrict peopl set unit state imprud recommend polici proven worth demonstr clinic trial pend evid develop marker salt restrict reserv demonstr efficaci"
"avoid interpret pitfal assess arrhythmia suppress myocardi infarct insight longterm observ placebotr patient cardiac arrhythmia pilot studi cap cardiac arrhythmia pilot studi cap year trial analyz safeti effect arrhythmia suppress patient surviv acut myocardi infarct greater equal ventricular prematur depolar greater equal run ventricular tachycardia holter record obtain day acut infarct patient receiv placebo doubleblind fashion year comprehens object analysi perform spontan arrhythmia base real data statist estim cap placebo group develop clinic event year death heart failur proarrhythmia attribut antiarrhythm drug toxic signific reduct frequenc ventricular prematur depolar occur week therapi signific decreas month initi placebo antiarrhythm therapi appar ventricular prematur depolar suppress greater equal reduct holter record evalu half holter record assess suppress perform"
"evalu preload reserv isometr exercis test patient myocardi infarct doppler echocardiograph studi estim preload reserv respons increas afterload patient myocardi infarct relat doppler echocardiograph inflow veloc pattern left ventricular enddiastol pressur investig isometr handgrip exercis test studi popul consist normal subject patient myocardi infarct patient subdivid group left ventricular enddiastol pressur rest group patient mm hg group ii patient mm hg rest ratio peak veloc atrial contract phase peak veloc earli diastol fill phase signific higher patient myocardi infarct normal subject valu subgroup myocardi infarct differ signific ratio left ventricular enddiastol pressur increas signific exercis group convers chang left ventricular enddiastol pressur exercis group ii signific greater group decreas ratio atrial compensatori mechan oper effect respons increas afterload patient normal left ventricular fill pressur compensatori mechan deterior patient elev left ventricular fill pressur due limit preload reserv"
"noninvas assess intrins ventricular load dynam dilat cardiomyopathi basi hemodynam theori noninvas method develop provid improv insight signific depress doppler left ventricular eject variabl patient dilat cardiomyopathi net forc intraventricular flow eject written dvdt eject veloc variabl relat geometri ventricl outflow tract instantan level forc calcul normal subject patient dilat cardiomyopathi doppler mode dimension echocardiographi maxim eject forc fmax kdyn normal subject kdyn dilat cardiomyopathi peak local acceler outflow veloc sever depress cardiomyopathi compar normal subject versus cms versus cm maxim eject forc attain earli eject signific linear correl found peak outflow acceler maxim eject forc time peak eject veloc net forc decreas peak cardiomyopathi normal subject decreas peak normal subject eject forc posit eject cardiomyopathi posit peak attain total left ventricular systol wall stress declin rapid eject normal subject peak endeject remain elev eject patient cardiomyopathi peak endeject versus normal maxim eject forc correspond calcul intraventricular peak pressur gradient mm hg normal subject mm hg cardiomyopathi averag contribut intrins compon left ventricular systol load wall stress ventricular aortic pressur gradient total myocardi load rang normal subject rang cardiomyopathi abstract truncat word"
"reproduc electr induc sustain monomorph ventricular tachycardia antiarrhythm therapi reproduc sustain ventricular tachycardia induct evalu prospect studi perform patient clinic sustain monomorph ventricular tachycardia program electr stimul perform protocol drugfre studi subsequ studi antiarrhythm therapi sustain monomorph ventricular tachycardia reproduc studi signific differ incid reproduc tachycardia drugfre state compar observ treatment class antiarrhythm drug increas number extrastimuli requir reiniti tachycardia studi singl doubl extrastimuli initi requir induc tachycardia studi reproduc tachycardia induct tachycardia signific differ electrocardiograph ecg configur cycl length observ suggest reproduc ventricular tachycardia induct suffici high provid reliabl marker evalu efficaci therapeut intervent specif tachycardia characterist cycl length ecg configur variabl studi assess effect subsequ intervent"
"differ qrs configur unipolar pace adjac site implic spatial resolut pacemap examin spatial resolut unipolar pacemap lead electrocardiogram ecg record pace pole quadripolar cathet mm interelectrod distanc examin unipolar pace perform pole late diastol threshold threshold ma cycl length ms patient pace perform ventricular apex left ventricular site pace distal cathet pole threshold index ecg simul site origin ventricular tachycardia ecg compar index ecg electrocardiogram evalu independ observ minor configur differ notch small compon chang amplitud individu compon chang qrs shape major differ configur larg compon mark chang amplitud exist compon minor peak peak amplitud minor differ configur lead pace mm distal electrod index site major differ configur lead pace mm index site differ amplitud lead ecg pace mm index ecg pace site"
"longitudin dissoci atrioventricular accessori pathway unusu properti atrioventricular av accessori pathway found electrophysiolog investig patient men woman anterograd longitudin dissoci accessori pathway observ patient retrograd longitudin dissoci patient accessori pathway slow conduct time anterograd direct retrograd direct observ expand knowledg spectrum electrophysiolog properti accessori av pathway"
"late noninvas evalu cardiac perform mild symptomat older patient ebstein anomali tricuspid valv role radionuclid imag ten patient year age isol ebstein anomali tricuspid valv evalu electrocardiographi maxim exercis treadmil test electrocardiograph ecg monitor echocardiographi rest radionuclid imag left ventricl patient present st year life undergon surgic intervent function class ii patient preexcit surfac ecg abnorm tachyarrhythmia bradyarrhythmia patient ecg monitor subnorm exercis perform observ patient echocardiographi demonstr typic variabl tricuspid valv displac paradox interventricular septal motion left ventricular enddiastol dimens normal patient posterior wall motion reduc moder sever tricuspid regurgit doppler jet veloc demonstr patient left ventricular radionuclid scintigraphi reveal subnorm eject fraction patient previous shown suboptim exercis perform youngest patient year arrhythmia normal exercis perform normal left ventricular eject fraction correl degre tricuspid valv displac regurgit presenc rhythm disturb exercis perform radionuclid left ventricular function late evalu patient ebstein anomali demonstr signific unsuspect abnorm cardiac rhythm exercis perform left ventricular function radionuclid scintigraphi noninvas techniqu assess left ventricular dysfunct patient"
"hospit mortal balloon aortic valvuloplasti frequenc factor percutan balloon aortic valvuloplasti accompani signific earli periprocedur morbid mortal identif factor increas mortal improv select patient mansfield scientif balloon aortic valvuloplasti registri analyz identifi frequenc hospit death factor patient undergo procedur die hospit stay valvuloplasti perform twenti patient die remaind die day procedur signific differ baselin clinic hemodynam characterist procedur postprocedur variabl patient die surviv hospit period multivari analysi identifi factor increas mortal occurr procedurerel complic lower initi left ventricular systol pressur smaller final aortic valv area lower baselin cardiac output baselin hemodynam procedur postprocedur variabl complic identifi increas mortal"
"predictor longterm surviv percutan aortic valvuloplasti report mansfield scientif balloon aortic valvuloplasti registri percutan balloon aortic valvuloplasti prospect treat elder symptomat nonsurg patient suffer sever aortic stenosi center north america europ year surviv rate eventfre surviv rate surviv free valv replac repeat valvuloplasti clinic catheter procedur variabl assess defin prognost variabl univari analysi reveal patient surviv lesser frequenc previous myocardi infarct versus lower incid sever ventricular dysfunct versus lower incid symptom heart failur versus histori angina versus ns syncop versus ns similar group valu obtain cardiac catheter differ survivor nonsurvivor includ lower pulmonari arteri systol pressur versus mm hg lower pulmonari arteri pressur versus mm hg larger initi valv area versus cm discrimin function analysi perform identifi variabl independ predict improv probabl surviv variabl signific independ predict includ age initi cardiac output initi left ventricular systol pressur initi left ventricular enddiastol pressur presenc coronari arteri diseas york heart associ dyspnea classif number balloon inflat final valv area"
"ventricular load optim unload therapi patient heart failur effect unload depress heart assess term optim coupl ventricl arteri system assess effect preload ventricular load coupl preload reduc lower bodi negat pressur mm hg nitroprussid evalu effect afterload coupl condit preload reduct compar lower bodi negat pressur patient heart failur eject fraction se direct arteri pressur simultan record left ventricular echocardiogram pressur elev phenylephrin left ventricular contractil properti defin slope ee endsystol pressurevolum relat effect arteri elast ea express slope endsystol pressurestrok volum relat left ventricular extern work endsystol potenti energi work effici defin extern work pressur volum area extern work potenti energi determin baselin ventricular load coupl patient character increas ratio arteri elast ventricular elast eaee ratio decreas signific nitroprussid increas lower bodi negat pressur endsystol potenti energi decreas nitroprussid unalt lower bodi negat pressur extern work compar decreas manipul indic work effici signific augment nitroprussid declin lower bodi negat pressur"
"cardiovascular hormon effect calcitonin generel peptid congest heart failur effect infus human alphacalcitonin generel peptid studi patient congest heart failur normal rabbit rabbit adriamycininduc cardiomyopathi patient heart failur calcitonin generel peptid caus dosedepend increas cardiac output decreas pulmonari system vascular resist pulmonari arteri pressur system blood pressur atrial pulmonari wedg pressur decreas highest infus rate ngkg min heart rate remain unchang plasma epinephrin increas aldosteron atrial natriuret peptid prolactin concentr decreas plasma norepinephrin renin activ cortisol growth hormon concentr remain unchang group rabbit drug decreas blood pressur increas cardiac output heart rate signific increas renal blood flow peptid affect contract amplitud human rabbit ventricular myocyt find suggest calcitonin generel peptid vasodil rabbit human direct effect ventricular myocardium peptid form heart failur"
"experiment pericardi effus relat abnorm respiratori variat mitral flow veloc hemodynam diastol heart collaps pericardi effus abnorm increas respiratori variat mitral flow veloc relat flow veloc pericardi pressur hemodynam dimension echocardiograph find establish sedat dog extens hemodynam instrument studi dimension doppler echocardiographi stage progress larger pericardi effus stage effus respiratori variat peak mitral flow veloc earli diastol left ventricular isovolumetr relax time increas compar baselin increas earliest stage effus pericardi pressur versus mm hg baselin preced unequivoc diastol heart collaps dog maxim respiratori variat coincid atrial collaps pericardi pressur mm hg inspiratori decreas aortic pressur mm hg aortic pressur versus mm hg baselin cardiac output versus litersmin baselin increas stage sever hemodynam compromis addit respiratori peak mitral flow veloc earli diastol simultan diastol transmitr pressur gradient conclud model acut pericardi effus increas respiratori variat earli diastol mitral flow veloc peak mitral flow veloc earli diastol left ventricular isovolumetr relax time occur immedi pericardi pressur increas persist stage increas pericardi effus abnorm respiratori variat occur equal intracardiac pressur onset unequivoc heart collaps respiratori variat occur result diastol transmitr pressur gradient magnitud respiratori chang necessarili predict pericardi pressur sever hemodynam compromis sever stage pericardi effus"
"spontan alter coronari blood flow veloc coronari angioplasti patient sever angina cyclic coronari arteri flow variat spontan declin coronari blood flow low level document stenos canin coronari arteri endotheli injuri flow variat transient platelet aggreg dislodg releas select mediat includ thromboxan serotonin cyclic spontan flow variat demonstr stenos coronari arteri human studi hypothesi test spontan coronari blood flow veloc variat occur patient stenos coronari arteri coronari arteri angioplasti patient sever limit angina underw intracoronari puls doppler velocimetri dilat arteri immedi percutan translumin coronari angioplasti control patient underw velocimetri angiograph normal coronari arteri cathet mhz doppler crystal posit achiev maxim stabl signal flow veloc signal record continu min spontan flow veloc variat greater equal chang doppler frequenc shift wide morpholog present patient test spontan flow veloc variat occur angioplasti patient angioplasti angioplasti addit patient spontan coronari arteri flow veloc variat angioplasti frank vasospasm adjac area distal area coronari dilat immedi balloon inflat data establish spontan coronari arteri flow veloc variat occur patient sever limit angina coronari angioplasti variat relat platelet aggreg coronari vasoconstrict site endotheli injuri result plaqu fissur ulcer endotheli medial injuri occur coronari angioplasti"
"elev plasma betaendorphin level patient congest heart failur recent experiment studi show opioid system import pathophysiolog cardiovascular impair congest heart failur plasma betaendorphin level measur patient congest heart failur compar age gendermatch normal subject relat plasma betaendorphin level cardiac function rest exercis capac assess patient dilat cardiomyopathi exercis capac determin symptomlimit maxim treadmil exercis expir gas analysi plasma betaendorphin level elev correl patient york heart associ function cardiac status control pgml class ii pgml class iii pgml class iv pgml sd relat found plasma betaendorphin level left ventricular systol perform assess mode doppler echocardiographi plasma betaendorphin level negat correl cardiac output determin doppler echocardiographi posit correl system vascular resist correl calf blood flow measur plethysmographi good correl found plasma betaendorphin level rest exercis capac correl peak oxygen consumpt anaerob threshold peak ratepressur product data show plasma betaendorphin level elev patient congest heart failur reflect degre sever diseas"
"implic echocardiograph assist diagnosi pericardi tamponad contemporari medic patient detect hemodynam embarrass identif suspect pericardi tamponad decis perform invas drainag pericardi space histor base classic bedsid find dimension echocardiographi improv detect pericardi effus excess sensit evalu patient hemodynam embarrass consecut medic patient examin identifi echocardiographi probabl tamponad defin presenc heart chamber collaps presenc pericardi effus underw combin side cardiac catheter percutan pericardiocentesi patient elev pericardi pressur minim evid hemodynam compromis systol blood pressur greater equal mm hg cardiac index greater equal litersmin pericardiocentesi result hemodynam improv frequent allevi dyspnea correct tachycardia patient malign tamponad high mortal rate cumul probabl surviv patient year echocardiograph assist diagnosi pericardi tamponad medic patient result identif substanti subset patient subtl evid hemodynam compromis subset patient differ sharpli medic patient previous report classic tamponad patient manag invas cathet pericardiocentesi complic natur histori optim manag strategi group resolv"
"recognit embol potenti intraaort atherosclerot debri atherosclerot diseas thorac aorta common elder patient clinic coronari arteri diseas embol occur atherosclerot debri thorac aorta common consid differenti diagnosi sourc system embol current studi preval clinic signific embol potenti intraaort atherosclerot debri detect transesophag echocardiographi determin intraaort atherosclerot debri identifi patient undergo transesophag echocardiographi embol event occur studi patient intraaort atherosclerot debri incid embol event higher debri peduncul high mobil patient layer immobil patient patient undergo invas procedur aorta incid embol conclus patient embol event thorac aorta consid potenti sourc transesophag echocardiographi reliabl detect intraaort atherosclerot debri identifi invas aortic procedur avoid"
"coronari arteri remodel studi highfrequ epicardi echocardiographi earli compensatori mechan patient obstruct coronari atherosclerosi coronari arteri remodel compensatori mechan limit advers effect coronari obstruct lesion expans entir vascular segment determin compensatori anatom chang occur patient highfrequ epicardi echocardiographi mhz transduc perform open heart surgeri patient normal coronari arteri undergo valvular surgeri coronari atherosclerosi stopfram videotap highfrequ epicardi echocardiograph imag crosssect measur lumin area total arteri area lumen intima media dens adventitia made patient atherosclerosi site arteri lesion proxim portion arteri remodel defin enlarg total arteri area normal arteri measur made proxim midarteri locat patient normal coronari arteri total arteri area determin highfrequ echocardiographi decreas proxim site midport arteri mm lumin area decreas mm patient coronari arteri lesion lumin area decreas proxim site arteri lesion site mm total arteri area increas mm coronari arteri evalu angiograph evid coronari collater format data coronari arteri remodel import compensatori mechan obstruct coronari diseas"
"detect coronari blood flow left main coronari arteri stenosi transesophag doppler color flow echocardiographi demonstr disord blood flow coronari arteri anticip presenc stenosi examin possibl disord coronari blood flow left main coronari stenosi left main coronari flow visual transesophag doppler color flow echocardiographi patient undergo coronari angiographi twenti patient signific left main coronari stenosi group patient group adequ dimension echocardiograph imag left main coronari arteri obtain patient group patient group sixteen patient group includ patient stenosi defin dimension echocardiographi exhibit alias reddishyellowish element produc mosaic pattern stenot poststenot segment contrast nonalias bluish jet suggest laminar flow transduc echocardiogram patient group group includ patient stenosi imag dimension echocardiographi alias mosaic pattern found patient group sensit detect stenosi improv doppler color flow imag appli flow veloc signific higher site stenosi patient group cm sd group cm suggest augment flow veloc turbul due stenosi contribut mosaic flow imag"
"forearm blood flow respons postur chang invas measur venous occlus plethysmographi peripher vascular respons postur chang elder peopl vulner develop orthostat hypotens due part risk util invas vascular monitor techniqu elder popul studi forearm vascular respons activ stand healthi young healthi impair elder subject invas techniqu venous occlus plethysmographi subject techniqu compar duplex doppler ultrasonographi measur postur forearm blood flow forearm blood flow determin venous occlus plethysmographi larger doppler measur method strong correl forearm vascular resist increas signific greater extent minut stand young subject group respons variabl group healthi elder impair elder subject unexpect forearm vasodilat minut stand minut forearm vascular resist increas similar amount group subject impair elder healthi young healthi subject orthostat hypotens defin greater equal mm hg declin arteri blood pressur minut stand forearm vascular resist correl blood pressur respons stand forearm vascular respons minut activ stand attenu elder subject abnorm impair adapt orthostat stress advanc age"
"ostium secundum atrial septal defect elder atrial septal defect asd common congenit cardiac anomali adult life expect shorten patient die age year progress congenit diseas congest heart failur relat factor onset pulmonari hypertens arrhythmia bronchopulmonari infect develop cardiovascular diseas describ case patient signific asd late develop symptom higher risk poorer longterm result surgic closur defect advanc age indic intervent elder patient care evalu"
"arteri aneurysm children clinicopatholog classif thirti arteri macroaneurysm pediatricag patient boy girl treat univers michigan averag age time diagnosi year rang month year vessel involv aorta hepat splenic gastroepiplo renal iliac superfici femor poplit brachial radial ulnar arteri twelv children exhibit overt clinic manifest includ presenc mass local pain hematemesi painless obstruct jaundic eleven children asymptomat lesion aneurysm exist confirm arteriographi oper child underw surgic therapi longterm survivor follow year oper death occur death occur year surgeri experi review previous report case serv basi categor childhood aneurysm diseas true aneurysm arteri infect ii giantcel aortoarter iii autoimmun connect tissu diseas iv kawasaki diseas ehlersdanlo syndrom marfan syndrom vi form noninflammatori medial degener vii arteri dysplasia viii congenitalidiopath factor ix fals aneurysm extravascular event caus vessel wall injuri disrupt knowledg vari clinicopatholog characterist arteri aneurysm children import treat patient"
"role duplex scan select patient translumin angioplasti part initi evalu determin patient lower extrem ischemia candid intervent arteri duplex examin perform noninvas vascular laboratori patient isol short stenos duplex examin refer translumin angioplasti hundr thirti arteriogram perform ischem peripher vascular diseas patient juli march hundr ten arteriogram preced lower extrem arteri duplex evalu fifti case schedul translumin angioplasti base find duplex examin translumin angioplasti perform case signific differ age sex diabet found patient refer translumin angioplasti data demonstr duplex scan lower extrem detect lesion amen translumin angioplasti duplex scan standard screen tool detect treatabl lower extrem lesion"
"ultrasound screen degre relat patient abdomin aortic aneurysm pedigre construct patient proband underw resect abdomin aortic aneurysm proband degre relat parent sibl child abdomin aortic aneurysm multiplex famili determin preval undiagnos abdomin aortic aneurysm ultrasound screen degre relat age year undertaken elig relat screen occult abdomin aortic aneurysm defin infraren aortic diamet greater cm infrarenalsupraren aortic diamet ratio greater incipi abdomin aortic aneurysm defin clear focal bulg infraren aorta cm greatest diamet relat found occult abdomin aortic aneurysm agesex found incipi abdomin aortic aneurysm agesex smaller abdomin aortic aneurysm patient younger oper proband averag age men year women year individu famili previous consid simplex increas actual multiplex famili frequenc abdomin aortic aneurysm found sibl age year older abdomin aortic aneurysm found relat age year children age year parent sibl age year older men women found previous undiagnos abdomin aortic aneurysm"
"influenc elast compress stock deep venous hemodynam determin effect elast compress stock deep venous hemodynam measur ambulatori venous pressur venous refil time maximum venous pressur exercis amplitud venous pressur excurs duplexderiv common femor poplit vein diamet peak flow veloc stock healthi subject patient chronic deep venous insuffici effect knee knee torr torr gradient stock studi document substanti stock compress effect skin pressur measur knee knee elast compress stock signific improv ambulatori venous pressur venous refil time maximum venous pressur exercis amplitud venous pressur excurs healthi patient patient deep venous insuffici greater patient deep venous insuffici stock modest increas poplit vein diamet flow veloc upright rest posit tipto exercis stock deep venous peak flow veloc increas healthi patient patient deep venous insuffici poplit vein common femor vein applic elast compress stock modest augment deep venous flow veloc occur group bare leg exercis elast compress stock improv deep venous hemodynam measur patient deep venous insuffici benefici effect stock treatment deep venous insuffici relat effect deep venous hemodynam"
"associ skin color blood pressur black low socioeconom status determin associ skin color measur reflectomet blood pressur black studi communiti sampl black citi person antihypertens medic exclud systol diastol blood pressur higher darker person increas mm hg sd increas skin dark associ depend socioeconom status measur educ index consist educ occup ethnic present person lower level indic multipl linear regress systol diastol blood pressur remain signific darker skin color lower level socioeconom status independ age bodi mass index concentr blood glucos serum urea nitrogen serum uric acid urinari sodium potassium associ skin color blood pressur low socioeconom strata due lesser abil group deal psychosoci stress darker skin color find consist interact environment factor low socioeconom status suscept gene higher preval person darker skin color"
"erythrocyt sediment rate congest heart failur background method physician long believ erythrocyt sediment rate low patient congest heart failur concept base misinterpret result singl report publish reevalu concept modern era measur sediment rate patient refer treatment chronic heart failur result sediment rate low mm hour patient percent increas mm hour percent patient low normal sediment rate equal mm hour sever hemodynam abnorm patient elev rate lower cardiac index sem liter minut squar meter bodysurfac area higher atrial pressur sem mm hg york heart associ function class iv symptom present percent patient low normal sediment rate compar percent elev rate month therapi patient sediment rate decreas show hemodynam clinic respons treatment cardiac perform function status improv patient rate increas comparison group sediment rate correl plasma fibrinogen level sediment rate treatment correl invers atrial pressur longterm follow patient low normal sediment rate wors year surviv patient elev rate percent conclus data erythrocyt sediment rate correl sever ill patient chronic heart failur lack discriminatori power test limit clinic manag disord"
"circadian rhythm blood pressur schoolag children normotens hypertens parent purpos studi describ characterist blood pressur rhythm schoolag children compar circadian mesor amplitud children normotens parent children hypertens parent sampl consist healthi children year children parent histori hypertens blood pressur measur hour day minut night hour cycl dinamap monitor equip automat printer cosinor analys reveal statist signific circadian rhythm systol diastol blood pressur subject acrophas systol diastol pressur occur hour systol mesor diastol mesor amplitud systol pressur diastol pressur statist signific differ circadian mesor amplitud children normotens parent children hypertens parent found"
"cineangiographi heart singl breath hold segment turboflash sequenc healthi volunt patient cardiac anomali studi comparison segment turboflash fast lowangl shot cine method magnet reson imag permit entir seri highresolut cine imag obtain breath hold standard cine segment turboflash gradientecho sequenc design short imag time combin segment data acquisit method presatur puls appli elimin blood pool signal signalnois ratio assess phantom standard hardwar imag reconstruct method breathhold imag consist show reduc ghost blur respir short echo time segment turboflash insensit dephas caus local field disturb flow author conclud reduc imag time elimin respiratori artifact segment turboflash perform cine studi heart great vessel"
"gynecolog vascular abnorm diagnosi doppler author describ duplex color doppler ultrasonographi pelvi women demonstr presenc venous malform patient pulsatil vagin mass shown arterioven malform vagin wall patient shown unsuspect venous angioma endometri caviti patient shown adnex varic close mimick hydrosalpinx case duplex color flow capabl endovagin probe import"
"noninvas assess cerebr collater blood suppli ophthalm arteri assess potenti mhz pulsedwav transorbit doppler ultrasonographi delin role ophthalm arteri sourc collater cerebr blood suppli compar oculopneumoplethysmographi transorbit doppler ultrasonographi periorbit continuouswav doppler ultrasonographi transcrani doppler ultrasonographi patient unilater intern carotid arteri occlus control normal intern carotid arteri systol ophthalm arteri blood veloc reduc ipsilater intern carotid arteri occlus cmsec compar contralater control veloc cmsec ophthalm systol pressur measur oculopneumoplethysmographi mm hg ipsilater intern carotid arteri occlus compar mm hg contralater side transorbit periorbit doppler ultrasonographi detect revers ophthalm arteri blood flow ipsilater intern carotid arteri occlus patient systol middl cerebr arteri blood veloc cmsec ipsilater intern carotid arteri occlus compar cmsec contralater side cmsec control revers ophthalm arteri blood flow low middl cerebr arteri blood veloc lack major intracerebr collater transorbit doppler ultrasonographi permit noninvas evalu ophthalm arteri"
"interpret result exercis studi acut myocardi infarct alter thrombolyt therapi coronari angioplasti bypass numer studi assess abil exercis modal predict patient outcom acut myocardi infarct ami implicit prior data assess prognosi patient undergo exercis studi assumpt patient select exercis assess similar time data generat past applic current patient popul studi retrospect assess clinic exercis rest exercis radionuclid angiograph data consecut patient refer exercis radionuclid angiographi month ami year period determin clinic exercis characterist patient refer exercis evalu infarct chang signific time paramet examin demonstr signific increas trend includ thrombolyt therapi time ami revascular procedur ami exercis assess age betablock usag wave ami inferior infarct exercis doubl product exercis capac signific stsegment depress exercis peak eject fraction chang eject fraction exercis data characterist patient select undergo exercis ami larg referr center chang signific time data applic referr center exercis test modal previous publish result exercis assess ami reconfirm patient select test result longer applic current era aggress medic intervent manag"
"effect nifedipin total ischem activ circadian distribut myocardi ischem episod angina pectori random doubleblind crossov studi conduct patient assess effect nifedipin versus placebo total ischem activ circadian distribut ischem episod baselin exercis treadmil test hour ambulatori electrocardiograph stsegment monitor patient receiv nifedipin dose mgday placebo administ time day initi dose immedi aris morn patient maintain stabl dose studi drug day underw repeat exercis treadmil test hour ambulatori electrocardiographi exercis treadmil test greater exercis durat achiev patient receiv nifedipin receiv placebo time greater equal mm st depress signific greater nifedipin baselin placebo ambulatori electrocardiograph monitor nifedipin reduc total number ischem episod baselin placebo total durat ischemia baselin minut placebo surg ischemia note baselin placebo therapi abolish nifedipin treatment nifedipin dosag administ manner effect reduc total ischem activ prevent morn surg ischem episod"
"ablat atrioventricular junction radiofrequ energi electrod cathet percutan cathet ablat radiofrequ energi interrupt atrioventricular av conduct patient supraventricular tachycardia refractori drug result radiofrequ ablat av junction customdesign cathet larg mmlong distal electrod mm interelectrod space shaft increas torsion rigid compar standard quadripolar electrod cathet bard ep electrocoagul microvas bicap suppli unmodul radiofrequ current khz appli distal electrod ablat cathet larg skin electrod modifi cathet patient persist complet av block induc applic radiofrequ power contrast complet av block produc histor control patient treat standard cathet similar number applic power output rise imped due desicc tissu coagulum format occur earlier frequent applic patient treat standard cathet patient treat modifi cathet cathet design increas surfac area electrodetissu contact radiofrequ energi deliv rise imped occur increas effect radiofrequ ablat av junction"
"relat import activ sequenc compar atrioventricular synchroni left ventricular function studi evalu relat hemodynam import normal left ventricular lv activ sequenc compar atrioventricular av synchroni respect systol diastol function twelv patient intact av conduct av sequenti pacemak underw radionuclid studi rest doppler echocardiograph studi rest submaxim exercis compar atrial demand pace aai sequenti av sens pace ddd ventricular demand pace vvi studi rest perform constant heart rate pace mode exercis studi perform constant heart rate work load cardiac output higher aai ddd vvi litersmin lv eject fraction likewis higher aai vvi av synchroni paradox septal motion pattern result impair region septal eject fraction addit lv contract durat homogen aai peak fill rate aai vvi higher ddd enddiastol volum vvi time peak fill signific shorter aai ddd ms"
"effect doxazosin blood pressur reninangiotensinaldosteron urinari kallikrein doxazosin quinazolinederiv postsynapt alpha adrenoceptor antagonist studi random doubleblind placebocontrol week studi effect blood pressur bp heart rate metabol function renal hormon analyz administr singl oral morn dose phase fashion administ patient women men year mild moder uncompl essenti hypertens titrat antihypertens effect dose biweek mgday end titrationpoint dose mg standard error week treatment adjust maintain diastol bp level equal mm hg week treatment final dose mgday bp decreas patient supin stand mm hg increas heart rate dose phenomenon reninaldosteron system electrolyt excret signific affect renal function metabol paramet remain unchang urinari kallikrein excret augment fold good toler patient discontinu studi dri nose result suggest longterm monotherapi doxazosin effect safe antihypertens agent mild moder essenti hypertens stimul urinari kallikrein excret"
"effect mitral regurgit volum load pressur halftim balloon valvotomi mitral stenosi doppler pressur halftim pht frequent assess mitral valv area mva reliabl pht recent challeng specif set balloon mitral valvotomi hemodynam abrupt alter effect volum load balloon mitral valvotomi comput mva gorlin pht patient highfidel micromanomet measur left atrial left ventricular pressur examin echocardiograph mva increas cm valvotomi volum load produc signific increas left atrial pressur mm hg valvotomi cardiac output litersmin valvotomi mitral valv gradient mm hg valvotomi hemodynam modest signific decreas pht increas mva estim pht cm valvotomi mva gorlin affect consist fashion volum load cm valvotomi correl gorlin mva pht fair signific poorer patient greater mitral regurgit regurgit analysi covari mitral regurgit effect"
"rariti preclin alcohol cardiomyopathi chronic alcohol year age preclin alcohol cardiomyopathi myocardi damag absenc overt congest heart failur chronic alcohol character necropsi attempt identifi clinic entiti death produc conflict result studi subject rest inclus older alcohol limit noninvas techniqu explain disagr determin preclin alcohol cardiomyopathi identifi independ aforement limit asymptomat chronic alcohol age year consum minimum pint whiskey pack beer greater equal day week greater equal year underw radionuclid ventriculographi measur systol diastol function rest peak supin exercis recoveri echocardiographi assess chamber size wall thick left ventricular mass red blood cell level selenium thiamin measur determin abnorm present potenti mediat alcohol cardiomyopathi comparison agematch group healthi control subject studi alcohol control subject rest eject fraction diastol peak fill rate enddiastol volum edv similar"
"prognost thallium perfus defect idiopath dilat cardiomyopathi assess prognost signific thallium perfus defect patient idiopath dilat cardiomyopathi idc patient underw thallium scintigraphi addit clinic echocardiograph angiograph hemodynam evalu eleven patient signific thallium perfus abnorm multipl small defect larg defect year patient diseaserel mortal patient die higher incid ventricular tachycardia increas cardiothorac ratio decreas fraction shorten increas pulmonari wedg pressur mm hg increas left ventricular enddiastol pressur mm hg abnorm thallium perfus defect compar survivor age gender left ventricular endsystol enddiastol dimens cardiac index eject fraction statist survivor versus patient die kaplanmei surviv estim year patient signific perfus abnorm patient multipl small defect patient larg defect log rank test"
"unusu venous anomali placenta author present unusu vascular anomali placenta placenta larg weigh fetal surfac numer dilat tortuous vessel observ chorion membran branch aros vein connect umbil vein cm aneurysm dilat secondari branch aros venous channel dilat tortuous longest secondari branch cm length cm diamet led placenta multipl sever coil straight small branch aris vessel observ vascular tangl smaller vessel led placenta abnorm vessel vein umbil cord normal membran insert placenta unremark larg size"
"system lytic state local thrombolyt failur anistreplas anisoyl plasminogen streptokinas activ complex apsac acut myocardi infarct relat coronari thrombolysi coagul variabl administr anistreplas anisoyl plasminogen streptokinas activ complex apsac studi patient acut myocardi infarct fifti consecut patient acut myocardi infarct anistreplas intraven hour onset symptom fall plasma concentr fibrinogen minut administr anistreplas consid reflect system lytic state coronari angiographi perform hour thrombolyt treatment patenc rate patenc rate signific patient system lytic system lytic state absenc system lytic state anistreplas administr high predict failur coronari thrombolysi coagul studi show evid inhibit anistreplas induc fibrinolyt activ explain failur thrombolyt treatment patient evid system lytic state"
"dipyridamol magnet reson imag comparison thallium emiss tomographi limit space motion artefact make magnet reson imag dynam exercis difficult pharmacolog stress dipyridamol altern exercis thallium scan forti patient histori angina abnorm exercis electrocardiogram studi dipyridamol thallium myocardi perfus tomographi dipyridamol magnet reson wall motion imag cine gradient refocus sequenc imag scan obtain obliqu horizont vertic long axi short axi plane pharmacolog stress dipyridamol myocardium divid segment direct comparison perfus wall motion segment assess visual gradesnorm hypokinesi reduc perfus akinesi reduc perfus dipyridamol revers wall motion abnorm patient coronari arteri diseas patient revers thallium defect site wall motion deterior site revers thallium defect thallium defect affect segment wall motion deterior singl segment thallium defect undetect magnet reson imag signific correl detect wall motion abnorm angiograph sever coronari arteri diseas induct chest pain dipyridamol signific differ ventricular volum eject fraction dipyridamol group detect revers wall motion normalis magnet reson signal intens abnorm move segment signific signal intens normal segment"
"control trial communiti base coronari rehabilit hundr patient suffer acut myocardi infarct week enter randomis control trial exercis treatment communiti sport centr supervis general practition eighti cent treatment group continu exercis return work complet month exercis complic exercis preval angina pectori fell treatment group rose control group perceiv energi level rose signific treatment group control rise predict maximum oxygen uptak signific greater treatment group control group reduct doubl product reflect myocardi workload peak exercis coronari rehabilit communiti safe effect"
"method haemodynam assess mitral stenosi atrial fibril construct nomogram accur haemodynam assess mitral stenosi hydraul formula requir measur valv gradient cardiac output calcul labori presenc atrial fibril averag valu obtain multipl beatbeat determin relat valv area end diastol gradient heart rate patient mitral stenosi atrial fibril examin patient end diastol pressur gradient cardiac cycl relat linear rr interv cycl relat unchang exercis slope intercept relat correl degre mitral stenosi measur gorlin valv area regress equat describ relat construct nomogram relat end diastol pressur gradient mitral valv area heart rate nomogram appli catheteris data patient result correl direct calcul valv area gorlin formula nomogram simpl requir measur cardiac output independ heart rate unnecessari patient exercis catheteris"
"lipoprotein coronari heart diseas prospect casecontrol studi general popul sampl middl age men object examin associ serum lipoprotein concentr subsequ coronari heart diseas designprospect casecontrol studi base year follow general popul sampl men age baselin serum sampl frozen time baselin examin degre year lipoprotein concentr sampl measur case control settingc gothenburg sweden subject men general popul sampl men sustain myocardi infarct die coronari heart diseas year random select control sampl remain free myocardi infarct case control histori myocardi infarct baselin main outcom measuresproport myocardi infarct death coronari heart diseas relat serum lipoprotein concentr resultsmen suffer coronari heart diseas signific higher serum lipoprotein concentr control differ mg confid interv mg men highest serum lipoprotein concentr cut point mg suffer coronari heart diseas rate men lowest concentr logist regress analysi show serum lipoprotein concentr signific coronari heart diseas independ risk factor conclus serum lipoprotein concentr middl age men independ risk factor subsequ myocardi infarct death coronari heart diseas"
"primari defect alphaadrenerg respons patient varicos vein respons superfici hand vein local infus noradrenalin compar patient primari varicos vein healthi volunt dorsal hand vein techniqu patient varicos vein requir signific higher dose noradrenalin halfmaxim venoconstrict dose requir control subject geometr ngmin patient compar ngmin control subject noradrenalin respons varicos vein signific hand vein respons patient find constitut decreas venous alphaadrenerg receptor respons patient varicos dilat varicos vein affect noradrenalineinduc venoconstrict"
"calcium entri blockad adrenerg vascular reactiv hypertens differ nicardipin diltiazem interfer nicardipin diltiazem infus brachial arteri system ineffect rate forearm vascular respons grade exogen norepinephrin evalu hypertens patient nicardipin microgramsdl forearm tissuemin absenc presenc propranolol increas forearm blood flow venous plethysmographi antagon dose depend vasoconstrictor effect norepinephrin suggest function alphaantagon particip vasodil possibl antihypertens effect drug contrari antagon potenti respons norepinephrin occur diltiazem microgramdl forearm tissuemin intraarteri propranolol abolish potenti action drug local vasodil isoproterenol reduc diltiazem interf betaadrenerg receptormedi vasorelax mechan human forearm arteriol data stress heterogen calcium entri blocker human"
"skelet muscl metabol heart failur nuclear magnet reson spectroscopi studi leg muscl  gastrocnemius muscl patient mild moder chronic heart failur healthi control subject studi nuclear magnet reson spectroscopi spectra collect rest increment symptomlimit exercis protocol blood flow measur studi interrupt exercis  phosphocreatinephosphocreatin inorgan phosphat ratio lower patient heart failur control subject exercis rate intracellular ph blood flow similar  cytosol free adenosin diphosph concentr mark increas patient heart failur exercis compar control subject exercis workload  maximum workload achiev patient heart failur half reach control subject ph phosphocreatinephosphocreatin inorgan phosphat ratio lower patient heart failur maxim load blood flow maxim exercis patient heart failur control subject reduc work load  phosphocreatin deplet induc gastrocnemius muscl exercis sever previous forearm patient heart failur  metabol abnorm skelet muscl contribut exercis intoler heart failur submaxim exercis"
"dynam associ arteri shear flow condit platelet cytosol free ca concentr human hypertens  blood cell vascular endotheli cell subject wide rang haemodynam generat shear stress forc vitro membran stretch shear stress observ activ ion channel cell metabol facilit erythrocyt platelet aggreg  present studi design evalu particip shear stress control appar platelet cytosol free ca concentr hypertens patient  shear condit platelet cytosol free ca concentr vitro studi dynam perturb induc month doubleblind treatment betaantagonist carteolol atenolol brachial arteri wall shear rate stress estim puls doppler velocimet blood viscos measur axial viscomet shear rate platelet cytosol free ca concentr simultan measur quin fluoresc chelat direct effect atenolol carteolol platelet cytosol free ca concentr vitro measur addit betablock plateletrich plasma  atenolol carteolol decreas blood pressur similar effect shear rate shear stress platelet cytosol free ca concentr differ month therapi contrast drug signific alter platelet cytosol free ca concentr vitro se  popul strong posit correl exist platelet cytosol free ca concentr shear rate shear stress absolut valu suggest haemodynam sheardepend modul transmembran ca transport"
"myocardi infarct prognost score system myocardi infarct prognost score system patient treat coronari care unit prognost signific variabl admiss analyz prognost index construct modifi stepwis logist regression analysi techniqu variabl score system killip hemodynam class infarct locat maxim st segment elev singl lead score system valid independ group patient includ group patient treat intraven streptokinas score system prove individu patient prognost manag strategi quantif infarct sever clinic studi"
"motiv cardiac rehabilit lack patient adher prescrib regimen fundament problem cardiac rehabilit program causat factor lack patient adher relat failur address differ individu health behavior motiv cardiac rehabilit group patient myocardi infarct sampl test relationship social support system health locus control health orient motiv pearson correl coeffici signific posit correl health locus control variabl health orient variat motiv health locus control health orient variabl enter multipl regress equat explain variat motiv awar individu motiv respons influenc health behavior cardiac rehabilit enabl nurs develop intervent strategi patient cardiovascular diseas benefit modifi riskproduc lifestyl"
"phase cardiac rehabilit earli recoveri patient cardiac diseas random control studi studi effect rehabilit teach exercis test perceiv efficaci perform daili activ compar exercis train subject patient myocardi infarct cardiac surgeri age year receiv inpati rehabilit servic subject random assign group treatment group receiv teach treadmil exercis test exercis train time week week treatment group receiv teach exercis test control group receiv routin care supervis exercis teach measur efficaci activ perform made hospit discharg week cardiac event repeatedmeasur analysi varianc show increas efficaci score perform physic activ group treatment group train group obtain highest score differ group nonsignific greater result sampl uncompl motiv patient particip phase inpati rehabilit program substanti improv efficaci perform daili activ made earli recoveri onset phase formal outpati therapi"
"myocardi infarct young adult cad young male adult age year general found usual risk factor cad lesser number young adult mis relat cocain sympathomimet effect increas myocardi oxygen demand factor consid respons acut mi cocaineabus patient young adult asymptomat acut mi pass treadmil exercis stress test level bruce stage shown normal coronari arteriogram subset requir routin coronari angiogram acut mi"
"proton magnet reson exerciseinduc water gastrocnemius muscl exerciseinduc water concentr determin medial gastrocnemius muscl noninvas imageguid vivo proton magnet reson spectroscopi mrs measur perform normal male volunt isometr ischemicisometr exercis maximum voluntari contract mvc observ water flux phase exercis interpret term fluid transfer vasculatur exercis muscl good correl individu mvc water flux decay water content observ mvc exercis level mrs result found consist report literatur base invas biopsi techniqu"
"effect etomid cerebr metabol blood flow canin model hypoperfus effect etomid nonbarbitur cerebr metabol depress cerebr metabol blood flow studi dog cerebr hypoperfus group anim studi minut normotens minut hypotens period control anim etomid anim receiv mgkg etomid bolus infus mgkgmin etomid lowdos group anim receiv dose etomid suffici suppress electroencephalograph burst highdos group arteri pressur fell similar level hypotens group mm hg cerebr oxygen extract fraction rose control anim test anim test lowdos group increas greater anim test highdos group cerebr blood flow level decreas group hypotens ml gmmin decreas anim test control group ml gmmin decreas anim test lowdos group ml gmmin decreas anim test highdos group summari cerebr oxygen extract fraction increas control anim lowdos recipi hypotens suggest presenc threaten cerebr tissu contrast cerebr oxygen extract chang hypotens highdos etomid administ conclud highdos etomid preserv cerebr metabol state hypotens present model"
"myocardi metabol fluorodeoxyglucos compar cell membran integr potassium analogu rubidium assess infarct size man pet potassium loss damag myocardi cell linear relat cpk enzym loss reflect extent necrosi potassium analog rubidium rb extract inject retain viabl myocardium trap wash necrot region compar myocardi cell metabol membran dysfunct indic necrosisvi patient evolv myocardi infarct coronari arteriographi positron emiss tomographi fluorodeoxyglucos fdg potassium analog rb percent heart show fdg defect rb washout sequenti imag indic failur retain potassium analogu visual assess quantifi autom softwar infarct size base rubidium kinet correl close size locat fdg imag visual autom suggest loss cell membran integr trap potassium analog rb parallel loss intracellular glucos metabol compar quantit marker myocardi necrosisvi"
"clinic valid miniatur nuclear probe system continu line monitor cardiac function stsegment miniatur cesium iodidephotodiod nuclear probe cardioscint develop continu line measur left ventricular function stsegment eject fraction ef measur patient compar gate equilibrium radionuclid ventriculogram probe posit left ventricl blind posit algorithm gamma camera background measur manual automat good correl probe posit blind gamma camera ef manual automat background gamma camera signific alter result correl probe stroke count thermodilutionderiv stroke index atrial pace subject satisfactori cardioscint provid reliabl estim ef track rapid cardiac volum"
"uk potent high select class iii antiarrhythm agent block potassium channel cardiac cell uk increas durat effect refractori period cardiac action potenti record vitro canin ventricular muscl purkinj fiber concentr depend manner nm microm rest membran potenti amplitud maximum upstrok veloc action potenti unaffect uk indic select class iii antiarrhythm properti agent uk nm microm increas effect refractori period isol guinea pig papillari muscl stimul frequenc hz hz influenc conduct veloc confirm uk devoid class antiarrhythm activ includ block sodium channel studi singl voltag clamp guinea pig ventricular myocyt uk concentr nm microm block timedepend current appreci effect timeindepend current calcium current uk high select channel block agent class iii antiarrhythm properti profil hold promis therapi lifethreaten cardiac arrhythmia"
"character ly lipoxygenas reperfus injuri ischem myocardium ly produc concentrationdepend inhibit isol guinea pig lipoxygenas lpo lpo activ human polymorphonuclear leukocyt vitro ic valu microm ly inhibit ic approxim microm zymosanstimul product leukotrien canin blood concomit effect product thromboxan concentr ly high microm inhibit product scaveng superoxid activ human neutrophil normal anesthet dog infus ly mgkgmin hr produc persist inhibit approxim leukotrien product blood challeng vivo zymosan plasma concentr approxim microm ly consist vitro data illustr select maxim inhibit lpo subsequ experi myocardi infarct size measur hr occlus circumflex coronari arteri hr reperfus continu infus ly mgkgmin effect baselin systol arteri pressur cardiac rate pressur rate product compar timerel observ control dog ly infus alter degre stsegment deviat intens durat cardiac arrhythmia coronari arteri occlus reperfus result myocardi infarct size left ventricl risk control dog dog ly myeloperoxidas activ infarct myocardium differ group"
"interact citrus juic felodipin nifedipin men borderlin hypertens felodipin mg water grapefruit juic orang juic felodipin bioavail grapefruit juic rang water dehydrofelodipinefelodipin auc ratio lower diastol blood pressur lower heart rate higher grapefruit juic water vasodilatationrel sideeffect frequent orang juic effect healthi men nifedipin mg water grapefruit juic bioavail grapefruit juic water"
"effect tilt matern fetal hemodynam variabl measur matern blood pressur heart rate fetal heart rate umbil arteri veloc waveform healthi women supin left degre degre tilt posit found signific differ variabl matern posit women hypotens symptomat supin degre tilt posit predict women symptomat recommend tilt pregnant women oper procedur week gestat includ lithotomi posit vagin deliveri"
"fluosol oxygendeliveri fluid percutan translumin coronari angioplasti fluosol intravascular perfluorochem emuls oxygencarri emuls deliv oxygen ischem myocardium percutan translumin coronari angioplasti ptca fluosol compos perfluorochem perfluorodecalin perfluorotripropylamin high capac oxygen solubl low viscos small particl size administr perfluorochem fluosol metabol expir gaseous particl lung remaind organ reticuloendotheli system expir administ balloon inflat ptca fluosol preserv ventricular wall motion global left ventricular eject fraction addit minim st segment preserv cardiac output fluosol patient poor contractil reserv multivessel diseas ill investig includ limit myocardi infarct size chemosensit radiosensit malign tumor advers effect secondari fluosol includ ventricular arrhythmia pruritus bradycardia chest pain dyspnea increas respiratori rate fluosol thaw admix warm bodi temperatur oxygen prior intracoronari administr usual administr rate mlmin balloon inflat"
"improv complianc increas control hypertens special hypertens popul approxim million peopl unit state hypertens half untreat treat blood pressur control risk hypertens establish benefit treatment major reason inadequ control hypertens poor adher treatment approxim patient hypertens fail follow appoint medic prescrib barrier effect therapeut adher includ poor doctorpati communic cost antihypertens therapi side effect drug increas control hypertens complianc therapi improv physician patient mutual commit achiev control blood pressur physician communic instruct prescrib therapi effect afford minim advers effect patient qualiti life cardiac risk profil special hypertens popul elder black young patient recogn address patient follow recommend alert physician problem medic relat side effect cost select drug therapi note older patient sensit volum deplet sympathet inhibit group patient initi drug dose low increment smaller gradual younger patient black patient hypertens show accentu respons diuret blunt respons betablock angiotensinconvert enzym ace inhibitor monotherapi diuret racial differ blood pressur lower effect betablock ace inhibitor"
"preclin pharmacolog celiprolol cardioselect betaadrenerg antagonist mild vasodil celiprolol antihypertens agent repres generat betablock combin cardioselect betaadrenerg antagon beta mild vasodil vasoselect betaadrenerg agon beta result anim studi show celiprolol beta antagonist potenc similar propranolol atenolol cardioselect slight greater atenolol celiprolol produc bronchoconstrict mild propranololresist bronchodilatori properti cat compound relax vascular smooth muscl propranololsensit fashion suggest mechan beta agon beta agon result select downregul beta receptor number respons tissu cultur peripher tissu celiprololtr volunt decreas beta receptor block concomit treatment propranolol celiprolol devoid cardiac depress activ fact mild cardiostimulatori action cardiostimul beta stimul abolish betablock dose propranolol model sever myocardi ischemia celiprolol attenu ischemiainduc myocardi acidosi improv region segment function result suggest myocardi protect summari celiprolol distinguish betablock virtu cardioselect vasorelax beta agon lack bronchoconstrict cardiodepress properti observ anim studi document clinic trial"
"clinic safeti efficaci celiprolol manag essenti hypertens requir therapeut select effect reduc diastol blood pressur tailor individu patient minim effect patient demograph concurr ill cardiovascular risk factor celiprolol hydrochlorid high cardioselect vasodil betaadrenoceptor antagonist proven effect safe treatment essenti hypertens compar therapi blood pressur control demonstr excel safeti profil favor hemodynam activ minim effect cardiovascular risk factor celiprolol offer physician uniqu therapeut altern"
"metabol choic therapi patient hypertens object treat patient hypertens simpli reduc blood pressur prevent morbid mortal recent assess clinic trial shown risk stroke consist lower antihypertens therapi degre success demonstr coronari arteri diseas cad explan prevent cad possibl therapi clinic trial primarili thiazid diuret betaadrenoreceptor blocker increas patient risk develop coronari atherosclerosi lethal arrhythmia class antihypertens agent recommend initi therapythiazid diuret betaadrenoreceptor blocker angiotensinconvert enzym ace inhibitor calcium entri blocker metabol effect thiazid diuret includ electrolyt disturb hypokalemia hypomagnesemia hyponatremia dyslipidemia increas triglycerid abnorm glucos metabol hyperglycemia hyperinsulinemia peripher insulin resist hyperuricemia betaadrenoreceptor blocker metabol advers reaction betaadrenoreceptor blocker intrins sympathomimet activ isa dyslipidemia lower highdens lipoprotein cholesterol increas triglycerid abnorm glucos metabol hyperglycemia hyperinsulinemia peripher insulin resist betaadrenoreceptor blocker isa generat betablock select partial agonist activ celiprolol dilevalol dyslipidemia date induc abnorm glucos metabol ace inhibitor decreas triglycerid increas highdens lipoprotein cholesterol captopril improv insulin sensit calcium entri blocker metabol neutral"
"correl isomer fatti acid human adipos tissu clinic risk factor cardiovascular diseas relationship adipos tissu concentr geometr posit fatti acid isom cardiovascular diseas risk factor determin freeliv adult male percentag tran isom total sd cis isom total sd adipos tissu general agre dietari estim base consumpt hydrogen oil major percentag twofold higher adipos tissu total level fatti acid isom adipos tissu factor deriv factor analysi repres isom dietari origin signific correl cardiovascular risk factor tran isom cis isom weak correl posit negat age bodi mass index plasma lipoprotein cholesterol blood pressur greater"
"blood pressur lower elder subject doubleblind crossov studi omega omega fatti acid elder age greater equal hypertens subject entri systol blood pressur sbp greater equal diastol blood pressur dbp greater equal mm hg specif aim random doubleblind crossov studi wk treatment period separ wk washout compar blood pressurelow effect fish oil omega fatti acid corn oil omega fatti acid wk baselin period subject random assign receiv fish oil receiv corn oil wk treatment group differ chang blood pressur treatment differ stand dbp baselin valu compar treatment dbp decreas mm hg fishoil group mm hg cornoil group group treatment fish oil corn oil lower blood pressur measur blood pressur lower treatment compar washout period signific group differ laboratori safeti test categor side effect fish oil lower triglycerid mmol elder subject diet omega omega supplement safe effect lower sbp dbp"
"cerebr emboli open heart oper transcrani doppler studi transcrani doppler techniqu enabl detect cerebr air emboli patient openheart valv oper standard deair procedur techniqu occurr emboli middl cerebr arteri continu patient undergo aortic mitral valv replac membran oxygen scatter emboli observ insert aortic cannula start cardiopulmonari bypass declamp aorta heart beat empti period aortic crossclamp emboli detect care deair procedur record larg amount emboli fill empti beat heart patient studi cerebr emboli open heart procedur occur redistribut blood heartlung machin patient heart begin eject activ care standard deair procedur meticul deair declamp aorta strong advoc addit short period fill beat heart final closur aortic incis vent decreas incid cerebr emboli concomit reduct cerebr blood flow hyperventil anesthet fill empti beat heart benefici"
"retrograd continu warm blood cardioplegia concept myocardi protect report present result clinic seri patient receiv continu warm blood cardioplegia coronari sinus warm oxygen blood cardioplegia theoret advantag continu suppli oxygen substrat arrest heart avoid side effect hypothermia retrograd infus cardioplegia offer advantag valv oper patient sever coronari arteri diseas complementari warm blood cardioplegia retrograd warm blood cardioplegia consecut patient men women age year undergo procedur percent patient die transient intraaort balloon pump support evid periop myocardi infarct spontan return rhythm coronari sinus injuri techniqu retrograd continu warm blood cardioplegia simpl safe reliabl method myocardi protect chang protect heart intraop"
"dopamin highdos insulin infus glucoseinsulinpotassium cardiac oper effect myocardi metabol myocardi insulin resist associ surgic stress restrict avail carbohydr increas load free fatti acid ffas heart theoret ground adrenerg drug expect aggrav situat opposit expect insulin influenc dopamin combin dopamin microgramskg bodi weightmin highdos insulin iukg myocardi energi metabol studi patient hour coronari oper infus dopamin microgramskg bodi weightmin induc metabol unfavor strain myocardium increas myocardi ffa load rise myocardi oxygen expenditur match increas myocardi substrat uptak oxygen wastag ffa metabol high circul catecholamin level suggest sign suggest amplifi system trauma respons system oxygen consumpt increas increas arteri level ffas glucos keton observ diverg metabol effect dopamin insulin demonstr promin metabol effect ad highdos insulin dopamin mark reduct arteri ffa level shift myocardi carbohydr util expens ffas myocardi uptak ffas ceas myocardi insulin resist signific extent overcom supraphysiolog dose insulin infus adrenerg drug"
"transesophag echocardiographi acut aortic transect confirm diagnosi acut transect descend aorta problemat unnecessari patient movement time delay convent investig describ patient injuri quick defin bedsid transesophag echocardiographi"
"apic aortic cannul applic method paraphernalia instrument assembl consist special aortic crossclamp doublelumen perfus cannula present applic instrument occlus ascend aorta travers perfus cannula insert direct apex heart simultan left ventricular vent"
"poplit aneurysm identifi intraarteri streptokinas chang pattern present patient present chronic subacut leg ischaemia due thrombos poplit arteri aneurysm aneurysm diagnos intraarteri streptokinas infus success lyse thrombus case aneurysm symptomat year year poplit aneurysm underdiagnos chronic leg ischaemia"
"influenc low osmol contrast media electrophysiolog hemodynam coronari angiographi differ ionic ioxagl nonion iohexol agent recent suggest addit sodium low osmol contrast media reduc incid ventricular fibril conduct disturb coronari angiographi random doubl blind studi patient undergo coronari angiographi examin electrophysiolog hemodynam effect low osmol contrast mediaioxagl sodium iohexol sodium standard ecg aortic blood pressur bundl electrocardiogram record contrast media toler arrhythmia observ induc transient decrement systol blood pressur reduct heart rate contrast inject ioxagl prolong qt interv analys observ period iohexol signific qtinterv ahinterv prolong ioxagl alter iohexol factor osmol sodium content contribut qt prolong contrast agent sodium ioxagl induc qt prolong studi"
"precertif percutan translumin coronari angioplasti medicar beneficiari melt pot nation standard health care financ administr contract state peer review organ pros effort assur qualiti servic elimin unreason inappropri care provid medicar beneficiari law state pro select procedur precertif coronari angioplasti chosen pros precertif criteria state develop advic local physician report describ find survey precertif criteria effort determin variabl compar pro criteria publish nation criteria creat expert panel current precertif criteria medicar beneficiari show signific variabl prioriti clinic practic cardiologist perform coronari angioplasti establish publish guidelin safe efficaci establish local base criteria coronari angioplasti geograph uneven expect impact care provid medicar beneficiari"
"rib compress coronari arteri report describ find coronari arteri narrow caus compress rib patient cardiomegali clinic signific find primari differenti diagnost entiti myocardi bridg"
"coronari stent implant acut vessel closur hour unsatisfactori coronari angioplasti report implant balloonexpand stent patient acut vessel closur state evolv myocardi infarct hr unsatisfactori coronari angioplasti stent implant success recan occlud left anterior descend arteri repeat unsatisfactori result balloon angioplasti adjunct thrombolyt therapi contraind residu stenosi document control angiogram hr week month"
"implant endolumin prosthesi distal anastomosi bypass graft abrupt closur balloon angioplasti coronari wallstent implant year saphen vein bypass graft ptca complic abrupt closur anterograd flow restor myocardi necrosi result week bypass surgeri perform due bleed complic anticoagul regimen"
"alfentanil pharmacokinet patient undergo abdomin aortic surgeri pharmacokinet alfentanil microgramskg iv determin patient undergo elect abdomin aortic reconstruct age sd patient yr weight kg patient underw aneurysm repair aortobifemor graft serum alfentanil concentr measur gasliquid chromatographi sampl drawn increas interv hr period compart model fit concentr versus time data volum central compart volum distribut steadi state vdss kg total drug clearanc mlminkg elimin halftim hr patient age posit correl vdss elimin halftim signific correl pharmacokinet variabl durat aortic crossclamp durat surgeri rate total volum iv fluid infus intraop general surgic patient elimin halftim alfentanil report hr elimin halftim alfentanil longer patient undergo abdomin aortic surgeri alfentanil elimin faster fentanyl sufentanil patient popul"
"transoesophag echocardiogram fail diagnos periop myocardi infarct report case yr man undergo aortocoronari bypass monitor electrocardiogram transoesophag echocardiogram intraop electrocardiogram simultan ecg record holter monitor show st elev greater mm wave format lead avf skin closur transoesophag echocardiogram show wall motion abnorm signific haemodynam abnorm observ period intraop ecg treat nitroglycerin infus confirm periop myocardi infarct document postop lead ecg cpkmb postop transthorac echocardiogram show hypokinet left ventricl anteroap infarct transoesophag echocardiographi fail detect apic wall motion abnorm probe midpapillari level limit overcom period obtain apic view probe imag plane"
"cardioprotect effect authent nitric oxid myocardi ischemia reperfus background method purpos studi determin effect nitric oxid believ endotheliumderiv relax factor reperfus injuri myocardi ischemia mi effect investig hr model mi reperfus openchest anesthet cat solut infus iv start min occlus left anterior descend coronari arteri continu reperfus hr hr estim concentr circul result areasrisk express percentag total left ventricular weight signific mi group necrot area express percentag myocardi arearisk signific lower treat mi cat compar mi vehicl group cardiac myeloperoxidas activ signific fewer neutrophil attract necrot zone treat mi cat compar mi cat receiv vehicl sodium nitrat nano ph major breakdown product fail exert protect effect model mi reperfus conclus provid signific myocardi protect ischemia reperfus afford cardioprotect incorpor circul blood cell neutrophil platelet inhibit accumul adher ischem region direct cardiac cytoprotect effect studi donor clinic relev mode treatment mi"
"pulmonari function cardiovascular risk factor relationship black white young men women cardia studi pulmonari function relat invers incid coronari heart diseas congest heart failur chronic obstruct lung diseas lung cancer death reason associ poor understood relationship cardiovascular diseas risk factor pulmonari function examin year black white male femal particip studi coronari arteri risk develop young adult cardia forc expiratori volum adjust height fevht signific lower smoker nonsmok person report short breath fevht correl posit histori strenuous physic activ durat exercis treadmil highdens lipoprotein cholesterol negat skinfold thick serum triglycerid fast serum insulin cook medley scale hostil associ pulmonari function heart diseas risk reflect associ physic fit vigor fat lipid profil cigarett smoke"
"ischemia reperfus intermitt coronari occlus man studi electrocardiograph cpk releas balloon inflat perform angioplasti singlevessel coronari arteri diseas prospect studi continu ecg record ischem ecg percent inflat inflat resolv percent deflat elev plasma cpk level found patient ischem ecg minut durat ischemia exceed minut patient cpk elev resolut ischem delay patient cpk elev initi inflat conclud patient noninfarct myocardium ecg follow coronari occlus reflow rapid detect coronari event high sensit lack rapid regress predict lack reperfus persist ischemia minut suffici myocardi necrosi"
"regress left main trunk lesion steroid administr takayasu aortiti year man unstabl angina due sever narrow left main trunk lmt examin emerg bypass surgeri perform intern mammari arteri graft saphen vein graft thicken edemat ascend aorta postop coronari angiographi show lesion lmt mark regress stenot lesion lmt caus activ aortiti partial revers steroid administr surgeri steroid therapi ad list treatment case lmt diseas takayasu aortiti sign activ inflamm present"
"monitor effect cpap left ventricular function continu mixedblood satur hypothet benefit cpap cardiac perform reduct vo test patient heart transplant acut myocardi infarct continu svo monitor cpap ad inotrop support enoximon dobutamin intraaort balloon pump dramat increas svo relat increas cardiac output decreas vo secondari respiratori work reduct valid initi hypothes"
"pseudo preexcit concertina effect idioventricular tachycardia concertina effect phenomenon qrs complex reflect altern phase gradual widen narrow common due ventricular preexcit qrs morpholog due variabl ventricular zone undergo preexcit present reflect case concertina effect due idioventricular tachycardia rate ident sinus rate variabl degre ventricular fusion occur concertina effect ensu relat slight variat sinus cycl"
"traumat spontan extracrani intern carotid arteri dissect seventi patient spontan traumat extracrani intern carotid arteri dissect studi clinic angiograph followup spontan group month traumat group sixti percent patient spontan group traumat group follow angiogram traumat dissect aneurysm common signific fewer aneurysm resolv smaller fewer stenos resolv improv stenos progress occlus traumat dissect leav patient neurolog deficit signific higher percentag patient spontan dissect asymptomat follow compar traumat group spontan traumat dissect extracrani intern carotid arteri carri good prognosi outcom favor traumat group"
"prospect random multicent comparison situ revers vein infrapoplit bypass perform prospect random multicent studi compar situ revers vein graft long limb salvag bypass proxim thigh infrapoplit arteri hundr eighti patient requir infrapoplit bypass critic lower extrem ischemia exclud short vein bypass perform vein consid inadequ remain patient random vein bypass revers situ group similar regard risk factor indic graft dimens outflow secondari patenc month similar techniqu revers se situ vein equal mm minimum distend diamet month patenc rate situ vein revers vein greater angiograph evalu fail graft reveal lesion similar type frequenc type graft includ focal situ revers diffus vein hyperplasia situ revers inflow outflow stenos situ revers incid wound complic mortal rate similar group data show signific differ patenc rate type vein graft year"
"ruptur abdomin aortic aneurysm harborview experi decad patient ruptur abdomin aortic aneurysm admit singl urban hospit nineti percent patient prehospit systol blood pressur mm hg manag includ paramed field resuscit transport emerg depart diagnost protocol complet averag minut rapid transport dedic emerg oper room aneurysmorrhaphi general surgeri chief resid supervis specialist vascular surgeon skill postop intens care unit care patient die postop day emerg depart oper room intens care unit ward home featuresag greater year femal gender persist preoper hypotens aggress crystalloid blood replac admiss hematocrit transfus requir exceed unit greater likelihood death patient preoper cardiac arrest surviv hour experi conclud optim prehospit emerg depart oper room postop care improv outcom patient ruptur abdomin aortic aneurysm shock patient die clinic featur predict excess mortal rate ruptur abdomin aortic aneurysm withhold oper reason screen patient high risk abdomin aortic aneurysm elect aneurysmorrhaphi"
"probabl ruptur abdomin aortic aneurysm unrel oper procedur prospect studi assum author patient abdomin aortic aneurysm increas risk ruptur unrel oper juli decemb patient men women abdomin aortic aneurysm underw oper twenti patient infraren abdomin aortic aneurysm patient thoracoabdomin aneurysm abdomin aortic aneurysm rang transvers diamet cm averag cm twenti patient underw singl oper patient rang oper perform abdomin cardiothorac headneck vascular urolog amput breast general anesthesia procedur spinalepidur regionalloc postop death occur cardiopulmonari failur patient die ruptur abdomin aortic aneurysm day coronari arteri bypass patient oper fourteen patient repair abdomin aortic aneurysm date averag week oper patient abdomin aortic aneurysm consid small warrant resect averag cm patient consid excess risk elect repair thoracoabdomin aneurysm repair patient await repair month period patient abdomin aortic aneurysm die ruptur abdomin aortic aneurysm oper procedur day day ruptur abdomin aortic aneurysm cm greater transvers diamet"
"accuraci ct scan diagnosi abdomin thoracoabdomin aortic aneurysm ct scan evolv reliabl clinic tool angiographi diagnosi aortic aneurysm diseas diminish fewer patient aortic aneurysm diseas undergo aortic angiograph evalu institut prospect clinic studi undertaken assess valid polici hundr patient clinic ultrasonograph evid aortic aneurysm evalu prospect period juli decemb patient underw ct scan initi evalu patient select angiographi fulfil criteria radiograph evid thoracoabdomin juxtaren aneurysm horsesho kidney clinic suggest renal arteri stenosi mesenter arteri insuffici aortoiliac occlus diseas lower extrem aneurysm diseas period patient underw ct scan angiographi indic angiographi thoracoabdomin aneurysm juxtaren aneurysm clinic evid mesenter insuffici renal insuffici evid lower extrem aneurysm diseas sever aortoiliac occlus diseas eighti patient underw ct scan radiograph evalu patient advers affect elimin angiograph evalu ct scan reveal inflammatori aneurysm retroaort renal vein horsesho kidney studi suggest patient aortic aneurysm diseas adequ evalu ct scan select polici angiograph evalu"
"lacunar transient ischaem attack clinic concept lacunar ischaem stroke syndrom clinic pathophysiolog prognost distinguish cortic ischaem stroke syndrom cerebrovascular transient ischaem attack tia share similar heterogen patient tia prospect studi underw carotid angiographi symptom greater stenosi ipsilater intern carotid arteri patient presum cortic tia patient presum lacunar tia find support view cortic tia ipsilater extracrani intern carotid arteri atheromat diseas patient lacunar tia absent insignific largevessel diseas probabl intracrani smallvessel diseas accur distinct lacunar cortic event implic investig treatment patient tia"
"degen aortic stenosi effect gray america degen calcif aortic stenosi evolv common geriatr problem symptom develop high lethal diseas respond medic therapi aortic balloon valvuloplasti offer palliat alter diseas aortic valv replac therapi choic high periop morbid mortal rate expect elder presenc appreci cardiac disord contribut occurr postop complic patient asymptomat aortic stenosi normal left ventricular function treat medic serial aortic valv area determin doppler echocardiographi"
"pulmonari arteri catheter worth risk bedsid pulmonari arteri catheter proven import addit clinic assess critic ill patient proper procedur provid hemodynam inform appar physic examin radiographi safe accomplish venous rout care avoid potenti complic"
"relationship blood group behavior pattern men myocardi infarct consist correl found physic dysfunct state blood factor disord psychosomat compon duoden ulcer myocardi infarct studi focus relationship blood type indic behavior pattern type behavior score anger rate young patient initi myocardi infarct patient blood type score signific higher type behavior scale relat indic blood type blood group respond scale type discuss util blood group futur research predict myocardi infarct methodolog limit relationship result tempera studi jenkin activ survey subtest pattern anti reactiv pattern hypothes relat blood factor behavior trait patient psychosomat disord"
"compar clinic pharmacolog calcium channel blocker calcium channel blocker effect antihypertens agent initi monotherapi combin antihypertens agent drug effect treatment chronic stabl angina variant angina supraventricular arrhythmia drug class affin calcium channel vascular smooth muscl cardiac muscl cardiac sinus atrioventricular node hypertens angina verapamil diltiazem control heart rate supraventricular arrhythmia nimodipin control vascular spasm subarachnoid hemorrhag calcium channel blocker treatment migrain headach raynaud phenomenon"
"complet left main coronari arteri occlus angiograph evalu collater vessel pattern assess hemodynam correl angiograph studi patient total occlus left main coronari arteri identifi patient chronic occlus acut complet occlus patient intercoronari collater pathway altogeth total specif collater channel recogn patient evid uniqu homocollater repres enlarg vasa vasorum creat vascular cuff surround total obstruct left main arteri ventricular function hemodynam paramet patient depend collater vessel affect sever coronari arteri diseas arteri suppli collater"
"dilat left ventricular caviti dipyridamol thallium imag marker triplevessel diseas investig signific mechan dilat left ventricular caviti dipyridamol thallium imag perform dipyridamol thallium imag dipyridamol radionuclid angiographi patient angiogram dipyridamoledelay ratio left ventricular dimens thallium imag defin left ventricular dilat ratio lvdr lvdr greater standard deviat patient coronari arteri diseas defin abnorm twenti patient show abnorm lvdr patient triplevessel diseas defect washout analysi sensit specif correct identifi patient triplevessel diseas lvdr sensit specif lvdr combin defect washout criteria sensit increas loss specif patient abnorm lvdrs enddiastol volum measur radionuclid angiographi chang dipyridamol infus dilat left ventricular caviti dipyridamol thallium imag reflect relat subendocardi hypoperfus induc dipyridamol actual chamber enlarg lvdr moder sensit high specif triplevessel diseas provid complementari inform dipyridamol thallium imag"
"percutan balloon valvotomi patient mitral stenosi initi follow result percutan doubl balloon mitral valvotomi pmv perform patient sever mitral stenosi month procedur women men age year rang hemodynam angiograph find evalu pmv clinic status assess follow signific decreas mitral gradient pmv mm hg increas cardiac output min increas calcul mitral valv area cm mitral regurgit develop increas sever patient time follow month patient requir elect mitral valv replac symptomat mitral regurgit remain patient continu improv function class pmv safe perform proper select patient symptomat mitral stenosi good follow result"
"limit doppler pressur halftim quantifi mitral stenosi comparison micromanomet cathet record purpos studi compar doppler catheter pressur halftim method estim mitral valv area valv area obtain gorlin equat group patient clinic signific mitral stenosi data analyz consecut patient undergo continuouswav doppler examin catheter micromanomet cathet doppler pressur halftim calcul interv peak transmitr veloc veloc divid squar root measur outer border spectral envelop doppler mitral valv area mva obtain equat mva divid pressur halftim catheter data pressur halftim measur direct simultan record left ventricular left atrial pressur patient pulmonari capillari wedg pressur patient catheter halftim time requir peak pressur gradient fall half initi calcul mitral valv area catheter obtain gorlin equat pressur gradient cardiac output determin mitral valv area determin gorlin equat case rang cm linear regress analysi compar cardiac catheter doppler halftim yield subgroup patient sinus rhythm correl improv"
"flosequinan vasodil posit inotrop activ flosequinan oral arteri venous vasodil investig treatment congest heart failur effect flosequinan ventricular perform myocardi contractil studi patient sever congest heart failur left cardiac catheter sixti minut mg oral dose flosequinan peak rate rise left ventricular pressur dpdt increas mm hgsec left ventricular enddiastol pressur decreas mm hg cardiac index increas minm pulmonari arteri pressur vascular resist decreas mm hg dyneseccm heart rate aortic pressur atrial pressur system vascular resist serum norepinephrin level chang signific increas left ventricular peak dpdt concomit decreas left ventricular enddiastol pressur chang system arteri pressur sympathet tone argu direct posit inotrop effect flosequinan"
"dietari taurin defici dilat cardiomyopathi fox taurin defici implic potenti dilat cardiomyopathi relationship taurin myocardi function present unclear purpos studi determin dilat cardiomyopathi fox dietari taurin defici total fox farm histori death caus dilat cardiomyopathi fox farm histori dilat cardiomyopathi studi dilat cardiomyopathi diagnos echocardiographi fox farm posit histori fox control farm fox month age common affect older fox plasma taurin concentr signific fox dilat cardiomyopathi nmolml control fox nmolml signific higher incid dilat cardiomyopathi present fox histori sibl offspr die dilat cardiomyopathi fox famili histori cardiac death fox dilat cardiomyopathi test myocardi taurin concentr lower mumolgm wet weight control fox mumolgm wet weight hepat cysteinesulfin acid decarboxylas activ signific fox dilat cardiomyopathi nmolmmmg protein control fox nmol commmg protein"
"beatbeat detect ventricular late potenti highresolut electrocardiographi detect dynam vlps develop lownois hrecg gain system beatbeat detect lowamplitud signal bedsid nonshield room averag process analysi perform normal subject group men women age year patient coronari arteri diseas document sustain ventricular tachycardia group men women age year patient coronari arteri diseas sustain monomorph ventricular tachycardia group men women age year comparison made timedomain signalaverag saecg case electrod posit ident bandpass filter group vlps detect total filter qrs durat msec sd time interv termin qrs exceed microv msec case msec group vlps detect hrecg patient total qrs durat msec sd group msec sd group group vlps detect hrecg patient total qrs durat msec sd group group msec sd group group concord result hrecg saecg observ case posit negat result late potenti exhibit dynam variat detect hrecg case low amplitud vlps detect saecg case conclus present studi demonstr feasibl bodysurfac record vlps beatbeat basi averag process bedsid nonshield room approach studi dynam vlps spontan ventricular arrhythmia ischemia"
"risk stratif survivor acut myocardi infarct routin cardiac catheter angiographi reason approach patient editori noninvas risk assess survivor ami effect subdivid patient group differ risk profil hospit discharg patient risk late death recurr ami incorrect identifi data cardiac catheter angiographi provid complementari general power prognost inform patient deriv benefit earli cardiac catheter angiographi includ patient ami complic recurr myocardi ischemia congest heart failur complex ventricular arrhythmia patient abnorm inconclus result noninvas test patient unabl perform exercis test patient abnorm left ventricular global systol function increas left ventricular endsystol volum young patient younger year age older patient older year age patient wave ami patient receiv thrombolyt therapi perform earli cardiac catheter angiographi virtual survivor ami select noninvas test provid efficaci risk assess ami test perform judici cost approach excess combin invas select noninvas test optim inform risk routin perform diagnost cardiac catheter angiographi survivor ami adequ care attent paid proper perform procedur detail proper analys data addit noninvas test select patient import prematur unnecessari revascular procedur perform subsequ optim patient care clinician obtain data avoid unnecessari repetit test accuraci individu test facil interpret data proper context counsel patient object manag strategi approach patient appropri benefit coronari arteri revascular correct identifi patient low risk minim residu coronari arteri diseas preserv left ventricular function patent infarctrel arteri similar identifi manag appropri elimin unnecessari addit test pharmacolog therapi final approach risk stratif choos individu patient import correct amelior risk factor coronari arteri diseas recogn undertaken"
"prognost import delay wave evolut hour initi thrombolyt therapi acut myocardi infarct time wave evolut prognost signific studi patient receiv thrombolyt therapi acut myocardi infarct ami hundr forti patient evid wave ami hour initi thrombolyt therapi develop wave hour hospit discharg discharg wave ami laboratori indic myocardi damag hospit morbid mortal greater patient wave ami wave ami index examin respect time wave evolut prognosi patient delay wave develop similar patient wave ami compar patient earli equal hour wave evolut patient delay wave evolut wave ami smaller creatin kinas peak iu preserv left ventricular function measur radionuclid ventriculographi discharg standard deviat lower incid congest heart failur discharg hospit mortal lower patient delay wave evolut wave ami differ signific"
"shortterm result coronari angioplasti registri determin relev recent refin angioplasti technolog practic record consecut patient undergo percutan translumin coronari angioplasti ptca center octob review time ptca patient class iv angina identifi multivessel diseas dilat attempt lesion patient chronic total occlus lesion judg anatom complex dilat lesion railtyp devic exclus success dilat achiev attempt lesion low incid major complic death myocardi infarct emerg bypass surgeri acut rethrombosi occur patient patient initi strategi repeat dilat success patient primari clinic success ptca achiev patient follow month studi patient eventfre rate freedom cardiac death myocardi infarct repeat ptca coronari bypass surgeri recurr sever class iii iv angina conclus complex coronari diseas patient present center high initi success rate accept shortterm outcom ptca achiev"
"sustain reduct valvular regurgit atrial volum tailor vasodil therapi advanc congest heart failur secondari dilat ischem idiopath cardiomyopathi afterload reduct therapi acut improv hemodynam function patient advanc heart failur unknown initi reduct mitral tricuspid regurgit atrial volum sustain oral therapi atrial volum atrioventricular valv regurgit measur dimension doppler echocardiographi colorflow imag patient dilat heart failur eject fraction day intens vasodil diuret therapi tailor hemodynam goal echocardiographi repeat month oral vasodil flexibl diuret regimen acut therapi reduc system vascular resist dynescm pulmonari arteri wedg pressur mm hg atrial pressur mm hg led increas stroke volum ml mitral tricuspid regurgit determin colorflow fraction initi decreas reduct sustain month signific decreas occur acut therapi reduct month left atrial volum cm atrial volum cm"
"frequenc sever mitral regurgit year balloon mitral valvuloplasti mitral regurgit mr evalu doppler echocardiographi patient mitral stenosi immedi year balloon mitral valvuloplasti bmv sever mr grade scale echocardiograph hemodynam variabl analyz studi potenti factor predict longterm persist mr echocardiograph variabl mitral valv thick motion subvalvular chang left atrial dimens commissur calcif effect balloonmitr anular diamet hemodynam variabl mitral pressur gradient pulmonari arteri pressur eject fraction mitral valv area index age gender cardiac rhythm mitral valv area index increas cmm immedi bmw cmm year follow immedi bmv mr grade chang patient increas patient patient patient decreas year follow patient sever mr requir valv replac fifti patient chang extent mr equal patient grade decreas mr patient grade increas mr clinic hemodynam variabl morpholog characterist mitral valv predict develop signific mr bmv conclud increment mr sever equal frequent bmv"
"limit transthorac echocardiographi assess atrial septal defect adult dimension color doppler echocardiographi accur detect presenc atrial septal defect asd adult age year confirm surgeri cardiac catheter correct categor patient ostium secundum ostium primum asd misdiagnos patient surgic proven sinus venosus asd shunt flow volum asd calcul standard doppler equat assum asd circular correl shunt flow volum obtain cardiac catheter maximum width color flow signal move asd diamet flow veloc determin place puls doppler sampl volum parallel flow asd visual color doppler color mode examin determin flow veloc previous valid method incorpor comput analysi pixel color intens pulmonari system blood flow ratio obtain colorguid convent doppler interrog left ventricular outflow tract correl poor cardiac catheter result patient tricuspid regurgit peak systol pulmonari arteri pressur obtain color dopplerguid continuouswav doppler correl obtain cardiac catheter maximum color doppler jet width flow asd poor correl asd size estim surgeri"
"congest heart failur coronari event atherothrombot brain infarct elder black white system hypertens echocardiograph electrocardiograph evid left ventricular hypertrophi hypertens present black white prospect studi elder black women elder white women hypertens correl echocardiograph electrocardiograph left ventricular lv hypertrophi incid congest heart failur chf coronari event atherothrombot brain infarct abi echocardiograph lv hypertrophi concentr lv hypertrophi preval hypertens black hypertens white hypertens black younger year hypertens white year coronari risk factor similar higher serum triglycerid white black follow month black month white incid chf coronari event signific black white abi incid black white multipl logist regress analysi show prior chf concentr lv hypertrophi echocardiograph lv hypertrophi independ risk factor chf echocardiograph lv hypertrophi serum total cholesterol concentr lv hypertrophi prior coronari arteri diseas independ risk factor coronari event prior abi echocardiograph lv hypertrophi electrocardiograph lv hypertrophi independ risk factor abi"
"evalu pharmacokinet electrocardiograph effect intraven verapamil intraven calcium chlorid pretreat normal subject evalu effect calcium pretreat disposit electrocardiograph effect verapamil healthi male volunt receiv treatment phase random doubleblind crossov manner phase denot ml intraven sodium chlorid mg intraven verapamil phase ii denot ml intraven calcium chlorid ml intraven sodium chlorid phase iii denot ml intraven calcium chlorid mg intraven verapamil blood sampl determin verapamil concentr drawn minut hour blood pressur heart rate pr interv measur time pretreat verapamil intraven calcium alter disposit intraven verapamil blood pressur signific alter treatment phase calcium tend increas arteri pressur verapamil abolish effect calcium signific affect verapamilinduc pr prolong maximum percent chang pr interv phase phase iii time maxim prolong phase hour phase iii hour area percent chang pr time curv phase phase iii verapamil caus reflex increas heart rate similar magnitud phase iii"
"peopl health conscious longitudin studi communiti secular cardiovascular health awar knowledg behavior observ biennial crosssect survey cohort survey england communiti relat health promot activ social milieu respond due nation mass media health campaign effect influenc outcom communitybas cardiovascular diseas prevent studi"
"intraop detect patent foramen oval transesophag echocardiographi studi report intraop contrast doppler echocardiographi techniqu diagnos patent foramen oval pfo fifti patient atrial septal defect undergo elect cardiovascular surgeri studi mhz esophag echocardiograph probe imag fossa ovali fo ml agit salin inject atrium apnea echocardiograph contrast inject endinspir cmho airway pressur opacif atrium complet airway pressur releas maneuv color pulsedwav doppler interrog atrial septum perform left passag salin contrast interatri septum patient doppler echocardiographi demonstr pfo patient contrast evid shunt combin contrast doppler echocardiographi identifi preval pfo approxim previous report autopsi rate contrast doppler techniqu detect patient risk paradox emboli identifi candid closur pfo"
"activ drainag cardiac lymph relat reduct size myocardi infarct experiment studi activ drainag cardiac lymph hyaluronidas attempt dog result satisfactori ischem myocardium salvag infarct risk area ratio decreas drainag region myocardi ischemia infarct provid ligatur left coronari arteri minut cardiac lymph collect convent procedur enzym releas myocardium increas signific cardiac lymph volum cardiac lymph gradual increas ligatur coronari arteri administr hyaluronidas increas cardiac lymph flow signific decreas ratio determin triphenyl tetrazolium chlorid ttc methylen blue stain drainag cardiac lymph salvag ischem myocardium reduct interstiti edema augment cardiac lymph flow hyaluronidas prevent develop infarct document effect activ drainag cardiac lymph develop infarct observ ratio"
"therapi ischem cardiomyopathi pentoxifyllin abnorm blood rheolog characterist coronari arteri diseas author evalu effect pentoxifyllin exercis capac eject fraction symptom patient ischem cardiomyopathi patient sign symptom left ventricular dysfunct major vessel obstruct determin coronari angiographi pentoxifyllin mg time daili administ twelv week patient respond increas eject fraction exercis toler exercis toler correl improv lack improv eject fraction patient twelv week posttherapi eject fraction increas baselin total treadmil time increas doubl product increas angin symptom signific improv baselin twelv week therapi greater dyspnea exert pentoxifyllin toler pentoxifyllin benefit ischem cardiomyopathi improv coronari perfus owe favor alter hemorheolog properti"
"effect dopexamin hcl collater perfus acut ischem myocardium anesthet dog effect lowdos molekgmin infus dopexamin hcl synthet catecholamin beta adrenerg dadopaminerg agonost action test anesthet dog acut ligat left anterior descend coronari arteri infus caus diastol arteri blood pressur fall mmhg microsphereestim collater blood flow ischem myocardium chang signific drug infus find suggest low dose dopexamin hcl coronari steal acut ischem myocardium"
"aortic dissect fistul communic atrium case report case aortic dissect type de bakey rent atrium ra diagnos echocardiographi echo confirm aortographi report patient present cardiac failur continu murmur intercost space patient surviv year medial treatment"
"relat dimension geometri inflow tract orific area shape veloc regurgit color doppler jet vitro studi relat dimension geometri inflow tract orific area shape veloc regurgit jet studi pulsatil vitro color doppler flow model mhz transduc connect diagnost ultrasound machin water tank face pulsatil jet durat obtain calibr injector flow rate mlsec test mm diamet circular orific dimension inflow tract geometri compar sharpedg venturi funnel converg conic diverg conic veloc jet measur continuouswav doppler echocardiographi drive pressur measur fluidfil cathet observ independ digit contour maxim color jet area comput system separ set experi result valu measur paramet jet area correl flow rate differ shape eccentr jet shape jet correl flow rate continuouswav veloc pressur gradient measur pressur gradient estim gradient continuouswav doppler echocardiographi similar correl"
"reproduc intravascular ultrasound imag vitro determin factor affect imag qualiti intravascular ultrasound cathet vivo influenc blood temperatur chang contrast media evalu addit confirm reproduc intravascular ultrasound imag measur crosssect lumen area intraobserv interobserv variabl determin find ultrasound imag blood mild attenu room temperatur bodi temperatur signific impact imag qualiti contrast media attenu imag intens dosedepend manner intravascular ultrasound imag cathet reproduc method measur arteri lumen area excel intraobserv interobserv correl"
"natur histori left ventricular spontan contrast spontan contrast left ventricl unusu entiti retrospect studi patient found spontan contrast present dimension echocardiogram specif note clinic characterist reproduc phenomenon presenc thrombi embol event prognost implic diagnos includ ischem heart diseas patient dilat cardiomyopathi patient hypertens cardiomyopathi patient eject fraction thromboembol event patient spontan contrast reproduc period time month patient improv left ventricular dysfunct underw aneurysmectomi disappear spontan contrast patient spontan contrast reproduc subsequ echocardiogram wors prognosi patient similar depress ventricular function larger studi verifi"
"role ultrason tissu character distinguish revers irrevers myocardi injuri tissu character reflect structur function integr tissu revers ischemia structur damag irrevers ischemia result persist structur myocardi damag postul ultrason tissu character distinguish type injuri anesthet open chest dog underw minut group minut group acut total occlus left anterior descend coronari arteri hour reperfus myocardi ischemiainfarct confirm segment shorten electronmicroscop examin triphenyl tetrazolium chlorid stain integr backscatt rayleigh ibr measur ultrason backscatt fourier coeffici amplitud modul fam index cardiac cycl depend variat backscatt measur baselin ischemia reperfus group revers ischemia show increas ibr db control db ischemia return baselin reperfus db fam blunt ischemia db control versus db ischemia recov complet reperfus segment shorten abolish ischemia control versus ischemia recov partial reperfus group anim irrevers myocardi injuri show increas ibr db control db ischemia paradox bulg ischem region ischemia"
"quantit echocardiograph analysi global region left ventricular function problem revisit record dimension echocardiogram simultan respir measur normal subject patient anterior myocardi infarct apic longaxi chamber view quantit analyz measur variabl global eject fraction region eject fraction region calcul inspir endexpir observ minim variabl endocardi contour redefin trace improv computerassist trace system variabl absolut differ beat endexpir signific inspir eject fraction variabl endexpir variabl inspir sd region eject fraction variabl endexpir variabl inspir sd intraobserv interobserv variabl valu beat endexpir eject fraction region eject fraction variabl patient myocardi infarct compar method record respir analyz left ventricular function endexpir contour definit trace system measur variabl report previous echocardiograph studi compar angiograph method"
"fenestr atrial septal aneurysm diagnosi transesophag echocardiographi diagnosi atrial septal defect transthorac echocardiographi remain difficult small subset patient suboptim acoust window unusu anatomi fenestr defect report case year woman fenestr atrial septal aneurysm incomplet visual transthorac echocardiographi subsequ transesophag echocardiographi demonstr defect atrial septal aneurysm left shunt defect normal pulmonari venous connect defin echocardiograph find confirm surgeri case demonstr addit diagnost accuraci transesophag echocardiographi detect diseas atrial septum"
"sustain improv left ventricular function success coronari angioplasti short long term effect success percutan translumin coronari angioplasti left ventricular function rest exercis investig patient thirti previous infarct group group technetiumm gate blood pool imag obtain rest exercis week fifteen month success angioplasti angioplasti sd eject fraction fell signific exercis group group group chang parallel worsen wall motion score group group week procedur chang rest eject fraction increas signific exercis group group concomit signific improv exercis wall motion score group group improv exercis eject fraction wall motion maintain follow signific deterior variabl sustain improv eject fraction group group wall motion score group group compar valu angioplasti"
"postextrasystol potenti compensatori paus normal diseas heart variabl deriv left ventricular volum studi postextrasystol potenti left ventriculogram obtain healthi individu patient coronari heart diseas previous myocardi infarct sign myocardi damag postextrasystol potenti induc regular driven atrial rhythm interrupt atrial extrasystol postextrasystol rr interv equal basic rr interv left ventricular end diastol volum preextrasystol postextrasystol beat equal group evid postextrasystol potenti indic left ventricular function eject fraction normalis systol eject rate systol volum stroke volum potenti evid patient left ventricular damag suggest compens mechan intrins properti myocardium frankstarl mechan contribut increas perform postextrasystol beat normal individu patient coronari arteri diseas"
"streptokinas treatment femor arteri thrombosi arteri cardiac catheteris infant children data children underw retrograd arteri catheteris studi assess frequenc femor arteri thrombosi safeti efficaci system streptokinas treatment complic transarteri balloon dilat perform patient impair arteri perfus due vascular spasm thrombus format cannul leg catheteris heparinis sign impair arteri circul persist patient total patient femor arteri thrombosi strong suspect undergon balloon dilat studi risk femor arteri thrombosi develop time greater transarteri balloon dilat arteri catheteris dilat system infus streptokinas start patient femor arteri thrombosi arteri perfus normal patient delay haematolog monitor show lengthen thrombin time decreas fibrinogen concentr streptokinas treatment complic system infus streptokinas safe treatment children persist femor arteri thrombosi arteri cardiac catheteris"
"preoper measur pulmonari vascular resist complet transposit great arteri transposit great arteri frequent complic earli onset pulmonari vascular diseas difficult measur pulmonari blood flow fick principl pulmonari arterioven oxygen content differ small bronchial blood flow increas condit patient age year rang month year transposit great arteri mass spectrometri measur oxygen uptak predict pulmonari end capillari blood oxygen content effect bronchial circul studi comput model close agreement pulmonari end capillari pulmonari vein blood oxygen content result percentag differ arterioven content differ signific se differ effect bronchial circul give spurious high estim pulmonari blood flow error greatest oxygen consumpt low aortic blood desatur"
"transmur myocardi deform ischem canin left ventricl myocardium complex dimension structur consist myocyt interconnect dens collagen weav cours direct region ischemia expect produc complex ventricular deform present studi examin effect ischemia dimension finit strain acut transmur myocardi ischemia openchest anesthet dog contrast systol deform observ control period circumferenti shorten exceed longitudin shorten result minut acut ischemia endsystol plane lengthen left ventricular wall occur approxim equal amount circumferenti longitudin direct extension strain signific negat transvers shear deform ischemia myocardi ischemia result loss normal endsystol transmur gradient shorten thicken dimension enddiastol strain left ventricular wall undergo signific passiv reconfigur vari transmur lengthen epicardi tangent plane wall thin increas epicardium endocardium larg systol shear deform ischemia potenti influenc collater blood flow uniaxi measur deform ischem myocardium account shear deform incomplet interpret caution normal transmur systol gradient deform anticip geometr ground lost ischemia impli materi properti ischem tissu load condit impos ischem region partial impair adjac myocardium vari transmur"
"protect effect increas glycolyt substrat systol diastol dysfunct increas coronari resist prolong global underperfus reperfus isol rabbit heart perfus erythrocyt suspens current therapi myocardi infarct includ earli reperfus simul myocardi perfus condit evolv myocardi infarct isol normotherm isovolum rabbit heart perfus buffer bovin red blood cell hematocrit assess effect high level glucos insulin therapi prolong minut sever underperfus reperfus protocol consist underperfus constant coronari perfus pressur mm hg control group receiv mmol glucos microunitsml insulin group treat high level glucos insulin receiv mmol glucos microunitsml insulin underperfus reperfus relat control group group experienc greater develop pressur underperfus increas recoveri reperfus preserv diastol function underperfus reperfus lower coronari resist greater coronari flow underperfus period increas glycolyt flux preserv glycogen store high energi phosphat level loss myocyt enzym creatin kinas alanin aminotransferas protocol coronari flow ident control heart underperfus period left ventricular enddiastol pressur mm hg group minim subendocardi damag vascular compress protocol effect intervent prevent increas coronari resist underperfus period distinguish myocellular metabol effect high substrat protect effect mechan metabol function mark similar protocol indic mechan protect underperfus affect cardiac function coronari resist conclud intervent clinic relev concentr mark protect sever underperfus myocardium minut benefici intervent combin reperfus therapi acut myocardi infarct"
"effect coronari hyperemia emax oxygen consumpt bloodperfus rabbit heart energet consequ gregg phenomenon assess relat increas contractil function oxygen consumpt vo increas coronari flow gregg phenomenon measur endsystol pressurevolum relat relat vo left ventricular systol pressurevolum area pva measur total mechan energi output bloodperfus isovolum contract rabbit heart control intracoronari adenosin infus adenosin infus constant perfus pressur mm hg coronari flow increas slope endsystol pressurevolum relat emax ventricular contractil index increas compar left ventricular volum pva increas vo adenosin vopva relat linear condit median increas coronari flow vointercept vopva relat unload vo increas chang slope parallel upward shift observ indic contractil effici energi convers effici contractil machineri remain constant increas emax unload vo elimin betaadrenerg blockad propranolol conclud increas coronari flow adenosin constant perfus pressur augment emax nonmechan energet cost excitationcontract coupl basal metabol nonadrenerg mechan chang contractil effici"
"spontan termin reentri cycl short nonsustain run role oscil excess dispers refractori studi describ factor contribut spontan termin reentri cycl induct singl prematur stimulus reentri studi vitro ring canin atrial tissu tricuspid valv orific activ record circular array extracellular bipolar electrod equal space ring experi transmembran monophas action potenti record made critic site termin reentri cycl induct record time experi import factor contribut termin obligatori revers activ sequenc result long coupl interv critic region site unidirect block prematur stimulus longer refractori period limit critic region facilit unidirect block contribut termin region activ short coupl interv end reentrant cycl termin nonsustain reentri longer cycl result oscil conduct refractori initi abrupt shorten cycl length initi reentri oscil conduct result intervaldepend conduct reentrant impuls encount partial refractori tissu reentri sustain oscil induct reentri dampen damp cycl length oscil induct identifi clinic tachycardia caus reentri partial excit gap"
"myocardi sulfhydryl pool alter occur reperfus prolong myocardi ischemia vivo myocardi sulfhydryl sh compound includ reduc glutathion gsh defens potenti marker reactiv oxygen metabolit injuri ischemia reperfus examin alter gsh myocardi sh pool reperfus anesthet dog expos minut prolong minut region ischemia caus occlus left anterior descend arteri nineti minut ischemia hour reperfus result myocardi necrosi area risk caus reduct total myocardi sh group decreas nonprotein myocardi sh group decreas gsh decreas gsh nonprotein sh group protein sh group signific reduc decreas ns myocardi releas gsh oxid glutathion gssg coronari venous effluent occur earli reperfus contrast minut ischemia minut reperfus alter myocardi total sh group protein sh group gsh decreas ns reperfus releas gsh gssg ischemia nonprotein sh group decreas due decreas gsh nonprotein sh pool ischemia occur alter myocardi gssg gshgssg ratio"
"accuraci exercis electrocardiographi detect physiolog signific coronari arteri lesion accuraci exercis electrocardiographi detect physiolog signific coronari arteri stenosi assess previous compar exercis test coronari arteriogram inher inaccuraci visual determin percent diamet stenosi measur lead conclus exercis electrocardiogram accur determin accuraci exercis electrocardiographi detect physiolog signific coronari stenosi studi patient vessel lesion coronari arteri diseas normal rest electrocardiogram hypertrophi prior infarct patient underw exercis electrocardiographi bruce protocol interpret abnorm st segment develop mv greater depress msec point physiolog signific coronari stenosi assess measur coronari flow reserv peak divid rest blood flow veloc stenot arteri doppler cathet intracoronari papaverin normal greater peakrest veloc percent diamet percent area stenosi produc lesion determin quantit angiographi browndodg method patient reduc coronari flow reserv greater peakrest blood flow veloc stenot arteri abnorm exercis electrocardiogram sensit confid interv convers patient normal coronari flow reserv normal exercis test specif confid interv exercis electrocardiogram abnorm patient mark reduc coronari flow reserv peakrest veloc patient moder reduc reserv peakrest veloc product systol blood pressur heart rate peak exercis signific correl coronari reserv patient abnorm exercis test comparison sensit confid interv specif confid interv exercis electrocardiographi detect greater diamet stenosi signific lower exercis electrocardiographi good predictor physiolog signific assess coronari flow reserv coronari stenosi patient normal rest electrocardiogram hypertrophi prior infarct broader larger patient popul requir studi result underscor import physiolog gold standard assess accuraci noninvas studi detect coronari arteri diseas"
"secular trend wave wave acut myocardi infarct minnesota heart survey minnesota heart survey examin trend wave wave acut myocardi infarct ami random sampl hospit discharg patient ami acut coronari diseas hospit hospit minneapolisst paul metropolitan area total potenti ami case abstract electrocardiogram code minnesota code ami valid computer algorithm base chest pain enzym electrocardiogram autopsi studi show consist standard diagnost algorithm attack rate wave ami chang signific attack rate wave ami decreas signific decad sensit cardiac enzym creatin phosphokinas creatin phosphokinasemb consid attack rate wave wave ami increas research document import trend communiti ami rate varianc report declin wave ami attack rate women outcom equal wors men casefat year surviv rate patient wave ami wors hospit prognos wave ami year surviv rate wors wave ami find demonstr standard diagnost criteria wave wave ami trend monitor futur trial oper nonop therapi ami undertaken increas import"
"impair myocardi ultrastructur cytoskeleton dilat cardiomyopathi studi design determin morpholog correl chronic heart failur myocardi tissu patient undergo transplant surgeri endstag dilat cardiomyopathi investig electron microscopi immunocytochemistri monoclon antibodi element cytoskeleton desmin tubulin vinculin vimentin tissu show hypertrophi atrophi myocyt increas amount fibrosi ultrastructur consist enlarg vari shape nuclei numer small mitochondria prolifer tubul accumul lipid droplet glycogen obvious ultrastructur alter decreas myofila rang raref complet absenc sarcomer cell fill unspecifi cytoplasm immunocytochemistri show desmin local line diseas myocardium amount desmin increas disord arrang tubulin form fine network myocyt signific increas cardiomyopath heart vinculin protein close cytoskeleton occur sarcolemma intercal disc myocardi cell ultrastructur alter cytoskeleton sever cell cell show moder sever remain cell normal vimentin present interstiti cell increas relat increas fibrosi conclud increas fibrosi degener hypertrophi myocardi cell alter cytoskeleton morpholog correl reduc myocardi function chronic heart failur"
"hla class ii dr dq antigen associ idiopath dilat cardiomyopathi valid studi metaanalysi publish hla associ studi previous report antigen frequenc differ hladr hladrw idiopath dilat cardiomyopathi idc patient healthi control pilot studi confirm find undertook independ studi prospect hypothesi frequenc dr drw type famili class ii antigen hladq includ proxim dq loci dr loci strong linkag disequilibrium dr dq allel compar consecut seri idc patient healthi blood bank control confirm increas dr antigen frequenc patient versus trend decreas express drw patient note patient versus control hladqw signific elev patient compar control versus relat risk etiolog fraction identifi combin drdqw haplotyp caucasian idc patient control comparison specif antigen frequenc preliminari valid studi reveal signific differ data studi examin combin combin studi dr elev versus control drw decreas versus control relat risk dr etiolog fraction"
"acut hemodynam effect captopril children congest restrict cardiomyopathi acut hemodynam effect captopril evalu cardiac catheter children age year cardiomyopathi twelv children congest cardiomyopathi restrict cardiomyopathi hemodynam measur obtain minut oral administr captopril mgkg blood pressur measur aorta pulmonari arteri atrium pulmonari capillari wedg posit cardiac output measur thermodilut techniqu hemodynam data obtain administr captopril child congest cardiomyopathi sever hypotens respons children congest cardiomyopathi cardiac index increas minm stroke volum increas mlm system vascular resist decreas unitsm aortic pressur chang signific contrast children restrict cardiomyopathi chang cardiac output captopril trend signific arteri hypotens aortic pressur decreas mm hg captopril acut reduc system vascular resist increas cardiac output stroke volum children congest cardiomyopathi children restrict cardiomyopathi captopril affect cardiac output decreas aortic pressur data captopril benefit children congest cardiomyopathi captopril children restrict diseas"
"method assess longterm outcom surgeri accessori pathway atrioventricular junction reentrant tachycardia success surgeri supraventricular tachycardia svt evalu varieti method hospit predict valu method compar method patient undergo surgeri svt westmead hospit surgic outcom assess earli test week surgeri serial lead electrocardiogram telemetr monitor electrocardiogram electrophysiolog studi perform epicardi wire test month surgeri lead electrocardiogram electrophysiolog studi symptomat review telephon interview median month surgeri earli test obtain test obtain symptomat review obtain patient examin test inaccur method surgic assess compar late electrophysiolog studi larg proport patient proven surgic failur late electrophysiolog studi detect earli test electrocardiogram symptomat assess accur assess surgic outcom requir late electrophysiolog studi permit comparison surgic techniqu late electrophysiolog studi accur inform current risk benefit propos surgeri communic patient enabl make inform decis futur treatment patient late electrophysiolog studi benefit clarif true surgic outcom"
"relat leisuretim physic activ blood pressur older women evid physic activ decreas blood pressur young middleag women physic activityblood pressur associ older women rare studi part ongo communitybas studi chronic diseas caucasian women age year blood pressur measur hypertens detect follow program protocol answer select health interview survey question leisuretim activ classifi categori light moder heavi physic activ estim metabol rate requir activ women engag physic activ signific younger thinner sedentari women lower fast hour postchalleng insulin level differ alcohol consumpt cigarett preval coronari heart diseas diabet rate systol diastol hypertens signific lower women particip light moder heavi physic activ compar sedentari women blood pressur level decreas increas report activ intens trend systol blood pressur approxim mm hg lower heaviest activ group compar systol blood pressur sedentari women intergroup differ remain statist signific adjust age bodi mass index physic activ lower fast hour postchalleng insulin level trend adjust insulin level alter blood pressur differ activ group"
"mechan reoxygen injuri cultur ventricular myocyt investig factor contribut reperfus reoxygen myocardi injuri expos layer cultur chick ventricular myocyt sever hypoxia hour presenc mm deoxyglucos glucos mm pyruv expos myocyt reoxygen lactat dehydrogenas ldh releas moder increas hour hypoxia increas mark reoxygen coincid intracellular calcium concentr ca cell motion measur hypoxia reoxygen hypoxia ca increas microm reoxygen ca abrupt decreas slight remain elev microm cell develop stabl rigor minut hypoxia reoxygen caus mark hypercontractur minut pretreat myocyt butanedion monoxim inhibit cadepend forc develop cyanid inhibit reoxygen hypercontractur ldh releas reoxygen signific reduc presenc butanedion monoxim treatment myocyt superoxid dismutas catalas hypoxia result decreas ldh releas reoxygen conclud abrupt increas ca reoxygen account reoxygen injuri presenc elev ca reoxygen result probabl resynthesi atp cadepend myofila crossbridg cycl result hypercontractur contribut myocyt damag generat oxygen free radic reoxygen contribut cell injuri system"
"method quantif regurgit flow rate color doppler flow imag flow converg region proxim discret orific vitro studi color doppler flow map yield quick sensit method visual turbul jet generat valvular insuffici quantif degre valvular insuffici limit depend visual turbul jet hemodynam instrumentrel factor color doppler flow imag capabl reliabl show spatial relat laminar flow area flow acceler proxim regurgit orific common visual left ventricular side mitral regurgit orific imag perform high gain low puls repetit frequenc area flow converg flow stream narrow symmetr quantifi veloc flow crosssect area chang invers proport streamlin center orific studi gravitydriven constantflow system sharpedg diaphragm orific rang mm diamet imag parallel perpendicular direct flow orific color doppler flow imag produc shift abrupt chang display color occur veloc alias boundari veloc measur radial distanc center orific determin isoveloc hemispher flow rate orific calcul pi vr radial distanc center orific color chang vr veloc color chang note vr valu cmsec obtain mhz transduc cmsec obtain mhz transduc calcul flow rate found correl measur flow rate slope regress line closest uniti lowest vr correspond largest calcul flow rate estim color doppler flow imag conjunct continuouswav doppler measur maxim veloc flow orific calcul orific area correl measur area"
"effect pressur volum receiv chamber spatial distribut regurgit jet imag color doppler flow map vitro studi regurgit jet dimens imag color doppler flow map evalu sever valvular insuffici clinic studi studi effect pressur volum receiv chamber magnitud spatial distribut regurgit jet assess color doppler techniqu design simpl constantflow model jet driven orific mm compliant receiv chamber steadyflow pump distal tube outflow close system maintain volum chamber constant pump oper vari flow rate mlmin elast balloon static complianc mlmm hg pressur mm hg balloon serv receiv chamber constant volum ml evalu effect volum receiv chamber ml pressur mm hg static complianc mlmm hg rang flow rate balloon jet area correl linear jet veloc orific flow rate flow rate volum receiv chamber jet area imag color doppler decreas pressur receiv chamber increas receivingchamb volum constant"
"left ventricular volum mass function develop regress supraventricular tachycardiainduc cardiomyopathi dispar recoveri systol versus diastol function chronic supraventricular tachycardia dilat cardiomyopathi man termin tachycardia result symptomat improv effect left ventricular lv volum mass function fulli examin hemodynam studi simultan echocardiographi catheter perform group pig subject rapid left atrial pace beatsmin week svt subject supraventricular tachycardia week termin pace week recoveri period psvt shamoper control ctr systol pump function assess fraction shorten fs peak eject rate peak dddt maximum rate pressur develop peak dpdt diastol function assess time constant isovolum pressur declin tau peak earli diastol fill rate peak dddt chamber stiff constant kc myocardi stiff constant km supraventricular tachycardia caus lv dilat enddiastol dimens edd increas cm ctr cm svt chang lv mass lv weightbodi weight ratio lvbw kg ctr kg svt index systol function abnorm fs fell ctr svt index relax fill slow tau increas msec ctr msec svt signific kc km termin supraventricular tachycardia lv volum fell remain greater ctr edd cm psvt versus ctr substanti lv hypertrophi develop lvbw kg psvt versus ctr systol function return normal fs psvt diastol function remain abnorm psvt tau remain prolong msec versus ctr kc increas ctr km increas ctr improv systol function occur termin supraventricular tachycardia develop lv hypertrophi persist diastol dysfunct"
"load depend left ventricular diastol pressurevolum relat shortterm coronari arteri occlus evalu effect alter load condit left ventricular lv diastol pressurevolum relat acut coronari arteri occlus produc inflat intracoronari balloon openchest anesthet dog instrument lv pressur micromanomet lv volum conduct measur disturb pericardium effect period occlus minut assess steadyst condit dextran infus pericardium present absent vena caval occlus steadyst condit dextran infus pericardium remov lv enddiastol pressur edp mm hg occlus result rightward shift diastol portion lv pressurevolum loop delta lvedp mm hg delta lvedv ml versus control dextran infus lvedp mm hg occlus result rightward upward shift diastol portion lv pressurevolum loop delta lvedp mm hg delta lvedv ml versus control low cardiac volum dextran infus intact pericardium affect respons occlus contrast dextran infus presenc intact pericardium lvedp signific increas delta mm hg lvdev delta ml ns parallel upward shift diastol portion lv pressurevolum loop elimin remov pericardium chang lv diastol pressur volum occlus vari depend baselin cardiac volum presenc pericardium dextran infus pericardium present absent coronari arteri occlus alter lv diastol chamber stiff paramet calcul diastol interv averag steadyst beat versus mm hgml ns dextran infus pericardium present absent coronari arteri occlus increas lv diastol chamber stiff paramet mm hgml versus control vena caval occlus elimin shift diastol portion lv pressurevolum loop pericardium present absentabstract truncat word"
"left ventricular diastol dysfunct limit maximum systol elast index contractil function test hypothesi maximum systol elast emax fail detect declin left ventricular lv contractil function diastol dysfunct present canin heart studi isol bloodperfus heart apparatus isovolum lv contractil dysfunct produc minut global ischemia minut reperfus normal heart underw minut ischemia underw minut ischemia ischemiareperfus sequenc develop pressur pressurevolum area myocardi atp level signific baselin heart group undergo minut ischemia lv diastol pressur increas emax decreas mm hgml group undergo minut ischemia diastol pressur increas mm hg emax chang signific mm hgml seri experi perform heart pressureoverload hypertrophi aorticband model echocardiographi catheter studi ischemiareperfus protocol evid pump failur remain compens minut ischemia minut reperfus develop pressur pressurevolum area myocardi atp level signific baselin heart group compens lv hypertrophi lv diastol pressur chang emax decreas mm hgml"
"natur histori peripher vascular diseas implic manag durabl eventu complic rate endovascular therapi percutan translumin angioplasti laserassist angioplasti atherectomi clear respect treatment atherosclerot lesion femoropoplit distal arteri segment indic firm establish natur histori occlus diseas type procedur intervent warrant presenc ischem rest pain tissu necrosi intermitt claudic complaint approxim patient present aortoiliac femoropoplit involv nondiabet patient experi substanti symptomat improv daili exercis program longterm risk abrupt deterior amput low comparison year mortal rate rang claudic clinic indic coronari arteri diseas shown angiograph candid myocardi revascular observ suggest tradit indic surgic treatment disabl claudic limb salvag appli endovascular therapi success confirm specul incident coronari diseas deserv attent patient lower extrem ischemia"
"impact nonop therapi clinic manag peripher arteri diseas nonop therapi includ conserv nonintervent modal endovascular intervent modal percutan translumin angioplasti varieti laser system atherectomi devic role impact nonop treatment consid perspect natur histori lowerextrem arteriosclerosi present surgic oper treatment nonop treatment replac facilit surgic treatment oper candid nonop method justifi treatment patient subject surgeri fact opinion relat nonop treatment present qualif credenti individu treat patient lowerextrem ischemia result peripher arteriosclerosi discuss"
"diagnosi evalu renovascular hypertens indic therapi renovascular hypertens caus distinct condit fibromuscular dysplasia atheroma diagnosi simpler reward atheromat lesion renal arteri secondari essenti hypertens import establish exist function renal ischemia anatom lesion univers screen hypertens patient recommend low preval diseas insuffici accuraci screen test renovascular hypertens clinic suspect oral captopril test reliabl offic screen test digit subtract angiographi renal vein renin captopril renographi step procedur promis requir evalu duplex scan renal arteri categori arteriographi renal ischemia angioplasti attempt time arteriographi"
"clinic anatom surgeri aortoiliac diseas result surgic treatment varieti surgic procedur treatment occlus diseas involv aorta iliac arteri oper patient determin princip diseas locat patient risk provid high effect relief disabl claudic limbthreaten ischemia low morbid mortal rate excel durabl result current surgic practic serv standard newer treatment modal compar"
"result complic angioplasti aortoiliac diseas percutan translumin angioplasti treat aortoiliac lesion patient long month month median month initi success rate lesion patient indic percutan translumin angioplasti includ claudic patient rest pain ischem night pain limb salvag aid wound heal seri patient cardiovascular risk factor angioplasti initi unsuccess patient patient lost follow follow obtain patient longterm result analyz life tabl method determin cumul patenc fourteen patient consid failur recurr diseas symptom project year cumul patenc rate respons redilat consid project year cumul patenc rate result percutan translumin angioplasti success correct aortoiliac lesion provid longterm benefit long year"
"standard evalu result intervent therapi peripher vascular diseas uniform standard evalu report result therapeut intervent peripher vascular diseas establish vascular surgeri repres report svsiscv committe vascular surgeon larg vascular interventionist articl major problemat report practic discuss illustr recommend advanc deal intend provid precis definit object criteria success failur standard sever gradat scheme peripher vascular diseas risk factor proper procedur report outcom form therapeut intervent agre report standard accept literatur peripher vascular diseas manag continu sourc confus enlighten"
"clinic anatom surgeri femoropoplit diseas result surgeri perform femoropoplit bypass oper patient oregon health scienc univers indic procedur claudic relief limbthreaten ischemia oper mortal occur oper includ death myocardi infarct death stroke femoropoplit bypass patient divid group patenc analysi includ undergo bypass surgeri good qualiti greater saphen vein versus altern bypass conduit patient undergo primari limb bypass versus undergo repeat bypass prior bypass failur primari graft patenc femoropoplit graft year patient undergo bypass good qualiti greater saphen vein primari graft patenc year patient undergo bypass conduit greater saphen vein year patenc patient undergo repeat bypass prior fail bypass year patenc"
"femoropoplit angioplasti factor influenc longterm success prospect data record percutan translumin angioplasti pta procedur perform superfici femor poplit arteri year period initi procedur patient serial noninvas studi patient repeat angiographi follow period year rang year standard lifet surviv analysi assess factor potenti affect longterm outcom exclud initi technic failur rate patenc year year prognosi failur rate linear long term year factor negat influenc longterm patenc includ presenc diabet mellitus diffus atherosclerot cardiovascular diseas threaten limb loss technic factor correl failur includ lesion length moder eccentr poor postpta"
"clinic anatom surgeri tibial diseas result surgeri bypass vein graft infrapoplit arteri achiev year cumul patenc equival vein graft poplit arteri techniqu situ vein graft tibial arteri result present year cumul patenc bypass year limb salvag patient approxim result coupl report center sizabl experi tibial arteri reconstruct suggest real progress past decad salvag lower extrem patient advanc peripher vascular diseas autogen venous bypass graft"
"hottip laser result complic hot tip laser system atheroabl mid devic broaden indic extend applic angioplasti manag lowerextrem atherosclerosi controversi devic system demonstr occasion manag occlus oppos stenot diseas infrainguin arteri close examin publish data fail demonstr consist improv primari success longterm patenc rate thermal energi appli atheroma recan lower extrem arteri"
"prevent hypertens vascular captopril treatment treatment femal spontan hypertens rat shr control wistarkyoto wki rat captopril carri addit drug drink water pregnanc lactat wean week age averag systol blood pressur treat shr mm hg control shr mm hg wki rat mm hg bodi weight heart rate shr affect treatment tissu level catecholamin increas captopril treatment superior cervic ganglia remain unchang plasma heart mesenter arteri adren gland shr wki rat left ventricular weight wall thick intern diamet left ventricl shr reduc treatment morphometr measur mesenter arteri show vascular alter present control shr prevent treatment superior mesenter arteri larg mesenter arteri smaller lumen size maxim relax found control shr normal level wki rat hypertrophi medial wall superior mesenter larg small mesenter arteri increas number smooth muscl cell layer larg mesenter arteri shr prevent treatment perfus studi mesenter vascular bed show reactiv vessel norepinephrin reduc sensit norepinephrin determin effect dose maxim respons increas shr captopril treatment sensit tail arteri respons norepinephrin alter treatment conclud longterm treatment captopril shr birth prevent develop hypertens structur function alter mesenter arteri cardiac hypertrophi"
"isol preferenti express gene kidney hypertens rat differenti hybrid complementari dnas design sa isol messeng rnas mrnas differenti express kidney spontan hypertens rat shr normotens wistarkyoto wki rat ident cytochrom iv sa encod protein amino acid residu carboxyl termin region slight homolog luciferas homolog sequenc report sequenc mrna time abund express kidney day shr agematch wki rat differ age week low nacl diet posit modul express gene mrna undetect kidney day wki rat detect agematch shr express level mrna liver week shr time higher agematch wki rat express mrna liver modul dietari nacl captopril sa mrna time abund express kidney shr wki rat age week administr captopril express sa mrna liver shr posit modul gene differenti express shr wki rat relat sodium metabol blood pressur control identif gene provid import probe examin mechan hypertens"
"impair insulin action skelet muscl metabol essenti hypertens previous studi shown essenti hypertens frequent insulin resist tissu respons metabol alter defin test hypothesi skelet muscl site insulin resist essenti hypertens perfus forearm techniqu hypertens age year bodi mass index kgm intraarteri blood pressur mm hg normotens age year bodi mass index kgm blood pressur mm hg male volunt studi glucos ingest normal glucos toler patient maintain expens heighten plasma insulin respons suggest presenc insulin resist grade local intraarteri hyperinsulinemia encompass physiolog rang milliunit glucos uptak forearm tissu signific reduc hypertens subject compar control insulin step averag addit forearm lactat pyruv releas signific stimul hypertens normotens group consequ decreas glucos influx forearm exchang oxygen carbon dioxid lipid substrat free fatti acid glycerol betahydroxybutyr potassium similar hypertens normotens group basal state insulin effect oxygen consumpt carbon dioxid product respiratori quotient studi group stimul free fatti acid glycerol potassium uptak extent hypertens normotens group"
"nicotin impair reflex renal nerv respiratori activ deoxycorticosteron acetatesalt rat smoke exacerb increas arteri pressur hypertens effect nicotin baroreceptormedi reflex respons renal nerv activ rna heart rate respiratori activ minut diaphragmat activ mda bolus inject phenylephrin compar deoxycorticosteron acet docasalt sensit normotens rat osmot minipump dispens nicotin mgkgday salin implant doca normotens rat day anesthet docanicotin docasalin controlnicotin controlsalin rat arteri pressur map mm hg nicotin decreas sensit baroreceptor reflex control rna delta rnadelta map docanicotin rat compar docasalin controlnicotin controlsalin rat reflex decreas respiratori activ delta mdadelta map impair controlnicotin docanicotin rat compar controlsalin docasalin rat reflex decreas heart rate absolut delta hrdelta map docanicotin controlnicotin rat augment compar docasalin controlsalin rat"
"effect drug diet treatment mild hypertens diastol blood pressur taim research group trial antihypertens intervent manag multicent random trial design examin diastol blood pressur respons combin pharmacolog dietari intervent treatment mild hypertens diastol blood pressur mm hg hundr seventi particip ideal weight random alloc drugdiet treatment group receiv placebo chlorthalidon mg atenolol mg combin usual weight loss low sodiumhigh potassium diet primari outcom diastol blood pressur chang baselin month hundr eighti particip follow data baselin diastol blood pressur mm hg particip male weight loss diet group lost averag kg multipl comparison account analysi signific greater lower diastol blood pressur mm hg achiev atenolol group compar low sodiumhigh potassium diet group mm hg weight loss group mm hg ad weight loss chlorthalidon signific enhanc blood pressur lower mm hg compar diuret mm hg ad low sodiumhigh potassium diet mm hg shortterm treatment mild hypertens diastol blood pressur sole drug outperform diet weight loss benefici diuret"
"character auscultatori gap wideband extern puls record type auscultatori gap call occur blood pressur measur identifi wideband extern puls record previous shown wideband extern puls record cuff deflat separ compon close relat korotkoff sound occur cuff pressur systol character presenc intermitt disappear gap relat phasic decreas arteri systol pressur exhibit hypertens patient gap relat phasic increas arteri diastol pressur occur cuff pressur diastol character presenc intermitt disappear hypertens patient exhibit gap gap occur cuff pressur systol diastol character underdevelop blunt signal hypertens patient exhibit gap identif auscultatori gap relat wideband extern puls qualit measur exist signific understand aspect auscultatori blood pressur measur techniqu object basi understand mechan"
"myocardi protein turnov patient coronari arteri diseas effect branch chain amino acid infus regul protein metabol human heart previous studi postabsorpt patient coronari arteri diseas heart protein synthesi degrad estim simultan extract intraven infus ringhphenylalanin phe dilut specif activ heart isotop steadi state subsequ examin effect branch chain amino acid bcaa infus heart protein turnov myocardi balanc amino acid branch chain ketoacid bcka patient postabsorpt state net releas phenylalanin arterialcardiac venous phe nmolml balanc nmol phemin reflect protein degrad nmol phemin excess synthesi nmol phemin net myocardi protein catabol bcaa infus protein synthesi increas equal degrad rate nmol phemin phenylalanin balanc shift negat neutral arterialcardiac venous phe nmolml balanc nmol phemin bcaa infus stimul myocardi uptak bcaa ketoacid conjug proport circul concentr net uptak bcaa great exceed essenti amino acid suggest role bcaa bcka metabol fuel plasma insulin level cardiac doubl product coronari blood flow myocardi oxygen consumpt unchang result demonstr myocardium postabsorpt human negat protein balanc primari anabol effect bcaa human heart"
"sclerotherapi varicos telangiectat leg vein minim scleros concentr hyperton salin relationship vessel diamet author report result doubleblind pairedcomparison studi salin scleros minus heparin addit studi design elucid effect increas concentr hyperton salin regard vessel diamet clinic efficaci complic discomfort hundr women bilater symmetr starburst telangiectasia varicos vein enter studi sodium chlorid minim scleros concentr salin produc effect vein sclerosi vessel mm diamet produc morbid optim concentr scleros vari diamet vessel therapeut"
"natur histori moder aortic stenosi natur histori sever symptomat aortic stenosi document natur histori moder aortic stenosi remain poor understood group patient identifi diagnosi moder aortic stenosi time cardiac catheter aortic valv area cm surgic therapi st day cardiac catheter follow period month patient die attribut aortic stenosi underw aortic valv replac estim probabl remain free complic aortic stenosi end year symptomat patient decreas eject fraction hemodynam evid left ventricular decompens greater risk complic conclud patient moder aortic stenosi signific risk develop complic"
"effect receptor stimul coronari arteri diamet patient variant angina comparison effect acetylcholin suggest histamin involv pathogenesi coronari spasm exact role remain unclear receptor stimul coronari arteri perform select intracoronari infus histamin microgramsmin patient variant angina blockad receptor cimetidin mgkg effect coronari arteri diamet examin intracoronari inject acetylcholin perform patient ergonovin mg intraven administ patient coronari arteri diamet measur cinevideodensitometr analysi plasma histamin concentr coronari sinus increas min histamin infus left coronari arteri coronari spasm induc patient histamin acetylcholin ergonovin effect histamin lumin diamet analyz site spasm coronari arteri spasm induc acetylcholin ergonovin coronari arteri normal arteriogram fix stenosi equal lumin diamet histamin decreas diamet increas caus chang coronari arteri fix stenosi greater equal histamin decreas diamet increas coronari arteri spasm induc acetylcholin ergonovin histamin increas diamet advanc atherosclerosi"
"percutan mitral valvuloplasti surgic high risk patient consecut patient undergo percutan mitral valvuloplasti judg high risk surgeri basi age greater year york heart associ function class iv eject fraction equal sever pulmonari hypertens coronari bypass addit valv surgeri sever pulmonari diseas baselin featur high risk group substanti wors patient age versus year echocardiograph score versus higher cardiac output versus litersmin mitral valv area versus mm lower high risk patient experienc technic failur major complic remain patient complet hemodynam success incomplet success hemodynam failur stepwis logist regress analysi retain echocardiograph score factor independ predict success percent increas mitral valv area correl echocardiograph score"
"variabl extent jeopard myocardium patient singl vessel coronari arteri diseas quantif thallium singl photon emiss comput tomographi assess extent jeopard myocardium patient singl vessel coronari arteri diseas variabl sever locat quantit exercis thallium singl photon emiss comput tomographi perform consecut patient angiograph prove singl vessel coronari arteri diseas extent abnorm left ventricular perfus quantifi computergener polar map dimension myocardi radioact patient moder stenosi tend small perfus defect irrespect coronari arteri involv perfus defect measur greater equal left ventricl found patient prior infarct sever greater equal stenosi observ patient moder stenosi perfus defect size increas increas sever stenosi entir group infarct left anterior descend circumflex coronari arteri stenosi correl stenosi sever perfus defect size modest left anterior descend arteri shown import coronari arteri provid left ventricular perfus proxim stenosi arteri produc perfus defect approxim larg found patient proxim circumflex arteri stenosi mark heterogen perfus defect size exist vessel compar stenosi sever appar left anterior descend coronari arteri mid vessel stenosi common produc perfus defect similar size found proxim stenos vessel"
"primari angioplasti myocardi infarct assess improv myocardi perfus technetiumm isonitril technetiummhexakismethoxyisobutylisonitril technetiumm isonitril radiopharmaceut compound reflect myocardi perfus kinet lack redistribut intraven administr permit assess myocardi perfus delay therapi tomograph imag rest obtain immedi day consecut patient undergo success primari angioplasti transmur myocardi infarct thirteen patient anterior infarct initi acut defect size angioplasti left ventricl decreas signific late scan correl time therapi reduct defect size twelv patient includ patient treat demonstr definit reduct initi defect size patient angiograph prove persist coronari occlus underw similar imag sequenc initi defect size group remain unchang late scan versus ns primari angioplasti effect approach salvag myocardium comparison thrombolyt drug therapi await result control clinic trial"
"differenti cardiomyopathi coronari arteri diseas nonischem dilat cardiomyopathi util positron emiss tomographi determin imag blood flow ammonia glucos metabol deoxyglucos positron emiss tomographi distinguish cardiomyopathi coronari arteri diseas nonischem dilat cardiomyopathi patient sever left ventricular dysfunct evalu cardiac transplant studi origin left ventricular dysfunct previous determin coronari angiographi ischem patient nonischem patient imag visual analyz observ grade scale left ventricular segment reveal fewer defect dilat cardiomyopathi compar ischem cardiomyopathi ammonia versus deoxyglucos versus index incorpor extent sever defect reveal homogen fewer sever defect subject nonischem ischem cardiomyopathi assess imag flow versus metabol versus diagnost accuraci distinguish subgroup visual imag analysi previous publish circumferenti count profil criteria patient dilat cardiomyopathi fewer ischem segment versus patient infarct segment versus patient patient cardiomyopathi coronari arteri diseas sensit differenti clinic subgroup circumferenti profil analysi specif index incorpor number sever defect deriv circumferenti profil analysi signific lower subject dilat cardiomyopathi ischem cardiomyopathi versus noninvas positron emiss tomograph imag ammonia deoxyglucos distinguish patient sever left ventricular dysfunct secondari coronari arteri diseas nonischem cardiomyopathi semiquantit index circumferenti profil analysi superior visual analysi"
"comparison pre postop conduct pattern patient surgic cure atrioventricular node reentrant tachycardia patient atrioventricular av node reentrant tachycardia characterist short constant retrograd atrium conduct time ha interv introduct ventricular extrastimuli suggest tachycardia circuit involv retrograd conduct accessori pathway locat perinod tissu mechan surgic cure av node reentrant tachycardia interrupt accessori pathway postop retrograd conduct expect thirteen patient drugrefractori av node reentrant tachycardia underw surgeri preoper ha interv short constant av node reentrant tachycardia earliest atrial activ bundl ms ventricular activ patient surgeri consist dissect atrial septal anterior input av node central fibrous bodi postop ha interv remain short constant compar preoper valu slight prolong versus ms twelv patient free tachycardia month patient evid av node block surgic cure av node reentrant tachycardia high success reason postul accessori pathway perinod tissu part tachycardia circuit mechan surgic success remain obscur"
"prolong fraction atrial electrogram sinus rhythm patient paroxysm atrial fibril sick sinus node syndrom intraatri cathet map atrium perform sinus rhythm patient group control patient paroxysm atrial fibril sick sinus node syndrom group ii patient paroxysm atrial fibril sick sinus node syndrom group iii patient paroxysm atrial fibril sick sinus node syndrom atrial electrogram record site atrium durat number fragment deflect atrial electrogram quantit measur durat number fragment deflect atrial electrogram group ms criteria abnorm atrial electrogram defin durat greater equal ms fragment deflect abnorm atrial electrogram observ patient group patient group ii patient group iii group ii versus group group iii versus group number abnorm electrogram patient abnorm electrogram group group ii group iii group versus group ii group ii versus group iii prolong fraction atrial electrogram characterist paroxysm atrial fibril close relat vulner atrial muscl"
"spontan ventricular tachycardia cycl length understand spontan fluctuat ventricular tachycardia cycl length requir develop algorithm ventricular tachycardia detect termin variat cycl length time stabl cycl length rang rr interv ventricular tachycardia analyz episod sustain monomorph ventricular tachycardia induc patient antiarrhythm medic linear regress demonstr cycl length variabl decreas time ms slower ventricular tachycardia cycl length variabl faster ventricular tachycardia ventricular tachycardia initi variabl tend remain variabl fifti percent episod stabil beat beat beat number beat stabl cycl length independ ventricular tachycardia rate averag rang cycl length episod ms ventricular tachycardia episod vari ms ms maxim rang rr interv singl episod ventricular tachycardia ms ventricular tachycardia demonstr wide rang cycl length timedepend variabl stabil cycl length consid algorithm ventricular tachycardia detect termin automat antitachycardia devic"
"echocardiograph evalu cardiac structur function elder subject isol systol hypertens hundr particip systol hypertens elder program shep trial age year examin doppler echocardiographi gain inform cardiac structur function alter isol systol hypertens particip systol blood pressur greater mm hg diastol blood pressur mm hg compar agematch normotens control subject left ventricular mass index signific higher particip normotens subject versus particip met echocardiograph criteria left ventricular hypertrophi compar normotens subject left atrial index greater particip normotens subject versus cmm particip left atrial enlarg doppler measur diastol fill signific group peak atrial veloc higher versus cm ratio peak earli atrial veloc lower versus particip correl left ventricular mass index doppler measur diastol function relat wall thick correl signific peak atrial veloc peak earli peak atrial veloc ratio differ mode eject phase index systol perform shorten fraction peak veloc circumferenti fiber shorten group"
"immunosuppress therapi manag acut myocard children clinic trial assess steroid therapi influenc clinic myocard pediatr popul find consecut infant children femal male biopsyprov myocard review age year rang congest heart failur present st wave cardiomegali pulmonari edema chest roentgenogram echocardiographi demonstr pericardi effus patient mitral regurgit left ventricular eject fraction prednison administ patient patient receiv azathioprin death survivor show clinic improv normal ecg heart size systol function signific side effect occur repeat myocardi biopsi patient demonstr improv elimin inflammatori infiltr immunosuppress therapi pediatr popul improv clinic cardiac function acut myocard advers side effect"
"effect atenolol diltiazem heart period variabl normal person time frequenc domain measur heart period variabl reduc week myocardi infarct reduc standard deviat normal rr interv period sdnn increas mortal predict accuraci heart period variabl reduc drug treat patient myocardi infarct random period placebocontrol crossov latin squar design determin effect atenolol diltiazem time frequenc measur heart period variabl calcul continu electrocardiograph record treatment atenolol diltiazem placebo normal volunt atenolol treatment averag normal rr nn interv increas measur tonic vagal activ signific increas atenolol treatment percent success normal rr interv greater ms root squar success differ normal rr interv high frequenc power heart period power spectrum low frequenc power increas indic variabl indic tonic vagal activ diltiazem signific effect averag nn interv measur heart period variabl decreas mortal rate myocardi infarct betaadrenerg blocker calcium channel blocker therapi attribut part increas vagal tone caus betablock"
"hypertrophi fibrosi diastol dysfunct earli canin experiment hypertens examin relat hypertrophi fibrosi diastol perform earli experiment hypertens control dog dog experiment left ventricular hypertrophi studi diastol function impair dog left ventricular hypertrophi decreas doppler earli atrial inflow veloc ratio versus increas atrial fill fraction versus decreas sonomicrometr peak rate wall thin versus liter fill versus liter prolong time constant isovolumetr relax tau versus ms chamber stiff aekv passiv elast stiff sigma sigma stress increas postmortem examin hypertens left ventricl weigh signific normal versus greater muscl fiber diamet endocardi epicardi sampl site apic free wall basal free wall septum diamet micron hypertens dog micron normal dog contrast percent fibrosi versus normal dog fibrot volum versus normal dog signific increas peak volumetr fill rate invers relat fiber diamet variabl left ventricular function signific relat percent volum fibrosi greater diastol dysfunct exist set hypertrophi signific fibrosi increas myocyt size earli diastol fill abnorm characterist hypertens left ventricl fibrosi import determin diastol perform"
"transesophag echocardiographi superior transthorac echocardiographi diagnosi sinus venosus atrial septal defect purpos studi compar transthorac transesophag echocardiographi diagnosi type atrial septal defect forti adult patient clinic diagnosi atrial septal defect studi transthorac transesophag echocardiographi women men year age transthorac echocardiographi demonstr atrial septal defect patient secundum type primum type sinus venosus type transesophag echocardiographi demonstr defect patient patient atrial septal defect demonstr transesophag transthorac echocardiographi sinus venosus type atrial septal defect patient secundum atrial septal defect technic poor transthorac echocardiogram small atrial septal defect transthorac echocardiographi fail demonstr sinus venosus defect patient anomal venous connect sinus venosus defect visual transesophag echocardiographi patient transthorac echocardiographi patient sinus venosus type atrial septal defect frequent visual adult convent transthorac echocardiographi transesophag echocardiographi recommend atrial septal defect clinic suspect visual transthorac echocardiographi"
"physician perspect cholesterol heart diseas earli spring questionnair mail midwestern physician survey attitud practic elev serum cholesterol referr nutrit counsel physician respond sixti percent physician thought reduc high serum cholesterol level substanti affect heart diseas physician attribut prevent reduc cholesterol level reduc blood pressur ceas smoke rang serum cholesterol diet therapi frequent initi mmol frequent rang initi drug therapi mmol physician report medic school train prepar adequ provid diet counsel feel prepar provid success counsel diet modif reduc serum cholesterol total sampl report regist dietitian dietari counsel believ physician respons provid counsel low respons rate limit conclus survey physician interest topic respond conclud regist dietitian explor special servic aggress market dietet servic benefit physician patient campaign reduc serum cholesterol"
"influenc dietari cod liver oil fatti acid composit plasma lipid human male subject myocardi infarct random crossov studi carri investig fatti acid profil concentr plasma lipid male patient myocardi infarct mi supplement diet ml cod liver oil daili week subject divid group group receiv cod liver oil daili week hospit discharg subsequ week group start cod liver oil week hospit discharg cod liver oil week diet medic smoke habit constant studi period cod liver oil intak eicosapentaeno acid epa docosahexaeno acid dha increas signific phospholipid pl triglycerid tg cholesterol ester ce linol acid la dihomogammalinolen acid dhgla arachidon acid aa signific decreas phospholipid plasma level tg signific decreas cod liver oil intak total cholesterol high densiti lipoprotein hdl cholesterol level apolipoprotein affect cod liver oil mi patient"
"atrioventricular plane displac sever congest heart failur dilat cardiomyopathi myocardi infarct echocardiograph record atrioventricular av plane displac cardiac cycl assess left ventricular lv global function patient congest heart failur chf studi popul consist patient chronic chf nyha function group iii iv dilat cardiomyopathi dcm myocardi infarct mi agematch healthi subject av plane displac record apic chamber view lv site locat degre repres septal anterior posterior part lv wall calcul site av patient chf show signific general reduct av plane displac compar healthi subject mm mm thirti chf patient underw radionuclid angiographi order determin eject fraction ef correl av ef good select av mm defin sever depress lv function ef gave sensit specif conclud av plane displac estim lv systol function patient chf"
"elev plasma neuropeptid immunoreact noradrenalin myocardi ischaemia man plasma level neuropeptid immunoreact npyli noradrenalin studi patient acut ischaem heart diseas admiss npyli level normal patient patient increas noradrenalin level initi plasma npyli differ patient acut myocardi infarct ami angina pectori initi plasma noradrenalin level higher patient ami angina pectori plasma level noradrenalin remain elev ami patient decreas normal valu patient angina pectori level npyli return normal patient tachycardia left ventricular failur relat high npyli noradrenalin level posit correl found noradrenalin npyli plasma suggest neuropeptid npi endogen vasoconstrictor peptid consid mediat involv cardiovascular respons sympathet activ induc myocardi ischaemia"
"unnecessari death valvular aortic stenosi annual mortal aortic valvular stenosi calcul potenti candid surgic replac aortic valv swedish central regist death patient age year die aortic stenosi year period counti stockholm popul million identifi retrospect analysi medic record show individu suitabl candid surgeri presenc aortic stenosi verifi autopsi patient remain patient aortic stenosi diagnosi establish invas investig perform death typic sign symptom aortic stenosi record patient consid physician suitabl candid surgeri prior death deceas patient compar group patient undergon aortic valv replac aortic stenosi period signific differ group regard symptom clinic find higher incid syncop oper group conclud surgic treat deceas elig patient aortic stenosi individu receiv surgic care time reason insuffici knowledg curabl diseas"
"high urinari camp hypertens care drug treatment epidemiolog studi dalbi popul correl serum calcium ca plasma parathyroid hormon pth hypertens determin populationbas crosssect studi care treat hypertens diastol blood pressur mmhg year compar normotens control diastol blood pressur mmhg year level urinari cyclicadenosinemonophosph camp plasma camp camp higher hypertens control case type drug treatment blood pressur level reach camp correl adrenalin multivari analys ca level higher mg level lower hypertens control explain thiazid treatment adequ blood pressur reduct substanti differ ca mg camp exist hypertens normotens control"
"increas blood viscos combin decreas erythrocyt fluiditi untreat patient essenti hypertens erythrocyt fluiditi haemorheolog variabl studi patient essenti hypertens compar age sexmatch healthi control hypertens patient display signific lower erythrocyt fluiditi similar signific elev valu haematocrit plasma blood viscos aggreg tendenc observ compar control differ respect control obvious relationship rheolog variabl systol diastol blood pressur signific lower erythrocyt fluiditi haemorheolog variabl red blood cell found hypertens patient explain enlarg metabol pool free calcium ion red blood cell suggest molecular mechan evolut essenti hypertens multifactori base singl molecular derang primari event result alter physicochem properti red blood cell work concert develop essenti hypertens addit increas avail calcium ion potenti role smooth muscl contract"
"assess myocardi perfus patient arteri switch oper patient undergon arteri switch oper adequaci myocardi perfus evalu thallium comput scintigraphi yr surgeri fourteen patient undergon arteri switch procedur pulmonari arteri band primari repair isoproterenol stress increas heart rate tomograph imag perform peak stress hr reperfus phase patient perfus defect perfus defect locat left ventricular apex extens inferolater wall left ventricular anterolater wall ventricular septum left ventricular inferior wall ventricular free wall defect due myocardi damag time surgeri result rais concern longterm adequaci myocardi perfus arteri switch procedur"
"myocardi uptak carbonacet indirect estim region myocardi blood flow rate clearanc myocardi carbon activ administr cacet shown correl close myocardi oxygen consumpt present studi hypothes region net myocardi uptak cacet reflect primarili deliveri extract tracer mark flowdepend potenti indirect index region myocardi blood flow patient stabl coronari arteri diseas region distribut earli net uptak cacet correl estim region myocardi blood flow assess oxygenwat myocardi imag cacet uptak high qualiti correl approach close affect metabol state tissu patient stabl coronari arteri diseas rest condit direct estim myocardi oxygen consumpt relat level deliveri tracer tissu obtain pet singl radiopharmaceut cacet approach prove streamlin clinic protocol design assess myocardi oxygen consumpt"
"bloodpool radionuclid angiographi patient novacor left ventricular assist devic bloodpool radionuclid angiographi investig left ventricular function patient receiv novacor assist devic bridgecardiac transplant studi perform maxim minim toler assist devic flow left ventricular eject fraction volum cardiac output pump eject fraction computerassess patient sever left ventricular dilat hypokinesi insert assist devic eject fraction improv maxim assist devic flow fell minim flow ventricular volum normal maxim assist devic flow increas signific minim flow pump visual eject fraction data assist devic effect unload left ventricl deterior eject fraction decreas assist devic flow depend patient devic sustain adequ hemodynam"
"earli scintigraph detect experiment myocardi infarct dog technetiummglucar acid recent data generat interest technetiummmtc glucar acid vivo viabil marker studi mtcglucar acid retent canin model myocardi ischemia min occlus ladmin reperfus acut myocardi infarct mi min lad occlusionhr reperfus chronic mi min occlus hr day reperfus region myocardi blood flow measur radiolabel microspher preferenti uptak glucar acid observ ischem viabl myocardium compound show high affin necrot myocardi tissu day injuri preferenti uptak infarct tissu disappear day injuri studi show mtcglucar acid act exclus marker necrosi canin model mi technetiummglucar acid clinic util earli cardiac imag myocardi infarct differenti recent injuri"
"effect coronari occlus myocardi viabil myocardi activ technetiummsestamibi time effect sestamibi administr respect onset myocardi ischemia reperfus studi swine group anim sestamibi administ prior coronari arteri occlus occlus hour reperfus sestamibi administ prior coronari occlus result insignific decreas mtc activ ischem zone infarct zone activ reduc nonischem zone contrast administr coronari occlus result similar signific reduct ischem infarct zone activ administr sestamibi reperfus result normal ischem zone activ mark reduc activ infarct zone signific reduc activ infarct zone found independ time sestamibi administr respect onset myocardi ischemia reperfus cell viabil requir uptak retent isotop activ"
"manag primari pulmonari hypertens primari pulmonari hypertens clinic syndrom character pulmonari hypertens absenc suffici cardiac parenchym pulmonari system diseas account popul patient primari pulmonari hypertens heterogen clinic histolog etiolog mechan unknown therapi direct consequ pulmonari vascular process oxygen supplement digoxin diuret symptomat heart failur anticoagul role treat primari pulmonari hypertens vasodil therapi main area investig screen vasodil respons defin favor vasodil effect predict longterm effect decid treat controversi approach highdos calcium channelblock agent continu intraven infus prostacyclin investig agent recent propos medic therapi exhaust heartlung lung transplant increas option select patient"
"thromboexclus ventricl children pulmonari atresia intact ventricular septum twelv children pulmonari atresia intact ventricular septum underw closur tricuspid valv part surgic procedur case concomit fontan oper perform patient ventricl small ventricular pressur higher system pressur ventriclecoronari connect provid flow desatur blood ventricl coronari arteri case children surviv oper postmortem examin reveal sever acut chronic myocardi ischem damag highgrad obstruct interrupt proxim left anterior descend coronari arteri preoper angiographi demonstr occlus coronari arteri result ventricular depend circul children die child surviv oper children surviv oper month year undergon subsequ success fontan oper consid suitabl candid oper tricuspid valv closur recommend care select group infant pulmonari atresia intact ventricular septum provid ventriculardepend coronari circul exclud basi preoper coronari cineangiographi"
"left ventricular mechan eject postischem heart left ventricular circulatori assist measur effect left ventricular circulatori assist ventricular mechan eject sheep heart global ischemia flow left atrium femor arteri rang mlkgmin circulatori assist preischem eject heart increas flow left ventricular assist devic progress decreas stroke volum enddiastol volum circumferenti systol wall stress slight decreas endsystol volum postischem eject heart left ventricular assist progress substanti decreas enddiastol volum endsystol volum high flow endsystol volum return normal rang preischem heart high flow assist devic shift endsystol point pressurevolum loop leftward increas stroke workenddiastol volum ratio eject postischem heart observ rais possibl left ventricular circulatori assist acut improv myocardi contractil postischem heart"
"evolut human cardiac myocyt dimens prolong mechan support anim model left ventricular assist system long time period myocardi cellular atrophi report rais concern prolong clinic system lead deterior left ventricular function univers pittsburgh longterm clinic novacor baxter healthcar corp novacor div oakland calif left ventricular support system patient await heart transplant studi effect longterm mechan support human subject studi determin cardiac myocyt dimens initi greater patient endstag cardiac diseas requir support patient diseas requir support myocyt dimens decreas day incept support decreas bring cell size closer valu usual patient chronic endstag cardiac diseas shrinkag observ novacor left ventricular assist system left ventricular atrophi longterm detriment left ventricular function"
"cerebr air embol treat pressur hyperbar oxygen pressur hyperbar oxygen treat patient cerebr air embol occur result invas medic procedur suffer perman damag detect clinic examin mri outcom contrast report infarct disabl untreat victim air embol"
"abdomin aneurysm childhood report case review literatur abdomin aneurysm rare children found associ congenit cardiac aortic malform connect tissu disord trauma previous arteri cathet placement year girl common iliac arteri aneurysm histori arteri cathet placement trauma evid marfan ehlersdanlo syndrom arter coarctat aorta diseas childhood aneurysm present resect aneurysm arteri reconstruct perform prosthet materi vein graft patholog examin show evid inflamm medial degener layer arteri wall fourth report found literatur document idiopath abdomin aneurysm child condit abdomin aneurysm childhood discuss literatur review"
"reduct cardiovascular diseaserel mortal postmenopaus women hormon evid nation cohort nation sampl white menopaus women greater equal year epidemiolog follow particip nation health nutrit examin survey review investig role hormon therapi alter risk death cardiovascular diseas women studi observ year baselin survey women die death due cardiovascular diseas histori diabet relat risk confid interv previous myocardi infarct relat risk confid interv smoke relat risk confid interv elev blood pressur relat risk confid interv strong predictor cardiovascular diseaserel death cohort adjust cardiovascular diseas risk factor smoke cholesterol bodi mass index blood pressur previous myocardi infarct histori diabet age educ postmenopaus hormon reduc risk death cardiovascular diseas relat risk confid interv protect effect provid postmenopaus hormon therapi women experienc natur menopaus relat risk confid interv"
"preval retin vascular abnorm children adolesc essenti hypertens studi children adolesc essenti hypertens evalu photograph optic fundus fluorescein angiographi photograph examin presenc arteriolar narrow tortuos arterioven nick intraobserv interobserv variabl determin abnorm low agreement narrow tortuos arterioven nick preval abnorm confid interv arteriolar narrow confid interv tortuos confid interv arterioven nick patient abnorm retin abnorm common young patient essenti hypertens"
"mucoid vasculopathi unknown etiolog vascular disord general deposit abnorm amount acid mucopolysaccharid amp materi arteri vein vasanervorum observ larg number autopsi author institut unlik vascular diseas emerg distinct disord vascular connect tissu mucoid vasculopathi unknown etiolog hitherto unreport entiti"
"giant left atrium case report seventyyear woman mitral stenosi present cardiomegali evid chest roentgenogram cardiac enlarg due giant left atrium distort cardiac structur echocardiogram pass nuclear angiogram delin huge left atrium"
"sudden coronari thrombus observ angiographi case report sudden coronari thrombus format document chanc cardiac catheter patient postinfarct angina thrombus success treat intraven urokinas heparin infus coronari angioplasti perform complic"
"spontan cerebr embol descend thorac aortic aneurysm case report case aneurysm proxim descend thorac aorta sourc retrograd cerebr embol atherosclerot diseas descend thorac aorta consid unusu sourc cerebr emboli"
"total occlus left main coronari arteri young woman surviv case report total occlus left main coronari arteri lmca rare surviv depend exist collater circul author present case total occlus left main coronari arteri surviv young woman rare case owe sex age patient"
"axillari subclavian vein thrombosi chang pattern etiolog diagnost therapeut modal fifti patient axillarysubclavian vein thrombosi treat year follow year eighteen treat year group year group group group includ effort spontan cent cent cathet insert relat cent cent malign system diseas cent cent patient group noninvas vascular test nit patient group ipgduplex imag nit case group case group treat convent anticoagul seventi cent residu pain exert venous claudic swell fourteen case posttreat nitvenographi show total resolut thrombus symptom free ten resolut symptomat case group treat thrombolyt therapi total resolut thrombus symptom free resolut residu symptom statist signific conclus patient axillarysubclavian vein thrombosi recent cathet insert relat diagnosi initi duplex imag thrombolyt therapi signific decreas residu symptom yield resolut anticoagul"
"relat left ventricular mass geometri morbid mortal uncompl essenti hypertens object assess prognost signific left ventricular mass geometri initi healthi person essenti hypertens design observ studi prospect identifi cohort set univers medic center patient hundr eighti patient essenti hypertens preexist cardiac diseas evalu echocardiographi hundr fifti subject famili member contact follow interview averag year initi echocardiogram obtain surviv status patient lost follow ascertain nation death index data measur main result left ventricular mass exceed patient cardiovascular event occur higher proport patient left ventricular hypertrophi compar patient increas ventricular mass higher risk cardiovascular death compar mortal compar electrocardiograph left ventricular hypertrophi predict risk patient normal left ventricular geometri fewest advers outcom cardiac death morbid event concentr hypertrophi death morbid event multivari analysi age left ventricular mass gender blood pressur serum cholesterol levelindepend predict outcom measur conclus echocardiograph determin left ventricular mass geometri stratifi risk patient essenti hypertens independ strong blood pressur potenti revers risk factor stratifi intens treatment"
"role calcium channel blocker treatment essenti hypertens calcium channel blocker origin develop treatment angina supraventricular arrhythmia shown lower elev blood pressur effect hypertens patient verapamil nifedipin diltiazem repres prototyp compound uniqu chemic class differ pharmacolog properti drug lower elev blood pressur efficaci compar common antihypertens combin therapi agent result addit respons side effect mild revers extens drug pharmacolog effect advers metabol effect lipid glucos potassium level common excel antihypertens effect calcium channel blocker potenti import varieti diseas state agent routin consid line antihypertens agent appropri select patient hypertens sever part comprehens plan minim cardiovascular risk"
"standard heparin nomogram manag heparin therapi nomogram adjust heparin dosag develop standard heparin therapi reduc delay achiev maintain therapeut activ partial thromboplastin time aptt result fifti consecut patient acut venous thromboembol continu intraven heparin therapi adjust heparin nomogram effect nomogram heparin therapi patient compar data histor control patient proport patient nomogram group reach therapeut aptt hour start heparin therapi increas hour contrast control patient reach therapeut aptt hour percentag therapeut aptt result total number aptt determin greater nomogram patient control heparin nomogram result achiev therapeut aptt hour larg proport patient reduc period inadequ anticoagul overanticoagul heparin therapi"
"ventricular tachycardia routin treadmil test risk prognosi exerciseinduc ventricular tachycardia exercis test consid increas risk test exerciseinduc ventricular tachycardia consid confer poor prognosi specif studi retrospect review patient undergon routin clinic exercis test septemb june identifi patient exerciseinduc ventricular tachycardia follow month rang month fifti patient nonsustain ventricular tachycardia exercis test patient die due congest heart failur follow period patient sustain ventricular tachycardia exercis test die sudden month test ventricular tachycardia reproduc patient underw repeat exercis test ventricular tachycardia routin clinic exercis test occur rare preval complic test total mortal exerciseinduc ventricular tachycardia group signific mortal entir popul nonsustain ventricular tachycardia occur clinic exercis test independ marker poor prognosi"
"echocardiograph assess atrial mechan behaviour relat movement atrioventricular ring left atrial ventricular dimens studi echocardiographi compar apexcardiographi doppler mitral flow veloc trace healthi control patient left ventricular hypertrophi dilat left ventricular systol atrioventricular ring structur common ventricl atrium move ventricular apex increas left atrial volum action match pulmonari venous return phase transvers left atrial dimens measur aortic root posterior left atrial wall earli diastol mitral ring move rapid atrium transmitr flow acceler requir forc direct ventricl atrium result elast recoil aris compress ventricular myocardium stretch atrial myocardium ventricular systol addit mechan ventricular fill atrial systol recognis increas ventricular volum atrioventricular ring move upward transvers left ventricular expans pressur driven transmitr flow undetect doppler apex account ventricular fill healthi control signific ventricular dilat left ventricular hypertrophi left ventricular fill maintain mechan compens reduc increas volum earli diastol interact atrium ventricl function import ventricular systol earli diastol atrial systol includ tradit separ atrial function reservoir conduit pump function"
"end diastol flow veloc beneath aortic isthmus assess puls doppler echocardiographi predictor aortic regurgit fraction end diastol flow veloc beneath aortic isthmus measur hour cardiac catheteris puls doppler echocardiographi control patient aortic regurgit end diastol flow veloc determin peak wave simultan record electrocardiogram control revers flow end diastol beneath aortic isthmus patient aortic regurgit end diastol flow veloc correl angiograph grade regurgit regurgit fraction sd valu cm patient regurgit fraction greater end diastol flow veloc greater cm predict regurgit fraction greater equal sensit specif studi suggest puls doppler deriv end diastol flow veloc index routin invas assess sever aortic regurgit"
"interatri shunt flow profil newborn infant colour flow puls doppler echocardiograph studi interatri shunt flow profil normal term infant examin serial colour flow puls doppler echocardiograph techniqu hour birth day birth shunt flow foramen oval detect normal infant hour birth minut occurr interatri shunt decreas age shunt signal detect infant fourth day life ductus arteriosus close normal infant direct interatri shunt flow predomin left coexist small left shunt diastol hour birth day found patient persist fetal circul direct interatri shunt flow predomin left biphas peak diastol systol earli stage diseas period left shunt flow cardiac cycl signific longer normal infant examin hour birth patient ductus close foramen oval time ductal closur patient persist fetal circul left shunt flow diastol period prolong find suggest interatri shunt predomin left common normal newborn infant"
"extrahepat portal vein aneurysm tortuous portal vein portal vein aneurysm rare etiolog controversi case extrahepat portal vein aneurysm unusu tortuous portal vein realtim ultrasonographi show anecho masslik lesion porta hepati communic superior mesenter vein intrahepat portal branch suggest presenc saccular portal vein aneurysm mm mm size magnet reson imag portal venographi confirm portal vein aneurysm unusu tortuous portal vein curv caudal liver histolog normal evid portal hypertens specul portal vein aneurysm congenit tortuous portal vein secondari hemodynam portal venous system"
"factor determin improv left ventricular function reperfus therapi acut myocardi infarct primaci baselin eject fraction improv left ventricular eject fraction measur salvag ischem myocardium reperfus therapi acut myocardi infarct degre improv left ventricular eject fraction influenc factor patient pair radionuclid angiogram obtain acut infarct hospit discharg retrospect evalu determin factor affect improv eject fraction baselin eject fraction correl signific improv eject fraction univari analysi eject fraction continu variabl eject fraction categor variabl equal versus greater multivari analysi reperfus status patent versus occlud infarct arteri extent coronari arteri diseas vessel signific factor multivari univari analysi locat infarct treatment modal time treatment correl chang eject fraction statist techniqu factor test baselin left ventricular eject fraction potent predictor improv ventricular function acut infarct knowledg baselin eject fraction decid treat patient equivoc indic contraind reperfus therapi clinic trial reperfus strategi stratifi patient basi baselin eject fraction eject fraction end point myocardi salvag"
"incid clinic signific transient creatin kinas elev diagnosi wave myocardi infarct coronari angioplasti assess incid clinic signific elev total plasma creatin kinas ck mb isoenzym fraction appar success coronari angioplasti prospect studi consecut elect procedur undertaken total ck normal iulit ck mb isoenzym normal measur immedi success complet procedur nonelect procedur result fulfil american heart associationamerican colleg cardiolog task forc guidelin criteria success result exclud analysi elect procedur success abnorm elev ck ck mb serum level found success outcom pattern abnorm enzym identifi patient ck greater equal iulit ck mb greater equal group patient ck greater equal iulitt ck mb equal group patient ck iulit ck mb greater equal group group distinguish natur complic caus enzym releas etiolog clinic manifest signific clinic appar event group group versus event persist electrocardiograph chest pain clinic import sequela recogniz group hospit discharg abnorm cardiac serum enzym releas appar success coronari angioplasti common includ minor complic earli revers impend major complic result perman clinic sequela"
"longterm follow medic versus surgic therapi hypertroph cardiomyopathi retrospect studi retrospect analysi patient hypertroph cardiomyopathi year rang year patient divid group group consist patient medic therapi group patient surgic therapi septal myectomi group subdivid medic treatment group receiv propranolol mgday group verapamil mgday group therapi group receiv verapamil mgday septal myectomi group medic therapi surgeri group patient die annual mortal rate group patient die mortal rate ns patient die approxim half group die sudden half die congest heart failur year cumul surviv rate group signific smaller group subgroup year surviv rate group versus versus year surviv rate group versus group versus conclud cumul surviv rate signific surgic medic treat patient"
"predict frequenc durat ambulatori myocardi ischemia patient stabl coronari arteri diseas determin ischem threshold exercis test import exercis protocol relat ambulatori myocardi ischemia result exercis test patient ischem heart diseas remain undefin dissimilar result previous report investig issu ascertain import exercis protocol determin relat patient stabl coronari arteri diseas underw ambulatori electrocardiograph ecg monitor treadmil exercis test withdraw medic patient exercis protocol slow nation institut health nih combin protocol brisk bruce protocol work load increment exercis durat longer nih combin protocol versus min maxim work load peak heart rate achiev greater bruce protocol versus met versus beatsmin close invers correl exercis test result ambulatori ecg monitor observ nih combin protocol strongest correl observ time exercis mm st segment depress number ischem episod bruce protocol signific weaker invers correl found heart rate onset st segment depress similar monitor exercis test nih combin protocol versus beatsmin signific higher bruce protocol"
"effect stand induct paroxysm supraventricular tachycardia evalu effect stand induct paroxysm supraventricular tachycardia electrophysiolog studi perform supin stand posit patient atrioventricular av reciproc tachycardia av node reentrant tachycardia av reciproc tachycardia induc patient av reciproc tachycardia supin posit stand effect refractori period av node mark shorten ms stand effect refractori period accessori pathway shorten slight ms stand av node reentrant tachycardia induc patient av node reentrant tachycardia supin posit stand effect refractori period slow pathway fast pathway shorten mark ms ms stand plasma norepinephrin level increas stand patient av reciproc av node reentrant tachycardia conclus stand increas sympathet tone chang electrophysiolog properti reentrant circuit facilit induct av reciproc tachycardia av node reentrant tachycardia"
"surgeri ebstein anomali clinic echocardiograph evalu techniqu ten consecut patient age rang year underw surgic repair ebstein anomali vertic plicat ventricl reimplant tricuspid valv leaflet patient die oper intraop postbypass echocardiographi document good result patient sever tricuspid regurgit patient underw prosthet valv replac period cardiopulmonari bypass patient ventricular papillari muscl dysfunct earli postop period show improv papillari muscl function concomit reduct tricuspid regurgit month patient evalu clinic echocardiographi month patient show clinic improv function class class sinus rhythm cardiothorac ratio decreas bicycl ergometri perform patient peak oxygen consumpt exceed mlkg min tricuspid regurgit diminish patient grade patient grade grade patient remain unchang comparison preoper postop puls doppler flow veloc pulmonari valv show increas peak veloc flow valv versus cm decreas time peak veloc versus ms"
"role chronotrop impair exercis mustard oper understand role chronotrop impair exercis perform atrial switch mustard oper patient undergon oper uncompl transposit great arteri exercis maxim volit min increment treadmil protocol heart rate oxygen consumpt carbon dioxid product minut ventil monitor continu dimension echocardiogram obtain test calcul ventricular inflow volum index bodi surfac area patient achiev maxim aerob capac base ventilatori pattern respiratori exchang ratio maxim heart rate reduc beatsmin predict age maxim oxygen consumpt decreas mlkg min predict age gender correl maxim oxygen consumpt maxim heart rate ventricular volum index signific invers correl maxim heart rate correl ventricular volum index heart rate rest result suggest decreas maxim oxygen consumpt patient mustard procedur result chronotrop impair ventricular dilat compensatori respons chronotrop impair"
"effect captopril angiotensinconvert enzym inhibitor patient angina pectori heart failur effect captopril placebo compar patient chronic heart failur angina pectori doubleblind crossov trial design symptom assess patient treatment prefer visual analogu score nitroglycerin consumpt exercis perform assess treadmil protocol work intens simultan measur oxygen consumpt supin bicycl exercis simultan radionuclid ventriculographi arrhythmia assess ambulatori electrocardiograph monitor patient general prefer placebo captopril due increas symptom angina captopril treadmil exercis time high intens protocol shorter captopril placebo low intens protocol angina frequent limit symptom exercis perform chang heart rateblood pressur product reduc larg reduct blood pressur heart rate supin bicycl exercis differ symptom exercis perform eject fraction blood pressur note ventricular arrhythmia reduc captopril clinic allevi angina pectori patient heart failur effect relat decreas coronari perfus pressur nonetheless desir metabol effect reduct arrhythmia potenti effect surviv requir studi captopril patient angina heart failur"
"region myocardi blood flow left ventricular diastol properti pacinginduc ischemia relat left ventricular diastol abnorm myocardi blood flow ischemia studi open chest dog critic stenos proxim left anterior descend circumflex coronari arteri heart pace time heart rate rest min dog coronari stenos left ventricular enddiastol pressur increas mm hg pace tachycardia mm hg pace increas enddiastol endsystol segment length ischem region left ventricular diastol pressureseg length relat ischem region shift upward pace tachycardia dog coronari stenos indic decreas region diastol distens dog coronari stenos left ventricular diastol pressureseg length relat unalt pace tachycardia coronari stenos induc increas anterograd coronari blood flow assess flow meter left anterior descend circumflex coronari arteri decreas region vascular resist dog coronari stenos region vascular resist pace decreas myocardi blood flow assess microspher unchang left anterior descend circumflex coronari arteri territori pace tachycardia coronari stenos region coronari vascular resist decreas subendocardi myocardi blood flow distal left anterior descend coronari arteri stenosi decreas mlmin subendocardi subepicardi blood flow ratio"
"pressurelength loop area compon analyz grade myocardi ischemia total pressurelength loop area compar effect shorten area systol lengthen area postsystol shorten area defin respect enddiastol endsystol length pressurelength loop myocardi ischemia anesthet dog instrument measur left ventricular pressur region segment wall motion sonomicrometri minor axi apic region left ventricl ischemia induc gradual tighten micrometercontrol snare left anterior descend coronari arteri suppli apic myocardium data obtain normal flow critic constrict loss pulsatil coronari flow mild ischemia ischemia onset region dysfunct postsystol shorten mild hypokinesia moder ischemia ischemia mark hypokinesia stage acut afterload perform partial occlud descend thorac aorta pressurelength loop analyz term area total loop area effect shorten area postsystol shorten area systol lengthen area total loop area decreas mark hypokinesia present mm hg mm ischemia versus mm hg mm ischemia effect shorten area total loop area baselin critic constrict ischemia ischemia postsystol shorten area total loop area baselin critic constrict ischemia ischemia chang signific progress stage ischemia"
"follow patient low output low gradient hemodynam percutan balloon aortic valvuloplasti mansfield scientif aortic valvuloplasti registri symptomat patient low cardiac output low aortic valv gradient poor prognosi high risk aortic valv surgeri outcom percutan balloon aortic valvuloplasti subgroup patient unclear patient group underw percutan balloon aortic valvuloplasti decemb novemb low cardiac index litersmin low aortic valv gradient equal mm hg procedur result compar patient group low cardiac index low aortic valv gradient greater mm hg procedur similar baselin present symptom balloon aortic valvuloplasti greater decreas aortic valv gradient patient group patient group sd mm hg mm hg signific differ improv estim aortic valv area cm ns hospit mortal patient group signific mortal patient group actuari probabl surviv month patient surviv initi hospit group group follow month surviv group patient display clinic improv compar surviv group patient"
"platelet thromboxan releas delay cerebr ischemia patient subarachnoid hemorrhag adenosin diphosphateinduc platelet aggreg thromboxan releas studi patient subarachnoid hemorrhag sah order detect associ alter platelet function develop cerebr ischem complic sah compar valu admiss patient show signific increas platelet aggreg thromboxan releas week sah highest valu thromboxan releas patient deterior due delay cerebr ischemia perman neurolog deficit thromboxan releas signific higher onset sever delay ischemia patient preoper ischemia compar patient delay ischemia ischem deterior elev thromboxan releas occur oper patient preoper valu similar valu ischem symptom observ suggest increas platelet aggreg thromboxan releas delay cerebr ischemia surgeri"
"endovascular occlus vertebr arteri treatment unclipp vertebrobasilar aneurysm twenti patient aneurysm vertebrobasilar circul underw unilater bilater endovascular occlus vertebr arteri patient present subarachnoid hemorrhag sah mass effect mass effect sah ischem symptom thirteen patient good outcom complet clinic angiograph cure patient partial thrombosi aneurysm death treatment failur patient suffer transient stroke conclud endovascular occlus vertebr arteri test occlus safe effect treatment proxim aneurysm vertebrobasilar circul"
"effect aminosteroid lipid peroxid subarachnoid clot present studi undertaken investig effect malondialdehyd product lipid peroxid subarachnoid clot eighteen cynomolgus monkey divid group ftreat group receiv dose mgkg placebotr group monkey underw baselin cerebr angiographi side craniectomi placement subarachnoid clot middl cerebr arteri mca treatment administ intraven hour day day experiment subarachnoid hemorrhag sah angiographi repeat anim kill placebotr group signific vasospasm occur mca side clot treatment dosag signific vasospasm develop clotsid mca content malondialdehyd measur thiobarbitur acid test highperform liquid chromatographi hplc compar method hplc prove accur thiobarbitur acid test measur low concentr malondialdehyd placebotr group malondialdehyd content signific increas day clot contrast malondialdehyd content fresh prepar clot low mgkg group malondialdehyd content clot signific day compar clot placebotr group malondialdehyd content clot mgkg ftreat group placebo signific malondialdehyd detect actual vessel wall mca group result suggest lipid peroxid subarachnoid clot play role pathogenesi vasospasm salutari effect vasospasm mediat reduct lipid peroxid sah"
"superior hypophys arteri aneurysm report case case saccular intracrani aneurysm aris superior hypophys arteri intern carotid arteri present angiograph find technic detail oper approach discuss attent focus fenestr angl clip"
"subarachnoid hemorrhag dissect aneurysm middl cerebr arteri case report case subarachnoid hemorrhag sah dissect aneurysm inferior limb middl cerebr arteri report patient clinic status initi follow angiograph aneurysm present diagnosi treatment briefli discuss suggest angiographi demonstr lumin narrow vascular occlus patient unexplain sah dissect aneurysm carotid system consid hemorrhag"
"role alpha adrenoceptor subtyp sympathet control acralcutan microcircul pith anesthet rat laserdoppl flowmetri evalu role alpha alpha adrenoceptor mediat sympathet respons acral region cutan circul intraven administr select alpha agonist phenylephrin potent vasopressor agent bh select alpha adrenoceptor agonist pith rat bh potent efficaci phenylephrin reduc cutan microvascular perfus cp bh caus greater increas cutan microvascular resist neural humor sympathet effect cp character select alpha alpha adrenoceptor antagonist prazosin rauwolscin found frequencyrel reduct cp elicit sciatic nerv stimul antagon prazosin rauwolscin fact rauwolscin enhanc neural evok reduct cp highest stimul frequenc prazosin rauwolscin antagon reduct cp elicit electr stimul thoracolumbar outflow sympathoadren activ ganglion stimul intraven dimethylphenylpiperazinium caus profound transient reduct cp abolish rauwolscin signific alter prazosin contrast dimethylphenylpiperaziniuminduc increas arteri pressur reduc prazosin rauwolscin ketamineanesthet rat rauwolscin caus doserel increas cp alter arteri pressur prazosin lower arteri pressur alter cp conclud acral region cutan vasculatur sensit alpha visvi alpha adrenoceptormedi vasoconstrict"
"peripher alpha alpha adrenerg receptor model hypertens rat vitro autoradiographi studi vitro autoradiographi compar peripher alpha alpha adrenerg receptor bind tissu hprazosin hrauwolscin model experiment hypertens rat model studi includ kidney clip hypertens kidney clip hypertens desoxycorticosteronesalt hypertens normotens control group kidney control kidney control saltload control blood pressur death signific higher hypertens group compar normotens control signific differ hypertens normotens group plasma norepinephrin level signific elev hypertens group compar respect control signific differ hypertens control group hypertens group signific reduct bind aortic mesenter vascular alpha receptor renal tubular alpha alpha receptor adren cortic alpha receptor compar respect control group reduc bind cardiac ventricular alpha alpha receptor found hypertens group statist signific level signific differ intestin alpha alpha receptor bind detect hypertens normotens group result suggest increas peripher sympathet activ model experiment hypertens regul alpha alpha receptor number peripher tissu control cardiovascular hemodynam fluid salt balanc evid increas peripher alpha receptor bind found model genet spontan hypertens"
"diverg effect serotonin coronaryarteri dimens blood flow patient coronari atherosclerosi control patient background studi anim shown serotonin constrict coronari arteri endothelium damag vitro studi reveal vasodil effect isol coronari segment intact endothelium investig effect serotonin human studi coronaryarteri crosssect area blood flow infus serotonin patient angiograph normal coronari arteri coronari arteri diseas method measur crosssect area coronari arteri quantit angiographi coronari blood flow intracoronari doppler cathet measur obtain base line intracoronari infus serotonin microgram kilogram bodi weight minut minut repeat measur infus ketanserin antagonist serotonin receptor thought block effect serotonin receptor arteri wall endothelium result patient normal coronari arteri highest dose serotonin increas crosssect area percent blood flow percent effect signific potenti administr ketanserin patient coronaryarteri atherosclerosi serotonin reduc crosssect area percent blood flow percent ketanserin prevent effect conclus serotonin vasodil effect normal human coronari arteri endothelium damag coronari arteri diseas serotonin direct unoppos vasoconstrict effect consid evid data suggest plateletderiv factor serotonin role acut coronari ischem syndrom"
"effect intracoronari serotonin coronari vessel patient stabl angina patient variant angina background serotonin major product platelet activ potent vasoact effect anim model role human coronari arteri diseas remain larg specul method quantit coronari angiographi compar effect intracoronari infus grade concentr serotonin mol liter coronari vessel group patient clinic present coronari diseas stabl angina variant angina effect control group subject normal vessel angiographi result normal coronari vessel biphas respons intracoronari serotonin dilat concentr mol liter constrict mol liter vessel patient stabl angina constrict concentr sem maxim decreas diamet percent base line proxim middl distal segment serotonin concentr mol liter smooth segment constrict irregular segment percent patient stabl angina mark reduct collater fill patient stabl angina angina intracoronari infus serotonin electrocardiograph note patient variant angina angina electrocardiograph local occlus epicardi coronaryarteri spasm concentr mol liter conclus patient stabl coronari diseas normal vasodil respons intracoronari serotonin progress constrict intens small distal collater vessel patient variant angina occlus coronaryarteri spasm dose dilat normal vessel slight constrict vessel patient stabl angina find suggest serotonin releas intracoronari activ platelet contribut myocardi ischemia patient coronari arteri diseas"
"orbitozygomat temporopolar approach high basilar tip aneurysm short intracrani intern carotid arteri surgic approach case high basilar tip aneurysm accompani short intracrani intern carotid arteri orbitozygomat temporopolar approach consist en bloc frontoorbitozygomat tempor craniotomi temporopolar approach carri angiogram height bifurc elong basilar arteri length intracrani intern carotid arteri interclinoid line anterior posterior clinoid process mm mm case mm mm case skin flap separ subfasci preserv frontotempor branch facial nerv frontoorbitozygomat tempor bone flap made part basal boni structur orbit roof sphenoid ridg tempor bone remov basilar tip aneurysm clip easili upward obliqu view wide oper space consist retract intern carotid middl cerebr arteri oculomotor nerv tentori hiatus empti anterior tempor fossa obtain partial divis tempor bridg vein oper procedur present detail compar surgic approach previous"
"impair cerebr autoregul develop chronic cerebr vasospasm subarachnoid hemorrhag primat studi impair autoregul cerebr blood flow cbf effect electr activ brain develop chronic cerebr vasospasm subarachnoid hemorrhag vasospasm model primat fourteen anim divid group clot group shamoper group induc subarachnoid hemorrhag anim underw craniectomi clot group autolog blood clot locat arteri dissect free arachnoid membran cerebr angiographi perform subarachnoid hemorrhag day day day region cbf pariet lobemeasur hydrogen clearanc method central conduct time studi grade hypertens hypotens clot group vessel calib cerebr arteri side clot side circl willi show signific reduct compar valu contralater clot side valu bilater pariet cbf shamoper group left pariet cbf clot group fair constant arteri blood pressur mabp rang mm hg clot group pariet cbf signific smaller left side mabp level mm hg increas mabp level mm hg pariet cbf increas arteri blood pressur increas show impair autoregul"
"cavern malform capillari telangiectasia spectrum singl patholog entiti cerebr vascular malform tradit divid categori arterioven venous cavern capillari telangiectas controversi exist separ lesion separ entiti critic claim distinct arbitrari unabl present convinc evid link type lesion review histori patient cavern malform analyz clinic radiograph surgicalautopsi data lesion patient multipl lesion includ cavern malform capillari telangiectas transit form identifi base analysi conclud capillari telangiectasia cavern malform repres patholog extrem vascular malform categori propos group singl cerebr entiti call cerebr capillari malform"
"depress acut myocardi infarct role primari care physician rehabilit depress common problem myocardi infarct diagnosi facilit criteria depress diagnost statist manual mental disord rate questionnair treatment involv psycholog pharmacolog intervent patient medic status care assess administr antidepress medic antidepress contraind immedi myocardi infarct sign symptom depress exhibit earli recoveri phase alprazolam xanax offer advantag tradit antidepress research determin safeti newer antidepress"
"assist aspir thrombectomi vitro investig author describ ultrasound aspir thrombectomi techniqu oscil probe insert thinwal largebor aspir cathet experi test abil devic cathet combin remov clot materi petri dish small larg vessel model made silicon glass tube result experi demonstr oscil mm probe insert aspir cathet diamet promot clot fragment continu aspir thrombi size compar simpl largebor cathet aspir mechan fragment probe cathet flush cool probe assist aspir thrombectomi demonstr signific result percutan transcathet remov fresh thrombi"
"renal vein renin inabl predict respons revascular patient hypertens determin captoprilstimul renal vein renin ratio csrvrr enabl identif patient hemodynam signific renovascular lesion respond revascular author measur csrvrrs consecut patient hypertens select clinic featur suggest renovascular hypertens patient underw convent renal arteriographi renovascular hypertens final diagnosi revascular result cure improv blood pressur complet data patient twenti patient renovascular hypertens csrvrr greater patient sensit greater patient renovascular hypertens falseposit rate posit predict csrvrr negat predict conclud csrvrr suffici sensit enabl predict patient respond revascular specif exclud patient renovascular hypertens"
"patient evalu cardiac transplant aim cardiac transplant improv qualiti life surviv patient endstag heart failur scarciti donor organ avail expens transplant process follow care tremend emot burden process place patient famili essenti care screen potenti candid symptomat function hemodynam psychosoci elig rule coexist hemodynam comorbid condit jeopard success transplant immunosuppress comprehens screen potenti transplant candid accomplish multidisciplinari team approach work close patient famili essenti insur maximum benefit deriv scarc valuabl resourc"
"electrocardiograph subset analysi diltiazem administr longterm outcom acut myocardi infarct multicent diltiazem postinfarct trial research group effect diltiazem longterm outcom acut myocardi infarct ami assess patient enrol multicent diltiazem postinfarct trial subsequ month studi popul includ patient prior ami index infarct patient ami wave ami inferior wave ami anterior wave ami post hoc analysi reveal patient wave inferior wave ami fewer cardiac event follow diltiazem placebo group revers true patient anterior wave ami prior infarct diltiazemplacebo cox hazard ratio confid limit trial primari end point cardiac death nonfat reinfarct whichev occur wave ami inferior wave ami anterior wave ami prior ami cardiac death end point gave sharpli focus treatment differ wave ami inferior wave ami anterior wave ami prior infarct analysi reveal differ effect diltiazem larg part reflect status electrocardiograph defin subset term left ventricular function"
"exercis echocardiographi technetiumm mibi singlephoton emiss comput tomographi detect coronari arteri diseas compar relat diagnost exercis echocardiographi perfus technetiumm metoxyisobutylisonitril singlephoton emiss comput tomographi spect detect coronari arteri diseas cad patient suspect cad normal electrocardiogram ecg rest includ prospect correl studi exercis echocardiogram spect studi perform conjunct symptomlimit bicycl exercis test develop wall motion abnorm revers perfus defect exercis regard posit test exercis echocardiograph spect studi result diagnost test compar coronari arteriographi exercis echocardiographi identifi spect patient signific cad defin greater diamet stenosi twenti patient signific coronari stenosi negat exercis echocardiograph result negat spect result exerciseinduc wall motion abnorm show good correl revers perfus defect result method concord patient agreement kappa diagnost accuraci exercis echocardiographi spect signific higher exercis ecg sensit specif detect individu diseas vessel exercis echocardiographi spect"
"impair left ventricular fill region diastol asynchroni rest coronari arteri diseas relat exerciseinduc myocardi ischemia impair left ventricular lv diastol fill rest frequent observ patient coronari arteri diseas cad normal lv systol function previous infarct test hypothesi abnorm diastol function rest reflect function sever cad estim exerciseinduc ischemia relat region global lv diastol function rest exerciseinduc ischemia evalu patient radionuclid angiographi patient normal systol function rest group patient manifest normal eject fraction respons exercis group patient abnorm respons data obtain agecompar normal volunt comparison region global diastol function normal subject group patient peak fill rate lower group patient normal subject enddiastol count region diastol asynchroni assess radionuclid data region sector analysi lv region interest greater group patient ms normal subject ms group patient ms patient cad normal lv systol function rest impair lv fill region asynchroni predict greater degre exerciseinduc ischemia suggest greater extent jeopard myocardium"
"predictor cardiac surviv percutan translumin coronari angioplasti patient sever left ventricular dysfunct assess outcom percutan translumin coronari angioplasti ptca patient sever left ventricular lv dysfunct determin predictor mortal patient lv eject fraction equal underw initi ptca analyz major patient prior greater week myocardi infarct patient congest heart failur unstabl angina present patient multivessel coronari arteri diseas present lv eject fraction rang intraaort balloon pump percutan cardiopulmonari bypass support infrequ angiograph success obtain lesion attempt complet revascular obtain patient clinic success procedurerel mortal patient patient greater equal equal month averag estim surviv year cox regress analysi reveal presenc congest heart failur lower lv eject fraction higher myocardi jeopardi score contractil myocardium independ predictor surviv ptca patient lv dysfunct conclus highrisk subset identifi patient sever lv dysfunct undergo ptca"
"comparison left ventricular eject fraction magnet reson imag radionuclid ventriculographi idiopath dilat cardiomyopathi assess valid gate magnet reson imag mri determin left ventricular lv eject fraction ef mri spin echo multislicemultiphas techniqu shortaxi plane compar equilibrium radionuclid ventriculographi patient idiopath dilat cardiomyopathi patient underw mri radionuclid ventriculographi perform consecut day time interv examin minut comparison lvef show high correl differ radionuclid ventriculographi mri data confid interv mri slight underestim lvef mri interobserv intrapati variabl assess patient show high correl conclus data suggest mri shortaxi approach multislicemultiphas techniqu accur noninvas high reproduc method evalu lvef patient idiopath dilat cardiomyopathi"
"stroke volum submaxim exercis endurancetrain normotens subject untrain hypertens subject beta blockad propranolol pindolol effect betaadrenerg blockad stroke volum sv increas submaxim exercis intens studi endurancetrain normotens untrain hypertens diastol blood pressur greater mm hg men age year subject assign treatment doubleblind random order placebo propranolol mg daili pindolol mg daili day period hour initi dose treadmil test day washout period drug cardiac output measur carbon dioxid rebreath method sv calcul cardiac output heart rate sv cardiac outputheart rate cardiac output estim rest walk treadmil subject previous determin maxim oxygen uptak vomax signific differ found cardiac output drug placebo rest rate work propranolol signific increas sv placebo valu train untrain group intens signific differ sv found pindolol placebo intens train group contrari expect sv show indic plateau propranolol train subject exercis intens plateau establish placebo condit vomax train untrain subject result suggest train untrain hypertens person exercis betaadrenerg blockad submaxim level compromis cardiac function"
"hypertens endothelium cardiovascular risk factor function endothelium effect hypertens atherosclerosi diabet endothelium review endothelium affect vascular tone releas vasodil modul effect vasoact substanc catecholamin bradykinin serotonin angiotensin ii relax vascular smooth muscl depend function intact endothelium releas endotheliumderiv relax factor nitric oxid endotheli cell releas hyperpolar factor relax smooth muscl activ sodiumpotassium pump endotheliumdepend contract factor similar found vascular injuri result hypertens atherosclerosi diabet risk factor coexist act synergist magnifi vascular injuri endothelium major target form injuri futur therapeut strategi focus prevent arrest revers endotheli injuri"
"cardiovascular risk reduct role antihypertens treatment effect antihypertens drug mortal stroke coronari arteri diseas cad nonvascular studi trial involv patient treat patient blood pressur mm hg lower placebotr patient mortal stroke reduc cad mortal reduc major reason lack effect cad mortal appar advers effect primari drug trial diuret beta blocker glucos toler lipid level insulin resist angiotensinconvert enzym inhibitor favor influenc cad risk factor expect reduc cad mortal patient treat hypertens"
"tangl web coronari risk factor epidemiolog genet pathophysiolog studi shown lowdens lipoprotein ldls involv develop coronari arteri diseas standard measur ldl cholesterol compris number separ compon contribut diseas process compon patholog import intermediatedens lipoprotein idl lipoprotein high atherogen speci account total ldl cholesterol disproportion elev patholog state contribut disproportion coronari diseas risk patient recent subclass ldl character small particl size increas densiti found increas risk coronari diseas level subclass design ldliii link number interrel hormon metabol factor risk coronari arteri diseas includ male gender postmenopaus abdomin adipos elev triglycerid level increas level apolipoprotein reduct highdens lipoprotein hdls hdl subclass studi demonstr factor common relat insulin resist hyperinsulinemia lipoprotein profil character relat increas ldliii reduct hdl indic constel metabol featur defin highrisk state make extrem difficult singl factor direct involv diseas process combin genet environment factor act tangl web risk factor account variat coronari diseas suscept found general popul"
"regress atherosclerosi angiograph evid coronari arteri atherosclerosi regress demonstr control clinic trial signific regress depend complex degre atherosclerosi present regress regimen initi angiograph trial lesion chang continuum gradual transit progress stabil regress diverg lesion chang patient progress lesion regress make perform comprehens survey visibl coronari segment evalu angiogram determin outcom clinic trial import find clinic trial lesion format reduc effect control atherosclerosi procedur noninvas coronari arteri imag method refin"
"insulin resist hyperinsulinemia hypertriglyceridemia etiolog clinic hypertens patient untreat hypertens shown resist insulinstimul glucos uptak hyperinsulinem hypertriglyceridem match group patient normal blood pressur addit insulin resist hyperinsulinemia hypertriglyceridemia demonstr spontan hypertens rat spraguedawley rat fed fructoseenrich diet defect insulinstimul glucos uptak experiment model shown cellular level experiment intervent prevent insulin resist hyperinsulinemia develop fructosef rat great attenu increas blood pressur endogen hyperinsulinemia hypertriglyceridemia identifi factor increas risk coronari arteri diseas cad contribut increas preval cad hypertens patient antihypertens treatment exacerb metabol abnorm explain difficult show lower blood pressur decreas risk cad observ rais possibl abnorm carbohydr lipoprotein metabol play role etiolog clinic hypertens"
"horizon treatment coronari arteri thrombosi applic recombin dna methodolog clinic medicin offer clinician generat potent specif therapi recombin method offer great promis treatment coronari arteri thrombosi review focus character molecul activ plasminogen local vicin thrombus system molecul offer approach inhibit platelet activ thrombin activ describ method uncov molecul character molecular level knowledg lead develop agent tailor clinic explor"
"influenc desfluran region distribut coronari blood flow chronic instrument canin model multivessel coronari arteri obstruct influenc desfluran myocardi perfus measur microspher techniqu total occlus left anterior descend coronari arteri concomit moder sever stenosi left circumflex coronari arteri evalu chronic instrument dog hemodynam region contractil function myocardi blood flow measur conscious state anesthesia desfluran control arteri pressur total left anterior descend occlus produc combin left circumflex coronari arteri stenosi signific increas heart rate left ventricular end diastol pressur absenc desfluran anesthesia desfluran administ presenc left anterior descend occlus left circumflex stenosi signific decreas arteri pressur left ventricular systol pressur left ventricular posit dpdt chang heart rate blood flow subendocardium normal myocardium reduc high concentr desfluran perfus subepicardium midmyocardium maintain conscious level left circumflex stenosi moder sever blood flow subendocardium distal stenosi reduc desfluran presenc sever stenosi perfus decreas subepicardium midmyocardium subendocardium stenot zone reduct arteri pressur produc desfluran collater blood flow left anterior descend region reduc dog moder sever left circumflex stenosi arteri pressur heart rate condit observ postocclus conscious state restor high concentr desfluran myocardi blood flow region return level present conscious state ratio flow occlud normal zone decreas hypotens produc desfluran uncontrol arteri pressur heart rate adjust conscious postocclus level partial thorac aorta occlus atrial pace ratio remain conscious control level degre left circumflex stenosi sever result investig desfluran redistribut blood flow collateraldepend myocardium region coronari steal mechan chronic instrument canin model multivessel coronari arteri diseas"
"narrow qrs ventricular tachycardia object determin frequenc clinic characterist narrow qrs ventricular tachycardia qrs durat equal design consecut survey patient ventricular tachycardia set tertiari referralbas arrhythmia servic univers medic center patient sequenti sampl patient induc ventricular tachycardia lead electrocardiogram tachycardia review measur main result patient ventricular tachycardia ci ventricular tachycardia qrs durat equal patient previous incorrect diagnos supraventricular tachycardia patient electrocardiograph find qrs durat suggest ventricular tachycardia conclus narrow qrs ventricular tachycardia consid differenti diagnosi narrow qrs tachycardia electrocardiograph find qrs durat present suggest diagnosi"
"increas plasma endothelin pulmonari hypertens marker mediat diseas object explor role endothelin potent endothelialderiv vasoconstrictor peptid pulmonari hypertens measur concentr arteri venous plasma design survey case seri studi set universityaffili hospit outpati clinic patient twenti patient pulmonari hypertens primari secondari pulmonari hypertens control group compris healthi volunt patient coronari arteri diseas evid pulmonari hypertens measur main result pulmonari arteri pressur mark increas mm hg patient pulmonari hypertens venous plasma immunoreact endothelin measur specif radioimmunoassay signific higher patient pulmonari hypertens pgml normal subject pgml patient coronari diseas pgml arterialven ratio immunoreact endothelin signific greater uniti primari pulmonari hypertens patient secondari pulmonari hypertens ratio contrast arterialven ratio signific uniti control group normal subject coronari diseas patient indic clearanc endothelin healthi lung conclus patient pulmonari hypertens substanti alter plasma immunoreact endothelin reflect net releas clearanc endothelin lung patient primari pulmonari hypertens high level arteri compar venous plasma suggest pulmonari product endothelin contribut elev pulmonari vascular resist"
"evalu drug therapi treatment hypertens urgenc emerg depart oral nifedipin clonidin treatment hypertens urgenc recent compar studi patient popul author review record hypertens patient treat emerg depart octob septemb select patient diastol blood pressur dbp greater mm hg evid acut end organ damag patient stratifi treatment group group receiv varieti drug therapi exclus systol blood pressur sbp dbp arteri pressur map percent decreas map map time lower blood pressur admiss discharg evalu efficaci safeti defin reach dbp mm hg map greater thirti patient identifi statist differ group race gender pretreat sbp dbp map signific reduc sbp dbp map compar differ observ map admiss discharg efficaci safeti time requir decreas blood pressur differ group min result varieti drug therapi equal effect safe treatment hypertens urgenc"
"experi esmolol treatment cocain cardiovascular complic author report experi esmolol ultrashort act betaadrenerg antagonist treatment patient cocain cardiovascular complic consist hemodynam benefit found drug declin heart rate rang unabl show consist antihypertens respons advers effect occur patient includ patient mark exacerb hypertens hypotens patient develop emesi lethargi esmolol therapi requir endotrach intub recommend routin esmolol cocain cardiotox"
"high resolut realtim ultrasound diagnosi venous thrombosi rehabilit set accur noninvas test deep venous thrombosi dvt convent method rehabilit patient lower extrem amput cast bandag skin problem present obstacl standard diagnost method report describ duplex ultrasound scan noninvas diagnosi dvt seventyyear man knee amput doppler plethysmographi examin perform experi gain techniqu venographi diagnosi dvt difficult ration"
"retin arteri macroaneurysm risk factor natur histori case control studi conduct identifi system ocular risk factor retin arteri macroaneurysm forti patient photograph confirm macroaneurysm locat forti agematch racematch concurr control patient identifi patient macroaneurysm decreas visual acuiti higher preval hypertens femal sex retin vein occlus control patient macroaneurysm venous occlus time higher preval macroaneurysm area retina drain occlud vein common find macroaneurysm includ retin haemorrhag patient retin exud vitreous haemorrhag macular involv distal arteriolar narrow arteriolar occlus occur spontan laser photocoagul"
"hirudin interrupt heparinresist arteri thrombus format baboon determin role thrombin high blood flow plateletdepend thrombot hemostat process measur relat antithrombot antihemostat effect baboon hirudin high potent specif antithrombin compar effect heparin antithrombin iiidepend inhibitor thrombin thrombus format determin vivo relev model homolog endarterectom aorta collagenco tube dacron vascular graft measur platelet deposit gamma camera imag inplatelet fibrin deposit assess incorpor circul ifibrinogen occlus continu intraven infus nmolkg minut recombin hirudin desulfatohirudin maintain constant plasma level mumolml hirudin interrupt platelet fibrin deposit dosedepend manner profound highest dose thrombogen surfac signific lowest dose thrombus format endarterectom aorta thrombot occlus prevent dose studi contrast heparin inhibit platelet fibrin deposit administ dose maxim prolong clot time kg greater intermedi effect produc fold dose kg heparin prevent occlus test segment hirudin inhibit platelet hemostat function concert antithrombot effect bleed time prolong intermedi higher dose comparison intraven heparin fail affect bleed time kg dose greater minim prolong bleed time kg dose conclud plateletdepend thrombot hemostat process thrombinmedi biolog antithrombin hirudin produc potent dosedepend inhibit arteri thrombus format great exceed minim antithrombot effect produc heparin"
"serum sialic acid concentr cardiovascular mortal object determin serum sialic acid concentr predict short long term cardiovascular mortal designprospect studi men women serum sialic acid concentr measur part general health survey averag year settinggeograph part counti varmland sweden subjectsresid area particip health check men women men incomplet data lost follow women exclud men women enter studi studi sampl restrict subject age year follow main outcom measuresserum sialic acid concentr serum cholesterol concentr diastol blood pressur bodi mass index general health survey visit cardiovascular cardiovascular death period follow year year year swedish mortal regist subject age result serum sialic acid concentr mg ml sd men women averag concentr increas age sex total men women die follow period death men women cardiovascular short year medium year long year term follow relat risk death cardiovascular diseas increas increas serum sialic acid concentr relat risk confid interv highest quartil sialic acid concentr compar lowest quartil men women similar result found death cardiovascular diseas relat risk men women relat risk signific lower death cardiovascular diseas multivari analysi total mortal cardiovascular mortal sialic acid concentr serum cholesterol concentr diastol blood pressur bodi mass index independ variabl impact sialic acid concentr virtual univari analysi conclusionserum sialic acid concentr strong predictor cardiovascular mortal explan find serum sialic acid concentr reflect exist activ atherosclerot process warrant investig"
"comparison exercis perform left main vessel coronari arteri diseas consecut seri patient underw rest exercis radionuclid angiographi year retrospect identifi patient left main coronari arteri diseas patient vessel coronari arteri diseas signific left main diseas result gate equilibrium radionuclid angiographi compar group multipl exercis hemodynam exercis electrocardiograph exercis radionuclid angiograph paramet consid attempt separ group paramet signific group exercis heart rate exercis heart rate meaning separ group differ prognosi patient left main vessel diseas similar exercis perform distinguish exercis electrocardiographi exercis radionuclid angiographi inabl distinguish group clear limit noninvas exercis modal"
"atrial septal occlus improv accuraci mitral valv area determin percutan mitral balloon valvotomi investig impact atrial communic mitral valv area calcul percutan mitral balloon valvotomi patient women men age year hemodynam measur mitral valv area calcul perform balloon occlus atrial septal punctur site mitral valv area determin balloon occlus signific smaller mitral valv area determin occlus cm similar echocardiograph determin valv area cm decreas calcul mitral valv area occlus decreas measur cardiac output chang mitral valv gradient diastol fill period occlus atrial septal punctur site permit accur determin mitral valv area provid refer point futur comparison question restenosi aris"
"preserv region myocardi function coronari angioplasti autoperfus balloon cathet case report echocardiograph assess region myocardi function perform standard balloon coronari angioplasti autoperfus balloon angioplasti proxim left anterior descend arteri stenosi septal apic akinesi occur standard balloon inflat region function preserv prolong autoperfus balloon inflat"
"success mitral valvuloplasti inou balloon patient mitral stenosi subvalvular fibrosi reduc left ventricular inflow caviti case report percutan transven mitral valvuloplasti ptmv perform cylindr pigtail balloon cathet year woman symptomat mitral stenosi subvalvular apparatus fibrous weld chorda subvalvular left ventricular space mark reduc result distort anatomi inflat balloon constant slip back left atrium full inflat obtain procedur mitral valv area mva estim echodoppl ed increas cm month mild clinic improv patient symptomat ed examin show mva cm ptmv perform inou balloon entir procedur hour stabl posit inou balloon complet dilat achiev ed examin show mitral valv area cm mitral regurgit atrial septal defect month class symptom mva estim ed cm"
"percutan brachial arteri approach cathet studi coronari arteri diseas prospect studi ischem patient cathet pigtail amplatz percutan brachial arteri approach group order compar techniqu group patient random studi femor rout group ii group iii cathet pigtail judkin paramet analyz chang initi elect cathet diamet arteri approach technic difficulti obtain lv lca rca angiogram total time ray exposur qualiti imag lv lca rca angiogram incid arteri punctur relat hematoma total arteri occlus durat local compress sheath remov differ brachial femor approach arteri compress time ray exposur time longer brachial approach rout show mild increas difficulti brachial femor mild decreas qualiti imag lca branchial femor mild hematoma frequent cathet procedur complet elect arteri type cathet patient group group ii group iii nonsignific differ percutan brachial arteri approach cathet similar femor arteri approach cathet show mild increas technic difficulti mild decreas qualiti imag compar lca angiogram complet reliabl angiogram read analysi"
"accuraci reproduc quantit coronari arteriographi french cathet cine angiograph acquisit determin suitabl french cathet quantit coronari arteriographi relat accuraci reproduc type cathet compar obtain standard french cathet stenos duplic inject polyurethan french cathet obtain hand power inject techniqu cineangiograph acquisit french cathet inject total stenosi measur percent diamet stenosi absolut dimens compar obtain hand inject cine acquisit french cathet gold standard reproduc dimens determin french cathet general similar obtain french cathet mm absolut diamet percent diamet stenosi accuraci signific french cathet measur absolut dimens appar suit serial measur stenos french cathet accur determin absolut arteri dimens french cathet"
"coronari balloon angioplasti diagnost french cathet investig ultralow profil balloon cathet scime ace usci probe cordi orion coronari angioplasti french diagnost cathet schneider cordi contrast inject assist hercul pump cordi case procedur angioplasti lesion select patient attempt lesionprocedur twelv lesion left anterior descend left circumflex coronari arteri balloon size vari mm twenti lesion success dilat french cathet lesion requir exchang french angioplasti guid cathet case balloon complet procedur final success rate patient lesion major complic small intern cathet lumen mm coronari visual adequ mechan support good failur french cathet attribut insuffici torqu control excess friction balloon cross taper end diagnost cathet coronari angioplasti diagnost french cathet feasibl repres reason altern simpl case session diagnost angiographi french high flow angioplasti guid cathet taper tip improv success retain advantag small femor punctur site"
"preliminari experi french diagnost cathet guid cathet coronari angioplasti reduct profil balloon dilat cathet recent intern dimens perform guid cathet mandat french system perform percutan translumin coronari angioplasti ptca cathet design sherwood medic st loui mo provid larg lumen permit fixedwir ptca balloon cathet good coronari visual potenti advantag includ reduc coronari arteri ostial trauma cathet induc damp enhanc patient comfort report initi experi patient undergo ptca guidefixedwir system age year ptca indic cardiogen shock postmyocardi infarct angina pectori grade iii angina unstabl angina pectori vessel attempt left anterior descend circumflex obtus margin diagon coronari arteri intern thorac arteri twelv patient femor approach brachial approach usci probe usci divis billerica ma lesion scime ace scime life system maplegrov mn cathet lesion success guidefixedwir dilat reduc stenosi success perform patient requir guid cathet dilat fixedwir balloon fail ptca dilat larger convent system total occlus cross guidewir fix wire balloon patient complic"
"applic coronari angioplasti septal perfor arteri signific coronari arteri diseas affect septal perfor arteri angin pain rhythm disturb septal infarct vessel inaccess coronari bypass surgeri tendenc angiograph angioplast overlook lesion septal perfor arteri experi suggest medic treatment suffici treat clinic manifest result septal perfor diseas coronari angioplasti consid therapeut altern revascular present patient underw coronari angioplasti major septal arteri discuss angiograph technic aspect procedur"
"cardiotox interferon review case cardiovascular complic occur clinic trial interferon review experi date cardiotox type interferon cancer patient common present cardiotox cardiac arrhythmia dilat cardiomyopathi symptom ischem heart diseas includ myocardi infarct sudden death cardiac effect relat daili dose cumul total dose period therapi patient interferon caus cardiovascular sequela histori coronari heart diseas previous chemotherapi drug cardiotox patient cardiac toxic revers cessat drug therapi"
"system pulmonari bronchial blood flow mitral stenosi measur system pulmonari bronchial blood flow qbr total cardiopulmonari bypass patient mitral stenosi elev pulmonari venous pressur group pulmonari wedg pressur mm hg sd patient coronari arteri diseas normal pulmonari venous pressur group qbr volum blood accumul left side heart absenc pulmonari coronari flow blood vent cannula introduc left atrium measur qbr mlmin percent extracorpor circul pump flow group total cardiopulmonari bypass pulmonari venous pressur approxim atmospher pressur differ system blood pressur extracorpor circul pump flow airway pressur observ group vascular resist bronchial vessel drain pulmonari circul reduc patient mitral stenosi elev pulmonari venous pressur"
"catheterinduc tricuspid regurgit incid clinic signific incid sever catheterinduc tricuspid regurgit studi extens frequenc heart cathet employ measur cardiac output import sever catheterinduc tricuspid regurgit suffici invalid measur thermodilut cardiac output purpos present prospect studi determin incid sever catheterinduc tricuspid regurgit men age year doppler ultrasound tricuspid valv interrog orthogon view pulsedwav color flow doppler presenc absenc french cathet tricuspid valv sever catheterinduc tricuspid regurgit grade semiquantit valid score system pulsedwav doppler studi show incid catheterinduc tricuspid regurgit percent averag tricuspid regurgit score increas color flow doppler studi show similar find incid catheterinduc tricuspid regurgit relat patient hemodynam status ventricular geometri conclus studi show time quantit extent catheterinduc tricuspid regurgit small import clinic regard assess thermodilut cardiac output"
"venous air embol diagnosi spontan side contrast echocardiographi report describ definit diagnosi venous airembol document spontan echo contrast cardiac chamber remov jugular venous cathet patient hepat failur complic potenti presenc concurr hepat coagulopathi prejud effect hemostasi central venous punctur site"
"effect thromboxan synthetas inhibit cardiopulmonari function endotoxemia sheep earli pulmonari hypertens endotoxin lipopolysaccharid report result releas thromboxan studi cardiopulmonari respons endotoxin sheep treatment thromboxan synthetas inhibitor oki anim implant instrument crystallograph dimens analysi left ventricl measur left ventricular aortic left atrial pulmonari arteri pressur cardiac index thirteen sheep receiv microgramskg escherichia coli endotoxin oki mgkg bolus microgramskgmin oki prevent increas pulmonari arteri pressur decreas cardiac index earli phase endotoxemia hour administr endotoxin cardiac index increas minm concomit endsystol pressurediamet relationship sensit myocardi contractil index signific decreas mm hgmm index left ventricular contractil maximum rate pressur rise reduc oki prevent decreas endsystol pressurediamet relationship maximum rate pressur rise"
"platelet fatti acid function distinct region belgium relationship age dietari habit compar dietari habit fatti acid composit plasma platelet phospholipid platelet function group healthi belgian male subject differ mortal rate coronari heart diseas chd walloon subject larger intak satur lower intak polyunsatur fat confirm fatti acid composit plasma platelet phospholipid plasma hdl total cholesterol similar present sampl communiti platelet aggreg epinephrin signific higher walloon subject popul divid younger year older year age group older walloon subject exhibit platelet hyperaggreg agonist compar group addit dietari fat alcohol smoke habit age import determin platelet phospholipid fatti acid platelet reactiv present result reinforc previous studi indic platelet behaviour signific affect main risk factor chd"
"potenti complic highdos epinephrin therapi patient resuscit cardiac arrest adult resuscit nontraumat cardiac arrest receiv intraven epinephrin dose chosen treat physician surviv hour studi determin highdos epinephrin produc complic standarddos total patient enrol evalu postresuscit complic attribut epinephrin tail test conting analysi patient receiv highdos epinephrin patient receiv standarddos epinephrin similar demograph variabl affect outcom differ potenti complic group serum calcium mmol sd highdos epinephrin group sd standarddos group hospit discharg rate highdos standarddos group neurolog status discharg signific highdos epinephrin produc increas direct complic cardiac arrest popul compar standarddos epinephrin"
"cardiomyopathi smoke crystal methamphetamin smoke crystal methamphetamin ice grow drug abus problem unit state toxic effect methamphetamin smoke describ patient cardiovascular toxic effect smoke crystal methamphetamin patient smokeabl methamphetamin subsequ develop pulmonari edema dilat cardiomyopathi patient smoke crystal methamphetamin produc diffus vasospasm result acut myocardi infarct cardiogen shock death recognit potenti lethal cardiac complic smoke crystal methamphetamin extrem signific emphas potenti abus drug"
"calor expenditur life status diseas male athlet athlet studi examin associ aerob calor exercis expenditur life status live deceas preval rate hypertens hbp cardiovascular diseas cvd male athlet ath athlet ath initi survey studi follow survey respond present studi subject respond fulli activ health question report dead aliv lost follow total subject ath ath assess calor expenditur group establish kilocalori kcal aerob exercis week kcal group kcal group kcal group kcal group kcal group kcal group activ consid aerob establish aerob categori death rate highest group subject group tend oldest year birth age cvd report signific relat mortal colleg athlet status exercis level signific relat mortal preval cvd hbp highest group suggest moder amount aerob activ optim"
"select inhibit synthet hirudin peptid fibrindepend thrombosi baboon determin import thrombin substrat recognit exosit fibrinogen bind format arteri venous thrombi evalu antithrombot effect tyrosinesulf dodecapeptid residu hirudin peptid nonhuman primat model peptid studi inhibit thrombin cleavag fibrinogen simpl competit block enzym catalyticsit function exterior arterioven access shunt model baboon papio anubi thrombus format induc place thrombogen devic made segment tube coat coval type collagen generat plateletrich thrombi arteri flow condit ii subsequ annular region flow expans produc fibrinrich thrombi typic venous valv vein thrombus format quantifi measur inlabel platelet ilabel fibrinogen deposit arterialflow venousflow portion devic continu infus peptid mgkg proxim devic min interrupt doserespons fashion format fibrinrich thrombus region disturb flow generat fibrinopeptid contrast peptid inhibit capac platelet deposit collagen surfac greater dose form hemostat plug assess measur bleed time greater dose find suggest competit inhibit fibrinogen bind thrombin fibrinrich venoustyp thrombus format select prevent strategi therapeut attract preserv normal platelet function convent anticoagul therapi contraind"
"home blood pressur read borderlin hypertens patient home blood pressur monitor provid valuabl inform physician manag borderlin hypertens patient studi conduct compar offic home blood pressur borderlin hypertens subject determin accuraci home monitor unit patient record home blood pressur extend period time home blood pressur monitor found accur blood pressur measur home signific lower read obtain offic subject studi averag home blood pressur mmhg lower offic read find support hypothesi home blood pressur monitor manag borderlin hypertens patient"
"vasodilatori betablock system region hemodynam effect system region hemodynam alter hypertens betaadrenerg receptor inhibit agent review hemodynam hypertens regard persist elev arteri pressur increas total peripher resist earli mild essenti hypertens increas total peripher resist readili recogn overrid effect increas cardiac output hemodynam blood pressur control complex mechan antihypertens agent appropri earli betablock reduc heart rate cardiac output immedi intraven administr immedi reduc arteri pressur calcul total peripher resist increas prolong oral treatment arteri pressur decreas maintain reduc heart rate cardiac output total peripher resist remain elev recent betablock celiprolol provid improv physiolog respons instant reduc arteri pressur total peripher resist reduc heart rate cardiac output expand intravascular volum"
"angina ischemia effort toler vasodil betablock betablock suppress exerciseinduc ischemia give rise problem fatigu dyspnea effort bradycardia seri doubleblind placebocontrol studi celiprolol cardioselect beta blocker beta agonist vasodilatori properti patient hypertens angina normal volunt found celiprolol produc bradycardia combin verapamil celiprolol reduc exerciseinduc ischemia reduct cardiac output rest exercis compar placebo compar atenolol celiprolol produc dyspnea fatigu submaxim level exercis conclud celiprolol possess differ compar convent betablock direct clinic benefit"
"cardiovascular risk factor effect intervent cardiovascular risk factor substanti modifi lifestyl diet exercis smoke cessat moder alcohol consumpt turn reduc blood pressur heart rate rest blood lipid concentr epidemiolog evid show chang serum cholesterol level chang likelihood develop coronari heart diseas addit longterm year chang mm hg diastol blood pressur reduc chanc stroke coronari heart diseas full impact broad rang intervent popul health fulli realiz countri includ unit kingdom recent evid support cardiovascular risk factor modif select review"
"dialysisinduc alter left ventricular fill mechan clinic signific quantit dimension doppler echocardiographi determin hemodialysi result alter left ventricular lv diastol fill contribut dialysisinduc hypotens assess hemodynam variabl indic diastol fill identifi patient greatest risk hemodynam unstabl dialysi sixteen male patient undergo routin mainten hemodialysi endstag renal diseas prospect studi hemodialysi hemodialysi signific prolong lv isovolumetr relax time ivrt signific reduct rate extent earli rapid ventricular fill contrast late atrialassist fill chang signific multipl stepwis linear regress analysi predialysi hemodynam paramet noninvas indic lv fill show signific independ invers relationship frequenc dialysisrel hypotens episod durat earli lv fill result suggest hemodialysi result discret alter earli lv fill signific compensatori increas late atrialassist ventricular fill patient shortest earli lv fill time greatest predilect hemodynam unstabl dialysi"
"fistula assess monitor detect stenos access fistula twenti unselect hemodialysi patient function access arterioven fistula studi prospect determin techniqu detect stenos fistula combin clinic assess fistula assess monitor compar transbrachi angiographi fistula assess monitor accur combin clinic assess accuraci stenosi detect complic angiographi occur patient complic fistula assess monitor fistula assess monitor combin clinic assess predict clinic outcom arterioven fistula month good angiographi routin fistula assess monitor reduc inappropri angiographi detect clinic signific silent stenos ideal method monitor arterioven access fistula"
"cyclosporineinduc thrombot microangiopathi result renal allograft loss success reus report case cyclosporineinduc thrombot microangiopathi rare complic renal transplant common lead graft loss mechan entiti unknown factor intrins donor kidney play import role describ case renal transplant patient lost graft secondari cyclosporineinduc thrombot microangiopathi patient success retranspl immunosuppress protocol includ longterm cyclosporin conclud graft loss entiti contraind subsequ success transplant cyclosporin"
"unsuspect mitral stenosi purpos patient method observ seri patient diagnosi mitral stenosi discov echocardiographi laboratori experi examin record patient echocardiograph evid rheumat mitral stenosi determin clinic characterist patient unsuspect mitral stenosi factor obscur diagnosi result patient mitral stenosi unsuspect clinic echocardiogram patient elder median age year refer echocardiographi cardiac symptom patient refer evalu congest heart failur patient refer evalu aortic valv diseas patient refer cerebrovascular accid atrial fibril dopplerdetermin diastol mitral gradient rang mm hg mm hg mitral stenosi rang sever trivial sever patient moder sever mitral stenosi estim mitral valv area equal cm mild trivial mitral stenosi estim mitral valv area greater cm evalu patient underw mitral valv surgeri improv congest failur patient warfarin therapi begun prevent emboli patient signific chang therapi discoveri mitral stenosi conclus diagnosi mitral stenosi suspect presenc advanc age cardiac medic condit mechan factor complic physic examin patient mitral stenosi hemodynam signific signific symptom"
"prognost signific valvular regurgit patient infect endocard purpos doppler ultrasound sensit modal detect quantit valvular regurgit patient infect endocard valvular regurgit lead heart failur evalu prognost signific dopplerdetect valvular regurgit patient endocard develop clinic heart failur patient method review medic record patient clinic diagnosi infect endocard march total patient includ studi patient nativ valv endocard patient prosthet valv endocard initi doppler echocardiogram examin patient determin presenc degre valvular regurgit result signific moder sever valvular regurgit detect patient presenc absenc signific valvular regurgit predict develop congest heart failur surgeri death ns develop congest heart failur signific surgeri death conclus conclud detect signific valvular regurgit patient infect endocard develop heart failur predict futur complic absenc signific valvular regurgit identifi group patient favor prognosi seri patient develop congest heart failur signific higher incid surgeri death decis clinic manag patient infect endocard made sole presenc absenc echocardiograph detect valvular regurgit"
"comparison labetalol versus enalapril monotherapi elder patient hypertens result hour ambulatori blood pressur monitor purpos studi compar safeti efficaci labetalol enalapril antihypertens therapi elder patient patient method random openlabel parallel control trial conduct complet week placebo phase elder year older patient averag stand diastol blood pressur bp mm hg mm hg random receiv week labetalol enalapril openlabel design patient bp heart rate evalu biweek train observ unawar treatment status drug dosag titrat mg day labetalol mg daili enalapril achiev stand diastol bp mm hg decreas mm hg baselin patient underw hour ambulatori bp monitor abpm end placebo phase week activ treatment result treatment group compar reduct supin diastol bp signific differ treatment labetalol demonstr signific greater reduct stand diastol bp end titrat period compar enalapril differ signific end studi period base hour abpm read labetalol reduc hour diastol bp heart rate enalapril labetaloltr patient signific diastol bp goal hour abpm period treatment equal toler conclus result labetalol enalapril equal effect lower supin diastol bp elder labetalol effect lower ambulatori bp heart rate day"
"elder patient congest heart failur prepaid care purpos concern qualiti care receiv medicar patient health mainten organ hmos care patient congest heart failur chf hmos compar care feeservic ffs medicar case patient method compar care patient chf enrol medicar hmos care similar ffs patient panel expert physician develop criteria evalu qualiti care special train nurs clinician abstract medic record result outpati evalu manag similar set hmo patient signific advis restrict salt intak ffs patient uncontrol hypertens medic regimen chang versus eject fraction obtain equal inpati manag similar group nonetheless hmo provid schedul follow visit week hospit discharg versus conclus studi suggest financi incent prepaid care detriment aspect care chf patient rapid follow hospit discharg patient chf suggest hmos effect deliv continu care patient chronic ill"
"emerydreifuss muscular dystrophi emerydreifuss syndrom rare form muscular dystrophi cardiac complic lead sudden death disord potenti anaesthet implic manag patient present orthopaed surgeri"
"druginduc supraventricular tachycardia case report fluoxetin report occurr supraventricular tachycardia hypotens year woman mainten therapi fluoxetin case tachycardia palpit report supraventricular tachycardia hypotens direct attribut fluoxetin"
"torsad de point therapi phenytoin present case woman myocardi infarct complic malign ventricular arrhythmia torsad de point torsad de point refractori convent therapi respons phenytoin case suggest clinic phenytoin adjunct therapi lifethreaten ventricular arrhythmia standard treatment modal fail"
"plasma concentr epinephrin cpr dog studi object purpos studi evalu mark increas plasma concentr epinephrin cardiopulmonari arrest basic life support bls due part decreas distribut elimin design intervent dog random assign undergo adrenalectomi shamoper adrenalectom anim receiv epinephrin infus measur main result shamoper dog plasma epinephrin concentr increas mark bls expect adrenalectom dog receiv constant infus epinephrin cardiopulmonari arrest bls induc sixfold increas plasma epinephrin concentr increas plasma epinephrin concentr calcul area curv ngml adrenalectom dog receiv constant epinephrin infus subject cardiopulmonari arrest plasma epinephrin concentr remain stabl final adrenalectom dog receiv epinephrin infus plasma epinephrin concentr bls calcul area curv increas ngml signific adrenalectom dog receiv epinephrin infus conclus increas plasma epinephrin concentr cardiopulmonari arrest bls due part alter disposit epinephrin"
"demograph social stress correl hypertens urban poor relationship demograph social psycholog variabl diagnosi hypertens popul urban poor predomin black patient report subject patient present health care wayn state univers famili practic clinic age race marit status attend religi servic educ employ status incom sourc incom interperson stress signific relat diagnosi hypertens sampl characterist found signific relat hypertens discrimin analysi show age race educ frequenc church attend import predict diagnosi hypertens patient sampl urban poor implic clinic care futur research consid"
"strain differ baroreflex inhibit central infus enalapril rat determin inhibit brain reninangiotensin system affect baroreflex similar rat strain compar month male fischer spraguedawley rat baroreflex sensit test rat awak record reflex heart rate respons elicit blood pressur elev phenylephrin lower sodium nitroprussid spraguedawley rat higher blood pressur lower heart rate initi chronic infus enalapril convert enzym inhibitor cerebr ventricl icv week lower blood pressur spraguedawley fischer rat reflex bradycardia unaffect rat strain reflex tachycardia select suppress fischer rat time control rule spontan day infus period result suggest central cardiovascular regul chang similar age rat strain remov brain reninangiotensin system lower blood pressur strain inhibit reflex tachycardia diverg brain reninangiotensin system act differ blood pressur elev spraguedawley rat modul reflex tachycardia fischer rat"
"prostacyclin product myocardi infarct acut phase follow twenti patient myocardi infarct monitor acut phase follow regard vivo product prostacyclin pgi thromboxan txa measur major urinari metabolit dinorketopgf alpha dinortxb patient pgi txa product assess exercis test perform week discharg approxim patient vivo product prostacyclin increas acut phase infarct process inabl decreas releas heart muscl enzym frequent observ women exercis toler test patient show increas prostacyclin product contrast healthi volunt signific increas differ patient increas prostacyclin product acut phase follow year myocardi infarct cardiac event occur note patient exhibit expect increas prostacyclin product associ infarct reason patient group larger primari infarct"
"rapid correct diagnosi myocardi infarct standard case histori clinic examin provid import inform correct referr monitor bed examin case histori diagnost tool hospit patient suspect myocardi infarct investig independ prospect studi limit number painrel element criteria obtain emerg room improv decis admit patient coronarycar unit studi criteria reduc number unnecessari coronarycareunit admiss reduct patient sampl criteria reduc number patient definit acut myocardi infarct admit general ward reduct favour result confirm independ smallerscal studi"
"serolog argument classifi raynaud phenomenon idiopath twenti patient idiopath raynaud phenomenon prospect period month clinic laboratori assess perform admiss followup sera analyz presenc autoantibodi antinuclear antiskeleton antiorganell antibodi sixteen patient antinuclear antibodi posit anticentromer antibodi posit patient produc antivimentin antimitochondri antigolgi complex anticentriol antibodi eleven patient produc antidesmosom antibodi patient antirnp antidesmosom antibodi posit develop system diseas mix connect tissu diseas followup initi screen sera classifi raynaud phenomenon idiopath accur"
"angiograph morpholog unstabl angina relat transient myocardi ischemia hospit outcom complex stenosi morpholog frequent occur patient unstabl angina pectori relat transient myocardi ischemia hospit outcom ascertain address issu patient signific greater equal coronari arteri diseas present angina onset worsen rest studi patient left main arteri diseas normal coronari arteri occlus ischemiarel arteri includ studi continu electrocardiograph record obtain hour angiographi perform week admiss complex morpholog defin stenosi irregular border overhang edg intracoronari thrombus data refer hospit outcom consid studi advers end point sudden death myocardi infarct emerg revascular analysi angiogram reveal complex morpholog patient group remain patient serv control subject group thirti group patient unfavor clinic outcom posit predict similar outcom occur group patient negat predict group patient unfavor clinic outcom cumul durat transient myocardi ischemia greater equal minut hour similar durat ischemia observ group group patient"
"angin symptom ischem electrocardiograph ambulatori monitor men coronari arteri diseas episod angina pectori electrocardiograph ecg sign myocardi ischemia hour ambulatori monitor studi patient histori stabl angina angiograph proven coronari arteri diseas posit exercis test result episod ischem ecg stsegment depress greater mm greater minut episod angina pectori observ episod consist ecg angina pectori episod consist ecg episod angina pectori durat magnitud stsegment deviat heart rate onset ischemia similar symptomat asymptomat episod ecg episod angina pectori ecg detect patient group episod angina pectori patient episod angina pectori ecg patient group angina pectori ecg observ episod accompani ischem ecg patient differ angiograph extent coronari arteri diseas exercis test data group maxim stsegment depress exercis test signific greater group group patient mm mm"
"depend doppler echocardiograph transmitr earli peak veloc left ventricular systol function coronari arteri diseas influenc systol function puls doppler echocardiograph transmitr flow veloc pattern assess postextrasystol pes potenti normal subject control group patient previous heal myocardi infarct mi group simultan highfidel left ventricular pressur measur perform patient program singlecoupl ventricular extrasystol induc echocardiograph subsequ cineangiocardiograph record adequ angiogram volumetr analysi baselin pes beat obtain patient control group mi group pes potenti contract pronounc mi group control group pes eject fraction stroke volum endsystol volum signific greater mi group control group mlm mlm contrast pes potenti prolong time constant left ventricular pressur declin deriv exponenti curv fit tw tb asymptot pressur mi group extent control group ms differ signific ns ms ns pes beat peak veloc remain unalt cm ns control group increas signific cm mi group"
"relat serum lipoprotein cholesterol level presenc sever angiograph coronari arteri diseas assess relat lipid level angiograph coronari arteri diseas cad lipid profil obtain men women undergo diagnost coronari angiographi cad defin greater equal diamet narrow major coronari arteri present men women multipl regress analys reveal highdens lipoprotein hdl cholesterol level men age totalhdl cholesterol ratio women independ presenc cad adjust risk factor hdl cholesterol level age signific correl extent number diseas vessel sever percent maximum stenosi cad men women age independ variabl relat sever age totalhdl cholesterol ratio relat extent patient total cholesterol mgdl cad multipl regress analys hdl cholesterol variabl independ relat presenc sever cad patient adjust age gender extent signific age male gender unrel lipid paramet multipl logist linear regress analys group patient hdl cholesterol power independ variabl presenc sever cad adjust age gender hdl cholesterol independ predictor extent age independ end point examin variabl signific relat extent data add grow bodi inform demonstr import associ hdl cad"
"edg detect versus densitometri assess coronari stent quantit optim method analyz quantit angiograph result coronari stent coronari arteri studi minim lumin crosssect area determin method edg detect densitometri patient underw percutan translumin coronari angioplasti ptca coronari stent implant symptomat coronari stenos correl coeffici angioplasti decreas coronari angioplasti increas stent implant differ edg detect densitometr determin minim lumin crosssect area mm ptca mm angioplasti mm coronari stent conclud correl variabl measur minim lumin crosssect area edg detect densitometri deterior ptca improv stent smooth vessel contour stent remodel stent segment circular configur stent coronari arteri edg detect densitometri equal accept method analysi"
"frequenc success complic coronari angioplasti stenosi ostium branch vessel author studi hypothes percutan translumin coronari angioplasti stenosi ostium branch vessel isol bifurc stenosi reduc procedur success increas hospit complic hundr patient ostial branch stenos compar patient underw angioplasti nonosti branch stenos ostial branch stenosi defin stenosi proxim mm major branch vessel diagon posterior descend obtus margin intermedi ostial branch stenosi isol patient bifurc stenosi balloon arteri ratio angiograph success ostial branch stenos versus nonosti stenos angioplasti ostial branch stenos result complic rate versus angioplasti nonosti branch stenos angioplasti ostial branch stenos result decreas procedur success signific residu stenosi adequ balloon size suggest arteri elast recoil signific increas complic"
"doppler echocardiograph comparison carpenti duran anuloplasti ring versus ring mitral valv repair mitral regurgit compar hemodynam result anuloplasti techniqu primari valv repair mitral regurgit patient prospect studi doppler echocardiogram day oper seventi patient mitral valv prolaps coronari arteri diseas patient rheumat mitral valv lesion patient infect endocard forti patient receiv flexibl duran ring receiv rigid carpenti ring patient receiv ring doppler echocardiographi demonstr signific decreas mitral valv area estim pressur halftim method patient receiv carpenti cm duran ring cm compar patient receiv ring cm signific differ observ peak transmitr diastol veloc peak transmitr diastol gradient grade mitral regurgit color flow doppler map patient ring etiolog mitral diseas concomit surgic procedur accompani mitral valv repair signific influenc mitral valv area peak veloc peak gradient data suggest carpenti duran ring decreas hemodynam mitral valv area decreas valv area small clinic import increas transvalvular gradient"
"thermolabil methylenetetrahydrofol reductas inherit risk factor coronari arteri diseas sever methylenetetrahydrofol reductas mthfr defici normal enzym activ character neurolog abnorm atherosclerot thromboembol discov variant mthfr defici character absenc neurolog abnorm enzym activ normal distinct thermol specif condit heat inactiv studi lymphocyt mthfr specif activ thermolabil variant control group nmol formaldehyd formedmg protein differ signific overlap individu valu group hand residu mthfr activ heat inactiv thermolabil variant control overlap enzym studi subject thermolabil mthfr famili member support hypothesi thermolabil mthfr inherit autosom recess trait elucid associ thermolabil mthfr develop coronari arteri diseas determin thermost lymphocyt mthfr patient proven coronari arteri diseas control clinic evid atherosclerot vascular diseas thermolabil mthfr found cardiac patient control differ incid group statist signific averag age onset clinic coronari arteri diseas patient thermolabil mthfr year year total plasma homocystein concentr patient thermolabil mthfr nmolml signific normal nmolml associ thermolabil mthfr major risk factor conclud thermolabil mthfr variant mthfr defici inherit autosom recess trait addit posit develop coronari arteri diseas determin vitro thermost lymphocyt mthfr reliabl method identifi subject abnorm"
"spectrum portal vein thrombosi liver transplant thrombosi portal vein patenc tributari contraind orthotop liver transplant oltx recent rapid progress surgic techniqu oltx year demonstr patient portal vein thrombosi safe success transplant present seri patient portal vein thrombosi transplant univers pittsburgh techniqu treat form thrombosi surviv rate seri patient surviv patient underw phlebothrombectomi placement jump graft superior mesenter vein surviv rate correl amount blood requir transfus surgeri conclud vast major patient thrombosi portal system technic transplant surviv rate compar patient patent portal vein"
"fibrous skeleton ventricular outflow tract doubleoutlet ventricl twenti heart great arteri aros ventricl studi establish variat present fibrous skeleton infundibular morpholog variat note locat ventricular septal defect measur obtain outlet septum circumfer arteri valv complet muscular subarteri infundibulum present heart vari degre fibrous continu leaflet arteri atrioventricular valv remaind aorta rightward posterior heart subaort subpulmonari ventricular septal defect present equal number group subaort defect present aorta sidesid side subpulmonari defect present heart posterior aorta ratio subpulmonari subaort length outlet septum signific note previous heart tetralog fallot"
"superior retrograd cardioplegia acut coronari occlus antegrad cardioplegia limit distribut cardioplegia coronari occlus studi undertaken determin retrograd coronari sinus cardioplegia superior myocardi protect revascular acut coronari occlus adult pig diagon branch occlud snare hour anim cardiopulmonari bypass underw minut ischem arrest multidos potassium crystalloid cardioplegia anim cardioplegia antegrad aortic root retrograd coronari sinus arrest period coronari snare releas heart reperfus hour postischem damag myocardium occlus assess wall motion score dimension echocardiographi normal dyskinesia chang myocardi ph preischemia area necrosisarea risk histochem stain heart protect retrograd coronari sinus cardioplegia tissu acidosi chang ph versus higher wall motion score versus signific myocardi necrosi versus conclud retrograd coronari sinus cardioplegia optim myocardi protect antegrad cardioplegia revascular acut coronari occlus"
"efficaci coronari sinus cardioplegia patient complet coronari arteri occlus myocardi area distal complet coronari arteri occlus poor protect antegrad cardioplegia assess effect coronari sinus cardioplegia patient undergo bypass oper high risk cardiopleg maldistribut anatom pattern coronari arteri diseas critic greater equal stenosi left main trunk total occlus coronari arteri patient critic greater equal stenosi coronari arteri total occlus left anterior descend patient circumflex arteri patient induct arrest aorta coronari sinus cardioplegia intermitt crossclamp period flow rate mlmin intraop occlud arteri consist found fill retrograd infus solut patient die earli postop low cardiac output patient die hospit stay arrhythmia autopsi patholog evid inadequ myocardi protect patient sustain myocardi infarct requir inotrop hour postop postop valu left stroke volum indic signific prebypass level result consist occurr limit intraop ischem damag infer suggest efficaci coronari sinus rout preserv myocardi area suppli complet occlud coronari arteri jeopardi inadequ cardioplegia deliveri"
"repair posterior left ventricular aneurysm year boy left ventricular aneurysm diverticula rare encount pediatr age group paper report case congest heart failur mitral regurgit year boy larg posterolater left ventricular aneurysm complet repair success perform excis aneurysm dacron patch reconstruct left ventricular free wall patch extend posterior annulus mitral valv restor mitral valv normal geometri correct mitral insuffici surgic literatur congenit cardiac diverticula acquir aneurysm children review summar"
"silicon pouch protect automat implant cardioverterdefibril lead automat implant cardioverterdefibril routin treatment recurr drugresist ventricular tachycardia document clinic experi devic perform inform avoid complic relat retriev sens defibril lead subcutan space report experi silicon pouch protect automat implant cardioverterdefibril lead simpl retriev lead case automat implant cardioverterdefibril generat"
"dural spinal cord arterioven malform multipl hospit admiss inpati rehabilit stay year woman transfer rehabilit facil paraparesi unknown etiolog previous studi includ ct scan mris demonstr lesion myelogram noncharacterist correct diagnosi confirm select angiographi ultim conting recognit clinic featur natur histori dural spinal cord arterioven malform scavm unusu combin multitud nondiagnost imag studi uncommon dural scavm serv delay diagnosi treatment delay great function consequ report illustr import suspect scavm recogn featur emphasi physiatrist role assur proper diagnosi expedit time treatment obtain function outcom review classif clinic featur pathophysiolog diagnosi prognosi scavm present"
"detect hypertens screen versus case find norway objectiveevalu detect hypertens adult counti nordtrondelag norway designcross section survey clinic follow examin settinghealth survey screen team nation health screen servic examin general practition counti subject person age year particip health survey main outcom measureshypertens assess standardis record questionnair drug treatment hypertens blood pressur threshold norwegian treatment programm subject posit screen group clinic examin treatment group result subject posit hypertens screen patient report antihypertens drug blood pressur monitor regular screen posit refer general practition evalu standard programm result drug treatment start particip screen blood pressur monitor patient antihypertens drug screen diagnos screen blood pressur monitor screen diagnos screen conclus blood pressur screen threshold hypertens defin clinic diagnosi result general practition find diagnos hypertens patient case find strategi"
"treatment deferoxamin ischemia improv function metabol recoveri reduc reperfusioninduc oxygen radic generat rabbit heart background iron play central role oxygen radic generat myocardi ischemia reperfus condit ischemia liber iron hypothes administr iron chelat deferoxamin ischemia result improv function metabol recoveri postischem reperfus method result isol perfus rabbit heart studi phosphorus nuclear magnet reson spectroscopi heart receiv treatment deferoxamin onset minut global ischemia deferoxamin bolus continu minut infus begun reflow standard perfus heart treat deferoxamin ischemia show recoveri develop pressur control heart versus baselin recoveri myocardi phosphocreatin content versus baselin function metabol benefit compar obtain deferoxamin treatment earli reperfus addit heart intraischem treatment deferoxamin result reduct oxygen radic concentr measur frozen tissu electron paramagnet reson spectroscopi end ischemia treatment elimin reperfusioninduc increas free radic generat observ control heart versus microm magnitud reduct similar deferoxamin onset reflow microm versus control conclus result demonstr improv function metabol recoveri myocardium treat deferoxamin ischemia accompani reduct reperfusioninduc oxygen freerad generat degre reflow treatment confirm import iron pathogenesi myocardi reperfus injuri"
"myocardi infarct sizelimit effect ischem precondit attenu oxygen freerad scaveng rabbit background limit effect ischem precondit infarct size report canin heart amount xanthin oxidas free radicalproduc enzym recent studi suggest free radic generat precondit contribut cardioprotect effect precondit present studi examin precondit limit infarct size rabbit human lack myocardi xanthin oxidas cardioprotect effect pc mediat free radic method result branch circumflex coronari arteri rabbit occlud minut reperfus hour myocardi infarct size area risk determin histolog fluoresc particl group studi untreat control group precondit group pc group highdos superoxid dismutas sodtreat precondit group highdos sodpc group lowdos sodtreat precondit group lowdos sodpc group sodcatalasetr precondit group sodcatpc group precondit perform episod minut ischemia minut reperfus free radic scaveng unitskg sod highdos sodpc group unitskg sod lowdos sodpc group unitskg sod unitskg catalas sodcatpc group infus intraven minut start minut precondit infarct size percentag area risk sem control group pc group highdos sodpc group lowdos sodpc group sodcatpc group versus control valu differ infarct size percent area risk pc highdos sodpc lowdos sodpc sodcatpc group signific conclus ischem precondit delay ischem myocardi necrosi myocardi xanthin oxidas content free radic major role mechan precondit rabbit"
"transvascular intracardiac applic miniatur phasedarray ultrason endoscop initi experi intracardiac imag piglet background recent advanc miniatur phasedarray mechan ultrasound devic result explor altern approach cardiac vascular imag form transesophag intravascular imag preliminari effort adapt phasedarray endoscop design transesophag transvascular approach fullsiz phasedarray devic introduc direct atrium openchest anim purpos studi assess feasibl custommad small phasedarray endoscop intracardiac imag introduc intravascular jugular venous approach young piglet method result experiment atrial septal defect creat piglet week close button atrial septal defect closur devic consist occlud left atrium counterocclud atrium day atrial septal defect closur piglet return experiment laboratori mm element mhz phasedarray probe mount mm endoscop introduc cutdown incis extern jugular vein advanc atrium atrium cardiac chamber inflow outflow valv imag minim superior inferior rotat highresolut imag atrial septum defin anatom accuraci verifi autopsi exact placement occlud counterocclud left side atrial septal defect absenc shunt atrial septum anim conclus effort transvascular passag small phasedarray probe easili accomplish promis techniqu detail visual cardiac structur approach provid altern transesophag echocardiographi guid intervent procedur placement transcathet closur devic pediatr patient"
"contractil stiff noninfarct myocardium coronari ligat rat effect chronic angiotensin convert enzym inhibit background previous studi shown global left ventricular function depress myocardi infarct effect myocardi infarct contractil passiveelast properti residu myocardium method result evalu isometr function passiv myocardi stiff isol noninfarct left ventricular papillari muscl rat week sham oper myocardi infarct maxim develop tension peak rate tension rise dtdt signific decreas untreat rat larg myocardi infarct compar control versus mm versus mmsec time peak tension prolong versus msec myocardi stiff increas untreat myocardi infarct rat compar control versus rat smaller myocardi infarct differ control respect prolong time peak tension papillari muscl myocyt crosssect area increas myocardi hydroxyprolin content increas rat larg myocardi infarct compar control determin treatment improv left ventricular function myocardi infarct improv myocardi function rat treat captopril begin week myocardi infarct continu week treatment captopril attenu prolong time peak tension myocardi infarct rat develop tension dtdt muscl stiff remain abnorm compar untreat myocardi infarct rat captopriltr myocardi infarct rat decreas myocyt crosssect area persist increas myocardi collagen content summari larg myocardi infarct rat contractil dysfunct increas stiff myocyt hypertrophi increas collagen content residu noninfarct myocardium treatment captopril alter process cardiac remodel hypertrophi improv paramet contractil noninfarct myocardium myocardi collagen content myocardi stiff remain abnorm conclus find suggest angiotensin convert enzym inhibit rat infarct model heart failur improv global cardiac perform combin effect myocardi function peripher circul"
"coronari blood flow dog contractil dysfunct due experiment volum overload background abnorm coronari blood flow respons stressinduc reduct contractil function pressur overload hypertrophi coronari blood flow volum overload studi test hypothesi coronari blood flow abnorm respons contractil abnorm experiment volum overload hypertrophi method result examin coronari blood flow rest pace dog contractil dysfunct secondari chronic experiment mitral regurgit averag regurgit fraction month month mitral regurgit left ventricular mass increas baselin slope endeject stressvolum relat index estim contractil function fallen baselin month mitral regurgit mitral regurgit dog coronari blood flow rest similar control dog endocardi blood flow control dog mlmin mitral regurgit dog mlmin ns epicardi blood flow rest control dog mlmin mitral regurgit dog mlmin ns pacinginduc stress coronari blood flow increas appropri control mitral regurgit dog ultrason dimens gaug endocardium epicardium demonstr deterior ventricular function pace mitral regurgit dog separ group control dog dog mitral regurgit left ventricular dysfunct coronari blood flow examin conscious closedchest state rest adenosin infus rapid atrial pace beatsmin blood flow increas similar group pace adenosin infus conclus conclud dog mitral regurgit develop contractil dysfunct abnorm coronari blood flow explain rest contractil dysfunct studi pacinginduc stress coronari vasodil adenosin demonstr substanti coronari blood flow reserv present type volum overload hypertrophi"
"myocardi perfusioncontract match implic coronari heart diseas hibern experiment studi demonstr shortterm region perfusioncontract match energi demand region myocardi contract reduc match diminish myocardi substrat suppli occur state low coronari blood flow rest condit exerciseinduc ischemia phenomenon rapid revers occur clinic set sustain perfusioncontract match observ state partial experiment ischemia intermedi durat hour condit call shortterm hibern resembl clinic condit unstabl angina pectori myocardi infarct residu perfus contractil defect improv reperfus provid ischemia sever transmur necrosi experiment clinic observ relat set region dysfunct rest patient chronic coronari heart diseas manifest acut ischemia absent improv wall motion abnorm occur cabg balloon angioplasti condit constitut hypothet state chronic myocardi hibern tentat evid exist metabol perfus studi pet condit prolong perfusioncontract match adapt process persist long period manifest ischemia remain investig"
"tenyear incid myocardi infarct prognosi infarct depart veteran affair cooper studi coronari arteri bypass surgeri background year incid myocardi infarct fatal nonfat prognosi infarct evalu patient stabl angina random assign medic surgic treatment veteran administr cooper studi coronari arteri bypass surgeri method result myocardi infarct defin wave find clinic symptom compat myocardi infarct accompani serum enzym elev electrocardiograph find treatment comparison made origin treatment assign medic cohort bypass surgeri year follow period cumul infarct rate higher patient assign surgeri medic patient due periop infarct acceler infarct rate year follow averag yr surgic group versus yr medic group year cumul incid death myocardi infarct higher surgic medic patient cox model estim risk death infarct lower surgic medic patient reduct postinfarct mortal surgeri strike month event month subsequ estim risk death absenc infarct ident treatment exclus periop infarct alter find conclus surgeri reduc incid myocardi infarct reduc risk mortal infarct day event fatal infarct"
"peak exercis oxygen consumpt optim time cardiac transplant ambulatori patient heart failur background optim time cardiac transplant ambulatori patient sever left ventricular dysfunct difficult determin measur peak oxygen consumpt vo maxim exercis test identifi patient transplant safe defer prospect perform exercis test ambulatori patient refer transplant octob decemb method result patient assign group basi exercis data group compris patient accept transplant vo equal mlkgmin group compris patient consid transplant vo greater mlkgmin group compris patient low vo reject transplant due noncardiac problem group compar york heart associ function class eject fraction cardiac index ns pulmonari capillari wedg pressur signific lower group group wide overlap patient preserv exercis capac group cumul year surviv rate equal surviv level transplant contrast patient reject transplant group surviv rate year year patient await transplant group surviv rate year versus patient vo greater mlkgmin death group sudden univari multivari analys peak vo predictor surviv pulmonari capillari wedg pressur provid addit prognost inform conclus data suggest cardiac transplant safe defer ambulatori patient sever left ventricular dysfunct peak exercis vo mlminkg"
"cathet modif atrioventricular junction radiofrequ energi control atrioventricular nodal reentri tachycardia background util transcathet applic radiofrequ energi elimin atrioventricular nodal reentrant tachycardia avnrt investig method result thirti patient age year rang year medic refractori avnrt underw perinod ablat radiofrequ energi customdesign cathet larg mmlong distal electrod interelectrod pace mm major case cathet ablat initi posit tricuspid anulus obtain largest bundl electrogram withdrawn obtain largest atrialventricular electrogram ratio small bundl electrogram equal microv applic radiofrequ energi khz stop pr prolong imped rise note endpoint procedur persist modif atrioventricular nodal conduct degre atrioventricular block impair ventriculoatri conduct noninduc avnrt isoproterenol administr radiofrequ energi appli time session follow month patient free avnrt high grade av block patient develop complet atrioventricular block pacemak implant patient unsuccess initi procedur patient initi success ablat recurr tachycardia week elimin avnrt due effect retrograd fast pathway patient conclus radiofrequ ablat perinod atrium safe effect treatment typic avnrt"
"fibrinogen viscos white blood cell count major risk factor ischem heart diseas caerphilli speedwel collabor heart diseas studi background recent studi suggest hemostat factor white blood cell count predict ischem heart diseas ihd relat fibrinogen viscos white blood cell count incid ihd caerphilli speedwel prospect studi method result studi common core protocol base combin cohort middleag men general popul follow constant interv year caerphilli year speedwel major ihd event occur ageadjust relat odd ihd men top distribut compar bottom confid interv fibrinogen confid interv viscos confid interv white blood cell count associ ihd similar men smoke exsmok current smoker result suggest part effect smoke ihd mediat fibrinogen viscos white blood cell count multivari analysi show white blood cell count independ risk factor ihd fibrinogen viscos possibl joint variabl signific improv fit logist regress model main convent risk factor model includ age smoke habit fibrinogen viscos white blood cell count predict ihd hemostaticrheolog variabl replac total cholesterol diastol pressur bodi mass index conclus joint fibrinogen viscos white blood cell count import risk factor ihd"
"upward shift lower rang coronari flow autoregul hypertens patient hypertrophi left ventricl background perfus pressur coronari reserv express differ autoregul maxim vasodil flow hypertens rais coronari resist reduc steep pressureflow relationship maxim vasodilat presenc cardiac hypertrophi line autoregul flow higher reason coronari reserv reduc point baselin flow approach maxim achiev flow shift higher perfus pressur reduct elev critic pressur lower coronari flow method result investig patient normotens control hypertens normal group augment lv mass index concentr lv hypertrophi group ii effortinduc angina angiograph normal left epicardi branch flow great cardiac vein measur thermodilut baselin stepwis mm hg minut decreas coronari perfus pressur titrat nitroprussid infus perfus pressur mm hg control mm hg hypertens end point baselin flow averag mlmin normotens mlmin hypertens group mlmin hypertens group ii end point flow similar baselin control group group ii coronari flow start declin myocardi extract start slight signific rise perfus pressur mm hg end point flow reduc baselin perfus pattern relat tensiontim index heart rate conclus associ high blood pressur reduc abil coronari arteriol dilat hypertrophi myocardium augment baselin coronari flow shift point exhaust coronari reserv higher perfus pressur make myocardium vulner treatmentinduc relat hypertens"
"concept maxim flow ratio evalu percutan translumin coronari angioplasti result videodensitometri background set percutan translumin coronari angioplasti ptca inform result intervent import morpholog paramet reliabl diagnost coronari arteriographi recent videodensitometr method introduc valid anim experi accur comparison maxim myocardi perfus situat degre stenosi method transit time tmn contrast agent maxim hyperemia paramet maxim flow strict accord dilat theori method result patient angina pectori singlevessel diseas posit exercis test time accept ptca approach appli evalu improv maxim flow achiev ptca maxim vasodil induc immedi minut ptca intracoronari administr papaverin digit angiograph studi perform special breathhold instruct motionless trigger imag acquisit heartbeat excel subtract imag obtain reliabl determin tmn maxim hyperemia patient ptca ratio maxim flow ptca call maxim flow ratio mfr repres ratio tmn intervent compar result exercis test hour day procedur correct pressur mfr dilat vessel normal vessel serv control patient mfr discrimin presenc absenc revers exercis test result posit negat line judgment success base angiograph paramet measur transstenot pressur gradient relat noninvas function improv present patient definit rang call normal tmn maxim hyperemia distinguish postptca valu success dilat arteri return complet normal rang conclus accur comparison maxim myocardi perfus ptca man improv maxim flow high relat function improv exercis test result method straightforward line evalu result intervent"
"heart rate adjust exerciseinduc st segment depress improv risk stratif framingham offspr studi background simpl heart rate adjust st segment depress exercis delta sthr index pattern st depress function heart rate exercis recoveri raterecoveri loop shown improv abil exercis electrocardiogram detect presenc coronari heart diseas chd perform method predict futur coronari event remain examin method result compar delta sthr index raterecoveri loop standard electrocardiograph criteria predict chd event asymptomat men women framingham offspr studi underw treadmil exercis electrocardiographi entri free clinic electrocardiograph evid chd follow year chd event sudden death myocardi infarct incid case angina pectori cox proport hazard model adjust age sex posit exercis electrocardiogram standard criteria greater equal mv horizont downslop st segment depress predict chd event chi contrast stratif presenc absenc posit delta sthr index greater equal microvbeatmin posit counterclockwis raterecoveri loop chd event risk chi separ subject group vari risk coronari event high risk test posit relat risk confid interv intermedi risk delta sthr index raterecoveri loop posit relat risk confid interv low risk test negat multivari adjust age sex smoke total cholesterol level fast glucos level diastol blood pressur electrocardiograph evid left ventricular hypertrophi combin delta sthr index raterecoveri loop criteria remain predict coronari event chi conclus heart rate adjust st segment depress delta sthr index raterecoveri loop exercis electrocardiographi improv predict futur coronari event asymptomat men women"
"electrocardiograph bodi surfac potenti map wolffparkinsonwhit syndrom noninvas determin ventricular insert site accessori atrioventricular connect background reliabl noninvas procedur determin locat accessori atrioventricular connect patient wolffparkinsonwhit syndrom add import diagnost tool clinic armamentarium method result bodi surfac potenti map bspm electrod size vest display calibr color map determin ventricular insert site accessori atrioventricular av connect patient wolffparkinsonwhit syndrom attempt made determin ventricular insert site guiraudon al patient electrophysiolog studi ep cardiac catheter surgeri ventricular insert site accur locat ep surgeri number physiolog observ made bspm conclus conclus drawn bspm qrs analysi accur predict ventricular insert site accessori av connect presenc delta wave electrocardiogram ventricular insert site accessori av connect determin bspm ep surgeri ident map site cm case accessori av connect broad ventricular insert bspm ep locat accessori av connect correl case fact bspm determin ventricular insert site ep determin atrial insert site accessori av connect suggest case multipl accessori av connect ep bspm complementari bspm identifi pathway ep identifi case broad ventricular insert bspm ep demonstr proport insert bspm st analysi accur predict ventricular insert site accessori av connect mark preexcit standard electrocardiographi gallagh grid methodolog attempt stimul maxim preexcit accur qrs analysi bspm predict ventricular insert site accessori av connect exact comparison hamper number size gallagh guiraudon insert site bspm qrs analysi accur predict ventricular versus left ventricular posterosept accessori av connect typic epicardi ventricular breakthrough indic conduct special av conduct system occur patient left ventricular free wall accessori av connect epicardi ventricular breakthrough observ case ventricular free wall anterosept accessori av connect epicardi ventricular breakthrough occur presenc posterosept accessori av connect left ventricular delay epicardi ventricular breakthrough case left ventricular insert provid marker estim degre ventricular preexcit"
"diagnost effici troponin measur acut myocardi infarct background present studi design evalu effici newli develop troponin enzym immunoassay detect acut myocardi infarct method result studi compris patient admit chest pain suspect myocardi infarct patient skelet muscl damag addit suspect myocardi cell damag troponin elev analyt sensit assay microgram patient wave rang microgram wave infarct rang microgram troponin serum earli hour onset pain patient remain elev patient hour reveal releas kinet free cytosol structur bound molecul diagnost effici troponin superior creatin kinasemb versus remain day admiss patient unstabl angina exclud analysi patient unstabl angina troponin elev rang microgram blood sampl patient circul troponin correl presenc revers st segment wave electrocardiogram frequenc hospit complic patient skelet muscl damag suspect addit cardiac muscl damag troponin test effici depend discrimin compar creatin kinasemb conclus data studi newli develop troponin test improv effici serodiagnost tool detect myocardi cell necrosi compar convent cardiac enzym"
"intravascular ultrasound imag human coronari arteri vivo analysi tissu character comparison vitro histolog specimen background intravascular ultrasound imag perform patient coronari balloon angioplasti quantifi lumen atheroma crosssect area method result mhz ultrasound cathet insert mm plastic introduc sheath dilat area obtain realtim imag timessec ultrasound imag distinguish lumen atheroma calcif muscular media presenc dissect media atheroma visual observ tissu character compar vitro studi human atherosclerot arteri segment correl ultrasound imag histolog prepar result highqual intravascular ultrasound imag control vitro condit provid accur microanatom inform histolog characterist atherosclerot plaqu similar qualiti crosssect ultrasound imag obtain human coronari arteri vivo quantit analysi ultrasound imag clinic studi reveal crosssect lumen area balloon angioplasti mm residu atheroma area level prior dilat mm correspond arteri crosssect area segment coronari arteri angiograph normal ultrasound imag demonstr presenc atheroma involv mm area bound media conclus intravascular ultrasound sensit angiographi demonstr presenc extent atherosclerosi arteri calcif intracoronari imag balloon angioplasti reveal signific amount atheroma present part explain incid restenosi high percutan translumin coronari angioplasti"
"xanthin oxidas inhibit limit canin infarct size background evid support role xanthin oxidas myocardi reperfus injuri base studi pharmacolog intervent inhibit enzym function controversi exist true role xanthin oxidas reperfus injuri studi perform determin xanthin oxidas inhibit limit myocardi injuri due coronari arteri occlus reperfus method result anesthet dog underw coronari arteri occlus minut reperfus hour oxypurinol mgkg amflutizol mgkg chemic unrel inhibitor xanthin oxidas vehicl infus intraven minut hour reperfus region myocardi blood flow determin radiolabel microspher infarct size determin tetrazolium method myocardi infarct size percent risk region oxypurinoltr dog compar control group infarct size amflutizoletr dog signific control group differ ratepressur product collater blood flow account differ infarct size uric acid concentr coronari venous plasma increas reperfus dog treat vehicl drugtreat dog xanthin oxidas inhibit demonstr drug treatment group oxypurinol limit extent myocardi injuri conclus previous report cardioprotect effect allopurinol note occur drug administ chronic relat properti oxypurinol major metabolit allopurinol benefici effect oxypurinol unrel inhibit superoxid format xanthin oxidasecatalyz oxid xanthin hypoxanthin"
"pulmonari effect ischem limb reperfus evid role oxygenderiv radic object evalu lung reperfus target limb ischemiareperfus measur specif oxygen radic respons reperfus design pair simpl random continu interv data depend variabl continu nomin independ variabl subject intervent spraguedawley male rat anesthet hind limb occlud hr overnight ld alveolar lavag perform anim hr reperfus survivor hr reperfus group undos pretreat alphatocopherol antioxid mgkgday day ischemia measur main result luminolenhanc chemiluminesc measur phorbol myrist acetatestimul unstimul macrophag nanomol superoxid radic alveolar cellsmin measur cytochrom reduct assay signific student test timedepend increas respons cell ischemicreperfus rat pretreat antioxid effect hr signific differ hr survivor conclus studi show alveolar lavag cell macrophag reflect reperfus ischemicreperfus hind limb signific increas oxygen radic activ effect part suppress antioxidantdos survivor"
"adrenerg stimul renal prostanoid lyon hypertens rat young genet hypertens lyon lh rat exhibit increas renal vivo turnov norepinephrin elev urinari excret thromboxan compar normotens ln low blood pressur ll control effect norepinephrin phenylephrin renal function urinari excret prostanoid assess isol perfus kidney week lh ln ll rat addit effect norepinephrin assess thromboxan aprostaglandin receptor blockad ah drug infus lh kidney differ ln ll control elev renal vascular resist decreas natriuresi glomerular filtrat rate urinari output prostaglandin alpha ketoprostaglandin alpha thromboxan similar strain constrictor effect norepinephrin phenylephrin signific increas lh rat kidney compar ll ln control pressurenatriuresi mark reduc norepinephrin phenylephrin induc fold dosedepend increas synthesi prostanoid pronounc lh ln ll rat thromboxan ah infus signific reduc vascular effect norepinephrin increas natriuret respons lh ln ll rat kidney"
"kinet abnorm red blood cell sodiumproton exchang hypertens patient present studi design examin kinet na exchang red blood cell normotens hypertens subject relat previous report abnorm nali exchang na antiport activ kinet studi vari cell ph measur net na influx mmol cell hr unit driven outward gradient nali exchang determin ph sodiumstimul li efflux untreat hypertens patient higher maxim rate nali exchang versus unit higher maxim rate na exchang versus unit similar affin cell ph compar normotens subject cell ph activ na antiport exhibit lower hill coeffici normotens subject versus index occup intern regulatori site found reduc hypertens patient hypertens untreat treat hypertens patient nali exchang unit unit exhibit elev maxim rate na exchang unit ns comparison nali exchang unit unit group exhibit reduc hill coeffici hypertens patient enhanc na exchang activ unit normal maxim rate nali exchang"
"specif supersensit mesenter vascular bed dahl saltsensit rat dahl saltsensit ds saltresist dr rat maintain diet normal high salt day ds rat slight higher systol blood pressur dr rat high salt diet fail signific elev pressur group compar low salt diet control sensit isol perfus mesenter vasculatur ds rat fed high salt diet nerv stimul greater compar group presenc absenc cocain microm similar differ sensit high salt ds rat high salt dr rat bolus inject norepinephrin observ presenc cocain chang sensit character leftward shift doserespons curv chang maximum respons differ sensit high salt ds group treatment group observ respons pressor agent kcl angiotensin ii hydroxytryptamin depressor agent acetylcholin data ds rat shortterm high salt diet possess signific specif elev sensit nerv stimul norepinephrin absenc increas blood pressur differ effect cocain group suggest differ exist neuron uptak uptak"
"high nacl diet enhanc arteri baroreceptor reflex naclsensit spontan hypertens rat previous studi laboratori shown arteri baroreceptor reflex control lumbar sympathet nerv activ blunt naclsensit spontan hypertens rat shr compar naclresist spontan hypertens rat shr normotens wistarkyoto wki rat current studi effect dietari nacl supplement arteri baroreceptor reflex control lumbar sympathet nerv activ heart rate assess shr control shr wki rat male shr shr wki rat fed diet nacl begin week age studi age week arteri baroreceptor reflexmedi lumbar sympathet nerv activ heart rate record conscious unrestrain rat phenylephrineinduc microgramskgmin nitroprussideinduc microgramskgmin arteri pressur shr maintain nacl diet blunt baroreceptor reflex control lumbar sympathet nerv activ acut increas map compar shr wki rat ingest nacl diet blunt absent indic enhanc baroreceptor reflex control lumbar sympathet nerv activ shr maintain nacl diet blunt arteri baroreceptor control lumbar sympathet nerv activ nitroprussideinduc decreas arteri pressur compar wki rat signific alter ingest nacl diet"
"effect age coronari circul imposit pressureoverload rat examin effect pressur overload coronari circul young adult month rat month week ascend aorta band vivo left ventricular pressur measur estim degre pressur load age group similar increas peak left ventricular pressur observ mm hg shamoper rat versus mm hg band rat young adult group mm hg shamoper rat versus mm hg band rat group isol heart perfus tyrod solut bovin red blood cell albumin rest coronari perfus pressureflow relat reactiv hyperem respons ischemia obtain beat nonwork condit young adult band rat signific myocardi hypertrophi observ organ level control left ventricular dri weightbodi weight ratio left ventricular dri weighttibi length ratio cell level minim coronari vascular resist obtain perfus pressurepeak flow relat reactiv hyperemia increas control coronari flow reserv decreas signific contrast myocardi hypertrophi observ organ cell level band rat minim coronari vascular resist increas flow reserv decreas signific pressur overload coronari arteri hypertens caus abnorm coronari circul subject absenc myocardi hypertrophi"
"systol hypertens elder program shep part analysi shep random placebocontrol trial follow standard clinic trial principl analyz data relat propos hypothes protocol state priori main object secondari subgroup hypothes sampl size calcul shep account dropin dropout activ therapi risk nonstrok death sampl size achiev particip adequ address propos question monitor procedur establish data safeti monitor board procedur close data trial board period examin data determin termin studi warrant"
"arteri mechan properti dilat cardiomyopathi age respons nitroprussid effect age arteri mechan properti respons nitroprussid examin patient dilat cardiomyopathi highfidel pressur record multisensor cathet puls wave veloc determin sensor thorac aorta arteri complianc determin analysi diastol waveform cardiac output baselin similar system vascular resist pulsatil load arteri complianc wave transmiss characterist puls wave veloc alter age arteri complianc reduc older greater yr versus younger yr patient mlmmhg intermedi yr age mlmmhg posit correl age puls wave veloc nitroprussid infus decreas resist increas arteri complianc lower puls wave veloc group advanc age greater fall wave veloc fall aortic pressur slope relat puls wave veloc aortic diastol pressur progress increas age mmhg multipl linear regress analysi reveal signific relat age data demonstr older patient dilat cardiomyopathi left ventricl coupl arteri circul greater pulsatil load similar steadi load agerel arteri system affect hemodynam respons pharmacologicallyinduc vasodilat"
"diastol dysfunct hypertroph cardiomyopathi effect activ forc generat systol test hypothesi intracellular ca ca overload diastol dysfunct patient hypertroph cardiomyopathi myocardi tissu obtain time surgeri transplant patient hypertroph cardiomyopathi compar control myocardium obtain patient heart diseas isometr contract electrophysiolog properti myocardi specimen record standard techniqu ca measur bioluminesc calcium indic aequorin contrast control action potenti ca transient isometr contract relax mark prolong hypertroph myocardium ca transient consist distinct compon degre hz pace frequenc state relat ca overload develop produc rise enddiastol ca incomplet relax fusion twitch result decreas activ tension develop found drug increas ca digitali exacerb abnorm drug lower ca verapamil agent increas cyclic amp forskolin prevent result explain patient hypertroph cardiomyopathi toler tachycardia poor import implic regard pharmacolog treatment patient hypertroph cardiomyopathi"
"thrombosisrel marker unstabl angina pectori thrombus format implic pathogenesi unstabl angina thrombusrel marker distinguish unstabl stabl angina defin fibrin dimer plasminogen activ inhibitor prospect analyz peripher blood patient unstabl angina stabl angina normal coronari arteri baselin blood sampl drawn rest pain patient unstabl angina patient patient unstabl angina sd median valu fibrin dimer plasminogen activ inhibitor valu measur microgramml iu compar microgramml iuml patient control group ns comparison group recurr hospit pain coronari anatomi intervent show relat level marker addit patient unstabl angina control patient sampl coronari sinus peripher blood analyz patient unstabl angina sampl drawn rest pain patient sampl drawn coronari sinus peripher blood gradient marker demonstr differ peripher coronari sinus dimer plasminogen activ inhibitor concentr similar patient unstabl angina control patient"
"coronari vasodil impair hypertrophi nonhypertrophi myocardium patient hypertroph cardiomyopathi studi nitrogen ammonia positron emiss tomographi assess region coronari reserv hypertroph cardiomyopathi region myocardi blood flow measur patient hypertroph cardiomyopathi control subject nitrogen ammonia dynam positron emiss tomographi patient hypertroph cardiomyopathi baselin studi region myocardi blood flow mlmin hypertrophi mm interventricular septum mlmin versus septal flow nonhypertrophi mm left ventricular free wall statist valu control subject mlmin ns pharmacolog induc coronari vasodil dipyridamol mgkg intraven min region myocardi blood flow patient hypertroph cardiomyopathi increas signific control subject septum versus mlmin free wall versus mlmin addit patient hypertroph cardiomyopathi histori chest pain pronounc impair coronari vasodil reserv histori chest pain dipyridamol coronari resist septum decreas patient histori chest pain decreas histori coronari resist free wall decreas patient histori chest pain"
"mechan left ventricular systol dysfunct aortic regurgit import predict function respons aortic valv replac test hypothesi combin timevari elast concept convent circumferenti stressshorten relat elucid differenti mechan left ventricular systol dysfunct sever chronic aortic regurgit predict function respons aortic valv replac control patient patient aortic regurgit studi studi includ micromanomet left ventricular pressur determin biplan contrast cineangiogram control condit radionuclid angiogram control condit methoxamin nitroprussid infus atrial pace patient aortic regurgit classifi group group normal emax stressshorten relat group ii abnorm emax normal stressshorten relat group iii abnorm emax stressshorten relat left ventricular enddiastol endsystol volum show progress increas eject fraction show progress decreas group iii valu differ control patient group decreas left ventricular volum signific chang eject fraction versus aortic valv replac contrast group ii reduct left ventricular volum increas eject fraction final group iii reduct left ventricular volum decrement eject fraction group patient compens adequ chronic volum overload group ii left ventricular dysfunct increas left ventricular volumemass ratio compar control patient group suggest inadequ hypertrophi assumpt spheric geometri final irrevers myocardi dysfunct superven group iii conclus combin analysi left ventricular chamber perform timevari elast concept myocardi perform convent circumferenti stressshorten relat complementari inform elucid differenti mechan left ventricular systol dysfunct predict function respons aortic valv replac"
"impact orific geometri shape jet vitro doppler color flow studi investig influenc orific geometri dimension shape jet vitro doppler color flow studi perform jet form discharg blood round orific orific majorminor axi ratio repeat orific area cm turbul laminar jet form orific doppler color flow imag obtain orthogon scan plane align major minor orific axe jet width measur cm interv cm orific calcul jet eccentr ratio major minor axi width rate diverg jet wall jet observ diverg rapid wall align orific minor axi major axi differenti spread led develop circular symmetri short distanc orific jet diverg theta occur rapid turbul jet jet form larger orific theta orific area cm laminar jet turbul jet combin orific eccentr scan orient rang orific imag major axi circular orific orific imag minor axi jet eccentr decay approxim exponenti distanc orific rapid turbul jet slowli larger eccentr orific"
"patient age result balloon aortic valvuloplasti mansfield scientif registri experi mansfield scientif aortic valvuloplasti registri investig patient enrol mansfield scientif aortic valvuloplasti registri month balloon aortic valvuloplasti result compar patient greater equal year age time valvuloplasti assess aortic valv area index bodi surfac area stenosi sever older patient incid congest heart failur greater age greater equal year result valvuloplasti compar age group index final valv area signific group hospit mortal rang complic signific group total month mortal perform registri studi balloon aortic valvuloplasti produc similar result older younger patient initi sever diseas older patient"
"drug respons electropharmacolog studi patient ventricular tachyarrhythmia import ventricular refractori clinic electrophysiolog predictor success antiarrhythm drug therapi patient induc ventricular tachycardia evalu consecut patient undergo serial electropharmacolog trial structur heart diseas frequent present patient effect therapi found presenc coronari arteri diseas histori prior myocardi infarct signific frequent present patient antiarrhythm drug therapi found correct qt interv ventricular effect refractori period measur pace cycl length ms signific shorter respond compar nonrespond qt interv versus ms ventricular effect refractori period versus ms addit interelectrogram coupl interv ventricular extrastimulus initi ventricular tachycardia signific shorter respond compar nonrespond versus ms logist regress analysi identifi short ventricular interelectrogram coupl interv absenc prior myocardi infarct independ predictor antiarrhythm drug suppress induct ventricular tachycardia greater druginduc increment ventricular effect function refractori period observ respond nonrespond shortest ventricular interelectrogram coupl interv baselin electrophysiolog measur identifi patient induc ventricular tachycardia respond antiarrhythm drug therapi patient demonstr greater druginduc electrophysiolog"
"tricuspid valv dysplasia displac intrauterin life case structur heart diseas diagnos prenat fetus dysplast displac tricuspid valv tricuspid valv dysplast fetus evid tricuspid regurgit result atrial dilat increas cardiothorac ratio abnorm pulmonari valv occur fetus remain fetus ebstein malform evid tricuspid incompet present abnorm pulmonari valv case pregnanc interrupt spontan intrauterin fetal death occur infant die postnat infant aliv addit abnorm found case chromosom anomali ventricular septal defect correct transposit chiari malform supraventricular tachycardia case coarctat aorta fetus sever abnorm select fetal echocardiographi chamber screen program high rate natur loss intrauterin life immedi birth observ case pregnanc continu explain higher incid tricuspid valv diseas prenat compar postnat seri increas cardiothorac ratio lesion ventricular outflow tract contribut poor outcom case detect prenat absenc featur good prognosi progress diseas occur advanc gestat age absolut measur singl echocardiograph featur emerg consist predict factor prognosi"
"antiischem effect atenolol versus nifedipin patient coronari arteri diseas ambulatori silent ischemia antiischem effect atenolol nifedipin compar random doubleblind crossov manner patient stabl exert angina transient silent ischemia ambulatori electrocardiograph ecg monitor atenolol nifedipin effect reduc averag number durat transient ischem event therapi atenolol signific greater reduct number durat silent ischem event analys silent ischem activ morn hour reveal therapi atenolol produc signific reduct averag durat patient averag durat silent ischemia event noon  fewer advers experi therapi atenolol result show atenolol nifedipin effect reduc silent ischem event treatment atenolol signific greater efficaci morn surg silent myocardi ischemia"
"ventricular electrogram record diagnosi arrhythmia precipit electr devic shock therapi antitachycardia pacemakercardioverterdefibril capabl store ventricular electrogram deliveri devic shock therapi implant patient patient experienc hospit devic shock therapi preced minim symptom limit electrogram analysi exist discuss care analysi registr electrogram supraventricular ventricular rhythm observ hospit test serv import refer subsequ arrhythmia diagnosi analyz electrogram rate rr interv stabil configur definit diagnosi establish patient atrial fibril polymorph ventricular tachycardia ratesens lead disrupt abil store ventricular electrogram shock therapi repres major advanc manag patient receiv electr devic treat ventricular tachyarrhythmia"
"case find data qualiti aspect compar myocardi infarct regist result south german regist studi populationbas augsburg coronari event regist resid age year regist total case acut myocardi infarct ami ami categor basi current diagnost algorithm ami regist design longitudin comparison annual ami risk incid attack rate death rate risk ami patient day case fatal methodolog specif issu encount registr data evalu estim complet case find qualiti control data review regist conduct annual show consist specif data structur stabl case find valid procedur local condit affect case find data complet case respons creation subset ami turn distinguish differ diagnost categori structur regard studi object differ subset effect rate calcul definit ami combin implic methodolog variat subset differ regist annual rate calcul result comparison discuss"
"sequenti fix sampl trial design case studi stochast simul properti wilcoxon rank sum test fix sampl size wilcoxontyp sampl sequenti test illustr compar stochast simul data real fix sampl trial resampl origin data construct ideal theoret distribut sequenti fix sampl test obtain equal power sequenti test includ fewer patient reach conclus median number patient includ lower fix sampl size hypothes small fraction simul run exceed fix sampl size find exemplifi result obtain theoret analys simul studi cover wide rang distribut opinion sequenti test obvious advantag case altern fix sampl test clinic trial"
"inabl demonstr physiolog correl subject improv patient taught relax respons object assess regular elicit relax respons produc sustain physiolog coincid symptomat relief improv psycholog state design prospect cohort pilot studi set clinic research center teach hospit patient thirteen athlet men age year borderlin labil hypertens medic complet studi intervent baselin assess psycholog state symptom checklist assess autonom respons infus beta agonist isoproterenol daili relax respons exercis consecut week repeat assess paramet discontinu relax exercis subsequ week repeat assess paramet measur main result elicit relax respons subject demonstr signific decreas anxieti somat symptom psycholog somat variabl return baselin subsequ discontinu relax exercis signific concomit chang urinari catecholamin heart rate respons isoproterenol blood pressur puls rate serum cholesterol demonstr conclus regular elicit relax respons improv psycholog perform reduc symptom physiolog mechan psycholog symptomat improv occur remain poor understood warrant investig"
"cardiac perform infant refer extracorpor membran oxygen perform cardiac evalu infant refer sever lung diseas determin cardiac perform impair requir extracorpor membran oxygen ecmo infant divid group group receiv convent therapi group receiv ecmo therapi meet establish criteria ventilatori oxygen index estim ventricular systol pressur measur loaddepend loadindepend echocardiograph index cardiac perform measur infant group similar diagnos age weight inotrop support ventil oxygen index admiss surviv heart rate estim preload afterload similar group ventricular shorten fraction group group signific veloc circumferenti fiber shorten vcfsec group group signific relationship wall stress ventricular shorten similar group differ cardiac output pulmonari arteri pressur estim mm hg group mm hg group signific differ found loaddepend loadindepend measur cardiac perform infant sever lung diseas treat ecmo convent therapi conclud cardiac failur primari clinic deterior infant sever lung diseas requir ecmo therapi"
"abdomin aortic aneurysm result famili studi data pertain abdomin aortic aneurysm degre relat patient abdomin aortic aneurysm present percentag famili affect degre relat proband multiplex famili multiplex famili parentoffspr transmiss abdomin aortic aneurysm note remain famili sibl affect age onset proband year affect year statist signific differ age onset gender note affect sibl proband sex ratio malefemal signific relat risk develop abdomin aortic aneurysm father mother brother sister"
"revascular ischem limb muscl pedicl flap rabbit model rabbit model hind limb ischemia design demonstr hemodynam signific arteri connect develop ischem skelet muscl independ perfus muscl pedicl flap common iliac arteri divid rabbit rabbit muscl flap base left deep inferior epigastr arteri transpos thigh flap group rabbit sham oper perform flap sutur abdomin wall sham group day angiographi demonstr arteri connect flap nativ limb circul flap group anim flap increas muscl perfus ischem limb ml gm muscleminut flap group ml gm muscleminut sham group hemodynam signific vascular connect develop perfus muscl flap ischem limb augment perfus provid connect quantifi"
"limit magnet reson imag ultrasounddirect duplex scan diagnosi subclavian vein thrombosi investig potenti role magnet reson imag duplex scan diagnosi catheterinduc subclavian vein thrombosi correl result arm phlebogram duplex scan phlebogram correl magnet reson imag scan thorac vein eighteen phlebogram normal normal magnet reson imag duplex studi eleven subclavian vein total occlud phlebographi duplex scan scan magnet reson imag duplex scan detect occlus magnet reson imag detect occlus scan occlus detect magnet reson imag duplex scan short segment occlus medial left subclavian vein nonocclus thrombi phlebographi duplex scan correct identifi magnet reson imag nonocclus thrombi identifi abnorm find duplex scan magnet reson imag confirm phlebographi short occlus proxim portion left subclavian vein undetect duplex scan occasion magnet reson imag modal sensit presenc nonocclus mural thrombi magnet reson imag high reliabl rule presenc thrombot process subclavian vein occas fail detect presenc subclavian thrombi reason case suspect subclavian vein thrombosi magnet reson imag diagnost modal"
"skewflap versus long posterior flap knee amput multicent trial multicent trial altern techniqu knee amput surgeon center random patient endstag occlus vascular diseas method stump construct skewflap techniqu perform long posterior flap perform group match respect age sex smoke diabet indic amput earli outcom compar term day mortal rate skew death versus long posterior flap state wound week primari heal group surgic revis level versus revis higher level versus follow inform month record mail questionnair month die interv show prosthet limb fit skew flap long posterior flap walk support achiev differ reach statist signific conclud skew flap effect long posterior flap excel option knee amput"
"suggest standard report arteri aneurysm subcommitte report standard arteri aneurysm ad hoc committe report standard societi vascular surgeri north american chapter intern societi cardiovascular surgeri literatur arteri aneurysm subject potenti misinterpret inconsist report standard joint council societi vascular surgeri north american chapter intern societi cardiovascular surgeri appoint ad hoc committe address issu communic prepar respons standard report defin classifi arteri aneurysm recommend standard describ manifest treatment outcom criteria import publish data aneurysm diseas"
"antihypertens therapi stop stop benefit continu antihypertens therapi extens document lack complianc prescrib regimen excess cost troublesom advers effect antihypertens agent led intermitt therapi complet discontinu therapi effect altern lifelong medic prospect studi deal subject report inconsist result identifi select criteria candid step discontinu antihypertens therapi candid includ patient mild essenti hypertens characterist young age normal bodi weight low salt intak alcohol consumpt low pretreat blood pressur success therapi drug minim sign target organ damag stop antihypertens therapi subsequ rise arteri pressur shown subset patient mild essenti hypertens period month year approach safe provid blood pressur monitor frequent improv complianc save treatment cost reduc advers effect drug longterm consequ morbid mortal remain determin"
"comparison level anticoagul therapi patient substitut heart valv cardiac valv replac patient blind random group receiv aspirin mg dipyridamol mg daili oral anticoagul acenocoumarol sintrom intern normal ratio assign group group group subsequ analyz thromboembol hemorrhag complic final evalu includ patient follow month group monthspati month group monthspati frequenc thromboembol equal group transient ischem attack group rate patientyear transient ischem attack group rate patientyear statist differ bleed complic group patient bled group rate patientyear repres incid episod year treatment patient bled group rate patientyear repres incid episod year treatment conclud intern normal ratio safer ratio confer good protect thromboembol oral anticoagul therapi conjoint platelet functioninhibit drug patient mechan substitut heart valv"
"analysi predictor pulmonari vascular resist cardiac transplant elev pulmonari vascular resist risk factor earli death acut ventricular failur orthotop cardiac transplant patient elev pulmonari vascular resist due primarili increas left atrial pressur reactiv frequent normal resist transplant studi detail time magnitud analyz respons pulmonari vascular resist cardiac transplant analyz data heart catheter patient undergo cardiac transplant jan  transplant patient pulmonari vascular resist greater wu pulmonari arteri systol pressur greater mm hg transpulmonari gradient greater mm hg group patient pulmonari vascular resist wu transpulmonari gradient mm hg pulmonari arteri systol pressur mm hg normal week cardiac transplant patient high preoper pulmonari vascular resist greater equal wu resist fell prompt week transplant continu slight elev period follow multipl regress analysi pulmonari vascular resist week year transplant signific correl pretransplant resist pulmonari vascular resist anytim transplant relat preoper resist bodi surfac area pulmonari arteri diastol pressur infer group cardiac transplant recipi normal pulmonari vascular resist transpulmonari gradient pulmonari arteri systol pressur week transplant chang year patient revers elev pulmonari vascular resist cardiac transplant typic reactiv fix compon cardiac transplant reliev reactiv fix compon result pulmonari vascular resist earli week late transplant fallen complet normal"
"mechan heart failur caus cardiac allograft reject reject cardiac allograft revers myocardi failur mechan understood examin phenomenon small anim model opportun multimod studi reject process heterotop cardiac transplant perform lewi rat lewi brownnorway allograft lewi isograft donor immunosuppress allograft complet reject day day cardiac graft explant mount modifi langendorff apparatus function measur submit patholog examin biochem determin highenergi phosphat day isograft minim histolog patholog examin day allograft show lymphocyt infiltr myocyt necrosi histolog featur antireject treatment clinic graft subject function studi heart rate cardiac output coronari flow stroke work determin baselin respons isoproterenol molml day allograft isograft similar baselin function chronotrop respons isoproterenol similar allograft isograft allograft diminish cardiac output stroke work isoproterenol adenosin triphosph level normal nmolmg day allograft evalu function biochem patholog myocardi dysfunct heterotop cardiac transplant reject small anim model reproduc demonstr diminish contractil reserv day allograft normal baselin function highenergi store histolog signific reject"
"mitral valv repair replac chorda tendinea polytetrafluoroethylen sutur expand polytetrafluoroethylen sutur replac diseas chorda tendinea reconstruct procedur mitral valv patient men women age year rang fourth patient york heart associ class iii iv replac primari chorda tendinea anterior leaflet perform polytetrafluoroethylen sutur doublearm sutur pass fibrous portion papillari muscl head tie arm sutur brought free margin leaflet pass area nativ chorda attach length arm adjust end tie ventricular side leaflet thirti patient degen diseas mitral valv incompet due prolaps anterior leaflet patient prolaps anterior posterior leaflet eleven patient rheumat mitral valv diseas stenosi regurgit mix lesion patient ischem mitral regurgit caus ruptur papillari muscl head oper death patient month doppler echocardiograph studi perform regular interv oper reveal normal mitral valv function patient failur necessit mitral valv replac acut mitral regurgit hemolysi late death valv relat replac chorda tendinea polytetrafluoroethylen sutur simpl reconstruct mitral valv patient requir mitral valv replac patient limit time longterm result procedur remain unknown"
"alcohol pyruv cardioplegia twentyhour situ preserv hamster heart isol hamster heart perfus normal krebshenseleit medium demonstr compar viabil heart perfus store hour solut solut physiolog salin pyruv substrat alcohol arrest heart group standard cardiopleg solut group alcoholfre physiolog salin pyruv substrat group recoveri term ratepressur product oxygen consumpt minut reperfus group group group percent physiolog recoveri relat recoveri adenosin triphosph adenosin triphosph level return approxim control level group group inorgan phosphat remain approxim control level minut reperfus phosphocreatin level signific higher group group result improv oxygen consumpt intracellular ph determin phosphor nuclear magnet reson spectroscopi physiolog group alkalin group alkalin caus leaki membran pyruv preserv mitochondri function depress oxygen deliveri hour storag period percent alcohol arrest heart combin pyruv alcohol solut standard cardiopleg solut maintain function capabl"
"dynam antegrad cardioplegia simultan coronari sinus occlus effect aortic root infus pressur coronari sinus pressur myocardi cool suggest antegrad cardioplegia coronari sinus occlus improv homogen myocardi cool reduc myocardi injuri presenc coronari arteri occlus data exact relationship basic element intervent includ antegrad infus rate aortic root pressur degre coronari sinus occlus coronari sinus pressur myocardi cool purpos studi determin relationship provid basic guidelin understand intervent twenti sheep cardiopulmonari bypass distal left anterior descend arteri occlud proxim coronari sinus snare sixteen combin infus rate mlkgmin coronari sinus occlus total subtot moder occlus occlus adopt minut antegrad cardioplegia yield measur myocardi temperatur occlud nonocclud region aortic root infus pressur coronari sinus pressur measur infus cardiopleg solut coronari sinus occlus releas heart reperfus minut infus cardiopleg solut measur result show good degre linear infus rate aortic root infus pressur coronari sinus occlus noninfus group posit effect coronari sinus occlus aortic root infus pressur observ grade increas infus rate degre coronari sinus occlus constant elev coronari sinus pressur note myocardi temperatur region occlud left anterior descend arteri signific lower coronari sinus occlus group nonocclus group myocardi temperatur nonocclud region decreas signific stepwis increas infus rate increas coronari sinus occlus signific base previous studi recommend induc coronari sinus pressur safe maintain rang mm hg studi focus infus rate mlkgmin subtot total coronari sinus occlus intervent antegrad cardioplegia coronari sinus occlus"
"freehand allograft aortic valv replac aortic root replac util intraop echocardiographi doppler color flow map seventeen consecut patient undergo plan aortic valv replac allograft valv stanford univers medic center studi intraop epicardi echocardiographi doppler color flow map cardiopulmonari bypass nativ aortic valv replac patient patient underw aortic valv procedur patient allograft select guid prebypass echocardiograph estim annular diamet length allograft aortic root requir prebypass find includ unanticip sever mitral regurgit patient preclud allograft aortic valv replac left shunt patient ascend aortic dissect aortic root diseas necessit coronari reimplant bypass postbypass echocardiographi demonstr accept compet allograft valv mild aortic insuffici postbypass echocardiographi document success repair shunt mild mitral regurgit patient versus bypass conclus intraop echocardiographydoppl map adjunct allograft aortic valv aortic root replac confid select tissu size aortic cross clamp minim delay allograft thaw procedur inform extent aortic root diseas coronari ostial anatomi bypass confirm allograft compet bypass detect accompani valvular hemodynam lesion allograft valv replac"
"depriv infanc adult life import mortal risk previous ecolog studi suggest earli life factor import adult cardiovascular respiratori diseas show geograph correl past infant mortal rate present adult mortal rate studi inadequ account fact area sever depriv earlier centuri remain depriv today ecolog relat infant adult mortal rate simpli reflect persist geograph distribut poor socioeconom circumst explor hypothesi infant mortal rate counti england wale correl specif adult mortal peopl age year adjust presentday social depriv social class strong simpl correl found infant mortal adult mortal general attenu abolish control indic presentday socioeconom circumst result suggest previous studi give strong support direct influenc factor act earli life adult coronari heart diseas mortal risk studi gather data infanc childhood full adult life requir clarifi issu"
"raynaud syndrom rang therapi patient raynaud syndrom common medic problem approach diagnosi involv search treatment includ avoid precipit factor biofeedback possibl pharmacolog therapi care risk"
"heart transplant patient sever pulmonari hypertens increas pulmonari vascular resist irrevers increas pulmonari vascular resist contraind cardiac transplant hospit patient refer recipi evalu systol pulmonari arteri pressur greater mmhg pulmonari vascular resist greater wood unit wu test intraven sodium nitroprussid revers patient increas systol pulmonari arteri pressur mmhg resist wu reduc nitroprussid orthotop heart transplant perform earli mortal heart catheter transplant reveal signific persist fall elev pulmonari arteri pressur pulmonari vascular resist conclud sever pulmonari hypertens elev pulmonari vascular resist revers nitroprussid patient safe undergo heart transplant"
"ultrastructur rat heart cold cardiopleg ischemia differ durat differ mode reperfus morpholog consequ prolong global hypotherm degre cardiopleg ischemia reperfus techniqu studi langendorffperfus rat heart gentl reperfus techniqu gradual rise perfus temperatur pressur physiolog level min heart hour hour group ischemia abrupt reperfus perfus degre mmhg perform heart ischem hour hour nonischem perfus heart serv control random select specimen left ventricl min reperfus prepar transmiss electron microscopi volum fraction myocardi structur compon calcul stereolog pointcount electron micrograph analysi varianc reveal interstiti edema develop increas ischem time influenc reperfus techniqu degre endotheli damag independ ischem time lessen gentl reperfus mitochondri injuri myocyt edema perfus temperatur pressur slowli rais hour ischemia"
"coronari trap complement activ product ca desarg myocardi reperfus openheart surgeri accumul complement factor found occur myocardium infarct studi possibl complement activ product ca desarg trap coronari circul reperfus ischem myocardium patient undergo routin coronari arteri bypass graft arteri blood sampl cardiopulmonari bypass blood drawn coronari sinus concomit arteri blood sampl min releas aortic crossclamp preoper ngml ca desarg rose cpb maximum end cpb reperfus min ca desarg ngml arteri coronari sinus blood signific differ amount ca desarg trap heart min reperfus show posit correl arteri concentr signific differ found min reperfus complement activ product trap heart earli reperfus period play pathogenet role myocardi ischemiareperfus injuri"
"subacut poison phosalon organophosph insecticid ill character weak dizzi gastrointestin symtom identifi crew migrant fieldwork employ grape grower madera counti california august onset symptom occur august august median day date employ crew member sought medic treatment august crew member admit hospit august august worker gastrointestin constitut symptom resolv short admiss patient episod sever sinus bradycardia persist day day admiss transient atrioventricular dissoci develop person interview crew member admit hospit identifi addit worker ill gastrointestin symptom moder sever inhibit plasma red blood cell cholinesteras worker test interview cholinesteras depress crew exposur august organophosph insecticid phosalon appli vineyard juli day earlier report unequivoc link phosalon fieldwork poison delay onset nonspecif natur symptom subacut poison hinder recognit previous similar episod"
"develop cardiopulmonari resuscit revis american heart associ guidelin develop clinic import occur field cardiopulmonari resuscit includ enhanc access earlier defibril highdos epinephrin standard dose fail assess resuscit effort endtid monitor addit drug amiodaron refractori ventricular fibril adenosin paroxysm supraventricular tachycardia time determin ultim role advanc manag cardiac arrest"
"late streptokinas infus antithrombot treatment myocardi infarct reduc subsequ myocardi ischemia consecut patient acut myocardi infarct elig attempt late thrombolysi random assign thrombolyt antithrombot treatment treatment group routin treatment control group patient treatment group receiv streptokinas initi late hour rang onset symptom heparin infus day warfarin dipyridamol month patient examin clinic bicycl ergometri discharg hospit month group differ respect death reinfarct trend lower incid angina pectori treatment group exercis toler group signific higher control group month differ account patient previous histori infarct angina pectori month ecg sign myocardi ischemia silent symptomat occur signific lower level exercis patient control group compar patient treatment group result support notion thrombolyt therapi late hour onset symptom reduc incid residu ischemia postinfarct period"
"region endocardi surfac expans coronari occlus canin left ventricl disproportion effect anterior versus inferior ischemia exact time onset function expans acut myocardi infarctionischemia remain unclear spite potenti link chronic patholog infarct expans potenti implic therapi examin earli chang ventricular morpholog openchest dog studi dimension echocardiographi occlus minut left anterior descend coronari arteri lad circumflex arteri circ endocardi surfac area esa area abnorm wall motion awm reconstruct echocardiograph data previous report techniqu quantit map esa extent awm total group esa occlus cm increas cm minut occlus lad subgroup esa occlus cm increas cm minut occlus circ subgroup esa occlus cm increas cm minut occlus esa increas lad subgroup signific larger circ subgroup lad rang cm versus circ rang cm coronari occlus result similar size region awm subgroup lad cm versus circ cm lad group largest increas endocardi circumfer occur zone awm apex endocardi surfac area expand immedi coronari occlus magnitud process primarili relat site anteroap extent awm"
"detect myocardi infarct presenc wolffparkinsonwhit syndrom qrst isoarea map dog possibl detect myocardi infarct mi presenc wolffparkinsonwhit wpw syndrom bodi surfac qrst isoarea map studi dog eighti bodi surfac ecg record simultan record atrial ra atrial ventricular ra rv sequenti pace simul wpw syndrom control period hour interv hour occlus left anterior descend coronari arteri ecg ra drive diagnost find mi abnorm wave observ obscur ra rv drive contrari qrst valu anterior chest drive posit coronari occlus decreas gradual time pass abnorm negat hour qrst isoarea map ra ra rv pace show similar pattern high correl studi greater find demonstr local abnorm result mi evid qrst isoarea map presenc preexcit fusion"
"acut reduct mitral valv area percutan balloon mitral valvuloplasti assess doppler continu equat method mitral valv area balloon mitral valvuloplasti serial determin doppler continu equat method patient ultrasound examin perform immedi balloon inflat hour week month valvuloplasti mitral valv area determin doppler continu equat method correl determin catheter gorlin formula immedi balloon inflat standard error estim cm serial calcul mitral valv area doppler continu equat method show slight signific decreas valv area hour balloon mitral valvuloplasti chang conclud doppler continu equat method accur estim mitral valv area balloon valvuloplasti mitral valv area dilat balloon inflat decreas slight hour procedur corrobor valv stretch mechan increas mitral valv area balloon valvuloplasti estim mitral valv area immedi balloon mitral valvuloplasti overestim longterm efficaci procedur"
"acut hemodynam effect intraven diperdipin dihydropyridin deriv coronari heart diseas acut hemodynam effect dihydropyridin calcium channel blocker diperdipin suitabl intraven administr studi left cardiac catheter patient coronari heart diseas diperdipin mark reduc system vascular resist improv stroke index left ventricular eject fraction pulmonari arteri wedg pressur slight increas consequ enhanc venous return atrial left ventricular enddiastol pressur signific chang increas preload augment left ventricular enddiastol volum index administr diperdipin left ventricular contractil estim endsystol pressurevolum ratio dpdt max signific chang analysi individu data suggest minim negat inotrop effect minor effect left ventricular contractil larg counterbalanc mark reduct afterload produc sharp improv stroke index enhanc left ventricular eject fraction reduct system vascular resist invers direct correl control valu diperdipin toler patient major untoward reaction consist ischem episod possibl relat drug administr conclus intraven diperdipin potent arteriolar dilat agent affect left ventricular contractil"
"ultra shortact intraven betaadrenerg blockad add therapi acut unstabl angina assess efficaci safeti ultra shortact betablock agent esmolol acut unstabl angina administ esmolol patient persist angina convent medic therapi baselin doppler echocardiograph examin esmolol titrat reduc ratepressur product patient receiv mainten dosag minut doppler echocardiograph studi repeat esmolol dose target respons mgmin dosag rang mgmin esmolol effect allevi angin chest pain patient patient eventu underw percutan translumin coronari angioplasti ptca coronari bypass surgeri remaind discharg receiv medic therapi includ oral betablockad esmolol therapi heart rate blood pressur decreas signific beatsmin mm hg cardiac output decreas min secondari decreas heart rate stroke volum remain unchang left ventricular eject fraction increas esmolol therapi chang statist signific fill fraction ratio ratio earlyl diastol fill veloc increas esmolol therapi indic improv left ventricular diastol function"
"improv systol diastol left ventricular wall motion serial echocardiogram select patient treat unstabl angina purpos studi evalu effect antiischem treatment left ventricular function select patient unstabl angina pectori due sever proxim left anterior descend coronari arteri narrow identifi subgroup liabl advers outcom term year effect antiischem treatment systol diastol left ventricular wall motion studi patient unstabl angina pectori electrocardiogram sever proxim left anterior descend coronari arteri narrow treatment consist revascular procedur patient antiangin drug therapi patient patient underw dimension echocardiograph studi hour hour entri studi studi semiquantit analyz systol perform ischemiarel segment calcul total wall motion score patient investig combin continu detail record apic interventricular septal wall motion detail studi includ measur region function provid typif pattern systol earli diastol excurs endocardi border apic interventricular septum repeat ultrason studi perform month median month day admiss result systol wall motion analys patient show treatment group signific improv systol wall motion anterior apic segment total wall motion score earli studi late studi revascular medic therapi"
"identif ratedepend function refractori period atrioventricular node simul atrial fibril continu observ success pair interv atrial fibril hypothes shortest interv preced interv pair repres function refractori period atrioventricular node preced interv test hypothesi simul atrial fibril isol crossperfus canin heart obtain interv scatterplot plot interv function immedi preced interv scatterplot enabl detect seri shortest interv wide rang preced interv estim ratedepend function refractori period atrioventricular node simul atrial fibril estim function refractori period correl measur convent method conclud propos method make estim ratedepend function refractori period atrioventricular node atrial fibril"
"septal ventricular pace immatur canin heart perspect cardiac pace initi epicardi transven apic ventricular electrod asynchron ventricular contract alter myocardi stress vector result advers cellular subcellular experiment anim clinic contribut advers hemodynam report longterm ventricular pace determin feasibl direct stimul ventricular special conduct system potenti mainten normal depolar pattern beagl puppi studi baselin ventricular activ contract pattern obtain intracardiac electrogram multig nuclear acquisit muga imag septal electrod insert aortoatri groov accomplish dimension echocardiographi continu electrocardiograph ecg monitor surfac ecg pacemak implant puppi standard ventricular epicardi electrod implant addit anim remain agematch pace control month observ repeat muga imag intracardiac electrogram demonstr normal biventricular activ contract pattern septalpac group histopatholog examin illustr normal cellular morpholog septalpac anim studi demonstr pace electrod insert proxim interventricular septum feasibl result util normal ventricular conduct pathway approach initi ventricular stimul attenu advers effect longterm ventricular pace"
"noninvas estim left atrial pressur patient congest heart failur mitral regurgit doppler echocardiographi complet noninvas method estim left atrial pressur patient congest heart failur mitral regurgit devis continuouswav doppler echocardiographi brachial sphygmomanometri patient studi mitral regurgit jet distinct doppler spectral envelop record peak ventriculoatri gradient obtain measur peak mitral regurgit veloc systol modifi bernoulli equat gradient subtract peak brachial systol blood pressur estim left ventricular systol pressur yield left atrial pressur left atrial pressur systol blood pressur mitral regurgit pressur gradient noninvas estim left atrial pressur patient plot simultan record pulmonari capillari wedg pressur result correl standard error estim mm hg continuouswav doppler echocardiographi sphygmomanometri select patient congest heart failur mitral regurgit noninvas estim left atrial pressur"
"myocardi imag tcm teboroxim techniqu initi result studi examin result tcm teboroxim imag patient age year compar result thallium exercis rest teboroxim studi obtain hour dose mcistudi short wash halflif teboroxim imag begun minut inject spect planar imag obtain spect protocol modifi chang number frame time frame filter reconstruct imag planar imag obtain supin upright posit shorter acquisit time spect secfram butterworth filter frequenc cutoff cyclecm power yield imag qualiti close agreement thallium result identifi abnorm normal perfus pattern vascular territori scan abnorm techniqu patient normal patient discord patient tcm teboroxim myocardi imag feasibl rest exercis spect planar imag shorter acquisit time filter spect imag upright posit planar imag improv imag qualiti conveni patient"
"futur direct vasodil therapi heart failur vasodil therapi major pharmacolog approach improv left ventricular function vasodil drug increas treatment heart failur ideal vasodil drug longterm manag heart failur show defin pharmacodynam effect includ reduc imped left ventricular eject increas venous capacit increas left ventricular eject fraction reduc heart size absenc neurohormon stimul slow progress left ventricular dysfunct mechan action site activ vasodil drug vari prove ideal treatment heart failur hypertens complex surround multipl vasoconstrictor mechan involv heart failur led rational combin vasodil therapi combin discuss therapeut standpoint develop drug multipl mechan action attract flosequinan vasodil agent cellular mechan action remain uncertain flosequinan advantag relax arteri venous bed benefici treatment heart failur"
"clinic efficaci flosequinan heart failur effect arteri venous vasodil flosequinan evalu varieti group patient chronic heart failur flosequinan improv central hemodynam effect heart failur group benefit appar hour singl oral dose group improv calf blood flow blood flow skelet muscl number test improv exercis perform patient group improv exercis toler produc similar captopril flosequinan properti drug benefit treatment patient chronic heart failur"
"earli benefici effect streptokinas left ventricular function acut myocardi infarct effect intraven streptokinas therapi time function recoveri investig control studi patient random hour onset acut myocardi infarct ami contrast ventriculographi perform day ami repeat week wall motion analyz centerlin method central infarct peripher infarct noninfarct region patient ventriculograph data earli catheter streptokinasetr patient sever hypokinesia central infarct region control patient standard deviat normal benefit streptokinas mark peripher infarct region result eject fraction slight higher treat versus control group differ signific week function streptokinas control group diverg continu improv streptokinasetr patient studi show streptokinas benefit left ventricular lv function day ami earlier previous report benefit limit peripher infarct region ischemia sever central infarct region implic thrombolyt therapi improv lv function period myocardi stun myocardi function recov"
"effect nisoldipin myocardi ischemia exercis daili activ antiischem properti nisoldipin dihydropyridin calcium antagonist assess multicent doubleblind placebocontrol trial repeat exercis test hour ambulatori electrocardiograph monitor patient coronari arteri diseas patient posit treadmil stress test result greater equal ischem episod hour includ studi administr chronic antiischem medic beta blocker discontinu week patient receiv placebo daili week patient receiv nisoldipin mg patient receiv placebo daili placebo group exercis paramet ambulatori electrocardiograph paramet nisoldipin group exercis durat increas time mm st depress increas time pain increas maxim st depress reduc mm ambulatori electrocardiograph paramet nisoldipin group number episod reduc patient signific reduct total ischem time minut patient signific side effect observ largest clinic trial date effect nisoldipin myocardi ischemia result nisoldipin effect improv exercis paramet partial effect suppress ischemia daili activ"
"blood lactat predictor shock develop acut myocardi infarct publish erratum cardiol apr data obtain analyz patient admit coronari care unit novemb juli patient classifi group patient mild left ventricular failur killip class ii hospit stay group patient killip class ii admiss develop cardiogen shock hospit group ii discrimin function analysi perform variabl patient age histori previous myocardi infarct diabet mellitus blood lactat urea creatinin creatin kinas aspart aminotransferas lactat dehydrogenas concentr chest ray cardiothorac ratio variabl found signific discrimin group patient age previous infarct ray cardiothorac ratio blood urea lactat concentr risk index comput blood lactat variabl greatest predict power shock develop sensit specif predict risk index cutoff point calcul cutoff sensit specif posit predict negat predict cutoff sensit specif posit predict negat predict"
"capabl supin exercis electrocardiographi versus exercis radionuclid angiographi predict coronari event abil supin exercis electrocardiographi exercis radionuclid angiographi predict time subsequ cardiac event cardiac death nonfat myocardi infarct late coronari bypass graft angioplasti compar patient normal rest electrocardiogram digoxin patient undergon coronari catheter initi treat medic follow studi perform median month separ logist regress model previous develop predict vessel left main coronari arteri diseas cad compar cox regress analysi predict time subsequ cardiac event exercis electrocardiographi model consist magnitud st depress exercis heart rate patient gender power predictor chisquar subsequ event exercis radionuclid angiographi model includ exercis respons pressurevolum ratio addit exercis electrocardiographi variabl similar prognost power chisquar separ analysi cardiac death nonfat myocardi infarct exercis electrocardiographi model remain signific predictor event chisquar radionuclid angiographi variabl ad signific prognost power exercis electrocardiographi model patient normal rest electrocardiogram digoxin supin exercis electrocardiographi model predict vessel left main cad predict futur cardiac event exercis radionuclid angiographi provid addit prognost inform patient"
"relat cardiac output rest exercis age essenti hypertens suggest declin cardiac output age due increas preval diseas occult coronari arteri diseas relat cardiac output direct oxygen fick method age analyz sixteen year men world health organ stage ii essenti hypertens time hemodynam studi aliv free cardiovascular complic year supin seat rest upright bicycl exercis peak work load cardiac output invers relat age relat independ weight intraarteri pressur stroke volum decreas advanc age supin rest rest exercis seat posit heart rate affect age supin posit slower older patient upright rest peak exercis conclus patient essenti hypertens remain free cardiovascular complic year cardiac output independ invers relat age level activ find suggest occult cardiovascular diseas explain declin cardiac output age patient essenti hypertens"
"comparison effect guanadrel sulfat propranolol blood pressur function capac serum lipoprotein glucos system hypertens control doubleblind crossov studi effect guanadrel sulfat propranolol blood pressur bp select cardiopulmonari metabol variabl compar physic activ moder hypertens subject guanadrel sulfat reduc systol diastol bp rest mm hg maxim exercis mm hg affect submaxim oxygen consumpt vo maxim vo ventilatori threshold forc vital capac forc expiratori volum fatigu assess perceiv exert contrast propranolol signific decreas diastol bp rest mm hg systol bp maxim exercis mm hg signific decreas submaxim vo mlkgmin maxim vo mlkgmin ventilatori threshold litersmin minut ventil submaxim exercis litersmin forc expiratori volum liter concomit increas rate perceiv exert maxim exercis guanadrel sulfat signific decreas fast plasma glucos total serum cholesterol propranolol result increas serum triglycerid contrast propranolol guanadrel sulfat decreas bp evok negat metabol consequ impair exercis toler"
"abnorm baroreflex control heart rate decompens congest heart failur revers compens congest heart failur chf impair baroreflex control heart rate hr determin derang revers cardiac chronotrop control assess patient class iv chronic chf etiolog compens achiev bed rest salt restrict diuret vasodil time studi day manag modifi day autonom evalu reestablish diet pharmacolog condit previous studi compens led signific reduct symptombas class bodi weight pulmonari system congest standard error hr respons beatsmin compens atropin mgkg handgrip maximum capac minut headup tilt minut standard error baroreflex sensit msmm hg rr respons phenylephrin amyl nitrateinduc systol pressur condit phenylephrin amyl nitrat signific correl improv hr respons atropin tilt bodi weight obtain find show revers compon impair baroreflex control hr sever chf possibl due congest effect"
"doppler echocardiograph studi porcin bioprosthet heart valv aortic valv posit patient evid cardiac dysfunct studi natur histori hemodynam perform bioprosthet heart valv doppler echocardiogram record group clinic stabl patient year replac nativ aortic valv bioprosthet valv eighteen patient complet year patient year follow examin effect orific area ident model bioprosthet valv hancock ii determin vitro leftsid heart puls duplic system vivo dopplerderiv effect orific area compar vitro measur valv size year follow examin dopplerderiv effect orific area signific vitro area interv ten valv evalu serial decreas greater cm dopplerderiv effect orific area studi decreas effect orific area valv evalu serial cm peak transaort gradient increas mm hg transaort gradient increas mm hg conclud serial doppler echocardiograph studi demonstr deterior hemodynam perform bioprosthet valv time patient symptom sign valvular dysfunct doppler echocardiographi identifi subclin bioprosthet valvular dysfunct"
"effect phospholipas inhibitor mepacrin injuri ischem metabol inhibit adult isol myocyt phospholipas inhibitor mepacrin shown delay cell death metabol inhibit cultur cardiomyocyt present studi initi determin mepacrin delay cell death develop osmot fragil metabol inhibit ischem adult rat cardiomyocyt isol myocyt suspens incub mmol millimolar iodoacet acid mmol amyt inhibit pellet slurri layer oil ischem presenc absenc mumol micromolar mepacrin rate contractur cell viabil determin trypan blue permeabl cell viabil osmot swell mosm media osmot fragil cell morpholog monitor mepacrin effect rate contractur found signific delay cell death isoton incub metabol inhibit ischem cell contrast mepacrin effect develop osmot fragil incub metabol inhibit myocyt calciumfre media delay contractur cell injuri attenu protect effect mepacrin studi confirm previous report mepacrin protect cell injuri extend observ protect ischem isol adult myocyt show develop osmot fragil inhibit mepacrin"
"recombin lipoprotein coagul inhibitor inhibit tissu thromboplastininduc intravascular coagul rabbit lipoprotein coagul inhibitor produc feedback inhibit tissu factor tissu thromboplastininduc coagul presenc factor xa recombin lipoprotein coagul inhibitor rlaci test abil modifi thromboplastininduc intravascular coagul rabbit model monitor iodin fibrin accumulationdisappear lung sampl blood measur coagul paramet infus thromboplastin rabbit caus rapid increas radioact lung possibl due accumul fibrin lung rapid declin radioact suggest remov fibrin lung thromboplastin caus rapid decreas system fibrinogen accompani lengthen activ partial thromboplastin time prothrombin time effect coinfus rlaci thromboplastin bolus inject rlaci thromboplastin infus studi high dose rlaci microgramskg bodi weight thromboplastininduc radioact increas lung system fibrinogen decreas complet suppress activ partial thromboplastin time prothrombin time plasma sampl lengthen possibl due presenc thromboplastin circul thromboplastininduc radioact increas lung complet suppress lower dose rlaci microgramskg bodi weight dose rlaci prevent system fibrinogen decreas bolus dose microgramskg bodi weight rlaci provid protect fibrinogen consumpt fibrinogen decreas compar rabbit treat thromboplastin result show rlaci effect inhibit thromboplastininduc coagul vivo"
"effect recombin human granulocytemacrophag colonystimul factor administr lymphocyt subset patient refractori aplast anemia human recombin granulocytemacrophag colonystimul factor rhgmcsf administ patient refractori aplast anemia aa effect rhgmcsf therapi lymphocyt phenotyp prolif respons mitogen phytohemagglutinin candida albican tetanus toxoid antigen natur killer nk activ circul lymphocyt studi sampl collect baselin rhgmcsf administr absolut number circul lymphocyt remain constant period experienc signific increas period increas promin cell cell increas detail investig lymphocyt subset show increas marker cd leu hladr transferrin receptor treatment give evid lymphoid cell activ nk cell activ suppress treatment prolif respons phytohemagglutinin candida antigen tetanus toxoid unaffect mechan defin gmcsf induc activ increas absolut lymphoid cell number cell decreas nk cytotox implic immun cell relat host resist microorgan remain establish"
"ultrastructur dimension organ telangiectas hereditari hemorrhag telangiectasia studi cutan telangiectat lesion hereditari hemorrhag telangiectasia hht rang size pinpoint mm light electron microscopi repres lesion reconstruct comput serial mm plastic embed section earliest clinic detect lesion hht focal dilat postcapillari venul continu enlarg eventu connect dilat arteriol capillari vascular lesion increas size capillari segment disappear direct arterioven communic form entir sequenc morpholog event perivascular mononuclear cell infiltr major cell lymphocyt minor monocytesmacrophag ultrastructur comparison find telangiectat mat scleroderma cherri angioma reveal previous shown compos dilat postcapillari venul perivascular infiltr produc capillari loop aneurysm"
"isol quantit human erythrocyt deform class techniqu fraction erythrocyt deform method modif method beutler al lab clin med small cellulos column remov white cell blood sampl find lengthwidth ratio column increas mix cellulos bed fraction red cell measur cell volum corpuscular hemoglobin concentr hemoglobin level deform index cell densiti show deform physic properti erythrocyt form basi fraction separ modal complement numer densiti gradient techniqu red cell experiment result obtain techniqu number cell defin degre rigid quantit erythrocyt popul larg number cell differ respect deform isol applic method sickl cell quantit remark heterogen cell regard deform"
"immun activ phenylhydrazineinduc anemia rat longterm phenylhydrazin phz treatment caus pronounc anemia concomit increas number circul leukocyt longevan rat leukocytosi caus elev mononuclear cell notabl lymphocyt popul phz report direct lysi erythrocyt nonimmun mechan recent report phz crosslink red cell band protein senesc antigen result bind autolog immunoglobulin igg recognit complex macrophag fc receptor mechan trigger rapid erythrophagocytosi spleen possibl liver studi analysi blood bone marrow spleen cell longterm week phztreat rat perform flow cytometri total serum igg level determin radial immunodiffus antibodi reactiv red cell sensit phz vivo vitro titer indirect coomb method serum prostaglandin titer determin time interv phz administr result phz induc increas circul antibodi prostaglandin titer correl onset anemia serum phztreat rat induc anemia normal recipi passiv transfer cytofluorograph studi reveal mark increas cell popul peripher blood spleen alter ratio helper suppressor cell time interv phz inject result addit induc senesc alter erythrocyt membran protein phz stimul product autolog igg recogn site promot lymphoid blastogenesi notabl cell lineag"
"benefit risk anemia correct recombin human erythropoietin children maintain hemodialysi ten children renal failur age rang year month year month median year month maintain longterm hemodialysi success correct anemia intraven administr recombin human erythropoietin dosag escal week iukgwk hemoglobin concentr increas gmdl blood cell count evalu correct anemia dialysi import children compliant water restrict higher hemoglobin concentr result improv qualiti life greater toler physic effort exercis toler doubl ventilatori anaerob threshold increas signific correct subclin central nervous system abnorm detect evok potenti test reduct bleed time side effect note sever hypertens develop patient postdialysi hematocrit episod hypertransaminasemia evid liver dysfunct conclud children renal failur recombin human erythropoietin correct anemia safe strong advis resolut symptom correl anemia"
"rapid detect prenat diagnosi betathalassaemia studi indian cypriot popul uk applic amplif refractori mutat system arm detect individu betathalassaemia mutat heterozyg parent risk fetus assess indian cypriot immigr popul uk trimest prenat diagnos entail detect mutat method determin mutat parent fetal dna day wide applic carrier detect prenat diagnosi monogen diseas heterogen molecular defect"
"twintwin transfus syndrom twintwin transfus syndrom complic monozygoticmonochorion twin perinat implic extens literatur review reveal current understand anatomi pathogenesi syndrom chang decad modern diagnost modal sonographi doppler studi antenat diagnosi chang current definit syndrom base data composit definit syndrom suggest definit includ criteria sonograph sign intertwin differ abdomin circumfer greater mm polyhydramniosoligohydramnio sign monozygos doppler velocimetri umbil arteri intertwin differ systolicdiastol ratio demonstr transplacent vascular shunt intertwin birth weight differ intertwin hemoglobin differ dl addit prenat diagnosi manag complic intrauterin treatment placent vascular anomali effect antenat therapeut option"
"iron defici young athlet overt anemia uncommon deplet bodi iron store common adolesc femal athlet poor dietari iron intak menstruat increas iron loss physic train import factor nonanem iron defici impair exercis perform uncertain nonetheless athlet low ferritin level risk impair erythropoiesi receiv therapeut iron supplement"
"incomplet synthesi glycan congenit dyserythropoiet anemia type ii caus defect gene encod alphamannosidas ii congenit dyserythropoiet anemia type ii hereditari erythroblast multinuclear posit acidifiedserumlysi test hempa genet anemia human inherit autosom recess mode enzym defect hempa patient previous propos lower activ acetylglucosaminyltransferas ii result lack polylactosamin protein lead accumul polylactosaminyl lipid recent hempa case analyz cellsurfac label fastatombombard mass spectrometri glycopeptid activ assay glycosyl enzym signific decreas glycosyl polylactosaminoglycan protein incomplet process asparaginelink oligosaccharid detect erythrocyt membran contrast earlier studi hempa case cell normal acetylglucosaminyltransferas ii activ low alphamannosidas ii alphamanii activ northern rna analysi poli mrna normal unrel hempa cell show doubl band kilobas posit detect alphamanii cdna probe express band cell substanti reduc normal southern analysi normal genom dna restrict fragment pattern detect alphamanii cdna probe indistinguish result suggest cell mutat alphamaniiencod gene result ineffici express alphamanii mrna reduc transcript messag instabl report demonstr hempa caus defect gene encod enzym synthesi asparaginelink oligosaccharid"
"haemopoiet growth factor avail recombin haemopoiet growth factor permit precis vitro experi human vivo studi perform general result accord expect previous vitro studi clinic exploit haemopoiet growth factor offer great promis care studi requir defin effect growth factor multipl complex assum improv blood cell count se benefici patient circumst random control trial clinic endpoint essenti situat chemotherapyinduc neutropenia larg studi requir show improv mortal lesser morbid easier demonstr field cancer therapi major benefit haemopoiet growth factor permit dosag escal consequ improv respons rate longterm surviv requir care patient select larg multicentr trial studi limit develop sever thrombocytopenia effect amelior elus thrombopoietin requir possibl haemopoiet growth factor adjunct treatment sever infect entic design trial evalu possibl fraught difficulti final note studi report date singl factor begin factor synergist combin give greater efficaci increas toxic"
"sarcoidosi abdomin manifest ct data literatur abdomin manifest sarcoidosi comput tomographi ct determin differ nodal distribut reliabl distinguish sarcoidosi hodgkin lymphoma nhl author retrospect review abdomin pelvic ct scan patient biopsyprov sarcoidosi patient biopsyprov nhl eleven patient sarcoidosi abdomin pelvic lymphadenopathi common nodal site retrocrur pelvic locat statist signific lower frequenc retrocru adenopathi sarcoidosi nhl nodal size signific greater nhl node tend confluent nhl discret sarcoidosi hepatomegali patient sarcoidosi splenomegali present ct depict hepat lesion patient biopsyprov hepat involv splenic lesion ct patient author overlap nodal distribut pose limit criteria accur diseas character"
"benzylacyclouridin revers azidothymidineinduc marrow suppress impair antihuman immunodefici virus activ increas extracellular concentr uridin urd report reduc vitro azidothymidin aztinduc inhibit human granulocytemacrophag progenitor cell impair antihuman immunodefici virus hiv activ clinic toxic chronic urd administr abil benzylacyclouridin bau effect vivo aztinduc anemia leukopenia assess agent inhibit urd catabol vivo increas plasma concentr urd dosedepend manner urdrel toxic mice render anem leukopen administr azt day drink water mgml continu administr azt daili bau mgkg oral partial revers aztinduc anemia leukopenia increas peripher reticulocyt increas cellular marrow improv megaloblastosi coadminist azt onset drug administr bau reduc aztinduc marrow toxic vitro concentr mumol bau possess minim antihiv activ effect abil azt revers hivinduc cytopath effect mt cell clinic biochem implic find discuss"
"isol character acquir antithrombin antibodi year man mitral valv replac present lowgrad chronic consumpt coagulopathi laboratori analysi show mild fibrinolysi minim effect coumadin therapi prolong thrombin time greater bovin iia purifi human iia thrombin time normal control suggest inhibitor bovin iia antiiia antibodi isol protein sepharos sigma st loui mo chromatographi affin chromatographi bovin iiasepharos column effect purifi antiiia antibodi bovin human iia procoagul anticoagul function studi isol immunoglobulin igg observ inhibit bovin iia assay test igg slight prolong fibrinogen clot human iia enzymelink immunosorb assay observ igg bound bovin iia bovin ii human iia human ii bind detect approxim fold lower concentr bovin iia nmol igg concentr human iia nmol igg concentr effect antibodi reaction iia iiiheparin investig human iia found protect iiiheparin neutral presenc antibodi result suggest patient develop antibodi strong bind inhibit bovin iia assay test antibodi signific affect human iia neutral iiiheparin effect human iia procoagul activ data suggest decreas effect iiiheparin patient iia contribut factor coagulopathi exact antibodi develop unclear role bovin topic thrombin cardiac valv replac surgeri suspect"
"fibrinogen baltimor polymer defect gamma glyval ggcgtc mutat fibrinogen baltimor congenit abnorm fibrinogen report decad ago molecular defect dysfibrinogen elud identif fact report misidentifi function defect baltimor impair fibrin monom polymer reversedphas highperform liquid chromatographi analysi lysyl endopeptidas digest purifi baltimor gammachain show abnorm peptid found exist normal gammachain heterozygot amino acid sequenc peptid gammachain gli replac valin observ confirm genet defect determin direct nucleotid sequenc polymeras chain reaction product codon gamma mutat ggcgtc molecular defect fibrinogen baltimor lie region gammachain requir fibrin polymer suggest integr gamma gli critic fibrin assembl"
"sra privat platelet antigen glycoprotein iiia neonat alloimmun thrombocytopenia platelet alloantigen sra defin alloantibodi detect serum healthi mother deliv child typic clinic sign neonat alloimmun thrombocytopenia nait antibodi react strong child father platelet platelet mother high select panel repres platelet alloantigen platelet unselect normal blood donor test negat suggest phenotyp frequenc german popul antigen present member generat patern famili indic autosom codomin inherit immunochem analysi glycoprotein gpspecif immunoassay varieti gp iibiiiaspecif monoclon antibodi antigen immobil maipa assay radioimmunoassay western blot show antigen resid kd proteolyt fragment gp iiia immunogenet data gene dosag studi reveal sra antigen relat platelet alloantigen accord establish criteria sra antigen repres privat platelet alloantigen bear signific rare instanc nait"
"human neutrophil releas leu lymph node home receptor cell activ leu molecul human homologu murin mel peripher lymph node home receptor express neutrophil speci import local cell site inflamm circul human neutrophil express leu molecul activ neutrophil phorbol myrist acet rapid declin leu membran fluoresc stain minut northern blot analysi total cellular rna neutrophil demonstr speci leu messeng rna major kb minor kb leu cdna clone obtain human lymphocyt predict encod transmembran phosphatidylinositol pianchor form molecul experi conduct determin leu anchor neutrophil pianchor slight decreas express leu neutrophil treat pispecif phospholipas piplc leu abund neutrophil obtain patient paroxysm nocturn hemoglobinuria determin fate leu molecul cell activ neutrophil label iantileu activ antibodi rapid lost cell surfac intern suggest leu releas cell membran cell activ cell extract neutrophil compar extract lymphoid cell sodium dodecyl sulfatepolyacrylamid gel electrophoresi immunoblot leu speci express neutrophil signific higher variabl relat mobil kd neutrophil kd jurkat cell addit leu molecul detect supernat activ neutrophil result human neutrophil express highmolecularweight form leu molecul convent transmembran anchor rapid releas membran activ loss leu membran glycoprotein activ mechan rapid alter neutrophil adhes characterist"
"molecular basi spectrin ankyrin defici sever hereditari spherocytosi evid implic primari defect ankyrin vari degre spectrin defici found major patient hereditari spherocytosi hs combin sever defici spectrin spectrinbind protein ankyrin report patient sever hs elucid molecular basi protein defici studi synthesi assembl mrna level spectrin ankyrin peripher blood reticulocyt previous report proband pulselabel studi show hs reticulocyt synthesi alphaspectrin compar control reticulocyt betaspectrin increas fourfold reflect increas erythropoiet drive hs reticulocyt membran amount newli assembl spectrin reduc half control valu reflect decreas synthesi spectrin bind protein ankyrin ankyrin synthesi absent cytosol amount membran ankyrin reduc half normal valu amount spectrin ankyrin mrnas quantit slot blot northern blot analys compar synthesi protein alpha spectrin mrna control rang betaspectrin mrna slight increas amount ankyrin mrna reduc control valu conclud primari defect combin spectrin ankyrin defici defici ankyrin mrna lead reduc synthesi ankyrin turn decreas assembl spectrin membran"
"variat hemoglobin product normal sickl cell adult relat nucleotid substitut gamma promot region singl nucleotid substitut promot region gamma gammaglobin gene increas fetal hemoglobin hbf product determin unrecogn substitut gamma promot region respons fold variat hbf product sickl cell patient normal adult random sampl sickl cell ss patient normal adult individu repres highest lowest hbf produc select studi common restrict fragment length polymorph betaglobin region haplotyp benin central african republ seneg found highest lowest hbf produc ss diseas polymeras chain reaction amplif direct sequenc amplifi dna product examin promot region gamma gamma gene bp bp cap site mutat found gamma gene promot region conclud nucleotid substitut promot region bp gamma gene respons mark variat hbf product ss normal individu"
"platelet vitronectin receptor express differenti iraqijewish arab patient glanzmann thrombasthenia israel glanzmann thrombasthenia rare inherit disord platelet glycoprotein iibiiia gp iibiiia complex previous identifi distinct popul disord israel iraqijew arab group indistinguish hemorrhag symptom platelet gp iibiiia receptor defici differ platelet immunodetect gp iiia beta iraqijewish popul express detect gp iiia arab popul express small amount examin platelet popul normal platelet alpha beta vitronectin receptor normal platelet approxim alpha beta vitronectin receptor judg bind antibodi alpha lm intact alpha beta vitronectin receptor complex lm addit normal platelet bound immobil vitronectin presenc mmollmncl adhes mediat predomin gp iibiiia distinct contribut alpha beta vitronectin receptor determin monoclon antibodi inhibit studi iraqijewish patient platelet profound decreas immunodetect alpha beta vitronectin receptor platelet adher vitronectin contrast arab patient platelet normal increas number platelet alpha beta vitronectin receptor receptor function vitronectin adhes assay adhes mediat gp iibiiia normal platelet studi defin heterogen molecular basi glanzmann thrombasthenia widespread implic understand synthesi function beta famili integrin receptor"
"mathemat model volum ph ion content regul reticulocyt applic pathophysiolog sickl cell dehydr develop mathemat model reticulocyt seek explain cell similar volum higher ionic traffic matur red cell rbc regul volum ph ion content physiolog abnorm condit analysi fluxbal requir reticulocyt conserv volum composit predict exist previous unsuspect nadepend cl entri mechan unlik matur rbcs reticulocyt tend return origin state perturb model predict hysteresi drift cell ph volum ion content transient alter membran permeabl medium composit irrevers cell dehydr occur permeabil transient medium acidif replac extern na imperm cation hysteresi drift perturb shown depend phi depend cl cotransport major reticulocyt transport behavior suggest mechan generat irrevers sickl cell direct reticulocyt stepwis progress manner discocyt experiment test model predict hypothesi paper"
"evid direct reticulocyt origin dens red cell sickl cell anemia explor hypothesi direct reticulocyt origin irrevers sickl cell isc fraction light reticulocyterich discocyterich sickl anemia red cell stractan gradient examin effect deoxygenationinduc sickl extern ca acidif replac extern na imperm methylglucamin nmg sickl permeabil light reticulocyterich cell cation na ca discocyt extern ca na influx match efflux stabl cell volum ca light low hemoglobin hb reticulocyt dehydr rapid prevent quinin cadepend channel inhibitor acidif oxygen discocyt high hb reticulocyterich fraction yield denser reticulocyteenrich cell lower hb light reticulocyt dens iscrich fraction light cell shrank nmg replac na support predict nadepend volum control system demonstr sicklinginduc cadepend dehydr hb free reticulocyt conserv acidstimul cl cotransport low hb reticulocyteenrich cell discocyt fraction support hypothesi ancillari find includ heparin stimul sicklinginduc na permeabil ca inhibit na leak"
"neutrophil nicotinamid adenin dinucleotid phosphat oxidas assembl transloc pphox pphox requir interact pphox cytochrom cytosol nadph oxidas compon pphox pphox transloc plasma membran normal neutrophil stimul phorbol myrist acet pma studi transloc process neutrophil patient chronic granulomat diseas cgd inherit syndrom oxidas system fail produc superoxid due lesion affect compon gpphox pphox subunit cytochrom membranebound termin electron transport oxidas pphox pphox contrast normal cell pphox pphox transloc membran pmastimul cgd neutrophil lack cytochrom patient rare link form cgd caus pro substitut gpphox neutrophil normal level mutant cytochrom transloc normal patient pphox defici pphox fail transloc pphox detect particul fraction pmastimul neutrophil patient defici pphox data suggest cytochrom close link factor essenti membran dock site cytosol oxidas compon pphox mediat assembl compon membran"
"preferenti express human fc gamma riiipmn cd paroxysm nocturn hemoglobinuria discord express glycosyl phosphatidylinositollink protein isoform fc gamma riii cd express pmn gpi membran anchor paroxysm nocturn hemoglobinuria pnh defici fc gamma riii express pmn contrari expect cd express preserv albeit reduc level affect pnh pmn complet lack gpianchor protein daf cd cd fc gamma riii negat pmn observ pnh patient examin studi analysi molecular weight glycosyl deglycosyl fc gamma riii pmn reduc fc gamma riii express variat size relat normal donor fc gamma riiipmn fc gamma riii express intermedi level phosphatidylinositolspecif phospholipas piplcsensit evid suggest express transmembran isoform data fc gamma riiipmn affect cell pnh gpilink isoform fc gamma riiipmn express preserv reduc level affect cell pnh pmn pnh patient retain capac intern fc gamma riiipmnspecif probe cona reduc level iggopson erythrocyt reduc express gpianchor molecul pnh pmn restrict fc gamma riiipmn intermedi level cd observ pnh pmn decayacceler factor dafneg fc gamma riiipmn intermedi addit discord express gpilink molecul individu cell restrict pmn dafcd monocyt observ pnh patient data suggest analyz individu cell level gpi anchor defect pnh absolut involv hierarchi access protein molecul gpi anchor distinct anchor biochemistri protein differenti regul proteinanchor assembl"
"erythroid coloni growth peripher blood bone marrow polycythaemia erythroid coloni growth presenc absenc erythropoietin compar patient primari prolif polycythaemia ppp idiopath erythrocytosi secondari polycythaemia pseudopolycythaemia normal subject erythroid coloni grow erythropoietin stimul endogen erythroid coloni peripher blood bfu found patient ppp idiopath erythrocytosi found secondari polycythaemia pseudopolycythaemia normal subject small number endogen coloni form unitserythroid cfu bfu cultur bone marrow normal subject suggest peripher blood cultur provid specif indic clonal erythropoiesi peripher blood endogen erythroid coloni growth effect conveni distinguish patient clonal erythrocytosi iron defici obscur diagnosi ppp convent criteria"
"fetal hemoglobin sickl sickl cell diseas increas number cell larg amount hb cell produc clinic benefit rare variant sickl cell diseas common encount patient fetal hemoglobin interfer polymer hb vitro laboratori studi carri homogen hemoglobin solut inadequ model event vivo rbcs heterogen mchc hb content studi hemoglobin switch sheep tissu cultur baboon led azacytidin induct increas hb synthesi ss patient drug trial success theori led altern theori flaw led hydroxyurea chronic administr drug lead impress increas hb synthesi appar clinic benefit clear clinic benefit real placebo effect clear effect hydroxyurea relat increas product cell increas cell control clinic trial studi properti rbcs treat patient answer question rais question show current understand biolog treatment sickl cell diseas complet"
"erythrocyt membran protein defici paroxysm nocturn hemoglobinuria paroxysm nocturn hemoglobinuria pnh acquir disord character intermitt hemolyt anemia membran abnorm blood cell patient pnh reason unusu sensit lysi autolog plasma complement patient typic clinic diseas consist pnh strategi pitfal treatment common vitro assay discuss document complementmedi lysi aberr pnh erythrocyt membran protein abnorm pnh cell characterist protein mechan action includ decay acceler factor inhibit cc convertas complement pathway cell surfac bind protein modul step termin complement lysi protein regul complementmedi lysi earli late step complement cascad"
"chloramphenicol toxic year research signific progress made recent year understand pathogenesi type hematolog toxic chloramphenicol common dosedepend revers bone marrow suppress chloramphenicol consequ mitochondri injuri greater erythroid suscept chloramphenicol function endogen mitochondri amino acid pool pathogenesi aplast anemia chloramphenicol treatment remain uncertain larg bodi indirect evid favor complex mechan involv metabol transform group chloramphenicol predispos subject lead product toxic intermedi caus stem cell damag concept present metabolit chloramphenicol generat intestin bacteria undergo metabol transform bone marrow situ product toxic intermedi concept marrow metabol site offend agent target toxic metabolit appli potenti myelotoxin"
"danazol danazol synthet attenu androgen interfer normal interact pituitaryhypothalam axi gonad effect mediat complex mechan includ danazol compet natur steroid bind androgen receptor sex hormonebind globulin possibl displac natur steroid protein bind reactiv site enzym requir synthesi natur steroid depress synthesi danazol impair pituitaryhypothalam interact gonad effect therapeut agent treatment endometriosi cystic diseas breast effect treatment hereditari angioneurot edema mechan therapeut success unclear danazol univers success treatment gynecolog hematolog disord"
"nitrogen metabol sickl cell anemia free amino acid plasma urin twenti hour urinari level fast plasma concentr free amino acid aa evalu adult sickl cell anemia hbss agematch hbaa subject compar daili energi protein intak hbss elicit signific reduct sum plasma indispens eaa chang dispens naa amino acid result promin reduct eaanaa ratio arg leu val aa sever affect twofold increas hour urin volum hbss compar hbaa subject total urinari loss eaa naa mark reduc group arg gli level promin affect compar hbaa control hbss subject show fourfold increas hour urinari orot excret relationship amount intak result adult subject hbss consum adequ rda healthi individu behav normal hbaa control low protein diet evid hbss subject precari state respect suffici amino acid arg classifi condit indispens human"
"surreptiti ingest longact vitamin antagonistrodenticid brodifacoum clinic metabol studi case vitamin metabol patient factiti purpura due brodifacoum ingest studi patient present bleed disord due defici vitamin depend blood clot protein refractori vitamin standard dose requir fresh frozen plasma control bleed larg dose vitamin metabol studi demonstr blockad vitamin util consist presenc vitamin antagonist patient deni anticoagul warfarin assay negat show factiti purpura patient due surreptiti ingest brodifacoum potent generat longact vitamin antagonist rodenticid coagulopathi respond longterm therapi larg dose vitamin serum elimin halftim brodifacoum rang day patient anticoagul effect long durat requir chronic vitamin treatment increas avail rodenticid factiti purpura due surreptiti ingest potent vitamin antagonist emerg problem previous warfarin import implic diagnosi treatment"
"immunochem electrophoret analys phosphoryl nativ recombin neutrophil oxidas compon pphox human polymorphonuclear neutrophil pmns possess potent oxygendepend microbicid system depend activ stimulusactiv multicompon nicotinamid adenin dinucleotid phosphat nadph oxidas patient chronic granulomat diseas cgd lack activ oxidas suffer sever frequent infect compon oxidas includ membranebound factor notabl cytochrom absent link form cgd cytosol factor absent autosom cgd patient cgd autosom type defect phosphoryl protein kd rang polyclon antiserum recogn cytosol oxidas compon kd identifi phosphoprotein cellfre oxidas system dimension gel electrophoresi show ident kd cytosol protein pphox recogn cation kd protein phosphoryl normal pphoxdefici cgd cytosol activ nadphdepend oxidas fulllength termin recombin pphox protein augment superoxidegener capac cellfre system phosphoryl ad cytosol normal subject patient pdefici autosom cgd studi provid compel evid kd cation protein substrat phosphoryl activ pmns fact pphox cytosol protein previous shown critic normal activ nadphdepend oxidas pmns"
"molecular basi alphathalassemia structur mutant hemoglobin suandok alpha leuarg publish erratum blood mar hemoglobin hb suandok alpha arg rare alphaglobin structur mutat link alphathalassemia alphath determin inherit tran alphath mutat result hb diseas low level suandok hb natur thalassem defect alpha sd mutat investig structur function studi sequenc analysi clone suandok allel show missens mutat codon normal alpha globin gene alpha sdglobin gene introduc mous erythroleukemia cell steadi state alphaglobin messeng rna mrna level equival alpha globin gene control vitro translat synthet alpha sdglobin mrna generat level alpha globin equival alpha aglobin mrna earli time point ratio alpha sd alpha globin decreas mark time point data suggest thalassem defect suandok mutat result signific instabl alpha sd globin"
"molecular defect coagul factor xfriuli result substitut serin prolin posit previous find suggest coagul factor xfriuli function defect owe point mutat portion factor gene code fulli activ heavi chain verifi exist postul chang analyz exon normal friuli factor gene exon amplifi genom dna polymeras chain reaction clone plasmid puc amplifi dna insert subject direct sequenc dideoxi chain termin method forward revers oligonucleotid sequenc primer point mutat transit nucleotid posit result code serin tcc place prolin ccc amino acid posit found substitut involv high conserv prolin residu orient spatial close cleavag site zymogen activ site enzym explain previous observ discret biochem function differ factor xfriuli normal factor mutat abolish hgici restrict site present normal factor gene chang constitut basi conveni method screen individu carri molecular defect prolin conserv region serin proteas superfamili factor belong part residu motif occur enzym comput analysi suggest motif essenti aspect conform featur import function properti factor serin proteas"
"hemoglobin cagliari beta valglu unstabl thalassem hemoglobinopathi report describ patient thalassemia intermedia phenotyp born normal parent globin gene sequenc detect abnorm hemoglobin hb due substitut codon betaglobin gene aris de novo mutat normal sequenc detect homolog betaglobin locus mutat result substitut polar glutam acid nonpolar valin residu corner heme pocket betaglobin chain variant design hb cagliari place birth propositus kinet globin synthesi perform splenectomi suggest hb variant synthes normal rate undergo rapid breakdown extrem labil variant explain clinic hematolog pictur character mark ineffect erythropoiesi thalassemia bone iron overload high proport hb peripher blood reduc betaalphaglobin chain synthesi ratio peripher blood reticulocyt absenc abnorm hb peripher blood extens protein structur analysi splenectomi case thalassem hemoglobinopathi suspect presenc patient thalassemia intermedia phenotyp born normal parent protein structur analysi fail detect abnorm hb dna sequenc defin mutat make proper diagnosi"
"trimethoprimsulphamethoxazol blood dyscrasia ten year experi swedish spontan report system year period total case blood dyscrasia report sweden evalu probabl causal relationship trimethoprimsulphamethoxazol sm case leucopenia agranulocytosi case thrombocytopenia haemolyt anaemia case bicytopenia case tricytopenia median age vari year leucopenia group year tricytopenia fatal rate rang group mild leucopenia group tricytopenia relat sale prescript data incid report sm blood dyscrasia million defin daili dose patient incid case prescript incid blood reaction sm low relat prescript data elder peopl overrepres reaction"
"clinicopatholog follow studi case essenti type ii cryoglobulinaem neuropathi ten patient essenti cryoglobulinaemia type ii examin peripher nerv damag case distal symmetr nerv involv present case abnorm restrict singl nerv found electrophysiolog morpholog data consist axon damag larger myelin fibr affect activ sign vascul immunoperoxidas stain immunoglobulin present endoneuri vessel wide damag abnorm thick endotheli cell redund basal membran find patchi distribut myelin fibr loss suggest ischaemia peripher neuropathi essenti cryoglobulinaemia type ii follow examin perform year haematologi remiss reveal peripher nerv damag occur"
"recognit distinct pattern gallium distribut sarcoidosi assess gallium ga uptak salivari lacrim gland intrathorac lymph node made consecut patient includ sarcoidosi distinct intrathorac lymph node ga uptak pattern resembl greek letter lambda observ sarcoidosi symmetr lacrim gland parotid gland ga uptak panda note sarcoidosi patient simultan lambda panda pattern panda radiograph bilater symmetr hilar lymphadenopathi present sarcoidosi patient presenc pattern preval roentgen stage ii conclud simultan lambda panda imag panda imag bilater symmetr hilar lymphadenopathi chest ray repres distinct pattern high specif sarcoidosi obviat invas diagnost procedur"
"develop radioimmunoassay erythropoietin recombin erythropoietin develop hour radioimmunoassay erythropoietin epo epo deriv recombin dna immunogen ligand present paper mix breed rabbit immun microgramskg epo deriv stabli transfect cell line elanex pharmaceut bothel washington usa mcdonnel dougla corp st loui missouri usa md produc antibodi epo high titer final dilut tube high affin liter good specif purifi epo sourc amgen biolog thousand oak california usa ag success radioiodin chloramin method ligand radioimmunoassay standard doserespons curv prepar epo commerci sourc signific show sensit mutub doserespons curv system show parallel serial dilut serum patient aplast anemia assay assay precis determin assay multipl replic serum pool recoveri exogen epo ad serum pool averag system rang normal human serum epo determin assay sera hematologicallynorm adult subject found muml md epo muml ag epo sera patient hematolog abnorm assay includ patient anemia endstag renal diseas sem muml conclus rapid sensit radioimmunoassay system measur epo level sera normal human subject patient type anemia therapeut drug monitor patient receiv epo commerci sourc"
"evolut genet diseas ethnic isol betathalassemia jew kurdistan betathalassemia hereditari diseas caus point mutat betaglobin gene specif popul general carri small number mutat common wide distribut region present studi constitut extens molecular character diseas small high inbr ethnic group high incid betathalassemia jew kurdistan unusu mutat divers observ sibship mutat identifi newli discov transvers cap site frameshift codon transit polyadenylyl signal mutat uniqu kurdish jew discov popul found kurdish jew iranian khuzistan region border kurdistan mutant chromosom carri mutat uniqu kurdish jew trace origin mutat specif geograph region kurdistan inform support haplotyp analysi suggest thalassemia central kurdistan northern iraq evolv primarili multipl mutat event turkish kurdistan primari mechan genet admixtur local popul iranian kurdistan founder effect part respons conclud evolutionari mechan contribut evolut betathalassemia small ethnic isol"
"antibiot hypoprothrombinemia review prospect studi antimicrobi agent hypoprothrombinemia precis mechan unknown alter vitamin status util involv postul mechan implic direct inhibit biosynthesi vitamin depend clot factor methylthiotetrazol nmtt moieti found antimicrobi agent erad vitamin produc intestin microflora patient reduc oral intak vitamin englishlanguag review prospect studi report serial prothrombin time monitor adult patient reveal incid hypoprothrombinemia vari nmtt regimen nmtt regimen detail evalu studi suggest risk factor includ malnutrit hepat renal dysfunct older age sever ill major determin hypoprothrombinemia hypothesi nmtt side chain primarili respons hypoprothrombinemia justifi conclud patient high risk coagulopathi care monitor prophylact vitamin case"
"venous doppler ultrasonographi fetus nonimmun hydrop eighteen pregnanc nonimmun hydrop fetali refer fetal echocardiographi rule congenit heart diseas case pulsat blood veloc record umbil vein normal popul nonpulsatil blood veloc pattern case pulsat umbil vein found intrauterin viral infect case examin umbil venous pulsat found reflect abnorm central venous pulsat atrial systol suggest increas fetal central venous pressur ventricular shorten fraction signific decreas group umbil venous pulsat compar versus fetus venous pulsat surviv pulsat surviv result suggest blood veloc record umbil central vein fetus give valuabl clinic inform regard presenc fetal congest heart failur differenti physiolog state nonimmun hydrop fetali implic fetal diagnost work prognosi"
"combin fineneedl aspir cytolog examin tuberculin skin test diagnosi cervic tubercul lymphaden prospect studi prospect studi evalu efficaci combin fineneedl aspir fna cytolog examin mantoux test diagnosi cervic tubercul lymphaden carri tuberculin reaction determin control subject preoper fna cytolog examin mantoux test perform patient cervic lymphadenopathi lymph node excis examin histolog cultur mycobacteria forti patient histolog confirm tubercul specif malign lymphadenopathi fineneedl aspir cytolog examin detect cervic tubercul lymphaden patient predict strong tuberculin reaction mycobacteri infect combin mantoux test fna cytolog examin diagnos case tubercul lymphaden cervic preoper combin fna cytolog examin mantoux test effici diagnosi tubercul lymphaden"
"morpholog sickl cell produc solut vari osmolar effect vari osmolar nacl solut mosmkg ho morpholog deoxygen sickl cell studi quantit computerassist imag analysi system discocyterich dens fraction sickl cell densiti equal suspend buffer nacl solut ph osmolar deoxygen room temperatur hour stain wright solut microscop imag analyz circular shape factor csf pi areaperimet ellipt shape factor esf short axislong axi paramet yield valu elong cell cell shape mapleleaf starshap cell morpholog sickl cell analyz numer found rate degre deform depend high osmot pressur media cell suspend hyperton solut sickl cell assum mapleleaf shape deform occur quick degre deform circular shape factor ellipt shape factor lower found isoton slight hypoton solut elong cell form hypoton isoton solut deform slower solut hyperton solut result shape degre deform deoxygen sickl cell high depend osmolar suspend medium rate deform invers relat osmolar relationship morpholog deoxygen sickl cell osmot pressur suspend media discuss"
"fibrinolysi thrombocytopenia coagul abnorm complic highdos interleukin immunotherapi highdos interleukin il immunotherapi hypotens respiratori distress interstiti edema thrombocytopenia similar endotox shock observ il direct effect coagul factor vitro observ alter coagul properti vascular endothelium investig possibl il infus initi plasma fibrinolysi dissemin intravascular coagul dic studi clinic platelet count coagul profil respons il infus patient metastat melanoma metastat renal cell carcinoma patient experienc hemodynam instabl thrombocytopenia patient suffer unusu complic mesenter thrombosi patient appreci prothrombin time partial thromboplastin time factor viii declin patient observ patient examin found decreas titer hageman factor factor xii high molecular weight kininogen prekallikrein plasma thromboplastin anteced consum reaction intrins pathway thrombin format circul dimer fragment found plasma patient point infus cycl observ decreas titer plasminogen patient mention suggest il infus initi fibrinolysi clot factor derang relat toxic phenomena ascrib firm dic activ intrins contact system coagul provid link vascular endotheli surfac alter caus il infus develop system toxic resembl septic shock"
"middl cerebr arteri blood veloc cerebr blood flow sickl cell diseas understand relationship blood veloc measur transcrani doppler cerebr blood flow measur xe inhal method examin patient undergo evalu comprehens sickl cell center columbia univers blood veloc middl cerebr arteri direct relat cerebr flow multivari analysi sampl made improv correl account variabl cerebr blood flow transcrani doppler measur veloc pulsatil patient age hematocrit combin doppler clinic demograph variabl diseas similar improv quantit estim cerebr blood flow"
"platelet aggreg plateletrich plasma blood patient myeloprolif disord vitro platelet aggreg plateletrich plasma prp blood wb assess patient idiopath myelofibrosi essenti thrombocytosi polycythemia vera chronic myelogen leukemia prp subject show normal reduc platelet aggreg wb major patient show increas platelet function spontan platelet aggreg spa observ frequent wb seldom observ prp spa wb inhibit vitro addit aspirin apyras spa partial depend high platelet count occur sampl normal platelet content varianc subject reactiv thrombocytosi spa observ sampl high platelet concentr platelet patient idiopath myelofibrosi highest tendenc undergo spa"
"polycythemia vera polycythem state diagnosi polycythemia requir accur independ assess plasma volum red blood cell mass patient increas red cell mass absolut polycythemia hypox erythropoietinsecret tumor spaceoccupi lesion compress kidney reduc plasma volum relat polycythemia tobacco smoker diuret cardiac medic ingest increas quantiti caffein beverag hand polycythemia vera system diseas multipl complic diagnos complex find outlin polycythemia vera studi group"
"platelet abnorm myeloprolif disord larg number platelet abnorm patient mpd abnorm serv diagnost purpos predict clinic manifest patient progress diseas platelet characterist consist report defect includ decreas platelet content serotonin adenin nucleotid decreas platelet densiti abnorm ultrastructur character pauciti granul hypertrophi surfac connect canicular system alter membran glycoprotein profil includ reduc level gpib reduc lipoxygenas activ aggreg respons epinephrin abnorm origin megakaryocyt level releas abnorm platelet undergo modif function biochem characterist result episod intravascular thrombosi age circul result progress treatment diseas creat paradox conflict relationship thrombot hemorrhag event result platelet function test observ disord"
"sarcoidosi cauda equina report case case sarcoidosi cauda equina present previous histori suggest sarcoidosi present pain flaccid paralysi diagnosi made myelographi laminectomi subsequ histolog patient previous diagnosi lupus pernio magnet reson imag mri aid diagnosi previous case report sarcoidosi present cauda equina system manifest report mri sarcoidosi lower mening"
"hemoglobin columbia missouri alpha alavalbeta highoxygenaffin hemoglobin erythrocytosi previous undescrib hemoglobin variant hemoglobin columbia missouri alpha alav detect year white man undergo assess erythrocytosi hemoglobin variant separ hemoglobin electrophoresi convent media isoelectr focus electrophoresi purifi globin chain urea exhibit high oxygen affin oxygen tension satur torr patient blood substitut hemoglobin columbia missouri intern residu end helix alpha chain hemoglobin okazaki arginyl residu substitut cysteinyl residu beta beta chain comparison hemoglobin okazaki substitut hemoglobin columbia missouri pronounc effect oxygen affin hemoglobin columbia missouri erythrocytosi hemoglobin okazaki"
"transfus requir effect patient thalassaemia major cooleycar programm analysi data italian greek patient regist cooleycar intern cooper programm qualiti assess treatment deliveri thalassaemia gave pictur treatment requir effect proport patient undergo splenectomi progress decreas age splenectomi increas time past year age transfus exceed year small import group patient milder form thalassaemia exist group children receiv modern treatment remain normal statur age tend stunt blood requir higher splenectomis splenectomis patient differ transfus interv week measur effect blood requir blood requir rise gradual haemoglobin concentr possibl linear fashion preval red cell alloimmunis rise delay start transfus transfus reaction report transfus leucocytedeplet patient"
"point approach anemia anemia sign diseas caus blood loss sequestr red blood cell rbcs impair rbc product primari marrow dysfunct effici clinic approach patient anemia question anemia microcyt macrocyt normocyt pancytopenia present marrow respons anemia determin reticulocyt count answer question focus laboratori evalu logic progress avoid cost shotgun approach"
"contemporari diseas concept iii pedant failur chang behavior problem anemia frequenc hous staff notic patient anem frequenc find patient anem diagnost accuraci endeavor measur intervent conduct team lectur subject anemia read materi subject social encourag solv problem follow improv found outcom variabl"
"ventil gas exchang exercis sickl cell anemia adult sickl cell anemia sca restrict lung impair increas alveolar dead space hypoxemia factor increas anaerob metabol thought exercis hyperventil assess role children patient sca control subject perform pulmonari function exercis test twenti patient sca spirometr valu lung volum patient sca arteri satur greater exercis low vomax mlminkg ventilatori anaerob threshold vat patient occur similar vomax control subject versus slope delta vedelta vco relationship vat work steeper patient versus ventilatori equival vevco steadyst exercis greater patient control subject versus endtid pco differ versus indic equival alveolar ventil patient higher dead spacetid volum ratio vdvt control subject versus paco signific lower lower hb differ ph conclus children sca increas exercis ventilatori respons caus part increas physiolog dead space part low hb greater dead space result sickl cell impair capillari perfus ventil alveoli"
"cardiac output oxygen deliveri exercis sickl cell anemia desatur patient sickl cell anemia sca lead intravascular sickl vascular occlus increas metabol demand exercis tend increas oxygen extract give rise fall satur capillari bed predispos sickl minim increas cardiac output aim studi assess role increas stroke volum sv augment cardiac output estim role enlarg arterioven content differ maintain transport children sca group children sca hb healthi control racial group similar height weight perform increment steadyst exercis wmax cardiac output measur indirect fick method steadi state slope delta hrdelta vo increment exercis higher sca subject compar control versus bpm mlminkg vo vo abnorm high patient older lower hb level hr predict higher patient control versus predict sv versus predict multipl linear regress predict sv predict hb age show posit correl age negat correl hb sv"
"prenat detect foramen oval obstruct hydrop fetali case prenat echocardiograph diagnosi obstruct foramen oval present ultrasound detect unexplain mark atrial ventricular dilat fetal hydrop specul fetal outcom depend sever time onset foramen oval obstruct utero"
"abnorm megakaryocytopoiesi belgrad laboratori rat belgrad laboratori rat hereditari hypochrom microcyt anemia defect transmembran iron transport erythroblast present studi prompt previous work show rat hypomegakaryocyt thrombocytopenia increas megakaryocyt size defin basic mechan abnorm rat studi megakaryocytopoiesi granulopoiesi anem rat chronic transfus rat irontr rat control found decreas concentr megakaryocyt granulocyt progenitor marrow rat full correct sever anemia chronic transfus result normal megakaryocyt progenitor small acetylcholinesteras posit cell megakaryocyt size platelet count granulocyt progenitor contrast partial correct anemia obtain iron treatment result improv normal paramet find abnorm megakaryocytopoiesi rat interpret consequ hypoxia sever anemia recent shown number erythroid progenitor rat low propos abnorm megakaryocytopoiesi anim reflect acquir stem cell disord induc prolong hypoxia result sever anemia"
"polycythemia vera blood burstform unitserythroid hypersensit interleukin polycythemia vera pv clonal hematopoiet stem cell diseas trilineag hyperplasia interleukin il stimul trilineag hematopoiesi studi respons high purifi pv blood burstform unitserythroid bfu recombin human il ril growth normal blood bfu vitro rapid declin incub ml ril growth pv bfu declin condit demonstr reduc depend ril reduc depend pv bfu recombin human erythropoietin rep present doserespons experi show fold increas pv bfu sensit ril fold increas sensit rep compar normal bfu blood bfu patient secondari polycythemia respond normal bfu endogen erythroid coloni eec format independ addit rep reduc erythroid colonyform cell generat pv bfu vitro ril repstimul erythroid coloni unaffect studi demonstr strike hypersensit pv blood bfu ril major factor pathogenesi increas erythropoiesi increas ep concentr"
"angiolymphoid hyperplasia eosinophilia angiolymphoid hyperplasia eosinophilia rare condit poor recogn otolaryngolog literatur condit character cutan nodul head neck region extern ear variabl lymphadenopathi peripher eosinophilia occur condit mimic neoplasia import awar diseas entiti order avoid overtreat surgic remov treatment choic multilobul poor delin lesion preclud initi wide excis local recurr common present case unusu condit resum literatur"
"longterm follow heterotop splenic autotransplant traumat splenic ruptur trap function heterotop splenic autotranspl hsa polytraumat patient age yr evalu heat damag technetiummlabel autolog red blood cell earli mo late yr period heterotop autotransplant omentum intens tracer accumul grade comparison liver uptak splenic tissu surfac calcul anterior project time shape transplant compar uptak foci suggest spontan splenosi scan averag surfac hsa cm earli cm late examin increas intens tracer accumul occas signific patient addit splenot foci found follow scan howelljolli bodi peripher blood detect patient earli remain detect lower number patient follow infect notic group patient work confirm excel surviv rate hsa improv trap function import spread origin implant site longterm follow"
"coldinduc granulocyt agglutin pseudoleukopenia transient cold agglutin granulocyt develop year woman left upper lobe pneumonia acut phase ill phenomenon manifest pseudogranulocytopenia multipl clump granulocyt peripher blood smear abnorm distribut granulocyt monocyt white blood cell histogram measur autom hematolog analyz coulter iv coulter electron hialeah fla postul igm autoantibodi direct compon granulocyt membran spurious leukopenia encount infrequ autom hematolog analyz coldinduc granulocyt agglutin recogn potenti pseudogranulocytopenia white blood cell count accur report unnecessari evalu patient leukopenia avoid"
"cyclosporin therapi advanc langerhan cell histiocytosi prompt evid langerhan cell histiocytosi lch nonmalign disord immun regul cyclosporin mgkg oral treat young children advanc multisystem lch patient partial respons cyclosporin month therapi evidenc complet resolut organ dysfunct regress major lesion complet respons attain ad nontox chemotherapi prednison vinblastin toxic cyclosporin compris mild revers elev serum creatinin blood urea nitrogen result evalu cyclosporin treatment patient advanc lch warrant"
"transmembran mobil phospholipid sickl erythrocyt effect deoxygen diffus asymmetri studi effect sickl transmembran reorient distribut phospholipid red blood cell patient homozyg sickl cell anemia ss purpos redistribut kinet trace amount spinlabel analogu natur phospholipid introduc membran outer leaflet normal sickl erythrocyt expos air nitrogen deoxygen effect lipid redistribut kinet normal aa cell membran atmospher po unfraction ss cell normal cell deoxygen induc sickl phosphatidylcholin passiv diffus acceler rate adenosin triphosphatedepend transport aminophospholipid reduc phosphatidylserin stationari distribut aminophospholipid leaflet slight asymmetr phenomenon pronounc phosphatidylethanolamin rapid revers reoxygen ss cell separ densiti dens light cell exhibit properti cite dens cell expos air possess lower aminophospholipid transport rate data favor relationship aminophospholipid translocas activ phospholipid transmembran asymmetri sickl cell diseas case aminophospholipid translocas patholog"
"iron defici anemia elder diagnost process object determin effect physician probabl estim calcul basi find historytak physic examin diagnosi iron defici anemia elder patient design prospect studi set communiti hospit offer secondari tertiari care patient total patient year age found previous undiagnos anemia measur physician estim likelihood iron defici pretest probabl posttest probabl laboratori test result hemogram physician made pretest probabl estim serum ferritin level prove power laboratori test result studi likelihood ratio posttest estim compar ratio serum ferritin level main result posttest probabl estim influenc serum ferritin level pretest estim posttest estim deriv find obtain historytak physic examin laboratori test result includ serum ferritin level slight accur predict iron defici serum ferritin level model pretest estim addit serum ferritin level predict iron defici prove power serum ferritin level limit posttest estim due misinterpret serum ferritin level find historytak physic examin ad import diagnost inform conclus physician awar test properti provid optim care patient test result proper interpret pretest probabl deriv find obtain historytak physic examin add inform lead accur diagnos"
"clinic spectrum thrombocytosi thrombocythemia platelet product result high order matur development hierarchi megakaryocyt progenitor cell regul varieti cytokin gmcsf ii ii stimulatori effect cytokin tgfbeta platelet releas glycoprotein platelet factor interferon inhibitori effect regul platelet product part autocrin control loop excess platelet product clinic character pseudothrombocytosi thrombocytosi thrombocythemia clinic featur criteria defin term thrombocytosi infer reactiv natur absenc arteri diseas prolong immobl pose risk platelet number contrast thrombocythemia primari myeloprolif lesion signific thrombohemorrhag event occur natur histori rational approach platelet reduct control clinic sequela review clinic therapeut option includ agent anagrelid"
"methaemoglobinaemia ingest amyl nitrit report case methaemoglobinaemia year girl ingest aphrodisiac nitrit avail product poor label intend presenc domest bedroom serv increas hazard pose young children"
"treatment aplast anemia children recombin human granulocyt colonystimul factor twenti children age year sever moder aplast anemia treat recombin human granulocyt colonystimul factor rhgcsf dose microgramsm day administ minut intraven iv infus daili week treatment increas neutrophil count fold patient increas dose microgramsm day administ patient respond initi dose show increas neutrophil count differenti count bone marrow bm aspir show increas myeloiderythroid ratio respons transient neutrophil count return baselin day discontinu treatment sever toxic attribut rhgcsf observ result suggest agent effect stimul granulopoiesi children aplast anemia studi rhgcsf manag patient aplast anemia complic bacteri fungal infect"
"prophylact effect administ pumpdriven subcutan igg infus patient antibodi defici tripleblind cross studi compar igg level versus adult patient hypoimmunoglobulinaemia random alloc initi low highlevel iggsubstitut igg administ subcutan mg ml ml infus pocketport electr infus pump infus time week month chang dose regimen month desir plasma igg level reach lag phase month rang month median rang individu plasma igg level ensu month period highlevel period rang lowlevel period rang highlevel period compar lowlevel period signific decreas paramet day bed home day miss work day fever sideeffect observ conclud plasma igg concentr readili achiev subcutan igg substitut prophylact effect superior obtain plasma igg concentr"
"fatal case ceftriaxon rocephininduc hemolyt anemia intravascular immun hemolysi fatal hemolyt anemia develop year woman treat cephalosporin ceftriaxon patient red cell rbcs coat rbcbound igg iga igm detect serum antibodi react cephalosporinco rbcs react strong rbcs vitro serum ad drug rbcs case immun hemolyt anemia ceftriaxon case fatal cephalosporininduc hemolyt anemia case cephalosporin antibodi show vitro vivo characterist thought call immun complex mechan"
"ceftazidimeinduc hemolysi patient drugdepend antibodi reactiv immun complex drug adsorpt mechan year woman develop acut intravascular hemolysi day begin ceftazidim direct antiglobulin test strong posit antiigg anticompl serum antibodi presenc ceftazidim sensit unmodifi reagent cell igg complement immunecomplex type serum agglutin ceftazidimepretr cell room temperatur degre drugadsorpt type retrospect test disclos drug adsorpt antibodi present current antibiot demonstr hemolysi reactiv immun complex antibodi develop day ceftazidim parallel degre hemolysi strength direct antiglobulin test author patient separ ceftazidimedepend antibodi antibodi reactiv immun complex mechan mediat episod acut intravascular hemolysi"
"comparison perform puls oximet condit poor perfus perform puls oximet finger probe evalu comparison read direct measur arteri blood oxygen satur sampl patient undergon cardiac surgeri hypotherm cardiopulmonari bypass poor peripher perfus differ bias accuraci standard deviat precis drop rate puls oximet determin rank perform puls oximet calcul criteria accuraci precis number read standard percentag read standard expect overread limit case puls oximet achiev combin accuraci precis measur expect oximet lowest drop rate"
"acquir methemoglobinemia relationship ill publish erratum dis child feb character methemoglobinemia children review chart patient admit children hospit year distinct group identifi endogen group includ patient methemoglobinemia intercurr ill exogen group includ patient methemoglobinemia secondari drug exposur similar initi methemoglobin level endogen exogen group children endogen group acidosi serum bicarbon level mmol arteri ph children exogen group methemoglobinemia secondari accident ingest stay day hospit children endogen group admit averag day children methemoglobinemia secondari drug exposur benign ill shorter durat children methemoglobinemia intercurr ill absolut level methemoglobin import determin sever ill"
"prenat screen hemoglobinopathi prospect region trial prenat hemoglobinopathi screen chosen model system studi patient recept unsolicit genet inform provid prenat care rochest ny offer free test prenat patient genet counsel women found posit prenat sampl test year period repres pregnanc rochest metropolitan region hemoglobinopathi found pregnanc type hemoglobinopathi detect common sickl cell trait hemoglobin trait betathalassemia trait hemoglobin trait time phlebotomi pregnanc wk durat sixti percent pregnanc occur patient unawar diagnosi occur patient unawar risk child blood disord posit pregnanc occur patient counsel women counsel screen pregnanc partner test partner test pregnanc found risk coupl late prenat diagnosi case condit fetus risk mild case prenat diagnosi offer remain pregnanc accept coupl result unselect patient primari care set region pregnant recept util genet inform"
"prenat screen hemoglobinopathi ii evalu counsel learn genet counsel expect context genet screen report describ learn result genet counsel pregnant women identifi hemoglobinopathi carrier sickl cell trait betathalassemia trait counsel design provid inform simpl clear nondirect manner special videotap produc purpos provid dramat role model illustr respons view videotap counsele opportun question counselor misconcept correct questionnair reveal signific increas knowledg result counsel hemoglobinopathi subject area test clinic manifest genet prenat diagnosi factor correl higher knowledg score counsel younger patient age year educ knowledg trait identif knowledg babi father trait counsel prior children"
"prenat screen hemoglobinopathi iii applic health belief model comprehens prenat hemoglobinopathi screen program rochest ny preced paper issu journal woman identifi carrier face decis accept offer counsel partner test partner test posit decis accept offer prenat diagnosi report analyz factor affect decis special attent factor invok health belief model factor predict patient identifi carrier counsel includ patient prior knowledg carrier gestat age wk caucasian race sickl cell trait counsele betathalassamia trait counsele factor found predict patient intent partner test greater postcounsel knowledg diseas lesser perceiv burden intervent belief partner carrier sickl cell trait counsele betathalassemia trait counsele factor predict partner test live partner gestat age identif equal wk lesser perceiv burden intervent greater perceiv diseas"
"decreas content surfac express alphagranul membran protein gmp type platelet alpha delta storag pool defici determin alphagranul membran present platelet patient storag pool defici alpha dens granul alpha deltaspd examin content surfac express alphagranul membran protein gmp patient sever alphagranul defici member famili famili milder alphagranul defici surfac express gmp stimul platelet assess flow cytometr measur bind antigmp monoclon antibodi normal valu platelet patient normal valu famili total platelet content gmp determin platelet lysat antigencaptur elisa normal patient normal member famili platelet patient found heterogen respect gmp content surfac express flow cytometri immunogold electron microscopi approxim platelet express gmp stimul remain express normal amount gmp show extens immunogold label typic alphagranul clear vacuol heterogen found platelet famili find sever alpha deltaspd patient clear contrast observ normal gmp content alpha deltaspd patient patient gray platelet syndrom report previous result illustr phenotyp heterogen alphagranul defici human platelet suggest defect granul format megakaryocyt account alphagranul defect form alpha deltaspd"
"success treatment catscratch diseas ciprofloxacin catscratch diseas benign limit diseas infect asymptomat common pain region lymphaden occasion diseas result system symptom dissemin adult patient age year diagnos catscratch diseas base posit histori cat scratch typic symptom includ pain region lymphaden malais posit catscratch skin test diagnost evalu reveal lymphaden patient receiv prior treatment antibiot patient fail improv antibiot treat oral ciprofloxacin mg mouth daili patient dramat improv symptom day relaps follow report success treatment catscratch diseas ciprofloxacin effect therapi catscratch diseas adult"
"aplast anemia antithyroid drug prognosi aplast anemia link degre hypoplasia bone marrow pancytopenia blood author intrigu patient methimazol aplast anemia satisfi criteria sever diseas recov rapid complet drug withdrawn review english languag literatur reveal ten fulli document case aplast anemia antithyroid drug methimazol carbimazol propylthiouracil analysi ten eleventh case present disord typic character sever pancytopenia profound marrow hypoplasia surpris good prognosi minimum surviv partial complet recoveri symptom cytopenia survivor week death brain hemorrhag patient transfus platelet discrep clinic laboratori sever antithyroid drug aplasia hand good prognosi short term mind patient bone marrow transplant therapi antithymocyt globulin"
"dystrophin analysi differenti diagnosi autosom recess muscular dystrophi childhood duchenn muscular dystrophi report patient childhood autosom recess muscular dystrophi patient slight muscl weak enlarg calf muscl involv facial muscl clinic cours static muscl histolog reveal characterist featur muscular dystrophi dystrophin identifi sarcolemma patient immunocytochem stain antidystrophin antibodi earli age immunocytochem analysi antidystrophin antibodi distinguish childhood autosom recess duchenn muscular dystrophi"
"mutat rhodopsin gene patient autosom domin retin pigmentosa background night blind earli symptom retin pigmentosa rod photoreceptor respons night vision rhodopsin photosensit pigment method result found mutat human rhodopsin gene occur exclus affect member famili autosom domin retin pigmentosa mutat transit involv separ nucleotid codon transvers codon mutat correspond chang amino acid residu rhodopsin molecul mutat found unrel normal subject serv control incid mutat ad previous report mutat involv codon unrel patient autosom domin retin pigmentosa percent found carri defect rhodopsin gene patient abnorm rod function monitor electroretinogram patient mutat involv codon descend singl ancestor conclus patient autosom domin retin pigmentosa diseas caus varieti mutat rhodopsin gene"
"express cystic fibrosi transmembran conduct regul correct defect chlorid channel regul cystic fibrosi airway epitheli cell cystic fibrosi transmembran conduct regul cftr express cultur cystic fibrosi airway epitheli cell cl channel activ assess singl cell fluoresc microscop assay patchclamp techniqu express cftr mutant form cftr delta correct cl channel defect correct phenotyp defect demonstr causal relationship mutat cftr gene defect cl transport hallmark diseas"
"express character cystic fibrosi transmembran conduct regul cystic fibrosi cf common lethal genet diseas manifest airway epitheli cell defect chlorid ion absorpt secret result part defect cyclic ampregul outwardlyrectifi cl channel apic surfac gene respons cf identifi predict encod membran protein term cf transmembran conduct regul cftr identif cryptic bacteri promot cftr code sequenc led construct complementari dna lowcopynumb plasmid avoid deleteri effect cftr express escherischia coli cdna express cftr vitro vivo demonstr cftr membran glycoprotein phosporyl vitro campdepend protein kinas polyclon monoclon antibodi direct distinct domain protein immunoprecipit recombin cftr endogen cftr nonrecombin cell partial proteolysi fingerprint show recombin recombin protein indistinguish data establish characterist protein respons cf enabl cftr function studi provid basi diagnosi therapi"
"evalu perinat autopsi protocol influenc prenat diagnosi confer team studi design evalu perinat autopsi adopt autopsi protocol univers utah medic center prenat diagnosi confer team compos obstetrician pediatrician geneticist health care profession individu involv care patient pregnanc risk congenit malform autopsi protocol design increas interact pathologist prenat diagnosi confer team evalu perinat death year protocol implement select retrospect review autopsi made specif diagnos compar addit congenit anomali diagnos increas number patient found congenit disord number attempt postnat autopsi chromosom studi increas chromosom abnorm detect final autopsi diagnos made provid inform physician genet patient counsel protocol adopt increas number case refer medic center evalu autopsi autopsi evalu life member prenat diagnosi confer team premortem sonogram earlier gestat age greater number anomali detect fewer fetus intrauterin death pregnanc termin induct labor gestat age deliveri declin"
"macrosom twin studi growthpromot twin evalu twin pregnanc repres tenth decil twin birth weight distribut investig larger twin face increas perinat risk macrosom singleton compar pregnanc ninth decil signific differ found matern age pariti gestat age rate present combin cesarean neonat sex ratio incid growthdiscord pair signific higher heavier group compar general twin popul tenthdecil group signific fewer primipara matern obes diabet infrequ explain increas birth weight neonat outcom excel comparison reveal insignific differ combin higher pariti malpresent rate malefemal ratio oper genesi larg twin"
"modifi superior base pharyng flap techniqu part ii anatom studi literatur topograph appli surgic anatomi relat superior base pharyng flap surgeri report appli surgic anatomi pharyng flap surgeri appli critic anatom relationship vessel muscl nerv"
"singl versus multipledos surfact replac therapi neonat week gestat respiratori distress syndrom assess efficaci multipledos protocol surfact replac therapi neonat week gestat neonat random assign control singledos surfact multipledos surfact group neonat hour age diagnosi respiratori distress syndrom elig subject random assign receiv mgkg bovin surfact air placebo neonat multipledos group elig receiv addit dose neonat surfact group show posit respons treatment mark improv oxygen minut postinstil surfact group oxygen control subject lower ventilatori paramet hour deterior oxygen ventilatori requir treatment group start hour dose deterior oxygen minim multipl dose extra dose effect diminish ventilatori requir time extub conclud surfact therapi hour age effect acut reduc oxygen ventilatori requir neonat week gestat respiratori distress syndrom multipl dose surfact greater effect sustain improv oxygen ventilatori requir studi requir determin optim dosag retreat strategi"
"cloacal malform radiolog find imag recommend imag studi record patient cloacal malform review malform cloacal configur urethr vagin type urinarycloac communic urethr vesic level rectal communic vagin cloacal vesic lower urinari tract abnorm frequent reflux ureter ectopia bladder diverticula bladder duplic urach remnant urethr duplic genit abnorm uterin duplic vagin duplic uterin atresia vagin atresia abnorm boni pelvi partial sacral agenesi pubic diastasi renal abnorm agenesi obstruct horsesho kidney contrast materi studi cloaca distal limb colostomi fluoroscopi project essenti diagnosi void cystourethrographi import detect vesicoureter reflux sonographi limit evalu malform valuabl imag kidney mr imag reveal spinal cord abnorm predict base lumbosacr spine common previous thought"
"neonat screen stagger earli treatment congenit disloc dysplasia hip consecut newborn babi result screen earli treatment congenit disloc dysplasia hip cdh evalu prospect follow studi barlow test famili histori record babi posit immedi abduct treatment screen result doubt test negat famili histori posit child radiograph month abduct treatment start form cdh barlowneg children famili histori refer group select age month age year disloc miss screen dysplasia month barlowneg children posit famili histori refer group children crude estim lower limit valid indic screen test show test effici identif disloc dysplasia babi treatment start immedi relaps dysplasia withdraw therapi avascular necrosi normal year treatment start month found relaps dysplasia avascular necrosi success year children dislocat hip propos wait treatment strategi earli ultrasonographi radiographi month"
"control trial splint versus ultrasonograph surveil congenit dislocat hip infant congenit dislocat hip diagnos clinic birth examin sonograph randomis control trial splint sonograph surveil week infant group splint age week instabl persist sonograph abnorm shown improv sonograph find clinic outcom differ group birth month follow conclud dislocat hip safe watch week birth spontan resolut approach requir resourc attent detail experi confirm import dynam sonograph scan low specif sonograph examin week life make unsatisfactori primari method screen birth adjunct clinic screen manag congenit disloc hip"
"bodi composit myelomeningocel bodi composit measur obes evalu subject myelomeningocel mmc age anthropometri measur bodi cell mass bcm intra extracellular water icw ecw deriv total bodi potassium deuteriumisotop dilut result compar refer data bodi composit normal preambulatori children mmc age signific deplet bcm total bodi water maldistribut water increas ecw decreas icw increas percentag bodi fat expect age sex find pronounc femal high lesion pronounc remain ambulatori result metabol nutrit maladapt stress relat bcm total bodi water deplet increas ecw decreas ambulatori activ suggest earli nutrit mobil program warrant studi"
"effect matern hyperoxia behavior activ growthretard human fetus thirteen pregnant women subsequ deliv infant birth weight percentil studi examin fetal heart rate fetal activ patient matern administr oxygen concentr room air hour fetus acidot birth matern transcutan po level increas mm hg mm hg hour observ result matern hyperoxia produc sustain fetal breath activ higher room air analysi varianc gross fetal bodi movement fetal heart rate acceler fetal heart rate variabl increas signific increas observ time analysi varianc signific alter matern hyperoxia room air conclud signific chang fetal breath activ ultrasonograph observ fetal behavior activ matern hyperoxia differenti sever growthretard grown human fetus specul alter fetal heart rate fetal bodi movement pattern intrauterin growth retard relat alter develop fetal central nervous system revers prolong matern administr oxygen"
"color match foveal densitometri patient carrier link progress cone dystrophi describ famili undescrib form link progress cone dystrophi generat pedigre report result male patient oblig femal carrier affect male show characterist pictur cone dystrophi foveal cone photopig densiti impair judg anomaloscop set foveal densitometri earli stage diseas carrier show fundus abnorm occasion due myopia anomaloscop demonstr mild pseudoprotanomali oblig carrier carrier foveal densitometri find perform carrier agre anomaloscop find conclud find pseudoprotanomali abnorm densiti differ femal famili ocular abnorm indic carrier state"
"ultrasound diagnosi congenit dysplasia disloc hip joint children older year evalu ultrasound diagnosi congenit dysplasia disloc hip cdh children older year age patient normal hip joint patient present previous cdh examin anterior ultrasound scan employ coverag femor head acetabular roof assess ultrasound measur compar standard roentgenographi good accord method found project femor head relat boni acetabular rim mm children younger ten year age sublux mm age year disloc reliabl imag obtain ultrasound age year ultrasound recommend primari imag techniqu evalu hip joint older children ultrasound replac roentgenographi follow examin children previous cdh"
"pulmonari atresia ventricular septal defect select patient systemicpulmonari arteri shunt base echocardiographi januari decemb infant pavsd diagnost result obtain echocardiographi dimension doppler color prospect compar angiocardiograph find classifi group patient confluent goodsiz pulmonari greater equal mm arteri singl ductus arteriosus normal pulmonari venous connect favor pattern patient pavsd classifi group unfavor pattern intracardiac anatomi morpholog pulmonari arteri pattern pulmonari blood suppli pulmonari venous connect correct identifi echocardiographi patient erron consid group falseposit favor pattern group detect echocardiographi effect tool infant pavsd order discrimin case favor unfavor pattern pulmonari arteri pulmonari blood suppli pulmonari vein group favor pattern consid systemicpulmonari shunt surgeri angiocardiographi base experi januari decemb patient favor pattern underw success systemicpulmonari arteri shunt echocardiograph diagnosi"
"di georg anomali atrioventricular canal report case di georg anomali atrioventricular canal combin anomali repres chanc occurr situat happen patient altern result singl unknown embriogenet mechan"
"child understand testicular feminis children adult worri adult diagnosi omin implic common left uninform judg understand deliveri pain inform vulner teenag year approach unfold truth stage stage match simpl statement child conceptu growth person implic final realis part matur process approach child testicular feminis"
"character splice mutat group xeroderma pigmentosum molecular basi group xeroderma pigmentosum xp investig comparison nucleotid sequenc multipl clone xp group complement gene xpac patient group xp normal gene clone show substitut splice acceptor site intron alter obligatori ag acceptor dinucleotid ac nucleotid sequenc cdnas amplifi polymeras chain reaction reveal singl base substitut abolish canon splice site creat abnorm splice mrna form larger form ident normal mrna dinucleotid delet end exon delet result frameshift prematur translat termin exon smaller form delet entir exon dinucleotid end exon result transfect studi provid addit evid singl base substitut diseasecaus mutat singl base substitut creat cleavag site restrict nucleas alwni analysi alwni restrict fragment length polymorph show high frequenc mutat japanes patient group xp unrel japanes patient homozyg heterozyg mutat caucasian black group xp mutant allel polymorph alwni restrict fragment conclud diagnosi group xp japanes subject includ prenat case carrier"
"mother postcounsel belief children genet disord mother postcounsel belief children genet disord investig sort consist statement belief sort group item basi congruenc subject belief subject educ knowledg genet child disord high level belief genet differ belief differ genet etiolog indic belief affect specif inform provid genet counsel factor analysi identifi cluster sort item character high person relationship disord person attribut select bless god action subject rate item low belief pattern design imperson consist scientif worldview psycholog distanc child disord subject rate item high person belief pattern mixtur scientif nonscientif belief sens person involv child disord subject belief pattern equal knowledg genet disord person belief pattern interfer accept understand inform provid genet counsel"
"waardenburg syndrom ws analysi singl famili ws mutat show linkag rflp marker human chromosom waardenburg syndrom type ws mim caus pleiotrop autosom domin mutat variabl penetr express individu mutat hear impair multilocus linkag analysi rflp data singl ws famili affect individu ws mutat famili link marker loci locat long arm chromosom alpp alkalin phosphatas placent fn fibronectin ds uniquecopi dna segment cola collagen vi alpha rflp marker loci multilocus linkag analysi mlink produc peak lod linkag relationship recombin fraction theta alppfnd la similar analysi produc linkag relationship theta valu marker ws fnwsalppd cola data confirm conclus foy al ws mutat map chromosom"
"ocular clinicopatholog studi gyrat atrophi perform histopatholog studi globe obtain post mortem patient document vitamin brespons gyrat atrophi retina posterior pole focal area photoreceptor atrophi adjac retin pigment epitheli hyperplasia abrupt transit normal retina zone total atrophi retina retin pigment epithelium choroid present fundus midperipheri electron microscop examin disclos abnorm mitochondria corneal endothelium pigment ciliari epithelium similar sever mitochondri abnorm present photoreceptor"
"stage repair pulmonari atresia ventricular septal defect major system pulmonari arteri collater fifti consecut patient pulmonari atresia ventricular septal defect hypoplast pulmonari arteri arbor defect major aortopulmonari collater enter program stage surgic repair januari juli prerepair preparatori procedur design encourag nativ pulmonari arteri growth increas blood flow unifoc pulmonari blood suppli transplant ligat major collater total stage procedur perform mortal hundr thirti major collater ligat transplant thirti patient eventu underw hemodynam repair earli mortal late mortal twenti current survivor repair remain clinic follow year ten patient stage prepar twelv patient fail achiev minimum requir repair stage await palliat heartlung transplant principl manag evolv year discuss"
"abnorm fucosyl ileal mucus cystic fibrosi histochem studi peroxidas label lectin peroxidas conjug lectin analys glycoprotein small intestin mucin normal infant cystic fibrosi ascertain detect histochem differ saccharid composit signific decreas lotus tetragonolobus ltg bind fucos shown normal small intestin mucin start week gestat total absenc stain term contrast age match patient cystic fibrosi show persist intens ltg bind fucos result provid clear histochem evid cystic fibrosi mucin abnorm confirm find previous biochem studi"
"abnorm fucosyl ileal mucus cystic fibrosi ii histochem studi monoclon antibodi fucosyl oligosaccharid abnorm fucosyl cystic fibrosi mucin previous shown peroxidas conjug lectin ileal tissu section abnorm fucosyl glycoprotein investig monoclon antibodi fucosyl oligosaccharid base type type blood group precursor chain result studi monoclon antibodi blood group glycoprotein cystic fibrosi negat abnorm fucosyl found lectin histochemistri monoclon antibodi lectin enzym glycosyl hydrolas delin abnorm found glycoprotein cystic fibrosi appropri fix ileal section obtain infant term present meconium ileus"
"quelprud nodul postauricular cartilagin nodul number minor variat configur extern ear recogn paper bring attent entiti character small cartilagin nodul promin aris posterior surfac pinna quelprud nodul prospect clinic survey patient attend ent clinic reveal popul studi possess nodul equal sex incid quelprud nodul identifi famili distribut suggest autosom domin inherit variabl express"
"cardiovascular abnorm infant prenat expos cocain studi util histor cohort examin relationship matern cocain pregnanc occurr congenit cardiovascular abnorm neonat drug screen perform boston citi hospit month period review screen highrisk neonat result toxicolog screen posit cocain neonat detect cocain compar occurr cardiovascular malform electrocardiograph abnorm group match sought infant pediatr cardiolog data base consist inpati consult outpati consult electrocardiographi forti patient drug screen enter cardiolog data base consult electrocardiogram electrocardiogram rate cardiac anomali cocaineposit infant signific higher relat risk confid interv rate anomali cocaineneg comparison group rate cocaineposit infant signific higher publish rate general popul infant electrocardiograph abnorm highgrad ventricular ectopi cardiorespiratori arrest note studi popul conclud cocain exposur prenat life predispos infant structur cardiovascular malform electrocardiograph abnorm possibl cardiopulmonari autonom dysfunct"
"genet diseas detect dna amplif clone thermost ligas polymeras chain reaction thermost dna polymeras revolution dna diagnost thermost enzym dna ligas har assay report amplifi dna discrimin singlebas substitut clone enzym specif link adjac oligonucleotid hybrid degre complementari target nucleotid perfect basepair junction oligonucleotid product exponenti amplifi thermal cycl ligat reaction presenc set adjac oligonucleotid complementari set target singlebas mismatch prevent ligationamplif distinguish method exploit detect target molecul discrimin normal beta sickl beta globin genotyp microlit blood sampl"
"doubleblind comparison oral transmucos fentanyl citrat oral meperidin diazepam atropin preanesthet medic children congenit heart diseas effect oral transmucos fentanyl citrat otfc preanesthet medic compar oral meperidin diazepam atropin mda pediatr patient schedul undergo repair congenit heart defect doubleblind manner patient receiv fentanyl lollipop microgramskg placebo oral solut mlkg placebo lollipop oral solut mlkg meperidin mgkg diazepam mgkg atropin mgkg patient vital sign systol diastol blood pressur heart rate respiratori rate oxyhemoglobin satur spo activ apprehens score evalu record baselin min interv patient emot status time parent separ induct anesthesia assess side effect onset action observ otfc onset sedat signific faster oral solut meperidin diazepam atropin group signific chang heart rate systol blood pressur diastol blood pressur respiratori rate show statist signific decreas clinic signific child emot status time separ parent induct similar group side effect otfc frequent nose itch occur bodi itch vomit patient otfctreat group hypoxem spo requir supplement oxygen group receiv oral meperidin diazepam atropin mild facial pruritus complain dri mouth"
"express gene insulin growth factor igf igfii igfbind protein fetal rat condit intrauterin growth retard caus matern fast evid suggest insulin growth factor ii igf ii play role regul fetal growth develop fetus igf ii complex specif bind protein igfbp thought modul action igf target tissu examin regul gene igf igfii igfbp igfbp fetal rat liver experiment model intrauterin growth retard caus matern fast day gestat weight fetus fast dam lower weight fetus fed dam concentr immunoreact igf decreas serum fetus fast dam concentr immunoreact igfii slight decreas serum fetus fast dam concentr immunoreact proigfii domain peptid decreas abund hepat igf mrna decreas fetus fast dam contrast abund igfii mrna fetal liver signific decreas matern fast matern fast caus fold increas abund igfbp mrna fetal liver chang abund igfbp mrna induct igfbp mrna liver growthretard fetus similar induct occur liver fast adult lack regul igfbp mrna differ strong induct igfbp mrna occur liver fast adult summari result matern fast decreas fetal igf gene express decreas fetal serum igf slight decreas fetal serum igfii proigfii domain peptid concentr matern fast increas fetal igfbp gene express fetal insulin glucos relat express igf igfbp gene growthretard fetus decreas express igf ii increas express igfbp gene contribut fetal growth retard observ model system"
"control spermoocyt switch caenorhabd elegan hermaphrodit fem untransl region caenorhabd elegan hermaphrodit germ line sperm oocyt made common pool germcel precursor decis differenti sperm oocyt regul sexdetermin gene fem express fem hermaphrodit germ line direct spermatogenesi negat regul switch oogenesi adult hermaphrodit produc oocyt fem rna found germ line consist requir fem hermaphrodit spermatogenesi matern effect fem embryon sex determin lossfunct mutant fem produc oocyt hermaphrodit carri fem gainfunct gf mutat make sperm produc continu vast excess wildtyp amount genet analys suggest femgf mutat escap negat control requir switch oogenesi report femgf mutant carri sequenc alter fem untransl region utr increas steadyst level femgf rna wildtyp increas polyadenyl femgf rna coincid unregul fem activ result titrat experi support hypothesi regulatori factor bind fem utr specul fem rna regul utr bind factor inhibit translat discuss idea control part general regul matern rnas"
"autosom domin sector retin pigmentosa famili transvers mutat codon rhodopsin cytosineadenin transvers codon rhodopsin rod visual pigment gene report recent dryja al unrel patient autosom domin retin pigmentosa clinic find delet report detail screen patient autosom domin retin pigmentosa codon transvers found posit result affect individu famili sector retin pigmentosa patient sector retin pigmentosa famili negat result suggest gene site locat give phenotyp chang patient histori light exposur locat degener retina hypothes light phototox play express role point mutat rhodopsin gene report type retin pigmentosa specif molecular gene defect actual pathophysiolog mechan unknown"
"ocular find patient autosom domin retin pigmentosa rhodopsin gene defect pro ocular find present unrel patient form autosom domin retin pigmentosa cytosineadenin transvers codon rhodopsin gene substitut histidin prolin amino acid rhodopsin design rhodopsin pro averag patient age year signific visual acuiti larger electroretinograph amplitud unrel patient age year autosom domin retin pigmentosa mutat patient separ famili relat mutat famili show interfamili intrafamili variabl respect sever ocular diseas suggest factor gene defect involv express condit form retin pigmentosa detect test leukocyt dna peripher blood mechan mutat rhodopsin gene lead rod photoreceptor cell death suggest"
"anomal subaort posit brachiocephal vein innomin vein echocardiograph studi patient congenit heart diseas brachiocephal vein anomal posit aortic arch higher proport case report high frequenc aris differ studi popul method diagnosi venous anomali common patient tetralog fallot ventricular septal defect pulmonari atresia patient venous anomali aortic arch anomal brachiocephal vein neck junction superior vena cava shown cross section echocardiographi doubt case doppler studi clarifi anatom arrang"
"polyorchid case report review literatur polyorchid rare anomali approxim case report literatur result transvers divis urogenit ridg hypothesi explain anatom featur supernumerari testicl primari accompani disord anomali includ maldescend testi inguin hernia torsion malign report case absenc concomit disord testicular tumor rule magnet reson imag ultrasonographi surgic explor biopsi unnecessari"
"woven coronari arteri case report therapeut implic report unusu anomali coronari arteri consist proxim branch arteri subsequ interweav branch refer woven coronari arteri implic differenti diagnosi discuss"
"cystic fibrosi transmembran conduct regul nucleotid bind synthet peptid multipl mutat gene respons cystic fibrosi locat region predict encod nucleotidebind fold amino termin half cystic fibrosi transmembran conduct regul protein amino acid peptid correspond central region putat nucleotid bind site chemic synthes purifi peptid bound adenin nucleotid appar dissoci constant kd trinitrophenyl tnp adenin nucleotid tnpadenosin triphosph tnpadenosin diphosph tnpadenosin monophosph nanomolar nanomolar greater micromolar kd adenosin triphosph micromolar circular dichroism spectroscopi show assum predomin beta sheet structur solut find consist secondari structur predict basi inform phenylalanin posit delet approxim percent individu cystic fibrosi local beta strand nucleotid bind peptid delet residu predict induc signific structur chang beta strand alter nucleotid bind"
"tuber sclerosi tuber sclerosi inherit disord character triad signsment retard seizur adenoma sebaceum hamartoma common affect multipl organ system plain film radiographi comput tomographi ultrasonographi assess lesion present abdomen kidney brain hamartoma tend bleed caus symptom prompt evalu"
"dimorph bp repeat cystic fibrosi gene absolut linkag disequilibrium delta mutat implic prenat diagnosi mutat origin gene caus cystic fibrosi cf recent clone major mutat delta account approxim cf chromosom uncov identifi end intron cf gene bp tandem repeat gatt exhibit interest featur pcr screen normal individu reveal repeat exist polymorph allel form hexam heptam allel hardyweinberg equilibrium predict heterozygot frequenc repeat repeat allel repeat found link delta cf chromosom investig demonstr strong linkag disequilibrium suggest delta origin gene bear repeat repeat allel link dna marker xvc km extend haplotyp generat haplotyp inform situat prenat diagnosi perform sole xvc km repeat marker locat cf gene recombin gene serv valuabl dna marker haplotyp analysi crossov identifi xvc km transfer delta haplotyp"
"frameshift mutat cystic fibrosi gene cystic fibrosi cf recess diseas caus mutat cf transmembran conduct regul cftr gene identifi exon frameshift mutat caus nucleotid insert caus nucleotid delet mutationscfinstc cfdelt predict shift read frame protein introduc uaaochr termin codon residu"
"closur ductus arteriosus indomethacin ventil neonat respiratori distress syndrom effect pulmonari complianc ventil report effect indomethacin pulmonari complianc variabl depend patient popul degre indomethacin result success ductal closur eleven fluidrestrict furosemidetr prematur infant mechan ventil respiratori distress syndrom rds signific patent ductus arteriosus pda pulmonari function test perform success closur pda diagnosi signific pda made clinic echocardiograph criteria indomethacin administ dosag mgkgdose dose control time interv achiev ductal closur prematur infant ventil rds signific pda pulmonari function evalu perform control independ effect fluid restrict diuret therapi pulmonari complianc prematur infant pda pulmonari function evalu perform interv success closur ductus indomethacin improv complianc ventil paramet infant indomethacintr infant indomethacintr group percent improv note paramet cldyn cli cle vt ve signific pulmonari function rds pda fluidrestrict furosemidetr control group conclus success closur ductus indomethacin signific improv complianc ventil paramet infant mechan ventil rds"
"lectin bind site normal scar lattic dystrophi cornea normal scar dystroph cornea histochem probe panel lectin avidinbiotin reveal system normal corneal epitheli cell keratocyt endotheli cell express distinct link oligosaccharid subset bisect biantennari bisect bitriantennari type corneal scar stain variabl lectin subset maclura pomifera agglutinin lattic dystrophi cornea show loss oligosaccharid express observ plasma membran normal epitheli cell concurr deposit extracellular glycoprotein corneal stroma oligosaccharid subset lost epitheli cell plasma membran extracellular stromal glycoprotein wide deposit amyloid extend stromal scar propos observ relat lattic corneal dystrophi glycoprotein shed plasma membran epitheli cell sequestr corneal stroma subsequ stimul amyloid deposit"
"requir replic protein ssb human dna excis repair replic repair essenti process maintain continu genet materi dissect simian virus sv dna replic result identif eukaryot replic protein biochemistri multienzym process dna excis repair defin protein absolut requir semiconserv replic sv dna vitro human singlestrand dnabind protein ssb call rf rp ssb consist polypeptid relat molecular mass act antigen topoisomeras unwind dna access replic protein human ssb stimul activ polymeras alpha delta suggest role elong dna replic found role human ssb dna excis repair cellfre system carri nucleotid excis repair vitro monoclon antibodi human ssb caus extens inhibit dna repair plasmid molecul damag ultraviolet light acetylaminofluoren addit purifi ssb revers inhibit stimul repair synthesi increas number repair event result show mammalian dna replic protein essenti repair"
"detect tuber sclerosi parent magnet reson imag perform detail physic examin mri gadolinium dtpa contrast coupl child tuber sclerosi ts parent ts diagnos physic examin famili histori diagnost procedur includ mri addit subject control subject nonspecif highsign white matter mri mri confirm diagnosi ts parent physic find diseas similar result earlier studi comput cranial tomographi ct sensit mri specif ts ct mri occasion substanti diagnosi ts parent find studi parent maxim accuraci genet counsel"
"brain growth fetus expos cocain utero asymmetr growth retard fetal growth retard matern cocain pregnanc pattern fetal growth retard analyz infant born women cocain alcohol pregnanc comparison group infant born mother alcohol cocain pregnanc infant mother alcohol cocain pregnanc statist signific differ head size unexpos cocaineexpos infant notabl head circumfer reduc proportion birth weight cocaineexpos infant pattern similar observ alcoholexpos infant alcohol cocaineexpos infant statist head circumfer conclud brain growth cocaineexpos infant similar report alcoholexpos infant cocaineexpos infant character asymmetr growth retard"
"cytogenet studi spontan abort direct analysi chorion villi karyotyp spontan abortus determin direct chromosom prepar chorion villi frequenc chromosom abnorm higher figur cite previous cytogenet survey convent method cell cultur autosom trisomi predomin abnorm polyploidi monosomi structur rearrang mosaic doubl trisomi doubl chromosom anomali direct prepar advantag result obtain rapid success rate karyotyp satisfactori maternalcel contamin minim"
"trimest diagnosi fetal ocular defect anomali report case ocular cataract hypertelor hypotelor anophthalmo microphthalmo rare malform common fetal anomali previous ocular malform detect midgest transvagin sonographi detect structur fetal anomali describ case report ocular anomali fetal screen transvagin sonographi week gestat sever cataract correct diagnos transvagin sonographi transvagin sonographi fail detect moder cataract case repeat cataract subsequ gestat anophthalmia secondari degen process middl late pregnanc case eye malform defect central nervous system"
"postterm infant big small concern postterm pregnanc shift difficult deliveri excess larg fetus current concern death utero undernourish smalldat fetus studi postterm pregnanc avail ultrasonographi includ larg proport erron menstrual date present studi infant undertaken reassess fetal growth postterm pregnanc expect date confin normal menstrual period date confirm day earli ultrasonographi result show gradual shift higher birth weight greater crownheel length head circumfer day gestat age evid postterm weight loss lower weight length demonstr concern postterm pregnanc fetal macrosomia intrauterin growth retard"
"cerebr blood flow crossbrain oxygen extract fontanell pressur hypoxicischem injuri newborn infant relationship arteri pressur intracrani pressur cerebr blood flow crossbrain oxygen extract cerebr metabol rate outcom studi therapi neonat consecut day sever hypoxicischem cerebr injuri crossbrain oxygen extract signific higher mldl neonat surviv normal neurolog outcom die sustain sever brain damag contrast global cerebr blood flow neonat normal neurolog outcom signific lower ml gm brainmin studi period differ crossbrain oxygen extract global cerebr blood flow infant neurolog recoveri die sustain brain damag occur presenc accept valu intracrani pressur arteri pressur cerebr perfus pressur preliminari data suggest crossbrain oxygen extract possibl global cerebr blood flow import variabl sever neuron injuri death hypoxicischem cerebr injuri"
"enamel pit common symptom tuber sclerosi dental enamel pit diagnost sign tuber sclerosi explor protocol oral examin patient person risk studi patient tuber sclerosi control patient examin dental enamel pit simpl clinic protocol establish examin dental disclos solut swab dri teeth incid enamel pit adult dentit patient tuber sclerosi adult dentit control group simplic test high probabl occurr tuber sclerosi make examin diagnosi genet diseas"
"left ventricular diastol fill pattern doppler echocardiographi cystic fibrosi onset cor pulmonal common termin find patient cystic fibrosi doppler echocardiographi detect diastol fill pattern prior onset systol dysfunct clinic symptom util techniqu determin detect left ventricular diastol fill pattern exist patient cystic fibrosi patient proport left ventricular fill attribut atrial contract signific increas compar agematch control individu fill pattern compar sever pulmonari diseas worsen pulmonari diseas direct correl shift left ventricular fill pattern conclud left ventricular pattern relax detect earli cystic fibrosi progress earli detect lead therapeut trial design improv left ventricular fill delay onset overt cor pulmonal"
"singl nucleotid primer extens detect genet diseas experiment applic hemophilia factor ix cystic fibrosi gene report describ approach detect presenc abnorm allel genet diseas frequenc occurr mutat high cystic fibrosi sickl cell diseas multipl mutat diseas sequenc variat affect member famili hemophilia initi subject dna fragment putat mutat site amplifi polymeras chain reaction fragment reaction mixtur prepar amplifi fragment primer mer longer sequenc ident code sequenc normal gene immedi flank end mutat site alphaplabel nucleotid normal code sequenc mutat site alphaplabel nucleotid mutant sequenc singl nucleotid primer extens carri analyz denatur polyacrylamid gel electrophoresi autoradiographi predict watsoncrick basepair rule wild type normal base affect member mutant base carrier normal mutant base incorpor primer essenti featur present methodolog base immedi templatebound primer alter mutant extens primer singl base give extend molecul characterist mutant wild type method rapid carrier detect prenat diagnosi genet diseas sequenc variat"
"neonat screen cystic fibrosi wale west midland clinic assess year screen screen newborn cystic fibrosi measur immunoreact trypsin undertaken altern week wale west midland year evalu clinic benefit earli diagnosi patient detect screen diagnos clinic symptom assess annual differ clinic anthropometr biochem variabl fifti infant consid risk cystic fibrosi present meconium ileus sibl cystic fibrosi detect screen compar children diagnos clinic group includ children screen negat recognis subsequ cystic fibrosi age diagnosi screen group signific lower group diagnos clinic exclud admiss diagnost test cystic fibrosi screen group spent signific shorter time hospit year life result comparison made screen group diagnos clinic similar age year"
"controversi manag gastroschisi studi patient forti infant gastroschisi refer paediatr surgeon year period surviv patient transfer utero refer postnat birth weight gestat age apgar score similar group primari closur defect success achiev patient prenat transfer group compar postnat group signific postop assist ventil trend favour earli discharg home note prenat transfer problem aris postnat transfer contribut differ major differ result mode deliveri identifi patient treat primari closur fare signific undergo stage repair prosthet materi prospect randomis studi requir confirm find"
"endotrach resuscit neonat rebreath bag thirti asphyxi neonat resuscit endotrach anaesthet rebreath bag system limit pressur volum chest movement criterion adequ inflat inflat pressur flow record resuscit flow integr obtain volum median pressur inflat cm ho drop resuscit cm ho volum deliv chang signific volum divid pressur increas median mlkgcm ho fourteen infant form part function residu capac artifici ventil spontan breath eleven infant show evid function residu capac format preterm infant strong associ absenc function residu capac format hyalin membran diseas requir ventil suggest pressur cm ho initi resuscit studi devic posit end expiratori pressur resuscit preterm infant"
"pelvic support osteotomi unusu congenit disloc hip year follow studi structur anatomi soft tissu result longstand congenit disloc hip cdh seldom literatur similar anatomi hip year pelvic support osteotomi cdh previous observ longterm follow autopsi studi bilater pelvic support osteotomi perform year autopsi subject show unexpect flatten sciatic nerv"
"chemic depend women descript effect outcom adequ parent purpos articl defin chemic depend women maladapt respons inadequ upbring descript situat psycholog variabl character chemic depend women offer attribut women lack effect parent dysfunct childrear pattern consequenti outcom children suggest clinic intervent provid"
"radiograph manifest congenit heart diseas adult patient improv preoper evalu surgic treatment postop care patient congenit cardiac diseas larg patient popul congenit cardiac abnorm reach adolesc adulthood noninvas diagnost imag procedur plain film radiographi echocardiographi comput tomographi magnet reson imag play increas import role evalu manag adult treat untreat congenit cardiac diseas role plain film radiolog emphas"
"mutat nucleotid bind fold cystic fibrosi gene discoveri year delet phenylalanin residu amino acid posit cystic fibrosi cf gene meant approxim mutant chromosom cf account report find substitut nucleotid posit cf gene result chang asparagin lysin amino acid posit diseasecaus mutat involv nonconserv amino acid chang found cf chromosom consist haplotyp background mutat detect direct sequenc pcramplifi genom dna confirm dot hybrid normal mutant allelespecif oligonucleotid mutat detect chromosom individu normal chromosom presenc heterozyg state correl clinic status individu patient"
"epidermolysi bullosa simplex koebner keratin disord ultrastructur immunohistochem studi skin biopsi specimen obtain month femal epidermolysi bullosa simplex koebner histolog intraepiderm separ consid form cytolysi epiderm basal cell ultrastructur basal cell lack cytoplasm tonofila initi chang cytolysi cleavag cytoplasm immunohistochem basal cell keratin express suprabas cell layer basal cell layer panepitheli keratin detect basal cell layer find suggest keratin product epiderm cell delay result weak basal cell minor trauma skin"
"autogen atrial tunnel direct cavopulmonari connect infant small children techniqu construct autogen atrial tunnel direct cavopulmonari connect infant small children requir fontan oper advantag subset patient method previous prosthet growthlimit materi suggest"
"mutat dnabind domain androgen receptor gene complet testicular femin patient receptorposit androgen resist androgen resist wide rang quantit qualit defect androgen receptor fibroblast cultur approxim patient clinic endocrin genet featur characterist androgen resist express normal quantiti appar normal androgen receptor cultur genit skin fibroblast receptorposit androgen resist analyz androgen receptor gene patient receptorposit complet testicular femin detect singl nucleotid substitut nucleotid zinc finger dnabind domain result convers arginin residu posit prolin residu introduct mutat androgen receptor cdna transfect express plasmid eukaryot cell lead synthesi receptor protein display normal bind kinet inact function assay receptor activ conclud substitut mutat dnabind domain androgen receptor receptorposit androgen resist"
"neuron ceroidlipofuscinosi preferenti metabol alter thalamus posterior associ cortex demonstr pet region brain glucos utilis investig positron emiss tomographi pet fluorodeoxyglucos fdg sibl neuron ceroidlipofuscinosi consist pattern found decreas glucos utilis grey structur mark level thalamus posterior associ cortex sever metabol anomali correl degre clinic impair diseas durat sever oldest patient affect clinic intermedi minim subject shortest period develop diseas observ suggest pet definit anatom target metabol diseas investig pathophysiolog"
"matern age birth defect popul studi women develop countri delay childbear older age import find birth defect result chromosom anomali relat matern age studi children birth defect unknown aetiolog identifi consecut livebirth british columbia case record link provinci birth record determin matern age birth exclud children chromosom anomali birth defect aetiolog birth defect categori studi show signific maternalagespecif trend decreas linear trend matern age patent ductus arteriosus chi df hypertroph pylor stenosi chi df bellshap curv risk increas matern age fall congenit dislocat hiphip click find populationbas analysi associ incid birth defect unknown aetiolog advanc matern age reassur healthi women opt delay childbear"
"activ chlorid channel normal cystic fibrosi airway epitheli cell multifunct calciumcalmodulindepend protein kinas cystic fibrosi defect regul apic membran chlorid channel airway epitheli cell channel normal cell activ cyclic ampdepend protein kinas protein kinas cystic fibrosi kinas fail activ normal cl channel cl flux cystic fibrosi cell normal cell activ rais intracellular ca ref report cell patch clamp studi normal cystic fibrosisderiv airway epitheli cell show cl channel activ ca mediat multifunct cacalmodulindepend protein kinas find intracellular applic activ kinas atp activ cl current similar activ ca ionophor peptid inhibitor kinas calmodulin block cadepend activ cl channel peptid inhibitor protein kinas block cadepend activ cacalmodulin activ cl channel present pathway therapeut potenti circumv defect regul cl channel cystic fibrosi"
"spatial local magnet reson spectroscopi brain normal asphyxi newborn phasemodul rotat frame imag modif magnet reson spectroscopi linear radiofrequ field gradient obtain spatial local biochem inform phasemodul rotat frame imag studi region cerebr energi metabol brain normal newborn newborn birth asphyxia relat concentr phosphorus metabolit intracellular ph determin brain tissu depth brain surfac neonat wide variat metabolit ratio normal neonat metabol heterogen demonstr individu neonat depthresolv spectroscopi asphyxi neonat sever hypoxicischem encephalopathi poor neurodevelopment outcom show expect rise inorgan orthophosph fall phosphocreatin concentr global spatial local spectra phasemodul rotat frame imag show metabol derang superfici deeper brain tissu inorgan orthophosphateadenosin triphosph ratio cm brain surfac accur global metabolit ratio identif neonat poor shortterm outcom data consist vulner subcort brain tissu hypoxicischem injuri fullterm neonat"
"neuropsycholog outcom pediatr liver transplant children endstag liver diseas undergo liver transplant unrecogn neuropsycholog academ deficit remedi program intellectu academ neuropsycholog measur pediatr patient receiv success liver transplant year previous compar patient cystic fibrosi control effect growth retard chronic ill match age age diagnosi physic growth parent socioeconom status liver transplant patient signific lower score nonverb intellig test sd liver transplant cystic fibrosi patient lower academ achiev lower zeta score age area learn memori abstract concept format visualspati function motor function differ found test verbal intellig alert concentr perceptualmotor sensoryperceptu area cyclosporin level found correl posit motor speed psychoeduc neuropsycholog evalu consid pediatr patient receiv liver transplant children maxim potenti"
"bovin surfact replac therapi neonat week gestat random control trial prophylaxi versus treatment influenc time surfact replac therapi treatment neonat respiratori distress syndrom evalu studi neonat week gestat random assign prior deliveri studi group control dummi instil air birth earli surfact surfact birth late surfact surfact hour age subject late surfact group avoid treatment clear chest roentgenogram requir supplement oxygen airway pressur cm water treat neonat elig receiv addit dose day life group compar respect birth weight gestat age perinat paramet lower cord arteri ph minut apgar score earli surfact group neonat random assign late treatment deem surfact suffici avoid treatment receiv dose age hour signific improv gas exchang week life surfact group compar control group reflect differ fraction inspir oxygen arterialalveolar po ventil index peak pressur rate ventil surfact therapi result lower incid pulmonari air leak sever chronic lung diseas defin requir respiratori support week postconcept age differ earli late surfact group paramet statist signific differ surfact group earli group higher incid mild chronic lung diseas respiratori support day age late treatment group neonat late treatment group extub earlier shorter neonat intens care unit stay control neonat earli group signific control neonat paramet conclud replac therapi bovin lung surfact extract neonat week gestat result decreas oxygen ventilatori requir week life lower incid pulmonari air leak sever chronic lung diseaseabstract truncat word"
"congenit orthoped anomali impact famili babi born congenit limb defici present challeng parent health care profession lack inform treatment option exacerb crisi famili treatment modal famili general depend child specif limb defici defici surgeri reconstruct defici workabl option patient abnorm joint soft tissu amput recommend patient defici difficult imposs manag prosthet limb lengthen option patient bone smaller normal prosthet wide treatment modal immedi equal limb length improv function babi born congenit limb defici initi respons parent shock denial adjust newborn mourn loss babi expect adjust process begin specif inform limb defici treatment option famili adjust child continu process child grow manag strategi chang adjust child chang time health care famili intervent child congenit limb defici happi success person"
"pediatr cardiac surgeri guid echocardiographi establish indic trend cardiac surgeri children preced cardiac catheter diagnosi base clinic find dimension doppler echocardiographi oper cardiopulmonari bypass major minor diagnost error case openheart surgeri major minor error malform suitabl nonbypass surgeri catheter reduc pulmonari blood flow requir systemicpulmonari arteri shunt aortic coarctat patent ductus arteriosus openheart surgeri invas investig atrial septal defect partial atrioventricular canal aortic pulmonari stenosi cardiac tumor isol valv disord classic candid recent experi select case complet atrioventricular canal tetralog fallot truncus arteriosus total anomal pulmonari venous connect transposit great arteri safe undergo primari repair cardiac catheter diagnost potenti pediatr cardiac surgeon familiar echocardiographi"
"antagonist agonist effect transform growth factorbeta il rheumatoid synovium investig potenti mechan lymphocyt infiltr rheumatoid synovium immunosuppress synovi fluid synovi tissu cultur supernat il bioactiv detect thymocyt prolifer assay prepar support prolifer fibroblast monolay consist presenc il fibroblast growth factor addit rheumatoid synovi fluid synovi cultur supernat exogen il il bioassay caus mark inhibit assay indic il inhibitor inhibit il revers treat effus supernat neutral antibodi transform growth factorbeta tgfbeta monocytemacrophag isol rheumatoid synovi fluid constitut releas latent activ tgfbeta cultur level suffici complet block biolog activ ml il product substanti level tgfbeta synovi macrophag appar abil inflammatori macrophag activ latent tgfbeta implic tgfbeta import inhibitor ilinduc lymphocyt prolifer key cytokin promot synovi fibroblast hyperplasia patholog"
"evid cutan antigenpres cell migrat region lymph node contact sensit studi address hypothesi agbear epiderm langerhan cell migrat region lymph node contact sensit function apc skin ch mice graft balb nude mice day recipi sensit fitc graft apc lymph node drain site sensit capabl sensit ch recipi fitc sensit mhc restrict cell reach lymph node graft skin induc contact hypersensit ch mice examin fitc drain lymph node cell immunofluoresc immunoelectron microscopi demonstr ia birbeck granul studi demonstr ia fitc cell skin langerhan cell leav skin epicutan sensit fitc particip initi contact hypersensit respons region lymph node"
"aberr prolifer lumenform cell stratifi epithelium porokeratosi skin present investig base postul propos reed leon porokeratosi lesion repres clonal growth epiderm cell compar studi immunocytochem stain epiderm cell cultur equilibrium ph gradient nephg gel electrophoresi analysi keratin extract carri patient type porokeratosi posit type iv collagen stain stratum corneum found lesion skin specimen patient normal control search connect type iv collagen basement membran epidermi skin surfac disclos infrequ intraepiderm streak type iv collagen posit stain transepiderm acrosyringium posit intraepiderm laminin stain porokeratosi lesion confirm transepiderm passag basementmembran materi epiderm cell cultur lesion skin show low plate effici coloni exhibit intracytoplasm vacuol format excess top cell shed nephg gel electrophoresi keratin extract show lesion profil keratin present glabrous skin possibl addit protein immunoloc periduct cell previous studi find strong suggest porokeratosi epidermi consist epitheli cell lumenform abil"
"innermost cell layer outer root sheath posit ki express cell prolifer human nuclear antigen immunohistochem studi human anagen hair hair follicl monoclon antibodi ki reaction ki matur anagen hair follicl observ hair matrix cell outer root sheath cell nuclear stain small number matrix cell cell find correspond thymidin bromodeoxyuridin label studi previous report addit pattern cytoplasm stain strong stain innermost cell imc weaker stain cell isthmus ki reactiv imc layer observ stage anagen regular upper bulb isthmus ki commerci antibodi detect cycl cell imc anagen hair follicl show cytoplasm label ki matrix cell upper bulb distal portion isthmus"
"increas phospholipas catalyz hydrolysi phosphatidylinositolbisphosph sndiacylglycerol content psoriat involv compar uninvolv normal epidermi evid suggest phospholipas protein kinas signal transduct system particip regul epiderm cell growth differenti psoriat epidermi character hyperprolifer defect differenti inflamm report determin activ phospholipas catalyz hydrolysi phosphatidylinositolbisphosph pip diacylglycerol content normal psoriat involv uninvolv epidermi diacylglycerol form phospholipas catalyz hydrolysi pip physiolog activ protein kinas pip hydrolysi assay solubl particul fraction prepar keratom biopsi normal psoriat skin total lipid extract normal psoriat epidermi diradylglycerol mixtur diacylglycerol ether acylglycerol quantit enzym assay diacylglycerol potent activ protein kinas relat proport diacyl ether acylglycerol uninvolv involv psoriat epidermi determin accomplish separ acet deriv diacylglycerol ether acylglycerol thin layer chromatographi solubl membran phospholipas catalyz pip hydrolysi increas time time psoriat involv compar uninvolv normal epidermi diradylglycerol content signific elev time psoriat involv versus uninvolv normal epidermi analysi acet deriv diradylglycerol psoriat uninvolv involv epidermi reveal diacylglycerol major speci signific differ phospholipas catalyz pip hydrolysi diacylglycerol content uninvolv normal epidermi diacylglycerol purifi normal involv psoriat epidermi capabl activ protein kinas normal epidermi vitro epiderm slice activ protein kinas addit tetradecanoylphorbolacet diacylglycerol dioctanoylglycerol result subsequ decreas protein kinas activ process term regul data consist possibl elev lesion diacylglycerol content account part previous report reduct protein kinas activ psoriasi horn mark fisher al invest dermatol"
"success cultur adult human melanocyt obtain normal vitiligo donor develop growth condit human melanocyt uninvolv skin vitiligo patient agematch normal adult prerequisit understand etiolog pigmentari disord growth condit pure melanocyt cultur prepar normal adult pigment skin vitiligo donor cell type grew lag period maintain month passag cultur expand thousand melanocyt origin cell suspens million cell pure cultur obtain result current standard condit cultur fetal melanocyt substanti modifi mem medium satisfactori mcdb adult normal vitiligo cell requir presenc exogen catalas microgramsml isol primari seed enzym melanocyt grew gave highest yield concentr calcium microm phorbol ester tetradecanoylphorbolacet tpa low nm growth factor includ mcdb media bfgf crude bovin pituitari extract insulin transferrin hydrocortison fcs antioxid alphatocopherol cholera toxin isobutylmethylxanthin ibmx omit mcdb growth medium slow growth low concentr result adult vitiligo melanocyt cultur preliminari studi normal vitiligo cell vitiligo melanocyt retain ultrastructur abnorm observ skin grown cultur"
"clinic signific immun reaction streptococc antigen rheumatoid arthriti level antibodi delayedtyp hypersensit group specif polysaccharid cell wall protein group streptococci determin patient rheumatoid arthriti ra healthi person patient articular disord enzym link immunosorb assay passiv hemaglutin leukocyt migrat inhibit test increas immun respons antigen group streptococcus found patient ra greatest sensit antigen typic high diseas activ short durat rapid progress ra high titer antibodi polysaccharid group streptococcus synovi fluid earli stage clinic develop ra valu immun respons streptococc antigen correl titer rheumatoid factor concentr immunoglobulin immun complex presenc group streptococcus urogenit tract patient ra healthi person possibl trigger role immun reaction antigen group streptococcus immunopatholog process ra discuss diagnost signific result"
"antibodi denatur type ii collagen rheumatoid arthriti negat associ igm rheumatoid factor serum sampl patient definit classic rheumatoid arthriti ra assay elisa antibodi denatur bovin type ii collagen dii patient activ diseas time serum sampl antidii antibodi found patient confid interv clinic laboratori featur presenc antidii antibodi seroneg igm rheumatoid factor igm rf seroneg patient antidii antibodi seroposit patient associ antidii antibodi age sex race diseas activ diseas durat function class presenc hladr dr dqw patient antibodi type ii collagen pathophysiolog role ra patient seroneg rf"
"puls suppress treatment rheumatoid arthriti intraven methylprednisolon nitrogen mustard persist polyarticular rheumatoid arthriti ra aggress diseas flare resist convent therapi effect control intraven puls methylprednisolon ivmp nitrogen mustard hn efficaci toxic immunolog effect agent review clinic respons evid day start therapi persist week ivmp day hn morbid agent minim precaut mortal direct relat modal report ra"
"elev serum level solubl interleukin receptor interleukin neopterin diffus limit scleroderma effect chlorambucil studi patient system sclerosi ssc elev serum level solubl interleukin receptor ilr interleukin il neopterin indic lymphocytemonocyt activ note earli untreat patient ssc diffus limit level ilr il neopterin lower patient longer durat diseas possibl chlorambucil therapi pharmacolog alter marker humor cell mediat immun accur reflect clinic efficaci chlorambucil"
"doubl blind placebo control trial low dose clotrimazol rheumatoid arthriti seventi patient rheumatoid arthriti random doubl blind studi receiv clotrimazol mgkgday day week week match placebo patient receiv clotrimazol signific improv baselin measur grip strength joint count patient assess pain show signific improv patient treat placebo advers experi predomin gastrointestin complaint occur patient clotrimazol result patient discontinu therapi"
"lack signific interact low dose methotrex ibuprofen flurbiprofen patient arthriti low dose methotrex mtx wide treatment rheumatoid arthriti current product recommend accompani mtx prepar advis concurr usag nonsteroid antiinflammatori drug nsaid advers pharmacokinet interact report combin patient receiv mtx studi oral parenter mtx mgdose nsaid ibuprofen mgday flurbiprofen mgday week dose serum mtx level obtain frequent interv serum separ mtx analyz radioimmunoassay ria observ interact mtx ibuprofen flurbiprofen respect area curv unit dose cmax cmaxdos tmax serum halflif pharmacokinet indic signific influenc rout administr"
"psycholog screen rheumatoid arthriti object examin util symptom checklist scl psycholog screen instrument patient rheumatoid arthriti ra subject male femal patient classic definit ra categor anatom stage group base roentgenogram erythrocyt sediment rate joint count scl obtain subject addit rheumatologist survey item analyz identifi potenti diseas relat item scl survey item analys support util scl psycholog screen instrument popul ra"
"reliabl pain scale assess liter illiter patient rheumatoid arthriti assess measur chronic pain reliabl valid sensit chang studi evalu reliabl pain scale visual analogu scale vas numer rate scale nrs verbal rate scale vrs liter illiter patient rheumatoid arthriti ra patient ra attend outpati rheumatolog clinic interview score pain level pain scale scale present random order regular medic consult nineti patient studi illiter liter pearson product moment correl assess vas nrs vrs liter patient group vas nrs vrs illiter patient group result nrs higher reliabl group patient"
"estim incid preval rare rheumatolog diseas review methodolog data sourc editori descript epidemiolog great popul base registri establish cost provid desir data instanc exist data inform system provid morbid inform suffici larg defin popul reason estim incid preval rare rheumatolog diseas"
"success pregnanc outcom associ lipoatroph diabet mellitus lipoatroph diabet mellitus rare syndrom character lipoatrophi insulinresist diabet mellitus partial lipodystrophi clinic diabet mellitus intrauterin growth retard fetal death report success pregnanc outcom women lipoatroph diabet mellitus"
"vancomycininduc red man syndrom total case red man syndrom collect children receiv vancomycin hospit estim preval retrospect analyz children compar agematch children receiv vancomycin red man syndrom develop patient red man syndrom patient reaction receiv vancomycin penicillinresist staphylococcus epidermidisposit cultur histori penicillin allergi differ observ dose kilogram group mgkg dose red man syndrom mgkg dose control children durat standard deviat vancomycin infus minut rang minut patient red man syndrom minut rang minut control group children red man syndrom rechalleng vancomycin slower infus rate prevent reduc syndrom emphas fact rate administr import determin red man syndrom suscept case clinic syndrom develop end infus patient earli minut initi infus manifest flush erythemat rash face neck ear frequent rash distribut bodi pruritus local upper trunk general children"
"major histocompat complex haplotyp studi ashkenazi jewish patient pemphigus vulgari ashkenazi jewish patient pemphigus vulgari carri major histocompat complex mhc class ii allel hladr dqw subtyp dr dqw studi patient famili haplotyp defin found patient carri hladr dqw carri case haplotyp hlab sc dr hlab sc dr extend haplotyp normal jew frequenc extend haplotyp ethnic group frequenc normal haplotyp jew remain drposit patient presum region segment defin sc dr dqw sc dr dqw variabl hla haplotyp patient dr dqw marker extend haplotyp number homozygot heterozygot dr dqw consist domin recess inherit class ii class iilink suscept gene diseas diseas attribut presenc antibodi intraepiderm intercellular cement substanc class ii suscept gene hlab sc dr dqw hlab sc dr dqw segment jewish patient control product antibodi domin express immun respons gene"
"sourc signific rais serum enzym rheumatoid arthriti hepatobiliari dysfunct rheumatoid arthriti suggest basi rais serum activ alkalin phosphatas nucleotidas lactic dehydrogenas gammaglutamyl transferas specif patholog lesion demonstr serum transaminas bilirubin invari normal paper report seri studi design determin tissu origin enzym offer altern interpret enzymolog find result suggest alkalin phosphatas origin liver lactic dehydrogenas nucleotidas origin synovi fluid polymorph synovi line cell serum alkalin phosphatas induc inflammatori mediat interleukin correl acut phase respons serum lactic dehydrogenas integr measur polymorph lysi joint offer marker joint inflamm specif measur esr level serum nucleotidas provid inform activ synovium final hepat necrosi occur transaminas monitor drug toxic"
"immunopatholog cicatrici pemphigoid affect conjunctiva conjunctiv biopsi specimen patient cicatrici pemphigoid agematch healthi individu undergo cataract surgeri analyz light microscopi immunohistochem techniqu includ panel monoclon antibodi character inflammatori mononuclear cell phenotyp result histolog examin cicatrici pemphigoid specimen show typic squamous metaplasia vasculopathi increas number mast cell abund plasma cell cicatrici pemphigoid specimen demonstr immunoreact epitheli basement membran zone bmz epithelium cicatrici pemphigoid conjunctiva show signific helper cell cd dendrit cell cd macrophag cd signific higher helpersuppressor ratio control substantia propria pemphigoid specimen show dramat increas inflammatori infiltr signific cell stain order frequenc cell cd cd helper cell cd suppressor cell cd macrophag cd mac dendrit cell cd hladr ten percent cell express interleukin receptor protein cd indic cell activ"
"case sideburn reconstruct temporoparietooccipit island flap preliminari case report larg tempor bald scar includ sideburn success reconstruct temporoparietooccipit island flap combin tissu expand flap consid kind reverseflow island flap occipit arteri fine vascular connect tempor branch superfici tempor arteri method potenti good solut sideburn reconstruct"
"individu pattern skin reactiv mold extract hundr atop patient skin test intraderm year period mold extract subject monitor reaction data suggest evalu mold sensit atop patient multipl mold extract"
"anogenit wart children clinic virolog evalu sexual abus seventi children anogenit wart examin sexual abus year period data suggest nonsexu transmiss common children year age approxim children younger age year age year evid sexual abus detect children"
"type vii collagen dej antigen comparison express inversa general variant recess dystroph epidermolysi bullosa express type vii collagen dej antigen examin patient recess dystroph epidermolysi bullosa rdeb compris gravi miti inversa indetermin subset determin specif sensit monoclon antibodi direct dermoepiderm junctionspecif epitop type vii collagen lh epitop absent patient gravi variant rdeb express diminish miti form diseas patient gravi miti variant appar normal amount type vii collagen skin contrast patient inversa variant normal express antigen patient rdeb lack dej antigen gravi variant absenc diminut infrequ observ miti inversa form intermedi find note patient classifi indetermin form rdeb variabl antigen express note affect sibl conclud assess express lh epitop type vii collagen diagnost overlap exist individu patient gravi miti form dej express sensit probe rdeb data prove assess newborn lack characterist featur gravi diseas addit base experi inversa rdeb alter express type vii collagen attribut blister format rare subset antigen strong detect dermoepiderm junction perilesion skin site"
"synovi fluid polymorphonuclear leucocyt patient rheumatoid arthriti reduc mpo nadphoxidas activ synovi fluid sf polymorphonuclear leucocyt pmn patient rheumatoid arthriti ra compar ra normal circul blood pmn ra sf pmn viabl blood pmn remain viabl cultur measur myeloperoxidas ra sf pmn degranul secret myeloperoxidas prior isol found extracellular compar ra normal blood pmn ra sf pmn show decreas basal nadphoxidas activ increas respons stimul chemotact peptid cultur stimul pmn phorbolmyrisitateacet evok equival respons popul cultur result demonstr major differ rest receptormedi activ superoxid releas ra sf pmn result import implic identifi role activ pmn ra"
"limit dilut analysi autocytotox autosuppressor cell rheumatoid arthriti limit dilut analysi shown autolog mix lymphocyt reaction regul cell popul autocytotox autosuppressor limit dilut analysi patient rheumatoid arthriti shown signific decreas popul compar control subject mechan consequ decreas"
"laboratori clinic studi pneumat grip strength devic inflat bag cuff measur grip strength establish techniqu method number problem bag diamet volum give statist signific pressur read squeez subject initi pressur mmhg mmhg gave signific result laboratori test materi test machin patient rheumatoid arthriti squeez bag techniqu squeez affect result intrins drawback system remain general familiar conveni recommend minimum detail requir pneumodynamometerderiv data publish"
"cycl combin antirheumat drug therapi rheumatoid arthriti open pilot studi combin hydroxychloroquin prednisolon altern month treatment sulphasalazin oral week puls methotrex investig patient rheumatoid arthriti ra refractori total diseas suppress medic result month signific improv visual analogu score pain joint count ritchi index scale disabl relat activ daili live esr rheumatoid factor reactiv protein degre improv maintain month commenc treatment pain score ritchi index esr paramet demonstr signific improv month therapi termin patient half due lack efficaci half side effect"
"methylsulphasalazin rheumatoid arthriti methylsulphasalazin differ sulphasalazin addit methyl group provid benefit parent drug fewer sideeffect rheumatoid arthriti ra describ outcom ra patient enter studi success complet month therapi develop advers effect withdrew reason unrel drug treatment stop inefficaci advers effect report statist signific improv clinic assess observ week onward signific improv plasma viscos observ trend improv serum crp histidin igm concentr good correl serial clinic biochem assess indic drug exhibit properti line agent median steadyst serum concentr methylsulphasalazin methylsulphapyridin microgramsml microgramsml"
"analysi il tnfalpha gene express human rheumatoid synoviocyt normal monocyt situ hybrid human il alpha il beta tnfalpha mrna express examin peripher blood monocyt pbm normal individu primari synoviocyt isol patient rheumatoid arthriti northern blot situ hybrid cell cultur presenc absenc lps analyz vitro synthes slabel sens antisens rna probe determin relat abund cell type express mrna potent inflammatori mediat result lpsstimul pbm express detect level il alpha mrna il beta mrna tnfalpha transcript major activ pbm produc il alpha il beta experi combin immunofluoresc il beta protein situ hybrid tnfalpha mrna demonstr monocyt express tnfalpha mrna produc il beta primari synoviocyt patient ra examin mrna express cytokin northern blot analys total rna isol lps mockstimul show il beta mrna abund express tnfalpha situ hybrid reveal il beta tnfalpha transcript detect exclus synovi tissu macrophag il alpha mrna detect cultur method"
"evid epiderm cytokin network cytokin glycoprotein synthes secret cell bind specif receptor target cell regul activ prolifer differenti immun immun cell keratinocyt injuri releas interleukin il il il colonystimul factor tumornecrosi factor growth suppressor factor strong evid network interact cytokin partial character maintain proper balanc excess insuffici product mediat contribut diseas state infecti autoimmun genesi understand cytokin interact elucid pathomechan diseas cytokin analogu antagonist prove therapeut"
"leukocyt chemoattract cytokin epidermi constitut product interleukin alpha materi normal human epidermi inflammatori properti mechan inflammatori action briefli review isol interleukin psoriat lesion vitro product leukocyt chemoattract properti evid suggest interleukin inflammatori cytokin major potenti import induct leukocyt infiltr human skin"
"interleukin interleukin psoriasi report level express il il skin psoriasi patient approach pursu initi level il beta il measur suction blister fluid lesion uninvolv skin psoriasi patient sensit enzymelink immunoabsorb assay elisa bioassay skin section examin presenc il il il beta ilspecif antibodi final express il il mrna determin cultur keratinocyt kc fibroblast psoriasi skin suction blister fluid lesion uninvolv psoriasi skin skin healthi individu detect level greater pgml il beta blister fluid psoriasi lesion low signific level il serum level il patient undetect cryostat skin section il betaspecif monoclon antibodi moab indirect immunoperoxidas techniqu diffus stain entir epidermi observ section uninvolv skin psoriasi patient cryostat section psoriasi lesion faint diffus stain epidermi pronounc dot intracellular stain pattern observ hand il betaspecif moab show indirect immunofluoresc techniqu unfix epiderm cell bright membran stain epiderm cell suspens psoriasi lesion slight elev level il beta il alpha mrna observ cultur kc psoriasi lesion compar normal kc hep cell line low level il mrna express kc psoriasi lesion healthi individu fibroblast psoriasi lesion express extrem low level il alpha il beta high level il mrna result point paradox situat psoriat skin blister fluid psoriasi lesion il beta il beta overexpress plasma membran intracellular compart epiderm cell find explain observ absenc il aqueous extract psoriat scale cultur kc psoriasi lesion express minim level il mrna dermal fibroblast inflammatori infiltr repres major sourc il psoriasi lesion vivo"
"role transform growth factorbeta system sclerosi system sclerosi remain unknown cellular molecular mechan possibl respons characterist clinic manifest fibrosi vascular damag raynaud phenomenon telangiectasi digit infect renal arteriopathi understood greater detail possibl import cytokin transform growth factorbeta tgfbeta involv review regard vascular lesion tgfbeta variabl shown inhibit endotheli cell growth vitro promot angiogenesi vivo paradox remain unresolv nonetheless injuri activ tgfbeta microvascular endotheli cell explain intim prolifer microvascular obliter result endotheli cell damag platelet activ document system sclerosi platelet alpha granul pool larg quantiti tgfbeta tgfbeta produc activ macrophag cell occur system sclerosi lesion import effect tgfbeta stimul fibroblast collagen fibronectin synthesi deposit extracellular matrix stimul tgfbeta account fibrosi dermi intern organ direct evid tgfbeta involv system sclerosi scanti await discoveri abnorm express respons tgfbeta biolog effect tgfbeta regul level activ latent polypeptid precursor form descript import cytokin patholog condit account activ regul nonetheless physiolog effect attribut tgfbeta make involv system sclerosi attract possibl explain manifest enigmat diseas"
"abnorm cutan topobiolog molecular basi dermatopatholog mononuclear cell pattern inflammatori skin diseas identif character adhes molecul lymphocyt function antigen intercellular adhes molecul chemotact factor interleukin monocyt chemotacticactiv factor modulatori cytokin gamma interferon tumor necrosi factor begin ascrib specif molecul cutan cellular reaction pattern abnorm topobiolog alter spatial distribut mononuclear cell rise diseasespecif pattern molecular term larg number divers skin diseas classifi group group highlight distinct cell type adhes molecul chemotact factor cytokin diseas group share function anatom reaction zone postul share common pathophysiolog pathway scan microscop field past static imag red bluestain cell dynam detail medley molecular defin event eman eyepiec"
"respons discoid subacut cutan lupus erythematosus recombin interferon alpha ten patient suffer discoid lupus erythematosus dle subacut cutan lupus erythematosus scle treat interferon alpha mark improv clear cutan lupus erythematosus lesion observ respons interferon short durat week interferon withdraw patient improv clear relaps studi suggest interferon alpha repres interest approach treatment dle scle ongo trial defin optim treatment schedul mainten interferoninduc improv cutan lupus erythematosus"
"applic betainterferon virusinduc papilloma eighti patient bilater common wart extrem treat week interv intralesion inject human fibroblast interferon placebo lyophil interferon unit dilut ml normal steril salin match ident vial placebo eighti set vial human fibroblast interferon placebo label control maintain code experi complet patient receiv unit interferon wart side placebo inject match extrem wart measur week progress lack thereof score scale wors cure therapi continu extrem clear patient receiv week inject final evalu score measur total progress patient studi sixti patient treat complet interferontr extrem cure respond effect therapi placebotr lesion respond fashion statist analysi data confirm effect intralesion interferon therapi averag number interferon inject cure advers effect observ applic interferon patient epidermodysplasia verruciformi flat wart studi intralesion interferon beta degre effect benign lesion epidermodysplasia verruciformi system treatment effect subcutan interferon beta uncontrol studi effect patient flat wart"
"atlantoaxi stabil rheumatoid arthriti atlantoaxi sublux patient rheumatoid arthriti common oper stabil sign symptom spinal cord compress occur recommend earli oper fusion evid appreci neural compress occur myelopathi patient irrevers prognosi poor symptom cord compress present risk sudden death atlantoaxi sublux increas asymptomat patient author rheumatoid arthriti patient good health advanc multisystem diseas year age consid oper stabil mobil atlantoaxi sublux greater mm seventeen patient sever rheumatoid arthriti atlantoaxi sublux treat posterior arthrodesi present method fusion devis senior author util case indic oper therapi patient includ evid spinal cord compress patient mobil atlantoaxi sublux greater mm sign symptom cord compress patient thirteen patient develop stabl osseous fusion patient align fibrous union patient malalign fibrous union patient die prior evalu fusion stabil detail oper techniqu manag strategi present technic advantag method fusion make approach patient rheumatoid arthriti multisystem involv diseas high rate osseous fusion difficult achiev"
"scar revis camouflag success revis camouflag facial scar art scienc teacher continu experi common sens broad knowledg option technic abil patienc choos practic challeng field patient facial scar vulner respons facial plastic surgeon evalu patient proper realist prepar process involv multipl procedur process expertis compass reward patient surgeon immeasur"
"autoantibodi ribonucleoprotein nucleolar rna protein particl patient system sclerosi studi sera consecut patient system sclerosi ssc scleroderma evalu sera test antinuclear antibodi immunofluoresc stain hep cell substrat exclud sera show dark nucleoli screen antibodi remain sera immunoprecipit plabel hela cell extract fifteen sera anti anti antibodi present ssc patient limit cutan involv diffus cutan involv ssc overlap syndrom control connect tissu diseas anti detect patient primari raynaud phenomenon year durat subgroup ssc limit cutan involv anti patient signific greater frequenc puffi finger small bowel involv hypothyroid signific lower frequenc arthralgia arthriti cumul surviv rate time onset symptom lower anti patient versus year primarili due death pulmonari arteri hypertens primari pulmonari hypertens pulmonari hypertens secondari pulmonari interstiti fibrosi serum anti antibodi present exclus patient ssc limit cutan involv primari raynaud phenomenon diseas evolv ssc limit cutan involv antibodi identifi patient greater risk reduc surviv"
"increas express type vi collagen gene system sclerosi express type vi collagen gene affect skin patient system sclerosi ssc examin situ hybrid human alpha vi collagen sequencespecif complementari dna patient diffus rapid progress ssc recent onset month studi result show increas express alpha vi collagen messeng rna transcript skin scleroderma patient compar skin normal subject find alter express type vi collagen gene similar previous type iii collagen present affect skin ssc patient alter result excess tissu accumul type vi collagen play role progress skin indur sclerosi promin featur ssc"
"increas express intercellular adhes molecul fibroblast scleroderma patient surfac express intercellular adhes molecul icam class class ii major histocompat complex molecul cultur dermal fibroblast scleroderma patient control donor compar scleroderma fibroblast line sem cell high level icam express icamhigh control fibroblast icamhigh differ express class class ii molecul icamhigh icamlow fibroblast produc equal amount total protein procollagen increas number icamhigh fibroblast scleroderma patient facilit cell activ lymphokin product indirect contribut fibrot process"
"associ hladw rheumatoid arthriti yakima indian evid share epitop hypothesi rheumatoid arthriti ra preval yakima indian nativ american tribe hladr hla specif common ra caucasian rare yakima specif oligonucleotid probe recogn dr nucleotid sequenc ra rare hladw gene identifi yakima patient ra yakima control subject share sequenc encod discret class ii epitop high correl ra dr posit dr negat individu"
"identif platelet dens granul membran protein defici patient hermanskypudlak syndrom monoclon antibodi rais inject mice isol human dens granul monoclon found recogn kd dens granul membran protein western blot immunofluoresc analysi confirm densegranul specif thrombin activ protein found patch extern platelet membran western blot slot blot analysi protein found mark defici patient hermanskypudlak syndrom studi neutrophil endotheli cell show presenc immunolog relat granulemembran protein western blot antisynaptophysin antibodi antibodi platelet kd protein suggest protein share homolog ident synaptosom membran protein synaptophysin"
"transvers anatomi androgen alopecia twenti biopsi specimen bald frontal scalp patient studi process includ vertic transvers horizont section toluidin blue hematoxylin eosin stain fix frozen section find includ decreas hair densiti increas number vellus hair alter normal follicular architectur transvers frozen section toluidin blue stain rapid reliabl tool studi androgen alopecia"
"urticaria clinic efficaci cetirizin comparison hydroxyzin placebo chronic urticaria problem physician patient effort avoid risk corticosteroid treatment generat hreceptor antagonist found induc undesir level sedat amount suffici control urticaria cetirizin pharmacolog activ oxid metabolit hydroxyzin develop provid select hreceptor inhibit depress central nervous system week multicent doubleblind placebocontrol safeti efficaci studi cetirizin day dose mg equival efficaci hydroxyzin divid dose mgday incid somnol cetirizin group signific placebo group hydroxyzin group incid somnol signific higher placebo group result studi demonstr cetirizin greater safeti margin older parent drug hydroxyzin"
"langerhan cell monocyt capabl antigen present vitro corticosteroid contact hypersensit corticosteroid suppress delayedtyp hypersensit dth reaction vivo impair lymphoid cell function vitro contact hypersensit chs corticosteroid corticosteroid capabl induc dth respons vivo present studi examin capac corticosteroid induc vitro prolifer lymphocyt patient chs corticosteroid peripher blood mononuclear adher cell antigenpres cell apc hydrocortisonebutyr hapten prolifer respons detect lymphocyt patient chs epiderm langerhan cell lc apc weak prolifer respons observ"
"valid sick impact profil psoriasi disabl index psoriasi prospect crosssect questionnair studi patient psoriasi carri order valid sick impact profil sip psoriasi compar sensit psoriasi disabl index pdi pdi score sip score correl pasi score good correl pdi sip score psychosoci factor sever impair physic activ patient psoriasi direct compar disabl experienc psoriat patient experienc patient suffer system diseas sip pdi method give rapid measur psoriasi disabl"
"doubleblind left comparison calcipotriol betamethason valer treatment psoriasi vulgari publish erratum lancet apr therapeut efficaci toler calcipotriol ointment betamethason valer ointment psoriasi compar multicentr prospect randomis doubleblind left trial inpati outpati psoriasi vulgari symmetr distribut treat daili week calcipotriol ointment microgram betamethason ointment random assign opposit side bodi main outcom measur psoriasi area sever index pasi investig assess erythema thick scale patient assess respons treatment sought week treatment signific reduc pasi score investig assess score visit pasi score signific lower calcipotriol betamethason week pasi reduct calcipotriol betamethason confid interv differ score erythema thick scale signific lower calcipotriol betamethason end treatment patient consid calcipotrioltr side betamethasonetr side improv great clear end treatment advers event report patient common advers event lesionalperilesion skin irrit slight signific common calcipotriol treatment patient withdrawn studi local advers event serum calcium studi calcipotriol ointment superior betamethason valer ointment psoriasi vulgari longterm result calcipotriol hold great promis antipsoriat agent"
"keratinocyt initi inflamm environment stimuli respons induc cutan inflamm includ contact allergen ultraviolet light postul divers stimuli trigger cutan inflammatori respons direct induc epiderm keratinocyt elabor specif proinflammatori cytokin adhes molecul consequ activ dermal microvascular endotheli cell select accumul specif mononuclear cell dermi epidermi keratinocyt act signal transduc capabl convert exogen stimuli product cytokin adhes molecul chemotact factor act autocrin paracrin fashion respons initi antigenindepend cutan inflamm initi phase facilit promot amplif phase addit product tumournecrosi factor alpha interferon gamma antigendepend pathway keratinocyt cellantigenpres dendrit cellular associ direct activ keratinocyt abil produc complet repertoir proinflammatori cytokin profound influenc endogen recruit immunocompet cell provid critic trigger respons swift clinic dramat alter occur contact epidermi host noxious agent"
"ultrastructur local calcium psoriat normal human epidermi ion captur cytochemistri previous demonstr distribut calcium ion murin epidermi pattern consist role ion regul epiderm differenti prolifer differenti defect psoriasi compar calcium distribut involv uninvolv psoriat lesion normal human epidermi normal human uninvolv psoriat epidermi reveal increas calcium precipit uppermost stratum granulosum contrast basal layer psoriat lesion extracellular calcium condit favor enhanc prolifer psoriat suprabas cell layer display heavier normal concentr calcium indic loss normal calcium gradient program termin differenti abnorm profil account differenti defect parakeratosi occur psoriasi final psoriat lesion display retain ionic ca intercellular domain upper stratum granulosum absenc normal intercellular bilay find underli abnorm desquam permeabl barrier psoriasi"
"papuloerythroderma case diseas describ case papuloerythroderma distinct clinic entiti character pruritus redbrown flattop papul exhibit deckchair sign eosinophilia lymphopenia propos langerhan cell central role pathogenesi papuloerthroderma describ excel respons photochemotherapi"
"newli identifi uu snrnpbind protein serum autoantibodi patient system sclerosi found serum autoantibodi direct protein bind exclus uu sm small nuclear ribonucleoprotein particl snrnp serum patient mas system sclerosi specif call antima distinct antibodi snrnp small nuclear rna plabel hela cell extract protein mr addit sm core protein methioninelabel extract immunoprecipit antima isoton solut sm core protein small nuclear rna separ proteinsepharos facilit mas immunoprecipit incub solut mm nacl immunoblot antima antibodi react protein mr hela cell nuclear extract fraction sdspage transfer nitrocellulos sheet monospecif immunoaffin purifi antibodi elut immunoblot band immunoprecipit small nuclear rna reblot protein mr data antima antibodi recogn antigen protein bind exclus uu snrnp"
"abnorm epiderm lipid metabol patient atop dermat atop dermat inflammatori skin diseas character dryness itch skin studi measur phospholipid content fatti acid pattern lesion lesionfre epiderm keratom biopsi patient comparison epiderm biopsi obtain healthi individu undergo plastic surgeri phospholipid content atop epidermi high healthi epidermi monounsatur fatti acid phosphoglycerid signific increas fatti acid signific decreas lesion atop epidermi compar lesionfre epidermi content esterifi arachidon acid phosphatidylcholin lesion epidermi found healthi epidermi content free arachidon acid higher content free longchain satur fatti acid decreas lesion compar lesionfre atop epidermi diseas sever calcul arbitrari index correl invers fatti acid content lesionfre atop epidermi find suggest atop epidermi character increas activ phospholipas incomplet transform phospholipid lipid class"
"effect retino acid plateletderiv growth factor pdgf bioactiv type pdgf receptor normal psoriat human fibroblast psoriasi common skin diseas retinoid benefici effect offer model studi benign hyperprolifer abnorm differenti dermi promin role epiderm lesion interest studi factor modul dermal cell prolifer studi role retinoid modul plateletderiv growth factor pdgf bioactiv studi normal subject psoriat fibroblast involv uninvolv tissu patient retino acid treatment psoriat fibroblast signific increas chemotact effect pdgf cell involv uninvolv skin ngml plateletderiv growth factor measur modifi boyden chamber assay retino acid treatment psoriat fibroblast increas mitogen plateletderiv growth factor cell retino acid treatment signific effect mitogen chemotact activ pdgf normal fibroblast bind homodim bb pdgf type receptor mediat mitogen chemotact effect pdgf modifi retino acid treatment psoriat normal fibroblast result suggest retino acid modul pdgf bioactiv psoriat fibroblast affect bind ligand cell influenc postreceptor event"
"character kd bullous pemphigoid antigen detergentinsolubl fraction cultur keratinocyt kd protein identifi antibodi patient bullous pemphigoid bp dual locat cultur normal human epiderm keratinocyt part highspe supernat homogen cell part particul fraction resist extract ionic deterg mild base antibodi affin purifi particul kd bp antigen extract presenc urea affinitypurifi antibodi bind cytosol kd protein show relat ident particul form produc discontinu granular pattern indirect immunofluoresc basement membran zone rabbit esophagus stratifi epiderm cultur express kd bp antigen limit basal cell data consist kd bp antigen involv keratinocyt basal cell interact extracellular matrix cultur cell provid model analysi kd bp antigen function"
"calciumsensit epitop pemphigus foliaceus antigen present murin tryptic fragment constitut major antigen region human autoantibodi recent find pemphigus foliaceus pf antigen involv epiderm cell adhes characterist pf lesion result loss function consequ autoantibodi bind present communic present data epitop involv human autoantibodi bind immunolog reactiv murin tryptic fragment pf antigen tfpf immunoprecipit experi show pf sera obtain north american colombian brazilian patient recogn calciumsensit epitop tfpf immunofluoresc block experi show preincub tfpf complet block immunofluoresc sera test human skin substrat sera test murin skin substrat result show calciumsensit epitop origin recogn human pf complex present murin tfpf constitut major antigen region human pf autoantibodi implic region pf antigen pathogenesi pf epiderm cell adhes"
"reduc neutrophil ltb releas atop dermat patient normal fatti acid composit proposit abnorm fatti acid metabol atop dermat patient prompt compar phospholipid fatti acid composit ltb releas neutrophil atop dermat patient adipos tissu triglycerid fatti acid composit healthi control match age gender smoke habit found differ tissu fatti acid composit group releas leukotrien caionophorestimul neutrophil patient averag measur control group similar arachidon acid content cell studi support assumpt abnorm fatti acid desatur atop dermat patient capac releas convert arachidon acid leukotrien neutrophil affect diseas"
"local neutrophilactiv peptideinterleukinimmunoreact normal psoriat skin cytokin past detect human skin neutrophilactiv peptid napil potent kd proinflammatori peptid purifi psoriat scale chemotact activ human neutrophil presenc psoriat scale relat role diseas present studi tissu distribut peptid examin immunohistochem monoclon antibodi recent produc character laboratori immunoreact detect normal psoriat skin result uniform suprabas keratinocyt stain normal skin keratinocyt immunoreact psoriasi correl inflammatori tissu reaction vari uniform absenc high activ psoriasi focal weak stain plaqu type psoriasi cell acrosyringium hair follicl posit unaffect inflammatori activ epiderm immunoreact detect studi close relat peptid il famili truncat extend form napil"
"character skininfiltr lymphocyt patient psoriasi studi skininfiltr cell psoriasi patient character biopsi involv uninvolv skin histolog examin biopsi show presenc cd cd cell lack lymphocyt skin biopsi tissu cultur medium supplement human serum interleukin il irradi autolog blood lymphocyt lymphocyt grew plaqu univolv skin biopsi consist heterogen popul cell subset immunophenotyp analysi cultur cell compar histolog examin frozen section greater number cdcdw cell cdcd cell cultur test prime lymphocyt test plt cellmedi lympholysi cml assay cultur test demonstr secondari prolif cytolyt reactiv plt result cell cultur generat autoreact autoreact found direct human leukocyt antigen hla minor hla restrict major hla antigen"
"igabind structur dermat herpetiformi skin independ elasticmicrofibrillar bundl dermat herpetiformi dh character part presenc granular deposit iga papillari dermi beneath dermalepiderm junction natur structur iga bind dh skin demonstr previous immunoelectronmicroscopi studi peroxidaseantiperoxidas techniqu conclud iga bind abnorm elast microfibrillar bundl recent antibodi develop major compon elast microfibril bundl fibrillin addit dermal matrix protein hexabrachion character found normal human skin distribut similar iga deposit dh util antibodi fibrillin hexabrachion human iga immunoelectronmicroscopi immunogold stain techniqu examin skin patient dh order local iga deposit normalappear skin patient dh exhibit electrondens patch dermi skin normal subject structur adjac basement membran zone amorph defin fibrillar structur electrondens patch label antihuman iga antibodi fibrillin hexabrachion antiiga antibodi label normal basement membran studi confirm presenc abnorm electrondens amorph structur skin patient dh due lack associ elast microfibril bundl lack label antibodi fibrillin suggest deposit distinct microfibrillar bundl elast tissu repres iga bound degrad basement membran isol dermal deposit iga"
"express basement membran protein interstiti collagen dermal papilla human hair follicl express basement membran molecul interstiti collagen human hair follicl mesenchym studi immunohistochem stain tissu section cell cultur dermal papilla type type iii collagen found dermal sheath dermal papilla hair cycl laminin type iv collagen express outer root sheath basement membran extracellular matrix dermal papilla anagen catagen follicl telogen follicl volum dermal papilla extracellular matrix reduc outlin stain dermal papilla cell laminin type iv collagen appar stain bullous pemphigoid antigen outer root sheath basement membran extend lower tip hair bulb anagen follicl stain bullous pemphigoid antigen interfac hair bulb epithelium dermal papilla stain dermal papilla linear stain bullous pemphigoid antigen continu hair follicl epithelium catagen telogen cell cultur human dermal papilla stain interstiti collagen type iv collagen laminin similar result obtain cultur dermal fibroblast stain antibodi express basement membran protein human dermal papilla resembl follicl mammalian speci suggest relev dermal papilla function cultur dermal papilla cell express similar pattern interstiti collagen basement membran protein tissu section find specif dermal papilla cell"
"cellular local interleukin induc tumor necrosi factoralpha psoriasi import immunolog mechan psoriasi deduc abil immunosuppress therapi amelior common chronic skin diseas histolog psoriat lesion suggest dialogu hyperplast keratinocyt infiltr lymphocyt macrophag begin dissect cytokin network involv pathophysiolog psoriasi locat epiderm dermal compart tumor necrosi factoralpha interleukin intercellular adhes molecul transform growth factoralpha protein mrna level identifi tumor necrosi factoralpha select potenti key regulatori cytokin induc cultur keratinocyt interleukin intercellular adhes molecul transform growth factoralpha product intercellular adhes molecul express keratinocyt psoriat epidermi identifi previous immunohistochem local tumor necrosi factoralpha identifi psoriat lesion intens diffus express dermal dendrocyt macrophag papillari dermi signific stain endotheli cell mast cell dermal langerhan cell focal keratinocyt intraepiderm langerhan cell function interact dermal dendrocyt keratinocyt suggest presenc interleukin express suprabas keratinocyt immedi tumor necrosi factoralphaposit dermal dendrocyt interleukin mrna transform growth factoralpha mrna detect epiderm roof psoriat lesion detect protein mrna level normal skin specimen treatment cultur human keratinocyt phorbol ester experiment produc psoriasiform mous skin tumor necrosi factoralpha increas interleukin transform growth factoralpha mrnas elucid cellular molecular basi genesi evolut psoriasi provid framework evalu treatment skin diseas"
"monoclon antibodi detect monocytemacrophag activ differenti antigen identifi function distinct subpopul human rheumatoid synovi tissu macrophag monoclon antibodi mab function heterogen popul human rheumatoid arthriti ra synovi tissu macrophag lipopolysaccharid lpsactiv cell generat mab character macrophag situ synovi pannus studi relat antigen express surfac cell isol synovium normal peripher blood monoclon antibodi anticd mab react antigen express surfac blood monocyt monocyt activationrel antigen upregul exposur monocyt interferongamma ifngamma lps express antigen increas parallel mhc class ii antigen express upregul cultur monocyt matur macrophag antigen express strong ra synovi tissu line cell thought compos macrophag antigen express detect mab increas blood monocyt cellular activ lps interferongamma contrast antigen increas monocyt matur vitro antigen express differenti densitydefin macrophag subpopul isol ra synovi tissu express strong macrophag nonangiogen angiogen"
"treatment brittl fingernail onychoschizia biotin scan electron microscopi patholog hoof hors swine normal administr biotin vitamin oral women brittl fingernail onychoschizia aim studi test favor clinic result corrobor scan electron microscopi investig distal end fingernail person group group consist control subject normal nail group compris patient brittl nail studi biotin treatment group patient brittl nail administr biotin coincid initi termin clip nail thick nail group increas signific group increas split nail reduc group irregular cellular arrang dorsal surfac brittl nail regular nail group nail group"
"lymphocyt infiltr skin associ cyclosporin therapi patient previous report erythemat papul nodul face upper part chest cyclosporin therapi inflammatori skin diseas histolog examin dna analysi perform case reveal benign dermal lymphocyt infiltr case prolifer cell occur case cell popul expand vacuolar degener basal layer epidermi igg igm deposit dermoepiderm junction find result cyclosporineinduc immun dysregul lesion resolv patient therapi stop"
"antibodi synthet peptid epsteinbarr nuclear antigen sera patient earli rheumatoid arthriti preill sera studi igg antibodi level synthet peptid epsteinbarr nuclear antigen ebna protein sequenc sera patient rheumatoid arthriti ra prera rheumatoid factor rf posit ra sera finland anti anti antibodi level signific elev ra sera compar rf negat rf posit nonrheumatoid control concentr anti anti antibodi preill sera lower ra sera year followup sampl patient ra slight decreas level anti anti antibodi compar sampl month diseas onset antip antibodi level differ signific group studi elev level antibodi glycin ebna peptid clinic ra"
"epiderm growth factor receptor fibroblast patient scleroderma epiderm growth factor receptor egf fibroblast patient scleroderma progress system sclerosi pss studi radioiodinatedegf bind assay bind normal fibroblast scatchard plot show decreas affin egf number egf pss fibroblast express higher level fold rna erbb egf gene transretino acid retinoid effect egf erbb gene express prolifer pss fibroblast data abnorm egf constitut featur pss fibroblast"
"report erythemat macular skin erupt diltiazem therapi diltiazem common prescrib calciumchannel antagonist hypertens ischem heart diseas incid rash diltiazem therapi report percent describ patient develop erythemat macular skin erupt approxim week institut diltiazem skin erupt resolv symptomat treatment patient receiv therapi calciumchannel antagonist diltiazem skin erupt rare advers effect incid rash occur frequent report postmarket surveil studi"
"cyclosporin nonpsoriat dermatos articl review indic efficaci mechan action cyclosporin treatment nonpsoriat dermatos dermatos categor respons cyclosporin therapi excel moder variabl nonrespons advantag disadvantag cyclosporin discuss guidelin propos nonpsoriat dermatos"
"manag patient side effect cyclosporin therapi cutan disord cyclosporin experiment treatment multipl inflammatori diseas presum autoimmun origin includ insulindepend diabet mellitus uveiti rheumatoid arthriti inflammatori bowel diseas grave diseas myasthenia gravi dermatolog drug success primari therapi psoriasi psoriat arthriti alopecia areata pyoderma gangrenosum behcet diseas atop dermat lichen planus dose mgkg day cyclosporin toler patient concern potenti short longterm side effect patient drug requir close monitor review discuss clinic laboratori evalu common unusu side effect manag drug alter pharmacokinet cyclosporin metabol criteria dosag adjust"
"laboratori monitor cyclosporin level guidelin dermatologist guidelin recommend laboratori monitor circul level cyclosporin dermatolog patient measur determin trough level blood plasma serum measur perform assay specif parent cyclosporin compound highperform liquid chromatographi method specif monoclon immunoassay result nonspecif immunoassay detect cyclosporin metabolit difficult interpret readili compar studi laboratori psoriasi patient circul concentr cyclosporin correl reliabl therapeut respons patient achiev excel respons blood level rang ngml show respons blood level high ngml patient poor clinic respons monitor cyclosporin level confirm drug provid estim degre absorpt metabol parent compound upper limit safeti circul concentr cyclosporin defin attempt achiev therapeut respons lowest dose clinician care monitor patient sign cyclosporin toxic circul concentr drug blood level exceed ngml avoid"
"effect cyclosporin renal function psoriasi patient prospect studi document effect oral cyclosporin treatment psoriasi cyclosporin limit concern possibl druginduc renal dysfunct review effect cyclosporin renal function"
"immun cyclosporin therapi cyclosporin cytotox inhibit product immunolog memorybuild growth factor cd lymphocyt inhibitori effect effector phase immun reaction inhibitori effect larg revers treatment stop immun compet cyclosporinetr patient return normal contrast convent cytotox immunosuppress agent tend extermin lymphocyt clone activ therapi clonal delet perman loss immunolog memori antigen lymphocyt readili restor adult involut thymus transplant patient receiv cyclosporin combin immunosuppress agent report suggest combin drug convent immunosuppress agent increas earli hodgkin lymphoma possibl endocrinerel tumor increas cancer observ patient treat cyclosporin condit psoriasi autoimmun diseas treatment adult cytotox immunosuppress drug perman delet lymphocyt clone requir control latent oncogen virus malign cell patient treat cyclosporin suppress cell function combin impair cytokinemedi stimul natur killer cell cytotox macrophag facilit tumor growth predict cyclosporin monotherapi increas incid tumor primarili affect psoriasi patient treat cyclosporin puva methotrex therapi eventu comparison cancer incid categori patient resolv issu"
"interact epiderm cell cell inflammatori skin diseas multipl cell type factor cytokin involv regul immun respons inflammatori skin diseas stimulatori inhibitori factor interact determin immun respons regul stimulatori signal counteract inhibitori signal prevent immun reaction initi exogen antigen irrit endogen factor alter immunogen peptid upset balanc occur cell activ inflammatori skin reaction develop lymphokin releas activ cell modifi phenotyp function normal keratinocyt induc express adhes molecul receptor involv antigen present stimul keratinocyt prolifer import develop hyperplasia inflammatori skin diseas psoriasi cytokin releas activ keratinocyt stimul attract cell epidermi continu ongo immun reaction"
"effect cyclosporin immunolog mechan psoriasi major impetus investig cellular immunolog mechan psoriasi discoveri cyclosporin potent immunosuppress high effect treatment psoriasi cyclosporin signific inhibitori effect abil cell activ direct activ drug human keratinocyt signal transduct growth difficult demonstr relev concentr treatment psoriasi tetradecanoyl phorbolacetatetr murin skin cyclosporin revers epiderm abnorm common system suggest compound exert indirect effect epiderm keratinocyt vivo immunocyt inhibit treatment psoriasi patient cyclosporin therapi result select number function antigenpres cell subset distinct langerhan cell cell subset accompani indirect evid decreas cell lymphokin releas lesion activ cyclosporinetr psoriasi patient close correl degre cell activ caus antigenpres cell cyclosporin inhibit lymphokin cytokin releas result decreas recruit langerhan antigenpres cell epidermi decreas immunoreact lesion"
"blister diseas diagnost primari care physician present differenti diagnosi bullous diseas difficult diagnosi clarifi factor nikolski sign age patient onset pattern distribut blister care review famili recreat occup drug histori identifi"
"rheumatoid arthriti develop treatment patient activ rheumatoid arthriti obtain signific relief nonsteroid antiinflammatori drug prompt institut diseasemodifi antirheumat drug dmard recommend agent fail present hydroxychloroquin plaquenil sulfat wide toler care follow essenti dmard toxic effect sever unpredict"
"mutat pro alpha gene cola type procollagen ehlersdanlo syndrom type vii evid suggest skip exon rna splice common phenotyp fibroblast proband ehlersdanlo syndrom type vii synthes approxim equal amount normal shorten pro alpha chain type procollagen nucleas probe protect experi mrna demonstr pro alpha chain shorten delet nucleotid exon exon codon cleavag site procollagen proteinas sequenc genom clone reveal singlebas mutat convert nucleotid intron mutat chang gtconsensus splice site produc effici exon skip allelespecif oligonucleotid hybrid demonstr proband mother father brother mutat mutat sporad analysi potenti splice site end intron favor valu common employ techniqu evalu site proband fourth report proband ehlersdanlo syndrom vii singlebas mutat skip exon splice rna cola gene cola gene mutat type procollagen gene found syndrom mutat common phenotyp primer develop screen similar mutat caus diseas"
"urticaria pigmentosa system evalu success treatment topic steroid patient adultonset urticaria pigmentosa studi incid extracutan mast cell involv efficaci potent topic corticosteroid therapi cutan lesion patient increas mast cell marrow biopsi specimen patient focal aggreg mast cell bone scan abnorm patient liverspleen scan reveal shift colloid uptak liver spleen patient abnorm gastrointestin tract roentgenogram obtain urinari histamin metabolit correl nodular bone marrow involv paramet result psychoneurolog test reveal signific deviat norm verbal memori deficit patient abnorm minnesota multiphas person inventori patient patient treat betamethason dipropion ointment occlus half bodi night week patient treat respond complet resolut lesion hypothalam pituitari adren axi suppress evalu intramuscular cosyntropin stimul metyrapon administr treatment patient medic improp develop transient abnorm slow return lesion note month complet therapi remiss lengthen singl week applic topic steroid system involv frequent patient cutan mast cell diseas demonstr bone marrow biopsi mast cell lesion safe effect treat topic steroid motiv patient"
"intercellular iga dermatosi childhood select deposit monom iga intercellular space epidermi describ year girl recurr prurit vesiculopustular lesion involv trunk extrem face oral mucosa histopatholog examin reveal intraepiderm bulla neutrophil eosinophil direct immunofluoresc test show deposit iga intercellular space epidermi circul iga antiintercellular antibodi detect indirect immunofluoresc test immunofluoresc studi monoclon antibodi human iga subclass show iga antibodi belong iga antisera chain secretori compon show specif intercellular stain surfac iga cell transient increas peripher blood activ stage diseas result extragut origin iga antibodi dapson therapi shown effect"
"intralesion bleomycin sulfat therapi wart bifurc needl punctur techniqu multipl punctur techniqu bifurc vaccin needl introduc bleomycin sulfat ml steril salin solut wart result elimin random seri wart singl treatment recurr observ month follow period patient requir treatment wart erad patient request altern therapi initi failur singl bleomycin treatment"
"scar revis scar revis techniqu compar similar scar patient comparison final result uniqu interest insight choos optim techniqu procedur histor perspect provid"
"transferrin subtyp patient rheumatoid arthriti transferrin tf subtyp investig patient rheumatoid arthriti ra frequenc tfc subtyp compar result normal individu frequenc tf gene frequenc tfc gene signific higher patient compar control group relat risk ra associ tfcc type associ tfcc type result statist signific paper confirm signific associ tfc ra result tfc homozyg phenotyp protect develop ra result discuss light earlier suggest tfc subtyp confer increas risk cellular damag enhanc hydroxyl radic format exist genet linkag tf variant locus influenc suscept ra"
"preval rheumatoid arthriti sultan oman thousand hundr twenti omani adult age studi househous survey repres area oman case femal satisfi ara criteria rheumatoid arthriti ra indic preval thousand adult adjust popul structur preval thousand adult complementari data present case ra ascertain special screen clinic rural health centr hospit rheumatolog clinic part studi case ra seroposit european popul account lower preval eros diseas"
"develop patient knowledg questionnair rheumatoid arthriti multichoic patient knowledg questionnair pkq develop patient rheumatoid arthriti ra testtest test stabil kuder richardson formula intern consist seventi random select ra patient complet pkq rheumatolog patient clinic larg teach hospit wide variat total score rang total score correl year general educ diseas durat age sixti cent patient knew ra unknown thought caus injuri cold damp weather fifti cent idea blood test patient form medic widespread confus diseasemodifi drug steroid antiinflammatori drug nsaid exercis understood patient unabl differenti method energi conserv joint protect studi highlight care individu knowledg assess tool pkq effect patient educ programm"
"recruit neutrophil igedepend cutan late phase reaction mous mast celldepend partial inhibit reaction antiserum tumor necrosi factoralpha clinic import patholog igedepend disord thought reflect action bloodborn leukocyt recruit respons evalu extent mast cell respons leukocyt infiltr igedepend cutan reaction attempt elicit respons normal mice genet mast celldefici wv mice wv mice select repair mast cell defici intraderm inject cultur mast cell deriv congen normal mice found tissu swell igedepend passiv cutan anaphylaxi reaction develop rapid diminish mark antigen challeng remain detect elicit respons infiltr leukocyt predomin neutrophil occur site reach maxim level antigen challeng persist high level larg wane virtual tissu swell leukocyt infiltr igedepend cutan reaction mast cell depend intraderm inject recombin murin tnfalpha rmtnfalpha elicit neutrophil infiltr similar magnitud kinet observ igedepend mast cell degranul rabbit antirmtnfalpha antirmtnfalpha antiserum inhibit neutrophil infiltr observ inject rmtnfalpha inhibit ige mast celldepend leukocyt infiltr separ experi find tnfalpha contribut mast celldepend recruit leukocyt igedepend cutan late phase reaction suggest mast cell mediat contribut respons"
"growth factorinduc acceler tissu repair direct induct activ rabbit dermal ulcer model role polypeptid growth factor promot wound heal direct specif sequenc respons tissu wound understood investig influenc growth factor rate heal full thick dermal ulcer avascular base rabbit ear wound model preclud signific wound contract requir granul tissu epitheli cell heal origin centripet microgram pmolmm plateletderiv growth factor chain pdgfbb basic fibroblast growth factor bfgf epiderm growth factor egf appli local time wound result twofold increas complet reepitheli treat wound pdgfbb chi squar analysi bfgf egf transform growth factor tgfbeta signific inhibit reepitheli pdgfbb tgfbeta uniqu increas depth area granul tissu influx fibroblast deposit matrix wound explant pdgfbbtreat wound remain metabol activ control incorpor hthymidin dna signific hleucin hprolin collagenasesensit protein result establish polypeptid growth factor signific select posit influenc heal full thick ulcer rabbit"
"identif collagen domain bullous pemphigoid autoantigen bp bullous pemphigoid bp autoimmun diseas character subepiderm vesicl presenc autoantibodi direct epiderm basement membran zone previous studi identifi protein compon hemidesmosom bp bp primari antigen target bp autoantibodi recent report isol kb bp cdna sequenc analysi present report reveal partial bp cdna encod protein domain primari structur characterist tripl helic domain collagen glycin posit remain residu prolin collagen domain length amino acid separ noncollagen stretch amino acid collagenas digest bp cdnaencod fusion protein generat peptid fragment size consist predict locat collagenas digest site physiolog function collagen domain bp hemidesmosom protein form stabl interact constitu extracellular matrix cutan basement membran zone interact provid molecular framework adhes basal keratinocyt basal lamina"
"abrad punch graft pit facial scar abrad punch graft procedur surround scar area graft superfici dermabrad correct defect altern procedur distinct advantag standard punch graft consid contempl surgic correct ice pick facial scar normal repar process abrad punch graft heal pleas aesthet"
"incision slit graft incision slit graft great improv techniqu hair transplant incision slit graft util larger number smaller graft tradit punch graft tissu remov recipi bed vascular suppli conserv result increas graft yield clump stalk effect tradit round graft elimin larg natur frontal hairlin achiev"
"region variat express pemphigus foliaceus pemphigus erythematosus pemphigus vulgari antigen human skin express pemphigus foliaceus pf pemphigus erythematosus pe pemphigus vulgari pv antigen region normal human skin evalu indirect immunofluoresc sera high titer pf pe pv antibodi region variat observ express antigen express pf pe antigen measur endpoint titer antibodi reactiv highest skin specimen obtain upper torso lowest buccal mucosa lower torso scalp distribut pattern differ pv antigen express highest buccal mucosa scalp pattern correl provid partial explan distribut skin lesion form pemphigus"
"glycosaminoglycan product cultur skin fibroblast pasini cockaynetourain form domin dystroph epidermolysi bullosa qualit quantit comparison glycosaminoglycan gag product made fibroblast line cultur skin patient pasini albopapuloid form domin dystroph epidermolysi bullosa albopapuloid form cockaynetourain line patient simplex recess dystroph epidermolysi bullosa line normal individu reason match donor age gender site passag number achiev contrari earlier report line pasini group unexcept amount gag secret proport sulfat nonsulf gag show consist differ cockaynetourain control line pasini line secret sem microgram gaguron acid cell cockaynetourain line microgram equival cell densiti sulfat gag repres averag pasini line cockaynetourain control find consist current view albopapuloid lesion unreli clinic sign epidermolysi bullosa bring question valid pasini entiti"
"druginduc pemphigus autoantibodi direct pemphigus antigen complex present penicillamin captoprilinduc pemphigus pemphigus autoimmun blister diseas character circul autoantibodi direct keratinocyt cell surfac variant pemphigus foliaceus pemphigus vulgari distinguish molecular level immunochem studi larg major patient pemphigus develop diseas spontan small group patient develop pemphigus treatment medic penicillamin captopril document patient druginduc pemphigus circul tissu bound epiderm cell surfac autoantibodi molecular specif autoantibodi studi perform immunoprecipit studi util extract ilabel suction blister epidermi sera patient druginduc pemphigus foliaceus due penicillamin due captopril patient captoprilinduc pemphigus vulgari found patient druginduc pemphigus foliaceus circul autoantibodi direct pemphigus foliaceus antigen complex patient druginduc pemphigus vulgari circul autoantibodi direct pemphigus vulgari antigen complex studi demonstr autoantibodi druginduc pemphigus patient antigen specif molecular level autoantibodi pemphigus patient"
"vagin birth cesarean metaanalysi morbid mortal cesarean birth rate continu climb effort counteract major reason rise practic elect repeat cesarean conduct metaanalysi includ studi total trial labor evalu associ birth rout cesarean morbid mortal mother infant summari odd ratio calcul matern febril morbid signific lower trial labor elect repeat cesarean intend birth rout made differ rate uterin dehisc ruptur oxytocin presenc recurr indic previous cesarean presenc unknown uterin scar unassoci dehisc ruptur exclud antepartum death fetus weigh congenit anomali incompat life found differ perinat death rate proport minut apgar score lower higher trial labor unabl exclud low birth weight fetus congenit anomali analysi find argu trial labor women cesarean birth"
"distribut skinderiv antileucoproteas skalp margin zone spread psoriat lesion elastas inhibitor skalp skinderiv antileucoproteas recent lesion skin psoriasi present studi investig distribut skalp activ margin zone spread psoriat plaqu mm zone immedi adjac erythematosquam plaqu skalp activ slight increas compar distant uninvolv skin lesion antielastas activ pronounc signific higher central zone plaqu compar peripheri skalp psoriat lesion late event compar endotheli involv intraepiderm accumul pmns epiderm prolifer abnorm keratin observ lend support hypothesi induct antielastas activ switch cutan inflamm"
"allerg contact photocontact dermat due psoralen patient psoriasi treat topic puva incid clinic featur allerg contact photocontact dermat due psoralen examin patient psoriasi treat topic puva psoralen deriv studi methoxypsoralen mop carbethoxypsoralen cps trimethylangelicin tma methyl pyridopsoralen mpp patient treat mop develop acut dermat puvatr area incid signific lower cps patient tma patient patient receiv mpp puva reaction confirm dermat reaction due contact photocontact allergi psoralen method includ patch photopatch test photopatch test map determin minim erythema dose med immunohistochemistri"
"induct lesion dermat herpetiformi autolog serum present studi factor contribut initi lesion dermat herpetiformi dh examin thirti patient dh bullous pemphigoid linear iga diseas healthi subject studi start treatment stop dapson day intraderm inocul fresh prepar autolog serum format dh lesion dh patient lesion erythemat papul vesicl microscop show papillari tip microabscess seruminduc format lesion occur patient activ dh spontan lesion format occur dh control format lesion doserel declin proportion dilut serum plasma prepar method anticoagul heparin citrat edta caus lesser reaction addit heparin epsilonamino caproic acid eaca citrat serum substanti inhibit format lesion suggest respons factor proteas vasoact agent includ histamin microgram compound microgram caus normal weal dh lesion occur subject challeng histamin challeng autolog serum elicit larg vesicular respons factor serum dh initi format lesion factor activ clot inhibit heparin eaca suggest proteas"
"erythema elevatum diutinum mimick porphyria cutanea tarda case erythema elevatum diutinum eed close resembl porphyria cutanea tarda pct report initi skin biopsi suggest pct porphyrin level urin stool plasma normal biopsi earli cutan lesion show leucocytoclast vascul fibrinoid necrosi vessel wall"
"acquir dermal melanocytosi face extrem case dermal melanocytosi symmetr area hyperpigment involv face extrem report light electron microscop studi show similar naevus ota"
"phosgen chlorophenylhydrazon strong sensit found yellow sweater bleach sodium hypochlorit defin causat allergen contact dermat experiment screen method anim publish erratum contact dermat nov young men develop allerg contact dermat wear yellow cotton sweater attempt identifi causat agent experiment screen method anim guinea pig sensit aceton extract sweater materi guinea pig maxim test gpmt activ ingredi separ extract stepstep patch test screen chromatograph fraction guinea pig final analyz gas chromatographymass spectrometri gcms allergen import activ fraction elut silica gel column hexan methanol fraction present studi focuss fatsolubl allergen hexan fraction gcms analysi reveal kind phosgen chlorophenylhydrazon pcphs present hexan fraction pcphs prepar laboratori show strong elicit activ guinea pig sensit extract male volunt sensit exposur yellow sweater irrit test phosgen dichlorophenylhydrazon main compon pcphs found sweater sensit guinea pig ppm level result conclud pcphs allergen respons case"
"patch prick test studi healthi subject recruit select militari health servic healthi histori present previous dermat ocular refract defect patch test girdca italian research group contact environment dermat standard seri patch test substanc process dye textil prick test major allergen react substanc frequent sensit thimeros case ammoni mercuri case phenolformaldehyd resin case paraben nickel dispers red case recruit react prick test allergen demonstr import establish refer valu healthi group correct evalu data collect select group"
"ammoni mercuri ointment outdat sever mercuri side effect poison high irrit allerg potenti weak potenc mercuri antisept antipsoriat agent topic mercuri prepar list pharmacopoeia includ unit state uk european countri topic mercuri effect toxic drug report case sever allerg reaction ammoni mercuri hope agreement pertin literatur contribut remov mercuri therapeut armamentarium"
"occup dermatos epoxi resin compound studi compris patient skin disord current previous occup exposur epoxi resin compound erc erc common case relev allerg contact dermat case epoxi resin base diglycidyl ether bisphenol dgebaer reactiv diluent amin harden deta epoxi acryl case irrit contact dermat due erc methyl hexahydrophthal anhydrid mhhpa epoxi harden caus case contact urticaria previous relev occup allerg contact dermat dgebaer detect case patch test erc allergen gave posit reaction epoxi resin standard seri case test epoxi reactiv diluent cycloaliphat epoxi resin epoxi acryl amin compound common epoxi harden extens patch test seri test patient erc remain import"
"immunodermatolog updat immunolog mediat vesiculobul diseas specif diagnosi immunolog mediat blister diseas made clinic histolog featur result direct indirect immunofluoresc studi multipl substrat case assess subepiderm intraepiderm group blister diseas direct immunofluoresc test perilesion tissu critic diagnosi condit indirect immunofluoresc test serum import diagnosi role manag select diseas dermat herpetiformi indirect test serum iga antiendomysi antibodi diagnosi manag indirect test serum igg antibodi intercellular substanc import diagnosi conjunct clinic find guid monitor diseas activ patient pemphigus immunoelectron microscopi immunoprecipit immunoblot studi identifi site immun deposit specif antigen immunolog mediat bullous diseas practic standpoint direct indirect immunofluoresc test conjunct clinic histolog evalu simpl rapid inexpens tool diagnosi manag"
"element diet refractori atop eczema total children refractori widespread atop eczema treat antigen avoid regimen compris hospitalis exclus feed element formula median durat day measur reduc exposur pet dust mite antigen home initi period food exclus food challeng perform interv day patient month ten children fail respond regimen relaps month improv eczema patient discharg hospit diseas sever score fallen median pretreat figur requir topic corticosteroid clinic laboratori find predict outcom drawback regimen prolong hospitalis median day fall bodi weight serum albumin concentr risk anaphylact shock case strict antigen avoid regimen improv atop eczema convent treatment fail"
"treatment rheumatoid arthriti anticd monoclon antibodi effect treatment monoclon antibodi cd antigen present helper cell studi patient sever intract rheumatoid arthriti open trial monoclon antibodi infus dosag mgkg bodi weight consecut day studi kinet demonstr drastic deplet cd cell low cellsmicrolit hour infus subsequ recoveri cd cell number hour infus reach initi level full day treatment cycl signific reduct number cd cell sd reduc invers cdcd ratio general persist week lymphocyt transform assay demonstr signific reduc reactiv patient complet day individu exhibit unexpect elev cell respons mitogen common antigen parallel laboratori studi show signific decreas erythrocyt sediment rate rheumatoid factor titer total immunoglobulin valu reduct reactiv protein level patient clinic signific reduct ritchi articular index number swollen joint advers effect urticaria patient led withdraw therapi chill fever suggest lymphokin releas syndrom patient low level human antimous immunoglobulin antibodi develop exceed mgliter repeat treatment cycl achiev efficaci patient reduct ritchi index number swollen joint find treatment monoclon antibodi cd antigen lead immunomodul result clinic benefit initi observ period month postinfus remain determin longterm remiss induc therapeut approach immunosuppress therapi repeat antibodi treatment consid"
"clinic correl serum cq level patient rheumatoid arthriti previous studi suggest serum cq level measur year rheumatoid arthriti ra predict extent subsequ joint damag evalu clinic signific marker ra level cq measur radial immunodiffus serum sampl character patient ra level cq higher patient diseas durat equal year microgramsml patient diseas durat greater year microgramsml serum cq level correl total joint count activ daili live score correl observ erythrocyt sediment rate radiograph score result suggest cq earli marker diseas activ patient ra"
"hla region antigen patient rheumatoid arthriti studi distribut hla region antigen group rheumatoid arthriti ra patient mild nonprogress diseas sever diseas result demonstr dr signific increas ra patient popul frequenc dr dr dqw allel group patient dr signific increas patient mild ra dr dqw signific increas patient sever diseas result present studi previous data laboratori investig incid hla region antigen ra suggest dr dq gene import confer suscept ra dr mild form diseas dq sever ra"
"effect nifedipin myocardi perfus metabol system sclerosi positron emiss tomograph studi assess effect nifedipin myocardi perfus metabol patient system sclerosi positron emiss tomographi perfus tracer potassium metabol tracer ffluorodeoxyglucos fdg nifedipin mg time daili week induc signific increas myocardi uptak signific decreas fdg myocardi uptak signific increas myocardi fdg ratio result increas myocardi perfus modif myocardi energi metabol result benefici antiischem effect nifedipin patient system sclerosi"
"doubleblind gastroscop evalu effect etodolac naproxen gastrointestin mucosa rheumat patient aim clinic endoscop studi evalu therapeut efficaci gastric toler etodolac antiinflammatori steroid drug compar naproxen studi conduct patient suffer rheumatoid arthriti complet trial initi oesophagogastroduodenoscopi exclud presenc gastric mucos lesion patient random alloc doubleblind treatment etodolac mg naproxen mg period week endoscop control treatment period drug prove effect reliev clinic symptom statist signific differ gastric mucos lesion observ etodolactr patient patient treat naproxen ci pain dyspepsia observ patient treat etodolac patient naproxen therapi studi demonstr etodolac activ naproxen reliev rheumat symptom administr result signific lower degre gastric damag"
"select vivo remov rheumatoid factor extracorpor treatment devic rheumatoid arthriti patient prospect phase ii trial conduct assess feasibl toler efficaci devic design select remov rheumatoid factor plasma rheumatoid arthriti patient devic terpolym hydrogelco plate chemic attach aggreg human immunoglobulin oper immunoaffin column sixti patient age underw week plasmapheresi treatment primari therapi phase trial patient continu current rheumatoid arthriti medic dose adjust patient receiv treatment primari therapi respond patient elig continu apheresi treatment week mainten therapi untoward side effect note studi treatment patient abort complaint dizzi angioedema chest tight short breath signific decreas serum iron signific complet blood count serum electrolyt renal hepat function test serum note trial design determin clinic efficaci patient note morn stiff longer time onset fatigu improv global pain assess signific object improv note joint pain tender swell number affect joint half treat patient percent improv object measur antirheumat activ"
"comput tomographi ultrasonographi adren gland paracoccidioidomycosi comparison cortisol aldosteron respons acth stimul fifteen patient proven dissemin paracoccidioidomycosi pcm comput tomographi ct ultrasonographi perform evalu form shape densiti size adren gland plasma urinari cortisol determin adren reserv assess measur cortisol aldosteron respons synthet acth adren ct show unilater lesion case bilater studi show frequent alter unilater bilater subject combin method increas sensit case patient normal plasma cortisol concentr normal increas urinari cortisol excret plasma aldosteron concentr normal patient hypokalemia patient show diminish cortisol respons subnorm aldosteron respons plasma aldosteron concentr increas stimul acth incid limit adren reserv patient acth stimul correl evid disord adren steroid respons acth morpholog reveal ct"
"genet relev orthoped recent advanc genet practic import patient orthoped problem specif gene isol map chromosom defin surgic specimen genet studi defin specif genet abnorm make specif genet diagnos import care patient famili"
"win battl lose war editori rheumatoid arthriti major advanc therapi ra requir futur scientif breakthrough understand pathophysiolog suggest clinic investig put hold entir focus research shift laboratori bench clinic studi earli ra includ earli treatment intervent major import character earli clinic identif patholog marker progress diseas formal random treatment studi earli diseas initi entir role aggress manag combin chemotherapi stage ra desper answer clinic practic combin chemotherapi wide resort treatment resist patient fail convent therapi publish clinic studi support prove valuabl potenti role combin chemotherapi set studi increas risk drug toxic limit readili appar combin base success observ patient difficult treat possibl fundament role combin chemotherapi treatment diseas advoc question resolv design random control trial urgent trial combin chemotherapi gain stronger foothold therapi"
"seroneg rheumatoid arthriti clinic studi hla type examin clinic determin hla dr antigen patient thought seroneg eros polyarticular rheumatoid arthriti ra finland ussr patient fulfil ara criteria ra hla type clinic find part collect followup patient fell group hlab relat diseas putat psoriat arthriti putat juvenil chronic polyarthr seroposit seroneg ra result patient seroneg ra diseas remain case presenc rheumatoid factor examin adequ earli phase diseas classif eros seroneg polyarticular patient discuss"
"phenotyp marker lymphocyt mononuclear phagocyt activ rheumatoid nodul investig rheumatoid subcutan nodul monoclon antibodi recogn function determin mononuclear phagocyt mph lymphocyt mph center rheumatoid nodul show strong express leukocyt intergrin cr consist presenc central chemotact stimulus mph express fcr gamma interferon regul molecul decreas case strong express mhc class ii variabl unstructur infiltr lymphocyt major cd posit lymphocyt show increas mhc class ii express interleukin receptor express low discern relationship number distribut phenotyp cell infiltr phenotyp predomin mph popul"
"administr folin acid low dose methotrex patient rheumatoid arthriti folin acid leucovorin supplement suggest treat short term side effect occur low dose methotrex mtx establish leucovorin abrog antiarthrit effect mtx enter patient rheumatoid arthriti treat mtx week random doubl blind crossov trial folin acid placebo dose folin acid equal dose mtx oral singl week mtx administr condit leucovorin decreas therapeut effect mtx incid stomat gastrointestin toxic lower leucovorin treatment studi lack suffici power establish statist signific differ"
"hypophospholipasemia system sclerosi phospholipas pla total pancreat quantit sera patient system sclerosi ssc total pla ml sd signific lower control ml patient pla sd sd normal serum pancreat pla signific lower ssc preval low serum total pla signific greater healthi adult patient rheumatoid arthriti system lupus erythematosus vascul repeat assay pla activ patient ssc document persist low pla patient ssc complet clinic laboratori assess low normal slight elev pla group show differ diseas manifest therapi group low serum pla lower erythrocyt sediment rate lower neutrophil monocyt count peripher blood find low serum pla activ add spectrum arachidon acid pathway abnorm ssc part relat pauciti inflammatori observ diseas"
"childhood bullous pemphigoid clinic immunolog featur treatment prognosi month femal infant present multipl tens bulla hand feet analysi biopsi specimen confirm clinic impress childhood bullous pemphigoid confirmatori data includ type iv collagen map basement membran zone readili techniqu distinguish childhood bullous pemphigoid childhood epidermolysi bullosa acquisita knowledg patient youngest childhood bullous pemphigoid opportun review literatur examin clinic immunolog featur treatment prognosi rare childhood immunobul disord"
"coexist pemphigus foliaceus bullous pemphigoid demonstr autoantibodi bind pemphigus foliaceus antigen complex bullous pemphigoid antigen pemphigus bullous pemphigoid autoimmun blister diseas skin character circul autoantibodi direct keratinocyt cell surfac epiderm basement membran zone coexist pemphigus bullous pemphigoid uncommon describ patient pemphigus foliaceus develop bullous pemphigoid show immunoprecipit studi util cultur keratinocyt suction blister epidermi patient circul autoantibodi direct pemphigus foliaceus antigen complex bullous pemphigoid antigen report demonstr coexist pemphigus foliaceus bullous pemphigoid molecular level"
"revis clinic laboratori criteria subtyp inherit epidermolysi bullosa consensus report subcommitte diagnosi classif nation epidermolysi bullosa registri inherit epidermolysi bullosa encompass number diseas common find blister format minor mechan trauma skin form signific eventu fatal extracutan diseas activ occur recent year applic newer technolog contribut substanti understand collect inherit diseas concurr phenotyp recogn part result ongo prospect patient registri unit state abroad result massiv literatur confound excess arbitrari subdivis epidermolysi bullosa variant concern mind subcommitte establish nation epidermolysi bullosa registri summar current literatur make recommend clinic laboratori criteria practic diagnosi subclassif patient inherit epidermolysi bullosa"
"allerg contact dermat antioxid latex glove thiobistertbutylmetacresol lowinox butylhydroxyanisol allergen altern gloveallerg patient allerg contact dermat develop hand face patient exposur latex examin glove patient patch test negat usual rubber allergen posit patch test reaction thiobistertbutylcresol lowinox patient patch test posit butylhydroxyanisol patient test glove find glove safe glove manufactur queri ascertain occurr lowinox butylhydroxyanisol brand latex vinyl examin glove list glove allergen generat provid assist dermatologist patient choos glove free specif allergen"
"pathogenesi onychoschizia lamellar dystrophi onychoschizia lamellar dystrophi nail common adult women inform theori involv environment factor support experiment data scarc studi vitro nail produc organ solvent deterg water polar materi acid basic solut challeng control fingernail clip examin grossli microscop scan electron microscopi regular interv progress increas sever prolong wet dri week scan electron microscopi demonstr unattach individu cell empti space separ promin basic solut caus soften layer peel repeat hydrat dehydr factor influenc onychoschizia typic produc normal nail day challeng repeat exposur water dehydr find suggest probabl condit logic approach manag"
"immun sensit epiderm antigen polymorph light erupt insight pathogenesi polymorph light erupt studi patient polymorph light erupt healthi person skin biopsi specimen obtain person previous ultraviolet lightirradi skin unirradi skin epiderm cell suspens skin homogen prepar specimen autolog cultur made peripher blood mononuclear cell combin irradi unirradi skin homogen peripher blood mononuclear cell combin irradi unirradi epiderm cell suspens cell prolifer assess hthymidin incorpor assay respons peripher blood mononuclear cell unirradi epiderm cell unirradi skin homogen similar patient control peripher blood mononuclear cell patient polymorph light erupt show signific increas prolif respons irradi epiderm cell irradi skin homogen result ultraviolet light increas stimulatori capabl polymorph light erupt epiderm cell unidirect mix cultur autolog peripher blood mononuclear cell suggest immun sensit autolog ultraviolet lightmodifi skin antigen occur polymorph light erupt"
"propylen glycol dermat propylen glycol common vehicl topic prepar suit purpos capabl produc primari irrit skin reaction allerg sensit literatur propylen glycol review attent natur advers cutan effect guidelin patient sensit propylen glycol discuss"
"persist light reaction hexachlorophen patient persist light reaction caus hexachlorophen report persist light reaction occur patient milder degre photosensit photopatch test perform"
"hereditari lactat dehydrogenas subunit defici lactat dehydrogenas activ skin lesion hair follicl year japanes girl desquam erythematosquam lesion extensor surfac extrem lesion wors summer patient mild muscl pain strenuous exercis patern matern grandfath cousin analysi lactic acid dehydrogenas ldh isozym serum reveal singl peak ldh analysi ldh isozym erythrocyt demonstr complet lack ldh subunit patient substanti lack parent epidermi diseas skin scalp hair follicl patient virtual devoid ldh activ"
"hereditari defici associ discoid lupus erythematosus year woman discoid lupus erythematosus undetect classic pathway complement activ hypocomplementemia due select defici children defici knowledg document case associ discoid lupus erythematosus defici"
"safeti immunolog respons recombin vaccinia virus vaccin express hiv envelop glycoprotein randomis phase trial recombin vaccina virus vaccin express gp envelop gene human immunodefici virus hivac healthi hivseroneg male histori smallpox immunis vaccinia naiv vaccin boost week hivac standard ny strain vaccinia virus frequenc durat titr virus isol vaccin site occurr local sideeffect similar group vaccine vacciniana vac subject shed virus vaccin site longer higher titr vacciniaprim vac individu day pfuml vitro cell prolif respons hiv antigen prepar develop vacciniaprim subject inocul hivac cell respons transient subject antibodi hiv detect vacciniana subject vaccin hivac show strong cell respons homolog heterolog strain virus recombin gp protein remain detect year antibodi hiv envelop develop recombin vaccinia virus vaccin induc cell prime foreign gene product individu sole immunis agent efficaci vacciniana individu"
"suspect connect tissu diseas connect tissu diseas suspect physic histor data collect build case clinic syndrom negat serolog result posit awar limit diagnosi clinic evid serolog confirm observ prefer overdiagnosi unnecessari treatment syndrom atyp physician evid clinic overlap reevalu regular open mind"
"puva therapi puva acronym psoralen ultraviolet radiat form photochem therapi common treatment psoriasi vitiligo benefici dermatolog diseas understand psoralen mechan action uniqu properti psoralen prepar import ensur optim result therapi"
"communiti screen hypercholesterolemia studi focus cholesterol screen educ program conduct scottsdal arizona determin preval hypercholesterolemia volunt particip program motiv lifestyl physician follow studi examin particip program monitor hypercholesterolemia month program individu screen previous histori elev cholesterol cholesterollow medic group previous histori hypercholesterolemia cholesterol level higher mmol mgdl level higher mmol mgdl subgroup person level higher mmol mgdl contact month screen group report improv diet exercis pattern consult physician result suggest peopl hypercholesterolemia communiti screen program monitor cholesterol level program ident highrisk individu program particip chang diet exercis pattern seek physician follow"
"hospit experi navajo subject type ii diabet match control histor cohort studi histor cohort studi design year follow found navajo adult type ii diabet mellitus hospit rate hospit patient year compar rate hospit patient year age sex resid match diabet control yield risk ratio match pair analysi sign test observ differ number hospit admiss statist signific averag durat hospit statist match pair analysi greater excess hospit diabet subject includ admiss poor metabol control diabet excess admiss infecti diseas excess admiss condit heart eye kidney traumat amput multivari analys variabl found greater hospit experi diabet subject year follow period includ older age entri studi poorer metabol control earli studi period presenc diabet complic"
"bodi mass index year mortal cohort black men women associ bodi mass index bmi mortal investig black male age year black femal age year member kaiser foundat health plan year follow male femal death identifi analys conduct separ lower upper rang bmi entir rang isol separ effect low weight high weight mortal attent paid potenti bias cigarett smoke anteced ill cox regress analys show entir rang bmi adjust bmimort associ signific shape men essenti flat women invers associ bmi mortal lower rang bmi statist signific men adjust relat hazard increas percentil bmi confid interv ci posit associ bmi mortal upper rang bmi high statist signific men adjust relat hazard increas percentil bmi ci control multivari analysi exclud year follow analys analyz bmimort associ smokingspecif illnessspecif subgroup smoke anteced ill impact bmimort associ sex general observ bmimort associ similar find white cohort"
"effect excess dietari tyrosin cholesterol bile acid metabol mixedfunct oxidas system rat excess dietari tyrosin caus hypercholesterolemia male wistar rat signific increas cytochrom content bile flow biliari output total bile acid signific increas rat fed diet biliari output cholesterol signific alter taurochol acid signific increas excess dietari tyrosin signific decreas fecal excret neutral steroid total steroid excret signific chang present result excess dietari tyrosin hypercholesterolemia modifi fecal total steroid excret support previous hypothesi stimul synthesi cholesterol main reason excess dietari tyrosin lead hypercholesterolemia"
"effect vitamin deplet serum cholesterol lipoprotein level od odod rat unabl synthes ascorb acid effect ascorb acid defici serum liver cholesterol phospholipid triglycerid level serum lipoprotein level serum lipoprotein cholesterol level examin male rat hereditari defect ascorb acid synthesi od rat male homozygot odod male rat parent strain divid treatment group fed vitamin defici vitamin replet diet cholesterol wk feedingperiod od odod rat fed vitamin defici diet gradual decreas food intak result lower bodi weight odod rat ascorb acid serum cholesterol level signific higher vitamin defici odod rat fed cholesterol diet tend higher fed control cholesterol diet liver lipid level remain unchang relat odod rat fed vitamin replet diet serum low densiti lipoprotein high densiti lipoprotein hdl cholesterol level lower odod rat fed vitamin defici diet cholesterol intermedi densiti lipoprotein low densiti lipoprotein cholesterol level mark higher vitamin defici odod rat odod rat ascorb acid dietari cholesterol level ratio hdl cholesterol hdl cholesterol higher vitamin defici odod rat parent strain odod rat show chang due vitamin defici result suggest vitamin defici delay low densiti lipoprotein metabol produc hypercholesterolemia male odod rat"
"ascorb acid effect vitamin hormon metabol bind guinea pig ascorb acid defici guinea pig fed vitamin replet diet caus moder reduct ca level serum bone hydroxycholecalciferol hydroxyergocalciferol ohd serum concentr tend declin renal hydroxycholecalciferolhydroxylas ohas activ decreas hydroxycholecalciferolhydroxylas activ increas fold chromatin dihydroxycholecalciferol receptor concentr intestin mucosa decreas percentag occupi receptor decreas receptor affin chang kd nmol kd nmol cooper coeffici decreas vitamin defici potenti effect vitamin depriv impair restor action vitamin accompani mark delay elev ohd concentr serum decreas ohas activ kidney lower concentr occupi receptor intestin mucosa data demonstr critic role ascorb acid vitamin metabol bind"
"vitamin defici decreas natur killer cell activ interferon product rat examin effect vitamin defici natur killer nk cell activ interferon ifn product rat wean age semisynthet diet microgram retinol diet time studi retinoldeplet rat serum vitamin concentr pairf control studi rat exhibit extern sign retinol defici deplet symptom observ splenic nk cell activ chromiumlabel yac cell signific decreas vitamin deplet rat valu control rat depend degre retinol defici ratio effector target cell vitamin deplet rat replet oral retinol nk cell activ consist normal understand mechan involv decreas nk cell activ investig ifn product concanavalin stimul spleen cell vitamin deplet replet control anim ifn titer signific decreas valu control rat supernat spleen cell cultur vitamin deplet rat replet vitamin result ifn activ rang control ad alphabeta ifn vitro spleen cell vitamin deplet anim increas nk cell activ number spleen cell react monoclon antibodi specif rat nk cell slight lower retinoldeplet rat account differ nk cell ifn activ data suggest vitamin defici affect nonspecif arm immun system possibl alter function capac cell produc lymphokin generat cytolyt respons"
"differenti effect alpha beta adrenerg blockad glucos lactat metabol acut stress studi examin role alpha beta blockad glucos lactat metabol acut stress insulininduc hypoglycemia group conscious dog chronic fit cathet femor arteri femor portal hepat vein studi hr fast hr basal period hypoglycemia induc insulin infus mukgmin hr group receiv treatment group receiv phentolamin microgramskgmin propranolol microgramskgmin begin minut experiment period similar hyperinsulinemia plasma glucos drop group mgdl group mgdl group maintain mgdl exogen glucos infus rate mgkgmin hepat glucos product increas group minut hour experi glucos util chang group increas group plasma lactat increas group mumol group mumol group earli rise mumol minut gradual drop basal"
"effect longterm monitor glycosyl hemoglobin level insulindepend diabet mellitus background routin measur glycosyl hemoglobin hemoglobin ac care patient diabet mellitus uncertain undertook studi determin knowledg hemoglobin ac valu result improv metabol control group patient insulindepend diabet mellitus iddm method random assign patient iddm group compar age sex durat diabet initi hemoglobin ac level patient year hemoglobin ac concentr measur month interv hemoglobin ac valu assess glycem control modifi therapi group care giver awar hemoglobin ac level reli blood urin glucos measur monitor treatment result patient year hemoglobin ac decreas signific percent group hemoglobin ac level monitor initi year valu control group percent proport patient poor control defin hemoglobin ac percent decreas percent group hemoglobin ac level monitor chang signific percent control group patient group hemoglobin ac level monitor insulin regimen chang hospit acut care diabet control group similar decreas hemoglobin ac valu occur control group year care giver knew hemoglobin ac valu conclus regular measur hemoglobin ac lead diabet treatment improv metabol control lower hemoglobin ac valu"
"prospect studi develop diabet relat patient insulindepend diabet background presenc cytoplasm isletcel autoantibodi recogn risk factor develop diabet mellitus relat patient insulindepend diabet mellitus iddm magnitud risk unknown influenc factor age sex race method studi initi nondiabet relat proband iddm determin risk iddm presenc titer autoantibodi factor result nondiabet relat percent isletcel antibodi initi serum sampl contract iddm isletcel antibodi frequent percent relat year age percent famili affect member multiplex pedigre independ risk factor develop diabet relat includ age year time initi studi membership multiplex pedigre posit test isletcel antibodi initi serum sampl twenti relat diabet develop percent posit test isletcel antibodi diagnosi iddm give relat risk iddm percent confid interv antibodyposit relat isletcellantibodi titer juvenil diabet foundat unit higher increas risk diabet conclus nondiabet relat proband iddm decad life member multiplex pedigre increas titer isletcel antibodi contract iddm"
"increas highdens lipoprotein level caus common cholesterylest transfer protein gene mutat background method plasma cholesterylest transfer protein cetp catalyz transfer cholesteryl ester highdens lipoprotein hdl lipoprotein recent japanes famili increas hdl level cetp defici due splice defect cetp gene assess frequenc phenotyp condit screen addit famili high hdl level radioimmunoassay cetp dna analysi result found cetp gene mutat famili region japan analysi restrictionfragmentlength polymorph mutant cetp allel show proband homozyg ident haplotyp famili member homozyg cetp defici moder hypercholesterolemia total cholesterol level sd mmol liter mark increas level hdl cholesterol mmol liter apolipoprotein decreas level lowdens lipoprotein cholesterol mmol liter apolipoprotein member heterozyg defici cetp level lower part normal rang moder increas level hdl cholesterol apolipoprotein increas ratio hdl subclass hdl subclass compar unaffect famili member  cetp defici found unrel subject elev hdl cholesterol level part unit state conclus cetp defici frequent increas hdl level popul japan possibl founder effect result observ heterozygot suggest cetp play part regul level hdl subclass evid prematur atherosclerosi famili cetp defici fact lipoprotein profil person cetp defici potenti antiatherogen increas life span"
"worldwid differ incid type diabet amino acid variat posit hladq beta chain presenc amino acid aspart acid posit hladq beta chain asp high suscept insulindepend diabet mellitus iddm aspart acid posit asp confer resist diseas hypothes fold differ iddm incid racial group countri relat variabl frequenc allel diabet nondiabet individu evalu popul includ low moder high risk hladq beta genotyp distribut iddm case group mark nondiabet control asp allel signific iddm area populationspecif odd ratio asp homozygot relat asp homozygot rang relat risk inform casecontrol studi popul incid data combin estim genotypespecif incid rate allegheni counti pa caucasian rate predict incid rate remain popul confid interv actual rate establish incid registri result consist hypothesi popul variat distribut asp allel explain geograph variat iddm incid"
"defect thermoregul malnutrit revers weight gain physiolog mechan clinic import previous studi infant elder shown low bodi weight defect thermoregul increas risk hypothermia present studi thermoregulatori respons cool stimulus measur young middleag patient lost cent bodi weight ill investig perform restor bodi weight weight gain kg se kg cool stimulus provid special suit perfus water degre degre weight gain increas metabol rate respons cool fall core temperatur weight gain thermogen respons cool restor normal peripher vasoconstrict princip mechan heat conserv similar weight gain thermogen respons infus adrenalin ngkgmin abolish weight loss suggest defect coldinduc thermogenesi weight loss due chang central control mechan thermoregul tissu unrespons phenomenon abnorm thermoregul weight loss return normal subsequ weight gain clinic import elder small fall core temperatur impair neuromuscular coordin cerebr function"
"genet defect lipoprotein metabol elev atherogen lipoprotein caus impair catabol protein call apolipoprotein surfac lipoprotein particl respons mediat bind cholesterolrich particl specif lipoprotein receptor surfac cell repres major pathway control blood cholesterol level import disord lipoprotein metabol provid insight molecular mechan respons elev specif atherogen lipoprotein type iii hyperlipoproteinemia result specif mutat apolipoprotein prevent normal bind chylomicron remnant lowdens lipoprotein remnant lipoprotein receptor patient disord elev level remnant lipoprotein develop atherosclerosi famili defect apolipoprotein result singl amino acid substitut apolipoprotein prevent lowdens lipoprotein bind lowdens lipoprotein receptor elev plasma cholesterol level famili hypercholesterolemia result elev level plasma lowdens lipoprotein prematur atherosclerosi caus varieti mutat lowdens lipoprotein receptor interfer normal bind lipoprotein receptor observ provid insight mechan respons normal lipoprotein metabol highlight potenti role specif lipoprotein atherogenesi"
"fatal hypernatremia exogen salt intak report case review literatur publish erratum mayo clin proc apr hypernatremia common electrolyt disturb caus volum deplet hypernatremia due sodium excess occur frequent fatal hypernatremia sole ingest tabl salt rare describ year man seizur hypernatremia ingest supersatur salt water solut intend gargl consum approxim cup tabl salt approxim salt meq sodium initi serum sodium concentr meqlit hypoton fluid therapi provid free water correct hypernatremia gradual patient fail recov initi insult die day review literatur reveal adult pediatr case hypernatremia attribut exogen intak salt type therapi fluid periton dialysi type fluid rate correct hypernatremia influenc surviv age patient initi serum sodium concentr import prognost indic young patient lesser degre hypernatremia rate surviv patient addit review illustr surpris small amount salt sever hypernatremia danger salt salin emet"
"molecular basi form metachromat leukodystrophi background metachromat leukodystrophi autosom recess inherit lysosom storag disord caus defici arylsulfatas form diseas distinguish sever age onset late infantil year juvenil adult greater method result understand molecular basi form diseas analyz arylsulfatas allel metachromat leukodystrophi allel term identifi account half arylsulfatas allel patient metachromat leukodystrophi examin suffici inform patient classif diseas instanc homozygos allel lateinfantil form diseas instanc homozygos allel adult form juvenil form allel present juvenil form result instanc heterozygos allel allel unknown lateinfantil diseas heterozygos allel onset diseas clinic variabl explain level residu arylsulfatas activ genotyp conclus lysosom storag disord metachromat leukodystrophi show clinic heterogen reflect genet heterogen allel allel earlier sever diseas allel"
"effect chronic alcohol administr transketolas brain liver rat estim nutrit patholog state thiamindeficiencyrel diseas wernickekorsakoff syndrom studi relationship transketolas activ transketolas concentr thiamin phosphat ester rat chronic fed alcohol brain alcoholf rat enzym activ concentr decreas posit correl contrari transketolas activ liver correl posit concentr transketolas activ concentr decreas thiamindefici group find suggest transketolas brain liver alter enzym activ brain base conform chang protein molecul caus chronic alcohol administr"
"influenc breakfast nutrient content glucos peptid insulin glucagon triglycerid gip insulindepend diabet examin influenc coingest fat protein mix meal carbohydr metabol subject insulindepend diabet mellitus niddm receiv breakfast vari amount fat protein group amount fat group compar standard breakfast insulin increas proteinrich meal decreas fatrich meal group glucos gastric inhibitori polypeptid gip remain constant contrast gip show signific increas highfat meal group niddm subject glucos insulin respons mix meal exclus mediat gip protein confirm potent stimul insulin secret factor alter betacel respons diabet gip incret consid explain report result"
"protein metabol obes effect bodi fat distribut hyperinsulinemia leucin turnov examin moder obes differ bodi fat distribut abnorm protein metabol leucin turnov measur group agematch premenopaus women ten upperbodyobes ub ob lowerbodyobes lb ob nonobes ob women studi overnight postabsorpt condit basal infus low physiolog amount insulin insulin clamp result show basal leucin carbon flux greater ub ob lb ob women ob women mumolkg lean bodi massmin sem leucin carbon flux suppress insulinclamp studi ub ob women lb ob ob women conclud moder obes increas proteolysi insulin antiproteolyt action impair upperbodi obes find implic futur studi treatment obes"
"effect trestatin amylas inhibitor incorpor bread glycem respons normal diabet patient effect incorpor pancreat alphaamylas inhibitor trestatin bread postprandi plasma glucos insulin excurs test healthi volunt insulindepend diabet patient dose level trestatin mg starch peak valu plasma glucos insulin reduc mark compar placebo ingest starch form bread healthi control subject diabet patient trestatin produc signific lower insulin excret signific reduct increment plasma glucos area dosedepend fashion conclud technolog feasibl incorpor trestatin starchi food loss activ impair tast posit effect trestatin glycem insulinem respons diabet lack side effect offer great potenti dietari treatment diabet patient"
"percent bodi fat obes white femal predict anthropometr measur percent bodi fat pbf anthropometr measur measur obes white femal random assign valid crossvalid group anthropometr equat predict percent bodi fat generat multipl regress equat includ residu lung volum rv factor correl coeffici standard error estim equat includ rv equat precis previous wide equat subgroup subject underw weight loss equat gave precis estim chang pbf conclud equat permit predict pbf obes white femal"
"vitreous fluorophotometri insulindepend diabet mellitus correl microalbuminuria diastol blood pressur vitreous fluorophotometri perform eye young subject insulindepend diabet mellitus type grade retinopathi concentr fluorescein measur anterior chamber posterior vitreous hour intraven inject fluorescein signific associ grade retinopathi level posterior vitreous leakag amount posterior vitreous leakag eye signific associ borderlin elev diastol blood pressur subject excess posterior vitreous leakag signific higher level urinari microalbumin excret multipl linear regress analysi posterior vitreous leakag retin grade consist enter model signific level equal blood pressur enter model posterior vitreous leakag signific level retin grade left eye worst eye result demonstr associ leakag retin renal vessel possibl link part elev diastol blood pressur"
"incid etiolog hyponatremia intens care unit evalu incid hyponatremia intens care unit icu patient retrospect prospect studi hyponatremia defin serum sodium concentr equal mmol meq prospect patient display hyponatremia relev data obtain twelv patient patient serum hypoosmol ten patient serum hypoosmol urin osmol maxim dilut urin sodium concentr greater mmol meq suggest inappropri antidiuret hormon secret siadh patient exhibit suppress adh level absenc maxim urinari dilut data suggest hyponatremia common icu patient renal dilut defect frequent hypoton fluid administ cautious"
"ration order electrolyt emerg depart studi object valid predict abil retrospect develop set clinic criteria detect clinic signific electrolyt abnorm patient popul design crosssect studi set emerg depart busi public hospit type particip hundr eighti patient emerg physician order serum electrolyt intervent predict properti ten clinic criteria evalu includ poor oral intak vomit chronic hypertens diuret recent seizur muscl weak age year alcohol abnorm mental status recent histori electrolyt abnorm measur main result hundr thirti patient electrolyt laboratori normal rang clinic signific electrolyt abnorm clinic criteria predict clinic signific electrolyt abnorm sensit falseneg case review electrolyt abnorm affect patient outcom implement criteria avoid unnecessari test patient conclus set clinic criteria elimin clinic judgment set clinic criteria substanti decreas electrolyt order compromis patient care"
"pediatr resid attitud insulindepend diabet mellitus children diabet nationwid pediatrician provid substanti portion health care children diabet belief attitud diabet children ill import influenc treatment decis attitud belief sampl pediatr resid compar data nation survey practic pediatrician belief attitud children insulindepend diabet mellitus diseas pediatr resid year train negat diabet diabet children member nation sampl practic pediatrician resid year colleagu"
"endothelin increas contractil adult rat ventricular myocyt role intracellular alkalosi induc activ protein kinas depend na exchang endothelin amino acid vasoact peptid potent posit inotrop agent mammalian heart demonstr endothelin inotrop effect due part appar sensit cardiac myofila intracellular calcium determin due rise intracellular ph phi isol adult rat ventricular cell load select fluoresc probe bcecf pm endothelin increas contractil amplitud baselin phi nm endothelin increas phi increas contractil amilorid prevent increas phi respons endothelin reduc inotrop respons inotrop effect readili restor subsequ nhclinduc alkalin similar inhibitor protein kinas sphingosin diminish abolish rise phi endothelin superfus caus declin inotrop effect compar observ amilorid pretreat pertussi toxin demonstr result complet adpribosyl alphasubunit gi gtpbind protein abolit endothelin posit inotrop effect partial reduc intracellular alkalin induc peptid suggest complex signal transduct mechan posit inotrop action endothelin due part stimul sarcolemm na exchang protein kinas mediat pathway result rise phi sensit cardiac myofila intracellular ca"
"mechan alternan acidosi ferret heart muscl acidosi lead mechan alternan altern larg small contract ferret papillari muscl altern size contract parallel altern size intracellular ca transient monitor photoprotein aequorin isol myocyt larg contract accompani prolong action potenti mechan alternan induc acidosi isol myocyt train voltageclamp puls mechan alternan secondari action potenti durat observ action potenti durat secondari size ca transient observ caactiv current show altern mechan alternan mechan link ca action potenti durat altern size ca transient secondari slow mechan restitut observ papillari muscl acidosi explain observ decreas stimul rate abolish alternan"
"effect captopril glucos concentr role augment postprandi forearm blood flow goal studi evalu effect captopril plasma glucos concentr daili profil plasma glucos level determin insulindepend diabet normotens subject treat captopril dose mg timesday forearm blood flow measur straingaug plethysmographi administr captopril improv daili profil plasma glucos level postprandi forearm blood flow augment meal result suggest angiotensinconvert enzym inhibitor improv glucos metabol diabet subject possibl enhanc blood flow skelet muscl"
"care predictor metabol control niddm patient object studi evalu relationship care behavior metabol control compar patient insulindepend diabet mellitus niddm insulin insulin studi niddm patient hospit elect admiss washington univers model demonstr unit admiss patient report frequenc exercis blood glucos monitor meal skip previous wk metabol control previous wk determin glycosyl hemoglobin assay crosssect analysi control patient sociodemograph health characterist glycosyl hemoglobin level posit relat meal skip negat relat frequenc blood glucos monitor care behavior explain varianc glycosyl hemoglobin level niddm patient multivari model demonstr signific interact effect insulin treatment care metabol control conclus find support clinic signific care activ metabol control niddm patient meal skip blood glucos monitor"
"theoret baselin diet weight control diabet black articl outlin theoret diet weight control insulindepend diabet mellitus niddm identifi factor import influenc success diet weight control niddm black popul longterm adher dietari weightcontrol regimen requir patient evalu restructur establish eat physic activ pattern social action theori conceptu framework complex behavior chang task understood function interplay regulatori mechan mechan influenc person capabl make physic condit general health status physic social environment context person materi social resourc factor differ black white direct suggest lesser potenti effect diet weightloss therapi black niddm patient compar white black limit incom low educ attain ambival weight control multipl health problem highfat highsodium lowfib diet food prefer evid suggest stateart counsel approach effect black white challeng adapt type approach suggest social action theori cultur costeffect deliveri black communiti healthcar set"
"exercis therapi prevent type ii diabet implic black rational exercis treatment type ii insulindepend diabet special implic black review perform regular basi exercis improv glycem control improv risk factor coronari heart diseas includ hypertriglyceridemia hypertens hyperinsulinemia addit adjunct diet produc weight loss metabol benefit exercis part relat abil enhanc insulin sensit benefit short live discontinu exercis problem complianc concurr medic problem patient type ii diabet good candid exercisediet program reason optimum target popul peopl risk type ii diabet prematur atherosclerosi popul includ offspr patient disord individu impair glucos toler hyperinsulinemia gestat diabet android pattern fat distribut type ii diabet common black general popul instanc cardiovascular risk factor benefit exercis studi effect regular exercis black type ii diabet risk"
"crosssect analysi renal function black american niddm object defin glomerular filtrat rate gfr renal plasma flow rpf black american insulindepend diabet mellitus niddm crosssect studi black niddm patient diagnos diabet durat mo yr hyperglycemia regul stabil patient enter studi gfr rpf determin clearanc iiothalam ilabel hippuran constantinfus techniqu urin collect period hyperfiltr defin gfr greater mlmin found patient newli diagnos yr durat niddm percentag patient hyperfiltr decreas increas durat diagnos diabet decreas gfr rpf occur increas durat diagnos diabet conclus renal hemodynam black american niddm similar occur white popul iddm"
"effect exercis obes skelet muscl amino acid uptak genet obes zucker rat reduc capac deposit dietari protein skelet muscl determin amino acid uptak muscl obes zucker rat impair soleus strip sol epitrochleari epi muscl wk lean obes zucker rat studi vitro calphaaminoisobutyr acid aib muscl fast rat incub basal condit rest treadmil run grade equat total work complet lean obes rat ran min muscl pin rest length preincub min degre krebsring bicarbon buffer mm glucos incub krebsring bicarbon mm aib caib hinulin marker extracellular fluid basal aib uptak epi sol obes rat signific reduc compar lean rat lean obes rat exercis increas basal aib uptak epi sol relat increas greater obes rat epi sol epi sol result demonstr genet obes zucker rat reduc basal skelet muscl amino acid uptak suggest physic inact partial contribut defect"
"regul forearm lipolysi type obes vivo evid adipocyt heterogen forearm system adipos tissu free fatti acid ffa releas measur nonobes lowerbodi obes upperbodi obes women basal hyperinsulinem hypoinsulinem condit determin forearm fat regul similar manner bodi fat result adipos tissu palmit releas greater forearm bodi mumolkg fatmin subject system palmit releas relat fat mass signific greater nonobes upperbodi obes upperbodi obes lowerbodi obes women forearm adipos tissu palmit releas pattern hyperinsulinemia suppress system forearm lipolysi similar degre hypoinsulinemia consist increas system palmit flux increas forearm palmit releas result confirm heterogen adipos tissu vivo model emphas adipos tissu depot respons differ system ffa flux obes nonobes human"
"diacylglycerol accumul microvascular abnorm induc elev glucos level present experi undertaken examin hypothesi glucoseinduc increas de novo synthesi diacylsnglycerol observ number tissu includ retin capillari endotheli cell expos elev glucos level vitro activ protein kinas play role mediat glucoseinduc vascular function report daili instil mm glucos rat skin chamber granul tissu model induc approxim fold increas diacylglycerol dag level versus tissu expos mm glucos associ mark increas vascular clearanc albumin blood flow glucoseinduc increas dag level vascular function prevent addit mm pyruv pharmacolog activ protein kinas phorbol ester tpa presenc mm glucos increas microvascular albumin clearanc blood flow similar effect observ monoolein mog pharmacolog inhibitor catabol endogen dag pharmacolog inhibitor protein kinas staurosporin great attenu rise microvascular albumin clearanc rise blood flow induc glucos mog find compat hypothesi elev concentr glucos increas tissu dag content de novo synthesi result protein kinas activ biochem event factor generat increas microvascular albumin clearanc"
"anderson diseas genet exclus apolipoprotein gene famili anderson diseas recess disord character intestin fat malabsorpt absenc postprandi chylomicron reduc level cholesterol triglycerid apoprotein ai studi famili children anderson diseas intestin apo apoaiv mrnas anderson patient normal size concentr decreas fivefold compar control dna digest restrict enzym restrict fragment length polymorph apo gene show conclus inform xba reveal lack cosegreg restrict fragment length polymorph anderson phenotyp linkag analysi perform polymorph apo gene minisatellit genom dna parent children amplifi polymeras chain reaction oligonucleotid primer flank apo gene hypervari locus famili child inherit apo allel parent recess mode transmiss diseas result incompat involv apo gene posttransl defect mutat gene encod protein essenti lipoprotein assembl secret involv"
"treat serum lipid abnorm highprior patient normal serum lipid level initi patient myocardi cerebrovascular peripher vascular diseas clinic trial coronari arteri diseas mortal rate reduc atherosclerosi stabil revers lipidlow therapi treatment lower lowdens lipoprotein cholesterol level mgdl total triglycerid level mgdl increas highdens lipoprotein cholesterol level mgdl men mgdl women nonlipid coronari risk factor elimin lipidlow therapi consist dietari modif drug treatment colestipol hydrochlorid colestid cholestyramin cholybar questran lovastatin mevacor gemfibrozil lopid nicotin acid nicolar"
"myoinositol pool util phosphatidylinositol synthesi deplet sciatic nerv rat streptozotocininduc diabet peripher nerv experiment diabet rat exhibit lower level myoinositol mi decreas incorpor hmi phosphatidylinositol pi indic diminish pi turnov causal relat reduc naatpas activ diabet nerv investig metabol compart mi essenti pi synthesi decreas tissu sciatic nerv segment streptozotocininduc diabet agematch normal rat incub vitro pi hcytidin presenc propranolol cation amphiphil agent redirect nerv phospholipid metabol produc enhanc incorpor pi decreas label phosphatidylcholin phosphatidylethanolamin accumul phosphatidyl cmp cmppa demonstr chromatograph enzymat incorpor hcytidin cmppa normal nerv increas fold mm propranolol present diabet nerv liponucleotid incorpor fold isotop readili label lower drug concentr compar normal nerv buildup hcmppa reduc dosedepend manner presenc mi incub medium concentr mm mi ad liponucleotid accumul preform cmppa util pi synthesi differ liponucleotid label normal diabet nerv abolish mm medium mi concentr level cyclitol tissu result strong suggest presenc nerv pool mi equilibrium bulk nerv mi preferenti pi synthesi metabol compart deplet diabet nerv readili replenish exogen mi correspond mi pool propos requir turnov portion tissu pi involv mainten normal naatpas activ"
"evid regul betacel glucos transport insulindepend diabet diabet hyperglycemia insulindepend diabet mellitus niddm attribut failur pancreat beta cell maintain insulin secret level suffici compens insulin resist zdf rat model niddm close resembl human syndrom previous report profound underexpress glut highkm facilit glucos transport express beta cell normal anim report islet diabet rat exhibit mark decreas volum glutposit beta cell reduct electronmicroscop level number glutimmunoreact site unit betacel plasma membran defici glut induc normal beta cell vivo vitro exposur high level glucos prevent beta cell prediabet zdf rat elimin hyperglycemia conclud dearth immunodetect glut niddm secondari hyperglycemia play causal role develop hyperglycemia"
"vitamin neurolog deficit past decad appar vitamin essenti nutrient maintain structur function integr develop human nervous system skelet muscl retina clinic histolog resembl human neuromuscular disord chronic fat vitamin malabsorpt observ experiment vitamin defici anim model strike chronic malabsorpt vitamin children cf chronic cholestasi abetalipoproteinemia short bowel syndrom risk develop neurolog deficit caus vitamin defici correct vitamin defici state prevent revers stabil neurolog dysfunct suscept individu advanc stabl isotop technolog permit studi hepat discrimin stereoisom form vitamin investig primari form vitamin defici isol vitamin defici syndrom promis delin normal physiolog process involv absorpt transport tissu deliveri vitamin studi progress address optim rout form vitamin therapi predispos condit major task remain defin mechan vitamin defici lead neurolog injuri"
"local aland island eye diseas locus pericentromer region chromosom linkag analysi aland island eye diseas aie chromosom disord character reduc visual acuiti progress axial myopia regular astigmat latent nystagmus foveal hypoplasia defect dark adapt fundus hypopigment syndrom origin report famili aland island determin local aie gene linkag studi perform famili total polymorph cover loci entir chromosom point analysi strongest evid linkag obtain aie dxs maximum lod score zmax maximum recombin fraction theta max marker loci dxs dxs dxs show recombin aie posit lod score theta max obtain marker local xy homolog region xqq number inform meios small multilocus linkag analysi probabl locat aie pericentromer region dxs dxs result rule local aie distal xp propos data exclud possibl aie incomplet congenit stationari night blind caus mutat gene question resolv care clinic comparison disord ultim molecular dissect gene"
"hyperlipidemia organ transplant hyperlipidemia long recogn difficult common problem organ transplant acceler atherosclerosi observ heart transplant recipi children renal transplant addit hyperlipidemia play role late renal graft loss posttranspl hyperlipidemia unclear patient treat azathioprin prednison hypertriglyceridemia commonest find result increas consumpt calori carbohydr fat resolut uremia conjunct glucos intoler secondari steroid administr patient treat cyclosporin hypercholesterolemia common form hyperlipidemia cyclosporin lipophil drug transport plasma larg associ lipoprotein requir lowdens lipoprotein ldl receptor intern cell hypercholesterolemia result interfer basic cholesterol feedback mechan ldl receptor addit cyclosporin affect bile acid synthesi worsen glucos toler factor promot hyperlipidemia therapeut approach hyperlipidemia transplant recipi dietari caloriefat restrict supplement solubl fiber ongo clinic trial pharmacolog lipidlow agent address safeti efficaci agent set immunosuppress time cautious low dose"
"schizophrenia fatal induc water intox appropriatelydilut urin year woman untreat chronic schizophrenia develop extrem polydipsia rapid led coma death due cerebr edema hyponatremia meqlit serum hypoosmol mosmkg mark polyuria mlhour appropri low urinari osmol mosmkg respond treatment case qualifi previous report review support possibl pure induc water intox major contribut inadequ releas antidiuret hormon occur extrem polydipsia overwhelm normal renal dilut capac psychot patient"
"hyperosmolar state composit extracellular fluid ecf remain stabl cell function proper normal individu vasopressin thirst zealous maintain total ecf concentr osmol narrow rang disrupt regulatori mechan rapid addit solut ecf lead hyperosmol neurolog symptom accompani form hyperosmol explain understand physiolog respons cell osmot stress review describ physiolog pathophysiolog differenti diagnosi therapi hyperosmolar state"
"hypokalemia induct anesthesia prevent beta adrenoceptor antagon observ serum potassium level measur immedi induct anesthesia preinduct lower measur day preoper preoper purpos investig determin studi magnitud differ elucid mechan occur studi preinduct meq sd signific lower level measur routin preoper test meq twenti patient preinduct level consid hypokalem equal meq patient normal preoper level studi test hypothesi preinduct decreas serum mediat beta adrenerg receptor preinduct determin patient singl preoper dose propranolol beta beta antagonist atenolol beta antagonist betablock control differ preoper preinduct serum patient receiv propranolol meq signific attenu compar differ control subject meq signific control patient pretreat atenolol meq result demonstr serum level measur intraop anesthet induct consist signific measur day preoper abil propranolol atenolol block chang suggest acut decreas level due beta adrenerg receptor stimul"
"role alpha adrenoceptor adrenalineinduc hyperkalaemia hyperkalaem action adrenalin investig anaesthet domest pig plasma epicardi concentr measur case ionselect electrod adrenalin microgram kg caus rapid increas plasma concentr mmol litr magnitud time epicardi concentr similar alphaadrenoceptor block phentolamin mg kg select block prazosin mg kg select alpha adrenoceptor block abolish hyperkalaem effect adrenalin plasma epicardium alpha adrenoceptor agonist phenylephrin increas concentr alpha adrenoceptor agonist uk chang concentr result suggest hyperkalaemia induc adrenalin occur interstiti fluid myocardium mediat alpha adrenoceptor find import patient risk hyperkalaemia implic suxamethonium induct anaesthesia"
"free protein level elev famili cbbind protein defici plasma protein free function cofactor anticoagul effect activ protein remain protein complex cbbind protein function inact famili hereditari cb bind protein defici identifi cbbind protein level affect father daughter microgramsml microgramsml valu signific normal rang protein microgramsml microgramsml sd total protein free bound normal individu microgramsml microgramsml normal microgramsml microgramsml free protein level mark increas microgramsml microgramsml normal microgramsml microgramsml experi natur show total protein level plasma affect absenc cbbind protein chronic elev free protein increas hemorrhag tendenc"
"dual defect pulsatil growth hormon secret clearanc subserv hyposomatotrop obes man examin mechan reduc circul gh concentr obes human computerassist deconvolut analysi determin endogen gh secretori clearanc rate quantit entir plasma gh concentr profil analys reveal halflif endogen gh signific shorter obes min normal weight subject min acceler blood dispos rate gh due decreas circul concentr ghbind protein similar obes normal weight men obes men signific fewer gh secretori burst day rare gh secretori burst occur obes subject signific prolong intersecretori burst interv min result daili gh product rate obes men reduc fourth normal weight individu gh secret rate burst frequenc negat correl degre obes ponder index decreas gh burst frequenc halflif specif gh secretori puls amplitud maxim rate gh releas mass gh releas burst durat computerresolv gh secretori burst obes normal weight men conclud obes men harbor doubl defect gh dynam involv gh secret clearanc sever gh secretori defici proportion degre obes"
"influenc thiamin supplement health general elder irish popul margin thiamin defici publish erratum gerontol sepm effect thiamin supplement health general random select healthi elder irish women popul margin thiamin defici studi key variabl affect thiamin status control week dietari intak subject feel activ assess measur week baselin week doubl blind treatment period clinic assess perform week period treatment subject random assign thiamin mg daili placebo group compar baselin placebo supplement valu thiaminsuppl women experienc signific increas appetit energi intak bodi weight general decreas fatigu thiamin supplement tend reduc daytim sleep time improv sleep pattern increas activ data suggest evalu thiamin status nonspecif condit anorexia weight loss fatigu depress sleep disord present elder person"
"abnorm arginin vasopressin respons cigarett smoke metoclopramid insulininduc hypoglycemia elder subject age reduc arginin vasopressin avp respons volumetr stimul increas avp respons osmot stimuli administr metoclopramid mcp order gain insight effect age avp secret evalu avp respons cigarett smoke mcp insulininduc hypoglycemia male subject age divid group age basal avp concentr similar group avp respons insulin toler test similar pattern magnitud fold increas group avp respons mcp cigarett smoke similar younger group plasma avp level increas time mcp time cigarett smoke contrast mcp cigarett smokinginduc avp rise signific higher oldest group plasma avp concentr increas time mcp time smoke data mcp cigarett smoke test combin regress analys show signific posit correl avp peak respons mcp cigarett smoke oldest subject data show elder human increas avp respons mcp cigarett smoke suggest common disord alter contrast lack agerel avp respons insulin toler test demonstr mechan avp respons hypoglycemia affect age"
"relationship clinic confirm cobalamin defici serum methylmalon acid year period examin consecut patient low serum cobalamin level detect primari screen test protein binder ria patient clinic cobalamin defici confirm remain patient character clinic cobalamin defici serum methylmalon acid level higher mumol sd normal control clinic character cobalamindefici subject level defici patient conclud serum methylmalon acid assay discrimin cobalamin defici cobalamin defici effici recommend assay adopt standard test diagnosi tissu cobalamin defici"
"drug relat admiss cardiolog depart frequenc avoid hundr sixti consecut patient admit depart cardiolog evalu drug event admiss drug event consid advers drug reaction adr doserel therapeut failur dtf definit probabl drug event account admiss confid limit eleven adr dtf inclus drug event rate drugrel hospit drh drhs character preponder acut admiss elder patient hypokalaemia mm observ patient receiv diuret relat case arrhythmia probabl adr averag serum potassium level similar diuret treat patient drug counteract hypokalaemia irrespect drug chosen definiteprob drhs consid due error prescript case judg avoid measur prescrib physician drh educ intervent programm primarili deal complianc prescript diuret digoxin problem constitut major case drh specif group doctor target respons drh avoid"
"lower cost lower cholesterol formulari polici lovastatin object describ medic center polici design cost lipidlow drug lovastatin primari care set examin effect polici cost examin physician accept polici set veteran affair medic center intervent polici made lovastatin physician failur therapi diet line drug document order form form educ inform includ price recommend niacin drug treatment choic patient design evalu effect polici lipidlow drug medic center compar similar center restrict lovastatin lipidlow drug unit state written questionnair survey physician reaction polici result lovastatin percentag total lipidlow drug center lovastatin polici fourth center nationwid niacin time greater estim save drug cost center lovastatin polici due differ year survey physician affect polici respons rate fourth view unfavor favor polici restrict drug subspecialti clinic conclus author experi formulari polici permit limit expens drug primari care set cost accept physician polici type increas number health care provid organ cover cost outpati medic"
"lovastatin therapi cholesterol ester storag diseas sister administ lovastatin sister age year cholesterol ester storag diseas autosom recess disord manifest hypercholesterolemia hypertriglyceridemia drug competit inhibitor hydroxymethylglutaryl coenzym reductas oral month serum lipid concentr determin month comput tomographi liver perform therapi evalu liver fat content younger sister liver biopsi month lovastatin therapi assess hepat cholesterol store patient mark decreas serum level cholesterol triglycerid lowdens lipoproteincholesterol highdens lipoproteincholesterol level increas comput tomographi treatment demonstr signific increas linear attenu suggest decreas liver fat content liver tissu obtain month lovastatin therapi initi esterifi cholesterol liver sampl obtain treatment conclud lovastatin effect treat children cholesterol ester storag diseas"
"estim metabol rate obes nonobes adolesc evalu valid equat calcul basal metabol rate compar measur metabol rate popul includ obes nonobes adolesc metabol rate calcul equat common estim metabol rate option mayo clinic nomogram food agricultur organizationworld health organizationunit nation univers faounu equat produc estim differ signific measur valu cohort sever obes adolesc girl faounu equat includ height weight provid accur estim metabol rate simplic recommend faounu equat estim metabol rate adolesc popul boy bmr weight kg girl bmr weight kg obes cohort studi faounu equat includ weight height predict metabol rate accur boy bmr weight kg height girl bmr weight kg height"
"nephron site respons reduc kaliuret respons mineralocorticoid hypokalemia rat rat hypokalemia induc eat low diet diminish kaliuret respons mineralocorticoid purpos studi determin due lower rate net secret cortic collect duct ccd enhanc rate reabsorpt medullari collect duct mcd secondari activ secret ccd rais lumen compar plasma tf tf greater secondari activ secret nephron segment tf ccd measur microcatheter collect duct group rat studi rat low diet acut administr doca rat normal diet treat doca chronic basi rat low diet tf rise valu signific greater acut administr doca contrast chronic administr doca rat fed normal diet result tf signific greater uniti degre hypokalemia signific rat absolut fraction reabsorpt mcd rat low diet doca conclud nephron segment respons reduc kaliuret respons mineralocorticoid ccd"
"effect chronic alcohol intak carbohydr lipid metabol subject type ii insulindepend diabet purpos studi effect chronic alcohol intak carbohydr lipid metabol subject insulindepend type ii diabet niddm evalu effect alcohol withdraw metabol control patient method studi group consist alcoholconsum patient niddm niddm group alcoholconsum patient niddm niddm group normal control subject patient admit hospit carbohydr lipid metabol assess individu immedi admiss hospit day result niddm group blood alcohol ethyl alcohol concentr low chronic alcohol intak higher fast postprandi glucos concentr higher hemoglobin ac signific differ found peptid level higher concentr hydroxybutyr free fatti acid observ niddm group niddm group differ found triglycerid concentr acidbas pattern electrolyt level metabol effect alcohol complet wane day complet withdraw conclus chronic alcohol intak deterior metabol control person niddm effect induc alcohol complet revers day withdraw strict metabol assess alcohol import constitu diet"
"inspiratori muscl perform pulmonari function insulindepend diabet mellitus studi examin pulmonari function paramet patient insulindepend diabet mellitus analyz inspiratori muscl perform control group consist healthi refer person sex ratio age height weight distribut similar patient pulmonari function test includ measur lung volum maxim expiratori flowvolum curv valu maxim sniff esophag pes transdiaphragmat pressur pdi paramet global inspiratori muscl strength diaphragm strength maximum voluntari ventil mvv test suppli paramet inspiratori muscl endur diabet patient show high signific decreas inspiratori vital capac vcin compar control subject versus inspiratori muscl perform diabet patient restrict sniff pes signific lower diabet group sniff pdi mvv low result correl durat diabet qualiti metabol control measur glycosyl hemoglobin concentr reduct vcin diabet patient caus part reduc capac inspiratori muscl"
"evalu albumin loss lowdens lipoprotein apheresi reduc plasma oncot pressur hypoproteinemia hyperlipidemia serum albumin level maintain lowdens lipoprotein ldl apheresi amount albumin loss evalu patient famili hypercholesterolemia ldl apheresi column pack dextran sulfatecellulos bead select adsorb ldl serum albumin level signific decreas sd dl dl albumin loss assess method radioimmunoassay microalbumin content discard fluid measur plasma albumin reserv albumin loss apheresi session depend method signific correl method amount albumin loss apheresi estim total plasma albumin reserv half decreas serum albumin level attribut dilut due electrolyt solut prime extracorpor circuit"
"diabet impair hepat insulin receptor tyrosin kinas activ studi mechan insulin receptor tyrosin kinas activ solubil liver control streptozotocin diabet rat studi histon hb polyglutyr phosphoacceptor substrat inhibit autophosphoryl exogen kinas activ ad receptor activ atp hb ad atp insulin stimul exogen kinas activ diabeticderiv receptor signific higher approxim control valu low hb concentr signific lower approxim control valu high hb concentr suggest decreas appar km maxim veloc diabet receptor tyrosin kinas hb receptor maxim autophosphoryl addit hb maxim hb kinas activ diabeticderiv receptor approxim lower control effect attribut alter atp kinet insulin receptor kinas activ substrat polyglutyr unalt insulinopen diabet insulin receptor alphabeta dimer detect control diabeticderiv prepar conclud impair hepat insulin receptor kinas activ insulinopen diabet reflect decreas abil maxim activ enhanc receptor activ presenc substrat hb impair signal diabeticderiv receptor depend type substrat concentr"
"hypothalamicpituitari axi streptozotocininduc diabet femal rat normal estradiol replac studi diabet rat found abnorm hypothalam pituitari ovarian level control estrogen level induc diabet purpos investig studi effect diabet hypothalamicpituitari axi ovariectom rat treat estradiol ovariectom day femal rat assign control diabet insulintr diabet di group diabet induc inject streptozotocin di group di group estrogen replac implant blank microgram microgram pellet sc pituitari lh respons gnrh assess anim anterior hypothalam midhypothalam concentr prognrh gnrh pituitari lh fsh serum level lh measur ria anterior hypothalam prognrh concentr decreas diabet rat treat microgram compar microgram control anim midhypothalam gnrh concentr reduc anim compar estrogen therapi gnrhstimul lh level greater etreat diabet femal similar treat control rat di anim sensit control inhibitori effect estrogen basal lh level pituitari lh fsh content lower microgram ereplac anim influenc diabet state data demonstr diabetesinduc decreas hypothalam prognrh gnrh concentr correct replac hyperrespons diabet rat pituitari gnrh suggest chronic lack gnrh stimul hypothalamus continu abil pituitari respond gnrh"
"longterm studi mental health greenvill gastric bypass oper morbid obes februari patient underw greenvill gastric bypass east carolina univers school medicin oper effect maintain satisfactori weight loss year weight preoper lbs month lbs month lbs gastric bypass favor affect insulindepend diabet hypertens physic role function recent patient studi extend studi effect gastric bypass mental health signific improv mental health indic observ month surgeri erod end year return mental health indic preoper status late occurr suicid death alcohol abus total patient suggest longterm follow continu emot support essenti ingredi success bariatr surgeri"
"human isophan lent insulin doubl blind crossov trial insulin depend diabet mellitus fifti children insulin depend diabet mellitus randomis receiv human isophan lent insulin prepar combin solubl insulin doubl blind trial patient month cross month treatment control assess glycat haemoglobin signific lower children human isophan insulin fast blood glucos fructosamin concentr number episod hypoglycaemia similar regimen children daili insulin regimen insulin profil hour period demonstr greater variabl lent compar isophan insulin ident administ insulin dose questionnair complet end studi show children parent prefer isophan insulin gave perceiv improv metabol control major reason choic"
"comparison mydriat retin photographi ophthalmoscopi patient mobil retin camera studi object determin mydriat polaroid retin photographi compar ophthalmoscopi mydriasi routin clinic screen earli treatabl diabet retinopathi designprospect studi ophthalmoscop find retin camera screen ophthalmoscopi outcom referr ophthalmologist settingoutpati diabet clinic teach hospit district general hospit patient adult select random diabet clinic exclud regist blind wheelchair unabl enter screen vehicl main outcom measuresnumb patient eye correct identifi techniqu requir referr potenti treatabl retinopathi vessel format maculopathi congruenc number microaneurysm haemorrhag exud report resultscamera screen miss case vessel format identifi referr ophthalmoscopi miss case vessel format referr reason maculopathi report eye camera screen eye ophthalmoscopi chi maculopathi subsequ confirm eye receiv laser treatment maculopathi detect camera screen compar ophthalmoscop detect chi camera screen underestim number microaneurysm chi haemorrhag chi ophthalmoscopi underestim hard exud chi conclusionsmydriat polaroid retin photographi good ophthalmoscopi mydriasi routin diabet clinic identifi vessel format absenc retinopathi signific detect exud maculopathi"
"xylos absorpt test urin blood xylos absorpt test decad evalu malabsorpt small intestin disagr exist recommend method perform test hr blood test hr urin test evalu test perform combin blood urin test patient normal xylos absorpt record blood urin test group abnorm test result blood urin record patient group patient patholog blood normal xylos excret urin twenti patient group normal hr blood xylos greater mg ml abnorm hr urin xylos hr fat bile salt malabsorpt document patient group stool fat analysi ccholylglycin breath test data suggest adult hr urin collect accur reflect intestin absorpt comparison hr blood"
"bmi topic activ retinoid low local system toxic treatment dermatolog disord topic appli retinoid potenti therapeut advantag improv local activ lower toxic system administ retinoid retinoid signific degre local irrit present studi abil produc local activ low local irrit potenti evalu retino acid deriv bmi cis cishydroxymethylretino acid deltalacton seri retino acid deriv carboxyl function polar end modifi aim achiev reduc local irrit system toxic retain local therapeut effect bmi evalu compar tran retino acid topic retinoid activ preclin assay system includ utricl reduct assay rhino mice tetradecanoylphorbol acet esterstimul ornithin decarboxylas induct hairless mice uv lightinduc photodamag skin model hairless mice bmi assess retinoidtyp side effect evalu skin irrit potenti rabbit repeat topic applic hypervitaminosi induc potenti mice inject bmi demonstr signific topic retinoid activ vivo model skin irrit potenti relat clinic concentr tran retino acid bmi show system activ produc evid hypervitaminosi syndrom system dose time greater effect dose tran retino acid"
"metabol alter contin urinari divers colon segment studi examin acidbas metabol patient contin colon urinari divers compar control popul divert patient demonstr mild acidosi urinari acidif defect ammonium chlorid load fail demonstr major differ abil patient handl acut acid challeng contin colon urinari divers creat signific acidbas patient normal hepat renal function"
"urinari bladder function month onset diabet spontan diabet bb rat urinari bladder function examin spontan diabet bb rat month onset diabet diabet caus signific decreas rat weight increas bladder bodi weight vivo bladder capac compar agematch control weight bladder base absolut contractil respons urinari bladder bodi base strip nerv stimul carbachol hydroxytryptamin atp phenylephrin kcl unalt diabet data correct tissu mass slight signific decreas contractil respons strip diabet rat increas total muscarin receptor number calcium channel bind site bladder bodi bb rat result increas tissu mass data monthdiabet bb rat differ streptozotocindiabet rat sensit urinari bladder complic diabet result insulin treatment requir bb rat aliv"
"comparison accuraci glucos reflect meter pregnant insulindepend diabet home monitor blood glucos reflect meter shown accur nonpregn diabet outpati glucos control pregnant diabet beckman astra glucos result sampl collect sodium fluorid standard studi comparison made glucos reflect meter accucheck ii touch diascan exactech reflect meter assess blood glucos trend pregnant diabet result obtain meter unaccept laboratori set errat combin proport constant bias correct factor easili ascertain laboratori physician reconsid reflect meter inpati evalu general popul screen pregnant women"
"pharmacokinet ranitidin morbid obes women pharmacokinet singl dose ranitidin mg iv determin ten normalweight ten morbid obes greater percent ideal bodi weight agematch femal subject signific differ normal obes subject found ranitidin peak serum concentr volum distribut clearanc elimin rate constant ranitidin volum distribut clearanc signific smaller obes subject kilogram total bodi weight kg kg normal ideal bodi weight kg kg conclud obes patient receiv ranitidin therapi treat standard dosag dosag base ideal bodi weight"
"plasma lecithincholesterol acyltransferas activ plasma lipoprotein composit concentr kwashiorkor publish erratum clin nutr sep plasma lecithincholesterol acyltransferas lcat activ lipoprotein composit lipoprotein concentr measur children kwashiorkor day day treatment day day lcat activ mumol decreas respect day mumol day mumol plasma total cholesterol tc cholesterol ester ce lipoprotein ces vldl idl ldl hdl reduc relat day treatment hdl composit abnorm day respect hdlapolipoprotein apo concentr mumol ldlapo concentr mumol day day ldl particl day decreas number deplet ce laden triacylglycerol surfac lipid lcat activ day correl ldlce linol reduc plasma lcat activ import factor relat abnorm lipoprotein composit concentr"
"preprandi blood glucos valu glycem respons insulindepend diabet mellitus constant insulinemia influenc preprandi blood glucos ppbg concentr glycem respons studi subject insulindepend diabet artifici pancrea achiev ppbg concentr mmol test meal parboil rice occas constant insulin infus provid observ period postprandialbloodglucoserespons area basal differ signific blood glucos concentr mmol reach mmol min negat correl ppbg concentr glycem respons test meal found fast insulin concentr ppbg concentr mmol lower ppbg concentr mmol conclus glycem respons carbohydr meal invers correl ppbg concentr insulindepend diabet subject"
"perman muscl weak famili hypokalaem period paralysi clinic radiolog patholog aspect myopathi accompani famili hypokalaem period paralysi hpp document paralyt attack diseas deriv eleven affect member larg kinship hpp studi clinic radiolog presenc myopathi patient muscl biopsi perform histolog find obtain autopsi compar ct scan muscl patient previous biopsi specimen amput leg examin histolog age studi individu rang yrs youngest patient show clinic sign myopathi ct scan demonstr discret hypodens lesion leg muscl muscl biopsi show vacuolar myopathi patient older yrs present clinic ct evid myopathi proxim distal muscl rang mild sever male slight affect femal patient ct grade made base abnorm found muscl group myopathi unrel histori paralyt attack strong correl found age ct grade conclud hpp myopathi perman muscl weak late onset patient express paralyt attack variabl"
"treatment niddm insulin agonist substitut insulindepend diabet mellitus niddm common disord occur adult western popul unit state patient diabet insulin niddm insulin therapi requir time niddm insulin therapi improv abnorm niddm reduc betacel function increas hepat glucos product reduc peripher glucos dispos lipid abnorm insulin sulfonylurea agent compar effect mild form niddm sever form insulin superior combin insulinsulfonylurea treatment improv respons sulfonylurea longterm control trial conduct shortterm insulin treatment restor respons sulfonylurea promis treatment human proinsulin nasal insulin somatostatin shown advantag convent insulin therapi insulin hypoglycemia peripher hyperinsulinemia hazard hyperinsulinemia weight gain hypoglycemia overst question atherogen effect remain resolv effect glycem control macro microvascular complic establish maintain fast blood glucos level mm protect progress retinopathi neuropathi nephropathi reduc sever ischem stroke dosag algorithm general intermedi longact insulin control basal glycemia regular insulin ad meal control postprandi glycemia effect therapi depend patient inform cooper monitor blood glucos insulin treatment intermitt increas risk immun complic resist allergi patient niddm benefit insulin therapi"
"insulin niddm effect insulin treatment pathophysiolog insulindepend diabet mellitus niddm review shortterm studi variabl partial reduct excess hepat glucos output decreas insulin resist enhanc betacel function benefici action due decreas secondari glucos toxic direct attack primari abnorm insulin initi treatment onset niddm presenc ketosi signific diabetesinduc weight loss residu obes sever hyperglycem symptom dietfailur patient prospect random studi compar insulin sulfonylurea treatment show approxim equal glycem outcom slight advantag insulin key goal insulin therapi normal fast plasma glucos level contrast convent morn inject intermedi longact insulin preliminari studi suggest potenti advantag administ insulin bedtim obes patient requir hundr unit insulin daili achiev satisfactori control addit sulfonylurea insulin reduc hyperglycemia insulin dose longterm benefit combin therapi remain demonstr conclus establish advers effect insulin treatment niddm hypoglycemia elder weight gain monitor blood glucos identifi patient excess weight gain caus subtl hypoglycemia insulin weight gain direct effect appetit energi util remain controversi potenti advers effect insulin suggest epidemiolog studi show associ hyperinsulinemia insulin resist increas risk coronari arteri diseas stroke hypertens potenti mechan atherogen action insulin exist current evid prove effect warrant withhold insulin therapi compromis dosag"
"intens insulin therapi treatment type diabet intens insulin therapi defin comprehens system diabet manag patient manag team partner system direct improv glycemia patient glycem target individu defin frequent monitor blood glucos time day essenti meticul control benefit includ improv psychosoci function potenti lessen risk chronic complic diabet risk relat problem hypoglycemia increas meticul glycem control sought import element intens therapi multiplecompon insulin program design provid effect insulinemia coincid major meal continu basal insulinemia day achiev continu subcutan insulin infus csii multipl inject insulin regimen csii offer real advantag term pharmacokinet insulin deliveri pharmacokinet issu consid involv select inject site time premeal insulin mix insulin studi shown albeit effort excel glycem control achiev intens insulintherapi regimen implement program intens therapi involv patient manag term alter insulin dosag food intak activ attempt achiev target level glycemia select motiv patient embark therapi intens insulin therapi worthwhil consid patient type insulindepend diabet mellitus"
"retino acid reiniti spermatogenesi vitamin defici rat high replic dose support full develop spermatogen cell effect dose retino acid ra seminifer epithelium vitamin defici rat studi general thought ra reiniti spermatogenesi vitamin defici rat inject mg ra strong stimul prolif activ spermatogonia evidenc fold increas number bromodeoxyuridinelabel spermatogonia ten day ra administr spermatogonia preleptoten spermatocyt seminifer tubul day zygoten spermatocyt present ra induc massiv synchron develop spermatogonia spermatocyt ra combin ra diet zygoten spermatocyt present day develop pachyten spermatocyt develop spermatid subsequ epitheli cycl spermatogonia spermatocyt form lower number cycl ra inject ra week format spermatogonia preleptoten spermatocyt continu higher level pachyten spermatocyt form develop spermatid final ra inject week pachyten spermatocyt round spermatid found day day elong spermatid found anim conclud ra similar retinol induc synchron prolifer differenti spermatogonia repeat inject ra support full develop spermatogen cell elong spermatid"
"failur insulin growth factor igf infus promot growth proteinrestrict rat normal serum igf concentr dietari protein restrict young rat induc gh resist character growth arrest low serum insulin growth factor igf concentr determin low serum igf concentr respons stunt growth infus week proteinrestrict rat recombin human igf microgramsday rat gh microgram bodi wtday osmot minipump week normal serum igf concentr igf infus carcass growth stimul contrast growth spleen kidney enhanc serum igfbind protein igfbp princip carrier igf serum age decreas proteinrestrict anim restor normal igf infus contrari select effect igf growth proteinrestrict rat nourish hypophysectom rat infus microgramsday recombin human igf show signific growth respons includ carcass organ growth normal igfbp valu respons igf prepar mode deliveri effect conclud dietari protein restrict organspecif resist growthpromot properti exogen igf igf mediat stimulatori effect growth hormon igfbp synthesi absenc carcass growth presenc normal serum igf concentr infus igf suggest growth arrest accompani protein restrict mediat part resist igf"
"pituitari insulin growth factor content gene express streptozotocindiabet rat evid tissuespecif regul insulinopen diabet mellitus rat reduc circul level insulin growth factor igf result primarili decreas igf synthesi liver extrahepat site plasma gh level anim suppress loss episod secret decreas pituitari synthesi intrapituitari igf postul exert local autocrineparacrin negat feedback regul gh synthesi secret present studi design examin regul pituitari igf peptid content gene express insulinopen streptozotocin stzdiabet rat compar liver testi serum igf level reduc stzdiabet rat reduct igf content liver testi control concomit liver testicular igf mrna level reduc control insulin treatment restor igf peptid level serum liver testi normal partial signific increas liver igf mrna contrast pituitari ifg peptid content increas stzdiabet rat control chang igf gene express insulin treatment complet revers rise pituitari igf peptid content result demonstr discord regul igf gene express peptid content pituitari tissu stzinduc diabet rat elev igf level pituitari anim part explain suppress gh synthesi secret stzdiabet rat provid evid potenti autocrin paracrin role pituitari igf gh regul"
"cerebrospin fluid loss ventricular cathet lead hyponatremia children present case patient hyponatremia due excess cerebrospin fluid loss ventricular drain possibl loss exist drain treat hydrocephalus monitor intracrani pressur find normal salin sodium concentr meq fluid replac ongo loss cerebrospin fluid ventricular drain start replac therapi ml ml drain"
"effect serum lipid ad instant oat usual american diet studi design test serum lipid respons dietari adapt recommend daili inclus instant oat regular diet hypercholesterolem adult random assign control intervent group particip intervent group packag instant oat request eat serv day approxim ounc dri weight substitut oat carbohydr food order maintain baselin calori intak weight stabl serum lipid measur blood collect venipunctur baselin week week baselin total cholesterol tc level mmol mmol intervent control group week serum total cholesterol intervent group lower mmol net differ tc group mmol ci lowdens lipoproteincholesterol similar reduc net differ mmol ci group solubl fiber intak increas slight impos reduct total fat satur fat dietari cholesterol intak intervent group group chang bodi weight daili inclus ounc oat facilit reduct serum total cholesterol ldl hyperlipidem individu"
"microcircul hemorheolog niddm patient author studi patient insulindepend diabet mellitus control match age sex blood lipid smoke habit group compar hemorheolog characterist evalu viscosimetri blood plasma serum erythrocyt filtrat aggreg microcircul studi subject group microalbuminuria determin retin fluorangiographi capillaroscop examin bulbar conjunct nail fold patient present microalbuminuria valu higher upper limit normal mgh fluoroangiograph alter observ patient present capillaroscop alter bulbar conjunctiva microaneurysm erythrocyt aggreg nail fold frequent finger toe similar alter detect control abnorm independ hemorheolog valu"
"putat mechan impair endotheliumdepend relax aorta atheromat plaqu herit hyperlipidem rabbit attenu acetylcholineinduc endotheliumdepend relax thorac aorta excis watanab herit hyperlipidem whhl rabbit linear correl percent area coat atheromat plaqu elucid mechan relat reduc endotheliumdepend relax presenc atherosclerosi acetylcholineinduc releas endotheliumderiv relax factor edrf assess function percent relax precontract detector strip obtain tunica media beneath intact intima atheromat plaqu aortic ring prepar relax normal detector effluent edrf thorac aorta stimul acetylcholin heterozyg homozyg whhl rabbit phenylephrineinduc precontract relax atherosclerot detector effluent edrf aorta stimul acetylcholin heterozyg homozyg whhl rabbit valu signific smaller normal detector superoxid dismutas ad perfus donor homozyg heterozyg whhl rabbit atherosclerot detector relax effluent stimul acetylcholin versus addit superoxid dismutas normal detector relax induc sodium nitroprussid contract acetylcholin phenylephrin kcl mm compar detector strip normal atherosclerot portion amount edrf releas acetylcholin reduc presenc atherosclerosi tunica media beneath atheromat plaqu extent respons superoxideinduc inactiv edrf"
"enhanc blood glucos awar adolesc young adult iddm object determin effect intervent program design improv blood glucos awar research design method youngadult outpati age yr adolesc inpati age yr insulindepend diabet mellitus particip intervent program adolesc inpati age yr serv untreat comparison group adult outpati unreli data remov treatment patient complet minimum blood glucos estim blood glucos test symptomr checklist symptom hypo hyperglycemia identifi patient session intervent focus intern person symptom extern time amount insulin food exercis cue enhanc blood glucos awar postintervent patient complet minimum addit blood glucos estim test comparison subject complet prepostassess receiv intervent result blood glucos estim accuraci evalu error grid analysi estimatedactu blood glucos valu plot zone accur estim zone benign error zone clinic danger error zone accuraci index ai calcul subtract sum percentag clinic danger estim zone percentag accur estim zone studi entri adolesc inpati ai signific poorer ai exhibit outpati youngadult sampl postintervent adolesc ai improv young adult outpati ai improv treat sampl exhibit increas sensit hypo hyperglycemia similar improv occur untreat comparison sampl conclus adolesc exhibit poorer blood glucos awar adult intervent program improv blood glucos awar adolesc adult patient postintervent blood glucos estim accuraci remain ideal"
"racial differ metabol control children adolesc type diabet mellitus object studi evalu racial differ metabol control children adolesc insulindepend type diabet mellitus examin interact effect race age sex research design method data demograph clinic variabl obtain black white children includ percentag total hba age age diagnosi durat diabet pubert status insulin dose kgday bodi mass index number clinic visit miss number hospit diabet ketoacidosi dka year socioeconom status ses result black children higher insulin dosag lower sess white children hba higher black white children statist adjust effect insulin dose diabet durat ses hbabas criteria black white children poor fewer good metabol control older children greater equal yr higher hba level younger yr children differ hba male femal interact effect race sex agegroup black children hospit dka frequent white children black white children miss clinic visit differ number visit conclus black youth type diabet mellitus poorer metabol control white youth"
"demonstr insulin transform product insulin vial highperform liquid chromatographi object assess import temperatur light agit regular withdraw insulin rate group insulin transform product itp vial human beef solubl insulin research design method twelv insulintr patient receiv human solubl insulin receiv beef solubl insulin particip studi reversephas highperform liquid chromatographi measur itp serial sampl vial store laboratori environ issu patient vial laboratori analyz occas wk issu patient analyz week result result express rate chang total proteinwk human insulin store degre sampl acceler transform storag higher temperatur caus rapid transform itp group human insulin suscept beef insulin exposur light acceler transform group itp fibril occur beef human insulin carri shirt pocket result patient vial consist report storag condit conclus itp group form human beef solubl insulin rate product function temperatur light exposur differ insulin due differ formul patient discourag hoard vial store insulin direct sunlight itp contribut residu immunogen modern insulin prepar"
"intern evalu specif mortal iddm diabet epidemiolog research intern mortal studi group object crosscultur studi complet evalu differ mortal pattern popul cohort japan israel allegheni counti pennsylvania finland research design method case diagnos januari decemb mortal determin januari death occur insulindepend diabet mellitus iddm patient countri standard protocol assess death specif mortal develop articl report result major mortal differ countri iddm subject japan die countri japan elev mortal result acut diabetesrel complic kidney diseas countri mortal acut diabetesrel complic account surpris high percentag death greater countri larger percentag case finland die result suicid countri conclus result suggest major crosscountri differ specif mortal prematur mortal diabet potenti prevent"
"superior radiobind assay elisa detect iaa newli diagnos type diabet children object liquid solidphas assay insulin autoantibodi iaa determin method iaa measur standard research design method iaa determin radiobind assay rba enzymelink immunosorb assay elisa larg agematch group nondiabet newli diagnos insulindepend type diabet children result posit iaa rba greater equal nondiabet sd nondiabet diabet children preval iaa rba signific higher youngest agegroup yr posit iaa elisa nondiabet diabet children concord rate assay control subject diabet children conclus conclud rba elisa iaa detect onset diseas addit data suggest iaa detect rba highaffin antibodi tempt specul iaa reflect matur immun reaction endogen insulin"
"vitamin reduct protein glycosyl diabet prospect prevent diabet complic object studi evalu possibl inhibit protein glycosyl vivo vitamin research design method group insulinrequir diabet patient match durat diseas metabol control receiv daili vitamin supplement mg mo group diabet patient match durat diseas metabol control serv control group receiv placebo fast plasma glucos daili plasma glucos fast labil hba glycosyl protein measur basal state mo treatment addit hyperglycem clamp studi perform basal state mo vitamin administr patient result glycem indic show signific studi fast labil hba glycosyl protein decreas signific mo patient vitamin administr stabl hba decreas mo glycem increment area hyperglycem clamp procedur similar treatment signific reduct labil hba increment area found vitamin supplement signific differ found fast increment labil hba level stabl hba glycosyl protein group diabet patient dose vitamin diabet patient receiv higher dose vitamin show greater reduct signific paramet observ diabet patient placebo administr conclus result demonstr vitamin administr reduc protein glycosyl diabet subject independ plasma glucos effect due inhibit labil glycosyl step maillard reaction longterm studi establish vitamin administr prevent diabet complic"
"archaeolog niddm excav thrifti genotyp numer case insulindepend diabet mellitus niddm observ american indian popul extrem high preval rate niddm occur strike tribe paleoindian ancestor migrat north america greater yr ago archaeolog evid period group paleoindian maintain arctic huntergather lifestyl area temper north america rang wyom arizona lifestyl featur relianc unpredict big game speci major food sourc time big game speci extinct hypothes paleoindian reli big game food sourc develop thrifti genotyp select advantag period fast occur big game kill hypothes thrifti genotyp indian contribut niddm sedentari lifestyl adopt food sourc constant insulin resist muscl major featur niddm insulin resist se phenotyp express thrifti genotyp"
"bant lectur betacel type ii diabet mellitus immunoassay insulin demonstr signific quantiti circul hormon insulindepend type ii diabet yr foster debat betacel abnorm play etiolog role syndrom earli effort determin adequaci islet betacel function show obes insulin resist major confound variabl subsequ recogn glucos direct regul insulin synthesi secret moder islet signal includ substrat hormon neural factor obes glucos account clear patient fast hyperglycemia abnorm islet function type ii diabet character defect phase acut glucoseinduc insulin secret defici abil glucos potenti islet nonglucos betacel secretagogu result hyperglycemia compens defect glucos potenti maintain normal basal insulin level insulin respons nonglucos secretagogu correct defect phase glucoseinduc insulin releas develop fast hyperglycemia phase glucoseinduc insulin secret defect progress islet failur match rise glucos level maintain basal phase insulin output relationship islet function fast plasma glucos steepli curvilinear loss betacel function time diagnost level mgdl exceed steadi state character glucos overproduct ineffici util insulin resist present patient contribut hyperglycemia augment glucos level compens decompens absolut hypoinsulinemia occur renal threshold glucos exceed prevent elev circul glucos etiolog islet betacel lesion hypothesi base basal hyperproinsulinemia islet amyloid deposit pancrea type ii diabet review recent discoveri islet amyloid polypeptid iapp amylin major constitu islet amyloid deposit integr hypothesi suggest proiapp proinsulin process matur peptid secret occur abnorm process secondari conjunct defect hormon secret lead progress accumul intracellular iapp proiapp cat monkey human form intracellular fibril amyloid deposit loss betacel massabstract truncat word"
"reduc neuroendocrin symptomat respons subsequ hypoglycemia episod hypoglycemia nondiabet human test hypothesi hypoglycemia reduc neuroendocrin symptomat respons subsequ hypoglycemia measur respons clamp hypoglycemia mm consecut morn occas interv afternoon hypoglycemia mm occas interv afternoon euglycemia mm nondiabet human measur respons reduc interv euglycemia contrast plasma epinephrin glucagon pancreat polypeptid cortisol total neurogen neuroglycopen symptom respons morn hypoglycemia reduc interv afternoon hypoglycemia singl episod hypoglycemia caus general reduct neuroendocrin symptomat respons subsequ hypoglycemia find import pathogenesi iatrogen hypoglycemia insulindepend diabet mellitus"
"impair glycerol phosphat shuttl islet rat diabet induc neonat streptozocin islet adult rat inject streptozocin neonat period oxid secretori respons glucos sever affect evok leucin explan preferenti defect sought compar rate aerob glycolysi sum cglucos convers label pyruv amino acid total glycolyt flux judg convers hglucos ho preferenti impair aerob relat total glycolysi found islet diabet rat incub low high glucos concentr coincid islet mitochondria diabet rat sever decreas basal ca generat ho hglycerolphosph cainduc increment hglycerophosph detriti mitochondria diabet rat effici control anim generat cketoglutar diabetesinduc alter ketoglutar dehydrogenas islet mitochondria mark fadlink glycerophosph dehydrogenas chang respons ca sonic islet mitochondria diabet rat display normal slight elev glutam dehydrogenas activ propos preferenti impair oxid secretori respons islet cell glucos experiment model diabet part attribut alter transfer reduc equival mitochondria mediat glycerol phosphat shuttl"
"effect pp vitamin platelet hyperaggreg fatti acid abnorm clinic manifest streptozocininduc diabet rat effect vitamin myoinositol trisphosph pp investig longterm studi streptozocininduc diabet rat fed purifi diet lipid polyunsatur satur fatti acid ratio supplement vitamin decreas plasma triglycerid platelet lipid biosynthesi delta delta desaturas abnorm urin keton bodi affect respons platelet aggreg pp complet normal platelet reactiv adp thrombin accompani normal platelet lipid biosynthesi diabetesinduc abnorm delta delta desaturas pp treatment reduc mortal rate extent urinari keton bodi protect effect pp platelet aggreg mortal rate dose relat pp molecul deriv phytic acid exert potent protect effect manifest diabet rat"
"insulinreceptor cdna sequenc niddm patient homozyg insulinreceptor gene rflp resist insulin action establish featur insulindepend diabet mellitus niddm believ contribut etiolog condit strong genet contribut etiolog niddm exist previous identifi insulinreceptor gene restrictionfragmentlength polymorph rflp niddm phenotyp attempt elucid structur defect insulin receptor primari insulin resist niddm analyz insulinreceptor cdna sequenc subject niddm homozyg rflp insulinreceptor cdna sequenc polymeras chain reaction pcr mrna transform lymphocyt revers transcrib amplifi overlap set primer span code sequenc alpha betasubunit differ found predict amino acid sequenc subject insulin receptor compar normal insulin receptor nucleotid posit subject heterozyg silent nucleotid polymorph affect amino acid sequenc exon encod amino acid insert alphasubunit due altern splice express lymphocyt insulinreceptor mrna exon amplifi genom dna pcr sequenc exon found normal addit patient transform lymphocyt maintain cultur abnorm insulin bind observ conclud insulin resist niddm subject due structur alter insulin receptor"
"product inhibitor insulinreceptor tyrosin kinas fibroblast patient insulin resist niddm insulindepend diabet mellitus niddm defect insulin action molecular basi resist unknown studi fibroblast mark insulinresist patient niddm acanthosi nigrican fibroblast resist insulin alphaaminoisobutyr acid uptak measur fibroblast patient demonstr normal insulinreceptor content measur insulinreceptor radioimmunoassay scatchard analysi compar nondiabet control subject insulinreceptor kinas assay wheatgermpurifi receptor prepar fibroblast show low basal insulinstimul tyrosin kinas activ insulin receptor remov wheatgerm fraction monoclon antibodi affin chromatographi insulinreceptordefici fraction inhibit basal insulinstimul tyrosin kinas activ high purifi insulin receptor specif inhibit test inhibit insulinlik growth factor receptor tyrosin kinas inhibit protooncogen pcsrc tyrosin kinas studi fibroblast insulinresist patient niddm produc specif glycoprotein inhibitor insulinreceptor tyrosin kinas studi rais possibl inhibitor play import role insulin resist patient"
"effect glucagon free fatti acid metabol human determin physiolog plasma glucagon concentr import regul basal adipos tissu lipolysi ffa flux cpalmit measur respons increas decreas plasma glucagon volunt insulindepend diabet mellitus iddm healthi nondiabet volunt studi pancreat clamp techniqu control plasma insulin gh glucagon concentr desir level palmit flux chosen euglucagonem hormon infus rate similar baselin valu  mumolkgmin iddm nondiabet subject signific palmit flux occur respons glucagon withdraw mild nondiabet volunt high physiolog iddm volunt hyperglucagonemia condit normal ffa avail plasma glucagon concentr physiolog rang effect adipos tissu lipolysi"
"acut serum osteocalcin induc hypocalcemia human level serum osteocalcin thought indic osteoblast activ bone format inform acut effect calcium pth level circul osteocalcin concentr studi effect stepwis decreas ioniz calcium cai osteocalcin level infus normal subject citrat min interv protocol protocol puls infus altern rate infus result rapid stepwis decrement serum cai protocol continu infus constant intermedi rate citrat infus produc slower decrement cai similar magnitud monitor serum cai intact pth osteocalcin concentr infus step puls infus osteocalcin respons cai general parallel pth invers correl cai osteocalcin concentr end min period higher begin period total min osteocalcin level rose microgram contrast period continu infus osteocalcin concentr chang slight period continu infus osteocalcin respond manner characterist observ puls infus data osteocalcin concentr circul acut regul calcium pth"
"nocturn elev glucos level fast noninsulindepend diabet defin spontan diurnal variat glucos regul fast noninsulindepend diabet niddm measur circul level glucos insulin peptid gh cortisol glucagon min interv patient untreat diabet match control subject studi period rate insulin secret deriv concentr peptid deconvolut compart mathemat model peptid distribut metabol group subject continu fast glucos level stop declin subsequ rose night reach morn maximum elev level persist noon morn glucos maximum correspond relat increas nadir niddm patient nondiabet subject niddm patient insulin level insulin secret rate parallel nocturn glucos contrast control subject nocturn glucos rise coincid similar increas insulin secret rate cortisol concentr patient niddm higher control subject studi period rose earlier control subject fail demonstr normal nocturn suppress group subject nighttim glucos elev tempor quantit correl circadian cortisol rise gh secret increas nighttim period compar daytim valu niddm patient control subject size morn glucos elev direct relat magnitud increas gh secret glucagon concentr similar group subject remain essenti constant studi period hypothes nocturn glucos rise occur fast repres normal diurnal variat setpoint glucos regul amplifi counterregulatori mechan activ fast condit"
"proglucagon product plasma noninsulindepend diabet nondiabet control fast state oral glucos intraven arginin investig major product proglucagon pg process plasma fast state intraven arginin oral glucos load noninsulindepend diabet niddm weight match control specif radioimmunoassay analyt gel filtrat fast state glucagonlik peptid glp immunoreact signific elev niddm group compar control group intraven arginin oral glucos load rise plasma concentr immunoreact moieti measur integr increment respons intraven arginin ident group oral glucos insulin concentr plasma lower concentr proglucagon product higher niddm group compar control group gel filtrat analysi show arginin stimul secret pancreat glucagon pg major proglucagon fragment pg glp pg amid group oral glucos stimul secret glicentin pg intestin glp pg amid insulinotrop hormon elev level immunoreact glp diabet fast state due increas concentr major proglucagon fragment"
"advanc glycosyl product quench nitric oxid mediat defect endotheliumdepend vasodilat experiment diabet nitric oxid endotheliumderiv relax factor induc smooth muscl relax import mediat regul vascular tone advanc glycosyl end product glucosederiv moieti form nonenzymat accumul longliv tissu protein implic complic diabet normal age demonstr advanc glycosyl product quench nitric oxid activ vitro vivo acceler advanc glycosyl process vivo result timedepend impair endotheliumdepend relax inhibit advanc glycosyl aminoguanidin prevent nitric oxid quench amelior vasodilatori impair result implic advanc glycosyl product import modul nitric oxid activ endotheliumdepend relax"
"normal blood glucos diabet rat phlorizin treatment revers insulinresist glucos transport adipos cell restor glucos transport gene express evid emerg direct role glucos independ insulin regul cellular glucos transport glucos util vivo studi investig potenti cellular molecular mechan regulatori effect glucos determin normal glycemia insulin therapi diabet rat influenc methylglucos transport express transloc genet distinct speci glucos transport gts adipos cell result compar alter glucos dispos vivo measur euglycem clamp rat render diabet pancreatectomi insulinstimul glucos transport adipos cell decreas parallel reduc insulinmedi glucos dispos vivo level adiposemuscl gts measur immunoblot decreas adipos cell subcellular membran fraction mrna level assess northern blot total adipos cell rna normal blood glucos diabet rat phlorizin impair renal tubular glucos reabsorpt enhanc glucos excret restor insulinstimul glucos transport adipos cell insulinmedi glucos dispos vivo import level adiposemuscl gt protein remain reduc lowdens microsom basal state reduc plasma membran insulinstimul state adiposemuscl gt mrna level remain approxim depress level hepgbrain gt protein mrna unalt diabet phlorizin treatment ambient glucos independ ambient insulin regul glucos transport respons insulin isol adipos cell respons parallel alter glucos uptak vivo effect occur alter express speci glucos transport present adipos cell transloc plasma membran respons insulin result gt function activ"
"role increas cytosol free calcium pathogenesi rabbit proxim tubul cell injuri protect glycin acidosi assess role increas cytosol free calcium caf pathogenesi acut proxim tubul cell injuri protect afford exposur reduc medium ph treatment glycin furaload tubul studi suspens singl superfus system ca ionophor ionomycin increas caf micromolar level rapid produc lethal cell injuri loss lactat dehydrogenas medium suspend tubul acceler leak fura failur exclud trypan blue superfus tubul decreas medium ca nm prevent ionomycininduc increas caf injuri reduc medium ph ad mm glycin medium prevent cell death prevent increas caf micromolar level cell treat uncoupl oxid phosphoryl produc sever adenosin triphosph atp deplet develop increas caf loss viabil prevent increas caf nm ca medium protect treat cell reduc ph glycin protect treat cell amelior increas caf data demonstr toxic potenti increas caf proxim tubul show caf sharpli increas prior loss viabil atp deplet model injuri increas necessarili contribut outcom potent protect action decreas ph glycin cell sustain increas caf micromolar level spite sever accompani cellular atp deplet develop lethal cell injuri"
"singl base substitut code region neurophysin ii famili central diabet insipidus elucid molecular mechan famili central diabet insipidus fdi sequenc arginin vasopressinneurophysin ii avpnpii gene patient belong pedigre consist autosom domin mode inherit patient idiopath central diabet insipidus idi normal studi avpnpii gene locat chromosom consist exon encod putat signal peptid avp npii glycoprotein polymeras chain reaction fragment includ promot region code region amplifi genom dna subject direct sequenc sequenc patient idi ident normal patient fdi singl base substitut detect allel avpnpii gene indic heterozygot mutat transit nucleotid posit exon result substitut gli ser amino acid posit npii moieti specul mutat avpnpii precursor mutat npii molecul conform respons avp defici"
"nutrit manag individu noninsulindepend diabet mellitus review diabet care educ dietet practic group noninsulindepend diabet mellitus niddm type ii diabet character primari defect insulin resist insulin secret major goal manag niddm achiev normal metabol control preventdelay microvascular macrovascular complic diabet nutrit exercis medic primari treatment modal niddm treatment regimen individu develop diabet manag goal qualitylif issu lean individu niddm encourag maintain bodi weight modifi food composit eat pattern minim glucos excurs primari treatment goal obes individu niddm weight loss process teach nutrit meal plan involv develop cooper allianc gather inform set realist goal intervent maintain chang nutrit intervent involv provid inform stage begin surviv skill inform progress depth inform dietitian respons promot continu learn introduc idea concept alter learn environ dietitian expand role diabet educ leadership role ensur individu niddm receiv comprehens individu care"
"dietari educ program hypercholesterolem children parent parentchild autotutori dietari educ program year hypercholesterolem children famili develop pilot test lesson program design week home talkingbook approach audiotap accompani pictur booklet child parent provid inform make recommend dietari hand activ children match instruct approach wide development rang children age span materi divid program level stori charact concept present program develop evalu children parent program level guid design refin lesson pilot test hypercholesterolem children treatment limit diet modif reveal children year age rang talkingbook approach identifi posit stori charact parent materi clear baselin month follow visit children exhibit signific increas knowledg heart healthi food decreas total fat consumpt approach signific signific decreas plasma lowdensitylipoprotein cholesterol valu"
"recommend daili vitamin low homebound elder popul sunlightdepriv elder studi determin daili intak vitamin dietari intak suffici maintain normal vitamin status twenti subject year serum creatinin mumol confin indoor month chosen communiti nurs home southeast baltimor day food record obtain serum level hydroxyvitamin ohd dihydroxyvitamin intact parathyroid hormon pth daili vitamin intak twofold greater adult recommend daili rda iu ohd level nmol normal nmol patient nmol particip ohd valu nmol vitamin intak iu rang iu conclud current rda inadequ older individu sun exposur popul elder risk develop vitamin defici complic"
"relationship symptomat biochem hypoglycaemia insulindepend diabet patient relationship symptomat subject feel biochem blood glucos concentr mmol hypoglycaemia studi random select insulindepend diabet patient normal condit daili life convent insulin inject regimen patient collect point diurnal blood glucos profil home consecut day week week felt hypoglycaem sampl time collect extra sampl felt hypoglycaem time studi period week frequenc symptomat biochem hypoglycaemia patient biochem hypoglycaemia present symptomat episod symptomat hypoglycaemia accompani biochem episod symptomat hypoglycaemia experienc median blood glucos concentr mmol rang mmol fifti cent symptomat biochem episod occur lunch remaind distribut day occurr biochem hypoglycaemia symptomat hypoglycaemia invers correl hbac median blood glucos concentr symptomat hypoglycaemia unreli indic biochem hypoglycaemia degre glycaem control blood glucos measur prerequisit diagnosi hypoglycaemia"
"modul dietari vitamin compound putat indigen dna modif rat liver kidney indigenouscompound agerel carcinogen adduct putat indigen dna modif detect ppostlabel assay untreat anim investig origin dna deriv examin effect dietari vitamin natur antioxid compound rat liver kidney dna weanl femal spraguedawley rat fed draper diet mgkg alphatocopheryl acet mo dna individu rat group analyz nucleas penhanc version ppostlabel assay dna adduct amount vitamin liver measur high perform liquid chromatographi rat fed vitamin defici diet mgkg show ident profil similar level compound fed mgkg diet spot signific intensifi tissuespecif extra spot found liver kidney dna rat fed mgkg vitamin diet major spot detect kidney weaker mgkg group mgkg group result show format compound affect vitamin defici diet longterm feed diet high level vitamin metabol alter lead increas format dnareact potenti mutagen carcinogen electrophil"
"lovastatin efficaci reduc lowdens lipoprotein cholesterol level high lowfat diet effect lovastatin compar highfat lowfat diet hypercholesterolem subject studi metabol ward condit diet period week receiv lovastatin mg placebo multipl lipoprotein level measur final week diet period nineteen subject complet studi highfat kilojoul diet lowfat kilojoul diet lovastatin reduc total cholesterol lowdens lipoprotein cholesterol compar placebo diet signific dietdrug interact highdens lipoprotein cholesterol rais diet regimen addit lovastatin lowfat diet permit subject diet highfat diet achiev current guidelin lovastatin produc compar percentag reduct lipoprotein profil diet accompani lowfat diet remain advis addit reduct lowdens lipoprotein cholesterol level goal"
"compar studi micropor cholestyramin analogu filicol gemfibrozil treatment sever primari hypercholesterolemia short longterm result hypolipidem effect gemfibrozil sever hypercholesterolemia establish fifti patient primari hypercholesterolemia includ patient famili hypercholesterolemia stabl lowdens lipoprotein cholesterol level greater mmol greater mgdl sd mmol mgdl hypolipidem diet assign treatment week filicol micropor cholestyramin analogu gemfibrozil random clinic trial toler good drug filicol gemfibrozil caus similar decrement total cholesterol lowdens lipoprotein cholesterol apolipoprotein close patient decreas greater lowdens lipoprotein cholesterol level drug gemfibrozil filicol signific increas plasma highdens lipoprotein cholesterol apolipoprotein level reduc triglycerid level loss efficaci observ drug subset patient good week respons rate extend therapi month studi demonstr gemfibrozil benefici effect aspect plasma lipid profil patient sever hypercholesterolemia clinic situat potenti advantag standard dose anionexchang resin"
"effect recombin human macrophag colonystimul factor plasma cholesterol level recombin human macrophag colonystimul factor rhmcsf hematopoiet growth factor stimul growth differenti prolifer activ cell monocytemacrophag lineag rhmcsf administ rabbit nonhuman primat evalu effect cholesterol homeostasi decreas plasma cholesterol concentr observ rhmcsf administr observ sd decreas rang dose nonhuman primat receiv rhmcsf continu intraven infus civi intraven bolus ivb inject approxim lowdens lipoprotein ldl cholesterol level decreas pretreat baselin valu anim receiv rhmcsf ivb normocholesterolem zealand white rabbit receiv rhmcsf rang dose civi show decreas baselin total cholesterol approxim ldl cholesterol level decreas approxim highdens lipoprotein level show variabl includ increas valu decreas total plasma cholesterol observ watanab herit hyperlipidem rabbit receiv rhmcsf civi day decreas attribut decreas ldl cholesterol fell approxim baselin mechan cholesterollow effect unknown result strong suggest rhmcsf provid treatment hypercholesterolemia investig mechan cholesterol homeostasi atherogenesi"
"risk disabl mortal due overweight finnish popul publish erratum bmj nov object investig effect overweight prematur mortal work disabl young middl age finn designprospect cohort studi base data collect multiphas health examin social insur institut finland follow set communiti finland subject women men employ age baselin main outcom measuresmort work disabl pension resultsbodi mass index weak predictor death strong predictor earli work disabl increas linear bodi mass index adjust age geograph region occup smoke relat risk work disabl women men bodi mass index greater equal kgm confid interv compar subject bodi mass index kgm increas risk due excess cardiovascular musculoskelet diseas mental diseas fourth disabl pension cardiovascular musculoskelet women half men attribut overweight bodi mass index greater kgm conclus modest overweight impact mortal predict sever function impair proport work disabl pension prevent effici weight control"
"differenti diagnosi criglernajjar diseas type bile pigment analysi phenobarbit respons bile pigment composit fraction biliari excret ratio bilirubin studi children criglernajjar diseas children serum bilirubin level decreas phenobarbit treatment pigment composit bile chang decreas proport unconjug bilirubin increas monoconjug diconjug children serum bilirubin level chang signific phenobarbit treatment patient bile pigment compris unconjug bilirubin monoconjug diconjug basi differ group classifi type criglernajjar diseas type bile pigment analysi parent patient criglernajjar diseas show increas proport monoconjug partner coupl test normal serum bilirubin level serum bilirubin level type patient amount mumol mumol addit fraction bilirubin excret ratio calcul ratio bilirubin bilebilirubin serumbil acid bilebil acid serum differenti group fold fold differ ratio patient criglernajjar diseas gilbert syndrom patient criglernajjar diseas control fraction bilirubin excret ratio prove excel tool differenti gilbert syndrom criglernajjar diseas criglernajjar diseas type differenti basi bile pigment analysi"
"hypomagnesemia parathyroid hormonevitamin endocrin system children insulindepend diabet mellitus effect magnesium administr insulindepend diabet mellitus alter electrolyt metabol derang parathyroid hormon pthvitamin endocrin system studi children diabet age year found lower serum valu total ioniz calcium magnesium intact pth calcitriol osteocalcin age sexmatch control subject patient magnesium oral mgkg daili element magnesium day treatment serum magnesium total ioniz calcium intact pth calcitriol osteocalcin concentr signific increas reach control valu day lowcalcium diet patient signific reduc deltaincr pth calcitriol comparison valu obtain hypomagnesemia magnesium replet deltaincr pth calcitriol respons lowcalcium diet signific control valu data suggest magnesium defici play pivot role alter miner homeostasi insulindepend diabet mellitus"
"diabet retinopathi modifi panretin laser photocoagul therapi shown modifi diabet retinopathi success develop therapi diabet retinopathi depend diseas process understood intervent identifi amelior circumv critic stage develop diseas model diseas process present serv framework piec puzzl area potenti intervent therapi conceptu"
"histori phlebotomi therapi hemochromatosi hemochromatosi recogn ironstorag diseas year propos treat remov hemoglobin davi arrowsmith credit report demonstr larger seri provid statist valid evid improv qualiti life increas longev earlier diseas discov risk morbid mortal screen test serum iron total ironbind capac serum ferritin recommend blood relat index case hereditari diseas clinic complic hemochromatosi treat liver disord mild diabet mellitus heart diseas arthropathi steril impot prematur menopaus abnorm pigment skin"
"comparison stainabl liver iron symptomat asymptomat hemochromatosi homozygot homozyg relat author compar amount hepat parenchym cell stainabl iron hemochromatosi homozygot separ group group symptomat hemochromatosi proband hemochromatosi age year identifi symptom sign iron overload group asymptomat proband hemochromatosi age year identifi popul screen studi routin health mainten evalu group homozyg relat age year group proband group homozyg relat age year group proband symptomat proband group year older stainabl hepat iron asymptomat proband group homozyg relat group symptomat proband older stainabl hepat iron homozyg relat group asymptomat proband result studi suggest popul screen studi result earli identif individu hemochromatosi massiv hepat iron overload occur symptom iron overload develop"
"immunogenet hereditari hemochromatosi hereditari hemochromatosi hh iron overload diseas caus unregul intestin iron absorpt recess hlalink diseas hh common inherit metabol disord individu gene develop diseas product hemochromatosi gene unknown mode inherit hlagenotyp proband sibl high predict genet propens develop clinic featur hh view immunoregulatori properti iron bind protein import determin high level storag iron hh influenc immunosurveil network hh patient clinic relev defin alter effector cell cellular arm immun system studi patient hh specif immun alter includ delay cutaneoustyp hypersensit anergi diagnos poor differenti adenocarcinoma stomach year hh diagnosi find consist interpret clinic situat elev bodi iron store immunoregulatori balanc environ tip favor growth develop cancer cell"
"immun system hereditari hemochromatosi quantit function assess cellular arm object investig evalu quantit function characterist effector cell cellular arm immun system hereditari hemochromatosi hh respect treatment status observ consist postul elev level storag iron vivo immunoregulatori properti absolut number cdposit cell signific elev untreat hh patient reduc treat patient compar control prolif respons peripher blood mononuclear cell untreat hh patient mitogen suboptim respons peripher blood mononuclear cell pbm treat hh patient normal immunoglobulin secret pbm treat hh patient compar control alter final effector cell abnorm unrel treatment status subset matur activ lymphocyt aberr form thermost erythrocyterosett te lymphoid surfac marker express thymocyt activ cell data defin immun alter consist interpret cellular immun influenc high level storag iron hh patient"
"psychosoci factor matern phenylketonuria prevent unplan pregnanc background women phenylketonuria pku treat prior concept pregnanc result fetal damag report factor prevent unplan late treat pregnanc method subject includ phenylketonur women comparison group compos femal acquaint diabet women interview administ test intellig general knowledg person result thirti percent sexual activ women pku contracept sporad variabl predict report frequenc birth control extent women felt social support contracept posit attitud birth control knowledg famili plan comparison group pattern variabl predict contracept locus control figur promin diabet social support birth control import acquaint conclus girl pku enter childbear age increas specif program address psychosoci factor matern pku"
"form famili hypobetalipoproteinaemia due mutat apolipoprotein gene famili hypobetalipoproteinaemia fhbl domin disord lipoprotein metabol character level apolipoprotein carri lipoprotein vldl idl ldl normal level heterozygot absent homozygot report recent shown defect fhbl involv mutat apo gene lead reduc level apo mrna product truncat form apo lower synthet rate higher catabol rate normal apo present generat famili fhbl member linkag analysi show absenc segreg apo gene allel hypocholesterolaem phenotyp conclud domin transmit mutat gene apo respons low plasma cholesterol level"
"hypoglycaem episod intensifi insulin treatment increas frequenc effect cognit function nineti patient insulin depend diabet mellitus iddm random intensifi convent treatment ict regular treatment rt hbac level sem reduc ict group rt group differ group signific period year ict patient confid interv rt patient ci episod hypoglycaemia parti assist result coma eighteen ict patient initi adrenerg symptom hypoglycaemia chang predomin neuroglycopen symptom case rt patient chang symptom relat increas frequenc hypoglycaemia symptom frequenc hypoglycaemia bor relationship insulin dose bodi mass index durat diabet autonom nerv function result neuropsycholog test differ group baselin chang studi sign deterior cognit function patient hypoglycaem episod"
"shortterm effect dehydroepiandrosteron treatment rat mitochondri respir administr dehydroepiandrosteron dhea rat result alter liver serum factor studi undertaken determin earliest metabol chang dhea treatment serum cholesterol triacylglycerol glucos insulin glucagon thyroid hormon hepat glucosephosph dehydrogenas activ general unalt obes zucker rat dhea treatment malic enzym longchain fatti acylcoenzym hydrolas catalas activ peroxisom betaoxid rate elev dhea treatment mitochondri betaoxid alter hepat mitochondri state respir liver glutamatemal elev dheatreat rat elev mg protein succinatesupport state respir liver elev dhea treatment mitochondria rat treat lower level cardiolipin phosphatidylethanolamin increas phosphatidylcholin fatti acid composit phospholipid occur dhea treatment addit studi rat treat dhea dhea ethidium bromid ethidium bromid inhibit increas mitochondri protein respir dhea treatment find mitochondri respir earliest factor affect dhea protein synthesi"
"endotoxin lipid peroxid vivo selenium vitamin defici adequ rat effect salmonella typhimurium endotoxin inject intraperiton mgkg bodi weight lipid peroxid vivo assess peroxid monitor measur ethan product autoxid product unsatur fatti acid weanl rat fed selenium vitamin defici basal diet supplement mg sekg mg vitamin kg wk feed ethan product tripl lpstreat se vitamin defici rat compar salinetr defici rat doubli defici adequ rat lps increas ethan product greater extent se vitamin defici rat dietari se vitamin supplement signific reduc ethan product lpstreat rat vitamin protect se lpsinduc lipid peroxid escherichia coli salmonella minnesota lps increas ethan product se vitamin defici rat result show low dose lps stimul lipid peroxid vivo se vitamin defici rat"
"endotoxin lipid peroxid vitro selenium vitamin defici adequ rat tissu effect salmonella typhimurium endotoxin inject intraperiton rat mgkg bodi weight subsequ lipid peroxid vitro assess peroxid monitor measur ethan product tissu slice thiobarbitur acidreact substanc conjug dien tissu homogen weanl rat fed selenium vitamin defici basal diet supplement mg sekg diet mg vitamin kg wk ethan product thiobarbitur acidreact substanc liver lung general increas lps treatment se vitamin defici rat conjug dien increas lps treatment liver se vitamin defici rat paradox higher se vitamin adequ liver tissu daili inject hydroxyureakg bodi weight cell prolifer inhibitor prior lps inject signific decreas lpsinduc ethan product se vitamin defici rat liver lung result show low dose lps inject rat stimul lipid peroxid vitro se vitamin defici rat liver tissu hydroxyurea decreas lpsinduc lipid peroxid vitro suggest neutrophil macrophag involv lpsinduc lipid peroxid"
"effect dehydr gastric empti gastrointestin distress run gastrointestin distress common report athlet ingest beverag specul ingest occur dehydr place high preval gi disord marathon runner lost greater equal bodi weight support theori test theori effect dehydr dehydr combin endur run gastric empti ge frequenc gastrointestin gi complaint test experi complet cross studi design sixteen subject ingest mlkg bw carbohydr mosmkg solut euhydr dehydr regim dehydr bw loss produc maxim speed run degre intermitt sauna exposur degre euhydr experi conduct rest period water administ min gastric drink volum measur min min empti curv compar semilog transform percentag empti data simpl linear regress slope line measur averag ge rate dehydrationexercis result slower ge treatment anova reveal signific effect dehydr exercis effect addit delay ge gi complaint report subject dehydrationexercis experi gi disturb report test"
"step model develop insulindepend diabet insulin resist betacel dysfunct occur develop insulindepend diabet mellitus niddm controversi exist lesion primari base longitudin studi pima indian popul world highest report preval niddm step model develop diseas propos step transit normal impair glucos toler insulin resist main determin step worsen impair glucos toler diabet betacel dysfunct play critic role hypothesi consist find ethnic group part world"
"feasibl effect diabet type ii protocol blood glucos monitor general practic diabet protocol character monitor blood glucos introduc general practic aim make frequenc consult depend metabol regul emphas bodi weight reduct feasibl programm investig result year compar convent care control practic experiment practic patient switch medic specialist general practition supervis remain supervis gp start monitor monitor rate consult frequenc protocol low number dropout inadequ referr adher therapeut scheme show protocol feasibl gps patient initi assess regul diabet wors patient experiment group compar control group hba averag patient experiment group lost kg bodi weight control group gain kg chang hba adjust initi experiment control group result protocol attribut combin greater particip patient individu consult frequenc prescript oral hypoglycaem agent bodi weight develop"
"influenc simvastatin adren corticosteroid product urinari mevalon adrenocorticotropin stimul patient heterozyg famili hypercholesterolemia adren gland requir continu suppli cholesterol biosynthesi adren corticosteroid suppli low densiti lipoprotein receptormedi uptak local synthesi present studi examin hypolipidem therapi potent hmg coa reductas inhibitor simvastatin compromis adren respons acth stimul adult patient heterozyg famili hypercholesterolemia adren respons continu acth infus determin baselin month simvastatin treatment mg daili patient simvastatin reduc total low densiti lipoprotein cholesterol level time increas serum cortisol concentr continu acth infus simvastatin therapi rate urinari excret free cortisol hydroxycorticosteroid ketosteroid urinari excret mevalon correl rate bodi cholesterol synthesi decreas sem muol baselin simvastatin signific urinari mevalon level simvastatin therapi acth stimul conclud hypolipidem effect simvastatin patient heterozyg famili hypercholesterolemia parallel decreas urinari mevalon drug advers affect acthstimul adren corticosteroid product"
"suppress chromogranin releas neuroendocrin sourc man pharmacolog studi chromogranin cga acid solubl protein virtual ubiquit occurr normal human neuroendocrin tissu potenti tissu sourc cga immunoreact contribut basal unstimul circul cga explor question studi effect select nonselect suppress secret site neuroendocrin system select disrupt sympathet outflow trimethaphan decreas basal cga suggest sympathet neuron contribut circul cga plasma cga patient unilater bilater adrenalectomi fell rang observ normal subject weigh adren medulla major sourc basal circul cga select suppress varieti anterior posterior pituitari cell type decreas plasma level usual resid peptid hormon left plasma cga unperturb propranolol treatment plasma cga remain unalt secretin suppress plasma pth calcitonin alter plasma cga level hand widespread nonselect suppress varieti neuroendocrin secretori cell somatostatin decreas plasma cga plasma catecholamin unalt somatostatin infus suggest somatostatin inhibit cga releas nonsympathoadren sourc infus somatostatin plasma epinephrin increment respons insulininduc hypoglycemia maintain plasma cga fall rise somatostatin cessat find suggest somatostatin inhibit transport stimulationreleas cga adren medulla circul conclus adren medulla major tissu sourc cga immunoreact man neuroendocrin site includ sympathet axon multipl endocrin gland influenc basal circul concentr cga"
"subclin vitamin defici postmenopaus women low vertebr bone mass defin potenti role subclin vitamin defici postmenopaus bone loss analyz level circul hydroxyvitamin ohd midwestern caucasian women screen osteoporosi low ohd nmol found subject age yr women low ohd reduc vertebr bone densiti vbd assess quantit comput tomographi compar agematch control signific lower level serum calcium phosphat lower urinari calcium higher serum alkalin phosphatas case increas immunoreact pth ipth concentr suggest secondari hyperparathyroid low ohd group vbd correl direct ohd invers ipth multivari analys reveal ipth major determin observ decreas vbd season variat serum ohd note control popul group ohd level correl sunlight exposur assess outdoor score vitamin defici develop endogen exogen sourc insuffici contribut reduc bone mass elder women"
"hla antigen hungarian patient idiopath haemochromatosi thirteen unrel patient idiopath haemochromatosi men women studi diagnosi base clinic biolog histochem find hla type perform degre relat hla present proband compar group healthi blood donor select hungarian popul hla present proband compar ab antigen associ found patient ab haplotyp found ab ab haplotyp found genotyp proband pedigre studi show unaffect homozygot heterozygot carrier extend famili popul studi establish preval gene hungari associ haplotyp ab"
"inpati postdischarg malnourish patient retrospect review medic record malnourish malnourish male veteran assess inpati year postdischarg dietet care treatment malnutrit malnourish sampl consist subject discharg proteinenergi protein malnutrit comorbid subject diagnosismatch agematch control sampl discharg malnutrit comorbid period data collect progress note includ diagnos inpati dietet feed servic provid discharg dietet care interven clinic visit rehospit initi admiss diagnos malnourish group fell diagnosi categori neoplasm respiratori system diseas digest system diseas endocrin nutrit metabol diseas mental disord includ alcoholrel disord malnourish subject receiv special feed dietet servic control initi admiss discharg postdischarg care receiv surviv member group similar fewer half member group receiv postdischarg care fifti malnourish control patient hospit find level inpati outpati dietet care coordin allevi malnutrit"
"relationship obes physic fit cardiopulmonari metabol function healthi older men relationship obes physic fit vomax cardiopulmonari metabol function examin healthi obes nonsmok men age obes men higher vomax lower bodi fat waisthip ratio whr obes men low vomax obes subject high whr upper bodi fat distribut higher systol blood pressur hyperinsulinemia impair glucos toler lower high densiti lipoprotein cholesterol hdl higher triglycerid tg vomax mlkg ffmmin lower older men variat account age forc expiratori volum pulmonari function normal variabl predict age height vomax whr glucos toler insulin correl vomax indic bodi composit age plasma tg hdl correl bodi composit vomax age age affect cardiopulmonari metabol function obes older men physic inact obes abdomin bodi fat distribut increas whr contribut signific reduct physiolog function"
"depend eat disord femal psychiatr inpati research oral depend eatingdisord individu similar person trait attitud behavior suggest depend factor dynam anorexia bulimia investig issu compar proport depend foodrel percept rorschach protocol match sampl eatingdisord obes eatingdisord normalweight femal psychiatr inpati eatingdisord patient report signific depend rorschach imageri obes normalweight control patient differ proport foodrel imageri found group result support hypothesi unresolv depend issu underli anorexia bulimia"
"comparison efficaci questran light formul cholestyramin powder regular questran maintain lower plasma cholesterol level sixti men hypercholesterolemia plasma cholesterol greater mgdl previous particip coronari primari prevent trial lipid research clinic program chosen part studi test effect lowcalori questran light cholestyramin formul proven effect market formul questran maintain lower plasma cholesterol level studi record fast plasma lipid total cholesterol highdens lipoprotein cholesterol triglycerid calcul lowdens lipoprotein cholesterol establish baselin lipidlipoprotein level week period particip receiv market formul men random group group questran light formul cholestyramin powder pack group continu market questran formul cholestyramin powder pack group consum total day cholestyramin divid dose end mainten phase studi statist signific percentag baselin endpoint lipidlipoprotein level group signific differ questran light group market questran formul group lowcalori cholestyramin formul equal effect maintain lower plasma cholesterol level market formul"
"effect educ program interview adopt guidelin manag neonat hyperbilirubinemia object determin physician adher guidelin manag neonat hyperbilirubinemia influenc decis investig treat condit effect educ program clinic recal interview complianc guidelin design retrospect chart audit set urban tertiari care hospit particip term neonat receiv phototherapi admit neonat intens care unit intervent educ program clinic recal interview measur chart review march period public guidelin novemb januari period ii public educ program audit repeat april june period iii interview phase octob decemb period iv month interview criteria determin phototherapi serum bilirubin level postnat day phototherapi start result proport infant receiv phototherapi order complet blood count investig hyperbilirubinemia increas period period iv frequenc order determin proport reticulocyt chang signific number infant receiv phototherapi decreas studi period proport receiv phototherapi accord criteria serum bilirubin level increas educ program insignific differ interview complianc guidelin greater infant day day physician prescrib phototherapi infant period iv prescrib accord guidelin prescrib accord guidelin infant decis investig treat phototherapi affect clinic parent factor addit guidelin physician interview state interview influenc manag futur case hyperbilirubinemia conclus clinic recal interview greater impact chang physician manag practic factual communic group basi"
"arginin restor cholinerg relax hypercholesterolem rabbit thorac aorta background reduc synthesi endotheliumderiv relax factor edrf explain impair endotheliumdepend vasodil hypercholesterolemia design studi determin endotheliumdepend relax hypercholesterolem rabbit restor suppli arginin precursor edrf method result normal hypercholesterolem rabbit receiv intraven arginin mgkgmin vehicl minut subsequ anim kill thorac aorta harvest vascular ring studi vitro ring contract norepinephrin relax acetylcholin chlorid sodium nitroprussid vasorelax quantifi determin maxim respons express percent relax contract ed dose drug induc relax express log vessel hypercholesterolem anim receiv vehicl fivefold rightward shift sensit acetylcholin compar normal anim group vessel hypercholesterolem anim arginin augment maxim respons acetylcholin versus versus vehicl increas sensit acetylcholin ed versus versus vehicl arginin affect maxim ec respons acetylcholin vessel normal anim arginin potenti endotheliumindepend respons group conclus conclud endotheliumdepend relax normal hypercholesterolem rabbit thorac aorta vivo exposur arginin precursor edrf"
"comparison effect hyperton sucros intracellular potassium deplet growth hormon receptor bind kinet regul im cell evid sequenti block receptormedi endocytosi understand complex kinet human gh hgh bind receptor investig im cultur human lymphocyt cellular locus slowli dissoci compon hormon bind homolog regul hgh receptor detail biphas kinet dissoci bound hormon control cell associ extend time requir halfdissoci fast compon slight decreas min slow compon increas concomit size slowli dissoci compon increas total matur bound hormon rapid slowli dissoci pool increas appar affin reflect molecular rearrang compar effect procedur report inhibit receptormedi endocytosi level coat pit previous report deplet intracellular abolish slowli dissoci compon regul hgh receptor contrast incub sucros deplet virtual abrog hgh intern dissoci kinet remain order regul hghreceptor slight reduc procedur block receptormedi endocytosi success compart cell surfac conclus propos conform chang hghreceptor cell surfac possibl cluster slow dissoci suffici regul"
"defect toler toxic metabol effect interleukin effect food intak bodi weight surviv mice recombin lipopolysaccharid lps tumor necrosi factorcachectin tnf interleukin il microgramsmous ip daili studi agent induc rapid reduct food intak bodi weight day treatment unlik tnf lps il daili administr microgram lethal day mice treat lps tnf rapid develop toler anorect effect toler il requir longer time develop complet investig role serum corticosteron glucos effect lps tnf il singl inject lps tnf il mark increas serum corticosteron level day chronic treatment mice lps tnf refractori induct serum corticosteron subsequ inject lps tnf mice il day fulli respons il il unlik tnf lps induc mark hypoglycem respons repeat administr il sensit hypoglycem effect lack adapt increas serum corticosteron hypoglycemia observ il lower nonleth dose microgram longer period day defect toler metabol toxic effect il experiment model major differ vivo biolog respons il tnf"
"frequenc effect apolipoprotein polymorph mexicanamerican niddm subject type insulindepend diabet niddm mexican american live starr counti texa common apolipoprotein apo allel type perform dna amplif hha restrict allel frequenc epsilon epsilon epsilon hardyweinberg equilibrium chi df differ random sampl popul chi df analysi varianc test differ lipid lipoprotein glucos level apo type signific differ type detect lowdens lipoprotein cholesterol ldlchol betalipoprotein cholesterol level ldlchol individu mm mm mm betalipoprotein cholesterol individu mm mm mm base result conclud effect apo polymorph lipid profil glucos level niddm subject nondiabet mexican american popul studi investig role apo polymorph diabet subject found increas triglycerid level individu possess epsilon allel increas frequenc epsilon allel hyperlipidem diabet subject found signific differ triglycerid level genotyp reason discrep discuss includ dna versus proteintyp method"
"blunt diuret natriuret respons central administr clonidin streptozocininduc diabet rat purpos studi determin diuret natriuret effect alter respons intracerebroventricular icv infus clonidin diabet rat diabet induc male spraguedawley rat mgkg inject streptozocin control rat inject vehicl wk experi blood glucos level signific elev diabet group mm compar control group mm icv infus clonidin microgramskgmin min urin flow sodium excret measur intact denerv kidney anesthet diabet control rat icv infus clonidin signific increas urin flow innerv denerv kidney control rat diabet rat signific increas sodium excret icv infus clonidin innerv kidney control rat denerv abolish effect diabet rat clonidin fail promot natriuresi intact kidney similar control rat promot natriuresi denerv kidney studi demonstr diuret respons icv infus clonidin blunt diabet rat natriuret respons icv infus clonidin blunt innerv kidney diabet rat"
"hepat glutathion metabol diabet glutathion import regul redox state declin tissu level consid indic increas oxid stress diabet studi diabet rat level hepat glutathion normal food intak restrict previous report reduct hepat glutathion diabet result food depriv diabet contrast characterist oxid stress efflux glutathion bile diabet anim signific decreas hepat mix disulfid unchang hepat gammaglutamyltransferas activ increas reproduc food depriv decreas biliari excret glutathion diabet reflect attempt conserv glutathion activ hepat gammaglutamyl cycl conclud disturb glutathion metabol diabet typic oxid stress food restrict"
"lack evid improv longterm glycem control pulsatil insulin infus streptozocininduc diabet baboon assess potenti therapeut pulsatil intraven insulin deliveri streptozocininduc diabet baboon treat altern wk period pulsatil continu insulin infus timeaverag insulin concentr match pulsatil administr period interven period continu insulin administr signific differ daili glucos determin perform period mm mm mm measur stabil glycem control percentag glucos valu mm glycosyl hemoglobin level determin end valu sd fast hepat glucos product suppress similar degre pulsatil continu insulin infus mumolkgmin mumolkgmin arteri glucagon level similar pulsatil continu insulin infus fast state ng postprandi ng pulsatil insulin infus fail entrain glucagon secretori rhythm data suggest metabol consequ longterm pulsatil continu insulin infus anim model human insulindepend diabet compar"
"independ effect youth poor diabet control respons hypoglycemia children evalu effect childhood poor control insulindepend diabet mellitus iddm counterregulatori hormon symptomat respons hypoglycemia studi nondiabet children yr nondiabet adult yr children iddm yr hba gradual reduct plasma glucos glucoseclamp techniqu plasma glucos reduc approxim approxim mm min serial assess counterregulatori hormon level symptom awar plasma glucos level trigger sustain rise plasma epinephrin consist higher nondiabet children adult mm poor control iddm elev glucos threshold epinephrin releas normoglycem level mm control group age iddm produc upward shift glucos level growth hormon releas symptom awar initi contrast effect glucos threshold maxim epinephrin respons symptom score increas age iddm fold higher children conclud childhood poor diabet control independ contribut upward shift glucos threshold counterregulatori hormon releas symptom awar mild hypoglycemia normoglycem counterregul interfer effort control diabet young patient"
"ray diffract studi human diabet age collagen extens investig solubl fluoresc collagen fiber diabet reveal signific physic properti increas crosslink format ray diffract studi human extensor tendon molecular level relat age diabet result diabet induc signific alter ultrastructur collagen pack molecul axial structur specimen induc normal tendon incub ribos glucosephosph normal process age"
"pretransl suppress glucos transport protein insulin resist adipocyt patient insulindepend diabet mellitus obes major portion insulinmedi glucos uptak occur transloc glut glucos transport protein intracellular depot plasma membran examin gene express glut transport isoform subcutan adipocyt classic insulin target cell understand molecular mechan caus insulin resist insulindepend diabet mellitus niddm obes subgroup lean bodi mass index bmi obes bmi control obes niddm bmi patient number glut glucos transport measur total postnuclear subcellular membran fraction specif antibodi western blot relat lean control cellular content glut decreas obes niddm total cellular membran obes cellular deplet glut primarili involv low densiti microsom ldm leav fewer transport insulinmedi recruit plasma membran pm niddm loss glut profound membran subfract pm ldm high densiti microsom observ correspond decrement maxim stimul glucos transport rate intact cell assess mechan respons deplet glut quantit level mrna specif hybrid human glut cdna northern blot obes glut mrna decreas compar lean control level correl cellular content glut protein wide spectrum bodi weight glut mrna adipocyt niddm patient profound reduc compar lean control relat weightmatch nondiabet counterpart express rna cell amount cho mrna interest glut mrna level patient impair glucos toler bmi decreas level overt niddm conclud obes insulin resist adipocyt due deplet glut glucos transport cellular content glut determin level encod mrna wide rang bodi weight niddm profound insulin resist caus reduct glut mrna protein attribut obes se suppress glut mrna observ patient impair glucos toler occur earli evolut diabetesabstract truncat word"
"differenti regul adipos tissu glucos transport genet obes fatti rat select increas adipos cellmuscl glucos transport glut express adipocyt young obes zucker rat exhibit hyperrespons insulinmedi glucos transport mark increas cytochalasin bind compar lean rat adipocyt examin cell express isoform glucos transport erythroid glut adipos cellmuscl glut type rat age emerg hyperinsulinemia glut protein mrna level ident genotyp age contrast level glut protein obes rat adipocyt fold lean litterm age perfect agreement genotyp effect insulinstimul glucos transport activ level glut mrna fat pad increas fold obes lean rat indic pretransl level regul obes phenotyp overexpress glut mrna gastrocnemius muscl work fa gene exert differenti control express glut glut adipos tissu evid independ hyperinsulinemia genotyp major regulatori factor glut express tissu"
"randomis prospect studi shortterm longterm initi stay hospit children diabet mellitus assess isol chang pattern care influenc outcom care hospit randomis prospect year studi consecut children newli diagnos insulindepend diabet mellitus iddm admit hospit diseas onset week compar children admit week insulin treatment educ diabet similar group durat initi stay hospit effect metabol control year time diagnosi signific respect effect haemoglobin haemoglobin ac insulin dose year children shortterm group longterm group peptid posit ns peptid posit correl age chang pattern care children iddm led pronounc decreas hospit patient group irrespect length initi stay hospit equal good metabol control obtain group year"
"intens manag type ii diabet goal intens treatment type ii diabet restor blood glucos level normal correct hyperlipidemia hypertens cardiovascular risk factor prevent hyperinsulinemia treatment begin attempt reduc weight diet exercis fact diet exercis stress vital compon diabet patient lifestyl matter treatment method drug treatment consist sulfonylurea increas insulin secret improv insulin resist exogen insulin achiev glucos control avoid danger chronic hyperglycemia combin attract investig control hypertens mandatori requir angiotensinconvert enzym inhibitor calcium channel blocker normal serum lipid level import patient agent advers affect glucos level avoid"
"postheparin lipolyt activ plasma lipoprotein respons omega polyunsatur fatti acid patient primari hypertriglyceridemia hypotriglyceridem action omega fatti acid attribut primarili reduct hepat triglycerid synthesi reduc secret lowdens lipoprotein vldls increas catabol triglyceriderich lipoprotein report due increas avail peripher lipoprotein lipas lpl hepat lipas hl studi plasma lipoprotein postheparin activ lpl hl determin patient primari hypertriglyceridemia isocalor substitut omega fatti acid wk omega polyunsatur result reduct plasma triglycerid vldlcholesterol concentr lowdensitylipoprotein ldlcholesterol concentr increas activ postheparin lpl hl essenti remain patient primari hypertriglyceridemia reduct plasma triglycerid concentr increas ldlcholesterol concentr mediat omega polyunsatur occur increas lpl hl activ"
"fat absorpt neonat comparison longchainfattyacid triglycerid composit formula fece blood studi malabsorpt fat neonat fed lardmodifi formula gestat age wk unmodifi formula gestat age wk group fecal lipid consist complet greater free fatti acid composit high correl formula fatti acid composit lard modifi standard group similar relat amount composit fecal cholesterol ester triglycerid plasma lesser extent erythrocyt membran longchainfattyacid composit correl formula suggest extens intestin hydrolysi limit absorpt dietari lipid part due lipolysi colon triglycerid colon due rapid smallintestin passag relat smallintestin lipolysi"
"lactos maldigest milk intoler healthi greek schoolchildren preval lactos maldigest greek adult age lactas activ start declin preval lactos maldigest intoler investig random select greek children breathhydrogen analysi ingest lactos kg bodi wt maximum milk preval lactos maldigest increas age age test report preval milkrel symptom children high low lactosedigest capac chi preval lactos intoler ingest milk chi children delta greater equal ppm postprandi intestin lactas activ declin age greek children report milkrel symptom true malabsorpt intoler lactos glass milk rare age"
"brain uptak glucos diabet mellitus role glucos transport diabetesrel reduct bloodbrain barrier bbb transport glucos due chang function capac transport unidentifi mechan occur plasma membran cytoplasm increas understand problem cerebr blood flow brain uptak index bui methyl glucos concentr hcytochalasin bind site determin diabet rat diabet rat treat insulin bui methyl glucos signific reduc diabet rat compar control rat chang attribut alter cerebr blood flow specif chang bbb permeabl normal blood glucos insulin therapi correct bui measur diabet rat level measur glucos transport measur hcytochalasin bind assay reduc diabet brain microvessel data reduc brain uptak glucos chronic hyperglycemia occur absenc chang glucos transport concentr"
"receptor autoimmun endocrin disord discoveri longact thyroid stimul grave diseas thyroidstimul antibodi semin mechan diseas reveal applic virtual endocrin system involv growth function endocrin cell endocrin gland fail autoimmun mechan destruct atrophi inhibit function destruct irrevers distinguish clinic receptor blockad caus atrophi metabol unrespons contribut made receptor autoimmun endocrin diseas thyroid diseas present unclear immunolog manipul potenti revers improv replic capac gland metabol respons"
"correl earli trimest glucos screen test result hundr twenti normal gravida pair earli trimest week hour oral glucos screen test perform trimest oral glucos screen test valu correl signific trimest glucos screen test result entir popul white white normalweight obes patient trimest oral glucos screen test valu mgdl seldom trimest oral glucos screen test result mgdl abnorm hour glucos toler test gtt result gravida diagnos gestat diabet mellitus trimest trimest glucos screen test result mgdl differ incid gestat diabet mellitus gravida trimest glucos screen test result mgdl valu mgdl high signific patient trimest glucos screen test valu mgdl trimest glucos screen unnecessari contrast gravida trimest glucos screen test result mgdl high posit predict elev repeat glucos screen test result earli trimest patient elev trimest glucos screen valu mgdl high risk elev glucos screen test result pregnanc forego repeat hour trimest glucos screen favor direct trimest hour gtt"
"fructosamin compar glucos load screen test gestat diabet hundr women screen gestat diabet week gestat receiv glucos polycos load week measur plasma glucos hour fructosamin level measur week interv week week full hour glucos toler test perform subject eighteen women diagnos gestat diabet glucos load sensit detect gestat diabet compar fructosamin week fructosamin screen test gestat diabet defin"
"diagnosi manag precoci puberti onset pubert develop age year girl year boy constitut precoci puberti numer precoci puberti classifi central peripher precoci puberti central precoci puberti result prematur activ hypothalamicpituitarygonad axi present physic hormon find similar found normal puberti peripher precoci puberti result extrapituitari gonadotropin secret secret sex steroid independ pituitari gonadotropin type precoci puberti character rapid growth advanc skelet age lead paradox tall child short adult result prematur epiphys fusion longact gnrh agonist afford effect select revers therapi central precoci puberti signific toxic gnrh agonist effect manag prematur sexual matur peripher precoci puberti number agent success agent includ testolacton ketoconazol medroxyprogesteron acet gnrh agonist treatment lead increas predict final height determin true benefit agent increas ultim height continu studi treat cohort follow growth pattern adult statur achiev"
"hyperthyroid children adolesc hyperthyroid infant children caus grave diseas diseas produc hyperthyroid age group pathophysiolog clinic condit differ optim treatment depend precis diagnosi"
"cush syndrom year journal review cs extraordinari advanc understand aspect diagnosi treatment spectrum call cush syndrom expand includ cd multipl sourc ectop acth secret appar autoimmun improv assay acth avail crf provid insight physiolog pathophysiolog hpa axi tool diagnosi cs combin select catheter sampl imag technolog improv visual pituitari adenoma provid power method identifi tumor ectop secret acth primari adren tumor final refin transsphenoid surgeri success treat cd provid safe effect therapi diseas occasion patient requir medic therapi drug decreas steroid biosynthesi understand fascin diseas process diagnos treat correct impati piec puzzl fall place ten year"
"primari secondari testicular insuffici possibl testicular insuffici common problem pediatr practition present vari sever defect development age achiev onset presenc abnorm common primari secondari testicular insuffici present time puberti present birth earli neonat period investig uncov diagnosi time intervent age secondari testicular failur difficult diagnos differenti simpl delay develop offer possibl develop spermatogenesi attain fertil gonadotropin gnrh replac program primari testicular failur impli intrins abnorm function element testi spermatogenesi induc hormon stimul treatment testicular failur neonat period unnecessari micropeni pubert boy testosteron replac treatment choic initi care age subject bone age psychosoci circumst goal therapi achiev normal progress physic puberti physic matur normal potenti sexual function"
"adolesc gynecomastia differenti diagnosi manag gynecomastia signifi transient perman disturb steroid hormon physiolog occur male breast expos decreas ratio androgen estrogen articl discuss pubert patholog gynecomastia diagnost approach treatment"
"disord sexual differenti develop psycholog aspect children abnorm sexual differenti develop smooth psychosoci develop spite signific risk challeng face chanc posit emot outcom made care handl patient time present parent unambigu accept child sex rear earli surgic intervent normal child extern genit critic element posit outcom pattern behavior document materi review articl suggest difficulti immatur social develop signific psychopatholog parentchild interact repeat found central child emot underscor provid parent adequ counsel support pattern repres find group patient predict emot social academ function individu clinic syndrom great individu variat social emot physic present final minim problem physician educ parent activ advoc children educ social arena"
"mathemat model myosin heterodim format rat heart thyroid hormon alter character mechan involv format myosin heavi chain mhc heterodim alpha betamhc homodim beta betamhc alpha alphamhc week normotens rat homogen made hypothyroid propylthiouracil drink water proport determin pyrophosph gel electrophoresi multicellular specimen left ventricl switch alphamhc betamhc betamhc occur initi form heterodim day greater day smaller day statist day onward smaller day propylthiouracil treatment stop remain hypothyroid rat inject daili dose thyroxin averag mgkg bodi wt result switch betamhc alphamhc day greater day onward smaller characterist unexplain heterodimer homodimer organ thick filament analyz mathemat model involv probabl calcul princip model establish assum exchang mhc dimer singl mhc thick filament paramet model estim minim routin squar discrep experiment predict isoenzym popul base good fit crucial model paramet conclud characterist organ thick filament account exchang involv predomin mhc dimer singl mhc fact lower expect format heterodim homodim random attribut prefer homodimer newli synthes mhc"
"dispar effect colchicin thyroxineinduc cardiac hypertrophi adrenoceptor shortterm day administr thyroxin mgkg daili adult spraguedawley rat induc modest degre cardiac hypertrophi increas heart weightbodi weight ratio direct opposit cardiac adrenoceptor increas betaadrenoceptor declin alpha adrenoceptor pretreat colchicin affect abil thyroxin induc cardiac hypertrophi prevent effect beta alpha adrenoceptor result suggest select involv microtubul action thyroid hormon express cardiac adrenoceptor gene"
"chronic diabet complic tissu glycosyl relev concern diabetespron black popul signific segment black popul affect chronic diabet subject sever cardiovascular renal neurolog complic shorten surviv diminish qualiti life import pathogenet mechan intens investig advanc tissu glycosyl tissu cell surfac protein modifi nonenzymat glucos shown high activ protein crosslink implic tissu damag proteinglucos interact call advanc glycosyl end product age process macrophag highaffin receptor coupl age protein age receptor result degrad remov simultan synthesi secret pluripotenti cytokin tumor necrosi factor interleukin suggest age act signal growthpromot factor secret coordin replac process tissu remodel chronic diabet acceler accumul tissu age occur disturb balanc lead patholog lytic prolif respons vasculopathi diabet progress made discoveri aminoguanidin hcl age inhibitor prevent signific patholog shortterm diabet anim studi"
"low serum thyrotropin thyroidstimul hormon older person hyperthyroid studi larg popul unselect ambulatori person older year determin preval low serum thyroidstimul hormon tsh level mu sensit assay level suggest hyperthyroid younger adult hundr person low serum tsh level half thyroid hormon remaind hyperthyroid year follow forti euthyroid person serum thyroxin level nmol repeat test show serum tsh level mu euthyroid person serum thyroxin level nmol hyperthyroid follow period serum thyroxin level nmol routin clinic examin sensit indic hyperthyroid permit discrimin euthyroid low serum tsh high sensit specif hyperthyroid low posit predict diagnosi addit thyroxin assay rais predict fivefold low serum tsh common older person hyperthyroid low valu euthyroid person accompani normal serum concentr nmol serum tsh level mu repeat test recommend measur serum tsh thyroid concentr sensit assay initi step test older person hyperthyroid measur serum concentr free index sampl approxim serum tsh level mu altern tsh assay repeat time"
"natur alter growth hormon secret hyperthyroid hyperthyroid accompani neuroendocrin regulatori disturb affect thyrotrop gonadotrop corticotrop somatotrop axe examin natur alter neuroendocrin control mechan direct somatotrop axi hyperthyroid appli deconvolut techniqu design estim number amplitud mass signific gh secretori event influenc gh metabol clearanc remov mathemat end blood sampl min interv hyperthyroid agematch euthyroid men subsequ gh time seri assay immunoradiometr assay sensit ngml submit quantit deconvolut analysi found hyperthyroid compar euthyroid men signific gh secretori burst  secret time gh burst ngml distribut vol achiev maxim rate gh secret burst fold higher control men ngmlmin fold higher endogen gh product rate hyperthyroid euthyroid men signific interburst tonic gh secret conclud somatotrop axi hyperthyroid men mark higher frequenc spontan gh secretori burst higher rate maxim gh secret attain burst larger mass gh releas burst neuroregulatori disturb result fold increas product rate gh thyrotoxicosi"
"fals elev serum parathyroid hormon level due immunoglobulin patient idiopath hypoparathyroid yr patient idiopath hypoparathyroid admit hospit immunoreact pth ipth level determin ria antiserum specif termin region pth upper normal rang ngml yr increas gradual ngml ipth level determin commerci ria kit remain constant decreas undetect rang studi mechan fals elev ipth patient patient serum bind protein tracer tyr human pth heterophil antibodi guinea pig immunoglobulin igg antibodi goat igg detect consist find dilut curv serum parallel standard bovin pth gel filtrat analysi reveal ipth substanc elut void volum appar mol wt greater ipth substanc adsorbod proteinsepharos column igg fraction purifi proteinsepharos affin chromatographi appli antihuman igg lambdasepharos column ipth substanc detect igg lambda result suggest fals elev ipth patient serum due igg igg lambda crossreact antiserum high specif termin region human pth"
"alphaandrostanediol glucuronid prematur normal pubarch investig role adren androgen alphaandrostanediol glucuronid ag product childhood compar serum ag androgen level dehydroepiandrosteron dhea dhea sulfat ds androstenedion delta testosteron children prematur pubarch due idiopath prematur adrenarch ipa partial hydroxylas defici betahydroxysteroid dehydrogenas defici normal prepubert male femal normal pubert tanner iiiii subject male femal serum ag nmol androgen concentr children ipa signific higher normal prepubert children ag nmol serum ag androgen level children prematur pubarch due hydroxylas defici betahydroxysteroid dehydrogenas defici higher normal prepubert children serum ag androgen level normal tanner iiiii male ag nmol femal ag nmol subject signific higher prepubert children serum ag dhea ds delta level children ipa similar normal tanner iiiii femal male serum children ipa nmol signific lower normal pubert femal nmol male nmol combin group ag level correl serum ds dhea delta level data suggest weak adren androgen ds dhea delta contribut substanti ag product prematur normal pubarch"
"pulsatil thyrotropin releas thyroid function acromegal subcutan octreotid infus pulsatil secret tsh studi patient activ acromegali treatment month therapi consist sc infus microgram octreotideday gh level decreas mu insulin growth factor level decreas nmol normal patient patient tsh level undetect octreotid therapi patient cluster analysi reveal puls puls width min puls height mu puls increment mu octreotid therapi puls paramet remain unchang puls height amplitud increas signific night untreat treat patient acrophas unchang therapi therapi level decreas nmol nmol rt level increas nmol nmol plasma level remain unchang studi conclud tsh puls generat unchang activ acromegali appar unaffect chronic octreotid infus"
"thyroid function healthi elder popul implic clinic evalu evalu thyroid function elder peopl complex generat controversi normal studi analyz thyroid function assay identifi healthi elder popul subject thyroxin free thyroxin triiodothyronin uptak supersensit thyrotropin thyroid antibodi titer perform histori treatment thyroid condit present popul test result addit reveal hypothyroid subject exclud statist analysi test result reveal signific differ younger control skew distribut ft tsh signific correl increas age gender elder popul popul exhibit elev tsf level normal valu exhibit titer thyroid antibodi current refer rang thyroid test broad includ rang valu healthi elder caution discuss"
"assess pupillari light reflex latenc dark adapt pupil size control subject diabet patient cardiovascular autonom neuropathi increas pupillari light reflex latenc found reduc dark pupil size diabet patient abnorm cardiovascular reflex find suggest parasympathet pupillari dysfunct preced sympathet pupillari denerv diabet autonom neuropathi"
"parathyroid autotransplant thyroid surgeri perman hypoparathyroid distress complic thyroid surgeri incid iatrogen complic vari percent patient undergo total thyroidectomi parathyroid injuri caus inadvert remov parathyroid ligat blood suppli destruct secondari capsular hematoma attent technic detail identif parathyroid dissect close thyroid gland preserv blood suppli parathyroid avoid manipul parathyroid reduc incid temporari perman hypoparathyrod parathyroid injur method preserv function autotransplant past year perform thyroidectomi attempt made identifi preserv parathyroid gland case lobectomi procedur ipsilater parathyroid identifi preserv parathyroid devascular separ surround structur autotranspl sternomastoid muscl sternomastoid chosen autotransplant forearm muscl avoid ad incis select measur parathormon essenti group patient prior autotransplant confirm natur tissu made frozen section small portion parathyroid gland parathyroid autotransplant perform instanc parathyroid injur member group patient develop temporari hypoparathyroid disappear week calcium supplement remain patient uncompl recoveri autotransplant parathyroid gland perform parathyroid devascular damag retract hematoma essenti thyroid surgeon familiar techniqu parathyroid autotransplant"
"epiderm growth factor induc function express dopamin receptor gh cell line gh cell clonal strain rat pituitari tumor synthes secret prl gh peculiar cell express receptor dopamin hormon releas insensit inhibitori effect dopamin receptor agonist exposur gh cell epiderm growth factor consecut day mark alter cell morpholog spheric elong flatten shape increas cell size morpholog accompani function express dopamin receptor shown presenc specif satur stereoselect high affin bind hspiroperidol epiderm growth factortr cell fact select agonist quinpirol recov properti inhibit prl secret cell cultur expos neurotroph factor effect egf function express receptor dose depend ec pm revers data suggest egf elicit major effect express specif gene lead differenti gh cell lactotroph cell endow dopamin receptor"
"thyroid hormon deiodinas rat fetus late gestat effect matern hypothyroid previous observ level fetal rat brain brown adipos tissu higher expect low circul level studi thyroid hormon concentr deiodinas activ rat fetal tissu day gestat dg dg period compris onset fetal thyroid activ total thyroid content increas fold concentr increas fold plasma carcass lung liver increas fold plasma liver level increas fold plasma fold liver development period activ increas fold fetal liver lung fetus hypothyroid thyroidectom dam bodi weight lower fetus normal dam total thyroid content initi decreas mark fetus dam end gestat earliest fetal age studi dg concentr lower carcass liver lung brain term consist differ fetal tissu control dam compensatori stimul thyroid secret liver decreas gestat lung activ lower end gestat thyroid hormon placenta dam low increas end gestat contribut fetal thyroid present result describ ontogen profil thyroid hormon concentr activ late fetal develop activ regulatori mechan present age frequent state rat fetus term defici thyroid hormon thyroid hormon economi independ matern thyroid status present result show term concentr tissu reach level adult anim fetal thyroid function influenc matern hypothyroid"
"iodin thyroid diseas iodin requisit substrat synthesi thyroid hormon minimum daili requir microgram autoregulatori mechan thyroid serv line defens fluctuat suppli iodin permit escap inhibit hormon synthesi larg quantiti iodin induc wolffchaikoff effect escap therefrom environment iodin defici continu signific public health problem worldwid compound geograph region presenc goitrogen stapl food patholog consequ sever iodin defici includ endem goiter endem cretin increas fetal infant mortal increas preval communiti cognit neuromotor disabl implement iodiz program prevent endem cretin reduc frequenc patholog consequ iodin defici iodin excess result princip iodin medicin prepar radiograph contrast media patholog consequ iodin excess ensu thyroid autoregul defect escap wolffchaikoff effect occur autoregul absent defect autoregul character fetal neonat thyroid hashimoto thyroid radioiodin surgic treat grave hyperthyroid thyroid patient cystic fibrosi thyroid expos weak inhibitor organ bind iodin circumst provis excess iodin lead iodid goiter hypothyroid absent autoregul featur longstand multinodular goiter provis excess iodin circumst induc thyrotoxicosi jodbasedow diseas patholog consequ iodin excess resolv sourc iodin dissip addit role revers iodin defici iodin adjunct therapi hyperthyroid inhibit proteolyt releas iodothyronin thyroglobulin induc prompt slow thyroid hormon secret effect exploit treatment thyrotox crisi sever thyrocardiac diseas iodin reduc thyroid cellular vascular prepar patient thyroidectomi final exploit failur escap wolffchaikoff effect iodin earli manag radioiodinetr grave hyperthyroid"
"problem nodular goiter nodular goiter worldwid problem involv million person endem goiter cretin total prevent ensur adequ dietari iodin intak elimin malnutrit dietari goitrogen therapi hand difficult goiter regress cretinoid irrevers nonendem goiter due autoimmun thyroid diseas genet defect thyroid hormon biosynthesi environment goitrogen neoplasia prevent usual therapi involv tsh suppress administr thyroxin oral frequent bring regress earli diffus goiter ineffect bring regress larg multinodular goiter patient surgic remov goiter allevi obstruct symptom research elucid factor involv develop multinodular goiter control autocrin paracrin factor involv nodul growth"
"estim burden diabet mellitus manitoba health insur claim pilot studi object estim burden diabet mellitus manitoba design review manitoba health servic commiss mhsc databas valid mhsc data establish substudi involv report survey elder manitoban involv peopl confirm diabet enrol provinci diabet educ program subject sampl peopl stratifi age sex mhsc health region age year age mhsc claim icdcm code diabet mellitus gestat diabet identifi main result sampl peopl found diagnosi diabet annual preval year age older annual incid rate year age pregnant women year diabet believ gestat diabet conclus incid preval rate similar determin basi report canadian nation survey administr databas mhsc provid key inform plan health servic diabet patient permit monitor longterm trend incid preval diseas"
"cardiac sympathet tone anaesthet diabet assess cardiac sympathet nervous function diabet heart rate attain pharmacolog dose intraven atropin microgramskg studi isofluran anaesthesia diabet nondiabet atropineinduc heart rate diabet signific lower nondiabet sd bpm bpm close relat preoper orthostat diastol blood pressur chang correl atropineinduc heart rate preoper rrvariat diabet find suggest cardiac sympathet function impair diabet orthostat hypotens"
"bind action insulin growth factor pituitari tumor cell insulin growth factor igf target hormon mediat growth effect gh suppress gh gene express feedback regulatori loop endocrin paracrin natur igf shown direct attenu gh gene transcript relationship igf bind action somatotroph cell remain unclear igf bind action compar pituitari cell line secret gh recombin human igf attenu gh secret gc cell dosedepend manner surpris igf fail suppress gh secret gh cell clonal relat pituitari cell line bind studi show kd igf similar cell type gc cell fold igf bind site compar gh cell possibl explain resist igf action cell line possess abund similar bind site insulin result impli igf signal gh gene regul receptormedi direct correl number pituitari igf bind site avail pituitari igf bind site import determin level gh express somatotroph"
"sexual dimorph pancreat betacel degener transgen mice express insulinra hybrid gene human ras oncogen induc cell degener diabet express pancreat betacel transgen mice diseas develop predomin male mice month age transgen femal mice manifest phenotyp greater age ovariectomi induc femal betacel degener similar male contrast castrat presenc testicular femin mutat alter diseas male treatment male ovariectom femal estrogen prevent develop diabet result suggest testicular androgen function testosteron receptor requir increas suscept male betacel effect ras oncoprotein relat resist femal betacel mediat estrogen addit genet compon femal betacel resist ras reveal cross transgen mice chebfej mice result pronounc increas incid femal diabet"
"pulsatil lutein hormon secret normal femal mice hypogonad femal mice preoptic area implant pulsatil lh secret driven gnrh hypothalam hormon lack hypogonad mutant mous preoptic area graft gnrh neuron correct reproduct deficit hypogonad mice studi evalu pattern lh secret hypogonad femal mice preoptic area graft hpgpoa normal femal mice normal femal ovariectom week age hpgpoa mice ovariectom month graft surgeri week mice receiv intracardi cathet day sequenti blood sampl obtain min awak freeli move mice ovariectomi normal hpgpoa ovarian weight mg signific lh puls detect normal mice hpgpoa mice puls frequenc normal hpgpoa puls interpeak interv normal hpgpoa min signific greater plasma lh level normal ngml hpgpoa ngml lh puls amplitud normal hpgpoa signific lower hpgpoa mice lower lh level lh puls amplitud ovariectom hpgpoa mice consist inabl mice show increas lh secret castrat find preoptic area brain graft capabl support episod lh releas hypogonad mous suggest presenc function gnrh puls generat major mice graft"
"riedel thyroid invas fibrous riedel thyroid rare thyroid condit unknown origin inflammatori fibroscleros process bodi condit benign limit import lie abil clinic mimic carcinoma complet necessit perform open biopsi establish correct diagnosi review thyroid oper perform loma linda calif univers medic center past year encount document case riedel thyroid patient present firm thyroid mass vocal cord paralysi symptom esophag compress surgeri perform obtain definit diagnosi prevent possibl subsequ addit tracheal compress airway compromis patholog find medic surgic treatment condit review"
"lack effect isoproterenol unload veloc sarcomer shorten rat cardiac trabecula recent report catecholamin act direct crossbridg cycl independ intracellular calcium concentr present studi investig effect isoproterenol peak forc twitch constant sarcomer length unload veloc sarcomer shorten isol ventricular trabecula heart isomyosin obtain euthyroid hypothyroid rat hypothyroid induc treatment rat propylthiouracil week electrophoret analysi show heart hypothyroid anim compos isomyosin heart euthyroid anim compos predomin isomyosin forc develop measur silicon strain gaug sarcomer length laser diffract techniqu shorten veloc determin contract sarcomer length initi held constant quick releas load control releas load isometr twitch forc unload sarcomer shorten veloc sigmoid function ca concentr isoproterenol optim ca unload shorten veloc lower myocardium hypothyroid anim myocardium euthyroid anim isoproterenol increas sensit isometr twitch forc unload shorten veloc ca trabecula euthyroid hypothyroid anim isoproterenol increas unload shorten veloc optim ca thyroid state result conclud betaadrenerg stimul se acceler rate limit step crossbridg cycl determin unload sarcomer shorten veloc intact cardiac cell"
"low growth hormon level relat increas bodi mass index reflect impair growth lutein hormonereleas hormon agonisttr children precoci puberti test hypothesi gh defici explain low growth veloc lhrh agonist lhrhatreat children central precoci puberti measur stimul spontan gh level lhrha treatment gh stimul test children receiv lhrha treatment perform day ethinyl estradiol administr thirti children underw gh stimul test subnorm respons equal microgram test administ stimuli includ precoci puberti idiopath hypothalam hamartoma eleven children underw measur nighttim spontan gh level level normal rang prepubert children microgram high incid subnorm gh level relationship gh level children growth characterist height growth veloc bone matur rate predict height insulin growth factor level children low gh level children normal gh level convers gh level children subnorm growth rate children normal growth rate variat growth rate lhrhatreat children central precoci puberti explain variat stimul spontan secret gh attempt understand high incid low gh level children precoci puberti examin relationship gh level bodi mass index bmi stimul spontan gh level invers relat bmi children precoci puberti group signific elev bmi se sd unit compar normal children age increas bodi mass explain high incid subnorm gh level patient normat gh level adjust bodi mass conclud appar subnorm gh level lhrhatreat children precoci puberti fact low"
"serum osteocalcin patient thyroxin subclin hyperthyroid serum osteocalcin index osteoblast activ increas hyperthyroid serum osteocalcin level negat correl bone densiti patient overt hyperthyroid osteocalcin level elev patient multinodular goiter subclin hyperthyroid measur serum osteocalcin level patient determin correl degre tsh suppress upward trend serum osteocalcin measur decreas tsh concentr signific differ serum osteocalcin group patient normal mu mild reduc mu undetect serum tsh mu weak negat correl serum tsh osteocalcin concentr slope osteocalcin correl serum free free concentr serum pth concentr patient group data suggest osteocalcin clinic marker increas bone turnov patient subclin hyperthyroid due therapi trend higher osteocalcin level patient suppress serum tsh valu weak negat correl serum tsh osteocalcin consist find reduc bone densiti patient"
"accuraci portabl blood glucos monitor effect glucos level prandial state glucos determin capillari venous blood sampl adult diabet methodolog glucoscan accucheck ii portabl glucos meter capillari kodak ektachem analyz venous glucos meter correl signific ektachem result signific posit bias found glucoscan compar ektachem found accucheck ii accucheck perform glucoscan venous plasma glucos level error glucoscan determin signific greater bias posit measur perform hour eat effect accucheck error multipl regress analysi reveal glucoscan measur independ influenc venous plasma glucos prandial state accucheck ii measur depend variabl run precis glucos meter compar"
"differenti express basement membran collagen chain diabet nephropathi diabet nephropathi character progress expans mesangi matrix thicken glomerular basement membran gbm kidney tissu patient insulindepend diabet mellitus studi immunohistochem techniqu distribut recent collagen peptid goodpastur antigen alport antigen compon classic type iv collagen alpha iv noncollagen nc globular domain alpha iv nc tripl helix recent design nc monom alpha iv alpha iv base limit amino acid sequenc diseas distribut chain alport peptid segreg complet classic type iv collagen diabet kidney antibodi alport peptid react intens thicken gbm mesangium contrast reactiv antibodi compon classic type iv collagen promin expand mesangi matrix signific decreas reactiv peripher capillari wall hyalin glomeruli compon classic type iv collagen virtual disappear alport peptid persist collaps gbm studi support view expans mesangi matrix thicken gbm involv separ distinct collagen compon differenti express alport peptid compar classic type iv collagen consequ differ site synthesi classic type iv collagen endothelialmesangi cell alport chain viscer epitheli cell independ control mechan differ degrad"
"role thyroid hormon develop beta adrenerg control ornithin decarboxylas rat heart kidney role thyroid status ontogeni beta adrenerg receptor control ornithin decarboxylas odc activ assess heart kidney neonat rat hyperthyroid induc administr triiodothyronin postnat day caus reduct abil isoproterenol stimul cardiac odc subsequ acceler onset postwean peak respons effect promin triiodothyronin administr postnat day hypothyroid induc propylthiouracil administr led persist subsensit cardiac odc respons beta receptor stimul kidney odc subject beta receptor regul wean resist hyperthyroidinduc reactiv hypothyroid result longterm respons deficit result suggest thyroid hormon permiss normal develop beta receptorodc link euthyroid state optim condit matur signal transduct mechan relat resist kidney odc respons alter hyperthyroid effect excess hormon express receptorenzym link compet final thyroid status equival effect abil vasopressin angiotensin stimul odc suggest site thyroid hormon action transduct locus common receptor type"
"gonadotropin releas hormon clinic applic gynecolog identif synthesi gonadotropin releas hormon gnrh year ago gnrh analog synthes evalu treatment varieti condit requir temporari revers suppress stimul gonadotropin secret effect stimul gonad requir pulsatil administr gnrh agonist prefer nativ decapeptid gonad suppress superagonist proven high effect intens studi promis innov clinic applic compound"
"artifactu elev thyroidstimul hormon clinic euthyroid patient found normal serum thyroxin level elev plasma thyrotropin tsh level measur fluoroimmunoassay thyroid hormon therapi fail suppress tsh level tsh level unrespons thyrotropinreleas hormon trh administr alphasubunit pituitari glycoprotein undetect plasma imag pituitaryhypothalam region normal measur tsh assay sheep antibodi tsh fail reveal tsh patient plasma addit mous igg tsh fluoroimmunoassay reduc patient tsh undetect level observ consist spurious elev tsh due presenc antimous antibodi artifactu elev tsh identifi common possibl consid tsh level inappropri appar state thyroid function"
"diabet care rural primari health care district patient educ high prioriti metabol evalu present populationbas studi compris diabet care rural primari health care centr patient educ high prioriti integr part treatment provid special train nurs dietician supervis general practition patient good metabol control reflect hba diettreat oral agenttr insulintr refer rang obvious reason high hba valu found"
"observ variat clinic assess thyroid gland order evalu reliabl clinic assess thyroid gland specialist endocrinolog younger doctor independ examin patient assess diffus goitr multinodular goitr solitari nodul normal gland patient observ agreement patient diagnos interobserv variat determin kappa valu found intraobserv variat smaller reveal kappa valu present studi suggest clinic assess thyroid gland lead misclassif type thyroid diseas optim choic therapi"
"postop comput tomograph evalu patient larg pituitari tumor treat oper decompress radiat therapi thirti consecut patient underw oper decompress radiat therapi larg sellar suprasellar pituitari tumor greater equal cm studi term serial comput tomograph ct men women age year follow month twenti patient transsphenoid surgeri hormon inact tumor radiat therapi begun month surgeri dose cgi postop ct scan obtain month surgeri month interv fourteen patient suprasellar tumor visual earli postop ct scan subsequ scan eleven patient persist suprasellar mass earli postop period resolv serial ct evalu time resolut month patient persist suprasellar mass serial ct evalu persist postop mass subsequ resolv patient thought caus gradual retract postop pack hematoma effect radiat residu tumor"
"islet amyloid polypeptid signific factor pathogenesi pathophysiolog diabet islet amyloid polypeptid iapp amylin recent discov minor secretori peptid betacel relat calcitonin generel peptid cgrp constitu amyloid deposit islet insulindepend type ii diabet individu elder nondiabet subject iapp synthes small precursor level approxim insulin process amid store betagranul releas insulin peptid analysi gene locat chromosom support evolutionari relationship calcitonin cgrp peptid share biolog action cgrp iapp antagon action insulin level muscl glycogen synthesi level requir effect higher report circul level evid overproduct iapp diabet subject found work defin normal secretori rate clearanc propos action iapp includ serum calciumlow effect smooth muscl relax effect promot uptak insulin circul islet deposit amyloid speci select due structur differ central part molecul initi intracellular type ii diabet mechan differ structur iapp precursor found individu maturityonset diabet young type ii diabet"
"newli identifi pancreat protein islet amyloid polypeptid relationship diabet islet amyloid polypeptid iapp amylin newli identifi amino acid coohterminalamid polypeptid major protein constitu amyloid deposit insulinoma amyloid deposit pancreat islet insulindepend type ii diabet human adult diabet cat iapp store insulin betacel secretori vesicl cosecret insulin respons glucos secretagogu iapp demonstr normal pancreat islet speci iappderiv amyloid develop common islet speci human cat associ agerel diabet iapp human cat inher short amyloidogen sequenc present speci form islet amyloid studi anim aberr synthesi process iapp lead local increas concentr iapp islet requir facilit convers iapp amyloid format islet amyloid contribut develop type ii diabet caus disrupt islet cell replac islet propos abnorm iapp homeostasi pathogenesi type ii diabet signific causal relationship iapp type ii diabet base report iapp inhibit glucosestimul insulin releas betacel iapp inhibit insulinstimul rate glycogen synthesi glucos uptak skelet muscl cell"
"increas incid diabet mellitus relat abdomin adipos older women relationship bodi fat distribut measur ratio waisthip circumfer whr year incid diabet mellitus examin cohort women age year women report onset diabet signific greater bodi mass index kgm whr case adjust bodi mass index bmi age educ level multivari logist regress whr signific independ predictor diabet doserespons fashion case time ci case upper tertil whr time ci middl tertil women highest tertil whr bmi fold ci higher risk diabet women lowest tertil result demonstr increas abdomin adipos signific independ risk factor develop diabet mellitus older women"
"premix insulin compar insulin prepar avail premix insulin physician diabet patient wider choic therapeut option premix prepar unit state consist nph insulin regular insulin major advantag premix insulin conveni improv accuraci suitabl patient impair mix insulin dose mixeddos ratio similar prepar"
"portabl blood glucos meter teach patient correct monitor diabet monitor blood glucos import compon treatment patient diabet recent improv glucos meter made patient test reliabl depend user techniqu success process depend train reassess support patient healthcar team"
"cell differenti autolog convent cell deplet bone marrow transplant recapitul normal cell ontogeni circul lymphocyt consecut patient autolog convent cell deplet bone marrow transplant serial analyz cell surfac antigen express function major patient develop chronic graftversushost diseas number circul cd cell normal fourth posttranspl month earliest detect cell express hladr cd surfac immunoglobulin slg cd leu lack express cd calla addit circul cell express cdc cd cd cd year transplant antigen express small percentag circul cell normal adult high express cord blood cell similar cord blood cell patient cell isol year transplant prolifer staphylococcus aureus cowan strain sac produc igm minim igg stimul pokewe mitogen sac unlik normal adult cell produc similar phenotyp function posttranspl cord blood cell similar rate declin patient normal children add evid support hypothesi cell differenti posttranspl recapitul normal cell ontogeni"
"transmiss htlv blood transfus prevent passiv immun rabbit determin minimum volum blood requir transmit human cell leukemia virus type htlv heparin blood collect virusinfect femal rabbit aliquot ml transfus group male rabbit rabbit transfus ml rabbit transfus ml seroconvert htlv week htlvproduc lymphoid cell line recipi origin establish seroconvert rabbit aliquot group determin abil passiv immun protect htlv infect group rabbit transfus ml blood virusinfect rabbit infus hour ml htlv immun globulin mgml igg prepar seroposit healthi person hour immun group seroconvert htlv observ period month hour immun group seroposit week result htlv transmit ml virusinfect blood passiv immun effect prevent cellcel infect htlv hour transfus virusinfect blood"
"adrenalin nocturn asthma object determin nocturn fall plasma adrenalin nocturn asthma designdoubl blind placebo control cross studi experi nocturn fall plasma adrenalin correct asthmat subject infus adrenalin parasympathet blockad microgramskg intraven atropin experi asthmat subject show similar variat peak expiratori flow rate nocturn fall plasma adrenalin correct infus atropin patientsasthmat subject diurnal variat home peak expiratori flow rate greater time week studi main outcom measurespeak expiratori flow rate plasma adrenalin resultscorrect nocturn fall plasma adrenalin rest pm level alter peak expiratori flow rate parasympathet blockad atropin conclus nighttim fall plasma adrenalin nocturn asthma"
"augment monocyt chemotaxi alphadihydroxyvitamin stimul defect migrat aid patient preincub alphadihydroxyvitamin mark augment chemotact respons human blood monocyt classic chemoattract fmlp modest enhanc monocyt spontan locomot absenc chemoattract observ maxim increas monocyt migrat observ pretreat detect fmlp concentr rang pretreat augment number monocyt high affin fmlp receptor site cell untreat dpretreat cell signific kd valu nm nm untreat dpretreat monocyt enhanc chemotaxi restrict fmlp dtreat monocyt show enhanc migrat respons activ compon chemotact cytokin agreement previous observ monocyt aid patient show defect migrat capac vitro exposur stimul monocyt migrat patient examin quantit differ individu regul respons matur monocyt chemoattract produc system situ immunocompet cell play role regul recruit monocyt site inflamm cellmedi immun bone resorpt potenti restor agent condit defect phagocyt recruit deserv explor"
"vivo effect antiil monoclon antibodi neonat induct toler autoimmun syndrom role il cellular interact lead induct ctl toler alloantigen develop lupus autoimmun diseas balb mice neonat inject cbl balbf cell investig vivo antiil mab treatment cellinject balb mice mg antiil mab shown interfer toler induct assess high percentag target cell lysi low undetect level cell chimer marker observ mice treatment mg antiil mab interf toler induct cellinject balb mice dose induc specif modul autoimmun manifest mice lead complet prevent diseas product antissdna igg total igg ige antibodi affect treatment prolifer membran ia express donor splenic cell thymic apc treatment cellinject balb mice life mg antiil mab interfer toler induct similar effect autoimmun syndrom treatment mg result suggest cell inject newborn mice il play import role cellular interact lead induct toler alloantigen develop autoimmun syndrom"
"loss epiderm integr cellmedi attack induc long term local resist subsequ attack ii thymus depend induct resist previous studi show cutan grafthost diseas gvhd induc intraderm inject autoreact cell epiderm structur spontan recov destruct resist subsequ attempt induc cutan gvhd resist correl fold increas number thi epiderm cell thyec show resist cutan gvhd induc athym nude mice adult thymectomi lethal radiat bone marrow reconstitut atxbm mice condit indic induct resist depend presenc thymus great increas number thyec similar observ epidermi athym nude atxbm mice spontan recov cutan gvhd remain suscept induct cutan gvhd result bthyb radiat chimera demonstr vast major increas thyec found suscept epidermi atxbm mice donor bone marrow origin increas number hostderiv thyec resist epidermi xbm mice thyec popul equal increas result expans thyec matur thymus crucial induct resist migrat bone marrowderiv thyec precursor epidermi occur independ presenc thymus"
"intact antigen receptormedi generat inositol phosphat increas intracellular calcium cd cd lymphocyt mrl lpr mice predomin lymphocyt accumul peripher lymphoid tissu mice homozyg lpr gene bear phenotyp cdcdcd function criteria cell impair cdmediat signal transduct respond alloantigen produc detect il lymphokin signal pathway adequ achiev cell function includ induct high affin ilr thymic delet clarifi basi discrep examin transmembran signal transduct cell subset lprlpr lpr mice defin increas ca generat inositol phosphat insp stimul lpr cdcd cell anticd antibodi produc prompt sustain increas concentr insp similar respons occur matur cell lpr mice slower kinet increas ca mark distinct anticdmedi respons con high dose stimul increas ca lpr cdcd cell modest increas insp matur cell lpr origin yield normal increas ca con reason differ signal transduct anticd con stimul lpr cdcd cell relat absenc surfac structur immatur cell requir activ con anticd data demonstr cd complex lpr cdcd cell coupl phospholipas hydrolyz phosphoinositid activ properti lpr cdcd cell interest function parallel thymocyt time thymic select toler induct matur lymphocyt"
"human sever combin immunodefici diseas phenotyp function characterist peripher lymphocyt human sever combin immunodefici diseas scid includ chromosomelink type character complet absenc matur cell hypogammaglobulinemia normal elev number cell suggest diseas result block earli cell differenti shown cell oblig carrier women disord exhibit preferenti nonmut chromosom activ shown cell suggest scid gene product direct effect cell cell examin question analyz phenotyp function characterist peripher cell infant scid found constant absenc spontan express activ ag cell membran scid patient test contrast phenotyp pattern exhibit agematch infant cell bear surfac ig express ag lesser extent transferrin receptor concurr cell scid patient profound impair respons stimuli induc vitro cell prolifer differenti ril lowmr cell growth factor potent induc prolifer agematch infant cell poor effici induc prolifer antimuactiv scid cell impair relat rest cell phenotyp scid cell shown comparison normal rest cell observ appar block cell differenti ril ril support sacactiv scid cell differenti lymphokin effici induc sacactiv agematch infant cell purifi rest cell differenti result suggest scid gene defect direct effect cell requir cell matur"
"surgeon risk aid probabilist model estim cumul risk surgeon human immunodefici virus hiv recent data suggest probabl infect percutan inocul case studi suggest frequenc percutan injuri surgeri case high case assum averag surgeon perform oper year practic year cumul risk hiv infect depend preval hiv infect surgic popul hiv preval cumul risk surgeon rang base risk estim crucial decreas frequenc percutan injuri case made substanti improv barrier protect modif surgic techniqu"
"pattern food hypersensit sixteen year doubleblind placebocontrol food challeng year doubleblind placebocontrol food challeng dbpcfc nation jewish center immunolog respiratori medicin determin advers reaction food occur children object studi explor reproduc advers reaction character skin test perform subject histori advers reaction food subsequ dbpcfc criteria entri studi children studi posit dbpcfc result children dbpcfcs show posit result egg peanut cow milk account posit dbpcfc reaction food produc reaction skin test result posit children posit dbpcfc reaction larg number patient asymptomat hypersensit limit accuraci posit skin test result predictor clinic symptom food ingest evalu result larg number children prolong period reveal reproduc pattern symptom time incrimin food placebo reaction rare procedur safe twelv youngster negat dbpcfc result subsequ posit reaction open challeng larg amount challeng food case reaction limit area direct contact food explain larger amount food ingest open challeng multipl food hypersensit rare find dbpcfc gold standard research clinic diagnost evalu supersed method develop"
"ibuprofen suspens treatment juvenil rheumatoid arthriti pediatr rheumatolog collabor studi group nineti children juvenil rheumatoid arthriti random assign treatment multicent doubleblind week trial design compar efficaci safeti liquid formul ibuprofen dosag mgkgday versus aspirin dosag mgkgday signific intergroup differ respons rate amount improv articular index diseas activ observ children treat aspirin discontinu treatment earli advers reaction trial addit patient juvenil rheumatoid arthriti enter week multidos mgkgday open trial ibuprofen suspens favor respons rate group similar continu improv observ week period doserespons relationship observ respect advers reaction upper gastrointestin tract conclud ibuprofen suspens effect nonsteroid antiinflammatori drug toler children accept"
"safeti efficaci methotrex therapi juvenil rheumatoid arthriti twenti children juvenil rheumatoid arthriti studi determin safeti efficaci methotrex therapi initi dose methotrex averag mgmwk singl oral week dose divid dose separ hour current antiinflammatori medic continu children lack efficaci toxic effect prior drug intramuscular oral administ gold hydroxychloroquin penicillamin intoler corticosteroid depend toxic effect present case methotrexatetr patient examin month minimum treatment durat requir assess efficaci toxic month rang treatment durat month month efficaci assess compar pretreat versus posttreat fever rash swollenjoint count articular index durat morn stiff function class hemoglobin level platelet count treatment methotrex effect control fever rash children system juvenil rheumatoid arthriti reduc morn stiff elimin recalcitr joint restrict reduc number swollen joint swell index signific toxic effect observ juvenil rheumatoid arthriti long durat major eros refractori methotrex therapi recommend earlier methotrex place slowact antirheumat drug juvenil rheumatoid arthriti respond usual therapi futur studi address potenti methotrex toxic effect lung reproduct system outcom discontinu methotrex treatment"
"laboratori marker surrog clinic endpoint evalu treatment hiv infect strong ethic practic reason hasten decisionmak efficaci treatment human immunodefici virus hiv infect strategi earli marker diseas progress cd lymphocyt level surrog ultim clinic endpoint develop acquir immun defici syndrom aid death evalu therapi simpl model transit health state aliv advers marker experienc definit clinic endpoint examin extent treatment comparison base surrog endpoint predict ultim clinic benefit paramet chosen model treatment hiv infect comput simul clinic trial demonstr substanti time save surrog endpoint relianc surrog led overestim ultim clinic benefit treatment entail delay toxic transient benefici effect likewis relianc surrog led underestim ultim clinic benefit treatment effect transit marker state reduc rate transit marker state ultim clinic endpoint direct state ultim clinic endpoint"
"immunoadsorb plasma perfus patient system lupus erythematosus extracorpor treatment acut system lupus erythemat sle plasmapheresi report year risk plasmapheresi includ unselect procedur immunoadsorb plasma perfus im column patient evalu improv treatment liter perfus analysi protein remov plasma perfus show semiselect im column circul immun complex antidsdna antibodi perfus liter plasma substanc reduc protein lower immunoglobulin result sever sle immunoadsorpt advantag lower side effect dispens wih foreign protein substitut"
"preval concentr igm rheumatoid factor polyarticular onset diseas compar system pauciarticular onset diseas activ juvenil rheumatoid arthriti measur elisa preval concentr igm rheumatoid factor rf children juvenil rheumatoid arthriti jra major diseas onset group remain uncertain studi enzym link immunoabsorb assay elisa children activ jra show igm rf area polyarticular onset diseas system onset diseas pauciarticular onset diseas median igm rf concentr fold higher polyarticular diseas compar system diseas preval igm rf polyarticular diseas greater sever diseas function class seroposit agglutin assay preval igm rf jra signific elisa polyarticular group posit igm rf system group posit low concentr igm rf similar system jra found high preval area children jra system rheumat diseas summari studi show elisa high concentr igm rf found essenti sera children polyarticular onset jra sever diseas"
"decreas number peripher blood cd cd lymphocyt increas vitro spontan product antidna antibodi patient activ system lupus erythematosus flow cytometr color analysi peripher blood lymphocyt patient system lupus erythematosus sle show reduct relat absolut number cd cd cell compar match healthi individu abnorm mark patient activ activ diseas absolut number cd cd cell negat correl spontan antidna ig product demonstr laboratori index strong correl clinic diseas activ score decreas percentag cd cd lymphocyt patient activ diseas observ"
"adult diseas multicent survey japanes patient comprehens survey japanes patient adult diseas made questionnair major institut rheumatolog unit japan case institut judg diagnos adult diseas major clinic featur patient consist high fever polyarthralgia rash increas erythrocyt sediment rate negat autoantibodi leukocytosi liver dysfunct hyperferritinemia incid featur show signific differ case previous nonjapanes case"
"growth differenti lymphocyt patient juvenil rheumatoid arthriti studi growth differenti lymphocyt patient juvenil rheumatoid arthriti jra cell enrich popul mitogen stimul led similar proportion increas prolifer immunoglobulin ig secret cultur patient control lymphocyt increas prolifer igg secret increas absenc mitogen nonmitogen activ ig synthesi reduc replac cultur medium fresh medium cultur part reconstitut addit recombin cytokin interleukin il il il il result suggest popul circul cell patient jra rheumat diseas suffici matur differenti secret ig respons cytokin"
"clonal analysi joint fluid lymphocyt patient juvenil rheumatoid arthriti synovi fluid sf lymphocyt patient pauciarticular juvenil rheumatoid arthriti jra patient polyarticular jra examin phenotyp function characterist patient high proport activ sf cell increas proport cdcd presenc cdcdcdwt lymphocyt function analysi clonal level patient clone show relev proport cytotox cell clone confin typic cytolyt phenotyp present cdcdcd cultur compar pauciarticular jra patient polyarticular diseas signific higher proport cell clone cytotox activ deriv limit number patient data suggest direct involv cell pathogenet mechan origin maintain articular damag possibl pronounc cell reactiv clinic diffus jra type"
"european experi bonemarrow transplant sever combin immunodefici outcom bonemarrow transplant bmt carri march patient sever combin immunodefici scid analys recipi hlaident bmts probabl surviv median follow month treat cure median follow month good prognosi rapid develop cell function hlaident celldeplet bmt gave signific lower surviv median follow month factor poor prognosi presenc lung infect bmt absenc protect environ femal donor male recipi condit regimen signific increas frequenc sustain engraft condit bmt result frequent engraft donor lymphocyt myeloid cell donor cell chimer strong develop normal cell function"
"measur airborn mite antigen home asthmat children airborn concentr major hous dust mite antigen der measur low volum sampl litresmin home allerg asthmat children presenc detect airborn antigen strong sensit mite signific relat sensit previous recommend threshold level microgram der carpet dust signific associ lower threshold level carpet dust microgram level associ strong air measur concentr airborn antigen higher room wool carpet synthet carpet hard floor signific differ dust level der carpet type air sampl method assess antigen exposur dust sampl asthmat patient"
"aid pediatr neurolog human immunodefici virus type hiv etiolog agent aid wide spectrum diseas children owe select tropism immun system nervous system organ children symptomat hiv infect unit state articl review current knowledg clinic neuroradiolog neuropatholog featur hivrel central nervous system involv infant children symptomat hiv infect"
"scid mutat mice general defect dna repair mice homozyg scid mutat chromosom sever combin immun defici result inabl correct rearrang immunoglobulin cell receptor gene scid mice precursor lymphocyt reach stage develop requir express surfac receptor defect recombinas system aberr cut rejoin receptor gene segment great reduc effici produc function receptor result scid mice detect lymphocyt demonstr scid defect specif lymphocyt develop myeloid cell fibroblast scid mice show mark increas sensit ioniz radiat indic scid mutat lead inabl repair dna damag induc ioniz radiat interf rearrang immunoglobulin cell receptor gene"
"multipl sclerosi sibl pair cluster onset famili predisposit evalu relapsingremit multipl sclerosi ms sibl pair deriv famili age date onset ms symptom clinic famili histori ms age sexmatch ms clinic patient provid statist comparison group age onset tend cluster multiplex famili initi symptom ms occur year age sibl pair compar control posit famili histori ms sibl present multiplex famili compar simplex control st rddegre relat live age risk famili member multiplex sibl pair probabl definit ms compar control famili member age onset cluster sibl concord ms increas risk ms famili member suggest factor influenc diseas onset part inherit kindr"
"diffus cns involv system lupus erythematosus intrathec synthesi compon complement extracerebr system lupus erythematosus sle complement system play promin pathogen role decreas serum concentr compon reliabl indic system diseas activ diffus cnssle pathogen role complement clear patient activ diffus cnssle present delirium organ person syndrom general seizur determin csf index complement compon factor igg iga igm signific increas index patient compar control signific higher csf index patient increas igm index conclud intrathec produc diffus cnssle"
"igg subclass concentr absolut partial transient iga defici childhood sixti children symptomat iga defici studi separ occas eighteen aigad present pigad iga concentr risen normal rang age children present aigad present pigad restudi median interv year igg subclass concentr measur enzym immunoassay serum sampl collect enrol children aigad children pigad igg igg concentr children centil age sex frequent expect igg chi squar igg chi squar preval igg defici igg defici differ signific aigad pigad igg concentr remain centil frequent expect retest children pigad resolv chi squar children aigad present igg igg concentr centil frequent expect igg chi squar igg chi squar igg igg concentr children pigad elev igg igg concentr present high igg igg concentr aigad compensatori mechan afford protect infect part select secondari respons repeat episod infect"
"nebul albuterol acut childhood asthma comparison dose thirti children adolesc year age moder sever acut asthma nebul albuterol therapi high mgkg bodi weight standard mgkg dose administ hour interv random doubleblind studi highdos hour regimen result signific greater improv forc expiratori volum fev patient receiv high dose show steadi improv fev start end studi fev plateau dose standarddos group rise heart rate fall serum potassium level occur side effect group highdos therapi result higher serum albuterol level standard dose correl drug level side effect initi subsequ fev conclud occasion hour highdos albuterol therapi consid pediatr patient acut asthma moder sever relaps dose"
"reaction iodin radiograph contrast agent identifi manag patient risk system advers reaction iodin radiograph contrast materi infrequ dramat number patient experienc reaction minim select diagnost studi patient identifi patient increas risk pretreat corticosteroid lowosmol contrast materi minim number sever reaction highrisk patient"
"celldirect hepatocyt damag autoimmun chronic activ hepat investig function activ lymphocyt autoimmun chronic activ hepat cell clone peripher blood patient studi clone show specif livermembran antigen prolifer stimul rabbit liver cell membran clone react liverspecif lipoprotein complex clone subclon respond asialoglycoprotein receptor asgpr target immun attack autoimmun chronic activ hepat clone stimul autolog lymphocyt produc livermembranespecif autoantibodi antibodi asgpr result suggest livermembranespecif activ lymphocyt peripher blood import autoimmun attack chronic activ hepat"
"serolog molecular survey htlv infect highrisk middl eastern group defin extent human cell leukaemia virus htlv infect group jewish immigr israel increas frequenc adult cell leukaemia serolog molecular screen method includ enzymelink immunosorb assay elisa antihtlv elisa antibodi recombin htlv ptax protein molecular detect infect polymeras chain reaction pcr amplif htlv provir dna peripher blood mononuclear cell dna htlv elisa rate infect immigr khurusan northeastern iran htlv carrier detect unselect jewish immigr part iran unexplain cluster htlv infect cohort elder women similar geograph origin home peopl seroposit elisa posit pcr find newli identifi highrisk popul suggest addit elisa screen techniqu requir detect carrier highrisk popul"
"bronchial hyperrespons young student southern china relat respiratori symptom diagnos asthma risk factor cross section studi carri determin preval bronchial hyperrespons asthma student age year urban rural area guangzhou canton china method includ administ questionnair histamin bronchial provoc test allergen skinprick test bronchial hyperrespons defin fall fev peak expiratori flow provok dose histamin pd mumol occas week respons rate area preval bronchial hyperrespons diagnos asthma total popul signific differ preval urban rural area boy girl year group higher preval bronchial hyperrespons older group bronchial hyperrespons defin sever moder pd mumol mild mumol slight bronchial hyperrespons mumol sever bronchial hyperrespons close relat diagnos asthma wheez cough half student bronchial hyperrespons symptom free common allergen hous dust hous dust mite citi hay dust pollen feather rural area odd ratio slight mild moder sever bronchial hyperrespons atopi earli respiratori infect histori parent asthma"
"dietari alphalinolen acid immunocompet human examin effect dietari alphalinolen acid ala indic immunocompet healthi freeliv men age consum meal western human nutrit research center stabil period start subject consum basal diet bd intervent period subject consum basal diet consum flaxseedoil diet fd intervent period feed fd suppress prolifer peripher blood mononuclear cell cultur phytohemagglutinin concanavalin delay hypersensit respons recal antigen ns concentr immunoglobulin serum salivari iga number helper cell suppressor cell total cell peripher blood affect diet"
"rice pollen allergi taiwan panel test includ intracutan skin test st radioallergosorb test rast immunoblot allergeninduc lymphoprolifer studi rice pollen allergi asthmat children character allergen asthmat patient skin test posit reaction wheal greater equal mm rice pollen extract concentr ml remain negat stposit patient rastposit rast negat stnegat patient normal immunoblot reveal major allergen molecular weight kd kd kd interest rastposit patient show ige respons allergen igg antibodi normal control stronger igg respons allergen kd ige antibodi preliminari result rice pollen protein inducedlymphoprolifer inform rice pollen protein elicit specif respons asthmat children normal pathogen role bronchial asthma studi"
"anaphylaxi pinon nut year white male develop life threaten system anaphylaxi ingest small amount cooki pinon nut skin test elisa basophil histamin releas studi demonstr pinon nutspecif ige electrophoresi pinon nut extract demonstr band dalton rang bound ige patient serum immunoblot ingest challeng perform due sever patient reaction centuri cultur pinon nut eaten frequent american diet physician awar potenti anaphylact reaction ingest food"
"bronchial challeng hous dust induc bronchoconstrict allerg asthmat patient goal studi evalu natur exposur hous dust elicit bronchoconstrict group asthmat patient studi asthmat allerg hous dust mite nonallerg asthmat baselin fev similar group subject challeng nasal mask connect nebul fill hous dust patient random assign inhal dust high low group allergen level allerg patient fev drop larger baselin drop maxim minut challeng fev remain unchang nonallerg asthmat allerg patient challeng high group allergen hous dust microgram fev drop larger challeng low group allergen hous dust microgram late asthmat reaction found patient challeng high group allergen hous dust patient fev drop greater baselin occurr symptom test drop fev correl natur exposur hous dust induc bronchial allerg asthmat dosedepend manner"
"bone marrow transplant interleukinactiv bone marrow interleukin therapi acut myeloid leukemia mice investig approach induc graftversusleukemia gvl effect autolog bone marrow transplant abmt graftversushost diseas improv surviv cure leukemia present studi show bone marrow transplant bmt syngen bone marrow activ interleukin abm hour vitro interleukin il therapi superior bmt fresh syngen bone marrow fbm term surviv cure mice acut myeloid leukemia led normal hematopoiet reconstitut addit il therapi bmt fbm improv result bmt fbm result suggest gvl effect abmt enhanc abm bmt il therapi compromis engraft"
"direct relationship remiss durat acut myeloid leukemia cell cycl kinet leukemia intergroup studi cell cycl characterist includ label indic li durat phase ts total cell cycl time tc determin standardrisk newli diagnos patient acut myeloid leukemia infus bromodeoxyuridin remiss induct therapi consist cytosin arabinosid daunomycin administ patient cours consolid achiev complet remiss cr older patient rapid cycl cell uniqu cell cycl characterist identifi patient achiev remiss versus resist diseas pretherapi cell cycl characterist strong prognost remiss durat cr patient divid leukem cell tc median median patient median durat respons day relaps day patient median reach patient continu complet remiss log rank wilcoxon conclud cell cycl characterist leukem cell play role determin remiss durat leukem cell patient regrow slowli cours chemotherapi"
"combin syngen bone marrow transplant immunotherapi murin cell lymphoma activ immun tumorderiv idiotyp immunoglobulin recurr malign remain major treatment failur autolog bone marrow transplant bmt patient lymphoma regard develop immunotherapeut approach design induc resist residu tumor cell persist bmt previous studi model system lethal cell lymphoma ch origin shown activ immun purifi tumorderiv surfac immunoglobulin id tumor antigen produc resist tumor growth id immun lethal irradi mice week reconstitut syngen bone marrow result signific prolong surviv tumor challeng compar nonspecif immun control low level idiotypespecif antibodi demonstr sera specif immun mice earli time function studi literatur immunocompet syngen reconstitut predict incomplet recoveri immun mice lethal irradi syngen marrow reconstitut induc signific resist tumor challeng suggest persist establish host antitumor immun total bodi irradi studi demonstr feasibl id immun conjunct bone marrow transplant"
"lack relationship acetyl phenotyp idiopath system lupus erythematosus southeast asian popul studi indian malay malaysian chines associ idiopath system lupus erythematosus isl genet determin acetyl polymorph suspect previous studi caucasian popul approxim incid slow rapid acetyl present studi incid isl acetyl status mix popul malaysia result support associ isl acetyl status frequenc slow acetyl isl patient malaysian chines malay differ signific respect healthi group small number indian survey valid comparison figur suggest lack associ isl acetyl status"
"quantit analysi serum il correl increas level serum ilr hivinduc diseas devis luminesc sandwich elisa quantif il sera cell cultur supernat detect limit fgml test sampl luminesc sandwichelisa low measur level il pgml averag found sera normal individu serum level il elev hivseroposit asymptomat carrier pgml averag il level correl degre hivinduc diseas progress aidsrel complex pgml averag aid pgml il immunoreact sera aid patient elut major peak biolog activ heatstabl minor peak sizeexclus hplc interest signific correl observ serum il level solubl ilr level vitro hiv infect phaactiv pbmc led enhanc releas il cultur supernat solubl ilr releas mark increas ad exogen il decreas ad neutral antiil mab cultur result demonstr increas il level signific silr level suggest increas level receptor patient hiv infect serum il serum ilr level hiv infect reflect stage hivinduc diseas"
"evid peptid map region cd involv gpcd interact lead hiv infect hivinduc syncytium format peptid fragment cd molecul compar abil inhibit cddepend hivinduc cell fusion inhibit cddepend hiv infect vitro block gp envelop glycoprotein bind cd peptid region cd inact underivat equipot inhibitor cddepend virus infect cell fusion cdgp bind derivat benzyl acetyl peptid ident chemic composit alter sequenc derivat pattern block gp bind cdposit cell solubil cd block infect fusion similar potenc block gpcd interact inact hiv infect cell fusion assay peptid fragment cd molecul inhibit fusion infect cdgp interact peptid cd deriv region cd implic bind cd antibodi neutral hiv infect cell fusion effect cddepend cell fusion hiv infect cdgp bind revers okta antileu blockad gp bind cd data provid evid region cd direct involv gp bind lead cddepend hiv infect syncytium format previous observ structur mutant cd suggest cdrhomolog region cd involv direct indirect bind gp cd cdr cdr domain cd contribut bind hiv envelop hiv infect hivinduc cell fusion"
"immunodomin grafthost diseas cell respons minor histocompat antigen immunodomin control generat ctl cblbi antibalb bmatch strain combin potenti respond numer individu minor histocompat ag balb apc focus ctl respons larg specif limit number target ag minor ag distinguish differenti express panel target cell cxb recombin inbr strain express composit origin balb minor ag hierarchi observ order immunodomin ag present cxbk cxbg cell order domin ag found cxbe cxbj cxbi cell test immunodomin play role develop lethal grafthost diseas gvhd direct multipl minor ag cell transplant cell deplet bone marrow irradi rad recipi balb cxb recombin inbr strain result hierarchi immunodomin exist gvhd differ predict vitro ctl studi gvhd observ balb cxbe cxbi cxbj recipi cxbg cxbk recipi presensit donor mice cxbg cxbk splenocyt wk transplant signific increas gvhd potenti cxbg cxbk recipi evid order immunodomin provid transfer cxbe cell atbm irradi cxbg balb recipi result potent gvhd"
"human murin antidna antibodi induc product antiidiotyp antibodi autoantigenbind properti epibodi immunenetwork interact examin potenti role immunenetwork interact product lupus autoantibodi normal nzw rabbit antibodi respons analyz immun ig prepar human lupus serum antidsdna antibodi human lupus serum antissdna antibodi mixtur human lupus serum antidsdna antissdna antibodi mrllprlpr antidsdna mab mrllprlpr antissdna mab rabbit produc ig typic lupus autoantibodi individu rabbit ig crossreact multipl autoantigen includ nucleic acid cardiolipin smrnp glomerular extract laminin exogen ag rabbit antiid human antidsdna antibodi high specif dsdna notabl serum autoantibodi activ confin antiid ig fraction similar spontan occur idantiid interact found antissdna antidsdna antibodi isol individu lupus patient result lupus autoantibodi share ag bind properti pathogen ig includ crossreact antidsdna antibodi induc product ig similar autoantigen bind properti immunenetwork interact phenomenon unregul lead amplif pathogen autoantibodi product individu system lupus"
"induct nfkb monocyt differenti hiv type infect product human immunodefici virus type hiv progeni promonocyt cell line stimul retino acid pma purifi human monocyt macrophag electrophoret mobil shift assay southwestern blot experi detect bind cellular transactiv factor nfkb doubl repeatkb enhanc sequenc locat long termin repeat pma treatment retino acid treatment cell act induc nfkb express nuclei nuclear extract monocyt macrophag induct nfkb occur cell previous infect hiv cell infect hiv induct nfkb factor detect high level progeni virion produc suggest factor requir viral replic result monocyt cell lineag hiv mimic differentiationactiv stimuli nuclear nfkb express"
"cell activ hiv infect ii cellcel interact cytokin requir studi examin mechan intens activ hivspecif cell observ peripher blood hivinfect subject spontan vitro synthesi antihiv antibodi total ig product dramat reduc accessori cell cell remov fall counteract addit ril cytokin monocytedeplet cultur antisera il suppress spontan antihiv antibodi synthesi dosedepend manner il appar sustain hivspecif cell activ increas serum il level observ pbmc seroposit subject produc increas amount il vitro compar seroneg control spontan presenc lps stimul final constitut express il gene document fresh isol pbmc find il play central role hivspecif cell activ seroposit patient stress import cytokin hiv infect"
"igedepend cytokin product human peripher blood mononuclear phagocyt studi demonstr igedepend product il beta tnfalpha circul blood monocyt il beta product demonstr biolog stimul prolifer clone ildepend murin cell line dg presenc submitogen concentr pha repres experi hthymidin uptak increas cpm presenc supernat obtain unstimul cell cpm supernat monocyt stimul igealpha ige immun complex elisa ige complex increas il beta product ng monocyt ng experi tnfalpha product ng ng experi il alpha secret observ rna hybrid analysi demonstr il beta product repres de novo synthesi cytokin stimul rna product observ minim incub maxim igedepend secret proinflammatori cytokin mononuclear phagocyt cell contribut inflamm characterist allerg respons"
"interferon treatment aid kaposi sarcoma american experi report intend summar interferon treatment kaposi sarcoma ks aid review basic focus trial unit state result approv food drug administr fda recombin interferon alpha treatment kaposi sarcoma"
"cdposit hela cell clone direct quantit infecti human immunodefici virus blood cell aid patient cdposit hela cell line clone increas sensit human immunodefici virus hiv isol deriv aid patient titer infect hiv isol level equal observ normal human phytohemagglutinin phastimul lymphocyt cultur clone focal immunoassay fia peripher blood mononuclear cell pbmc produc hiv detect seroposit asymptomat patient aid patient frequenc pbmc hiv detect primari fia correl low cdposit cell count hiv activ cocultur pha blast result increas number cell releas hiv start day cocultiv low incid hiv detect direct fia compar high incid hiv isol cocultiv pha blast provid quantit infect data suggest hiv state latenc low express pbmc aid patient"
"iopamidol myelographi morbid patient previous intoler iodin deriv record patient underw iopamidol myelographi januari septemb review group patient histori suggest untoward sequela iodin intak contact administr chart patient care review reaction sequela suggest toxic allerg respons iopamidol myelographi conclud patient previous histori suggest intoler iodin administr iopamidol myelographi general safe procedur"
"control trial home ambulatori program asthmat children care asthmat children episod therapeut prevent year random control trial involv children measur impact comprehens home ambulatori program pediatr asthma manag object outcom measur intervent studi group year includ month clinic visit educ home visit special train research nurs control subject continu receiv regular care famili physician pediatrician subject complet studi studi subject school absente control subject day show signific small airway function year asthma sever improv studi subject worsen revers true control subject studi subject exhibit meter aerosol techniqu control subject fewer day spent hospit studi subject admit compar control subject day year studi control famili report asthmat child respons asthma manag intervent fail reduc exposur secondhand smoke household pet signific differ medic visit theophyllin level record asthma symptom year discontinu intervent mark washout effect observ comprehens ambulatori program childhood asthma manag improv object measur ill sever sustain"
"discord express antigen intraepiderm intraderm cell mycosi fungoid immunohistochem method author studi express pan majoritycel antigen cd cd cd tcrbeta cd cell subset antigen cd cd cutan cell mycosi fungoid mf biopsi patient varieti inflammatori lesion biopsi patient author detect absenc pan majoritycel antigen cell subset antigen cell epidermi dermi mf biopsi mf patient inflammatori skin lesion opposit pictur character lack antigen express dermal cell mf inflammatori lesion absenc antigen express epiderm dermal cell author term antigen discord preval cd cd tcrbeta discord mf case patient test mf biopsi show antigen discord biospi patient discord antigen antigen discord artifact treatment patient show discord receiv treatment time initi discord biopsi discord immunophenotyp abnorm detect discord mf biopsi antigen discord import diagnost featur immunophenotyp distinct mf varieti inflammatori skin lesion"
"hla antigen juvenil arthriti pauciarticular polyarticular juvenil arthriti immunogenet distinct dna techniqu investig role hladr dq dp allel suscept juvenil arthriti ja studi group patient ja diseas prognosi pauciarticular form benign polyarticular diseas frequent lead joint destruct disabl persist pauciarticular diseas develop preferenti patient hladrwdw dqwdw antigen confer suscept patient diseas convert polyarticular form hladpw addit suscept factor patient ja pauciarticular onset polyarticular form ja hladpw major factor suscept give relat risk addit found drw dqw increas hladr mark decreas patient pauciarticular polyarticular diseas result addit share factor distinct hla class ii allel import pauciarticular polyarticular ja conclud type oligonucleotid probe predict outcom children arthriti"
"restor dna bind activ estrogen receptor mrllprlpr mice polyamin biosynthesi inhibitor divers data link estrogen influenc frequenc sever system lupus erythematosus human murin lupus fundament mechan action estrogen involv interact hormon receptor protein transform dna bind form measur concentr uterin estrogen receptor dna bind normal balb mice lupuspron mrllprlpr mice mrllprlpr mice treat difluoromethylornithin dfmo uterin estrogen receptor level week mice group signific contrast dna bind activ signific higher balb mice sd fmolesmg dna untreat mrllprlpr mice fmolesmg dna treatment dfmo increas uterin estrogen receptor dna bind fmolesmg dna mrllprlpr mice polyamin level fold higher uterin tissu untreat mrllprlpr mice compar balb mice signific reduc dfmo treatment result link uterin polyamin product dysfunct estrogen receptor mrllprlpr mice reduct polyamin level irrevers inhibit ornithin decarboxylas dfmo restor estrogen receptor function"
"antibodi profil earli htlv infect publish erratum lancet dec defin antibodi profil earli seroconvers infect human cell lymphotrop virus type htlv consecut serum sampl subject presum seroconvert basi particl agglutin test studi enzym immunoassay confirmatori test radioimmunoprecipit western blot sampl posit sampl indetermin confirmatori test reactiv enzym immunoassay recombin envelop antigen enzym immunoassay particleagglutinationneg sampl prozon effect confirmatori test identifi seroconvert women man serum sampl studi antibodi reactiv western blot assay htlv specif antigen recombin protein span termin middl termin env glycoprotein gp recombin transmembran protein gp recombin tax protein gag protein seroconvert antibodi reactiv termin region aminoacid residu gp gag seroconvers detect"
"aid mind swedish peopl order assess knowledg attitud behaviour relat aid annual mail survey random sampl general public age year total individu sampl averag respons rate knowledg major rout infect general good entir studi period fear unverifi infect risk contact hivinfect peopl decreas period studi remain high entir period respond express strong fear spread hiv popul increas percentag respond report alter sexual habit result fear aid sexual behaviour chang suffici reduc risk spread sexual transmiss diseas progress knowledg attitud behaviour aim prevent transmiss infect unnecessari fear counteract prejudic rapid middl studi period public debat aid peak knowledg attitud chang year studi respect revert previous level"
"complementmedi enhanc hiv infect monoblastoid cell line assess role complement complement receptor hiv infect monocyt macrophag studi infect hiv isol peripher blood patient subacut aidsrel encephalopathi human monoblastoid cell line hiv hivinfect cell capabl activ complement system classic altern pathway low concentr hiv infect cell easili presenc absenc complement higher virus concentr infect longer facilit presenc complement infect cell reduc presenc monoclon antibodi mab okta anticd okm anticr anticr combin mab reduc infect greater amount data complement receptor port entri complementco hiv"
"immunolog primari hiv infect homosexu men symptomat primari hiv infect display pronounc lymphopaenia signific depress number cd cd cd cell cell week ill subsequ cd cell count rose parallel number cd cell atyp lymphocyt activ cd hladr cell attain maxim level month onset ill contrast cd cell number remain low extend period time earli sign host respons includ transient interferonalpha blood rais level neopterin beta microglobulin beta cdcd cell ratio beta resum complet normal valu follow period year find shed light pathogenet event earli hiv infect suggest infect acut symptomat stage enter stage chronic activ latent infect"
"heterosexu transmiss hiv employe spous larg busi zair understand reason hiv infect zair north america europ acquir heterosexu transmiss assess impact hiv infect larg urban african workforc enrol male employe femal employe femal spous employe larg kinshasa busi textil factori commerci bank prospect studi hiv infect hiv seropreval rate higher male employe spous bank male employe spous textil factori busi hiv seropreval higher employe manageri posit worker lowerlevel posit multivari analysi male employe receipt transfus histori genit ulcer diseas work bank urethr divorc separ independ hiv infect aid common death recent employ worker account death textil factori commerci bank hiv seropreval rate higher femal worker spous male worker multivari analysi wive worker hivseroposit spous receipt blood transfus histori genit ulcer diseas independ hiv infect"
"transit dynam hiv diseas cohort african prostitut markov model approach progress hivrel diseas infect death repres stage markov model transit stage consid revers model fit data cohort african prostitut maximum likelihood progress symptomat diseas center diseas control stage iv popul rapid report studi western countri"
"recreat drug sexual behavior chang cohort homosexu men multicent aid cohort studi mac relationship recreat drug highrisk hivtransmit homosexu behavior examin multicent aid cohort studi mac popul men complet baselin month follow evalu sexual activ month prior enrol report class recreat drug conjunct sexual activ analyz crosssect prospect relationship pattern sexual behavior level sexual risk behavior index baselin proport men highest risk categori unprotect anal exposur multipl partner increas men drug men drug volatil nitrit examin multivari logist analys volatil nitrit signific failur maintain attain lower sexual risk level control effect age educ level number highrisk partner result suggest volatil nitrit play import role associ recreat drug highrisk sexual behavior homosexualbisexu men"
"world health organ qualiti assess programm hiv test serum panel compris sampl posit negat undisclos hivantibodi content distribut nation refer laboratori hiv serolog order simul normal circumst referr particip test panel hivantibodi status normal procedur result test return particip great variat number combin test number rang assay laboratori laboratori test employ combin high averag success rate posit sampl error occur negat sampl averag correct negat report negat specimen report negat particip"
"toxic efficaci anticel ricin toxin chain immunotoxin murin model establish graftversushost diseas induc major histocompat barrier graftversushost diseas gvhd induc murin major histocompat complex inject cbl bone marrow splenocyt lethal irradi bbr murin recipi immunotoxin compos pan cell monoclon antibodi call antili murin homologu human anticd conjug ricin toxin chain antilyrta treat recipi mice vitro activ free rta bound select inhibit cell prolifer absenc potenti mice administ antilyrta vivo ongo gvhd dose microgram day show lower number splenic thi cell signific improv surviv compar mice phosphatebuff salin pbs irrelev control rta protect transient gvhd weight loss occur inject ceas surviv enhanc crosslink rta low oligosaccharid fraction purifi rta treatment antilyrta caus signific elev neutrophil higher dose mild hepatotox contrast infus ident dose schedul pan cell immunotoxin antithyrta caus signific decreas lymphocyt neutrophil precipit increas weight decreas total plasma protein tpp increas pleural periton effus reminisc vascular leak syndrom vls toxic effect antithyrta sever show surviv advantag gvhd model histopatholog studi show definit antigvhd effect signific declin gvhd compar pbstreat control observ skin lesser extent liver lung investig toxic antithyrta administ intraperiton lethal irradi bbr recipi syngen bone marrow recipi show weight gain hypoproteinuria vls observ gvhd model death occur higher antithyrta dose microgramsdaili inject administ day posttranspl antithyrta neglig effect renal function histolog studi show patchi dropout renal tubul treatment result pulmonari vascular congest patholog evid liver brain colon toxic weight gain enhanc irradi nonirradi normal mice undergo precipit weight increaseabstract truncat word"
"observ effect chimer anticd monoclon antibodi patient mycosi fungoid chimer murinehuman anticd monoclon antibodi infus patient mycosi fungoid success patient receiv dose mg antibodi week consecut week patient clinic improv respons short durat serum level chimer antibodi vari function dose mg dose level antibodi readili observ biopsi skin lesion coat antibodi cd posit cell blood signific deplet cd posit cell lowlevel antibodi respons mous ig variabl region human ig allotyp constant region determin observ patient clinic signific patient made primari antibodi cell prolif respons simultan administ foreign protein test antigen mark suppress mix lymphocyt reaction conclud dose level studi chimer anticd monoclon antibodi clinic efficaci mycosi fungoid toler low level immunogen immunosuppress effect induc toler inject antigen"
"evolv role etoposid manag lymphoma hodgkin diseas etoposid deriv epipodophyllotoxin import drug introduc manag malign lymphoma past decad grow number specif protocol includ agent manag malign lymphoma time primari treatment relaps broad activ etoposid histolog subtyp malign lymphoma hodgkin diseas potenti fulli exploit optim dose schedul etoposid singleag activ rival earlier drug alkyl agent doxorubicin function protein synthesi topoisomeras ii inhibitor offer potenti crossresist cytotox comment singleag activ etoposid report focus integr etoposid multiag protocol primari treatment malign lymphoma hodgkin diseas specif find protocol prednison methotrex doxorubicin cyclophosphamid etoposidecytarabin bleomycin vincristin methotrex promacecytabom nation cancer institut nci etoposid doxorubicin cyclophosphamid vincristin prednison bleomycin vacop vancouv primari treatment malign lymphoma vinblastin etoposid cyclophosphamid doxorubicin bleomycin vincristin prednison vecabop vancouv treatment previous untreat patient advanc hodgkin diseas discuss"
"longitudin studi fatal asthma effect care follow treatment modif patient admiss nfa studi incit event recogn bdp patient prenfa follow day death patient readmit asthma patient attain normal fev pch blunt percept breathless chang vas ratiochang fev found measur normal asthmat subject airway respons milder ventilatori respons differenti individu nfa patient nfa asthmat normal subject comparison nfa cohort asthma admiss cohort show asthma admiss year risk factor nfa episod"
"relationship aid patient clinic metaphor prevent bioethic aid diseas evok compel tragic stori aid epidem plagu seek optim therapeut relationship embodi metaphor coven fundament human possibl heal die death teach live advoc aid patient explicit question work generat convers facilit congruenc relationship reluct talk uncertainti limit major sourc prevent ethic conflict major obstacl fulfil therapeut possibl doctorpati relationship durabl power attorney health care dpa facilit discuss patient famili success prevent bioethic communic open patient doctor broadest possibl hear understand express doctor parent fighter technician teacher covenant import role moment patient experienc diseas variabl infecti chao brutal enemi spiritu challeng opportun growth context communic real relationship includ love respect humor hope genuin interest person live"
"interleukin releas site human cutan allerg reaction interleukin il promot cell recruit influenc allerg mediat releas analyz histamin prostaglandin il leukocyt accumul hour hour skinchamb site local ragwe challeng allerg subject cutan latephas reaction ragwe induc peak histamin hour diminish steadili increas prostaglandin level peak hour decreas approach prechalleng level hour leukocyt infiltr predomin neutrophil detect hour challeng select enrich mononuclear cell eosinophil basophil ws observ hour il bioactiv detect fluid hour challeng control site analysi il beta level ria reveal initi peak hour ngml elev ngml hour ragwe challeng nonatop subject chang level mention mediat cell bioactiv chamber fluid antigenchalleng site atop subject signific neutral antiil beta antiserum treatment antiil alpha antiil beta complet neutral il releas local cutan allerg reaction contribut igedepend cutan inflamm"
"alpha betaadrenergicreceptor system bronchial asthma subject asthma reduc mononuclear cell betareceptor bronchial asthma assess adrenergicreceptor system individu bronchial hyperreact betaadrenerg receptor mononuclear cell membran alphaadrenerg receptor platelet membran camp respons cell type stimuli includ plateletactiv factor paf determin studi assess subject mild asthma methacholinesensit subject asthma normal subject densiti affin betareceptor alphareceptor determin scatchard analysi find subject asthma signific lower densiti betareceptor compar normal subject subject asthma signific lower camp respons isoproterenol stimul compar group subject asthma paf decreas basal camp level signific inhibit respons isoproterenol stimul differ densiti affin platelet alphareceptor platelet camp respons stimul alphaagonist group camp respons betareceptor densiti mononuclear cell signific correl pulmonaryfunct test fevfvc time sensit methacholin coldair inhal result suggest patient asthma lower isoproterenol camp respons decreas densiti betaadrenerg receptor mononuclear cell absenc betaagonist therapi specul releas paf mediat secondari allergen exposur absenc overt attack asthma inhibit respons endogen exogen betaadrenerg agonist"
"relationship earli late rechalleng reaction nasal challeng antigen observ role inflammatori mediat cell challeng consecut ragwe rwallerg patient hay fever grade increas dose ragwe extract investig frequenc relationship earli er late lpr rechalleng reaction rcrs nasal challeng evalu nasal respons measur level histamin tameesteras activ kinin nasal lavag fluid grade symptom fifti subject er consist dosedepend concommit increas mediat symptom total amount tameesteras activ kinin generat er correl signific specif serum ige ssige intraderm skin test st sensit basophil histamin releas bhr antigen twenti subject develop late increas mediat subject symptom subject er develop lpr level lateappear mediat predict st ssige bhr signific weak associ intens er lpr signific differ ige antibodi st bhr intens threshold er dual earli reactor number eosinophil neutrophil lpr lavag increas prechalleng baselin number correl er kinin er tameesteras activ case eosinophil er histamin"
"dihydroxyvitamin potenti decreas respons lymphocyt atop subject agent increas intracellular cyclic adenosin monophosph inhibitori effect prostaglandin histamin isobutylmethylxanthin dihydroxyvitamin mitogen stimul peripher blood lymphocyt normal atop subject studi found lymphocyt atop patient suscept inhibit agent elev intracellular cyclic adenosin monophosph camp concentr activ metabolit vitamin inhibit atop patient compar normal donor agent inhibitori effect campelev agent potenti addit lymphocyt cultur potenti pronounc lymphocyt atop donor increas respons level compar level lymphocyt normal donor synthet corticosteroid dexamethason similar potenti effect inhibitori action prostaglandin view benefici action betaagonist phosphodiesteras inhibitor corticosteroid treatment allergi potenti effect action campelev agent therapeut interest"
"comparison effect loratadin airway skin respons histamin methacholin allergen subject asthma loratadin high select longact hreceptor antagonist random doubleblind crossov studi evalu effect loratadin mg placebo administ daili day skinwheal respons histamin airway respons inhal histamin methacholin skinwheal airway respons allergen subject asthma evid bronchodil action hour oral dose airway geometr provoc concentr histamin caus fall fev placebo loratadin mg mgml mgml signific mgml concentr ratio activ treatment placebo loratadin mg dose loratadin signific effect methacholin doserespons relationship skin loratadin displac histamin logconcentr respons curv concentr ratio loratadin mg protect effect earli latephas bronchoconstrictor respons inhal allergen skin loratadin mg signific inhibit wheal area allergen dose regimen studi loratadin moder potent select antagonist skin airway fail attenu earli late airway respons inhal allergen"
"alter product histaminereleas factor hrf activ respons hrf immunotherapi children asthma delin work mechan immunotherapi hyposensit product respons histaminereleas factor hrf studi group group consist newli diagnos children asthma good respond poor respond older year healthi subject result demonstr peripher blood mononuclear cell patient produc greater hrf activ spontan stimul normal subject spontan hrf activ decreas signific good respond poor respond increas allergen mite mitogen phytohemagglutinin phastimul hrf activ decreas decreas signific good respond activ chang poor respond granulocyt patient respond hrf vigor granulocyt normal subject respons diminish signific good poor respond magnitud decreas slight greater posit correl pha mitestimul hrf activ mitestimul hrf activ respons hrf plasma histamin level respons hrf patient invers correl phastimul hrf product respons hrf good respond correl posit poor respond suppress hrf activ type spontan synthesi respons hrf clinic benefit children asthma effect explain part efficaci proport allerg patient"
"allergi fish speci codallerg children vivo vitro studi presenc posit clinic histori skin test st result fish speci anchovi bass carp dogfish eel gilthead mackerel mullet perch red mullet salmon sardin sole tench tooth gilthead trout tuna investig children codposit clinic histori st rast children posit food cod cow milk chicken egg white peanut tomato codposit children posit clinic histori st fish speci frequent codneg children codposit children high frequenc posit sts eel bass dentex sole tuna observ posit dogfish frequent rastinhibit experi suggest presenc crossreact antigen cod bass dentex eel sole tuna result studi demonstr cod allergi reliabl index fish allergi codposit children toler speci test inclus diet"
"select desensit semin plasma protein fraction immunotherapi postcoit anaphylaxi year white woman report sexual intercourserel pruritus hive wheez dyspnea minut ejacul system reaction srs prevent condom prick test confirm sensit sephadex separ fraction husband semin plasma intraderm end point threshold concentr microgram protein millilit fraction leukocyt histamin releas studi exhibit releas fraction releas fraction day protocol rapid immunotherapi perform subcutan increment dose human semin plasma husepl fraction patient experienc sr receiv cumul dose microgram fraction day day rapid fraction administ patient experienc mild sr receiv cumul dose microgram log increas intraderm fraction end day continu time week month patient toler microgram dose fraction month coitus resum srs husepl stop intraderm fraction increas month cessat husepl inject log decreas fraction experi demonstr system toler achiev parenter administr select husepl fraction partial immunolog desensit patient anaphylact sensit achiev"
"cetirizin antiallerg therapi tradit antihistamin decad tradit antihistamin treatment allerg diseas effect reduc histaminerel symptom agent limit sedat anticholinerg side effect advers effect fewer recent introduc antihistamin cetirizin human metabolit hydroxyzin character high select receptor site reliabl consist inhibit histamineinduc allerg reaction block eosinophil infiltr site allergeninduc cutan reaction cetirizin prove effect treatment season perenni allerg rhiniti urticaria excret primarili renal mechan toler elder patient cetirizin low rate penetr bloodbrain barrier minim central nervous system impair day cetirizin low incid sedat anticholinerg side effect contribut high profil safeti articl characterist pharmacolog pharmacokinet mode action cetirizin review"
"aid famili physician attitud experi studi develop examin current experi opinion nation sampl famili physician regard acquir immunodefici syndrom aid survey respons rate questionnair return sampl approxim respond care hivinfect patient percentag vari low midwest high east coast thirti percent famili physician practic communiti fewer dealt ill communiti greater seventi percent respond provid care hivinfect individu physician refus care patient infect aid virus forti percent lose patient care aid patient offic final vast major survey favor requir partner notif inform sexual partner hivposit patient patient refus"
"glycoprotein express malign lymphoma revers clinic drug resist chemotherapi highdos verapamil glycoprotein transmembran protein thought function efflux pump detoxifi cell multidrug resist laboratori system recent found human tumor vitro clinic drug resist immunohistochem method employ monoclon antibodi jsb detect express glycoprotein lymphoma patient newli diagnos untreat lymphoma patient previous treat drugresist patient detect level glycoprotein base prior report suggest verapamil sensit drugresist cancer cell chemotherapi competit inhibit glycoprotein test efficaci verapamil chemosensit patient drugrefractori diseas patient previous fail relaps month doxorubicinvincristin drug regimen patient receiv day cyclophosphamid day continu infus doxorubicin vincristin oral dexamethason cvad cvad combin day continu infus verapamil maxim toler dose patient respond treatment includ complet remiss crs median durat respons day median surviv day doselimit toxic verapamil infus temporari cardiac dysfunct includ hypotens congest heart failur cardiac arrhythmia conclud glycoprotein uncommon express untreat lymphoma frequent express clinic drugresist diseas chemotherapi cvad maxim toler dose verapamil result high respons rate patient care select clinic drug resist"
"superior promacecytabom promacemopp treatment advanc diffus aggress lymphoma result prospect random trial publish erratum clin oncol apr hundr nineti patient stage ii iii iv follicular largecel diffus largecel diffus mix immunoblast diffus small noncleavedcel burkitt lymphoma random receiv cyclophosphamid mgm intraven iv doxorubicin mgm iv etoposid mgm iv day mechlorethamin mgm iv vincristin mgm cap mg total dose iv day prednison mgm oral daili day procarbazin mgm oral daili day methotrex mgm iv day leucovorin mgm oral hour dose begin hour methotrex cycl repeat day promacemopp day treatment promacemopp cytarabin mgm iv bleomycin iv vincristin mgm cap mg total dose iv methotrex mgm iv day leucovorin mgm oral hour dose begin hour methotrex prednison mgm oral daili day cycl repeat day promacecytabom trimoxazol doublestrength tablet oral daili period treatment ad promacecytabom regimen increas risk pneumocysti carinii pneumonia found patient receiv combin median follow year patient treat promacemopp achiev complet remiss cr complet respond relaps patient die includ treatmentrel patient treat promacecytabom achiev cr complet respond relaps patient die complet respons rate surviv signific higher patient treat promacecytabom mortal promacecytabom treatment patient treatmentrel mortal patient treat prophylact trimoxazol promacecytabom combin chemotherapi trimoxazol prophylaxi safe effect treatment patient aggress histolog malign lymphoma superior promacemopp"
"care asthmat oral maxillofaci surgeri patient estim asthma affect million peopl unit state natur diseas make special concern oral maxillofaci surgeon manag asthmat patient regard anesthesia surgic procedur oral maxillofaci region discuss"
"tuftsin defici aid tuftsin endogen tetrapeptid stimul phagocytosi releas fc fragment igg splenic endocarboxypeptidas tuftsin activ splenic function measur patient aid patient aidsrel complex arc patient undergon splenectomi healthi volunt signific invers correl tuftsin activ splenic function subject tuftsin activ signific lower patient aid arc undergon splenectomi compar healthi volunt tuftsin defici contribut risk bacteri infect symptomat hivposit individu"
"absenc high homolog sequenc htlv japanes multipl sclerosi detect htlvrelat sequenc japanes patient multipl sclerosi high sensit method employ polymeras chain reaction pcr genom dna southern blot hybrid analysi amplifi htlv sequenc primer ltr pol gag env code region fourteen patient definit ms diseas control normal control patient htlv myelopathi ham investig result particl aggreg assay htlv antibodi negat serum subject ham patient ms patient control show presenc high homolog sequenc htlv observ faint signal gag pol env code region low stringent hybrid ms patient normal control nucleotid sequenc analysi faint band homolog major histocompat complex molecul htlv genom"
"betamicroglobulin concentr pediatr human immunodefici virus infect serum concentr betamicroglobulin correl diseas outcom children infect human immunodefici virus serum serum concentr mg ml decreas concentr indic stabl diseas note pretermin lymphopen children patient concentr mgliter progress diseas remain stabl patient valu decreas time elev concentr note infant younger year age denot activ human immunodefici virus infect serum concentr prognost marker human immunodefici virusinfect children"
"primari combin immunodefici result defect transcript multipl cell lymphokin gene circul lymphocyt femal child recurr opportunist infect normal number phenotyp exhibit poor prolifer decreas synthesi cell growth factor interleukin il respons mitogen recombin il fulli restor prolif respons cell suggest poor immun function relat il defici northern blot analysi total cellular rna patient cell reveal mark decreas level il mrna normal size addit mrna level lymphokin select express cell includ il il il sever depress absent level interferon gamma mrna moder decreas granulocytemacrophag coloni stimul factor lymphokin product restrict cell unaffect decreas level lymphokin mrna patient lymphocyt enhanc catabol result diminut transcript rate affect lymphokin gene normal transduct cell receptorcd complex biochem signal initi lymphokin gene transcript defect distal membran signaltransduc apparatus defect hypothes involv cellspecif transact regulatori factor requir transcript affect lymphokin gene"
"autoimmun preganglion sympathectomi induc acetylcholinesteras antibodi system inject monoclon antibodi neural acetylcholinesteras adult rat caus syndrom perman complementmedi destruct presynapt fiber sympathet ganglia adren medulla ptosi hypotens bradycardia postur syncop ensu sympathet ganglia acetylcholinesteras activ disappear neuropil nerv cell bodi cholin acetyltransferas activ ultrastructur defin synaps lost electr stimul presynapt fiber superior cervic ganglion ceas evok endorgan respons hand direct ganglion stimul remain effect postganglion adrenerg system intact motor perform cholin acetyltransferas content skelet muscl preserv parasympathet vagal function model select cholinerg autoimmun repres tool autonom physiolog relev pathogenesi human dysautonomia"
"evolut sequenc encod princip neutral epitop human immunodefici virus host depend rapid continu princip neutral epitop human immunodefici virus local variabl domain extern envelop shown bind isolatespecif antibodi extent variat nucleic acid sequenc encod epitop studi dna direct obtain peripher blood mononuclear cell children plasma donor reveal quasispeci distribut sequenc obtain clone vari recipi recipi distanc donor sequenc increas time nucleotid evolut rate averag site year silent site site year nonsil site site year control region adjac region individu differ observ correl serum antigen level diseas progress sequenc epitop code region control region upstream divert donor sequenc children progress aid children progress aid evolut sequenc appar host depend rapid independ level antigen express"
"aggress hodgkin lymphoma aid univers colorado experi author perform retrospect studi investig relationship hodgkin lymphoma nhl acquir immunodefici syndrom aid januari decemb case aid nhl diagnos univers colorado affili hospit identifi submit chart review twenti patient fulfil criteria diagnosi aid biopsyproven nhl addit patient met criteria diagnosi primari central nervous system lymphoma includ analysi patient risk factor develop aid biopsi proven tumor categor high grade patient present stage iv diseas extra nodal involv median surviv month death progress lymphoma opportunist infect data similar previous publish seri clinic trial evalu effect treatment warrant"
"comparison median posterior tibial nerv somatosensori evok potenti ambulatori patient definit multipl sclerosi somatosensori evok potenti sep record stimul median nerv posterior tibial nerv control subject subject multipl sclerosi ms year durat ambulatori experienc exacerb document peripher nerv conduct reveal abnorm subject central abnorm respons median posterior tibial nerv stimul found spinal level scalp ms patient latenc initi negat scalp sep posterior tibial sep abnorm signific median sep calcul suggest signific increas spinal conduct time high incid abnorm sep support substanti physiolog recoveri group ms patient"
"lack evid infect effect growth hematopoiet progenitor cell vivo vitro exposur human immunodefici virus pathogenesi hematolog abnorm common observ patient acquir immunodefici syndrom aid incomplet understood report vitro growth myeloid cfugm erythroid bfu progenitor cell patient aid signific normal human immunodefici virus hiv seroneg donor cfugm low densiti marrow cell bfu observ aid patient versus cfugm bfu control hivdna individu coloni cfugm bfu detect polymeras chain reaction pcr techniqu hiv dna detect peripher blood mononuclear cell patient similar normal bone marrow cell expos vitro isol hiv recombin purifi hiv envelop glycoprotein gp exhibit differ growth cfugm bfu compar mock expos bone marrow cell hiv dna detect pcr techniqu individu coloni deriv hiv expos marrow studi suggest commit myeloid erythroid progenitor aid patient respons hematopoiet growth factor vitro hiv dna hiv envelop gp alter growth hematopoiet progenitor cell vitro evid hiv infect progenitor cell demonstr impair hematopoiesi patient aid relat direct effect hiv commit progenitor cell"
"retino acid receptor myeloid leukemia character receptor retino acidresist cell mrna retino acid receptor alpha raralpha express myeloid leukemia leukemia cell exhibit phenotyp respons expos retino acid ra determin ra resist relat alter ra receptor structur function perform detail analysi nuclear ra receptor raresist cell cell exhibit ra receptor approxim molecular weight similar kd exhibit rasensit hl leukemia cell line number ra receptor raresist cell cell signific lower exhibit rasensit hl cell cell retroviralmedi transduct raralpha cdna signific increas number ra receptor cell raralphatransduc cell incub ra exhibit diminish cell prolifer decreas myc express accumul cell gg addit ratreat cell exhibit downregul cd surfac antigen slight increas hemoglobin product manifest evid signific erythroid megakaryocyt myeloid differenti result elev number nuclear ra receptor involv alter prolifer necessarili differenti ratreat myeloid leukemia cell"
"longterm surviv ki lymphoma patient histolog immunolog featur kiposit larg cell lymphoma experienc longterm surviv present patient year age adenopathi case initi misdiagnos metastat carcinoma malign histiocytosi subsequ review sinus diffus growth larg pleomorph cell berh ki cd posit case mark cell lymphoma uchl case express cell cell marker case negat cell cell marker patient receiv chemotherapi receiv local radiat patient treat year initi diagnosi patient recurr evid lymphoma patient month surviv time rang year case longest report survivor ki lymphoma year longest surviv time previous report noteworthi berh lymphoid antigen preserv formalinfix paraffinembed tissu prolong period retrospect studi evalu natur histori ki lymphoma spontan treatmentinduc regress"
"multipl sclerosi australia zealand determin genet environment preval multipl sclerosi ms recent report region australia zealand mark variat preval latitud ms time common southern zealand tropic queensland current evid suggest countri variat predomin due environment genet factor"
"multipl sclerosi unit kingdomborn children immigr indian subcontin africa west indi multipl sclerosi ms uncommon ethnic asian indian subcontin asian african resid commonwealth countri africa west indi uncommon migrat england countri contrast children born unit kingdom asian african west indian immigr age group studi high preval ms similar order occur general popul england"
"formal prior direct patient hivrel diseas object examin knowledg counsel prior direct patient hivrel diseas design crosssect survey person interview part evalu multisit aid health servic program set outpati clinic aid communitybas organ patientsparticip elig survey subject year age enrol aid health servic program month client interview communiti measur main result survey thought moder great amount proxi health care decis major patient knew prior direct counsel prior direct counsel physician counsel gaybisexu men counsel execut prior direct counsel obtain prior direct counsel subject time obtain prior direct counsel conclus gap exist subject knowledg implement prior direct bridg gap author recommend physician attend technic aspect patient care determin patient valu lifesustain therapi counsel patient prior direct"
"risk human immunodefici virus hiv transmiss blood transfus implement hiv antibodi screen transfus safeti studi group inform risk human immunodefici virus type hiv infect patient transfus routin antihiv screen blood donor institut march model develop estim proport number transfus recipi san francisco bay area infect hiv year preced routin donor screen antihiv model base analysi donat histori hivinfect donor identifi region blood center hiv seropreval estim homosexu bisexu men san francisco hiv infect surviv rate recipi trace transfus safeti studi irwin memori blood center back program incid transfus hiv infect estim risen rapid occurr peak late approxim percent transfus unit decreas coincid implement highrisk donor deferr measur estim approxim transfus recipi infect hiv san francisco region number suggest higher preval transfus hiv infect general recogn continu trace potenti expos recipi data strong support effect earli donor educ exclus measur emphas import continu research develop area"
"associ psychiatr manifest antibodi ribosom protein system lupus erythematosus purpos goal studi determin elev serum level antibodi ribosom protein anti antibodi neuropsychiatr manifest patient system lupus erythematosus sle addit experi examin characterist antibodi pathogen patient method larg number serum sampl collect patient sle control subject rheumat diseas normal individu time serum sampl obtain patient sle categor presenc psychosi depress manifest central nervous system cns involv serum anti antibodi activ quantit enzymelink immunosorb assay util synthet peptid major protein epitop result group normal individu se igg anti activ individu valu greater sd similar result obtain measur igm anti activ normal level found sera patient rheumatoid arthriti patient demonstr pattern antinuclear anticytoplasm antibodi activ elev anti level found patient sle patient sle demonstr elev level igg igm anti antibodi includ patient patient neuropsychiatr manifest frequenc posit test result vari great depend natur cns involv frequenc patient sever depress psychosi compar patient nonpsychiatr neurolog diseas entir sle group odd ratio associ anti antibodi sever psychiatr manifest confid interv review patient sle origin classifi sever psychiatr diseas patient treat antidepress medic elev level anti antibodi serial studi serum level anti antibodi correl activ psychiatr diseas correl activ manifest sle anti antibodi patient igg direct primarili termin amino acid protein differ characterist observ patient psychiatr manifest compar pair serum cerebrospin fluid csf sampl obtain patient activ neuropsychiatr diseas express fraction total igg present anti activ mark lower csf serum conclus elev level autoantibodi termin region ribosom protein specif marker sle sever depress psychosi diseas assay easili reproduc distinguish sleinduc psychiatr diseas caus process"
"effect inhal corticosteroid maxim degre airway narrow methacholin asthmat subject airway hyperrespons asthma character increas sensit maxim respons airwaynarrow stimuli longterm therapi inhal corticosteroid reduc airway hypersensit asthmat patient investig drug reduc maxim degre airway narrow studi effect inhal budesonid maxim respons plateau doserespons curv inhal methacholin mild asthmat patient rais plateau measur sixteen atop patient mild asthma random parallel treatment group receiv doubleblind budesonid microgram daili placebo inhal turbuhal wk treatment wk treatment wk wash complet doserespons curv methacholin obtain standard min tidal breath method respons measur fev express fall baselin plateau log doserespons curv consid data point fell respons rang maxim respons obtain averag valu plateau mfev sensit calcul provoc concentr methacholin caus fall fev pc wk budesonid treatment mfev decreas fall mfev signific placebo budesonid geometr pc increas mgml pc group"
"morphometri airway late respons antigen challeng rat quantit structur airway contribut late bronchial respons lr antigen challeng kill brownnorway rat sensit ovalbumin oa challeng aerosol lr compar dimens intraparenchym airway control anim lung rapid frozen liquid nitrogen fix carnoy solut paraffin section stain hematoxylinphloxinesaffron time lr min oa challeng rl increas baselin cm homl cm homl rl chang signific control rat lumen size wall area membran airway measur correct airway size divid basement membran length squar bm increas airway wall area oachalleng anim lumen larg airway bm mm signific oachalleng anim mm control anim mm addit rat distribut mast cell mc bronchial tree determin tissu fix carnoy solut stain modifi grunwaldgiemsa stain signific mc larg airway medial small airway conclud smooth muscl constrict larg airway airway wall edema account lr rat distribut mast cell correspond close site bronchoconstrict"
"methotrexateinduc asthma patient rheumatoid arthriti develop pulmonari symptom function test abnorm consist asthma methotrex therapi assess airway respons methacholin therapi reveal airway hyperreact revert normal methotrex stop extens methotrex dosag interv day result abolit asthma remain remiss return week cycl month period day cycl"
"preval mycobacterium avium complex respiratori specimen aid aid patient san francisco hospit past year larg increas recoveri mycobacterium avium complex mac isol respiratori specimen submit clinic laboratori san francisco general hospit sfgh increas mac recoveri correl increas number case acquir immunodefici syndrom aid communiti mac isol patient aid isol mac respiratori specimen attribut contamin specimen mac organ present environ determin increas mac isol recov sfgh due increas environment contamin specimen increas aid patient popul conduct studi preval mac respiratori specimen aid versus aid patient result specimen submit clinic laboratori sfgh cultur mycobacteria review yr period preval mac respiratori specimen aid aid patient determin yr period preaid year year aid report san francisco preval mac respiratori specimen equal mac isol recov aid patient preval mac respiratori specimen aid aid patient"
"delayedtyp hypersensit initi earlyact cell antigen mismatch mhc incompat lateact delayedtyp hypersensit effector cell elicit delayedtyp hypersensit dth respons mice mediat sequenti activ agspecif thi cell requir earli phase elicit due dthiniti thi cell cd sig produc agspecif factor act ige antibodi sensit tissu local challeng ag releas vasoact amin serotonin releas serotonin local recruit activ cd classic dth effector cell secret lymphokin attract activ nonspecif perivascular infiltr circul bone marrowderiv leukocyt current studi isol subpopul dthiniti dtheffector cell determin phase elicit dth separ contact sensit model dth earlyact dthiniti cell lateact dtheffector cell oxazolon oximmun picryl chlorid pclimmun cba balb donor transfer cba balb recipi result show dthiniti mediat polyclon dthiniti cell ag mismatch mhc incompat lateact dth effector cell fact dthiniti cell ag mismatch mhc incompat lateact cell addit potenti interact cell popul rule show dthiniti mediat dthiniti clone ag mhc mismatch lateact dtheffector cell oxspecif balb clone initi dth pclspecif cba cell cba recipi recipi challeng ox pcl challeng ox pcl suggest elicit dth reaction mice comprehens descript respons accommod fact earli late phase respons begin ag specif end specif humor factor thi cell dth ag specif suggest form delay chronic inflamm initi hypersensit immun reactiv set ag prolong perpetu delay reactiv set ag"
"ultraviolet radiat convert langerhan cell immunogen tolerogen antigenpres cell induct specif clonal anergi cd helper cell recent demonstr singl dose uvb radiat abrog capac mous epiderm langerhan cell lc splenic adher cell sac present keyhol limpet hemocyanin klh agspecif mhcrestrict cd cell present studi determin unrespons repres longlast immunolog toler address question preincub klhpuls uvblc uvbsac isol restimul unirradi apc lc sac klh exogen ril absenc apc preincub klh uvblc uvbsac render unrespons subsequ restimul apc klh addit defect autocrin il product respond exogen ril indic unrespons due function inactiv cell death unrespons agspecif mhcrestrict long greater day addit unrespons due releas solubl suppressor factor uvblc uvbsac supernat cell effect prolifer addit unirradi allogen sac preincub prevent induct unrespons uvblc uvbsac suggest uvb interfer capac lc sac deliv costimulatori signal provid allogen sac conclud uvb convert lc sac immunogen tolerogen apc"
"il product human lymphocyt express htlvinfect normal cell il import regul humor cellular immun cytokin produc divers cell type produc lymphocyt physiolog condit agent induc cell express il analyz product il human peripher blood cell human thymocyt human cell line pure popul cell stimul combin mitogen cytokin il activ detect analysi purifi alpha beta gamma delta cell show cell subset produc il similar il mrna detect cell thymocyt popul stimul pcr assay il mrna cell found virtual neglig chang cell activ situ hybrid shown cell express il mrna mitogen activ pbmc belong cell lineag analyz human cell express il vivo examin lymphoid tissu situ hybrid normal human thymus detect signal il tonsil show posit cell parenchyma strong express il epitheli cell crypt contrast normal lymph node rare cell posit il lymph node patient castleman diseas show il express cell occupi margin sinus interfollicular area screen human cell line show cell line infect htlv secret il activ express il mrna addit vitro infect peripher blood cell htlv induc de novo synthesi secret il il express htlvinfect cell enhanc stimul il beta tnfalpha contrast il detect infect cell line studi il physiolog product human lymphocyt infect cell htlv result aberr express cytokin"
"plasma adenosin deaminas marker human immunodefici virus infect plasma concentr isoenzym adenosin deaminas ada adenosin deaminas ada adenosin deaminas ada measur cohort ambulatori patient infect human immunodefici virus hiv control sensit isoenzymespecif radioisotop assay system develop studi hivinfect patient plasma ada signific elev compar control subject uninfect subject risk factor hiv infect plasma ada stage diseas defin clinic status greater helper cd lymphocyt count greater evid suggest elev plasma ada surrog marker hiv infect occur earli diseas process"
"cost aid los angel articl report find studi medic medic expenditur person acquir immun defici syndrom aid los angel sociodemograph clinic data inform medic nonmed expenditur person aid obtain patient interview review medic bill person aid requir hospit year day hospit care charg month diagnosi aid inpati medic care outpati medic care medic cost averag patient year cost devot outpati pharmaceut azt aerosol pentamidin nonmed cost care volunt servic counsel kind assist result similar recent publish estim medic cost person aid data support chang problem care pwas increas outpati medic care pharmaceut decreas hospit resourc"
"epidemiolog pediatr hiv infect perinat transmiss human immunodefici virus hiv continu increas estim infect children born unit state transmiss spread area citi origin affect citi continu bear greatest toll adolesc vulner hiv infect educ counsel critic control epidem age group"
"aid transfus recipi summari hiv virus transmit approxim recipi infecti blood blood product transfus prior donor product test begun march elimin risk donor year prior test donor blood reduc number infect donat virtual contamin donor elimin multipli transfus patient develop stimul dysregul immun system due numer antigen iron red cell plasma dysregul immun system result variabl respons ad exposur hiv virus incub period progress diseas prolong variabl small number patient progress rapid risk group continu therapeut intervent natur histori diseas continu monitor determin ultim outcom transfus recipi"
"antivir therapi human immunodefici virus infect children antiretrovir therapi children earli stage progress made slowli zidovudin administ mgmdose hour current standard therapi symptomat children low cd count standard evolv test clarifi optim dosag zdv popul children zdv monitor close month hematolog side effect common ill children role newer antiretrovir ddi ddc licens establish toxic profil zdv work combin issu peripher neuropathi lack easi test measur make ddc ddi young preverb children daunt proposit zdv optimum dosag time fix ddc ddi regimen combin therapi antiretrovir drug dideoxynucleosid develop hightit antivir immunoglobulin involv technolog easi studi antisens oligom technolog hurdl overcom agent move laboratori clinic goal agent work site revers transcriptas reason work perfect categori drug difficult slow meantim children hiv symptomat support offer effect antiretrovir regimen"
"psychosoci aspect aid children adolesc publish erratum pediatr clin north junviii part articl address neuropsychiatr aspect human immunodefici virus hiv infect children adolesc includ development delay depress dementia specif clinic issu disclosur diagnosi discuss death child examin part present aspect impact aid famili approach hiv antibodi test therapeut intervent famili"
"laboratori diagnosi hiv infect laboratori diagnosi human immunodefici virus hiv infect complic absenc data sensit specif predict test appli children presenc matern antihiv passiv transmit placenta confound diagnosi author review data detect hiv hiv genom hiv gene product diagnost detect serolog cellular respons hiv infant children"
"host defens abnorm hiv infect infect human immunodefici virus hiv impair immun function abnorm host defens hiv infect due helper cell dysfunct studi defin abnorm hivinfect patient larg adult complet understand immunodefici occur infant young children congenit infect hiv await studi immun function effect virus develop immun system"
"allergen oral administ immunoglobulin prepar foodallerg children passiv immun oral administr immunoglobulin prepar deriv bovin milk chicken egg human sera propos method prevent treatment enter diseas allergen potenti protein factor limit widespread diseas prevent vitro studi sera milk eggallerg children perform determin immunoglobulin prepar allergen potenti protein extract milk bovin immunoglobulin egg white human immun globulin egg yolk antivir immunoglobulin prepar bound nitrocellulos paper prepar probe specif ige bind sera milk eggallerg patient milkhypersensit patient specif ige bind bovin immunoglobulin prepar eggallerg patient specif ige bind egg yolkderiv antivir chicken immunoglobulin control sera negat milk egg prepar western blot analysi confirm milk eggallerg patient igespecif antibodi bovin chicken immunoglobulin molecul remov contamin protein milk egg antibodi prepar elimin allergen potenti contrast sera milk eggallerg patient display detect ige bind human immunoglobulin prepar data administr antibodi prepar deriv bovin chicken sourc lead sever allerg reaction milk eggsensit patient sensit nonallerg individu"
"fatal reaction intraven nonion contrast materi case fatal relat lowosmol contrast materi locm present locm reduc unpleas side effect reaction data insuffici determin death rate highosmol contrast agent present trend univers convers locm continu enorm cost lifesav benefit incur"
"predict sever advers reaction ionic nonion contrast media japan evalu pretest report japanes committe safeti contrast media nationwid prospect studi advers reaction intraven contrast media cm japanes committe safeti contrast media compar highosmolar ionic cm lowosmolar nonion cm total case analyz reliabl pretest intraven inject small amount cm predict sever fatal reaction evalu predict valu pretest ionic nonion cm sensit valu low valu render test meaningless predict patient risk sever advers reaction comparison incid sever advers reaction nonpretest pretest patient nonpretest pretest patient negat result disclos statist signific differ benefici effect premed patient posit pretest prove author conclud pretest intraven inject small amount cm predict sever reaction ionic nonion cm"
"multipl sclerosi specif mr diagnosi specif magnet reson mr imag diagnosi multipl sclerosi ms measur systemat convent mr head imag sagitt local axial multipleecho sequenc long repetit time obtain patient clinic verifi ms schumach criteria healthi volunt subject hypertens patient dementia reader aid clinic demograph inform classifi studi ms ms reader classifi studi suppli subject age sex trueneg trueposit diagnos ms tabul specif mr diagnosi ms trueneg result proport ms studi control group includ small risk misinterpret incident periventricular white matter foci plaqu ms mr studi"
"aidsrel lymphoma histopatholog immunophenotyp associ epsteinbarr virus demonstr situ nucleic acid hybrid investig rang patholog shown acquir immun defici syndrom aidsrel lymphoma aris epidemiolog defin group patient case lymphoma recogn danish human immunodefici virus hivinfect individu end studi twenti case highgrad hodgkin lymphoma nhl hodgkin diseas found give cumul incid rate danish aid patient morpholog nhl patient classifi group highgrad tumor predomin popul immunoblast monomorph polymorph plasmacyt differenti burkitttyp nhls cell paraffinsect immunophenotyp epsteinbarr virus ebv dna demonstr tumor cell case situ nucleic acid hybrid slabel probe paraffin section epsteinbarr virus dna found group group tumor studi suggest exist main group aidsrel lymphoma pathogenes immunoblastrich lesion ebv morpholog resembl lymphoma immunosuppress organtransplant patient burkitttyp tumor ebv sequenc common pathogenet analog sporad burkitt lymphoma"
"fibroblast growth factor gene express aidskaposi sarcoma detect situ hybrid biopsi sampl acquir immun defici syndrom aidskaposi sarcoma aid kaposi sarcoma assay situ rna hybrid paraformaldehydefix paraffinembed skin section presenc fibroblast growth factor gene transcript fgfb fgf fgf gene express detect characterist kaposi sarcoma spindleshap cell sampl human immunodeficiencyposit hiv patient fgfb transcript detect kaposi sarcoma cell epidermi hiv hiv patient result complement observ growth factor gene express kaposi sarcomaderiv cell line repres vivo demonstr contrast express pattern fgf fgfb gene involv growth factor pathogen cascad lead kaposi sarcoma"
"cyclic anaphylaxi menstruat middleag woman develop recurr episod sever lifethreaten anaphylaxi episod strike day menstrual bleed temporari relief achiev indomethacin therapi patient fulli recov abdomin hysterectomi salpingoophorectomi role sex hormon prostaglandin alpha pathogenesi problem discuss"
"emerg room care asthmat comparison auckland toronto compar emerg room visit treatment asthma larg downtown teach hospit auckland zealand toronto canada determin differ asthma mortal zealand canada reflect pattern emerg room physician manag emerg room past decad enumer hospit chart sole diagnosi asthma review detail defin studi period toronto auckland number emerg visit asthma increas signific past decad rate rise signific higher auckland auckland asthmat admit toronto signific fewer admit object measur pulmonari function document frequent emerg room physician zealand canada versus pulmonari function measur primarili peak flow meter auckland common spiromet toronto pulmonari function measur compar direct center center admit patient signific lower pulmonari function indic discharg patient zealand peak flow predict asthmat assess toronto fev predict toronto pulmonari function measur miss healthier discharg patient puls rate respiratori rate pulsus paradoxus document consist auckland toronto"
"hiv infect cohort haemophil patient hiv infect haemophil patient age year evalu clinic examin laboratori test evalu time median month patient die aid patient deterior assess brodthelm classif nineteen patient decreas absolut helper cell count cd posit cellsmicrolit patient reduc helper cell lymphocyt ratio hiv isol peripher lymphocyt patient diseas progress number posit viral cultur increas progress hiv infect haemophil children adolesc median evalu period month transit symptomless hiv infect immunodefici easili recognis lower ratio helper cell lymphocyt marker begin deterior immun system"
"long term outcom ventil asthmat year period asthmat children receiv artifici ventil acut asthma alder hey children hospit occas altogeth episod occur declin number episod year period children die intermitt posit pressur ventil ippv survivor children subsequ die asthma seventeen children year ippv sixteen symptom asthma half symptom day ten cooper pulmonari function test forc expiratori volum predict geometr provoc histamin concentr pc mgml follow studi fourth patient die asthma ippv continu requir small number asthmat children year survivor remain high risk group signific continu morbid mortal"
"histopatholog featur highgrad hodgkin lymphoma acquir immunodefici syndrom french studi group patholog human immunodefici virus tumor highgrad cell hodgkin lymphoma observ patient acquir immunodefici syndrom describ histolog subtyp group pathologist form hundr thirteen case review classifi work formul updat kiel classif recent descript morpholog variant highgrad cell hodgkin lymphoma major type intermedi highgrad lymphoma observ largecel centroblast polymorph lymphoma compon immunoblast case immunoblast lymphoma plasmablast plasmacyt featur case case small cleav cell burkitt burkitt lymphoma case case fit typic criteria burkitt lymphoma heterogen case size shape cell presenc plasmablast featur vari frequent patholog site involv present lymph node gastrointestin tract bone marrow brain oral caviti muscl comparison histolog type site involv show case involv lymph node bone marrow muscl small noncleav cell burkitt burkitt lymphoma affect gastrointestin tract brain oral caviti centroblast immunoblast lymphoma consist plasmacyt differenti case previous persist general lymphadenopathi syndrom present case lymphomat prolifer follicular diffus hyperplasia lymph node biopsi specimen lymph node"
"interpret criteria western blot assay serodiagnosi human immunodefici virus type infect publish erratum arch pathol lab med aug project design evalu criteria interpret human immunodefici virus type hiv western blot assay group serum sampl blind examin collect individu attend public health depart central north carolina individu complet anonym link questionnair sociodemograph risk factor bloodborn infect western blot assay human immunodefici virus type interpret criteria establish univers north carolina hospit chapel hill center diseas control atlanta ga associ associ state territori public health laboratori director iowa citi iowa american red cross washington dc consortium retrovirus serolog standard davi calif food drug administr washington dc result obtain group posit negat indetermin organ criteria analyz context risk factor result institut perform human immunodefici virus type western blot confirmatori test adopt criteria center diseas control state territori public health laboratori director"
"enhanc immunoreact lymphoid malign neoplasm paraffinembed tissu refix zinc sulfateformalin previous demonstr improv cytomorpholog detail obtain tissu block initi fix formaldehyd solut runback procedur aqueous phase solut refix proteinprecipit agent zinc sulfat formaldehyd solut anecdot experi immunostain reprocess tissu suggest improv result perform prospect trial involv case compar intens immunoreact reprocess case studi varieti antibodi reagent note definit improv stain preferenti weakest origin immunoreact"
"evalu peak flow symptom manag plan control asthma general practic object compar peak flow manag plan asthma symptom plan designrandomis manag plan follow year set partner rural train practic norfolk subject patient children adult asthma prophylact treatment asthma attend nurs run asthma clinic main outcom measur number doctor consult cours oral steroid short term nebulis salbutamol treatment number patient requir doctor consult cours oral steroid short term nebulis salbutamol result manag plan produc signific reduct outcom measur signific differ degre improv group result similar children adult proport patient requir doctor consult fell peak flow group symptom group proport requir oral steroid median number doctor consult reduc peak flow group symptom group conclus peak flow meter crucial ingredi improv ill group teach patient import symptom action asthma deterior key effect manag asthma simpli prescrib peak flow meter system manag regular review improv patient care"
"promin slow acetyl phenotyp patient sulfonamid hypersensit reaction delay hypersensit reaction sever advers effect sulfonamid current clinic reaction occur differ metabol detoxif reactiv metabolit sulfonamid acetyl major metabol pathway sulfonamid slow acetyl phenotyp risk factor develop reaction determin acetyl phenotyp patient suffer hypersensit reaction sulfonamid femal male group age year age rang year acetyl phenotyp determin determin ratio urinari caffein metabolit methylxanthin aminoformylmethyluracil oral dose mg caffein nineteen patient slow acetyl compar incid slow acetyl racematch control popul suggest slow acetyl phenotyp risk factor develop sulfonamid hypersensit reaction support role imbal genet determin pathway metabol detoxif sulfonamid pathogenesi reaction"
"plasma histamin epinephrin cortisol leukocyt betaadrenerg receptor nocturn asthma plasma histamin cortisol epinephrin cyclic adenosin monophosph camp leukocyt betaadrenerg receptor measur asthmat patient nocturn asthma pm compar normal subject twofold higher plasma histamin concentr observ compar pm group chang plasma cortisol epinephrin camp concentr compar pm patient nocturn asthma signific decreas mononuclear polymorphonuclear leukocyt betaadrenerg receptor densiti differ bind affin group polymorphonuclear leukocyt patient nocturn asthma signific impair respons isoproterenol sem increas camp compar patient nocturn asthma normal subject signific chang betaadrenerg receptor densiti function occur night patient nocturn asthma"
"classif acut myeloid leukemia detail descript subtyp acut myeloid leukemia provid import cytochemistri monoclon antibodi discuss"
"immunophenotyp acut myeloid leukemia cell articl consid express myeloid cell antigen normal malign myeloid cell progress monoclon antibodi myeloid cell surfac antigen diagnosi subclassif treatment acut myeloid leukemia discuss result bone marrow purg monoclon antibodi remov leukemia cell purpos autolog bonemarrow transplant promis"
"granulocyt sarcoma granulocyt sarcoma variant present acut myeloblast leukemia occur extramedullari locat uncommon occur site age necessit inclus differenti diagnosi undifferenti tumor histolog touchimprint cytolog cytochemistri immunocytochemistri electron microscopi molecular studi contribut diagnosi"
"growth regul human matur cell line antiigm antiigd antibodi ebna human lymphoma cell line establish cell express igd igm surfac thought basic characterist matur cell growth cell inhibit treatment panel antiigm antibodi cell cycl analys reveal transit cell gg phase cell cycl mark inhibit treatment antiigm antibodi progress cell phase cell cycl found suppress presenc antiigm antibodi contrast entranc gg phase cell phase progress phase cell phase cell cycl inhibit signific treatment antiigm antibodi result mechan inhibit growth cell antiigm antibodi blockag transit phase cell cycl contrast antiigm antibodi antiigd antibodi growth inhibit cell cell growth factor il il effect inhibit growth cell antiigm antibodi ifnalpha beta cell growth factor activ increas number cell surviv treatment antiigm antibodi excel experiment model studi mechan signal transduct sig function differ sigm sigd"
"hyperphosphoryl cd hairi cell alter low molecular weight cell growth factor ifnalpha hairi cell leukemia hcl cell tumor affect preplasma stage cell differenti hairi cell produc cell growth factor bcgfrelat growth factor previous shown low mol wt lmwbcgfinduc prolifer hairi cell inhibit vitro vivo ifnalpha suggest effect contribut exquisit sensit hcl ifnalpha therapi elucid mechan involv therapeut effect ifnalpha analyz pattern phosphoryl protein hairi cell detect presenc hyperphosphoryl protein molecular mass kda protein identifi cd molecul structur uniqu phosphoprotein exclus detect cell express stage cell develop incub hairi cell mitogen concentr lmwbcgf induc addit increas cd protein phosphoryl contrast preincub cell ifnalpha ifngamma decreas basal lmwbcgfinduc cd phosphoryl cd phosphoryl hairi cell reduc vivo ifnalpha administr contrast case patient unrespons ifnalpha therapi cd phosphoryl alter vitro ifnalpha treatment lmwbcgf elicit cd phosphoryl stimul result suggest ifnalpha act hcl part inhibit leukem cell prolifer regul phosphoryl cd phosphoryl thought cellular prolifer model involv dysregul cd discuss"
"synergist action monoclon antibodi direct chain human ilreceptor tu mous igg mab direct chain human ilr analyz abil interact il bind isol chain ytc cell high affin pp receptor human alloreact cell clone inhibit ilinduc prolifer cell cooper antip chain mab inhibit il bind prolifer tu il bound isol chain express ytc cell respect dissoci constant kd nm crossinhibit bind inhibit constant ki agreement respect kd valu natur interact pure competit suggest nonident epitop ligand chain cell il bound high affin kd pm tu affin similar found ytc cell bind tu il mutual exclus cell mechan interact tu il complex inhibitori potenc antibodi depend temperatur antibodi preincub time assay data obtain degre presenc suboptim tracer concentr il intrins affin tu high affin configur fold lower isol chain argu favor affinityconvers model oppos preform complex model dissoci absenc il degre tu inhibit il bind short time assay min longer time min il bind result complet disappear effect tu suggest intern high affin ppil complex enabl cell escap inhibitori effect tu presenc mab interact tu il resembl observ ytc cell suggest inhibit ilinduc associ antibodi found synerg cell result cooper mechan block format high affin complex tu bind higher affin tu block il bind chain prolifer studi corrobor bind experimentsabstract truncat word"
"hla multipl sclerosi itali review literatur hla antigen locus dr dq type italian multipl sclerosi patient healthi control result compar publish italian literatur italian studi review ethnic origin type popul preval diseas data suggest lack associ antigen italian multipl sclerosi relev dr locus antigen dr dr addit dr suscept diseas"
"wernick encephalopathi patient acquir immunodefici syndrom alcohol homosexu patient acquir immunodefici syndrom aid report develop acut wernick encephalopathi termin stage ill patient present vascular congest minut haemorrhag prolifer microglia vessel wall predilect site wernickekorsakoff process patient mamillari bodi involv wernick encephalopathi primari cerebr immunoblastoma cerebr toxoplasmosi found patient show sever enceph numer microgli multinucl giant cell react posit antihiv antibodi develop wernick encephalopathi malign diseas catabol trend metabol immunodefici patient consecut thiamin defici consid princip pathogenet mechan"
"prognost factor aggress malign lymphoma descript valid prognost index identifi patient requir intens therapi group etud des lymphom agressif object studi determin prognost factor respons treatment freedomrelaps ffr surviv surviv aggress malign lymphoma patient treat doxorubicin cyclophosphamid vindesin bleomycin methylprednisolon methotrex leucovorin ifosfamid etoposid asparaginas cytarabin lnh regimen construct prognost index factor isol multivari analys valid prognost index set patient complet respons cr reach lnh patient relaps median follow month median ffr surviv median surviv reach low serum albumin level high tumor mass weight loss bone marrow involv greater equal extranod site increas lactic dehydrogenas ldh level low respons rate advanc stage increas ldh level nonlargecel histolog subtyp diffus mix lymphoblast small cleav statist high relaps rate short ffr surviv increas ldh level low serum albumin level tumor mass larger cm greater equal extranod site advanc stage age older year statist short surviv paramet ldh level stage number extranod site tumor mass put construct prognost index index partit lnh patient subgroup good intermedi poor prognosi cr rate relaps rate year ffr surviv year surviv prognost index appli test set patient patient treat protocol nebraska lymphoma studi group index patient year ffr surviv year surviv patient aggress lymphoma simpl prognost index distinguish patient requir intens treatment autolog bone marrow transplant complet remiss treat standard regimen"
"role dose intens determin outcom intermediategrad hodgkin lymphoma determin dose intens chemotherapeut regimen correl complet remiss rate adult patient advancedstag intermediategrad lymphoma report compar trial therapi review report identifi medlin refer review articl review select abstract twenti studi includ random cohort trial analyz assess project dose intens studi analyz assess role receiv dose intens dose intens calcul method correl complet remiss rate individu trial assess level evid metaanalysi random trial crosstrial analysi compar trial weight squar linear regress perform level evid support obtain hypothesi dose intens correl remiss rate trial dose intens indirect test studi direct test dose intens confound variabl includ aris assumpt made calcul dose intens exclud metaanalysi show relat probabl achiev complet remiss confid interv favor pool arm high dose intens crosstrial analysi show weak associ dose intens remiss rate report retrospect assess receiv dose intens suggest increas dose intens superior remiss rate analys suggest dose intens correl remiss rate advancedstag intermediategrad lymphoma proper design trial direct test dose intens perform confirm hypothesi"
"miller fisher syndrom system lupus erythematosus describ case miller fisher syndrom guillain barr variant complic system lupus erythematosus symptom sign mimick brainstem syndrom treatment high dose gamma globulin patient worsen requir mechan ventil plasma exchang patient improv"
"effect vitro electr stimul enhanc suppress malign lymphoma cell prolifer suppress enhanc prolifer mous el lymphoma cell vari signific cell electr stimul narrow rang lowlevel direct current platinum electrod suppress characterist observ narrow rang window direct current center approxim microa enhanc characterist observ broad rang lowlevel direct current approxim microa result prolifer eukaryot cell direct control stimul lowlevel direct current"
"common variabl immunodefici disord treatment case common variabl immunodefici rare disord present case complic presenc antiiga antibodi patient serum histori anaphylact reaction prior intraven infus gammaglobulin common variabl immunodefici heterogen group demonstr immunoglobulin defici common low level immunoglobulin isotyp inabl form antibodi antigen absenc gross defect cellmedi immun presenc recurr bacteri infect histori immunoglobulin defici treatment review primari therapi common variabl immunodefici gammaglobulin replac ancillari measur earli treatment infect antibiot import intraven gammaglobulin replac therapi prefer intramuscular replac therapi patient intramuscular dose limit volum minim local pain day achiev maxim blood level time situ degrad administ dose occur intraven gammaglobulin prepar unit state potenti advers effect intraven gammaglobulin infus precaut ensur safeti administr product discuss"
"broad neutral antibodi elicit hypervari neutral determin hiv publish erratum scienc jan princip neutral determin pnd human immunodefici virus hiv resid loop envelop protein antibodi elicit peptid region neutral divers isol serum anim immun human cell lymphoma virus htlviiimn pnd peptid rp neutral mn sequencediverg htlviiib isol serum anim immun amino acid iiib pnd peptid rp neutral isol character sera reveal crossneutr antibodi bound amino acid sequenc glyproglyargalaph gpgraf present isol sequenc frequent found pnds analyz random select hiv isol sera rabbit immun peptid gpgraf residu neutral diverg isol includ iiib mn"
"clinic aspect multipl sclerosi northeast scotland refer prognosi prognosi multipl sclerosi ms factor affect assess group patient repres unselect epidemiolog sampl observ northeast grampian region scotland period rang yrs diseas began age yrs age yrs remaind onset age yrs malefemal ratio diseas durat observ death patient yrs signific differ sex prognosi assess interv onset death degre disabl defin period time depend length follow quarter benign poor prognosi remitt relaps cumul progress start factor note affect prognosi prognosi signific independ sex earli onset yrs age retrobulbar neuriti brainstem lesion sensori symptom onset short durat initi symptom month long onset relaps interv greater yr remitt begin lack famili histori ms factor predict poor prognosi includ late onset greater yrs age progress start multipl site lesion initi cerebellar spinal cord lesion onset psychiatr persist urinari symptom onset yrs persist initi symptom yr earli relaps month famili histori ms social class status iv bilater prolong visual evok potenti vep latenc address childhood onset diseas csf ct brain scan predict"
"aid california famili medicin chang experi knowledg geograph distribut inform practic pattern specif acquir immunodefici syndrom aid obtain famili physician california mail survey data analyz counti group los angel counti counti standard metropolitan statist area counti standard metropolitan statist area comparison made data telephon survey conduct differ time analyz percentag physician treat refer patient aid doubl counti standard metropolitan statist area percentag physician report diagnos case aid tripl find suggest import aid famili medicin increas rapid rate addit survey result major survey lack aidsrel knowledg compet effect deal aid"
"search retrovir sequenc peripher blood mononuclear cell brain tissu multipl sclerosi patient dnas peripher blood mononuclear cell pbmcs patient multipl sclerosi ms patient tropic spastic paraparesi tsp dnas brain spinal cord ms case control examin human cell lymphotrop virus htlvrelat sequenc polymeras chain reaction primer deriv htlv gag env tax gene amplifi product separ agaros gel blot nylon membran hybrid specif radiolabel oligonucleotid sensit amplif hybrid copi target dna cellular genom specimen posit htlv sequenc tsp probe negat data signific brain materi ms patient studi studi fail support specul htlv involv aetiolog multipl sclerosi"
"brainstem auditori evok potenti multipl sclerosi relat vep sep csf immunoglobulin hundr patient multipl sclerosi ms analys retrospect respect investig brainstem auditori evok potenti baep pattern revers visual evok potenti vep somatosensori evok potenti sep cerebrospin fluid immunoglobulin csfig baep abnorm normal vep sep examin patient normal csfig chanc obtain abnorm ep lower patient normal csfig patient abnorm csf dispers ratio includ criteria baep abnorm sensit increas compar convent baep criteria recommend baep includ ep test batteri patient suspect ms"
"vascular bone marrow transplant vbmt induct stabl mix cell chimer transplant toler unmodifi recipi preliminari report model vbmt semiallogen barrier consist bring antigenspecif host toler absenc gvhd major recipi immunolog radiolog intervent util result emphas potenti import mechan lowlevel stabl mix lymphoid chimer smlc toler induct independ immun suppress effect due irradi immunopharmacolog intervent"
"hiv risk behavior reduct intervent key opinion leader popul experiment analysi background purpos peer norm influenc adopt behavior reduc risk hiv human immunodefici virus infect experiment interven communiti level modifi risk behavior norm promot general reduct hiv risk practic popul method train person reliabl identifi popular opinion leader gay men small citi serv behavior chang endors peer opinion leader acquir social skill make endors compli talk frequent friend acquaint intervent conduct survey men patron gay club intervent citi match comparison citi result intervent citi proport men engag unprotect anal intercours month period decreas percent percent percent baselin reduct percent percent percent baselin unprotect recept anal intercours relat baselin level percent increas condom anal intercours percent decreas proport men sexual partner chang observ men comparison citi period time conclus intervent employ peer leader endors chang produc acceler popul behavior lessen risk hiv infect"
"behavior health psychosoci factor risk hiv infect sexual activ homosexu men multicent aid cohort studi examin homosexu men engag recept anal intercours elev risk seroconvers possess specif behavior health psychosoci vulner characterist potenti factor examin heavi drink moder heavi drug younger age signific relat seroconvers variabl increas number sexual partner anonym sex failur condom"
"sexual risk behavior aid knowledg belief aid runaway sexual risk behavior knowledg acquir immunodefici syndrom aid belief aid prevent examin runaway previous month percent youth sexual activ sexual activ runaway male report median partner femal report partner percent report consist condom runaway demonstr moder high aid knowledg belief endors aid prevent condom abstin direct relat belief prevent aid"
"secur measur aid hiv studi describ measur aid surveil offic countri ensur secur inform patient aid hiv infect secur measur evalu cumul number aid case report partner notif servic provid hiv seroposit report requir studi show public health depart extra step ensur secur aid hiv data"
"anaphylact anaesthet reaction paper radioallergosorb test ige antibodi muscl relax thiopenton paper radioallergosorb test suxamethonium alcuronium thiopenton evalu suxamethonium radioallergosorb test employ cholin conjug paper disc prove reliabl detect allergi neuromuscular blocker confirm common anaphylact reaction general anaesthesia thiopenton radioallergosorb test recommend conjunct suxamethonium radioallergosorb test preliminari investig reaction patient posit suxamethonium radioallergosorb test requir test includ alcuronium radioallergosorb test skin test wide rang drug concentr leucocyt histamin releas test"
"allergeninduc asthmat respons relationship increas airway respons increas circul eosinophil basophil progenitor inflammatori respons allergeninduc asthma assess serial measur peripher blood eosinophil eo basophil eo progenitor cell eocfu group stabl asthmat individu beta agonist inhal provoc test allergen test total diluent serial blood sampl test methylcellulos cultur eocfu granulocytemacrophag gmcfu score day circul eo eocfu increas allergen inhal result increas histamin airway respons subject isol earli asthmat respons eo eocfu count chang chang gmcfu allergen ratio chang circul eocfu negat correl baselin histamin airway respons subject isol earli respons blood allergen develop increas histamin airway respons increas eo eo progenitor inhal allergen result subject allergeninduc increas histamin airway respons inflammatori respons occur includ increas number eo progenitor respons possibl mediat eo growth differenti factor lead accumul cell airway contribut airway inflamm present asthma"
"asthma elder comparison patient recent acquir longstand diseas character asthma elder consecut nonsmok pulmonari clinic patient age met american thorac societi criteria asthma identifi patient develop asthma advanc age greater yr group lateonset asthma durat diseas yr remain group earlyonset asthma durat ill yr day evalu patient underw pulmonari function test medic group indistinguish symptom medic requir hypersensit skin test aeroallergen uniform negat patient histamin control posit ige level group elder control subject earlyonset asthma greater likelihood previous allerg diseas signific greater degre airflow obstruct pre postbronchodil pulmonari function test studi suggest longstand asthma lead chronic persist airflow obstruct mimic chronic bronchiti emphysema copd"
"inhal alkalin aerosol subject mild asthma result bronchoconstrict recogn inhal acid aerosol subject asthma bronchoconstrict effect inhal alkalin aerosol unknown supplement inflat restraint automobil air bag deploy alkalin aerosol releas aerosol compos particl sodium carbon sodium bicarbon sodium hydroxid mass median aerodynam diamet mmad aerosol approxim micron ph aerosol group volunt male subject mild asthma inhal increas concentr aerosol min period mouth tidal ventil pulmonari function test perform baselin preexposur inhal room air control period inhal aerosol total subject inhal aerosol nomin concentr mgm subject inhal aerosol concentr approxim mgm fev specif airway resist sraw subject inhal higher concentr averag highest concentr mgm sem chang lung function clinic statist signific conclud inhal high concentr alkalin aerosol subject mild asthma result bronchoconstrict"
"respiratori membran permeabl bronchial hyperreact patient stabl asthma effect therapi inhal steroid patient stabl asthma assay plasma protein bronchoalveolar lavag fluid obtain inform plasma exud airway fourteen nonsmok patient asthma stabl period diseas nonsmok healthi volunt studi ratio concentr albumin ceruloplasmin cp alphamacroglobulin blood epitheli line fluid calcul cqalb cqcp cqam cqalb increas patient mannwhitney test patient bronchial hyperreact assess histamin provoc test signific relationship cqalb cqcp cqam hand pc hand found spearman rank correl fourteen patient treat inhal microgram glucocorticosteroid day month prospect studi exclud studi intercurr exacerb asthmat symptom therapi patient stabl asthma cqalb cqam decreas treatment inhal steroid wilcoxon match pair sign rank test result show patient stabl asthma increas plasma exud airway caus increas respiratori membran permeabl plasma exud correl bronchial hyperreact histamin decreas corticosteroid therapi"
"abnorm airway smooth muscl fatal asthma comparison trachea bronchus tracheal smooth muscl case fatal asthma demonstr increas contractil respons histamin acetylcholin electr stimul intrins cholinerg nerv impair relax isoproterenol possibl theophyllin evid fourth generat bronchial spiral patient studi result compar trachea normal bronchi contrast trachea contractil respons asthmat bronchi acetylcholin histamin cholinerg nerv stimul similar control bronchi potenc isoprenalin ic reduc fold similar trachea fold theophyllin respons normal discrep result obtain reflect differ diseas process includ rate postmortem chang anatom site"
"lack evid beta receptor select studi metaproterenol fenoterol isoproterenol epinephrin patient asthma order investig pharmacodynam select number betareceptor agonist asthma compar pulmonari extrapulmonari effect repeat inhal epinephrin fenoterol isoproterenol metaproterenol patient asthma random doubleblind crossov studi drug administ metereddos inhal min interv dose total dose puff compound measur heart rate blood pressur total electromechan systol measur inotrop respons qtc interv plasma potassium fev made min dose min final dose fenoterol metaproterenol signific greater inotrop electrocardiograph chronotrop hypokalem effect isoproterenol epinephrin differ bronchodil effect metaproterenol fenoterol isoproterenol agent caus signific greater increas fev epinephrin concept increas beta select metaproterenol fenoterol compar isoproterenol support clinic set"
"igemedi anaphylact degranul isol human skin mast cell isol human skin mast cell hsmc prepar cultur overnight function electron microscop studi mast cell suspens examin stimul antiig produc anaphylact degranul examin bufferincub control histamin releas measur replic sampl control isol hsmc studi electron microscopi preserv fulli granul granul pattern report human mast cell found crystal granul preval true hsmc situ individu mast cell crystal scroll granul occur lipid bodi rare hsmc situ control isol mast cell express granul piecem degranul recoveri wound heal situ morpholog anaphylact degranul present spontan histamin releas control sampl anaphylact degranul isol hsmc accompani maximum histamin releas characterist show extrus alter membranefre granul multipl pore plasma membran exterior cell morpholog aspect anaphylact degranul express isol human lung mast cell present event includ granul swell fusion alter matrix content degranul channel format pore format shed granul membran surfac process ultrastructur morpholog isol hsmc igemedi degranul show differ similar studi isol human lung mast cell human lung gut mast cell biopsi sampl differ includ crystal granul predomin granul pattern minor number lipid bodi extrus granul anaphylact degranul characterist hsmc contrast isol human lung gut mast cell scroll granul particl granul lipid bodi isol human lung mast cell anaphylact degranul exclus intracellular fusion event character format complex degranul channel alter granul matrix materi solubil addit morpholog differ mast cell skin lung gut origin function differ report mast cell organ ultrastructur morpholog isol hsmc ident skin mast cell biopsi sampl valid sourc hsmc correl function morpholog studi"
"evid graftversuslymphoma effect allogen bone marrow transplant exist immunolog antileukemia reaction allogen bone marrow transplant bmt establish similar graftversustumor effect lymphoma demonstr analyz result bmt consecut patient relaps hodgkin diseas aggress hodgkin lymphoma patient year age hlamatch donor allogen marrow transplant patient receiv purg autolog graft median age year allogen autolog graft recipi patient respons convent salvag therapi transplant factor influenc eventfre surviv bmt patient respons salvag therapi bmt type graft signific influenc probabl relaps bmt actuari probabl relaps patient respond convent salvag therapi bmt allogen bmt compar autolog bmt actuari probabl eventfre surviv year versus patient respons lymphoma receiv allogen autolog transplant benefici antitumor effect allogen bmt offset higher transplantrel mortal larg result graftversushost diseas allogen bmt induc clinic signific graftversuslymphoma effect magnitud effect similar report leukemia"
"clinic assess ankylos spondyl studi observ variat spinal measur twenti measur repeat sequenti patient observ undertaken determin reliabl routin clinic measur signific interobserv variat coeffici reliabl greater cervic rotat cervic flexion tragus wall distanc fingertip floor distanc sagitt flexion iliac crest line distract modifi schober index conclud measur statist unreli clinic unhelp mild moder ankylos spondyl clinic cervic rotat protractor cervic flexion goniomet thoracolumbar flexion iliac crest line distract thoracolumbar flexion fingertip floor distanc modifi schober index"
"cytomorpholog immunocytochem nucleic acid flow cytometr studi lymph node fineneedl aspir comparison result obtain subsequ excision biopsi fifti patient clinic suspect previous diagnosi lymphoma underw fineneedl aspir fna subsequ excision biopsi lymph node result cytolog diagnosi made direct smear conjunct immunocytochem studi cytospin prepar nucleic acid flow cytometr studi fcm compar result obtain histolog section cryostatimmunohistochem studi nucleic acid fcm perform resect lymph node studi demonstr result immunocytochem dnafcm analysi fnaderiv materi compar major case obtain surgic specimen immunostain cytospin prepar immunoglobulin ig background stain case easier interpret perform frozen section monotypia fna conjunct cytomorpholog studi specif lymphoma polytyp stain ig exclud hd cell lymphoma cell malign focal involv lymph node"
"fludarabin therapi hairi cell leukemia studi evalu efficaci fludarabin adenin nucleosid analogu typic variant form hairi cell leukemia hcl patient hcl patient variant form hcl hclvariant resist progress diseas prior treatment studi fludarabin mgm administ intraven minut daili day month patient hcl hclvariant achiev partial respons patient minor respons report encourag activ fludarabin typic variant form hcl experi fludarabin disord"
"human immunodefici virusinfect macrophag produc solubl factor histolog neurochem alter cultur human brain establish vitro human model aid dementia pursu hypothesi diseas process result solubl factor produc hivinfect macrophag human brain aggreg prepar brain specimen treat supernat vitro hivinfect macrophag si uninfect macrophag su infect cell macrophagecondit media aid patient treat brain expos si show peripher rarefact wk incub ultrastructur analysi show cytoplasm vacuol aggreg brain cultur treat si wk smaller approxim decreas size degre appar toxic brain expos patientderiv macrophag supernat parallel proport macrophag found express hiv ultrastructur abnorm observ brain treat supernat hivinfect cell uninfect macrophag lpsactiv macrophag level neurotransmitt amino acid decreas comparison structur amino acid leucin find suggest hivinfect macrophag infect vitro deriv aid patient peripher blood produc factor reproduc histochem ultrastructur function abnorm human brain aggreg"
"limit cell repertoir sever combin immunodefici mice engraft peripher blood mononuclear cell deriv immunodefici normal human abil engraft human pbmc fetal tissu immun cell sever combin immunodefici scid mous creat character system applic diseas model demonstr scid mice reconstitut pbmc support growth differenti restrict set cell human igg level mgml normal human serum level routin achiev spite serum half life ig level peak ig product maintain greater ig greater igg igm iga igd ige detect human igg produc hupblscid mice pauciclon analyz isoelectr focus kappalambda light chain usag polymeras chain reaction base analysi capabl monitor individu vh famili util found engraft cell show skew restrict human vh subfamili util paramet mark variabl hupblscid mice reconstitut donor cell popul earli late stage greater hupblcviscid mice construct cell patient common variabl immunodefici vitro block termin cell differenti produc human ig respons quantit produc hupblscid mice normal donor hupblscid system pbmc lead growth ig product small number cell result restrict cell repertoir"
"effect thromboxan receptor antagonist aa bronchial hyperrespons methacholin subject asthma bronchial hyperrespons bhr stimuli major clinic featur bronchial asthma studi effect thromboxan txa receptor antagonist aa bhr methacholin evalu patient asthma methacholin inhal test perform oral administr aa day mgday provoc concentr methacholin produc fall fev pc measur index bhr signific increas pc geometr sem mgml geometr sem mgml mgday aa baselin valu fvc fev chang treatment twenti milligram day aa alter pc paramet baselin pulmonari function find support hypothesi subthreshold concentr txa bronchial tissu effect bronchomotor tone se involv bhr asthma studi potent specif txa receptor antagonist confirm conclus"
"secret granul protein eosinophil neutrophil increas asthma activ eosinophil neutrophil granulocyt respect secret granul protein studi patient asthma vari sever diseas granulocyt stimul serumopson sephadex particl releas amount eosinophil cation protein ecp eosinophil protein epx myeloperoxidas measur specif radioimmunoassay eosinophil patient asthma releas signific ecp epx minut incub cell control subject asthma releas myeloperoxidas neutrophil higher serum concentr ecp epx signific increas group asthma signific relationship found clinic variabl secretori activ eosinophil neutrophil conclud eosinophil extent neutrophil subject asthma increas propens releas granul protein suggest consequ prime cell"
"fooddepend exerciseinduc anaphylaxi studi japanes case eleven patient fooddepend exerciseinduc anaphylaxi studi patient experienc anaphylact symptom eat food shellfish wheat grape exercis remain patient specif food identifi act eat predispos anaphylaxi anaphylact symptom distinguish cholinerg urticaria histori patient develop anaphylact symptom year age atop atop degre relat patient increas serum ige level ige antibodi causat food allergen detect skin prick test rast case contrast patient develop symptom year age atop background ige level normal rang case patient group develop symptom ingest food made wheat exercis patient sensit wheat determin skin prick test patient rise plasma histamin concentr observ exercis challeng treadmil food intak exercis induc increas patient"
"modern haemophilia treatment medic improv qualiti life adequ replac therapi haemophilia decad led improv life expect physic status haemophilia patient studi conduct investig led improv qualiti life aim inform obtain dutch haemophiliac mail questionnair relationship marriag famili life employ haemophilia patient marri men general popul fewer lower total number children lower marri twenti cent patient employ receiv incom disabl fund sever haemophilia joint damag age increas risk disabl note home treatment reduct risk remark haemophilia patient differ general popul view qualiti health result studi show posit influenc modern haemophilia treatment qualiti life present aid overshadow optimist feel field result demonstr benefit achiev adequ replac therapi justifi expect improv futur"
"mriguid stereotax brain biopsi neurolog symptomat aid patient patient aidsrel neurolog dysfunct evalu comput tomograph ct brain scan magnet reson imag mri ct scan essenti normal patient mri reveal focal lesion amen brain biopsi newli develop instrument mriguid stereotax brain biopsi perform complic benefit impact technolog care neurolog symptomat aid patient discuss"
"multicent profici trial gene amplif pcr detect hiv sensit specif polymeras chain reaction pcr detect hiv provir dna determin laboratori extens experi pcr test panel consist hivseroneg specimen regular repeat blood donor risk factor hiv infect hivseroposit cultureposit specimen cohort homosexualbisexu men code laboratori amplif procedur test algorithm specimen judg posit negat indetermin vari laboratori averag sensit laboratori laboratori achiev averag specif vari falseposit rate falseneg rate indetermin rate determin made laboratori misclassif classif error occur specimen uninfect individu distribut laboratori laboratori error inher reactiv sampl emphas standard pcr test caution interpret posit pcr reaction hivseroneg person"
"serial cd lymphocyt count develop aid low cd lymphocyt count increas risk progress aid human immunodefici virus hiv infect investig extent time progress aid explain sole term declin cd lymphocyt count haemophiliac year infect hiv median cd lymphocyt count made patient appli simpl linear model declin cd lymphocyt count time estim date develop aid patient determin patient correct classifi develop aid jan model result suggest differ time patient hiv progress aid larg explain differ rate declin cd lymphocyt count"
"canadian cooper trial cyclophosphamid plasma exchang progress multipl sclerosi canadian cooper multipl sclerosi studi group find specif immunosuppress benefici multipl sclerosi ms randomis placebocontrol singlemask trial carri univers centr patient clinic laboratorysupport definit ms progress phase deterior expand disabl status scale edss previous year randomis receiv intraven cyclophosphamid oral prednison daili oral cyclophosphamid altern day prednison week week plasma exchang week placebo medic sham plasma exchang patient month month monitor neurologist awar treatment alloc evalu neurologist primari analysi comparison rate treatment failur worsen evalu neurologist assess edss consecut month assess signific differ group primari analysi treatment failur cyclophosphamid plasma exchang placebo differ proport improv stabilis worsen month assess chang edss final assess cyclophosphamid plasma exchang placebo slight trend favour plasma exchang group month follow sustain final assess studi fail confirm previous report immunosuppress treatment result stabilis improv progress ms"
"unusu amyloid polyneuropathi predomin lumbosacr nerv root plexus involv report year patient progress asymmetr peripher neuropathi distal lower limb imag studi show enlarg lumbosacr root plexus proxim sciatic nerv sacral plexus biopsi reveal amyloidosi endoneuri edema immunohistochemistri antiprealbumin serum amyloid immunoglobulin light chain antisera fail label amyloid"
"aminosteroid inhibit stimul monocyt hydrogen peroxid chemiluminesc measur ms patient control monocyt recruit activ site multipl sclerosi ms demyelin promot local tissu injuri generat inflammatori respons mediat part product toxic oxygen metabolit corticosteroid frequent effect amelior ms exacerb inadequ knowledg mechan assess effect aminosteroid ua class steroid deriv glucocorticoid mineralocorticoid effect product hydrogen peroxid ho chemiluminesc stimul monocyt harvest stabl ms patient age sexmatch control ho measur chemiluminesc signific reduc group ua result demonstr aminosteroid reduc product toxic oxygen metabolit monocyt inflammatori potenti suggest agent potenti effect safe treatment ms exacerb"
"human immunodefici virusinfect multinucl histiocyt oropharyng lymphoid tissu asymptomat patient human immunodefici virus hivinfect multinucl giant cell previous detect central nervous system hivposit patient report case infect cell observ central nervous system oropharyng lymphoid tissu tonsil adenoid remov individu asymptomat homosexu men follicular hyperplasia interfollicular multinucl giant cell contact close proxim mucous membran posit lysozym alpha antichymotrypsin okm protein accord histiocyt origin situ hybrid hiv envelopespecif rna probe demonstr presenc viral rna multinucl giant cell find support role peripher histiocyt primari virus reservoir earli diseas underlin potenti role oropharyng tissu primari target case"
"earli cellular event evolv cutan delay hypersensit human delayedtyp hypersensit reaction dhr human skin prototyp inflammatori dermatos cellular event preced gross lesion format unknown studi inflammatori cell popul adhes molecul express earli phase dhr elicit dinitrochlorobenzen evalu discern event hour mast cell degranul induct endotheli leukocyt adhes molecul elam express dermal postcapillari venul hour endotheli leukocyt adhes molecul express peak hour declin hour contrast endotheli express intercellular adhes molecul icam remain constitut level intrafollicular cell migrat occur independ icam express commenc earli hour challeng matur activ cdposit lymphocyt express helperinducermemori phenotyp predomin earli lesion result demonstr vivo mast cell degranul elam express memori cellfollicular interact key event subclin evolutionari stage cutan dhr"
"lack benefit methotrex sever steroiddepend asthma doubleblind placebocontrol studi object determin effect lowdos methotrex asthmat patient steroid asthma symptom score pulmonari function airway reactiv blood cellular compon immunoglobulin level design random doubleblind parallel placebocontrol week clinic trial follow patient open trial methotrex conclus doubleblind studi set asthma care outpati clinic patient februari march patient sever steroiddepend asthma enrol studi patient exclud analysi intervent patient administ methotrex placebo intramuscular assur complet absorpt week week studi result patient methotrex placebo signific decreas steroid dose ci ci pulmonari function differ signific methotrex placebo group addit airway reactiv symptom score unchang methotrex placebo signific toxic week blind studi patient methotrex prednison follow period develop pneumocysti carinii pneumonia die continu methotrex year increas methotrex mg week signific benefit methotrex asthma control shown conclus studi support methotrex treatment sever asthma"
"treatment multipl sclerosi hyperbar oxygen result nation registri hundr twelv patient enter longterm studi effect hyperbar oxygen multipl sclerosi protocol call initi treatment monoplac multiplac chamber daili basi month booster treatment year hundr seventi neurologist institut provid data studi control group studi base schumach postul scientif valid studi test efficaci therapi choos patient definit diagnos multipl sclerosi year impos treatment overwhelm major subject fail wors year observ period efficaci treatment manifest expand kurtzk disabl status scale edss assess sever diseas state dropout rate high patient finish initi treatment twenti percent finish year booster therapi complet year month booster deterior kurtzk edss score full step begin treatment evalu differ outcom shortest longest period time onset symptom hyperbar oxygen treatment treatment pressur made differ outcom kurtzk edss score bore relationship booster treatment patient onset treatment initi kurtzk edss score deterior averag kurtzk point patient initi kurtzk edss score greater deterior averag point interest patient report temporari improv bladder function improv maintain patient year follow fifteen patient longterm worsen signific chang work status patient hyperbar oxygen treatment studi treat patient accord protocol report produc benefit multipl sclerosi unabl substanti longterm effect hyperbar oxygen therapi"
"preval hiv infect kagera region tanzania populationbas studi populationbas survey carri kagera region unit republ tanzania determin magnitud hiv infect studi risk factor region divid urban rural zone multistag cluster sampl techniqu adopt antibodi hiv determin enzymelink immunosorb assay confirm western blot analysi total adult age year children age year studi preval hiv infect adult higher preval urban zone rural zone figur children urban area rural area agespecif seropreval adult highest age group year agestandard sexspecif preval higher women men urban zone rural zone chang sexual partner adult increas risk hiv seroposit travel region countri found increas risk hiv infect rural popul"
"evolutionari dynam hiv quasispeci develop immunodefici diseas paper present theori explain develop immunodefici diseas long variabl incub period infect hiv assumpt central theori mutat revers transcript viral replic generat viral strain resist neutral antibodi specif earlier mutant host virus kill cdposit lymphocyt play role mount immunolog attack direct virus theori examin develop mathemat model reveal increas number antigen distinct viral strain overwhelm immun system host viral divers increas level immun system unabl suppress popul growth strain simultan intuit explan pattern model behaviour lie assumpt virus kill cdposit lymphocyt specif viral strain lymphocyt direct immunolog attack singl viral strain"
"cohort studi hivinfect adult patient contamin blood product bordeaux group epidemiologi cliniqu du sida en aquitain gecsa publish erratum aid mar hospitalbas surveil hiv infect implement bordeaux region univers hospit franc report system initi group epidemiologi cliniqu du sida en aquitain identifi adult patient transfus hiv infect report case contamin occur august june diagnosi made june patient fullblown aid die follow period month month incub period time interv contamin transfus develop fullblown aid month median month confid interv ci month year contamin cumul probabl reach aid stage ci probabl surviv ci surveil system estim southwestern franc end cumul incid transfus hiv infect case million inhabit anticip increas transfus aid case year report contamin august systemat screen hiv antibodi implement french blood bank confirm efficaci screen countri franc risk contamin blood product minim"
"recombin human granulocytemacrophag colonystimul factor combin standard induct chemotherapi de novo acut myeloid leukemia base vitro data suggest recombin human granulocytemacrophag colonystimul factor rhgmcsf capabl stimul acut myeloid leukemia aml blast cell sensit cellcyclespecif drug conduct phase ii studi de novo aml patient pts rhgmcsf microgramsm continu intraven infus administ pts suffer de novo aml combin standard induct chemotherapi daunorubicin mgm day cytosinearabinosid ara mgm continu infus day gmcsf start hour chemotherapi prephas pts pts high white blood cell count wbc rhgmcsf start chemotherapyinduc cell reduct wbc mm prephas gmcsf induc increas neutrophil blast cell count pts vivo recruit leukem cell drugsensit phase cell cycl demonstr multiparamet cellcycl analys peripher blood bone marrow specimen day complet aplasia evid pts gmcsf administ recoveri chemotherapyinduc myelosuppress absolut neutrophil count anc greater mm fifteen pts achiev complet remiss cycl shorter durat neutropenia evid pts compar histor control anc greater mm day pts achiev complet remiss cycl combin rhgmcsf pts die bone marrow aplasia invas pulmonari aspergillosi clinic side effect possibl relat gmcsf fever diarrhea weight gain mild toler world health organ toxic grade equal rhgmcsf recruit kinet quiescient aml cell vivo enter drugsensit phase cell cycl promot earli myeloid recoveri aplasia exposur standard induct chemotherapi aml"
"express fgr hck proteintyrosin kinas acut myeloid leukem blast earli commit differenti event monocyt granulocyt lineag member src protooncogen famili intracellular tyrosin kinas fgr hck select express differenti myeloid cell studi express gene acut myeloid leukemia aml determin specif myeloid lineag stage myeloid differenti express gene acquir seri case de novo aml differenti model level fgr hck fms encod colonystimul factor receptor mrna transcript correl presenc specif cell surfac antigen morpholog cytochem featur aml blast undifferenti leukem myeloblast hladr cd cd cd cell surfac immunophenotyp frenchamericanbritish fab character lack fms fgr express low level fms fgr detect undifferenti myeloblast fab express cd low antigen densiti hck transcript undetect cell express low level contrast hck mrna transcript identifi blast progranulocyt morpholog fab fms fgr hck express high level blast differenti myelomonocyt monocyt featur fab fms fgr hck transcript evid leukem cell erythroid lineag fab undifferenti leukem myeloblast hladr cd cd induc differenti vitro cell monocyt characterist express fms fgr cd cell surfac antigen induc high level accompani acquisit hck cd express contrast hladr cd cd blast induc differenti vitro cell granulocyt characterist hck cd express induc data suggest acquisit fgr hck express earli commit differenti event distinct myeloid lineag assess express kinas provid molecular tool assign lineag aml conjunct morpholog cytochemistri cell surfac antigen express"
"macrophag colonystimul factor csf gene express human lymphocyt clone macrophag coloni stimul factor csf cytokin control differenti surviv prolifer monocyt macrophag set human cell clone chosen phenotyp divers test abil express csf mrna hour stimul phorbol myrist acet pma calcium ionophor cal cell clone express major kb transcript abund kb transcript minor speci pattern express typic csf mrnas alloreact cell clone analyz show definit messag csf specif antigen stimul delay kinet effici condit stimul induc releas csf protein cell cultur medium find demonstr time normal cell produc csf previous report limit case tumor cell cell lineag"
"loss interferon antibodi prolong continu interferonalpha therapi hairi cell leukemia high activ hairi cell leukemia hcl interferon ifn curat diseas current data prolong ifn therapi control diseas major patient previous observ acquir ifn resist associ neutral ifnalpha antibodi small number patient hcl find suggest requisit longterm therapi compromis increas incid time neutral antibodi perform follow studi ifn antibodi patient receiv continu ifn therapi patient previous antibodi negat remain surpris patient previous neutral ifn antibodi antibodi negat median month patient neutral antibodi antibodi negat neutral antibodi median month time neutral antibodi detect patient persist neutral antibodi inhibit neopterin synthesi inhibit generat oligoadenyl synthetas activ inabl detect ifn serum subcutan inject ifnalpha observ patient test neutral ifn antibodi confirm antibodi function signific vivo conclud neutral ifn antibodi inhibit effect ifn vivo antibodi produc transient longterm therapi longterm effect drug affect patient neutral antibodi"
"effect tamoxifen cell line display multidrugresist phenotyp examin effect tamoxifen tmx verapamil daunorubicin dnr cell line display multidrugresist mdr phenotyp laser flow cytometri quantit intracellular dnr content vinblastineresist human lymphoblast lymphoma cell line cemvbl simultan incub dnr tmx mumol tmx mumol increas intracellular dnr fluoresc dosedepend manner demonstr uptak pattern similar dnr verapamil similar result obtain vincristineresist human myeloid leukemia cell line hlrv cellular retent dnr measur cell line result suggest continu exposur cell tmx result higher intracellular dnr content compar cell resuspend fresh medium effect tmx verapamil observ drugsensit parent cell line cem hl clonogen experi perform determin tmx inhibitori cell growth tmx potenti dnr cytotox tmx mumol signific inhibit cemvbl hlrv cell hour exposur cultur methylcellulos tmx mumol signific inhibitori cell line cell incub dnr tmx mumol demonstr mark increment growth inhibit compar cell incub dnr tmx mumol base data present suggest clinic test tmx dnr pursu set mdr play role"
"rapid simultan detect multipl retrovir dna sequenc polymeras chain reaction capillari dna chromatographi polymeras chain reaction pcr techniqu power tool amplifi target dna sensit detect specif nucleic acid sequenc import potenti pcr involv screen donat blood suppli transfusiontransmit virus realiz goal limit requir multipl discret pcr reaction amplifi detect target sequenc virus lack rapid nonhazard specif detect pcramplifi product report simultan amplif distinct target sequenc discern loss sensit singl target sequenc demonstr rapid separ detect pcramplifi viral dna autom capillari dna chromatographi amplifi dna peak initi identifi scan capillari effluent ultraviolet wavelength discrimin human immunodefici virus type human cell leukem virus type pcramplifi dna accomplish virusspecif fluoresc label primer probe result progress autom system screen blood suppli nucleic acid sequenc multipl pathogen"
"detect earli human cell lymphotrop virus type antibodi pattern seroconvers transfus recipi cohort human cell lymphotrop virus type htlv expos transfus recipi enrol jamaican transfus studi select detail laboratori evalu recipi month interv month bimonth year evid htlv seroconvers regard result screen assay pretransfus posttransfus sampl test licens htlv virus screen enzym immunoassay eia recombin eia antibodi tax px pe envelop standard virus western blot wb wb enhanc recombin pe radioimmunoprecipit assay ripa earli period posttransfus antibodi gag core protein predomin antip general antip recombin antip envelop protein eia wb format frequent earliest envelop reactiv detect antigp wb antigp ripa system antitax antibodi time seroconvers virus eia sensit confirmatori assay combin wb ripa wb enhanc recombin pe equal effect confirm sampl posit public health servic gene group confirmatori algorithm specif assay approach address studi"
"reduct budesonid year increas random control trial evalu improv airway respons clinic asthma maintain demonstr recent year regular inhal budesonid produc substanti improv airway respons accompani signific improv clinic asthma sever present studi design evalu improv maintain dose budesonid reduc end origin studi subject asthma activetreat arm studi random continu dose budesonid origin studi dose reduc airway respons methacholin bronchodil requir symptom spirometri assess week month month subject experienc asthma exacerb evid chang airway respons subject steroid reduc provoc concentr caus drop fev initi mgml final mgml chang chang subject maintain higher dose initi mgml final mgml similar evid chang bronchodil requir month reduc steroid small declin spirometri fev percent predict initi final chang signific chang subject steroid reduc initi final month symptom predomin sputum product begin redevelop reduc budesonid group"
"environment exposur cockroach allergen analysi monoclon antibodybas enzym immunoassay quantit site monoclon antibodi mabbas enzymelink immunoassay cockroach cr allergen bla bla ii develop measur allergen level housedust sampl dust collect crinfest home patient asthma charlottesvill va demonstr wide variat level bla depend locat dust collect dust kitchen floor cabinet fold allergen gm dust dust bedroom upholst furnitur gm hundr forti dust sampl collect bedroom live room children asthma control subject asthma live atlanta ga twenti home children asthma control subject detect bla gm dust bla ii level assay kitchen bedroom live room sampl home wilmington del highest level bla ii detect kitchenfloor dust gm dust addit approxim home visual evid cr infest signific level bla ii dust sampl greater gm dust result demonstr cr occult allergen home kitchen primari site crallergen accumul signific crallergen level found site home mabbas assay quantit environment exposur cr allergen"
"bronchoalveolar lavag fluid mediat level minut allergen challeng atop subject asthma relationship develop late asthmat respons inflammatori mediat implic pathogenesi human asthma demonstr increas bronchoalveolar lavag fluid time asthmat respons iar allergen instil lung relationship mediat measur earli late asthmat respons lar airway reactiv clinic asthma unknown present studi evalu mediat level bronchoalveolar lavag fluid minut allergen challeng subject group atop subject asthma atop subject asthma lar lar atop subject asthma lar lar subject asthma differenti subject lar base decreas fev hour postallergen inhal mediat prostaglandin thromboxan leukotrien ltc histamin measur allergen instil baselin prechalleng level similar case ltc ltc detect baselin signific frequent atop subject asthma lar subject compar atop subject asthma detect versus detect group signific increas mediat level observ group asthma postallergen challeng compar atop subject asthma atop subject asthma lar signific higher level mediat challeng atop subject asthma lar atop subject asthma"
"airway effect inhal bradykinin substanc neurokinin sheep effect inhal bradykinin bk substanc sp neurokinin nka pulmonari resist airway respons carbachol studi conscious allerg sheep inhal bk breath mgml caus dosedepend increas pulmonari resist inhal sp nka breath mgml produc signific bronchoconstrict allerg sheep respons sp enhanc pretreat neutral endopeptidas inhibitor thiorphan breath mgml sheep allerg ascari suum antigen time sensit constrictor effect bk nonallerg sheep bkinduc bronchoconstrict block dosedepend fashion bk beta receptor antagonist npc argininehydroxyprolinephenylalaninebk atropin mgkg intraven nedocromil sodium mgkg ml salin aerosol signific inhibit bkinduc bronchoconstrict chlorpheniramin mgkg intraven effect nka caus transient increas airway respons allerg sheep produc fold leftward shift doserespons curv aerosol carbachol hyperrespons evid hour nka challeng sp bk chang airway respons allerg sheep inhal bk caus pronounc bronchoconstrict observ nonallerg sheep bronchoconstrict block bkreceptor antagonist partial mediat cholinerg reflex"
"comparison cockroach allergen activ bodi fecal extract previous studi establish cockroach allergen import sensit agent inductionexacerb urban asthma present investig compar salin extract american cockroach periplaneta americana bodi fece german cockroach blattella germanica bodi fece import sourc allergen extract test gel filtrat sephadex column fraction previous skin test studi subject asthma extract american german cockroach demonstr signific correl reactiv bodi fecal extract speci direct rast sera cockroach skin testposit subject general greater german bodi extract gwbes german fecal extract gfes compar american bodi fecal extract good correl rast reactiv gwbe gfe rast inhibit demonstr gfe allergen activ present gwbe studi demonstr allergen similar cockroach bodi fecal extract suggest cockroach fece import sensit agent atop asthma"
"analys microvascular permeabl respons mediat hypersensit mediatorinduc microvascular permeabl studi rodent skin monitor evan blue dye iodin rat albumin igg tritiat neutral dextran molecul molecular radii intraderm inject serotonin histamin bradykinin degre radiolabel tracer efflux determin measur extent blue level radioact skin biopsi specimen mediat vari potenc molar basi serotonin greater bradykinin greater histamin efflux result similar kinet studi reveal vasoact agent caus mark transient increas macromolecular permeabl minut determin pore size creat effect charg transud macromolecul interstitium fraction neutral hdextran molecular size averag radii nm infus singl combin ilabel rat albumin igg intraderm inject serotonin histamin bradykinin compound mediat differ demonstr macromolecular efflux molecular size charg tracer mediat hypersensit reaction studi produc venular gap greater nm addit display similar vasoperm characterist"
"administr il mice cyclophosphamideinduc lymphopenia acceler lymphocyt repopul lymphopenia induc mice singl inject cyclophosphamid il control protein administ mice daili cellular composit spleen lymph node bone marrow thymus determin time point comparison control cyclophosphamidetr mice anim receiv cyclophosphamid il acceler regener splenic lymph node cellular signific differ rate recoveri bone marrow thymus control iltreat mice assess pre cell compart reveal dramat increas total pre cell number spleen bone marrow iltreat mice measur flow microfluorimetri pre cell colonyform assay day signific increas surfac igm cell number level normal valu spleen lymph node il administr cyclophosphamidetr mice result acceler recoveri peripher cd cd cell number spleen lymph node number cd cell increas twofold normal level cyclophosphamidetr mice receiv il myeloid recoveri determin cyclophosphamid treat mice assess number cfugranulocytemacrophag mac cell signific differ myeloid recoveri cyclophosphamidetr mice receiv il control protein result suggest administr il chemicalinduc lymphopenia therapeut benefit shorten period requir achiev normal lymphoid cellular"
"direct identif putat surfac igm receptor molecul encod murin cellspecif mb gene cellspecif mb gene recent report encod putat surfac glycoprotein cd structur properti hombach al suggest present evid show mb gene encod kda membran glycoprotein igmalpha igmr molecul identifi mb gene product direct cell affinitypurifi mbspecif antibodi prepar immun rabbit synthet mb oligopeptid immunoprecipit combin dimension diagon gel electrophoresi analysi reveal antibodi detect cellspecif surfac glycoprotein similar igmalpha protein hombach al mb protein exist monomer form surfac cell contrast igmalpha detect dimer igmalphaigmalpha igmalphaigbeta protein found mb protein express sigm pre cell lymphoma suggest altern function role cellspecif mb protein cell differenti molecular ident mb protein igmalpha discuss"
"preval allerg bronchopulmonari aspergillosi patient asthma determin serolog radiolog criteria patient risk allerg bronchopulmonari aspergillosi hitherto uncommon potenti crippl complic asthma occur unknown preval unit state modern serolog criteria complet histori asthma radiolog find make diagnosi allerg bronchopulmonari aspergillosi consecut patient asthma cutan reactiv aspergillus fumigatus outpati set problem comprehens criteria diagnosi discuss"
"major histocompat gene product human immunodefici virus infect present paper analyz role major histocompat gene product human leukocyt antigen pathophysiolog acquir immunodefici syndrom associ found human leukocyt antigen hla frequenc human immunodefici virus type hiv infect signific associ report popul hla haplotyp opportunist infect secondari cancer regard human leukocyt class antigen role restrict element present hiv virusspecif cytotox lymphocyt establish increas serum level solubl form correl diseas stage demonstr circul molecul interfer immun respons hiv contribut develop immunodefici antigen similar detect human leukocyt class ii antigen hiv envelop protein homolog explain presenc hivposit sera antihla class ii antibodi mediat lysi cdhla class ii cell falseposit reaction hivneg sera antihla class ii antibodi test hiv antibodi reduc level complement factor human leukocyt class iii antigen detect hivinfect subject defect play role progress diseas affect clearanc hiv complementmedi antibodi respons data report review suggest hla antigen involv step immun defici hivinfect subject contribut pathophysiolog acquir immunodefici syndrom"
"studi rp taxoter semisynthet analogu taxol rp taxoter semisynthet analogu taxol potenti import chemotherapeut agent treatment cancer report drug potent inhibitor cell replic taxol promot vitro assembl stabl microtubul absenc guanosin triphosph induc microtubulebundl format cell compar taxol rp slight activ promot tubulin polymer inhibitor cell replic rp fold potent taxol cell fold potent taxolresist cell"
"aid adolesc reduc risk aid adolesc case problem increas import unit state infect human immunodefici virus hiv exist high school univers campus present real threat teenag american engag drug abus sexual activ appropri target educ effort limit hiv transmiss adolesc adolesc awar highrisk activ lead hiv transmiss alter sexual behavior avoid aid import move impart knowledg aid transmiss move chang riski behavior strategi aid risk reduct adolesc implement countri support intervent urgent adolesc high risk"
"human immunodefici virus transmiss child sexual abus children test posit human immunodefici virus hiv duke univers durham nc pediatr acquir immunodefici syndrom team confirm sexual abus sexual abus child evalu mode hiv transmiss children pathway identifi studi children acquir hiv child sexual abus abus sourc transmiss child sexual abus frequent proven mode acquisit hiv popul proven mode acquisit vertic transmiss hivcontamin blood transfus twelv male identifi suspect perpetr knew hiv time assault awar child hiv time assault indic child safe sex precaut observ children hiv infect multipl risk factor abus neglect sociolog descriptor live abus children show multipl risk factor sexual abus overlap risk factor sequela acquisit hiv infect includ drug abus alcohol home prostitut parent lack parent poverti chronic ill child prevent effort recogn children adult risk sexual transmit hiv infect"
"anaphylaxi annatto dye case report annatto dye orangeyellow food color extract seed tree bixa orellana common chees snack food beverag cereal previous report advers reaction annatto dye includ urticaria angioedema present patient develop urticaria angioedema sever hypotens minut ingest milk fiber cereal annatto dye subsequ skin test milk wheat corn negat patient strong posit skin test annatto dye control respons nondialyz fraction annatto dye sdspage demonstr protein stain band rang kd immunoblot demonstr patient igespecif band control show bind annatto dye contamin residu seed protein patient develop ige hypersensit annatto dye potenti rare anaphylaxi"
"relationship skin prick test radioallergosorb test chemiluminesc assay allerg children result skin prick test spt radioallergosorb test rast multipl chemiluminesc test dhscla grass mix parietaria farina pteronyssinus evalu allerg children cla test valid posit negat control thread chemiluminesc assay class match rast class cla class rast class  farina pteronyssinus grass result obtain cla rast spt investig princip compon analysi show good associ method measur allergen result present studi confirm dhscla effect vitro method detect igeallergen specif antibodi"
"cluster fungal allergenspecif ige antibodi respons allerg subject statist analysi specif ige immun respons panel allergen patient demonstr signific cluster aspergillus fumigatus alternaria alternata cladosporium herbarum explain crossreact element repres link high respond status fungal antigen allerg popul"
"inhal bronchodil asthma low high dose studi effect regular inhal lowdos highdos fenoterol lowdos highdos combin fenoterol ipratropium bromid mainten treatment adult moder sever asthma doubleblind random parallel group design compar week treatment regimen fenoterol microgramsdos fenoterol microgramsdos fenoterol microgram ipratropium microgramsdos singl inhal berodu fenoterol microgram ipratropium microgramsdos singl inhal duovent baselin activ treatment period patient record pefr morn symptom rescu inhal daili peak expiratori flow rate asthma symptom show signific differ treatment regimen week compar baselin period rescu inhal differ group activ treatment patient assess efficaci activ treatment favor lowdos fenoterol lowdos combin side effect record highdos combin group week compar group conclud mainten therapi chronic asthma high dose fenoterol combin ipratropium bromid offer clinic advantag low dose contrari lowdos fenoterol lowdos combin accept toler patient"
"treatment career attitud prehospit care provid potenti exposur hivaid career treatment attitud relat potenti human immunodefici virus acquir immunodefici syndrom hivaid exposur report base survey maryland career volunt prehospit care provid train provid basic bls advanc al life support sixti percent state potenti exposur hivaid major occup stressor nineti percent state treat hivaid patient protect choic avoid provid treatment hivaid patient eighteen percent consid resign emerg medic servic em work attitudin scale aidstress develop evalu treatment career reaction respond signific higher negat reaction aidstress score bls provid men paid provid personnel year field experi work urban area personnel formal educ high school state hivaid train inadequ implic find qualiti care career decis make inservic educ discuss"
"identif function distinct domain human granulocytemacrophag colonystimul factor monoclon antibodi granulocytemacrophag colonystimul factor gmcsf glycoprotein requir surviv growth differenti hematopoiet progenitor cell primari structur gmcsf cdna clone relationship structur function gmcsf fulli understood fifteen monoclon antibodi moab human gmcsf generat map immunolog distinct area molecul moab biotinyl shown enzymelink immunosorb assay bind recombin gmcsf affix solid phase unconjug moab compet biotinyl moab bind gmcsf crossblock studi identifi distinct epitop nativ gmcsf epitop present denatur gmcsf western blot epitop partial conserv gmcsf reduc betamercaptoethanol moab epitop neutral recombin glycosyl nonglycosyl natur human gmcsf gm colonyform unit cfugm assay block gmcsfinduc activ neutrophil antibodi good correl neutral activ capac block bind igmcsf neutrophil blast neutral antibodi epitop partial block bind igmcsf neutrophil moab neutral interleukin csf csf locat epitop partial map regard amino acid structur determin reactiv gmcsf synthet peptid humanmous chimer gmcsfs neutral antibodi found map amino acid moab identifi function domain gmcsf identifi region involv receptor interact"
"inhibit hydroxymethylglutaryl coenzym reductas activ induc paradox increas dna synthesi myeloid leukemia cell effect competit inhibit hydroxymethylglutaryl coenzym hmg coa reductas compactin vitro prolifer peripher blood myeloid leukemia cell studi cell patient acut myeloid leukemia chronic myelogen leukemia blast phase cell patient show doserel inhibit dna synthesi incub compactin unexpect cell patient resist inhibitori effect compactin dna synthesi respond hmg coa reductas inhibit actual increas incorpor clabel thymidin dna patient studi display inhibit stimul dna synthesi biphas respons depend concentr compactin maximum enhanc rate cellular dna synthesi observ lower compactin concentr mol requir maximum inhibit dna synthesi mol leukemia cell display stimul respons compactin signific lower baselin dna synthet rate cell show inhibitori respons dna synthesi compactin correl cell vari dna synthet respons compactin measur baselin hmg coa reductas activ acet convers cholesterol observ cellular dna synthesi stimul hmg coa reductas inhibit observ mammalian cell paradox explan emerg light grow knowledg import isoprenyl function cell regulatori protein"
"epsteinbarr virus infect preced clonal expans burkitt acquir immunodefici syndrom lymphoma epsteinbarr virus ebv distinct form human lymphoid malign includ endem ebl sporad form burkitt lymphoma sbl acquir immunodefici syndrom hodgkin lymphoma aidsnhl ebv pathogenet role tumor passeng virus conclus demonstr element distinguish possibl determin ebv infect preced possibl contribut clonal expans infect occur clonal expans contribut pathogenesi end analyz structur heterogen genom termini ebv marker clonal infect panel ebl case sbl case aidsnhl case biopsi show ebv termini uniform clonal sbl ebl aidsnhl strong suggest ebv infect preced contribut clonal expans malign"
"stage ii diffus larg cell lymphoma prognost factor longterm result chopbleo radiotherapi hundr forti patient ann arbor stage ii diffus larg cell lymphoma dlcl treat combin chemotherapi consist cyclophosphamid doxyrubicin prednison lowdos bleomycin chopbleo involvedfield radiat xrt complet remiss cr attain patient stage diseas patient stage ii diseas thirti patient relaps diseas occur year year surviv rate count death patient stage compar patient stage ii determin surviv rate censor unrel death similar surviv rate multivari analysi identifi independ prognost factor age tumor extent serum lactic dehydrogenas ldh level combin effect tumor extent ldh level analysi risk group surviv identifi group consist patient minimum tumor normal ldh level year determin surviv patient extens tumor elev ldh level poorest surviv rate intermediaterisk group determin surviv compos patient extens tumor elev ldh level differ demonstr develop treatment strategi base risk factor surviv patient appar local ann arbor stage ii dlcl"
"individu aerob high intens train asthmat children exercis readapt program train adapt exercis order defin role individu train intens condit program asthmat children train asthmat age year ventilatori threshold vth intens level month period aerob train maxim intens month high intens train vth point nonlinear increas ve occur group asthmat age serv control subject cardiopulmonari fit determin cycl ergomet train session studi demonstr aerob train correct adapt child physic abil induc rapid mark cardiovascular fit increas decreas ve work rang vth increas great import hyperventil major determin exerciseinduc bronchospasm contrast high intens train toler indoor swim pool longterm effect unsuit asthmat children decreas vth involv increas hyperventil exercis perform submaxim intens"
"combin zidovudin interferonalpha treatment patient aid kaposi sarcoma effect addit interferonalpha ifnalpha zidovudin patient aid kaposi sarcoma assess random phase ii clinic trial twenti patient treat oral zidovudin mg daili ifnalpha increas mu daili week evalu patient achiev partial respons week month ifnalpha dose escal patient respons myelotox mild fatigu doselimit sideeffect prevent dose escal elig patient combin treatment result decreas hivag summari result addit ifnalpha zidovudin patient aid kaposi sarcoma efficaci treatment"
"scid mutat mice confer hypersensit ioniz radiat defici dna doublestrand break repair sever combin immunodefici scid mice carri scid mutat sever defici cell cellmedi immun appar result defect join immunoglobulin cell receptor gene element present studi defin tissu cellular molecular basi characterist mice hypersensit ioniz radiat bone marrow stem cell intestin crypt cell epitheli skin cell scid mice fold sensit irradi situ congen balb control independ isol embryo fibroblast scid mous cell line display similar hypersensit gammaray addit cell line sensit cell kill bleomycin produc dna strand break dna crosslink agent mitomycin uv irradi measur rejoin gammarayinduc dna doublestrand break pulsedfield gel electrophoresi anim defect repair system suggest gammaray sensit scid mous fibroblast result reduc repair dna doublestrand break common factor particip repair dna doublestrand break rejoin lymphocyt develop murin autosom recess mutat prove extrem fundament studi radiationinduc dna damag repair"
"long charg run system lupus erythematosus autoantigen system lupus erythematosus chronic system autoimmun diseas circul autoantibodi reactiv limit set nuclear protein rigor statist method identifi segment high signific charg concentr major characterist nuclear cytoplasm autoantigen extrem long run charg residu includ sequenc greater consecut charg residu pure acid mix basic acid occur protein equival run found mammalian protein sequenc extrem charg cluster type locat conserv nonsimilar antigen propos supercharg surfac render target host protein strong immunogen antinuclear antibodi profil result chronic exposur intracellular content possibl conjunct crossreact viral product limit number potenti system autoantigen part due rariti requisit charg properti"
"aid epidemiolog inconsist human immunodefici virus infecti diseas newli defin syndrom aid includ unrel parasit neoplast noninfecti indic diseas base epidemiolog correl syndrom thought due sexual parenter transmit retrovirus term human immunodefici virus hiv epidemiolog data conflict hypothesi noncorrel exist hiv aid aid risk infect subject vari greater fold gender countri abnorm health risk control independ aid aid statist drug addict hemophilia correl direct abnorm incid aid diseas aid diseas occur risk group absenc hiv ii american aid incompat infecti diseas exclus restrict male occur averag year transfus hiv specif aid diseas transmiss risk group unlik infecti diseas aid spread exponenti aid test establish aid receiv current definit iii epidemiolog evid hiv longestablish perinat transmit retrovirus hiv act marker american aid risk rare transmiss horizont contact frequent transfus intraven drug repeat promiscu sex conclud american aid infecti suggest unidentifi noninfecti pathogen aid"
"frequenc nonparenter occup exposur blood bodi fluid univers precaut train purpos annual period univers precaut train compar frequenc health care worker report cutan exposur blood bodi substanc patient patient presum infect human immunodefici virus type hiv subject method report cutan exposur blood sputum urin fece bodi substanc evalu separ worker survey worker result annual blood exposur decreas annual exposur substanc decreas determin match analys subset particip complet survey similar result report exposur blood infecti blood sputum infecti sputum urin signific decreas particip test antibodi hiv particip report cutan exposur acquir hiv infect upper bound confid interv risk hiv infect singl cutan exposur blood presum hiv bodi substanc presum hiv conclus data suggest univers precaut train signific decreas elimin cutan exposur blood bodi substanc result suggest risk hiv infect cutan exposur substanti lower risk parenter exposur"
"major differ dynam primari secondari progress multipl sclerosi patient primari secondari progress multipl sclerosi ms major differ pattern extent abnorm cerebr magnet reson imag mri group recent demonstr present studi patient match age sex durat diseas disabl serial gadolinium diethylenetriaminepentaacet acidenhanc mri month period patient secondari progress group total lesion time lesion patient year enhanc enhanc occur edg preexist lesion contrast lesion primari progress group lesion patient year enhanc differ degre clinic deterior group month period find differ dynam diseas activ form progress ms relat inflammatori compon lesion import implic select patient monitor diseas activ therapeut trial"
"correl phasic muscl strength corticomotoneuron conduct time multipl sclerosi central motor conduct time adductor pollici muscl twitch forc muscl scalp magnet motor cortex stimul maximum forc phasic voluntari contract muscl measur patient multipl sclerosi test manual dexter hand studi purdu pegboard test maxim frequenc scissor movement thumb index finger patient normal strength minim weak intrins muscl hand clinic examin central motor conduct time adductor pollici muscl patient longer normal peak twitch forc adductor pollici muscl evok cortic stimul maximum forc phasic voluntari contract adductor pollici muscl smaller normal strong correl measur central motor conduct time patient invers correl voluntari phasic forc twitch forc cortic stimul longer central motor conduct time weaker forc prolong central motor conduct time accompani conduct block corticomotoneuron pathway correl central motor conduct time voluntari phasic forc twitch forc reflect degre conduct block tempor dispers delay conduct se result object assess phasic muscl strength reveal correl central motor conduct time evid convent clinic examin assess tonic muscl contract strength"
"system lupus erythematosus iceland nationwid epidemiolog studi unselect popul nationwid studi revis ara criteria appli classif system lupus erythematosus sle unselect group patient includ case diagnos manag hospit hospit iceland year period seventi case found incid femal male risk age diagnosi year twenti percent patient miss studi includ hospit patient clinic pattern previous studi found illustr low incid kidney diseas nephriti found patient comparison studi sle iceland show actual increas incid period year year surviv year surviv"
"juvenil system lupus erythematosus egyptian children prospect analysi egyptian children system lupus erythematosus sle conduct year period averag followup period month age onset rang year case present classic featur diseas present primarili major organ involv case present cardiac tamponad report seri clinic laboratori manifest diseas present complet studi requir confirm differ diseas manifest compar found popul contrari frequent held view result suggest childhood onset sle rare africa part contin"
"diagnosi sulfit aspirin sensit addit recogn allerg respons individu high mol wt substanc pollen mold anim dander suscept asthmat experi advers reaction low mol wt substanc sulfit asa nsaid diagnosi sulfit aspirin sensit made appropri conduct provoc challeng precaut assur safeti patient lifethreaten reaction occur understand mechan mechan involv advers reaction substanc provid inform diagnos reaction improv understand treatment asthma"
"pulmonari function test diagnosi treatment asthma asthmat remark pulmonari function respons numer extern stimuli intern control serial pulmonari function test offic hospit home work place object measur intellig diagnos treat patient patient physician understand techniqu monitor degre airway obstruct key medic manag decis"
"human growth hormonevari biolog activ somatogen lactogen human ghvariant hgh gene member ghprl gene famili express placenta trimest gestat secret hgh protein differ pituitari gh hgh amino acid previous demonstr hgh bind somatogen lactogen cell surfac receptor vitro ratio somatogen lactogen receptorbind affin substanti higher hgh character somatogen lactogen bioactiv hgh contrast bioactiv hgh somatogen bioactiv assay stimul weight gain hypophysectom rat lactogen bioactiv assay mitogen respons nb lymphoma cell line averag increas rat bodi weight respons fix concentr hormon compar hgh hgh mitot respons lactogeninduc nb cell signific hgh compar somatogen lower lactogen bioactiv hgh relat hgh parallel previous report receptor bind profil hormon suggest hgh potenti perform uniqu role human gestat"
"sensit liver repres rich sourc endogen leukotrien abil liver produc endogen leukotrien immunolog stimul test organ rat guinea pig passiv sensit rat vivo monoclon murin antidinitrophenolig antigen challeng isol perfus liver system elicit rapid hepat product biliari excret leukotrien judg radioimmunoassay separ individu leukotrien highperform liquid chromatographi min antigen infus leukotrien leukotrien acetylleukotrien bile biliari excret rate antigeninduc cysteinyl leukotrien rose pmolminkg bodi mass challeng pmolminkg bodi mass min declin prechalleng level quantit similar hepat product cysteinyl leukotrien elicit isol perfus guinea pig liver challeng ovalbumin activ sensit anim ovalbumin al exclud extrahepat contribut observ leukotrien product passiv sensit antidinitrophenolig subsequ antigen challeng perform isol rat liver perfus bloodfre medium exclus hepat sensit challeng result massiv product leukotrien biliari excret rate cysteinyl leukotrien amount approxim pmolminkg bodi mass min period antigen challeng compar pmolminkg bodi mass challeng"
"transform growth factorbeta suppress humor immun respons hiv infect report previous pbmc hiv patient spontan releas increas level tgf beta contribut defect cellular immun respons studi defin implic tgf beta overexpress humor immun hiv infect found staphylococcus aureus cowan sac stimul cell hiv donor lymphocyt prolif respons decreas defici correl close increas tgf beta secret pbmc hivinfect donor condit medium hiv pbmc purifi tgf beta similar inhibitori effect sac ebvinduc cell prolifer cell hivinfect donor sensit inhibit tgf beta cell normal donor antibodi tgf beta neutral inhibitori effect hiv cultur supernat normal cell increas low prolif respons hiv cell pwm stimulus cell differenti shown activ tgf beta hiv pbmc signific reduc induct immunoglobulin effect abrog antitgf beta studi support concept hiv infect tgf beta potent suppressor cellular humor immun respons"
"autocrin role urokinas phorbol estermedi differenti myeloid cell line human myeloid cell line hl secret urokinasetyp plasminogen activ upa express receptor stimul phorbol myrist acet pma secret upa express receptor regul cell differenti adher phenotyp adhes respons mark reduc presenc upa antibodi pma respons restor addit nativ upa aminotermin fragment upa residu devoid proteolyt activ synthet peptid residu upa growth factor domain mediat receptor bind contrast addit catalyt activ low molecular weight upa miss growth factor domain peptid catalyt domain residu ineffect influenc upa antibodi marker macrophag differenti cystein proteinas activ examin cystein proteinas activ hl cell increas pmatreat cell fail increas presenc antiupa increas cathepsin activ restor exogen upa experi autocrin interact growth factor domain upa receptor mediat essenti step pmamedi myeloid cell differenti"
"binari method continu outcom parametr altern diseas state diseas defin subdomain continu outcom variabl subdomain diastol blood pressur greater mmhg defin hypertens classic method estim risk preval defin diseas state dichotom outcom variabl cutoff standard statist analysi risk diseas exploit method develop specif binari data base binomi distribut present method base assumpt gaussian normal distribut continu outcom resort dichotom specif estim risk varianc present sampl situat focus risk differ ratio odd ratio binomi approach appli dichotom data found effici propos method found accur small sampl size sensit substitut distribut thicker tail distribut canadian total cholesterol data illustr problem sampl case approach illustr data studi arteri oxygen patient lung anesthesia thorac surgeri sampl case data prognost studi renal function lupus nephrit patient"
"phase trial monoclon antibodi acut myelogen leukemia specif bone marrow target intern radionuclid ten patient myeloid leukemia treat phase trial escal dose mous monoclon antibodi mab reactiv cd glycoprotein found myeloid leukemia blast earli hematopoiet progenitor cell normal stem cell tracelabel iodin detail pharmacokinet dosimetr studi serial sampl blood bone marrow bodi gammacamera imag total dose mg administ safe advers effect absorpt target vivo demonstr biopsi pharmacolog flow cytometri imag satur site occur dose greater equal mgm entir bone marrow specif imag begin hour inject optim imag occur lowest dose bone marrow biopsi demonstr signific doserel uptak earli hour infus patient major dose found marrow tumor regress observ estim radmci deliv bodi radmci deliv plasma radmci deliv red marrow compart im rapid modul major bound immunoglobulin igg intern target cell vivo data bone marrow ablat dose im expect rapid specif quantit deliveri bone marrow effici intern target cell vivo suggest deliveri isotop auger alpha emitt toxin biolog import molecul leukemia cell normal hematopoiet progenitor cell feasibl"
"program director attitud resid care patient aid object evalu educ strategi experi resid program train primari care provid care patient aid design crosssect administ questionnair survey set survey conduct novemb april particip militari intern medicin famili medicin program director survey respond intervent measur main result director felt primari care aid patient import educ experi report program aid inpati report major traine care aid patient continu clinic program typic aid inpati director report resid care aid patient continu clinic unsur resid adequ train aid ambulatori care report improv resid educ area high prioriti encourag resid assumpt primari care concern aid care stress resid aid care complic generalist clinic faculti qualifi supervis resid care aid patient conclus program director view educ aid ambulatori care import resid adequ train encourag resid assumpt primari care aid patient resid provid care program strategi augment resid ambulatori experi aid care"
"pathogenesi recent therapeut approach graftversushost diseas effect prophylaxi acut gvhd bring improv patient surviv decreas sever infect month transplant reduc incid chronic gvhd compromis qualiti hematopoiet engraft increas incid leukem relaps impair graftversusleukemia effect current approach prevent gvhd succeed meet expect postgraft immunosuppress therapi closest ideal techniqu cell deplet effect reduc incid gvhd condit program develop success elimin host immun malign cell doubt achiev system chemotherapi total bodi irradi innov approach monoclon antibodi link shortliv radioact isotop short linear energi transfer promis result toxic effici program provid erad malign diseas amelior problem graft failur conceiv kill leukem cell chemoradiotherapi form graftversusleukemia effect essenti futur distinguish lymphocyt caus graftversusleukemia effect caus gvhd isol attempt therapi meantim postgraft immunosuppress drug frequent prevent treat gvhd steadili improv surviv statist expect"
"effect therapeut plasma concentr theophyllin behavior cognit process affect children asthma publish erratum pediatr jul pt doubleblind random crossov studi assess effect theophyllin behavior mood effici cognit process thirti children age year moder asthma random assign day theophyllin placebo placebo theophyllin experiment condit separ day washout period theophyllin plasma concentr pulmonari function test perform studi cognit function test report measur administ baselin medic phase behavior rate obtain parent teacher parent teacher rate reflect theophyllin effect attent activ level children report show mood statist signific differ found measur cognit process larg individu differ sensit theophyllin effect present children toler theophyllin attent achiev problem vulner advers effect individu respons differ focus futur studi"
"travel eastern europ guidelin patient patient medic prepar physician counsel travel eastern european countri addit baselin immun measl booster polio booster typhoid vaccin immun globulin prophylaxi hepat advic air pollut contamin food water civil unrest motor vehicl mishap countri polici hiv screen level healthcar poor contact american british embassi consul recommend emerg"
"ritual circumcis umkhwetha xhosa ciskei umkhwetha ancient custom ritual circumcis practis xhosa peopl southern africa consecut youth requir hospit admiss mortal rate complic year review manag discuss"
"recruit mononuclear cell endotheli cell bind wound skin select timedepend process defin molecular interact wound heal involv complex seri interact cell dermi epidermi import relationship exist keratinocyt resid dermal cell monocyt lymphocyt secret cytokin capabl stimul dermal repair influenc keratinocyt fibroblast migrat prolifer mechan mononuclear cell recruit wound unknown test hypothesi wound skin special endotheli cell induc mediat peripher blood mononuclear cell pbmc emigr vasculatur dermi purpos partialthick wound made keratom back domest pig excis wound biopsi test capac adher select pbmc result pbmc overlaid section wound day adher select dermal endothelium distinct peak adher observ day day contrast pbmc adher tissu section overlaid frozen section normal skin wound skin addit studi bind properti pbmc subset reveal monocyt adher maxim day cell adher optim day postwound adhes process energi magnesium depend calcium depend involv surfac protein carbohydr moieti pbmc surfac pretreat pbmc monoclon antibodi lfa adhes receptor inhibit bind greater suggest lfa adhes receptor play import role bind process studi provid evid recruit monocyt lymphocyt wound activ dynam regul process mediat part specif adhes interact mononuclear leukocyt dermal endotheli cell"
"comparison function recoveri nonsurg surgic treatment condylar fractur articl evalu case condylar fractur treat surgic compar case treat nonsurg year follow sever displac luxat fractur involv surgic group rigid intern fixat satisfactori postop function occlus achiev level nonsurg group sever complic"
"effect longterm administr haloperidol electrophysiolog properti rat mesencephal neuron haloperidol mgkgday administ rat drink water period week month anim withdrawn neurolept week rat haloperidol month exhibit signific perior dyskinesia control singleunit extracellular record obtain substantia nigra ventral tegment area subject urethan anesthesia month year treatment signific decreas fire rate substantia nigra par reticulata neuron found subtl respons par reticulata neuron striatal stimul extend haloperidol intak consist effect haloperidol administr week month found number spontan activ dopamin neuron fire rate histopatholog assess tissu dorsomedi dorsolater ventrolater sector striatum reveal signific effect longterm haloperidol treatment neuron cell count result discuss refer neurolepticinduc tardiv dyskinesia"
"progress character anatom injuri valu descript anatom injuri present anatom profil ap compon summar injuri greater ai headbrain spinal cord thorax front neck remain injuri relationship ap compon surviv rate reaffirm head injuri logist function model relat ap compon injuri sever score iss surviv probabl base major trauma outcom studi mtos patient mortal rate submit model perform comparison base mtos patient mortal rate submit ap discrimin survivor nonsurvivor provid increas sensit compar iss iss ap reliabl predict patient outcom predict power method estim patient surviv probabl includ physiolog indic profil patient age anatom profil compar current method ap base sever locat injuri ration basi compar patient sampl iss"
"injur driver alcohol culpabl convict pre postcrash drive histori culpabl crashrel traffic convict pre postcrash drive record group injur impair blood alcohol level greater mgdl driver admit level trauma center compar group admit unimpair driver group driver year age older sustain moder injuri defin injuri brain spinal column cord extrem pelvi abbrevi injuri score greater discharg home crash culpabl defin impair driver caus signific greater percentag crash compar unimpair driver unimpair driver consid culpabl caus crash receiv traffic convict compar culpabl impair driver number total precrash traffic violat higher impair driver unimpair driver number total postcrash convict unimpair impair signific number pre postcrash alcohol convict signific higher impair driver compar unimpair driver data suggest injuri protect legal prosecut alter impair drive practic"
"effect prehospit fluid surviv trauma patient effect prehospit intraven fluid surviv studi trauma patient prehospit time minut group patient receiv fluid group volum fluid administ signific group surviv compar die eighti cent patient injuri sever score iss mortal rate patient group receiv fluid similar patient receiv fluid  twelv cent patient iss sixti cent patient receiv fluid mortal rate similar patient receiv fluid compar  cent patient iss greater mortal rate highest group influenc administr fluid  comparison group similar probabl surviv triss methodolog fail show influenc fluid administr surviv mortal rate patient initi systol blood pressur bp torr greater compar rate patient admiss bp torr hypotens signific higher mortal rate administr fluid influenc rate"
"blunt trauma adult children compar analysi trauma remain major death children young adult adult pediatr patient differ signific mechan physiolog respons injuri review record consecut adult pediatr blunt trauma patient admit major metropolitan trauma center year period extens computer databas maintain patient compar statist analysi mechan injuri specif organ injuri clinic outcom perform altogeth adult children treat studi period blunt trauma account adult pediatr injuri patient consid analysi diagnost periton lavag perform children adult respect accuraci mechan injuri compar group children injur fall bicycl accid struck automobil compar analysi specif injuri demonstr signific fewer pediatr chest spine pelvic injuri central nervous system cns injuri children strong determin outcom pediatr cns trauma tenfold increas mortal mortal children absenc cns injuri spinal injuri predictor poor outcom pediatr popul mortal greater surviv age independ adult children survivor"
"alcohol intox injuri danger behavior revolv emerg depart door suicid homicid motor vehicl crash violent death injuri link inextric alcohol associ injuri alcohol obvious emerg depart ed physician sought determin extent intox patient ed proper diagnos counsel refer substanc abus care review chart consecut patient teach hospit ed blood alcohol level mg male white young age year sever intox bal rang mg forti cent visit trauma half patient victim violent assault intox patient receiv extens medic surgic manag averag test ray perform patient receiv medic discharg refer followup medic surgic clinic contrast patient evalu danger behavior refer treatment alcohol patient depress suicid homicid advis stop drink receiv referr psychiatrist mental health worker alcohol rehabilit facil forti cent patient receiv stat intraven thiamin wernickekorsakoff syndrom rare contrast receiv stat site psychiatr consult danger behavior common alcohol strong statist signific negat associ occurr injuri decis initi treatment referr alcohol"
"oxygen deliveri consumpt headinjur multipl trauma patient critic ill patient demonstr bodi oxygen consumpt vo depend oxygen deliveri retrospect studi relationship vo patient isol head injuri compar patient multipl trauma mt head injuri pulmonari capillari wedg pressur central venous pressur arteri pco cardiac index oxygen deliveri signific lower oxygen consumpt group group delta patient signific correl vo delta vo patient relationship patient delta vo delta mt patient delta vo delta group divid high hematocrit greater low hematocrit patient low hematocrit demonstr steeper regress slope chang reflect vo chang signific greater slope patient high hematocrit mt patient high low hematocrit data show correl oxygen deliveri consumpt similar headinjuri patient multipl trauma patient head injuri relationship greatest headinjur patient low hematocrit relationship vo group suggest influenc neurohumor factor local tissu phenomena"
"skelet transfix treatment comminut fractur distal end radius elder nineti patient femal male averag age year year comminut distal radial fractur treat transfix wire kirschner wire base metacarp ii elbow plaster cast case earli infect sudeck dystrophi encount followup studi averag month month conduct patient sarmiento rate patient fell good categori good fair poor case comminut intraarticular fractur type good result achiev simpl straightforward method"
"serum phospholipas patient multipl injuri catalyt phospholipas activ capla concentr immunoreact pancreat pla irpla measur serum sampl patient multipl injuri median injuri sever score capla increas patient posit correl found extent increas capla mortal impair pulmonari function irpla valu slight increas serum patient multipl injuri patient addit blunt abdomin trauma hand relationship found irpla capla valu find confirm immunoadsorpt experi antiserum human pancreat pla demonstr increas serum level irpla respons increas capla valu result suggest exist immunolog phospholipas enzym sera patient multipl injuri"
"reassess periton lavag leukocyt count blunt abdomin trauma hundr patient undergo diagnost periton lavag dpl year period retrospect review evalu util white blood cell wbc count lavag fluid eleven patient dialys wbc count greater mm erythrocyt count mm patient lavag hour injuri intraabdomin patholog patient lavag hour demonstr intraabdomin injuri hundr twenti patient grossli clear dialys laboratori analysi patient requir laparotomi conclud wbc count dpl fluid diagnost victim blunt abdomin trauma lavag hour injuri addit laboratori analysi clear dialys requir patient"
"analysi intraabdomin aortic injuri blunt trauma case report literatur review blunt trauma caus aortic injuri infrequ primarili involv thorac aorta abdomin aortic injuri blunt trauma frequent vari present month period trauma unit diagnos treat case abdomin aortic injuri secondari blunt trauma belt passeng motor vehicl accid secondari crush injuri addit case bring number found literatur review case emphas prompt recognit treatment vascular catastroph"
"reduc depend arteriographi penetr extrem trauma influenc wound locat noninvas vascular studi indic arteriographi penetr extrem trauma remain controversi review clinic experi patient extrem penetr trauma admit prior year period injuri caus stab wound extrem gunshot wound extrem thirti stab wound requir urgent explor underw arteriographi arteriogram posit unsuspect arteri injuri group forti gunshot wound underw mandatori explor arteriogram perform extrem forti arteriogram demonstr evid unsuspect arteri injuri year random select extrem studi mode ultrasonographi segment doppler pressur measur subsequ arteriographi gold standard sensit specif gunshot wound categor locat posit arteriogram injuri thigh arm result posit arteriogram posit studi observ medial posterior arm antecubit fossa forearm medial posterior thigh poplit fossa calf injuri recommend arteriographi gunshot injuri identifi highrisk area clinic evalu accur stab wound extrem gunshot wound thigh outer arm preliminari data suggest expand mode ultrasonographi reduc depend arteriographi case"
"impact volum outcom injur trauma patient year experi chicago trauma system american colleg surgeon state develop trauma system import ensur volum injur patient trauma center order achiev accept mortal rate clinic data support recommend lack analysi perform injur trauma patient determin relationship volum mortal rate separ statist method pearson correl coeffici mortal odd ratio direct pairwis mortal comparison addit tobit analysi introduc method analyz relationship volum mortal mortal rate adjust confound variabl head injuri pearson correl coeffici volum adjust mortal mortal odd ratio compar lowvolum pts trauma center highvolum greater pts trauma center adjust mortal rate ci categor analysi show signific mortal rate center adjust patient mix tobit analysi show relationship volum mortal signific account observ variat mortal rate addit tobit analysi construct model predict mortal rate specif volum patient data suggest invers relationship exist volum mortal support necess configur trauma system manner ensur design trauma center high volum injur patient"
"acut hospit cost trauma unit state implic region system care part larger effort determin total direct indirect cost injuri unit state nation estim number expenditur acut hospit due traumat injuri deriv data nation hospit discharg survey nhds estim number hospit episod total expenditur report paper subgroup patient defin age sex bodi region ai sever injuri sustain million individu sustain traumat injuri result hospit hospit expenditur total billion inclus profession fee adolesc young adult age year account half discharg total hospit cost elder repres popul account addit quarter total discharg hospit cost quarter hospit half total expenditur minor icdai injuri moder icdai sever icdai injuri account total episod total expenditur patient trauma care dollar involv injuri suffici sever requir treatment trauma center"
"geograph pattern urban trauma mechan sever injuri purpos studi investig distribut mechan injuri relat sever injuri case geograph zone larg urban area computer emerg medic servic em dispatchpati record databas studi citi popul million resid divid geograph grid mile incid relat sever injuri mechan determin zone result year separ em incid involv patient transport injuri incur motor vehicl accid fall lacerationsstabwound beat gunshot autopedestrian accid analysi zone show disproportion number em respons citi center centralmost grid account respons call volum progress diminish peripheri citi minor relat incid sever injuri mechan remain proport uniform zone geograph locat contrari popular notorieti incid sever injuri type general necessarili predict neighborhood predilect demand em zone citi"
"manag complex perin softtissu injuri debrid fecal divers rectal washout propos primari therapi complex perin lacer seri survivor pelvic sepsi rate retrospect studi patient sustain sever perin lacer die hour injuri due exsanguin pelvic injuri remain patient underw sigmoidoscopi divers fecal stream irrig distal rectal stump radic initi debrid necrot soft tissu enter access obtain patient patient mandatori daili debrid pulsatil irrig pelvic sepsi occur patient daili debrid pelvic sepsi complic recoveri abil patient resum oral nutrit signific delay necessit total parenter nutrit patient conclud sigmoidoscopi total divers fecal stream irrig distal rectal stump enter access feed radic initi debrid necrot soft tissu mandatori daili debrid pulsatil irrig optim recoveri devast injuri"
"intraabdomin retroperiton organ injuri diagnos dynam comput tomogram obtain assess renal trauma efficaci dynam comput tomographi assess renal intraabdomin retroperiton organ injuri analyz patient techniqu contribut valuabl inform diagnosi coexist injuri patient sustain blunt trauma ct identifi abdomin retroperiton organ injuri patient clinic examin ct prove invalu assess injuri bowel mesenteri pancrea retroperiton vascular structur give rise hematoma ct diagnos injuri clinic examin pancrea retroperiton hematoma patient penetr injuri dynam cts ad valuabl inform status viabil injur organ high number fals posit diagnos result unnecessari explor patient erron diagnosi reveal repeat cts undertaken inconsist clinic clinic find initi suggest ct diagnosi time explor undertaken correct confirm injuri discoveri intra retroperiton organ injuri patient sustain blunt trauma result modif treatment prevent late sequela complic substanti reduc hospit time"
"rehabilit techniqu athlet reconstruct anterior cruciat ligament publish erratum mayo clin proc jan wide spectrum protocol rehabilit anterior cruciat ligament reconstruct agreement exist specif strengthen exercis sequenc activ articl discuss current rehabilit techniqu mayo clinic athlet undergon anterior cruciat ligament reconstruct techniqu base establish principl rehabilit clinic experi inform relat biomechan knee illustr case reflect benefit rehabilit program year divid stage earli stage focus protect mobil strengthen program emphas close open kinet chain exercis neuromuscularpropriocept train sportspecif agil train redevelop reaction time coordin engram athlet competit highqual surgic care close supervis rehabilit program base kinesiolog biomechan factor pertain anterior cruciat ligament success outcom"
"specialist versus general practition treatment problem drinker efficaci specialist versus general practition gp treatment problem drinker assess randomis control trial problem drinker refer consecut specialist alcohol clinic gp assess random alloc gp specialist clinic treatment group subject receiv initi advic counsel clinic drink specialist clinic group receiv continu care clinic includ admiss hospit patient gp group return care gp contact support specialist month follow signific reduct alcohol consumpt alcoholrel problem group signific differ found group respect main outcom measur differenti treatment effect found sever depend drinker find show initi detail assess advic session treatment provid gps effect specialist clinic respect improv drink behaviour alcoholrel problem initi assess advic specialist clinic encourag gps involv subsequ care problem drinker practic base individu patient adequaci support offer gps"
"manag segment facial nerv injuri surgic repair report describ experi evolv philosophi regard manag segment facial nerv injuri present result facial nerv repair traumat injuri segment facial nerv peripher facial nerv branch contribut essenti element normal mimet facial movement recommend earli repair nerv segment recommend base principl establish manag disrupt main trunk facial nerv offer patient chanc complet recoveri facial function"
"vagin birth cesarean deliveri result year multicent collabor studi cesarean deliveri frequent perform major oper unit state widespread vagin birth previous cesarean deliveri potenti elimin cesarean physician reluct adopt polici larg studi conclus demonstr safeti studi evalu matern perinat outcom case labor previous cesarean deliveri multicent studi began initi includ california hospit year trial labor result vagin birth januari addit hospit join collabor project year trial labor result vagin birth particip hospit entir studi period patient opt trial labor deliv vagin matern death triallabor group perinat mortal signific general obstetr popul result support find numer smaller studi conclud polici routin repeat cesarean deliveri abandon"
"tibial defect reconstruct method ilizarov altern ussr method ilizarov recent employ north america manag bone defect case patient tibial bone defect present deep infect treat gradual compress defect transport tibial segment fill tibial defect preserv regain origin bone length patient defect obliter leg length maintain method minim invas weightbear permit modif strategi treat bone defect requir close attent detail steep learn curv"
"preoper plan treatment nonunion correct malunion long bone detail analysi step preoper plan employ clinic present found techniqu great anticip requir fulfil correct malalign obtain heal malalign occur nonunion decid malalign correct anatom match normal extrem trace aid surgeon kinet oper procedur defin method stabil result correct"
"treatment tibial malunion nonunion ream intramedullari nail ream intramedullari nail effect lowrisk techniqu manag delay union nonunion malunion tibia close techniqu open realign execut minim dissect bone graft rare interlock nail ad degre secur control rotat"
"treatment nonunion pseudarthros humer shaft summari aoasif principl open reduct stabl intern fixat nonunion pseudarthros humerus plate fixat supplement shingl petal cement loos screw bone graft defect atroph nonunion success heal oper procedur achiev full correct preoper deform return function rang motion achiev earli activ exercis physiotherapi occasion continu passiv motion support hing brace cast brace postop period union occur union achiev averag month oper procedur"
"intraarticular malunion nonunion principl intraarticular fractur care stabl intern fixat appli intraarticular nonunion malunion result restor amaz function joint total doom arthrodesi arthroplasti high degre success achiev case illustr amaz recup power human joint articular cartilag congruenc stabil establish correct axial deform mobil joint"
"diagnosi treatment nonunion malunion acetabular fractur surgic treatment nonunion malunion acetabular fractur challeng diagnosi nonunion malunion rest clinic radiolog examin union troubl involv column case justifi extensil approach"
"heat ill fluid electrolyt issu pediatr adolesc athlet primari mechan maintain normal bodi temperatur physic exercis heat evapor sweat profus sweat water loss exceed electrolyt loss rigor exercis heat place athlet risk thermoregulatori dysfunct dehydr children inher effici thermoregul adult greater risk heat ill primari syndrom heat ill heat cramp heat exhaust heat stroke treatment heat ill base reduct bodi temperatur rehydr heat stroke true medic emerg high mortal rate reduct bodi temperatur critic surviv patient prevent heat ill base reduc risk factor physic activ modifi face high ambient temperatur humid athlet begin exercis hydrat frequent consumpt cold water exercis decreas likelihood signific dehydr exercis athlet continu drink replac fluid loss cloth lightweight skin expos greater evapor surfac preseason condit program combin day period acclimat reduc risk heat injuri athlet engag endur sport benefit drink carbohydrateelectrolyt solut major young athlet cold water remain prefer choic fluid replac exercis greater bodi surfac area young athlet place risk hypothermia special attent athlet compet cold environment condit"
"review prophylact knee brace footbal review studi prophylact knee brace worn player american tackl footbal lend support doublehing brace highschool level evid colleg level persuas caution exercis interpret studi owe probabl presenc bias confound variabl difficulti general result studi popul studi assign brace random found lower injuri rate knee knee ligament highschool highschool size player convers larg multiteam collegi studi found signific higher rate knee injuri brace user differ remain control posit skill previous injuri"
"strength train children adolesc strength abil exert muscular forc resist fundament requir daili physic activ children adult strength train progress resist exercis method specif increas strength strength train children adolesc risk proven medic concern relat back shoulder joint injuri hypertens relat diseas rate injuri low compar youth activ consid safe incid sever injuri minim adher guidelin present children expect stronger train increas strength enhanc perform athlet activ strength power speed requir reduc incid sever overus injuri sport expect protect acut injuri sport"
"substanc abus educ pediatr histor physician receiv formal educ relat alcohol drug abus depend survey pediatr program unit state conduct assess current status alcoholdrug educ pediatr medic student resid train level program requir formal instruct offer elect medic student resid respond endors inclus requir elect alcohol drug educ curriculum program includ futur plan major impedi identifi curriculum time constraint medic student level resid level lack qualifi instructor medic student level resid level survey result suggest strong develop faculti structur alcohol drug abus educ plan specif pediatr"
"predict visibl lesion cheek lip oropharynx suspect caustic ingest endoscopi omit complet negat pediatr patient relationship absenc presenc grossli visibl lesion cheek lip oropharynx burn incid site degre viscer burn evalu children refer hospit suspect caustic ingest year period children underw esogastroduodenoscopi hour children show visibl sign contact caustic substanc endoscopi reveal burn viscer site children sustain potenti danger lesion degre sixti children show visibl lesion endoscopi reveal burn viscer site fourteen patient sustain potenti danger lesion degre total esophag burn record degre degre degre patient lesion lesion develop esophag stenosi patient group die complic relat tracheostomi total gastric burn record gastric perfor observ group remain lesion heal residu asymptomat scar minim scar observ patient burn total lesion record larynx duodenum"
"initi manag trauma minut hemodynam stabil achiev trauma patient detail physic examin diagnost studi perform success manag trauma demand immedi lifethreaten problem receiv top prioriti patient continu reexamin problem repriorit condit chang final imper surgic evalu treatment undertaken trauma patient languish undergo extens examin hospit lack surgic specialist train treat problem identifi transfer facil special diagnost test evalu treatment surgic specialist accomplish quick"
"trilaminar skin coverag techniqu treatment sever deglov injuri extrem torso percent deglov injuri involv torso lower extrem year boy success manag employ trilaminar skin coverag techniqu avuls flap attach bed inch splitthick graft epithelium superfici dermi rais powerdriven dermatom harvest site level deeper layer consist splitthick dermi inch layer mesh expand remain deglov flap excis steril bench defat produc layer deep dermi case layer ultim lost function temporari biolog dress depend donorsit morbid potenti applic method major burn injuri feasibl"
"brachial plexus injuri chest restraint seatbelt case report rapid deceler wear lapshould strap seatbelt result traction injuri brachial plexus side shoulder strap occult vascular injuri consid patient injuri pattern deficit recov neuroprax type injuri"
"biochem analysi electroejacul spinal cord injur men comparison normal ejacul address consist find asthenospermia spinal cord injur men compar biochem constitu antegrad fraction electroejacul patient manual ejacul volunt semen sampl group analyz biochem paramet ph osmol organ compon includ triglycerid glucos fructos uric acid creatinin urea total protein albumin cholesterol metabol enzym includ glutam oxaloacet transaminas glutam pyruv transaminas lactat dehydrogenas alkalin phosphatas measur inorgan constitu includ chlorid sodium potassium zinc phosphor signific higher level blood urea nitrogen creatinin demonstr electroejacul suggest urinari contamin antegrad specimen electroejacul signific lower level fructos albumin alkalin phosphatas signific higher level chlorid note signific differ osmol ph found electroejacul level glucos uric acid inorgan constitu approach level serum conclud biochem abnorm semin plasma contribut semin dysfunct spinal cord injur men result neurolog injuri accessori sex gland electroejacul procedur"
"popul pedigre studi reveal lack associ dopamin receptor gene alcohol dopamin receptor clone lambda hdg blum al recent found dtaq allel present deceas alcohol equal number control assess associ evalu dtaq polymorph singlestrand conform polymorph detect polymeras chain reaction nondenatur gel electrophoresi pcrsscp noncod region receptor gene studi unrel white alcohol racial match control white pedigre schedul affect disord schizophrenialifetim version sad clinic diagnost interview rate blind clinician sad interview data ascertain diagnos diagnost statist manual mental disord revis edit dsmiii criteria alcohol subtyp age onset sever presenc antisoci person famili histori signific differ dtaq pcrsscp allel frequenc observ alcohol subpopul alcohol control pcrsscp polymorph provid independ inform linkag receptor locus recombin dtaq locus alcohol observ white famili alcohol parent possess allel studi support widespread consist associ receptor gene alcohol"
"nicotinereplac therapi transderm nicotin patch random doubleblind placebocontrol trial rate smoke signific reduc volunt subject provid effect nicotin replac materi week visit nurs week nicotinereplac therapi transderm nicotin patch nicolan doubl week smokingcess rate comparison placebo group versus subject smoke cigarett day baselin subject activ nicotin patch skin reaction reaction primarili mild activ placebo patch level patient complianc high subject continu smoke cigarett decreas baselin smoke level activ nicotin patch placebo patch outcom week show substanti relaps rate group nicotinereplac therapi provid exist concurr behavior intervent train prevent relaps part protocol"
"prefabr composit free flap stage microvascular transfer experiment clinic studi feasibl prefabr free flap induc process stage reconstruct arterioven bundl surround fascia perfus select block tissu investig experiment clinic sixteen rat knee joint wrap ipsilater superfici inferior epigastr sie fascia joint composit flap resect en bloc immedi replac orthotop pedicl superfici inferior epigastr vessel remain joint resect orthotop transfer perform week joint group benefit stage period found perfus long finger proxim interphalang joint child reconstruct stage microvascular transfer toe proxim interphalang joint stage temporali fascia flap wrap toe proxim interphalang joint revascular dorsali pedi vessel week joint temporali fascia envelop dissect prefabr joint flap transfer hand revascular wrist vessel boni union progress unev excel recoveri rang motion conclud indigen vascular anatomi unlimit array composit free flap construct transfer base induc larg vascular pedicl"
"blunt trauma children signific periton fluid hundr nineti consecut children undergon periton lavag underw imag comput tomographi ct blunt trauma collect periton fluid prospect character small children moder children larg children injuri includ hepat splenic injuri isol renal pancreat injuri isol pelvic fractur isol hollow viscus injuri combin periton fluid ct abnorm children signific correl found presenc increas size periton fluid collect clinic sign hemodynam instabl lower trauma score analysi varianc presenc arteri hypotens chi test hematocrit chi test addit presenc amount periton fluid correl laparotomi mortal chi test"
"clinic efficaci tripleinject wrist arthrographi tripleinject wrist arthrographi demonstr increas likelihood ligament perfor injur wrist diagnos compar imag singl inject contrast materi radiocarp joint tripleinject arthrographi increas patient expens signific increas time requir patient arthrograph obtain diagnosi goal decreas number tripl inject author review consecut tripleinject wrist arthrogram techniqu base highvolum inject contrast materi achiev complet distent joint author achiev falseneg rate demonstr complet perfor radiocarp inject partial perfor includ case patient treatment alter addit inform provid inject falseneg rate signific lower report previous rais question circumst easier timeconsum singl radiocarp inject"
"accumul erythrocyt nucleotid pattern lead worker nucleotid erythrocyt leadexpos subject analyz highperform liquid chromatographi hplc pyrimidin level correl blood lead concentr pb pyrimidin nucleotidas pn activ high signific correl found pb uridin diphosphateglucos udpg cytidin triphosph ctp cdpcholin cdpc level compound sharpli elev pn activ reduc level mumol hemoglobin hb correspond pb microgram concentr nucleotid provid index lead poison adenosin triphosp atp concentr correl negat pb adenosin monophosph amp concentr correl posit pb result suggest lead affect pyrimidin nucleotid metabol purin nucleotid metabol energi product system"
"occult exposur asbesto steel worker reveal bronchoalveolar lavag investig asbesto burden steelplant environ count asbesto bodi ab bronchoalveolar lavag fluid balf steel worker retir previous work area plant coke oven blast furnac mainten product worker basi occup anamnesi occasion past profession exposur asbesto remain worker deni contact asbesto total whitecollar worker occup exposur asbesto includ studi control increas preval concentr ab found balf steel worker electron microscopi edax analysi ab steel worker reveal core fiber amphibol ab found balf mainten worker product worker balf steel worker deni contact asbesto reveal increas ab burden control demonstr steel worker subject occult exposur amphibol steelplant environ"
"high mortal shorten lifespan patient itaiitai diseas subject suspect diseas follow studi conduct patient diagnos itaiitai diseas subject suspect diseas control nineti subject categori select match age sex residenti area cumul surviv rate patient definit diagnosi itaiitai diseas signific lower control group period cumul surviv rate subject suspect itaiitai diseas sever renal dysfunct due cadmium pollut signific lower control group result demonstr endur negat influenc itaiitai diseas prognosi cadmium pollutioninduc renal disord advers affect health inhabit cadmiumpollut area"
"blunt traumat cardiac ruptur year experi blunt traumat cardiac ruptur high rate mortal review computer trauma registri identifi patient injuri age year age year men women twenti patient injur vehicular crash pedestrian accid motorcycl accid sustain crush injuri injur fall kick chest hors anatom injuri includ atrial ruptur left atrial ruptur ventricular ruptur left ventricular ruptur ruptur cardiac chamber diagnosi made thoracotomi patient present cardiac arrest remain patient diagnosi establish emerg left anterolater thoracotomi subxyphoid pericardi window patient clinic cardiac tamponad signific upper torso cyanosi injuri sever score iss trauma score ts glasgow coma scale gcs score survivor nonsurvivor mortal rate patient survivor present vital sign patient patient ruptur cardiac chamber ventricular ruptur die mortal rate myocardi ruptur high rapid prehospit transport high index suspicion prompt surgic intervent contribut surviv patient"
"role inhal injuri burn trauma canadian experi thermal injur patient admit firefight burn center univers alberta hospit thirteen hundr forti male femal total burn surfac area tbsa sem rang tbsa sixteen hundr thirti patient surviv discharg hospit surviv rate hundr twenti burn patient suffer concomit inhal injuri diagnos bronchoscopi patient inhal injuri suffer larger tbsa versus inhal injuri inhal injuri increas number death burn injuri versus independ age tbsa inhal injuri threefold prolong hospit stay versus day independ age tbsa multifactori probit analysi perform inhal noninhalationinjur burn patient tbsa age adjust rate mortal burn popul present maximum detriment effect inhal injuri burn patient outcom occur coexist moder tbsa larg tbsa thermal injuri data demonstr inhal injuri import comorbid factor burn injuri increas number death substanti import injuri independ prolong durat hospit high unpredict fashion compar patient cutan burn data illustr extrem import inhal injuri comorbid factor thermal injuri reveal present limit accur quantif magnitud respiratori tract injuri accompani thermal trauma"
"antibodi human retrovirus drug user east coast american citi person attend methadon mainten clinic east coast veteran hospit enrol survey hepat antibodi preval sera test human immunodefici virus hiv human lymphotrop virus htlv htlv htlvii immunoblot clinic death record review sera hiv antibodi upper confid limit reactiv htlv profil reactiv suggest subject expos htlvii htlv preval high earli today correl durat drug age cancer specif neurolog diseas excess death ascrib seroposit htlv htlvii common infect drug user year advers outcom infect demonstr"
"movement hemostat clip ventricl aqueduct lumbar spinal canal case report author report patient rebleed oper left tempor arterioven malform result disloc multipl hemostat clip clip includ yasargil aneurysm clip detect incident lumbar spinal canal clinic sign symptom note retrospect passag aneurysm clip aqueduct detect computer tomographi scan perform evalu seri epilept seizur"
"conserv manag duoden trauma multicent perspect experi trauma center duoden injuri analyz identifi trend oper manag sourc duodenalrel morbid mortal year period end decemb duoden injuri identifi patient age rang year class class ii class iii class iv class injuri injuri mechan penetr patient blunt primari repair duoden injuri perform patient includ patient manag pylor exclus tube duodenostomi duoden resect primari anastomosi patient pancreatoduodenectomi death death uncontrol hemorrhag sever hepat vascular injuri patient patient death attribut duoden injuri result duoden repair dehisc subsequ sepsi duodenalrel morbid document patient includ patient intraabdomin abscess duoden fistula frank duoden dehisc summari analysi demonstr great major duoden injuri manag simpl repair tube duodenostomi mandatori compon oper treatment pylor exclus adjunct complex injuri pancreatoduodenectomi rare civilian duoden trauma morbid duoden trauma depend intraabdomin injuri extent duoden trauma mortal duoden injuri primarili relat vascular hepat trauma"
"mortal trauma patient interact host factor sever data host factor influenc mortal trauma patient spars contradictori develop model health polici decis examin trauma admiss acut care hospit state california year influenc host factor age gender preinjuri medic condit mortal stratifi injuri sever studi group mortal rate mortal increas start age year independ influenc gender presenc preexist diseas bodi region injur patient minor injuri mortal rate higher elder age patient injuri moder sever mortal increas middl age elder group male gender risk factor present elder middl age group presenc preexist medic diseas injuri head abdomen relat increas mortal middleag patient sever level account effect gender conclus age gender influenc mortal trauma patient effect explain document preexist diseas region injuri age gender serv observ marker subgroup patient impair respons injuri middleag male compris previous unrecogn highrisk subgroup impair respons"
"manag larg softtissu defect closerang shotgun injuri larg softtissu defect closerang shotgun blast remain major technic challeng trauma surgeon period patient surviv greater hour injuri manag center locat softtissu defect extrem abdomenchest headneck patient underw surgic explor wide debrid devit tissu repair injuri manag includ mandatori frequent dress debrid irrig oper room periop administr broadspectrum antibiot patient abdomin wall defect initi close temporari placement rayon cloth prevent eviscer patient underw delay primari closur cover splitthick skin graft closur myocutan flap close secondari intent patient transfer initi manag develop wound sepsi due inadequ debrid eventu requir amput patient develop earli myonecrosi lengthi arteri repair frequent oper dress adequ debrid irrig minim sepsi closerang shotgun blast treatment choic devast injuri techniqu wound closur individu situat"
"nonop manag blunt liver injuri adult continu surveil comput tomographi ct scan blunt abdomin trauma nonop manag select patient liver injuri report describ adult patient liver injuri treat surgeri thirti hepat injuri minor grade ii consid major grade iii free intraperiton blood small larg amount evid ct patient death seri major complic miss intraabdomin injuri delay hemorrhag liver injuri heal rapid serial ct scan small percentag patient residu liver defect persist month risk futur complic"
"dynam computer tomographi occiputatlasaxi complex trauma patient odontoid mass asymmetri month period patient age year present level trauma center odontoid mass asymmetri mm proper center ap openmouth ray patient asymptomat cervic pain limit rang motion patient cervic spine fractur disloc fix deform exclud clinic signific asymmetri determin util dynam axial ct scan occiput atlas axi head neutral degre degre activ rotat nineteen patient demonstr greater degre relat motion bilater patient degre relat motion bilater patient degre relat motion left rotat patient formal treatment normal cervic rang motion clinic examin time hospit discharg find asymmetr odontoidlater mass interspac proper center openmouth ap ray presenc normal cervic spine ray conscious patient fix deform incident requir evalu treatment"
"complic evalu abdomin trauma diagnost periton lavag versus computer axial tomographi review experi dpl ct obtain resuscit phase year period trauma system determin signific complic modal dpl complic fals negat fals posit technic error ct complic includ fals negat scan fals posit scan delay oper room obtain abdomin ct evalu delay result prevent death modal low complic rate dpl ct dpl prevent mortal morbid ct evalu abdomin trauma"
"blunt carotid arteri dissect incid injuri screen treatment blunt carotid dissect bcd rare injuri occur victim blunt injuri year experi trauma system case bcd perform match blunt trauma patient casecontrol analysi determin pattern injuri increas risk bcd patient combin head facial cervic spine injuri extrem fractur prove signific increas risk bcd duplex scan screen tool patient anticoagul prefer treatment neurolog deficit present"
"unintent injuri death rate rural appalachia rural unintent injuri ui death rate higher rate urban region trauma center serv rural appalachian ap counti counti rural state investig impact prehospit hospit resourc ui death rate referr area ageadjust averag age sexspecif ui death rate compar rural ap counti appalachian nap counti unit state counti group comparison level prehospit care advanc life support al basic life support bls presenc absenc nh hospit death rate calcul data popul census nation center health statist nchs state vital statist ap counti ambul servic al servic hospit agespecif ap rate higher nap rate year age group ap death rate highest bls nh counti age group rural ui death rate region remain unaccept high reason ap death rate exceed nap rate uncertain al servic hospit lower death rate propos educ epidemiolog program identifi defin addit problem"
"trauma center improv outcom trauma center evalu region trauma care discharg abstract data patient manag categori develop region medic care system treat patient sustain major accident injuri trauma victim base autopsi studi demonstr hospit meet accept criteria readi trauma center prevent needless death trauma victim autopsi data trauma center previous compar morbid data trauma center trauma hospit studi examin discharg abstract data patient classif system call patient manag categori pmc generat abstract data evalu length stay los complic death compar morbid mortal data trauma center trauma center discharg abstract patient pmc femor shaft fractur oper obtain hospit western pennsylvania maryland year data trauma center identifi compar trauma center criteria time equal day greater day age greater year injuri develop complic death patient treat trauma center signific fewer complic lower mortal rate treat trauma center injuri age complic delay time signific increas intens length stay trauma trauma center signific increas cost care provid patient type center"
"manag issu trauma patient alcohol estim patient treat emerg depart inpati trauma drink bac gmdl mmol higher problem drinker alcohol smoker abus drug acut ingest chronic abus alcohol increas frequenc sever injuri complic patient manag mimick head trauma mask intraabdomin injuri caus circulatori collaps reduc immun respons alter hepat metabol caus delirium tremen proper manag trauma patient alcohol includ bac determin care histori alcohol referr evalu treatment determin drug misus failur put physician legal risk improp care patient expos injuri patient crash discharg emerg depart impair alcohol"
"metabol platelet activ factor paf lysopaf polymorphonuclear granulocyt sever burn patient studi metabol hplatelet activ factor paf lysopaf human polymorphonuclear granulocyt pmn sever burn patient day posttrauma patient suffer sever burn trauma total bodi surfac area stimul pmn healthi donor caionophor result convers hlysopaf paf total radioact alkylacylglycerophosphorylcholin alkylacylgpc burn patient signific reduc format hpaf observ day posttrauma day pattern normal patient surviv trauma septic period observ week posttrauma patient succumb injuri sustain inhibit paf format observ death decreas format paf correl weak immatur granulocyt analyz cell fraction ratio immatur cell versus pafform"
"manag closerang shotgun injuri chest diaphragmat transposit case report method reconstruct chest wall closerang shotgun injuri techniqu requir detach diaphragm peripher sutur chest wall defect result intact chest caviti abdomin wall defect problem address varieti standard method patient present excel longterm result diaphragmat transposit armamentarium surgeon deal trunk trauma"
"fractur coracoid process present case review literatur coracoid process fractur rare uncommon clinic entiti case base coracoid process present fractur isol case case combin injuri acromioclavicular disloc fractur superior glenoid caviti disord patient fractur clavicl coracoid process treatment conserv case result satisfactori nonop manag advoc"
"civilian gunshot wound head prospect studi previous retrospect studi cranial gunshot wound fail determin aggress field resuscit triag neurosurg center earli surgic intervent improv assum poor outcom sever injur patient studi consecut patient prospect establish systemat approach treatment patient retain neurolog sign aggress field resuscitationintub comput tomograph scan perform rapid surgic debrid patient deterior clinic brain death glasgow coma scale gcs score resuscit patient patient patient patient seventi comput tomograph scan craniotomi perform glasgow outcom scale score show patient die veget sever disabl moder disabl good outcom postop death patient gcs score satisfactori outcom outcom progress improv gcs score increas conclud cranial gunshot patient initi receiv aggress resuscit patient stabl vital sign examin comput tomograph scan patient gcs score resuscit oper hematoma present therapi offer patient gcs score greater receiv aggress surgic therapi"
"concept softtissu trauma repair proper evalu treatment softtissu trauma face extrem import psycholog cosmet function sequela occur injuri facial trauma surgeon wide armamentarium techniqu manag softtissu facial trauma approach repair meticul scientif fashion repair acut trauma goal perform camouflag revis procedur scar high likelihood hypertroph scar inappropri heal trauma scar"
"sagitt index manag thoracolumbar burst fractur effort quantifi risk late progress burst fractur sagitt index si defin assess segment deform level fractur si measur kyphot segment deform correct normal sagitt contour level deform segment prospect studi devis burst fractur treatment complet data patient male femal averag follow month si greater degre group member treat surgic techniqu si degre group member treat conserv control group includ patient si greater degre treat author protocol independ reason result suggest si criteria assess deform predict progress segment kyphosi"
"nonop observ clinic occult arteri injuri prospect evalu forti patient clinic occult injuri major arteri studi prospect determin natur histori lesion safeti nonop manag penetr trauma predomin mechan lower extrem arteri common involv morpholog arteri injuri includ case intim flap case segment arteri narrow pseudoaneurysm acut arterioven fistula death result unrel injuri oper immedi arteriograph diagnosi remain injuri nonop serial arteriographi clinic examin interv month rang day month complet resolut document injuri improv remain unchang worsen period follow worsen case involv small occult pseudoaneurysm subsequ enlarg underw surgic repair subsequ morbid injuri requir surgeri nonop observ safe effect manag option clinic occult arteri injuri"
"axi ii comorbid substanc abus object assess complex relationship substanc abus person disord author determin preval person disord group middleclass substanc abus compar subject person disord method subject drawn patient consecut admit inpati substanc abus program privat psychiatr hospit agre particip substanc depend diagnos dsmiii patient assess structur clinic interview dsmiii person disord alcohol inventori mmpi health daili live form shipley institut live scale measur chemic life satisfact result substanc abus person disord patient differ signific patient person disord greater involv illeg drug pattern alcohol greater psychopatholog satisfi live impuls isol depress conclus mark differ substanc abus person disord uniform approach substanc abus treatment inadequ"
"psychiatr morbid adult inpati childhood histori sexual physic abus object extend knowledg longterm effect childhood abus psychiatr patient larg sampl author explor childhood sexual physic abus adult inpati consecut admiss method patient admit tertiarycar militari medic center patient interview abus histori dsmiii diagnosi characterist record result preval report childhood abus sexual abus physic abus physic abus sexual abus combin abus femal male patient report abus alcohol disord common victim physic combin abus sexual abus nonabus patient axi ii diagnos borderlin person disord frequent abus victim nonabus patient histori drug alcohol abus common patient report physic combin abus nonabus patient suicid frequent abus nonabus inpati note patient histori combin abus combin abus women physic abus men famili histori psychiatr ill common alcohol male relat conclus find emphas greater attent famili dynam aggress diagnosi treatment alcohol famili determin patient abus histori repeat question"
"accident firearm fatal mexico children studi hypothesi risk factor unintent gunshot fatal children includ gender race deced type firearm load gun store home studi popul mexico children year unintent kill firearm method mexico offic medic investig master mortal file review retrospect identifi unintent firearm fatal occur mexico children year period medic investig autopsi polic report analyz identifi epidemiolog factor death chisquar fisher exact test analyz data result twenti unintent firearm fatal identifi death occur frequent children play load firearm found home disproportion number involv handgun conclus studi result provid basi prevent strategi limit access decreas lethal load firearm home"
"report contamin needlestick injuri emerg health care worker studi hypothesi report contamin occup needlestick sharp object injuri emerg health care worker popul conveni sampl emerg physician emerg nurs emerg medic technician emt method survey instrument elicit demograph workrel factor develop administ survey item includ age sex occup year occup number procedur perform week number contamin needlestick sharp injuri recal number injuri formal report previous year nonseg visual analog scale assess attitud possibl nonreport analysi analysi varianc multipl linear regress stepwis variabl elect result hundr fifti subject recal contamin exposur year studi period formal report injuri occur emt compar nurs physician physician recal contamin exposur nurs recal emt recal physician formal report exposur emt report nurs report physician formal report eighth injuri compar emt nurs report event percept risk occup year occup concern excess paperwork power predictor low report rate conclus workrel contamin sharp object injuri report emerg health care worker emerg physician"
"hangman fractur week infant hangman fractur infanc childhood bilater avuls pedicl synchondros vertebr bodi frequent anterior disloc present case youngest infant medic literatur hangman fractur discuss anatomi kinemat injuri radiograph diagnosi treatment"
"psychiatr disord relat proband opiat addict previous research document high rate major depress antisoci person opiat addict studi design investig relationship dual diagnosi opiateaddict proband famili histori psychiatr disord substanc disord biolog relat psychiatr disord substanc disord evalu direct interview famili histori sampl degre relat opiat addict relat normal control result compar relat normal subject opiat addict relat substanti higher rate alcohol drug abus depress antisoci person relat depress opiateaddict proband elev rate major depress anxieti disord disord suggest valid subtyp opiat addict presenc absenc major depress contrast relat antisoci opiat addict rate disord signific relat opiat addict antisoci person implic find classif treatment substanc abus discuss"
"psychiatr diagnos treatmentseek cocain abus sampl cocain abus seek inpati outpati treatment rate psychiatr disord determin schedul affect disord research diagnost criteria met current met lifetim criteria psychiatr disord substanc disord common previous report clinic sampl cocain abus rate larg account major depress minor bipolar condit hypomania cyclothym person anxieti disord antisoci person histori childhood attent deficit disord affect disord alcohol onset drug abus anxieti disord antisoci person attent deficit disord typic preced drug abus"
"symptom tobacco withdraw replic extens smoker quit random assign doubleblind manner group nicotin placebo gum report observ symptom tobacco withdraw collect cessat followup week month month report observ anger anxieti crave difficulti concentr hunger impati restless promin symptom tobacco withdraw symptom return precess level month increas weight hunger crave continu month smoker nicotin gum decreas symptom includ crave hunger weight abstin smoker intens withdraw relaps abstin smoker gain weight relaps"
"hyperact boy grown replic psychiatr status previous report prospect follow studi young adult male condit diagnos hyperact childhood compar control proband signific higher rate attentiondeficit antisoci drug disord follow age year present studi attempt replic find independ sampl hyperact boy clinic compar normal control assess made clinician blind group membership inform obtain origin cohort previous studi signific proband control ongo diagnos attentiondeficit disord antisoci disord drug disord absolut rate disord compar group studi adjust odd ratio differ signific previous increas risk affect disord grown hyperact children present studi power replic natur young adult outcom childhood hyperact"
"outbreak pneumococc pneumonia men shelter report retrospect studi homeless men hospit acut pneumonia april march recent stay shelter streptococcus pneumonia serotyp resist cotrimoxazol isol patient percent blood cultur posit percent patient young year thirti percent heavi smoker percent alcohol radiolog pattern atyp case percent fatal case link adult respiratori distress syndrom rate outbreak pneumococc pneumonia underestim homeless high risk pneumococc pneumonia addit close exist shelter favor occurr outbreak suggest shelter resid benefit pneumococc vaccin"
"trajectori reconstruct trace evid flight paper review trace evid recov spent bullet establish trajectori inform deriv trace evid combin geometr techniqu trajectori reconstruct data discuss case review analysi trace evidenti materi adher bullet reconstruct event"
"applic probabl theori group breathalcohol bloodalcohol data jurisdict se drivingintox dwi status express term bloodalcohol concentr bac standard gram ml equival breathalcohol brac analysi typic employ determin bac challeng assum convers ratio concern relev light data show low percentag case brac greater bac concern increas brac predict bac context se legisl probabl theori basi estim likelihood individu brac greater equal bac ml actual field data state wisconsin evalu determin probabl occurr probabl occurr involv multipl law independ event comput probabl data actual number occurr brac greater equal bac ml result probabl concern brac greater bac critic se level low probabl occurr support reason se dwi legisl base bloodalcohol standard determin breathalcohol analysi"
"lung surfact phospholipid lsps diagnosi drown author studi lung surfact phospholipid lsps isol lung tissu marker drown group rabbit sacrif drown fresh salt water phospholipid composit compar drown control seri phospholipid studi lung lavag phosphatidyl cholin phosphatidyl ethanolamin phosphatidyl glycerol proport differ control group drown group freshwat saltwat drown anim result lipid analyz employ marker forens autopsi differenti death drown postmortem immers freshwat saltwat drown lung tissu phosphatidyl cholin phosphatidyl inositol show signif differ result confirm lsps strong affect drown"
"death result trichlorotrifluoroethan poison fatal due accident exposur chlorin hydrocarbon industri set infrequ report death case occur poor ventil enclos compart area case present year male die result exposur trichlorotrifluoroethan work open pit chromatograph result tissu concentr present"
"tubular cooki cutter bullet uniqu projectil recent market pmc pan metal corpor ultramag tubular hollow point ammunit uniqu construct part projectil compos tubular copper bullet teflon wad fatal gunshot wound ammunit uniqu radiograph pattern result test fire present"
"human skin fabric bite mark templat case report comparison suspect biter dental arch pattern injuri bite mark difficult bite occur anatom locat small radius curvatur complex compound curv author present case report human skin templat reproduct bite case victim skin skin anatom similar person ink dental cast photographi transpar overlay signific reduc error common analysi bite mark high curv area"
"combatrel ptsd psychosoci adjust problem substanc abus veteran purpos studi determin preval combatrel posttraumat stress disord ptsd symptom veteran seek assist veteran administr medic center substanc abus treatment facil examin relat contribut vietnam war zone variabl ptsd symptom develop studi psychosoci adjust problem vietnam combat exposur ptsd symptom seek substanc abus men male veteran present treatment signific vietnam combatrel ptsd symptom measur mississippi scale combatrel ptsd clinic signific ptsd symptom occur subsampl combatexpos vietnam veteran substanc abus problem degre combat exposur import militari stressor distinguish vietnam veteran ptsd ptsd group differ age war zone duti durat war zone duti wound veteran serv vietnam differ veteran war zone duti paramet psychosoci adjust subgroup vietnam veteran ptsd symptom report signific greater psychosoci adjust problem counterpart ptsd deleteri effect combatrel ptsd confin adjunct psychiatr difficulti unemploy increas risk arrest antisoci conduct found veteran ptsd methodolog clinic implic find discuss"
"psycholog absorpt affect invest marijuana intox absorpt trait capac total attent involv report increas episod marijuana intox subset absorpt scale item specif character marijuana intox group user nonus show differenti affect involv experi addit drug group posit correl frequenc marijuana affect rate experi found find support hypothesi specif type alter conscious enhanc capac total attent involv absorpt character marijuana intox enhanc act reinforc possibl influenc futur"
"lag screw fixat anterior mandibular fractur techniqu appli lag screw treat fractur anterior mandibl present review patient lag screw treat fractur show success method provid rigid intern fixat advantag techniqu bonepl fixat discuss"
"gilli method fractur zygoma analysi case prospect studi analyz case treat gilli tempor approach fractur zygoma case suffici case requir open reduct suggest gilli method frequent minim morbid short durat general anesthesia"
"lowdos caffein physic depend human studi investig effect termin low dose level caffein mgday normal human substitut placebo capsul caffein capsul occur doubleblind condit subject rate dimens mood behavior phase studi substitut placebo consecut day result order withdraw syndrom subject peak day progress decreas prewithdraw level week data remain subject provid evid withdraw phase studi general withdraw effect examin repeat substitut placebo mgday caffein day period separ averag day differ subject respect presenc natur magnitud symptom subject demonstr statist signific withdraw effect phenomenon caffein withdraw previous present report document incid caffein withdraw higher subject daili dose level withdraw occur lower rough equival amount caffein singl cup strong brew coffe caffein soft drink rang symptom experienc broader includ headach fatigu dysphor mood muscl painstiff flu feel nauseavomit crave caffein heretofor recogn"
"hyperbar oxygen therapi acut smoke inhal injuri hyperbar oxygen therapi import adjunct manag respiratori injuri secondari smoke inhal injuri complic inhal toxic chemic carbon monoxid cyanid carbon monoxid poison therapi standard practic inform abil hyperbar oxygen reduc reperfus injuri anticip therapi standard practic manag smoke inhal injuri cyanid poison"
"biomechan fractur risk predict hip spine quantit comput tomographi review made simpl engin concept summar current effort relat qct measur bone densiti strength varieti vitro experi cadaver vertebra femora evid appar ash densiti strong linear function qct measur coeffici determin rang relat error qct data confid determin compress modulus rs relat error compress strength rs relat error trabecular bone proxim femur vertebr bodi cortic bone materi properti correl weak qct measur experi design relat qct data failur load proxim femur vertebr bodi remark success coeffici determin rang relat error vitro failur load determin experi compar estim vivo load spine hip appar elder vivo load close fractur vitro assess possibl develop qctbase clinic predictor fractur risk individu patient introduc concept factor risk engin design account uncertainti estim servic load compon strength factor risk load condit defin ratio expect servic load failur load extend concept densitometr fractur risk predict vivo import recogn densitometr data predict ultim load carri capac region interest ultim load compar forc expect vivo compar load condit difficulti approach vivo forc atraumat agerel fractur hip vertebra forc appli hip spine traumat event fall estim vivo load bend lift appar elder factor risk spine easili approach abstract truncat word"
"close reduct cervic spine disloc traction cervic facet disloc reduc rapid effect axial traction weight appli tradit pound limit fifti sequenti patient cervic facet disloc review thirti patient requir pound traction achiev rapid reduct sixti percent entir seri show signific improv neurolog function case signific loss function cadav studi confirm cranial tong support pound traction care applic pound low risk neurolog compromis tong failur result effect reduct disloc"
"strategi trauma resuscit victim penetr trauma arriv trauma center minut sustain injuri state deep circulatori shock patient requir extens resuscit effort benefit rapid massiv normotherm fluid resuscit initi year period patient requir oper requir rapid infus defin greater liter hour hour surviv rate oper cent encourag data rapid infusor level level technolog modifi increas normotherm fluid deliveri millilit minut eleven subsequ patient requir rapid infus statist signific improv clinic flow rate decrement resuscit time unexpect surviv group survivor includ clinic dead field arriv trauma center rapid infus normotherm fluid benefit penetr trauma general manag massiv hemorrhag"
"increas intraocular pressur sever burn patient eye patient sever bodi burn intraocular pressur rang mm hg extrem orbit congest canthotomi perform caus abrupt decreas intraocular pressur rang mm hg patient histori glaucoma narrow angl precondit pupillari block mechan patient surviv optic nerv damag increas intraocular pressur hospit discharg tonometri perform patient sever burn orbit congest patient receiv larg amount intraven fluid canthotomi benefit reliev potenti damag high intraocular pressur"
"util administ alcohol screen test saast schizophren patient util administ alcohol screen test saast determin alcohol abus alcohol assess preliminari studi schizophren patient hospit acut care psychiatr unit admiss met dsmiii criteria schizophrenia detect alcoholrel diagnosi saast score rang score forti percent saast score greater equal indic probabl alcohol score higher patient saast score higher met dsmiii criteria alcohol abus depend basi patient interview independ chart review interview signific contrast half high saast scorer admit problem drink extens studi interview saast item found high predict abus alcohol saast greater sensit interview sixti percent schizophren patient met dsmiii criteria alcohol abus report degre relat alcoholrel problem contrast nonalcohol patient pattern alcohol schizophren patient respons saast item reveal greater denial lack insight nonschizophren alcohol subject"
"alcohol secobarbit effect function famili alcohol acut psychophysiolog effect previous research demonstr respons differ administr alcohol adult male posit fhp versus negat fhn famili histori alcohol respons differ thought reflect differ vulner depend alcohol role posit famili alcohol histori increas risk addict varieti drug class studi determin fhp subject show respons drug class alcohol present studi determin doseeffect function varieti physiolog heart rate skin conduct skin temperatur subject analog mood drug effect subject high assess scale psychomotor measur hand tremor bodi sway digit symbol substitut test eyehand coordin numer recal fhp fhn collegeag male secobarbit mg mouth ethanol kg fhp fhn subject match lightmoder drink pattern anthropometr dimens age year school drug equival blood alcohol level familyhistori posit subject report greater effect ethanol familyhistori negat subject subject measur high dose secobarbit fhp fhn subject show elev subject effect effect substanti evid fewer measur ethanol contrast effect subject measur ethanol secobarbit produc compar impair group subject psychomotor respons group differ obtain physiolog measur"
"son alcohol report greater hangov symptom son nonalcohol pilot studi investig alcoholinduc hangov colleg men high low risk alcohol thirteen son alcohol report signific greater hangov symptom past year son nonalcohol group report compar quantityfrequ recent drink extent hangov repres acut withdraw syndrom alcohol rais question son alcohol dependencepron"
"tast reactiv alcohol prefer nonpref rat tast reactiv test examin orofaci respons alcohol prefer rat alcohol nonpref np rat tast alcohol initi exposur naiv rat test reactiv concentr alcohol water solut sucros quinin bottl consumpt test week period rat access alcohol prefer test tast reactiv test solut initi reactiv test result signific differ tast reactiv rat np rat initi exposur np rat made signific mouth movement bottl test consumpt alcohol rat consist higher np rat test day tast reactiv test rat show increas number ingest respons decreas number avers respons alcohol np rat tast reactiv alcohol remain unchang exposur exposur rat np rat respons sucros quinin chang exposur exposur conclud innat tast respons differ np rat alcohol alcohol experi rat show signific increas ingest respons concomit decreas avers respons tast alcohol"
"subject select bias alcohol volunt treatment studi baselin differ alcohol problem sever compar alcohol volunt particip treatment effect studi posit relationship found report alcoholrel problem degre research particip group differ reveal rate treatment complet explan solut volunt bias discuss"
"alcohol abus grandson alcohol preliminari find draw report famili histori alcohol present studi compar level alcohol abus grandson alcohol matern patern grandfath base small sampl grandson result signific higher level alcohol abus matern compar patern grandson"
"relationship neuropsycholog test perform eventrel potenti alcohol nonalcohol sampl eventrel potenti nonconcurr measur neuropsycholog test perform correl sober male femal middleag alcohol peer control administ oddbal eventrel potenti erp task hour batteri neuropsycholog np test alcohol perform signific poorer control np test male alcohol signific alter erp respons nda amplitud femal alcohol differ erp variabl control number signific correl erp np measur present consist find posit correl perceptualmotor pm test amplitud pz male femal alcohol male alcohol negat correl pm test latenc pz find similar parkinson patient signific correl numer famili histori posit alcohol result lead conclus grant postul sober alcohol manifest intermedi durat organ mental disord support lack erp differ femal erp measur consid causal relat np perform"
"comparison administ alcohol screen test saast khavari alcohol test kat result alcohol popul collater studi examin report patient collater drink practic measur summari scale khavari alcohol test annual absolut alcohol intak aaai alcohol relat behavior pattern assess administ alcohol screen test saast outpati milwauke area substanc abus treatment hospit number collater particip studi patient collater respons aaai saast compar pair test result signific differ patient report compar collater report demonstr direct relationship aaai tail saast tail report patient volunt collater compar report patient volunt collater show signific differ aaai saast demonstr consist report patient believ report compar inform provid collater aaai saast corrobor diagnos patient suffer alcohol multivari analysi reveal signific effect demograph variabl aaai saast studi show impress concord patient collater report appar intact memori evid denial measur instrument efficaci measur aaai saast vast scale measur dimens alcohol"
"format kd proteinacetaldehyd adduct liver alcohol treatment depend alcohol dehydrogenas activ proteinacetaldehyd adduct proteinaa form vivo chronic alcohol ingest proteinaa report includ kd proteinaa liver cytosol cytpii aa hepat microsom hemoglobinaa serum proteinaa postul acetaldehyd reactiv acetaldehyd radic generat microsom ethanol oxid system meo cytpii explain format cytpiieaa sourc acetaldehyd respons format cytosol kd proteinaa determin report examin effect pyrazol adh inhibitor cyanamid aldehyd dehydrogenas inhibitor format kd liver proteinaa vivo vitro found feed rat alcohol liquid diet supplement cyanamid enhanc diet supplement pyrazol complet abolish format kd liver proteinaa liver rat fed pyrazol supplement alcohol diet show signific higher content cytpii rat fed diet alcohol hand feed cyanamid supplement alcohol liquid diet enhanc content cytpii similar ad cyanamid cultur medium enhanc ad methylpyrazol inhibit product kd proteinaa cultur hepatocyt combin alcohol methylpyrazol increas content cytpii fold control cell result demonstr format kd liver proteinaa depend adh meo"
"acut alcohol ingest reduc fatti acid extract heart liver small intestin ethanol profound effect distribut perfus substrat util liver heart due vasodil properti generat high level circul acet lactat fatti acid high extract heart liver normal circumst relationship perfusionfatti acid uptak sensit indic alter perfus metabol substrat avail test hypothesi studi perform rat fed kg dose ethanol fatti acid uptak estim methyl substitut reagent chain length equival carbon methyl group posit prevent beta oxid prolong resid fatti acid tissu eighteen hour acut alcohol administr fatti acid uptak reduc heart small intestin liver uptak increas unchang acut ethanol administr result increas perfus enhanc uptak thallium heart liver small intestin fatti acid extract heart liver small intestin defin concentr fatti acid divid concentr thallium mark decreas alcohol ingest alcohol effect dosedepend tempor relat data suggest ethanol ingest potenti alter heart function exercis prolong fast heart reli primarili fatti acid extract circul generat adenosin triphosph atp"
"indic surgic debrid human bite hand indic oper intervent human bite hand determin base physic examin time elaps injuri hundr twenti patient admit chariti hospit orlean la stratifi time elaps injuri treatment earli hour delay day late greater day patient earli group treat conserv wound care consist local wound explor irrig emerg depart late group underw surgic debrid patient delay group receiv conserv wound care underw debrid oper room earli late group recov excel hand function result delay group variabl improv result depend rapid surgic debrid drainag"
"effect granulocytemacrophag colonystimul factor burn patient studi effect granulocytemacrophag colonystimul factor burn patient serial measur granulocyt oxid function obtain treat patient group control match age total burn size administr granulocytemacrophag colonystimul factor result increas leukocyt count group show signific baselin increas granulocyt cytosol oxid function treat patient show normal stimul cytosol oxid function signific depress compar untreat patient myeloperoxidas activ increas treat patient postburn week declin normal level untreat patient signific increas myeloperoxidas activ week injuri untreat patient exhibit signific decreas superoxid activ week injuri treat patient demonstr normal superoxid activ"
"univers precaut univers adher univers blood bodi fluid precaut studi surgic patient care area univers hospit effort identifi potenti hazard health care personnel practic surgic team unit oper room surgic ward patient care team patient care personnel bed surgic intens care unit observ routin patient care activ studi studi specif educ program held improv univers precaut complianc infract occur observ procedur studi observ procedur studi studi infract occur oper room procedur surgic ward procedur surgic intens care unit procedur studi procedur infract rate surgic intens care unit complianc signific improv noncompli univers precaut occur frequent care patient undergon surgeri type infract specif offend vari patient local violat unamen time educ effort substanti improv aris ongo educ program direct specif personnel care patient undergon surgeri"
"seatbelt effect cost noncompli driver admit trauma center enact seatbelt legisl maryland present opportun compar seatbelt complianc injur driver admit level trauma center establish level sever length stay hospit cost differ studi popul fifti random select driver examin total surgic popul seatbelt complianc rate reflect rate communiti seatbelt reduc total number injuri major injuri minor injuri death occur belt group unbelt group injuri sever score time great belt group hospit time longer doubl cost major injuri face chest pelvic region prevent seatbelt belt group sever injuri occur head neck abdomin region recommend air bag automat restrain devic requir driver trauma occur daili highway elimin acut hospit cost minim"
"carbidopalevodopa overdos year woman ingest tablet carbidopalevodopa tablet carbidopa mg levodopa mg ibuprofen carisoprodol hydrocodon acetaminophen patient develop choreiform movement persist obtund attempt extinguish naloxon morphin diazepam patient develop rise level creatin phosphokinas myoglobinuria treat ventilatori support pancuronium requir paralysi hour chorea resolv"
"river regatta accid em perspect river regatta accid occur august formula race craft collid shore injur spectat author retrospect examin prehospitalbas respons multiplecasualti incid emerg medic servic em physician paramed station water landbas post triag evacu patient minut patient transport hospit includ level trauma center accomplish minut em respons uniqu number respect prehospitalbas rescu entir triag stabil phase accomplish river rescu unit transport paramed diver em physician trauma suppli patient signific inordin proport pediatr patient account case success medic care result plan base daili routin doctrin escal exist treatment protocol adequ suppli personnel transport adapt local geographi patient popul communic includ servicesem polic fire prehospit physician input ensur correct triag order patient disposit"
"measur endexpiratori pressur transtrach high frequenc jet ventil laryngoscopi anaesthet techniqu high frequenc jet ventil propos direct laryngoscopi expos patient risk barotrauma order assess risk measur endexpiratori airway pressur eep injector solenoid valv mount seri end insuffl valv switch apparatus deadspac connect atmospher larg exit port adjust time decompress time valv switch inject line connect transduc measur eep injector accuraci measur test airway pressur measur direct trachea pt lung model provid decompress time long ms apparatus deadspac small ml differ eep pt cm ho frequenc hz clinic evalu perform patient general anaesthesia laryngoscopi eep correl endexpiratori pulmonari volum apnoeic frc infer abdomin thorac displac jet frequenc hz correl variabl satisfactori greater suggest eep good indic pulmonari overdistens"
"histori classif knee brace great deal concern orthoped communiti lack object data multitud knee brace flood marketplac articl hope fill void present overview histori classif knee brace"
"choos function knee brace choos function brace knee injuri complex issu complic lack quantit research subject increas number brace market correct brace decis facilit understand knee injuri biomechan understand choic ultim select brace base sound mechan criteria individu patient brace mechan effectu patient confid toler combin aggress rehabilit function brace make signific contribut return individu function activ"
"function analysi anterior cruciat ligament brace anterior cruciat ligament acl brace work subject debat research effort undertaken understand brace divid front static function analysi articl explor issu surround function analysi acl brace"
"knee brace rehabilit articl profil knee brace augment rehabilit program knee injuri outlin aspect rehabilit continu passiv motion devic form exercis train brace enhanc patient recoveri continu passiv motion devic orthoped problem good success understand mechan devic move knee forc appli knee decid ligament reconstruct rehabilit knee surgeri requir good understand effect exercis knee reconstruct gradual progress exercis knee knee ligament reconstruct overstress heal tissu type knee brace exist care evalu enhanc patient recoveri"
"effect brace collater ligament knee disrupt ligament structur knee common competit sport role prophylact function brace controversi prophylact brace shown conclus protect function brace capac provid protect effect"
"clinic signific evalu prophylact knee brace studi footbal review studi prophylact knee brace american tackl footbal found support doublehing brace high school support collegi level problem bias confound make caution exercis interpret result studi group result appli consid studi assign brace random found lower injuri rate high school highschools player knee injuri knee ligament injuri convers larg multiteam collegi studi found signific higher rate knee injuri brace user differ remain control posit skill previous injuri"
"manag smoothblunt gastric foreign bodi asymptomat patient guidelin manag asymptomat patient smoothblunt gastric foreign bodi establish pediatr literatur questionnair pediatrician famili practition pediatr gastroenterologist pediatr surgeon respons rate agreement regard long observ patient recommend intervent correl year clinic experi length observ recommend review preendoscop literatur reveal spontan evacu type foreign bodi pediatr patient observ period week strong consid asymptomat patient smoothblunt gastric foreign bodi includ anatom abnorm gastric outlet previous gastric outlet surgeri possibl toxic object"
"clinic magnet reson imag evalu menisc disord prospect doubleblind studi design evalu capabl magnet reson imag serv diagnost tool patient clinic suspect disord meniscus imag studi provid diagnost accuraci cent sensit cent specif cent posit negat predict valu cent diagnost sensit cent lesion medial meniscus differ signific cent lesion meniscus cent specif lesion medial meniscus extrem low compar rate cent lesion meniscus intermedi part meniscus diagnost sensit cent medial side cent side valu signific averag cent menisc segment imag studi provid accuraci cent detect degener meniscus cent identif menisc tear cent delin postop lesion"
"accuraci diagnos magnet reson imag knee multicent analysi thousand fourteen patient magnet reson imag knee made patient diagnosi subsequ confirm arthroscop accuraci diagnos imag cent medial meniscus cent meniscus cent anterior cruciat ligament cent posterior cruciat ligament magnet reson examin center result vari substanti center accuraci rang cent medial meniscus cent meniscus cent anterior cruciat ligament result magneticreson unit compar find suggest increas accuraci unit stronger magnet field menisci magnet reson signal report grade ii linear intramenisc signal extend superior inferior menisc surfac cent found torn arthroscopi"
"carpometacarp disloc longterm follow twenti patient disloc medial carpometacarp joint averag year rang year fifteen patient treat open reduct intern fixat week injuri longterm result excel thirteen unsatisfactori result patient injuri rigid carpometacarp joint concomit ulnarnerv injuri"
"heal digit flexor tendon import interv injuri repair biomechan biochem morpholog studi dog effect elaps interv time injuri oper repair flexor tendon investig canin model transect intrasynovi flexor tendon repair immedi delay twenti day biomechan biochem morpholog characterist compar week valu angular rotat linear excurs ultim load linear slope determin concentr collagen reduc collagen crosslink index newli synthes collagen measur ultrastructur morpholog tendon examin highvoltag electron microscopi tendon repair immedi valu angular rotat degre week repair day degre repair twenti day degre signific effect delay repair angular rotat linear excurs group tensil test bonetendon complex reveal signific effect delay valu ultim load greater signific differ total concentr collagen site repair level reduc schiffbas crosslink indic newli synthes crosslink tendon group"
"fat distribut steroid hormon women alcohol abus anthropometr hormon liver function paramet examin premenopaus women histori earli alcohol abus compar data random select control age alcohol women show slight elev level transaminas clinic laboratori sign advanc liver damag women character increas waisthip ratio due enlarg waist circumfer endocrin abnorm found includ irregular absent mens low oestrogen progesteron deltaandrostendion level concentr free testosteron high sexhormonebind globulin low data suggest abdomin distribut bodi fat hyperandrogen alcohol premenopaus women postul endocrin abnorm respons abdomin fat distribut"
"associ report injuri alcohol consumpt medic outpati object studi design examin associ minor injuri level alcohol consumpt adult outpati design administ survey alcohol level injuri prior month set adult outpati attend universitybas general intern medicin privat practic patientsparticip month period patient age year complet questionnair wait physician complet form appropri includ studi intervent measur main result total number drink total number injuri report preced month calcul nondrink report averag sd injuri prior month drinker sd injuri minor injuri report frequent heavier alcohol consum younger patient rr associ report injuri alcohol consumpt patient year age rr conclus minor injuri heavier alcohol consumpt younger patient attend general medic practic older patient research establish causal relationship alcohol drink minor injuri"
"massiv transfus outcom blunt trauma patient month period patient consecut admit level trauma center nineti blunt trauma patient requir massiv transfus mt unit pack red blood cell rang eighti cent transfus blood hour admiss forti patient longterm survivor twenti patient die hour exsanguin eighteen patient die greater hour die multipl organ failur die sever close head injuri chi clinic predictor increas mortal shock admiss close head injuri age forti survivor year rang year patient die followup patient home year patient requir continu medic assist thirti patient return work conclud blunt penetr trauma patient receiv mt similar surviv rate shock close head injuri age predict increas mortal preclud surviv longterm outcom blunt patient requir mt excel postdischarg death rare survivor return work justifi high cost acut care"
"save fuel reduc injuri automobil increas fuel economi reduc injuri portray incompat goal base fals assumpt vehicl weight determin factor physic predict size veloc weight primari factor affect crash forc increas weight increas veloc consum fuel analysi fatal injuri rate injuri cost fuel relat vehicl weight vehicl size engin horsepow confirm weight minim import injuri sever compar factor fuel function weight horsepow injuri fuel reduc reduc vehicl horsepow chang vehicl size"
"highpressur inject injuri hand major highpressur inject injuri produc damag hand injuri follow benign inject substanc possess harm natur treatment injuri requir aggress surgeri circumst conserv treatment justifi instanc year period case highpressur inject injuri encount type inject materi paint greas water benzen hydraul oil time import factor result type inject materi modifi clinic cours advis etiolog highpressur inject injuri establish initi factor choos treatment option"
"traumat ruptur interventricular septum tricuspid valv case report cardiac injuri blunt trauma import morbid mortal unsuspect isol chamber ruptur valvular injuri infrequ recogn consequ nonpenetr trauma report describ patient develop perimembran ventricular septal defect disrupt septal leaflet tricuspid valv consequ blunt trauma diagnosi manag traumat ventricular septal ruptur discuss"
"bullet fragment venous embolus heart case report report describ case bullet fragment embolus heart smallcalib gunshot wound mouth skull spine film account projectil chest ray fluoroscopi dimension echocardiographi demonstr venous missil embolus heart bullet palpat trap ventricl easili extrud"
"penetr injuri duplic uret case report duplic genitourinari tract uncommon sourc confus earli diagnosi ureter trauma presenc suspect present case delay diagnosi penetr injuri duplic uret manag"
"traumat scapulothorac dissoci case report year man suffer traumat scapulothorac dissoci tsd carbicyclist accid tsd devast forequart injuri character brachial plexus damag major upper extrem musculoskelet disrupt exsanguin hemorrhag patient surviv hematocrit prompt recognit aggress manag tsd multipl injuri crucial"
"improv outcom earli fixat skelet unstabl pelvic fractur thirti consecut patient unstabl pelvic fractur divid group group juli decemb earli fixat routin group januari march earli fixat perform contraind hospit stay decreas group group patient disabl month versus group discharg rehabilit facil versus group group complic patient versus patient group undergo earli fixat requir fewer unit blood group fractur surgeri delay surviv group versus earli pelvic fractur fixat reduc hospit stay longterm disabl result fewer complic decreas blood loss surviv"
"earli measur system lipid peroxid product plasma major blunt trauma patient sought evid oxidantinduc biolog membran damag resuscit blunt trauma patient averag iss hour injuri anaesthesia surgeri plasma level lipid peroxid product conjug dien cds nm malondialdehyd mda nmolml oxidantinduc effect trauma plasma normal fmlpstimul neutrophil compar control subject differ observ plasma level mda nmolml cds nm stimul neutrophil superoxid product nmol pmns observ persist patient analyz base injuri sever presenc long bone fractur class shock present conclud evid oxidantinduc membran damag manifest increas plasma level cds mda hour blunt injuri"
"spine trauma injuri longitudin prospect gather data base spine trauma develop review consecut hospit admiss identifi presenc injuri individu frequent involv head chest long bone twenti cent injuri spine fractur involv lower cervic thoracolumbar junction comparison presenc absenc injuri spine fractur level show signific differ eighti cent thorac fractur lumbar fractur injuri compar lower cervic spine fractur signific relationship type injuri spine fractur level injuri neural deficit hospit admiss death earli assess transport spine trauma victim carri manag injuri convers multipl trauma victim handl due regard spine fractur spinal unit special train personnel emphas"
"epidemiolog seatbelt injuri studi examin frequenc spine abdomin injuri motor vehicl occup crash victim relationship type injuri associ restraint motor vehicl occup treat region trauma center spine abdomin injuri year period patient chancetyp fractur lumbar spine rear seat passeng lap belt patient type spinal injuri similar patient hollow viscus injuri rear seat passeng lap belt patient injuri spleen liver pancrea kidney lumbar chancetyp fractur hollow viscus injuri includ children increas risk chancetyp fractur hollow viscus injuri increas lapbelt seat restraint popul"
"fibrinogen degrad product fibrinogen serum chang polymorphonuclear granulocyt activityposs import posttrauma sever trauma favor suscept patient infect shown protein protein fragment respons endogen immunodepress trauma coagulopathi accompani increas serum level fibrinogen degrad product fdp found examin fdp influenc activ polymorphonuclear neutrophil pmn pmnactiv measur superoxidespecif method cytochrometest inttest method found decreas pmn activ fdp compar fibrinogen albumin control protein influenc pmn activ unphysiolog high concentr method quantifi pmn activ chemiluminesc unspecif method develop oxygen radic speci activ lipoxygenas pathway contrast superoxid specif test found inhibitori effect fibrinogen serum compar fdp chemiluminesc"
"delay union fibular fractur accompani fractur tibial shaft adult patient tibial shaft fractur accompani fibular fractur case radiograph ununit fibula month injuri unev tibial union fractur sever softtissu injuri exclud studi patient treatment method tibial fractur conserv compris close reduct immobil long plaster cast patient intramedullari kuntscher nail case delay fibular union occur frequenc typic accompani fibular fractur develop delay union comminut middl distal bone followup examin year origin injuri fractur found ultim spontan unit show radiograph indisput nonunion patient undergon segment fibular ostectomi persist local pain remain patient subject symptom neglig occurr delay fibular union associ rigid intramedullari nail concomit tibial shaft fractur phenomenon trauma surgeon awar natur condit benign"
"alcohol cocain year colleg student survey year student univers virginia month arriv campus alcohol time live survey design identifi alcohol cocain relat psychosoci pattern men drank women data suggest bodi weight consid defin drink heavili defin frequent heavi drink drink row week men drink row week women frequent heavi drinker cocain user student psychosoci problem disproportion student plan join fratern soror year student cocain infrequ user pattern frequent heavi drinker effort correct alcohol cocain misus colleg student direct part social organ greeklett societi attend psychosoci featur predispos alcohol cocain misus"
"pharmacokinet dose phenobarbit treatment alcohol withdraw syndrom pharmacokinet deriv phenobarbit dose protocol treat alcohol withdraw syndrom patient admit famili medicin inpati servic describ protocol includ case report document efficaci benzodiazepin agent consid primari agent choic base experi eas administr relat safeti therapeut efficaci lower cost phenobarbit reconsid promis altern compar trial therapeut class clarifi role treatment alcohol withdraw syndrom"
"survey drink pattern medic school studi document common alcohol medic student signific fraction student show pattern alcohol abus author point implic physician impair due alcohol present estim survey junior senior medic student data support earlier survey preval alcohol abus student tend drink heavili frequent enter medic school clinic proven cage question survey show statist signific associ heavi frequent drink medic school respond school offici drink drug abus problem find suggest routin administr screen instrument medic student educ minim intervent strategi individu risk"
"comparison lung alveolar tissu cell silicainduc inflamm silicon dioxid miner cristobalit crs induc inflamm involv alveolar cell connect tissu compart studi compar lung cell recov lung lavag digest lung tissu rat vari time day exposur aerosol crs control expos rat examin wk exposur lavag cell obtain bronchoalveolar lavag phosphatebuff salin lung wall cell prepar collagenas digest lung tissu slice cell lavag lung wall separ percol densiti centrifug upper fraction macrophag cultur condit medium assay effect lung fibroblast growth activ lysosom enzym acetylbetaglucosaminidas result demonstr cell separ lung wall exhibit reaction pattern compar cell recov lavag lung wall cell exhibit progress increas number macrophag lymphocyt compar steadi state cell lung lavag increas macrophag appar due low densiti cell show featur silica exposur secret fibroblaststimul factor consist high lung wall macrophag lung lavag macrophag show inconsist variat secret nag increas lung lavag macrophag decreas observ time lung wall macrophag differ found cell densiti fraction fibroblast stimul enzym secret"
"emerg center laboratori evalu pediatr trauma victim emerg center er trauma evalu includ leukocyt count lc serum amylas sa electrolyt el urin analysi review record pediatr er patient determin util test manag blunt injuri sa evalu patient rang patient normal ct scan sa patient intraabdomin retroperiton injuri sa ns lc determin patient rang ml ml patient normal abdomin ct lc ml rang ml patient injuri ct lc ml rang ml er sa lc alter patient manag thirti patient serum sodium potassium chlorid bicarbon determin sodium potassium chlorid level uniform normal bicarbon leukocyt count uniform abnorm initi evalu expect respons sever injuri determin alter patient care combin laboratori urinarlysi la urin dipstick da analysi hematuria sensit cent specif la predict injuri sensit cent specif da predict injuri sensit cent specif da accur repres la result sensit specif da rapid effect replac la evalu trauma patient emerg center"
"realtim digit contrast enhanc magnif assess scaphoid wrist injuri studi commerci desktop digit magnifiercontrast enhanc detect system made seri patient present acut wrist injuri radiologist vari experi independ review radiograph convent lightbox digit scaphoid seri case perform experienc radiologist margin digit experienc radiologist perform slight wors digit improv confid radiologist diagnos correct presenc scaphoid fractur experienc radiologist expens identifi normal wrist seri case digit result minor increas true posit decreas fals negat observ offset concomit minor increas fals posit decreas true negat categori evalu softtissu plane wrist joint show limit identif scaphoid fractur posit predict correl softtissu presenc absenc scaphoid fractur slight wors digit appar poorer perform digit discuss relat merit potenti unit"
"prognost signific radiolog detect knee joint effus absenc fractur signific radiolog detect knee joint effus marker soft tissu injuri trauma uncertain studi patient present casualti depart acut injuri effus fractur assess follow requir investig proceed surgeri signific soft tissu injuri conclud radiolog detect knee joint effus marker soft tissu injuri"
"assess efficaci activ charcoal treatment acut toxin poison superact charcoal assess efficaci decreas lethal oral parenter exposur toxin fungal metabolit death ill ingest vitro bind studi analyz langmuir adsorpt isotherm show activ charcoal maxim bind capac mg toxinmg charcoal dissoci constant mg charcoal vivo oral administ activ charcoal assess treatment acut oral parenter exposur toxin mice oral toxin administr mgkg untreat mice show surviv hr charcoal treatment kgpo immedi hr toxin exposur result signific improv surviv valu parenter toxin exposur mgkg sc untreat charcoaltr kg po mice show surviv hr ld toxin determin hr intox increas signific mgkg untreat control mgkg activ charcoal treatment"
"occup risk cytomegalovirus infect daycar provid prospect studi daycar provid daycar center southeastern iowa determin occup risk primari cytomegalovirus infect defin epidemiolog risk factor nineti daycar provid seroposit cytomegalovirus latex agglutin entri studi seroneg provid follow seroconvers occur particip center yield annual seroconvers rate median time seroconvers provid month kaplanmei estim risk determin risk seroconvers provid center rang month month risk cytomegalovirus acquisit provid independ race age educ presenc child home care children younger year daycar center risk seroconvers daycar provid parallel rate cytomegalovirus excret acquisit children center"
"multipl alcoholrel problem unit state rise drink problem rise general popul survey drink practic problem conduct unit state includ numer question alcoholrel problem ident ident word data survey test order increas time preval indic multipl problem consid current year lifetim basi studi preval men women age survey preval multipl problem indic rare consid current basi relat increas preval rang found multipl problem indic men women lifetim current problem current problem women rare condit survey statist signific show trend signific respond subgroup age subgroup show increas sampl size decreas signific test order increas time consist"
"alcoholpredict cue enhanc toler precipit crave alcohol social drinker studi attempt show toler alcohol larg part learn respons precipit contextu cue predict uncondit drug effect aim show contextu cue integr environmentdepend toler function increas motiv desir drink alcohol male student drink averag unit alcohol week random assign group group ingest mlkg alcohol alexpt exterocept contextu cue typic alcohol alunexpt context alcohol group placebo believ drink alcohol fact consum nonalcohol beverag alcoholexpect context fourth group drank juic alcoholunexpect context predict toler deleteri effect alcohol cognit motorperform subject desir consum alcohol influenc alcoholpredict contextu cue physiolog index puls rate tend confirm cue elicit condit compensatori respons alcohol implic find toler motiv drink alcohol nonpatholog popul discuss"
"boundari condit effect alcohol placebo present research assess condit subject consum alcohol consum placebo beverag report consum alcohol manipul check question equival respect subject respons alcohol male subject told drink alcohol consum beverag alcohol beer nonalcohol beer vodka tonic lime tonic lime measur subject intox bodi sensat breath alcohol time beverag consumpt subject intox rate higher subject receiv alcohol compar subject receiv placebo report consum alcohol alcohol subject achiev blood alcohol concentr group differ subject intox rate alcohol subject achiev blood alcohol concentr data suggest orthogon manipul alcohol consumpt expect effect problemat blood alcohol concentr"
"diagnost valid mast alcohol depend scale assess dsmiii alcohol disord compar valid michigan alcohol screen test mast alcohol depend scale ad screen current dsmiii alcohol abusedepend disord evalu scale administ patient present treatment alcohol drug problem dsmiii alcohol disord diagnos diagnost interview schedul receiv oper characterist roc analysi determin optimum threshold score mast ad compar screen abil instrument optimum cut point mast ad accuraci classif instrument threshold score area roc curv sd signific differ mast ad abil screen alcohol abus depend popul mast ad correl high result report studi applic revis dsmiii field trial found high level agreement alcohol disord diagnost system categor versus dimension approach assess alcohol discuss"
"recent trend develop alcohol drug treatment servic ontario articl summar major trend develop alcohol drug treatment servic ontario trend contrast object provincewid addict research foundat arf communiti develop program design establish expand addict servic time period data obtain treatment servic provinc survey undertaken period analysi rapid increas number addict program total cost total treatment caseload specif consist arf object stabil hospit bed addict treatment increas communitybas versus hospitalbas treatment resourc increas provincewid capac comprehens client assess larger represent women addict program arf object achiev major increas nonresidenti treatment altern increas proport treat case special popul youth elder requir suggest made futur program develop"
"predict adult drink pattern drink parent studi shown relationship adolesc parent drink pattern parent influenc maintain children adult remov earli influenc repres general popul sampl adult live york state interview current drink famili structur drink pattern parent grow logit model analysi reveal natur father drink grow natur mother drink grow famili structur father present sex respond signific predictor current heavi drink adult control variabl model conclud earli famili influenc longterm consequ drink behavior"
"drink colleg consumpt pattern problem sex differ legal drink age data undergradu respond drawn random sampl rutger univers demonstr fewer colleg student drink compar previous estim larg number heavi drinker addit tradit demograph variabl continu predict alcohol consumpt level student report similar varieti drink relat problem previous colleg drink studi women constitut half heavi drinker men report equal amount alcoholrel problem sampl control race white student continu drink show heavi drink rate compar previous larg colleg sampl northeast student live campus drink commut counterpart drink age effect consumpt level total report alcoholrel problem alter context drink find general compar previous recent colleg drink data sex differ similar discuss find legal drink status implic prevent effort suggest"
"famili background alcohol abus relationship alcohol consumpt colleg student unexpect find purpos studi determin associ posit famili background alcohol abus parent grandpar drank amount alcohol consum week colleg student addit determin differ student posit compar student negat famili background alcohol abus drink pattern survey instrument indirect measur famili background alcohol abus crosssect studi quota sampl colleg student region unit state select result reveal associ famili histori amount alcohol consum week total sampl men women curv analysi slight posit skew curv total group male femal student test chisquar analysi found signific differ posit negat famili background amount alcohol consum drink pattern posit famili background cluster scatter plot heavi light amount alcohol consum result show remark similar alcohol consumpt drink pattern student classifi posit oppos negat famili background conclud posit famili background heavi drink light heavi alcohol consumpt nation sampl colleg student"
"drink style adolesc young adult drink adolesc young adult receiv attent recent past research focus drink style character younger peopl typolog drink behavior special relev group adolesc year young adult year format develop drink habit studi model appli normal drink behavior adult set drink variabl expand cover wider rang activ set behavior intend reflect potenti problem drink deriv nation council alcohol criteria diagnosi alcohol set normal drink behavior factor analyz yield factor structur factor similar previous work adult drink style remain factor relat drink younger peopl problem drink variabl yield factor structur set consist uncommon experi set consist common experi normal drink factor signific predictor problem drink score suggest style drink lead problem"
"lowlevel lead exposur children cognit function preschool year cohort middl uppermiddl class children particip prospect studi child develop lowlevel lead exposur higher blood lead level age month lower score age month mccarthi scale children abil blood lead level age month microgramsdl sd percentil child microgramsdl current definit elev level adjust confound score general cognit index decreas approxim point se natur log unit increas month blood lead level invers associ lead level perform promin visualspati visualmotor integr skill higher prenat exposur lower score month subgroup children high concurr blood lead level greater equal microgramsdl concentr lead dentin shed decidu teeth signific children perform adjust confound"
"earli asbestosi evalu highresolut ct determin earliest stage lesion asbestosi diagnos assess progress asbestosexpos patient minim abnorm plain radiographi examin highresolut comput tomographi hrct interv month examin patient parenchym abnorm found major parenchym featur ct includ thicken intralobular interlobular line subpleur curvilinear line pleuralbas nodular irregular hazi patch increas attenu small cystic space small area low attenu pair serial ct subpleur isol dot branch structur connect peripher branch pulmonari arteri start lower subpleur zone confluent creat pleuralbas nodular irregular ctpatholog correl led conclus confluenc subpleur peribronchiolar fibrosi creat subpleur fibrosi"
"splenic trauma ct grade system enabl predict success nonsurg treatment capabl comput tomograph ct grade system enabl predict success nonsurg treatment splenic trauma children adult evalu fifti patient document splenic injuri examin ct standard trauma protocol ct scan grade recent propos grade system chart patient review correl ct grade clinic outcom determin grade system forti patient underw success nonsurg treatment patient underw delay celiotomi splenic ruptur failur nonsurg treatment grade nonsurg treatment viabl patient splenectomi patient underw surgeri case ct grade error document surgeri case extent injuri underscor ct case injuri overscor clear sever splenic injuri defin ct correl clinic outcom"
"bullet identif radiographi author provid simpl radiograph method estim bullet weight calib deform undeform bullet enabl accur determin calib gamut bullet shape degre confid weightdetermin procedur base correl bullet crosssect area deriv orthogon radiograph bullet weight determin data base properti bullet remov human equat develop bullet weigh undeform bullet addit method calcul calib direct diamet bullet bodi radiograph method enabl correct predict weight calib bullet method result reliabl testimoni base result accept local polic case meet requir testimoni court case involv gunshot"
"assess nutrit critic ill patient critic ill creat vigor metabol respons permit repair injur tissu nutrit essenti medic manag critic ill patient individu adequ endogen nutrit reserv rapid develop complic starvat nutrit supplement essenti critic ill patient readili toler nutrit support calori withheld patient toler util nutrit support decis initi nutrit support made nutrit status level stress metabol condit vital organ function influenc patient nutrit requir assess patient metabol condit data determin supplement electrolyt macronutri data provid inform vital organ function util fuel substrat aggress monitor judici nutrit supplement afford critic ill patient chanc recoveri"
"famili alcohol primari unipolar major depress disord object studi suggest relationship depress proband alcohol relat studi inappropri control group fail divid proband sex method present studi control sex proband comparison group explor famili relationship depress alcohol diagnos direct interview relat proband primari unipolar depress compar diagnos control subject chosen acquaintanceship method demograph resembl relat affect disord proband diagnos uninterview relat control depress subject comparison result result higher rate alcohol famili depress women famili depress men conclus famili associ alcohol depress result genet environment factor interact"
"effect financi manag alcoholrel hospit object treatmentunrespons alcohol zealand unabl care tend hospit lengthi period time author examin effect ad financi manag therapeut manag patient null hypothesi effect durat alcoholrel hospit method alcohol patient regist alcohol outpati clinic receiv financi manag period year includ studi alcoholrel disabl sever result result lengthi frequent period hospit financi manag involv put patient incom check account budget advisori offic cosignatori withdraw advisor patient basic live requir met expenditur alcohol detriment effect particip voluntari voluntari patient involuntari commit patient durat patient alcoholrel hospit compar equal period time financi manag institut result null hypothesi support durat alcoholrel hospit financi manag institut manag conclus patient struggl face excess drink cope task daili live includ provis adequ shelter nutrit benefit ad financi manag therapeut strategi consid"
"drug abus schizophren patient clinic correl reason object studi aim determin substanc abus preval prefer divers sampl schizophren schizoaffect schizophreniform inpati compar drugabus drugabus patient demograph clinic variabl acut stabil phase hospit obtain data patient reason drug abus acut staterel period intox method eighti psychot inpati consecut admit york citi teach hospit evalu sixti schizophrenia schizoaffect disord schizophreniform disord diagnos structur clinic interview dsmiii patient receiv rate psychiatr rate scale global assess scale scale assess negat symptom admiss discharg evalu premorbid adjust extens interview drug alcohol result forti patient receiv diagnos drug alcohol abus depend drugabus patient primarili cannabi alcohol cocain report abus drug high reliev depress relax signific fewer posit negat symptom discharg sexual adjust wors school perform adolesc famili histori drug abus drugabus patient conclus schizophren patient abus drug repres subgroup patient prognos sever clinic characterist schizophrenia drug abus advers affect global outcom"
"ray fluoresc measur lead burden subject lowlevel communiti lead exposur ray fluoresc xrf instrument measur vivo bone lead low level popul adult histori excess lead exposur questionnair gather inform relev occup environment lead exposur administ prior measur min measur produc averag estim uncertainti mcg lead bone miner midtibi diaphysi subject eighteen subject bone lead level measur uncertainti remaind bone lead level rang mcg lead bone miner bone lead level greater older subject young adult subject bone lead level greater measur uncertainti confin subject grown hous estim build prior childhood environ high risk foster exposur biolog absorb lead ingest lead paintcontamin dust lead pipecontamin water conclud xrf techniqu potenti distinguish low level lead burden epidemiolog studi"
"clinic patholog studi adult case acut mercuri inhal toxic report case fatal mercuri vapor inhal rare occurr mercuri vapor releas privat home occup smelt silver dental amalgam unknown amount mercuri hour incid occup began short breath necessit hospit admiss clinic cours briefli detail includ rapid deterior respiratori failur chest roentgenogram case consist adult respiratori distress syndrom patient treat dimercaprol mercuri chelat die surviv vari day postexposur autopsi perform patient lung case heavi firm airless histolog examin reveal sever diffus alveolar damag variabl amount fibrosi conform acut lung injuri stage organ addit postmortem find includ acut proxim renal tubular necrosi vacuolar hepatox spectrum central nervous system alter includ multifoc ischem necrosi gliosi vascul"
"circadian variat heart rate affect environ studi continu electrocardiograph monitor member symphoni orchestra twenti hour ambulatori st segment monitor perform member player member managementtechn team british broadcast corpor bbc symphoni orchestra histori cardiac diseas period includ final rehears live perform audienc radio music richard strauss mozart royal festiv hall rachmaninov tchaikovski barbican art centr period monitor person transient st segment heart rate signific higher live perform rehears heart rate live perform rachmaninov tchaikovski signific higher strauss mozart monitor occas heart rate manag technic team higher player recognis circadian pattern heart rate peak morn wake hour alter similar concert day primari peak occur hour lesser peak morn musician managementtechn staff studi show environment factor primari import defin circadian pattern heart rate import implic identifi peak period cardiovascular stress tailor drug treatment patient angina pectori"
"abus elder peopl carer object assess preval abus elder peopl carer characterist abus abus designinform abus risk factor collect month carer patient risk factor identifi abus group compar abus control group settingcar interview home patient examin ward putney barn geriatr hospit london subject patient refer sourc respit care geriatr servic month period carer main outcom measuresamount physic verbal abus neglect quantif risk factor correl presenc absenc abus result carer open admit form abus patient admit abus signific risk factor physic abus alcohol consumpt carer signific risk factor poor premorbid relationship previous abus year abus reciproc social dysfunct patient servic deliveri respit care level mental physic disabl signific abus conclus high level abus found elder patient respit care alcohol abus long term relationship poor qualiti difficult chang increas provis servic care communiti solut peopl"
"intrapulmonari distribut bronchial blood flow moder smoke inhal system blood flow airway left lung determin radioact microspher techniqu smoke inhal conscious sheep smoke group sheep insuffl air sham group smoke inhal caus sixfold increas system blood flow lower trachea baselin injuri mlmin fold increas intrapulmonari central airway baselin rang mlmin injuri mlmin trend hyperem respons greater airway diamet decreas trachea mmdiam central airway airway smaller mm hyperem respons diminish total system blood flow lung predomin small peripher airway show signific increas baselin level mlmin lung homogen occlus bronchoesophag arteri decreas central airway blood flow peripher airway blood flow sham smoke group"
"toxic epiderm necrolysi lyell syndrom toxic epiderm necrolysi formid diseas encount dermatologist uncommon rare toxic epiderm necrolysi occur person year franc remain puzzl disord year ago lyell toxic epiderm necrolysi sever form erythema multiform subject discuss physiopatholog event lead rapid extens necrosi epidermi understood indirect evid suggest hypersensit reaction search potenti immunolog mechan result data support hypothesi accumul clinic evid point drug import toxic epiderm necrolysi sulfonamid longact form anticonvuls nonsteroid antiinflammatori agent antibiot case toxic epiderm necrolysi drug implic isol case report organ involv process destruct epithelium observ epidermi system consequ acut skin failur patient widespread burn sepsi import complic death approxim patient toxic epiderm necrolysi die elder patient patient extens lesion higher mortal rate surviv patient complet heal week residu potenti disabl ocular lesion prognosi improv adequ therapi provid burn unit aggress fluid replac nutrit support coher antibacteri polici corticosteroid advoc high dose halt hypersensit process shown studi detriment avoid"
"protect behavior captopril hginduc toxic kidney mitochondria vivo vitro experi mercuri induc morpholog function modif kidney mitochondria work studi vitro vivo protect effect captopril deleteri effect hginduc nonspecif membran permeabl ca membran deenerg vivo administr captopril prevent toxic effect mercuri poison membran permeabl oxid phosphoryl ca homeostasi captopril preserv kidney tissu morpholog hginduc damag protect effect captopril relat exist sulfhydryl group drug"
"energi balanc elder patient surgeri femor neck fractur studi energi protein balanc elder patient surgeri spontan energi protein intak rest energi expenditur ree measur elder femal patient femor neck fractur age sd rang year weight rang kg day period surgeri ree measur min indirect calorimetri ventil canopi averag kcalmin day decreas kcalmin day postsurgeri ree posit correl bodi weight ree extrapol hr ree kcalday daili food energi intak measur day follow period kcalday posit correl ree daili energi balanc kcalday day kcalday day postsurgeri ns studi period kcalday extra kcalday energi cost physic activ daili energi balanc day studi period calcul kcalday measur total hr urinari nitrogen excret obtain subgroup patient"
"human growth hormon combin nutrit support critic care unit administr growth factor potenti acceler recoveri critic ill reduc bodi protein catabol enhanc wound heal improv skelet muscl function purpos phase studi evalu safeti initi efficaci recombin growth factor human growth hormon gh combin nutrit support critic care unit initi control week individu receiv gh mgday daili consecut week constant nutrient intak provid parenter enter feed studi period vital sign clinic paramet blood valu nutrient excret monitor daili gh administr clinic signific advers effect week studi nitrogen excret decreas mmolday day control mmolday day growth hormon associ mark reduc urea generat signific reduct potassium excret control mmolday gh phosphorus excret mmolday occur gh proteinconserv effect gh sustain week treatment growth hormon enhanc effici administ protein facilit nitrogen retent clinic signific advers effect small patient group control trial determin anabol hormon reduc hospit time improv clinic outcom sever injur patient combin nutrit support"
"factor contribut increas energi expenditur thermal injuri review studi employ indirect calorimetri summari remark close agreement exist mee measur studi sever burn trauma surpris variabl sampl size measur techniqu studi design dpbs studi mee calcul data publish report list final column tabl case unweight mee kcalday studi prior mee exceed kcalday report publish mee pre report differ kcalday accept notion degre elev mee proport bsab bsab general sens appli caution recent studi includ proportion burn exceed bsab suggest elev mee case physiolog plateau appar exist slight normal rmr peak mee magnitud mee respons result undefin interact factor examin inflammatori mediat begin receiv studi contribut reduct mee intervent control cardiac output peripher cool core temperatur evapor water heat loss substrat cycl review import indirect calorimetri patient care highlight larg variabl similar injur individu unexplain compon regress analys"
"biomechan lumbar pedicl screwplat fixat trauma investig conduct determin alter biomechan strength stiff characterist lumbar spine fixat steffe instrument compar studi paramet conduct lumbar column fresh human cadav run conduct tl column control injur fixat specimen load compressionflexion mode failur control run reload injuri run failur deform determin control run screwplat insert level proxim distal injuri specimen reload fixat run radiograph trial data deform forc histori gather loaddeflect respons injur fixat specimen bimod repres stiff control failur load stiff higher injur fixat spine initi stiff signific higher fixat injur column final stiff similar increas initi stiff fixat specimen compar injur specimen strength ad posterior region spine smaller alter final stiff fixat injur column load share anterior column suggest critic strain level anterior column absorb higher portion extern load posterior fixat inadequ sole treatment trauma"
"free vascular thin corticoperiost graft paper describ thin corticoperiost graft harvest medial condylar supracondylar area femur base articular branch descend genicular arteri vein consist periosteum thin mm layer outer cortic bone retain cortex cambium layer preserv thought osteogen capac vascular periost graft graft treat patient fractur nonunion upper extrem convent treatment fail unev boni union achiev patient week"
"simultan bilater forearm revascular success simultan bilater forearm revascular perform year boy function recoveri forearm evalu month injuri patient hand activ daili live employ signific psycholog problem temporari intralumin silicon shunt extrem reduc ischem damag injur limb suffici skelet shorten upper limb replant crucial import wound manag aggress repeat debrid accur primari nerv repair essenti earli postop rehabilit import achiev satisfactori function return function replant revascular upper extrem superior amput prosthesi case bilater upper extrem amput devascular"
"theodor kocher scientif foundat wound ballist system ration approach kocher coupl interest research wound ballist year result clear elucid principl form basic scientif foundat modern wound ballist valid work prove repeat battlefield world centuri present sound scientif precept reveal kocher essenti technolog investig framework good judgment"
"nailgun suicid case report young men commit suicid nail gun shot heart left lung shot head case complet suicid nail gun previous report english literatur case report uncommon natur repres potenti fatal common industri implement"
"suicid starter pistol air gun report case year depress woman commit suicid starter pistol load cs tearga ammunit propel gase contact shot enter chest left sixth intercost space exsanguin caus perfor pericardium apex heart autopsi reveal metal foreign bodi origin propel cartridg bulletlik materi injuri caus propel mg cs degrad product cyanid detect cardiac blood report case year man suffer depress psychosi commit suicid air rifl leadpoint diabolo bullet enter brain larg wing sphenoid bone travers tempor brain pole damag middl cerebr arteri optic tract final lodg left central ganglia extens basal subdur hemorrhag tamponad cerebr ventricl death attribut cerebr failur list case suicid rare weapon"
"forens photographi ultraviolet imag wound skin ultraviolet light uvl studi document pattern injuri human skin open frontier law enforc articl discuss photograph techniqu involv reflect fluoresc uvl document skin wound photographi dynam video photograph techniqu util method uv illumin cover techniqu import courtroom present evid gather lacer contus abras bite mark present case studi control experi injuri common sequela crime child abus rape assault"
"suicid thiopenton infus suicid intraven thiopenton infus search literatur reveal case pauciti possibl due report suicid occur medic personnel"
"homicidesuicid stab rare assail kill afterward commit suicid stab scene report describ young soldier kill young girlfriend kill"
"wrist slash detent center case report review literatur suicid occur custodi rare requir extens forens analysi asphyxia hang common suicid success suicid commit uniqu case suicid custodi present prison slash wrist eyeglass len evid proceed led suicid review data compar behavior pattern world literatur suicid incarcer review"
"suicid chloroform ingest mutil case suicid combin element psychot mutil chronic termin poison ingest chloroform illustr unusu method investig death peopl pattern bizarr behavior access unusu fatal materi"
"ineffect dantrolen sodium treatment heatstrok studi object determin efficaci dantrolen sodium treatment heatstrok design random doubleblind placebocontrol trial set heatstrok center makkah saudi arabia patient fifti adult patient heatstrok intervent patient assign receiv dantrolen sodium mgkg bodi weight iv placebo convent cool therapi initi measur main result signific differ cool time treatment control group min death control group complic patient receiv dantrolen sodium patient receiv placebo differ statist signific signific differ number hospit day day conclus treatment dantrolen sodium dose prove benefici patient heatstrok"
"mandibular ramus anatomi relat medial osteotomi sagitt split ramus osteotomi sagitt split ramus osteotomi frequent procedur correct mandibular skelet dentofaci deform numer improv techniqu year procedur introduc number troublesom complic occur includ unfavor fractur surgeri paresthesia relaps purpos studi determin fusion buccal lingual cortic plate occur upper mandibular ramus thought placement horizont medial osteotomi point fusion interven medullari bone lead unfavor fractur split forti human mandibl section vertic locat perpendicular surfac ramus occlus plane measur made locat vertic point fusion buccal lingual cortic plate relat lingula depth sigmoid notch point fusion occur mm lingula mandibl fusion level lingula anterior ramus posterior ramus mandibl fuse level level halfway lingula sigmoid notch mandibl fuse anterior ramus mid posterior ramus incid high locat medial horizont osteotomi tip lingula higher level cut increas difficulti split incid unfavor fractur"
"cocain metabolit detect homicid victim analyz blood homicid victim presenc cocain major metabolit benzoylecgonin fulton counti georgia homicid victim test benzoylecgonin test posit proport black victim firearm injuri test posit benzoylecgonin signific larger respect proport white victim injuri involv firearm data show proport benzoylecgonin posit larger previous report literatur relationship homicid race firearm cocain deserv studi"
"predict histor physic characterist diagnosi child abus child abus burn difficult recogn injuri small histor physic find elicit initi examin initi depth investig injuri inconsist histori delay seek medic treatment frequent report elicit suspicion isol find low predict presenc factor increas yield child abus identif"
"childhood firearm fatal metropolitan dade counti experi review case childhood firearm fatal file medic examin depart metropolitan dade counti miami florida comparison case year period year period note basic epidemiolog paramet show death due firearm increas children age year younger"
"anterolater ankl disloc fractur disloc tibiotalar joint fractur rare present case open anterolater ankl disloc complet ligament disrupt contrast report intern fixat requir maintain reduct tibiotalar joint disloc found disloc grossli unstabl requir syndesmot screw calcaneotalotibi transfix pin stabil"
"alcohol abus adolesc alcohol abus teenag increas problem physic social consequ earli diagnosi adolesc alcohol delay reason physic indic alcohol abus adult identifi teenag alcohol general believ adult problem histori care respect confidenti famili physician determin extent young person alcohol abus begin process treatment adolesc patient famili"
"left ventricular size mass function relat durat quantiti heavi drink alcohol left ventricular lv hypertrophi mild dysfunct frequent observ alcohol relat durat sever alcohol abus lv size mass function studi echocardiographi systol time interv middleag male alcohol gave detail account durat heavi drink quantiti recent ethanol consumpt durat abstin compar healthi nonalcohol alcohol higher lv mass index standard error thicker posterior wall mm longer endsystol diamet index mmm higher preeject periodeject time ratio multivari linear regress model abnorm prove independ drink histori posterior wall thick weak relat durat heavi drink standard correl coeffici univari analys suggest lv mass index systol time interv ratio curvilinear relat total durat heavi alcohol consumpt conclud lv hypertrophi dysfunct found alcohol poor relat durat sever report alcohol abus data suggest simpl linear doseinjuri relat longterm cardiotox ethanol factor modifi myocardi effect ethanol studi futur"
"motorcycl licensur ownership injuri crash involv interrelationship motorcycl licensur ownership injuri crash involv investig sampl motorcycl driver sever fatal injur california owner motorcycl crash driverown valid licens random sampl motorcycl owner crash percent thirti percent crashinvolv driver valid motorcycl driver licens percent oper motorcycl drivernonown drivernonown valid licens driverown percent percent licens rate crashinvolv drivernonown percent owner unlicens rate valid licensur lowest youngest driver virtual crashinvolv drivernonown age licens case owner young unlicens"
"alcohol abus random sampl physician medic student background studi sought resolv conflict view physician prone alcohol abus method anonym mail questionnair substanc survey physician pharmacist student physician pharmacist select random state societi membership list student select local school list follow survey nonrespond week interv result physician medic student drink heavili vulner alcohol counterpart pharmaci profess physician differ pharmacist style drink greater frequenc smaller quantiti total amount alcohol consum drink habit physician medic specialti type practic posit relat gender male drank femal age older doctor apt qualifi heavi drinker younger doctor conclus physician abus substanc nonmed profession group alcohol univers incur risk abus impair"
"respons alcohol servic studi server manag environment impact respons alcoholservic train program evalu impact chang belief knowledg behavior server manag chang establish polici encourag safer drink environ train program signific impact chang belief knowledg server manag observ week train show effect server behavior tendenc establish polici compar control"
"spinal cord injuri prognosi ambul base sensori examin patient initi motor complet purpos retrospect studi document patient motor complet injuri preserv pin appreci addit light touch zone injuri prognos regard ambul patient light touch preserv medic record examin spinal cord injuri sci patient admit twenti frankel patient upper motor neuron lesion admit hour injuri identifi patient divid group group patient touch sensat pin appreci zone injuri group patient partial complet pin appreci light touch zone injuri chart examin patient abil walk independ reciproc gait feet data analyz fisher exact test group patient ambul compar group patient frankel sci patient touch preserv zone injuri poor prognos ambul preserv pin appreci zone injuri excel prognos regain function ambul"
"chronolog age time injuri time measur effect adjust spinal cord injuri peopl live longer spinal cord injuri sci limit research address issu age adjust sci purpos studi timesequenti design identifi relationship adjust sci facet age chronolog age time injuri time measur life situat questionnair obtain sampl particip sci sampl particip group cohort base chronolog age cohort base time injuri group base time measur manova perform chronolog age time measur time injuri time measur result chronolog age time injuri work oppos direct aspect adjust declin greater chronolog age aspect improv increas time injuri activ strong relat chronolog age medic stabil strong relat time injuri chronolog age time injuri correl aspect life satisfact comparison time measur limit posit adjust time result point complex relationship age adjust rehabilit profession multipl age factor"
"posttraumat hyperlipofuscinosi human retin pigment epithelium light microscopi includ fluoresc microscopi electron microscopi appli studi photoreceptorretin pigment epithelium rpe complex human eye sever traumatis month prior enucl main featur interest massiv accumul lipofuscin retin pigment epithelium posterior pole quantit fluoresc microscopi provid valu time obtain control tissu photoreceptor layer normal posterior pole progress atroph peripheri concentr lipopofuscin proport degre preserv retin photoreceptor electron microscopi cell rpe pack mixtur lipofuscin granul melanolysosom complex occasion photoreceptor phagosom found bruch membran choriocapillari normal attribut hitherto unreport abnorm rpe trauma dysfunct consequ overload monolay photoreceptor debri time trauma"
"administr interleukin stimul multilineag hematopoiesi acceler recoveri radiationinduc hematopoiet depress hematopoiet depress subsequ suscept potenti lethal opportunist infect document phenomena radiotherapi method therapeut mitig radiationinduc myelosuppress offer great clinic vivo studi laboratori demonstr interleukin il stimul pluripot hematopoiet stem cell cfu granulocytemacrophag progenitor cell gmcfc erythroid progenitor cell cfu prolifer normal mice base result abil il stimul hematopoiet regener radiationinduc hematopoiet injuri evalu chhen femal mice expos gy radiat subcutan administ salin il microgramskg day postexposur day femor splenic cfu gmcfc cfu content peripher blood white cell red cell platelet count determin compar salin treatment day day il treatment acceler hematopoiet recoveri day treatment produc greater effect compar normal control valu femor splenic cfu number iltreat mice day postirradi versus salinetr mice time bone marrow splenic gmcfc valu versus salinetr mice bone marrow splenic cfu number versus salinetr mice peripher blood white cell red cell platelet valu versus salinetr mice studi demonstr therapeut administ il effect acceler multilineag hematopoiet recoveri radiationinduc hematopoiet injuri"
"bell ringer bruis broken bone caper crise campanolog object determin incid aeriolog outcom injuri due bell ring designretrospect review year issu ring world advertis ring world postal questionnair activ ring tower subjectsregular bell ringer resultsseventi injuri identifi review advertis ring world incid injuri ringer identifi postal questionnair year conclus soner bell ring danger occasion fatal doctor awar danger campanologist expos"
"occurr repetit hospit admiss accid preschool children object examin trend time rate admiss hospit accid preschool children studi pattern repeat admiss accid children designanalysi link routin abstract hospit inpati record accid set district oxford region health author cover oxford record linkag studi subjectsrecord children age year time record admiss hospit main outcom measurenumb admiss hospit resultsrecord analys group person base annual admiss rate calcul calendar year child record admiss identifi child record linkag year admiss child record admiss identifi year children averag annual resid popul children admiss accid year age admiss injuri poison burn admiss rate declin poison substanti time found admiss rate injuri burn total children year year children year year admiss accid year year children year admiss accid number children accid greater expect accid random occurr poison admiss poison injuri burn burn admiss burn conclusionshospit admiss accid children common averag child popul admit year multipl admiss uncommon occur expect chanc"
"doserespons relationship effect insulin glucos fat metabol injur patient control subject  twenti patient studi day musculoskelet injuri order defin natur impair sensit insulin insulin infus unit min plasma glucos concentr clamp mmol forearm uninjur glucos extract blood flow measur bodi substrat oxid energi product rate assess indirect calorimetri patient compar normal control subject  plasma insulin concentr infus similar patient control subject show similar metabol clearanc insulin infus rate rate glucos infus maintain euglycaemia patient control subject doserespons curv bodi glucos infus rate plasma insulin concentr show diminish sensit diminish maxim respons patient similar pattern forearm glucos uptak mark impair sensit insulin maxim respons  rest metabol rate increas patient compar control subject fail respond insulin infus final metabol rate similar patient control subject higher insulin infus rate final rate bodi oxid carbohydr signific patient control subject fat signific greater"
"percutan screw fixat fractur scaphoid describ percutan techniqu screw fixat type fractur scaphoid year period end case treat method return evalu compris materi report postop time month recent fractur unit delay nonunion sclerot nonunion"
"fracturesepar distal humer epiphysi review case fracturesepar distal humer epiphysi initi misdiagnos fractur condyl elbow disloc cubitus varus deform common fracturesepar supracondylar fractur common children year age close reduct simpl immobilis adequ older child recommend year age close reduct percutan pin carri angl assess immedi reduct elbow varus wire remov reduct repeat treatment straight traction maintain valgus carri angl"
"bone structur remov intern fixat plate singlephoton absorptiometri assess forearm bone remov intern fixat plate patient found convinc evid cortic atrophi patient plate remov prematur month suggest plate retain month bone densiti return prefractur level recommend aoasif group support"
"femor head blood flow femor neck fractur analysi intraoss pressur measur studi patient fractur femor neck intracapsular extracapsular intraoss pressur measur transduc bone quantifi blood flow intracapsular pressur needl introduc joint space intracapsular pressur lower extracapsular fractur intraoss pressur femor head unchang aspir joint intracapsular fractur aspir produc signific decreas intraoss pressur increas puls pressur femor head result suggest aspir intracapsular haematoma produc increas femor head blood flow reliev tamponad"
"alcohol consumpt synthesi ethyl ester fatti acid adipos tissu ethyl ester fatti acid eefa found form ethanol metabol human adipos tissu high concentr free fatti acid substrat eefa synthesi tissu great potenti eefa format order explor potenti marker alcohol abus eefa concentr activ eefasynthes enzym determin adipos tissu men belong categori teetotal social drinker alcohol treatment establish alcohol found die result alcohol intox order estim halflif eefa synthas activ induct alcohol examin time period abstin alcohol comparison made establish marker alcohol abus eefa found teetotal found low concentr social drinker eefa found alcohol forens case high concentr eefasynthes enzym activ found subject increas teetotal social drinker fold higher alcohol fold higher dead alcohol induct enzym abstin halflif order week correl found eefa synthas activ previous establish marker alcohol abus remain long time period abstin erythrocyt corpuscular volum preliminari studi suggest possibl eefa synthas induct adipos tissu longer halflif previous marker alcohol abus suggest induct eefa synthas potenti marker alcohol abus appar proport alcohol intak prolong time period presum specif longterm elev alcohol abstin potenti marker analys"
"landmark case asbestosi publish account diseas attribut occup asbesto exposur nelli kershaw die circumst relat case explan greater impact polici time case start set context miss opportun prevent major public health hazard effect hazard wit today"
"divingrel ear injuri divingrel ear barotrauma ieb ear decompress sick result perman sever cochleovestibular deficit diagnosi reach correct treatment commenc earli case sportdivinginduc ear injuri refer isra naval hyperbar institut octob septemb present regard evalu treatment follow diagnosi ieb diver explor tympanotomi carri remark result patient ieb remain reliev bed rest patient recompress extend navi tabl good shortterm result role complet otoneurolog evalu decisionmak process lead correct diagnosi treatment emphas"
"dimension computer tomographi evalu laryng injuri comparison diagnost inform obtain physic examin convent dimension axial computer tomographi scan ct dimension display computer tomographi ct perform patient sustain laryng trauma patient laryng fractur patient incomplet ossifi thyroid cartilag normal variant simul fractur ct dimension display computer tomographi found superior convent ct assess presenc natur laryng injuri correct identifi anatom variant"
"secondari prevent lowback pain clinic trial clinic trial aim secondari prevent lowback pain perform hospit employe report annual episod condit particip random assign group calisthen program cal month biweek session flexion exercis back school program session control group effect intervent program evalu year period baselin preintervent data evalu end month intervent addit month collect month surveil year show pain month cal group versus month back school control group superior cal group achiev part signific increas trunk forward flexion initi increment abdomin muscl strength increas trunk flexion rate particip cal session research answer question intens versus type exercis compar intervent program similar intens"
"effect hydroxybutyr posttraumat metabol man patient suffer trauma injuri sever score greater patient receiv dlhydroxybutyr ohb rate mumolkgmin hour remain patient receiv sodium dllactat rate control subject increas arteri concentr keton bodi femor arterioven differ arteri concentr minus venous concentr keton bodi increas proport ohb group venous concentr nonesterifi free fatti acid alanin glycin valin decreas signific ohb group compar control group concentr differ femor vein arteri venous concentr minus arteri concentr substrat decreas indic decreas releas extrem decreas venous concentr alanin differ femor vein arteri reach mumol mumol sd ohb infus decreas alanin releas muscl ohb infus traumat patient suggest suppress effect keton bodi posttraumat protein catabol"
"composit skin graft compos cultur human keratinocyt fibroblast collagengag matrix cover fullthick wound athym mice patient extens fullthick burn wound coverag acceler skin expand produc skin replac reproduc suppli blood wound good structur qualiti addit develop skin replac benefit patient requir reconstruct replac larg area abnorm skin develop composit skin replac compos cultur human keratinocyt hk fibroblast cultur human fibroblast seed interstic cultur hks appli surfac matrix compos type collagen crosslink glycosaminoglycan defin physic structur hks reach confluenc matrix surfac composit graft fullthick wound dorsum athym mice graft accept confirm posit stain antibodi specif human hlaabc antigen hks approxim defin skin structur present histolog day graft differenti epithelium subepiderm layer dens popul fibroblast capillari evid inflamm fluoresc light microscopi identifi laminin type iv collagen electron microscopi confirm presenc basement membran compon day graft attach graft wound similar addit human basic fibroblast growth factor potent angiogen agent skin replac graft placement wound"
"relat respiratori symptom type farm lung function disord farmer respiratori symptom function examin random sampl farmer pig farmer dairi farmer age year wheez short breath work anim hous signific pig farm odd ratio current smoke odd ratio bronchial hyperreact odd ratio low fev odd ratio pig farmer slight lower fev dairi farmer versus predict ns symptomat farmer signific lower fev symptomless farmer versus predict multipl linear regress analysi cross section valu fev show declin fev pig farm mlyear pig farm smoke mlpack year addit age relat declin mlyear multipl linear regress analysi pc histamin show bronchial reactiv increas age number pack year number year pig farm work close pig rear unit pulmonari health hazard declin lung function"
"characterist adult chronic hair puller object studi construct detail demograph phenomenolog featur chronic hair puller assess psychiatr comorbid sizabl studi group method subject drawn outpati popul chronic hair puller refer trichotillomania clinic respond newspap advertis announc treatment studi adult pull hair sixti adult chronic hair puller complet semistructur interview focus hairpul behavior demograph characterist incorpor screen question dsmiii axi disord data tabul deriv comprehens pictur group result typic subject year woman pull hair site year subject tension reliefgratif pull hair primari site fail describ characterist fail fulfil dmsiii criteria trichotillomania forti subject qualifi past current axi diagnos trichotillomania characterist studi group suggest phenomenolog differ obsessivecompuls disord trichotillomania conclus adult trichotillomania chronic disord frequent involv multipl hair site high rate psychiatr comorbid relat obsessivecompuls disord requir clarif tensionreduct requir dsmiii diagnosi trichotillomania restrict"
"transderm nicotin smoke behavior psychiatr patient author doubleblind crossov design observ effect transderm administ nicotin smoke behavior psychiatr patient stop smoke patient smoke signific fewer cigarett receiv nicotin receiv placebo data suggest transderm administ nicotin adjunct treat nicotineaddict psychiatr patient smoke environ"
"diagnost periton lavag limit indic due evolv concept trauma care studi undertaken determin appropri celiotomi consecut patient underw celiotomi sole posit diagnost periton lavag dpl blunt stab abdomin trauma total patient posit dpl laboratori criteria blunt trauma greater rbcmm greater wbcmm stab trauma greater rbcmm greater wbcmm dpl patient posit gross inspect patient dpl laboratori result return surgeri satisfi laboratori definit posit dpl cent underw therapeut celiotomi tc cent underw nontherapeut celiotomi ntc grade ii spleen liver injuri led cent ntcs posit dpl determin gross inspect laboratori test poor accuraci rate evalu light evolv belief promot nonop therapi grade ii liver spleen injuri posit dpl sole indic celiotomi patient blunt stab abdomin trauma unaccept larg number ntcs perform dpl limit role evalu patient abdomin trauma"
"splenic trauma choic manag modern era splenic surgeri injuri began riegner report splenectomi year construct worker fell height present abdomin pain distens tachycardia oliguria report set stage routin splenectomi perform splenic injuri generat earli report pearc morri bullock splenectomi anim caus impair defens infect challeng routin splenectomi made king schumack report syndrom overwhelm postsplenectomi infect opsi studi demonstr import spleen prevent infect encapsul organ overwhelm postsplenectomi infect occur children adult intraop splenic salvag popular achiev safe patient deliv spleen pancrea incis care repair spleen direct vision adjunct sutur repair includ hemostat agent splenic wrap intraop splenic salvag patient activ bleed organ presenc alcohol cirrhosi role splenic replant patient requir oper splenectomi studi provid signific longterm splenic function nonop splenic salvag suggest year ago billroth modal popular children adult patient intrasplen hematoma splenic fractur extend hilum judg comput tomographi observ success oper intervent blood transfus nonop splenic salvag fractur involv splenic hilum sever shatter spleen patient treat earli oper intervent splenectomi injuri polyval pneumococc vaccin decreas likelihood opsi routin role prophylact penicillin uncertain antibiot minor infecti problem splenectomi"
"increas gut permeabl burn trauma twenti femal hartley guinea pig weigh fullthick burn injuri gastrointestin permeabl assess burn postburn day administ ml isoton mixtur lactulos rhamnos gavag measur urinari excret hour normal guinea pig lactulos molecular weight absorb paracellular rout rhamnos molecular weight absorb transcellular rout gut permeabl rhamnos increas burn injuri microgram burn microgram day burn contrast gut permeabl lactulos increas signific greatest hour burn injuri microgram burn microgram day burn gut permeabl lowmolecularweight compound increas immedi burn trauma paracellular transcellular mechan"
"inject drug femal streetwork prostitut glasgow difficulti calcul preval covert illeg stigmat activ paper outlin method develop calcul preval druginject street prostitut inject street prostitut glasgow data glasgow higher level inject drug report prostitut british citi"
"downregul platelet surfac glycoprotein ibix complex blood stimul thrombin adenosin diphosph vivo wound wash platelet system thrombin demonstr downregul platelet surfac express glycoprotein gp ib gpix present studi address question physiolog milieu blood downregul platelet surfac gpib gpix induc thrombin adenosin diphosph adp vivo wound thrombininduc downregul gpib gpix surfac individu platelet blood demonstr flow cytometri panel monoclon antibodi moab inhibit fibrin polymer peptid glycylprolylarginylprolin platelet identifi blood gpivspecif moab exclus monocyt light scatter properti flow cytometr analysi blood emerg standard bleedingtim wound establish downregul platelet surfac gpib gpix occur vivo gpibix complexspecif antibodi gpib gpix remain surfac platelet activ vivo vitro fulli complex simultan analysi individu platelet fluorophor demonstr thrombininduc platelet surfac exposur gmp degranul complet time downregul platelet surfac gpibix initi degranul prerequisit adp downregul platelet surfac gpibix expos gmp platelet surfac inhibitori effect cytochalasin demonstr activationinduc downregul gpix gpib depend actin polymer summari downregul platelet surfac gpibix complex occur blood stimul thrombin adp vivo wound independ alpha granul secret"
"superior humer disloc complic decompress debrid rotat cuff tear larg rotat cuff tear surgic irrepar circumst debrid edg cuff bursal decompress reliev pain paper case develop superior migrat humer head debrid bural decompress patient attempt made repair rotat cuff case repair fail humer head migrat patient humer head replac fractur patient prosthesi displac upward complic follow debrid releas subacromi bursa rotat cuff repair achiev correct superior humer migrat reestablish roof bursa carri case procedur effect consid futur case"
"surgic treatment sever comminut intraarticular fractur distal radius small ao extern fixat devic prospect halfyear follow studi fractur distal radius common optim treatment delin prospect studi patient young activ adult comminut unstabl intraarticular fractur distal radius end result close reduct rigid fixat small ao extern fixat includ patient excel good result roentgenogram patient show accur align heal fractur patient fair function result partial restrict rang movement roentgenogram demonstr good align heal fractur small ao extern fixat conveni method reconstruct treatment comminut intraarticular fractur distal radius"
"semiinvas method articular coll fractur extern fixat devic limit motion wrist joint disrupt anatom align articular coll fractur studi juli april month period patient articular coll fractur case bilater involv treat modifi dynam extern skelet devic close reduct full supin forearm excel anatom reduct sound wrist satisfactori function result sound wrist gain month follow period forearm muscl exert compress forc distal radial metaphys fractur heal period procedur devic provid constant counterforc action forearm muscl fractur heal result loss anatom reduct adequ distract counterforc provid extern fixat devic superior convent method simpl applic low rate complic excel anatom function result"
"diagnost oper arthroscopi wrist evalu diagnosi wrist disord tradit difficult problemat ligament wrist sprain carpal instabl triangular fibrocartilag complex disrupt cartilag injuri virtual imposs fulli assess inadequaci current diagnost techniqu arthroscopi wrist evalu softtissu structur cartilagin surfac radiocarp midcarp joint select case wrist arthroscopi employ surgic modifi intraarticular lesion assist plan reconstruct oper"
"intercondylar notch measur special refer anterior cruciat ligament surgeri femor intercondylar notch width measur patient chronic anterior cruciat ligament acl insuffici group patient acut tear acl group fresh anatom specimen knee group specimen knee anatom studi intercondylar notch perform tissu remov averag intercondylar distanc mm group mm group mm group differ high signific intercondylar notch wider posterior part cross boni ridg general concav wall provid function shelf acl insert side signific osteophyt format stenosi anterior outlet intercondylar notch occur earli acldefici knee narrow anterior outlet intercondylar notch osteophyt found knee acut acl ruptur reconstruct acl notchplasti perform concomit"
"anteriorcruciateinsuffici knee treat physiotherapi year follow studi patient late diagnosi evalu function neuromuscular train program focus strength endur postur control agil patient ruptur anterior cruciat ligament acl diagnos late examin start train period year studi period patient acl reconstruct twenti patient treat surgeri satisfi improv knee function activ level month physiotherapi complianc rehabilit program good improv achiev complet train period maintain year group recreat sportsmen women quadricep strength function knee score activ level function perform improv train maintain follow period"
"disloc knee result treatment vascular ligament injuri patient suffer complet disloc knee review patient injuri patient injuri poplit arteri arteri reconstruct saphen vein bypass graft success intraop arteriographi vascular repair show narrow anastomosi requir revis patient distal thrombi requir remov patient delay arteri repair respons failur eleven patient satisfactori result earli open ligament repair result favor patient treat earli ligament repair"
"varus talus ankl mortis secondari calcaneus fractur case report varus displac talus ankl mortis secondari calcaneus fractur observ year man similar calcaneus fracturedisloc mechan involv inferior medial displac talus bodi calcaneus patient ankl deform correct ankl ligament reconstruct correct requir distract subtalar bone block fusion success reconstruct hindfoot calcaneus fractur requir care analysi patholog lesion unusu case correct requir restor lost hindfoot bone structur"
"blunt traumat ruptur heart pericardium tenyear experi blunt traumat ruptur heart pericardium rare diagnos preoper carri high mortal rate patient admit level trauma center retrospect review identifi patient requir emerg surgeri condit injuri result vehicular accid motorcycl crash pedestrian struck vehicl fall crush struck hors crane seventeen patient isol ruptur pericardium ruptur cardiac chamber patient sign life scene transport vital sign admiss chamber injuri pericardi ruptur combin injuri diagnosi establish emerg thoracotomi patient arriv cardiac arrest remain patient diagnosi made urgent thoracotomi subxiphoid pericardi window laparotomi chest radiographi mortal rate patient vital sign admiss rapid transport expediti surgic treatment save patient injuri"
"function outcom pediatr trauma patient identifi salvag survivor retrospect studi pediatr trauma patient month undertaken evalu function outcom patient categor salvag survivor nss function outcom determin denver development screen test ddst children year age rappaport sever rate scale rdrs year older patient assign abbrevi injuri score ai injuri sever score iss glasgow coma scale gcs trauma score ts total number patient classifi sever classifi salvag salvag survivor prevent death studi suggest current trauma score system tend overestim salvag popul identifi salvag surviv high probabl meaning function recoveri current trauma score system revis identifi salvag survivor children make meaning neurolog recoveri"
"humer mobil treatment hang cast retrospect review patient treatment humer fractur hang cast perform averag followup time year rang year function result good excel patient assess flexibl shoulder elbow joint paramet measur bodi side neutral method debrunn cumul comparison paramet reveal decreas flexibl upper limb treatment hang cast reduc abduct move shoulder blade reduc free abduct reduc anteelev reduc extern rotat hang arm increas flexion shoulder reduc extens elbow  find show longterm defici humer mobil treatment hang cast exist"
"result oper treatment intraarticular fractur calcaneus treatment displac intraarticular calcan fractur consist open reduct distractor bone graft intern fixat splint appli earli postop movement precis preoper plan ct scan requir proper time care preoper plan essenti prevent softtissu complic total fractur good clinic radiolog result achiev case result satisfactori poor patient return work averag month patient receiv disabl compens compar favor nonop treatment major comminut intraarticular fractur calcaneus profit open reduct intern fixat reliabl function result achiev conserv therapi"
"differenti regul lymphocyt activ sever burn patient studi vitro express regul cd cd tac surfac antigen peripher blood lymphocyt pbl sever burn patient burn injuri rang tbsa order evalu lymphocyt activ process thermal trauma spontan cytokin il ilinduc express cd repres cell activ marker signific reduc week postburn compar healthi donor contrast cd express activ cell show mark increas spontan indic vivo activ stimul il pha concomit cell prolifer induc pha con suppress number cell remain unchang data demonstr impair earli event lymphocyt program sever burn patient activ cell downregul refractori extern helper signal addit cell high activ fail proceed prolifer respons mitogen stimuli"
"sonograph screen mass casualti abdomin renal injuri armenian earthquak sonographi acut trauma evalu general underestim opinion controversi sonographi perform primari screen procedur mass casualti patient trauma admit larg hospit hour armenian earthquak realtim sector scanner recept area hospit averag time spent patient minut followup sonograph examin requir trauma patholog abdomen retroperiton space detect patient fals negat fals posit author sonograph screen mass casualti quick effect detect abdomin retroperiton injuri sonographi purpos routin gain experi maintain prepared sonograph screen trauma case mass casualti situat"
"delay diagnosi extrem injuri patient multipl injuri total patient treat intens care unit depart orthoped traumatolog helsinki univers central hospit analyz studi fractur luxat pelvi extrem trauma surgeon radiologist duti initi miss injuri account eventu late symptom sever delay diagnos injuri locat hip knee joint patient delay diagnos averag sever ill primari blood transfus assist respir resembl patient die trauma complic common delay diagnosi radiograph patient notat visibl injuri radiograph inferior qualiti radiograph unnot radiologist report fractur visibl outermost corner radiograph fractur hidden fractur excess obes patient contribut delay studi present measur improv diagnost strategi delay diagnos total erad"
"success replant leg childyear followup case report replant lower extrem infrequ procedur rare due usual sever primari injuri possibl good prosthet substitut report case success replant leg year boy aspergillus flavus septicemia followup year case suggest leg replant consid young patient report case success replant leg"
"spontan heal traumat thorac aortic tear case report patient deceler trauma thorac aorta caus signific intim disrupt complet angiograph resolut document period medic manag review literatur experi suggest traumat aortic disrupt constitut spectrum injuri phenomenon surgeri multipli injur patient delay postpon indefinit injuri limit"
"role computer tomographi diagnosi occult femor neck fractur ipsilater femor shaft fractur case report report nondisplac femor neck head fractur diagnos acut ct scan case illustr potenti benefit acut femor neckhead ct scan obtund polytrauma patient highenergi femor shaft fractur"
"bilater fracturedisloc sacroiliac joint case report bilater fracturedisloc sacroiliac joint intrapelv displac sacrum rare extrem sever injuri treat patient bilater fracturedisloc sacroiliac joint nonop method obtain excel function result"
"traumat renal avuls chest case report case report patient surviv blunt renal avuls herniat kidney ruptur diaphragm symptom mild sever injuri prompt diagnosi unusu combin injuri aid contrastenhanc comput tomographi ct"
"educ status drink pattern repres colleg student data larg nation repres sampl multipl regress sex ethnic age educ status show drink pattern colleg student differ signific dropout high school graduat colleg student colleg student alcohol tend drink quantiti drink day nonstud age sex differ smaller colleg student group proport abstain white drink colleg black colleg student drink age associ drink conclus base school sampl general nonschool popul test repres databas"
"associ alcohol cocain sampl problemdrink employe increas cocain creat challeng cohort problem drinker dual multipl addict part random trial compar altern alcohol treatment employe industri plant interview alcohol client employe assist program eap cocain month prior eap intak compar employe report recent cocain cocain user younger marri report heavier drink alcoholrel problem job control demograph occup factor drink indic cocain user report bing drunk hour blackout margin signific absente warn unaccept job perform alcohol eap client cocain engag riskier drink troubl job report cocain differ specif attribut cocain"
"sex differ person trait cope style hospit alcohol forti inpati alcohol detox unit larg municip hospit administ batteri test consist cope style scale person profil scale depress scale mast demograph compar comparison group outpati attend medic screen clinic hospit complet batteri group differ term age educ ratio men women signific differ cope style person characterist alcohol nonalcohol larg extent men women alcohol group practic signific differ found men group femal alcohol differ great nonalcohol women term cope style person variabl term conflict find differ alcohol nonalcohol sampl due larg pattern uniqu character femal alcohol group result discuss term cultur expect"
"effect alcohol screen ambulatori care set hundr eighti subject ambulatori care clinic particip studi design assess psychometr properti smast dsmiii criteria alcohol diagnost standard eighti subject complet nimh diagnost interview schedul met dsmiii criteria alcohol abus depend sensit smast general accept weight cut score greater specif unweight cut score greater produc sensit specif result studi suggest smast screen ambulatori care clinic popul optimum balanc sensit specif achiev unweight cut score greater addit alcohol subscal diagnost interview schedul easi administ consid diagnost standard clinic set"
"factor alcohol adolesc relat influenc number famili individu characterist frequenc intens alcohol group older adolesc assess sampl consist person rang age year obtain high school studi logist regress analys perform frequenc intens alcohol white male higher socioeconom background live urban suburban area extern locus control weak famili orient tend drink frequent consum larger quantiti alcohol drink episod result explain sociocultur perspect"
"develop measur examin children role alcohol famili measur assess role play children alcohol famili present studi item pool generat target distinct role discuss alcohol literatur item review panel expert children role inventori cri administ adult children alcohol respons refin measur observ level intern consist adequ cronbach alpha rang replic effort studi cri administ adult children alcohol intern consist remain accept level rang studi examin cri converg discrimin valid sampl adult children alcohol sampl adult nonalcohol famili complet cri measur esteem index social support reliabl result studi replic sampl likewis sampl cri subscal differenti predict esteem size satisfact social support network"
"children alcohol parent communiti relationship parent alcohol risk maladjust offspr investig communiti sampl children parent met criteria disdsmiii alcohol abus depend children parent met criteria ten diagnos compar children normal parent data obtain merg data bank major psychiatr epidemiolog studi adult child popul puerto rico result parent alcohol addit creat advers famili environ effect relat risk maladjust offspr measur score child behavior checklist previous studi report higher level extern behavior children alcohol increas risk intern symptom observ children studi similar find obtain children parent psychiatr disord suggest effect parent alcohol children age consequ parent mental ill se"
"nitinol gooseneck snare remov foreign bodi experiment studi clinic evalu author describ angl snare made nickeltitanium nitinol cabl retriev foreign bodi iatrogen devic snare loop angl cabl size mm radiograph visual enhanc goldplat tungsten coil snare retriev wire cathet fragment introduc thorac vasculatur dog eleven attempt success attempt retriev intravascular foreign bodi success patient patient mm snare remov fractur end ventriculoatri shunt tube left pulmonari arteri patient ureter stent success remov fluoroscop guidanc retriev perform vascular sheath standard techniqu angiograph equip complic patient dog"
"tear cruciat ligament menisci evalu cine mr imag cine magnet reson mr imag techniqu involv acquisit kinemat sagitt imag knee movement evalu symptomat knee joint result compar obtain static dimension mr imag twenti anterior cruciat ligament acl tear normal ligament correct identifi cine mr imag sensit specif static mr imag yield sensit specif posterior cruciat ligament tear identifi cine mr imag menisc tear cine mr imag yield sensit specif sensit specif mr imag cine mr imag prove static mr imag assess tight cruciat ligament partial torn assess movement meniscalfre fragment increas inform obtain cine mr imag warrant continu investig clinic applic"
"skateboard injuri children wave motiv number skateboardrel injuri emerg depart undertook investig skateboard injuri mid studi consum product safeti commiss injuri frequenc estim resurg injuri children year injur greatest frequenc nontrivi injuri common children younger year reflect larger proport head neck injuri boy sustain frequent sever skateboardrel injuri observ injuri pattern head neck injuri younger children extrem injuri older children sever head neck injuri older children reflect role psychomotor develop risk exposur biomechan prevent strategi includ warn skateboard children younger year prohibit skateboard street highway promot helmet protect gear"
"predict onset chronic women problem drink year longitudin analysi background longitudin studi adult drink typic exclud sampl small number problem drink women measur limit rang influenc women drink behavior method studi develop women problem drink time year follow interview conduct group respond nation survey women drink problem drinker nonproblem drinker regress analys examin effect predictor measur problem drink problem drinker nonproblem drinker separ result nonproblem drinker predictor onset problem drink indic includ younger age cohabit lifetim drug alcohol consist predictor persist chronic problem drink sexual dysfunct predictor includ employ parttim marri experienc recent depress divorc separ predict lower level subsequ alcohol depend problem drinker conclus find suggest person social factor predict onset problem drink compar continu point nontradit lifestyl sexual dysfunct role depriv potenti import variabl"
"import plan health educ prevent ski injuri plan health educ aim prevent sport injuri incomplet state explicit instanc evalu incomplet nonexist present theoret framework plan evalu health educ illustr main point health educ downhil skier systemat plan consist analyz magnitud problem behavior risk factor studi behavior determin design optim intervent implement intervent evalu phase deal effect level implement intervent determin behavior incid injuri common pitfal mention special attent studi determin behavior design intervent import pretest health educ materi communiti approach educ sport particip underlin health educ regul facil constitut health promot strategi prevent sport injuri sport strong research etiolog determin behavior effect prevent realiz"
"meniscus repair anterior cruciat defici knee isol repair peripher vascular zone menisc tear perform patient menisci acl insuffici reason patient underw repair reconstruct acl meniscus repair open arthrotomi case arthroscop techniqu case purpos studi evalu success rate menisc repair anterior cruciat defici knee averag age patient time surgeri year averag followup month patient mild occasion pain requir medic patient moder pain requir nonnarcot pain medic patient occasion give episod underw acl reconstruct year frequent give patient requir postop manipul inadequ rang motion neurovascular injuri infect patient fail repair retear requir subsequ subtot meniscectomi patient clinic symptom sign menisc tear signific differ result open arthroscop repair failur rate meniscus repair greater unstabl knee conclud meniscus repair contraind anterior cruciat defici knee"
"conserv treatment anterior cruciat defici knee seventi recreat athlet averag age year complet acl tear treat nonligament arthroscop surgeri monitor rehabilit function brace activ modif averag followup month rang month patient ultim underw ligament reconstruct consid failur nonreconstruct treatment remain patient subject detail analysi excel good fair poor result patient satisfi knee activ daili live satisfi knee sport twenti signific modifi athlet activ age sex interv injuri treatment menisc tear articular cartilag damag appar effect outcom poor result note patient signific pivot shift multipl repeat injuri repeat arthroscopi isokinet deficit increas length followup poor result"
"prevent common overus injuri shock absorb insol prospect studi sedentari individu militari recruit start physic train program substanti risk develop overus injuri lower limb studi investig effect neopren insol incid overus injuri week basic militari train experiment group consist random select recruit recruit control group insol experiment group complianc monitor panel doctor document classifi injuri occur week period total injuri report experiment control group group major injuri overus experiment group control group week incid total overus injuri tibial stress syndrom signific lower experiment group incid stress fractur lower experiment group signific studi show incid total overus injuri tibial stress syndrom week basic militari train reduc wear insol"
"diagnost capabl magnet reson imag comput tomographi acut cervic spinal column injuri present studi conduct evalu imag capabl magnet reson imag mri evalu acut cervic spinal column injuri compar result comput tomograph ct imag forti patient undergo mri level region spinal cord trauma center evalu cervic spinal column injuri studi seventi injuri identifi mri injuri classifi osseous fracturedisloc disc herniat spinal cord injuri edemacontusiontransect diagnost imag result patient undergo mri ct compar ct demonstr fracturedisloc compar mri mri demonstr disc protrus compar ct addit mr imag cord injuri compar ct mr imag prove superior demonstr spinal cord patholog intervertebr disc herniat ct superior mri demonstr osseous injuri ct mri determin presenc extent spinal column injuri"
"barium sulfat bronchographi report complic alveolar barium sulfat subsequ retent barium sulfat year demonstr patient dilut suspens barium sulfat water bronchographi patholog examin patient show barium sulfat macrophag alveolar space wall perivascular peribronchi interstitium residu barium sulfat interfer imag procedur lung repres unwant event patient pulmonari diseas highresolut comput tomographi prefer method evalu bronchiectasi bronchogram perform perform bronchoscopi oili propyliodon dionosil"
"everett idri evan memori lectur inhal injuri import question answer anim data signific differ exist group observ resuscit ringer lactat lead increas lymph flow total transcapillari protein flow spite drop protein oncot pressur plasma ringer lactat lower lymph plasma protein ratio signific negat differ observ pulmonari capillari wedg pressur pulmonari vessel resist anim surviv experi experi advantag vital paramet ascertain administr albumin factor born mind inhal injuri heat sourc toxic substanc involv inhal trauma induc absenc surfac burn wound durat observ hour caution observ appli find clinic situat evalu clinic result differ establish regard pulmonari capillari wedg pressur extravascular lung water ringer lactat albumin group spite drop oncot pressur valid hour assum protein drop coupl rais hydrostat filtrat coeffici lead interstiti edema"
"persist fetal bovin serum protein human keratinocyt cultur human keratinocyt skin graft success limit late graft loss develop antibodi fetal bovin serum fbs protein cultur media vitro keratinocyt growth identifi persist fbs antigen skin graft import induct immun respons suscept keratinocyt immunemedi injuri magnitud longev fbs protein persist human keratinocyt studi secondari passag human keratinocyt grown media supplement fbs media chang supplement pool human ab serum amount fbs protein incorpor tissu measur day elisa reaction direct fbs antigen incorpor fbs antigen decreas day maximum signific decreas day keratinocyt grown altern serum supplement nuserum collabor research bedford mass serum hazelton research product lenexa kan reduc amount fbs offer signific reduct fbs protein incorpor durat antigen persist make human keratinocyt suscept cell destruct immun respons fbs contribut delay loss human keratinocyt graft"
"time alter lung lymph bronchial blood flow inhal injuri effect inhal injuri pulmonari microvascular fluid flux bronchial blood flow examin longterm studi sheep insuffl breath cotton smoke air deepli anesthet halothan injuri anesthesia discontinu anim mechan ventil experiment period hour bronchial blood flow increas signific time point record reach peak minut inhal trauma mlhr mlhr bronchial blood flow decreas time baselin measur remaind studi period blood flow concomit increas lung lymph flow variabl gradual increas baselin mlhr mlhr hour challeng smoke control anim show chang cardiopulmonari function experiment period correl increas bronchial blood flow lung lymph flow pattern cotton smoke inhal injuri"
"elev serum aluminum level sever burn patient receiv larg quantiti albumin aluminum contamin fluid intraven therapi bone diseas encephalopathi albumin high contamin aluminum elimin primarili renal excret patient burn receiv larg quantiti albumin impair renal function put hypothet risk aluminum load assess risk aluminum load analyz sera patient burn aluminum concentr serum aluminum concentr elev patient level toxic serum aluminum serum creatinin level direct correl relat found serum aluminum amount albumin receiv patient highest serum aluminum level sever burn surviv patient burn receiv albumin risk aluminum load impair renal function contribut aluminum retent"
"observ stabil contract composit skin graft xenodermi allodermi isograft overlay composit skin graft xenodermi allodermi thin splitthick isograft overlay evalu stabil contract male inbr lewi rat recipi buffalo rat serv allogen dermi donor cryopreserv human skin xenodermi graft compon composit graft xenodermi allodermi isograft overlay graft oper surgic creat wound wound observ year composit skin graft fair spotti loss overlaid isograft note xenodermi allodermi remain grossli intact year graft composit skin graft anim model contract sheet isograft"
"burn hot oil greas public health hazard examin incid etiolog morbid burn due hot oil greas year period patient hospit burn injuri due hot greas oil age year patient year total bodi surfac area degre burn rang averag length hospit stay day fifti percent patient requir splitthick skin graft requir intub requir tracheostomi seventi percent oil burn occur home common circumst consist children grab handl electr cord fri pan pull hot oil nineteen children year burn due cook oil greas morbid high boil point high viscos potenti combust oil increas potenti softtissu damag compar typic scald injuri hot water danger children pull applianc danger transport hot oil import supervis children cook import knowledg manag greas fire stress public educ underlin potenti burn"
"descript summari jersey burn popul data obtain jersey state depart health hospit patient burn data collect nation burn victim foundat standard burn report form analyz gather inform epidemiolog burn children year age continu largest percentag year age group sustain burn injuri injuri sustain children age male account total burn popul admiss white patient admit partialthick burn admit fullthick burn largest primari payer parti payer patient burn discharg home care data analyz examin select age group determin individu specif group analysi burn injuri report nation burn victim foundat confirm previous report home place burn injuri occur flame scald injuri predomin scald injuri compris sustain burn gasolin vapor account burn injuri caus flame data support effort develop program address urban child year age group elder inform collect serv redefin object burn prevent program"
"drug femor neck fractur casecontrol studi hundr consecut patient femor neck fractur fnf control match age sex nurs home resid number admiss year interview recent drug match criteria chosen achiev case control group compar regard physic disabl preliminari studi shown fnf strong nurs home resid correl number recent hospit admiss fnf found negat coronari drug ci posit drug general ci class psychotrop drug consist greater statist signific inher problem interpret find diseas predispos subject fnf drug creat causal relationship"
"control drink treatment effect diseas model addict commentari ideolog stanton peel long histori extravag claim sober discomfirm advoc control drink continu promot nonabstin treatment goal procedur alcohol recent claim stanton peel favor control drink examin critic context continu debat empir studi nonabstin treatment goal treatment effect inpati versus patient treatment alcohol peel view convent diseasebas alcohol treatment control drink diseas model shown base larg inadequ scholarship misrepresent literatur inappropri comparison unwarr general strawman argument"
"univers precaut effect reduc number occup exposur health care worker prospect studi physician medic servic daili questionnair prospect studi physician hospit medic servic incid exposur blood bodi fluid barrier implement univers precaut found implement signific increas frequenc barrier exposur incid implement implement univers precaut implement led decreas number exposur incid result direct contact blood bodi fluid actual exposur exposur physician patient care month increas avert exposur direct contact prevent barrier devic exposur patient care month implement exposur patient care month implement implement affect type bodi fluid procedur involv rate exposur incid patient care month increas barrier prevent direct contact blood bodi fluid convert actual exposur avert conclud univers precaut effect reduc risk occup exposur physician medic servic"
"catastroph injuri fatal high school colleg sport fall spring direct indirect death catastroph injuri defin injuri incur particip high schoolcolleg sponsor sport perman sever function neurolog disabl nonfat transient perman function neurolog disabl present sport period fall spring footbal contribut greatest number catastroph injuri largest number particip ice hockey gymnast wrestl sport particip greatest risk catastroph injuri death mechan injuri sport correct action identifi discuss high school colleg catastroph injuri total elimin dramat reduc reliabl injuri data collect analysi"
"clinic toxicolog resourc emerg physician impact poison control center studi object clinic toxicolog resourc emerg physician unclear implic futur train resourc avail studi design assess current emerg physician resourc design prospect evalu mail item questionnair type particip emerg physician utah intervent result respons rate resourc fund knowledg consult occasion frequent resourc occasion frequent poison control center pcc toxicolog textbook expert colleagu hous poisindex contact pcc toxic inform manag recommend acut symptomat overdos case contact pcc advers drug reaction pill identif consult physician toxicologist asymptomat exposur chronic toxic sole report case american associ poison control center data base access hous poisindex consult pcc hous poisindex contact pcc access provid access physician toxicologist consult thought import role pcc physician option conclus vast major emerg physician utah consult pcc acut symptomat overdos view access physician toxicologist consult import role pcc seldom avail hous poisindex decreas likelihood pcc consult emerg depart frequenc emerg physician consult pcc decreas poisindex hospit"
"flumazenil benzodiazepin antagonist flumazenil recent discov pharmacolog antagonist cns effect benzodiazepin act bind cns benzodiazepin receptor competit block benzodiazepin activ inhibitori gabaerg synaps anim studi human studi demonstr flumazenil weak intrins agonist activ hand studi inconclus demonstr invers agonist effect agent evid suggest flumazenil toler human broad rang dose oral parenter produc advers effect set isol benzodiazepin overdos flumazenil capabl complet revers coma minut effect hour repeat dose safe revers recurr effect longeract benzodiazepin flumazenil undergo evalu food drug administr drug receiv approv emerg depart varieti clinic set effect rapid revers benzodiazepineinduc sedat administ facilit medic orthoped surgic procedur event inadvert respiratori depress flumazenil therapeut role manag patient benzodiazepin overdos patient manag success support therapi flumazenil obviat intub respiratori support patient elimin advers effect shortterm endotrach intub final flumazenil diagnost therapeut patient acut alter mental status unknown etiolog drug overdos flumazenil specif antagon benzodiazepineinduc respiratori cns depress empir confirm exclud role benzodiazepin generat mental status set overdos coma unknown origin turn obviat expens comput tomographi invas lumbar punctur diagnost modal benzodiazepineinduc coma distinguish coma sign symptom benzodiazepin overdos confirm elimin clinic ground studi continu defin ultim agent"
"risk factor manifest digoxin toxic elder incid digoxin toxic increas age larg common condit benefit digoxin congest heart failur atrial fibril mark preval age elder sensit effect digoxin age se unclear factor render elder suscept digoxin toxic includ agerel declin renal function decreas volum digoxin distribut increas number comorbid condit includ cardiovascular chronic obstruct pulmonari diseas heighten suscept digoxin toxic treatment diseas interact medic quinidin calcium channel blocker increas serum level digoxin similar electrolyt imbal hypokalemia hypomagnesemia occur frequent elder result diuret therapi recent data suggest manifest digoxin toxic younger older patient differ similar incid cardiac toxic gastrointestin toxic alter mental status found patient popul treatment digitali toxic elder younger patient respons rate digibind diminish elder"
"result multicent studi digoxinspecif antibodi fragment manag digitali intox pediatr popul digitali toxic continu problem pediatr patient undergo therapi cardiac glycosid heart failur arrhythmia accident ingest articl previous digoxinspecif antibodi fab fragment treat digitali overdos intox children review case report cite medic literatur pediatr case gather result multicent clinic trial postmarket surveil studi report digoxinspecif antibodi fab fragment effect amelior sign digitali poison children fab fragment rapid erad potenti lifethreaten arrhythmia conduct defect effect treat hyperkalemia noncardiac manifest digitali toxic small sampl patient studi date complic minim allerg reaction digoxinspecif fab fragment observ recommend manag digitali intox children outlin"
"recognit manag digitali intox implic emerg medicin digitali intox common advers drug reaction clinic medicin recent develop radioimmunoassay accur measur serum concentr digoxin assist digitali intox remain difficult diagnosi make certainti difficulti diagnos digitali intox aris nonspecif sign symptom common symptom includ fatigu weak nausea anorexia symptom occur ill digitali intox similar electrocardiograph disturb caus cardiac glycosid nondiagnost arrhythmia common digitali toxic nonspecif reflect patient heart diseas measur serum digoxin level studi demonstr overlap level group toxic due modul cardiac effect digitali glycosid clinic variabl myocardi renal diseas electrolyt acidbas imbal factor correl toxic serum digoxin concentr vari inher difficulti confirm diagnosi digitali intox case digoxinspecif fab antibodi play role diagnost tool digoxinspecif fab antibodi play signific part treatment digitali intox fab antibodi success revers effect digoxin digitoxin oleand poison antibodi treatment acut chronic digitali intox age group includ geriatr pediatr popul"
"chang pattern manag fractur children advanc radiograph imageri great facilit diagnosi treatment pediatr musculoskelet injuri recent year indic oper intervent treatment children fractur defin"
"influenc protect passiv mobil interv flexor tendon heal prospect random clinic studi prospect multicent clinic studi carri determin improv tendon glide achiev greater durat daili passivemot rehabilit flexor tendon repair fifti patient random control passivemot protocol group patient receiv greater interv passivemot rehabilit continu passivemot devic group patient treat tradit earli passivemot protocol tendon rehabilit group patient interv control motion rehabilit hour week number cycl group patient interv control passiv motion hour week number cycl minimum follow time month month strickland glogovac formula activ motion digit group degre degre motion tendon group degre degre differ group statist signific effect number tendon injur digit group signific data experi durat daili control motion interv signific variabl postrepair flexor tendon function concern"
"fractur index metacarp base sublux trapeziometacarp joint case report year man fell outstretch arm suffer fractur index metacarp base sublux thumb basal joint small fractur fragment base index metacarp attach base thumb metacarp strong ligament note time surgeri pattern injuri ligamentrevers bennett fractur previous report"
"pes anserinus interposit proxim tibial physeal fractur case report tenyear girl suffer salterharri type ii fractur proxim tibia inspect reveal interposit pes anserinus pa open physi prevent reduct case report pa interposit"
"occurr accessori immunolog cell bone induct differenti tissu fractur heal deminer bonepowderinduc dbp bone format investig monoclon antibodi respect occurr iaposit cell macrophag lymphocyt interleukin receptor il ia refer molecul cell surfac belong class ii major histocompat complex specif speci individu type granul tissu fractur heal dbp implant mesenchym cell surround musculatur accompani larg number iaposit cell common macrophag occurr il receptor spars fractur heal rich dbp induct immunogen properti weak day exist cell dbp induct iaposit signifi immunolog effector phase appar direct remain passiv bone powder peripheri central part insert bone powder produc cartilagin cell matrix presenc accessori immunolog cell fractur heal due surveil function standard respons injuri cell differenti depend activ mediat emit iaposit cell macrophag investig strengthen concept induc bone develop occur experiment fractur heal"
"stimul effect growth hormon fractur heal depend onset durat administr effect onset durat growth hormon administr biomechan properti heal rat tibial fractur investig day heal biosynthet human growth hormon mgkg bodi weightday daili inject group rat entir heal period day day heal group control rat inject salin group maximum load stiff heal fractur increas compar control group group maximum load stiff maximum stress energi absorpt maximum load increas compar control group group statist detect effect found result show growth hormon stimul fractur heal part heal period entir heal period"
"surgic treatment brachial plexus birth palsi brachial plexus birth palsi remain challeng condit infant function result improv obtain observ surgic explor repair perform clinic recuper bicep function occur month age recoveri slow comprehens follow studi reconstruct conserv manag children requir prevent joint contractur children benefit palliat procedur tendon transfer identifi"
"individu care treatment alcohol discuss case vignett author emphas util individu tailor treatment approach work peopl experienc problem relat alcohol consumpt patient achiev abstin believ diseas concept alcohol attend alcohol anonym meet part treatment patient control drink desir outcom abstin import entertain multipl perspect conduct clinic work patient discuss"
"staf pattern american methadon mainten program methadon mainten frequent util treatment heroin addict repres aidsprevent tool iv drug popul import role report methadon mainten clinic staf survey cover aspect program oper includ staf clinic list nation directori drug abus alcohol treatment program anova staf pattern compar program function clinic size citi size region countri fund resourc differ found base citi clinic size staf pattern vari function region locat sourc clinic fund"
"depress alcohol turkish sampl aim present studi identifi predictor variabl depress alcohol turkish mental hospit questionnair beck depress inventori bdi util collect data male alcohol stepwis multipl regress analysi bdi score demograph healthrel variabl result identif marit problem physic problem due alcohol risk factor find discuss context find western countri similar point"
"manag autoemascul psychot state report case inflict penil amput offer differ surgic option contrast surgic result due vari time delay case repair immedi repair case delay day due psychot state patient psychiatr background episod discuss techniqu repair reconstruct"
"evid histamin causat toxin scombroidfish poison background highest morbid worldwid fish poison result ingest spoil scombroid fish tuna mackerel clear histamin respons spoil scombroid fish larg quantiti histamin histamin causat toxin remain question address issu investig histamin homeostasi alter poison peopl method urinari excret histamin metabolit methylhistamin measur person scombroidfish poison scombrotox ingest marlin measur alpha betadihydroxyoxotetranorprostenedio acid pgd princip metabolit prostaglandin mastcel secretori product assess mast cell activ releas histamin result fish high level histamin mumol tissu symptom scombrotoxismflush headachebegan minut ingest fish urin sampl collect hour fish ingest level histamin methylhistamin time time normal subsequ hour level fell time time normal valu level normal day pgd excret increas time person treat diphenhydramin prompt amelior symptom conclus scombroidfish poison urinari excret histamin quantiti exceed requir produc toxic histamin deriv spoil fish result identifi histamin toxin respons scombroidfish poison"
"signific bb air rifl injuri child head bb gun year ago construct coil spring generat forc projectil pose threat injuri today coil spring construct replac pump action pneumat chamber generat muzzl veloc ftsec speed ftsec ftsec requir skin penetr bone penetr present year boy suffer intracrani parenchym injuri airpow bb gun projectil play friend discuss literatur suggest innoc toy harbing sever fatal injuri"
"earli definit bone softtissu reconstruct major gunshot wound face craniofaci surgic techniqu extend open reduct rigid fixat plate screw replac sever damag miss bone bone graft treatment complex facial fractur appli manag sever gunshot wound face earli definit bone softtissu reconstruct perform patient hundr seventi primari bone graft util patient orbit nasal zygomat maxillari reconstruct twenti patient requir mandibular repair compress reconstruct plate softtissu reconstruct provid combin flap patient extens softtissu loss replac free vascular oment flap omentum provid circumferenti coverag mandibular reconstruct reconstruct floor mouth tunnel circl cheek middl upper face omentum reconstruct deficit hard palat upper buccal sulcus wrap zygomat orbit midfaci bone graft fill dead space maxillari ethmoid frontal sinus omentum provid contour bulk cover bone graft plate fill dead space care shape bone graft provid correct craniofaci scaffold earli restor midfaci boni scaffold prevent softtissu contract facilit secondari reconstruct late total nasal reconstruct tissueexpand forehead skin wrap bone graft perform"
"heal facial bone fractur process secondari union mechan heal facial bone fractur investig rabbit model twelv zealand white rabbit underw surgic induc fractur infraorbit rim fractur ostectomi mm left infraorbit rim anim sacrif week postfractur bone includ periosteum obtain fractur fractur osteoctomi site divid longitudin hematoxylin eosin stain fluoresc microscopi microangiographi microradiographi sequenti fluorochrom label oxytetracyclin mgkg alizarin complexon mgkg dcaf mgkg xylenol orang mgkg administ hour preoper week postfractur fractur fractur ostectomi site demonstr vascular ingrowth miner woven bone format week postop begin cartilag precursor subsequ woven bone replac remodel lamellar bone result complet boni heal week postop step substanti microscop microradiograph radiolog examin specimen studi demonstr fractur facial bone rabbit model heal process bone format resembl secondari union endochondr bone"
"analysi softtissu respons compon manufactur breast implant rat anim model implanttissu respons silicon gel mammari prosthesi requir evalu light recent concern relat human connectivetissu diseas contractur infect neoplasia silicon prosthesi homogen implant milieu silicon chemistri silicon polym precursor prosthesi compon silicon shell shell extract lowmolecularweight compon silicafre silicon silicon oil fume silica silicon extract implant subcutan nonhemorrhag techniqu back lewssn rat implant rat period day total implant materi time period histolog analysi perform specimen harvest soft tissu intens cellular capsular respons lowest silicon oil increas materi molecular weight increas materi complianc decreas fume silica elicit high reactiv cellular respons studi appar polym molecular weight influenc migrat encapsul intens cellular respons silicon extract distil elicit high intens cellular respons pronounc lymphocyt invas human relev work await correl implant retriev vivo perform"
"experi rehabilit zone ii flexor tendon repair dynam traction splint review flexor tendon repair man land perform januari june evalu efficaci method rehabilit finger patient complet lacer flexor digitorum profundus flexor digitorum superficiali tendon zone ii finger phalang fractur joint injuri signific skin loss exclud follow rang month rehabilit consist week protocol militari combin regimen control motion featur techniqu control activ extens rubber band passiv flexion control passiv extens passiv flexion incorpor palmar pulley modif kleinert dynam traction splint util strickland total activ motion formula employ determin result result classifi categori excel good fair poor fifti finger percent rate excel finger percent rate good finger percent rate fair finger percent rate poor"
"island flap suppli dorsal branch ulnar arteri case report fasciocutan island flap employ suppli ulnari dorsali arteri method propos becker gilbert origin techniqu modifi author produc venous outflow vascular pedicl includ ascend branch arteri vena comitant superfici vein respect subderm band techniqu optim length vascular pedicl"
"strut fixat extens flail chest indic prefer approach oper stabil posttraumat chest wall instabl uncertain suggest simpl rapid effect approach surgic stabil luqu rod strut flail segment oper requir"
"electrophysiolog investig mandibular nerv injuri isol lesion mandibular branch trigemin nerv rare report report occurr isol lesion mandibular nerv unilater mandibular fractur substanti electrophysiolog year man involv motor vehicl accid result multipl fractur includ unilater mandibular fractur temporomandibular joint disloc evid intracrani patholog ct scan note neurolog examin nonfoc dysfunct mandibular nerv ipsilater fractur site bilater facial nerv latenc blink reflex normal emg evalu muscl facial express mastic demonstr denerv confin muscl innerv mandibular branch trigemin nerv patient complain facial sensori dysfunct malocclus weak muscl mastic mandibular fractur electrophysiolog examin assist evalu cranial nerv integr"
"oper exposur abdomin arteri trauma traumat injuri abdomin arteri requir oper exposur flexibl repair divid abdomin arteri tree zone base exposur expedi precis repair major abdomin arteri"
"surgeon prefer care trauma patient survey washington state chapter american colleg surgeon undertaken document opinion surgeon trauma care issu thirti percent total sampl surgeon respond prefer treat trauma patient surgeon older practic urban set feel trauma call negat impact elect practic strong reimburs trauma patient equal nontrauma patient agre strong statement patient requir greater time commit pose increas medicoleg risk signific influenc prefer treat trauma patient exert percept negat impact practic older age percept increas medicoleg risk reimburs issu locat practic influenti factor inform target concern barrier activ particip trauma care system tailor strategi deal effect"
"childhood injuri caus air gun object determin sever nonfat injuri children caus air gun pellet gun design case seri hospit chart review set inpati ward children hospit eastern ontario patient children year age admit hospit jan dec icd code suffer air gun injuri main outcom measur person data circumst event clinic data result children boy median age year circumst accid case children play clean gun children thought gun unload case bullet ricochet eye injuri inflict injuri extrem eye head neck median length hospit stay day children longterm disabl result eye injuri cataract surgeri requir enucl eye conclus air gun injuri children sale ban care regul"
"adequ resuscit burn patient measur urin output vital sign object compar vital sign urin output monitor burn patient invas monitor earli resuscit design retrospect review set univers hospit burn unit patient fourteen burn patient pulmonari arteri monitor monitor data compar baselin fluid challeng result correl invas deriv physiolog variabl vital sign urin output vital sign urin output chang fluid challeng variabl invas monitor demonstr signific chang half patient oxygen consumpt increas fluid challeng vital sign urin output distinguish patient conclus urinari output vital sign guid initi burn resuscit lead suboptim resuscit invas cardiorespiratori monitor optim resuscit burn patient"
"outcom prolong intens care unit stay multipl trauma patient object describ hospit outcom trauma patient requir icu stay greater day charg incur design retrospect case seri analysi data collect patient chart trauma registri set level region trauma center part statewid trauma system patient yr period patient trauma icu admiss prolong stay greater day icu constitut studi group blunt trauma respons injuri injuri sever score sd result mechan ventil requir time spent icu time spent mechan ventil day icu day hospit day infecti complic occur organ dysfunct patient mortal rate patient greater yr patient yr lower mortal rate signific higher injuri sever score lower glasgow coma scale score compar greater yr patient greater yr discharg chronic care facil younger  number patient month discharg death hospit profession charg patient conclus length icu stay close mechan ventil presenc premorbid ill age greater yr organ dysfunct increas mortal trauma patient requir prolong icu stay util resourc ultim outcom fair good"
"unusu treatment rare dilemma oesophag foreign bodi identif intramur oesophag fishbon oper difficult case discuss attempt accur radiolog local site preoper case report"
"motor vehicl crash injuri pattern virginia seat belt law injuri front seat occup tow crash charlottesvill va area compar year year virginia seat belt law effect vehicl occup data combin examin crash injuri pattern report seat belt crash increas law substanti decreas injuri front seat occup receiv medic treatment crash postlaw period reduct number injuri greater passeng front seat driver frontal crash type crash injuri reduct effect occur primarili reduct number head face injuri occur contact windshield instrument panel"
"efficaci eyepad corneal heal corneal foreign bodi remov patient corneal epitheli defect due remov corneal foreign bodi random alloc receiv chloramphenicol continu applic eyepad chloramphenicol eyepad corneal defect heal heal statist signific differ group discomfort greater eyepad group control group eyepad confer benefit heal uncomfort"
"anterior cruciat ligament injuri evalu arthroscop reconstruct rehabilit advantag arthroscop reconstruct anterior cruciat ligament tear arthrotomi obvious reduc pain morbid arthroscopist perform procedur outpati basi physician choos graft substitut anterior cruciat ligament replac autograft consist iliotibi band semitendinosus gracili meniscus graft common autograft bonepatellar tendonbon shown tensil strength anterior cruciat ligament state art surgic altern anterior cruciat ligament tear arthroscop reconstruct midthird patellar tendon treatment anterior cruciat ligament injuri requir prompt adequ evalu laxiti ligament structur knee treatment option offer patient complet descript knee function treatment option comprehens rehabilit program patient complianc integr part success procedur nurs includ descript injuri preoper test surgic intervent rehabilit program educ patient success postop anterior cruciat ligament rehabilit program multifacet general specif guidelin appli physic therapist knowledg surgic procedur understand principl ligament heal abil individu program level athlet activ person achiev goal phase high perform level addit object measur document progress physic therapist physician import reassur patient normalci restor"
"stress fractur athlet stress fractur prevent proper condit preseason train essenti select agerel sport adequ warm cool import prevent muscl injuri contribut stress fractur athlet awar fatigu contribut factor stress injuri rate proper dress equip basic method prevent good sportsmanship safe particip sport anticip demand expect highperform athlet preval educ rehabilit sportsinjur patient import emerg sport medicin disciplin injur athlet return play arena rapid newer protocol techniqu readi rapid assess diagnos treat sport injuri awar alert possibl injuri wear tear make diagnosi prescrib treatment regim"
"common spinal injuri athlet special athlet spine injuri consid plan treatment patient patient return competit safe rapid nurs understand patientsathlet put perspect respect diagnosi treatment degre disabl support encourag understand knowledg health profession invalu"
"pelvic fractur patient care reflect past implic futur nurs care patient pelvic fractur chang dramat past decad fractur care necessit long period immobl consequ complic influenc classif system extern fixat recent intern fixat evolut pelvic fractur patient care great influenc nurs care patient"
"bone stimul fusion fractur complet understand electr respons bone fulli obtain data end gather develop devic bone electrophysiolog properti impact patient care health care profession remain skeptic effect electr stimul bone heal research practition formul educ opinion form therapi"
"transderm clonidin versus chlordiazepoxid alcohol withdraw random control clinic trial prospect doubleblind comparison assess efficaci transderm clonidin chlordiazepoxid treatment moder sever acut alcohol withdraw syndrom signific withdraw symptom hospit men random assign receiv transderm clonidin chlordiazepoxid day studi period outcom evalu daili medic psychiatr object subject measur depend variabl patient studi group seizur progress delirium tremen group receiv transderm clonidin signific respons global sign symptom alcohol withdraw measur alcohol withdraw assess scale clonidin effect lower elev systol diastol blood pressur heart rate core target symptom anxieti decreas signific patient receiv transderm clonidin measur hamilton anxieti rate scale subscal somat anxieti cognit function respond equal studi popul clonidinetr patient report diarrhea dizzi headach fatigu chlordiazepoxidetr patient report nausea vomit conclud transderm clonidin effect treatment acut alcohol withdraw syndrom"
"pediatr injuri surveil hospit discharg data base mortal data tradit describ epidemiolog childhood injuri fatal outcom repres injuri event provid limit character problem futur epidemiolog studi result injuri prevent depend develop morbiditybas injuri surveil system code hospit discharg data base extern injuri valuabl sourc inform monitor control nonfat injuri code injuri discharg data base develop evalu children hospit alabama birmingham addit patient demograph length stay total charg method payment code code anatom site injuri data collect year studi period discharg hospit document children injuri year age adjust discharg rate childyear injuri account million total charg total day stay fall unintent poison burn bicycl motor vehiclepasseng motor vehiclepedestrian injuri common injuri closedhead trauma account motor vehiclepasseng injuri bicycl injuri fall hot water scald caus burn clonidin ingest account unintent poison"
"fatal incid involv pickup truck alabama death injuri result crash involv light truck pickup truck signific problem data show fatal crash occup fatal involv light truck steadili increas project describ vehicl crash involv passeng ride bed pickup truck actual crash identifi fatal accid report system nation highway traffic safeti administr incid studi involv pickup truck passeng kill sustain visibl injuri carri scene bruis abras visibl injuri briefli unconsci document complaint pain risk death pickup truck passeng fulli eject vehicl time passeng fulli eject correspond risk eject truck time greater occup ride bed occup ride cab"
"isol subclavian arteri dissect blunt trauma present case report patient isol dissect subclavian arteri blunt trauma patient admit center motor vehicl accid complain chest neck pain physic find diminish left extrem puls arteriographi show occlud subclavian arteri possibl dissect dissect confirm surgeri proxim extent origin distal origin vertebr arteri distal extent dissect determin oper repair perform carotidsubclavian arteri bypass obliter fals lumen dissect run vascular anastomosi patient discharg day repair normal extrem neurovascular function month follow"
"plateletderiv growth factorbb transform growth factor beta select modul glycosaminoglycan collagen myofibroblast excision wound recombin plateletderiv growth factor pdgf transform growth factor beta tgfbeta influenc rate extracellular matrix form treat incision wound incision heal process difficult quantifi fullthick excision wound model rabbit ear develop permit detail analys growthfactormedi tissu repair present studi quantit qualit differ acut inflammatori cell influx glycosaminoglycan gag deposit collagen format myofibroblast generat pdgfbb bb homodim tgfbeta treat wound detect analyz histochem ultrastructur growth factor signific augment extracellular matrix format heal day wound compar control pdgfbb mark increas macrophag influx gag deposit tgfbeta select induc signific matur collagen bundl lead edg granul tissu transform growth factorbeta treat wound fibroblast demonstr activ collagen fibrillogenesi accret subfibril ultrastructur level myofibroblast phenotyp modifi fibroblast consid respons wound contract observ control absent earli growthfactortr granul wound result provid import insight mechan soft tissu repair pdgfbb induc inflammatori respons provision matrix synthesi wound qualit similar quantit increas compar normal wound tgfbeta preferenti trigger synthesi rapid matur collagen earli wound growth factor inhibit differenti fibroblast myofibroblast wound contract requir due increas extracellular matrix synthesi"
"clinic util positionmonitor cathet pulmonari arteri unsuspect distal migrat tip pulmonari arteri cathet lifethreaten complic prospect evalu clinic util pa watch cathet patient cardiac surgeri hour measur pulmonari arteri distal lumen ventricular middl lumen central venous proxim lumen pressur cathet consid proper posit middl lumen port locat cm tip transmit ventricular pressur waveform satisfactori initi cathet placement obtain patient postop monitor clinic unsuspect distal cathet migrat presenc pulmonari arteri pressur waveform middl lumen port occur patient patient episod occur requir cathet withdraw distanc cm rang cm pa watch cathet prove indic unsuspect distal cathet migrat postop period pa watch cathet assess cathet tip placement proxim pulmonari arteri decreas catheterinduc complic"
"anim model human masset muscl histochem character mous rat rabbit cat dog pig cow masset muscl masset muscl anim speci investig histochem method demonstr acidst alkalist myosin adenosin triphosphatas atpas subdivis fiber type type fiber show weak atpas activ ph type im fiber react moder type ii fiber react strong rat mous masset muscl type ii fiber rabbit masset muscl rabbit masset muscl possess equal amount type ii fiber cat dog masset muscl possess type ii fiber type ii predomin cow masset muscl consist type fiber cow masset muscl small number type ii fiber pig masset muscl type ii im fiber characterist human masset muscl type im fiber rare muscl masticatori muscl pig masset muscl suitabl anim model experiment studi investig distribut diamet fiber type masticatori muscl orthognath surgeri"
"collagen dystroph hamster diaphragm collagen content diaphragm measur normal dystroph hamster age day diaphragm collagen content greater dystroph hamster control hamster age effect greater older hamster collagen content express term percentag dri weight relat surfac area total collagen increas appar expens muscl tissu major factor contribut respiratori muscl weak dystrophi advanc"
"cellular metabol requir induct macrophag procoagul activ murin hepat virus strain vitro cellular basi variat induct monocyt procoagul activ pca murin hepat virus strain mhv examin set recombin inbr strain mice deriv resist suscept cbj progenitor induct pca mhv requir live virus host protein rna synthesi absolut restrict induct pca observ level macrophag periton macrophag resist parent ri strain axb induc express pca stimul mhv presenc lymphocyt suscept compat ri mice axb respond endotoxin lps contrast macrophag suscept axb semisuscept axb ri strain mice express similar increas pca stimul mhv absenc lymphocyt level pca express macrophag presenc thi lymphocyt correl suscept diseas thi lymphocyt suscept ri axb mice induc level pca macrophag semisuscept ri axb mice equival cultur macrophag lymphocyt suscept mice subfraction thi cell demonstr lt cell instruct macrophag produc pca thi cell mhv immun resist axb mice immun mice suppress induct pca suppressor cell activ detect day immun reach maxim activ day signific suppress day pca shown direct prothrombin cleav activ prothrombinas elisa immunofluoresc stain mab result demonstr induct uniqu pca prothrombinas restrict level macrophag defin regulatori role lymphocyt induct"
"local dystrophin postsynapt region central nervous system cortic neuron moder progress cognit impair consist featur duchenn muscular dystrophi dmd central nervous system cns abnorm identifi recent studi elucid molecular defect dmd includ absenc protein dystrophin affect individu normal brain tissu dystrophin messeng rna dystrophin present low abund brain regul tissu part promot differ muscl antibodi immunocytochem method demonstr dystrophin plasma membran mous human muscl proven inadequ local precis dystrophin mammalian cns made antibodi anti sensit previous immunolabel dystrophin cns antibodi found mous dystrophin abund neuron cerebr cerebellar cortic local postsynapt membran special dystrophin role neuron muscl alter synapt level basi cognit impair dmd"
"parent mhc molecul haplotyp express sjl swrf mice acut experiment allerg encephalomyel induc synthet peptid myelin proteolipid protein determin ag induc autoimmun diseas influenc parent mhc haplotyp molecul express situ mhc heterozygot acut experiment allerg encephalomyel eae induc encephalitogen peptid sjl swrf mice mice sensit synthet peptid mous myelin proteolipid protein plp residu yktticgkglsatv induc eae swr sjl mice synthet peptid plp residu hclgkwlghpdkf encephalitogen sjl swr mice mice kill moribund day sensit twelv mice plp peptid mice plp peptid develop eae wk sensit cryostat section brain sampl parent mice immunostain panel mab identifi class ii mhc molecul brain control class mhc molecul express choroid plexus endotheli cell microglia class ii mhc molecul absent eae lesion class ii mhc molecul present inflammatori parenchym cell degre parent haplotyp molecul express vari peptid ag test sjl swrf mice myelin plp peptid domin ag respect clinic histolog diseas parent haplotyp mhc molecul express propos unifi hypothesi consist result previous observ differenti ia express respond responderf guinea pig suggest mhc molecul bind local deriv peptid ag inflammatori site interact influenc level mhc haplotyp molecul apc"
"dystrophin requir normal thin filamentmembran associ myotendin junction dystrophin defici gene product duchenn muscular dystrophi locat subjac muscl cell membran myotendin junction entir muscl cell myotendin junction site thin filament link cell membran end associ thin filament membran cell membran site normal muscl fold extens dystroph junction display normal contact end thin filament subsarcolemm densiti dystroph junction defici associ thin filament membran display membran fold control structur defect result stress concentr site thin filament attach membran membran tear muscl activ largediamet matur muscl cell defici dystroph myotendin junction structur contribut understand previous unaccount aspect etiolog duchenn muscular dystrophi"
"role influenza virus hepat steatosi mitochondri abnorm mous model rey syndrom hepat steatosi observ influenza virus mous model rey syndrom attribut infecti virus altern decreas food intak virustr mice impur virus prepar resolv issu wk male balb mice intraven inject hemagglutin unit influenza lee virus phosphat buffer salin bovin serum albumin virus prepar ultracentrifug infect allanto fluid sucros densitygradi purif virus prepar ultracentrifug infect allanto fluid irradi virus prepar ultracentrifug infect allanto fluid inactiv virus infect titer virus prepar ultracentrifug infect allanto fluid higher sucros densitygradi purifi virus prepar infect allanto fluid egg infecti dose virus prepar ultracentrifug infect allanto fluid hemagglutin unit egg infecti dosehemagglutin unit sucros densitygradi purifi virus prepar infect allanto fluid control mice receiv phosphatebuff salin bovin serum albumin uninfect allanto fluid dilut phosphatebuff salin bovin serum albumin mice fast elimin dietari variat liver obtain hr virus administr treatment virus prepar ultracentrifug infect allanto fluid caus clinic ill increas hepat triglycerid compar control hepat triglycerid virus prepar ultracentrifug infect allanto fluid correl histopatholog vacuol score"
"irradi improv mdx mous muscl model myofib loss dmd mdx mous genet biochem homologu human duchenn muscular dystrophi dmd present compar mild histopatholog clinic phenotyp differ partial attribut greater efficaci regener mdx mous dmd muscl lessen dispar singl dose irradi gy inhibit regener leg mdx mice result complet block muscl fiber regener lead progress loss muscl fiber replac loos connect tissu surviv fiber peripher nucleat surpris larg diamet irradi convert mdx muscl model system degen process studi isol complic effect myofib regener system test method allevi myofib degener common mdx dmd"
"low zinc intak affect mainten pregnanc guinea pig zinc defici pregnanc sever effect anim extent effect anim appli human pregnanc pregnant guinea pig share characterist pregnant women make model experi guinea pig zn intak reduc begin gestat reduc zn intak experi result abort prematur deliveri zincsuppl anim feed intak restrict zndefici anim abort deliv prematur zincsuppl anim fed ad libitum access deliv live young term fetalneonat liver zn concentr low guinea pig compar report anim affect lesser extent low zn intak dam zinc concentr neonat plasma speci chang activ angiotensinconvert enzym addit zn vitro greater plasma zndefici guinea pig znadequ guinea pig indic zn status"
"dystrophin express myotub form fusion normal dystroph myoblast mdx mous dystrophi character absenc muscl cytoplasm membran high molecular weight protein call dystrophin avenu treatment muscular dystrophi inject normal myoblast dystroph muscl form hybrid muscl fiber hybrid myotub form vitro fusion normal rat dystroph mous mdx myoblast stain hoechst dye permit clear distinct mous rat nuclei immunostain demonstr dystrophin present entir membran hybrid myotub nuclei ratio normaldystroph low"
"menstrual state exercis determin spinal trabecular bone densiti femal athlet object studi effect amenorrhoea intens back exercis bone miner densiti lumbar spine femal athlet designcross section studi compar amenorrho eumenorrho athlet rower rower set british olymp medic centr northwick park hospit patient elit femal athlet compris rower runner dancer amenorrho eumenorrho main outcom measuretrabecular bone miner densiti lumbar spine measur comput tomographi result trabecular bone miner densiti mgcm confid interv mgcm lower amenorrho eumenorrho athlet differ high signific trabecular bone miner densiti mgcm mgcm lower rower rower signific interact effect conclus effect intens exercis lumbar spine partial compens advers effect amenorrhoea spinal trabecular bone densiti"
"nuclear techniqu analysi urinari calculi section urinari calculi prepar pointpoint analys linescan carri techniqu protoninduc ray emiss pix nuclear reaction analysi nra correl pair element includ trace element note clear composit stone vari mark stage develop"
"singl lumen ileum myectomi altern pelvic reservoir restor proctocolectomi altern procedur construct pelvic ileal reservoir assess avoid pouch provid adequ rectal substitut good contin thirti femal adult beagl allot random undergo total colectomi ileoan anastomosi ileoan anastomosi cm myectomi ileoan anastomosi myectomi ileoil valv ileoan anastomosi duplic pouch anim studi oper week interv week oper mortal rate similar ileal complianc increas signific myectomi mlmmhg median interquartil rang ileoan anastomosi mmhg increas maintain ileal capac increas myectomi pouch ileoan anastomosi ml ml ileoan anastomosi myectomi ml ml ileoan anastomosi myectomi ileoil valv ml rang ml ileoan anastomosi pouch ml rang ml bowel function group mark superior ileoan anastomosi transit time signific ileoan anastomosi ileoan anastomosi myectomi ileoan anastomosi pouch addit ileoil valv produc increas transit time rang myectomi singl lumen ileum altern pelvic ileal reservoir restor proctocolectomi"
"evid receptoroper event neutrophil mediat neutrophil accumul vivo pretreat inneutrophil pertussi toxin vitro inhibit accumul vivo role neutrophil chemoattract receptor neutrophil stimul vitro establish precis mechan local neutrophil accumul inflammatori site vivo defin fundament question remain open chemoattract act endotheli cell neutrophil initi process neutrophil migrat vivo address question investig neutrophil accumul vivo occur chemoattract receptor occup uncoupl neutrophil stimul purpos pertussi toxin pt pharmacolog tool investig effect vitro pretreat rabbit neutrophil pt respons vitro accumul vivo pretreat rabbit neutrophil pt inhibit fmlp ca pma induc increas cd express neutrophil adher degranul vitro pretreat procedur pt inhibit accumul radiolabel neutrophil vivo respons intraderm inject fmlp ca ca des arg leukotrien il zymosan rabbit skin contrast vitro result pt inhibit pmainduc inneutrophil accumul vivo interest pretreat neutrophil pt inhibit accumul respons intraderm inject il report il lack neutrophil chemoattract activ vitro experiment techniqu distinguish stage neutrophil migrat involv result suggest accumul neutrophil induc local extravascular chemoattract vivo depend pertussi toxinsensit receptor oper event neutrophil pma il releas secondari chemoattract vivo"
"inhibit neutrophil migrat tumor necrosi factor vivo vivo studi comparison vitro effect coincub neutrophil tnf inhibit chemoattractantdirect migrat neutrophil agaros enhanc migrat multiwel chemotaxi chamber assess physiolog signific differ vitro tnf effect vivo vivo investig perform anim model neutrophil peripher blood rabbit preadminist system tnf show impair abil migrat chemoattract vitro addit system tnf administr suppress zymosanactiv plasmainduc local accumul leukocyt mous skin result circul tnf act suppressor local inflammatori reaction"
"express character tca murin inflammatori protein tca cdna origin isol activ cell transcript gene shown correl aginduc cellular activ cell mast cell base predict amino acid sequenc encod cdna previous propos tca repres cytokin report rdna technolog express tca mammalian cell line case tca express secret molecul appar molecular mass kda digest rtca enzym glycanas reveal approxim kda caus link glycosyl intraderm inject rtca mous footpad result rapid swell respons site inject character histolog local accumul neutrophil find discuss attent famili relat protein member inflammatori properti"
"cytokin regul il beta gene express human polymorphonuclear leukocyt recent polymorphonuclear leukocyt pmn identifi produc il beta respons lps granulocytemonocyt coloni stimul factor abil cytokin induc product il beta pmn il tnf shown import prime agent agent induc migrat pmn investig effect il beta gene express human peripher blood pmn present studi demonstr human peripher blood pmn produc il beta respons il alpha il beta tnfalpha control unstimul human pmn virtual undetect level il beta mrna il beta tnf induc pmn transient express il beta mrna peak express return untreat level dose respons ngml il beta tnf result il beta induct maxim effect ngml il beta ngml tnf il alpha il beta exhibit similar dose respons il beta mrna induct cytokin shown synergist effect cell function studi induc pmn combin maxim effect dose tnf il beta demonstr cooper effect il beta gene express mrna level sustain hour il beta ag express measur elisa parallel il beta mrna express cell peak level il beta ag level pmn lysat supernat correl il beta mrna level tnf il greater tnf greater il studi repres demonstr il tnf induct il beta gene express pmn time induct uniqu pmn peak induct mrna consist short live natur cell inflammatori lesion"
"retrovir express transform growth factoralpha transform fibroblast keratinocyt transform growth factor alpha tgf alpha peptid impart anchorageindepend growth normal rat kidney nrk cell vitro secret rodent human tumor cell direct investig transform properti factor construct replicationdefect murin retrovirus express human sequenc code tgf alpha infect niht cell tgf alpha retrovirus led integr transcript activ provirus overexpress biolog activ tgf alpha fail induc morpholog transform similar tgf alpha retrovirus fail induc morpholog transform type rodent fibroblast investig effect tgf alpha express growth balbmk mous keratinocyt requir epiderm growth factor egf prolifer show exogen ad tgf alpha extrem potent mitogen balbmk cell retrovir express tgf alpha balbmk cell fail reliev depend exogen ad egf tgf alpha cell growth result suggest overexpress tgf alpha transform rodent fibroblast keratinocyt"
"dna sequenc analysi inhibitorposit hemophilia patient gross gene delet identif mutat factor ix gene hemophilia patient antifactor ix antibodi detect gross delet factor ix gene southern blot analysi investig molecular level exon accompani splice junction site presumpt promot region factor ix gene patient total kb length amplifi polymeras chain reaction complet nucleotid sequenc analysi type singl base substitut basepair nucleotid delet identifi patient hb point mutat factor ix gene locat promot region nucleotid transit found exon vi gene chang gln stop codon patient hb point mutat splice acceptor site interrupt normal splice intron small nucleotid delet exon iii detect patient hb yield frameshift amino acid termin stop codon resuslt suggest gross gene delet factor ix gene point mutat small nucleotid delet interrupt code inform matur protein synthesi predispos develop antifactor ix inhibitor patient hemophilia"
"ektacytometri determin red cell suscept oxid stress defin sensit reliabl method determin cellular characterist erythrocyt oxid damag viscodiffractometr method ektacytometri measur effect oxid stress erythrocyt incub presenc hydrogen peroxid butyl hydroperoxid cumen hydroperoxid phosphat buffer treatment result decreas cellular deform intact erythrocyt addit deform fragil measur erythrocyt ghost membran increas membran dynam rigid alteredmechan stabil consequ oxid stress observ onset hemolysi observ decreas deform accompani oxid hemoglobin alter membran protein lipid peroxid continu measur time decreas deform intact erythrocyt oxid stress ektacytometr method develop erythrocyt oxid challeng viscomet constant osmol shear stress chang deform monitor typic rang defin erythrocyt normal individu comparison erythrocyt patient sickl cell diseas normal individu demonstr higher suscept sickl red cell oxid stress"
"assess clinic effect prevent maneuv analyt principl systemat method review evid develop clinic practic recommend report canadian task forc period health examin paper examin process evalu clinic effect develop recommend systemat method review evid publish clinic research reach sound conclus medic polici methodolog address import compon analyt process criteria satisfi clinic practic consid effect proper method review evid publish clinic research determin clinic practic meet criteria includ method perform comprehens literatur review judg qualiti individu studi synthes pool result multipl studi theoret practic concern translat result scientif review sound clinic practic recommend import document guidelin safeguard minim effect review object consist analyt method"
"effect inflamm copper intak rat liver erythrocyt cuzn superoxid dismutas activ level stress inflamm produc acut phase respons includ elev level ceruloplasmin main copper compon plasma inflammatori effect cellular copper enzym activ level larg unknown cuzn superoxid dismutas sod activ liver main site ceruloplasmin secret decreas turpentineinduc inflamm ml intramuscular leg rat fed copper level adequ mgkg margin mgkg defici mgkg ceruloplasmin activ rose signific inflamm adequ margin group defici anim hepat cuzn sod immunoreact protein level unaffect copper status inflammatori state erythrocyt cuzn sod activ influenc dietari copper inflamm addit group rat fed mg copperkg show turpentineinduc decreas liver cuzn activ level inflammatori effect copper enzym activ occur evidenc increas ceruloplasmin decreas serum extracellular sod conclus acut phase respons rat increas amount dietari copper requir maintain hepat cuzn sod activ level equal nonstress copperadequ rat rat erythrocyt cuzn sod activ provid blood measur reflect copper intak stress valu reflect decreas liver cuzn sod activ inflamm"
"prospect evalu effect temporomandibular joint arthroscopi prospect studi evalu therapeut arthroscopi intern derang temporomandibular joint tmj fifti patient abnorm joint evalu preoper pain nois maxim incis open mio deviat open preoper postop magnet reson imag mri scan obtain joint patient treat superior joint arthroscopi lysi adhes lavag steroid inject preoper postop splint physiotherapi pain nois motion evalu time period earli day intermedi month late greater month earli intermedi late follow increas mio statist signific nois return major patient disc posit evalu mri chang joint correl clinic outcom result studi tmj arthroscopi effect reduc pain increas motion patient tmj intern derang"
"improv techniqu develop pectorali major myocutan flap pectorali major myocutan flap common employ muscl skin transfer softtissu reconstruct defect upper neck jaw region articl present conceptu technic develop pectorali major myocutan flap preserv greater vascular pedicl enhanc flap arc rotat data consecut case modifi approach show reduct complic greater rang consist heal radiat nonradi tissu requir section remov clavicl caus signific chest deform modif produc predict transfer compar report techniqu"
"import routin surveil distal bypass graft duplex scan studi revers vein graft assess util routin duplex surveil infrainguin revers vein graft perform independ teach hospit prospect enter surveil protocol march august averag postop duplex graft flow veloc gfv measur graft obtain follow interv month graft gfv measur greater cmsec fail month normal surveil examin gfv measur cmsec graft led arteriographi graft identifi stenot lesion bypass seri inflow lesion present outflow stenos intrins graft stenos bypass graft identifi fail duplex scan reduct anklebrachi index greater secondari reconstruct perform graft base detect reduc gfv measur reconstruct patent follow month duplex surveil reliabl identif fail vein graft determin anklebrachi index"
"surgic procedur manag takayasu arter takayasu arter inflammatori arteriopathi progress obliter multipl larg arteri variabl result report medic surgic manag twenti femal patient takayasu arter treat eleven patient hypertens upper lower extrem ischemia present patient cerebrovascular insuffici patient initi manag corticosteroid improv sign symptom arteri insuffici eleven patient vascular procedur indic renovascular hypertens extrem ischemia cerebrovascular insuffici dilat ascend aorta aortic insuffici thorac aortic aneurysm abdomin aortic aneurysm procedur includ aortoren bypass carotidsubclavian axillari brachial bypass aortocarotid bypass aneurysm resect supraceliac aortofemor bypass ascend aortaaort valv replac nephrectomi clinic improv occur patient oper death aliv follow year month year revis initi reconstruct requir recurr renovascular hypertens patient extrem ischemia patient remain symptomat improv symptomat takayasu arter frequent requir arteri reconstruct symptomat improv excel longterm graft patenc expect arteri reconstruct"
"predict risk noncardiac oper cardiac oper determin preoper variabl affect mortal rate develop sever complic patient myocardi revascular valv replac undergo noncardiac oper retrospect studi data patient year thirti percent patient noncardiac oper month cardiac oper mortal rate morbid rate statist comparison predict accuraci postop complic simpl wide classif american societi anesthesiologist physic status york heart associ classif massachusett general hospit cardiac risk index demonstr superior simplifi class cardiac risk index massachusett general hospitalcardiac risk index predict accuraci multivari discrimin analysi variabl popul variabl myocardi infarct previous month gallop jugular vein distent arrhythmia preoper electrocardiogram emerg oper delay cardiac noncardiac oper identifi predict postop complic variabl function df obtain linear discrimin analysi predict accuraci postop complic reach perform model prospect valid popul remain satisfactori massachusett general hospitalcardiac risk index class index df extens statist analysi data test valid studi provid simpl predict model base clinic variabl easili emerg situat"
"locat maxillari os import endoscop sinus surgeon function endoscop sinus surgeri continu gain popular support necess clear accur understand anatomi ostiomeat complex essenti clarifi anatomi serial cadav dissect perform anatomi ostiomeat complex detail dimens emphasi precis local intern os maxillari sinus relat orbit natur antronas canal ethmoid infundibulum measur posit intern os relat posit anterior posterior wall maxillari sinus posit orbit dimens configur antronas canal relationship infundibulum detail measur relationship understood endoscop sinus surgeon locat natur ostia injur orbit"
"role facial nerv latenc test prognosi bell palsi eighti patient idiopath facial nerv palsi evalu facial nerv latenc test depend latenc time patient classifi group group patient normal latenc time msec group patient slight extend latenc time msec msec group patient extend latenc time msec msec group patient display complet disappear evok compound muscl action potenti respons therapeut regimen determin latenc time normal close normal function recoveri nerv complet complet recoveri time short latenc time extend respons function recoveri nerv incomplet absent"
"ossicl homograft bone prosthes middl ear thesi propos human cadav ossicl tempor homograft bone middl ear reconstruct materi bone obtain otic capsul histolog resembl ossicl bone bodi otic capsul due proxim middl ear harvest middl ear structur bone core obtain make easili access prosthes cost effect multipl prosthes sculptur tempor bone core paper propos introduct ossicl homograft primari stapedectomi select case bypass incus superstructur stape audiolog data provid graft middl ear year extrus complic method harvest preserv steril present pictori illustr finish product relat natur ossicl histolog specimen present basi audiolog result fact ossicl extrud resorb propos ossicl tempor bone homograft place transplant surgeri"
"pediatr behavior neurolog updat neurolog aspect depress hyperact learn disabl publish erratum neurol clin febviii high incid poor social adjust longterm follow studi depress children relat inadequaci pharmacotherapi sustain longlast remiss possibl repetit inappropri stress insuffici antidepress therapi result intermitt depressioninduc dysfunct social function perform cerebr hemispher permit child develop interperson skill caus failur social situat cognit difficulti complic academ perform repeat school failur chronic social ineptitud preclud develop skill success independ live societi symptom depress found imper learningdis behavior disturb child adolesc receiv adequ antidepress therapi ensur complet longterm remiss depress addit learningdis individu appar diagnos depress ill offer method learn communic reduc stress educ strategi offer poor perform ensu continu trial antidepress therapi consid recognit depress natur symptom treatmentinduc improv occur depress learn disabl resolv improv academ perform improv cognit function treatmentinduc remiss depress episod dramat resolut appar learn disabl poor educ achiev chronic learn difficulti ultim affect adult social function untreat improp treat chronic depress result develop person disturb attribut school problem children untreat condit depress disord exclud antidepress therapi remov appar inappropri stress includ inappropri demand brain function provid children adolesc evid depress"
"cortic tremor variant cortic reflex myoclonus patient action tremor thought origin cerebr cortex show fine shiver finger twitch provok action postur surfac emg show rhythmic discharg rate hz resembl essenti tremor electrophysiolog studi reveal giant somatosensori evok potenti sep enhanc longloop reflex premov cortic spike jerklock averag method treatment betablock show effect anticonvuls clonazepam valproat primidon effect suppress tremor amplitud sep call involuntari movement cortic tremor fact variant cortic reflex myoclonus"
"topograph map electrophysiolog measur patient homonym hemianopia analyz electroencephalograph eeg activ spatial distribut patternrevers visual evok potenti pvep patient unilater lesion retrochiasm visual pathway focal abnorm consist lesion locat present topograph analyz eeg vep patient compar detect rate convent analysi techniqu quantit analysi spectral analyz eeg reveal focal abnorm patient convent eeg interpret normal diffus slow focal paroxysm spike present eeg patient miss eeg map fals local quantit eeg abnorm contralater lesion occur patient topograph analysi pvep sensit retrochiasmat lesion convent analysi occipit electrod conclud topograph map valid techniqu detect local cerebr lesion"
"control postop pain topic bupivacain hydrochlorid laparoscop falop ring tubal ligat conflict report exist literatur effect topic local anesthet appli seros surfac fallopian tube control postop pain mechan band clip tubal ligat sixti patient studi prospect outpati laparoscop falop ring tubal ligat modifi mcgill present pain intens scale patient random assign group receiv topic bupivacain hydrochlorid fallopian tube tube left tube receiv control uniqu studi design incorpor untreat fallopian tube serv subject control patient receiv unilater treatment statist analysi confirm signific benefit fallopian tube treat compar treatment consist evid decreas postop pain percept treat side patient receiv unilater treatment topic bupivacain demonstr subject patient respons mcgill pain scale reduc pain medic outpati discharg data support topic bupivacain appli seros surfac fallopian tube reduct postop pain outpati laparoscop mechan band clip tubal ligat"
"qualiti assur indic shortterm outcom hysterectomi fifteen gynecolog qualiti assur indic recent publish american colleg obstetrician gynecologist appli previous report hysterectomi data base chart review perform recent case data base repres month interv indic divid group intend identifi morbid mortal intend screen appropri care rate actual morbid case fail meet publish criteria set hysterectomi determin chart review presenc qualiti assur indic total indic identifi case includ patient morbid indic appropri indic actual morbid correct identifi case morbid indic present case signific morbid identifi chart review identifi indic yield posit negat predict valu accuraci morbid indic contrast case appropri indic present fail meet publish criteria set addit case fail meet criteria set identifi chart review identifi indic yield posit predict negat predict accuraci appropri indic"
"primari mass closur midlin incis continu polyglycon monofila absorb sutur mass closur midlin incis run largebor perman monofila polypropylen sutur general surgeri gynecolog patient report small incid fascial dehisc lateoccur wound sinus format problem report perman sutur materi month period patient midlin incis close continu run polyglycon monofila delay absorb sutur close space bite cm cm fascial edg patient surgeri gynecolog cancer highrisk factor includ obes diabet previous irradi chemotherapi ovarian cancer stage procedur patient remain patient half extens oper procedur rang exenter hysterectomi lymph node dissect wound complic note patient superfici infect eviscer develop ventral hernia wound sinus occur closur techniqu safe expedi distribut tension equal continu line addit advantag eventu absorpt sutur materi avoid wound sinus problem occasion report largebor perman sutur"
"clomiphen citrat stimul adjunct locat ovarian tissu ovarian remnant syndrom ovarian remnant syndrom result residu ovarian tissu bilater oophorectomi syndrom chronic pelvic pain suspect premenopaus level fsh lh present patient document bilater oophorectomi histolog demonstr ovarian tissu oper confirm diagnosi treat patient ovarian remnant syndrom day clomiphen citrat mg daili stimul residu ovarian tissu facilit local preoper ultrasound reveal cm cystic mass adnex region exploratori laparotomi easili local mass remov intact histolog slide demonstr normal ovarian tissu multipl follicl stage develop corpus luteum cyst clomiphen citrat capabl stimul ovarian remnant produc enlarg cystic structur easili local ultrasound increas size preoper knowledg locat facilit surgic remov"
"umbil cord hematoma diagnost funipunctur major complic funipunctur report rare report diagnost funipunctur perform week fetus singl umbil arteri multipl malform immedi procedur volumin hematoma develop site needl insert associ sever fetal bradycardia fetal death confirm minut needl insert hypothes risk complic funipunctur vari clinic indic procedur increas presenc fetal malform rapid evolut complic occur present case underlin import clear plan manag event mishap discuss plan parent undertak diagnost funipunctur"
"dental patient reaction electrocardiogram screen nineti patient receiv routin dental treatment univers minnesota school dentistri particip electrocardiogram screen studi purpos studi evalu patient reaction electrocardiogram screen dental school clinic vast major patient test easi intrud dental appoint patient report test valuabl servic dental offic patient test perform dental offic patient express signific concern anxieti test complet twenti percent patient found cardiac arrhythmia nonseri arrhythmia impact plan dental procedur patient identifi arrhythmia requir medic referr dental treatment start"
"rapid sequenc anesthesia induct emerg intub emerg intub varieti reason emerg depart ed patient rapid control induct anesthesia facilit intub reduc complic intub refer rapid sequenc induct rsi anesthesia literatur atropin thiopent fentanyl diazepam ketamin vecuronium succinylcholin drug applic rsi purpos articl describ rsi airway manag ed patient nineteen pediatr patient requir emerg intub intub rsi vecuronium thiopent actual intub difficulti rsi signific anticip intub difficulti rsi complic caus intub rsi signific impact patient outcom feel sedat combin vecuronium repres optim achiev rsi ed set induct general anesthesia anesthesiologist emerg physician experienc physician immedi manag airway critic emerg object protocol make easier emerg physician perform procedur"
"bell palsi ensur outcom bell palsi thought idiopath polyneur distinguish disord facial weak case differenti accomplish basi histori physic examin clinic routin follow care ensur recoveri occur electrodiagnost test assess prognosi eye care corticosteroid therapi recommend"
"infant reddish diaper infant reddish diaper present diagnost challeng primari care physician dr baumgardn benign omin disord rule"
"regul calmodulinrel gene transform human mammari epitheli cell human cdna librari obtain cultur normal mammari epitheli cell hmec search subtract hybrid gene decreas express relev epitheli transform clone identifi procedur correspond kilobas mrna design nb express decreas greater fold hmec tumorigen transform vitro exposur benzopyren kirsten sarcoma virus sequenc analysi nb cdna reveal open read frame high degre homolog calmodulin nb express demonstr polymeras chain reaction amplif normal breast prostat cervix epiderm tissu presenc nb transcript variabl primari breast carcinoma tissu undetect tumorderiv cell line breast prostat origin nb mrna express regul cultur hmec exposur reconstitut extracellular matrix materi exposur transform growth factor type beta increas relat abund protein encod nb ca bind properti perform function similar authent calmodulin role differenti suppress tumorigen epitheli tissu remain examin"
"tumorigen cell maintain alkalin intracellular ph physiolog condit earliest event respons mammalian cell mitogen activ na exchang increas intracellular ph phin absenc hco extern ph valu prolif respons block prevent phin increas prolif respons stimul artifici rais phin weak base high medium ph observ support hypothesi optim phin suffici compon proliferativerespons sequenc hypothesi recent challeng observ transfect nih cell yeast atpas render tumorigen previous measur transfect cell maintain higher phin absenc hco atpas transfect rais phin physiolog relev condit current report show transfect cell maintain higher phin control cell presenc hco support possibl elev phin prolif trigger situ show cell serumindepend growth glycolyz rapid phenotyp normal cell"
"simian virus small tumor antigen aminotermin domain larg tumor antigen share common transform function residu aminotermin sequenc simian virus larg tumor antigen tag small tumor antigen tag ident genet analysi tag lack amino acid reveal transformationdefect reveal agar growth assay introduc presenc tag lack overt transform activ function sequenc common tag tag suffici tag transform activ tag provid function equival tran tag part view portabl copi tag function domain"
"identif character regul promot element epiderm growth factor receptor gene identifi basepair proxim element relat aug translat initi codon epiderm growth factor receptor region function promot mediat induct respons epiderm growth factor phorbol myrist acet cyclic amp act orientationindepend manner region function enhanc transfer heterolog promot tata box mutat basepair region alter function assay report gene express recipi cell protein identifi demonstr bind specif mutant dna sequenc correl promot activ observ vivo basi dna bind characterist size identifi protein distinct previous identifi transcript factor bind rich region"
"identif preliminari character proteincystein farnesyltransferas ras protein isoprenyl conserv cystein residu carboxyl terminus cys mammalian ras protein order exert biolog activ previous studi intermedi mevalon pathway farnesyl pyrophosph donor isoprenyl group inhibit mevalon synthesi revert abnorm phenotyp induc mutant rasval gene saccharomyc cerevisia block matur xenopus oocyt induc oncogen ras protein human origin result rais possibl inhibitor mevalon pathway block transform properti ras oncogen mevalon precursor end product essenti mammalian cell dolichol ubiquinon heme cholesterol studi describ enzymat activityi capabl catalyz farnesyl unprocess ras protein vitro correct cys residu farnesyl activ heatlabil requir mg mn ion linear time enzym concentr present mammalian cell line tissu test gel filtrat analysi partial purifi prepar protein farnesyltransferas reveal peak activ kda kda avail vitro protein farnesyltransferas assay screen potenti inhibitor ras oncogen function interfer aspect mevalon pathway"
"small nuclear rna play direct role format revregul human immunodefici virus env mrna remain unsplic revregul express hiv envelop protein simian virus late replac vector found depend presenc splice site env mrna spite fact mrna remain unsplic splice site upstream env open read frame delet mutat express envelop protein lost rna analysi cell transfect splicesit mutant show dramat reduct steadyst level env mrna rev present envelop express restor splicesit mutant cotransfect plasmid express suppressor small nuclear rna compensatori mutat experi show small nuclear rna play direct essenti role format unsplic rna subject regul rev"
"identif relat human gro gene encod cytokin function product human gro gene cytokin inflammatori growthregulatori properti gro call mgsa melanoma growthstimulatori activ identifi addit gene gro beta gro gamma share ident deduc amino acid level origin gro alpha isol amino acid substitut prolin gro alpha leucin gro beta gro gamma lead larg predict chang protein conform signific differ exist untransl region includ number attta repeat mrna instabl basepair region region conserv gro gene part conserv chines hamster genom suggest role regul dna hybrid oligonucleotid probe partial sequenc analysi genom clone confirm form deriv relat gene chromosom locus identifi gro alpha cdna clone hybrid gene express studi reveal tissuespecif regul regul specif induc agent includ interleukin tumor necrosi factor phorbol myrist acet lipopolysaccharid"
"retroorbiculari oculus fat roof resect aesthet blepharoplasti year studi patient sixti nonconsecut patient undergon resect retroorbiculari oculus fat roof conjunct aesthet blepharoplasti patient consist abil soften flatten heavi bulki upper orbit region patient develop postop hematoma patient transient dryey symptom blepharoplasti twenti percent patient transient degre numb supraorbit nerv region patient note transient numb upper brow region patient demonstr signific paralysi orbiculari oculus corrug muscl experi retroorbiculari oculus fat resect adjunct standard blepharoplasti techniqu select patient"
"augment mammaplasti transrectus rout oper techniqu develop augment mammaplasti inframammari incis anterior rectus sheath enter pocket dissect submuscular plane perform procedur patient date complic capsular contractur rate patient greater year percent inframammari creas lower techniqu make mastopexi unnecessari patient moder ptosi"
"comparison lymphat venous interposit autograft experiment microsurgeri canin lymphat mongrel dog autolog lymphat vein graft interposit bridg defect femor collect lymphat group lymphat autograft interposit good result obstruct observ month group venous autograft interposit irrig heparin salin autograft interposit irrig week irrig graft partial occlud red thrombus month graft total occlud group lymphaticolymphat anastomos envelop silicon sheet provok prolong devascular vessel patent anastomot patenc inspect vivo postop specimen studi light microscopi scan transmiss electron microscopi prolong devascular damag endotheli cell result show lymphat vessel autograft choic interposit autograft bridg defect lymphat vessel"
"intracerebr hematoma complic split calvari bonegraft harvest case report intracerebr hematoma harvest split calvari bone full recoveri patient occur complic calvari bone graft harvest review potenti devast complic warrant altern sourc bone pure elect surgic candid"
"treatment frontal sinus hypertrophi treatment frontal sinus hypertrophi anterior wall remov invert attach result depress fill bone dust detail discuss case present"
"angiograph techniqu dimension determin arteri suppli pattern cadav soft tissu method arteri tree map cadav soft tissu present situ angiogram photograph supplement profil angiogram narrow band tissu remov specimen method suit map suppli pattern softtissu arteri network situ angiogram dissect practic problem encount solut provid radiopac structur support vessel pure barium sulfat found suitabl fill vascular tree capillari level leakag excis specimen"
"pinch syndrom complic implant subclavian venous access devic implant central venous access devic subclavian vein obstruct thrombosi imping vein wall compress clavicl rib term pinch syndrom pos eleven patient pos studi includ cathet fractur cathet fragment compar match control patient consecut routin clinic patient cathet grade normal abrupt chang lumin narrow lumin narrow complet cathet fractur pos present case week placement grade cathet common control subject grade uncommon cathet fractur fragment case longterm greater week pinch grade cathet conclus reach grade repres signific cathet compress potenti complic grade uncertain clinic signific due high preval control subject"
"mitral valv prolaps comparison diagnosi physic examin echocardiographi determin physic examin find suggest mitral valv prolaps mvp correl echocardiograph evid mvp retrospect review chart patient refer air forc cardiolog clinic echocardiographi rule mvp case refer physician specialti find cardiac physic examin record patient mode echocardiographi half patient dimension echocardiographi sensit specif likelihood ratio physic examin calcul echocardiographi comparison standard combin systol click systol murmur physic examin find predict echocardiograph mvp posit likelihood ratio combin physic find yield likelihood ratio close differ found base specialti examin physician conclud practic physician find systol click murmur mvp present echocardiographi patient normal echocardiogram combin physic find predict echocardiograph mvp"
"select measur health status mexicanamerican mainland puerto rican cubanamerican children nation vital statist system hispan health nutrit examin survey assess health status mexicanamerican mainland puerto rican cubanamerican children examin preval pregnanc outcom chronic medic condit lowbirthweight rate hispan compar favor hispan white greater poverti lower level educ hispan examin hispan subgroup signific differ present mainland puerto rican highest preval lowbirthweight infant prematur birth common hispan subgroup hispan white mexicanamerican cubanamerican children similar preval chronic medic condit compar hispan white children puerto rican children higher preval chronic medic condit assess health status indic hispan children health status similar hispan white children mainland puerto rican children greater risk poor health reflect hispan popul heterogen health program target hispan appropri group differ"
"strategi reduc infant mortal matern mortal review histor model fetal infant mortal review propos reduc infant mortal unit state nation program element guidelin direct nation multidisciplinari steer panel staff technic advisori capac translat guidelin work local region review committe local review committe special emphasi lack limit effort previous infant mortal review fetal mortal plan propos broad classif potenti contribut mortal relat strict medic care health system individu patient factor effect target respons factor identifi local critic impetus gain american colleg obstetrician gynecologist lead effort privat medic sector partnership nation state local public health agenc nation medic societi"
"poloxam intraperiton barrier materi prevent postsurg adhes format reform rodent model reproduct surgeri comtemporari adhesionprevent regimen infertil surgeri emphas barrier materi effect physic separ injur surfac reperiton poloxam biocompat polym display revers thermal gelat characterist materi exist liquid room temperatur solid bodi temperatur properti make ideal materi laparoscop surgeri antiadhes properti poloxam evalu model experi golden hamster subject standard adhesionproduc lesion left uterin horn poloxam solut concentr rang appli injur horn locat thick extent adhes format assess day signific reduct posttraumat adhes format observ treatment solut experi design paradigm typic situat encount infertil surgeri prevent adhes reform lysi establish adhes zealand white rabbit subject laparotomi day interv placement adhesionproduc lesion evalu prescor surgic lysi induc adhes subsequ evalu adhes reform postscor effect appli poloxam adhesiotomi compar control treatment adhes reform postscor mark reduc poloxam treatment trial materi clinic set"
"effect topic glaucoma drug fistul rabbit conjunctiva conjunctiv fibroblast prolifer contract scar format implic glaucoma filter surgeri failur effect glaucoma medic bulbar conjunctiva evalu eye pigment rabbit rabbit group receiv singular topic appli daili dose timolol epinephrin pilocarpin artifici tear mask fashion month posterior lip sclerectomi perform rabbit treatment group remain rabbit serv nonsurg control addit rabbit receiv eye drop includ nonmed control group rabbit serv nonsurg control immunostain perform identifi presenc myofibroblast fistul conjunctiva treat surgic eye medic higher myofibroblast cell prolifer treat nonsurg eye fistul eye medic increas cell prolifer pilocarpin elicit dramat increas compar group"
"increas skinflap surviv vasoact drug buflomedil effect buflomedil protect skin tissu ischemia necrosi studi random cutan flap measur perform intravit microscopi microcirculatori level capillari perfus flap model hairless mous hairless mice singlepedicl flap measur mm rais perpendicular spine anim flap develop reliabl amount necrosi distal edg period day group mice receiv intraven inject buflomedil dose mgkg day dilut ml normal salin begin hour flap elev consecut day postop addit anim receiv treatment start minut flap elev mice serv control normal salin equal volum experiment group appli intravit microscopi function vessel densiti fvd determin mm increment flap base distal edg hour elev skinflap surviv quantifi measur necrot area day digit planimetri function vessel densiti preserv distal flap anim pretreat buflomedil reveal higher function vessel densiti mm mm mm flap base compar control"
"abdomin wall reconstruct mutton chop flap reconstruct fullthick abdomin wall defect difficult surgic challeng reconstruct epigastrium vex prosthet mesh signific drawback pedicl myofasci myocutan flap advantag present consecut case demonstr high success reconstruct massiv abdomin wall defect myofasci myocutan flap prosthet mesh extend rectus femori flap mutton chop flap capabl resurfac epigastrium complic minim myofasci unit rectus femori consid techniqu choic reconstruct major abdomin wall deficit"
"analysi brain cerebrospin fluid volum mr imag impact pet data correct atrophi part ii age alzheim dementia computer segment techniqu magnet reson mr imag produc accur volumetr measur brain cerebrospin fluid csf limit comput tomographi retrospect analysi digit tweight mr imag healthi elder control subject patient alzheim dementia ventricular extraventricular csf quantifi effect age studi group atrophi measur correct metabol valu obtain positron emiss tomographi patient alzheim dementia higher total csf extraventricular total ventricular ventricular csf volum lower brain volum control group patient show mark declin brain volum greater increas csf volum advanc age control group increas correct brain metabol rate control group increas techniqu provid basi studi age dementia includ region volum analysi"
"disrupt human scl locus illegitim recombinas activ fusion complementari dna cell line hsb elucid provoc mechan disrupt putat hematopoiet transcript factor scl fusion cdna result interstiti delet previous unknown locus sil scl interrupt locus untransl region scl similar transloc delet disrupt scl regulatori region event mediat recombinas activ locus immunoglobulin cell receptor cell line cem rpmi essenti ident delet lymphocyt growthaffect gene immun receptor risk rearrang"
"interpleur analgesia thoracotomi examin effect variabl interpleur analgesia thoracotomi addit epinephrin local anesthet thoracostomi drainag cathet placement locat cathet tip twenti patient random cathet paravertebr tip locat cathet paravertebr thorac wall tip locat interpleur cathet sutur pariet pleura surgeon time wound closur patient random assign receiv ml bupivacain epinephrin singl cathet ml bupivacain epinephrin cathet supin bupivacain concentr blood thoracostomi drainag fluid assay gas chromatographi actual content bupivacain drainag fluid calcul degre analgesia assess verbal numer pain score opioid demand addit epinephrin bupivacain influenc degre analgesia approxim administ dose bupivacain lost thoracostomi tube period correl true initi dose mg minus thoracostomi drainag cmax cathet result signific opioid requir initi period failur achiev adequ interpleur analgesia postthoracotomi patient relat loss anesthet thoracostomi drainag presenc extravas blood tissu fluid pleural space possibl sequestr channel flow local anesthet restrict motion oper lung"
"blind comparison noninvas vivo phosphorus nuclear magnet reson spectroscopi vitro halothanecaffein contractur test evalu malign hyperthermia suscept malign hyperthermia mh potenti fatal anestheticinduc syndrom accur diagnos suscept syndrom test biopsi skelet muscl contractur respons halothan caffein invas diagnosi author previous report mhsuscept patient studi vivo phosphorus nuclear magnet reson nmr spectroscopi demonstr higher rest inorgan phosphat pi phosphocreatin pcr ratio skelet muscl slower postexercis recoveri pcrpi compar normal control present blind studi author compar vivo nmr determin rest pipcr recoveri rate pcrpi forearm muscl vitro halothanecaffein contractur test result patient forti control subject studi establish normal nmr valu rest pipcr recoveri rate pcrpi find compar patient shown mhsuscept patient mhnegat contractur test mhsuscept group signific higher rest pipcr mhnegat control group mhsuscept group signific slower postexercis recoveri rate pcrpi pcrpimin mhnegat pcrpimin control pcrpimin group twenti mhsuscept patient demonstr abnorm nmr test result rest pipcr greater equal recoveri rate pcrpimin mhnegat patient normal nmr result nmr paramet diagnost reliabl nmr test util paramet accur nmr test contractur test demonstr agreement coposit coneg sensit specif nmr test estim role nmr diagnosi mh suscept mechan observ discuss"
"effect dose epidur morphin relief postcholecystectomi pain previous establish effect dose intrathec morphin relief postcholecystectomi pain determin studi effect dose epidur morphin relief postcholecystectomi pain patient epidur inject placebo group mg morphin group mg morphin group intraop mix lidocain percentag patient request analges mg im pentazocin relief pain postop hour signific greater group group patient mg im pentazocin postop number time pentazocin administ signific greater group group percentag patient develop respiratori depress vomit postop hour similar group base present data previous report intrathec morphin conclud epidur morphin dose mg intrathec morphin dose mg equipot relief postcholecystectomi pain"
"caffein cardiac arrhythmia purpos review evid support belief caffein cardiac arrhythmia data sourc studi publish identifi computer search medlin toxlin chemic abstract review bibliographi relev articl subject caffein cardiac arrhythmia studi select clinic studi examin caffein cardiac arrhythmia select basic scienc experi illustr caffein effect vitro data extract studi qualiti assess clinic data pertain caffein arrhythmia summar result data analysi electrophysiolog studi caffein increas suscept provok cardiac arrhythmia placebocontrol trial caffein dose mg daili equival cup coffe increas frequenc sever ventricular arrhythmia larg epidemiolog studi report increas frequenc ventricular extrasystol person consum cup coffe daili conclus moder ingest caffein increas frequenc sever cardiac arrhythmia normal person patient ischem heart diseas preexist ventricular ectopi"
"reperfus inhibit elev splanchnic prostanoid product hemorrhag shock publish erratum ann surg feb effect reperfus hemorrhag shock splanchnic prostanoid releas studi anesthet male rat bled arteri blood pressur mmhg minut kill treat shed blood minut kill superior mesenter arteri bed cannul perfus vitro oxygen kreb collect venous effluent minut analyz ketopgf alpha pgi metabolit pge pgf alpha thromboxan radioimmunoassay shock shock reperfus sham group major prostanoid releas ketopgf alpha time higher shock group compar sham group reperfus shed blood abolish increas ketopgf alpha found shock group data show attempt rat splanchnic bed compens hemorrhag shock increas releas pgi potent vasodil abolish reperfus blood"
"camp mediat ilinduc lymphocyt penetr endotheli monolay endotheli cell incub il shown adher lymphocyt nontreat endotheli cell demonstr il increas lymphocyt penetr endotheli monolay vitro il induc transient increas number lymphocyt penetr endotheli monolay filter time dosedepend manner effect mimick increas cytosol camp level endotheli cell forskolin dibutyrylcamp concomit show il increas cytosol camp level endotheli cell inhibitor adenyl cyclas ddado decreas ilinduc camp elev lymphocyt penetr protein kinas inhibitor ha inhibit ilinduc lymphocyt penetr protein kinas guamidinoethylisoquinolinesyl foamid hydroclorid calciumcalmodulin aminohexylchloronaphthalensulfanamid inhibitor effect ad dibutyrylcgmp calcium ionophor endotheli cell mimic ilinduc penetr final il induc pkc transloc endotheli cell data support view il act camp messeng regard lymphocyt penetr endotheli cell data demonstr ilinduc lymphocyt penetr endotheli cell ilinduc signal transduc camp endotheli cell"
"interferon collagen product immunoregulatori antivir antiprolif agent interferon profound effect collagen synthesi interferon alpha beta gamma suppress collagen synthesi dermal fibroblast addit interferon gamma ifngamma inhibit constitut increas collagen synthesi characterist fibroblast deriv lesion patient scleroderma ifngamma inhibit collagen synthesi myofibroblast synovi fibroblast cell inhibit collagen synthesi ifngamma coordin inhibit transcript type iii collagen addit ifngamma suppress level procollagen mrna type ii collagen synthesi human articular chondrocyt vivo studi mice demonstr ifngamma inhibit collagen synthesi fibrot respons implant foreign bodi bleomycininduc pulmonari fibrosi heal respons cutan thermal burn case collagen content wound scar decreas hyaluron acid increas mice receiv ifngamma compar control accord vitro studi show interferon alpha beta decreas product glycosaminoglycan ifngamma increas product glycosaminoglycan interest acut inflamm site thermal injuri elicit proinflammatori agent separ experi suppress mice treat ifngamma ifngamma inhibit collagen synthesi involv transcript regul singl report interferon alpha decreas size keloid recent onset human patient interferon inhibit collagen synthesi vivo studi warrant evalu agent treatment diseas state character abnorm fibrot respons potenti alter heal respons therapeut intervent"
"longterm outcom anterior cerebr arteri ligat ruptur anterior communic arteri aneurysm longterm prognosi year determin patient undergon anterior cerebr arteri aca ligat sole treatment anterior communic arteri aneurysm number earli late reble lower expect previous ruptur aneurysm late ischemia major complic late postop epilepsi occur survivor review previous publish seri aca ligat signific reduc rate earli late rebleed studi defin late result conserv oper ruptur aneurysm"
"treatment sever intraventricular hemorrhag intraventricular infus urokinas patient sever intraventricular hemorrhag treat direct intraventricular infus urokinas case hemorrhag extend ventricular chamber cast format expans fourth ventricl found immedi therapi start day onset symptom reduct intraventricular hematoma volum observ computer tomographi averag fourth ventricl clear day hemorrhag case ruptur aneurysm patient show excel good outcom develop delay hydrocephalus infect rebleed observ outcom retrospect studi group patient treat urokinas report author conclud easi method treatment great improv prognosi sever intraventricular hemorrhag"
"continu arterioven rewarm experiment result thermodynam model simul treatment hypothermia evalu techniqu treat hypothermia extracorpor circul requir heparin pump assist hypothermia degre induc anesthet dog thermistor pulmonari arteri liver bladder esophagus rectum muscl skin experiment anim rewarm creat fistula connect arteri venous femor line interpos countercurr heat exchang extern rewarm control bleed time bt coagul profil pt ptt tt cardiac output measur rewarm core temperatur rose signific faster cavr averag time rewarm min hrs control haptoglobin platelet fibrinogen fibrin split product level unaffect continu arterioven rewarm cavr improv bt coagul profil faster method report requir heparin cardiac bypass applic cavr posttraumat hypothermia warrant investig"
"morbid financi impact colostomi closur trauma patient year period patient undergon elect colostomi closur bellevu hospit retrospect review order evalu morbid colostomi closur traumat injuri financi impact sixti cent colostomi left colon side interv origin injuri colostomi takedown vari day day postop hospit stay entir group day cost death anastomot leak entir seri morbid rate ensu small bowel obstruct frequent signific complic occur ten patient result prolong hospit stay day addit cost patient addit patient develop subphren abscess requir oper drainag necessit addit day hospit increas cost complic prolong hospit stay includ superfici wound infect transient respiratori failur patient return date incision hernia stoma site morbid encount seri suggest colostomi closur lowmorbid procedur consid import factor favor primari repair coupl signific financi impact colostomi format takedown ampl justif exist greater effort avoid colostomi format feasibl"
"hilger facial nerv stimul year updat percutan nerv excit test hilger facial nerv stimul introduc year ago test reliabl easi inexpens continu frequent method predict prognosi facial nerv disord record nerv excit test patient test peripher branch trunk multipl regress model determin effect nerv stimul valu age sex race diabet hypertens partial complet clinic paralysi diagnosi herp zoster year test eventu facial paralysi recoveri profil discuss statist reliabl provid tabl interpret result offer tip trap invalu practition prospect studi patient residu facial paralysi evalu separ otolaryngologist determin intertest reliabl"
"gene human major histocompat complex class ii region control class antigen present pathway major histocompat complex mhc class molecul export peptid cell surfac surveil cytotox lymphocyt intracellular peptid bind critic proper assembl transport class molecul mechan impair result function peptid suppli factor gene psf human mutant cell line genom lesion mhc identifi psf mhc class ii region delet map mutant chromosomewalk psf homolog mammalian bacteri atpdepend transport protein suggest oper intracellular transport peptid"
"median nerv somatosensori evok potenti glasgow coma scale predictor outcom comatos patient head injuri median nerv somatosensori evok potenti ssep grade glasgow coma scale gsc score obtain patient head injuri week injuri determin relationship score individu combin outcom score obtain month injuri ssep grade base presenc absenc cortic evok potenti amplitud earli cortic generat wave form conduct time brain nn interpeak latenc ssep respons side brain combin grade gcs grade verbal compon maximum score patient intub patient unrespons command median ssep grade correl glasgow outcom scale barthel index score gcs score combin ssep grade gcs score improv predict power model ssep grade patient die remain veget state contrast ssep grade patient moder disabl good recoveri studi demonstr prognost earli quantit median nerv ssep grade patient head injuri unrespons command week injuri"
"persist primit trigemin arterycavern sinus fistula report case case persist primit trigemin arterycavern sinus fistula present case fistula treat balloon tandem techniqu method accomplish introduc inflat detach silicon balloon trigemin arteri preserv carotid basilar blood flow unusu case similar fistula contralater exophthalmo report relationship type fistula presenc aneurysm persist primit trigemin arteri relationship traumat event discuss"
"quantif leakag pressur durotomi repair canin studi undertaken investig relat strength dural repair standard sutur techniqu sutur supplement tissu adhes tissu adhes uniform mm dural defect creat adult beagl repair subject pressur test defect repair sutur initi leak rang physiolog pressur supplement tissu adhes repair tissu adhes fail higher pressur level histolog section obtain dura treat fibrin adhes sealant demonstr minim inflammatori respons signific section examin site repair sutur substanc fibrin adhes sealant effect dural repair due abil withstand pressur greater obtain sutur"
"capillari leakag inflamm studi vascular label local inject pure inflammatori mediat induc venular leakag test effect endogen mediat die tissu vascular leakag author devis experiment model simul infarct live vessel expos fragment organ undergo asept necrosi tissu donor rat implant asept cremaster sac control rat implant materi deem close nonirrit boil tissu sphere teflon glass point rat inject intraven carbon black kill hour cremast mount show vascular label strict venular hour mix capillari label hour exclus capillari hour histolog show acut inflammatori infiltr label area similar weaker label pattern accompani milder inflamm control result vascular leakag asept inflamm biphas venular capillari capillari phase induc inflammatori reaction possibl form diffus angiogenesi"
"childhood trauma outlin overview childhood psychic trauma crucial etiolog factor develop number disord childhood adulthood childhood rheumat fever psychic trauma set number problem motion lead defin mental condit author suggest characterist relat childhood trauma long period life matter diagnosi patient eventu receiv visual repeat perceiv memori traumat event repetit behavior traumaspecif fear chang attitud peopl life futur divid childhood trauma basic type defin find character type type trauma includ full detail memori omen mispercept type ii trauma includ denial numb hypnosi dissoci rage crossov condit occur sudden shock death accid leav children handicap instanc characterist type type ii childhood trauma exist side side sad find childhood trauma discuss author illustr case exampl"
"cognit behavior effect coadministr dextroamphetamin haloperidol schizophrenia object author sought determin acut dose dextroamphetamin posit effect affect cognit schizophren patient maintain regimen haloperidol variabl predict improv method twenti patient chronic schizophrenia hospit research ward receiv singl oral dose dextroamphetamin mgkg doubleblind placebocontrol crossov studi patient receiv mgkg day haloperidol cognit test motor test global rate mood rate videotap rate determin effect coadministr drug ventriclebrain ratio deriv ct scan predict respons coadministr drug result amphetamin improv perform measur concept format wisconsin card sort test result perform test memori attent group patient activ perform psychomotor test quick receiv amphetamin patient judg clinic rater improv term affect cooper engag environ improv enlarg cerebr ventricl increas blink rate placebo activ drug condit patient unequivoc worsen conclus result consist theori coadministr amphetamin haloperidol produc select enhanc cortic dopaminerg activ acut natur trial special research environ conduct author advoc amphetamin routin clinic treatment schizophrenia"
"prospect analysi intramuscular meperidin promethazin chlorpromazin pediatr emerg depart patient studi object examin physiolog respons efficaci mgkg im meperidin promethazin chlorpromazin mpc children design prospect unblind trial set univers communiti emerg depart patient sixti hemodynam neurolog stabl children intervent singl dose im mpc measur main result serial respir heart rate arteri systol blood pressur oxygen satur glasgow coma scale measur minut interv effect assess independ observ separ visual analog scale cooper sedat time sleep minut sit upright minut ed discharg hour eat hour normal behavior hour accept minor statist signific respir rate heart rate oxygen satur glasgow coma scale occur minut mpc complic resuscit requir visual analog scale score case interobserv agreement good cooper effect twenti percent children judg insuffici sedat conclus im mpc safe general effect agent ed procedur select children"
"comparison rectal axillari tympan membran temperatur infant young children studi object evalu reliabl tympan membran thermomet detect fever young children present emerg depart set pediatr emerg depart urban teach hospit designmeasurementparticip temperatur measur obtain sequenti bodi site children year present pediatr ed axillari rectal temperatur obtain electron thermistor probe diatek tympan membran temperatur obtain noncontact infrar sens devic temp patient stratifi age ear canal patenc presenc otiti media rectal temperatur result patient enrol febril correl axillari tympan membran measur rectal strata sensit detect fever axillari tympan membran site otiti media ear patenc influenc correl tympan membran measur low tympan membran temperatur sensit result probe configur conclus tympan membran axillari temperatur view caution children year detect fever reliabl"
"core temperatur measur hypovolem resuscit studi object accur core temperatur measur sever hypovolem patient difficult achiev dog model determin conveni method measur core temperatur relat accuraci multipl site design prospect laboratori anim model studi set oper suit anim care depart particip adult anesthet greyhound dog intervent continu temperatur monitor thermistor brain central vein tympan membran bladder rectum esophagus subcutan tissu hemorrhag initi intravascular volum autolog transfus cool blood serial temperatur measur record measur main result read analyz pearson correl coeffici brain temperatur correl tympan membran temperatur rectum bladder esophagus correl brain central venous temperatur correl poor temperatur site reflect mark swing intravascular temperatur caus cold transfus wide variat damp site correl central venous temperatur brain bladder tympan membran correl fair conclus intravascular hypothermia sourc arrhythmia hemostat abnorm earli resuscit hypovolem patient result suggest bladder tympan membran initi temperatur site initi resuscit end organ brain temperatur import accur reflect tympan membran temperatur"
"code systemat approach respond medic emerg occur hospit member public expect receiv effici medic care acut ill injur hospit institut awar organ system respond emerg involv patient visitor local communiti resid hospit employe insid hospit ground surround build search literatur provid inform respons survey surround hospit reveal plan effect institut design plan superimpos exist system respond hous cardiac respiratori arrest code result half year encourag recommend establish emerg respons system health care institut"
"comparison neurolog metabol structur genet evalu person risk huntington diseas compar diagnost data set assess individu risk huntington diseas fifti choreafre person evalu neurolog examin positron emiss tomographi measur glucos metabol radiograph computer tomograph measur caudat size genet test polymorph dna loci ds ds ds twelv person abnorm caudat metabol subtl abnorm motor control comput tomograph evid caudat atrophi compar expect gene frequenc popul person unambigu genet test result subsequ phenotyp express huntington diseas chorea greater sensit positron emiss tomograph measur caudat metabol relat comput tomographi clinic examin determin subpopul probabl huntington diseas gene carrier hypometabol putamen globus pallidus hypermetabol precentr gyrus high probabl carri huntington diseas gene find support hypothesi abnorm cerebr metabol preced clinic structur comput tomograph abnorm geneposit individu risk huntington diseas"
"quadricep myopathi form frust becker muscular dystrophi examin dystrophin protein product duchenn muscular dystrophi gene muscl biopsi specimen male patient quadricep myopathi show mild slowli progress myopathi confin quadricep muscl patient clear abnorm dystrophin diagnos becker muscular dystrophi immunofluoresc immunoblot examin dystrophin abnorm molecular mass visual muscl cryosect patchi discontinu immunostain surfac membran muscl fiber patient brother show widespread myopath consist typic becker muscular dystrophi conclud syndrom call quadricep myopathi includ group form frust becker muscular dystrophi"
"dystrophin analysi duchenn becker muscular dystrophi carrier correl intracellular calcium albumin immunocytochem local immunoblot analysi dystrophin muscl fiber oblig probabl carrier duchenn becker muscular dystrophi reveal abnorm express protein local calcium albumin endogen marker extracellular fluid penetr show presenc molecul insid fiber lack dystrophin morpholog studi show initi stage lead fiber necrosi duchenn muscular dystrophi present carrier mosaic comparison dystrophin studi restrict fragment length polymorph analysi creatin kinas level show immunocytochem immunoblot techniqu dystrophin sensit provid basi genet counsel"
"suicid twin suicid cluster famili suggest genet factor play role behavior studi twin pair twin commit suicid monozygot twin pair concord suicid compar dizygot twin pair presenc psychiatr disord twin famili examin subsampl twin pair concord suicid eleven twin suicid victim treat psychiatr disord surviv cotwin addit twin pair degre relat treat psychiatr disord twin data suggest genet factor relat suicid larg repres genet predisposit psychiatr disord suicid leav open question independ genet compon suicid"
"valproat treatment acut mania placebocontrol studi conduct placebocontrol doubleblind studi valproat drug origin develop antiepilept patient acut manic episod previous fail respond toler lithium carbon treatment durat day psychotrop medic permit lorazepam mg day treatment serum valproat concentr measur time week unblind investig adjust dosag produc serum concentr mg valproat prove superior placebo allevi manic symptom patient random activ drug demonstr median decreas score young mania rate scale compar median decreas patient receiv placebo point global assess scale psychiatr function patient receiv valproat improv median point compar point chang placebo signific differ emerg psychiatr rate scale number supplement dose lorazepam requir patient group substanti antiman effect day achiev therapeut serum valproat concentr advers effect infrequ advers effect signific frequent valproat placebo conclud valproat repres drug treatment manic patient"
"carbamazepin mainten treatment outpati schizophren doubleblind crossov trial evalu carbamazepin sole mainten treatment chronic nonman schizophren outpati condit stabil neurolept prior studi criteria treatment effect includ number patient relaps time relaps day neurolepticfre period carbamazepin placebo administ relaps determin concord psychiatr rate independ clinic judgement indic signific worsen result patient receiv carbamazepin receiv placebo involv phase treatment comparison nondifferenti corrobor descript find phase patient evid support exist treatmentrelev subgroup defin episod dyscontrol phenomena"
"reaction year medic student initi encount cadav dissect room studi report result questionnair survey year medic student prepar reaction encount human cadav dissect room student awar psycholog physic reaction experi felt adequ prepar prior class express desir greater prepar discuss experi anatomi staff surpris number student prior exposur dead human bodi signific influenc reaction result studi suggest improv prepar cope dissect follow opportun deal profession emot issu rais human dissect"
"hemoglobin montreal variant extend beta chain due delet asp gli leu posit insert ala arg cys gln locat unstabl hemoglobin montreal delet amino acid residu asp gli leu posit beta chain insert residu ala arg cys gln locat observ year canadian boy suffer moder hemolyt anemia introduct extra amino acid residu crevic heme group locat instabl hemoglobin variant list detect analys tryptic peptid betamontr chain sequenc amplifi dna hybrid amplifi dna plabel oligonucleotid probe suggest mispair involv agtg sequenc codon codon normal beta gene caus repetit bp segment delet nucleotid due recombin slippag short delet dna repair result modifi sequenc betamontr gene"
"somatosensoryevok potenti monitor total hip arthroplasti hundr consecut patient monitor somatosensoryevok potenti sep monitor detect intraop sciatic nerv compromis total hip arthroplasti peron nerv stimul contralater extrem rule system influenc sep trace loss amplitud increas latenc greater consid signific patient exhibit met criteria femal patient loss amplitud trace time closur patient exhibit postop sciatic nerv palsi fals negat femor ream reduct surgic event common nerv reaction patient prior hip procedur higher risk correl intraop sep age weight surgic approach leg lengthen compar unmonitor patient reduct incid sciatic palsi"
"effect smoke signalaverag electrocardiogram normal subject tobacco smoke increas risk sudden cardiac death possibl alter substrat propag sustain ventricular tachyarrhythmia test hypothesi longterm smoker coronari arteri diseas abstain tobacco smoke underw saecg min min smoke cigarett minor lengthen filter qrs durat signific chang timedomain saecg paramet note conclud late potenti produc cigarett smoke ventricular arrhythmia substrat measur saecg variabl worsen longterm smoker evid coronari arteri diseas"
"snore daytim sleepi regular heavi snorer fifteen men age year investig bodi mass index kgm respiratori disturb index good nocturn oxygen satur subject monitor night devic tightfit facial mask pneumotachomet esophag balloon monitor nasal continu posit airway pressur multipl sleep latenc test administ experiment night baselin night nasal cpap night determin short eeg arous nocturn sleep perform relationship short eeg arous esophag pressur nadir airflow decreas investig determin relationship clinic report decreas daytim alert mslt result relationship mslt result frequenc eeg arous monitor heavi snorer present signific increas pes nadir abrupt decreas flow lead eeg arous frequenc eeg arous occur impact mslt score nasal cpap improv mslt score elimin respirationrel eeg arous heavi snorer obstruct sleep apnea syndrom risk decreas daytim alert"
"pharyng volum asymptomat snorer compar nonsnor volunt studi object determin asymptomat snorer smaller pharyng volum age heightmatch nonsnor design recruit asymptomat heavi snorer nonsnor studi snorer match age year height inch nonsnor nonsnor requir ideal bodi weight volunt underw overnight polysomnographi pulmonari function test magnet reson imag pharynx awak volum pharynx determin comput data input digit instrument set veteran administr hospit univers florida teach hospit particip volunt recruit snorer nonsnor group particip paid intervent measur result differ sleep variabl group signific differ pharyng volum group conclus volum pharynx asymptomat snorer similar volum age heightmatch nonsnor"
"polyamin ornithin decarboxylas repair duoden mucosa stress rat investig show polyamin ornithin decarboxylas role duoden mucos repair stressinduc microscop damag rat fast hour restraint cage immers water xiphoid process hour anim kill immedi period stress hour interv hour duoden mucosa examin histolog ornithin decarboxylas polyamin level measur ornithin decarboxylas activ increas signific hour stress peak hour level time prestress control hour enzym activ return normal increas mucos putrescin spermidin spermin content parallel ornithin decarboxylas activ peak hour stress stress result microscop damag evidenc complet absenc villi signific macroscop lesion present stress mucos repair evid hour stress complet hour restitut villi short blunt decreas mucos dna rna protein content caus stress restor reach normal level hour period stress anim specif inhibitor ornithin decarboxylas alphadifluoromethylornithin increas duoden mucos ornithin decarboxylas activ polyamin level inhibit mucos repair complet prevent stress alphadifluoromethylornithin prevent recoveri dna rna protein content duoden mucosa result duoden mucos damag stress repair rapid repair process accompani signific increas ornithin decarboxylas activ polyamin level increas ornithin decarboxylas polyamin absolut requir normal repair mucosa"
"respiratori input imped anesthet paralyz patient respiratori imped zrs measur hz anesthet paralyz patient appli forc oscil low amplitud inlet endotrach tube effect respiratori resist rrs cmho fell sharpli sd hz hz rrs decreas slight frequenc hz respiratori reactanc xrs cmho hz reach approxim hz hz effect respiratori elast er pi frequenc xrs cmho hz increas mark frequenc hz interpret zrs data term network mechan model repres proxim branch central airway resist inert shunt pathway account bronchial distens alveolar gas compress distal branch includ newtonian resist compon tissu peripher airway viscoelast compon tissu viscoelast compon repres kelvin bodi model bate al  appl physiol good fit obtain entir frequenc rang reason valu paramet estim strong frequenc depend rrs er observ hz anesthet paralyz patient interpret term tissu viscoelast high er found low volum excurs suggest tissu exhibit plasticlik properti"
"theophyllin minim alter contractil properti canin diaphragm vitro examin effect theophyllin contractil properti highfrequ fatigu canin diaphragm vitro eighteen diaphragm muscl bundl obtain anesthet dog equilibr oxygen kreb solut mg theophyllin bundl compar match control bundl contralater hemidiaphragm statist signific differ twitch tension tetan tension twitchtetanus ratio time peak tension halfrelax time observ concentr mg theophyllin signific increas forc product hz similar tendenc present lower concentr exhibit clear doserespons behavior highfrequ fatigu similar control theophyllinetr bundl conclud supratherapeut vitro concentr theophyllin increas maxim tetan tension protect muscl fatigu potenti relat forc product low stimul frequenc small effect explain poor diffus drug muscl bundl theophyllin concentr muscl bath muscl bundl virtual ident remain unclear potenti benefici effect achiev vivo attain serum concentr"
"ventilatori effect acut pulmonari hypothermia isol effect cool pulmonari circul ventil quantifi anesthet dog pulmonari arteri rpa cannul pericardium system blood pump left atrium rpa period cool cool blood bolus inject rpa condit bolus temperatur degre volum mlkg bodi wt vari inspiratori time ti expiratori time te breath durat tt peak integr activ peak determin diaphragm emg result postinject breath convert percent valu preinject breath linear relationship bolus temperatur ti slope degre te degre tt degre peak unaffect inject temperatur degre invers linear relationship exist bolus volum ti mlkg te mlkg dog test effect bolus inject minim residu volum progress increas lung volum effect cold bolus inject elimin vagotomi dog result cool vagal receptor lung increas breath frequenc primarili shorten te"
"valid canin platelet aggregometri predict vascular graft patenc laboratori found canin platelet aggregometri predict thrombot potenti vascular graft adenosin diphosph adp frequent agonist unspecifi differ concentr studi design evalu predict adpinduc platelet aggregometri valid methodolog platelet aggregometri respons adp assay dog twenti percent aggreg aggreg indetermin dog treat aspirin dipyridamol vascular prosthes implant bilater aortoiliac antiplatelet therapi continu week doserespons adp studi concentr dog aggreg aggreg aggreg time sampl studi evalu dog chang aggreg aggreg hour daili reproduc studi dog chang aggreg status day patenc aggreg aggreg platelet aggregometri signific predict graft patenc methodolog standard"
"ultrastructur evid effect shear stress variat intim thicken dog arteri transplant autolog vein graft base find wall shear stress rate blood flow main hemodynam factor relat intim hyperplasia autolog vein graft investig effect wall shear stress variat sequenti ultrastructur intim hyperplasia arteri transplant autovein graft canin model note wall shear stress variat tauvari defin variat wall shear stress cardiac cycl desktop flow waveform analyz group high flow rate mlmin low tauvari dynescm intim hyperplasia signific ultrastructur mark transform intim smooth muscl cell secretori cell week implant surfac intima line modifi smooth muscl cell week implant group ii low flow rate mlmin normal tauvari dynescm intim hyperplasia minim layer contractil type smooth muscl cell characterist myofibrilla surfac intima line endotheli cell week implant find suggest region low wall shear stress variat intim smooth muscl cell autovein graft secretori cell enhanc platelet adher occur earli intim repair caus intim hyperplasia develop"
"clip repair peripher sidesid arterioven fistula evalu method dog preliminari result human simpl techniqu repair peripher arterioven fistula clip applic present procedur rapid effect minim extent dissect elimin applic vascular clamp vessel anticoagul safeti procedur confirm dog experi clinic appli success patient suitabl simpl uncompl sidesid fistula amen procedur"
"spheric connect tissu inclus epitheli hyperplasia breast collagen spherulosi partial myoepitheli differenti common simpl epitheli hyperplasia epitheliosi breast function myoepitheli differenti basement membran product exceed rare peculiar chang hyalin globul benign epitheli hyperplasia recognis collagen spherulosi type iv collagen shown immunohistochemistri case show presenc laminin collagen iv iii prolifer electron microscopi examin case materi retriev wax block show vari degre myoepitheli differenti cell immedi surround spherul basal lamina materi includ matur collagen fibril case degre myoepitheli differenti cell surround spherul correl differ type amount extracellular matrix spherul histopathologist awar rare chang misinterpret situ carcinoma"
"fluorometr determin pseudocholinesteras activ postmortem blood sampl fluorometr assay hydroxyphenyl propion acid hppa conduct determin activ pseudocholinesteras che enzym commiss ec postmortem blood sampl test organophosph poison enzymat reaction che substrat benzoylcholin produc cholin oxid cholin oxidas generat hydrogen peroxid hppa oxid hydrogen peroxid peroxidas fluorogen dimer concentr measur fluorometr excit emiss wavelength nm elimin emiss wavelength nm select sensit present method found superior convent ph spectrophotometr method"
"brain marker suicid relationship found recent work suggest person commit suicid alter neurochemistri brain remain unclear report abnorm reliabl present reflect specif psychiatr disord disposit violent impuls number technic interpret problem clarifi postmortem test indic subject high risk suicid eventu emerg approach rule suicid alter neurochemistri involv case"
"sudden cardiac death exercis weight lifter anabol androgen steroid patholog toxicolog find year previous healthi weight lifter collaps bench press workout anabol androgen steroid parenter previous month pertin autopsi find includ mark cardiac renal hypertrophi hepatosplenomegali region myocardi fibrosi focal myocardi necrosi nandrolon testosteron metabolit identifi postmortem urin etiolog cardiac find discuss"
"adren hormon anorect respons adapt rat amino acid imbal role adren function anorect respons adapt rat diet isoleucin ile imbal investig experi rat fed mild ileimbalanc diet treatment metyrapon inhibitor glucocorticoid synthesi separ experi rat present mild sever ileimbalanc diet imbalanc amino acid mixtur bilater adrenalectomi final effect ic serotonin receptor antagonist intak mild ileimbalanc diet test adrenalectom anim experi factori design metyrapon adrenalectomi alter initi depress intak imbalanc diet adapt phase respons adrenalectom rat fed mild ileimbalanc diet control adrenalectom rat fed sever ileimbalanc diet unabl adapt adrenalectomi alter antianoret activ ic model result suggest adren hormon initi anoret respons adapt rat ileimbalanc diet implic antianorect effect serotonin blockad"
"pharmacolog character ly structur tetrazolesubstitut competit methylaspart acid antagonist short durat action studi report activ structur excitatori amino acid receptor antagonist ly cishtetrazolylmethylpiperidinecarboxyl acid tetrazol competit methylaspart acid nmda antagonist ly potent inhibit nmda receptor bind rat brain membran shown vitro displac cgs ic nm appreci affin halphaaminohydroxymethylisoxazolepropion acid ampa hkainat bind assay observ ic valu greater nm vitro nmda receptor antagonist activ demonstr select inhibit nmdainduc depolar cortic wedg ic microm microm nmda ly effect vivo system administr number anim model neonat rat ly select block nmdainduc convuls ed mgkg short durat action hr pigeon ly potent antagon ed mgkg behavior suppress effect mgkg nmda dose mgkg requir produc phencyclidin catalepsi pigeon mice ly protect maxim electroshockinduc seizur lower dose ed mgkg impair horizont screen perform ed mgkg cholinerg gabaerg neuron degener striatal infus nmda prevent singl multipl dose ly summari antagonist activ ly system administr demonstr potenti therapeut condit neuron cell loss due nmda receptor excitotox short durat action ly make compound advantag neuroprotect agent treatment acut condit cerebr ischemia"
"biolog properti pyrroloquinolin quinon relat compound inhibit chemiluminesc lipid peroxid rat paw edema pyrroloquinolin quinon pqq inhibit chemiluminesc cl mous periton cell initi zymosan carrageenin formylmethionylleucylphenylalanin cl generat xanthinexanthin oxidas reaction lipid peroxid rat brain homogen inhibitori activ pqq potent idebenon alphatocopherol ascorb acid assay system xanthinexanthin oxidas reaction pqq effect format uric acid concentr cl inhibit result suggest pqq radic scaveng activ structureact relationship pqq relat compound show carboxyl group pqq orthoquinon structur respons radic scaveng activ addit nh group pyrrol ring pqq essenti antilipid peroxid activ rat brain homogen administ pqq inhibit develop carrageenininduc paw edema rat result suggest pqq therapeut effect diseas develop exacerb radic oxygen"
"applic puls continu wave micron wavelength yag laser canin tracheobronchi tree compar studi previous investig shown good clinic potenti micron wavelength yag laser soft tissu absorpt micron wavelength yag laser micron wavelength yag laser absorpt coeffici water time higher micron wavelength yag laser compar vivo studi laser soft tissu effect perform micron wavelength micron wavelength yag laser puls wave pw mode continu wave cw mode contact endoscop deliveri system standard mm mucos lesion made canin tracheobronchi tree level perichondrium soft tissu cartilag effect examin light scan electron microscopi acut week week oper comparison made laser modal creat similar lesion higher energi requir micron wavelength yag laser soft tissu injuri greater micron wavelength cw mode cartilag damag occur pw mode soft tissu cartilag repair week micron wavelength laser comparison laser contact yag laser prove precis cut tool micron wavelength micron wavelength yag laser yag laser wavelength coagul vapor tissu blood vessel studi determin effect micron wavelength endotrach tumor"
"transscler applic semiconductor diod laser diod laser output power fiberopt light pipe micron diamet deliv laser energi sclera pigment rabbit ciliari bodi destruct occur energi level mw exposur time sec retin photocoagul achiev energi level mw sec histolog examin acut lesion demonstr thermal destruct ciliari bodi process retina chorioretin scar format observ clinic histolog week data transscler diod laser destruct ciliari bodi process peripher retin coagul pigment eye"
"coweld venous anastomosi enhanc weld strength heterolog fibrin glue milliwatt laser perform endend anastomos canin jugular vein high disrupt rate laserweld vein fibrin glue form human freshfrozen plasma enhanc weld strength decreas disrupt rate result patenc equal contralater sutur vein patenc burst strength improv fibrin glue transmur necrosi present initi group extend longer distanc vessel wall laserweld anastomos sutur anastomos exhibit greater inflammatori respons laserweld anastomos endotheli cell confluent sutur anastomos week carbon dioxid laserweld endend vein anastomos impract disrupt easili addit heterolog fibrin glue weld result strong anastomosi histolog properti benefici vein bypass graft"
"decreas osmot stabil dystrophin muscl cell mdx mous human link duchenn becker muscular dystrophi due defect dystrophin product larg gene dystrophin character spectrin submembran cytoskelet protein experiment evid function structur mainten muscl current hypothes attribut necrosi dystrophin fibr situ mechan weaken outer membran excess influx ca ion combin mechan possibl mediat stretchsensit ion channel hypoosmot shock determin stress resist mous model mdx human diseas show function dystrophin contribut stabil cultur myotub isol matur muscl fibr"
"mous insulin growth factor type receptor imprint close link tme locus matern effect tme maternaleffect mutat mous defect nuclearencod embryo inherit delet tme locus mother die day gestat genom imprint region mous genom imprint gene clone tme locus absent chromosom delet mutant thp tlub posit local delet cm region report gene insulin growth factor type receptor igfr mitochondri superoxid dismutas sod absent delet probe gene plasminogen plg complex peptid tcp pulsedfield gel map show tme lie region kb demonstr embryo express igfr matern chromosom tcp plg sod express chromosom igfr imprint close link ident tme"
"quantif magnet reson scan hippocamp parahippocamp atrophi alzheim diseas brain patient alzheim diseas ad invari exhibit neuropatholog hippocampus entorhin cortex examin postmortem magnet reson imag mri offer noninvas highresolut method quantifi volumetr ad brain antemortem patient diagnos probabl ad agematch control mri scan test batteri cognit olfactori test hippocampus entorhin cortex parahippocamp gyrus show signific atrophi reduct size area brain high involv degen state ad striatum show signific volumetr hippocamp parahippocamp gyrus volum highest correl score miniment state examin lower correl smell identif test odor matchsampl test visual matchsampl test"
"recurr peripher facial nerv palsi dental procedur peripher facial palsi uncommon complic dental procedur case begin immedi dental anesthesia resolv hour report recurr facial palsi dental manipul previous report patient episod peripher facial palsi year develop hour dental procedur episod contralater facial weak develop year event event relat dental manipul exact mechan dental manipul rare result precipit recurr bell palsi"
"physiolog induct revers focus format tumorigen nih cell publish erratum proc natl acad sci apr nih cell undergo morpholog transform respons condit constrain growth occur low serum concentr confluenc transform express small fraction cell discret foci multipli cell confluent monolay quiescent cell isol expand cell popul dens light foci cell popul effici reproduc foci morphotyp grown background nontransform nih cell cultur deriv dens foci sublin found number focusform unit stabl cell remain tumorigen subject repeat thriceweek passag calf serum equival passag calf serum eventu render cell incap focus product tumor format result show capac produc tumor morpholog transform produc respons physiolog constraint growth metabol absenc carcinogen properti revers lift constraint behavior typic adapt respons support evid show tumorigenesi requir convent genet alter"
"cationdepend mannos phosphat receptor intern signal cytoplasm domain publish erratum proc natl acad sci feb signal requir rapid intern bovin cationdepend mannos phosphat receptor local distinct region amino acid cytoplasm domain signal includ phenylalanin phenylalanin involv tyrosin signal potent present maxim rate receptor intern signal share similar intern signal recycl receptor"
"long termin repeat retrotransposon mobil hybrid dysgenesi drosophila virili hybrid dysgenesi syndrom similar drosophila melanogast occur drosophila virili laboratori stock cross wild strain collect batumi region georgia mutat loci obtain cross induc insert dna sequenc clone induc white mutat character insert sequenc respons mutant phenotyp sequenc kilobas kb transpos element ulyss element flank unusu larg kb long termin repeat ulyss landmark characterist retrotransposon famili trnabind site adjac long termin repeat open read frame encod putat product homolog revers transcriptas proteas integras domain typic protein encod vertebr retrovirus mutat obtain copi ulyss element mutant locus suggest transpos element respons mutat ulyss primari entir dysgen syndrom mobil result activ independ mobil element"
"repair oethylguanin dna protect rat cell tumorigen convers ethylnitrosourea oethylguanin oetgua dozen alkyl product form dna cell expos alkyl nitroso carcinogen ethylnitrosourea etnu evalu select relat capac cell specif enzymat repair oetgua determin probabl malign convers eleven oetguarepairprofici variant subclon isol oetguarepairdefici clonal rat fibroblast line select resist bischloroethylnitrosourea frequenc approxim equal contrari wildtyp cell variant express omethylguaninedna methyltransferas activ kind cell defici repair dna ethyl product oethylthymin exposur etnu equal microgramsml min cell analyz format pile foci monolay cultur anchorageindepend coloni semisolid agar medium depend etnu concentr frequenc pile foci agar coloni variant low wild type contrast cell variantderiv agar coloni cell agar coloni gave rise high malign tumor implant subcutan syngen rat signific differ frequenc pile foci found wildtyp variant cell exposur major reactiv metabolit benzopyren beta alphadihydroxi alphaepoxi alphatetrahydrobenzo pyren stabl bind guanin cellular dna observ relat capac cell repair oalkylguanin critic determin risk malign convers nitroso carcinogen"
"ligament laxiti ccc complex axial torquerot characterist failur axial torqu failur ligament occipitoatlantoaxi complex ccc subject axial angular rotat theta character biaxial mts system special fixtur gearbox permit axial rotat specimen failur impos addit constraint design obtain data averag valu axial rotat torqu point maximum resist degre specimen offer minim resist approxim averag axial rotat degre complex torqueangular rotat theta curv divid region region steadili increas resist transit zone connect region increas resist region point maximum resist region steadili increas resist repres straight line averag slope degre posttest dissect specimen disclos point maximum resist correspond rough axial rotat complet bilater rotari disloc cc facet occur type injuri observ relat magnitud axial rotat impos specimen test softtissu injuri stretchruptur capsular ligament sublux cc facet confin specimen rotat close point maximum resist specimen subject rotat point maximum resist curv spontan reduc complet remov test apparatus spontan reduct specimen test slight point maximum resist"
"perinat grief mourn grief mourn parent experi perinat loss devast loss older love pattern mourn anticip intervent implement proper parent pass catastroph time live minimum scar physician stop reach listen support parent dramat effect live parent manner start paper close quotat parent suffer loss daughter die daughter live half heart day life long rememb thin blue lip uneven gasp incub rack breath pain watch long rememb held felt soft count toe color eye dead pale hand cover gown home moist earth smell small casket tear hold hand souvenir occas sheet paper fill statist certif smudg footprint tini bracelet engrav girl smith feel feel "
"studi genesi doubl potenti record high atrium atrial flutter role reentri circuit atrial flutter investig genesi doubl potenti dp separ wave role reentri circuit atrial flutter af perform overdr pace odp high atrium hra case spontan af dp record hra case dp arbitrarili design show progress fusion odp addit return cycl immedi termin odp correspond af cycl return cycl correspond pace cycl dp caus collis direct wave suggest hra play import role prevent shortcut reentri wave stabil reentri circuit af"
"echograph diagnosi dural carotidcavern sinus fistula standard ophthalm echographi identifi specif abnorm patient lowpressur lowflow dural arterioven malform patient scan ultrasonographi show engorg ipsilater vertic vein scan ultrasonographi dynam imag rapid blood flow superior ophthalm vein enlarg culpabl ocular muscl patient restrict ophthalmopathi degre test distinguish venous engorg optic nerv sheath apic compress optic nerv enlarg ocular muscl"
"leukotrien synthesi inhibit receptor blockad inhibit hypox pulmonari vasoconstrict sheep line evid suggest leukotrien mediat hypox pulmonari vasoconstrict hpv effect leukotrien inhibit hpv remain controversi present studi investig effect leukotrien synthesi inhibit receptor blockad hpv halothaneanesthet sheep initi baselin measur pulmonari pressor respons min global hypoxia fio measur set baselin measur obtain sheep receiv combin cyclooxygenaselipoxygenas inhibitor bwc select lipoxygenas inhibitor leukotrien receptor antagonist ly hemodynam measur obtain drug administr subsequ hypox challeng fio initi hypox challeng increas pulmonari arteri pressur increas pulmonari vascular resist pulmonari hemodynam recoveri hypoxia similar initi baselin valu drug administr signific hemodynam effect hypox challeng drug administr result pulmonari pressor respons ident initi hypox challeng leukotrien synthesi inhibit receptor blockad alter respons hypoxia conclud leukotrien obligatori mediat hpv critic review literatur support modulatori obligatori role leukotrien hpv"
"effect neurolept agent rat skelet muscl contractur vitro purpos investig examin compar effect vivo pretreat vitro treatment neurolept agent droperidol haloperidol trifluoperazin skelet muscl contractur vitro model strip normal rat diaphragm challeng succinylcholin halothan halothan subsequ vitro administr microm vivo pretreat mgkg droperidol haloperidol trifluoperazin equilibr maximum increas tension record data analyz analysi varianc droperidol trifluoperazin administ vivo contractur valu exposur succinylcholin halothan signific decreas vivo pretreat haloperidol vitro administr droperidol succinylcholineinduc contractur signific reduc contractur subsequ induc halothan signific differ control vitro treatment haloperidol trifluoperazin produc signific increas tension muscl expos succinylcholin halothan studi evid droperidol consid safe anesthet adjunct malign hyperthermiasuscept patient addit caution exercis interpret result studi contractur test perform muscl patient treat neurolept agent"
"simultan superior obliqu sheathectomi inferior obliqu tuck congenit brown syndrom harold brown superior obliqu tendon sheath syndrom numer surgic techniqu explor treat condit tenectomi homolater superior obliqu combin weaken procedur homolater inferior obliqu techniqu advoc good function result rare achiev singl procedur delay complic frequent advantag improv dissect reduc trauma afford surgic microscop techniqu recommend abandon brown reapprais techniqu consist dissect sheath attach superior obliqu preserv tendon combin mm tuck homolater inferior obliqu typic sever atyp congenit case classif brown treat fashion full correct achiev"
"effect hyaluron acid fraction rabbit eye fraction hyaluron acid molecular weight ial molecular weight healon molecular weight inject intracamer intravitr rabbit eye fraction higher molecular weight caus increas intraocular pressur chang paramet found administr fraction lower molecular weight inflammatori reaction ocular tissu observ slitlamp biomicroscopi administr healon ial inflammatori reaction found subchron instil compound"
"pleural anesthet epidur cathet secur insid chest tube pain manag thorac surgic procedur difficult clinic problem varieti pain manag method variabl efficaci paper present effect method pleural anesthet administr pleural cathet insert chest tube"
"intraop coronari angiographi fluorescein intraop coronari angiographi fluorescein appli evalu patenc saphen vein graft complet distal anastomosi techniqu area revascular myocardium estim real time intraop directvis examin time precis inform coronari arteri bypass graft"
"delay chest wall pain due sternal wire sutur report describ patient disabl chest wall pain due sternal wire sutur pain occur month median sternotomi pain sharp stab deepseat ach involv wire exagger fibrous tissu reaction surround twist portion adjac noninvolv wire minim reaction patient serial section fibrous tissu reveal entrap sensori nerv fiber electr potenti measur found elev indic wire damag twist ferroxyl test confirm collect iron ion anod point result corros remov involv wire fibrous tissu surround anod point reliev symptom pain tender result entrap sensori nerv"
"free arteri graft fail due spasm rat femor arteri free graft studi day patenc graft day day day day day histolog show intim thicken day media control consist ten layer myocyt reduc cell layer week graft segment impair contract expos kreb solut mmol month graft segment approach control higher contractil forc thromboxan mimic elicit full contractil forc time potenc signific lower day noradrenalin unabl induc contract graft segment day day regain full contractil forc signific potent approxim time graft segment compar control studi suggest intim thicken hypercontractil problem free muscular arteri graft"
"primari care patient refus special mental health servic chart patient complet mental health care referr compar patient fail complet referr year referr noncompli patient made medic visit compliant patient compar compliant patient signific greater proport noncompli patient medic visit difficultexplain somat symptom mental health referr physician success referr physician attend patient pattern health care util primari care physician identifi patient high risk noncompli mental health referr"
"suicid attempt attempt suicid elder major psychiatr problem nineti patient year age evalu psychiatr consult servic suicid attempt characterist group includ high degre premedit tendenc firearm wound head male sex coexist medic problem intent increas decad solitari live arrang presenc histori major psychiatr ill ill health report precipit suicid major depress common psychiatr diagnosi congest heart failur chronic obstruct pulmonari diseas frequent note physic ailment elder popul attempt resembl older person complet suicid differ signific person age year attempt suicid heighten investig depress featur treatment alcohol abus earli referr psychiatr care limit access firearm strategi aim decreas social isol recommend decreas likelihood complet suicid elder"
"relationship hypochondriasi medic ill forti diagnost statist manual mental disordersiiirevis hypochondriac accru primari care practic seventi control subject select random remaind patient clinic subject complet structur diagnost interview standard report questionnair medic morbid assess medic record audit primari physician rate hypochondriac comparison sampl differ aggreg medic morbid hypochondriac sampl undiagnos complaint nonspecif find medic record comparison sampl higher level medic morbid higher level hypochondriac symptom occur primarili medic disord bodili preoccup diseas convict somat hypochondriac sampl correl found degre hypochondriasi extent medic morbid"
"preoper aspirin therapi reoper bleed coronari arteri bypass surgeri perform casecontrol studi estim relat risk reoper bleed coronari arteri bypass graft patient aspirin day preced surgeri comparison case reoper match control subject gave estim odd ratio reoper confid interv preoper coagul valu similar case signific blood case unit control subject unit median interquartil rang pack red blood cell case unit control subject unit platelet case unit control subject unit control subject case intens care unit stay day sd day control subject postop hospit day day control subject conclud aspirin exposur day coronari bypass surgeri increas rate reoper bleed reoper larg increas transfus requir intens care unit hospit stay"
"calcium agonist bay vitro diagnosi suscept malign hyperthermia studi effect calcium agonist bay vitro halothan test malign hyperthermiasuscept mhs mh equivoc halothan mheh mh suscept mhn control patient bay potenti halothaneinduc contractur muscl strip mhs mheh patient drug produc obvious differ contractur respons mheh group compar mhn control group"
"regulatori control termin complement protein surfac human endotheli cell neutral cb inhibitor antibodi cd function inhibitori antibodi plasma membran complement inhibitor cd investig control termin complement protein endotheli cell surfac antibodi purifi human erythrocyt cd polyclon anticd monoclon antibodi moab found bind specif monolay cultur human umbil vein endotheli cell western blot recogn kd endotheli protein bound endotheli monolay anticd immunoglobulin fab fragment potenti membran pore format induc bind cb augment cbinduc cellular respons includ stimul secret von willebrand factor express catalyt surfac prothrombinas enzym complex potenti endotheli respons termin complement protein anticd effect respons cell stimul histamin data suggest human endotheli cell express cd cell surfac inhibitor termin complement protein serv protect cell poreform cellstimulatori effect cb complex data suggest inactiv delet cell surfac regulatori molecul increas likelihood procoagul endothelium expos complement activ plasma"
"regulatori element erythropoietin gene human hepatoma cell line hepb produc erythropoietin epo regul fashion investig cisact regulatori element epo gene comparison primat mous sequenc show strong homolog code sequenc flank region intron flank region portion epo gene insert report gene human growth hormon gh base pair bp hindiiixb fragment extend bp cap site intron obviat problem fals initi translat epo atg start codon site chang tag sitedirect mutagenesi bp acclbglii fragment extend bp upstream epo termin codon cover noncod region homolog plasmid dnas transfect electropor hepb cell rsvcat intern standard correct transfect effici aliquot cell expos mumol cocl end incub gh epo measur cell media cell pellet assay cat product gh stimul fold cobalt hypoxia addit gh gene irrespect orient stimul gh product fold cocl fold hypoxia stabl cell line produc cotransfect construct select marker psvneo clone exposur hypoxia result mark fold induct gh stimulus gh epo product hypoxia partial abrog carbon monoxid result demonstr presenc promot enhanc element human epo gene appropri respons hypoxia cobalt"
"ethamsyl reduc haemorrhag transurethr prostatectomi doubleblind randomis trial consecut patient undergo transurethr prostatectomi demonstr ethamsyl dicynen reduc blood loss oper post oper period"
"acceler lutein hormon puls frequenc function hypothalam amenorrhea dopaminerg blockad constel neuroendocrin secretori aberr includ reduc lh puls frequenc prl concentr document women function hypothalam amenorrhea fha pituitari function preserv aberr attribut alter hypothalam neuromodul investig particip dopaminerg system genesi reduc lh puls frequenc suppress prl level fha studi women fha cyclic women earli follicular phase obtain blood sampl min interv sequenti infus salin dopamin receptor blocker metoclopramid mcp hypothalam pituitari site action infer pulsatil characterist mcp consist elicit increas lh puls frequenc women fha se puls contrast eumenorrh women show signific chang lh puls frequenc respons mcp puls prl concentr signific lower fha group infus salin mcp relat increas prl mcp similar group acceler lh puls frequenc blockad dopamin receptor impli increas hypothalam dopaminerg inhibit gnrh puls frequenc women fha"
"simpl stress test evalu hypothalamicpituitaryadren axi month life normal infant divid age group month month month plasma cortisol measur baselin plasma cortisol expect low infant sem valu nmol group thirti min pain stimulus venipunctur plasma cortisol increas signific reach maximum increas nmol age group conclud infant hypothalamicpituitaryadren axi function intact respond pain stimulus venipunctur signific increas plasma cortisol test simpl procedur evalu integr hypothalamicpituitaryadren axi administr pharmacolog agent valid patient disord system"
"stress retir find normat age studi stress retir transit event experienc past year life stage investig transit stress assess life event approach stage stress hassl approach respond male particip normat age studi retir retir past year respond spous retir rate stress list event found retir stress retir hassl frequent report rate stress work hassl men labor forc consist predictor transit stage retir stress poor health famili financ person predict retir stress"
"live arrang sourc caregiv studi examin preval type caregiv term relat individu live import caregiv relat elder individu caregiv examin term iadl emot support analys conduct separ random sampl marri live spous live live nonspous winnipeg manitoba canada result confirm previous research point marri peopl tend receiv assist spous nonmarri children frequent primari caregiv children live tend receiv assist friend live nonspous receiv assist sibl data document import structur characterist live marit status assist iadl"
"social network health emot oldest london survey health social circumst peopl age live home london conduct primari aim analyz structur social support network sampl relat respond emot met unmet practic conceptu methodolog framework appli studi deriv theori social network confirm common assumpt peopl age younger elder peopl survivor high level social support inform respond associ found social network variabl provis inform multifactori analysi show health status explain variat emot"
"coumadininduc gastrointestin hemorrhag ileal duplic year man recurr gastrointestin hemorrhag aortic valv replac initi anticoagul therapi coumadin radionuclid bleed scan subsequ contrast angiogram demonstr site hemorrhag distal ileum surgeri cm spheric duplic found histolog examin duplic line normal ileal mucosa mouth duplic inflammatori ulcer prove site hemorrhag young patient anticoagul gastrointestin hemorrhag alimentari tract duplic consid"
"larg telangiectat focal nodular hyperplasia present normal radionuclid studi case report cmlesion telangiectat focal nodular hyperplasia incident identifi yr femal typic ray comput tomographi ultrasonographi scintigraphi technetiummmtc colloid mtcdiethyliminodiacet acid mtclabel red cell fail demonstr abnorm find felt reflect relat lack architectur disrupt histolog character lesion present report imag characterist telangiectat form focal nodular hyperplasia"
"techniqu emerg ventil model evalu tidal volum airway pressur gastric insuffl design model evalu effect noninvas method ventil upper airway simul head resuscianni attach test lung esophagus stomach simul penros drain connect roll seal spiromet peep valv fifteen paramed volunt ventil model util mouthmouth mouthmask bagvalvemask portabl field ventil impact harv record tidal volum gastric volum proxim distal airway pressur complet level complianc normal complianc method harv met exceed american heart associ standard complianc decreas tidal volum fell gastric insuffl increas complianc cm ho method fail meet aha standard gastric insuffl volum equal deliv tidal volum mouthmouth mouthmask techniqu mouthmouth mouthmask techniqu generat largest tidal volum creat largest volum gastric insuffl impact ventil provid accept tidal volum minim gastric insuffl result suggest mouthmask ventil supplement oxygen enrich effici techniqu invas airway manag"
"prostaglandin alpha level neonat extracorpor membran oxygen infant receiv extracorpor membran oxygen therapi undergo longterm cardiopulmonari bypass system heparin frequent receiv platelet transfus prostacyclin power inhibitor platelet aggreg potent vasodil level stabl metabolit prostaglandin alpha increas signific children undergo cardiopulmonari bypass heart oper decreas preoper level bypass determin effect longterm bypass prostacyclin level multipl plasma sampl analyz human neonat extracorpor membran oxygen therapi hour extracorpor membran oxygen prostaglandin alpha stabl metabolit prostacyclin quantit radioimmunoassay picogram millilit prostaglandin alpha level elev patient receiv extracorpor membran oxygen therapi decreas durat extracorpor membran oxygen infant prostaglandin alpha level rose wean extracorpor membran oxygen remain elev hour extracorpor membran oxygen extracorpor membran oxygen influenc circul prostaglandin alpha level fluctuat prostaglandin alpha level clinic signific manag vasomotor tone platelet function common problem care prevent hemorrhag critic ill infant"
"reevalu heparin requir cardiopulmonari bypass determin reduct standard heparin administr cardiopulmonari bypass accomplish safe membran oxygen experiment studi design evalu heparin administr protocol cardiopulmonari bypass hollowfib membran oxygen group pig submit hypotherm cardiopulmonari bypass degre hour rewarm decannul reassess hour group control heparin administ maintain activ clot time excess group ii activ clot time maintain total heparin administ unit group unit group ii concentr coagul factor ii viii fibrinogen platelet count determin hour bypass signific differ coagul paramet observ group perform oxygen similar group evid thrombosi reduc heparin administr activ clot time relat major coagul factor platelet consumpt derang oxygen perform"
"analysi medtron intact bioprosthet valv effect pressur fixat longterm perform currentdesign porcin xenograft valv satisfactori valv general fix low pressur mm hg medtron intact medtron minneapoli minn valv fix pressur propos altern exist xenograft valv mechan analysi valv carri determin intact valv differ signific lowpressur fix xenograft twelv circumferenti strip tissu mm wide cut leaflet clinicalgrad intact valv stressstrain stress relax flexur behavior examin mechan histolog intact valv extens lowpressur fix xenograft versus strain relax faster pliabl xenograft buckl lowpressur fix xenograft enforc bend buckl signific fresh porcin aortic valv tissu intact valv relax signific slowli fresh tissu bend stiff stronger depend leaflet thick bend thick fresh tissu weaker depend bend thick lowpressur fix xenograft materi intact valv demonstr larg variabl extens bend stiff buckl behavior correl paramet valv wrinkl leaflet fix pressur shrinkag leaflet materi low fixat pressur import modifi elast behavior valv cusp intact valv natur elast behavior lowpressur fix xenograft experi lower stress normal valv function conclud pressur fixat preserv desir stressreduc properti aortic valv tissu"
"neutrophil influx inflammatori site inhibit solubl home receptorigg chimaera neutrophilmedi inflamm involv number human clinic manifest includ adult respiratori distress syndrom multiorgan failur reperfus injuri inhibit type inflammatori respons block competit adhes interact neutrophil endothelium adjac inflam region lectin murin adhes molecul gpmel home receptor found leukocyt cell includ neutrophil mel monoclon antibodi direct adhes molecul block lymphocyt traffic lymph node extravas neutrophil blood inflammatori site show administr mice solubl immunoglobulin chimaera murin home receptor extracellular domain signific decreas number neutrophil migrat peritoneum respons inflammatori irrit thioglycol result solubl form singl type adhes molecul home receptor clinic effect compound inhibit neutrophilmedi inflamm"
"alter mrna stabil protein ribonucleas encod structur gene escherichia coli vitro vivo analysi ribonucleas defici rne alter mrna stabil proteindefici strain escherichia coli demonstr carri mutat structur gene strain encod thermolabil rnase rne protein defect rrna process mrna turnov immedi shift nonpermiss temperatur chemic decay rate bulk mrna slow fold min precursor rrna begin accumul addit phenotyp rne allel complement recombin plasmid carri previous genet studi result suggest role ribonucleas mrna turnov involv endonucleolyt cleavag propos acagauuug consensus sequenc"
"nerv growth factor bind domain nerv growth factor receptor structur analysi rat lowaffin nerv growth factor ngf receptor undertaken defin ngf bind domain mutant ngf receptor dna construct express mous fibroblast cos cell abil mutant receptor bind ngf assay mutant amino acid residu intracellular domain receptor remov receptor bound ngf kd compar wildtyp receptor mutant cysteinerich sequenc extracellular portion protein mutant express cos cell result protein secret solubl form receptor bind ngf termin delet cysteinerich sequenc part cysteinerich sequenc remov bound ngf mutant lack cysteinerich sequenc unabl bind ngf result show cysteinerich sequenc ngf receptor ngf bind domain"
"molecular evolut invers drosophila pseudoobscura amylas gene region amylas region chromosom drosophila pseudoobscura clone local cytolog band seri high polymorph invers serv conveni tool molecular evolutionari analysi invert gene arrang amylas pseudoobscura famili gene chromosom delet overlap clone cover kilobas isol probe survey dna restrict map polymorph line repres major invers type found natur popul singl chromosom close relat speci drosophila persimili drosophila miranda restrictionsit differ greater gene arrang chromosom gene arrang cluster restrict map haplotyp yield dendrogram concord phylogeni generat independ cytogenet invers polymorph estim million year"
"plateletderiv growth factor receptor alphasubunit gene pdgfra delet mous patch ph mutat plateletderiv growth factor receptor compos subunit alpha beta associ form function activ dimer receptor speci subunit encod separ loci human speci studi convent interspecif backcross map analysi delet mutat establish close linkag alphasubunit gene pdgfra domin spot locus mous chromosom analyz restrict fragment length polymorph interspecif hybrid demonstr close patch ph locus carri delet pdgfra observ confirm dna rna analysi day fetus produc cross ph heterozygot fetus analyz pdgfra genom sequenc absent mrna receptor detect fetus development abnorm presumpt ph homozygot determin delet ph mutat extend code sequenc adjac kit gene analysi genom dna interspecif hybrid presumpt ph homozygot absenc pdgfra genom sequenc lack detect messag ph mutat make mutant valuabl asset understand role receptor alpha subunit mammalian develop"
"role iliolumbar ligament lumbosacr junction biomechan function iliolumbar ligament human lumbosacr junction investig analyz dimension movement lumbar lumbosacralilium specimen experi repeat condit intact iliolumbar ligament iliolumbar ligament transect bilater iliolumbar ligament transect repres valu increas motion compar intact transect bilater iliolumbar ligament degre flexion degre extens degre axial rotat degre bend restrict motion govern iliolumbar ligament lumbosacr junction bend bilater iliolumbar ligament specimen restrict flexion extens lumbosacr junction unilater iliolumbar ligament prepar restrict motion iliolumbar ligament function restrict rotat movement lumbosacr junction"
"biomechan evalu lumbar spinal stabil grade facetectomi vitro experi fresh human lumbar function spinal unit effect divis posterior ligament consist supraspinousinterspin ligament grade facetectomi investig grade facetectomi consist unilater bilater medial facetectomi unilater bilater total facetectomi kind moment appli rang motion rom neutral zone nz determin dimension stereophotogrammetr method rang motion affect divis supraspinousinterspin ligament load mode flexion rom increas slight unilater medial facetectomi axial rotat rom increas left unilater total facetectomi rang motion affect bilater total facetectomi extens bend studi suggest medial facetectomi affect lumbar spinal stabil convers total facetectomi creat unilater make lumbar spine unstabl"
"red cell antibodi aris solid organ transplant rbc antibodi aris transplant organ direct recipi rbcs repres establish immunohematolog complic solid organ transplant abounmatch organ frequenc sever graft antibodi hemolysi general increas size lymphoid content organ kidney liver heartlung transplant case review frequenc hemolysi increas cyclosporinetr kidney transplant recipi liver transplant recipi decreas group ab liver transplant recipi kidney transplant recipi receiv azathioprin lowdos postop graft irradi data distinguish cyclosporinetr recipi abounmatch kidney liver total develop graft antibodi conclus effect date age race gender donor recipi cadav versus live kidney donor patient secretor status case livingdonor kidney graft donor patient mother wife expos recipi rbc antigen pregnanc abo antibodi typic igg day transplant month spin crossmatch routin dat recommend compat test abounmatch transplant immunosuppress regimen chang cyclosporin therapi affect durat antibodi patient requir transfus limit process case hemolysisinduc acut renal failur report death attribut complic hemolysi rbc plasma exchang perform fulmin case rbcs donor blood type antibodi worker recommend transfus prophylaxi time surgeri liver transplant plasma accompani larg amount group rbcs periop problemat center abounmatch liver transplant equival graft surviv pittsburgh adult patient hemolysi reduc earli graft surviv case review igg rh antibodi kidney graft direct recipi rbcs observ begin week cyclosporinetr transplant month oper caus mild hemolysi case repres primari immun respons previous unsensit donorabstract truncat word"
"associ hypothermia mortal rate prematur infantsrevisit incid hypothermia axillari temperatur degre admiss infant neonat intens care unit retrospect analyz lowbirthweight gm newborn infant smaller infant greater risk hypothermia larger neonat mortal relat hypothermia suggest associ bear effect relationship"
"myocardi epinephrin sensit subanesthet concentr halothan dog author investig myocardi epinephrin sensit subanesthet concentr halothan doserespons relationship action halothan examin etomid vari subanesthet concentr halothan dog arrhythmogen threshold epinephrin decreas dosedepend manner endtid concentr halothan endtid halothan greater reduct arrhythmogen threshold epinephrin occur plasma concentr epinephrin produc prematur ventricular contract ngml sem halothan endtid concentr result suggest presenc etomid halothan produc myocardi sensit epinephrin subanesthet concentr low increas halothan produc reduct arrhythmogen dose epinephrin"
"endotheliumderiv relax factor inhibit hypox pulmonari vasoconstrict rat hypothesi endotheliumderiv relax factor edrf modul hypox pulmonari vasoconstrict hpv test isol bloodperfus rat lung ventil gas mixtur normoxia hypoxia microm ngmonomethylarginin nmma inhibitor edrf product caus reduct endotheliumdepend relax respons acetylcholin ach ach concentr microm concentr indic nmma act inhibit edrf product nmma induc concentrationrel augment hpv concentr microm compar vehicl control group concentr pressor respons dose angiotensin ii ii produc increas pulmonari arteri pressur induc hypoxia signific augment lesser extent augment hpv microm nmma complet revers mm arginin precursor edrf arginin isom arginin mm arginin mm arginin caus signific inhibit hpv compar vehicl control group small signific reduct iimedi contract"
"neural substrat memori impair demonstr intracarotid amobarbit procedur intracarotid amobarbit sodium amyt procedur iap perform patient tempor lobe epilepsi left seizur foci seizur foci anteromedi tempor lobectomi neuron densiti establish hippocamp subfield ca ca ca hilum dentat granul cell layer intracarotid amobarbit procedur memori result relat ca neuron loss patient demonstr memori inject contralater seizur focus signific fewer cell ca patient addit signific correl observ intracarotid amobarbit procedur memori examin raw score inject contralater seizur focus ca cell densiti chi analysi signific differ document frequenc memori demonstr inject contralater seizur focus group patient classifi degre ca neuron loss find support prior research show subfield specif memori process"
"memori complaint older adult fact fiction complaint poor memori patient earli symptom patholog process alzheim diseas import determin patient complaint memori impair accur reflect real memori disturb relationship memori complaint metamemori object memori perform mood age verbal intellig sex examin group healthi communiti dwell adult year memori complaint demonstr stronger associ depress mood perform memori test increas report depress symptom memori complaint verbal intellig age sex contribut memori complaint patient higher verbal intellig report fewer complaint emphasi forget older individu report greater frequenc forget greater frequenc memori techniqu specif type memori complaint forget type memori aid employ result show rate memori disturb older adult relat depress mood poor perform memori test"
"clinic choic circulatori assist devic approxim open heart surgeri patient unwean cardiac bypass surgic procedur addit patient accept cardiac transplant die wait donor heart pulsatil pneumat ventricular assist devic vad provid realist solut dilemma manufactur compet major market share clinic devic novacor thermet thoratec symbion abiom competit vad system system optim patient limit similar strength system enhanc patient outcom devic success vad system bridg transplant ventricular recoveri approach adher strict patient select institut vad manag center detail attent anticoagul prompt diagnosi treatment complic"
"deoxyribonucl acid region involv hormon regul thyroglobulin gene express transcript thyroglobulin tg gene stimul tsh camp character sequenc element respons hormonedepend express tg gene rat thyroid frtl cell intern delet linkerscan mutant minim tg promot basepair fuse bacteri chloramphenicol acetyltransferas report gene tg gene regul region locat bp tgiii bp tg transcript initi site interven region delet signific effect promot activ region promot hormonedepend transcript dnase footprint assay show tg tgiii princip proteinbind site protein interact region induc tsh camp result suggest hormonedepend express tg gene achiev cooper interact protein bound tg tgiii"
"effect surgic stress vitro metabol thyroxin rat liver kidney brain man acut stress extens surgeri lead rapid prolong decreas serum concentr present studi carri investig mechan abrupt decreas tneogenesi occur respons acut surgic stress male spraguedawley rat surgic thyroidectom treat microgram bwday underw wide vertic horizont incis extend abdomin caviti receiv light ether anesthesia dietari manipul perform investig superimpos influenc reduc carbohydr calor intak tneogenesi metabol label outer phenol ring investig liver kidney brain homogen anim kill surgeri liver valu proport degrad percent generat iodid unaffect laparotomi percent generat experi nm concentr sd fed control anim free access glucos unoper control restrict amount chow glucos oper anim free access chow glucos expect neogenesi liver unoper anim signific reduc rat fast reduct similar laparotom rat fast surgeri liver effect laparotomi metabol kidney brain homogen observ final serum total concentr affect surgeri conclud acut surgic stress thyroidectom replac rat influenc metabol liver kidney brain homogen affect serum concentr thyroid secret elimin care attent paid calor intak rat model previous report abnorm serum thyroid hormon concentr tneogenesi state nonthyroid ill man rat includ surgeri contribut thyroid secret calor depriv carbohydr"
"rat glucagon gene regul protein kinas depend pathway pancreat islet cell camp respons element cre identifi proxim flank region rat glucagon gene activ campdepend pathway fetal rat intestin cell lead increas level glucagon mrna transcript contrast human glucagon gene similar cre result studi immort rat hamster islet cell line suggest glucagon gene express regul camp reconcil observ studi control glucagon gene express incub primari rat islet cell cultur forskolin presenc low liter high glucos result fold increas level glucagon mrna transcript forskolin stimul secret synthesi immunoreact glucagon import protein kinasedepend pathway regul glucagon gene express examin hamster islet inrg cell cotransfect glucagonchloramphenicol acetyltransferas cat fusion gene glucagon cre cdna encod catalyt subunit protein kinas result stimul glucagoncat activ hamster islet cell catalyt subunit cotransfect activ somatostatincat activ rsvcat detect result experi suggest rat glucagon gene regul protein kinasedepend pathway endocrin pancrea"
"sympathet neural adjust stress physic train untrain human purpos studi determin state physic train influenc sympathet neural activ acut stress human record muscl sympathet nerv activ microneurographi peron nerv arteri blood pressur heart rate high train endur athlet year sem untrain subject year supin rest control lower bodi negat pressur mm hg orthostat stress isometr handgrip maximum exercis stress hand immers ice water cold pressor test thermal stress bodi weight group athlet lower bodi fat content versus supin rest muscl sympathet nerv burst frequenc versus burstsmin athlet versus untrain subject burst incid versus burst heart beat arteri blood pressur group heart rate lower athlet versus beatsmin"
"electrophysiolog find fontan repair function singl ventricl cardiac arrhythmia recogn sequela fontan oper complex congenit anomali studi electrophysiolog effect fontan procedur evalu patient underw cardiac catheter electrophysiolog studi year sd modifi fontan repair function singl ventricl abnorm sinus node ectop pacemak automat detect patient determin prolong correct sinus node pacemak recoveri time total sinoatri conduct time prolong patient normal sinus rhythm sinus node ectop atrial pacemak function normal patient predomin atrial rhythm normal sinus ectop atrial junction abnorm atrial effect function refractori period note patient pronounc faster pace cycl length atrial endocardi cathet map reveal intraatri conduct delay adjac site patient test patient induc intraatri reentri program atrial stimul induc nonsustain supraventricular arrhythmia patient sustain arrhythmia intraatri reentri common induc arrhythmia present patient sustain patient nonsustain atrial arrhythmia atrioventricular conduct abnorm note patient patient induc ventricular arrhythmia program ventricular stimul electrophysiolog find fontan repair includ abnorm sinus node function prolong atrial refractori delay intraatri conduct induc atrial arrhythmia"
"patient persist veget state attitud reaction famili member patient persist veget state pvs constitut approxim popul milwauke nurs home order understand famili member attitud reaction patient famili member patient pvs contact studi age patient rang age year famili member age rang age year etiolog pvs vari dementia cerebr trauma durat pvs month rang famili member report visit patient time year onset pvs visit rate visit year time interview signific correl frequenc famili member visit durat pvs patient famili member age famili member relationship patient nineti percent patient consid famili member awar pain light dark environ tast verbal convers famili member presenc famili member thought understood patient medic condit major expect patient improv major famili member patient undergo therapeut intervent includ transfer acut hospit surgeri"
"separ character saponin adjuv activ quillaja saponaria molina cortex saponin purifi quillaja saponaria molina bark silica revers phase chromatographi result purifi saponin test adjuv activ mice distinct saponin design qs qs qs qs demonstr boost antibodi level fold mous immun ag bsa beef liver cytochrom purifi saponin increas titer major igg subclass determin optim dose mice adjuv respons qs qs test doserespons studi intraderm immun bsa mice purifi saponin adjuv respons determin stimul elisa titer bsa maximum dose microgram shown plateau highest dose test microgram purifi saponin vari toxic assess lethal mice main compon qs toxic saponin qs qs show low toxic mice saponin stimul product reagin antibodi monosaccharid composit saponin show similar distinct composit fucos xylos galactos glucuron acid predomin differ observ quantiti rhamnos arabinos glucos monom determin size exclus hplc determin rang"
"effect sitespecif mutat biolog activ recombin human il examin structureact relationship human il determin effect specif mutat biolog activ human ril express bacteria type mutant examin variant serin place natur occur cystein seri cystein delet mutant singl intern amino acid delet cysteinefre variant singl amino acid delet mutant type constitut set nonoverlap adjac delet span amino acid amino acid natur human il mutant express full length cystein analogu escherichia coli fusion protein join betagalactosidas collagen linker system microgram quantiti ril variant partial purifi small bacteri cultur chromatograph refold step ril variant releas betagalactosidas fusion protein collagenas recov ril quantit laser densitometri coomassiestain sds polyacrylamid gel sp ac ril variant determin assay induct igm secret ebv transform human cell line induct fibrinogen secret human hepatoma cell line induct fibrinogen secret rat hepatoma cell line induct prolifer murin hybridoma cell line replac cystein serin reduc activ relat cystein ril rat hepatoma assay mous hybridoma assay activ human cell line reduc data suggest murin rat cell line select human cell line requir recognit biolog activ il delet amino acid result loss activ assay result suggest inform activ portion il molecul multipl segment protein requir biolog activ test"
"chronic hypomagnesemia caus cisplatin effect calcitriol group patient hypomagnesemia serum magnesium equal mmol previous treatment cisplatin ovarian testicular cancer receiv calcitriol dose microgramday period week determin treatment vitamin metabolit improv hypomagnesemia respons treatment serum magnesium concentr fell progress associ rise serum urinari calcium level decreas parathyroid hormon level singl previous report activ vitamin metabolit mark improv renal magnesium wast present studi increas serum urinari calcium level suppress parathyroid hormon factor decreas magnesium reabsorpt overwhelm direct effect calcitriol enhanc magnesium reabsorpt net effect mark exacerb renal magnesium wast"
"antiplatelet drug femoropoplit vein bypass multicent trial evalu influenc antiplatelet drug patenc femoropoplit vein bypass vascular surgeon recruit patient random doubleblind trial aspirin mg dipyridamol mg placebo daili start day surgeri continu indefinit graft occlus measur object independ coordin cardiovascular event myocardi infarct stroke studi express life tabl analyz statist log rank confid interv ci random achiev compar group graft insert rest pain gangren oper complic aspirin dipyridamol includ reoper bleed hematoma compar placebo ns graft failur occur earli failur rate patientmonth month reduc month subsequ year cumul graft patenc placebo year compar aspirin dipyridamol differ patenc ci year ci year fail achiev signific follow month patientyear cardiovascular event myocardi infarct cerebrovascular accid occur patient placebo compar aspirin dipyridamol signific differ antiplatelet therapi influenc femoropoplit vein patenc subsequ myocardi infarct stroke reduc patient peripher vascular diseas"
"prospect random comparison ring nonring polytetrafluoroethylen femoropoplit bypass graft preliminari report kink compress knee flexion thought failur knee polytetrafluoroethylen femoropoplit bypass prevent problem polytetrafluoroethylen graft extern support rigid ring develop present random prospect studi compar ring nonring polytetrafluoroethylen graft patient underw femoropoplit bypass sever limb ischemia patient match surgic indic risk factor signific differ year graft patenc rate ring versus nonring polytetrafluoroethylen femoropoplit bypass similar signific differ found year graft patenc rate ring versus ring knee knee polytetrafluoroethylen femoropoplit bypass year graft patenc rate knee polytetrafluoroethylen femoropoplit bypass slight greater knee polytetrafluoroethylen femoropoplit bypass differ statist signific year limb salvag rate ring polytetrafluoroethylen graft compar nonring polytetrafluoroethylen graft differ statist signific data date studi fail support recommend ring polytetrafluoroethylen graft preferenti convent polytetrafluoroethylen graft patient requir femoropoplit bypass synthet graft"
"glucoseinduc exert fatigu muscl phosphofructokinas defici background exercis capac patient muscl phosphofructokinas defici low fluctuat day day basi variabl exercis toler unknown patient disord report fatigu activ muscl rapid highcarbohydr meal method result determin effect carbohydr exercis perform patient muscl phosphofructokinas defici perform cycl exercis condit differ avail substrat overnight fast infus glucos triglycerid heparin kilogram bodi weight overnight fast compar fast infus triglycerid heparin glucos infus lower plasma level free fatti acid keton reduc maxim work capac percent lower maxim oxygen consumpt percent glucos increas relat intens submaxim exercis higher heart rate workload exercis maxim cardiac output oxygen deliveri affect vari substrat avail maxim system arterioven oxygen differ signific lower glucos infus se ml decilit fast ml decilit infus triglycerid heparin ml decilit conclus muscl phosphofructokinas defici oxid capac muscl capac aerob exercis vari avail bloodborn fuel glucos infus lower exercis toler inhibit lipolysi depriv muscl oxid substrat plasma free fatti acid keton impair capac work muscl extract oxygen lower maxim oxygen consumpt"
"incid advers event neglig hospit patient result harvard medic practic studi background part interdisciplinari studi medic injuri malpractic litig estim incid advers event defin injuri caus medic manag subgroup injuri result neglig substandard care method review random select record random select acut care nonpsychiatr hospit york state develop popul estim injuri comput rate age sex patient specialti physician result advers event occur percent hospit percent confid interv percent advers event due neglig percent confid interv percent advers event gave rise disabl month percent caus perman disabl injuri percent led death percentag advers event attribut neglig increas categori sever injuri wald test chi weight total estim patient discharg york hospit advers event advers event involv neglig rate advers event rose age percentag advers event due neglig mark higher elder signific differ rate advers event categori clinic specialti differ percentag due neglig conclus substanti amount injuri patient medic manag injuri result substandard care"
"psychometr descript perspect ill impact life span articl describ develop instrument quantifi ill life sampl compris women age alumna master program nurs submit inform ill experienc decad life time period rate multidimension durat discomfort interfer threat life reflect impact condit decad decad impact comput general decad magnitud rate increas age indic greater diseas impact interrat reliabl intern consist reliabl scale high evid construct valid includ substanti differ specif ill condit correl hospit histori health rate cluster analysi pattern decad distinct pattern emerg subject group"
"benign biliari strictur treatment percutan cholangioplasti result percutan balloon cholangioplasti patient benign biliari strictur compar publish radiolog surgic seri determin strictur locat relat therapeut success patient undergo percutan surgic therapi treatment consid success anatom evid recurr strictur surgeri follow month treatment success intrahepat zone strictur extrahepaticextrapancreat zone strictur intrapancreat zone strictur bilienter anastomot zone strictur restenosi occur patient cholangioplasti ultim success patient redil stent placement basi result publish radiolog surgic seri author cholangioplasti treatment choic zone strictur effect surgeri zone strictur patient zone strictur concomit portal hypertens histori multipl previous biliari surgic procedur consid good candid cholangioplasti zone strictur treat surgic percutan"
"domin negat regul mous alphafetoprotein gene adult liver transcript mous alphafetoprotein gene activ develop fetal liver gut repress tissu short birth germlin transform mice cisact element identifi upstream transcript initi site alphafetoprotein gene respons repress gene adult liver negat element act repressor positiondepend manner"
"hot spot growth hormon gene delet homolog region alu repeat famili growth hormon defici type autosom recess diseas caus delet growth hormon gh allel ten patient heterogen geograph origin show differ restrict fragment length polymorph haplotyp nondelet region flank gh suggest delet aros independ unequ recombin event deoxyribonucl acid dna sampl ten patient show crossov occur homolog base pair bp segment flank gh dna sampl patient crossov occur bp segment flank gh bp repeat homolog alu repeat frequent site recombin adjac gh involv recombin event studi result suggest length degre dna sequenc homolog import defin recombin site result gh delet"
"methylationsensit sequencespecif dna bind myc basic region function myc oncoprotein role cell growth control unclear basic region myc structur relat basic motif helixloophelix hlh leucin zipper protein provid sequencespecif dna bind function myc basic region test abil bind dna attach hlh dimer interfac enhanc bind factor dimer chimer protein term specif bound box element ggccacgtgacc recogn hlh protein manner depend integr myc basic motif methyl core cpg box recognit site specif inhibit bind hlh protein express dna bind mutant suppress abil myc cooper ras rat embryo fibroblast transform assay suggest dna recognit specif relat myc vivo"
"death function outcom spontan intracerebr hemorrhag prospect studi case multivari analysi death function status end point prospect analyz outcom month spontan intracerebr hemorrhag patient admit acutecar stroke unit day stroke seventi patient die satisfactori outcom poor function outcom earli day surviv correl morpholog paramet initi comput tomogram hemorrhag size midlin shift intraventricular spread hemorrhag month surviv correl age logist regress found independ predictor satisfactori outcom month age hemorrhag size intraventricular spread hemorrhag limb paresi communic disord age import predictor"
"mild hypotherm intervent grade ischem stress rat investig effect mild degre postischem hypothermia hippocamp neuron damag rat function durat forebrain ischemia temperatur durat investig normotherm group ischemia minut hypotherm group ischemia minut immedi lower mainten rectal temperatur degre hour day ischem insult rat sacrif brain prepar histolog analysi percentag necrot neuron total neuron popul select ca sector hippocampus determin signific decreas percentag necrot neuron central versus versus area ca sector hippocampus versus minut hypotherm group compar minut normotherm group contrast differ detect area hippocampus minut normotherm minut hypotherm group data mild postischem bodi hypothermia amelior neuron surviv ischemia minut minut"
"increas microvascular permeabl vivo respons intraderm inject neutrophilactiv protein nap rabbit skin neutrophilactiv protein nap nhtermin process form plateletreleas product beta thromboglobulin beta tg purifi homogen stimul human blood leukocyt presenc vasodil substanc pge cgrp picomolar pmol amount nap induc neutrophil accumul plasma leakag intraderm inject rabbit skin longer form beta tg connect tissueactiv peptid iii ctapiii effect napinduc increas microvascular permeabl neutrophil depend fast onset halflif minut compar previous report structuralrel neutrophilactiv proteininterleukin napil nap show lower potenc protein provok skin reactiv find platelet releas product elicit neutrophilmedi inflamm narrow gap thrombot event inflammatori disord"
"somatostatin analogu treatment inhibit postresect adapt small bowel rat postresect hyperplasia phenomenon residu small bowel increas size absorpt capac segment enterectomi experi studi effect somatostatin analogu therapi develop structur paramet postresect hyperplasia rat subject proxim small bowel resect octreotid acetatetr rat fail develop increas villus height micron relat salinetr rat micron augment residu intestin weight signific impair analoguetr rat versus mgcm conclud somatostatin analogu treatment earli postop period impair growth residu bowel rat find rais concern drug postop patient undergon massiv small bowel resect process postresect adapt critic susten enter nutrit"
"prospect random trial biofragment anastomosi ring bar investig group random trial undertaken compar biofragment anastomot ring bar convent intraperiton colorect anastomot techniqu patient random scheme bar versus sutur bar versus stapl anastomosi patient enter studi patient sutur anastomosi patient stapl anastomosi bar comparison bar combin sutur stapl control reveal signific differ wound complic abscess rate bleed anastomot leak ileus obstruct death differ return bowel function return normal diet hospit stay intraop difficulti occur bar patient signific higher sutur stapl anastomos occurr problem advers effect outcom data suggest bar safe satisfactori altern sutur stapl colorect anastomos"
"laparoscop guid cholecystectomi cholecystectomi remain effect form therapi patient symptomat cholelithiasi altern method gallbladd remov laparoscop guid cholecystectomi attempt patient patient requir convers laparoscop procedur open laparotomi reason discoveri pancreat malign patient extens adhes presenc aberr accessori hepat duct common hepat duct injuri avuls cystic duct ductal injuri occur earli phase clinic program patient undergo laparoscop cholecystectomi discharg hour surgeri return normal activ week laparoscop guid cholecystectomi offer number advantag patient care signific reduct health care expens gallbladd diseas train laparoscop surgeri order avoid oper complic"
"year experi splenectomi gaucher diseas gaucher diseas inherit metabol disord caus defect activ acid betaglucosidas result accumul glucosyl ceramideladen macrophag liver bone spleen splenectomi prefer treatment patient gaucher diseas develop massiv splenomegali accompani hypersplen mechan pressur symptom chart patient gaucher diseas undergo splenectomi institut januari decemb analyz determin short longterm result procedur thirti patient total splenectomi patient partial splenectomi postop death total splenectomi patient postop complic eleven patient present acceler bone diseas total splenectomi follow month patient partial splenectomi follow month develop progress bone diseas patient die surgeri death due malign diseas occur patient total splenectomi result largest report seri splenectomi gaucher diseas confirm total partial splenectomi perform minim morbid mortal total splenectomi accompani aggress bone diseas predisposit malign prospect random trial substanti partial splenectomi treatment choic splenomegali gaucher diseas"
"growth veloc sudden infant death weight veloc infant die sudden infant death syndrom sid compar control match sex birth weight type feed found sid infant gain weight slowli differ signific infant breast fed week estim growth veloc breast fed infant period growth centil expect differ predict babi die sid frequent episod poor growth infant die"
"measur height made health visitor suffici accur routin screen growth find measur height made health visitor suffici accur routin screen children carri interobserv intraobserv reliabl studi height measur made group children age year age year set health visitor microtois wall chart measur compar made train auxologist harpenden stadiomet singl assess height piec equip gave accur result child age year height measur microtois cm true height expect probabl lie cm cm age year measur cm child true height expect lie cm cm narrowest confid interv growth rate year achiev microtois measur conclud measur made health visitor suffici accur routin screen height measur calcul height veloc improv structur train"
"nocturn faecal soil anal masturb case late onset faecal soil result anal masturb children mental handicap psychot studi role soil aid young person famili avoid separ matur highlight suggest associ anal masturb resist nocturn soil unrecognis"
"system idiopath fibrosi cell receptor gene rearrang case system idiopath fibrosi analyz southern blot probe immunoglobulin heavi chain cell receptor gene year man present bilater neck swell develop lower back pain find comput tomograph scan consist idiopath retroperiton fibrosi biopsi specimen neck lesion show morpholog characterist typic idiopath fibros cervic immunophenotyp lesion reveal polymorph lymphoid popul molecular analysi probe immunoglobulin cell receptor gene disclos germlin dna pattern immunoglobulin gene rearrang pattern cell receptor gene"
"persist chronic constip children biofeedback treatment investig efficaci biofeedback treatment evalu anorect factor respons persist chronic constip encopresi group children abnorm contract pelvic floor strain persist chronic constip encopresi convent treatment children unsuccess learn relax pelvic floor strain biofeedback treatment patient contract pelvic floor follow success biofeedback treatment recov twenti children relax pelvic floor follow recov recov chronic constip nonrecov patient learn relax pelvic floor signific decreas rectal anal respons rectal distens compar recov patient initi follow anorect manometr studi psycholog factor social compet behavior problem respons recoveri nonrecoveri chronic constip encopresi"
"clinic physiolog studi anal sphincter ileal pouch preileostomi closur month closur loop ileostomi spontan evolut pouch anal function absorpt featur assess patient underw proctocolectomi ileal pouch anastomosi conserv rectal muscular cuff patient studi preileostomi closur month closur protect loop ileostomi stool frequenc ident month sem day sixti percent patient month patient month defec time night stool weight steatorrhea decreas signific month closur loop ileostomi rest anal pressur remain unchang month closur loop ileostomi cm ho maximum squeez anal pressur increas signific month rectoan inhibitori reflex absent period maximum pouch capac increas signific month ml maximum infus volum salin contin test signific month percentag evacu reservoir volum ileal contract reservoir increas signific month conclus patient ileoan anastomosi pouch reservoir closur loop ileostomi spontan modif anal pouch paramet"
"kupffer cell activ endotheli cell damag storag rat liver effect reperfus reperfus injuri character loss endotheli cell viabil occur cold ischem storag liver transplant surgeri ultrastructur store rat liver examin scan transmiss electron microscopi increas time storag eurocollin solut hr min reperfus degre sequenc structur alter observ involv endotheli kupffer cell widen endotheli fenestr occur hr progress hr retract cellular process ball round sinusoid denud ultrastructur derang consist loss cell viabil kupffer cell exhibit progress round ruffl cell surfac polar wormlik densiti vacuol degranul similar time contrast structur parenchym fatstor cell undisturb cold storag reperfus alter endotheli kupffer cell studi function time reperfus hr storag endotheli cell show retract cytoplasm reperfus progress quick loss viabil denud reperfus kupffer cell activ ruffl degranul reperfus slower occur deterior endotheli cell liver store eurocollin solut compar liver store univers wisconsin cold storag solut improv preserv medium transplant univers wisconsin solut provid preserv endotheli structur mark reduc parenchym cell bleb swell reperfus univers wisconsin solut reduc kupffer cell activ releas lysosom enzym conclus endotheli cell deterior kupffer cell activ occur increas time cold ischem storag reperfus rat liver contribut pathophysiolog graft failur caus reperfusionmedi storag injuri"
"interpleur analgesia publish erratum heart lung jul postop pain relief patient comfort facilit ventil ambul opioid analgesia intraven intramuscular intraspin ineffect respiratori depress administr local anesthet pleural space techniqu provid analgesia rapid onset long durat analgesia accomplish caus respiratori depress sedat opioid innov analges method select critic ill patient present surgeri intens care set critic care nurs encount patient receiv local anesthet administ interpleur cathet"
"develop special care unit chronic critic ill patient intens care unit icus recogn expens servic provid hospit icus grow popul patient stay extens prolong complic chronic health condit exacerb critic ill patient chronic critic ill cost hospit term actual dollar term burden care nurs physician articl describ creation special care unit scu design specif meet chronic critic ill patient scu environ compos physic design accommod limit technolog care aim famili involv rehabilit case manag practic model share govern manag model structur contrast tradit icu environ includ physic layout high technolog close monitor patient primari nurs deliveri system bureaucrat manag model research project compar effect scu effect tradit icus nurs patient outcom"
"treatment strategi shock oxygen transport measur shock tradit categor shock result hemorrhag primari cardiac failur central nervous system failur trauma sepsi therapeut principl develop etiolog type end point therapi includ optim pulmonari capillari wedg pressur cardiac output blood pressur urin output recent investig agre common denomin shock syndrom reduct amount oxygen consum cell logic therapeut approach increas oxygen deliveri support increas metabol demand cell end point resuscit optim oxygen deliveri oxygen consumpt variabl easili calcul data obtain pulmonari arteri cathet laboratori measur physician nurs care critic ill patient understand rational oxygen transport calcul method manipul oxygen deliveri simpl explan principl includ import hemoglobin cardiac index percent satur hemoglobin suggest treatment strategi present"
"flowvolum characterist pulmonari circul isol ferret canin lung valid method assess determin vascular volum pulmonari circul left atrial pressur pla constant mmhg flow rais step physiolog rang vascular volum delta increment determin opposit perfus system reservoir weight increas lung weight level pulmonari arteri left atrial cannula simultan occlud vascular pressur equilibr static pressur ps equal complianceweight averag pressur circul occlus hypoxia inspir po torr ferret lung intens constrict arteri extraalveolar vessel effect slope ps relationship interpret repres resist downstream complianc control mmhgmlmin hypoxia psaxi intercept increas mmhg indic modest increas effect backpressur flow downstream compliant region complianc circul obtain slope relationship delta ps unaffect hypoxia control mlmmhg hypoxia contrast histamin canin lung constrict vein caus slope ps relationship increas mmhgmlmin complianc decreas mlmmhg"
"region ho concentr rat brain hyperox convuls toxic central nervous system cns result enhanc generat reactiv speci superoxid ho high po studi measur ho product region rat brain convuls induc hyperbar hyperoxia hbo ho concentr determin vivo method base hodepend declin catalas activ presenc irrevers inhibitor compound aminotriazol region catalas activ brain rang mumol ominmicrogram dna cerebellum medullapon presenc aminotriazol catalas activ declin hboinduc convuls normox valu rate inactiv catalas predict averag steadyst valu ho concentr brain structur estim ho concentr hbo vari pm cerebellum posterior subcortex repres increas time normox valu find suggest ho import mediat select neuron vulner cns toxic"
"transfect stabl transform adult mous schwann cell sv larg antigen gene cultur schwann cell deriv adult mous dorsal root ganglia peripher nerv transfect plasmid sv larg antigen gene coloni stabl transform obtain expand reclon transfect cell line design ms express sv larg antigen show continu cell growth doubl time hour ms cell distinct schwann cell phenotyp protein laminin cyclic nucleotid phosphodiesteras protein shown immunofluoresc microscopi ms cell expos dibutyryl cyclic adenosinemonophosph dbc amp extend long bipolar process tenfold longer untreat ms cell frequent form whorl align similar palisad format organoid pattern observ human schwannoma neurofibroma result suggest transform schwann cell model analyz regulatori mechan schwann cell neuronschwann cell interact experiment schwann cell neoplasm vitro"
"acut experiment allerg encephalomyel sjl mice induc synthet peptid myelin proteolipid protein clinic histolog ultrastructur characterist acut experiment allerg encephalomyel eae induc sensit synthet peptid mous myelin proteolipid protein plp residu hclgkwlghpdkf studi sjl mice group mice immun nmol peptid kill day sensit moribund begin day mice show sign eae diseas progress rapid paralysi central nervous system cns inflamm edema gliosi demyelin found mice kill day white matter lesion area correl clinic score time mice kill peripher nerv root cauda equina lesion rang studi sever clinic histolog diseas plp peptid dose ten mice immun nmol mice smaller dose synthet peptid mous myelin basic protein mbp show clinic eae mice small number cns lesion indistinguish plp peptidesensit mice find demonstr immun sjl mice plp peptid produc diseas clinic morpholog featur cns tissu plp mbp mbp peptideinduc acut eae plp major encephalitogen immun reaction epitop myelin protein induc ident pattern injuri cns"
"reliabl clinic electromyograph examin tendon reflex reliabl clinic examin tendon reflex examin studi interobserv agreement twenti patient examin neurologist brisk tendon reflex arm leg score point scale examin reflex observ disagre scale unit disagr presenc asymmetri occur reflex pair observ judg reflex pair symmetr observ found asymmetri scale unit experi clinic observ appar asymmetr quadricep reflex compar measur surfac electromyographi signific semilogarithm relationship found clinic score measur reflex amplitud measur reflex asymmetri agre clinic asymmetri magnitud left amplitud differ correl magnitud clinic observ asymmetri bedsid examin tendon reflex subject interobserv disagr"
"treatment advancedstag massiv mediastin hodgkin diseas case combin modal treatment initi seri patient treat nation cancer institut nci mechlorethamin vincristin procarbazin prednison mopp chemotherapi hodgkin diseas review present chest radiograph patient show patient mediastin mass greater greatest posteroanterior chest diamet patient stage iib diseas stage iii iv diseas thirti patient achiev complet remiss mopp chemotherapi fourteen complet respond relaps achiev durabl remiss respons subsequ therapi thirti patient die induct failur relaps patient complet respond remiss median follow year rang surviv group diseasefre surviv complet respond subset patient receiv mantl radiat therapi maxim respons mopp patient fail achiev complet remiss complet respond relaps contrast patient achiev complet respons mopp relaps mopp prospect compar mopp radiat therapi treatment advancedstag massiv mediastin hodgkin diseas seri retrospect analysi show signific differ diseasefre surviv favor combin modal treatment differ tumor mortal mopptreat combin modalitytr patient signific surviv differ patient treat mopp treat combin modal therapi signific mortal relat late complic combin modal treatment"
"variant arterioven fistula wall dural sinus result combin surgic endovascular therapi dural arterioven av fistula thought acquir lesion form area thrombosi sinus sinus remain complet thrombos venous drainag lesion occur cortic vein sinus open venous drainag involv sinus patient dural av fistula evalu past year uniqu type dural av fistula superior sagitt transvers straight sinus cortic venous drainag occur patent involv sinus fistula locat wall patent dural sinus outflow involv sinus variant dural av fistula put patient risk hemorrhag neurolog dysfunct caus venous hypertens patient present hemorrhag progress neurolog dysfunct seizur bruit headach combin surgic endovascular techniqu close fistula preserv flow sinus"
"manag hemorrhag complic preoper embol arterioven malform endovascular embol procedur undergon dramat evolut improv recent year advanc controversi remain optim role procedur treat cerebr arterioven malform avm purpos presurg adjunct primari therapi controversi risk fragment disciplin broader effort improv manag cerebrovascular disord author report case lifethreaten hemorrhag occur stage invas therapi avm illustr unifi team approach optim patient care patient underw embol procedur polyvinyl alcohol particl case occlus proxim feed vessel platinum microcoil case attempt detach endovascular balloon patient cathet penetr subarachnoid space result subarachnoid hemorrhag patient suffer ruptur larg feed vessel balloon inflat final patient sustain intracrani hemorrhag hour hour day embol patient underw emerg craniotomi time complic case underscor advantag interdisciplinari manag optim decisionmak provid expediti care lifethreaten complic develop"
"dorsal root ganglionectomi fail back surgeri syndrom year follow studi dorsal root ganglionectomi suggest method treatment chronic intract radicular pain theoret advantag dorsal rhizotomi interrupt ventral root affer indic procedur patient persist pain lumbosacr spine surgeri establish longterm result report infrequ publish seri follow period month author review experi seri patient fail back surgeri syndrom dorsal root ganglionectomi perform patient select basi clinic present diagnost root block suggest monoradicular pain syndrom follow data obtain year dorsal root ganglionectomi follow interview assess outcom conduct disinterest parti treatment success sustain relief pain patient satisfact result record patient year surgeri year equivoc success relief clearcut patient satisfact record patient year postop improv activ daili live record minor patient loss sensori motor function report frequent patient minor patient reduc elimin analges intak result suggest dorsal root ganglionectomi limit role manag fail back surgeri syndrom method select patient receiv procedur refin altern approach consid"
"intraop monitor facial nerv decompress surgeri hemifaci spasm consecut patient intraop electromyograph emg record made facial muscl microvascular decompress hemifaci spasm patient record obtain technic reason patient abnorm remain patient abnorm respons resolv decompress resolv immedi time decompress fail resolv patient reliev hemifaci spasm patient abnorm resolv time decompress precis intraop correl decompress nerv disappear abnorm emg respons case guid decompress vessel result confirm find moller jannetta support techniqu intraop monitor facial nerv decompress procedur provid strong circumstanti evid vascular crosscompress import etiolog factor hemifaci spasm"
"scalpel vasectomi refin method deliv vas deferen vasectomi develop china method elimin scalpel result fewer hematoma infect leav smaller wound convent techniqu extracutan fixat ring clamp encircl firm secur vas penetr skin sharp curv hemostat punctur dilat scrotal skin vas sheath vas deliv clean occlud surgeon prefer techniqu contralater vas deliv open punctur wound contract mm visibl man requir sutur closur report incid hematoma men china hematoma infect identifi procedur perform surgeon unit state oper time china unit state procedur rang minut disadvantag techniqu hand train number case gain profici advantag surgeon patient enhanc popular vasectomi"
"elev petrous bone caus hyperplasia occipit bone present hemifaci spasm diagnost valu magnet reson imag dimension comput tomograph imag bone anomali case elev petrous bone due hyperplasia occipit bone present hemifaci spasm report year man sought treatment twitch buccal muscl side progress rapid sever week onset anatom detail petrous occipit bone delin comput tomograph scan bone window level detail brain stem shown magnet reson imag bone anomali display realist dimension comput tomograph reconstruct faith represent structur radiolog studi mandatori prepar surgic plan complic bone anomali"
"saccular aneurysm distal anterior cerebr arteri report seri consecut patient aneurysm distal anterior cerebr arteri aca patient aneurysm aneurysm aneurysm thirti patient ruptur distal aca aneurysm patient size aneurysm mm diamet mm larger mm eighteen patient multipl aneurysm distal aca aneurysm respons subarachnoid hemorrhag thirti patient underw direct surgeri excel outcom month surgeri treatment patient distal aca aneurysm technic difficult broad neck configur coexist aneurysm present studi emphas distal aca aneurysm tend bleed irrespect size excel outcom obtain direct surgeri"
"periton closur closur cesarean periton closur time cesarean birth evalu prospect hundr forti women undergo low transvers cesarean pfannenstiel skin incis assign group peritoneum open peritoneum close sem surgic time open group minut signific close group minut postop differ group incid wound infect dehisc endometr ileus length hospit stay studi suggest leav pariet peritoneum unsutur accept manag patient cesarean deliveri"
"calmodulin delet central helix function replac nativ protein yeast cell delet glu glu glu serglugluglu residu central helix mammalian calmodulin result time decreas appar vitro affin calmodulindepend enzym base vitro experi difficult estim delet affect vivo cellular function yeast saccharomyc cerevisia requir calmodulin growth excel system evalu delet protein vivo base abil restor normal growth characterist yeast cell mammalian calmodulin function ident yeast protein evalu effect delet residu central helix sequenc encod delet protein unalt control sequenc introduc yeast shuttl vector express control yeast calmodulin promot delet control calmodulin produc level similar observ yeast protein complet restor normal growth characterist result suggest region delet central helix critic activ yeast calmodulin target requir cell growth divis twist shorten motion delet central helix alter signific spatial relationship lobe calmodulin abil delet calmodulin restor complet normal growth characterist yeast cell suggest lobe delet protein appropri posit calmodulintarget complex consist hypothesi central helix calmodulin analog flexibl tether rigid connector lobe molecul"
"noncatalyt src homolog region segment abl tyrosin kinas bind tyrosinephosphoryl cellular protein high affin protein implic regul cell prolifer common noncatalyt domain src homolog region sh bacteri express sh domain abl proteintyrosin kinas evalu abil domain bind cellular protein ablsh specif bound number tyrosinephosphoryl protein cell transform tyrosin kinas oncogen filterbind assay subset protein solut sh probe bound exclus tyrosinephosphoryl protein bind elimin dephosphoryl cell protein free phosphotyrosin partial disrupt sh bind suggest phosphotyrosin direct involv bind interact result demonstr sh domain suffici confer direct highaffin phosphotyrosinedepend bind protein suggest general role sh domain cellular signal pathway"
"nasal augment split calvari graft orient studi report experi autogen split calvari graft nasal augment orient percent patient procedur perform local anesthesia outpati set total oper time harvest split calvari graft rang minut minut patient rang age year year follow month year averag year intraop discomfort uniform low toler local anesthesia complic rate percent case minor seromahematoma format bonegraft donor site treat aspir recipientsit complic case complet bone resorpt occur dens fibrot nose preexist septal perfor case overcorrect success rasp year easi access beneath scalp split calvari graft nose type nasal augment techniqu offer practic altern alloplast materi"
"donor seroposit prednisolon therapi risk factor cytomegalovirus infect diseas cyclosporintr renal allograft recipi attempt assess import blood transfus donor seroposit prednisolon therapi risk factor cytomegalovirus infect cyclosporintr renal allograft recipi primari infect diagnos patient cent recurr infect patient cent receipt bank blood unselect donor transplant increas incid primari infect transfus patient kidney donor seroposit mainten prednisolon addit cyclosporin increas incid primari recurr infect cytomegalovirus infect clinic mild presum bacteri pneumonia occur patient recurr cytomegalovirus infect absenc sever cytomegalovirus diseas reflect minim prednisolon match seroneg donor seroneg recipi unjustifi cyclosporintr renal transplant patient"
"abdomin wall complic reoper surgeri abdomin wall sourc signific problem patient undergo multipl abdomin oper orient sequenti incis care consid avoid compromis abdomin wall blood suppli result acut dehisc delay ventral hernia complic infect problem multipli oper abdomin wall complic rang simpl wound infect necrot fasciiti manag requir simpl drainag infect entail extens debrid necrot process multipli oper abdomin wall requir reconstruct lost fascia polypropylen mesh employ safe effect purpos"
"reoper biliari strictur benign bile duct strictur follow intraop injuri recogn ideal reconstruct entail mucosamucosa anastomosi tension stent tube maintain patenc postop period mortal rate reoper bile duct reconstruct patient cirrhot approxim success rate averag prevent oper injuri cholangiographi care dissect remov gallbladd fundus downward treatment"
"reoper intraabdomin abscess reoper procedur patient abscess septic complic remain difficult manag problem general surgeri diagnosi intraabdomin septic complic great enhanc year remain imperfect requir clinic judgment transcend object method surgic drainag remain mainstay care patient postop intraabdomin abscess"
"perform cesarean section absorb stapl stapl techniqu gain wide accept general surgeri common obstetr  surgic corpor introduc stapl devic suitabl cesarean section copolym stapl blend polylact polyglycol acid maintain tensil strength heal occur absorb produc granul tissu benefit includ minim trauma tissu reduc oper time blood loss postop morbid juli februari patient undergo low transvers cervic cesarean section random group uterin incis perform routin manner group uterin incis cut stapl stapler preoper manag intraop techniqu postop surveil similar group uterin incis assess pelvic sonographi postpartum period statist analysi perform fisher exact test chisquar analysi group compar age race pariti gestat age primari diagnosi length oper procedur signific shorter stapl group patient statist signific decreas incid uterin incis lacer paramet signific group stapl uterin incis visibl ultrasonographi patient stapl group postpartum period sutur group stapl uterin incis accept altern tradit sutur techniqu visual incis postpartum period"
"correl apach ii score drainag techniqu outcom postop intraabdomin abscess apach ii score stratifi retrospect sever ill patient postop undergo drainag intraabdomin abscess method initi abscess drainag percutan oper select attend physician group patient initi drainag perform percutan versus oper similar respect age sex abscess locat import sever ill assess apach ii score calcul day abscess drainag mortal rate cent patient cent patient apach ii score die compar cent apach ii equal cent patient apach ii equal undergo percutan drainag surviv compar cent patient underw surgic drainag procedur chisquar analysi demonstr independ outcom drainag techniqu outcom depend sever ill paradox attract percutan techniqu abscess drainag ill patient seri statist improv chanc surviv note surgic treatment recommend object sever score system assess result treatment intraabdomin infect surgic treatment avoid patient consid ill"
"death smother investig case report detail extens death investig result led certif suicid manner death smother pillow addit assist person mechan devic death chronic mental ill person approv profession treatment major investig aspect case deathscen observ bodi elimin possibl homicid studi analysi subject psychiatr ill reason uncommon report death categori discuss"
"death notif famili notif sudden unexpect violent death major respons law enforc medic examin coron offic report review discuss process procedur util death notif suggest accomplish difficult task effect"
"longterm result ionescushiley valv tricuspid posit retrospect analysi longterm result ionescushiley pericardi bioprosthesi tricuspid posit carri patient men women procedur ten tricuspid valv replac remaind combin valv procedur follow year rang year age patient year rang year seventi patient suffer tricuspid valv dysfunct rheumat heart diseas postop death day give mortal rate actuari surviv year survivor function class ii primari tissu valv failur tricuspid posit occur patient year implant requir reoper patient bioprosthet tricuspid valv endocard develop incid thromboembol complic conclud ionescushiley pericardi bioprosthesi satisfactori prosthesi tricuspid posit patient acquir valvar dysfunct"
"dosag haloperidol schizophrenia eighti newli admit inpati schizophrenia random receiv mg oral haloperidol treat doubleblind condit week acut symptom remit sooner surviv analysi show differ treatment side effect minim treatment group differ side effect group result suggest dosag higher mg haloperidol patient addit benefici effect treatment acut exacerb schizophrenia"
"disord colorect motil intract constip hysterectomi colorect anal sphincter motil electrophysiolog investig women profound constip hysterectomi compar asymptomat group control subject twelv patient complain signific urinari symptom differ motor function anal sphincter detect latenc pudendoan reflex unchang hysterectomi proctometrogram demonstr signific increas rectal volum complianc hysterectomi group deficit rectal sensori function basal state signific proximaldist sigmoid colon motil gradient exist control group stimul prostigmin gradient enhanc control group paradox revers hysterectom patient constitut function obstruct denerv supersensit demonstr patient test carbachol provoc control subject find suggest dysfunct autonom innerv hindgut patient undergon hysterectomi result sever constip"
"emerg saphen vein graft stent acut occlus percutan translumin coronari angioplasti report describ initi unit state emerg intravascular stent treatment acut coronari occlus complic elect saphen vein graft angioplasti case add support role balloon expand stent effect bail devic fail angioplasti"
"altern oxygen deliveri system infant children postanaesthesia care unit random control trial compar complianc blow oxygen method standard face mask children recov anaesthesia rate face mask reject appli infant children pacu compar propos hose method efficaci hose method oxygen supplement children low high risk develop postop hypoxaemia compar face mask nellcor puls oximet infant children age yr rang mo yr continu monitor min arriv pacu patient random receiv oxygen supplement face mask propos hose method result show greater cent reject face mask contrast cent complianc hose method sao measur min supplement hose signific higher sao measur obtain room air arriv pacu patient preexist cardiopulmonari diseas cent incid arteri oxygen desatur arriv pacu versus cent patient preexist diseas conclud hose high patient complianc effect pacu increas sao children low high risk develop postop hypoxaemia"
"oxygen debt metabol acidemia quantit predictor mortal sever ischem insult hemorrhag shock background method experiment canin model hemorrhag hypovolem shock oxygen debt metabol consequ lactic acidemia metabol base deficit independ variabl predict probabl death result lactic acidemia metabol base deficit compar convent hemodynam variabl bp cardiac output qt predictor outcom shown superior modifi kaplanmei probabl statist ld oxygen debt shown mlkg mmol lactat mmol base excess comparison made abil qt bp shed blood lactat predict oxygen debt conclus singlevari predictor show highest explain variabl combin predict lactat superior regress comput oxygen debt estim accur actual level oxygen debt lactat valu obtain hemorrhag hypovolemia serial determin time increas biochem variabl oxygen debt baselin estim rate oxygen debt accumul time remain ld reach indic sever total bodi ischemia result hemorrhag shock"
"longterm postthoracotomi pain pain questionnair evalu preval function signific longterm postthoracotomi pain data patient month postsurgeri analyz thirti patient percent median follow month persist pain pain free median month postthoracotomi pain report patient percent year surgeri patient percent year percent year ten patient percent greater year postthoracotomi pain intens low patient state pain slight moder interf live patient suffici sever chronic pain requir daili analges nerv block relax therapi acupunctur referr pain clinic conclud longterm chest wall pain common postthoracotomi general sever small proport patient experi persist moder disabl pain"
"stressinduc adrenocorticotropin secret diurnal respons decreas stress depend corticosteron test diurnal rhythm stress respons depend corticosteron mediat negat feedback respons intact sham adrenalectom adx rat restraint minut ip inject salin morn pm compar sham adx rat acth respons restraint stress larger intact rat result fast negat feedback due rate rise stress pm delay negat feedback due high basal concentr stress pm diurnal pattern stress respons depend relat respons restraint ip inject found adx rat determin lack respons adx rat pm stress due loss sensit endogen secretagogu adx rat crf arginin vasopressin avp anesthet ether min restraint pm pituitari respond exogen secretagogu find pm plasma acth concentr adx rat decreas substanti period restraint lack mediat negat feedback pm adx rat restrain min stress ether min acth concentr ether suggest pituitari adx rat respond exogen crf avp stress addit stress ether exposur longer stimul endogen crf avp releas min restraint time day min restraint pm relationship acth posit negat provid evid ongo mediat negat feedback sham rat mechan respons decreas acth secret adx rat occur sham rat result conclud diurnal rhythm stress respons pm adx rat decreas plasma acth stress larg independ"
"militari famili syndrom revisit number concern rais high level psychopatholog militari children author standard psychopatholog rate scale survey twelveyear children militari parent parent result children symptom report teacher rate children children symptom level level consist nation norm contrast parent mother rate children signific higher nation norm parent rate symptom parent symptom report show stronger relationship life stressor affect child children teacher report result suggest parent report children symptom mediat effect militari life stressor parent stressor necessarili result higher symptom children result support notion level psychopatholog great increas children militari parent studi militari famili address effect rank socioeconom status hous current impact life stressor parent children order avoid draw erron conclus part militari communiti"
"outpati orthognath surgeri criteria review case year period orthognath procedur perform outpati environ procedur perform includ horizont mandibular osteotomi rapid palat expans bilater sagitt split osteotomi posterior anterior maxillari osteotomi le fort osteotomi fourteen patient subsequ admit hospit observ full inpati care rate admiss vari procedur length anesthesia statist relat frequenc admiss patient select criteria facil review"
"mechan vein graft atherosclerosi ldl metabol endotheli actin reorgan explor effect arteri hemodynam endotheli cell morpholog lowdens lipoprotein metabol human saphen vein segment harvest tissu donor arteri pulsatil perfus system impos physiolog pressur flow hour saphen vein companion control femor arteri segment venous perfus apparatus employ perfus control saphen vein segment period time calcul fluid shear wall tensil stress perform relat induc endotheli cell geometri cytoskelet actin organ incorpor degrad local intact lowdens lipoprotein vessel wall result compar nativ arteri vein hour exposur test saphen vein arteri hemodynam induc signific increas endotheli cell lumin surfac area perimet independ align flow disassembl dens peripher band actin concomit assembl stress fiber fourfold elev undegrad lowdens lipoprotein content local primarili subendotheli intima exact mechan result uncertain focal accumul intramur lowdens lipoprotein relat loss normal barrier function endotheli cell enlarg accompani transient cytoskelet reorgan adapt arteri flow"
"senesc nickeltransform cell chromosom epigenet control transfer normal chines hamster chromosom carri mous donor cell line nickeltransform chines hamster cell line xq chromosom delet result senescens previous immort cell earli passag acx donor cell hamster chromosom high activ induc senesc coloni obtain transfer nickeltransform cell senesc reduc chines hamster chromosom transfer passag cell full senesc activ intact hamster chromosom restor treatment donor mous cell azacytidin induc demethyl dna result suggest senesc gene gene locat chines hamster chromosom regul dna methyl escap senesc possibl loss tumor suppressor gene activ occur epigenet mechan"
"laparoscop cholecystectomi report case initi experi patient laparoscop cholecystectomi shown numer advantag open cholecystectomi intraop blood loss postop pain medic minim patient discharg hour resum normal activ day aesthet aspect obvious advantag laparoscop procedur avoid disfigur abdomin scar previous abdomin surgeri contraind attempt procedur base experi laparoscop cholecystectomi safe patient candid open cholecystectomi includ elder obes acut gangren cholecyst"
"studi influenc left bundl branch block signalaverag electrocardiogram qualit quantit analysi studi influenc left bundl branch block lbbb signalaverag electrocardiogram saecg quantit qualit analys saecg paramet undertaken patient electrocardiograph evid intrins lbbb patient normal surfac qrs durat msec underw ventricular pacinginduc lbbb assum pace ventricular apex suitabl model conduct defect sustain monomorph ventricular tachycardia smvt induc patient intrins lbbb patient pacinginduc lbbb util filter set hz late potenti defin total filter qrs durat greater equal msec root squar voltag termin msec rms equal microv durat signal microv las greater equal msec rms las criteria patient lbbb prolong las fragment signal termin portion filter qrs characterist patient lbbb aberr patient intrins lbbb total filter qrs durat rms las induc noninduc patient signific msec microv msec noninduc patient normal qrs durat demonstr decrement rms pacinginduc lbbb result fals posit incid late potenti pacinginduc lbbb correl similar low rms patient intrins lbbb induc smvt give rise fals posit incid late potenti standard rms las criteria result low specif posit predict paramet select analyz combin rms equal microv las greater equal msec yield statist result sensit specif total predict accuraci conclus reduct rms prolong las fragment signal termin portion filter qrs characterist lbbbabstract truncat word"
"shortterm variabl ventricular arrhythmia rapid assess drug efficaci statist criteria suppress aggrav ventricular arrhythmia defin shortterm drug test perform patient patient spontan variabl sv evalu linear regress analysi hourhour ectopi hour holter monitor respons singl oral dose disopyramid mg flecainid mg propafenon mg measur trial hour lidocain administ intraven increment dose mgmin evalu hour threshold valu ventricular arrhythmia confid limit calcul baselin record ascertain likelihood true drug effect minimum decreas hour ectopi indic arrhythmia suppress averag increas requir proarrhythm effect efficaci criteria appli shortterm test reveal drug effect contrast threshold deriv studi daili variabl employ trial negat individu determin hour arrhythmia variabl yield stringent criteria extrapol dayday spontan variat"
"prosthet valv children adolesc purpos paper present short longterm result prosthet valv replac children year period end april children age year underw valv replac aortic valv replac mitral valv replac multipl valv replac nineti percent lesion rheumat origin congenit infecti valv replac mechan valv heterograft mitral posit patient surgic mortal rate aortic valv mitral valv multipl valv replac year actuari surviv aortic valv replac mitral valv replac multipl valv replac major event includ reoper death progress myocardi failur led death sudden unexpect death thromboembol complic death subacut bacteri endocard death bleed requir transfus patient year complicationfre actuari surviv rate aortic valv replac mitral valv replac multipl valv replac respect year complicationfre surviv rate signific morbid mortal rate valv replac effort made preserv nativ valv plastic repar procedur prosthet replac mitral valv contempl data suggest heterograft insert children year age younger heterograft children year age expect valv surviv compar mechan valv complic anticoagul therapi review platelet inhibit drug satisfactori patient aortic valv replac patient mitral valv replac requir warfarin therapi warfarin patient multipl valv replac reduc risk thromboembol complic"
"improv molecular diagnost ornithin transcarbamylas defici clone cdna link ornithin transcarbamylas otc diagnost accuraci otc defici prenat carrier detect great improv linkag analysi rflpbase diagnosi limit mutat diseas report direct mutat detect pcrbase techniqu experi linkagebas diagnosi famili previous report chemic mismatch cleavag detect mutat amplifi mrna genom dna patient techniqu util prenat diagnosi primer specif amplif otc exon develop employ map delet otc gene famili primer detect alter taqi site found exon mutat otc gene lead abolit taqi site otc cdna discov mutat exon lie exon exon addit pcr product probe identifi exonspecif band southern blot map polymorph bamhi mspi site common linkag analysi inform facilit interpret alter band pattern delet case case point mutat affect restrict site util combin molecular techniqu permit accur diagnost evalu famili"
"approach diagnosi prevent treatment cytomegalovirus infect transplant infect occur solid organ transplant continu exert detriment effect patient allograft surviv search target immunosuppress regimen continu seek improv abil diagnos treat infect occur transplant viral infect general cytomegalovirus cmv infect repres area substanti progress made improv diagnost modal rapid precis identif cmv infect diseas antivir agent possess activ cmv prophylaxi treatment frequent lifethreaten diseas prophylact present agent combin develop toxic potent anticmv agent serv lessen impact cmv diseas field solid organ transplant"
"bacteri overgrowth intestin atrophi etiolog gut barrier failur rat bacteri transloc occur anim model shock trauma sepsi parenter element enter aliment bowel atrophi cecal bacteri overgrowth implic pathophysiolog bacteri transloc model defin etiolog bacteri transloc result dietari manipul rat fed elementaldefinedformula diet dfd week ad libitum random intestin decontamin nonabsorb antibiot neomycin antibiot treatment neomycin treatment signific reduc incid bacteri transloc dfd associ signific reduct number cecal gramneg bacteria loss bowel mass dfd bowel composit affect oral neomycin bacteri transloc dfd result cecal bacteri overgrowth loss physic intestin barrier due atrophi"
"arteri oxygen satur induct anaesthesia group asa patient studi determin incid hypoxaemia oxygen satur equal puls oximetri induct mask anaesthesia simpl oxygen techniqu prevent occurr survey anaesthetist major hospit ascertain techniqu method anaesthesia anaesthesia induc patient thiopenton maintain nitrous oxid isofluran group receiv oxygen nitrous oxid carrier gase group normal breath oxygen thiopenton administr oxygen nitrous oxid group receiv oxygen loss eyelash reflex spontan breath establish patient receiv posit pressur ventil spontan breath establish patient group hypoxaem compar group patient hypoxaem group thirti percent anaesthetist respond survey appli posit pressur ventil establish spontan breath apnoea prolong anaesthetist fulli preoxygen patient lung conclud avoid occurr hypoxaemia induct mask anaesthesia minimum breath preoxygen"
"randomis doubleblind studi interpleur analgesia cholecystectomi continu interpleur analgesia provid hour inject ml bupivacain adrenalin microgramsml compar placebo randomis doubleblind studi cholecystectomi patient administ intraven morphin patientcontrol analgesia devic high signific differ morphin consumpt group mg compar mg visual analogu pain score tend lower bupivacain group signific hour respiratori function measur signific group peak venous plasma bupivacain concentr sixth dose microgramsml symptom suggest local anaesthet toxic occur conclud regimen provid effect continu analgesia cholecystectomi combin administr interpleur bupivacain system morphin effect morphin postop period dose bupivacain requir optim techniqu lead signific total plasma bupivacain concentr hour"
"patient expect patientcontrol analgesia patientcontrol analgesia increas popular method postop pain relief patient worri therapi eighti asa patient age year list advantag disadvantag patientcontrol analgesia import advantag perceiv patient reduc time spent nurs give medic concern direct person contact lessen preserv control autonomi rapid onset analgesia abil titrat analgesia lack inject advantag addict machin fault minim problem preserv patientnurs contact great import ensur success postop analgesia"
"patientcontrol analgesia children report experi introduc patientcontrol analgesia royal hospit sick children glasgow twenti children techniqu orthopaed general surgeri grasebi system pump load mgkg morphin sulphat ml bolus dose mgkg ml lockout interv minut initi set dose pain sedat score respiratori rate arteri oxygen satur record age rang year method hour oper morphin requir averag microgramskghour sd pain control good sedat minim advers effect minor educ patient parent nurs essenti success safeti techniqu effect safe provid good qualiti analgesia school age children"
"clinic efficaci oraltransderm clonidin combin periop period attempt maintain stabl level alpha adrenerg agonist periop period oraltransderm clonidin dosag regimen administ random doubleblind placebocontrol studi patient undergo abdomin surgeri determin clinic efficaci high lowdos clonidin regimen sedat hemodynam paramet anesthesia analgesia lowdos clonidin group patient receiv cm clonidin transderm patch cataprestt supplement oral dose clonidin approxim microgramskg prior surgeri morn surgeri highdos clonidin group receiv cm clonidin transderm patch cataprestt oral clonidin approxim microgramskg bedtim microgramskg morn surgeri placebotr control patient receiv occlus patch activ ingredi oral placebo tablet bedtim morn surgeri preanesthet medic includ midazolam microgramskg intramuscular im anesthesia induc alfentanil microgramskg intraven iv thiopent mgkg iv vecuronium mgkg iv maintain nitrous oxid oxygen continu infus alfentanil microgramkgmin isofluran ad blood pressur exceed patient prestudi pain relief postop patient receiv morphin mg iv bolus patientcontrol analgesia pump lowdos clonidin patient group plasma clonidin concentr vari ngml preoper ngml postop day"
"benefici effect upper thorac epidur anesthesia experiment hemorrhag shock dog influenc circul catecholamin question reduct plasma catecholamin concentr contribut benefici effect upper thorac epidur anesthesia surviv hemorrhag shock examin twenti dog anesthet halothan nitrous oxid blood withdrawn reduc arteri blood pressur map mmhg dog group receiv upper thorac epidur anesthesia hemorrhag intraven infus epinephrin ngkgmin norepinephrin ngkgmin hemorrhag dog group receiv min start bleed plasma catecholamin concentr increas group tenfold signific intergroup differ respect concentr point experiment period min period hemorrhag anim group group die signific differ surviv group min hypotens period general wilcoxon test result suggest surviv benefit upper thorac epidur anesthesia explain simpli differ level catecholamin plasma differ level catecholamin nerv end factor import"
"memori retrain support educ reintegr memori retrain packag specif design facilit reintegr head injur patient educ environ adolesc patient sever head injuri administ memori retrain packag approxim month postinjuri singl case studi multipl baselin design evalu efficaci memori retrain program result suggest promis avenu improv memori function facilit educ reintegr moder sever memori deficit involv studi involv group patient collect data general requir confirm"
"interleukin receptor express human megakaryocyt vitro effect prolifer endorepl interleukin il pleiotrop cytokin play import role megakaryocyt differenti recent observ il synthes human cell line megakaryocyt featur studi investig similar phenomenon occur normal megakaryocyt differenti human megakaryocyt mk obtain cultur normal marrow liquid cultur aplast plasma ap il secret bone marrow cultur enrich mk purifi mk popul demonstr biolog assay il mrna detect purifi popul mk polymeras chain reaction dot blot analysi il mrna protein undetect platelet situ hybrid procedur demonstr presenc il mrna individu immatur mk fourth il protein detect mk unicellular level immunoalkalin phosphatas techniqu monoclon antibodi il presenc il receptor il mk demonstr situ hybrid il probe situ autoradiographi bind ilabel recombin il il endogen produc liquid cultur normal human plasma ap subsequ neutral result decreas mk growth minor shift ploidi distribut lower valu semisolid cultur addit antiil antibodi led decreas coloni number cultur stimul il condit cultur result suggest normal human megakaryocytopoiesi regul part il autocrin loop"
"molecular character erythrocyt glycophorin variant human erythrocyt glycophorin play function import role maintain erythrocyt shape regul membran mechan stabil immunochem serolog studi identifi number glycophorin variant includ yus gerbich webb phenotyp report molecular character variant amplif glycophorin mrna yus phenotyp oligonucleotid primer span code domain generat bp fragment compar bp fragment generat amplif normal glycophorin mrna sequenc mutant bp fragment identifi bp delet correspond exon glycophorin gene similar analysi show delet bp exon gerbich phenotyp contrast generat shorter normal dna fragment mrna amplif yus gerbich phenotyp amplif mrna webb phenotyp generat normals fragment sequenc dna fragment show substitut nucleotid code sequenc result substitut asparagin serin modif account alter glycosyl glycophorin phenotyp result enabl character glycophorin variant phenotyp involv delet exon glycophorin gene point mutat exon result alter glycosyl protein"
"metastat tumor unknown origin clinic metastat lesion obvious primari sourc tumor common event tumor registri figur epidemiolog data grossli underst actual frequenc unknown primari primari site assign patient guess basi posit proof tumor origin major patient primari tumor continu elud detect extens diagnost imag studi fail produc inform alter patient clinic rare cite prove general rule imag studi target select patient dissemin malign identif primari tumor benefit qualiti life length surviv"
"condit prepuls biphas defibril waveform enhanc refractori fibril wavefront mechan biphas waveform defibril threshold reduct unknown test hypothesi refractori period stimul sarcolemm hyperpolar puls biphas waveform facilit excit channel recoveri enhanc grade respons produc depolar puls prolong cellular refractori fibril wavefront compar monophas depolar stimulus monophas msec rectangular wave symmetr biphas msec puls current inject stimuli time threshold scan action potenti refractori period cycl length msec myocardi cell aggreg waveform deliv normal revers polar test hyperpolar action biphas waveform respons stimulus simul potenti incom fibril wavefront determin result show biphas waveform produc longer grade respons immedi refractori period monophas waveform maximum differ respons durat produc biphas monophas waveform msec maximum differ occur msec end refractori period longer respons durat produc biphas produc longer refractori stimulus maximum differ total refractori msec occur ss coupl interv maximum differ respons durat prolong refractori protect ventricular cell refibril wavefront act cellular basi greater biphas waveform defibril efficaci"
"endotheliumdepend respons longterm human coronari arteri bypass graft present studi respons longterm human coronari arteri bypass graft cabg endotheliumdepend vasodil acetylcholin calcium ionophor thrombin histamin authent nitric oxid putat endotheliumderiv relax factor studi sixteen cagb isol hour heart patient receiv cardiac transplant total ring segment prepar cabg studi vitro durat cabg rang month year addit acetylcholin microm calcium ionophor microm thrombin unitml histamin microm consist produc dose endotheliumdepend relax reach maximum sem signific differ observ cabg durat transplant relax respons segment entir length cabg mark differ endotheliumdepend respons correl invers develop intim prolif lesion cabg addit nitric oxid microm produc potent dose endotheliumindepend relax slight depress cabg sever intim prolifer result demonstr longterm transplant human saphen vein graft retain endotheliumdepend respons develop sever intim prolif lesion durat graft result mark alter reactiv transplant cabg"
"oral clofilium produc sustain lower defibril energi requir canin model effect longterm oral administr antiarrhythm drug defibril energi requir understood examin effect clofilium drug prolong cardiac action potenti durat slow cardiac conduct defibril energi requir ventricular effect refractori period canin model week period epicardi patch electrod implant dog baselin test conduct fentanyl anesthesia day oral clofilium mgday regimen start day clofiliumtr control dog underw repeat test day surgeri truncat trapezoid shock repeat store energi random order deliv current imped measur deliv energi calcul energi current success defibril determin control anim increas compar baselin day day contrast clofiliumtr dog decreas day current requir remain stabl compar baselin control anim day clofilium administr decreas day"
"life tabl analysi fecund intraven gonadotropinreleas hormonetr patient normogonadotrop hypogonadotrop amenorrhea success pulsatil intraven iv gonadotropinreleas hormon gnrh treatment patient normogonadotrop hypogonadotrop amenorrhea studi retrospect life tabl analysi hundr forti ovulatori cycl normogonadotrop hypogonadotrop patient evalu cumul concept rate cycl concept rate cycl compar cycl cycl signific differ concept rate observ subdivis made relat presenc addit infertil factor histori weight loss actual weight estrogen status primari versus secondari amenorrhea life tabl curv patient infertil factor signific statist signific differ found subdivis conclud iv gnrh therapi high success patient normogonadotrop hypogonadotrop amenorrhea infertil factor present"
"respons plasma endorphin corticotropin cortisol lutein hormon corticotropinreleas hormon stimul test eumenorrh amenorrh athlet compar pituitari respons corticotropinreleas hormon crh test eumenorrh amenorrh endur athlet maxim oxygen capac vomax determin exercis test bicycl ergomet larger amenorrh se mlmin kg eumenorrh mlmin kg athlet microgram bolus human crh administ intraven blood sampl collect minut basal concentr endorphin adrenocorticotrop hormon acth cortisol show signific differ group cumul respons acth crh test larger eumenorrh pmol amenorrh pmol athlet respons endorphin cortisol differ group negat correl found vomax acth respons crh test total group athlet find function hypothalamicpituitaryadren axi amenorrh athlet attribut intens train"
"evalu therapi breakthrough bleed women triphas oral contracept studi design investig incid pattern breakthrough bleed btb women prescrib time triphas oral contracept oc evalu hypothesi manag btb persist cycl user compar control group women oc month incid btb control group user month breakthrough bleed occur late packag earli midway packag hypothes latepackag btb improv patient switch monophas pill similar estrogen formul begin packag vice versa earli midpackag btb seventi women btb month random month breakthrough bleed improv women switch compar packag btb occur"
"steroid hormon abnorm women sever idiopath constip patient sever idiopath constip exclus women reproduct age investig possibl sex hormon abnorm condit compar rang sex hormon follicular luteal phase menstrual cycl healthi women age year patient sever idiopath constip age year spontan bowel frequenc week patient reduct follicular phase progesteron nmol median control patient hydroxyprogesteron nmol cortisol nmol testosteron nmol androstenedion nmol dehydroepiandrosteron sulphat mumol luteal phase reduct oestradiol pmol cortisol nmol testosteron nmol concentr sex hormon bind globulin prolactin luteinis hormon follicl stimul hormon signific phase cycl women sever idiopath constip consist reduct steroid hormon"
"fatigu failur noncement porousco implant retriev studi mechan failur noncement porousco compon studi cobaltchromium alloy titanium alloy implant fractur month implant includ acetabular compon femor condylar patellar tibial compon examin fractur surfac reveal fatigu mechan failur case porous coat process requir fabric result weaken reduct substrat thick addit factor stress concentr due limit localis bone ingrowth featur design implant"
"micromot cement uncement femor compon evalu initi stabil cement uncement femor compon femor canal cadav femur simul singl limb stanc stair climb type stabl simul singl limb stanc maximum micromot micron cement micron uncement compon simul stair climb cement compon stabl uncement compon micron micron greater variat stabil uncement compon simul stair climb compon move micron futur implant design aim improv initi stabil cementless femor compon torsion load improv chanc boni ingrowth"
"repair cartilag lesion biolog implant compar histolog biomechan studi goat report experiment biolog implant restor articular surfac defect glutaraldehydefix bovin menisc xenograft glutaraldehydefix bovin costal cartilag xenograft viabl osteochondr allograft graft implant knee goat freefield activ studi year natur articular surfac menisc fibrocartilag provid excel articular surfac time equal good articular surfac restor host tissu growth cover costal cartilag graft month month surfac degener major allograft surviv integr host month show sign failur month ungraft defect heal complet month heal surfac degener month"
"success treatment sever premenstru syndrom combin gonadotropinreleas hormon agonist estrogenprogestin abolish ovarian cyclic longact gnrh agonist gnrh effect treatment premenstru syndrom pms limit sequella result hypoestrogen studi effect estrogenprogestin replac symptomat improv afford gnrh evalu women sever pms month studi design includ month control month gnrh month exogen steroid replac random doubl blind placebocontrol cross fashion month conjug equin estrogen cee day mg medroxyprogesteron acet mpa day cee day mpa day placebo mood physic symptom measur daili valid reliabl instrument calendar premenstru experi expect administr gnrh result improv luteal phase symptom score  combin sequenti administr cee mpa addit gnrh effect maintain reduc symptom score gnrh superior addit cee mpa placebo combin cee mpa result improv compar luteal phase control month behavior total symptom conclud undesir consequ ovarian steroid defici treatment pms gnrh overcom addit sequenti estrogen progestogen replac signific reduc effect gnrh disord"
"intranas administr neostigmin potenti intraven intranas growth hormon ghreleas hormoneinduc gh releas short children administr cholinerg agonist increas basal ghreleas hormon ghrhinduc gh secret act inhibit endogen somatostatin releas aim studi verifi group children idiopath short statur effect intranas administr neostigmin inn mg cholinesteras inhibitor basal gh level somatotroph respons ghrh peptid administ iv ivghrh microgramkg intranas inghrh microgramskg group age yr inn induc signific gh increas inn salin area curv auc sem microgram potenti somatotroph respons ivghrh inn ivghrh ivghrh microgram group age yr ivghrh induc gh rise higher induc inghrh microgram administr inn induc gh rise similar occur inghrh auc microgram mark increas inghrhinduc gh respons microgram inn inghrh overlap induc ivghrh conclus cholinerg agonist neostigmin increas basal ghrhinduc gh secret short children intranas combin intranas administr neostigmin ghrh microgramskg induc gh rise similar induc ivghrh microgramkg suggest potenti combin cocktail rout administr treatment short statur"
"screen nineteen unrel famili general resist thyroid hormon point mutat thyroid hormon receptor beta gene detect mutat general resist thyroid hormon grth syndrom character impair tissu respons thyroid hormon distinct point mutat hormon bind domain thyroid hormon receptor tr beta recent identifi unrel famili grth mf involv replac normal glycin arginin exon mh replac normal prolin histidin exon probe presenc mf mh defect unrel famili grth appli separ polymeras chain reaction allelespecif oligonucleotid primer normal mutant nucleotid posit total affect subject normal famili member studi mode inherit domin famili unknown famili recess famili consanguin subject affect primer substitut specif mf mh amplifi exon affect member index famili primer normal sequenc amplifi exon tr beta gene subject affect member famili famili recess inherit grth exon amplifi combin primer dna blot reveal absenc code exon result major delet tr beta gene includ dna hormon bind domain heterozyg member famili affect presenc singl normal allel suffici normal function tr beta data support hypothesi domin mode grth inherit presenc abnorm tr beta interfer function normal tr beta distinct mutat respons grth unrel famili"
"murin mast cell synthes basement membran compon potenti role earli fibrosi mast cell resid tissu associ endotheli epitheli cell basement membran increas site inflamm injuri fibrosi mast cell releas generat proinflammatori molecul respons inflammatori stimuli normal biolog function demonstr ildepend mous pt mast cell mous bone marrowderiv mast cell rat basophil leukemia cell express larg amount mrna collagen iv laminin heparan sulfat proteoglycan western blot analysi confirm mast cell synthes secret signific amount collagen iv laminin chain data suggest mast cell contribut normal tissu repair earli overproduct basement membran compon varieti fibrot condit"
"nurs home patient transfer ambul va emerg depart nurs home resid frequent transfer hospit emerg depart delay transfer lead poor outcom inappropri transfer frail elder social financi problem prospect evalu consecut ambul transfer communiti nurs home va emerg depart object studi describ process outcom transfer patient determin altern intervent feasibl result problem half studi group treat nurs home visit physician minim medic equip admit hospit ill prolong length stay day high mortal rate complex issu physician reimburs proprietari nurs home budget dayday expedi involv decis transport patient ambul va emerg depart"
"endotheli cell adhes human lymphocyt inhibit transform growth factorbeta recombin human transform growth factorbeta tgfbeta found inhibit adhes phenotyp human umbil vein endotheli cell human pbl purifi lymphocyt phaactiv lymphoblast tgfbeta inhibit lymphocyt attach rest human umbil vein endotheli cell endotheli monolay stimul proinflammatori cytokin tnfalpha il beta investig show abil endotheli cell respond tgfbeta alter adhes lost prolong cultur cell loss select tgfbeta inhibit cell prolifer earli late passag endotheli cell result suggest vivo tgfbeta inhibit adhes phenotyp endotheli cell limit immunolog respons occur endotheli cell barrier"
"cytokin releas syndrom induc anticd monoclon antibodi mice prevent high dose methylprednisolon hamster mab specif cd complex murin lymphocyt share properti okt includ induct cell activ vivo inject entail varieti patholog relat system releas cytokin test effect cytokin releas syndrom dose methylprednisolon pds interv time mab administr high dose pds mgkg mab result complet inhibit system releas tnfalpha il il patholog concern hypothermia acut renal tubular necrosi fatti infiltr liver complet prevent hypoglycemia partial attenu protect effect pds toxic confirm reduct mortal rate galactosaminesensit mice inhibit releas cytokin pds affect immunosuppress trigger assess ctl activ alloantigen measur inject mab conclud administr high dose glucocorticoid prevent releas cytokin attenu acut toxic mab similar protocol mitig cytokinereleas syndrom induc okt mab man"
"lovastatintr rodent model barrier disrupt epiderm hyperplasia recent studi link epiderm cholesterol synthesi mainten permeabl barrier assess direct import cholesterol synthesi appli lovastatin potent inhibitor cholesterol synthesi hairless mous skin transepiderm water loss tewl began increas daili applic applic cholesterol block expect increas tewl demonstr import cholesterol develop lesion histolog lovastatintr skin reveal epiderm hyperplasia accompani acceler dna synthesi cholesterol synthesi initi reduc lovastatintr epidermi treatment cholesterol synthesi normal fatti acid synthesi acceler great total free sterol content lovastatintr epidermi remain normal fatti acid content increas coincid barrier disrupt final morpholog abnorm lamellar bodi structur deposit intercellular content occur coincid emerg biochem abnorm abnorm barrier function model ascrib initi inhibit epiderm sterol synthesi alter cholesterol fatti acid synthesi lead imbal stratum corneum lipid composit abnorm membran bilay structur"
"secret uniqu collagen spontan transform murin keratinocyt pam cell vitro spontan transform murin keratinocyt cell line pam cell found secret nondisulfidelink collagen polypeptid appar molecular weight mw kd kd pulsechas experi kd polypeptid secret cultur medium process kd collagen compon process inhibit edta kd polypeptid sensit pepsin kd fragment produc mild pepsin treatment degre cyanogen bromid peptid map kd polypeptid distinct type ii iii iv collagen properti similar type viiirel collagen produc human astrocytoma cell secret collagen rapid reach maximum level day cultur subsequ declin cell prolifer acceler process kd polypeptid observ cultur condit high cell densiti similar collagen found produc normal human keratinocyt result kd polypeptid potenti function protein particip format extracellular matrix keratinocyt"
"immunopatholog olfactori mucosa injuri olfactori bulb remov olfactori bulb perform rat attempt elucid process olfactori dysfunct head injuri degener regener olfactori mucosa examin histopatholog immunohistochem antisera olfactori marker protein omp neuron specif enolas nse marker matur olfactori receptor neuron rapid degener bulbectomi olfactori receptor neuron regener omp nse cell day cell popul neuroepithelium revert number observ oper neuroepithelium month lack connect regener axon olfactori bulb result immatur neuron replac reduc number olfactori receptor neuron"
"enlarg adenoid adenoidectomi adult endoscop approach histopatholog studi adenoid enlarg uncommon adult examin nasopharynx indirect posterior rhinoscopi inadequ case enlarg adenoid adult misdiagnos maltreat studi conduct case enlarg adenoid age year nasal endoscop util identifi adenoid mass adenoidectomi transnas endoscop control perform excis materi histopatholog examin adenoidectomi result mark improv cent case major complic histopatholog examin reveal specif inflammatori reaction case cent pure reactiv predomin follicular hyperplasia case cent mix pattern case cent endoscop follow averag month identifi recurr patient conclud enlarg adenoid tissu adult histopatholog differ children adenoidectomi transnas endoscop control safe reliabl"
"delay posit gastrointestin bleed studi technetiummr blood cell util inject patient studi technetiummlabel red blood cell rbcs gastrointestin bleed posit find hr delay imag time site bleed ascertain instanc addit delay imag suggest activ bleed occur aliquot rbcs label inject site activ hemorrhag identifi imag patient delay gi bleed imag posit view obtain ascertain pattern intralumin activ renew activ hemorrhag suspect reinject dose label rbcs identifi bleed site"
"warm heart surgeri hypothermia wide acknowledg fundament compon myocardi protect cardiac oper prolong period ischem arrest reduc oxygen demand hypothermia number major disadvantag includ detriment effect enzymat function energi generat cellular integr hypothes ideal protect state heart electromechan arrest perfus blood aerob arrest condit fundament hypothermia question develop approach myocardi protect cardiac oper base concept chemic arrest heart perfus continu blood maintain degre consecut coronari bypass procedur compar approach histor cohort consecut patient treat hypotherm cardioplegia periop myocardi infarct signific preval versus warm cardiopleg group intraaort balloon pump versus preval low output syndrom versus cardiac output immedi bypass signific higher bypass versus min warm cardioplegia group heartbeat patient treat continu warm cardioplegia convert normal sinus rhythm spontan remov aortic crossclamp compar hypotherm group time remov aortic crossclamp discontinu cardiopulmonari bypass reperfus time signific shorter warm cardioplegia group versus minut result suggest continu normotherm blood cardioplegia safe effect conceptu repres approach problem maintain excel myocardi preserv cardiac oper"
"studi control reperfus ischemia xx reperfus composit detriment effect initi asanguin cardiopleg washout acut coronari occlus studi test initi asanguin washout potenti toxic substanc accumul ischemia improv recoveri produc blood cardiopleg reperfus evalu role plasma versus blood cardioplegia method twenti dog underw hour occlus left anterior descend coronari arteri minut blood cardiopleg reperfus total vent bypass dog minut infus crystalloid plasma cardiopleg solut ph calcium potassium osmolar blood cardioplegia immedi reoxygen blood cardioplegia region oxygen uptak coronari vascular resist measur control reperfus segment shorten ultrason crystal tissu water content histochem damag triphenyltetrazolium chlorid stain assess hour bypass discontinu result asanguin cardiopleg washout reoxygen blood cardiopleg solut result progress increas coronari vascular resist unit low oxygen util minut blood cardiopleg reperfus ml gm coronari vascular resist remain low blood cardiopleg reperfus washout unit oxygen util ml gm plasma crystalloid washout restor substanti region systol shorten systol shorten versus systol shorten blood cardioplegia asanguin washout caus myocardi edema versus water content produc extens transmur triphenyltetrazolium chlorid damag versus nonstain area risk initi blood cardiopleg reperfus conclus asanguin cardiopleg washout blood cardiopleg reperfus limit oxygen util subsequ control reperfus restrict earli recoveri systol shorten myocardi edema produc extens histochem damag avoid initi reoxygen blood cardioplegia red blood cell import plasma compon blood cardioplegia"
"studi control reperfus ischemia xxii reperfus composit effect leukocyt deplet blood blood cardiopleg reperfus acut coronari occlus object studi evalu role leukocyt deplet initi reoxygen normal blood blood cardiopleg reperfus limit reperfus damag method twenti dog underw hour ligat left anterior descend coronari arteri initi reperfus degre deliv total vent bypass left anterior descend arteri calibr pump intern mammari arteri graft mm hg minut dog receiv normal normokalem nonenrich blood reperfus leukocyt count mm reperfus leukocytedeplet normal blood leukocyt count mm dog reperfus substrateenrich hyperkalem blood cardiopleg solut receiv cardiopleg solut leukocyt count mm result leukocyt deplet normal blood reduc reperfusioninduc arrhythmia coronari vascular resist initi reperfus low remain low substrateenrich blood cardiopleg reperfus normal reduc leukocyt count contrast coronari vascular resist rose normal blood reperfus increas avoid leukocyt deplet versus mm hg mlmin coronari vascular resist minut higher blood cardioplegia normal decreas leukocyt count neglig function recoveri reperfus normal blood leukocytedeplet blood control systol shorten contrast substanti segment recoveri blood cardiopleg reperfus systol shorten improv leukopheresi systol shorten leukocyt deplet normal blood reperfus reduc histochem damag histochem damag blood cardiopleg reperfus normal reduc leukocyt count conclus find suggest import role leukocyt reperfus damag reperfus leukocyt filtrat inferior blood cardiopleg reperfus leukocyt deplet blood cardiopleg solut unnecessari hour ischemia"
"longterm suppress tremor chronic stimul ventral intermedi thalam nucleus highfrequ stimul ventral intermedi nucleus vim neurosurg procedur disabl tremor assess patient parkinson diseas essenti tremor patient undergon thalamotomi contralater stimul side bilater vim stimul time chronic stimul electrod connect puls generat implant vim tremor amplitud rest postur hold action intent manoeuvr assess accelerometri thalami stimul show complet relief tremor major improv improv maintain month follow sd month advers effect mild erad reduct cessat stimul revers adapt control sideeffect make thalam stimul prefer thalamotomi treatment side brain"
"diaphragmat fatigu produc constant modul electr current anesthet rabbit effici phrenic nerv stimul train electr current studi ventil effect bilater nerv stimul electrophren ventil unilater nerv stimul anim ventil pump open chest train rectangular electr puls rpt constant amplitud frequenc sine wave amplitud frequenc modul control comput mswt anim mswt close reproduc physiolog shape transdiaphragmat pressur wave diaphragm fatigu determin decreas maxim relax rate twitch occur minut bilater unilater nerv stimul rpt min unilater stimul min bilater stimul mswt data show import motor signal pattern longlast nerv stimul"
"raf protein kinas requir growth induc niht cell growth factor regul cytoplasm raf protein kinas consist central role transduct growth signal kinas ubiquit express promot prolifer manner depend growthfactor receptor membran oncogen examin depend serum tpa tetradecanoylphorbolacetateregul niht cell growth raf kinas determin raf essenti receptor signal inhibit raf function express raf antisens rna kinasedefect raf mutant antisens rna raf interfer prolifer normal niht cell revert raftransform cell revert cell dna replic induc serum tpa elimin reduc proportion reduct raf protein level express kinasedefect raf mutant craf regulatori domain fragment hcr inhibit seruminduc nihtcel prolifer raf transform effici inhibit antisens rna craf block prolifer transform ki hara oncogen conclud raf function essenti signal transduc downstream serum growth factor receptor protein kinas ras"
"effect flunarizin essenti tremor investig effect flunarizin treatment mg subject essenti tremor doubleblind placebocontrol design tremor assess clinic score tremograph record subject rate subject subject complet studi show improv conclud flunarizin effect treatment essenti tremor"
"case myelinoclast diffus sclerosi adult report case rapid progress cerebr demyelin diseas previous healthi year woman case satisfi diagnost criteria myelinoclast diffus sclerosi mds unusu age onset st case mds adult full document clinic biochem radiograph patholog featur"
"fullthick skin graft vaginoplasti treatment stenot foreshorten vagina vagin stenosi foreshorten surgeri radiat therapi lead dyspareunia report concern success fullthick skin graft flank iliac crest treat vagin stenosi foreshorten oper consist incis involv area creat space recipi site ellipt piec fullthick skin harvest area iliac crest clear fat trim fit recipi site sutur place vagin pack graft recipi bed ten patient treat success techniqu signific complic sequela follow week month show excel postsurg vagin capac patient similar excel function result achiev patient distinct improv remain procedur addit gynecolog surgeon armamentarium"
"gtpaseactiv protein interact viral cellular src kinas gtpaseactiv protein gap regul activ ras protein implic mitogen signal transduct growthfactor receptor oncoprotein tyrosin kinas activ oncogen viral src pvsrc encod rous sarcoma virus possess elev tyrosin kinas activ compar nononcogen normal homolog cellular src pcsrc examin molecular interact gap src kinas immunoprecipit src gap prepar cell lystat resolv gel electrophoresi analyz immunoblot procedur antibodi gap src probe result suggest pcsrc complex gap immunoprecipit lysat normal rat chicken cell gap phosphoryl pcsrc immunoprecipit subject vitro kinas reaction contrast gap undergo tyrosyl phosphoryl vitro immunoprecipit pvsrc prepar transform cell lysat incub atp find suggest pvsrc pcsrc associ complex gap provid biochem link kinas gapra signal transduct pathway result consist hypothesi gap role mediat normal function pcsrc oncogen activ pvsrc"
"molecular basi activ tumorigen potenti gaginsulin receptor chimera previous studi show human insulin receptor ir activ insert portion cdna encod beta subunit retrovirus genom form gagir fusion protein capabl transform cell cultur ir cdna virus call uir induc tumor anim subsequ isol spontan sarcomagen variant call uirt parent uir uirt molecular clone sequenc found harbor mutat amino acid delet immedi upstream transmembran domain gagir fusion protein remov extracellular sequenc ir remain origin uir construct addit singl nucleotid delet end result truncat replac carboxyltermin amino acid amino acid specif kinas activ uirt fold higher parent uir cellular substrat detect uirttransform cell compar uir cell virus delet mutat construct assess biolog function data delet suffici confer tumorigen abil conclud sequenc immedi upstream transmembran domain impos negat effect transform tumorigen potenti gagir fusion protein"
"transcript transactiv human foami virus map bel genom region human foami virus hfv genom possess open read frame bel locat env long termin repeat analog human retrovirus region select candid encod viral transactiv result present confirm show delet introduc bel open read frame plasmid deriv infecti molecular clone hfv abolish transactiv contrast delet bel bel minor effect abil transactiv role bel genom region transactiv investig eukaryot express genom fragment hfv span bel open read frame construct express bel control heterolog promot found transactiv hfv long termin repeat dosedepend fashion shown region hfv long termin repeat suffici respond hfv transactiv"
"transgen mice suscept poliovirus poliovirussensit transgen mice produc introduc human gene encod cellular receptor poliovirus mous genom express receptor mrnas tissu transgen mice analyz rna blot hybrid polymeras chain reaction human gene express tissu transgen mice tissu human transgen mice suscept poliovirus serotyp mice inocul poliovirus show clinic symptom similar observ human monkey rabbit antipoliovirus serum detect antigen motor neuron anterior horn spinal cord nerv cell medulla oblongata pon paralyz transgen mice cell type sensit poliovirus central nervous system transgen mice ident human monkey dose oral poliovirus vaccin strain virul strain requir paralysi transgen mice reflect observ virul strain multipli effici central nervous system attenu strain transgen mice excel anim model studi molecular mechan pathogenesi poliovirus assess oral poliovirus vaccin"
"abil mos product associ phosphoryl tubulin mos protooncogen product ppmos protein kinas equat cytostat factor csf activ unfertil egg thought respons arrest meiosi metaphas ii biochem properti potenti substrat ppmos examin unfertil egg transform cell order studi protein function csf transform ppmos protein polym condit favor tubulin oligomer present approxim kilodalton core complex condit favor depolymer betatubulin preferenti coprecipit ppmos immunoprecipit major phosphoryl product ppmosdepend immun complex kinas assay immunofluoresc analysi nih cell transform xenopus mos show ppmos coloc tubulin spindl metaphas midbodi aster telophas disrupt microtubul nocodazol affect tubulin ppmos organ ppmos tubulin protein kinas particip modif microtubul contribut format spindl activ express interphas somat cell respons transform activ ppmos"
"cauda equina anatomi intrathec nerv root organ dimension organ human cauda equina previous part due difficulti dissect individu unfix nerv root newli develop situ fixat embed techniqu fresh human cadav crosssect anatomi cauda equina defin ll ls high consist crosssect pattern observ specimen lower sacral ss coccyg root locat dorsal aspect thecal sac lumbar sacral root exhibit obliqu layer pattern ascend motor bundl situat anteromedi respect sensori bundl layer invagin arachnoid held nerv root fix relationship previous undescrib dimension anatomi thecal sac aid understand treatment trauma neurocompress syndrom tumor cauda equina"
"acrom award basic scienc cauda equina anatomi ii extrathec nerv root dorsal root ganglia inconsist data exist anatomi spinal nerv root thecal sac newli develop situ techniqu precis defin anatom paramet fresh human cadav angl nerv root thecal sac decreas approxim degre ll degre motor bundl direct ventral sensori fiber individu root extrathec dorsal root ganglia size vari vertebr level major ganglia lie direct beneath vertebr pedicl overli portion intervertebr disc previous undescrib relationship aid understand lumbosacr neurocompress disord import note pedicl screw insert posterolater decompress spinal trauma paravertebr approach disc herniat"
"prospect studi patient sciatica comparison conserv treat patient patient undergon oper part patient characterist differ group base prospect studi sciatica patient examin rhizographi aim determin factor rhizographi find grade durat symptom relat select patient undergo oper compar surgic treat patient conserv treat patient undergo oper patholog rhizographi find pessimist attitud surgeri express desir retir consid work physic stress women group older lower pain indic women underw oper conserv treat patient negat rhizographi sever occup handicap minor expect surgeri physic strenuous job requir difficult physic posit lower indic pain adl oper patient social ergonom background problem emphas sciatica patient conserv treat rhizographi"
"prospect studi patient sciatica comparison conserv treat patient patient undergon oper part ii result year follow prospect studi includ sciatica patient undergon oper nop sciatica patient undergon oper op examin rhizographi follow studi nop op nop divid group patient patholog rhizographi pr patient negat rhizographi nr pain adl occupationhandicap indic show year follow op group result nr group lowest result pr group good result op group sciatica patient candid conserv therapi patholog find rhizographi symptom mild improv therapeut outcom accur diagnost tool develop specif therapi sciatica patient negat rhizographi"
"preliminari studi dyeenhanc laser photosclerosi laser ablat vein inject wavelengthspecif dye enhanc local energi absorpt provid adjunct current treatment option enhanc absorpt diod laser energi nm ear vein rabbit infus ml indocyanin green dye maximum absorpt nm expos anim kill day oper discret time interv laser exposur exist size vessel ablat signific thermal injuri tissu small vessel mm diamet blanch exposur mediums vessel mm diamet requir vessel ablat power densiti low cm specimen immedi laser exposur show vessel wall thin reirradi effect creat laser energi initi absorb dye reemit seventh day oper brisk inflammatori respons acanthosi epiderm layer develop lumen partial fill thrombus cellular invas postop day epiderm thicken inflammatori reaction resolv vessel wall fibrot lowpow aircool diod laser conjunct wavelengthspecif dye provid simpl viabl cosmet appeal altern treatment superfici varicos extrem"
"treatment solitari arterioven fistula patient solitari arterioven fistula treat transvascular balloon embol techniqu result complet fistula closur patient partial closur vertebr arterioven fistula peron arterioven fistula radial arterioven fistula fistula spontan traumat partial occlus peron fistula opinion due technic failur balloon inflat slight proxim fistular orificium orificium complic morbid opinion transvascular balloon embol techniqu treatment choic solitari arterioven fistula"
"munchausen syndrom proxi document discrep blood type author describ case munchausen syndrom proxi form child abus document routin blood bank serolog procedur immunohematolog test legal arena resolv issu disput patern investig instanc crimin act author document applic clinic disord"
"analysi erythrocyt morpholog characterist urin hematolog flow cytomet microscop method method examin erythrocyt morpholog urin phase contrast microscopi microscopi cytocentrifug stain prepar erythrocyt analysi technicon analysi method discrimin dysmorph isomorph erythrocyt red cell distribut width paramet discrimin author found good correl microscop method clinic impact method studi urin sampl patient confirm diagnosi discrimin renal nonren hematuria similar phase contrast microscopi cytocentrifug prepar discrimin recommend"
"small bowel enteroscopi intraop enteroscopi obscur gastrointestin bleed intraop endoscopi ioe accept ultim diagnost procedur complet evalu small bowel patient obscur gastrointestin gi bleed small bowel enteroscopi sbe report nonsurg evalu small intestin patient find limit incomplet small bowel intub lack tip deflect twenti patient underw sbe exam subsequ ioe exam surgic explor continu bleed patient bleed histori averag yr averag transfus requir unit find ioe sbe examin conclud sbe ioe compar depth insert abil detect small vascular ectasia procedur miss patholog due limit visibl evanesc natur ectasia longterm success abolish bleed combin techniqu expect patient sbe preced surgeri find diffus ectasia preclud benefit oper intervent"
"endoscop manag postop biliari leak review case report case biloma format biliari leak uncommon complic abdomin surgeri left untreat result signific morbid mortal tradit treatment surgic author report success endoscop manag review case endoscop manag postop biliari leak report literatur past yr endoscop treatment technic success case result biliari leak heal cystic stump leak prognosi heal compar common bile duct hepat duct leak present addit case postop biliari leak biloma format success treat endoscop stent placement experi lend addit support endoscop manag prefer approach postop biliari leak"
"heparin skin necrosi delay occurr patient hemodialysi case skin necrosi patient receiv intraven iv heparin routin intermitt hemodialysi report multipl erythemat tender lesion develop abdomen thigh rapid necrot biopsi show fibrin thrombi dermal venul capillari cellular infiltr patient month regular hemodialysi skin necrosi heparin occur week begin heparin therapi report patient receiv heparin hemodialysi mechan includ acquir antithrombin iii defici lead heparininduc skin necrosi discuss"
"toxic rat free versus liposom encapsul cisplatin wistar rat group mgkg free cisplatin mgkg liposom encapsul cisplatin salin solut intraperiton biweek inject rat free drug group show signific weight gain rat die studi necropsi free cisplatintr rat show gross microscop evid periton fibrosi detect remain group free cisplatintr rat show serum histolog evid renal damag rat moder sever acut tubular necrosi renal abnorm detect rat receiv mgkg focal mild found rat receiv mgkg liposom prepar neurotox determin nerv conduct inclin plane studi develop rat treat free liposom cisplatin result encourag warrant investig"
"acetazolamid treatment abnorm oculovestibular respons treat patient incapacit vertigo elicit walk groceri store aisl drive car result neurolog neuroophthalm neuroradiolog examin normal episod vertigo secondari abnorm oculovestibular respons diagnos patient trial mg acetazolamid daili symptom resolv complet patient patient resolut symptom patient relief carbon anhydras activ demonstr ear acetazolamid shown affect ion balanc ear fluid"
"genet psychiatri unherald window environ recent review american journal psychiatri british journal psychiatri report progress understand genet psychiatr disord review focus progress prelud psychiatr diagnost therapeut base molecular biolog review recogn latest data behavior genet support environment abnorm develop psychopatholog support genet genet data point type environment central import environ specif uniqu sibl famili"
"nortriptylin treatment depress cardiac transplant recipi safeti tricycl antidepress cardiac transplant recipi establish author nortriptylin treat major depress episod cardiac transplant recipi nortriptylin therapi increas qrs interv heart rate signific affect hemodynam ecg variabl cyclosporin dose requir nortriptylin safe depress cardiac transplant patient"
"splenectomi massiv enlarg spleen experi nation cancer institut case splenectomi massiv splenomegali greater equal gram review assess indic patholog oper postop procedur median age year thirti splenectomi perform malign chronic lymphocyt leukemia chronic myelogen leukemia lymphoma hairi cell leukemia myeloid metaplasia nonmalign condit indic splenectomi includ hypersplen patient symptom diagnosi splenic ruptur midlin incis patient common median oper time hour minut median oper blood loss ml rang ml unit splenic arteri ligat initi patient correl blood loss oper time median splenic weight gram rang gm postop complic rate cent complic patient includ infect patient bleed patient patient requir reoper bleed abscess small bowel obstruct patient day oper mortal cent patient exclud oper death patient follow evalu twenti patient improv paramet splenectomi patient chang splenectomi find patient massiv splenomegali benefit splenectomi procedur high risk postop morbid mortal"
"erythrocyt sediment rate predict earli relaps surviv earlystag hodgkin diseas eortc lymphoma cooper group object assess elev greater mm westergren erythrocyt sediment rate esr predict earli relaps surviv therapi patient clinic stage ii hodgkin diseas intervent studi patient earlystag hodgkin diseas particip separ multicent clinic trial trial modern field radiotherapi patient multiag chemotherapi main result esr pattern base pretherapi posttherapi assess pattern normal pattern elev therapi normal immedi therapi pattern elev therapi normal month therapi pattern elev pattern normal therapi oscil normal elev therapi pattern elev therapi oscil normal elev therapi multivari analysi independ patient receiv chemotherapi initi therapi protocol esr pattern shown predictor earli relaps surviv patient stratifi type chemotherapi receiv number involv nodal area patient esr pattern relat risk death time patient pattern earli relaps import factor predict death irrespect esr patient earli relaps esr pattern relat risk death earli relaps esr pattern relat risk death chemotherapi initi chang relat risk show esr initi therapi predictor earli relaps death due hodgkin diseas conclus unexplain elev esr therapi modern radiotherapi independ factor strong suggest presenc aggress resist hodgkin diseas elev esr predict earli relaps poor prognosi presenc justifi earli aggress therapi"
"surgic complic cochlear multiplechannel intracochlear implant experi hannov melbourn surgic complic multiplechannel cochlear implant oper carri medizinisch hochschul hannov oper univers melbourn clinic royal victorian eye ear hospit present hannov experi major complic wound breakdown wound infect electrod tie eros extern auditori canal electrod slippag persist increas tinnitus facial nerv stimul incid wound breakdown requir remov packag hannov melbourn complic oper clinic accept level consid wound breakdown requir implant remov minimum make generous incis sutur flap tension"
"role calcium ion calcium channel entri blocker experiment ischemiareperfusioninduc liver injuri verapamil administ treatment treatment benefici effect minut warm ischemiareperfus rat liver injuri model activ proteas convert xanthin dehydrogenas xanthin oxidas signific mitochondri calcium load ischem period potenti calcium oxygenderiv free radic promot injuri mitochondria mechan support studi base histolog observ pattern enzym leak acut ischem event"
"deleteri effect crimin victim women health medic util longterm consequ crimin victim physic health examin adult women nonvictim victim crime data includ health status rate object servic util find sever victim women compar nonvictim report distress made physician visit frequent index year outpati cost time greater crimin victim sever power predictor physician visit outpati cost util data year preced crime obtain rape victim physic assault victim noncontact crime victim compar continu year util nonvictim victim physician visit increas year crime compar chang nonvictim conclud longterm deleteri effect suggest crimin victim women medic treatment transcend tradit focus emerg care forens evalu"
"refer rang lymphocyt subset comparison standard rapid blood lysi techniqu refer rang lymphocyt subset vari process techniqu monoclon reagent analyt method compar refer rang obtain lymphocyt subset standard manual blood lysi wash step rapid wash blood lysi system techniqu demonstr refer rang similar previous literatur report rang establish standard rapid lysi similar antibodi direct cluster design slight statist differ relat percentag cd cd lymphocyt observ differ clinic signific data rapid techniqu standard method enumer lymphocyt peripher blood"
"anatom metabol neuropsycholog molecular genet studi pair ident twin discord dementia alzheim type pair twin prove monozygos shown discord dementia alzheim type remain discord period year dementia alzheim type demonstr histori serial clinic examin serial measur cerebr glucos util positron emiss tomographi cerebr ventricular volum rate chang volum quantit comput tomographi serial neuropsycholog test result measur show evid clinic abnorm unaffect twin dna marker proxim long arm chromosom distinguish affect unaffect member pair ident twin famili pedigre negat alzheim diseas result suggest environment nongenet factor contribut alzheim diseas discord monozygot twin case aris postzygot somat mutat"
"anterior femor cutan nerv injuri femor arteri reconstruct surgeri case present exhibit symptom sign bilater anterior femor cutan nerv injuri clinic spare femor nerv branch saphen nerv quadricep muscl occur surgic dissect femor triangl femor arteri reconstruct surgeri anterior femor cutan nerv injuri consid anterior medial thigh pain numb occur aortofemor bypass graft surgeri type femor arteri reconstruct surgeri"
"perinat mortal rate isol general practition matern unit object determin perinat mortal rate form singleton babi birth weight greater equal bath health district base intend place deliveri time onset labour time diagnosi intrauterin death design number live birth stillbirth collect month return matern unit concern death infant age equal week collect return intend place deliveri confirm month perinat mortal meet matern fetal factor discuss set rural health district popul deliveri occur isol general practition matern unit integr general practition unit remaind consult unit subject babi women deliveri book district onset labour diagnosi intrauterin death exclud twin babi lethal congenit malform main outcom measuresoutcom deliveri pariti mother result deliveri analys perinat mortal rate birth consult unit deliveri isol general practition unit deliveri integr general practition unit deliveri perinat death attribut asphyxia common isol general practition unit consult unit perinat mortal rate babi born nullipar women birth consult unit isol general practition unit born multigravid women conclus outcom deliveri influenc pariti antenat intrapartum care respons higher perinat mortal rate isol general practition unit integr unit share midwiferi staff consult unit work analysi intend place deliveri time onset labour diagnosi intrauterin death suggest care isol unit improv train general practition consult supervis antenat care"
"role fistulographi fistulaano report case retrospect review patient undergo anal fistulographi present etiolog fistula studi cryptoglandular infect ibd crohn cuc iatrogen foreign bodi perfor twenti fistulogram reveal direct communic anus rectum abscess cavitiestract fistulogram reveal radiograph evid fistula patient fistulogram patient percent inform obtain fistulogram reveal unexpect patholog direct alter surgic manag conclud anal fistulographi proper select patient add inform definit manag fistulaano"
"chronic care higher prioriti acut care remain focus health care deliveri system shift place chronicil mortal develop effect chronicdiseas manag process tough context today acut care orient william henri presid foresight strategi associ st paul mn"
"revis total knee arthroplasti fail unicompartment replac result nineteen patient twenti knee fail unicompartment knee replac revis total knee arthroplasti evalu twelv excel good fair poor result interv unicompartment replac revis total knee arthroplasti rang month year time revis major osseous defect found sixteen knee cent durat follow revis rang ten year recent follow examin radiograph reveal radioluc line thirteen knee cent technic difficulti revis oper evid unicondylar arthroplasti conserv procedur total knee arthroplasti easili result support argument revis perform failur unicondylar arthroplasti technic demand perform fail primari total knee arthroplasti"
"crosslink hemoglobin solut resuscit fluid hemorrhag rat intramolecular alphaalpha crosslink hemoglobin report oxygen transport properti similar blood present studi evalu efficaci diaspirin alphaalpha crosslink hemoglobin solut resuscit fluid heart rate arteri pressur transcutan oxygen tension studi paramet rat bled approxim total blood volum mlkg remov anesthet resuscit hemoglobin solut anim receiv mgkg mgkg hemoglobin solut respond quick posit infus arteri pressur drop prehemorrhag level return baselin minut initi infus minut arteri pressur hemoglobininfus group signific higher equal autolog shed blood lactat ringer group heart rate transcutan oxygen tension respons halfvolum fullvolum replac hemoglobin group match respons autolog shed blood hour observ favor hemodynam respons infus crosslink hemoglobin solut hemorrhag suggest materi compar autolog shed blood superior lactat ringer solut resuscit fluid assess model"
"slowli progress aphasia case languag memori ct pet data case slowli progress speech languag disturb studi point post onset year languag neuropsycholog brain imag comput tomographi positron emiss tomographi evalu complet patient data suggest syndrom progress aphasia involv uniform symptom complex necessarili develop full blown dementia syndrom vari great rate progress case case normal brain structur comput tomographi abnorm left tempor lobe metabol measur fluorodeoxyglucos fdg positron emiss tomographi pet patient histolog find consist alzheim diseas necropsi"
"enantiom oxybutynin vitro pharmacolog character muscarin receptor vivo effect urinari bladder contract mydriasi salivari secret guinea pig major side effect racem oxybutynin oxi treatment urinari incontin dri mouth xerostomia blur vision mydriasi high purifi enantiom oxi oxi oxi compar racem vitro function studi vivo guinea pig evalu pharmacolog action relat advers effect affin oxi oxi muscarin receptor subtyp determin field stimul rabbit vas deferen guinea pig atria bladder strip stereoselect antimuscarin effect oxi greater equal oxi greater oxi evid receptor subtyp isomer ratio oxyoxi rang oxi oxi slight select fold relat muscarin receptor stereoselect evid vivo volumeinduc urinari bladder contract measur cystometrogram paramet oxyoxi approxim mydriasi oxyoxi approxim salivari gland secretori respons oxyoxi approxim absolut potenc oxi oxi mydriasi saliv similar inhibit intraves bladder pressur oxi oxi equipot antagon cholinergicmedi cns effect mice collect data suggest activ oxi resid predomin enantiom oxi offer signific pharmacolog advantag oxi term princip therapeut side effect profil"
"evid intralumin ca regulatori site defect sarcoplasm reticulum malign hyperthermia pig muscl malign hyperthermia mh pharmacogenet diseas human anim speci predispos lifethreaten anesthet agentinduc syndrom mh thought consequ abnorm sustain increas myoplasm ca sarcoplasm reticulum sr membran mh muscl shown ca releas channel defect present studi test hypothesi abnorm ca releas mechan mh express ca load presenc pyrophosph sr membran vesicl isol normal mh pig muscl load ca presenc absenc pyrophosph cainduc ca releas occur circumst threshold amount ca load ca releas occur lower sr mh pig skelet muscl differ amount ca preload explain result obtain compar rate ca uptak number ryanodin bind site amount calsequestrin sr vesicl mh normal muscl conclud studi pyrophosph ca load ablat abnorm ca releas sr mh muscl suggest studi small amount sr biopsi human muscl data suggest abnorm intralumin low affin ca bind site regul ca releas occur sr membran mh pig muscl"
"absorb mesh splenorrhaphi sever splenic injuri function studi anim model addit patient seri polyglycol acid mesh introduc method control hemorrhag sever damag spleen studi examin effect splenic wrap immun function spleen abil control splenic bleed trauma patient thirti purebr beagl dog divid group subject sham oper group splenectomi group splenic wrap group immunolog studi show differ wrap group group spleen intact group induct specif antibodyproduc lymphocyt splenic tissu inject attenu pneumococci splenic injuri treat cook counti hospit januari retrospect analyz patient splenic injuri underw mesh splenorrhaphi mortal complic studi demonstr immun function spleen preserv mesh splenorrhapi techniqu clinic set safe efficaci result"
"lumbar spinal nerv neural foramen mr proxim lumbar spinal nerv magnet reson mr imag author knowledg mr imag section obtain cadav freez microtom correl character mr proxim spinal nerv junction dorsal ventral rami dorsal ventral root consist group fascicl measur mm length fascicl mr imag obtain short repetit time small foci lower signal intens surround fat proxim spinal nerv relationship intervertebr disk osseous margin neural foramen demonstr effect mr imag"
"dutch experi percutan translumin angioplasti narrow saphen vein aortocoronari arteri bypass percutan translumin coronari angioplasti procedur perform netherland april januari longterm follow patient underw angioplasti greater equal saphen vein bypass graft review patient singl graft angioplasti attempt patient sequenti graft angioplasti attempt clinic primari success rate hospit mortal patient sustain procedur myocardi infarct patient underw emerg bypass surgeri follow period year patient aliv aliv eventfre myocardi infarct repeat bypass surgeri repeat angioplasti patient initi angioplasti attempt unsuccess eventfre year versus success dilat patient time interv angioplasti attempt previous surgeri signific predictor year eventfre surviv eventfre surviv rate patient bypass surgeri year year year angioplasti patient previous bypass surgeri angioplasti graft remain eventfre year patient angioplasti year bypass surgeri longterm result achiev"
"intraoss infus dobutamin isoproterenol intraoss infus advoc emerg rout sick infant children intraven access readili obtain dobutamin hydrochlorid isoproterenol hydrochlorid emerg drug studi administ bone marrow swine model compar physiolog respons heart rate arteri pressur cardiac output dobutamin isoproterenol infus deliv intraven intraoss minut interv observ statist signific effect dobutamin isoproterenol deliv intraoss rout addit effect result intraoss infus statist similar result intraven administr drug conclud intraoss infus dobutamin isoproterenol effect method emerg administr medic"
"effect growthpromot therapi comparison growth hormon clonidin levodopa abil growth hormon clonidin levodopa stimul growth compar short slowli grow children random assign treatment regimen month children group addit subject serv control growth hormon improv height veloc height veloc sd score height sd score height veloc height veloc sd score signific increas clonidin levodopa enhanc height veloc sd score treat children patient receiv growth hormon receiv clonidin receiv levodopa height veloc rais cm increment height veloc height sd score greatest growth hormon group clonidin induc increas height veloc signific control children control group signific reduct height sd score time"
"unsuspect cocain exposur young children object determin preval cocain exposur preschool children clinic unsuspect sign symptom design preval studi set pediatr emerg depart citi hospit particip children age week year underw urin assay cocain prior discharg emerg depart intervent measurementsmain result urin assay confid interv posit benzoylecgonin major urinari cocain metabolit posit urin assay children younger year children posit urin assay younger month children present complaint identifi clinic problem childhood exposur cocain exposur rout includ breastfeed intent administr accident ingest cocain cocainecontamin household dust normal handmouth activ passiv inhal crack vapor conclus citi children serv hospit signific number infant young children expos cocain exposur occur clinic unsuspect popul"
"role experi respons simul critic incid experienc anesthesiologist faculti privat practition present simul critic incid previous present anesthesia traine detect correct time incid measur complianc advanc cardiac life support acl guidelin cardiac arrest occurr unplan incid experienc personnel tend react rapid traine differ year anesthesia resid ca experienc anesthesiologist statist signific high variabl perform incid group unplan error manag flaw occur experi subject respons incid anesthesia complex process involv multipl level cognit activ vulner error experi traine acquir adequ respons routin end ca year formal reason play minor role respond intraop event exact natur anesthesiologist cognit remain investig"
"lowdos bupivacain improv postop epidur fentanyl analgesia orthoped patient publish erratum anesth analg epidur infus microgramsml fentanyl combin lowdos bupivacain compar epidur infus fentanyl postop analgesia total knee joint replac detect differ group analgesia visual analogu scale rang mm infus rate averag ml serum fentanyl level reach ngml incid side effect includ nausea vomit pruritus similar patient receiv fentanyl lowdos bupivacain develop transient unilater motor sensori loss develop signific hypotens respiratori depress addit lowdos bupivacain improv epidur fentanyl infus analgesia knee surgeri increas morbid"
"patient flow emerg depart chest pain patient prompt treatment chest pain patient emerg depart ed crucial ensur prompt treatment identif factor delay flow patient depart essenti identifi factor delay patient flow ed author conduct prospect studi chest pain patient timeflow analysi eighti patient requir critic unit admiss averag depart stay hour flow differ critic noncrit care patient primari sourc delay identifi critic unit bed avail registr process role unit admit resid addit find confirm efficaci role triag nurs patient flow nurs medic educ staf address communiti emerg medic servic examin analyz disposit patient arriv ed ambul"
"immun function treatment growth hormonedefici children biosynthet human growth hormon immun function includ cell surfac marker interleukin receptor level respons lymphocyt mitogen stimul evalu growth hormon defici children age year treatment biosynthet deriv human growth hormon treatment result decreas cell total cell decreas individu patient mitogen respons interleukin receptor level note transient similar previous demonstr pituitaryderiv human growth hormon treatment result overt clinic manifest patient potenti interact growth hormon immun function consid physician treat children growth hormon"
"oxygen desatur fiberopt bronchoscopi pediatr patient studi object puls oximetri measur arteri oxygen satur extent hypoxemia pediatr patient undergo fb design arteri oxygen satur measur prior procedur provid baselin bronchoscop posit nasopharynx bronchoscop posit midtrachea set fiberopt bronchoscopi perform pediatr special care unit pediatr pulmonari laboratori olympus bfc fiberopt bronchoscop mm outer diamet patient particip thirti children underw diagnost therapeut bronchoscopi varieti reason evalu rang age month male femal intervent intervent measur result patient experienc fall sao level exceed percent baselin valu youngest age group month show greatest drop satur compar group desatur signific increas midtrach fb conclus declin arteri oxygen satur substanti infant children undergo fb examin frequent note smaller infant bronchoscop posit midtrachea supplement oxygen brisk procedur time minim risk danger hypoxia"
"pattern resourc consumpt medic intens care intens care scrutin major factor increas health care cost examin consecut admiss medic icus univers medic center studi pattern consumpt icu resourc proport resourc patient admit monitor found skew distribut icu resourc consumpt highcost percent icu resourc lowcost percent forti percent admiss receiv acut icu treatment admiss consum percent icu resourc reduc number patient admit monitor small impact hospit charg percent highcost patient die improv understand prognosi physicianpati communic substanti reduc proport critic care resourc expend futil treatment"
"activ passiv rhythm explan bigemin rhythm similar wave describ criteria differenti diagnosi sinoatri block atrial bigemini due ectop focus sinus parasinus zone sinoatri block rr interv basic rhythm similar short interv pair rhythm atrial bigemini interv basic rhythm similar long interv pair rhythm"
"immunoglobulin cytomegalovirus recurr infect recipi allogen bone marrow transplant occurr signific specif iga igm cytomegalovirus cmv recurr cmv infect evalu allogen lymphocytedeplet bone marrow transplant bmt recipi previous cmv seroposit patient cmv infect viruria detect cmvspecif iga igm fourfold rise igg median time bmt detect viruria day iga igm igg day igm iga respons day median time high igg titer persist twelv patient develop cmv diseas viruria iga igm preced rise igg cmvspecif iga igm valuabl diagnost tool bmt recipi recurr cmv infect"
"oper everest ii ventilatori adapt gradual decompress extrem altitud assess ventilatori adapt gradual ascent extrem altitud studi healthi male part simul ascent mt everest hypobar chamber measur rest ventil ve min arteri oxygen satur sao ventilatori respons oxygen breath isocapn hypox ventilatori respons hvr hypercapn ventilatori respons hcvr sea level prior ascent torr feet torr feet torr descent torr ve increas min torr min torr remain elev min descent oxygen breath decreas ve min torr isocapn hvr express posit slope vesao minsao increas torr torr torr hvr elev return sea level hcvr vepetco mintorr increas sea level torr remain elev return sea level studi investig ventilatori respons extrem altitud descent show hypox hypercapn respons increas prolong progress hypox exposur remain signific elev preascent level immedi descent"
"seismic communic blind subterranean mammal major somatosensori mechan adapt evolut underground seismic communic lowfrequ pattern substrateborn vibrat generat head thump travel long distanc underground import nonvisu communic subterranean mole rat spalax ehrenbergi superspeci israel import pertain intraspecif adapt interspecif speciat neurophysiolog behavior anatom find studi suggest mechan longdist seismic communic basic somatosensori independ auditori mechan seismic communic channel communic import evolut subterranean mammal display major adapt life underground"
"cluster trna gene schizosaccharomyc pomb centromer dna sequenc repeat centromer dna sequenc repeat schizosaccharomyc pomb chromosom ii found cluster trna gene centromer ii region cen includ trna gene distribut copi sequenc repeat gene trnail trnaala trnaval individu repeat trna gene includ trnali trnaarg trnaglu centromer region cen trna gene copi repeat element includ gene trnail trnaala trnaglu multipl tandem arrang cluster trna gene conserv due restrict recombin frequenc centromer region"
"quantif midlin shift predictor poor outcom head injuri retrospect studi patient outcom base admiss comput tomographi carri consecut patient head injuri comput tomographi data collect includ type extent intracrani hemorrhag extent midlin shift ratio midlin shift compar extent intracrani hemorrhag midlin shift consid proport intracrani hemorrhag midlin shift septum pellucidum exceed extent hemorrhag measur radial tabl skull comput tomographi data analyz logist regress signific predict factor poor outcom intracrani hemorrhag intracrani hemorrhag midlin shift midlin shift proport extent intracrani hemorrhag patient outcom mortal rate consid studi midlin shift proport extent intracrani hemorrhag high predictor poor patient outcom head injuri"
"ketamin analges total intraven anaesthesia propofol prospect studi patient underw noncardiac surgeri perform studi ketamin analges total intraven anaesthesia propofol comparison made combin propofolfentanyl propofolketamin combin result haemodynam stabl anaesthesia addit analges postop behaviour normal patient patient report dream oper propofol effect elimin side effect subanaesthet dose ketamin human recommend propofolketamin combin total intraven anaesthesia surgeri stabl haemodynam requir"
"awar caesarean section patient question recal dream general anaesthesia caesarean section patient recal oper report dream uniform adher rigid anaesthet protocol includ public incid report courtroom stimul relax regimen incid awar decreas incid dream reduc recollect surgeri confin manipul nois voic patient complain pain time interview inadequaci initi protocol approach inform consent discuss"
"nation institut mental health longitudin studi chronic schizophrenia prognosi predictor outcom publish erratum arch gen psychiatri jul perform longitudin studi chronic schizophren patient hospit research purpos nation institut mental health nimh intramur program earli assess present outcom predictor data initi cohort young chronic schizophren patient year nimh index hospit follow sampl show substanti function impair level symptom sampl demonstr good outcom addit strong intercorrel note symptom function index follow neuropsycholog test frontal cortic function signific correl outcom level negat symptom social function level posit symptom period index hospit follow assess sampl suffer relaps attempt suicid episod major affect ill level posit negat symptom ascertain patient receiv optim neurolept treatment index hospit signific predict outcom level symptom function time spent hospit follow period contrast level index posit negat symptom ascertain drugfre state predict outcom symptom function data suggest treatment respons critic predictor variabl examin implic data ill schizophren"
"posthospit outcom schizophrenia studi earli schizophrenia assess earli phase young dsmiii schizophren patient success posthospit followup year index hospit sampl poor outcom sever impair function symptom suicid follow period rehospit rate decreas signific posthospit assess sampl show persist psychosi small group schizophren patient show complet remiss follow follow patient suicid exclud progress deterior common schizophrenia negat find challeng conclus longitudin studi implic data schizophren discuss"
"plasma concentr bupivacain metabolit continu interscalen brachial plexus block interscalen brachial plexus block perform cathet ml bupivacain adrenalin surgeri shoulder region patient constant infus bupivacain mg kg continu surgeri light general anaesthesia analges maintain plasma concentr total unbound free fraction bupivacain desbutylbupivacain dbb hydroxybupivacain ohb alpha acid glycoprotein aag measur predetermin interv continu block greatest plasma concentr bupivacain measur min sd microgram ml min microgram ml small statist signific increas plasma concentr bupivacain infus unbound concentr bupivacain plasma decreas microgram ml total bupivacain concentr microgram ml aag concentr plasma increas metabolit dbb ohb detect plasma min gradual increas infus concentr dbb ohb microgram ml microgram ml toxic reaction block"
"pharmacokinet clinic experi infus methohexiton intens care patient postop pyrexia studi pharmacokinet infus methohexiton young patient postop fever undergo artifici ventil lung infus rate adjust patient unrespons vocal stimul react tracheal suction steadi state concentr methohexiton requir mg litr unbound mg litr sd total clearanc methohexiton ml min kg greater volunt normal surgic patient unbound clearanc correl posit bodi temperatur infus termin halflif methohexiton hydroxi metabolit mark haemodynam effect infus excess sedat infus clearanc methohexiton high variabl possibl direct effect postop fever individu titrat rate infus emphas"
"sciatic nerv monitor revis total hip arthroplasti studi present simpl method intraop sciatic nerv monitor revis total hip arthroplasti tha util intraop somatosensori evok potenti method sciatic nerv protect surgic correct shorten limb length revis tha twenti revis thas perform intraop sciatic nerv monitor postop peripher nerv complic occur averag increas mm leg length rang mm mm"
"import ghq general practic relationship general health questionnair ghq score complaint present general practition offic examin show correl high expect patient present psychosoci problem gp low ghq score patient high ghq score exclus present somat complaint assess gp pure somat implic result discuss"
"morpholog featur blood access stenosi result noninvas angioplasti investig connect result noninvas angioplasti blood access stenosi morpholog featur dialysi case case present stenosi origin arteri area dilat noninvas techniqu case stenosi arteri vein downstream needl insert point extracorpor circul show longterm dilat procedur case stenosi upstream point show longterm dilat unsuccess case angl form axe stenos portion normal vessel degre distanc anastomosi stenos portion mm"
"reliabl stimul spontan growth hormon gh level identifi child low gh secret reliabl stimul spontan gh level identifi child low gh secret subject debat compar abil gh concentr pharmacolog stimul levodopa clonidin spontan peak pool gh concentr sleep singl night estim maximum spontan gh secret night children age yr height percentil height veloc percentil age consecut overnight gh secretori profil maximum stimul gh concentr correct categor children maximum spontan gh concentr microgram doubl monoclon immunoradiometr assay gh tandem hgh hybritech remain children stimul gh concentr spontan gh concentr microgram cut maximum gh concentr night correct categor children night night variat gh secret low children low spontan gh secret maximum spontan peak pool gh concentr equal microgram pool gh concentr night concord case conclud uncommon stimul gh concentr underestim spontan gh secret acclimat hospit set measur spontan gh secret singl night reliabl identifi child low endogen gh secret gh stimul test"
"qualiti life elder chronic ill outpati qualiti life ql elder outpati poor character interview elder outpati health care set identifi attribut event affect assess ql outpati rate ql accept cite medic care health interperson relationship financi status function status affect ql ql rate strong object indic demograph characterist health care servic subject indic includ patient percept health memori financi concern correl independ global ql sigma conclud older chronic ill patient general ql accept affect varieti factor includ percept emot socioeconom intellectu physic function ql poor object indic assess ql elder chronic ill outpati physician elicit inform percept"
"combin assess physic health function status communitydwel age prospect studi florenc itali survey health social condit repres sampl person age year older citi florenc itali undertaken follow survey cohort perform document death survivor individu locat function abil baselin assess world health organ item scale indic physic health status includ chronic diseas status number drug physician visit day hospit adjust age sex function abil indic physic health status found independ statist signific predictor mortal result studi support view biomed function assess comprehens evalu older popul"
"decis criteria pureton detect age group normalhear hearingimpair listen respons criteria task detect threshold test procedur measur group adult younger normalhear older normalhear younger hearingimpair older hearingimpair test procedur audiolog procedur control respons bias fc adapt procedur control bias signal hz tone present quiet group show equal conserv respons bias task addit age hear loss affect differ db threshold measur"
"effect rate sequenc memori auditori process elder auditori sequenc rate memori evalu age group seri subtest requir identif tone repetit test tallal pierci older elder group age younger elder group age perform signific poorer young adult group age auditori memori tone requir interstimulus interv decreas perform relat hear sensit suggest auditori mechan occur age encompass loss hear sensit perform repetit test correl memori digit relationship auditori process higher cortic function"
"nonorganiz religi particip elder black adult studi investig rate particip nonorganiz religi activ elder black adult indic particip examin read religi materi watch listen religi program prayer request prayer demograph religi denomin health disabl factor influenc particip behavior find discuss implic develop multidimension conceptu religios"
"health percept surviv global evalu health status predict mortal evalu health status shown predict mortal contribut predict made indic base presenc health problem physic disabl biolog lifestyl risk factor reason associ discuss methodolog shortcom previous studi render associ spurious psychosoci influenc mortal involv explain associ evalu health status direct independ effect year follow mortal data yale health age project explor possibl analysi control contribut numer indic health problem disabl risk factor make adjust standard error complex sampl design find favor possibl independ effect extent set psychosoci factor examin explain basic associ extent control variabl adequ comprehens set"
"popul age pattern expans mortal hypothesi mortal compress framework examin pattern mortal data nation vital statist record analysi chang age death percentil popul data social secur administr census bureau calcul forc mortal age death percentil includ oldest group risen interv examin coeffici variat age death suggest relat increas variabl age death oldest data fit hypothet sequenc normal densiti distribut increas declin standard deviat forc mortal year decreas pattern similar year current mortal pattern suggest expans compress mortal oldest age refin observ improv data mortal oldest delin mortal pattern"
"stress event life satisfact elder men women purpos studi examin interrelationship stress event domainspecif assess life satisfact global evalu life satisfact research guid compet theoret formul bottom theori older adult assess feel satisfact specif life domain base part experi stressor encount area domainspecif view subsequ synthes form sens satisfact life contrast top theori suggest person ongo sens satisfact life predispos assess satisfact specif domain congruent initi sens global life satisfact analysi data provid older particip nationwid survey support bottom perspect"
"rest metabol rate energi balanc amenorrh eumenorrh runner studi investig metabol nutrit factor associ athlet menstrual dysfunct amd group women studi amenorrh runner amenorrh eumenorrh runner eumenorrh eumenorrh sedentari control sedentari amenorrh eumenorrh similar age weight percent bodi fat hydrodensitometri train pace mileag km race time year run maxim oxygen consumpt adjust bodi weight fatfre mass analysi covari rmr signific lower amenorrh eumenorrh sedentari daili calor intak group differ signific amenorrh score signific higher eumenorrh sedentari scale aberr eat pattern amenorrh high mileag runner adequ diet eumenorrh runner maintain energi balanc stabl weight reduct rmr"
"menstrual function eat behavior femal recreat weight lifter competit bodi builder group femal weight lifter wl control women answer survey eat behavior attitud includ eat disord inventori menstrual function incid menstrual dysfunct defin oligomenorrhea amenorrhea signific higher wl contracept pill women amenorrhea incid dysfunct highest subset wl compet bodi build competit comp comp birth control pill menstrual dysfunct wl report miss menstrual period year wl score signific higher drive thin subscal eat disord inventori edi fifteen percent wl achiev criteria subscal weight preoccupi greater signific wl respond terrifi fat wl obsess food wl laxat weight control wl claim anorex past wl examin answer comp reveal item signific remaind wl anorex terrifi fat experienc uncontrol urg eat"
"skelet muscl tonic overload function structur analysi function overload skelet muscl induc compensatori hypertrophi adapt respons increas function demand overload extensor digitorum longus edl muscl rej strain male mous induc unilater surgic remov synergist muscl tibiali anterior ta respons edl overload analyz muscl weight myofib type distribut myofib crosssect area fiber type speed contract relax muscl forc contract myofib morpholog integr weight edl signific increas overload caus impair muscl contractil signific effect isometr twitch contract time peak tension time half relax twitch overload muscl demonstr transient shift fiber type profil preferenti hypertrophi type iia fiber occur earli phase overload type iib fiber recruit signific increas myofib number overload muscl occur morpholog load muscl parallel found patient neurogen muscular disord overload muscl exhibit signific occurr fiber branch control midbelli region muscl"
"oxygen uptak heart rate respons hypox exercis children adult control ventil heart rate exercis undergo matur aerob metabol vo previous found hypoxia exercis produc ventilatori respons children compar adult hypothes vo heart rate kinet exercis show similar matur respons hypoxia test hypothesi examin respons progress ramp constant work rate test children adult breath room air hypox gas fio correct bodi weight children adult similar valu lactic acidosi threshold lat mlminkg vomax mlminkg normoxia hypoxia signific lower lat mlminkg vomax mlminkg children adult metabol effici delta vodelta work rate voheart rate relationship delta vodelta hrkg similar group unaffect hypoxia constant work rate exercis vo kinet time constant phase respons pi deficit similar children adult signific slow hypoxia consist current understand control oxid metabol final heart rate increas rest exercis hypoxia time reach endexercis respons delay signific group"
"video display termin risk spontan abort background relat spontan abort video display termin vdts great public health concern previous investig issu report inconsist find method determin electromagnet field emit vdts increas risk spontan abort cohort femal telephon oper vdts work compar cohort oper vdts obtain reliabl estim exposur determin number hour vdt week compani record measur electromagnet field vdt workstat purpos comparison workstat vdts oper vdts higher abdomin exposur lowfrequ khz electromagnet field workstat vdts emit lowfrequ energi abdomin exposur extremelylowfrequ field hz similar oper vdts women interview pregnanc met criteria inclus studi result found excess risk spontan abort women vdts trimest pregnanc odd ratio percent confid interv doserespons relat appar examin women hour vdt week odd ratio hour week percent confid interv odd ratio greater hour week percent confid interv continu risk vdts account multipl pregnanc conduct separ analys earli abort late abort fetal loss limit analys spontan abort physician consult conclus vdts exposur accompani electromagnet field increas risk spontan abort studi"
"comparison formul tac tetracain adrenalin cocain anesthesia minor lacer children random prospect doubleblind studi compar formul topic anesthet solut tac lacer repair undertaken children children wound anesthet tac origin formul tetracain adrenalin cocain tac ii tetracain adrenalin cocain tac iii tetracain adrenalin cocain prior repair solut compar respect efficaci accept wound complic side effect found compar efficaci formul similar efficaci lidocain infiltr facial scalp wound anesthesia extrem wound adequ case tac strength wound complic side effect expect accept limit find support tac face scalp lacer chang concentr tac prepar tac iii safer widespread"
"experi free tram flap breast reconstruct data patient undergo free tram flap breast reconstruct unit examin averag patient age year averag weight kg forti percent patient chronic smoker percent low abdomin scar twelv percent exercis abdomin muscl regular eighteen percent undergon radic mastectomi percent undergon modifi radic mastectomi percent undergon subcutan mastectomi postop radiotherapi percent patient percent receiv postop chemotherapi averag time mastectomi month breast reconstruct immedi averag oper time hour averag blood loss unit averag hospit stay day complic includ total flap loss percent partial flap loss percent abdomin hernia occur patient percent"
"methyl prednisolon doublelumen gelsalin submuscular mammari prosthes doubleblind prospect control clinic trial time breast reconstruct submuscular implant consecut patient breast random group receiv gelsalin doublelumen implant cc salin ad outer lumen receiv implant cc salin mg methyl prednisolon mg patient minimum year group match patient age implant size evalu month capsular contractur steroid atrophi complic complet doubleblind studi patient submuscular gelsalin implant salin ad capsular contractur rate percent month percent month percent month methyl prednisolon capsular contractur rate percent month remain unchang end studi rate complic compar methyl prednisolon dose mg cc salin concentr mg outer lumen doublelumen gelsalin implant submuscular pocket safe efficaci reduc risk capsular contractur minimum year patient undergo breast reconstruct submuscular mammari implant"
"radiograph manifest congenit anomali spine forego review embryolog develop congenit anomali spine infant children necessarili common encount abnorm review attempt made cite stage embryolog develop abnorm origin note congenit abnorm spine uncommon profound clinic signific past decad signific develop diagnosi treatment abnorm ultrasonographi ct scan mr imag neonat spinal cord neural outflow evalu ultrasonographi osseous element begin fuse mr imag procedur choic permit evalu spine spinal cord plane imag detail evalu effect osseous abnorm neural structur final plain radiograph spine evalu neonat spectrum sacral dimpl rare presenc signific cutan subcutan abnorm ultrasonographi prefer modal evalu"
"characterist accessori pathway exhibit decrement conduct preval electrophysiolog characterist function signific decrement conduct accessori pathway examin retrospect studi patient accessori pathway demonstr electrophysiolog studi decrement conduct identifi patient patient anterograd decrement conduct accessori pathway pariet septal patient left pariet patient patient retrograd decrement accessori pathway left pariet posterosept pariet anterosept patient anterograd conduct accessori pathway absent patient retrograd decrement retrograd conduct accessori pathway absent patient anterograd decrement signific differ accessori pathway effect refractori period shortest cycl length conduct accessori pathway anterograd retrograd direct shortest rr interv atrial fibril preexcit qrs complex longer patient anterograd decrement conduct control group patient anterogradeconduct accessori pathway decrement properti data demonstr decrement conduct accessori pathway uncommon anterograd decrement conduct occur side septal pathway conduct retrograd direct"
"sotalol suppress chronic ventricular arrhythmia sotalol uniqu betablock drug possess signific class iii antiarrhythm activ efficaci safeti dose sotalol mgday divid dose compar placebo week random doubleblind multicent studi patient chronic ventricular prematur complex vpcs frequenc greater equal hour sotalol signific reduc vpcs patient receiv low high dose compar patient receiv placebo sotalol placebo high low dose individu efficaci criterion greater equal vpc reduct achiev lowdos highdos sotalol versus placebotr patient sotalol placebo high low dose repetit beat suppress placebo differ signific lowdos highdos sotalol sotalol decreas heart rate increas pr correct jt interv chang eject fraction proarrhythmia nonfat occur sotalol placebo patient discontinu therapi advers effect low dose high dose summari sotalol efficaci antiarrhythm drug vpc suppress lower dose effect toler"
"percept life event daili stress nonulc dyspepsia previous studi associ nonulc dyspepsia major life event perform emphasi percept event yield conflict result present studi examin percept life event addit role daili hassl stress event patient nonulc dyspepsia thirti dyspept patient defin normal endoscopi ultrasonogram control compar sex age social class recruit studi group select major life event experienc give rate perceiv select similar item daili stress rate sever item result demonstr number posit negat event posit score similar dyspept patient control dyspept patient higher perceiv magnitud negat event higher score total life chang summat magnitud posit negat event hassl score signific dyspept patient control analysi individu life event reveal dyspept patient signific higher score control item minor law violat major chang close famili member major person ill injuri conclud patient nonulc dyspepsia higher negat percept major life event psycholog factor play role pathogenesi nonulc dyspepsia"
"clinic molecular diagnosi millerdiek syndrom report result clinic cytogenet molecular studi patient millerdiek syndrom mds famili sever type lissencephali grossli normal cerebellum distinct facial consist promin forehead bitempor hollow short nose upturn nare protuber upper lip thin vermilion border small jaw abnorm growth defici frequent constant chromosom analysi show delet band mds proband rflp somat cell hybrid studi probe region includ pynz ds pynh ds pd ds detect delet proband test includ chromosom analysi normal cytogenet molecular data combin delet detect proband parent origin de novo delet determin patient patern origin occur matern origin demonstr cytogenet molecular delet mds proband prove delet critic region compris genet loci band mds phenotyp suspect remain patient smaller delet involv propos critic region detect probe"
"blockad prostaglandin product increas cachectin synthesi prevent depress macrophag function hemorrhag shock hemorrhag sever depress macrophag function increas tnfalpha pge product respons studi chhen mice bled blood pressur mmhg minut resuscit treat ibuprofen mgkg bodi weight vehicl salin hemorrhag increas plasma prostaglandin pge level signific decreas periton macrophag pm phi antigen present ap ia express interleukin il synthesi compar sham ibuprofen treatment reduc pge plasma level signific increas ap ia express il synthesi cachectin synthesi compar vehicletr anim result prostaglandin cachectin involv suppress pm phi function hemorrhag blockad prostaglandin synthesi improv depress macrophag function enhanc cachectin synthesi"
"site action continu extrapleur intercost nerv block continu extrapleur intercost nerv block shown random control studi effect reduc postop pain thoracotomi restor pulmonari mechan assess extent spread bupivacain infus extrapleur cannula insert thoracotomi iohexol omnipaqu infus day postop patient comput tomographi perform contrast medium confin paravertebr space cover averag intercost space studi demonstr anatom site action bupivacain infus extrapleur cannula primarili paravertebr space"
"simplifi hepat resect prolong vascular inflow occlus ten consecut patient schedul undergo liver resect studi prospect standard protocol includ routin vascular inflow occlus reduc blood loss blood transfus requir fibrin sealant spray raw liver surfac abdomin drainag perform death occur postop remark smooth normotherm liver ischem time minut minut toler amount blood transfus reduc rang occurr infect intraabdomin bile collect patient preexist biliari tract infect suggest abdomin drainag perform patient vascular inflow occlus recommend liver resect"
"babi born arriv hospit object establish preval babi born arriv local hospit identifi women risk give birth arriv morbid mortal birth design case control studi babi born arriv mother compar born hospit random control match gestat birthweight mother set matern unit serv east birmingham solihul subject babi mother born arriv hospit januari decemb main outcom measuresperinat mortal rate pattern perinat morbid demograph social obstetr featur mother result consecut birth arriv hospit bba group perinat mortal rate bba group death compar inborn babi relat risk confid interv bba group birthweight ci random control group gestat day day ci day random control group hypothermia commonest morbid women deliv arriv tend multigravid citi asian live long hospit unmarri unbook younger white european conclus high perinat mortal relat immatur low birthweight birth arriv group mother risk deliveri arriv identifi inform establish addit antenat care benefici women babi"
"role phenytoin heal larg abscess caviti promot heal larg abscess caviti attain topic phenytoin evalu control studi clinic experiment wound clinic abscess caviti phenytoin applic patient compar convent treatment patient result earlier separ slough decreas oedema control pain enhanc heal rate reduct wound area cmday phenytoin group versus cmday control day cmday versus cmday day volum reduct rate day cmday phenytoin versus cmday control day patient treat phenytoin rate heal complet compar control standard guineapig model clinic abscess caviti includ inocul wound bacillus proteus klebsiella pneumonia enhanc heal rate observ day cmday phenytoin versus cmday control anim treat phenytoin heal day compar control biopsi wound treat phenytoin show inflamm necrosi enhanc neovascular collagen deposit fibroblast prolifer compar control bacteri coloni decreas rapid phenytoin"
"effect fibrin sealant heal colon anastomosi rat fibrin adhes advoc protect seal colon anastomosi prevent leakag order assess effect fibrin glue seal compar heal sutur colon anastomosi rat group addit humanderiv fibrin sealant group control reaction foreign protein group sutur anastomosi seal special prepar rat fibrin adhes day ten anim group kill adhes format score situ burst pressur measur collagen concentr degrad estim measur hydroxyprolin adhes format signific increas group compar control group day burst pressur group day burst pressur group signific lower group find correspond result collagen measur day concentr hydroxyprolin signific reduc group histolog examin show infiltr neutrophil granulocyt sealant day day sealant vanish result conclud fibrin seal colon anastomosi rat improv heal demonstr burst pressur hydroxyprolin concentr contrari negat influenc"
"mechan spastic muscl hypertonus variat reflex gain time spastic electromyograph emg respons initi passiv bicep brachii muscl impos extens appli elbow studi hemiparet normal subject relax normal subject bicep muscl found respond displac veloc deg singl earli burst activ bicep emg contrast hemiparet subject addit earli emg activ show late activ persist stretch veloc low deg late activ stretch reflex present fulli plegic arm spastic subject tone bicep clinic assess rais observ subject normal muscl tone level emg respons high correl displac veloc durat durat appli displac suggest reflex emg activ major factor genesi spastic hypertonus arm aris reduct threshold stretch reflex muscl patholog increas stretch reflex gain shown activ high level month onset spastic reflex gain signific reduc spastic establish year conclud passiv mechan properti play role spastic establish year major spastic muscl hypertonus patholog increas stretch reflex activ"
"alter left ventricular diastol twist mechan acut human cardiac allograft reject background contract obliqu orient left ventricular lv fiber result twist motion left ventricl purpos studi assess effect acut human cardiac allograft reject lv twist pattern twistvolum relat method result tantalum marker implant lv midwal transplant recipi measur timevari dimension chamber twist computerassist analysi biplan cinefluoroscop imag twist defin longitudin gradient circumferenti rotat lv long axi plot normal percent eject fraction ef result twistnorm ef relat divid phase systol lv twist linear relat eject blood contrast diastol untwist character earli rapid recoil chang lv volum gradual untwist bulk diastol fill occur acut reject episod patient maximum twist peak systol twist rate slope systol twistnorm ef relat chang contrast slope earli fill diastol twistnorm ef relat earlydia decreas signific prereject versus radcm reject result prolong tau time requir untwist versus diastol decreas percent untwist diastol lv fill versus greater proport lv untwist occur diastol reject reflect increas slope middia middl late fill diastol twistnorm ef relat versus radcm peak rate untwist affect resolut reject earlydia percent untwist earli diastol return baselin level ns versus baselin trend middia return prereject valu ns versus baselin chang reach statist signific compar reject valu conclus acut cardiac allograft reject alter diastol twist mechan absenc demonstrat systol abnorm reject myocardi edema factor result intrins elast properti myocardium lead modif recoil forc respons earli rapid unwind deform ventricl"
"smallvolum resuscit hemorrhag shock dog effect system hemodynam system blood flow background method studi compar canin system hemodynam organ blood flow radioact microspher techniqu resuscit salin na meq hyperton salin na meq hydroxyethyl starch salin hydroxyethyl starch salin volum approxim shed blood volum twenti endotrach intub mongrel dog kg underw min period hemorrhag shock time min shock period fluid resuscit data collect baselin min shock period immedi fluid infus min begin resuscit min interv hr min begin resuscit min begin resuscit anim receiv random assign iv resuscit fluid salin mlkg hyperton salin mlkg hydroxyethel starch mlkg hyperton salinehydroxyethyl starch mlkg result arteri pressur increas group resuscit cardiac output increas resuscit group exceed baselin salin hyperton salinehydroxyethyl starch group compar hyperton salin hydroxyethyl starch sixti minut begin resuscit cardiac output signific greater colloid group hyperton salin group resuscit hyperton salin hydroxyethyl starch produc minim improv hepat arteri flow hyperton salinehydroxyethyl starch increas hepat arteri flow baselin level salin mark increas hepat arteri flow level exceed baselin salin hydroxyethyl starch hundr twenti minut begin resuscit hepat arteri flow decreas group hepat arteri flow hyperton salin group decreas level compar shock myocardi renal brain blood flow signific group conclus smallvolum resuscit combin hyperton salinehydroxyethyl starch compar larger volum salin equal hyperton salin hydroxyethyl starch abil restor sustain bp improv organ blood flow resuscit hemorrhag shock"
"corticotropinreleas factor modul immun respons stress rat examin role crf key mediat endocrin respons stress modul immunosuppress subacut stress intermitt electr shock administr shock intact rat result decrement lymphocyt prolifer decreas natur killer cytotox similar suppress paramet immun function respons shock note adrenalectom rat immunosuppress effect shock signific compar blunt intact adrenalectom anim pretreat iv high potent polyclon crf antibodi specif crf antagonist intracerebroventricular high affin monoclon antibodi crf specif crf antagonist immunomodulatori role crf support find administr exogen crf iv microgramsanim intracerebroventricular microgramanim result signific decrement lymphocyt prolifer natur killer cytotox similar stress paradigm observ crf play signific role modul immun respons subacut stress larg adrenalindepend mechan"
"pituitaryadrenocort system neonat rat respons stress develop timedepend stressorspecif fashion respons neonat hypothalamuspituitaryadren hpa axi stress thought impair diminish week life previous found full respons hypothalamuspituitari unit adrenalectomi young rat day fail measur signific increas acth min ether administr age studi design test function activ hpa axi singl repeat exposur stress qualit time stressorspecif circadian quantit acth corticosteron respons stressor test day life exposur min ether vapor increas acth secret rat increas amplitud acth respons function age peak secret acth occur min onset stress pgml time maxim increas function age stressor matern separ cold min histamin inject mgkg bw ip provok signific stressorspecif acth respons rat histamin administr increas acth secret vehicleinject rat peak secret min drug inject pgml histamineinduc secret peak min microgramsdl contrast earli respons observ ether separ histamin stress cold stress pup caus larg acth releas onset cold compar matern depriv pup acth cold pgml separ cold microgramsdl separ detect morningeven pm differ pattern magnitud acth respons matern separ cold stress suppress coldinduc acth releas inject mgkg bw stress observ stress pm cold effect pm prevent rise acth level observ abstract truncat word"
"manag geriatr arrhythmia general cardiac arrhythmia increas common peopl age clinic signific sinus node dysfunct av conduct disturb ventricular supraventricular arrhythmia found symptomat treatment asymptomat arrhythmia controversi symptomat elder therapi elder found benefit younger patient specif guidelin appli age group base suscept side effect"
"risk factor emphysema cigarett smoke reduct associ rate constant lung alpha antitrypsin neutrophil elastas increas risk develop emphysema individu smoke cigarett normal level alpha antitrypsin alpha hypothes result decreas antineutrophil elastas capac lower respiratori tract alpha smoker compar nonsmok evalu hypothesi compar timedepend kinet inhibit neutrophil elastas lung alpha healthi young cigarett smoker nonsmok alpha antitrypsin purifi lavag fluid affin molecular siev chromatographi associ rate constant assoc neutrophil elastas quantifi assoc smoker plasma alpha similar nonsmok plasma greater mark contrast assoc smoker lower respiratori tract alpha signific lower nonsmok alpha  smoker lower respiratori tract alpha assoc signific autolog plasma consid context concentr alpha lower respiratori tract epitheli line fluid inhibit time neutrophil elastas smoker lung alpha twofold greater nonsmok lung alpha smoker nonsmok concentr alpha lower respiratori tract long equival amount neutrophil elastas inhibit smoker lung compar nonsmok lung observ support concept cigarett smoke decreas lower respiratori tract neutrophil elastas inhibitori capac increas vulner lung elastolyt destruct increas risk develop emphysema"
"hypoxia induc specif set stress protein cultur endotheli cell vascular endotheli cell ec initi cell vascular wall expos decreas blood ambient oxygen concentr mechan toler low level oxygen unknown parallel respons cellular stress heat shock hypoxia found decreas total protein synthesi cultur bovin aortic pulmonari arteri ec sdspage autoradiograph analysi smethioninelabel protein demonstr concomit induct specif set protein mr kd cell type hypoxia protein hap cell regul time oxygen concentrationdepend manner comparison protein heat shock protein hsps demonstr hap distinct hsps ec maintain chronic continu synthes elev level hap regul protein expos presenc time normal media glucos concentr alter hap hypoxia sensit renal tubular epitheli cell regul protein hap irrevers damag exposur vitro translat experi demonstr steadyst level mrnas higher anox ec normox ec encod protein mr kd protein encod hsp mrnas induct hap acut hypoxia continu synthesi chronic hypoxia suggest hap import mainten endotheli cell integr condit decreas ambient oxygen"
"acut biolog respons excim versus thermal laser angioplasti experiment atherosclerosi vascular injuri platelet accumul balloon angioplasti potenti import trigger process restenosi minim laser energi ablat atherosclerot plaqu type laser suitabl achiev goal remain unknown angiograph histolog studi quantit platelet deposit analysi perform atherosclerot rabbit iliac arteri random treatment excim laser thermal laser angioplasti excim laser angioplasti achiev mjmm nm xenon chlorid irradi deliv cathet made concentr arrang micron fiber optic repetit rate hz puls durat ns thermal laser angioplasti achiev mm metal probe heat continu wave argon laser energi baselin postlas lumin diamet excim lasertr vessel mm similar observ thermal lasertr vessel mm perfor occur thermal lasertr arteri excim lasertr arteri spasm observ thermal lasertr vessel basi quantit histolog grade scheme damag score greater degre injuri measur thermal versus excim lasertr vessel versus"
"differenti impair semant episod memori alzheim huntington diseas control prospect studi control prospect studi compar perform patient dementia alzheim type dat patient huntington diseas hd match level dementia batteri semant episod memori test dat patient signific impair measur delay verbal figur episod memori addit show rapid rate declin test depend integr semant knowledg number inform similar categori fluenci contrast hd patient signific wors show rapid declin letter fluenci test task sensit defici retriev hd patient impair dat patient vocabulari test copi geometr figur observ doubl dissoci offer compel evid aetiolog distinct form dement ill result pattern cognit impair"
"skin reflect puls oximetri vivo measur forearm calf studi describ result seri human experi demonstr abil measur arteri hemoglobin oxygen satur sao forearm calf reflect puls oximet sensor special optic reflect sensor includ heat element interfac temperatur control commerci datascop accusat puls oximet adapt studi perform reflect puls oximet reflect puls oximet sensor evalu group healthi adult volunt steadyst hypoxia hypoxia induc gradual lower inspir fraction oxygen breath gas mixtur simultan sao measur obtain forearm calf ident reflect puls oximet compar sao valu measur finger sensor interfac standard datascop accusat transmitt puls oximet equat fit linear regress line percent reflect spo transmitt spo valu rang spo spo forearm spo spo calf regress analysi forearm data reveal sd error sao sao sao regress analysi calf data reveal sd error sao sao sao"
"patientcontrol analgesia children adolesc random prospect comparison intramuscular administr morphin postop analgesia random prospect trial patientcontrol analgesia pca method analgesia administr involv computerdriven pump activ patient receiv small dose defin limit perform children adolesc major orthoped surgeri compar intramuscular administ morphin pca morphin pca morphin lowdos continu morphin infus pca patient receiv pca pca lower pain score greater satisfact patient receiv intramuscular administ morphin group equal amount morphin measur recoveri ident group pca pca increas incid opioidrel complic patient receiv pca sedat patient receiv intramuscular therapi conclud pca pca safe effect method pain relief children adolesc orthoped surgeri accept intramuscular inject increas periop morbid"
"cell deriv oment fat tissu seed vascular prosthes endotheli origin studi origin epitheloid cell deriv omentum microvascular endotheli cell deriv oment tissu advoc seed vascular graft autolog endotheli cell high densiti purpos studi evalu precis origin cell compar cellular characterist cell endotheli cell isol collagenas treatment human umbil vein oment cell isol oment tissu patient incub collagenasedispas solut part materi process percol densiti gradient centrifug attempt purifi isol cellular characterist type cell determin studi morpholog featur cell determin presenc von willebrand factor antigen en pal specif endotheli cell cytokeratin vimentin desmin uptak diiacetyl lowdens lipoprotein epitheloid cell oment tissu isol collagenas treatment purifi nonpurifi percol densiti gradient centrifug differ human umbil vein endotheli cell respect presenc surfac microvilli express von willebrand factor en pal presenc cytokeratin desmin von willebrand factor granular stain pattern presenc en pal detect human umbil vein endotheli cell vimentin present cell type cytokeratin desmin present cell deriv omentum data conclud call microvascular endotheli cell omentum endotheli mesotheli natur"
"subclavian arteri innomin vein fistula insert hemodialysi cathet insert hemodialysi cathet temporari preferenti perform percutan infraclavicular subclavian vein catheter method involv passag stiff dilat peel sheath guid wire carri fluoroscopi part prove valuabl safe approach small incid major complic occur emphas sixteen case arterioven fistula subclavian arteri branch subclavian vein report literatur date case subclavian arteri innomin vein fistula report report case complic suggest prevent measur"
"diagnosi poplit arteri entrap syndrom role duplex scan author present diagnost procedur quick noninvas diagnos poplit arteri entrap syndrom larg person experi surgic treatment diseas case patient focus optim diagnost procedur detect problem earli stage techniqu base continuouswav doppler duplex scan studi rest state activ contract calf muscl compress poplit arteri occur contract calf muscl detect decreas flow find direct radiologist obtain film maneuv repeat make diagnosi miss juli total patient evalu continuouswav doppler suspect chronic ischemia group patient select studi combin continuouswav doppler duplex scan method poplit arteri entrap syndrom case discov verifi dynam angiographi guid continuouswav doppler treat surgic"
"follow status patient angiograph normal coronari arteri panic disord cardiolog patient normal coronari angiographi demonstr continu substanti social health work disabl hypothes diagnosi panic disord mark continu disabl interview patient time normal angiogram averag month panic disord demonstr signific disabl follow studi patient conclud patient normal angiogram panic disord disabl panic disord panic disord psychiatr sampl shown high treatabl earli identif treatment panic disord group minim suffer condit"
"effect musclespar versus standard posterolater thoracotomi pulmonari function muscl strength postop pain increas interest altern approach thoracotomi develop morbid standard posterolater techniqu conduct prospect random blind studi consecut patient compar postop pain pulmonari function shoulder strength rang shoulder motion standard posterolater muscl spare thoracotomi techniqu pulmonari function forc expiratori volum forc vital capac shoulder strength rang motion measur preoper week month postop pain quantit postop narcot requir visual analogu scale mcgill pain questionnair morbid mortal hospit stay compar standard posterolater musclespar techniqu differ postop pulmonari function shoulder rang motion extent lung resect surgic approach time mortal hospit stay signific postop pain musclespar group narcot requir hour visual analogu scale score signific lower postop week shoulder girdl strength decreas week standard incis group strength preserv musclespar approach muscl strength return preoper level month group morbid ident group postop seroma preval seroma musclespar group standard incis group demonstr musclespar incis reason altern standard posterolater approach"
"hospit manag voluntari total fast polit prison polit detaine held trial month admit hunger strike johannesburg hospit south africa held regul state emerg revok held incommunicado section intern secur act forc guidelin ethic manag base declar tokyo includ understand detent constitut mental tortur condit detent hospit complic polic interfer medic nurs care chain prison bed doctor uniqu posit protest inhuman treatment prison author"
"cerebrospin fluid fistula endoscop sinus surgeri case cerebrospin fluid fistula occur result endoscop sinus surgeri total ethmoidectomi discuss case refer consult cerebrospin fluid fistula intrasphenoid posterior ethmoidbas skull anterior ethmoid ethmoid cribriform fistula close endoscop sphenoid sinus cerebrospin fluid fistula close success fibrin glue gelfoam cerebrospin fluid fistula close success fascia muscl gelfoam cerebrospin fluid fistula treat conserv stop anatom technic aspect relat occurr cerebrospin fluid fistula discuss manag treatment cerebrospin fluid fistula occur endoscop sinus surgeri emphas identifi intraop delay cerebrospin fluid fistula manag success endoscop techniqu"
"synchron posit negat myoclonus due pontin hemorrhag report case synchron posit negat myoclonus pontin hemorrhag constant synchron jerk eye tongu face mandibl larynx pharynx diaphragm persist sleep jerk limb muscl occur volit activ rest inabl sustain glottic adduct phonat contribut sever dysarthria electromyographi emg reveal posit myoclonus branchial musculatur synchron negat myoclonus general distribut treatment trazodon reduc ocular myoclonus worsen dysphagia suggest singl neural rhythm generat produc posit negat myoclonus"
"mec gene member famili caenorhabd elegan gene mutat induc neuron degener domin mutat mec gene mechanosens touchreceptor neuron caenorhabd elegan degener deg elegan gene mutat induc neuron degener similar sequenc mec defin gene famili crosshybrid sequenc detect speci rais possibl degen condit organ caus mutat similar gene domin mec mutat affect amino acid effect aminoacid substitut posit suggest steric hindranc induc degen state"
"protein synthesi requir anchor mutant protein temperaturesensit nuclear transport protein render temperaturesensit point mutat rat cell transform mutant activ ras oncogen grow degre ceas dna synthesi cell divis shift degre immunostain demonstr mutant protein nucleus arrest cell degre cytoplasm grow cell degre protein temperaturesensit nuclear transport transloc cytoplasm nucleus vice versa occur temperatur shift coincid inhibit dna synthesi transport cytoplasm nucleus requir protein synthesi remark inhibit protein synthesi degre result rapid mutant cell nucleus result suggest presenc shortliv protein respons hold cytoplasm degre degre analysi temperaturesensit mutant protein show cytoplasm locat sensit protein synthesi inhibitor temperatur"
"hypoxanthin level vitreous humor evid hypoxia infant die sudden infant death syndrom postmortem hypoxanthin vitreous humor human investig hypoxanthin form hypox degrad adenosin monophosph repeat sampl perform deceas adult bodi degre increas hypoxanthin level estim mumol hour sampl start hour death rang mumol hour result hypoxanthin measur vitreous humor infant sudden infant death syndrom infant children die sudden violent death neonat die sudden hypoxemia prior death correct expect postmortem hypoxanthin increas time death autopsi similar group studi correct median hypoxanthin level group sudden infant death syndrom mumol signific higher group mumol group violent death mumol neonat group find confirm sudden infant death preced long period tissu hypoxia case"
"esophag gastric endoscopi critic ill patient bleed upper gastrointestin tract critic ill patient tough diagnost situat endoscopi physician determin bleed provid therapeut option author discuss applic current technolog"
"emerg resuscit children role intraoss infus intraoss infus temporari procedur pediatr emerg intraven access difficult multipl drug fluid safe administ intraoss rout dosag rate infus essenti intraven infus"
"patient anorexia bulimia understand step anorexia nervosa bulimia nervosa recent year disord major concern young women prone eat disord substanti number involv practic identifi problem understand disord recogn develop treatment approach effect medic bulimia report date fluoxetin hydrochlorid prozac concurr particip physician nutritionist famili therapist care patient ideal"
"interact rel protein nfkappa dna bind site avian reticuloendotheliosi virus genom oncogen rel express gene respons induct lymphoid tumor bird recent rel gene shown relat dna bind subunit transcript factor complex nfkappa bind site nfkappa complex found enhanc region number gene includ immunoglobulin kappa gene human immunodefici virus long termin repeat communic identifi activ avian reticuloendotheliosi virus transform avian lymphoid cell bind electrophoreticmobilityshift assay nfkappa bind site kappa enhanc activ protein immunolog relat rel detect polyclon monoclon antibodi direct rel dna affin precipit assay nfkappa site human immunodefici virus long termin repeat rel protein identifi data suggest oncogen transform rel result alter pattern gene express"
"nerv growth factor correct development impair basal forebrain cholinerg neuron trisomi mous trisomi ts mous share genet phenotyp homolog syndrom exhibit impair develop basal forebrain cholinerg system basal forebrain obtain ts euploid litterm fetus day gestat dissoci cultur complet defin medium cholinerg neuron identifi cholin acetyltransferas chat immunoreact ts cultur exhibit fewer chatimmunoreact neuron smaller emit shorter smoother simplifi neurit euploid litterm addit betanerv growth factor ngml augment specif activ chat neurit extens ts euploid cholinerg neuron ts cultur exhibit increas number size chatimmunoreact neuron ts chatimmunoreact neurit form varicos presenc betanerv growth factor"
"stage transit lymphocyt differenti correl limit variat nuclear protein total nuclear protein extract cell line repres stage differenti mous lymphocyt studi comput analysi dimension gel spot present gel vari signific intens differenti variat occur step correl classic defin cell differenti seventeen spot detect stage qualit variat repres switch gene code nuclear protein detail analysi variabl spot show fall small set character similar express profil argu combinatori multistep control mechan gene express addit analysi express nuclear protein resolv gel differenti lineag cell myeloid cell suggest import transit cell differenti occur rest cell plasmocyt stage"
"expression potenc mrnas encod receptor voltageactiv channel postmortem rat brain stabil integr mrnas encod neurotransmitt receptor voltageactiv channel postmortem rat brain investig isol poli mrna inject xenopus oocyt examin express function neurotransmitt receptor voltageactiv channel oocyt membran electrophysiolog record approach assess stabil mrnas brain incub oxygen mammalian ringer solut length time brain fresh frozen thaw room temperatur oocyt inject mrna hr postmortem brain gave larg agonist voltageactiv respons indic mrnas encod neurotransmitt receptor voltageactiv channel stabl postmortem brain tissu contrast oocyt inject mrna brain incub ringer solut exhibit smaller respons oocyt inject mrna tissu frozen thaw display small undetect respons northern blot analysi nucleic acid probe rat brain nachannel mrna size na current inject oocyt reflect level mrna na channel mrna prepar expression potenc mrnas encod neurotransmitt receptor voltageactiv channel stabl postmortem brain situ reduc brain oxygen salin freez thaw tissu result rapid degener mrna"
"longchain sphingoid base inhibit multistag carcinogenesi mous cht cell treat radiat phorbol myrist acet sphingosin longchain sphingoid base inhibit protein kinas putat cellular receptor tumor promot phorbol myrist acet pma exert potent effect divers cell function test abil longchain base modul multistag carcinogenesi mous cht cell expos gammaray pma sphingosin sphinganin complet block enhanc radiationinduc transform pma promot partial suppress transform radiat acetylsphingosin ceramid analog inhibit transform sphingosin rapid cell metabol longchain base ad daili achiev prolong inhibit longchain base inhibit protein kinas activ cht cell suppress regul enzym pma result establish longchain base high effect inhibitor carcinogenesi model result suppress effect mediat part inhibit protein kinas data suggest sphingosin longchain base deriv complex sphingolipid act cancerprev agent"
"openheart surgeri jehovah wit year period adult member religi sect jehovah wit underw cardiac surgeri extracorpor circul homolog blood transfus bloodconserv procedur employ initi collect autolog blood haemofiltr process cell saver blood collect extracorpor circul reinfus shed mediastin blood total periop blood loss averag ml mlkg bodi weight equal total bodi blood volum haemoglobin discharg hospit ml periop mortal postop pulmonari function good morbid jehovah wit surgerynecessit heart diseas offer oper compris recogn bloodconserv procedur"
"effect dipyridamol persantin blood flow patenc aortocoronari vein bypass graft effect dipyridamol investig patient undergo coronari bypass surgeri random alloc receiv dipyridamol mg oral day preoper mgkg bodi weight perop mg oral year postop placebo withdrawn studi patient dipyridamol placebo cardiovascular cerebrovascular event anticoagul treatment reason withdraw dipyridamol placebo group logist regress analysi risk factor influenc graft patenc show signific relat perop measur coronari blood flow posit trend treatment observ vein graft blood flow measur bypass surgeri patient signific greater dipyridamol group occlus rate lower vessel perop blood flow greater mlmin veinmargin veindext veindiagon dipyridamol increas coronari blood flow graft patenc coronari bypass surgeri"
"factiti cyclic hypersomnia variant factiti disord central goal patient factiti disord receiv medic care unnecessari diagnost procedur recurr hospit ensu year man variat disord factiti cyclic hypersomnia simul recurr episod excess sleep case highlight observ patient ill simul divers symptom syndrom immun factiti imit attempt treatment exceed challeng conting recognit"
"routin preoper laboratori test predict postop complic multivari analysi purpos studi evalu abil preoper laboratori test predict postop complic hundr twenti patient undergo elect surgeri american societi anesthesiologist classif ponder index electrolyt valu glucos level blood urea nitrogencreatinin valu complet blood count coagul studi total proteinalbuminlymphocyt count electrocardiogram chest radiograph urinalysi pulmonari function test type anesthesia type oper record preoper patient prospect surgeri develop complic data analyz univari multivari method postop complic strong american societi anesthesiologist classif type anesthesia type oper laboratori test electrocardiogram chest radiograph nutrit status postop complic general preoper laboratori test undertaken specif indic recommend routin test made depend age patient"
"bacteriolog qualiti intraop autotransfus controversi remain bacteriolog aspect intraop blood salvag widespread techniqu prospect studi intraop salvag blood cultur patient direct plate techniqu bacteri growth detect case result compar obtain control studi steril water blood bank unit cultur condit microorgan coagulaseneg staphylococci skin environment contamin quantit estim contamin show low count colonyform unit cfuml posit cultur yield cfuml cfuml patient minimum month detect septic complic statist signific correl found bacteriolog result autotransfus blood infecti complic studi suggest bacteriolog monitor patient undergon autotransfus detect surgic field contamin confirm intraop autotransfus add septic risk cardiac surgeri"
"predispos factor bladder calculi review case hundr patient age twenti nineti year underw procedur remov bladder calculi patient type bladder outlet obstruct type stone identifi appar form upper tract trap bladder case form bladder presenc type outlet obstruct stone analysi reveal uric acid stone percent calcium oxal stone percent stone mix composit percent patient metabol abnorm predispos stone format case abnorm discov evalu stone diseas treatment depend stone characterist patholog general health patient review literatur regard morbid mortal combin treatment vesic calculi bladder outlet obstruct secondari prostat obstruct includ"
"applic microwav tissu coagul partial nephrectomi microwav tissu coagul partial nephrectomi mongrel dog clamp renal arteri major complic retroperiton hematoma abscess format macroscop infarct kidney tissu relat procedur advantag microwav coagul reduc blood loss shorter oper time minim risk vascular injuri"
"effect nisoldipin hemodynam respons defibril sequenc ventricular fibrillationdefibril transient hypertens hypothes adrenerg overshoot blunt function antiadrenerg effect calcium channel block drug nisoldipin potenti benefici reduct myocardi oxygen requir calcium channel block drug shown reduc shock success defibril deleteri effect purpos studi assess effect nisoldipin hemodynam respons sequenc ventricular fibrillationdefibril effect energi requir defibril dog administ intraven nisoldipin microgramkg bolus infus microgramkgmin lower blood pressur baselin ventricular fibril induc electr shock vari energi level joul administ determin defibril energi requir heart rate blood pressur record minut shock determin hemodynam respons measur made nisoldipin administr level druginduc blood pressur declin found usual systol blood pressur overshoot defibril typic maximum shock signific blunt nisoldipin administr heart rate slow defibril cholinerg respons affect nisoldipin alter shock success rate vari se joul joul nisoldipin blunt adrenerg overshoot systol blood pressur defibril potenti benefici effect alter energi requir transthorac defibril"
"isoton highsodium oral rehydr solut increas sodium absorpt patient shortbowel syndrom compar effect standard oral rehydr solut highsodium polymericglucos solut sodium absorpt shortbowel syndrom patient high jejunostomi test random order standard solut solut maltodextrin glucidex enrich nacl solut administ nasogastr tube rate mlmin jejun effluent collect period net fluid absorpt signific period glucos absorpt greater administ amount solut net sodium absorpt greater maltodextrin solut standard solut mmol conclud replac glucos maltodextrin addit sodium standard oral rehydr solut result improv sodium absorpt shortbowel syndrom"
"hairless micropig skin model studi cutan biolog report structur immunohistochem similar yucatan hairless micropig hmp skin human hairless micropig skin surfac compos complex intersect furrow creat geometr pattern remark similar human skin surfac glyphic dermalepiderm interfac consist undul downgrowth interdigit dermal papilla hairless micropig epidermi morpholog distinct popul basal keratinocyt serrat nonserr similar heterogen human epidermi primat palmar epidermi immunohistochemistri reveal hmp epidermi reactiv monoclon polyclon antisera keratin protein melanocyt reactiv antisera protein human skin observ hmp epidermi organ dermal extracellular matrix includ collagen elast fiber organ reactiv microvasculatur antisera factor viii consist human skin costicosteroidinduc atrophi subsequ rebound phenomenon withdraw steroid observ hmp skin similar observ human conclud hmp skin approxim human skin signific precis exist speci excel model studi cutan physiolog pharmacolog"
"induct inflammatori cell infiltr necrosi normal mous skin combin treatment tumor necrosi factor lithium chlorid previous report lithium chlorid licl potenti tumor necrosi factor tnfmediat cytotox vitro vivo murin normal skin model shown subcutan inject tnf licl induc acut dermal subcutan inflamm necrosi histolog show mark initi dermal subcutan neutrophil infiltr approxim hour predomin mononuclear infiltr hour remain present day tumor necrosi factor licl induc neglig inflamm disappear hour necrosi ulcer skin case singleag applic vitro studi show combin tnf licl agent direct cytotox fibroblast cell murin skin inflammatori infiltr visibl tumor treat intratumor perilesion tnf licl treatment result perilesion leukocyt infiltr combin tnf licl effect macrophag cytotox tumor"
"cultur human atherosclerot plaqu smooth muscl cell retain transform potenti display enhanc express myc protooncogen prolifer vascular smooth muscl cell smc critic atherosclerot plaqu format monoclon hypothesi propos stimulus smc prolifer mutat event describ procedur grow human plaqu smooth muscl cell smc cultur show smcs deriv patient differ smc cultur normal vascular tissu express protooncogen myc smc strain extens character diploid karyotyp normal cell finit life span cultur ultrastructur examin reveal popul classic contractil smc modul synthet state northern blot show fold fold enhanc express myc smc compar smc deriv healthi human aorta hasmc saphen vein hvsmc contrast smc hvsmc express similar level messag gene myc myc hara fos sis myb ldl receptor egf receptor igf receptor igf ii hmg coa reductas final smcs tumorigen dna isol cell posit transfectionnud mous tumor assay myc transform gene newli introduc human myc gene detect smc nude mous tumor human atherosclerot smcs possess activ myc gene transform gene retain cell passag"
"tradit versus laparoscop cholecystectomi laparoscop cholecystectomi minim invas procedur gallbladd remov laparoscop techniqu indic similar elect tradit cholecystectomi select patient import success contraind evolv patient advanc cholecyst abdomin sepsi ileus bleed disord pregnanc morbid obes undergo procedur procedur requir good tradit surgic skill addit laparoscop laser skill oper time slight longer tradit cholecystectomi decreas experi morbid low concern bile duct injuri mortal low compar tradit cholecystectomi major advantag laparoscop cholecystectomi short hospit stay averag day earli return normal activ day result reduct hospit cost adequ train credenti import process foster good patient outcom"
"european experi laparoscop cholecystectomi retrospect survey european center involv surgeon undertook laparoscop cholecystectomi perform procedur complet patient convers open cholecystectomi patient technic difficulti onset complic instrument failur death report total postop complic rate complic requir laparotomi total incid bile duct damag median hospit stay day rang day median time return full activ discharg day rang day"
"complic laparoscop cholecystectomi emerg laparoscop cholecystectomi viabl altern tradit cholecystectomi greet enthusiasm surgic communiti techniqu complic potenti real complic diagnost laparoscopi document tradit cholecystectomi laparoscop cholecystectomi incid occurr vari remain earli evalu complic rate procedur report larg seri begin emerg earli report encourag caution bile duct injuri hemorrhag death occur earli enthusiasm method temper care practic complic rate maintain accept level procedur earn perman place armamentarium surgeon"
"interrupt profession home activ laparoscop cholecystectomi french american patient laparoscop approach patient undergo cholecystectomi shorter hospit minim pain quicker recoveri demonstr patient return work laparoscop cholecystectomi faster tradit week absenc work standard open procedur survey french american patient undergo laparoscop cholecystectomi reveal postop discomfort complet resolv week french american patient french american patient back normal home activ week oper american french patient profession activ home return work day american patient french patient return work week oper amount physic activ job correl period work interest patient hard physic activ work includ construct worker return full work activ week data suggest earli return work pain resolv quick laparoscop cholecystectomi econom benefit patient back job quick expect cultur norm chang regard leav absenc major surgeri"
"enhanc mobil intracellular ca induc halothan hepatocyt isol swine suscept malign hyperthermia halothan dosedepend manner induc releas intracellular ca hepatocyt prepar swine magnitud releas induc halothan greater hepatocyt prepar anim suscept malign hyperthermia mh normal swine method ascertain releas ca induc halothan releas ca nonmitochondri store saponinpermeabil hepatocyt measur luminesc intact hepatocyt load casensit photoprotein aequorin record observ inositol trisphosph ip guanosinetriphosph arachidon acid induc signific releas ca permeabil swine hepatocyt quantiti ca releas ip signific greater hepatocyt prepar anim suscept mh data abnorm ca homeostasi hepatocyt isol swine suscept mh support hypothesi membran system multipl organ affect genet disord"
